<SEC-DOCUMENT>0001295947-22-000015.txt : 20220506
<SEC-HEADER>0001295947-22-000015.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220506162012
ACCESSION NUMBER:		0001295947-22-000015
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		134
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220506
DATE AS OF CHANGE:		20220506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prestige Consumer Healthcare Inc.
		CENTRAL INDEX KEY:			0001295947
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				201297589
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32433
		FILM NUMBER:		22901364

	BUSINESS ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591
		BUSINESS PHONE:		(914) 524-6800

	MAIL ADDRESS:	
		STREET 1:		660 WHITE PLAINS RD.
		CITY:			TARRYTOWN
		STATE:			NY
		ZIP:			10591

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Brands Holdings, Inc.
		DATE OF NAME CHANGE:	20040727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prestige Household Brands, Inc.
		DATE OF NAME CHANGE:	20040630
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>pbh-20220331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e,d:93b55e0f793c4f3ba5f606ea7711c37f--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:pbh="http://www.prestigebrandsinc.com/20220331" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pbh-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl8zLTEtMS0xLTE4OTY5_04295d65-2c2d-44b9-b493-08b9daa78f14">0001295947</ix:nonNumeric><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl81LTEtMS0xLTE4OTY5_7d3f80ba-c6f6-4309-868f-3b8914799ab3">2022</ix:nonNumeric><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl82LTEtMS0xLTE4OTY5_e7f52d62-2b28-4d4c-ae63-a8e6c047f7f4">FY</ix:nonNumeric><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl83LTEtMS0xLTE4OTY5_c8375154-86c1-4faa-a5bd-49779052af5d">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pbh-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7683433268a44f5ea2cd487803f35f28_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib4fe5d55882d42cba9c5a5c6c603bfa9_I20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i7d976548ec964eb5954900d40178b30f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7de1d5544ee45609a500258ca33677e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a00f6c3c9634209a4b9779c5515e978_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic98e8e0686d4426182259a392bf61706_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53deaff486304c7d94652052dc9167fa_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id433e0cb04fa4a559bfc9daff43da79c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iab3ff8d1f6794953b2718ae0cc777203_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0c43cd8d468472d94116a8e5f90b255_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied280415580b4c01b9d20134fe0942a6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82cf1b32e6744300b132ae0f6010879a_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8c44dcdbf354244af1c10b649888486_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5017c74f1406407b84f0e42bfc4e14b9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f04dcc6a386483c8e41444865c3338e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26e4d56df93243c68792ea4edcfb7c70_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7078a151136c4d6ca604de73f3a0f375_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i885a0fcf0beb4e3390d5033af15a8d3e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1558437735154cda9e3f0cd847af31a4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0563f46bd444eeb3340a8c043684ce_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00682c142e94501beff83d90b5f454e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30644c0d223c4d21aedacfe884a3e842_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b41f5abff7240c98ef304b465718181_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc55215d50342ce978c618ef06bf4d4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id898db802a534902a0a79a56b47eda29_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c94e91055aa44298481132638e69b2d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if58b3ac1efda48e494333a3e29f1a136_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed41fa55067490bae70eb2e695faf9d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b265cae0684a099432fb41e9650c63_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e37d99ba11a4709b212d9d7ca7583bd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id26512b5a56544dc91371cd7b2b3ac87_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72dfac16b5ac44ea83be7c443c0e2c13_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecdca0932c648d682c7125240a2a75d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbaca07b4355474988048d221f663307_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3178bc0f361448aca1bad203c38ba1d1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93685426db444f7bb2e2083559bad12c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">pbh:SydneyAustraliaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iaf52d5526c8542f5ba5ef401cb74e77f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie68302d173624012909bcb1af5423f95_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf17434e163e4883b63bc1d499d3bfcd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8afee60cac74f0bbb72d34f37171669_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472664bf20994bc58e71a154e858a6ed_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57c0f0620294543a556b227a34dfc06_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc44748f9f649259312b1379e06e3bf_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91d87e0f74c461e83248aab966de593_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>pbh:segment</xbrli:measure></xbrli:unit><xbrli:context id="if25f80c767b745ce88d01566c788c2ec_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628847fe21c845faa7ad04720f019f4b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9932c6e574f043a6b2eba1f46190d488_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied214f5ee4e64721bc76b33c5c12a69d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f4c56c383e4cadb7732fd1d3749213_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedfff890d1e84d249e980571ec6bbcf9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd914b5ed7ee4a2c8bba1ee5e7e2efe8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fb8878771394bb997fb34a8c9708c34_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc3645f563ff42219ffff940481757a4_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic475742a3fe44eb5ac7769813e20ce42_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63adfa16455749529a578a107f9b488f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e0c797835694c38b0ed72ecec2427b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6359612b8c648048fe362216a04a7f3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33cda2011cd9439296ec2aee3a52e2a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73a57ecc254455cae6f5b9d171bc153_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73e9364fde841a2a844b91fca700d71_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68eec35a89b640abb6b59a67cc2c458e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b8a0ad3b3d24ce481be054872bcc00e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i609a7e847bec4a5eb87c67671f78c7e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d91fe5ae4e4557a2fa616f58e373cc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04801f9b35a145479c2f926a02758888_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d090ede7de343c8a1442413f0a934af_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacff4498c9324023bb8e6dc3cbbd98d6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f29776a97564733a0caac2100d77ef5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5038f7608994e62940ad33470b50c1b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d5785a0756b4597a3f801623955484e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589118616c4549cca227abd6b606ab67_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c1d8c3521584fbe86801d6a297495f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19e3761c71cf440882e905e4bc852d25_D20210228-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-28</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f61b06bc453405295e67e755ad9dc7d_D20210228-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalAnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-28</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bb6c96119cc4504a07f59227add5e1a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia591d66195e84c68ad6bca8e400d493a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13817405df1449ac862beb623f788537_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bacb62d2b764d98ab587019221feb5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b518b4ab33c4fb7b07453e2656c888b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ba4d3341224392858a56fe1feccb8b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7c6d4c44a9497fbbbbe5882fa1a870_D20211215-20211215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pbh:ZaditenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b414dfd69f8433e8240e27a0edef648_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied44a8b51f55435492975e4a49f6cfb9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d08238dbfa4d19a42daf28b60de30d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b1d55aab74e4d9d9ebe57a0c1b36420_D20220228-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55324cd11967477cb55c9dbf85c8b0ba_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd308cfa7f4743acae74277795a0cbde_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335edd3216614cc694f48efa6d5a9a28_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589c5b16c5f2469aaba1478b0dd6dd6d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe2ba61b566469dbb5a593ca0b80d99_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09fd1299e2a3429cbcae381ab51a8154_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bcfb0f753744a1ab751cb65c0dc7aea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb76c60a4e494bd39785dbbddef2aee3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7902118aff74b92a991aec7dec64d48_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0046cff099774243b2fe9bcef53f28b4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f62c80458240b1a4ab90648a7ad1aa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e7166028fc3449da1b745c1053364a9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cfd3cfbed7740a9a4326dec51b02b1f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67542c5b47c4477989e0e9f42edffbf8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16a8c37cbf24b36ae290009040fbdb3_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13e53b28c8d5419cba8e60d19ff30867_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c7d3689acf4430baf1e0a96d60aabd_I20120131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:TermLoan2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:TermLoan2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-31</xbrli:startDate><xbrli:endDate>2012-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c172aec253140b2b6067b78d9e369bc_I20120131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-31</xbrli:startDate><xbrli:endDate>2012-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba56d9afb135474e8bfe4cffa9c2e86f_D20130221-20130221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-02-21</xbrli:startDate><xbrli:endDate>2013-02-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee6d3227d18744bdbefdbd1cecdc8ae8_I20130221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18f08dc2f7ca4e3ba24144835eb55cb2_I20130221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-02-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2b839503ec42fc8fe2a49df981bff1_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0558c1bb126d4298b73cefd18fa9c46f_D20140903-20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-09-03</xbrli:startDate><xbrli:endDate>2014-09-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42ad38caa804913950ccf7ea487d0bb_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319c15fd01bd47548445643d00863bf3_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef2f1d69f724bb493a3a655ac79be25_D20140903-20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-09-03</xbrli:startDate><xbrli:endDate>2014-09-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4727399a7346ea91615137b5e4dc2f_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cbc0bb0d6054954997646711fb51951_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f95eb55c54445286593337ec154069_D20140903-20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-09-03</xbrli:startDate><xbrli:endDate>2014-09-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c9d6e5813094b2c81201639ca24cd5c_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2012ABLRevolverAmendment3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b0e800bd3d649b68c6b357ca77f8220_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pbh:FederalFundsRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic759cbf7a7b842cb9529c38f67458e9b_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd6d3dec26f448899c5ad59eb21db2f_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e52034a43564d1586e14c7c32da2efd_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55b044eff678498fbe6c714272119acf_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4df9522b555a408989b96f6b0910ddd7_I20140903"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-09-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2bcbe34278c447fb245a931855163bc_I20150508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac25b9d7e324eea8f7f44cb83be491e_I20150508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786615716fbf49968cb2764459adaf9e_I20150508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49b28f7f8b24a8e9f452cf83fddd6d0_D20150609-20150609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-06-09</xbrli:startDate><xbrli:endDate>2015-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1611c74aa45e494f956f74b6f8d18d37_D20150609-20150609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:ABLRevolverAmendment4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-06-09</xbrli:startDate><xbrli:endDate>2015-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb5f29165d140ce8590ce4f580057ba_D20160204-20160204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:ABLAmendmentNumber5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-04</xbrli:startDate><xbrli:endDate>2016-02-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aa9ed85523f4bffa275deb4f8aac069_I20170126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ccccc1f26f341a68d9ca89cfab4434c_I20170126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2012ABLRevolverAmendment6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122c1f4cf7fe4f93a9cccfdf65056fa3_D20180321-20180321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-21</xbrli:startDate><xbrli:endDate>2018-03-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de06c1d14cf41cb863a5a08b674bea3_I20180321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde342a964df4c25b081ffb70c172b7a_D20180321-20180321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-21</xbrli:startDate><xbrli:endDate>2018-03-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0224233392114adf91fe01fed058dea0_I20180321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70fb5e5a361b41159fce56b86161af71_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a04c87c425240ca949ab30cc154c591_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be594bcf6624e02a2fa508bbcec16c8_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i329303f1b639409c82598b0f32e87c4e_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e71bab1d60d488aa52d8528a9dd9265_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88dbcd32abb43569e49cbca38a7b8e8_D20191211-20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-11</xbrli:startDate><xbrli:endDate>2019-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf0b48ee76264f7a92f392720f3b43d6_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6d0ebd6d014edc800dfa6316c8c320_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc75511f253c4893ab0567e3b34323e1_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e22f021780647258b15b6e00a871903_D20210701-20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia969b1c646c440768cf974287fc7426e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i415c7e0679e349e58f0e0f20395cc300_I20210701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4baae0737d004ba09ced690b2fcdc5b1_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39e0fc9224654a75a98d2b9ed9edc137_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fefd0d85f3643e9802fd44c8698e2bb_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7127b05ed9074792951125aaeef43725_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-02-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d5fa51d2444398b1d51583678eaf8b_I20180321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eb1f46f0bf54dc5a706fbd97b3158e1_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5421f769ee30441db0b2ce75192fb6f4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05cfda891a7744f5b7d546839fc9debe_I20191202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f3231c50694b299fb23343bca2e463_D20191202-20191202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-02</xbrli:startDate><xbrli:endDate>2019-12-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f3a14330e24f06a067b44676509588_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5055f03438d40a28763e3b37020019b_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5924d593cc74de19659e3600415162d_D20160219-20160219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndirectGuaranteeOfIndebtednessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-19</xbrli:startDate><xbrli:endDate>2016-02-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id053d9ccecdc4922a30a236b55ee8a89_D20160219-20160219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndirectGuaranteeOfIndebtednessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-02-19</xbrli:startDate><xbrli:endDate>2016-02-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea11cc7d2fda42e280337193b1699cff_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc097b28fbd4380a0360d7a9dfa4ddb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia447a00c02b64ada88fb01a499a27242_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5a200e2c9f497380a032d410c1bf18_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a985936f76451ab3fba68c9cfbb22a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf2802073574efd967d051aa138686d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e28d594c87497abef8cb2c70f091a9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812c0fab06ed49c4a178a37547c973b2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12ce07c5f2394037b12bb08cd70c30b6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999987ebde3747f6b643feea79f7c7ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37214d0e0e284a65a18a75b349e2c4a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f58c0d3bfd4d80880075fbd365ccff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b6829a1a1044fe8860313bc836df84_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4af8d5e816894fc2b3902012dc67bcab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie316289b2f544ed59d0d0c3677efd55a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875d8339508c48e8978c56e91c5f446d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad6deab13ed5410ca24419a0d749762c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d45f458359341cb9aed375cbf7b034c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5d83887fa7a4b3c9a18182a81d1150b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5131113e97495bb1af3c5ddaaf3fed_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d1883fd10de4c37988d741ed8d438e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b76519112f34e67a8eec0a25b6d11bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9090b056ebb41eba6e4947e52c3b6ca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia009767826ab453aa6bb77d03d05a92b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib347d67febad441b8e0c8e676e6f04af_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b30d6662357490791b05cb990415ede_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if895d74cebc04b28ab194e74118c2951_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6fb85e27ce8425b9221751a38ecb76d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63aa3373adc547ef8f9843d4e4e99a56_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605faa87f3fa47b3bd583aa47c0b905f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46552cb961884a2e9f30308dfc3d5c18_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f5cb1ef37b47e0a992d6060ab3a446_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacae129a7469439e8699880e38e9c750_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01612b88bf7d4228961f615de0e3bc6c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1065eae966a4e23a6d80c3a4c53c9e1_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>pbh:vote</xbrli:measure></xbrli:unit><xbrli:context id="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6409d99de594b52889f5652216b4812_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4373da025543d89003a05d5de73749_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59613ba2ed6449e8ac420dc8ea0ee548_I20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872fd2fcec7d4bceb22e9ecae5396854_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8537058553437296cbf47a294cbc0c_D20140531-20140531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-05-31</xbrli:startDate><xbrli:endDate>2014-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11506770ce994fd08f2fc8766933e916_D20140601-20140630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-06-01</xbrli:startDate><xbrli:endDate>2014-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688dea0bee1948f2a6d571409bce4665_I20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f7753689274ada97cf2c0bb4c3001d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44a6c8be63164b3a838a938732b3f2c9_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907bf7654d494d8786dce88601c9edf2_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i330f93470c3944a7884dc0e46ce08542_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-03</xbrli:startDate><xbrli:endDate>2021-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c27223f84a24212910eb3aeea93eaf1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc5220759bc469998f6d5c89b112a71_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22fb9cffca2c4cddb633b8b7447cd658_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15a44884d6e49a5a914ecd71387e80c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80f789044f294f2593d384da1434a1aa_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27256c09baf422db24a2becba8b461a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i410e808bfa6046c0b7bc6cd1eeb717fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1687a3f206264e8a9491e1485f31dbb2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7fc1c11e8e4d5ab859abc4f504db82_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c394a5473c4367bd8d152963753341_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f0e76da8d7e4425bd35dcb13791235b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2c3f181ff64a18befbaf556c259b21_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1862059d98a4f86a844ec510bb54683_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pbh:RetirementPlanContributionAxis">pbh:ContributionTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20570904260143f09bd86146ffd27dba_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="pbh:RetirementPlanContributionAxis">pbh:ContributionTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice63f8b82a3a41e5b98abd0d12861032_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3582466457e4fa4b369b2316cdd0686_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a3457f45285462fb87d13aa61a3f683_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18eeee208fa54c9c94b0e5c5a0efc290_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba787bef5fbd42209b679fe0c7f29990_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59ae6b30db4c49f8a69b46325778804b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d96a8c72d94839a80320f2374f58ff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a29f55b009477797275b056efd188d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b34dcaf34dd43b98d9f6b725d940736_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i724425dab8ca4eadac2088fa582751bc_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284d3a442bf04e5cb360a7e96ba61668_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd1018ca3a7741649a9198acafea0150_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie702dabc815748c5bc0488c985ebed02_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83c0747f5c71456088f94f029b3f9866_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d62723af3a64d1bb9252b80927be2e6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78a158429ca4e789c941c6bb4801167_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9808f2a5dec34206ae929d7fa60f2d90_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if67fb66e7897486a9f80811afd7f6951_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">pbh:ThirdPartyManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddcf560297f4cbdb307e23b2a762c97_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6cfa4a5d82842f885da2acd0bc2b4de_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b54127ec5714e2686bd5832ba581101_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bda21851d0429eac0d1110fc51c45f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc29d572ef4048c48685cf3987d915f6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a3c181fa51445a5a25f5120f9046d9b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18191d87fd6b4de7a17225dc12eee7f6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="manufacturer"><xbrli:measure>pbh:manufacturer</xbrli:measure></xbrli:unit><xbrli:context id="i2a2dd8e6335e47d6909ca71624a16c91_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3de54342685484fa1e90d25044d65b3_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec86293b1daa4d37b8ee94fb83cd3fb2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a5f4ee39164abea82cf5e9e5d39277_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f656cd6192a49a8b0474d9588199e42_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff2c33ba3b24ce3835abeb593b95b50_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f247a503b8943d8a3ad2e615aab0ff6_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5aa716616894b2f84935e0374ea04e7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic029fed0956549baa7ec88dac897d2c8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c295d6ba7346f3a20449e046450179_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef95b48e1034b91aaf6fd8e8409b9ad_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3294e803eb844221be72afcd3f38c4d7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5b824968d64c17a23ce9b8e959483a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37751a73f9944309da3a6209420d28a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if488c5f576284dd2b32d7aca3c3ac7da_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99bb552abe54bfd9db35d442b507668_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98203bb0fdee45e0a76bebb95fdaa091_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee5ebd4f9b4f40b4a4a08959e40f8232_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04beadabffb1494192c4f1432581e3e9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f1098b70cf4c3a9d398ae76f4418b2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6611cae507e467aae33483a930263e9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6528481919014cca8fa35e096227a2a4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia993e09fc5da4f1bb3419721565e91c9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d0d76f1e26446ca6c10a8acbccbda1_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1118888fef148b0b3d06df4c4ca9bf2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83b05de81bc4440b8a7586ab5058ae8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb112ef71bd4025a8a7c045b35fda05_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c552006b60d4b08b007787d0e7c1b31_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i015c2f7ac3ca4d218c5d12d1f385211e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86e42570a994afab266a376ed0ac2f9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fbea258f054a63ba94905ba9c1dc40_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75173fc3463d4172a4889323f35f8ce7_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24d6f74c12547b9b437f46f93f8e81b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4612ad4393fa41f2bf9ac148b747c4ba_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1279b5a211240cdbc3c48972315db77_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b826369aad440f284486a46f6980adf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i847749d31c8d4decba0abfa61b2399d6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce1b2b252c24eba903fe426d1e8f9d4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i453f0da9e5204e0a9a8f290c4314b16b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43727784ec8f4d619cf24289b32d65d3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8157da33ba78498d8401bafd7a8fc602_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5ecc92af704cae9ac690e78c08e5ef_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf001558139e4bd8ab9cd40cebbfb430_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549188b894974e3f9c66c305dff4ec5c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f7f2a80b24c4f3a837fc32b805a4f04_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7cc9eb035334f0083ea1c824a1b091d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c0cbb726f74abe9ca0f96e0c1f9657_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb44edcc32594a3a91c1dd365c21d677_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6542cd977dd429bb80eb6e889d6eec0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690400e5143b4fab85db90f58029c2af_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c52313a45fa4bdc8707f54d8c7b0f79_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892942ab686d43ff9f78b51f385c281d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50816ace3fa42db88ab7771863e34c1_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bfd881300fd43768d4fd18c5b8399ac_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef22b30afc84db9bda8dc263f3e2890_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib90b15b3c2e24cb48a2cba51ae97b668_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86b7b9808f604b5d8c96d94c8752d25b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de86537a7564a0e846cbacec3a5d86f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0954b90f854c9c8c6b9d5991778c49_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b222ffe8f542fb9a020f3fae60ba89_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife659f1768004fb5be70b186e77e5297_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd63fc992cf4852a161722fc0811307_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie159feb199e54e298d894fb67e2ecb91_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6255fa73dfc94124a1c4ebaee132b040_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e964d1b021431e9f1b1934d39a6d37_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if064a3f9803e44a281b0d06b27be87d4_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb2e510d032b4dd9b8d6e4efeba5bae8_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda1d905a84541a487e2a38b30d11e2b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcfc25de9722466e932dc1e06bb976b9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99db4439e2494b88b17e934ed9c39536_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447cea4350b049899445c056e36a842e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216903c2e83a43b3b92dd97b7bee014c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b3152923a2411e85c99e2bcf72e13b_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3a43743f4d400dabfa688570f0f5d3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38d3aa13aac246e9b25041fae4b7cc75_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10259ed0744a4da29b08fbd71f4fa0eb_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb6a46d6609484692d15c0a359f03f9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f96d631e0f6493aa473b4f5d6764c83_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b5567d70b54cbd823e42bd98407d52_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05beda4dd5af4462b06464252419026d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21751c4b85644cc9bc4db3085d5e2e0f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187399c858c245c4be01180f7d21b89f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128d4737fe924482950bf5e29e3e58d8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188dc6462826477a91b4a176c33f06fd_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c5b66ea38624883a01debe481d7aabb_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie501c1ea8abe4c0fb019b579c2aba132_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ed6fa3737e451aa617050d4c8ce914_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f5a12f3ffc1452b894efd73785526ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f3910479bb242f9adc9ca0b36080c63_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8310fdbeb364e46af48af59d5abb8d0_I20220503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9c7b100290a4efeb19c0cc9bfb64604_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1dbf1db8a004389a087448443b06363_D20220502-20220502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-02</xbrli:startDate><xbrli:endDate>2022-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434c5f76f05c469e89d0f4d63b175529_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8fcceb1e254220aeb7da81ab31cb58_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45b2f889b82d49398a7b0afa2193e87c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0651eae9b2249d1a150fa2d3bda71fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269d76c784f548c19f48f6c4f35139ec_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9e5a57a02a949ac99c1b929db087c5c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6361373daa34522988116123cf37d3d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea56f97f93bb4d4a986d72945ac41527_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b960c0b2a34f049a1eb507349cdc62_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0659c3b10104b4d93e871d273dc3a9e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3363e6b458345d4aefbc25a191f087a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i920d5d39c27c43a7ada8c478509c80e2_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21a87850c1e3427aab790ab25ea38814_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf417621972e4bfb95d92b68b8db4ee0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf45542f39ba4a4999f6783fd74f411f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b62934366984576b94bf37d4e78c277_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i840967a79d094690b99943768e44e986_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001295947</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Washington, D.C.&#160;20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg4_53e5da3a-118f-4bb6-9cc6-7d15411cc32c">10-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MmVjOWI1YjYwOGRlNDQwNDk2MGVjOWFjNmU2MTMxZTAvdGFibGVyYW5nZToyZWM5YjViNjA4ZGU0NDA0OTYwZWM5YWM2ZTYxMzFlMF8wLTEtMS0xLTE4OTY5_917da7f9-4b64-4fb1-a3c9-fd8b88e58494">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the fiscal year ended <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMzc_6b458dbe-d552-4fe1-85c9-1944a1a09f2a"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMzc_f0cb451d-9c97-4705-bb90-4d5e7b8fd727">March 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OR</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6NjZlYzU4N2E4NzQ2NGNhMjgyZjczOWQyYWNhNjZmZTYvdGFibGVyYW5nZTo2NmVjNTg3YTg3NDY0Y2EyODJmNzM5ZDJhY2E2NmZlNl8wLTEtMS0xLTE4OTY5_e9cb0c2b-b4c8-4fd8-8073-432820aac911">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ______ TO ______</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commission File Number: <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgy_73cc1db9-7d8f-44d1-b20f-b0f69f4d9561">001-32433</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="pbh-20220331_g1.jpg" alt="pbh-20220331_g1.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:230px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg5_5b8a3a17-d2af-4db1-b4eb-42693ed39290">PRESTIGE CONSUMER HEALTHCARE INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTkyMGJhMjk3MDFiNGQ4MTkxYjVjYWYyNjg1N2I3YWUvdGFibGVyYW5nZTphOTIwYmEyOTcwMWI0ZDgxOTFiNWNhZjI2ODU3YjdhZV8wLTAtMS0xLTE4OTY5_168365e2-9db8-4717-8168-5c80f71df4eb">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTkyMGJhMjk3MDFiNGQ4MTkxYjVjYWYyNjg1N2I3YWUvdGFibGVyYW5nZTphOTIwYmEyOTcwMWI0ZDgxOTFiNWNhZjI2ODU3YjdhZV8wLTItMS0xLTE4OTY5_88bf1d3c-7993-4caa-8b38-f1fddedacb0e">20-1297589</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc2_272dc5d2-8940-4c35-9433-0c2e34ba05ca">660 White Plains Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgz_259623e3-b4c7-4e4e-a77a-98e4a431920a">Tarrytown</ix:nonNumeric>, <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc3_b8b858d0-df9a-405c-b7ef-118dff2ea021">New York</ix:nonNumeric> <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc4_33e68135-d9a7-4858-bbee-fc2b84e6fb9f">10591</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg2_79ef80ff-b7a7-4bff-a704-7b8cb446a901">914</ix:nonNumeric>) <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTkw_ff6ffa3f-b099-4f49-9496-2f0cb97631cb">524-6800</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant's Telephone Number, Including Area Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTAtMS0xLTE4OTY5_0086026a-a5be-41a6-8fc7-7cb03de38e74">Common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTEtMS0xLTE4OTY5_99913a83-6031-44b0-99ad-11aee2e9e1dd">PBH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTItMS0xLTE4OTY5_5bfe0fc2-0229-48c0-b804-a2eca492125e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc5_6f091532-9389-4d23-9822-4c7902b115ed">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTkx_9ab3d2f6-fe41-4039-b809-9684416212c6">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgw_fea0a133-539f-48ec-a956-960021e7502e">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;&#160;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgx_a23c3866-1fac-44b7-9760-b0261b0c9ca3">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.912%"><tr><td style="width:1.0%"></td><td style="width:19.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8wLTAtMS0xLTE4OTY5_bf90ce44-14de-4b18-8250-8d349513ca9c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8xLTYtMS0xLTE4OTY5_32010fab-669e-48cb-9340-989508915843">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8yLTYtMS0xLTE4OTY5_129e0098-7d62-4086-b687-143e4eb372b3">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg0_22a2b162-589f-4b7c-a40a-103d7f3c72ec">&#9746;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMTU0NDg3MjA5NDkwMg_8110bac8-2c20-49e1-8c44-bccca093cef6">&#9746;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the Registrant&#8217;s most recently completed second fiscal quarter ended September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i7683433268a44f5ea2cd487803f35f28_I20210930" decimals="-5" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8yODIz_37ed4c83-bb80-42d9-be62-cedc80204c4f">2,798.6</ix:nonFraction> million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May 2, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="ib4fe5d55882d42cba9c5a5c6c603bfa9_I20220502" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8yODY1_fed61e45-26d8-4a73-8175-657d3709181c">50,279,419</ix:nonFraction> shares of common stock outstanding.</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg3_42edf133-4aee-4c5e-b8a8-0c865b434425" escape="true">Portions of the Registrant&#8217;s Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders (the &#8220;2022 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent described herein.</ix:nonNumeric></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_13">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_16">14</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_19">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_22">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_25">26</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_28">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_34">28</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Reserved)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_37">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_40">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_55">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_58">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_151">88</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_154">88</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_157">88</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_163">89</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_166">89</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_169">89</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions,&#160;and Director Independence</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_172">89</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_175">89</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits, Financial Statement Schedules</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_181">90</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_184">94</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRADEMARKS AND TRADENAMES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and tradenames used in this Annual Report on Form 10-K are the property of Prestige Consumer Healthcare Inc. or its subsidiaries, as the case may be.&#160;&#160;We have italicized our trademarks or tradenames when they appear in this Annual Report on Form 10-K.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;), including, without limitation, information within Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#160;&#160;The following cautionary statements are being made pursuant to the provisions of the PSLRA and with the intention of obtaining the benefits of the &#8220;safe harbor&#8221; provisions of the PSLRA.&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements speak only as of the date of this Annual Report on Form&#160;10-K.&#160;&#160;Except as required under federal securities laws and the rules and regulations of the SEC, we do not intend to update any forward-looking statements to reflect events or circumstances arising after the date of this Annual Report on Form 10-K, whether as a result of new information, future events or otherwise.&#160;&#160;As a result of the risks and uncertainties described below, readers are cautioned not to place undue reliance on forward-looking statements included in this Annual Report on Form 10-K or that may be made elsewhere from time to time by, or on behalf of, us.&#160;&#160;All forward-looking statements attributable to us are expressly qualified by these cautionary statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements generally can be identified by the use of words or phrases such as "believe," "anticipate," "expect," "estimate," "plan," "project," "intend," "strategy," "goal," "objective," "future," "seek," "may," "might," "should," "would," "will," "will be," or other similar words and phrases.&#160;&#160;Forward-looking statements are based on current expectations and assumptions that are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Price increases for raw materials, labor, energy and transportation costs, and for other input costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions of supply of sourced goods or parts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of the COVID-19 pandemic or other disease outbreaks on global economic conditions, consumer demand, retailer product availability, and business operations including manufacturing, supply chain and distribution;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The high level of competition in our industry and markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to increase organic growth via new product introductions, line extensions, increased spending on advertising and marketing support, and other new sales and marketing strategies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of customers for a large portion of our sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to successfully identify, negotiate, complete and integrate suitable acquisition candidates and to obtain necessary financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes by retailers in inventory management practices, delivery requirements, and demands for marketing and promotional spending in order to retain or increase shelf space or online share;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to grow our international sales;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General economic conditions and incidence levels affecting sales of our products and their respective markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility in or worsening conditions from geopolitical conflicts, public health issues, and other factors beyond our control;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial factors, such as increases in interest rates and currency exchange rate fluctuations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changing consumer trends, additional store brand or branded competition, accelerating shifts to online shopping or pricing pressures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party manufacturers to produce many of the products we sell and our ability to transfer production to our own facilities or other third-party suppliers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party logistics providers to distribute our products to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our distribution center or manufacturing facility;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential changes in export/import and trade laws, regulations and policies including any increased trade restrictions or tariffs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Acquisitions, dispositions or other strategic transactions diverting managerial resources, and creating additional liabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actions of government agencies in connection with our manufacturing plant, products, advertising or regulatory matters governing our industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims, product recalls and related negative publicity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third parties for intellectual property relating to some of the products we sell;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our information technology systems from threats or disruptions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on third-party information technology service providers and their ability to protect against security threats and disruptions;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our assets being comprised virtually entirely of goodwill and intangibles and possible changes in their value based on adverse operating results and/or changes in the discount rate used to value our brands;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The costs associated with any claims in litigation or arbitration and any adverse judgments rendered in such litigation or arbitration;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our level of indebtedness and possible inability to service our debt or to obtain additional financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The restrictions imposed by our financing agreements on our operations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in federal, state and other geographic tax laws.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see &#8220;Risk Factors&#8221; contained in Part I, Item 1A of this Annual Report on Form 10-K.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated by the context, all references in this Annual Report on Form 10-K to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;Prestige&#8221; refer to Prestige Consumer Healthcare Inc. and our subsidiaries.  Prior to August 17, 2018, the Company's name was Prestige Brands Holdings, Inc.&#160;&#160;Reference to a year (e.g., &#8220;2022&#8221;) refers to our fiscal year ended March 31 of that year.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We formed as a Delaware corporation in 1996 and are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter (&#8220;OTC&#8221;) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;We use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team to our competitive advantage.&#160;&#160;Our ultimate success is dependent on several factors, including our ability to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Develop and execute effective sales, advertising and marketing programs to maintain or grow our share versus competitors over time;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Establish and maintain our third-party manufacturing and distribution relationships to fulfill customer demands;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Develop innovative new products;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continue to grow our presence in the United States and international markets through acquisitions and organic growth; and;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocate capital effectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown our product portfolio both organically and through acquisitions.  We develop our existing brands by investing in new product lines, brand extensions and strong advertising support.  Acquisitions of consumer health and personal care brands have also been an important part of our growth strategy.  We pursue this growth following an acquisition through spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations and innovative development of brand extensions.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, business model, competitive strengths and growth strategy face various risks that are described in "Risk Factors" in Part I, Item 1A of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the percent of our net revenues by segment:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:48.015%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.147%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.147%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information concerning our business segments, please refer to Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 19 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Brands and Market Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our major brands, set forth in the table below, have strong levels of consumer awareness and retail distribution across all major channels.&#160;&#160;These brands accounted for approximately 81.4%, 80.3%, and 80.5% of our total revenues for 2022, 2021, and 2020, respectively. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:14.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.807%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Major&#160;Brands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Group</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Position </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Market&#160;Segment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Brand Information</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">North American OTC Healthcare:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">BC and Goody's </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Analgesics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Analgesic Powders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed over 90 years ago, BC and Goody&#8217;s provide fast pain relief at the speed of powder</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Boudreaux's Butt Paste </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baby Ointments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products include various diaper rash treatments and skin protectants manufactured with high-quality ingredients</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chloraseptic </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sore Throat Liquids and Lozenges (Medicated)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products include sprays and lozenges to relieve sore throats and mouth pain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Clear Eyes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redness Relief</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective line of eye care products that provide soothing comfort, including relief from redness and itchiness</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Compound W </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wart Removal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provides safe and effective at-home removal of common and plantar warts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Debrox </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ear Wax Removal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provides a safe and gentle way to remove excess ear wax or water from ear canal</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">DenTek </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PEG Oral Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Products include dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Dramamine </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motion Sickness Relief</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Includes non-drowsy, kids', original and nausea-free formulas</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fleet </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adult Enemas and Suppositories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Founded in 1869, products include enemas and other laxative products</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gaviscon </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Upset Stomach Remedies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Creates a protective foam barrier to help block stomach acid from splashing up into the esophagus</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Luden's </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cough Drops <br/>(Non-Medicated)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cough drop brand that is over 130 years old and includes a variety of flavors</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Monistat </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vaginal Anti-Fungal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provides fast relief for yeast infections and is available in several different doses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Nix </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lice and Parasite Treatments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective and safe lice and super lice treatments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Summer's Eve </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Feminine Hygiene</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Offers a variety of feminine care products including washes, cloths, and sprays</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">TheraTears</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dry Eye Relief</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Doctor created and recommended therapy for relief of dry eyes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International OTC Healthcare:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fess</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nasal Saline Sprays and Washes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helps relieve nasal and sinus congestion due to allergy, hay fever, colds and flu<br/></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Hydralyte</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oral Rehydration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Relieves symptoms of dehydration and helps replace water and electrolytes lost due to vomiting, diarrhea, heavy sweating, vigorous exercise and occasional hangovers</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">We have prepared the information included in this Annual Report on Form 10-K with regard to the market position for our brands based in part on data generated by Information Resources, Inc. (&#8220;IRI&#8221;), for the 52-week period ended March 20, 2022.  International information was derived from several sources.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Fess</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Hydralyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> data are for the Australian market. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">&#8220;Market segment&#8221; is defined by us and is either a standard IRI category or a segment within a standard IRI category and is based on our product offerings and the categories in which we compete.&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Some brands in the North American OTC Healthcare segment are also sold in the International OTC Healthcare segment.</span></div><div style="text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold through multiple channels, including mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores, which reduces our exposure to any single distribution channel.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Position</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, approximately 67.5% of our total revenues were from major brands with a number one market position, compared with approximately 69.2% and 69.4% of total revenues during 2021 and 2020, respectively.&#160;&#160;In 2022, these brands included </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">BC </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Goody's, Chloraseptic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clear Eyes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compound&#160;W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debrox, Dramamine, Fess, Fleet, Gaviscon, Hydralyte, Monistat, Nix,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competitive Strengths and Growth Strategy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our product portfolio is positioned for long-term growth based on the following factors:  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversified Portfolio of Well-Recognized and Established Consumer Brands</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and market a diverse portfolio of well-recognized consumer brands, some of which were established over 100 years ago.&#160;&#160;Our diverse portfolio of products provides us with multiple sources of growth and minimizes our reliance on any one product or category.  We provide significant marketing support to our portfolio, which is designed to enhance our sales growth and our long-term profitability across our major brands and other significant brands, sometimes referred to as core brands.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Competitor in Attractive Categories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete in product categories that address recurring consumer needs.&#160;&#160;We believe we are well positioned in these categories due to the long history and consumer awareness of our brands, our strong market positions, and our low-cost operating model.  The markets in which we sell our products, however, are highly competitive and include numerous national and global manufacturers, distributors, marketers and retailers.  As a result, any one or more of our brands could suffer a decline in market position or sales.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proven Ability to Develop and Introduce New Products</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We focus our marketing and product development efforts on the identification of under-served consumer needs, the design of products that directly address those needs, and the ability to extend our highly recognizable brand names to other products.  One of our strategies is to broaden the categories in which we participate and increase our share within those categories through ongoing product innovation. &#160;As an example of this philosophy, in 2022 we launched a number of new products, including D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">enTek Fresh Protect Dental Guards, Dramamine Nausea Ginger Chews, BC Max Strength Lemonade-flavored powder, Summer&#8217;s Eve Spa Luxurious Wash and Clear Eyes Sensitive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. &#160;In 2021, we launched </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Summer's Eve Active Chafe Gel and Sprays, Monistat Feminine Cleanser, and Compound W Gel Plus ConSeal Patches</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">.  While there is always a risk that sales of existing products may be reduced by new product introductions, our goal is to grow the overall sales of our brands.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Advertising and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in advertising and marketing to drive the growth of our core brands.&#160;&#160;Our marketing strategy is focused primarily on consumer-oriented initiatives that target consumers via mass media, digital marketing, in-store programming and coupons. While the absolute level of marketing expenditures differs by brand and category, we have often increased the amount of investment in our brands after acquiring them.&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing Distribution Across Multiple Channels</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our broad distribution base attempts to ensure that our products are well positioned across all available channels and that we are able to participate in changing consumer retail trends.&#160;&#160;In an effort to ensure continued sales growth, we continue to focus on expanding our reliance on direct sales while reducing our reliance on brokers for our customers, other than our top 25 customers.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pursuing Strategic Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acquisitions are a part of our overall strategy for growing revenue.  We have a history of growth through acquisitions.  In 2022, we acquired the consumer health business assets from Akorn Operating Company LLC.  While we believe that there will continue to be a pipeline of acquisition candidates for us to investigate, strategic fit, availability of capital and relative cost are of the utmost importance in our decision to pursue such opportunities.  We believe our business model allows us to integrate acquisitions in an efficient manner, while also providing opportunities to realize significant cost savings.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing Our International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales beyond the borders of North America represented 10.9%, 10.0% and 10.8% of total revenues in 2022, 2021, and 2020, respectively.  We have designed and developed both products and packaging for specific international markets and expect that our international revenues as a proportion of our total revenues will continue to grow over the long-term.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our brands have previously been sold internationally, and we seek to expand the number of brands sold through our existing international distribution network and continue to identify additional distribution partners for further expansion of our brands into other international markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Efficient Operating Model</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To gain operating efficiencies, we oversee the production planning and quality control aspects of the manufacturing, warehousing and distribution of our products, while we primarily outsource the operating elements of these functions to well-established third-party providers.&#160;&#160;This approach allows us to benefit from their core competencies and maintain a highly variable cost structure with low overhead, limited working capital requirements, and minimal investment in capital expenditures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Team with Proven Ability to Acquire, Integrate and Grow Brands</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has grown through acquisition and expansion of the many brands we have purchased as a result of the efforts of our experienced management team.  Our management team has significant experience in consumer product marketing, sales, legal and regulatory compliance, product development and customer service.&#160;&#160;We rely on experienced personnel to bear the substantial responsibility of brand management and to effectuate our growth strategy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing and Sales</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing strategy is based primarily on the acquisition and renovation of established consumer brands that possess what we believe to be significant brand value and unrealized potential and to grow categories with existing brands where we have leading market positions.&#160;&#160;Our marketing objective is to increase sales and market share by developing innovative new products and line extensions and executing creative and cost-effective advertising and marketing programs.  This brand-building process involves the evaluation of the existing brand name, the development and introduction of innovative new products, and the execution of marketing support programs. &#160;Brand priorities will vary from year-to-year.&#160; Recognizing that financial resources are limited, we allocate our resources to focus on our core brands with the most impactful, consumer-relevant initiatives that we believe have the greatest opportunities for growth and financial success.&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team and dedicated sales force strive to maintain long-standing relationships with our top 25 domestic customers.&#160;&#160;We also contract with third-party sales management enterprises that interface directly with many of our remaining customers and report directly to members of our sales management team. &#160;In an effort to ensure continued sales growth, we continue to focus on expanding our reliance on direct sales while reducing our reliance on brokers for our non-top 25 customers.&#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enjoy broad distribution across each of the major retail channels, including mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores.&#160;&#160;The following table sets forth the percentage of gross sales for our domestic customers across our six major distribution channels during each of the past three years ended March 31:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Gross Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Channel of Distribution</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mass</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Drug</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Food</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Dollar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Convenience</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Club</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes estimates for some of our wholesale customers that service more than one distribution channel.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes e-commerce retailers such as Amazon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the diversity of our product lines, we believe that each of these channels is important to our business, and we continue to seek opportunities for growth in each channel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that our emphasis on strong customer relationships, speed and flexibility and leading sales technology capabilities, combined with consistent marketing support programs and&#160;ongoing product innovation, will continue to maximize our competitiveness in the increasingly complex retail environment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021, and 2020, Walmart accounted for approximately 20.5%, 21.6%, and 23.1%, respectively, of our gross revenues.  We expect that for future periods, our top ten customers, including Walmart, will in the aggregate continue to account for a large portion of our sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outsourcing and Manufacturing</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In order to maximize our competitiveness and efficiently allocate our resources, third-party manufacturers fulfill most of our manufacturing needs.&#160;&#160;We have found that contract manufacturing often maximizes our flexibility and responsiveness to industry and consumer trends while minimizing the need for capital expenditures.&#160;&#160;We select contract manufacturers based on their core competencies and our perception of the best overall value, including factors such as (i) depth of services, (ii) professionalism and integrity of the management team, (iii) manufacturing agility, quality and capacity, (iv) regulatory compliance, and (v) competitive pricing.  We require each of our suppliers, most of whom are based in the United States and Canada, to comply with our Supplier Code of Conduct, which sets forth the basic and minimal expectations that all suppliers must meet in order to do business with us.  We also conduct thorough reviews of each potential manufacturer&#8217;s facilities, quality standards, capacity and financial stability.&#160;&#160;We generally purchase only finished products from our manufacturers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary contract manufacturers provide comprehensive services from product development through the manufacturing of finished goods.&#160;&#160;This approach results in minimal capital expenditures and maximizes our cash flow, which allows us to reinvest to support our marketing initiatives, fund brand acquisitions or repay outstanding indebtedness.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had relationships with 128 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 23 manufacturers that produced items that accounted for approximately 69.0% of our gross sales for 2022, compared to 19 manufacturers with long-term contracts that accounted for approximately 70.5% of our gross sales in 2021.&#160;&#160;The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results of operations.  Although we are in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our long-term supply and manufacturing agreements explicitly outline the manufacturers&#8217; obligations and product specifications with respect to the brand or brands being produced, including allocation of product liability risk.  Pursuant to the terms of these agreements, the purchase price of products is subject to change due to fluctuations in input costs such as raw material, packaging components and labor costs.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of our other products are manufactured on a purchase order basis, which is generally based on batch sizes and results in no long-term obligations or commitments.  To the extent we rely on purchase orders, rather than supply and manufacturing agreements, to govern our commercial relationships with suppliers, we typically rely on implied warranties with respect to the products manufactured, and we do not have specifically negotiated allocation of risk with these third-party manufacturers.  With regard to our products both manufactured under long-term agreements and purchase orders, in periods of high inflation we have experienced and may continue to experience frequent increases in prices of products due to availability and fluctuations in input costs such as raw material, packaging components and labor costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to relying on contract manufacturers, we operate a manufacturing facility in Lynchburg, Virginia, which manufactures products accounting for approximately 13% of our gross sales.  We intend to move the manufacture of certain of our more highly regulated products to our facility in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that most of the raw materials and packaging components used to produce our products at our manufacturing facility in Virginia and at our third-party manufacturing facilities are generally available through multiple sources acquired on both a contract and purchase order basis but are also subject to inflationary pressure.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warehousing and Distribution</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage product distribution in the continental United States through one facility, which is owned and operated by GEODIS Logistics LLC ("GEODIS"), a third-party provider.  We entered into an agreement with GEODIS in May 2019 and transitioned to this facility from our previous provider during fiscal 2020.  GEODIS provides warehouse services including storage, handling and shipping, as well as transportation services, with respect to our full line of products, including (i) complete management services, (ii) carrier claims administration, (iii) proof of delivery, (iv) procurement, (v) report generation, and (vi) freight payment services.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business of selling brand name consumer products in the OTC health and personal care market is highly competitive.&#160;&#160;This market includes numerous national and global manufacturers, distributors, marketers and retailers that actively compete for consumers&#8217; business both in the United States and abroad.&#160;&#160;In addition, like most companies that market products in this category, we are experiencing continued competition from &#8220;private label&#8221; products introduced by major retail chains.&#160;&#160;While we believe that our branded products provide superior quality and benefits, we are unable to predict the extent to which consumers will purchase &#8220;private label&#8221; products as an alternative to branded products, although we expect that this could increase during an economic downturn or periods of high inflation. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our principal competitors include AbbVie, Alcon, Bausch Health Companies Inc., Bayer, Combe, GlaxoSmithKline, Johnson &amp; Johnson, Mondelez International, Reckitt Benckiser, Sanofi, Sunstar Group, The Honey Pot Company, and The Procter &amp; Gamble Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete on the basis of numerous factors, including brand recognition, product quality, performance, value to customers, price, and product availability at the retail and e-commerce level.&#160;&#160;Advertising, marketing, merchandising and packaging, the timing of new product introductions, and line extensions also have a significant impact on customers&#8217; buying decisions and, as a result, on our sales.&#160;&#160;The structure and quality of our sales force, as well as sell-through of our products, affect in-store and online positioning, wall display space and inventory levels for retail sale.&#160;&#160;Our markets are also highly sensitive to the introduction of new products, which may rapidly capture a significant share of the market.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the competitors noted above are larger and have substantially greater research and development and financial resources than we do, and may therefore have the ability to spend more aggressively and consistently on research and development, advertising and marketing, and to respond more effectively to changing business and economic conditions.  See &#8220;Competitive Strengths&#8221; above for additional information regarding our competitive strengths and Part I, Item 1A &#8220;Risk Factors&#8221; below for additional information regarding competition in our industry.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The formulation, manufacturing, packaging, labeling, distribution, importation, sale and storage of our products are subject to extensive regulation by various U.S. federal agencies, including the U.S. Food and Drug Administration ("FDA"), the Federal Trade Commission ("FTC"), the Consumer Product Safety Commission (&#8220;CPSC&#8221;), and the Environmental Protection Agency (&#8220;EPA&#8221;), and various agencies of the states, localities and foreign countries in which our products are manufactured, marketed, distributed and sold.  Our Regulatory and Quality team is guided by a senior member of management and staffed by individuals with appropriate quality, legal and regulatory experience.  Our Regulatory, Quality and Operations teams work closely with our third-party manufacturers and our own manufacturing operation on quality-related matters. We monitor our own manufacturing operations and our third-party manufacturers' compliance with FDA and relevant foreign regulations and perform periodic audits to ensure compliance.  This continual evaluation process is designed to ensure that our manufacturing processes and products are of high quality and in compliance with known regulatory and quality requirements.  If the FDA or a foreign governmental authority chooses to audit a particular third-party manufacturing facility, we require the third-party manufacturer to notify us immediately and update us on the progress of the audit as it proceeds.  If we or our manufacturers fail to comply with applicable regulations, we could become subject to significant claims or penalties or be required to discontinue the sale of the non-compliant products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the adoption of new regulations or changes in the interpretations of existing regulations may result in significant additional compliance costs or discontinuation of product sales.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our U.S. OTC drug products are regulated pursuant to the FDA&#8217;s monograph system.  The monographs set out the active ingredients and labeling indications that are permitted for certain broad categories of U.S. OTC drug products.  When the FDA has finalized a particular monograph, it has concluded that a properly labeled product formulation is generally recognized as safe and effective and not misbranded.  A tentative final monograph indicates that the FDA has not made a final determination about products in a category to establish safety and efficacy for a product and its uses.  However, unless there is a serious safety or efficacy issue, the FDA typically will exercise enforcement discretion and permit companies to sell products conforming to a tentative final monograph until the final monograph is published.  Products that comply with either final or tentative final monograph standards do not require pre-market approval from the FDA.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our U.S. OTC drug products are New Drug Application (&#8220;NDA&#8221;) or Abbreviated New Drug Application (&#8220;ANDA&#8221;) products and are manufactured and labeled in accordance with an FDA-approved submission.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These products are subject to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting requirements as set forth in FDA regulations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moving forward, OTC drug products will fall under the requirements of The Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") signed into law on March 27, 2020, which includes the Over-the-Counter Monograph Safety, Innovation, and Reform Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These new requirements are expected to be delineated by the FDA in 2023/2024.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our U.S. OTC Healthcare products are medical devices regulated by the FDA through a system that may involve pre-market clearance.  During the review process, the FDA makes an affirmative determination as to the sufficiency of the label directions, cautions and warnings for the medical devices in question.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our products are considered cosmetics regulated by the FDA through the Federal Food, Drug, and Cosmetic Act ("FDC Act") and the Fair Packaging and Labeling Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA does not require pre-market clearance for cosmetics but manufacturers must ensure the products are not adulterated or misbranded. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the FDC Act and FDA regulations, we and our third-party manufacturers of U.S. products must also comply with the FDA&#8217;s current Good Manufacturing Practices (&#8220;GMPs&#8221;).  The FDA inspects our facilities and those of our third-party manufacturers periodically to determine that both we and our third-party manufacturers are complying with GMPs.  We intend to move the manufacture of certain of our more regulated products to our own manufacturing facility, which will subject our facility to increased regulatory requirements and scrutiny with respect to both our existing and new operations there.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dietary supplement products are governed by the Dietary Supplement Health and Education Act of 1994 ("DSHEA"), which defines and regulates dietary supplements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under DSHEA, supplements are also effectively regulated by the FDA for GMPs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of our products are regulated by the CPSC under the Federal Hazardous Substances Act (&#8220;FHSA&#8221;), the Poison Prevention Packaging Act of 1970 (the &#8220;PPPA&#8221;) and the Consumer Products Safety Improvement Act of 2008 (&#8220;CPSIA&#8221;).  In addition, a small number of our products are subject to regulation under the PPPA and can only be legally marketed if they are dispensed in child-resistant packaging or labeled for use in households where there are no children.  The CPSIA requires us to make available to our customers certificates stating that we are in compliance with any applicable regulation administered by the CPSC.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nix Lice Control Spray</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is considered a pesticide under the Federal Insecticide, Fungicide, and Rodenticide Act (&#8220;FIFRA&#8221;).  Generally speaking, any substance intended for preventing, destroying, repelling, or mitigating any pest is considered to be a pesticide under FIFRA.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pesticides under FIFRA are required to be registered with the EPA and contain certain disclosures on the product labels.  In addition, the contract manufacturers from which we source these products must be registered with the EPA.  Our EPA registered products are also subject to state regulations and the rules and regulations of the various jurisdictions where these products are sold.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Canadian and international business is also subject to product regulations by local regulatory authorities in the various countries where these businesses operate, including regulations regarding manufacturing, labeling, marketing, distribution, sale and storage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sustainability and Environmental, Social and Governance (&#8220;ESG&#8221;) Regulations </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that sustainable operations are both financially and operationally beneficial to our business, and critical to the health of the communities in which we operate. Our operations are subject to federal, state, local and foreign laws, rules and regulations relating to environmental concerns, including air emissions, wastewater discharges, solid and hazardous waste management activities, and the safety of our employees.  We endeavor to take actions necessary to comply with such regulations, including periodic environmental and health and safety audits of our facilities. The audits, conducted by independent firms with expertise in environmental, health and safety compliance, include site visits as well as a review of documentary information, to determine compliance with such federal, state, local and foreign laws, rules and regulations.  We seek to ensure responsible sourcing of our products and to improve our suppliers&#8217; environmental, labor, health and safety and ethical practices through our Supplier Code of Conduct.  We seek to minimize our resource footprint at our locations with a focus on managing waste, water and energy consumption.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to a variety of other regulations in various foreign markets, including regulations pertaining to import/export, antitrust and pharmacovigilance issues.  To the extent we decide to commence or expand operations in additional </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">countries, we may be required to obtain an approval, license or certification from the country&#8217;s ministry of health or comparable agency.  We must also comply with product labeling and packaging regulations that may vary from country to country.  Government regulations in both our domestic and international markets can delay or prevent the introduction, or require the reformulation or withdrawal, of some of our products.  Our failure to comply with these regulations can also result in a product being removed from sale in a particular market, either temporarily or permanently.  In addition, we are subject to FTC and state regulations, as well as foreign regulations, relating to our product claims and advertising.  If we fail to comply with these regulations, we could be subject to enforcement actions and the imposition of penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of Regulations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these various regulations has an impact on capital expenditures, earnings and our competitive position. Additional or shifting governmental regulation has and in the future could require reformulation of certain products to meet new standards, recalls or discontinuance of certain products not able to be reformulated, additional record-keeping requirements, increased documentation of the properties of certain products, additional or different labeling, additional scientific substantiation, expanded adverse event reporting or other new requirements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those changes have and will continue to require capital investments in facilities and equipment to meet the requirements, as well as additional product development, material and production costs which may impact our earnings, financial condition and ability to compete.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own a number of trademark registrations and applications in the United States, Canada and other foreign countries.&#160;&#160;The following are some of the most significant registered trademarks we own in the United States and/or Canada:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;BC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound&#160;W, Debrox,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DenTek, Dramamine, Fleet, Gaviscon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goody's, Hydralyte, Luden's, Monistat, Nix, Summer's Eve, Fess </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> TheraTears. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trademarks and tradenames are how we convey that the products we sell are &#8220;brand name&#8221; products.&#160;&#160;Our ownership of these trademarks and tradenames is very important to our business, as it allows us to compete based on the value and goodwill associated with these marks.&#160;&#160;Additionally, we own or license patents on innovative and proprietary technology.&#160;&#160;The patents evidence the unique nature of our products, provide us with exclusivity, and afford us protection from the encroachment of others.&#160;&#160;None of the patents that we own or license, however, is material to us on a consolidated basis.  Enforcing our rights, or the rights of any of our licensors, represented by these trademarks, tradenames and patents is critical to our business and may require significant expense.&#160;&#160;If we are not able to effectively enforce our rights, others may be able to dilute our trademarks, tradenames and patents and diminish the value associated with our brands and technologies.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own all of the intellectual property rights applicable to our products.&#160;&#160;In those cases where our third-party manufacturers own patents that protect our products, we are dependent on them as a source of supply for our products.  In addition,&#160;we rely on our suppliers for their enforcement of their intellectual property rights against infringing products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first quarter of our fiscal year generally is the least profitable quarter due to the increased advertising and marketing spending to support those brands with a summer selling season, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clear Eyes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compound W, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and generally the lowest level of sales attributable to multiple factors.&#160;&#160;The effectiveness of advertising and marketing campaigns in the third quarter influences sales of products such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chloraseptic,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Little Remedies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Luden's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the fourth quarter cough and cold winter months.&#160;&#160;Additionally, the fourth quarter typically has the lowest level of advertising and marketing spending as a percent of revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Culture &amp; Diversity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to deliver high-quality consumer health and personal care products that improve and enrich the lives of our consumers. Our Company culture is founded on the principles of Leadership, Trust, Change and Execution.  Of those principles, Trust is among the most important.  Trust in the safety and performance of our products, the integrity of our manufacturing and marketing processes, the character of our people, and the benefit to our consumers and society.  We also reward employees who take ownership and embody our principle of Leadership with projects that positively impact our business, community and stakeholders.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We take pride in the wide range of backgrounds, races, nationalities, personalities, ideas, and talents that make up our organization.  We continue to build on our long commitment of equal employment opportunity and anti-discrimination by consciously and proactively promoting inclusion and equity of people with unique cultural and ethnic heritage, color and backgrounds, gender identification and sexual orientation, and other traits. We endeavor to facilitate the acquisition of diverse attitudes, skills and talents particularly for future leadership roles through hiring, workplace practices and employee </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">development.  We strive to create and sustain an environment where all employees are heard and inspired to achieve their full potential. We continually review our Company employee demographics to help us adhere to these principles.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also believe in working productively with one another and with our stakeholders to ensure long-term success. Some of the ways we encourage this is by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Recruiting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: With employees across the U.S. and the world, we understand the importance of hiring and advancement practices that ensure diversity and equality at all levels of the organization as well as talent development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Monitoring:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a strict Code of Conduct and Ethics that fosters a work environment that is free from intimidation, harassment and violence. Our team employs a process to investigate and resolve any potential conduct or ethics concern that may violate our mission of diversity and inclusion. We use a third-party reporting avenue for employees to exercise any such concern with anonymity and confidentiality.  Raising a concern honestly or participating in an investigation cannot be the basis for any adverse employment action, including termination, suspension, loss of benefits, threats, harassment or discrimination.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Employees</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, we had approximately 535 global employees. Approximately 90% of our workforce operates in the United States, 9% in Australia and Asia and 1% in Europe.  60% of our employees are salaried and 40% are paid hourly wages, mostly in production.  We employ only a few part time employees.  Our workforce is 52% female and 48% male. None of our employees are a party to a collective bargaining agreement.   Management believes that our relations with employees are good.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Development and Empowerment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encourage all employees to achieve their full potential by participating in our mentorship opportunities, career development programs and Company-provided learning tools.  We provide meaningful responsibility and development opportunities to our employees worldwide.  We employ a performance management process under which all employees receive reviews that not only assess performance, but identify specific developmental opportunities and learning goals for the individual. By empowering our employees to develop and enhance their skills through enterprise-wide tools, videos and coursework that focus on continuous learning and professional and personal development, we help all of our employees reach their full potential, which in turn helps our organization succeed. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Safety</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing a safe work environment for our employees and require employees to share this concern by abiding to rigorous safety measures.  To enable this and assure that the message of health, safety and well-being are part of our work culture, we conduct regular training programs at our production facility.  We seek to comply with all federal, state and/or local occupational safety and health standards and report our safety records in accordance with the Occupational Safety and Health Administration ("OSHA").  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we implemented protocols in response to the COVID-19 pandemic across all locations, in an effort to ensure both the safety of our employees and compliance with federal and local requirements and guidelines.  These protocols continued through fiscal 2022.  During the pandemic, our dedicated production employees at our manufacturing facility in Lynchburg, VA continued to operate three shifts a day with enhanced safety and health measures in place to protect their well-being.  Our office-based employees were initially transitioned to a remote workforce but later returned to the office with appropriate safeguards to protect their health and well-being.  These measures have allowed employees the flexibility to attend to other unique personal and family needs brought on by the pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Community</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a responsible corporate citizen and we resolve to live by our principles as we continue to grow our global business. We seek out opportunities to be active members of our communities to enhance the lives of our neighbors and consumers.  We encourage employees to become involved in their respective communities, and we enable office locations the freedom to develop programs that are appropriate to their community needs.  For example, our corporate headquarters office location traditionally has an annual &#8220;Day of Giving&#8221; where employees spend a day every December giving back to the nearby communities, while other office locations support their communities through various volunteerism events.  With the pandemic and employees working remotely, our charitable efforts this year focused on feeding those in need in the communities where employees live and a Company contribution to Feeding Westchester, a nonprofit hunger relief network of food banks across the County of Westchester, NY.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information surrounding our Company&#8217;s human capital development and sustainability efforts are available on our Company&#8217;s website at https://www.prestigebrands.com/about-us/corporate-responsibility.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the World Health Organization ("WHO") declared a global pandemic due to a new strain of coronavirus ("COVID-19").  The pandemic has caused significant volatility in the United States and global economies.  In addition, the Russian invasion of Ukraine has led to further economic uncertainty.  We expect economic conditions will continue to be highly volatile and uncertain and could affect demand for our products and put pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We experienced a temporary but significant decline in consumer consumption of our brands in the first quarter of fiscal 2021, followed by more stable consumption and customer orders over the remainder of the year. Generally, throughout the pandemic, some categories were positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products, as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel-related activity. In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio. Our business also benefited from a significant increase in demand in travel-related categories and channels as well as the Cough &amp; Cold category, previously impacted by the COVID-19 virus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both the COVID-19 pandemic and the geopolitical environment have also impacted the supply of labor and raw materials and exacerbated rising costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These circumstances could change, however, in this dynamic, unprecedented environment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the COVID-19 outbreak worsens or geopolitical conditions cause further disruption in the global supply chain, the availability of labor or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreak and recovery period and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet address is www.prestigeconsumerhealthcare.com.&#160;&#160;We make available free of charge on or through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports, as well as the Proxy Statement for our annual stockholders&#8217; meetings, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (the &#8220;SEC&#8221;).&#160;&#160;Information on our Internet website does not constitute a part of this Annual Report on Form 10-K and is not incorporated herein by reference, including any general statement incorporating by reference this Annual Report on Form 10-K into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may read and copy any materials that we file with the SEC at the SEC&#8217;s Public Reference Room at 100&#160;F&#160;Street, NE, Washington, DC 20549.  You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct and Ethics Policy, Code of Ethics for Senior Financial Employees, Policy and Procedures for Complaints Regarding Accounting, Internal Controls and Auditing Matters, Corporate Governance Guidelines, Audit Committee Pre-Approval Policy, and Charters for our Audit, Compensation and Nominating and Corporate Governance Committees, as well as a Related Persons Transaction Policy and Stock Ownership Guidelines.&#160;&#160;We will provide to any person without charge, upon request, a copy of the foregoing materials.&#160;&#160;Any requests for these documents from us should be made in writing to:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">660 White Plains Road</span></div><div style="text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tarrytown, New York&#160;10591</span></div><div style="text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention: Secretary</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to disclose future amendments to these documents, policies and guidelines and any waivers of these documents, policies and guidelines, on our Internet website and/or through the filing of a Current Report on Form 8-K with the SEC, to the extent required under the Exchange Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price increases for raw materials, labor, energy, transportation costs and other manufacturer, logistics provider or distributor demands could continue to have an adverse impact on our margins.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The costs to manufacture and distribute our products are subject to fluctuation based on a variety of factors.  Volatility and increases in commodity raw material (e.g.  resins), packaging component prices, and labor, energy, and transportation costs and other input costs, including as a result of supply chain issues or shortages, could significantly affect our profit margin and could have a significant impact on our financial condition and results of operations if our raw material suppliers, third-party manufacturers, logistics providers or distributors pass along those costs to us.  Certain product categories have been impacted by higher inflation due to, among other things, the continuing impacts of the COVID-19 pandemic, Russia&#8217;s invasion of Ukraine, civil unrest, and related labor shortages, global supply chain disruptions and the uncertain economic and geopolitical environment which has impacted our gross margin in 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturers we use have and may continue to increase the cost of many of the products we purchase, which could adversely affect our margins in the event we are unable to pass along these increased costs to our customers or identify and qualify new manufacturers.  If we are unable to increase the price for our products to our customers or continue to achieve cost savings in a rising cost environment, any such cost increases would likely reduce our gross margins and could have a material adverse effect on our financial condition and results of operations. If we increase the price of our products in order to maintain our current gross margins for our products, the increase may adversely affect demand for, and sales of, our products, which could have a material adverse effect on our business, financial condition and results of operations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Volatility in or worsening of economic conditions from geopolitical conflicts, public health issues, and other factors beyond our control could reduce consumer spending, which could adversely impact demand for our products and our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our financial performance depends on the stability of conditions that impact consumer spending. Adverse conditions in or volatility in financial markets or the economy could adversely impact consumer confidence, resulting in reduced consumer spending leading to reduced consumption of our products. The COVID-19 pandemic and the Russian invasion of Ukraine have both caused volatility in the global economy, including by creating supply chain issues and rising costs. Other factors beyond our control could also adversely impact demand for our products, including rising interest rates, inflation from rising costs, unemployment, and the availability of consumer financing. Any reduction in consumer demand for our products could have a material adverse impact on our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The high level of competition in our industry, much of which comes from competitors with greater resources, could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business of selling brand name consumer products in the OTC health and personal care market is highly competitive.  This market includes numerous manufacturers, distributors, marketers and retailers that actively compete for consumers&#8217; business both in the United States and abroad.  Many of these competitors are larger and have substantially greater resources than we do, and may therefore have the ability to spend more aggressively on research and development and advertising and marketing, and to respond more effectively to changing business and economic conditions, including in connection with inflation or recessionary conditions.  If this were to occur, it could have a material adverse effect on our financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our product lines that account for a large percentage of our sales have a smaller market share relative to our competitors.  In some cases, we may have a number one market position but still have a relatively small share of the overall market.  Alternatively, we may hold a number two market position but have a substantially smaller share of the market versus the number one competitor.  See &#8220;Part I, Item 1. Business - Major Brands&#8221; of this Annual Report on Form 10-K for information regarding market share.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete for consumers&#8217; attention based on a number of factors, including brand recognition, product quality, performance, value to consumers, price and product availability at the retail level.  Advertising, marketing, merchandising and packaging and the timing of new product introductions and line extensions also have a significant impact on consumer buying decisions and, as a result, on our sales.  Our markets are highly sensitive to the introduction of new products, which may rapidly capture a significant share of the market.  New product innovations by our competitors, or our failure to develop new products, the failure of a new product launch by the Company, or the obsolescence of one or more of our products, could have a material adverse </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect on our business, financial condition and results of operations.  If our advertising, marketing and promotional programs are not effective, our sales may decline.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The structure and quality of our sales force, as well as sell-through of our products, affect in-store and our e-commerce product position, wall display space and inventory levels for retail sale.  If we are unable to maintain our current distribution network, product offerings for retail sale, inventory levels and in-store and online positioning of our products, our sales and operating results could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, competitors may attempt to gain market share by offering products at prices at or below those typically offered by us.  The introduction or expansion of store brand products that compete with our products at a lower price point could in the future impact our sales and results of operations. This could be exacerbated by rising costs and other economic conditions that shift consumer demand to lower-priced products, as well as supply chain issues that result in reduced availability for our products. Competitive pricing may require us to reduce prices, which may result in lost revenue or a reduction of our profit margins.  Future price adjustments by our competitors or our inability to react with price adjustments of our own could result in a loss of market share, which could have a material adverse effect on our financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of customers with whom we have no long-term agreements for a large portion of our gross sales, and the loss of one or more of these customers or changes in their strategies and policies could reduce our gross sales and have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2022, Walmart, which accounted for approximately 20.5% of our gross sales, was our only customer that accounted for more than 10% of our gross revenues.  We expect that for future periods, our top ten customers, including Walmart, will, in the aggregate, continue to account for a large and potentially increasing portion of our sales. Many of our customers have sought to obtain lower pricing, logistics or other changes to the customer-supplier relationship.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to effectively respond to the demands of our customers, these customers could reduce their purchases of our products and increase their purchases of products from competitors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Reductions in inventory by our customers, the loss of one or more of our top customers, including as a result of consolidation in the retail industry, or any significant decrease in sales to these customers based on changes in their strategies or policies such as a reduction in the number of brands they carry, the amount of shelf space or positioning they dedicate to store brand products, inventory management, or a significant decrease in our retail display space or online positioning or in any of these customers&#8217; stores, could reduce our sales and have a material adverse effect on our financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our business is based primarily upon individual sales orders.  We typically do not enter into long-term contracts with our customers.  Accordingly, our customers could cease buying products or reduce the number of items they buy from us at any time and for any reason.  The fact that we do not have long-term contracts with our customers means that we have no recourse in the event a customer no longer wants to purchase products from us or reduces the number of items purchased.  If a significant number of our smaller customers, or any of our significant customers, elect not to purchase products from us, our financial condition and results of operations could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We primarily depend on third-party manufacturers to produce the products we sell.  If we are unable to maintain these manufacturing relationships or are unable to successfully transfer manufacturing to another third-party or our own manufacturing facility we may be unable to meet customer demand, and our business, sales and profitability could suffer as a result.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products are produced by a limited number of third-party manufacturers.  Our ability to retain our current manufacturing relationships and engage in and successfully transition to new relationships or to our own manufacturing facility is critical to our ability to deliver quality products to our customers in a timely manner.  Without adequate supplies of quality merchandise, our sales would decrease materially and our business would suffer.  In the event that our primary third-party manufacturers are unable or unwilling to ship products to us in a timely manner, we would have to rely on secondary manufacturing relationships or, to the extent unavailable, identify and qualify new manufacturing relationships.  Because of the unique manufacturing requirements of certain products, the Company may be unable to timely qualify new suppliers or at the quantities, quality and price levels needed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, certain of the Company's manufacturers have had difficulty meeting demand, which can and has caused shortages of our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In such instances, we may not be able to identify or qualify secondary manufacturers for such products in a timely manner, and such manufacturers may not allocate sufficient capacity to allow us to meet our commitments to customers.  In addition, identifying alternative manufacturers without adequate lead times may involve additional manufacturing expense, delay in production, or product disadvantage in the marketplace.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some instances, we may seek to transfer the manufacture of certain products to our own facilities, which may result in additional manufacturing expense, delay in production, additional regulatory requirements and other disruptions to our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business. In general, the consequences of not securing adequate, high quality and timely supplies of merchandise would negatively impact inventory levels, which could damage our reputation and result in lost customers and sales, and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had relationships with 128 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 23 manufacturers that produced items that accounted for approximately 69.0% of our gross sales for 2022, compared to 19 manufacturers with long-term contracts that produced approximately 70.5% of gross sales in 2021.&#160;&#160;The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate costly price increases, which could have a material adverse effect on our business and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we are in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption in our third-party distribution center or our Virginia manufacturing facility may prevent us from meeting customer demand, and our sales and profitability may suffer as a result.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third-party through one primary distribution center in Clayton, Indiana, and we operate one manufacturing facility located in Lynchburg, Virginia, which manufactures many of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fleet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products, comprising approximately 13% of our gross revenues.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with a third-party distribution manager, or labor shortages or contagious disease outbreaks or other public health emergencies at our distribution center or manufacturing facility could also materially impact our product distribution. Any disruption could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times should we be required to replace our distribution center, the third-party distribution managers or the manufacturing facility.  As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The continuation of the COVID-19 pandemic, further outbreaks of COVID-19, or any future outbreak of other highly infectious diseases or public health emergencies could have a material adverse impact on our results of operations and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Beginning in early 2020, the COVID-19 pandemic caused significant volatility in the global economy and resulted in materially reduced economic activity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Globally, numerous government orders and restrictions implemented to reduce the spread of COVID-19 required many businesses to temporarily close or limit operations and mandated that individuals substantially restrict daily activities, which adversely affected workforces, customers, and consumer sentiment, decreased consumer spending and increased unemployment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our operations are impacted by consumer spending levels, the availability of our products at retail stores or for online purchase, and our ability to manufacture and distribute products to our customers and consumers in an effective and efficient manner. Although the COVID-19 pandemic has not materially adversely impacted our business or our operations to date, we could experience a material adverse impact in future quarters if conditions worsen or if other pandemics occur.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For example, sales have varied during the most restrictive phases of the COVID-19 pandemic, with some categories positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold, and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have experienced adverse impacts from COVID-19, and we could experience adverse impacts from other pandemics, in a number of ways, including, but not limited to, the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">supply chain delays or disruptions due to closed supplier facilities or distribution centers, reduced workforces, scarcity of raw materials and scrutiny or embargoing of goods produced in infected areas;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">shutdown of our manufacturing facility due to illness or government order;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">reduced consumer demand for certain of our products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as a result of the economic downturn or restrictions on in-person purchases; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">change in demand for or availability of our products as a result of retailers or distributors modifying their restocking, fulfillment, or shipping practices;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">decrease in our ability to develop innovative products due to reprioritization of suppliers and/or retailers;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">increase in working capital needs and/or an increase in trade accounts receivable write-offs as a result of increased financial pressures on our suppliers or customers;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">impairment in the carrying value of goodwill or intangible assets or a change in the useful life of definite-lived intangible assets from sustained changes in consumer purchasing behaviors, government restrictions, or financial results; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">increase in raw material and other input costs resulting from market volatility; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">fluctuation in foreign currency exchange rates or interest rates resulting from market uncertainties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the COVID-19 pandemic has not negatively impacted our results of operations to date, the extent to which it, and any related global economic downturn, could affect our business, results of operations and financial condition in future quarters will depend on developments that are highly uncertain and cannot be predicted, including the severity and duration of any further outbreak and recovery period, the availability, acceptance and efficacy of vaccines, future actions taken by governmental authorities and other third parties in response to the pandemic, and the impact on our customers, employees and suppliers, distributors and other service providers.  For example, we believe that government stimulus payments during the COVID-19 pandemic may have helped improve sales, and any termination or reduction of further stimulus funds may result in reduced consumer spending, which could adversely impact our results of operations. Accordingly, the ultimate impact on our financial condition and results of operations cannot be determined at this time. Nonetheless, we anticipate that it could adversely affect our results of operations and financial condition, including by negatively impacting demand for our products, restricting our operations and sales, marketing and distribution efforts, disrupting supply chain and manufacturing processes and other important business activities. Moreover, the effects of the COVID-19 pandemic could exacerbate the other risks described in this &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Consumption trends for our products may not correlate to our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We regularly review consumption levels for our brands to provide an indication of the strength of our expected results of operations.  Total company consumption is based on domestic IRI multi-outlet + C-store retail sales for the relevant period, retail sales from other third parties for certain e-commerce sales in North America, Australia consumption based on IMS data, and other international net revenues as a proxy for consumption.  Our calculation of consumption levels may not accurately reflect actual retail consumption given limitations of tracked data.  In addition, many retailers have implemented inventory management strategies that include reductions in the amount of inventory they carry and related reductions in retail space and may continue such efforts in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability claims and product recalls and related negative publicity could adversely affect our sales and operating results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on consumers&#8217; perception of the safety and quality of our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative consumer perception may arise from product liability claims and product recalls, regardless of whether such claims or recalls involve us or our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The mere publication of information asserting concerns about the safety of our products or the ingredients used in our products could have a material adverse effect on our business and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our products are safe and effective when used in accordance with label directions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, adverse publicity about ingredients used in our products may discourage consumers from buying our products containing those ingredients, which would have an adverse impact on our sales. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we are subject to various product liability claims.  Claims could be based on allegations that, among other things, our products contain contaminants, include inadequate instructions or warnings regarding their use, or include inadequate warnings concerning side effects and interactions with other substances.  Whether or not successful, product liability claims could result in negative publicity that could adversely affect the reputation of our brands and our business, sales and operating results.  Additionally, we may be required to pay for losses or injuries purportedly caused by our products.  In addition, we could be required for a variety of reasons to initiate product recalls, which we have done on several occasions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product recalls could have a material adverse effect on our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we have supply and manufacturing agreements with certain of our third-party manufacturers, which explicitly outline the allocation of product liability risk with respect to the products these manufacturers produce, some of our other products are manufactured on a purchase order basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the extent we rely on purchase orders to govern our commercial relationships with suppliers, we have not specifically negotiated the allocation of risk for product liability obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Instead, we typically rely on implied warranties from the suppliers with respect to these products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result, we may have difficulty enforcing these implied warranties, and we may bear all or a significant portion of any product liability obligations rather than transferring this risk to our third-party manufacturers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although we maintain, and require our suppliers and third-party manufacturers to maintain, product liability insurance coverage, potential product liability claims may exceed the amount of insurance coverage or may be excluded under the terms of the policy, which could have a material adverse effect on our financial condition.  In addition, in the future we may not be able to obtain adequate product liability insurance coverage or we may be required to pay higher premiums and accept higher deductibles in order to secure adequate product liability insurance coverage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Acquisitions and Product Development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to successfully identify, negotiate, complete and integrate suitable acquisition candidates and to obtain necessary financing could have an adverse impact on our growth and our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achievement of our strategic objectives includes the acquisition, or potentially the disposition, of certain brands or product lines, and these acquisitions and dispositions may not be successful.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our historical growth has been driven by acquiring other brands and companies. At any given time, we may be engaged in discussions with respect to possible acquisitions that are intended to enhance our product portfolio, enable us to realize cost savings, and further diversify our category, customer and channel focus. Our ability to successfully grow through acquisitions depends on our ability to identify, negotiate, complete and integrate suitable acquisition candidates and to obtain any necessary financing. However, we may not be able to identify and successfully negotiate suitable strategic acquisitions at attractive valuations, obtain financing for future acquisitions on satisfactory terms, or otherwise complete future acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All acquisitions entail various risks such that after completing an acquisition, we may also experience:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulties in integrating any acquired companies, suppliers, personnel and products into our existing business;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulties in realizing the benefits of the acquired company or products, including expected returns, margins, synergies and profitability;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Higher costs of integration than we anticipated;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Exposure to unexpected liabilities of the acquired business;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulties in retaining key employees of the acquired business who are necessary to operate the business;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulties in maintaining uniform standards, controls, procedures and policies throughout our acquired companies;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Adverse customer or stockholder reaction to the acquisition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, any acquisitions we pursue or complete could adversely impact our business, financial condition and results from operations. In addition, any acquisition could adversely affect our operating results as a result of higher interest costs from any acquisition-related debt and higher amortization expenses related to the acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we decide to divest of a brand or product line, we may encounter difficulty finding, or be unable to find, a buyer on acceptable terms in a timely manner. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the pursuit of acquisitions and divestitures could also divert management's attention from our business operations and result in a delay in our efforts to achieve our strategic objectives.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If new products and product line extensions do not gain widespread customer acceptance or are otherwise discontinued, the Company's financial performance could be impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future performance and growth depends on its ability to successfully develop and introduce new products and product line extensions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be certain that we will achieve our innovation goals.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successful development and introduction of new products involves substantial research, development, marketing and promotional expenditures, which the Company may be unable to recover if the new products do not gain widespread market acceptance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product development and marketing efforts, including efforts to enter markets or product categories in which the Company has limited or no prior experience, have inherent risks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks include product development or launch delays, competitor actions, regulatory approval hurdles, and the failure of new products and line extensions to achieve anticipated levels of market acceptance. A negative outcome in any of these risks could adversely impact our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks associated with doing business internationally</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 11% of our total revenues are attributable to our international business. We generally rely on brokers and distributors for the sale of our products in foreign countries.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some of our third-party manufacturers are located outside the United States.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks of doing business internationally include, but are not limited to:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Political instability or declining economic conditions in the countries or regions where we operate or rely on third-party manufacturers or suppliers that adversely affect sales of our products or our ability to obtain adequate supply of our products;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Currency controls that restrict or prohibit the payment of funds or the repatriation of earnings to the United States;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Fluctuating foreign exchange rates that result in unfavorable increases in the price of our products or cause increases in the cost of certain products purchased from our foreign third-party manufacturers;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Compliance with laws and regulations concerning ethical business practices;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Trade restrictions and exchange controls;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulties in staffing and managing international operations;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Difficulty protecting our intellectual property rights in these markets; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Increased costs of compliance with general business and tax regulations in these countries or regions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are dependent on foreign distributors and sales agents for compliance and adherence to foreign laws and regulations that we may not be familiar with, and we cannot be certain that these distributors and sales agents will adhere to such laws and regulations or adhere to our business practices and policies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any violation of laws and regulations by foreign distributors or sales agents or a failure of foreign distributors or sales agents to comply with applicable business practices and policies could result in legal or regulatory sanctions or potentially damage our reputation. If we fail to manage these risks effectively, we may not be able to continue our international operations, and our business and results of operations may be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory matters governing our industry could have a significant negative effect on our sales and operating costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both the United States and in our foreign markets, our operations are affected by extensive laws, governmental regulations, administrative determinations, court decisions and similar constraints.  Such laws, regulations and other constraints exist at the federal, state and local levels in the United States and at analogous levels of government in foreign jurisdictions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The formulation, manufacturing, packaging, labeling, distribution, importation, marketing, sale and storage of our products are subject to extensive regulation by various U.S. federal agencies, including the FDA, FTC and CPSC, the EPA, and by various agencies of the states, localities and foreign countries in which our products are manufactured, distributed, stored and sold.  The FDC Act and FDA regulations require that the manufacturing processes of our facilities and third-party manufacturers of U.S. products must also comply with the FDA&#8217;s GMPs.  The FDA inspects our facilities and those of our third-party manufacturers periodically to determine if we and our third-party manufacturers are complying with GMPs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health regulatory bodies of other countries have their own regulations and standards, which may or may not be consistent with the U.S. FDA GMPs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our and our suppliers&#8217; operations are subject to the oversight of the Occupational Safety and Health Administration and some suppliers by the National Labor Relations Board.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our activities are also regulated by various agencies of the states, localities and foreign countries in which our products and their constituent materials and components are manufactured and sold.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to move the manufacture of certain of our more highly regulated products to our own manufacturing facility, which will subject our facility to increased regulatory requirements and scrutiny with respect to both our existing and new operations there.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our third-party manufacturers or distributors fail to comply with applicable regulations, we could become subject to enforcement actions, significant penalties or claims, which could materially adversely affect our business, financial condition and results of operations.  In addition, we could be required to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Suspend manufacturing operations;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Modify product formulations or processes;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Suspend the sale or require a recall of non-compliant products; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Change product labeling, packaging, distribution, storage, marketing, or advertising, or take other corrective action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new regulations or changes in the interpretation of existing regulations may result in significant compliance costs or the cessation of product sales and may adversely affect the marketing of our products, which could have a material adverse effect on our financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our failure to comply with FDA, FTC, EPA or any other federal and state regulations, or with similar regulations in foreign markets, that cover our product registration, product claims and advertising, including direct claims and advertising by us, may result in enforcement actions and imposition of penalties, litigation by private parties, or otherwise materially adversely affect the distribution and sale of our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to increasing focus on Environmental, Social and Governance (&#8220;ESG&#8221;) issues, including those related to climate change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As climate change, land use, water use, deforestation, recyclability or recoverability of packaging, plastic waste, ingredients and other ESG and sustainability concerns become more prevalent, federal, state and local governments, non-governmental organizations and our customers, consumers and investors are increasingly focused on these issues. This increased focus on sustainability may result in new laws, regulations and requirements that could cause disruptions in or increased costs associated with developing, manufacturing and distributing our products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could also lose revenue if our consumers change brands, our customers refuse to buy our products, or investors choose not to invest in our debt or common stock if we do not meet their ESG and sustainability expectations. For example, since 2020, some of our major customers requested we respond to various questionnaires to evaluate our ESG efforts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to meet these standards could impact our costs, and failure to meet our customers&#8217; expectations could impact our sales and business reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we strive to minimize the environmental impact of our global operations, we may experience reduced demand for our products and loss of customers if we do not meet their ESG expectations, which could result in a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property and Data Privacy and Security</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect our intellectual property rights, our ability to compete effectively in the market for our products could be negatively impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for our products depends to a significant extent upon the goodwill associated with our trademarks, tradenames and patents.  Our trademarks and tradenames convey that the products we sell are &#8220;brand name&#8221; products.  We believe consumers ascribe value to our brands, some of which are over 100 years old.  We own or license the material trademarks, tradenames and patents used in connection with the packaging, marketing and sale of our products.  These rights prevent our competitors or new entrants to the market from using our valuable brand names and technologies.  Therefore, trademark, tradename and patent protection is critical to our business.  Although most of our material intellectual property is registered in the United States and in applicable foreign countries, we may not be successful in asserting protection.  If we were to lose the exclusive right to use one or more of our intellectual property rights, the loss of such exclusive right could have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other parties may infringe on our intellectual property rights and may thereby dilute the value of our brands in the marketplace.  Brand dilution could cause confusion in the marketplace and adversely affect the value that consumers associate with our brands, which could negatively impact our business and sales.  In addition, third parties may assert claims against our intellectual property rights, and we may not be able to successfully resolve those claims, which would cause us to lose the right to use the intellectual property subject to those claims.  Such loss could have a material adverse effect on our financial condition and results of operations.  Furthermore, from time to time, we may be involved in litigation in which we are enforcing or defending our intellectual property rights, which could require us to incur substantial fees and expenses and have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on third parties for intellectual property relating to some of the products we sell, and our inability to maintain or enter into future license agreements may result in our failure to meet customer demand, which would adversely affect our business and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have licenses or manufacturing agreements with third parties that own intellectual property (e.g., formulae, copyrights, trademarks, trade dress, patents and other technology) used in the manufacture and sale of certain of our products.  In the event that any such license or manufacturing agreement expires or is otherwise terminated, we will lose the right to use the intellectual property covered by such license or agreement and will have to develop or obtain rights to use other intellectual property.  Similarly, our rights could be reduced if the applicable licensor or third-party manufacturer fails to maintain or protect the licensed intellectual property because, in such event, our competitors could obtain the right to use the intellectual property without restriction.  If this were to occur, we might not be able to develop or obtain replacement intellectual property in a timely or cost-effective manner.  Additionally, any modified products may not be well-received by customers.  The consequences of losing the right to use or having reduced rights to such intellectual property could negatively impact our business and sales due to our failure to meet consumer demand for the affected products or require us to incur costs for the development of new or different intellectual property, either of which could have a material adverse effect on our business, financial condition and results of operations.  In addition, development of replacement products may be time-consuming and ultimately may not be feasible.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Virtually all of our assets consist of goodwill and intangible assets and are subject to impairment risk. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our financial statements indicate, the majority of our assets consist of goodwill and intangible assets, principally the trademarks, tradenames and patents that we have acquired.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an annual basis, and otherwise when there is evidence that events or changes in circumstances indicate that the carrying value of intangible assets might not be recoverable, we assess the potential impairment of our goodwill and other intangible assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our brands sustain significant or prolonged declines in revenues or profitability or performance not in line with our expectations, the carrying value may no longer be recoverable, in which case a non-cash impairment charge may be recorded.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, if the Company&#8217;s brand performance is weaker than projections used in valuation calculations, the value of such brands may become impaired.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that such analysis would result in the fair value being lower than the carrying value, we would be required to record an impairment charge. A significant charge in our financial statements would negatively impact our financial condition and results of operations.   Although we experienced revenue declines in certain brands and we recorded non-cash impairment charges in recent years for certain assets, we continue to believe that the fair value of our brands exceed their carrying values as adjusted. However, sustained or significant future declines in revenue, profitability, lost distribution, other adverse changes in expected operating </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results, and/or unfavorable changes in economic factors used to estimate fair value of certain brands including the discount rate could indicate that the fair value no longer exceeds the carrying value, in which case a non-cash impairment charge may be recorded in future periods. Should the value of those assets or other assets become further impaired or our financial condition be materially adversely affected in any way, our tangible assets that could be sold to repay our liabilities would be reduced.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, our creditors and investors may not be able to recoup the amount of the indebtedness that they have extended to us or the amount they have invested in us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely significantly on information technology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any inadequacy, interruption, theft or loss of data, malicious attack, integration failure, failure to maintain the security, confidentiality or privacy of sensitive data residing on our systems or other security failure of that technology could harm our ability to effectively operate our business and damage the reputation of our brands.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely extensively on our information technology systems, some of which are managed by third-party service providers, to manage the data, communications and business processes for all of our functions, including our marketing, sales (including e-commerce), manufacturing, logistics, customer service, accounting and administrative functions. These systems include programs and processes relating to internal communications and communications with other parties, ordering and managing materials from suppliers, converting materials to finished products, marketing and selling products to customers (including through e-commerce channels), customer order entry and order fulfillment, shipping product to customers, billing customers and receiving and applying payment, processing transactions, summarizing and reporting results of operations, complying with regulatory, legal or tax requirements, collecting and storing customer, consumer, employee, investor, and other stakeholder information and personal data, and other processes necessary to manage the Company's business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and certain of our suppliers, have been, and likely will continue to be, subject to malware, computer viruses, computer hacking, attempted acts of data theft, phishing, other cyber-attacks and employee error or malfeasance related to our information technology systems.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any of these attacks or events has had a material adverse impact on our business, but future attacks could result in a serious information security breach and have a material adverse impact on our business or results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased information technology security threats and more sophisticated computer crime, including advanced persistent threats, pose a potential risk to the security of the information technology systems, networks, and services of the Company, its customers and business partners, as well as the confidentiality, availability, and integrity of the data of the Company, its customers and business partners. As a result, the Company's information technology systems, networks or service providers could be damaged or cease to function properly or the Company could suffer a loss or disclosure of business, personal or stakeholder information, due to any number of causes, including system disruptions, catastrophic events, power outages, cyber-attacks and security breaches. To help guard against these possibilities, the Company provides employee security training and maintains a compliance program with updated security policies to help evaluate and address potential threats and attacks. The Company has also conducted regular security audits by an outside firm based on the National Institute of Standards and Technology ("NIST") standards to address any potential service interruptions or vulnerabilities. Further, the Company has implemented continuity and recovery plans in the event of a disruption. However, if these plans do not provide effective protection, the Company may suffer interruptions in its ability to manage or conduct its operations, including in all of the Company&#8217;s functions described above, which may adversely affect its business and results of operations. The Company maintains security risk insurance in the event of a cybersecurity breach or incident; however, the coverage may not be sufficient to cover all losses. The Company may need to expend additional resources in the future to continue to protect against, or to address problems caused by, any business interruptions or data security breaches. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any breach of our data security, including the failure to maintain the security of confidential data and information or the misappropriation of such confidential data and information, could result in an unauthorized release or transfer of customer, consumer, user or employee information, or the loss of valuable business data or cause a disruption in our business. These events could give rise to unwanted media attention, damage our reputation, damage our customer, consumer or user relationships and result in lost sales, fines, lawsuits, remediation costs, or otherwise adversely impact the Company's results of operations and financial condition. We may also be required to expend significant capital and other resources to protect against or respond to or alleviate problems caused by a security breach. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we conduct our operations, we move data across national borders, and consequently we are subject to a variety of continuously evolving and developing laws and regulations in the United States and abroad regarding privacy, data protection and data security. The scope of the laws that may be applicable to us is often uncertain and may be conflicting, particularly with respect to foreign laws. For example, the European Union&#8217;s General Data Protection Regulation (the &#8220;GDPR&#8221;), which greatly </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increases the jurisdictional reach of European Union law and adds a broad array of requirements for handling personal data, including the public disclosure of significant data breaches, became effective in May 2018. In addition, several states have enacted data privacy laws applicable to entities serving or employing residents and other states are doing the same. We may not be able to comply with all of these evolving compliance and operational requirements and to do so may impose significant costs that are likely to increase over time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Financing</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our&#160;indebtedness could adversely affect our financial condition, and the significant amount of cash we need to service our debt would not be available to reinvest in our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, our total indebtedness, including current maturities, was approximately $1.5 billion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our indebtedness could:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Increase our vulnerability to general adverse economic and industry conditions;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Limit our ability to engage in strategic acquisitions;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Require us to dedicate a substantial portion of our cash flow from operations toward repayment of our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and investments and other general corporate purposes;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Limit, among other things, our ability to borrow additional funds on favorable terms or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the indentures governing our 3.750% senior notes due April 1, 2031 (the "2021 Senior Notes") and our 5.125% senior unsecured notes due January 15, 2028 (the "2019 Senior Notes"), and the credit agreement governing our term loan and revolving credit facility, allow us to issue and incur additional debt only upon satisfaction of the conditions set forth in those respective agreements.  If new debt is added to current debt levels, the related risks described above could increase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the United Kingdom Financial Conduct Authority announced its intention to transition away from LIBOR, with its full elimination to occur after 2021. The subsequent announcement in March 2021 indicated the last committed publication date for 1-month LIBOR will cease publishing immediately after June 30, 2023, and therefore may not continue to be available on the current basis (or at all) after this date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Alternate Reference Rate Committee, convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, has endorsed the Secured Overnight Financing Rate ("SOFR") as its preferred replacement benchmark for U.S. dollar LIBOR. SOFR is calculated and published by the New York Federal Reserve Bank and reflects the combination of three overnight U.S. Treasury Repo Rates. The rate is different from LIBOR, in that it is a risk-free rate, is backward-looking instead of forward-looking, is a secured rate and currently is available primarily as an overnight rate rather than a 1-,3- or 6-month rate available for LIBOR. Our term loan and revolving credit facility currently use LIBOR as a benchmark for establishing the interest rate.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If LIBOR ceases to exist and we do not want to use the alternative base rate under our term loan and/or cannot come to an agreement on a replacement rate under our revolving credit facility, we may need to renegotiate the terms of that indebtedness to replace LIBOR with SOFR or the new standard that is established.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the potential effect of eliminating LIBOR could increase the cost of our variable rate indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any increase in LIBOR or other interest rates, which have been rising in fiscal 2022 and are expected to continue to rise in fiscal 2023, will increase our cost of servicing our variable rate debt and further limit our ability to fund working capital, capital expenditures, and acquisitions.  At March&#160;31, 2022, we had $123.3 million of borrowing capacity available under our revolving credit facility to support our operating activities.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our capital structure and ability to engage in strategic transactions is limited in significant respects by the restrictive covenants in our senior credit facility and the indentures governing our senior notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior credit facility and the indentures governing our senior notes impose restrictions that could impede our ability to enter into certain corporate transactions, as well as increase our vulnerability to adverse economic and industry conditions, by limiting our flexibility in planning for, and reacting to, changes in our business and industry.  These restrictions limit our ability to, among other things:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Borrow money or issue guarantees;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Pay dividends, repurchase stock from, or make other restricted payments to, stockholders;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Make investments or acquisitions;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Use assets as security in other transactions;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Sell assets or merge with or into other companies;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Enter into transactions with affiliates;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Sell stock in our subsidiaries; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Limits our subsidiaries' ability to pay dividends or make other payments to us.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to engage in these types of transactions is generally limited by the terms of the senior credit facility and the indentures governing the senior notes, even if we believe that a specific transaction would positively contribute to our future growth, operating results or profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our senior credit facility requires us to maintain certain leverage, interest coverage and fixed charge ratios.  Although we believe we can continue to meet and/or maintain the financial covenants contained in our credit agreement, our ability to do so may be affected by events outside our control.  Covenants in our senior credit facility also require us to use 100% of the proceeds we receive from non-permitted debt issuances or certain issuances of refinancing debt to repay outstanding borrowings under our senior credit facility.  Any failure by us to comply with the terms and conditions of the credit agreement and the indentures governing the senior notes could result in an event of default, which may allow our creditors to accelerate our debt and therefore have a material adverse effect on our financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The senior credit facility and the indentures governing the senior notes contain cross-default provisions that could result in the acceleration of all of our indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The senior credit facility and the indentures governing the senior notes contain provisions that allow the respective creditors to declare all outstanding borrowings under one agreement to be immediately due and payable as a result of a default under another agreement.  Consequently, failure to make a payment required by the indentures governing the senior notes, among other things, may lead to an event of default under the senior credit facility.  Similarly, an event of default or failure to make a required payment at maturity under the senior credit facility, among other things, may lead to an event of default under the indentures governing the senior notes.  If the debt under the senior credit facility and indentures governing the senior notes had both been accelerated, the aggregate amount immediately due and payable as of March&#160;31, 2022 would have been approximately $1.5 billion.&#160;&#160;We presently do not have sufficient liquidity to repay these borrowings in the event they were to be accelerated, and we may not have sufficient liquidity in the future to do so.&#160;&#160;Additionally, we may not be able to borrow money from other lenders to enable us to refinance our indebtedness.&#160;&#160;At March&#160;31, 2022, the book value of our current assets was $293.3 million.&#160;&#160;Although the book value of our total assets was $3,670.7 million, approximately $3,275.6 million was in the form of intangible assets, including goodwill of $579.0 million, a significant portion of which may not be available to satisfy our creditors in the event our debt is accelerated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to comply with the restrictions of the senior credit facility, the indentures governing the senior notes or any other subsequent financing agreements may result in an event of default.  Such default may allow the creditors to accelerate the related debt, as well as any other debt to which the cross-acceleration or cross-default provisions apply.  In addition, the lenders may be able to terminate any commitments they had made to supply us with additional funding.  As a result, any default by us under our credit agreement, indentures governing the senior notes or any other financing agreement could have a material adverse effect on our financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation may adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to the risk of, and from time to time in the ordinary course of business we are involved in, litigation by employees, customers, consumers, suppliers, competitors, regulators, stockholders or others through private actions, class actions, administrative proceedings, regulatory actions or other litigation.  The outcome of litigation, particularly class action lawsuits and regulatory actions, is difficult to assess or quantify.  Plaintiffs in these types of lawsuits may seek recovery of very large or indeterminate amounts, and the magnitude of the potential loss relating to such lawsuits may remain unknown for substantial periods of time.  The cost to defend current and future litigation may be significant.  There may also be adverse publicity associated with litigation that could decrease customer or consumer acceptance of our products, regardless of whether the allegations are valid or whether we are ultimately found liable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, although our marketing is evidence-based, consumers and competitors may challenge, and have challenged, certain of our marketing claims by alleging, among other things, false and misleading advertising with respect to advertising for certain of our products. Such challenges could result in our having to pay monetary damages or limit our ability to maintain current marketing claims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversely, we have, and may be required in the future to, initiate litigation against others to protect the value of our intellectual property and the related goodwill or enforce an agreement or contract that has been breached.  These matters may be time consuming and expensive, but may be necessary to protect our assets and realize the benefits of the agreements and contracts that we have negotiated.  As a result, litigation may adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our key personnel, and the loss of the services provided by any of our executive officers or other key employees could harm our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends to a significant degree upon the continued contributions of our senior management.  These employees may voluntarily terminate their employment with us at any time.  We may not be able to successfully retain existing personnel or identify, hire and integrate new personnel.  While we believe we have developed depth and experience among our key personnel, our business may be adversely affected if one or more of these key individuals were to leave or were to experience serious illness, become disabled, or pass away.  We do not maintain any key-man or similar insurance policies covering any of our senior management or key personnel.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our amended and restated certificate of incorporation and Delaware law may discourage potential acquirers of our company, which could adversely affect the value of our securities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation provides that our Board of Directors is authorized to issue from time to time, without further stockholder approval, up to five million shares of preferred stock in one or more series of preferred stock issuances.  Our Board of Directors may establish the number of shares to be included in each series of preferred stock and determine, as applicable, the voting and other powers, designations, preferences, rights, qualifications, limitations and restrictions for such series of preferred stock.  The shares of preferred stock could have preferences over our common stock with respect to dividends and liquidation rights.  We may issue additional preferred stock in ways which may delay, defer or prevent a change in control of the Company without further action by our stockholders.  The shares of preferred stock may be issued with voting rights that may adversely affect the voting power of the holders of our common stock by increasing the number of outstanding shares having voting rights, and by the creation of class or series voting rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation, as amended, contains additional provisions that may have the effect of making it more difficult for a third-party to acquire or attempt to acquire control of our company.  In addition, we are subject to certain provisions of Delaware law that limit, in some cases, our ability to engage in certain business combinations with significant stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, either alone, or in combination with each other, give our current directors and executive officers the ability to significantly influence the outcome of a proposed acquisition of the Company.  These provisions would apply even if an acquisition or other significant corporate transaction was considered beneficial by some of our stockholders.  If a change in control or change in management is delayed or prevented by these provisions, the market price of our outstanding securities could be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our provision for income taxes or adverse outcomes resulting from examination of our income tax returns could adversely affect our results. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes is subject to volatility and could be adversely affected by several factors, some of which are outside of our control, including:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in the income allocation methods for state taxes, and the determination of which states or countries have jurisdiction to tax our Company;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">An increase in non-deductible expenses for tax purposes, including certain stock-based compensation, executive compensation and impairment of goodwill; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Transfer pricing adjustments;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Tax assessments resulting from tax audits or any related tax interest or penalties that could significantly affect our income tax provision for the period in which the settlement takes place; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Tax liabilities from acquired businesses;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in accounting principles; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in tax laws or related interpretations, accounting standards, regulations, and interpretations in multiple tax jurisdictions in which we operate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required to determine the recognition and measurement of the attributes prescribed in Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 740.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a multinational corporation, we conduct our business in several countries and are subject to taxation in many jurisdictions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The taxation of our business is subject to the application of multiple and sometimes conflicting tax laws and regulations as well as multinational tax conventions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate is dependent upon the availability of tax credits and carryforwards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax laws themselves are subject to change as a result of changes in fiscal policy, changes in legislation, and the evolution of regulations and court rulings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, taxing authorities may impose tax assessments or judgments against us that could materially impact our tax liability and/or our effective income tax rate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may be subject to examination of our income tax returns by the Internal Revenue Service and other tax authorities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If tax authorities challenge the relative mix of our U.S. and international income, or successfully assert the jurisdiction to tax our earnings, our future effective income tax rates could be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.  UNRESOLVED STAFF COMMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.  PROPERTIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our corporate headquarters located in Tarrytown, New York.&#160;&#160;Primary functions performed at the Tarrytown facility include marketing, sales, operations, quality control, regulatory affairs, finance, information technology and legal.&#160;&#160;The lease expires on December 31, 2027.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our logistics provider, GEODIS, has leased a warehouse on our behalf located in Clayton, Indiana.  This property serves as our primary warehouse. The lease expires on September 30, 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own an office and manufacturing facility in Lynchburg, Virginia.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.  LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved from time to time in routine legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the resolution of routine matters and other incidental claims, taking our reserves into account, will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.  MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II</span></div><div style="text-align:center"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.  MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on The New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;PBH.&#8221;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May 5, 2022, there were 17 holders of record of our common stock.&#160;&#160;The number of record holders does not include beneficial owners whose shares are held in the names of banks, brokers, nominees or other fiduciaries.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not in the past paid, and do not expect to pay, cash dividends on our common stock.&#160;&#160;Instead, we anticipate that all of our earnings in the foreseeable future will be used in our operations, to facilitate strategic acquisitions, to repurchase our common stock, or to pay down our outstanding indebtedness.&#160;&#160;Any future determination to pay dividends will be at the discretion of our Board of Directors and will depend, among other factors, on our results of operations, financial condition, capital requirements and contractual restrictions limiting our ability to declare and pay cash dividends, including restrictions under our 2012 Term Loan and the indentures governing our senior notes, and any other considerations our Board of Directors deems relevant.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part III, Item 12. "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" of this Annual Report on Form 10-K is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERFORMANCE GRAPH </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph (&#8220;Performance Graph&#8221;) compares our cumulative total stockholder return since March&#160;31, 2017, with the cumulative total stockholder return for the Russell 2000 Index, Standard &amp; Poor's SmallCap 600 Index and our peer group index.  The Company is included in each of the Standard &amp; Poor's SmallCap 600 Index and the Russell 2000 Index.  The Performance Graph assumes that the value of the investment in the Company&#8217;s common stock and each index was $100.00 on March&#160;31, 2017.&#160;&#160;The Performance Graph was also prepared based on the assumption that all dividends paid, if any, were reinvested.&#160;&#160;The Peer Group Index is a self-constructed peer group consisting of companies in the consumer products industry with comparable revenues and market capitalization, from which the Company has been excluded.  Two companies in the Old Peer Group, Akorn, Inc., and Amag Pharmaceuticals, Inc were replaced in the New Peer Group by Lannet Co. and Usana Health Sciences, Inc. as they ceased to be relevant peers due to bankruptcy and acquisition, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="pbh-20220331_g2.jpg" alt="pbh-20220331_g2.jpg" style="height:395px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:28.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.970%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company/Market/Peer Group</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prestige Consumer Healthcare Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.02&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell 2000 Index</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P SmallCap 600 Index</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Peer Group Index </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Old Peer Group Index</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.64</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Peer Group index is comprised of: (i) B&amp;G Food Holdings Corp., (ii) Hain Celestial Group, Inc., (iii) Church &amp; Dwight Co., Inc., (iv) Helen of Troy, Ltd., (v) Vista Outdoors, Inc., (vi) Tupperware Brands Corporation, (vii) Revlon, Inc., (viii) Jazz Pharmaceuticals PLC, (ix) Edgewell Personal Care Company, (x) Energizer Holdings, Inc., (xi) Calavo Growers, Inc., (xii) Primo Water Corporation,  (xiii) Lannet Co., and&#160;(xiv) Usana Health Sciences, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Old Peer Group index is comprised of: (i) B&amp;G Food Holdings Corp., (ii) Hain Celestial Group, Inc., (iii) Church &amp; Dwight Co., Inc., (iv) Helen of Troy, Ltd., (v) Vista Outdoors, Inc., (vi) Tupperware Brands Corporation, (vii) Revlon, Inc., (viii) Jazz Pharmaceuticals PLC, (ix) Edgewell Personal Care Company, (x) Energizer Holdings, Inc., (xi) Calavo Growers, Inc., (xii) Primo Water Corporation, (xiii) Akorn, Inc., and (xiv) Amag Pharmaceuticals, Inc.&#160; </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Performance Graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Annual Report on Form 10-K into any filing under the Securities Act or the Exchange Act, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed filed under such Acts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.  RESERVED</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read together with the Consolidated Financial Statements and related notes included elsewhere in this Annual Report on Form 10-K.&#160;This discussion and analysis may contain forward-looking statements that involve certain risks, assumptions and uncertainties that could cause actual results to differ materially from those implied or described by the forward-looking statements.  Future results could differ materially from the discussion that follows for many reasons, including the factors described in Part I, Item 1A. &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K, as well as those described in future reports filed with the SEC.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name OTC health and personal care products to mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160; We use the strength of our brands, our established retail distribution network, a low-cost operating model and our experienced management team to create our competitive advantage.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown our product portfolio both organically and through acquisitions.  We develop our existing brands by investing in new product lines, brand extensions and strong advertising support.  Acquisitions of consumer health and personal care brands have also been an important part of our growth strategy.  We have acquired well-recognized brands from consumer products and pharmaceutical companies and private equity firms. While certain of these brands have long histories of brand development and investment, we believe that, at the time we acquired them, most were considered &#8220;non-core&#8221; by their previous owners.  As a result, these acquired brands did not benefit from adequate management focus and marketing support during the period prior to their acquisition, which created opportunities for us to reinvigorate these brands and improve their performance post-acquisition.  After adding a core brand to our portfolio, we seek to increase its sales, market share and distribution in both existing and new channels through our established retail distribution network.  We pursue this growth through increased spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations and innovative development of brand extensions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn") pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9&#160;million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under the 2012 ABL Revolver and the net proceeds from the refinancing of our term loan originally entered into on January 31, 2012 (the "2012 Term Loan").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  During 2022, we incurred acquisition-related costs of $5.1&#160;million, which are included in General and administrative expense.  In connection with the acquisition, we also entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  These purchase price allocations are preliminary as we are in the process of finalizing the valuation.  The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this preliminary analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $1.6&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired.  Goodwill is deductible and is being amortized for income tax purposes. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the World Health Organization ("WHO") declared a global pandemic due to a new strain of coronavirus ("COVID-19").  The pandemic has caused significant volatility in the United States and global economies.  In addition, the Russian invasion of Ukraine has led to further economic uncertainty.  We expect economic conditions will continue to be highly volatile and uncertain and could affect demand for our products and put pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We experienced a temporary but significant decline in consumer consumption of our brands in the first quarter of fiscal 2021, followed by more stable consumption and customer orders over the remainder of the year. Generally, throughout the pandemic, some categories were positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products, as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel-related activity. In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio. Our business also benefited from a significant increase in demand in travel-related categories and channels as well as the Cough &amp; Cold category, previously impacted by the COVID-19 virus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both the COVID-19 pandemic and the geopolitical environment have also impacted the supply of labor and raw materials and exacerbated rising costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These circumstances could change, however, in this dynamic, unprecedented environment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the COVID-19 outbreak worsens or geopolitical conditions cause further disruption in the global supply chain, the availability of labor or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreak and recovery period and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Reform </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  </span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in the notes to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.&#160;&#160;While all significant accounting policies are important to our Consolidated Financial Statements, certain of these policies may be viewed as being critical.&#160;&#160;Such policies are those that are both most important to the portrayal of our financial condition and results of operations and require our most difficult, subjective and complex estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses or the related disclosure of contingent assets and liabilities.&#160;&#160;These estimates are based on our historical experience and on various other assumptions that we believe to be reasonable under the circumstances.&#160;&#160;Actual results may differ materially from these estimates.  The following are our most critical accounting estimates:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition, Customer Programs and Variable Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#8217;s carrier.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product.  It is at this point that we have a right to payment and the customer has legal title.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Obligations and Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process. The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discount rate assumption for our defined benefit plans changed to a range of 3.26% to 3.48% at March&#160;31, 2022 from a range of 2.58% to 2.95% at March&#160;31, 2021.  This increase was due to market changes.  While we do not currently anticipate a change in our fiscal 2023 assumptions, as a sensitivity measure, a 0.25% decline or increase in our qualified discount rate would increase or decrease our qualified pension expense by less than $0.1 million. Similarly, a 0.25% decrease or increase in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the expected return on our pension plan assets would increase or decrease our qualified pension expense by approximately $0.1 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts that we recognize in our financial statements for pension benefit obligations are determined by actuarial valuations.  Inherent in these valuations are certain assumptions, the more significant of which are:  (i) the weighted average discount rate used for discounting the liability, (ii) the weighted average expected long-term rate of return on pension plan assets, (iii) the method used to determine the market-related value of pension plan assets, and (iv) the anticipated mortality rate tables.  We believe the current assumptions used to estimate plan obligations and pension expense are appropriate in the current economic environment.  However, as economic conditions change, we may change some of our assumptions, which could have a material impact on our financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute. During fiscal 2022, we made total contributions to our pension plans of $0.4&#160;million.  We do not expect to make a contribution to our qualified defined benefit pension plan during fiscal 2023.  Changes in interest rates and the market value of the securities held by the plans could materially change, positively or negatively, the funded status of the plans and affect the level of pension expense and required contributions. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets amounted to $3,275.6 million and $3,053.8 million at March&#160;31, 2022 and 2021, respectively.&#160;&#160;At March&#160;31, 2022 and 2021, goodwill and intangible assets were apportioned among similar product groups within our operating segments as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275,611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:54.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, the brands with the highest carrying value were </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Monistat, Summer's Eve, BC/Goody's, TheraTears and DenTek</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, comprising 60.6% of our total intangible assets value.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets comprise the majority of all of our assets.&#160;&#160;Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination.&#160;&#160;Intangible assets generally represent our tradenames, brand names and patents.&#160;&#160;When we acquire a brand, we are required to make judgments regarding the value assigned to the associated intangible assets, as well as their respective useful lives.&#160;&#160;Management considers many factors both prior to and after the acquisition of an intangible asset in determining the value, as well as the useful life, assigned to each intangible asset that we acquire or continue to own and promote.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant factors are:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Brand History</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A brand that has been in existence for a long period of time (e.g., 25, 50 or 100 years) generally warrants a higher valuation and longer life (sometimes indefinite) than a brand that has been in existence for a very short period of time.&#160;&#160;A brand that has been in existence for an extended period of time generally has been the subject of considerable investment by its previous owner(s) to support product innovation and advertising and marketing.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Market Position</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer products that rank number one or two in their respective market generally have greater name recognition and are known as quality product offerings, which warrant a higher valuation and longer life than products that lag in the marketplace.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Recent and Projected Sales Growth</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent sales results present a snapshot as to how the brand has performed in the most recent time periods and represent another factor in the determination of brand value.&#160;&#160;In addition, projected sales growth provides information about the strength and potential longevity of the brand.&#160;&#160;A brand that has both strong current and projected sales generally warrants a higher valuation and a longer life than a brand that has weak or declining sales.&#160;&#160;Similarly, consideration is given to the potential investment, in the form of advertising and marketing, required to reinvigorate a brand that has fallen from favor.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">History of and Potential for Product Extensions</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration is given to the product innovation that has occurred during the brand&#8217;s history and the potential for continued product innovation that will determine the brand&#8217;s future.&#160;&#160;Brands that can be continually enhanced by new product offerings generally warrant a higher valuation and longer life than a brand that has always &#8220;followed the leader&#8221;.</span></div><div style="padding-left:36pt;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After consideration of the factors described above, as well as current economic conditions and changing consumer behavior, management prepares a determination of an intangible asset&#8217;s value and useful life based on its analysis.&#160;&#160;Under accounting guidelines, goodwill is not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount.&#160;&#160;In a similar manner, indefinite-lived assets are not amortized.&#160;&#160;They are also subject to an annual impairment test or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Additionally, at each reporting period an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life.&#160;&#160;Intangible assets with finite lives are amortized over their respective estimated useful lives and must also be tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an annual basis, during the fourth fiscal quarter, concurrent with our annual strategic planning process, or more frequently if conditions indicate that the carrying value of the asset may not be recovered, management performs a review of both the values and, if applicable, useful lives assigned intangible assets and tests for impairment.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report goodwill and indefinite-lived intangible assets in two reportable segments: North American OTC Healthcare and International OTC Healthcare.  We identify our reporting units in accordance with the FASB ASC Subtopic 280.  The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies.&#160;&#160;As a result, any material changes to these assumptions could require us to record additional impairment in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have experienced declines in revenues and profitability of certain brands in the North American OTC Healthcare segment.&#160;&#160;Sustained or significant future declines in revenue, profitability, other adverse changes in expected operating results, and/or unfavorable changes in other economic factors used to estimate fair values of certain brands could indicate that fair value no longer exceeds carrying value, in which case additional non-cash impairment charges may be recorded in future periods. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually and whenever events and circumstances indicate that impairment may have occurred.  As of February&#160;28, 2022 (our annual impairment review date), we had 14 reporting units with goodwill.  As part of our annual test for impairment of goodwill, management estimates the discounted cash flows of each reporting unit to estimate their respective fair values.&#160;&#160;In performing this analysis, management considers current information and future events, such as competition, technological advances and changes in advertising support for our trademarks and tradenames, that could cause subsequent evaluations to utilize different assumptions. &#160;The discount rate utilized in the analysis, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation.  Additionally, should the related fair value of goodwill be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances or changes in advertising and marketing expenses, we may be required to record additional impairment charges in the future.  In addition, we considered our market capitalization at February&#160;28, 2022, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.  An impairment charge is then recognized for the amount by which the carrying amount exceeds the reporting unit's fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2021, in conjunction with the annual test for goodwill impairment, we recorded an impairment charge of $1.2&#160;million to adjust the carrying amount of goodwill related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in our International OTC Healthcare segment to its fair value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2022, in conjunction with the annual test for goodwill impairment, we recorded an impairment charge of $0.3&#160;million to write off the remaining goodwill related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in our International OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our analysis at February&#160;28, 2022, all other reporting units tested had a fair value that exceeded their carrying value by at least 10%.  We performed a sensitivity analysis on our weighted average cost of capital and determined that a 50 basis point increase in the weighted average cost of capital would not have resulted in any of our other reporting units' implied fair value being less than their carrying value.  Additionally, a 50 basis point decrease in the terminal growth rate used for each reporting unit would also not have resulted in any of our other reporting units&#8217; implied fair value being less than their carrying value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Indefinite-Lived Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangibles are tested for impairment annually and whenever events and circumstances indicate that impairment may have occurred.  We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The discount rate utilized in the analysis, as well as future cash flows, may be influenced by such factors as changes in interest rates and rates of inflation.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting period, management analyzes current events and circumstances to determine whether the indefinite life classification for a trademark or tradename continues to be valid.&#160;&#160;If circumstances warrant a change to a finite life, the carrying value of the intangible asset would then be amortized prospectively over the estimated remaining useful life.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management tests the indefinite-lived intangible assets for impairment by comparing the carrying value of the intangible asset to its estimated fair value.&#160;&#160;Since quoted market prices are seldom available for trademarks and tradenames such as ours, we utilize present value techniques to estimate fair value.&#160;&#160;Accordingly, management&#8217;s projections are utilized to assimilate all of the facts, circumstances and expectations related to the trademark or tradename and estimate the cash flows over its useful life.&#160;&#160;In a manner similar to goodwill, future events, such as competition, technological advances and changes in advertising support for our trademarks and tradenames, could cause subsequent evaluations to utilize different assumptions.&#160; Once that analysis is completed, a discount rate is applied to the cash flows to estimate fair value.  In connection with this analysis, management:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reviews period-to-period sales and profitability by brand;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analyzes industry trends and projects brand growth rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prepares annual sales forecasts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Evaluates advertising effectiveness;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analyzes gross margins;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reviews contractual benefits or limitations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Monitors competitors&#8217; advertising spend and product innovation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prepares projections to measure brand viability over the estimated useful life of the intangible asset; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Considers the regulatory environment, as well as industry litigation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2022, in conjunction with the annual test for impairment of intangible assets, there were no indicators of impairment of indefinite-lived intangible assets under the analysis and accordingly, no impairment charge was taken. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of our analysis at February&#160;28, 2022, all indefinite-lived intangible assets tested had a fair value that exceeded their carrying value by at least 10%, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename which had a fair value exceeding its carrying value by 7%.  We performed a sensitivity analysis of our weighted average cost of capital, and we determined that a 50 basis point increase in the weighted average cost of capital used to value the indefinite-lived intangible assets would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename was acquired on July 1, 2021 and, given the close proximity of the acquisition to the annual impairment test, we would expect the fair value to more closely approximate the carrying value.   A 50 basis point increase in the weighted average cost of capital would result in an impairment charge of $4.3 million on our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename.  Additionally, a 50 basis point decrease in the terminal growth rate used for each of our indefinite-lived intangible assets' would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Finite-Lived Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an annual basis, or when events or changes in circumstances indicate the carrying value of the assets may not be recoverable, management performs a review similar to indefinite-lived intangible assets to ascertain the impact of events and circumstances on the estimated useful lives and carrying values of our trademarks and tradenames.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the analysis warrants a change in the estimated useful life of the intangible asset, management will reduce the estimated useful life and amortize the carrying value prospectively over the shorter remaining useful life.&#160;&#160;Management&#8217;s projections are utilized to assimilate all of the facts, circumstances and expectations related to the trademark or tradename and estimate the cash flows over its useful life.&#160; Future events, such as competition, technological advances and changes in advertising support for our trademarks and tradenames, could cause subsequent evaluations to utilize different assumptions.&#160; In the event that the long-term projections indicate that the carrying value is in excess of the undiscounted cash flows expected to result from the use of the intangible assets, management is required to record an impairment charge.&#160;&#160;Once that analysis is completed, a discount rate is applied to the cash flows to estimate fair value.&#160;&#160;The impairment charge is measured as the excess of the carrying amount of the intangible asset over fair value, as calculated using the excess earnings method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, did not exceed its carrying amount.  As such, we recorded an impairment charge of $1.2&#160;million. The decline in the fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was primarily related to a decline in expected future sales due to a regulatory change that now requires </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to be prescribed by physicians rather than sold over-the-counter direct to consumers.   At February&#160;28, 2021, in conjunction with the annual test for impairment of intangible assets, there were no additional indicators of impairment of our finite-lived intangible assets and accordingly, no additional impairment charge was taken. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2022, in conjunction with the annual test for impairment of intangible assets, an impairment charge of $0.7&#160;million was recorded.  In connection with our long-term planning, two non-core brands in our North American OTC Healthcare segment were discontinued and therefore the related finite-lived intangible assets were written off. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation and Equity topic of the FASB ASC 718 requires us to measure the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;For most of our awards, compensation expense is to be recognized over the period during which an employee is required to provide service in exchange for the award, generally referred to as the requisite service period.  We also grant performance stock units, which are contingent on the attainment of certain goals of the Company.&#160;&#160;Information utilized in the determination of fair value includes the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Type of instrument (i.e., restricted shares, stock options, warrants or performance shares);</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strike price of the instrument;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market price of our common stock on the date of grant;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Discount rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Duration of the instrument; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility of our common stock in the public market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, management must estimate the expected attrition rate of the recipients to enable it to estimate the amount of non-cash compensation expense to be recorded in our financial statements.&#160;&#160;While management prepares various analyses to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimate the respective variables, a change in assumptions or market conditions, as well as changes in the anticipated attrition rates, could have a significant impact on the future amounts recorded as non-cash compensation expense.&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued and adopted accounting pronouncements is included in the notes to the Consolidated Financial Statements in Item 8, Note 1 of this Annual Report.</span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 compared to 2021 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Segment Revenues</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents total revenue by segment, including product groups, for each of the fiscal years ended March&#160;31, 2022 and 2021.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">North American OTC Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total North American OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967,881&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">International OTC Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,885&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consolidated</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,447&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total segment revenues for 2022 were $1,086.8 million, an increase of $143.4 million, or 15.2%, versus 2021.  Both of our business segments contributed to the growth over the prior year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the North American OTC Healthcare segment increased $118.6 million, or 14.0%, during 2022 versus 2021.  2022 was primarily positively impacted by the Eye &amp; Ear Care, Cough &amp; Cold, and Gastrointestinal categories, as well as certain other categories. The positively impacted categories benefited from increased consumer travel, as well as improved demand, as a result of easing COVID-19 restrictions.  The current period also benefited from the newly acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand (included in the Eye &amp; Ear Care category) as part of the Akorn asset acquisition, with revenues in North America of $42.2 million in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for the International OTC Healthcare segment increased $24.9 million, or 26.5%, during 2022 versus 2021.  The $24.9 million increase was mainly attributable to increased sales in our Australian subsidiary, primarily related to an increase in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hydralyte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (included in the Gastrointestinal category) as a result of easing COVID-19 restrictions, as well as an increase in consumer illnesses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the fiscal years ended March&#160;31, 2022 and 2021.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Gross Profit </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for 2022 increased $73.2 million, or 13.4%, versus 2021.  As a percentage of total revenues, gross profit decreased to 57.1% in 2022 from 58.0% in 2021.  The decrease in gross profit as a percentage of revenues was primarily due to increased supply chain costs and related to charges for the step up of the inventory valuation of the acquired Akorn brands in fiscal 2022 of $1.6 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the North American OTC Healthcare segment increased $58.5 million, or 11.9%, during 2022 versus 2021.&#160; As a percentage of North American OTC Healthcare revenues, gross profit decreased to 56.7% during 2022 from 57.7% during 2021, primarily due to increased supply chain costs and charges related to the inventory valuation of the acquired Akorn brands in fiscal 2022 of $1.6 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the International OTC Healthcare segment increased $14.7 million, or 25.6%, during 2022 versus 2021.  As a percentage of International OTC Healthcare revenues, gross profit decreased to 60.5% during 2022 from 60.9% during 2021, primarily due to increased supply chain costs.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contribution Margin</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin is our segment measure of profitability.  It is defined as gross profit less advertising and marketing expenses.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our contribution margin and contribution margin as a percentage of total segment revenues, by segment for each of the fiscal years ended March&#160;31, 2022 and 2021.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Contribution Margin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,303&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,420&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">North American OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin for the North American OTC Healthcare segment increased $42.6 million, or 11.6%, during 2022 versus 2021.  As a percentage of North American OTC Healthcare revenues, contribution margin for the North American OTC Healthcare segment decreased to 42.4% during 2022 from 43.3% during 2021.  The contribution margin decrease as a percentage of revenues was primarily due to an increase in advertising and marketing expenses as well as the decrease in gross profit margin noted above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International OTC Healthcare Segment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution margin for the International OTC Healthcare segment increased $13.8 million, or 34.9%, during 2022 versus 2021. As a percentage of International OTC Healthcare revenues, contribution margin for the International OTC Healthcare segment increased to 44.8% during 2022 from 42.0% during 2021.  The contribution margin increase as a percentage of revenues was primarily due to decreased advertising and marketing expenses as a percentage of revenues in 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General and Administrative</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $108.5 million for 2022 versus $85.5 million for 2021. The increase in general and administrative expenses was primarily due to increases in compensation costs and professional fees, as well as costs related to the acquisition of Akorn of $5.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $24.9 million for 2022 versus $23.9 million for 2021.  The increase in depreciation and amortization expenses was attributable to an increase in amortization expense due to the addition of certain brands purchased in conjunction with the Akorn acquisition, partly offset by certain assets being fully depreciated during 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $64.3 million during 2022 versus $82.3 million during 2021.&#160; The average indebtedness remained at $1.6 billion during 2021 and 2022.  The average cost of borrowing decreased to 4.1% for 2022 from 5.1% for 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on Extinguishment of Debt</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we recorded a loss on extinguishment of debt of $2.1 million, related to the amendment of our 2012 Term Loan on July 1, 2021.  During 2021, we recorded a loss on extinguishment of debt of $12.3 million, representing the premium paid to redeem our 6.375% 2016 Senior Notes in March 2021 of $9.6 million and the related write off of debt costs of $2.7 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes during 2022 was $57.1 million versus $39.4 million in 2021.&#160;&#160;The effective tax rate on income before income taxes was 21.7% during 2022 versus 19.3% during 2021.  The increase in the effective tax rate in 2022 compared to 2021 was primarily due to the final GILTI regulations issued in July 2020, which resulted in the release of the valuation allowance on foreign tax credit carryforwards of $5.4&#160;million for 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 compared to 2020 <br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of fiscal 2021 compared to 2020, please refer to our 2021 Annual Report on Form 10-K Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, filed with the SEC on May 7, 2021. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of cash comes from our cash flow from operations.  In the past, we have supplemented this source of cash with various debt facilities, primarily in connection with acquisitions.  We have financed our operations, and expect to continue to finance our operations over the next twelve months, with a combination of funds generated from operations and borrowings.&#160; Our principal uses of cash are for operating expenses, debt service, capital expenditures, share repurchases, and acquisitions.  Based on our current levels of operations and anticipated growth, excluding acquisitions, we believe that our cash generated from operations and our existing credit facilities will be adequate to finance our working capital and capital expenditures through the next twelve months, although no assurance can be given in this regard.  See "Economic Environment Since the Coronavirus Outbreak" above.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.313%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256,511)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,570)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,673)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,419)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,431)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,117)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,458)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,688)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 compared to 2021 </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $259.9 million for 2022 compared to $235.6 million for 2021.&#160;&#160;The $24.3 million increase in net cash provided by operating activities was due to an increase in net income after non-cash items, partly offset by increased working capital. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $256.5 million for 2022 compared $22.2 million for 2021.&#160;&#160;The increase was primarily due to acquisitions of $247.0 million in the current period, partly offset by a decrease in capital expenditures in the current period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in financing activities was $7.6 million for 2022 compared to $279.4 million for 2021.   In 2022, we had no net change in our long-term debt principal, as prepayments served to offset the borrowings to finance the Akorn acquisition and payments of debt costs of $6.1 million.  In 2021, we reduced our outstanding long-term debt by $250.0 million, paid debt costs of $17.7 million and repurchased common stock of $11.9 million.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 compared to 2020</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $235.6&#160;million for 2021 compared to $217.1&#160;million for 2020.&#160;&#160;The $18.5&#160;million increase in net cash provided by operating activities was due to an increase in net income after non-cash items, partly offset by increased working capital.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $22.2&#160;million for 2021 compared $16.6&#160;million for 2020.&#160;&#160;The increase was primarily due to an increase in capital expenditures in 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $279.4&#160;million for 2021 compared to $131.4&#160;million for 2020.&#160; The increase was primarily due to increased repayments of debt of $97.0 million, decreased borrowings of $85.0 million and an increase in payment of debt costs of $11.1 million in 2021 compared to 2020, partly offset by a decrease in our repurchase of common stock of $44.8 million compared to the prior year.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2012 Term Loan and 2012 ABL Revolver:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2012, Prestige Brands, Inc. ("the Borrower") entered into a senior secured credit facility, which consists of (i) a $660.0 million term loan (the "2012 Term Loan") with an original 7-year maturity and (ii) a $50.0 million asset-based revolving credit facility (the "2012 ABL Revolver") with an original 5-year maturity.  In subsequent years, we have utilized portions of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $85.0 million to $135.0 million and reduced our borrowing rate on the 2012 ABL Revolver by 0.25% (discussed below).  The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to the Borrower of $650.1 million.  The 2012 Term Loan is unconditionally guaranteed by Prestige Consumer Healthcare Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower.  Each of these guarantees is joint and several.  There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2013, we entered into Amendment No. 1 ("Term Loan Amendment No. 1") to the 2012 Term Loan.  Term Loan Amendment No. 1 provided for the refinancing of all of the Borrower's existing Term B Loans with new Term B-1 Loans (the "Term B-1 Loans").  The interest rate on the Term B-1 Loans under Term Loan Amendment No. 1 was based, at our option, on a LIBOR rate plus a margin of 2.75% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin.  In addition, Term Loan Amendment No. 1 provided the Borrower with certain additional capacity to prepay subordinated debt, our then-outstanding senior notes and certain other unsecured indebtedness permitted to be incurred under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2014, we entered into Amendment No. 2 ("Term Loan Amendment No. 2") to the 2012 Term Loan.  Term Loan Amendment No. 2 provided for (i) the creation of a new class of Term B-2 Loans under the 2012 Term Loan (the "Term B-2 Loans") in an aggregate principal amount of $720.0 million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility and financial maintenance covenant relief, and (iii) an interest rate on (x) the Term B-1 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.125% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin, and (y) the Term B-2 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.50% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin (with a margin step-down to 3.25% per annum, based upon achievement of a specified secured net leverage ratio). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on September 3, 2014, we entered into Amendment No. 3 ("ABL Amendment No. 3") to the 2012 ABL Revolver.  ABL Amendment No. 3 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility.  Borrowings under the 2012 ABL Revolver, as amended, bore interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., and (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs.  The applicable margin for borrowings under the 2012 ABL Revolver could be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter.  In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we were required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder.  The initial commitment fee rate was 0.50% per annum.  The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments by an amount set forth in the credit agreement covering the 2012 ABL Revolver.  We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2015, we entered into Amendment No. 3 ("Term Loan Amendment No. 3") to the 2012 Term Loan.  Term Loan Amendment No. 3 provided for (i) the creation of a new class of Term B-3 Loans under the 2012 Term Loan (the "Term B-3 Loans") in an aggregate principal amount of $852.5 million, which combined the outstanding balances of the Term B-1 Loans of $207.5 million and the Term B-2 Loans of $645.0 million, and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  The maturity date of the Term B-3 Loans remained the same as the Term B-2 Loans' original maturity date of September 3, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2015, we entered into Amendment No. 4 (&#8220;ABL Amendment No. 4&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 4 provided for (i) a $35.0 million increase in the accordion feature under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief and (iii) extended the maturity date of the 2012 ABL Revolver to June 9, 2020, which was five years from the effective date of ABL Amendment No. 4.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2016, we entered into Amendment No. 5 (&#8220;ABL Amendment No. 5&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 5 temporarily suspended certain financial and related reporting covenants in the 2012 ABL Revolver until the earliest of (i) the date that was 60 calendar days following February 4, 2016, (ii) the date upon which certain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DenTek&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assets were included in the Company&#8217;s borrowing base under the 2012 ABL Revolver and (iii) the date upon which the Company received net proceeds from an offering of debt securities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Fleet acquisition, on January 26, 2017, we entered into Amendment No. 4 ("Term Loan Amendment No. 4") to the 2012 Term Loan.  Term Loan Amendment No. 4 provided for (i) the refinancing of all of our outstanding term loans and the creation of a new class of Term B-4 Loans under the 2012 Term Loan (the "Term B-4 Loans") in an aggregate principal amount of $1,427.0 million and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  Term Loan Amendment No.4 also extended the maturity date of the 2012 Term Loan to January 26, 2024.  In addition, Citibank, N.A. was succeeded by Barclays Bank PLC as administrative agent under the 2012 Term Loan. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 26, 2017, we entered into Amendment No. 6 ("ABL Amendment No. 6") to the 2012 ABL Revolver.  ABL Amendment No. 6 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver, (ii) an extension of the maturity date of revolving commitments to January 26, 2022, and (iii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility consistent with Term Loan Amendment No. 4. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2018, we entered into Amendment No. 5 (&#8220;Term Loan Amendment No. 5&#8221;) to the 2012 Term Loan.  Term Loan Amendment No. 5 provided for the creation of Term B-5 Loans (the "Term B-5 Loans") by repricing of the Term B-4 Loans under the credit agreement governing the 2012 Term Loan to an interest rate that is based, at our option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.00%, or an alternative base rate plus a margin of 1.00% per annum, with a floor of 1.00%. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Company and the Borrower entered into Amendment No. 7 ("ABL Amendment No. 7") to the 2012 ABL Revolver.  ABL Amendment No. 7 provides for (i) an extension of the maturity date of the 2012 ABL Revolver to December 11, 2024, which is five years from the effective date of the ABL Amendment No. 7, (ii) increased flexibility under the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility, (iii) an initial applicable margin for borrowings under the 2012 ABL Revolver that is 1.00% with respect to LIBOR borrowings and 0.0% with respect to base-rate borrowings (which may be increased to 1.25% or 1.50% for LIBOR borrowings and 0.25% or 0.50% for base-rate borrowings, depending on average excess availability under the facility during the prior fiscal quarter), and (iv) a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder of 0.25% per annum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2021, we entered into Amendment No. 6 ("Term Loan Amendment No. 6") to the 2012 Term Loan.  Term Loan Amendment No. 6 provided for (i) the refinancing of our outstanding term loans and the creation of a new class of Term B-5 Loans under the credit agreement governing the 2012 Term Loan in an aggregate principal amount of $600.0&#160;million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, and (iii) an interest rate on the Term B-5 Loans that is based, at the Borrower's option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.50%, or an alternative base rate plus a margin of 1.00% per annum.   In addition, Term Loan Amendment No. 6 provided for an extension of the maturity date of the 2012 Term Loan to July 1, 2028.  In connection with this refinancing, we recorded a loss on extinguishment of debt of $2.1&#160;million to write off a portion of new and old debt costs relating to this refinancing.  Under Term Loan Amendment No. 6, we are required to make quarterly payments each equal to 0.25% of the aggregate principal amount of the 2012 Term Loan.     </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March&#160;31, 2022, the average interest rate on the 2012 Term Loan was 3.6%.  For the year ended March&#160;31, 2022, the average interest rate on the amounts borrowed under the 2012 ABL Revolver was 1.2%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2013 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2013, the Borrower issued $400.0 million of senior unsecured notes, with an interest rate of 5.375% and a maturity date of December 15, 2021 (the "2013 Senior Notes").  These notes were redeemed on December 16, 2019 using the funds from the issuance of our 2019 Senior Notes described below.  In conjunction with the redemption of our 2013 Senior Notes, we wrote off related debt costs of $2.2 million in the year ended March 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 19, 2016, the Borrower completed the sale of $350.0 million aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#8220;Initial Notes&#8221;).  On March 21, 2018, the Borrower completed the sale of $250.0 million additional aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#8220;Additional Notes&#8221;).  Both the Initial Notes and the Additional Notes (the "2016 Senior Notes") were redeemed on March 1, 2021 using funds from the issuance of our 2021 Senior Notes described below.  In conjunction with the redemption of the 2016 Senior Notes, we wrote off related debt costs of $2.7 million and paid a premium to redeem the 2016 Senior Notes of $9.6 million in the year ended March 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2019, the Borrower issued $400.0 million aggregate principal amount of 5.125% senior notes due January 15, 2028 (the "2019 Senior Notes") pursuant to an indenture dated December 2, 2019, among the Borrower, the guarantors party thereto (including the Company) and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2019 Senior Notes, together with cash on hand, to redeem all $400.0 million of our outstanding 2013 Senior Notes, which were due in 2021, and to pay related fees and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we issued $600.0 million aggregate principal amount of 3.750%  senior notes due April 1, 2031, (the "2021 Senior Notes") pursuant to an indenture dated March 1, 2021, among the Borrower, the guarantors party thereto (including the Company), and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2021 Senior Notes to redeem all $600.0 million of our outstanding 2016 Senior Notes, which were due in 2024, and to pay related fees and expenses. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemptions and Restrictions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2019 Senior Notes at any time on or after January 15, 2023 at the redemption prices set forth in the indenture governing the 2019 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2019 Senior Notes), the Borrower will be required to make an offer to purchase the 2019 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2021 Senior Notes at any time on or after April 1, 2026 at the redemption prices set forth in the indenture governing the 2021 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2021 Senior Notes), the Borrower will be required to make an offer to purchase the 2021 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates.  Additionally, the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  At March&#160;31, 2022, we were in compliance with the covenants under our long-term indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had an aggregate of $1.5 billion of outstanding indebtedness, which consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$400.0 million of 5.125% 2019 Senior Notes due January 15, 2028;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$600.0 million of 3.750% 2021 Senior Notes due April 1, 2031; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$495.0 million of borrowings under the Term B-5 Loans due July 1, 2028.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had no balance outstanding on the 2012 ABL Revolver and a borrowing capacity of $123.3 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we entered into two interest rate swaps to hedge a total of $400.0 million of our variable interest debt.  One swap settled on January 31, 2021 and the other settled on January 31, 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Covenants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt facilities contain various financial covenants, including provisions that require us to maintain certain leverage, interest coverage and fixed charge ratios.&#160; Specifically, we must:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a leverage ratio of less than 6.50 to 1.0 for the quarter ended March&#160;31, 2022 and going forward (defined as, with certain adjustments, the ratio of our consolidated total net debt as of the last day of the fiscal quarter to our trailing twelve month consolidated net income before interest, taxes, depreciation, amortization, non-cash charges and certain other items (&#8220;EBITDA&#8221;));</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have an interest coverage ratio of greater than 2.25 to 1.0 for the quarter ended March&#160;31, 2022 and going forward (defined as, with certain adjustments, the ratio of our consolidated EBITDA to our trailing twelve month consolidated cash interest expense); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have a fixed charge ratio of greater than 1.0 to 1.0 (defined as, with certain adjustments, the ratio of our consolidated EBITDA minus capital expenditures to our trailing twelve month consolidated interest paid, taxes paid and other specified payments).  Our fixed charge requirement remains level throughout the term of the agreement.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we were in compliance with the applicable financial and restrictive covenants under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  Additionally, management anticipates that in the normal course of operations, we will be in compliance with the financial and restrictive covenants during fiscal 2023.  During the year ended March&#160;31, 2022, we made a required repayment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $1.5&#160;million as well as voluntary principal payments of $103.5&#160;million against the outstanding balance under our 2012 Term Loan.  Since we have made optional payments that exceed all of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity on July 1, 2028.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had ongoing commitments under various contractual and commercial obligations as follows: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments Due by Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less&#160;than</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1&#160;to&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4&#160;to&#160;5</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After&#160;5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1&#160;Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contractual cash obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:26.68pt">Represents the estimated interest obligations on the outstanding balances at March&#160;31, 2022 of the 2021 Senior Notes, 2019 Senior Notes, Term B-5 Loans, and 2012 ABL Revolver, assuming scheduled principal payments (based on the terms of the loan agreements). We estimate our future obligations for interest on our variable rate debt by assuming the weighted average interest rates in effect on each variable rate debt obligation at March&#160;31, 2022 remain constant into the future.  This is an estimate, as actual rates will vary over time. In addition, we assume that the average balance outstanding for the last month of fiscal 2022 remains the same for the remaining term of the agreement.  The actual balance outstanding may fluctuate significantly in future periods, depending on the availability of cash flow from operations and future investing and financing considerations. Estimated interest obligations would be different under different assumptions regarding interest rates or timing of principal payments.&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Purchase obligations for inventory costs are legally binding commitments for projected inventory requirements to be utilized during the normal course of our operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Purchase obligations for other costs are legally binding commitments for marketing, advertising and capital expenditures.  Our capital expenditures primarily relate to manufacturing equipment.&#160;&#160;Activity costs for molds and equipment to be paid, based solely on a per unit basis without any deadlines for final payment, have been excluded from the table because we are unable to determine the time period over which such activity costs will be paid.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">We have excluded obligations related to uncertain tax positions because we cannot reasonably estimate when they will occur.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any off-balance sheet arrangements or financing activities with special-purpose entities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflationary factors such as increases in the costs of raw materials, packaging materials, purchased product, labor costs, transportation costs and overhead may adversely affect our operating results and financial condition.&#160;&#160;Although we do not believe that inflation has had a material impact on our financial condition or results of operations for the three most recent fiscal years, the COVID-19 pandemic, the Russian invasion of Ukraine and other supply and labor disruptions may have an inflationary impact on our costs and a high rate of inflation in the future could have a material adverse effect on our financial condition and results of operations.&#160;&#160;More volatility in crude oil prices may have an adverse impact on transportation costs, as well as certain petroleum based raw materials and packaging material.&#160;&#160;Although we make efforts to minimize the impact of inflationary factors, including raising prices to our customers, a high rate of pricing volatility associated with crude oil supplies or other raw materials used in our products may have an adverse effect on our operating results. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to interest rate risk because our 2012 Term Loan and 2012 ABL Revolver are variable rate debt.&#160;&#160; At March&#160;31, 2022, approximately $495.0 million of our debt carries a variable rate of interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holding other variables constant, including levels of indebtedness, a one percentage point increase in interest rates on our variable rate debt would have had an adverse impact on pre-tax loss and cash flows for the year ended March&#160;31, 2022 of approximately $4.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2022 and 2021, approximately 13.2% and 12.0%, respectively, of our net revenues were denominated in currencies other than the U.S. Dollar.  As such, we are exposed to transactions that are sensitive to foreign currency exchange rates, including insignificant foreign currency forward exchange agreements.  These transactions are primarily with respect to the Canadian and Australian Dollar.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis with respect to exchange rates for the year ended March&#160;31, 2022 and 2021.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a 2.6% impact on pre-tax income of approximately $6.8 million for the year ended March&#160;31, 2022 and a 2.2% impact on pre-tax loss of approximately $4.4 million for the year ended March&#160;31, 2021. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The supplementary data required by this Item are described in Part IV, Item 15 of this Annual Report on Form 10-K and are presented beginning on page 89.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_61"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audited Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2022 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:83.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm<br/>PricewaterhouseCoopers LLP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_64">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Income and Comprehensive Income for each of the three years in the period ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_67">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets at March 31, 2022 and 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_70">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Stockholders&#8217; Equity for each of the three years in the period ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_73">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for each of the three years in the period ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_76">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_79">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule II&#8212;Valuation and Qualifying Accounts for the years ended March 31, 2022, 2021 and 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93b55e0f793c4f3ba5f606ea7711c37f_148">87</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act).&#160;&#160;Internal control over financial reporting is a process designed by, or under the supervision of the Chief Executive Officer and Chief Financial Officer and effected by the Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.&#160;&#160;Therefore, even those systems determined to be effective can provide only reasonable, not absolute, assurance that the control objectives will be met.&#160;&#160;Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate over time.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company's internal control over financial reporting as of March&#160;31, 2022.&#160;&#160;In making its evaluation, management has used the criteria established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013 Framework).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on management's assessment utilizing the 2013 Framework, management concluded that the Company's internal control over financial reporting was effective as of March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PricewaterhouseCoopers LLP, an independent registered public accounting firm, has issued a report on the effectiveness of our internal control over financial reporting as of March&#160;31, 2022, which appears below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;6, 2022 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Board of Directors and Stockholders of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prestige Consumer Healthcare Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Prestige Consumer Healthcare Inc. and its subsidiaries (the &#8220;Company&#8221;) as of March 31, 2022 and 2021, and the related consolidated statements of income and comprehensive income, of changes in stockholders&#8217; equity and of cash flows for each of the three years in the period ended March 31, 2022, including the related notes and financial statement schedule listed in the accompanying index (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of March 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2013)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2022 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (2013) issued by the COSO. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 8. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">is a matter</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Goodwill and Indefinite-Lived Intangible Asset Impairment Assessments for Reporting Units and Tradenames of Certain Product Groups</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Notes 1, 5, and 6 to the consolidated financial statements, the Company&#8217;s consolidated goodwill and indefinite-lived intangible asset balances were $579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> million and $</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> million, respectively, as of March 31, 2022. Goodwill is classified as the excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations. Intangible assets </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">generally represent tradenames, brand names and patents.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Goodwill and indefinite-lived intangible assets are tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level, and indefinite-lived intangible assets are tested at the individual asset level. An impairment loss is recognized if the carrying amount of the reporting unit or asset exceeds its fair value. Management utilized the discounted cash flow method to estimate the fair value of its reporting units and the excess earnings method to estimate the fair value of individual indefinite-lived intangible assets. Assumptions subject to significant uncertainties in developing the fair value measurement of the reporting units and indefinite-lived intangible assets include future sales, gross margins, advertising and marketing expenses, and the discount rates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal considerations for our determination that performing procedures relating to goodwill and indefinite-lived intangible asset impairment assessments for reporting units and tradenames of certain product groups is a critical audit matter are (i) the significant judgment by management when developing the fair value measurements, (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s significant assumptions related to future sales, gross margins, advertising and marketing expenses, and the discount rates, and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#8217;s impairment assessments of goodwill and indefinite-lived intangible assets, including controls over the valuation of the Company&#8217;s reporting units and individual indefinite-lived intangible assets. These procedures also included, among others, (i) testing management&#8217;s process for developing the fair value measurements of the reporting units and tradenames for certain product groups, (ii) evaluating the appropriateness of methods used in developing the fair value measurements, (iii) testing the completeness and accuracy of underlying data used, and (iv) evaluating the reasonableness of significant assumptions used by management related to future sales, gross margins, advertising and marketing expenses, and the discount rates. Evaluating management&#8217;s assumptions related to future sales, gross margins, and advertising and marketing expenses involved evaluating whether the assumptions used by management were reasonable considering (i) current and historical performance, (ii) the consistency with external market and industry data, and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&#8217;s fair value methods and the discount rates.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82NC9mcmFnOmEzZjZmOTEyNjBiZDQ4MmQ4ZmRlNTdiNmE0ZmQxZTRkL3RleHRyZWdpb246YTNmNmY5MTI2MGJkNDgyZDhmZGU1N2I2YTRmZDFlNGRfMzg0ODI5MDcxODUwMw_2bc5886a-391d-4bf0-ba0e-31e79b3079d6">PricewaterhouseCoopers LLP</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82NC9mcmFnOmEzZjZmOTEyNjBiZDQ4MmQ4ZmRlNTdiNmE0ZmQxZTRkL3RleHRyZWdpb246YTNmNmY5MTI2MGJkNDgyZDhmZGU1N2I2YTRmZDFlNGRfMzg0ODI5MDcxODUwNQ_e5b4573f-869c-40e3-be1d-80f6f3a9f515">Stamford, Connecticut</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May 6, 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since at least 1999. We have not been able to determine the specific year we began serving as auditor of the Company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income and Comprehensive Income</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:63.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d976548ec964eb5954900d40178b30f_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy0xLTEtMS0xODk2OQ_9268f5e5-cabd-4b97-b535-58314ecec268">1,086,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7de1d5544ee45609a500258ca33677e_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy0zLTEtMS0xODk2OQ_6cd595c3-4ab4-4d63-8bf9-99206b418d61">943,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a00f6c3c9634209a4b9779c5515e978_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy01LTEtMS0xODk2OQ_7311dc4b-cdd4-4aed-961f-d68bcc022709">962,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98e8e0686d4426182259a392bf61706_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC0xLTEtMS0xODk2OQ_1358c210-e86a-4d2a-a947-26ed5bd2b06a">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53deaff486304c7d94652052dc9167fa_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC0zLTEtMS0xODk2OQ_2926dd5d-7235-4645-97a4-913d49ae4ee1">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id433e0cb04fa4a559bfc9daff43da79c_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC01LTEtMS0xODk2OQ_0f0ca570-0e98-4937-8488-c5476f7887ac">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS0xLTEtMS0xODk2OQ_8e55c7d9-18f7-40aa-a32e-00e7f7458946">1,086,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS0zLTEtMS0xODk2OQ_71f1fe47-c2b9-45ee-9aad-b91a210d1bff">943,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS01LTEtMS0xODk2OQ_2523c53d-4d6d-4760-9680-7ff85acb245e">963,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales excluding depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC0xLTEtMS0xODk2OQ_8406da1a-6d81-4b7a-8ec3-185d6de50766">458,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC0zLTEtMS0xODk2OQ_1c07eae8-764f-43a8-b202-5e1160474e3b">389,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:CostOfSalesExclusiveOfDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC01LTEtMS0xODk2OQ_2e30bb57-fdd6-4483-b4c3-9bbffe876e6a">406,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS0xLTEtMS0xODk2OQ_55a7c6e7-b8f7-49ca-b203-8b781bae8074">7,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS0zLTEtMS0xODk2OQ_503adc6b-4e22-4198-92b6-dc0e6330d2a2">6,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS01LTEtMS0xODk2OQ_989adfd4-2531-4306-83b3-c1479f16e0f7">4,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtMS0xLTEtMTg5Njk_609af7a9-50fb-4091-be59-c8ad153b2774">466,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtMy0xLTEtMTg5Njk_e67986d1-372e-4eec-9b69-4c8d9a718f87">395,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtNS0xLTEtMTg5Njk_25c09ffb-c218-489f-b148-10c81913dde3">410,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtMS0xLTEtMTg5Njk_1f503224-e784-45ea-b02e-7635c6457e77">620,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtMy0xLTEtMTg5Njk_0a2fc5d0-b0e4-4265-a9d9-fcb9a8a8e507">547,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtNS0xLTEtMTg5Njk_78180621-c547-4247-9533-52ec2ea417eb">552,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtMS0xLTEtMTg5Njk_f8c9b5f2-de52-4769-8b05-54cb241ec38c">157,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtMy0xLTEtMTg5Njk_4736bd59-a6b6-4510-8e68-2eaa99499ef2">140,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtNS0xLTEtMTg5Njk_ce7219eb-6502-41ed-a3b8-1fd5b85bcfcb">147,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtMS0xLTEtMTg5Njk_15d79cc8-f07f-4fcf-81da-30e527f3559c">108,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtMy0xLTEtMTg5Njk_ddc5d787-2349-4cb0-bd47-6e4ef4674f30">85,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtNS0xLTEtMTg5Njk_c52539b3-4953-4195-b41f-8cac234d6787">89,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtMS0xLTEtMTg5Njk_b746c819-40d6-4236-93ff-3b2a2d9eee5e">24,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtMy0xLTEtMTg5Njk_ae478e7e-57db-454f-854e-33c00fd26080">23,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OtherDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtNS0xLTEtMTg5Njk_55e621fe-e8b9-41f7-bb95-78e02db73cd6">24,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktMS0xLTEtMTg5Njk_72c7da96-a022-4628-9193-03ab92ca8cd8">290,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktMy0xLTEtMTg5Njk_367440f9-b356-4591-a3a0-20cce0765182">250,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktNS0xLTEtMTg5Njk_a22c6ee2-2e8e-4559-b720-e16380122268">261,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtMS0xLTEtMTg5Njk_65f8cc1a-93c0-4884-a986-f529740b6563">329,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtMy0xLTEtMTg5Njk_6d3a514b-3b41-4b51-aeaa-cdd0d719ba3c">297,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtNS0xLTEtMTg5Njk_14780245-5469-4b06-98b5-4b1f83169571">291,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other expense (income) </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtMS0xLTEtMTg5Njk_1d6f6462-353d-4f12-8265-8b83e9660d88">64,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtMy0xLTEtMTg5Njk_25fa11f2-e251-474f-bf60-5e8aad73707e">82,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtNS0xLTEtMTg5Njk_e0c25b78-1ac1-49ea-818c-b6df9a1bd876">96,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtMS0xLTEtMTg5Njk_6f5d9880-d082-4435-8cec-8757f738b020">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtMy0xLTEtMTg5Njk_f69595a9-3c24-4e1d-bece-f3f2388d48c8">12,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtNS0xLTEtMTg5Njk_887c1467-46c5-4819-8b92-d9f8401358e8">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtMS0xLTEtMTg5Njk_b2e5712c-f371-4271-a2d7-ec5de096999e">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtMy0xLTEtMTg5Njk_29ab1533-795e-47d7-9d20-5016da4b5000">1,366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtNS0xLTEtMTg5Njk_9260da82-f09f-44c7-b7ec-cd65d9c482aa">1,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtMS0xLTEtMTg5Njk_eff040b8-be16-4b6a-90be-5831db2061dd">67,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtMy0xLTEtMTg5Njk_b68b1dd0-dec9-4642-9c87-0b7ddd90ffa2">93,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="pbh:TotalOtherIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtNS0xLTEtMTg5Njk_8766894b-8372-4858-856a-f8d51d06eb41">100,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctMS0xLTEtMTg5Njk_8d4f64c4-8082-45f0-9a17-43d947dde22d">262,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctMy0xLTEtMTg5Njk_51d1fdbb-760f-4ae0-9e60-97b23d54064f">204,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctNS0xLTEtMTg5Njk_398d8ed7-6b64-4929-9b6b-6190097b62bb">191,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtMS0xLTEtMTg5Njk_8811d5fb-1a80-440d-bdd1-93e642266e47">57,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtMy0xLTEtMTg5Njk_622e9a05-8ac4-4948-92fa-6dc57f618c10">39,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtNS0xLTEtMTg5Njk_863785d0-36fe-4571-a551-d83a9254a318">48,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktMS0xLTEtMTg5Njk_3379c5b0-ebe7-4624-8d7a-b8222161ecca">205,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktMy0xLTEtMTg5Njk_3d25d341-137c-4f84-b8aa-e1ee49eb44f8">164,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktNS0xLTEtMTg5Njk_b3c65e37-217f-47fa-9709-c8a12983c3f0">142,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItMS0xLTEtMTg5Njk_6e161bdd-1cd7-4d1b-b516-cee27ffd8c3d">4.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItMy0xLTEtMTg5Njk_44d9d325-47f9-4c96-8bcb-0aaf2def4380">3.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItNS0xLTEtMTg5Njk_168dd05c-e083-403d-afd8-81c0d9128839">2.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctMS0xLTEtMTg5Njk_fabefc69-5047-4d48-b45b-38e0d05ce721">4.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctMy0xLTEtMTg5Njk_14a21c17-f255-4828-a5ff-e5e95c631d9e">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctNS0xLTEtMTg5Njk_2f1c0ff6-d079-4426-89cd-067b7585659a">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItMS0xLTEtMTg5Njk_2cbf55dd-d86f-436b-9d5f-60744e8f3621">50,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItMy0xLTEtMTg5Njk_b0a440a3-a906-461b-a91b-e53f3ca3518b">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItNS0xLTEtMTg5Njk_b16ae0c1-e4e0-4948-848d-48f2b5e3fd25">50,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtMS0xLTEtMTg5Njk_5b8eeea6-4b66-4598-9c38-2841fc2f396e">50,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtMy0xLTEtMTg5Njk_89ba20ff-a53a-4f42-b21b-75d858371725">50,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtNS0xLTEtMTg5Njk_c40954eb-8da2-4b4e-bed5-5e50d43fab9f">51,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtMS0xLTEtMTg5Njk_242e68a1-ac91-4f92-b312-823084c1a18e">1,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtMy0xLTEtMTg5Njk_12cb31d6-776e-4c92-a2bd-391ff0fafcfb">20,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtNS0xLTEtMTg5Njk_693fadb7-777c-4ec3-887b-3553a3c0ca41">12,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctMS0xLTEtMTg5Njk_b3ffcbbd-2ad8-429f-b802-4e6ecd5664cc">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctMy0xLTEtMTg5Njk_9de25d7d-bcef-4d3e-87ff-16eb3386bc0b">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctNS0xLTEtMTg5Njk_b9d7ab8e-39c4-4b3f-a873-745c08d0da9d">4,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtMS0xLTEtMTg5Njk_9ca2ad47-87aa-4d84-bf8d-c87c963cc109">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtMy0xLTEtMTg5Njk_56e82455-0759-460c-950b-0d015064ddf7">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtNS0xLTEtMTg5Njk_8d07c104-ad3c-437d-a4de-8b4e3dae7d9f">1,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain on pension distribution reclassified to net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktMS0xLTEtMTg5Njk_c052e649-07d0-402e-a4b3-7cc8f6c4d4c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktMy0xLTEtMTg5Njk_b661cc04-f864-4276-b2aa-b8a6a744cee5">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktNS0xLTEtMTg5Njk_7695e2d7-40f3-4dc6-87d2-94dc90dd371a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtMS0xLTEtMTg5Njk_bc20c2db-5cd5-48f2-8623-391a5b978c03">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtMy0xLTEtMTg5Njk_2d964429-66d9-465f-9a79-b916deb84fdd">24,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtNS0xLTEtMTg5Njk_dcd27201-7dc9-4d93-9904-cfc5a9f5ca23">18,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtMS0xLTEtMTg5Njk_927b6889-f20d-4c7d-a907-265737917a97">206,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtMy0xLTEtMTg5Njk_cf57ff80-c3a3-4f89-b0cb-2d62aa91d317">189,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtNS0xLTEtMTg5Njk_2dd2a9ce-5dca-4972-9a1b-f164062fbb2b">123,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:75.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMy0xLTEtMS0xODk2OQ_ba68c0fa-297d-43c6-8bab-0db4eef6062d">27,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMy0zLTEtMS0xODk2OQ_8c3bc867-7c5c-488c-a09d-c886613be657">32,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance of $<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0wLTEtMS0xODk2OS90ZXh0cmVnaW9uOjlkNTIzNDhmYTJjMjQ2YTA4YTU0ZTVhZWMyMzU4NGY2XzQ1_5e41b527-ccaf-4fc1-92d7-274ed7499fb8">19,720</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0wLTEtMS0xODk2OS90ZXh0cmVnaW9uOjlkNTIzNDhmYTJjMjQ2YTA4YTU0ZTVhZWMyMzU4NGY2XzUy_0984d1e6-4228-461a-a0cc-f0bd19fa5fc6">16,457</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0xLTEtMS0xODk2OQ_6cef6026-2342-4c21-9676-fa174a4bcc65">139,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0zLTEtMS0xODk2OQ_4e9e7e8b-e77e-48a4-9fc7-795c79faec35">114,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNS0xLTEtMS0xODk2OQ_4bc3ff8a-8369-4c5a-af11-96175f19bb39">120,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNS0zLTEtMS0xODk2OQ_d7a1b983-d310-4aed-ba76-b4f9af64c82c">114,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNy0xLTEtMS0xODk2OQ_f9db42fb-cf2e-4701-b41c-101955fce8ef">6,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNy0zLTEtMS0xODk2OQ_b98397ed-6edf-4fd6-90f4-1a37f21f9f7e">7,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfOC0xLTEtMS0xODk2OQ_33eeee8a-06a6-4589-92ac-c379abec474a">293,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfOC0zLTEtMS0xODk2OQ_3902f42b-f8e5-471a-9f64-f71a8f67c587">269,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTAtMS0xLTEtMTg5Njk_e58bf2b9-306d-4d12-9948-5096c9072870">71,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTAtMy0xLTEtMTg5Njk_35b8cd78-cad8-484d-8f63-6c7d9e1c8efc">70,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTEtMS0xLTEtMTg5Njk_7c6fec2d-b11a-4b38-958e-c97701fdfb3d">20,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTEtMy0xLTEtMTg5Njk_f0ffe99b-4d6d-43f9-978c-5a22cf5c624a">23,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTItMS0xLTEtMTg5Njk_c3736d56-ccb4-4425-88ab-a773a053b471">6,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTItMy0xLTEtMTg5Njk_33145386-3d2a-484c-94e6-4852ade6ff44">8,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTMtMS0xLTEtMTg5Njk_de1152db-c550-4125-bc79-6e5a9c20d503">578,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTMtMy0xLTEtMTg5Njk_2f32ba8c-6aef-4230-a18c-7d9566ccfb7f">578,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTQtMS0xLTEtMTg5Njk_642012fc-8ae0-4f92-836f-c6682811afe8">2,696,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTQtMy0xLTEtMTg5Njk_b83fd866-a7f0-45d8-a366-13dc7bcd3e46">2,475,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTUtMS0xLTEtMTg5Njk_9894e25e-3cc6-4803-8101-e0c04d81380d">3,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTUtMy0xLTEtMTg5Njk_2388a35d-d36a-4017-8f89-46bf2edc8dee">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTYtMS0xLTEtMTg5Njk_e7666e8b-1374-45d4-8ac4-a32cf89d2cb1">3,670,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTYtMy0xLTEtMTg5Njk_082889eb-59d9-405d-9a46-f92f27e0d25b">3,429,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjAtMS0xLTEtMTg5Njk_13ef7e98-cfc5-4d50-a228-5550cb06353c">55,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjAtMy0xLTEtMTg5Njk_7a3bf7e6-5d14-4d64-81d3-efed73127345">45,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InterestAndDividendsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjEtMS0xLTEtMTg5Njk_50dc3f2c-8e49-400d-b845-973dea8196e0">4,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InterestAndDividendsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjEtMy0xLTEtMTg5Njk_b722bd11-64dd-465f-94ae-ae6a18539559">6,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjItMS0xLTEtMTg5Njk_c19c6b5b-190e-4481-9b37-436e93581df9">6,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjItMy0xLTEtMTg5Njk_3a834227-a538-4ad9-b486-496b6b891cab">5,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjMtMS0xLTEtMTg5Njk_cac5de5f-33fb-4e97-bc50-a9a857b1ff2b">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjMtMy0xLTEtMTg5Njk_bdd49d9d-477d-4275-9913-f33984d974ce">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjQtMS0xLTEtMTg5Njk_112a2d9d-1e0e-40d1-81a5-948f4ee2b1a3">74,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjQtMy0xLTEtMTg5Njk_f68b0459-7328-462f-ab1d-c3a3129163ca">61,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjUtMS0xLTEtMTg5Njk_c8a70cb0-8a92-4ab6-8ce1-a4da4d2d98c7">143,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjUtMy0xLTEtMTg5Njk_9cf5a85d-0d67-40ee-8971-6dd46bdcf6db">122,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjktMS0xLTEtMTg5Njk_716fa786-0159-455b-9cd1-69e95510a5c5">1,476,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjktMy0xLTEtMTg5Njk_d7d01352-24a7-4633-b19b-5a795b1a7620">1,479,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzAtMS0xLTEtMTg5Njk_80186aa7-ea95-46e9-83a0-730bf1520089">444,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzAtMy0xLTEtMTg5Njk_80003cb8-b8fe-4215-b5d9-3f1f804ce4a3">434,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzEtMS0xLTEtMTg5Njk_b3ac40f3-5bb6-41a0-a221-5f1f168e12f5">16,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzEtMy0xLTEtMTg5Njk_421eb9d2-84ef-4434-abac-02c31d72272a">19,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzItMS0xLTEtMTg5Njk_73475206-5930-4b21-9373-f850904cb500">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzItMy0xLTEtMTg5Njk_e6d78957-079b-4fd1-b1d6-f37754b38bf2">6,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzMtMS0xLTEtMTg5Njk_e18ffd82-0ab5-4514-9a89-d6161c805ea8">7,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzMtMy0xLTEtMTg5Njk_c465b28f-6e5a-49b8-9229-8c35218a4d49">8,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzQtMS0xLTEtMTg5Njk_9585d99c-aa6b-46ac-9443-e770956e8d8d">2,093,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzQtMy0xLTEtMTg5Njk_fd7fccbf-c7fe-4052-97b4-cc674a16a7bd">2,070,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and Contingencies &#8211; Note 17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzYtMS0xLTEtMTg5Njk_19c9764f-6103-4938-8ace-2c0851ccd14b"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzYtMy0xLTEtMTg5Njk_1b72e6f8-1846-4493-b1ad-aa825106129b"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock &#8211; $<ix:nonFraction unitRef="usdPerShare" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzktMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5OGI4NjhmNmJhNmQ0YTNlYmQyNzBlZWNkNGE3MzQxZF8yMg_02b0485f-7109-4039-a6a1-802660405ccb"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzktMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5OGI4NjhmNmJhNmQ0YTNlYmQyNzBlZWNkNGE3MzQxZF8yMg_eb5ad547-6e1b-4247-b846-02dfd9f16fb5">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized &#8211; <ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDAtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjowNjliNWRmMGQ2MTY0NjI2Yjc5YWE5OWY3ZDg5ZjMyYV8xNw_4f151594-eaaa-4cd7-af96-d8efd5f9240a"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDAtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjowNjliNWRmMGQ2MTY0NjI2Yjc5YWE5OWY3ZDg5ZjMyYV8xNw_9b7cec9d-2050-4efc-a5c4-39c5301ad1ac">5,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued and outstanding &#8211; <ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_3503f7b3-dca0-48f6-a306-9aad9423d079"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_823bbb85-4ae1-47f5-9113-d015c091e9b3"><ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_c0c0f3c9-68d7-4c66-850a-6412737a038f"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_e372ef43-9d2a-4b9a-8bb2-a65f94081faf">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMS0xLTEtMTg5Njk_22efbdbd-5525-4a57-ba19-76cd436f987c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMy0xLTEtMTg5Njk_8da9e3dd-65be-4a68-a70d-47ec9aee129a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock &#8211; $<ix:nonFraction unitRef="usdPerShare" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDMtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplOWI5OTBiODVhOGE0MTE3YTljMzMyNTRjNWFjZTNjM18xOQ_b2e9da50-8b83-446f-a1a2-5c4bdff88758"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDMtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplOWI5OTBiODVhOGE0MTE3YTljMzMyNTRjNWFjZTNjM18xOQ_ff356ad6-1a3a-4eda-8bca-7f2920e0f895">0.01</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Authorized &#8211; <ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ODgzN2NkYTIxNzQ0ODg2YjU5Y2I4YzI2NmVkODI2YV8xNw_1bc508a9-b4b8-4d51-84c6-ff01e8baea45"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ODgzN2NkYTIxNzQ0ODg2YjU5Y2I4YzI2NmVkODI2YV8xNw_efd832aa-837c-44a3-9b19-75019d8fc153">250,000</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued &#8211; <ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo1YmQyNzQ5MmJmMTA0ZGEyOTFiZDkwYTg1YjJkZmJjNF8xMw_8c6e188e-e42b-493a-b918-52e96c1c2b56">54,430</ix:nonFraction> shares at March 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo1YmQyNzQ5MmJmMTA0ZGEyOTFiZDkwYTg1YjJkZmJjNF80NQ_fce393d2-a527-4361-949d-38a00c02b395">53,999</ix:nonFraction> shares at March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMS0xLTEtMTg5Njk_ada1b955-f511-46a8-8163-7ad529a0bbd9">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMy0xLTEtMTg5Njk_548d1125-cd28-4cff-951d-c9547af10a42">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDYtMS0xLTEtMTg5Njk_5c50569f-4903-4763-951e-73fd21aa45b4">515,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDYtMy0xLTEtMTg5Njk_6f0d9259-7dc1-4f95-9293-3bc608db5be8">499,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozNzVlOGUyMDc3NDI0NDliYWJmOTliZTRmNzNmMDdmNV8zMA_08f83b89-d5b0-47df-96fc-d9819c184db1">4,151</ix:nonFraction> shares at March 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozNzVlOGUyMDc3NDI0NDliYWJmOTliZTRmNzNmMDdmNV82Mg_89c60232-60f0-4543-a0f8-846192b5076c">4,088</ix:nonFraction> shares at March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMS0xLTEtMTg5Njk_d67e15c5-d328-457a-b45e-5f05705154b0">133,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMy0xLTEtMTg5Njk_299446ce-7817-4ddd-b447-132a329b61d1">130,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDgtMS0xLTEtMTg5Njk_9b5c4d67-c85c-40a1-9689-2a7bac23ec62">19,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDgtMy0xLTEtMTg5Njk_ffd05cc4-5e95-4d9f-9251-b8fb06dd4987">19,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDktMS0xLTEtMTg5Njk_f384c8be-0ca6-4101-abf7-5cd420f61f00">1,214,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDktMy0xLTEtMTg5Njk_07cb121b-fe27-4e11-b70a-1a73ddd7b7bd">1,008,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTAtMS0xLTEtMTg5Njk_63e7ef16-53c6-435b-8869-8b93c4914c89">1,577,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTAtMy0xLTEtMTg5Njk_3e136979-4ecb-4e2f-a4c4-821d3d3ed9e5">1,358,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Stockholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTEtMS0xLTEtMTg5Njk_9163a2c7-81e5-488e-b329-7d98dafd2a7f">3,670,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTEtMy0xLTEtMTg5Njk_c934e73c-4249-4b88-9b27-48d6ae67440f">3,429,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_73"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Stockholders&#8217; Equity </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.557%"><tr><td style="width:1.0%"></td><td style="width:20.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.427%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated <br/>Other <br/>Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Par <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xLTEtMS0xODk2OQ_ed9bb19e-7316-4143-a53f-13c97f8b68aa">53,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0zLTEtMS0xODk2OQ_f1ec618a-c35e-484c-9091-a49e66b23d41">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied280415580b4c01b9d20134fe0942a6_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi01LTEtMS0xODk2OQ_da27901b-9f67-402f-8618-537111805548">479,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82cf1b32e6744300b132ae0f6010879a_I20190331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi03LTEtMS0xODk2OQ_8b49ceec-5e23-4fdd-97e0-48996818274a">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82cf1b32e6744300b132ae0f6010879a_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi05LTEtMS0xODk2OQ_16e74634-acaa-4984-82b8-acd197ef811f">59,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8c44dcdbf354244af1c10b649888486_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xMS0xLTEtMTg5Njk_1cb256d0-573c-4f72-9331-7899b18a5ea8">25,747</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5017c74f1406407b84f0e42bfc4e14b9_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xNS0xLTEtMTg5Njk_d0916339-aa08-4373-9340-ec20668d1627">701,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xNy0xLTEtMTg5Njk_eacdb805-24e0-4bcd-9f4f-2707a875fb47">1,095,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNS01LTEtMS0xODk2OQ_c26bc704-59be-49de-b1a6-44681bda4e92">7,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNS0xNy0xLTEtMTg5Njk_2aeccde4-80a7-4e3c-806a-21f0d896046f">7,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0xLTEtMS0xODk2OQ_905c6fdd-7d25-4caf-9474-33bb5191fc01">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0zLTEtMS0xODk2OQ_c9d2ada3-74c2-4319-bc14-68d3194855a1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi01LTEtMS0xODk2OQ_bc64d4bf-2393-46f6-8fa6-526e7753f7f3">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0xNy0xLTEtMTg5Njk_f89e7cc8-f504-4b3e-ac65-d0c96ef21d64">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0xLTEtMS0xODk2OQ_57ea0296-a398-413e-aefc-7765c27314b1">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0zLTEtMS0xODk2OQ_6d198f63-1311-4696-b10e-e801d83bfbc3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC01LTEtMS0xODk2OQ_e88bfa70-0212-490c-9d0e-9a305c5abcaf">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0xNy0xLTEtMTg5Njk_88dae8e2-726b-4476-ac4e-850c579cced7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS03LTEtMS0xODk2OQ_3507a824-19ba-49d0-83fc-b6a4614a7158">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS05LTEtMS0xODk2OQ_a4921d92-0cf4-49cb-9246-62e78de9c34d">57,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS0xNy0xLTEtMTg5Njk_84a5c06a-3d5e-4eaf-b6cf-889b0c24e045">57,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f04dcc6a386483c8e41444865c3338e_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTQtMTUtMS0xLTE4OTY5_c21bad6b-d1c4-4c74-83f9-55fe5aa9f377">142,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTQtMTctMS0xLTE4OTY5_6845b4ae-d62d-45d5-a6eb-a14259b2b18c">142,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26e4d56df93243c68792ea4edcfb7c70_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTctMTEtMS0xLTE4OTY5_800d5998-a885-4fbc-8521-82f36c538978">18,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTctMTctMS0xLTE4OTY5_e82ac9ab-acf9-4173-a1de-23fba5d0132e">18,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7078a151136c4d6ca604de73f3a0f375_I20200331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMS0xLTEtMTg5Njk_f3c95391-6f3f-41d7-b483-114e9bb86357">53,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7078a151136c4d6ca604de73f3a0f375_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMy0xLTEtMTg5Njk_ae4f7e01-f179-4fbd-838d-4b0ad30dbe28">538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i885a0fcf0beb4e3390d5033af15a8d3e_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktNS0xLTEtMTg5Njk_78f08c9a-d9e2-4500-884d-33f765e8cfc3">488,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1558437735154cda9e3f0cd847af31a4_I20200331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktNy0xLTEtMTg5Njk_547fcdde-34ea-497d-81d1-372c054a9237">3,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1558437735154cda9e3f0cd847af31a4_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktOS0xLTEtMTg5Njk_503096a8-7f8a-42b7-aa28-e22e24e20156">117,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied0563f46bd444eeb3340a8c043684ce_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTEtMS0xLTE4OTY5_3b991dbc-4d82-4f14-b87c-0aeea146005c">44,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00682c142e94501beff83d90b5f454e_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTUtMS0xLTE4OTY5_af108679-99c6-4d56-af59-1fbfc5e9d366">844,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTctMS0xLTE4OTY5_ccaa3920-d23c-4bdb-be3f-5003a3cbd799">1,170,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjItNS0xLTEtMTg5Njk_2e79abfd-4e34-4885-8478-d5fe483afc82">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjItMTctMS0xLTE4OTY5_5e0f4cf2-dbe9-4047-81b4-731df764d6d3">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMS0xLTEtMTg5Njk_bd4c944a-ad11-46ae-ada0-66ad79cc14c9">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMy0xLTEtMTg5Njk_5030c08f-9400-4266-9351-96c1380e4e6a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtNS0xLTEtMTg5Njk_5a03ae41-0248-42e0-828b-34538d338c7a">2,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMTctMS0xLTE4OTY5_57fcc768-f205-4bae-b218-b6635544f043">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMS0xLTEtMTg5Njk_adc4c7f4-351b-44c2-bb50-59ff40db8e1e">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMy0xLTEtMTg5Njk_18134987-8664-4b0c-88b6-41e119299803">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtNS0xLTEtMTg5Njk_1f7e247b-e674-49b2-87ea-b608eb786038">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMTctMS0xLTE4OTY5_95edcb0b-eecb-440f-adaf-8039fd298539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtNy0xLTEtMTg5Njk_77ecd82f-f679-449b-937e-6f5934d4ffe3">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtOS0xLTEtMTg5Njk_ce7a7bdf-a5a8-466d-b752-b6fc3630f16e">13,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtMTctMS0xLTE4OTY5_418327cc-336d-44d2-8fbe-3fb624e91348">13,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc55215d50342ce978c618ef06bf4d4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzAtMTUtMS0xLTE4OTY5_40756784-c647-4d71-983d-6fadb60bdbc7">164,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzAtMTctMS0xLTE4OTY5_27c7150d-e0b1-4b81-b0f6-e65e7b521249">164,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id898db802a534902a0a79a56b47eda29_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzMtMTEtMS0xLTE4OTY5_3ff6dfbf-85a0-4072-992e-ca2c634a2c1f">24,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzMtMTctMS0xLTE4OTY5_97dbfbc1-730f-4895-9814-379a0800465d">24,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMS0xLTEtMTg5Njk_66fbb2a2-d322-4c18-86df-4940fcc2222a">53,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMy0xLTEtMTg5Njk_66ecd082-0699-4dd7-8eb5-280146d9b476">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c94e91055aa44298481132638e69b2d_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtNS0xLTEtMTg5Njk_4ac6321b-c746-4014-8b29-1b6010ea18b9">499,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if58b3ac1efda48e494333a3e29f1a136_I20210331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtNy0xLTEtMTg5Njk_cd57d984-c2a5-4839-868e-1b8fef80cbc5">4,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if58b3ac1efda48e494333a3e29f1a136_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtOS0xLTEtMTg5Njk_954d50bb-101c-42de-8617-af9c779fc6df">130,732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTEtMS0xLTE4OTY5_f7ab8a99-6eb4-47b4-9651-d44f6204ec43">19,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibed41fa55067490bae70eb2e695faf9d_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTUtMS0xLTE4OTY5_b1471658-0002-4b95-9f51-6df9d1ce7a7e">1,008,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTctMS0xLTE4OTY5_17e4c834-ec64-45cf-99a7-72d572ecad61">1,358,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzgtNS0xLTEtMTg5Njk_51150fd4-66ff-484c-be0e-1a421ba98c5d">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzgtMTctMS0xLTE4OTY5_ea50510d-ec34-45eb-b076-925a3ca1140d">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMS0xLTEtMTg5Njk_c4e8d558-6739-4e5e-8b6f-14f79fd3d365">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMy0xLTEtMTg5Njk_93772fac-88db-42bc-9ca5-570d33c960e6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktNS0xLTEtMTg5Njk_de5847b8-b1cf-4f08-be40-dcb9366093b8">7,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMTctMS0xLTE4OTY5_8b1dbddd-248f-4df6-b6a2-da5c4b203f40">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares related to restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMS0xLTEtMTg5Njk_c105a81b-1de9-4e98-a831-e79139e0e97f">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMy0xLTEtMTg5Njk_d8e15315-c5d8-422e-9f35-830f19faed0a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtNS0xLTEtMTg5Njk_cccd8389-c309-45ed-8214-f517df45bf70">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMTctMS0xLTE4OTY5_d259a5b4-0016-4314-a040-eb5ac70aae3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItNy0xLTEtMTg5Njk_126d10ba-c1a7-4d58-823b-f311aa308c2e">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItOS0xLTEtMTg5Njk_59bb353d-9e75-4ed7-9435-b16eb4f092ce">2,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItMTctMS0xLTE4OTY5_9e8d0d9d-2934-4e8a-990f-7baa37e0cfa7">2,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b265cae0684a099432fb41e9650c63_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDUtMTUtMS0xLTE4OTY5_09bcc222-6b7e-4906-9f91-6a73abad55a5">205,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDUtMTctMS0xLTE4OTY5_68ce6b26-9ed6-4654-bbb9-cb9104be1a28">205,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e37d99ba11a4709b212d9d7ca7583bd_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDgtMTEtMS0xLTE4OTY5_843e9c31-728e-4c1f-92ba-b9eb833179dc">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDgtMTctMS0xLTE4OTY5_87380145-e690-4ea8-9181-bdefe5416177">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id26512b5a56544dc91371cd7b2b3ac87_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMS0xLTEtMTg5Njk_0f9800e2-9c0b-4534-b42c-23d9c09a3cf1">54,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id26512b5a56544dc91371cd7b2b3ac87_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMy0xLTEtMTg5Njk_91b17ad9-1396-4937-b0a2-797f777ab9fe">544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72dfac16b5ac44ea83be7c443c0e2c13_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtNS0xLTEtMTg5Njk_4d162012-d9fd-4121-a6a4-75bb9a4e2f87">515,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ecdca0932c648d682c7125240a2a75d_I20220331" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtNy0xLTEtMTg5Njk_307b8da6-bbc0-4d64-85c7-1e2836ef58fd">4,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ecdca0932c648d682c7125240a2a75d_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtOS0xLTEtMTg5Njk_3090e616-8062-4028-85ca-6b4d7041e269">133,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbaca07b4355474988048d221f663307_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTEtMS0xLTE4OTY5_6a2eea27-7fa0-411b-b819-5fa9477d0b74">19,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3178bc0f361448aca1bad203c38ba1d1_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTUtMS0xLTE4OTY5_2b9241b6-960d-4cfe-9d03-607580158d82">1,214,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTctMS0xLTE4OTY5_afca13d4-2157-4648-8a65-60ca11f673d7">1,577,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:64.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy0xLTEtMS0xODk2OQ_574ea72a-3742-4a1a-a8dd-54ee612b297d">205,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy0zLTEtMS0xODk2OQ_1d317902-3c57-474c-aeb5-c576e1634c75">164,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy01LTEtMS0xODk2OQ_a2704a9e-00f5-4b8c-8441-ad34851e3b7a">142,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS0xLTEtMS0xODk2OQ_4cc674aa-26ec-4a2c-8803-02e269a99c01">32,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS0zLTEtMS0xODk2OQ_1e0eaae9-7d93-4c97-b829-d2ae716c207c">30,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS01LTEtMS0xODk2OQ_5c4c346a-a408-4218-9c2e-9ea770ba56a2">28,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale or disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy0xLTEtMS0xODk2OQ_dd35f4be-68fb-47f7-a892-16966fa580c9">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy0zLTEtMS0xODk2OQ_dcc7305d-f57e-436d-ae4f-d03a5593cd1e">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy01LTEtMS0xODk2OQ_ce54f124-823f-493a-a277-43e1b7302c49">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS0xLTEtMS0xODk2OQ_e20d08ec-9880-4122-ba26-999f5f166bcc">9,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS0zLTEtMS0xODk2OQ_3e48f651-a966-4bfd-9967-da00ba7295ed">18,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS01LTEtMS0xODk2OQ_40f9695d-ec15-4677-ae03-38279f9fe0ab">13,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtMS0xLTEtMTg5Njk_bd980ccd-5a65-4366-ad2b-e11db0197dfc">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtMy0xLTEtMTg5Njk_2199ebcb-1cd1-43e4-9ffd-754c6c5a0d87">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtNS0xLTEtMTg5Njk_409a4849-f5e9-4783-8ec9-f2bfec88e674">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtMS0xLTEtMTg5Njk_10400bb4-1279-4d56-af82-29ad6759facc">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtMy0xLTEtMTg5Njk_e869f459-c0ed-49c6-ade5-da0b5609306c">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtNS0xLTEtMTg5Njk_5e467d7a-8410-40a7-8b7a-cad996d0172c">7,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtMS0xLTEtMTg5Njk_4f602eca-72bb-4b2e-a070-c30cfdf0205f">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtMy0xLTEtMTg5Njk_757c54c2-0ce2-454b-92c3-cc3260b8d84c">12,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtNS0xLTEtMTg5Njk_4bd0c8cd-690d-470d-a5e6-d03f3e22b30a">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtMS0xLTEtMTg5Njk_702e63eb-9442-4b35-a56b-a9413688bad3">6,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtMy0xLTEtMTg5Njk_0af06b23-0a15-42de-aab0-b5aed965414e">7,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:AdditionsToOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtNS0xLTEtMTg5Njk_85ac985f-5ccd-4b9f-874f-c64bc134c4d1">8,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtMS0xLTEtMTg5Njk_c8d67a19-be6f-4498-a506-d80405e40c24">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtMy0xLTEtMTg5Njk_79276060-01bd-4de3-a48f-882d1e1f94f1">2,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtNS0xLTEtMTg5Njk_4a122e0c-ddde-4a5e-afa0-e3cf321d9abc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItMS0xLTEtMTg5Njk_8692ea48-98fe-44b1-b714-b06f2ae5c848">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItMy0xLTEtMTg5Njk_86b75e3a-f250-40d9-99a1-a4b11ed85b93">7,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItNS0xLTEtMTg5Njk_0aff628f-b14f-4e7c-a788-2c84fa692860">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtMS0xLTEtMTg5Njk_c56418aa-f466-4080-867c-3167024b0952">24,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtMy0xLTEtMTg5Njk_15fc1335-b87c-4589-a60d-9f857c1c801e">36,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtNS0xLTEtMTg5Njk_c9cbff04-773c-47c9-ab3b-c62969b7cc64">2,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtMS0xLTEtMTg5Njk_162e0fc7-cea5-425b-b2f1-b226dbb541d0">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtMy0xLTEtMTg5Njk_f2cb07f6-e135-4563-8333-0c39e9b4c7c0">2,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtNS0xLTEtMTg5Njk_bbea4548-da33-4d18-a105-787952478f41">2,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtMS0xLTEtMTg5Njk_cea6dfbc-2ef9-41e5-a6a5-37c46d3e1a89">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtMy0xLTEtMTg5Njk_ad2f69f4-71bb-40c0-a38b-9799b3305c43">3,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtNS0xLTEtMTg5Njk_6d83864a-2570-4c6a-a577-107cb0754489">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctMS0xLTEtMTg5Njk_3f97e725-d697-4b17-a97f-e6bd59c85ff8">9,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctMy0xLTEtMTg5Njk_ae487174-89fc-4f3c-924c-64d11fe113b5">17,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctNS0xLTEtMTg5Njk_a43f98bf-3aaf-423a-a968-0ae142e79e98">6,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtMS0xLTEtMTg5Njk_b1410a74-fea8-4276-a4e0-837946490044">9,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtMy0xLTEtMTg5Njk_a93cd7f9-f15b-4a6c-b627-efae415aed3a">14,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtNS0xLTEtMTg5Njk_c142b8f2-9daa-4557-9451-01a897f956d4">12,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktMS0xLTEtMTg5Njk_db0c22eb-46ca-456e-8039-cbc0c201f099">6,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktMy0xLTEtMTg5Njk_1a055527-060c-456c-92f9-a518122e8a4a">6,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="pbh:IncreaseDecreaseInOperatingLeasesLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktNS0xLTEtMTg5Njk_7aa623e6-321a-4897-b377-93702e50ec6d">8,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtMS0xLTEtMTg5Njk_7fe353e9-c6ab-4b69-b75a-f41f44dca453">725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtMy0xLTEtMTg5Njk_ea4e446e-c3f4-47ec-b9c9-1fa66e09b5d4">3,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtNS0xLTEtMTg5Njk_63a2ba1d-eead-4072-91a1-457a2aa703ae">1,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItMS0xLTEtMTg5Njk_4ad6679a-2d51-41e6-a288-f8b61441c8b5">259,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItMy0xLTEtMTg5Njk_1c109627-f6a9-4936-a600-1294a9572478">235,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItNS0xLTEtMTg5Njk_aa56a832-547a-49d6-b82e-7af42a87176d">217,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtMS0xLTEtMTg5Njk_c6819ec1-9a5f-4a58-880c-e2a2859a853c">9,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtMy0xLTEtMTg5Njk_5b0acb0c-820b-460e-8c8f-196cc0e234f2">22,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtNS0xLTEtMTg5Njk_656654a4-59cc-4bc9-8b30-e95f117c50a5">14,560</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow receipt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:EscrowReceipt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctMS0xLTEtMTg5Njk_2aa1d046-4864-49d0-8bb2-9b0f0da40457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:EscrowReceipt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctMy0xLTEtMTg5Njk_fc374d38-48d5-4095-8a11-b74c71854b74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:EscrowReceipt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctNS0xLTEtMTg5Njk_f201612c-b747-4599-8fd7-04f3701fa3e8">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtMS0xLTEtMTg5Njk_e882c67c-bcf9-4cde-9c09-2c267713704d">247,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtMy0xLTEtMTg5Njk_53152268-1674-40d1-af60-90b4336a265d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtNS0xLTEtMTg5Njk_7ea7402d-fb03-4c70-9551-af8bf30ddfcf">2,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctMS0xLTEtMTg5Njk_dab23772-26cf-4ecc-8561-6c5b8640885a">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctMy0xLTEtMTg5Njk_645b50d5-dd66-421d-b418-4a70cd48c225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctNS0xLTEtMTg5Njk_985861ff-2698-4aba-93e5-8f605ce436b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtMS0xLTEtMTg5Njk_66ce4e62-5b85-4c2f-bbc7-d55fa555e187">256,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtMy0xLTEtMTg5Njk_4492a0a6-47b1-4ad8-8792-b4486bbfe976">22,243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtNS0xLTEtMTg5Njk_eb5ca9a0-7e96-44e2-a502-8966d06e6027">16,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtMS0xLTEtMTg5Njk_c7daf199-f22d-4ae8-b05f-c049cf91f514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtMy0xLTEtMTg5Njk_c4927eae-9965-49b7-9785-02620aedb197">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtNS0xLTEtMTg5Njk_3500cca5-4635-4097-b3be-93e210e6d2bc">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctMS0xLTEtMTg5Njk_7851b417-437d-479d-9671-b941675b3a5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctMy0xLTEtMTg5Njk_32501c5c-7168-447e-805e-bbd38d2af60c">600,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctNS0xLTEtMTg5Njk_921389d2-c170-4b11-ba60-dfeba1da3fa9">400,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan repayments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtMS0xLTEtMTg5Njk_c4b915ae-3871-4bea-8592-1a04bfa238cf">600,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtMy0xLTEtMTg5Njk_6c90dd81-59f8-43eb-818d-be3da59028b8">195,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtNS0xLTEtMTg5Njk_7d4c6427-05b8-45b0-9ced-50dafe775d93">48,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from refinancing of Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMS0xLTEtMTk1NzQ_ca9a3a89-74c6-479d-b816-a3b005855885">597,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMy0xLTEtMTk1ODE_bd0fba0d-ad85-495a-9023-7c60016f75c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItNS0xLTEtMTk1ODg_60386104-f08f-41c3-b4ff-11e0e6ce4a49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under revolving credit agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMS0xLTEtMTg5Njk_3cd3a320-3498-4d3c-8024-867dd5bb2e52">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMy0xLTEtMTg5Njk_44e349f7-2a1b-4ede-b8b4-bdb02aa54cc8">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItNS0xLTEtMTg5Njk_88d4c0b6-4aef-4693-abc3-b5c3bb15e56a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments under revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtMS0xLTEtMTg5Njk_18e66a6f-7b15-42f6-aa5d-854474ae400b">85,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtMy0xLTEtMTg5Njk_6b1c6ee5-7d73-473c-a84f-d537ffcf70c4">70,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtNS0xLTEtMTg5Njk_edead6ad-35db-4c5e-9eae-259c0f37e115">120,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of debt costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtMS0xLTEtMTg5Njk_4bf41191-3073-4095-85d4-79ffbe62defd">6,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtMy0xLTEtMTg5Njk_52eae641-2435-4b78-b7ca-f69bedf292c0">17,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtNS0xLTEtMTg5Njk_c898453f-e51f-476a-9b7b-460911ee5d31">6,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtMS0xLTEtMTg5Njk_81091f30-17f6-4588-a666-8221d581f01f">2,582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtMy0xLTEtMTg5Njk_24c49ee7-e69c-42ce-9b22-2c8e773cfe33">1,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtNS0xLTEtMTg5Njk_c4fb26b6-2a10-47de-b522-2ef212ba018d">476</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtMS0xLTEtMTg5Njk_70829fc2-f7af-4d37-b7bf-6cb92b1e0dc3">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtMy0xLTEtMTg5Njk_21de9338-6e02-4b68-85fc-a9da529bb27d">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtNS0xLTEtMTg5Njk_fc1ae561-10a0-4a69-822b-933df03ed82e">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of shares surrendered as payment of tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtMS0xLTEtMTg5Njk_0bf02190-7d0a-452b-87b8-1bc72e954887">2,916</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtMy0xLTEtMTg5Njk_c124f2a3-9132-4724-8bf3-d028089fdc68">1,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtNS0xLTEtMTg5Njk_b06dd3ec-a753-47e3-bf70-dc59cd3bbcdb">974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktMS0xLTEtMTg5Njk_82f21834-f2cc-40cb-b197-f95d1d1b9114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktMy0xLTEtMTg5Njk_33f70bfb-1439-44b9-b116-59ca8ae330d6">11,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktNS0xLTEtMTg5Njk_7ca821fb-e4da-470f-8d17-1d596094fcd3">56,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtMS0xLTEtMTg5Njk_dbd78d56-8bb0-44ba-8374-6734e64e306e">7,569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtMy0xLTEtMTg5Njk_2ef6aabe-91a1-40db-92f0-2f1f615c3453">279,419</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtNS0xLTEtMTg5Njk_deb8c543-fcb1-4bb7-a3b1-72b9760eb963">131,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItMS0xLTEtMTg5Njk_5a641b91-941f-4904-9d52-2a90c044e2e7">959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItMy0xLTEtMTg5Njk_8843bd0a-107b-47d9-bd98-b8677db68e46">3,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItNS0xLTEtMTg5Njk_936037fb-eb17-40b1-b058-3ef2e00a13dc">1,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtMS0xLTEtMTg5Njk_4c86ddf5-7e44-4fc5-9069-b226ddcb5807">5,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtMy0xLTEtMTg5Njk_1e841d57-2bcb-4d9f-b66d-be678ff85890">62,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtNS0xLTEtMTg5Njk_96ac4fc5-0226-4808-8481-a07e3cb65439">67,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtMS0xLTEtMTg5Njk_c862926f-a542-407a-b643-6492a0b929f7">32,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtMy0xLTEtMTg5Njk_f9e355b5-7805-4a3b-8889-7c0011fa753a">94,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtNS0xLTEtMTg5Njk_837d7c86-69b6-4eb3-93d3-71852b1ba9fd">27,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtMS0xLTEtMTg5Njk_95ea6dda-40cd-4767-b2c5-740e1b3dab02">27,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtMy0xLTEtMTg5Njk_7ae43179-ed55-4d26-bcd1-708bf77ec146">32,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtNS0xLTEtMTg5Njk_86b272c1-90c7-4e26-b5e4-9671c5575a04">94,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctMS0xLTEtMTg5Njk_d84631b7-7348-436f-b63f-56159130f504">61,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctMy0xLTEtMTg5Njk_f78a221d-e243-4f0e-855e-4553e7225ea1">80,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctNS0xLTEtMTg5Njk_69a9baaf-5194-4ef5-8755-1f05a3f12b99">92,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtMS0xLTEtMTg5Njk_442460cd-00e9-4406-ac2e-58d656a07fe0">46,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtMy0xLTEtMTg5Njk_46921eed-49a4-44b2-aec1-7d28f753ae67">34,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtNS0xLTEtMTg5Njk_4463e80c-c532-4f0c-9019-71844b598dd8">30,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prestige Consumer Healthcare Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1OTI_3b3914d8-09ae-4159-9d07-b81a27701044" continuedAt="i5c655970e51a41bba3e94edff4fad0dc" escape="true">Business and Basis of Presentation</ix:nonNumeric></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:continuation id="i5c655970e51a41bba3e94edff4fad0dc" continuedAt="i376312dfe49c41368f8d7fe7ef08c5cb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we&#8221;, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 9 to these Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the World Health Organization ("WHO") declared a global pandemic due to a new strain of coronavirus ("COVID-19").  The pandemic has caused significant volatility in the United States and global economies.  In addition, the Russian invasion of Ukraine has led to further economic uncertainty.  We expect economic conditions will continue to be highly volatile and uncertain and could affect demand for our products and put pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We experienced a temporary but significant decline in consumer consumption of our brands in the first quarter of fiscal 2021, followed by more stable consumption and customer orders over the remainder of the year. Generally, throughout the pandemic, some categories were positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products, as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel-related activity. In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio. Our business also benefited from a significant increase in demand in travel-related categories and channels as well as the Cough &amp; Cold category, previously impacted by the COVID-19 virus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both the COVID-19 pandemic and the geopolitical environment have also impacted the supply of labor and raw materials and exacerbated rising costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These circumstances could change, however, in this dynamic, unprecedented environment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the COVID-19 outbreak worsens or geopolitical conditions cause further disruption in the global supply chain, the availability of labor or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreak and recovery period and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MDc_673eb927-550a-408c-b05f-449d3bced185" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;Our fiscal year ends on March 31st of each year.&#160;&#160;References in these Consolidated Financial Statements or notes to a year (e.g., &#8220;2022&#8221;) mean our fiscal year ended on March 31st of that year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk0OTk_5574e086-f303-495b-ae40-e945b38cd860" continuedAt="i32edcc46d7534697920c08758ffba7ac" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i376312dfe49c41368f8d7fe7ef08c5cb" continuedAt="i583c45de0f644702ad82b05f62e6fd39"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32edcc46d7534697920c08758ffba7ac">based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160;&#160;As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NTU_943cced4-3226-456d-bb7e-abbfccf3dc28" continuedAt="i145d3f7c01984f47962f4f2b5610d6e4" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i145d3f7c01984f47962f4f2b5610d6e4">We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents.&#160;&#160;At March&#160;31, 2022, approximately <ix:nonFraction unitRef="number" contextRef="i93685426db444f7bb2e2083559bad12c_I20220331" decimals="2" name="pbh:PercentageofDepositsHeldinOneLocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfNTgyOA_73503135-3153-4c73-884c-282612a3898d">44</ix:nonFraction>% of our cash is held by a bank in Australia and approximately <ix:nonFraction unitRef="number" contextRef="iaf52d5526c8542f5ba5ef401cb74e77f_I20220331" decimals="2" name="pbh:PercentageofDepositsHeldinOneLocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfNTg5Mg_5984458c-b914-4565-a5d7-93da9d623f48">18</ix:nonFraction>% is held by a bank in Singapore.  Substantially all of our remaining cash is held by a large U.S. domestic bank.&#160;&#160;We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.</ix:continuation>  Substantially all of the Company's cash balances at March&#160;31, 2022 are uninsured. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MTk_9dc38f22-0627-4567-bb70-bd1ea65f34cd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We extend non-interest-bearing trade credit to our customers in the ordinary course of business.&#160;&#160;We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable.&#160;&#160;In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers&#8217; financial condition, (iii) monitor the payment history and aging of customers&#8217; receivables, and (iv) monitor open orders against an individual customer&#8217;s outstanding receivable balance.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDc_ec1a62fc-ebaf-4c84-8137-cbf8813650cb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, where cost is determined by using the first-in, first-out method.&#160;&#160;We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value.&#160;&#160;Factors utilized in the determination of estimated net realizable value include (i) product expiration dates, (ii) current sales data and historical return rates, (iii) estimates of future demand, (iv) competitive pricing pressures, (v) new product introductions, and (vi) component and packaging obsolescence.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MDU_4cc8254d-cdfe-4f05-a3fa-8747b0f9425a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NzA_ebae8444-1501-4c9b-bbb2-17aed19d7d62" continuedAt="ie0a39240060947cbab8120f6ad9d277d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMS0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjBiM2YyNjA3NzdkMjRiNWRhMzVmMmNiMWUxNGFmYjExXzQ_d4792571-9688-46c3-b036-839c197bc982">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ie68302d173624012909bcb1af5423f95_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMS0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjBiM2YyNjA3NzdkMjRiNWRhMzVmMmNiMWUxNGFmYjExXzEw_5f9a1bfc-55d8-4f9c-a46d-f95615adb97b">40</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf17434e163e4883b63bc1d499d3bfcd_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMi0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjhhZmMxNDczYjBiMDQwODhhOWQ2Yjc0Yjc3MTRjMmE3XzQ_62c15434-d934-4aab-a286-54abe7b7681c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ie8afee60cac74f0bbb72d34f37171669_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMi0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjhhZmMxNDczYjBiMDQwODhhOWQ2Yjc0Yjc3MTRjMmE3XzEw_84f3d94b-509e-4bed-9669-bbb55dc71cec">15</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i472664bf20994bc58e71a154e858a6ed_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMy0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOmNhMzdhMmI5MWM1ZjQ4NmE5YTg1NWM3MDFjNmI4NWI2XzQ_cbab24cd-fca5-49a7-a63d-8021a3d77851">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ib57c0f0620294543a556b227a34dfc06_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMy0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOmNhMzdhMmI5MWM1ZjQ4NmE5YTg1NWM3MDFjNmI4NWI2XzEw_c1b312b8-d821-444d-b554-efea69af9c50">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5cc44748f9f649259312b1379e06e3bf_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfNC0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjZlOWU5YmViNmMwZTRhZWQ5NWM1MTA1MDE3NGQ2YTMxXzQ_421370ac-9545-4573-b37a-7408735586e9">7</ix:nonNumeric> to <ix:nonNumeric contextRef="ib91d87e0f74c461e83248aab966de593_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfNC0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjZlOWU5YmViNmMwZTRhZWQ5NWM1MTA1MDE3NGQ2YTMxXzEw_6501f810-4e42-44d2-825b-16ef254ebfba">10</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred.&#160;&#160;When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NTc_43f593af-165c-4f49-93eb-874d04ff4b64" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill.&#160;&#160;Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level.  An impairment loss is recognized if the carrying amount of the reporting unit exceeds its fair value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1Mzg_0383e695-4c0e-4a2d-9203-d8d9b96d07ac" continuedAt="ia7ce044d474b48b0a17ab03e745994c8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets generally represent tradenames, brand names and patents and are stated at cost less accumulated amortization.&#160;&#160;For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from <ix:nonNumeric contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfOTM5OA_633be965-e6b9-4718-a9cf-f89672ddcaeb">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfOTQwNA_d78af178-780d-46b7-b0c7-816923dc7c64">30</ix:nonNumeric> years.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i583c45de0f644702ad82b05f62e6fd39" continuedAt="i2f3fe76fb0614522b07db8f2ebeae70c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia7ce044d474b48b0a17ab03e745994c8">Indefinite-lived intangible assets are tested for impairment at the individual asset level at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Intangible assets with finite lives are reviewed for impairment on an annual basis, or whenever events or changes in circumstances indicate that their carrying amount may exceed their fair values and may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</ix:continuation></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDU_ba381a59-d449-4dcd-8a9d-b3f6968c6179" continuedAt="icac046ad243345f589cb67611e1fe143" escape="true">Debt Origination Costs</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icac046ad243345f589cb67611e1fe143">We have incurred debt origination costs in connection with the issuance of long-term debt.&#160;&#160;These costs are amortized over the term of the related debt, using the effective interest method for our senior notes and our term loan facility and the straight-line method for our revolving credit facility.  Costs associated with our revolving credit facility are reported as a long-term asset and costs related to our senior notes and the term loan facility are recorded as a reduction of debt.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1ODU_31162139-b488-437d-85e4-02ce6b03cc3d" continuedAt="i0288a20816ce4851ae936e7929ba85e6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Nature of Goods and Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from product sales.  We primarily ship finished goods to our customers and operate in <ix:nonFraction unitRef="segment" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTA4MTY_b756d201-92f5-4158-bf75-e10328a28bca">two</ix:nonFraction> segments: North American OTC Healthcare and International OTC Healthcare.  The segments are based on differences in geographical area.  The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough &amp; Cold, Women's Health, Gastrointestinal, Eye &amp; Ear Care, Dermatologicals, and Oral Care.  Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels, all of which sell our products to consumers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 19 for disaggregated revenue information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Satisfaction of Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#8217;s carrier. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to the disclosure of remaining performance obligations.  Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time.  Accordingly, we have elected the practical expedient available under ASC 606 not to disclose </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2f3fe76fb0614522b07db8f2ebeae70c" continuedAt="i96c073f8fc5e43e4b1ed169187bee82f"><ix:continuation id="i0288a20816ce4851ae936e7929ba85e6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remaining performance obligations for our contracts.  The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less.  As such, we do not adjust product consideration for the effects of a significant financing component.  The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="pbh:CostOfSalesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NjY_ec70f3fb-d668-4fbb-85c2-30ad4157194f" continuedAt="ief42769bc22647368a299ea89c4d3231" escape="true">Cost of Sales</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ief42769bc22647368a299ea89c4d3231">Cost of sales includes costs related to the manufacturing of our products, including raw materials, direct labor and indirect plant costs (including but not limited to depreciation), warehousing costs, inbound and outbound shipping costs, and handling and storage costs.</ix:continuation>&#160;&#160;Warehousing, shipping and handling and storage costs were $<ix:nonFraction unitRef="usd" contextRef="if25f80c767b745ce88d01566c788c2ec_D20210401-20220331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2MjQ_09ecb3ab-c6ba-47ae-9022-941924411433">67.8</ix:nonFraction> million for 2022, $<ix:nonFraction unitRef="usd" contextRef="i628847fe21c845faa7ad04720f019f4b_D20200401-20210331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2MzU_4b28e83e-f395-4235-8948-ee8c91e5e6bf">52.1</ix:nonFraction> million for 2021 and $<ix:nonFraction unitRef="usd" contextRef="i9932c6e574f043a6b2eba1f46190d488_D20190401-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2NDk_e0a79d57-2a31-4e80-8eeb-f74b403fa992">61.9</ix:nonFraction> million for 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDI_7149f08e-678d-41ee-8fe8-79aa675c7923" continuedAt="i7ba4843d568e45c386e13b2399c7244a" escape="true">Advertising and Marketing Costs</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ba4843d568e45c386e13b2399c7244a">Advertising and marketing costs are expensed as incurred.&#160;&#160;Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.</ix:continuation>&#160;&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NDA_7f1271dc-7b44-41d0-999a-e545319ca784" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense by measuring the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1ODc_067588f1-0a83-4f46-bbce-78030cfffd8a" continuedAt="i2b89d3b5eea54a7596c088c83252578d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $<ix:nonFraction unitRef="usd" contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTcxMDE_f4d26b5b-2035-42a7-ad54-528c631df90a">7.0</ix:nonFraction> million and we recognized a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTcxNDM_0662fbfb-2b58-4bcf-9d0e-145991578b09">0.2</ix:nonFraction> million as a result of the payout.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process.  The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b89d3b5eea54a7596c088c83252578d">The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute.  Changes in interest rates and the market value of the securities held by the plans could materially change the funded status of the plans, positively or negatively, and affect the level of pension expense and required contributions in fiscal 2023 and beyond.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NzY_a8b68fbe-e8d4-441c-befb-bf2bf7e73437" continuedAt="i8e0f160603a845408d01ddd8d14f84f4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Income Taxes topic of the FASB ASC 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&#160;&#160;The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.  As a result, we have applied such guidance in determining our tax uncertainties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the United States and various state and foreign jurisdictions.&#160;&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i96c073f8fc5e43e4b1ed169187bee82f" continuedAt="ifb6d46b656d247fe9aa07ab0f43248ae"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e0f160603a845408d01ddd8d14f84f4">We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NDg_ab111b19-68e0-44ee-895e-510479c9399c" continuedAt="i1c6842fdd59845b08049161c1f9eb501" escape="true">Earnings Per Share</ix:nonNumeric><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1c6842fdd59845b08049161c1f9eb501">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an antidilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share.</ix:continuation>  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MTU_9a549462-ef8b-449b-9a64-f0c877d1b038" continuedAt="i0768cc7ffc5f41cd83d0a801afc2c239" escape="true">The following table sets forth the computation of basic and diluted earnings per share:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i0768cc7ffc5f41cd83d0a801afc2c239"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy0xLTEtMS0xODk2OQ_418a4bca-bbc4-4bff-9196-9322e25f2a0e">205,381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy0zLTEtMS0xODk2OQ_ebeb65a2-14a1-4377-892b-e2ec9dd975cb">164,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy01LTEtMS0xODk2OQ_48038d0e-3c0b-4fe2-9c4b-f257fc8189c7">142,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share - weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC0xLTEtMS0xODk2OQ_2cbf55dd-d86f-436b-9d5f-60744e8f3621">50,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC0zLTEtMS0xODk2OQ_b0a440a3-a906-461b-a91b-e53f3ca3518b">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC01LTEtMS0xODk2OQ_b16ae0c1-e4e0-4948-848d-48f2b5e3fd25">50,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS0xLTEtMS0xODk2OQ_f7f7cf0f-a8a9-4c24-89a1-9dece65c6a61">583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS0zLTEtMS0xODk2OQ_0430ab08-4448-423c-a44d-a27c72d22278">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS01LTEtMS0xODk2OQ_6aa3bd7d-8813-4c25-836b-babf51d1d5d7">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtMS0xLTEtMTg5Njk_ef065b64-322f-4234-9c4a-09da1c724116">50,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtMy0xLTEtMTg5Njk_368d3cd4-dc4b-4b4c-9d40-22d62f4a8f2a">50,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtNS0xLTEtMTg5Njk_5f549077-55b6-45c2-acc7-9a009258b71d">51,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtMS0xLTEtMTg5Njk_6e161bdd-1cd7-4d1b-b516-cee27ffd8c3d">4.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtMy0xLTEtMTg5Njk_44d9d325-47f9-4c96-8bcb-0aaf2def4380">3.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtNS0xLTEtMTg5Njk_168dd05c-e083-403d-afd8-81c0d9128839">2.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctMS0xLTEtMTg5Njk_fabefc69-5047-4d48-b45b-38e0d05ce721">4.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctMy0xLTEtMTg5Njk_14a21c17-f255-4828-a5ff-e5e95c631d9e">3.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctNS0xLTEtMTg5Njk_2f1c0ff6-d079-4426-89cd-067b7585659a">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, 2021, and 2020 there were <ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEyOTA_5b8ddf6e-5c40-4866-aec7-012b2508cd3c">0.4</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEyOTQ_9f92b200-e7f6-4442-8bea-841ef2a813bd">0.5</ix:nonFraction> million, and <ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEzMDI_8eed4bf3-fc73-438f-abe4-e39bef029037">0.3</ix:nonFraction> million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1Njg_389eb137-0319-4c3e-9528-cbb70266abed" continuedAt="iddacf4c7a9fd4ee2bd140672a176509e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. These leases have lease terms of <ix:nonNumeric contextRef="ied214f5ee4e64721bc76b33c5c12a69d_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2MDM_736558b2-f216-48dd-9c58-e1f787f8f9cb">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i07f4c56c383e4cadb7732fd1d3749213_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2MDk_988d1110-020e-437d-bbb9-56fd004183fb">10</ix:nonNumeric> years, some of which include options to terminate or extend leases for up to <ix:nonNumeric contextRef="ied214f5ee4e64721bc76b33c5c12a69d_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2ODk_e7716278-ac0c-4f94-b5f9-5abcc48bb06e">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i07f4c56c383e4cadb7732fd1d3749213_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2OTU_8b5a3536-b71f-4f61-87b2-65bb40e56eb9">5</ix:nonNumeric> years or on a month-to-month basis.  The exercise of lease renewal options is at our sole discretion and our lease right-of-use ("ROU") assets and liabilities reflect only the options we are reasonably certain that we will exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset.  ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.  Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments, which do not vary based on an index or rate, are excluded from the ROU asset and lease liability determination.  Variable lease payments are typically usage-based and are recorded in the period in which the obligation for those payments is incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in our leases is unknown, we used our incremental borrowing rate based on the information available at the date of adoption for existing leases and at the lease commencement date for new leases in determining the present value of future lease payments. We give consideration to our credit risk, term of the lease, total lease payments and adjust for the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifb6d46b656d247fe9aa07ab0f43248ae" continuedAt="i30c7dc4e81a94f11b4fc10987a685d89"><ix:continuation id="iddacf4c7a9fd4ee2bd140672a176509e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impacts of collateral, as necessary, when calculating our incremental borrowing rates.  Rent expense for our operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the measurement and classification of our lease agreements, we group lease and non-lease components into a single lease component for all underlying asset classes. We have also elected to exclude any leases within our existing classes of assets with a term of twelve months or less.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk0OTg_617f7fd2-5ce2-46c6-a241-4f3ac8755868" continuedAt="i2fd3db2e2bd4487fa5204f2d1b5f55da" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We adopted this standard effective April 1, 2021, and the adoption of this standard did not have a material impact on our Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020 using the modified retrospective approach, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We adopted this standard effective April 1, 2021 and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This update amended a number of aspects of lease accounting, including requiring lessees to recognize all leases with a term greater than one year as a ROU asset and corresponding lease liability, measured at the present value of the lease payments.  On April 1, 2019, we adopted Topic 842 using the modified retrospective approach.  Results for the years ended March&#160;31, 2022, 2021 and 2020 are presented under Topic 842. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020 (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above).  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022,  including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i30c7dc4e81a94f11b4fc10987a685d89"><ix:continuation id="i2fd3db2e2bd4487fa5204f2d1b5f55da"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_1729"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8zODQ4MjkwNjk5OTc1_f541d3fc-03ba-41ee-96ee-78393ed1a025" continuedAt="i3c1857b36eae40dd906948e0e5d4101e" escape="true">Acquisition</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3c1857b36eae40dd906948e0e5d4101e" continuedAt="idda7f4d4d1f647f880bc1018e00f0054"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn"), pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNzU2_13c57913-7f89-4586-910a-211e33b21e18">228.9</ix:nonFraction>&#160;million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 9).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  During 2022, we incurred acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="iedfff890d1e84d249e980571ec6bbcf9_I20220331" decimals="-5" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwMzM1_2916705f-a048-4936-83f5-b03e58b90bec">5.1</ix:nonFraction>&#160;million, which are included in General and administrative expense.  In connection with the acquisition, we also entered into a supply arrangement with Akorn for a term of <ix:nonNumeric contextRef="ibd914b5ed7ee4a2c8bba1ee5e7e2efe8_D20210401-20220331" name="pbh:SupplyCommitmentTermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjI4OTM5_4796d278-634b-4de5-b61a-cf9cb53fd900">three years</ix:nonNumeric> with optional renewals at prevailing market rates.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  These purchase price allocations are preliminary as we are in the process of finalizing the valuation.  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8zODQ4MjkwNjk5OTc2_78b34fd1-91e8-4e93-81c8-7cd1253cf68b" continuedAt="i2b80b56919a646f49c091d7ab6d7abf3" escape="true">The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i2b80b56919a646f49c091d7ab6d7abf3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl80LTEtMS0xLTE5ODU4_59068d04-4ee1-4360-8f8b-5204aa2dfa0b">6,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl83LTEtMS0xLTE5ODU4_e82ef5c1-a3bf-4572-a404-92d88cd7f62a">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl84LTEtMS0xLTE5ODU4_f8c6efb9-8378-495d-a771-bf6895bcbb46">225,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMC0xLTEtMS0xOTg1OA_b209dda5-6577-442c-9e33-08603f86d895">233,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMi0xLTEtMS0xOTg1OA_60019b66-11c9-4581-adc7-56c7dc3f2940">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMy0xLTEtMS0xOTg1OA_9688acde-76da-4428-8eaa-3b8418c5b0c4">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xNC0xLTEtMS0xOTg1OA_ad92fe7a-6c96-4cdd-b356-177fd976bacd">3,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xNy0xLTEtMS0xOTg1OA_2dde8979-0ff7-49f6-ab4f-289278e4533b">4,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xOC0xLTEtMS0xOTg1OA_bcb7d3a4-4e0a-4a6e-acec-a3589d080c16">228,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="idda7f4d4d1f647f880bc1018e00f0054" continuedAt="i0f3d11a7c7e347e589eeeb9370e7fbf5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this preliminary analysis, we allocated $<ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDI1_04dbe9f5-b5a7-43af-8b19-57bada958276">195.9</ix:nonFraction>&#160;million to non-amortizable intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-5" name="pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDI5_5a2fc805-c96b-4a32-8689-39e2bd526720">29.5</ix:nonFraction>&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $<ix:nonFraction unitRef="usd" contextRef="icc3645f563ff42219ffff940481757a4_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDUz_2f593f5e-96b0-491f-ab39-dbcf372f96e4">20.4</ix:nonFraction>&#160;million are classified as customer relationships and $<ix:nonFraction unitRef="usd" contextRef="ic475742a3fe44eb5ac7769813e20ce42_I20210701" decimals="-5" name="pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDQz_24dba9ad-2928-4dc2-9912-77c726478953">9.1</ix:nonFraction>&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of <ix:nonNumeric contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDg0_1511d76d-1f5c-4f6c-adea-475b9cee4a7e">12.5</ix:nonNumeric> years (see Note 6).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDk2_1b4baf6f-fb2d-4fe7-b3e5-f41561d1255c">1.6</ix:nonFraction>&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired (see Note 5).  Goodwill is deductible and is being amortized for income tax purposes. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i0f3d11a7c7e347e589eeeb9370e7fbf5">The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.</ix:continuation> </span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMzAw_bbe2674f-aca8-4a38-a1b3-b70d1f8d5346" continuedAt="i4a6913291827460fa33af2c40426d997" escape="true">Inventories</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4a6913291827460fa33af2c40426d997"><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjkx_795b8769-17a0-4d6d-8471-b40d8a5eb2f6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfMy0xLTEtMS0xODk2OQ_ddda218f-f5db-458d-940b-b7a6a882183a">16,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfMy0zLTEtMS0xODk2OQ_dd9aae36-88c6-482d-ac13-1b13d6166e7b">8,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNC0xLTEtMS0xODk2OQ_4990dd3d-c736-4065-91ba-98596afcc032">338</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNC0zLTEtMS0xODk2OQ_0d5957ef-9c01-4316-9c3f-c7c67d3c03e2">326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNS0xLTEtMS0xODk2OQ_d8329495-34be-4963-a1d7-4a82c7315517">103,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNS0zLTEtMS0xODk2OQ_6e865a18-869f-4a7d-8978-1ee03e07dd2e">106,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNi0xLTEtMS0xODk2OQ_a6512b82-d568-40a1-8fa2-8b226cd903af">120,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNi0zLTEtMS0xODk2OQ_2f140ea6-b20b-4f4b-86bf-35b13aac0b12">114,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjAy_38f6c721-1a9a-45e7-ac75-5349f69dd1cd">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjA5_e4ee506a-0946-4b1b-9b4f-1faa6dbe0a15">4.0</ix:nonFraction> million at March&#160;31, 2022 and 2021, respectively, related to obsolete and slow-moving inventory.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTk1_3413b731-fb5b-460b-add9-2d872b4f8930" continuedAt="i0b5d2f218f334940ba34f2fdb6d62f75" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ie0a39240060947cbab8120f6ad9d277d"><ix:continuation id="i0b5d2f218f334940ba34f2fdb6d62f75" continuedAt="i32b65355852c4ec2998b3faf4a91b77a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Property, Plant and Equipment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63adfa16455749529a578a107f9b488f_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMy0xLTEtMS0xODk2OQ_8acc6acb-228c-4914-911d-c7348db55ce0">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0c797835694c38b0ed72ecec2427b7_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMy0zLTEtMS0xODk2OQ_d376643c-e8eb-490e-af6d-0b92ed0086bb">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6359612b8c648048fe362216a04a7f3_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNC0xLTEtMS0xODk2OQ_5d41b099-9d40-43f7-8b21-e4d887f3a9e4">29,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cda2011cd9439296ec2aee3a52e2a0_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNC0zLTEtMS0xODk2OQ_7668ad00-1c84-44f0-aee2-1659187b2e6f">27,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73a57ecc254455cae6f5b9d171bc153_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNS0xLTEtMS0xODk2OQ_a57327a1-f8ba-4d6d-b33d-6f0ae516c5e9">48,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e9364fde841a2a844b91fca700d71_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNS0zLTEtMS0xODk2OQ_2909a7b9-96ec-404c-ab65-9f217468eb8a">45,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68eec35a89b640abb6b59a67cc2c458e_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNi0xLTEtMS0xODk2OQ_778127b0-6558-4936-b731-5a04a651f37b">25,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8a0ad3b3d24ce481be054872bcc00e_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNi0zLTEtMS0xODk2OQ_7c8b30b5-a3a3-42e7-969a-c7d07548c009">24,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i609a7e847bec4a5eb87c67671f78c7e0_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNy0xLTEtMS0xODk2OQ_83ceda14-5c40-42f3-8cf3-2a45c567038d">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63d91fe5ae4e4557a2fa616f58e373cc_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNy0zLTEtMS0xODk2OQ_49cd8c34-c1a1-4519-b047-aafc9f9e8bab">3,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04801f9b35a145479c2f926a02758888_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOC0xLTEtMS0xODk2OQ_e2c6b5a1-2e27-43a3-87c5-944e96af41d2">9,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d090ede7de343c8a1442413f0a934af_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOC0zLTEtMS0xODk2OQ_067f3721-3ef6-4efa-aa9b-86ba4415c93a">9,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacff4498c9324023bb8e6dc3cbbd98d6_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOS0xLTEtMS0xODk2OQ_d89a14c2-d42e-4df2-8357-58cbf710656a">16,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f29776a97564733a0caac2100d77ef5_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOS0zLTEtMS0xODk2OQ_baec4e70-9723-4197-8470-a792083807c6">14,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTAtMS0xLTEtMTg5Njk_4269f79d-979e-40ba-9fef-6be5cbf16eb8">132,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTAtMy0xLTEtMTg5Njk_11049afd-b3a2-4f40-be98-c3646ea460e4">124,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTEtMS0xLTEtMTg5Njk_5a035c97-7f5a-47b7-b927-1fcc68a027aa">60,715</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTEtMy0xLTEtMTg5Njk_ca5b0ba1-5586-45a9-8193-d8900c691c36">54,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTItMS0xLTEtMTg5Njk_8c25876f-7633-47ed-b2a7-0d928b25f3ef">71,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTItMy0xLTEtMTg5Njk_3edc1957-537c-4eb8-a732-a091022a9045">70,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32b65355852c4ec2998b3faf4a91b77a">We recorded depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTQy_94f602c1-53f1-4f53-9448-19099bcec5d0">8.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTQ2_65cec828-e143-49a5-9efb-f6587956a99b">8.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTU0_740a7e21-c56d-431f-b9ed-d0a29a733a03">8.8</ix:nonFraction> million for 2022, 2021, and 2020, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMzA0Mw_b22b1324-fe05-4255-84ac-acb82fc614bc" continuedAt="i999c3dcd8a634c61b1d0e2fecaa917ac" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i999c3dcd8a634c61b1d0e2fecaa917ac" continuedAt="if8090ea3104649e8a7e25d753302de27"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMzA0MA_e469a150-b760-4d8a-b037-9d0555798ea5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2020, 2021, and 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi0xLTEtMS0xODk2OQ_cd10b70b-a2d0-462e-8064-ba9556230366">710,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5785a0756b4597a3f801623955484e_I20200331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi0zLTEtMS0xODk2OQ_8ab371fa-4538-4429-9d6f-6afbbb814a20">28,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi03LTEtMS0xODk2OQ_b5b7f871-9344-40d0-9f6d-63509d7f65a5">738,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy0xLTEtMS0xODk2OQ_2a5d7951-6586-4d9e-aae2-9bfbff9215d6">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5785a0756b4597a3f801623955484e_I20200331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy0zLTEtMS0xODk2OQ_96a620ba-89b9-4b7f-a76a-77a2356985cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy03LTEtMS0xODk2OQ_dece9361-11ad-4587-9a91-584684652483">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC0xLTEtMS0xODk2OQ_d2761a85-53f8-47aa-8154-65a0b892b089">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5785a0756b4597a3f801623955484e_I20200331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC0zLTEtMS0xODk2OQ_a988f4a8-b127-41dd-ab33-0577806bbf08">28,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC03LTEtMS0xODk2OQ_bbfe1775-bbe1-434d-9377-8e1c6e28b067">575,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 43.75pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtMS0xLTEtMTg5Njk_ab876bf1-f8fb-4200-bc65-2457825d65de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtMy0xLTEtMTg5Njk_4b5c76ac-d91a-4eee-aed0-b270c53d29ed">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtNy0xLTEtMTg5Njk_ce5aec9d-9ed4-43c4-a79b-44f43353611f">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtMS0xLTEtMTg5Njk_2b427a26-496b-4083-8a1f-cd356c7ca974">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtMy0xLTEtMTg5Njk_5675d08b-753f-44cc-8b11-e3b4073c511b">1,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtNy0xLTEtMTg5Njk_5b40d0d2-957a-4888-88cb-cb8b26c31786">1,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtMS0xLTEtMTg5Njk_62067ce8-4807-4ae7-ac95-2d2113e9047c">710,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtMy0xLTEtMTg5Njk_b5ab5642-d0ad-492d-b2ad-0887701988f3">32,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtNy0xLTEtMTg5Njk_8a1250c1-e5eb-47b1-9230-ce64594fd383">743,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtMS0xLTEtMTg5Njk_38fe0bac-cee6-42c9-aad3-9f405ff4779c">163,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtMy0xLTEtMTg5Njk_b64c1165-0398-40ed-bf75-d7c2fb12ce62">1,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtNy0xLTEtMTg5Njk_8b88d91f-fe8d-4f61-b440-608e28ee726e">164,958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtMS0xLTEtMTg5Njk_28dc3a2b-b6d5-4234-9dfa-0283000f0ce6">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtMy0xLTEtMTg5Njk_46179f9f-dc96-4491-a02d-bda05fe92f22">31,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtNy0xLTEtMTg5Njk_8b68ce67-9715-40be-b409-b01cbe4cf52b">578,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtMS0xLTEtMTg5Njk_c42c3712-9d9c-44da-b5ab-536864ce3658">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtMy0xLTEtMTg5Njk_8308fe14-5737-4be9-a600-2cdc3bf109e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtNy0xLTEtMTg5Njk_3c701922-cf82-45a3-854e-1a354b4385b6">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItMS0xLTEtMTg5Njk_131c4ee9-0b3d-4847-8f47-2e64591f8596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItMy0xLTEtMTg5Njk_856b7d48-86bc-4e1a-baeb-accdc92e8241">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItNy0xLTEtMTg5Njk_39f6bcdf-c6bc-42b3-9610-e2041a96d2ba">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtMS0xLTEtMTg5Njk_88c6c549-844d-4383-a0ab-36b9a1e324ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtMy0xLTEtMTg5Njk_59c90e21-7de9-4a1e-a330-efa1d490f565">340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtNy0xLTEtMTg5Njk_a52b639b-d040-497a-b365-399ed6df7877">340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtMS0xLTEtMTg5Njk_00230eca-a407-4ef6-baf8-39ebcbb360ac">712,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtMy0xLTEtMTg5Njk_e1a700a3-81b4-468a-a9e3-6541938648f6">32,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtNy0xLTEtMTg5Njk_27a24e7b-1a5e-4d73-b7c6-d3490108e472">744,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctMS0xLTEtMTg5Njk_0dbb3652-958f-40ce-b36c-ccddcc7d52e0">163,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctMy0xLTEtMTg5Njk_581bd8bd-1c33-4c49-9750-0fe1b1522938">1,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctNy0xLTEtMTg5Njk_e791f0b1-90c9-4a6a-bbad-1dea0e43e34e">165,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtMS0xLTEtMTg5Njk_06cb090a-787c-46da-8587-f7784f49b3ed">548,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtMy0xLTEtMTg5Njk_aafd57d1-c38e-4d3a-a151-ea5c385ed8cd">30,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtNy0xLTEtMTg5Njk_84ef5614-59e5-48a9-91fb-2a69cd5f3bbe">578,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2, on July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn.  In connection with this acquisition, we recorded goodwill of $<ix:nonFraction unitRef="usd" contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzMTIwNA_16771e69-f564-420c-a5b3-672d5efef09a">1.6</ix:nonFraction>&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At February 28, 2021, in conjunction with the annual test for goodwill impairment, we recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i19e3761c71cf440882e905e4bc852d25_D20210228-20210228" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzMjU0OA_6a622862-ac72-448a-84e0-152f4896bc9d">1.2</ix:nonFraction>&#160;million to adjust the carrying amount of goodwill related to our International Analgesics reporting unit in our International OTC Healthcare segment to its fair value.  The goodwill impairment was a result of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename impairment discussed in Note 5.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At February 28, 2022, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, we recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i5f61b06bc453405295e67e755ad9dc7d_D20210228-20210228" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzNzI4OQ_dbc22bf1-139e-4059-bbd2-724f4eb3f53f">0.3</ix:nonFraction>&#160;million to write off the remaining goodwill related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">brand in our International OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify our reporting units in accordance with the FASB ASC Subtopic 280.  The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies.  The discounted cash flow methodology is a widely-accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently.&#160;&#160;We also considered our market capitalization at February&#160;28, 2022 and February&#160;28, 2021, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.&#160;&#160;The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, increased product costs, supply chain/material cost inflation, or the potential impacts of COVID-19.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value. If these assumptions are adversely affected, we may be required to record impairment charges in the future. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if8090ea3104649e8a7e25d753302de27">As a result of our analysis at February&#160;28, 2022, all reporting units had a fair value that exceeded their carrying value by at least <ix:nonFraction unitRef="number" contextRef="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331" decimals="4" name="pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjU0Mg_e24fc4fd-a160-402e-b10d-486f2b9efb60">10</ix:nonFraction>%.  We performed a sensitivity analysis on our weighted average cost of capital and we determined that a <ix:nonFraction unitRef="number" contextRef="i8bb6c96119cc4504a07f59227add5e1a_D20210401-20220331" decimals="4" name="pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjY0OA_2a5fd539-fccf-4f98-8232-df3cedf2f90c">50</ix:nonFraction> basis point increase in the weighted average cost of capital would not have resulted in any of our other reporting units' fair value being less than their carrying value.  Additionally, a <ix:nonFraction unitRef="number" contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331" decimals="4" name="pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjgzOQ_d156492e-e654-4621-b418-5eb33f5dbcc4">50</ix:nonFraction> basis point decrease in the terminal growth rate used for each reporting unit would also not have resulted in any of our other reporting units' fair value being less than their carrying value.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_100"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQzODY_ffa1e90a-50b2-43ad-89fa-c1f33a38f630" continuedAt="i056388aaa36740d68622bbf64d561366" escape="true">Intangible Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i056388aaa36740d68622bbf64d561366" continuedAt="i8aaed2a9ca3e4b9e9e219a6ce05c50f2"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="pbh:ScheduleOfIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQ0MDQ_ff2b5e62-94af-437d-a4b9-b3e81fcc6859" continuedAt="if3edd1b36b38481da2e084965eb6749a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net for each of 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtMS0xLTEtMTg5Njk_24f6d7ba-f100-4f0e-9c68-073e7ee7e53e">2,281,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtMy0xLTEtMTg5Njk_29bd5cf2-8d3a-48d6-a55f-836e375bb040">389,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtNS0xLTEtMTg5Njk_3f54a844-6b28-4328-bdfc-01ff93d7e392">2,671,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtMS0xLTEtMTg5Njk_2fdd146c-5244-4be1-9648-6dfc5ea0a9ea">195,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtMy0xLTEtMTg5Njk_4a42cd7f-c7d4-4272-b54d-9c4d208a85b0">47,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:IntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtNS0xLTEtMTg5Njk_bbe9da3f-dee6-48f2-a1dc-3b2289a9b938">243,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctMS0xLTEtMTg5Njk_a887f8ff-12d8-441a-b368-4633576caad4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctMy0xLTEtMTg5Njk_98715a27-2227-4155-8679-b98801e422fb">1,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctNS0xLTEtMTg5Njk_5216ecb2-c440-48f5-a1a3-639c6365af5f">1,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtMS0xLTEtMTg5Njk_4380d9ef-e38c-4dcf-97cf-4fe077844d6f">1,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtMy0xLTEtMTg5Njk_4a76a035-5f86-4a60-9275-a29403d56c96">885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="pbh:IntangibleAssetsTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtNS0xLTEtMTg5Njk_126b06d6-9806-486e-82d1-afaa279e6916">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13817405df1449ac862beb623f788537_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktMS0xLTEtMTg5Njk_d76c4e8d-9a7a-49c1-b583-cf45f0466816">2,476,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktMy0xLTEtMTg5Njk_f6b5fec8-7cb9-4d24-81bd-00b690094943">436,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktNS0xLTEtMTg5Njk_998424e7-869f-448b-976e-c8fbb68fa42f">2,912,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEyLTMtMS0xLTE4OTY5_bbf46585-6a94-40bb-a708-a56732a75aef">195,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEyLTUtMS0xLTE4OTY5_06db1e57-7d5e-4a67-816a-9dd6ba58ea86">195,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEzLTMtMS0xLTE4OTY5_33d391fd-59bd-48cb-8cd2-7d2f03260823">21,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEzLTUtMS0xLTE4OTY5_ae7d25ef-c200-417b-ae35-250a6cd89ce5">21,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE0LTMtMS0xLTE4OTY5_75cdbc9f-4874-4175-9def-aa3000e5f5f1">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE0LTUtMS0xLTE4OTY5_c773ca65-a23b-44fb-8e82-52227faba850">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331" decimals="-3" sign="-" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE1LTMtMS0xLTE4OTY5_d7e0b107-f7be-41d9-afd3-8e951e2877c8">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE1LTUtMS0xLTE4OTY5_89be38f7-1f94-4df7-9f2e-5061e319675f">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE2LTMtMS0xLTE4OTY5_ca7cd9f7-9d02-4c95-ab20-21e41590a625">216,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE2LTUtMS0xLTE4OTY5_546679bd-e421-4be1-892d-f9135d1ea0cf">216,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13817405df1449ac862beb623f788537_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTEtMS0xLTE4OTY5_dfac46e2-67d6-4dc9-9c02-8a80b235a3d9">2,476,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTMtMS0xLTE4OTY5_1634f32b-9bee-4b4b-bae5-8325e1352b7e">220,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTUtMS0xLTE4OTY5_dbcbf9e5-65e0-4875-9231-b4683ed610c4">2,696,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bacb62d2b764d98ab587019221feb5e_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTEtMS0xLTE4OTY5_64c00d1c-934b-4351-bd4d-dc722ce5afb5">2,391,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b518b4ab33c4fb7b07453e2656c888b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTMtMS0xLTE4OTY5_94524791-c2d2-4797-85dc-5efb51e61725">198,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTUtMS0xLTE4OTY5_0ce80d40-65f7-4d96-88b4-e864efd28630">2,589,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ba4d3341224392858a56fe1feccb8b_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTEtMS0xLTE4OTY5_5c3270eb-8351-4da1-9edb-cff6c4c1e361">85,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTMtMS0xLTE4OTY5_f0a41f1d-bc4d-4b3e-84ea-c8c44ef89cf0">21,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTUtMS0xLTE4OTY5_eb5ebf28-5fb3-46f8-a507-1583ef73498f">106,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13817405df1449ac862beb623f788537_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTEtMS0xLTE4OTY5_3c5dcdf7-c683-4284-a97e-ab4340dd34cd">2,476,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTMtMS0xLTE4OTY5_e7edc9fa-b83a-4adf-96f5-1add5bc144f3">220,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTUtMS0xLTE4OTY5_c35d82b5-d29c-47f4-8852-54596ee0329b">2,696,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $<ix:nonFraction unitRef="usd" contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701" decimals="-5" name="pbh:IntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2Mzc4NTg_4b64bf83-ecfd-42a4-b84b-7accd03aa197">225.4</ix:nonFraction> million to intangible assets based on our preliminary analysis for Akorn and $<ix:nonFraction unitRef="usd" contextRef="i6e7c6d4c44a9497fbbbbe5882fa1a870_D20211215-20211215" decimals="-5" name="pbh:IntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2MzMzNzQ_8c3ea7ab-1f98-4ba2-a511-89fbdbf7047d">18.1</ix:nonFraction> million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i8aaed2a9ca3e4b9e9e219a6ce05c50f2" continuedAt="i2b6278f2aa7842fe95573421f90886ea"><div style="text-align:justify"><ix:continuation id="if3edd1b36b38481da2e084965eb6749a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b414dfd69f8433e8240e27a0edef648_I20200331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtMS0xLTEtMTg5Njk_7a8a05fb-66f6-417c-ac9f-0b9c3a0f9d98">2,265,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied44a8b51f55435492975e4a49f6cfb9_I20200331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtMy0xLTEtMTg5Njk_a43893a3-96f2-448e-811e-4db9899fe357">389,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtNi0xLTEtMTg5Njk_342782d7-6138-4dc3-922e-4687e7c5b653">2,655,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctMS0xLTEtMTg5Njk_c4561ed6-2dfe-43f9-8676-6df1dcf93ab2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctMy0xLTEtMTg5Njk_2db31aab-a1bb-4ba6-8345-689012f82639">1,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctNi0xLTEtMTg5Njk_ae2138c9-25cd-4be3-aea9-c3a4c500cc6d">1,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtMS0xLTEtMTg5Njk_da79405a-dac8-4fa7-94a9-2e28729df023">16,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtMy0xLTEtMTg5Njk_5a504e3a-f082-441f-9c9a-ff1fa9660101">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:IntangibleAssetsTranslationAdjustmentsGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtNi0xLTEtMTg5Njk_50854343-d6f3-4f95-aca2-e068b408a2a2">17,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktMS0xLTEtMTg5Njk_09094d8d-2b82-42c6-89c2-69f616b2af48">2,281,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktMy0xLTEtMTg5Njk_5d6f5ced-10d0-4579-a965-85740004222e">389,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktNi0xLTEtMTg5Njk_89d4f5a2-9ba2-4272-8097-fa4eec5ff227">2,671,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied44a8b51f55435492975e4a49f6cfb9_I20200331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEyLTMtMS0xLTE4OTY5_119175c2-2fd2-49fc-a557-242968787872">175,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEyLTYtMS0xLTE4OTY5_55f65508-6bac-4344-8eea-b3f564d8ff78">175,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEzLTMtMS0xLTE4OTY5_ccd62783-24de-4ca2-a4fe-e7a02b50e430">19,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEzLTYtMS0xLTE4OTY5_7ce31aea-50e2-4aed-a83b-6cc5fc02feb8">19,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE1LTMtMS0xLTE4OTY5_7e7ab8f9-dd59-4f3b-a72e-6eb9d2d87b0b">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE1LTYtMS0xLTE4OTY5_0f324ac4-eba1-4469-83b6-1366b7f7f5c6">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE2LTMtMS0xLTE4OTY5_b4cdc0e9-02b3-47a6-8e55-d8b4d1fa8fc2">195,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE2LTYtMS0xLTE4OTY5_6171c274-7206-49f7-8e30-c5c9caae98ce">195,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTEtMS0xLTE4OTY5_b68a632a-636e-4d59-81d0-d6422e0da835">2,281,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTMtMS0xLTE4OTY5_c5973f57-c617-4ea2-bb8d-805bfb992fe9">193,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTYtMS0xLTE4OTY5_60b7c9f3-d0d7-4ce0-8ddf-b9112b6487c2">2,475,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTEtMS0xLTE4OTY5_de86e7a4-e417-4b40-812e-7eb8edd18c64">2,195,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTMtMS0xLTE4OTY5_1ef0e867-1e20-43d2-9158-5d9aeed386e9">190,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTYtMS0xLTE4OTY5_7a33cafb-c7f9-4c14-af51-683f8771356e">2,386,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTEtMS0xLTE4OTY5_916ab835-e4b7-49a9-9bc8-241b6896ced1">86,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTMtMS0xLTE4OTY5_5220d4ec-7b2e-4d6f-ba95-d2c2cdc14de0">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTYtMS0xLTE4OTY5_e0dbfe7e-5259-4d72-80eb-30837d78784d">89,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTEtMS0xLTE4OTY5_5ceccd99-20da-4a86-81f0-f5420ddc6773">2,281,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTMtMS0xLTE4OTY5_35df9ec1-5efa-4462-a743-a6a8ecc35579">193,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTYtMS0xLTE4OTY5_56941b62-8c11-4502-8a2f-274894f9c7fa">2,475,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of each fiscal year, in conjunction with our strategic planning process, we perform our annual impairment analysis.  We utilized the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins and advertising and marketing expenses.   The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, increased product costs, changes in advertising and marketing expenses, or the potential impacts of COVID-19, we may be required to record impairment charges in the future.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, did not exceed its carrying amount.  As such, we recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i69d08238dbfa4d19a42daf28b60de30d_D20210701-20210930" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2NDk4MDA_1df453b3-b27c-4f4e-b993-e7f6b9d2540d">1.2</ix:nonFraction>&#160;million. The decline in the fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was primarily related to a decline in expected future sales due to a regulatory change that now requires </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be prescribed by physicians rather than sold over-the-counter direct to consumers</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2022, in conjunction with the annual test for impairment of intangible assets, we recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i0b1d55aab74e4d9d9ebe57a0c1b36420_D20220228-20220228" decimals="-3" sign="-" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2MzgwMzU_08d30e51-879f-43d9-a759-10fd2e70e3a7">0.7</ix:nonFraction>&#160;million.  In connection with our long-term planning, two non-core brands in our North American OTC Healthcare segment were discontinued and therefore the related finite-lived intangible assets were written off. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our analysis at February&#160;28, 2022, all indefinite-lived intangible assets tested had a fair value that exceeded their carrying value by at least <ix:nonFraction unitRef="number" contextRef="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331" decimals="INF" name="pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzM4NDgyOTA3MTY5ODM_acd901b1-5702-4b1d-8907-1d5286fbaa15">10</ix:nonFraction>%, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename which had a fair value exceeding its carrying value by <ix:nonFraction unitRef="number" contextRef="i55324cd11967477cb55c9dbf85c8b0ba_D20210401-20220331" decimals="INF" name="pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3ODI_3c22f652-7eeb-4970-9b47-d5fc1a372eea">7</ix:nonFraction>%.  We performed a sensitivity analysis of our weighted average cost of capital, and we determined that a <ix:nonFraction unitRef="number" contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331" decimals="4" name="pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NTY_7c736a59-6089-4837-9b01-ec05490765b1">50</ix:nonFraction> basis point increase in the weighted average cost of capital used to value the indefinite-lived intangible assets would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename was acquired on July 1, 2021 and given the close proximity of the acquisition to the annual impairment test, we would expect the fair value to more closely approximate the carrying value.  A <ix:nonFraction unitRef="number" contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331" decimals="4" name="pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NjA_2da662d5-7ee7-4ea8-9515-2bb74bd21de9">50</ix:nonFraction> basis point increase in the weighted average cost of capital would result in an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="icd308cfa7f4743acae74277795a0cbde_D20210401-20220331" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3Njg_f9dc6a4e-e719-408c-97f7-cb9f43ad14e4">4.3</ix:nonFraction>&#160;million on our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename.  Additionally, a <ix:nonFraction unitRef="number" contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331" decimals="4" name="pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NjQ_538b7520-4a2e-42c3-b98b-fd3ca4e77b48">50</ix:nonFraction> basis point decrease in the terminal growth rate used for each of our indefinite-lived </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2b6278f2aa7842fe95573421f90886ea"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intangible assets' would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining life for finite-lived intangible assets at March&#160;31, 2022 was approximately <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQwMzY_f20b1838-06e9-45c7-9945-e55b777e9439">9.8</ix:nonNumeric> years, and the amortization expense for the year ended March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQwOTY_d19ccf6d-070b-48a7-bfca-7f32a9758ffc">21.5</ix:nonFraction> million.  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQzOTk_bc312eb0-8952-46d0-8beb-4d79215104ae" continuedAt="i4f21a2154bbd4b7ebc32eb44d4eea552" escape="true">At March&#160;31, 2022, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of <ix:nonNumeric contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQyNDE_0ff0b1f0-b934-45c7-8362-6c789e4c0ab1">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQyNDc_ac8a96be-cdf0-4f9d-b3f1-b97ea9dcf499">30</ix:nonNumeric> years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i4f21a2154bbd4b7ebc32eb44d4eea552"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzItMS0xLTEtMTg5Njk_28be3bbc-099e-423d-8ba0-4d8f87f29934">22,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzMtMS0xLTEtMTg5Njk_fbd1103d-9279-4242-a4c1-ebd7a6fdce6c">22,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzQtMS0xLTEtMTg5Njk_262420a0-eb3b-45ca-86af-b1a9a05d2b85">20,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzUtMS0xLTEtMTg5Njk_d72cf59d-32a7-4ac1-942a-c55fd3eaea88">18,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzYtMS0xLTEtMTg5Njk_906ecf02-a2a5-4eee-9d56-f3b8d3a5deea">16,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzctMS0xLTEtMTg5Njk_864f5c54-73e8-4496-bda8-285f5106d50d">119,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzgtMS0xLTEtMTg5Njk_0ced082b-077b-4b80-8f56-9f9a42e8aaa8">220,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OA_52014afe-4618-4ee2-8ae9-807e2bb50389" continuedAt="ia80b8a35553442bdafe466f57c84d21b" escape="true"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OA_fc88f4b2-0a62-4c10-b750-a4c2065d2261" continuedAt="i78054812835742029956039afab87f03" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia80b8a35553442bdafe466f57c84d21b" continuedAt="i1611ae513a004340a8a7db697f0fda67"><ix:continuation id="i78054812835742029956039afab87f03" continuedAt="iefb8f560ad0745c9b6e3c599ed1f86ec"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OQ_5744463c-dc92-4c60-b14f-8f13a34c0507" continuedAt="iecae51eee90b42b099a5d4572b70bd61" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzMtMS0xLTEtMTg5Njk_ce674889-64fe-428c-831b-95695f40a0f5">2,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzMtMy0xLTEtMTg5Njk_19adc31a-c485-4889-9120-e747817463c7">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzQtMS0xLTEtMTg5Njk_5b46e8a1-5d2e-40b9-88f2-1eb851bc8425">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzQtMy0xLTEtMTg5Njk_97335b22-51ed-41bb-a8ed-af66bdd35893">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzUtMS0xLTEtMTg5Njk_6389669f-d9d1-4b65-bd11-c2c592fab350">6,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzUtMy0xLTEtMTg5Njk_397b673a-6674-47fe-b4c7-dd4cc4e00753">6,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzYtMS0xLTEtMTg5Njk_4424d99d-8ceb-4434-8bcc-7121d97c0f03">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzYtMy0xLTEtMTg5Njk_fed98efb-bce5-4e21-9c0f-2ff8d6303a18">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzctMS0xLTEtMTg5Njk_4fac9aee-f7b3-4570-8a65-eaef21a40b87">42,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzctMy0xLTEtMTg5Njk_4f7d854d-f16d-44f7-b070-7ccdfe078414">46,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzgtMS0xLTEtMTg5Njk_9a7c86ba-ea6c-418e-b29c-dfec1d61ff07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzgtMy0xLTEtMTg5Njk_b56fb888-5e91-4c1c-8e4e-e1bfc8b92d09">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzktMS0xLTEtMTg5Njk_97d4e8d6-e4af-4faa-bf0e-66ffb4671549">52,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzktMy0xLTEtMTg5Njk_b11fdeb0-e920-41d1-84a2-a30cbd130ace">55,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1611ae513a004340a8a7db697f0fda67"><ix:continuation id="iefb8f560ad0745c9b6e3c599ed1f86ec"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY1MA_327101b0-1d54-4f44-a773-a73fd229e01c" escape="true"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY1MA_a0eec146-edac-438d-bf34-5c531c1894da" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:56.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItMi0xLTEtMTg5Njk_94e65519-796d-487b-8423-c0ca968701a4">6,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItNC0xLTEtMTg5Njk_3d17831b-d644-4ec9-a8a6-dd6cb1fb87a6">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItNi0xLTEtMTg5Njk_1d0627fb-6ec9-45a6-9635-42bf8d83bfd1">9,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtMi0xLTEtMTg5Njk_6022f668-db36-4dbe-b709-df4f42c9ff0c">6,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtNC0xLTEtMTg5Njk_33cd937a-d100-455c-b401-820e4f300243">2,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtNi0xLTEtMTg5Njk_3844a7fb-563b-46f5-abd4-39195b7ad1c7">9,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtMi0xLTEtMTg5Njk_9a677bac-4530-42e8-b008-b028d5f194cf">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtNC0xLTEtMTg5Njk_1972b080-b710-4ea7-9a7c-b44b096f583e">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtNi0xLTEtMTg5Njk_f7775938-6d30-4728-8c2c-1960f7cf9802">6,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtMi0xLTEtMTg5Njk_25836e51-42b5-45d7-9267-96424ed2cd85">2,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtNC0xLTEtMTg5Njk_af8f258a-0f87-46a5-9019-171d94f5e95e">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtNi0xLTEtMTg5Njk_562e9f04-067d-4ac2-9946-2859c962d847">2,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtMi0xLTEtMTg5Njk_6cbe5acb-70f2-4868-bc2f-9a28e43f73a5">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtNC0xLTEtMTg5Njk_a6721e94-f306-44f2-827a-f41ef4b30fba">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtNi0xLTEtMTg5Njk_a4f69a5f-d31a-4be3-8ad6-9f537597a7b6">1,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctMi0xLTEtMTg5Njk_b9112ae1-c88b-4f85-8f4e-bc929dee7cad">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctNC0xLTEtMTg5Njk_48c20288-7692-4b45-9160-78a368632634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctNi0xLTEtMTg5Njk_1d0c28f6-0485-4b5c-8442-2544143d2c4c">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtMi0xLTEtMTg5Njk_d849f38e-fead-406c-8d3a-b69511728593">24,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtNC0xLTEtMTg5Njk_cf1aacab-6cff-421a-8730-07e61e96a36c">7,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityPaymentDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtNi0xLTEtMTg5Njk_7a6b1679-9218-4cd1-9bd2-d71760bb16cd">31,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktMi0xLTEtMTg5Njk_c9295b40-c888-4658-8444-70c8bb6ea38d">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktNC0xLTEtMTg5Njk_c46135a5-d1d1-43d4-bcaf-ceb8e36b615d">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktNi0xLTEtMTg5Njk_5562b0de-6a11-4249-ad27-6ff8edad3a66">1,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTItMS0xLTE4OTY5_4f2ab02d-efe4-48f9-b44f-cde8d8949657">22,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTQtMS0xLTE4OTY5_dcb88167-2a11-45cf-aa52-9a2293e39a5c">7,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:OperatingAndFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTYtMS0xLTE4OTY5_9c5ee95f-5dec-4ddf-b69a-f058ccd3283e">29,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="iecae51eee90b42b099a5d4572b70bd61"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:6.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzItMy0xLTEtMTg5Njk_9908dce8-0e7b-4d2d-bdcd-00a883962cf2">4.03</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzMtMy0xLTEtMTg5Njk_da2da686-9d0b-4ee8-840d-5a45d5fbce69">2.64</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzUtMy0xLTEtMTg5Njk_5f94a776-dcf9-4a84-953c-818a6e26b991">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzYtMy0xLTEtMTg5Njk_c86e8e42-9d41-4fef-b34e-03e9ac8a3bc9">2.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during 2022, 2021 and 2020.  The noncash lease liability arising from obtaining ROU assets was $<ix:nonFraction unitRef="usd" contextRef="i335edd3216614cc694f48efa6d5a9a28_I20220331" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzM4NDgyOTA2OTc5OTA_befe6721-ee79-4312-a13c-29383cb19f24">0.5</ix:nonFraction>&#160;million for the assets that went into service in 2022, $<ix:nonFraction unitRef="usd" contextRef="i589c5b16c5f2469aaba1478b0dd6dd6d_I20210331" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzQ5NA_503b9901-9b47-46ff-a555-bc1f6bc15c9b">5.2</ix:nonFraction>&#160;million for the assets that went into service in 2021 and $<ix:nonFraction unitRef="usd" contextRef="i5fe2ba61b566469dbb5a593ca0b80d99_I20200331" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzU0Nw_4a15c23c-c58d-4634-97d6-78f75e6744ab">6.4</ix:nonFraction>&#160;million for assets that went into service in 2020.  These amounts represent noncash financing activities.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_109"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90ZXh0cmVnaW9uOmFkMjlmZjBiZDNlNjRlMTViMjk2NDIzN2ZlOWQyNWFjXzk1_0fe9f371-28bf-4ff4-97a6-7f11935975d1" continuedAt="ibc68a653a2694ccfb0acab9bbde41f99" escape="true">Other Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ibc68a653a2694ccfb0acab9bbde41f99"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90ZXh0cmVnaW9uOmFkMjlmZjBiZDNlNjRlMTViMjk2NDIzN2ZlOWQyNWFjXzEwMw_7e8150f1-ceb6-48a3-97a9-b83cb7d4e31a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzItMS0xLTEtMTg5Njk_c360b78d-23ad-43a6-a95d-b2e7b094a4d1">36,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzItMy0xLTEtMTg5Njk_8ba0d7ac-8987-4049-a8e3-1f9d08a30fad">29,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzMtMS0xLTEtMTg5Njk_4f6346c2-5e7b-46a9-a960-812717c589fa">19,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzMtMy0xLTEtMTg5Njk_2e761648-b649-40de-ba5a-531fd32428ec">14,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzQtMS0xLTEtMTg5Njk_ae337e3e-8aba-462b-ba5b-f315ae0ff8d0">1,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzQtMy0xLTEtMTg5Njk_09386a7b-4ca4-4545-a264-08ee4779135a">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzUtMS0xLTEtMTg5Njk_68df6c5c-15bf-465e-a098-8a468188ce71">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzUtMy0xLTEtMTg5Njk_7d0ce473-6449-4785-9048-ba0a82d78c4b">1,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzYtMS0xLTEtMTg5Njk_fdb0e8cf-977d-4861-8375-3e512896f46c">4,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzYtMy0xLTEtMTg5Njk_c1b9fe6d-cedd-4c56-bc4b-1da7e0ae7b27">4,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:AccruedProductionCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzktMS0xLTEtMTg5Njk_59eda578-b1a0-4088-9ac7-7133f6163fa3">3,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:AccruedProductionCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzktMy0xLTEtMTg5Njk_b2be7160-f255-45ec-b68d-dfa823cb1d1b">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEyLTEtMS0xLTE4OTY5_3ff72072-32b6-4380-b0ce-f74b07900325">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEyLTMtMS0xLTE4OTY5_571a2f2e-ebb2-4cd4-8136-4a24dbbec339">2,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEzLTEtMS0xLTE4OTY5_16973341-918c-413f-9d75-afce2d548461">6,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEzLTMtMS0xLTE4OTY5_90322d71-3bad-45c7-9a65-1a60c0b626b2">4,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzE0LTEtMS0xLTE4OTY5_21ebba8b-cb83-4fcc-90b1-b49451c1ff88">74,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:AccruedAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzE0LTMtMS0xLTE4OTY5_b5b4fa63-6b1d-461d-8c52-63a3de1fd0bd">61,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ3_b82a9c63-c214-43e0-8be2-9ed7467a1b63" continuedAt="i88b6a545c13a45f49e24f2755abd5fff" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i88b6a545c13a45f49e24f2755abd5fff" continuedAt="i3832e90044354e01a47acb2a2a0da54c"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ1_1e8f79d1-14e8-4102-a8fb-d87c6dbb53d2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="i09fd1299e2a3429cbcae381ab51a8154_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5ZDdlYjQ0MTJjMWU0NTA4YjkzYTVlZTMxNDNlNzk1Nl80Mg_1f1f907f-3d30-418a-9236-f90803283f09">3.750</ix:nonFraction>%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09fd1299e2a3429cbcae381ab51a8154_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItMi0xLTEtMTg5Njk_500492ab-cb24-4820-b500-f5bab3fe83e0">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bcfb0f753744a1ab751cb65c0dc7aea_I20210331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItNC0xLTEtMTg5Njk_98503333-a1a7-4ec8-be5c-ce5dfe2a4715">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at <ix:nonFraction unitRef="number" contextRef="idb76c60a4e494bd39785dbbddef2aee3_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiMDhlZDRkNWI3MWQ0ZDgwYWQ3YzBkZjczYWMzZmVkNF80Mg_1fc68beb-8efa-42b5-8387-a7949ae22893">5.125</ix:nonFraction>%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb76c60a4e494bd39785dbbddef2aee3_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtMi0xLTEtMTg5Njk_c019ae55-1efa-4ab4-b4ec-93892387924b">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7902118aff74b92a991aec7dec64d48_I20210331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtNC0xLTEtMTg5Njk_61e6a65b-3592-4836-899f-a20765e6777f">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml85OQ_c00134fe-a314-49c9-a43c-9b6b4a78b352">2.00</ix:nonFraction>%, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331" decimals="INF" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xMjU_56c8ed22-37d6-4ce9-856f-aec58cd7256a">0.00</ix:nonFraction>%, or an alternate base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xNzI_06b38bbb-9149-428a-ba45-390d1a45e6da">1.00</ix:nonFraction>%, with a floor of <ix:nonFraction unitRef="number" contextRef="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331" decimals="INF" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xOTI_90b912ac-352d-4639-8e27-adf62aa0c0c2">1.00</ix:nonFraction>%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0046cff099774243b2fe9bcef53f28b4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMi0xLTEtMTg5Njk_e400b389-f2e2-42f1-92c0-318a2edd316d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f62c80458240b1a4ab90648a7ad1aa_I20210331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtNC0xLTEtMTg5Njk_a839871c-7788-4db7-a327-269cf20c0aaa">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of <ix:nonFraction unitRef="number" contextRef="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF85OQ_2fa2fa1a-29ab-4055-8780-e65c61fc021c">2.00</ix:nonFraction>%, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331" decimals="INF" name="pbh:DebtInstrumentVariableRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF8xMjU_cd2431cf-f49e-40e1-b520-2edfbb07b4a7">0.50</ix:nonFraction>%, or an alternate base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i7e7166028fc3449da1b745c1053364a9_D20210401-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF8xNzI_874c68e8-89b9-4b7f-aa79-64cd2909e39c">1.00</ix:nonFraction>% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfd3cfbed7740a9a4326dec51b02b1f_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMi0xLTEtMjA2MjM_74beb768-ada4-4c30-8655-b0bd5543e49c">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67542c5b47c4477989e0e9f42edffbf8_I20210331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctNC0xLTEtMjA2MjM_29c6deca-a6b5-4126-af3e-4f3affe73b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzExLTItMS0xLTE4OTY5_bc3a18a1-cc91-4a96-969b-c09c6990810d">1,495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzExLTQtMS0xLTE4OTY5_22fce555-b40a-4ad7-bf47-dc19830f7a5f">1,495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEyLTItMS0xLTE4OTY5_16f94f45-9aee-4ae1-8469-4d59615e156d">18,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEyLTQtMS0xLTE4OTY5_a410c69b-a466-4938-b378-fd4332715dc7">15,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEzLTItMS0xLTE4OTY5_bab2de6c-825c-4c29-88f0-0aa335c3bb89">1,476,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEzLTQtMS0xLTE4OTY5_69f9c058-6297-4689-8987-6fb09f7968be">1,479,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had <ix:nonFraction unitRef="usd" contextRef="ic16a8c37cbf24b36ae290009040fbdb3_D20210401-20220331" decimals="INF" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNg_14385518-f713-4dd2-85d5-e345c4c4761e">no</ix:nonFraction> balance outstanding on the 2012 ABL Revolver and a borrowing capacity of $<ix:nonFraction unitRef="usd" contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE5Mg_fce68ea6-5218-44f4-8b91-47f11d850da6">123.3</ix:nonFraction> million. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2012 Term Loan and 2012 ABL Revolver:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2012, Prestige Brands, Inc. (the &#8220;Borrower")  entered into a senior secured credit facility, which consists of (i) the $<ix:nonFraction unitRef="usd" contextRef="i35c7d3689acf4430baf1e0a96d60aabd_I20120131" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzM2OQ_558beacf-e2ad-4a0a-b01c-d7d5ff03b4f9">660.0</ix:nonFraction> million 2012 Term Loan with an original <ix:nonNumeric contextRef="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyMg_4cf40436-a27c-4223-8120-9f2b2713b281">7</ix:nonNumeric>-year maturity and (ii) the $<ix:nonFraction unitRef="usd" contextRef="i0c172aec253140b2b6067b78d9e369bc_I20120131" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ1MA_98348aff-3b63-46fc-b253-20f59be4cd5a">50.0</ix:nonFraction> million 2012 ABL Revolver with an original <ix:nonNumeric contextRef="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzUzNA_6f0fa544-5a85-4a87-bf39-58443d02b7b1">5</ix:nonNumeric>-year maturity.  In subsequent years, we have utilized portions of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $<ix:nonFraction unitRef="usd" contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331" decimals="INF" name="pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzcwNQ_443b728e-9219-4792-90f1-5de927919b5a">85.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzcxMQ_f9044374-7762-4c63-9473-7fe6e4b1c4b9">135.0</ix:nonFraction> million and reduced our borrowing rate on the 2012 ABL Revolver by <ix:nonFraction unitRef="number" contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331" decimals="INF" sign="-" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzc3Mw_8f225ef1-ff9b-435a-a233-2b1a6b1e4e57">0.25</ix:nonFraction>% (discussed below).  The 2012 Term Loan was issued with an original issue discount of <ix:nonFraction unitRef="number" contextRef="i35c7d3689acf4430baf1e0a96d60aabd_I20120131" decimals="INF" name="pbh:DebtInstrumentDiscountPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg2MQ_aeaa3ca1-ab78-4c1b-8db5-d7805899b3da">1.5</ix:nonFraction>% of the principal amount thereof, resulting in net proceeds to us of $<ix:nonFraction unitRef="usd" contextRef="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzMg_bb69ca13-6499-40f8-837e-29cf2c3276a4">650.1</ix:nonFraction> million.  The 2012 Term Loan is unconditionally guaranteed by Prestige Consumer Healthcare Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower.  Each of these guarantees is joint and several.  There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2013, we entered into Amendment No. 1 ("Term Loan Amendment No. 1") to the 2012 Term Loan.  Term Loan Amendment No. 1 provided for the refinancing of all of our existing Term B Loans with new Term B-1 Loans (the "Term B-1 Loans").  The interest rate on the Term B-1 Loans under Term Loan Amendment No. 1 was based, at our option, on a LIBOR rate plus a margin of <ix:nonFraction unitRef="number" contextRef="iba56d9afb135474e8bfe4cffa9c2e86f_D20130221-20130221" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE2OTk_33d0f4ca-a26b-4f68-af0a-4efcc86f0717">2.75</ix:nonFraction>% per annum, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="iee6d3227d18744bdbefdbd1cecdc8ae8_I20130221" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE3MzU_5489139e-ff0f-4fa6-9d11-1d39cdb31303">1.00</ix:nonFraction>%, or an alternate base rate, with a floor of <ix:nonFraction unitRef="number" contextRef="i18f08dc2f7ca4e3ba24144835eb55cb2_I20130221" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE3ODI_8b24cb40-aa0e-465b-80f7-9c3d541a052d">2.00</ix:nonFraction>%, plus a margin.  In addition, Term Loan Amendment No. 1 provided the Borrower with certain additional capacity to prepay subordinated debt, our then-outstanding senior notes and certain other unsecured indebtedness permitted to be incurred under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2014, we entered into Amendment No. 2 ("Term Loan Amendment No. 2") to the 2012 Term Loan.  Term Loan Amendment No. 2 provided for (i) the creation of a new class of Term B-2 Loans under the 2012 Term Loan (the "Term B-2 Loans") in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="iaa2b839503ec42fc8fe2a49df981bff1_I20140903" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzIzNzU_7916c887-b7d5-40ec-9f6d-ed84bde889e6">720.0</ix:nonFraction> million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility and financial maintenance covenant relief, and (iii) an interest rate on (x) the Term B-1 Loans that was based, at our option, on a LIBOR rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i0558c1bb126d4298b73cefd18fa9c46f_D20140903-20140903" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI3Mjk_58c5b942-6e14-4753-bb91-6ba932f3f84e">3.125</ix:nonFraction>% per annum, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="ia42ad38caa804913950ccf7ea487d0bb_I20140903" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI3NjU_9295bd8a-dc1b-4328-8ebd-da942df21dd9">1.00</ix:nonFraction>%, or an alternate base rate, with a floor of <ix:nonFraction unitRef="number" contextRef="i319c15fd01bd47548445643d00863bf3_I20140903" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI4MTI_eb942edd-fe8e-4d48-9c24-368a6fd5dc20">2.00</ix:nonFraction>%, plus a margin, and (y) the Term B-2 Loans that was based, at our option, on a LIBOR rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i5ef2f1d69f724bb493a3a655ac79be25_D20140903-20140903" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI5MjI_4c8bd2ba-9927-42ad-bfbd-56c00afb5166">3.50</ix:nonFraction>% per annum, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="iaf4727399a7346ea91615137b5e4dc2f_I20140903" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI5NTg_a6605b5e-c140-4e74-b16f-cdca0c6c1115">1.00</ix:nonFraction>%, or an alternate base rate, with a floor of <ix:nonFraction unitRef="number" contextRef="i3cbc0bb0d6054954997646711fb51951_I20140903" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMwMDU_4c8022fd-6afc-4f4d-b60c-b68888a13e56">2.00</ix:nonFraction>%, plus a margin (with a margin step-down to <ix:nonFraction unitRef="number" contextRef="i59f95eb55c54445286593337ec154069_D20140903-20140903" decimals="INF" name="pbh:DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMwNTE_698a2212-bd13-470f-9985-5fed7d9a76ba">3.25</ix:nonFraction>% per annum, based upon achievement of a specified secured net leverage ratio). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, on September 3, 2014, we entered into Amendment No. 3 ("ABL Amendment No. 3") to the 2012 ABL Revolver.  ABL Amendment No. 3 provided for (i) a $<ix:nonFraction unitRef="usd" contextRef="i2c9d6e5813094b2c81201639ca24cd5c_I20140903" decimals="INF" name="pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMyODQ_55dac0d0-9013-450a-ad8b-5fd53a53beed">40.0</ix:nonFraction> million increase in revolving commitments under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility.  Borrowings under the 2012 ABL Revolver, as amended, bore interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus <ix:nonFraction unitRef="number" contextRef="i6b0e800bd3d649b68c6b357ca77f8220_I20140903" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzM3ODg_807026fe-d43b-4a0d-904e-7c2f07bc7d42">0.50</ix:nonFraction>%, (b) the prime rate of Citibank, N.A., and (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3832e90044354e01a47acb2a2a0da54c" continuedAt="i53c9e99840584a6c958b20e6b9246f5e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plus <ix:nonFraction unitRef="number" contextRef="ic759cbf7a7b842cb9529c38f67458e9b_I20140903" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQwMDQ_13141477-5318-4441-8693-080135a26944">1.00</ix:nonFraction>% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs.  The applicable margin for borrowings under the 2012 ABL Revolver could be increased to <ix:nonFraction unitRef="number" contextRef="i2cd6d3dec26f448899c5ad59eb21db2f_I20140903" decimals="INF" name="pbh:DebtInstrumentVariableRateConditionalVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyNzg_8e6ac83a-3c9f-43d9-8860-82752d48605a">2.00</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i3e52034a43564d1586e14c7c32da2efd_I20140903" decimals="INF" name="pbh:DebtInstrumentVariableRateConditionalVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyODQ_0d94a2f4-1635-4d71-97e0-a00737f85915">2.25</ix:nonFraction>% for LIBOR borrowings and <ix:nonFraction unitRef="number" contextRef="i55b044eff678498fbe6c714272119acf_I20140903" decimals="INF" name="pbh:DebtInstrumentVariableRateConditionalVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQzMTI_ed281e6d-12ac-42a1-b46e-ec23f35c94a0">1.00</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i4df9522b555a408989b96f6b0910ddd7_I20140903" decimals="INF" name="pbh:DebtInstrumentVariableRateConditionalVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQzMTg_42ce5d63-bc3a-43d3-b97f-706e78249391">1.25</ix:nonFraction>% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter.  In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we were required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder.  The initial commitment fee rate was <ix:nonFraction unitRef="number" contextRef="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ3MDc_cc90bbbf-6a60-4e31-9db1-f6884644d162">0.50</ix:nonFraction>% per annum.  The commitment fee rate will be reduced to <ix:nonFraction unitRef="number" contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331" decimals="INF" name="pbh:LineOfCreditFacilityConditionalCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ3NjU_83589f35-2eb2-485c-9cbb-0f14b7c0aa19">0.375</ix:nonFraction>% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments by an amount set forth in the credit agreement covering the 2012 ABL Revolver.  We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2015, we entered into Amendment No. 3 ("Term Loan Amendment No. 3") to the 2012 Term Loan.  Term Loan Amendment No. 3 provided for (i) the creation of a new class of Term B-3 Loans under the 2012 Term Loan (the "Term B-3 Loans") in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ib2bcbe34278c447fb245a931855163bc_I20150508" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzUzNzA_11153703-3a86-4483-ba93-be8d9f9947fb">852.5</ix:nonFraction> million, which combined the outstanding balances of the Term B-1 Loans of $<ix:nonFraction unitRef="usd" contextRef="i5ac25b9d7e324eea8f7f44cb83be491e_I20150508" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU0Mzk_f8c0fa93-ba83-46fd-afc1-53768ff836e9">207.5</ix:nonFraction> million and the Term B-2 Loans of $<ix:nonFraction unitRef="usd" contextRef="i786615716fbf49968cb2764459adaf9e_I20150508" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU0Njg_7780a89d-a90c-41c9-8684-029d89813501">645.0</ix:nonFraction> million, and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  The maturity date of the Term B-3 Loans remained the same as the Term B-2 Loans' original maturity date of September 3, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2015, we entered into Amendment No. 4 (&#8220;ABL Amendment No. 4&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 4 provided for (i) a $<ix:nonFraction unitRef="usd" contextRef="id49b28f7f8b24a8e9f452cf83fddd6d0_D20150609-20150609" decimals="INF" name="pbh:LineofCreditFacilityIncreaseinAccordionFeature" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU5NzY_52e0528d-df80-4ebf-a21f-73a57f454031">35.0</ix:nonFraction> million increase in the accordion feature under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief and (iii) extended the maturity date of the 2012 ABL Revolver to June 9, 2020, which was <ix:nonNumeric contextRef="i1611c74aa45e494f956f74b6f8d18d37_D20150609-20150609" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzYzNzA_d44b0b03-c23a-4ad9-bda5-d2b4b65b514c">five years</ix:nonNumeric> from the effective date of ABL Amendment No. 4.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2016, we entered into Amendment No. 5 (&#8220;ABL Amendment No. 5&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 5 temporarily suspended certain financial and related reporting covenants in the 2012 ABL Revolver until the earliest of (i) the date that was <ix:nonNumeric contextRef="iddb5f29165d140ce8590ce4f580057ba_D20160204-20160204" name="pbh:DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzY2ODg_ed46dba1-9d0e-4bd4-bd23-ebd97942f7ed">60</ix:nonNumeric> calendar days following February 4, 2016, (ii) the date upon which certain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DenTek&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assets were included in the Company&#8217;s borrowing base under the 2012 ABL Revolver and (iii) the date upon which the Company received net proceeds from an offering of debt securities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Fleet acquisition, on January 26, 2017, we entered into Amendment No. 4 ("Term Loan Amendment No. 4") to the 2012 Term Loan.  Term Loan Amendment No. 4 provided for (i) the refinancing of all of our outstanding term loans and the creation of a new class of Term B-4 Loans under the 2012 Term Loan (the "Term B-4 Loans") in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i6aa9ed85523f4bffa275deb4f8aac069_I20170126" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzczNDE_5c6e8d30-96cf-40dd-b57d-87636acc08d9">1,427.0</ix:nonFraction> million and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  Term Loan Amendment No. 4 also extended the maturity date of the 2012 Term Loan to January 26, 2024.  In addition, Citibank, N.A. was succeeded by Barclays Bank PLC as administrative agent under the 2012 Term Loan.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, on January 26, 2017, we entered into Amendment No. 6 ("ABL Amendment No. 6") to the 2012 ABL Revolver.  ABL Amendment No. 6 provided for (i) a $<ix:nonFraction unitRef="usd" contextRef="i4ccccc1f26f341a68d9ca89cfab4434c_I20170126" decimals="INF" name="pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzc5NTQ_03a3aeb8-b023-4ac5-92f1-1f942123294d">40.0</ix:nonFraction> million increase in revolving commitments under the 2012 ABL Revolver, (ii) an extension of the maturity date of revolving commitments to January 26, 2022, and (iii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility consistent with Term Loan Amendment No. 4.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2018, we entered into Amendment No. 5 (&#8220;Term Loan Amendment No. 5&#8221;) to the 2012 Term Loan.  Term Loan Amendment No. 5 provided for the creation of Term B-5 Loans (the "Term B-5 Loans") by repricing of the Term B-4 Loans under the credit agreement governing the 2012 Term Loan to an interest rate that is based, at our option, on a LIBOR rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i122c1f4cf7fe4f93a9cccfdf65056fa3_D20180321-20180321" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg3MjI_5cc056bc-405a-4b90-995c-685391b9686d">2.00</ix:nonFraction>% per annum, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i4de06c1d14cf41cb863a5a08b674bea3_I20180321" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg3NTg_45de5c9c-84ed-4de4-ab09-e333a7ad936f">0.00</ix:nonFraction>%, or an alternative base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="icde342a964df4c25b081ffb70c172b7a_D20180321-20180321" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg4MDc_5c93ee0d-60f6-4eeb-a873-0c0fd311d7b9">1.00</ix:nonFraction>% per annum, with a floor of <ix:nonFraction unitRef="number" contextRef="i0224233392114adf91fe01fed058dea0_I20180321" decimals="INF" name="pbh:DebtInstrumentReferenceRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg4Mzc_bb4204a9-b718-4a2d-928b-12993f64f395">1.00</ix:nonFraction>%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, we entered into Amendment No. 7 ("ABL Amendment No. 7") to the 2012 ABL Revolver.  ABL Amendment No. 7 provides for (i) an extension of the maturity date of the 2012 ABL Revolver to December 11, 2024, which is <ix:nonNumeric contextRef="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkwODM_2a4726b7-7e1c-43d1-a694-8fdbe19df0de">five years</ix:nonNumeric> from the effective date of ABL Amendment No. 7, (ii) increased flexibility under the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility, (iii) an initial applicable margin for borrowings under the 2012 ABL Revolver that is <ix:nonFraction unitRef="number" contextRef="i70fb5e5a361b41159fce56b86161af71_D20191211-20191211" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzNTY_4f13b962-050b-43e0-8abe-03bcd5ddb0b1">1.00</ix:nonFraction>% with respect to LIBOR borrowings and <ix:nonFraction unitRef="number" contextRef="i6a04c87c425240ca949ab30cc154c591_D20191211-20191211" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzOTY_5f61b4b8-a353-4c11-9060-9e74260115ac">0.0</ix:nonFraction>% with respect to base-rate borrowings (which may be increased to <ix:nonFraction unitRef="number" contextRef="i3be594bcf6624e02a2fa508bbcec16c8_D20191211-20191211" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0NjM_0968dbf5-ac2b-4b62-b60d-919664c7ba4a">1.25</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="i329303f1b639409c82598b0f32e87c4e_D20191211-20191211" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0Njk_fdda98a1-6e9d-404b-a0e4-1a7f66a32c46">1.50</ix:nonFraction>% for LIBOR borrowings and <ix:nonFraction unitRef="number" contextRef="i1e71bab1d60d488aa52d8528a9dd9265_D20191211-20191211" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0OTc_89fe8c28-0a21-4493-845b-e37c7879917c">0.25</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="ib88dbcd32abb43569e49cbca38a7b8e8_D20191211-20191211" decimals="INF" name="pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk1MDM_a41dfad3-935d-4745-b2e2-1065d21f0d5c">0.50</ix:nonFraction>% for base-rate borrowings, depending on </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i53c9e99840584a6c958b20e6b9246f5e" continuedAt="ia04043623c0b47ceaac74bf465dcb0bf"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">average excess availability under the facility during the prior fiscal quarter), and (iv) a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder of <ix:nonFraction unitRef="number" contextRef="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk3NTA_7c522122-8940-4615-b825-402a44394f17">0.25</ix:nonFraction>% per annum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2021, we entered into Amendment No. 6 ("Term Loan Amendment No. 6") to the 2012 Term Loan.  Term Loan Amendment No. 6 provided for (i) the refinancing of our outstanding term loans and the creation of a new class of Term B-5 Loans under the credit agreement governing the 2012 Term Loan in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="icf0b48ee76264f7a92f392720f3b43d6_I20210701" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0NTU_a243da21-7437-46eb-b673-dbf28ddd922a">600.0</ix:nonFraction>&#160;million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, and (iii) an interest rate on the Term B-5 Loans that is based, at the Borrower's option, on a LIBOR rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i1e6d0ebd6d014edc800dfa6316c8c320_D20210701-20210701" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0Nzc_ab2504b4-64d6-4d67-add2-4b36c4ba49fa">2.00</ix:nonFraction>% per annum, with a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="ibc75511f253c4893ab0567e3b34323e1_D20210701-20210701" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0OTA_660ac795-050b-49a9-9efe-bd2743ade429">0.50</ix:nonFraction>%, or an alternative base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="i7e22f021780647258b15b6e00a871903_D20210701-20210701" decimals="INF" name="pbh:DebtInstrumentAlternativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1MDM_78e75458-dfac-4765-ad51-374222bfbc8e">1.00</ix:nonFraction>% per annum.   In addition, Term Loan Amendment No. 6 provided for an extension of the maturity date of the 2012 Term Loan to July 1, 2028.  In connection with this refinancing, we recorded a loss on extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ia969b1c646c440768cf974287fc7426e_D20210401-20220331" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1MjM_a8b0b4c0-a4b8-4f94-aa71-e03f03eb2b81">2.1</ix:nonFraction>&#160;million to write off a portion of new and old debt costs relating to this refinancing.  Under Term Loan Amendment No. 6, we are required to make quarterly payments each equal to <ix:nonFraction unitRef="number" contextRef="i415c7e0679e349e58f0e0f20395cc300_I20210701" decimals="INF" name="pbh:DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1NDM_60f0b549-9565-4b59-b160-21a00cb1abe3">0.25</ix:nonFraction>% of the aggregate principal amount of the 2012 Term Loan.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the new class of Term B-5 Loans were used to refinance our outstanding term loans, finance the acquisition of Akorn and pay fees and expenses incurred in connection with these transactions (see Note 2).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March&#160;31, 2022, the average interest rate on the 2012 Term Loan was <ix:nonFraction unitRef="number" contextRef="i4baae0737d004ba09ced690b2fcdc5b1_D20210401-20220331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk4NDA_ae00d714-eb50-4f04-bffe-e9f45e23e884">3.6</ix:nonFraction>% and the average interest rate on the amounts borrowed under the 2012 ABL Revolver was <ix:nonFraction unitRef="number" contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk5Mjk_1ed2d43a-6d48-443a-94b1-a7198bd37b18">1.2</ix:nonFraction>%.  For the year ended March&#160;31, 2021, the average interest rate on the 2012 Term Loan was <ix:nonFraction unitRef="number" contextRef="i39e0fc9224654a75a98d2b9ed9edc137_D20200401-20210331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDY1OTM_3d99675d-80ab-46e2-9b67-a32b4cf3235a">3.9</ix:nonFraction>% and the average interest rate on the amounts borrowed under the 2021 ABL Revolver was <ix:nonFraction unitRef="number" contextRef="i2fefd0d85f3643e9802fd44c8698e2bb_D20200401-20210331" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDY2OTg_8840a3f5-b61a-4cf6-a0c9-f84fe8e23a20">1.7</ix:nonFraction>%.   During the year ended March&#160;31, 2022, we made required repayments of $<ix:nonFraction unitRef="usd" contextRef="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDUxNjU_bf113f08-0878-4deb-a6a3-49cae6d67143">1.5</ix:nonFraction>&#160;million as well as voluntary principal payments of $<ix:nonFraction unitRef="usd" contextRef="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331" decimals="-5" name="pbh:DebtInstrumentPeriodicPaymentVoluntaryPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDUyMTM_0583cf15-fe11-46e6-9c90-2924cf6eed37">103.5</ix:nonFraction>&#160;million against the outstanding balance under our 2012 Term Loan.  Since we have made optional payments that exceed all of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity on July 1, 2028.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2013 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2013, the Borrower issued $<ix:nonFraction unitRef="usd" contextRef="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwMTU1_83807784-b71f-4581-ba81-01c9459c5c71">400.0</ix:nonFraction> million of senior unsecured notes, with an interest rate of <ix:nonFraction unitRef="number" contextRef="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwMjEw_154c2ef5-1c66-49d2-b7b3-a8dd019c18fb">5.375</ix:nonFraction>% and a maturity date of December 15, 2021 (the "2013 Senior Notes").  These notes were redeemed on December 16, 2019 using the funds from the issuance of our 2019 Senior Notes described below.  In conjunction with the redemption of our 2013 Senior Notes, we wrote off related debt costs of $<ix:nonFraction unitRef="usd" contextRef="i7127b05ed9074792951125aaeef43725_D20190401-20200331" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNTAy_528fec94-a460-4452-bdf7-bf43a5196285">2.2</ix:nonFraction> million in the year ended March 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 19, 2016, the Borrower completed the sale of $<ix:nonFraction unitRef="usd" contextRef="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNTg0_091a053c-27ea-45d6-bfe9-1a1704263150">350.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNjE3_d5ef9ea7-50e1-423c-9cd3-c37fd50d2cd8">6.375</ix:nonFraction>% senior notes due March 1, 2024 (the &#8220;Initial Notes&#8221;). On March 21, 2018, the Borrower completed the sale of $<ix:nonFraction unitRef="usd" contextRef="i76d5fa51d2444398b1d51583678eaf8b_I20180321" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNzI4_6cabed01-31b3-4a83-9b83-b8b24ecbe655">250.0</ix:nonFraction> million additional aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i76d5fa51d2444398b1d51583678eaf8b_I20180321" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNzYx_f42d2fa8-1558-435a-a240-471c8d5ae718">6.375</ix:nonFraction>% senior notes due March 1, 2024 (the &#8220;Additional Notes&#8221;).  Both the Initial Notes and the Additional Notes (the "2016 Senior Notes") were redeemed on March 1, 2021 using funds from the issuance of our 2021 Senior Notes described below.  In conjunction with the redemption of the 2016 Senior Notes, we wrote off related debt costs of $<ix:nonFraction unitRef="usd" contextRef="i1eb1f46f0bf54dc5a706fbd97b3158e1_D20200401-20210331" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMDg3_b0f7f96f-ce2a-4f08-a670-231f196c34a0">2.7</ix:nonFraction> million and paid a premium to redeem the 2016 Senior Notes of $<ix:nonFraction unitRef="usd" contextRef="i5421f769ee30441db0b2ce75192fb6f4_I20210331" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMTQ0_deb4736f-498e-4de3-81d0-94393683e3b8">9.6</ix:nonFraction> million in the year ended March 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2019, the Borrower issued $<ix:nonFraction unitRef="usd" contextRef="i05cfda891a7744f5b7d546839fc9debe_I20191202" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMjA5_8a064a7d-7680-4fdd-9934-8e67cb92b017">400.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i05cfda891a7744f5b7d546839fc9debe_I20191202" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMjQy_9e31b894-e7f8-49e9-ae8f-265fe5941c8b">5.125</ix:nonFraction>% senior notes due January 15, 2028 (the "2019 Senior Notes") pursuant to an indenture dated December 2, 2019, among the Borrower, the guarantors party thereto (including the Company) and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2019 Senior Notes, together with cash on hand, to redeem all $<ix:nonFraction unitRef="usd" contextRef="i08f3231c50694b299fb23343bca2e463_D20191202-20191202" decimals="-5" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNjA2_d8a9912d-34b9-4f51-8a6a-efce79cb5f83">400.0</ix:nonFraction>&#160;million of our outstanding 2013 Senior Notes, which were due in 2021, and to pay related fees and expenses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Borrower issued $<ix:nonFraction unitRef="usd" contextRef="if0f3a14330e24f06a067b44676509588_I20210301" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNzY5_c6f3d389-1e5b-4c3f-8a24-430e4677797c">600.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if0f3a14330e24f06a067b44676509588_I20210301" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExODAy_d02465ac-194d-4938-8407-42a0be62582b">3.750</ix:nonFraction>% senior notes due April 1, 2031 (the "2021 Senior Notes") pursuant to an indenture dated March 1, 2021, among Prestige Brands, Inc., the guarantors party thereto (including the Company), and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2021 Senior Notes to redeem all $<ix:nonFraction unitRef="usd" contextRef="ie5055f03438d40a28763e3b37020019b_D20210301-20210301" decimals="-5" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEyMTMy_f9aa0a23-476a-4746-8153-f4e01fa72818">600.0</ix:nonFraction>&#160;million of our outstanding 2016 Senior Notes, which were due in 2024, and to pay related fees and expenses. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemptions and Restrictions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2019 Senior Notes at any time on or after January 15, 2023 at the redemption prices set forth in the indenture governing the 2019 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2019 Senior Notes), the Borrower will be required to make an offer to purchase the 2019 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="ib5924d593cc74de19659e3600415162d_D20160219-20160219" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEyNzQ1_b07d2e22-8c93-4e30-9b5f-8cd3255d7177">101</ix:nonFraction>% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia04043623c0b47ceaac74bf465dcb0bf"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2021 Senior Notes at any time on or after April 1, 2026 at the redemption prices set forth in the indenture governing the 2021 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2021 Senior Notes), the Borrower will be required to make an offer to purchase the 2021 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="id053d9ccecdc4922a30a236b55ee8a89_D20160219-20160219" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEzMzQ3_b84a5733-3fe6-4955-976b-da900d4e2ec8">101</ix:nonFraction>% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates.  Additionally, the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  At March&#160;31, 2022, we were in compliance with the covenants under our long-term indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we entered into two interest rate swaps to hedge a total of $<ix:nonFraction unitRef="usd" contextRef="iea11cc7d2fda42e280337193b1699cff_I20200131" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE0NjI2_17ea6316-d741-4805-875f-9025721e11ba">400.0</ix:nonFraction>&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and the other settled on January 31, 2022 (see Note 11 for further details).    </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ2_0c489fef-21d2-42f6-bafc-91d7b3c65f70" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzItMi0xLTEtMTg5Njk_0177e135-877a-4d98-b926-3dc6d72ed42a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzMtMi0xLTEtMTg5Njk_ea8419b3-4e7e-424a-a772-deb49c344286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzQtMi0xLTEtMTg5Njk_be4201e5-70ea-4b6e-8083-e80a0bf005a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzUtMi0xLTEtMTg5Njk_f79af13e-1357-46ed-8a23-0d494f3011e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzYtMi0xLTEtMTg5Njk_97093ea1-4035-41d5-9304-16d8dd4b1b54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzctMi0xLTEtMTg5Njk_7f1ab41c-d38f-4d12-a8cf-b1a47903f8f0">1,495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzgtMi0xLTEtMTg5Njk_84e807a9-7e4b-499d-85d9-87b2a0306e72">1,495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90ZXh0cmVnaW9uOmFjYjM0ZGZjNmYwOTQ4MTNhNTNhN2U1MTY5MzI0YzllXzIyOTM_a30903f5-62a0-45ee-b841-b0332f813e77" continuedAt="i8f5d8d483e374c318b112eef74bcedaf" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8f5d8d483e374c318b112eef74bcedaf" continuedAt="i083a8dc9301c43ed863117184adfb553"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90ZXh0cmVnaW9uOmFjYjM0ZGZjNmYwOTQ4MTNhNTNhN2U1MTY5MzI0YzllXzIyODk_321460c6-cae4-45e2-84ce-aeabd47c5369" continuedAt="ice409e0da8bf4d9f85bd8a231913d732" escape="true">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the Term B-5 Loans, the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March&#160;31, 2022 and 2021). </ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i083a8dc9301c43ed863117184adfb553"><div style="text-align:center"><ix:continuation id="ice409e0da8bf4d9f85bd8a231913d732"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc097b28fbd4380a0360d7a9dfa4ddb_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtMi0xLTEtMTg5Njk_57f549cc-695b-4920-aea6-fdd2425e32b1">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia447a00c02b64ada88fb01a499a27242_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtNC0xLTEtMTg5Njk_e648ac23-c831-468a-8c3a-5e55b9fd6177">397,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5a200e2c9f497380a032d410c1bf18_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtNi0xLTEtMTg5Njk_7efcbe05-cd64-433e-8287-a123714e0e16">400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a985936f76451ab3fba68c9cfbb22a_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtOC0xLTEtMTg5Njk_5b3080d0-6915-4e12-8680-d7f25fa1e812">417,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf2802073574efd967d051aa138686d_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtMi0xLTEtMTg5Njk_5397d71e-2e58-4363-aa19-95ebe3f6df2c">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e28d594c87497abef8cb2c70f091a9_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtNC0xLTEtMTg5Njk_59bcfdc4-c2b9-4c39-9cf9-ffc03eb9fb5b">534,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812c0fab06ed49c4a178a37547c973b2_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtNi0xLTEtMTg5Njk_a4824630-4128-47fe-89b3-b4495dc2c45b">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12ce07c5f2394037b12bb08cd70c30b6_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtOC0xLTEtMTg5Njk_af4e3427-6067-4c31-ad9f-942d9ad17d3a">570,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999987ebde3747f6b643feea79f7c7ef_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctMi0xLTEtMTg5Njk_ded7ad5d-e50f-4653-946d-2f6b64cac303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37214d0e0e284a65a18a75b349e2c4a3_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctNC0xLTEtMTg5Njk_b9135d46-83e7-449e-a767-90715b788f06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14f58c0d3bfd4d80880075fbd365ccff_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctNi0xLTEtMTg5Njk_b49e8549-df24-4057-a45c-488e33b20ea2">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82b6829a1a1044fe8860313bc836df84_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctOC0xLTEtMTg5Njk_c18adf51-61d4-4454-af76-d7c7713d640c">493,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4af8d5e816894fc2b3902012dc67bcab_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtMi0xLTEtMjA4MjI_e8225054-9ecc-42b3-8181-7a006b72dbdb">495,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie316289b2f544ed59d0d0c3677efd55a_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNC0xLTEtMjA4MjI_29d1a97e-ad15-464a-b3d8-6c5195af962b">493,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875d8339508c48e8978c56e91c5f446d_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNi0xLTEtMjA4MzE_907faa4c-bdd3-4e49-9985-62259bef41fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6deab13ed5410ca24419a0d749762c_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtOC0xLTEtMjA4MzE_dab613b6-5e63-4562-859d-f62957095e04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d45f458359341cb9aed375cbf7b034c_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtMi0xLTEtMTg5Njk_6493a330-aa82-42b6-87ce-d39b6b462d47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5d83887fa7a4b3c9a18182a81d1150b_I20220331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNC0xLTEtMTg5Njk_7c2cb2d0-b083-4ca6-8431-1c7731c070f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5131113e97495bb1af3c5ddaaf3fed_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNi0xLTEtMTg5Njk_a009c02a-3614-456c-88b0-a5a07d875250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d1883fd10de4c37988d741ed8d438e1_I20210331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtOC0xLTEtMTg5Njk_0cfa7007-34ae-4050-a057-916fbd6243c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b76519112f34e67a8eec0a25b6d11bd_I20220331" decimals="-3" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktMi0xLTEtMTg5Njk_2b72e732-11fe-452c-adf3-8ac34b3d2bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9090b056ebb41eba6e4947e52c3b6ca_I20220331" decimals="-3" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktNC0xLTEtMTg5Njk_f5588b53-ac16-4a1a-a109-bb1fd1967dd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia009767826ab453aa6bb77d03d05a92b_I20210331" decimals="-3" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktNi0xLTEtMTg5Njk_5ee34f94-9b9a-4717-8914-369562fc8697">2,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib347d67febad441b8e0c8e676e6f04af_I20210331" decimals="-3" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktOC0xLTEtMTg5Njk_1095a61b-eebd-4096-b8ba-50ec83fd49ef">2,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, we did not have any assets or liabilities measured in Level 1 or 3.  During 2022, 2021 and 2020, there were no transfers of assets or liabilities between Levels 1, 2 and 3.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASU 2015-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, investments that are measured at fair value using net asset value ("NAV") per share as a practical expedient have not been classified in the fair value hierarchy.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzA_f4104578-4be7-4ec5-955e-1d96fc1c11d1" continuedAt="i334c5298baa4409695f4a9cf8fcfa3d1" escape="true">Derivative Instruments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i334c5298baa4409695f4a9cf8fcfa3d1" continuedAt="i8c25ab6b901540aca751414afac38505"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020, we entered into two interest rate swaps to hedge a total of $<ix:nonFraction unitRef="usd" contextRef="iea11cc7d2fda42e280337193b1699cff_I20200131" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzE4OA_4e91f263-6418-4d08-9593-a4bee90ea226">400.0</ix:nonFraction>&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and other settled on January 31, 2022.  The fair value of these interest rate swaps was reflected in the Consolidated Balance Sheets in other accrued liabilities.  We do not use derivatives for trading purposes.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzE_bd00a4a5-79c4-462b-a44d-6fac04861b89" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b30d6662357490791b05cb990415ede_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzMtNi0xLTEtMTg5Njk_f2aa6db3-8fde-4934-862d-f7c02d2643fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if895d74cebc04b28ab194e74118c2951_I20220331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzMtOC0xLTEtMTg5Njk_cdf6b568-eec3-4265-bac3-f0c587fd79b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if895d74cebc04b28ab194e74118c2951_I20220331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzQtOC0xLTEtMTg5Njk_6fe4233e-41dd-432f-82a5-dd0b601fd108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fb85e27ce8425b9221751a38ecb76d_I20210331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzMtNi0xLTEtMTg5Njk_decf9220-0a99-4368-8524-02f45335f40b">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63aa3373adc547ef8f9843d4e4e99a56_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzMtOC0xLTEtMTg5Njk_20befc91-1f66-4788-9b13-d6d70982593b">2,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63aa3373adc547ef8f9843d4e4e99a56_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzQtOC0xLTEtMTg5Njk_867b2dcc-9bfa-4f80-add4-7f3bbfbe2143">2,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzI_54b8dd60-144c-4980-928c-0f1742e91a20" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i605faa87f3fa47b3bd583aa47c0b905f_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtNC0xLTEtMTg5Njk_d2258279-9a89-48e4-ad73-24270379d33f">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46552cb961884a2e9f30308dfc3d5c18_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtNi0xLTEtMTg5Njk_fd10c741-4ddf-438d-bc38-ee14d88a9103">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66f5cb1ef37b47e0a992d6060ab3a446_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtOC0xLTEtMTg5Njk_3e8816d8-14a3-4011-93f9-1bc5f2e59a2e">4,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacae129a7469439e8699880e38e9c750_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItNC0xLTEtMTg5Njk_93b135a1-fc29-465a-8ed6-f2c24361f100">2,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01612b88bf7d4228961f615de0e3bc6c_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItNi0xLTEtMTg5Njk_daa9ebba-fe70-4915-93f4-aa0972a6ba42">4,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1065eae966a4e23a6d80c3a4c53c9e1_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItOC0xLTEtMTg5Njk_101a1ed5-92d7-40ca-bd78-f1b80fbc841e">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk:</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8c25ab6b901540aca751414afac38505">We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk2Ng_2a0a14ce-e20a-447b-a2d0-222a338bf520" continuedAt="ida344dee77954b668aad02474a5a5ef8" escape="true">Stockholders' Equity </ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ida344dee77954b668aad02474a5a5ef8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzY4_186e954c-25b2-4a8c-a20e-36483125d414">250.0</ix:nonFraction> million shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk1_d2eb04f8-a1ea-4aed-81d7-0e6ec296548e">0.01</ix:nonFraction> par value per share, and <ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzEyMw_bf74b355-b5d7-4a8d-aa18-b5aa90d8693f">5.0</ix:nonFraction> million shares of preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzE1Mw_d694c561-9ff6-4013-8650-c92d83ff3385">0.01</ix:nonFraction> par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to <ix:nonFraction unitRef="vote" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="pbh:VotingRightsNumberOfVotesPerCommonShareOwned" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzM5Mg_f72b1b03-f372-479b-8abf-fbe3f95a53ec">one</ix:nonFraction> vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends.&#160;&#160;<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="INF" name="us-gaap:DividendsCommonStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzcxNA_1bc17e9c-289d-47c2-a989-349e01bf4e89">No</ix:nonFraction> dividends have been declared or paid on the Company's common stock through March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk2Nw_2714e2a6-da22-4d9a-8627-d88d48d7a90a" continuedAt="i391d1b0059f94ede9001772a84dfd25e" escape="true">Our share repurchases consisted of the following:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i391d1b0059f94ede9001772a84dfd25e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzMtMS0xLTEtMTg5Njk_af168718-7262-46f8-b87f-3f2d3d1946f8">63,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzMtMy0xLTEtMTg5Njk_08640077-8cec-4d2d-b386-f7a248c16fd3">31,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzQtMS0xLTEtMTg5Njk_830a8e97-ba54-4d9c-a73c-9cd2adf73326">46.04</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzQtMy0xLTEtMTg5Njk_ca29cf0f-af0c-4659-968c-2dd124b1ac89">39.91</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzUtMS0xLTEtMTg5Njk_9132a697-b26e-4752-a026-0c90804eef3f">2.9</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzUtMy0xLTEtMTg5Njk_b773b74b-0773-4953-b8d8-a52c78f2808d">1.2</ix:nonFraction> million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzgtMS0xLTEtMTg5Njk_f522e965-86e8-4964-aacb-9e74ec81144e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzgtMy0xLTEtMTg5Njk_30367323-6c29-4d51-8651-67cab469f897">337,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzktMS0xLTEtMTg5Njk_46a0833f-7cb0-475b-8f03-b85784fc6ad0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzktMy0xLTEtMTg5Njk_85f8c5c8-3e3e-418e-9071-47fd06ecf2eb">35.20</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzEwLTEtMS0xLTE4OTY5_59326eb1-99bc-4896-bf8d-575c2580e9eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzEwLTMtMS0xLTE4OTY5_7b30d5ad-553e-4b96-9c1f-e1d15d563f60">11.9</ix:nonFraction> million</span></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTE_49bf5e83-2e46-45ed-9d46-73cf10a54d21" continuedAt="i8829fb4f318b422289d21deebcac5fe9" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8829fb4f318b422289d21deebcac5fe9" continuedAt="i84dbbf7129644868aed1dc014ecac8b2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i59613ba2ed6449e8ac420dc8ea0ee548_I20140531" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIyNA_4862a428-7eaa-4dcb-ac15-bca6823f94e6">5.0</ix:nonFraction>&#160;million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional <ix:nonFraction unitRef="shares" contextRef="i872fd2fcec7d4bceb22e9ecae5396854_D20140601-20140630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQyOA_ecd35bfc-bb2c-45bb-8dd0-32a3929166ea">1.8</ix:nonFraction>&#160;million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from <ix:nonFraction unitRef="shares" contextRef="i0e8537058553437296cbf47a294cbc0c_D20140531-20140531" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzY2NQ_01b7a85b-910c-4d4b-87f2-2903d0346927">1.0</ix:nonFraction>&#160;million to <ix:nonFraction unitRef="shares" contextRef="i11506770ce994fd08f2fc8766933e916_D20140601-20140630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzY3MQ_8169e701-fc91-4a24-a522-0f9198cacda9">2.5</ix:nonFraction>&#160;million shares, and an extension of the term of the 2005 Plan by <ix:nonNumeric contextRef="i11506770ce994fd08f2fc8766933e916_D20140601-20140630" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMQ_d8dd1325-2abd-4a56-b4bf-d1f3ab16dc3d">ten years</ix:nonNumeric> to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of <ix:nonFraction unitRef="shares" contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzExODk_7ff0f72a-8627-4d4f-af7e-d6627c458083">2,827,210</ix:nonFraction> shares were available for issuance under the 2020 Plan (comprised of <ix:nonFraction unitRef="shares" contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804" decimals="INF" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEyNjA_4e5c0270-db19-48c4-a98a-b90fa4b5ad71">2,000,000</ix:nonFraction> new shares plus <ix:nonFraction unitRef="shares" contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804" decimals="INF" name="pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEyNzk_3c616b22-780a-4816-96c8-df0d8dc371b3">827,210</ix:nonFraction> shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzM_fbe79a93-eeb1-401f-98d9-29f105cd7f84" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItMi0xLTEtMTg5Njk_805a7d3f-cf04-4f88-be4a-333465e40bf4">9,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItNC0xLTEtMTg5Njk_a16e811e-bbe4-49d4-b483-640f60afab7b">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItNi0xLTEtMTg5Njk_4302e44d-3773-4369-ac86-26646ca47327">7,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtMi0xLTEtMTg5Njk_64968296-981c-468f-8e38-ad161199a042">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtNC0xLTEtMTg5Njk_96fb67f3-fdb4-4060-8517-9f63eac481a6">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtNi0xLTEtMTg5Njk_3edef5dd-dbaa-4f77-930f-6d70751861ca">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtMi0xLTEtMTg5Njk_c289b1ed-dc85-47cf-9832-d1e7e94eca24">7,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtNC0xLTEtMTg5Njk_fff7dd10-2fcb-44e1-a5e4-615815afeffd">6,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtNi0xLTEtMTg5Njk_9b7bc2e6-7627-437e-b1ee-ece3cd08f686">7,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtMi0xLTEtMTg5Njk_4453080b-20cc-43dd-9084-6b5b96d04126">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtNC0xLTEtMTg5Njk_7d615404-ee14-4a2a-b144-32f787a8e80e">2,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtNi0xLTEtMTg5Njk_2006892a-1c63-4760-9a68-1d007f3ea8f8">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtMi0xLTEtMTg5Njk_52ee89ac-4639-4647-8183-6b2c79871e78">3,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtNC0xLTEtMTg5Njk_2fd39387-f529-499f-a205-fb7d67cb8fa5">1,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtNi0xLTEtMTg5Njk_93e19bab-1043-41b2-af60-5af781e20fea">745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, there were $<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE1NjY_efbd2c2c-2f60-4edf-b913-9e2c593dca82">2.8</ix:nonFraction> million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i84dbbf7129644868aed1dc014ecac8b2" continuedAt="i33386bb088cb43129da74dfaee3beb94"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted average period of <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE4MjQ_d353e8eb-b15c-44f7-a89b-463f54cb4baf">1.7</ix:nonNumeric> years.  At March&#160;31, 2022, there were&#160;$<ix:nonFraction unitRef="usd" contextRef="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU0MDE_7da6503c-1517-4795-b097-b469f3871feb"><ix:nonFraction unitRef="usd" contextRef="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU0MDE_db0afacf-cc15-4257-81e3-db5b83db46da">8.5</ix:nonFraction></ix:nonFraction> million of unrecognized compensation costs related to unvested RSUs and performance-based stock units ("PSUs") under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures that may occur.  We expect to recognize such costs over a weighted average period of <ix:nonNumeric contextRef="i22f7753689274ada97cf2c0bb4c3001d_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU2NDM_b2c1eac1-5847-4010-b542-918357114c98">1.5</ix:nonNumeric> years.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE4NDc_7e660656-6e41-4cb5-8468-ce814fd33553">2.5</ix:nonFraction> million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 3, 2021, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="i44a6c8be63164b3a838a938732b3f2c9_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwMTk_e7d04f4b-b8a9-4fc1-8db0-2fa53793c10b">77,345</ix:nonFraction> performance units, <ix:nonFraction unitRef="shares" contextRef="i907bf7654d494d8786dce88601c9edf2_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwNDE_e3638e07-5c96-4dd0-84ff-64da1123a47a">73,108</ix:nonFraction> RSUs and stock options to acquire <ix:nonFraction unitRef="shares" contextRef="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwNzc_a26d8637-3e3f-481e-88a4-1e6647a58b80">222,660</ix:nonFraction> shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzI2ODM_7c21e5a3-fb77-4708-bde0-662e68a4acca">44.33</ix:nonFraction> per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">A newly appointed independent member of the Board of Directors received a grant under the 2020 Plan of <ix:nonFraction unitRef="shares" contextRef="i330f93470c3944a7884dc0e46ce08542_D20210503-20210503" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzI4ODU_41756fb5-9d65-4df2-acad-38063c1c7e4f">1,636</ix:nonFraction> RSUs on May 3, 2021.  </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Each of the independent members of the Board of Directors received a grant of <ix:nonFraction unitRef="shares" contextRef="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzMwMDY_44af429e-77c4-4feb-bccf-69a240b9b7bf">2,808</ix:nonFraction> RSUs on August 3, 2021 under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of <ix:nonFraction unitRef="shares" contextRef="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803" decimals="INF" name="pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzMxNDA_b9825144-7596-437e-b9cc-c2cad6d99f42">one</ix:nonFraction> share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted to employees under the 2005 Plan and the 2020 Plan generally vest in <ix:nonNumeric contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzQ_0e8394e3-6ded-4acd-8467-121adb7fe197">three years</ix:nonNumeric>, primarily upon the attainment of certain time vesting thresholds, and, in the case of performance share units, may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before interest, income taxes, depreciation and amortization targets.&#160;&#160;The RSUs provide for accelerated vesting if there is a change of control, as defined in the 2005 Plan and the 2020 Plan.&#160; The RSUs granted to employees generally vest either ratably over <ix:nonNumeric contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTU_636f26fc-1ee2-468b-af7d-a2bd525ae3b2">three years</ix:nonNumeric> or in their entirety on the <ix:nonNumeric contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzY_3c6d8286-bad0-4700-a1a2-cf57ab2c0ffa">three-year</ix:nonNumeric> anniversary of the date of the grant.  Upon vesting, the units will be settled in shares of our common stock.  Termination of employment prior to vesting will result in forfeiture of the RSUs, unless otherwise accelerated by the Committee or, in the case of RSUs granted in May 2018 and later, subject to pro-rata vesting in the event of death, disability or retirement.  The RSUs granted to directors prior to fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of <ix:nonFraction unitRef="number" contextRef="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331" decimals="INF" name="pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQ0Nzg_1a474602-d9c3-4c52-9230-0b957a6a1824">one</ix:nonFraction> share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's disability or (iii) the six-month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.  The RSUs granted to directors beginning in fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of <ix:nonFraction unitRef="number" contextRef="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331" decimals="INF" name="pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQ4ODY_a6bffce9-43ff-4f92-93a2-04146ed48cb7">one</ix:nonFraction> share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's separation from service or (iii) a change in control of the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i33386bb088cb43129da74dfaee3beb94" continuedAt="i28f9a4b677ea454f81b27b918a5c1cd3"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNDE_7050ec73-c57e-4c31-9338-9e14b933d9b3" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSUs granted under the 2005 Plan and 2020 Plan is presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:66.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c27223f84a24212910eb3aeea93eaf1_I20190331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzItMi0xLTEtMTg5Njk_388a9d23-4635-4fb9-8e48-d37a474a8f4a">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c27223f84a24212910eb3aeea93eaf1_I20190331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzItNC0xLTEtMTg5Njk_09e07044-c8fe-4c71-b70f-b420aae17a2a">38.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzQtMi0xLTEtMTg5Njk_22d5dabf-8855-481b-b616-0c696d1dd02c">220.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzQtNC0xLTEtMTg5Njk_989eb93a-6be8-4d4c-8ecd-29110bdebf4a">31.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzUtMi0xLTEtMTg5Njk_7a0f21b1-9f69-4e6b-92b8-b33fe8f50b04">98.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzUtNC0xLTEtMTg5Njk_22a5d4d9-41d1-4938-90bd-026c961c92bd">44.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzYtMi0xLTEtMTg5Njk_ca373a17-a2ff-464d-944b-531bc67de1f9">34.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzYtNC0xLTEtMTg5Njk_8853e7d0-71c6-4594-ac34-6df920e44b75">35.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzctMi0xLTEtMTg5Njk_a4391729-a4c0-4f73-a0c1-3a9dbe6327cf">387.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzctNC0xLTEtMTg5Njk_3eefb9ec-b084-4517-8f26-42c2131481f4">33.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzgtMi0xLTEtMTg5Njk_12fc631f-4f7f-4767-b3d3-ca7fb433e0c9">124.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzgtNC0xLTEtMTg5Njk_0426b012-fa7b-40a6-b150-a9d134b5fc44">30.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEwLTItMS0xLTE4OTY5_a5fc1a42-1fb6-4ca8-878f-c922f2a1df3a">179.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEwLTQtMS0xLTE4OTY5_b7a0d12c-2747-4439-939a-496da15512e2">40.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzExLTItMS0xLTE4OTY5_b2dc58db-821d-4ef4-b818-5bed4e9dce3e">100.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzExLTQtMS0xLTE4OTY5_5e0e1e7a-55a7-4d9a-94e9-637a34f54d2d">42.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEyLTItMS0xLTE4OTY5_b5eaf37b-9530-4b1e-8181-f7d617aa753e">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEyLTQtMS0xLTE4OTY5_785a630b-1054-44cf-b730-fde2b1ae18f1">43.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEzLTItMS0xLTE4OTY5_c165ffb8-f599-471b-8ee1-0578044c89fe">457.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEzLTQtMS0xLTE4OTY5_e6f87a52-fdd0-4d9f-8c29-df0d2b7a2c05">33.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE0LTItMS0xLTE4OTY5_613b82f5-527c-42b7-b9f3-1cbeceb13dc1">150.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE0LTQtMS0xLTE4OTY5_9997d694-572b-4d91-9ef1-4a9e918800b8">31.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE2LTItMS0xLTE4OTY5_8978a0f5-5672-4a92-8ac9-c900443d8440">170.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE2LTQtMS0xLTE4OTY5_a293c31d-098c-4d69-aa20-97a6fd3e081b">45.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE3LTItMS0xLTE4OTY5_aaec605c-a005-463b-a448-49138ac1d8cd">162.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE3LTQtMS0xLTE4OTY5_59cc5e4c-edf7-408f-83c6-a7d5797c4591">32.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE4LTItMS0xLTE4OTY5_b0f34664-5a7e-499b-84d5-4b6af2dfd52d">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE4LTQtMS0xLTE4OTY5_c9f8609b-d1a0-492f-a660-95af59b53b27">30.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE5LTItMS0xLTE4OTY5_145c39d7-c483-4bdf-bfe6-c756ef1bf040">440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE5LTQtMS0xLTE4OTY5_9b8c0c31-8f9c-446c-8be4-1f94ac200566">38.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331" decimals="-2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzIwLTItMS0xLTE4OTY5_5d2dd719-0007-4508-9250-f00dc453aa0c">106.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331" decimals="2" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzIwLTQtMS0xLTE4OTY5_9a58e39c-11b3-412f-9547-955fd2540aa4">36.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2005 Plan and the 2020 Plan provide that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted.&#160;&#160;Options granted have a term of no greater than <ix:nonNumeric contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331" name="pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzU1NDc_24cbafb9-4aec-40b1-b623-e834274e3c46">ten years</ix:nonNumeric> from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally <ix:nonNumeric contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMjk_6bfc3a33-dc5f-4501-87dd-9c70ccaf9abd">three years</ix:nonNumeric>.&#160;&#160;The option awards provide for accelerated vesting in the event of a change in control, as defined in the 2005 Plan and the 2020 Plan.  Except in the case of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested stock options.  Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the 2005 Plan and the 2020 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below.&#160;&#160;Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies.&#160;&#160;We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors.&#160;&#160;Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation.&#160;&#160;The expected terms of the options granted are derived from our historical experience, management&#8217;s estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding.&#160;&#160;The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzA_32948ca3-f9ec-4101-a0ff-345c224d7987" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxMzIxODg4ZDZlZmU0ZWRmOWE4YjYxYzVlNDI0MzVjYl80_48ae8931-729d-4ea9-bf7c-6cf8f0a55757">31.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxMzIxODg4ZDZlZmU0ZWRmOWE4YjYxYzVlNDI0MzVjYl85_ee83c3e0-97ee-4645-a698-543bb4844336">31.9</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo4NGI0YjU2YmM1YmU0YjgwYTlmZjkxYjA3ZDZiMTBjNF80_db493ffa-8ee5-4286-bcf4-538b813b8956">32.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo4NGI0YjU2YmM1YmU0YjgwYTlmZjkxYjA3ZDZiMTBjNF85_4d9d2847-a731-43db-82c7-5f641c9beac8">32.2</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZGRlZDZiMTJhMjc0NzlkODdkZjViM2JhNjkyYzJiYl8xMDk5NTExNjI3Nzkw_087304e2-cc9e-477f-b0e5-332f224a9508">30.9</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZGRlZDZiMTJhMjc0NzlkODdkZjViM2JhNjkyYzJiYl8xMDk5NTExNjI3Nzk3_8fd14696-0f54-4613-a549-e823c60eac2f">31.3</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtMS0xLTEtMTg5Njk_6c3b79b7-3a90-40e1-ad09-5584fbad3a03">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtMy0xLTEtMTg5Njk_bd864855-e8f0-4cf0-a440-9991991e8abf">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtNS0xLTEtMTg5Njk_563b5d86-ef1d-41e3-b126-552c4336b3c7">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozOTMzZDY0M2I2Nzg0ZjM0Yjc3OGJjZTE1NzE0MjEyM180_f33b5c1e-281d-4866-b03c-9268890c9cdc">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozOTMzZDY0M2I2Nzg0ZjM0Yjc3OGJjZTE1NzE0MjEyM18xMA_26448002-8859-4fec-b7cb-b87506dfbd59">7.0</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplNGU1ZWI0NzM4YmE0ZjI1YThmMDUxNzJjODEzNzE3Yl80_c88ff491-46fc-4a49-9ace-fc7a57b00f90">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplNGU1ZWI0NzM4YmE0ZjI1YThmMDUxNzJjODEzNzE3Yl8xMA_c8a18af2-47db-42ad-af8a-9681281a6cf3">7.0</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxOGRhYzYyY2E5MDY0YmUzYWZiODM4ZWU3ZmU0MDM4Ml8xMDk5NTExNjI3Nzg2_c1ae966e-6318-4f85-8f1d-d06386916e27">6.0</ix:nonNumeric> to <ix:nonNumeric contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxOGRhYzYyY2E5MDY0YmUzYWZiODM4ZWU3ZmU0MDM4Ml8xMDk5NTExNjI3Nzkz_4462986e-8e06-48d1-b2c3-ecea4328c5af">7.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjMGIyM2Y2MjNlZmE0OTlmYWExOGU1ZDliMTU4ZDNmZF8xMDk5NTExNjI3Nzg0_565d3676-08f6-4211-ba2b-fa8d4d38d616">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjMGIyM2Y2MjNlZmE0OTlmYWExOGU1ZDliMTU4ZDNmZF8xMDk5NTExNjI3Nzky_c0893b5d-61d0-43d5-b97b-1dec6e5aaabb">1.3</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo2YTg1MjA3NGFjMjI0YmFiYWEyYzI1M2NiYTE3NzllZl80_4513ec75-5234-47e7-ad2d-1f5a6e3f5bbd">0.5</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiNTAyMGNlN2M0MTA0Y2E5OWI5NjM1NDc1MWMwY2FmMl8xMDk5NTExNjI3Nzg4_fa36a688-2aac-48b6-aa05-8e03fe3f2ee8">2.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiNTAyMGNlN2M0MTA0Y2E5OWI5NjM1NDc1MWMwY2FmMl8xMDk5NTExNjI3Nzk1_b5e0454b-f4da-49c7-8dda-885ec5f4c220">2.4</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtMS0xLTEtMTg5Njk_868304ce-2eaf-4723-91f3-d3064fb281d6">14.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtMy0xLTEtMTg5Njk_b28de132-f195-4c3e-81c6-9c2a18b37062">12.91</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtNS0xLTEtMTg5Njk_744efe1b-c957-41e3-9ec6-e46c556eb891">10.83</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i28f9a4b677ea454f81b27b918a5c1cd3" continuedAt="idbb9dc6f1b9a4af2a924b43454cf2c22"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTY_8b537d45-9ddd-42e9-aa6a-c5928491e140" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and 2020 Plan is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted <br/>Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzItMi0xLTEtMTg5Njk_85e6421a-7053-4a4d-b13b-95af7f501542">944.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzItNC0xLTEtMTg5Njk_cac51471-275b-46f0-8566-d1a7ec96e3ec">38.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzQtMi0xLTEtMTg5Njk_12f53cee-017d-40ef-b9f6-f22032194d8a">302.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzQtNC0xLTEtMTg5Njk_e2f5badc-98da-456d-89de-444b8293825a">30.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzUtMi0xLTEtMTg5Njk_40cafb65-f3b4-4060-a4b1-dc1d78314578">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzUtNC0xLTEtMTg5Njk_a913dcf0-5c13-4714-9d54-cc861a042221">27.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtMi0xLTEtMjExNTU_556bb23c-61ec-4174-b7df-a0911fb44ee8">79.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtNC0xLTEtMjExNjI_2f84719d-843c-4316-88e8-0c81f3455c5e">32.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtMi0xLTEtMTg5Njk_bddaa164-0460-4b9c-8922-51a45837de64">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtNC0xLTEtMTg5Njk_3970102f-4bcb-4995-a714-7a08754d7adc">50.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzctMi0xLTEtMTg5Njk_140124c9-eb01-4bb4-b58d-320f246bae82">1,020.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzctNC0xLTEtMTg5Njk_cf06daee-15ff-4a21-b41d-cdbaedbe03ef">35.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzktMi0xLTEtMTg5Njk_56b3d4af-7bee-4cc7-8c93-93f7f8b4b4cf">249.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzktNC0xLTEtMTg5Njk_048800b2-a003-419e-a628-bb6c04acf155">39.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEwLTItMS0xLTE4OTY5_677ed8e5-5821-41e4-8e76-9c7b79f09cf4">119.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEwLTQtMS0xLTE4OTY5_280fefd5-d335-41d7-a5c2-f9fccbd64b12">23.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTItMS0xLTIxMTcx_afc99931-c94f-4e4d-b188-6c39651d5a46">21.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTQtMS0xLTIxMTc4_c0e72f41-923e-456a-a036-c105a91fc979">34.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzExLTItMS0xLTE4OTY5_cc6d0462-341e-42df-8ede-d95af65125b6">13.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzExLTQtMS0xLTE4OTY5_fd291e0b-aa75-4413-8a39-81b60cc00577">52.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTItMS0xLTE4OTY5_d80daa4f-5d5c-4a78-a128-778bd607d244">1,114.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTQtMS0xLTE4OTY5_f6f6077a-3cd3-4019-a33e-00a1e7db7964">37.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE0LTItMS0xLTE4OTY5_141f2526-e4cb-431d-b688-b1b8d66d2039">234.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE0LTQtMS0xLTE4OTY5_4d6ac76e-f60e-4005-83cf-4b7aa461e4e3">44.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE1LTItMS0xLTE4OTY5_7d4b0855-a30c-4f1b-8c54-14b0b39b8eda">226.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE1LTQtMS0xLTE4OTY5_adcb6b73-2613-4a2e-9088-b92eb2deba0b">31.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTItMS0xLTIxMTg2_59adcf45-ce59-4a0d-8c7c-2182b090ca39">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTQtMS0xLTIxMTk0_8d5a5b8e-961f-4c45-8a4d-c62a3c5c6f3c">37.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE2LTItMS0xLTE4OTY5_29c036af-25cf-4e49-b7fa-8d6e16ba3046">8.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE2LTQtMS0xLTE4OTY5_d311f3c2-6a84-4628-b51b-72ac0dcbce28">56.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTItMS0xLTE4OTY5_2c707004-cf3d-4088-992a-24b695350013">1,100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTQtMS0xLTE4OTY5_68e7a6f2-1d4c-4c2a-a65a-7430a7071f87">40.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTYtMS0xLTE4OTY5_e04ecb96-46d8-4b05-ab2c-145d12e2d21b">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTgtMS0xLTE4OTY5_55bfee92-03ae-4f03-82ab-230e467cae53">14,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTItMS0xLTE4OTY5_2da2907a-bffd-4584-8d96-218db76626ac">621.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTQtMS0xLTE4OTY5_16a8e3e6-4e7c-4903-82fb-85c03d262b5c">40.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTYtMS0xLTE4OTY5_3fdc512a-abb9-478e-aa1e-384389246436">5.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTgtMS0xLTE4OTY5_13b6f091-80bb-4288-b17b-0df7be732e23">8,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idbb9dc6f1b9a4af2a924b43454cf2c22">The aggregate intrinsic value of options exercised during 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzcyOTc_6b97984b-bab8-4623-affa-3c7204122555">6.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMDE_8681f698-50ca-454d-a67f-f4cce8cee663">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMDg_9b754292-f156-4b19-a8a7-23264896dcbd">0.4</ix:nonFraction> million, respectively.</ix:continuation>   </span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="pbh:AccumulatedOtherComprehensiveIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90ZXh0cmVnaW9uOjA5NTZhZTllZWQ5NDRmYTlhNjA4NjNkNDFlYTRmOTllXzMzNA_7ab35938-59db-435a-978f-73d6e2f78892" continuedAt="i08c8c394227e4be0b4895683f047fe93" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i08c8c394227e4be0b4895683f047fe93"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90ZXh0cmVnaW9uOjA5NTZhZTllZWQ5NDRmYTlhNjA4NjNkNDFlYTRmOTllXzM0NA_1aa2eee9-e391-46af-954b-8376c50bbd47" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI consisted of the following at March&#160;31, 2022 and 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if27256c09baf422db24a2becba8b461a_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzMtMS0xLTEtMTg5Njk_9d565104-0200-4866-9682-292e3264c524">20,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410e808bfa6046c0b7bc6cd1eeb717fc_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzMtMy0xLTEtMTg5Njk_0ad39f18-075e-4e96-9cfa-b0d955f7fb25">18,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ZTg3MDkzMjFjOGI0Y2JmOTY4MjY5ODdlZTMxZTk0Zl81OA_73887818-0800-419a-942e-e6491da20f30">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ZTg3MDkzMjFjOGI0Y2JmOTY4MjY5ODdlZTMxZTk0Zl82NQ_79ea7f78-ebe9-42e4-a693-ee6150a26d8c">543</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1687a3f206264e8a9491e1485f31dbb2_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMS0xLTEtMTg5Njk_b01e7062-ac35-4051-a301-12092f549103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe7fc1c11e8e4d5ab859abc4f504db82_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMy0xLTEtMTg5Njk_616a92a6-7a63-4ea8-b052-24c85e6a48ae">1,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZDlkMmY4N2MxYTU0YWYwOGRkMWIyZDE3MWFiYWQ1OV82NQ_ef6ccfc5-9ede-4922-88ca-118d25047e89">350</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZDlkMmY4N2MxYTU0YWYwOGRkMWIyZDE3MWFiYWQ1OV83Mg_2b9e9fba-aac4-4f9f-8d19-9862bc0f827e">276</ix:nonFraction>), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c394a5473c4367bd8d152963753341_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMS0xLTEtMTg5Njk_16e46d9c-9387-4b4b-801f-be56f26e335d">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f0e76da8d7e4425bd35dcb13791235b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMy0xLTEtMTg5Njk_1adcb974-36b8-4f86-9da9-6ce1c2a6adb2">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbaca07b4355474988048d221f663307_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzctMS0xLTEtMTg5Njk_c4e7932b-e558-42ee-ab8d-86a7b5d153d3">19,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzctMy0xLTEtMTg5Njk_b9a6e0b3-de65-42f0-ae07-59a5aa0591a0">19,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_130"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NDI_567646d1-6fed-4374-a895-0eb84099b674" continuedAt="ib6355f2ea8324bc283d52aab292f4948" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib6355f2ea8324bc283d52aab292f4948" continuedAt="i5b80e0caee61405cb8c1c2febd89752e"><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0MzY_4d67872f-4a03-42a9-99cd-d1575769912c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItMS0xLTEtMTg5Njk_e8f9515b-c708-4c35-9d4c-7708ac6431d6">236,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItMy0xLTEtMTg5Njk_ed4550f9-7255-4994-aafe-f73f7e3623d2">195,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItNS0xLTEtMTg5Njk_11630177-1564-473c-84d5-fbd038105cbf">167,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtMS0xLTEtMTg5Njk_a215fc0d-6d2e-4125-bc68-e7fb159a7a2d">26,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtMy0xLTEtMTg5Njk_c9477408-b1e8-4a9a-a20b-2df4ccc5b9d6">8,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtNS0xLTEtMTg5Njk_5e1f9f49-be2f-4a86-aad1-d04fc72ee4af">23,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtMS0xLTEtMTg5Njk_f0275bc9-27a0-4485-a600-cd96537172f2">262,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtMy0xLTEtMTg5Njk_f970d1e3-acc8-4d75-9849-85f3a0580e35">204,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtNS0xLTEtMTg5Njk_6ab5cda4-d887-44d3-ba37-f6eb884e8b3c">191,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0Mzg_c4ddd125-8af0-4431-8fa7-577bd0f9d1c6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtMS0xLTEtMTg5Njk_aa5917ba-7758-4151-9dd6-29423e6294d5">34,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtMy0xLTEtMTg5Njk_7f420ed7-9dfe-4f03-8881-d89fcf93b855">11,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtNS0xLTEtMTg5Njk_f6978c4d-1818-4476-8e61-9a253c674c35">24,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtMS0xLTEtMTg5Njk_d373cb2c-24c1-4822-b32f-4d89af332828">3,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtMy0xLTEtMTg5Njk_13552eb6-c0a8-407d-a152-297988a05fff">3,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtNS0xLTEtMTg5Njk_7673b703-d8e0-4a86-bd76-0497966e0f35">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtMS0xLTEtMTg5Njk_5c11888e-3d4f-4095-a450-52c6b1a1c520">8,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtMy0xLTEtMTg5Njk_7053c151-4a94-4864-a36f-e46b4eab362a">5,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtNS0xLTEtMTg5Njk_1e94c778-5ad1-4df6-8e8f-d77073aed5d8">8,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctMS0xLTEtMTg5Njk_c034f195-5d8b-4670-88f2-b6c4504d9844">12,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctMy0xLTEtMTg5Njk_c4ca94bb-2d49-49cb-acc1-b47437b009f5">14,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctNS0xLTEtMTg5Njk_5256ad69-637a-452f-b8af-b29399d4a6f4">14,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtMS0xLTEtMTg5Njk_ca7f8070-2d35-42bc-b133-29b21610858c">1,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtMy0xLTEtMTg5Njk_de709cbb-f2e6-419d-ab14-be0e3a996e9b">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtNS0xLTEtMTg5Njk_921436f5-e813-4d9f-bdb0-a9e8d5a0e821">341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktMS0xLTEtMTg5Njk_dfda9cfc-5107-46a8-9d14-d93b3f4e0625">715</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktMy0xLTEtMTg5Njk_31aee113-deab-4990-9c96-3c0ba6184474">336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktNS0xLTEtMTg5Njk_6313c82d-44e5-438f-a069-1bb542afaf78">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTEtMS0xLTE4OTY5_6c0a8dc7-7ba7-4e11-91a4-5e58cb3b6f6a">57,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTMtMS0xLTE4OTY5_5dfd0f38-3016-48b9-aad0-6ddf59fcc58f">39,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTUtMS0xLTE4OTY5_af80fcbb-ca9a-46ca-a4ce-70df012e7093">48,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5b80e0caee61405cb8c1c2febd89752e" continuedAt="i8d4c653b37ea4c099c9fe4158e6376d2"><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NjY_234ff41d-1184-4c15-80ad-b77ea3d74c59" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal components of our deferred tax balances are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzMtMS0xLTEtMTg5Njk_b36f9485-7f39-43e6-8144-be70b97d155d">4,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzMtMy0xLTEtMTg5Njk_ac874320-2b66-4a81-a11c-27c3f954695a">4,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxAssetsInventoryRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzQtMS0xLTEtMTg5Njk_386e2b14-3bbc-421b-abc5-50178a1aee44">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxAssetsInventoryRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzQtMy0xLTEtMTg5Njk_d1a9d7d8-00ba-41ee-83d3-0dd143a64d2c">1,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxAssetsInventoryReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzUtMS0xLTEtMTg5Njk_a132ee54-bd39-44e3-8361-a8aa511a3a44">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxAssetsInventoryReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzUtMy0xLTEtMTg5Njk_a88ba283-6510-4dcd-8b0f-2dcb770025d9">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzYtMS0xLTEtMTg5Njk_6b1eb97c-0b9a-43ba-a1d1-14f284bec5bd">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzYtMy0xLTEtMTg5Njk_62bd0fe3-2d00-41f3-9502-260730060ac9">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzctMS0xLTEtMTg5Njk_fc21acd2-1aad-4d19-9e6a-932ca3dee17c">9,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzctMy0xLTEtMTg5Njk_a316d643-ba2f-4f78-badc-11080329b920">10,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzgtMS0xLTEtMTg5Njk_907c6caa-a767-440a-abd6-d974d9db7f33">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzgtMy0xLTEtMTg5Njk_a798baac-5904-47f8-a877-0a7c9cf9fde2">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzktMS0xLTEtMTg5Njk_b3dd77d3-ed61-44ed-a29b-2d28921081a4">4,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzktMy0xLTEtMTg5Njk_40fbfa0b-5bf1-4a8a-93f9-78c9ff96e061">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEwLTEtMS0xLTE4OTY5_a0a6350e-932d-4469-8481-d6b4c763ddc6">4,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEwLTMtMS0xLTE4OTY5_77a87554-d259-45a3-a7bd-26ebaabe2eeb">4,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzExLTEtMS0xLTE4OTY5_bd36905d-9a57-49f7-ad9f-527330e1792f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzExLTMtMS0xLTE4OTY5_96738095-2e52-4323-be6a-a855a12c9c2b">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxAssetsLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEzLTEtMS0xLTE4OTY5_7080f02b-fdda-48a8-9deb-a62deed49839">6,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxAssetsLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEzLTMtMS0xLTE4OTY5_3c9cb283-19bb-4ceb-ad04-0c670bc0f575">8,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE0LTEtMS0xLTE4OTY5_c36ff6ff-4bb0-459f-b28f-ea2e979c8bab">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE0LTMtMS0xLTE4OTY5_0337b3d6-896a-407c-814e-7f6e22fc5bd4">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE1LTEtMS0xLTE4OTY5_ad31a743-6ba4-4ffe-9268-40f24ca836cd">5,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE1LTMtMS0xLTE4OTY5_2b08ecd0-dd89-4be2-96b6-a5de694898a1">5,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE2LTEtMS0xLTE4OTY5_4e8a3c1e-0b6d-48a5-a8af-fd4020b404d0">41,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE2LTMtMS0xLTE4OTY5_2939298a-05e7-4729-b92a-9acc3583640d">40,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE5LTEtMS0xLTE4OTY5_7025d6f5-1120-40a3-b6e0-3cabc3c25c44">7,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE5LTMtMS0xLTE4OTY5_8c8a2c7f-71a1-4b85-8f30-970595184dcd">7,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIwLTEtMS0xLTE4OTY5_8f2e8962-0024-4648-a04a-6499b8757d82">471,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIwLTMtMS0xLTE4OTY5_b6ddad40-e205-4a08-a96d-74645750ab24">458,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred cumulative catch-up adjustments - revenue recognition adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIxLTEtMS0xLTE4OTY5_26fb6eb2-294f-4650-a5fa-2fa1323c0ffa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIxLTMtMS0xLTE4OTY5_c9bd8474-7a2e-4971-89fd-95faecff7193">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="pbh:DeferredTaxLiabilityRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIyLTEtMS0xLTE4OTY5_9f0908b1-c9e7-4dda-80f7-d8f0b6d786c9">6,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="pbh:DeferredTaxLiabilityRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIyLTMtMS0xLTE4OTY5_554d6fb0-b3b4-439d-be7c-a2a6ae9a338f">7,605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIzLTEtMS0xLTE4OTY5_c97d1b42-d3c6-46cb-bad7-3c6b3f219c60">484,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIzLTMtMS0xLTE4OTY5_b4e4a543-e92f-457e-bbda-1f7cda5e789b">473,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzI3LTEtMS0xLTE4OTY5_71cc56f9-63dc-458e-a694-3b01f705e3ce">443,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzI3LTMtMS0xLTE4OTY5_94857d65-ef08-4b37-95cf-c7dc9a4ed560">432,860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net deferred tax liability shown above is net of $<ix:nonFraction unitRef="usd" contextRef="iee2c3f181ff64a18befbaf556c259b21_I20220331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEyNTU_7a0ff3b8-8a6f-4c4d-bdb8-e461bd95c3ab">1.9</ix:nonFraction> million of foreign deferred tax assets as of March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="if1862059d98a4f86a844ec510bb54683_I20210331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzMDI_d5dcb223-8f6a-425a-ac46-8fb37b88c6e7">1.2</ix:nonFraction> million of foreign deferred tax assets as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzNTQ_c2a98ef8-dc2d-42e8-ac27-b498e5c9dd9d"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzNTQ_caec7ab2-920c-475d-9e03-fe4877c11dc9">no</ix:nonFraction></ix:nonFraction> valuation allowance as of March&#160;31, 2021 and March&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NDg_c265b8a6-2497-4599-b571-3e7468399c00" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:34.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMS0xLTEtMTg5Njk_dd2eb0a7-07e4-41a5-bc4c-3f3aec075935">55,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMy0xLTEtMTg5Njk_51cbdd87-a5e9-4b3c-88b5-cfe05589acae">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtNS0xLTEtMTg5Njk_df37ea0c-b750-448c-8c32-c9dbc2f0f72b">42,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtNy0xLTEtMTg5Njk_177be8b3-f788-4641-ae35-6a92272d59a1">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtOS0xLTEtMTg5Njk_db7259e9-dbf6-4dab-8d79-3059af817ad8">40,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMTEtMS0xLTE4OTY5_0e6e147c-d227-4d46-9b1c-eefb5e9bacf1">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMS0xLTEtMTg5Njk_97e99fe1-cae4-40f7-8aba-957da6c6a1ce">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMy0xLTEtMTg5Njk_e23f4107-ab32-4b28-800c-c31cb37b1103">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtNS0xLTEtMTg5Njk_9d17bd15-5357-49d7-96ff-517d4565b6e0">3,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtNy0xLTEtMTg5Njk_2181484c-8660-4c26-9c16-9064df48e9ba">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtOS0xLTEtMTg5Njk_dac26a24-37f3-48d3-95bd-2a948d1c8d94">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMTEtMS0xLTE4OTY5_8b13f947-c8c7-427a-ab0a-ecc6abb81fd7">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMS0xLTEtMTg5Njk_cd0c8f16-a7ee-4206-b871-064376d9d50f">1,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMy0xLTEtMTg5Njk_2635dc84-512a-4b73-a13e-b8ca219c32c1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtNS0xLTEtMTg5Njk_28d9296d-667a-44b7-aaa4-4f5e3590b5c3">7,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtNy0xLTEtMTg5Njk_36aef1a6-7b5c-4e21-967a-0d09755fe253">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtOS0xLTEtMTg5Njk_cbc3fc9c-1757-4de7-8c54-2c8357ba9185">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMTEtMS0xLTE4OTY5_ea333a7e-b849-4677-8d56-b4083e36449e">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMS0xLTEtMTg5Njk_5ede7e7b-2180-43f3-afca-d81ebba977fa">213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMy0xLTEtMTg5Njk_fbb0c2a6-7ab0-4dbf-a5b7-a070ed3a71e5">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktNS0xLTEtMTg5Njk_9cca5276-a77a-4d24-a529-c5cf6330e1c3">156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktNy0xLTEtMTg5Njk_b3e39185-5b79-42c7-8edc-15b5b20de578">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktOS0xLTEtMTg5Njk_d2372657-8581-41b0-a1ba-f83977cc9e18">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMTEtMS0xLTE4OTY5_cf7d617b-7059-4c44-ac8d-06296cedc6ff">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTEtMS0xLTE4OTY5_f67b53c6-4303-4b2c-ad56-6031612ee437">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTMtMS0xLTE4OTY5_0a940c41-bc30-47be-b2b4-68dd0726f959">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTUtMS0xLTE4OTY5_80bea642-4a60-4dbb-a228-ecc2ca435813">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTctMS0xLTE4OTY5_67dbbe93-d720-4c5e-b071-1bd52045b377">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTktMS0xLTE4OTY5_454c63a1-81a8-4443-ad2d-7b020ecb4660">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTExLTEtMS0xODk2OQ_b2cd970c-6c87-4895-94d4-33476f9c1a7c">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTEtMS0xLTE4OTY5_60c43685-4568-40b5-bafe-c31ef73057f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTMtMS0xLTE4OTY5_5509bde1-deb0-48cf-94ec-d8fc2ca3ab76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTUtMS0xLTE4OTY5_c87c124c-c7a8-4462-aeb8-81a64dad3da1">5,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTctMS0xLTE4OTY5_70233c09-aa58-4685-8549-7b98739b42ac">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTktMS0xLTE4OTY5_7afc3ac1-8c6f-4d7c-9598-d3e5980b9f01">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTExLTEtMS0xODk2OQ_564ddf88-75f7-4baf-871d-4f335bc9102c">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTEtMS0xLTE4OTY5_3d510630-affa-4570-a71b-85e4d84f02f7">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" sign="-" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTMtMS0xLTE4OTY5_ee1da7f3-bf38-4568-bf74-b74dbf171b59">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTUtMS0xLTE4OTY5_a76babd6-b3f1-484b-a7e7-3007d5a460dc">7,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" sign="-" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTctMS0xLTE4OTY5_1bfbf4be-656b-472c-aa85-b92a5f7a42c1">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTktMS0xLTE4OTY5_35a1c361-db40-470e-9d96-d0f982275c8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTExLTEtMS0xODk2OQ_4f5767d4-9fba-405c-b81d-8e09beac84f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTEtMS0xLTE4OTY5_92b50bb7-910d-4e33-bcd5-03e41f336a8a">3,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTMtMS0xLTE4OTY5_b72da1ea-2733-4f97-a904-3b4571725cdc">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTUtMS0xLTE4OTY5_0f92ce69-4171-4fc5-bfa0-38f73313868e">2,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTctMS0xLTE4OTY5_0b6c021e-1dbd-4e68-aa41-1028e5a164dc">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTktMS0xLTE4OTY5_0a446134-6e2e-4558-91bc-f2b93d399560">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTExLTEtMS0xODk2OQ_d7c9b250-e20e-4a9e-a7b3-35058a34ff4f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTEtMS0xLTE4OTY5_0003dfbe-f06e-4191-b9d6-8763be1cbc1e">57,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="3" name="pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTMtMS0xLTE4OTY5_2908a332-6d5c-49dd-ac65-b0b7a066d75f">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTUtMS0xLTE4OTY5_89fcc945-58db-49a6-a53b-b6b44d7d6a44">39,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="3" name="pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTctMS0xLTE4OTY5_1b65c421-5221-4ce1-b2e1-8c1f3c2991fa">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTktMS0xLTE4OTY5_f4b89d3a-c0e1-463e-b04c-6c3a3d7e3558">48,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="3" name="pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTExLTEtMS0xODk2OQ_b89377ab-bdd9-4c55-b02d-867adc7f951f">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8d4c653b37ea4c099c9fe4158e6376d2"><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0Njg_a01a1653-97cb-4f30-a891-8b9c95bf2c67" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax liability activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItMS0xLTEtMTg5Njk_e5ecee92-5913-4021-a8f5-c885fbbbdf10">4,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItMy0xLTEtMTg5Njk_a2c9cbcb-5036-4fe1-8a9b-9fb07d978e43">10,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItNS0xLTEtMTg5Njk_35f76193-fd42-45db-af11-9076f8bf15d4">9,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtMS0xLTEtMTg5Njk_5950c3ba-6323-439e-a474-2b89b072b142">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtMy0xLTEtMTg5Njk_41d376ce-0176-4267-b2d8-e6ed6013d8ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtNS0xLTEtMTg5Njk_fa54286c-9d1e-41ac-9419-9ed140e2d19b">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtMS0xLTEtMTg5Njk_b00f9ae9-65ba-43c8-81fa-56d54132a24b">585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtMy0xLTEtMTg5Njk_9dbe33b6-ec05-4004-b672-417a408ca318">6,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtNS0xLTEtMTg5Njk_d54213ad-99b5-40b0-80a7-5b493061c67c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other movements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtMS0xLTEtMTg5Njk_df65d222-4a18-4460-9b74-40e3c8628adf">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtMy0xLTEtMTg5Njk_98aad7f9-4440-46a7-9c96-7d1882a994e9">417</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtNS0xLTEtMTg5Njk_c45a7209-9f7f-41b7-be27-e14c1f3cce2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtMS0xLTEtMTg5Njk_237c548c-6b57-47ee-adea-7b86ddf4eadb">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtMy0xLTEtMTg5Njk_aec38681-1581-4232-a468-a040e06f2a16">4,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtNS0xLTEtMTg5Njk_74f4556e-3ffa-4715-a589-bd805cca25f1">10,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to uncertain tax positions as a component of income tax (benefit) expense.  We did not incur any material interest or penalties related to income taxes in 2022, 2021 or 2020.  We reasonably anticipate that uncertain tax positions could decrease in the next year by approximately $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="pbh:EstimatedReductionInUncertainTaxProvisionsNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzIxMTY_8257399c-5748-4424-8694-b86658351a22">0.5</ix:nonFraction> million, principally due to the statute of limitation expirations if recognized and would impact the effective tax rate in a future period.  We are subject to taxation in the United States and various state and foreign jurisdictions, and we are generally open to examination from the year ended March 31, 2018 forward.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mjg_793530de-46af-4ee7-9b1b-5257976e4fcc" continuedAt="ib8c5cbe96ab34bbab3e7d16361339f8d" escape="true">Employee Retirement Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib8c5cbe96ab34bbab3e7d16361339f8d" continuedAt="i170e594a7324471cb47ec24bbc37d7be"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined contribution plan in which all U.S. full-time employees are eligible to participate.  The participants may contribute from <ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="INF" name="pbh:DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzE3OA_0a506826-e1bc-4915-9835-4b4626a2f31c">1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzE4NA_658960a5-e149-4a69-943e-74af01b6047b">70</ix:nonFraction>% of their compensation, as defined in the plan.  We match <ix:nonFraction unitRef="number" contextRef="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI0NA_388c4e88-3bf9-411a-ac6f-d575ff34bb51">100</ix:nonFraction>% of the first <ix:nonFraction unitRef="number" contextRef="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2MA_7ae0e432-c7ff-43aa-ab0a-b4c949c7fa8b">3</ix:nonFraction>%, plus <ix:nonFraction unitRef="number" contextRef="i20570904260143f09bd86146ffd27dba_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2OQ_f722f811-4508-42c4-b004-a5edc8fc3af9">50</ix:nonFraction>% of the next <ix:nonFraction unitRef="number" contextRef="i20570904260143f09bd86146ffd27dba_D20210401-20220331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI4NA_60438279-5a1d-4a77-81f7-3bdb465a5c96">3</ix:nonFraction>%, of each participant's base compensation with full vesting immediately.  We may also make additional contributions to the plan as determined by the Board of Directors.  The total expense for the defined contribution plan was $<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUxMg_6b821428-18b4-47b8-8f01-02a13179e024">1.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUxNg_29ee6999-76e9-4a24-8808-eed9e9da5ed6">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUyMw_0e866118-9293-468c-8f4a-d4d05d8eabb8">1.5</ix:nonFraction> million for 2022, 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under ERISA. The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan (the "Plan") with an effective date of March 1, 2015.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the Plan and began the Plan termination process.  Pension obligations related to the Plan of $<ix:nonFraction unitRef="usd" contextRef="ice63f8b82a3a41e5b98abd0d12861032_I20210430" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzEyNTA_0134d069-3000-4648-8fe6-e38457907d16">47.2</ix:nonFraction>&#160;million are expected to be distributed through a combination of lump sum payments to eligible Plan participants who elect such payments and through the purchase of annuity contracts to the remaining participants. The benefit obligation for the Plan as of March 31, 2021 was therefore determined on a plan termination basis for which it is assumed that a portion of eligible active and deferred vested participants will elect lump sum payments.  The Plan likely has sufficient assets to satisfy all transaction obligations and all payments related to the termination are expected to be paid out of Plan assets.  No distributions have been made as of March 31, 2022.   The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefit Obligations and Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDY_e0cc0029-470d-497d-b9cc-fc2f45f33dbe" continuedAt="i3d93331661ea42ba88bd26a6622d7080" escape="true">The following table summarizes the changes in the U.S. pension plan obligations and plan assets and includes a statement of the plans' funded status as of March&#160;31, 2022 and 2021:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i170e594a7324471cb47ec24bbc37d7be" continuedAt="i88f636ab5f214415893a3f9997159808"><div style="text-align:justify"><ix:continuation id="i3d93331661ea42ba88bd26a6622d7080" continuedAt="i5ac750adc01141fcaad41c70400282c1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzMtMS0xLTEtMTg5Njk_8c52fb6c-a3c5-4b03-8700-0f02af03fe58">56,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzMtMy0xLTEtMTg5Njk_c5153b41-4147-4a8a-be67-32ad37fcb408">61,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzQtMS0xLTEtMTg5Njk_4dd12d0d-4233-42dd-a2ea-94d9eebe43d1">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzQtMy0xLTEtMTg5Njk_8ccada31-bbed-48b2-8218-b43f2123ff36">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzUtMS0xLTEtMTg5Njk_79c12776-6982-4886-9261-5a3017a7a4d8">2,888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzUtMy0xLTEtMTg5Njk_36069e45-d077-4e56-88e1-0a07b7937127">3,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzYtMS0xLTEtMTg5Njk_49323757-33cc-4d77-bce2-337f700664c6">3,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzYtMy0xLTEtMTg5Njk_52a7e59d-5844-4275-be78-b94b39d3d33f">10,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzctMS0xLTEtMTg5Njk_226be842-5b22-4638-a315-fdb4e4d2ab3c">51,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzctMy0xLTEtMTg5Njk_b042d018-ef4e-4ed3-84b4-45d9cee62efa">56,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEwLTEtMS0xLTE4OTY5_e6baff4f-fef7-4423-a7a5-1d43a611609d">53,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEwLTMtMS0xLTE4OTY5_31c8f522-b865-45d8-ba10-bbed64fb1d7f">52,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzExLTEtMS0xLTE4OTY5_ceebdae2-4c14-4062-ba13-a7e6bc10ebb7">1,405</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzExLTMtMS0xLTE4OTY5_1b8ad970-38f0-4fa4-8e9b-813da4b8b484">7,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEyLTEtMS0xLTE4OTY5_e0bad1d3-973f-4934-bbea-932d6f0a2be2">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEyLTMtMS0xLTE4OTY5_99253f38-a359-410c-8747-e5756f18d7a9">3,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEzLTEtMS0xLTE4OTY5_95e0e950-a4c0-4651-8e80-3590402b9aa9">3,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEzLTMtMS0xLTE4OTY5_92ede9c7-547a-4c22-9d13-4fd03629defe">10,503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE0LTEtMS0xLTE4OTY5_bc1e6274-0146-40b4-a0df-d09ae20cb1f7">48,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE0LTMtMS0xLTE4OTY5_bea0f7a4-cad9-4d0f-933c-5392bc644792">53,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE2LTEtMS0xLTE4OTY5_b0a68a59-4cdf-48f3-ace9-b61aa7209016">2,799</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE2LTMtMS0xLTE4OTY5_655c2724-7658-423a-b169-3230d64e45ba">3,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mzg_35106df6-b762-4451-97bd-9c88ce30d9fd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet at the end of the period consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzItMS0xLTEtMTg5Njk_ea048754-c2ad-4fee-ae03-2328a06d5923">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzItMy0xLTEtMTg5Njk_20716533-0f10-4261-9416-7e3c3bee299f">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzQtMS0xLTEtMTg5Njk_c8df6e7d-8c46-4f1d-9833-f7036a871b98">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzQtMy0xLTEtMTg5Njk_c2e9e291-cfc3-4b70-91ec-871b0201fa39">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzUtMS0xLTEtMTg5Njk_b70a0ff4-9856-44f9-8d99-442de61686eb">3,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzUtMy0xLTEtMTg5Njk_d55dd255-a249-4652-98be-61ae4a1b9426">4,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzYtMS0xLTEtMTg5Njk_245f4350-4fd3-41dc-9b37-b56921ad82ce">4,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzYtMy0xLTEtMTg5Njk_9f5f89a2-fb9a-4a39-a0fa-4d637007e92d">4,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzgtMS0xLTEtMTg5Njk_45926dab-e670-4f2a-a29b-3da1e5d2d53d">2,799</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzgtMy0xLTEtMTg5Njk_d6ba9777-5d58-4847-8839-226e8c51fe7c">3,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4MzU_2803e467-c48a-4b84-8c24-1c479bbeb28e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefit Cost (Income) consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItMS0xLTEtMTg5Njk_5134dd50-ebf8-4207-b826-7bdda356268e">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItMy0xLTEtMTg5Njk_a502ece6-88f5-40c1-beae-2650d60b1805">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItNS0xLTEtMTg5Njk_a5463015-e120-4a47-be6c-be52d9e5eae6">2,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtMS0xLTEtMTg5Njk_93c62438-72d2-495f-85e9-539ed6cb0a91">1,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtMy0xLTEtMTg5Njk_2fcbc9f1-b103-4b76-88a9-cbd168224fbc">2,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtNS0xLTEtMTg5Njk_f237238e-fdfa-49e9-9aec-7afd277c429c">2,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtMS0xLTEtMTg5Njk_1687b3fc-eac2-4b01-8cf6-360e7f154886">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtMy0xLTEtMTg5Njk_ae739d64-878a-40d0-b663-358dc704af08">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtNS0xLTEtMTg5Njk_2fdd4d1c-5ca2-439b-8654-5cfa5721b3ff">559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i5ac750adc01141fcaad41c70400282c1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our pension plans with an accumulated benefit obligation and a projected benefit obligation in excess of plan assets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzItMS0xLTEtMTg5Njk_5998874c-ba38-4f98-a4cc-826017a5125f">51,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzItMy0xLTEtMTg5Njk_194e731d-e9f7-4852-88ce-a6c6215f6c6f">56,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzMtMS0xLTEtMTg5Njk_a6a79152-19b2-40d6-8aee-92c1f578fa89">48,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzMtMy0xLTEtMTg5Njk_824cba37-5f26-450d-a13b-6f5feaff6e7c">53,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzUtMS0xLTEtMTg5Njk_e34265ac-9a5d-4023-bbbb-36049b9b62cf">51,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzUtMy0xLTEtMTg5Njk_4e97ce6d-c1fa-4872-9db5-6307fcb3c12c">56,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzYtMS0xLTEtMTg5Njk_161c274d-15f4-4c92-9213-e6091412f4b5">48,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzYtMy0xLTEtMTg5Njk_d2264b9d-ea7e-4c64-9073-a810cb415d6f">53,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i88f636ab5f214415893a3f9997159808" continuedAt="i66b5ac07b65241f294ffb129d55a0597"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pension benefit amounts stated above include one pension plan that is an unfunded plan.  The projected benefit obligation and accumulated benefit obligation for this unfunded plan were $<ix:nonFraction unitRef="usd" contextRef="i9a3457f45285462fb87d13aa61a3f683_I20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI1ODQ_f41f1c6b-c4cc-4348-b66c-6604a2bea4ad">4.3</ix:nonFraction> million as of March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i18eeee208fa54c9c94b0e5c5a0efc290_I20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2MDA_937cd53d-dfcc-4879-90d0-7203e7be7efc">4.7</ix:nonFraction> million as of March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDg_540117dd-90fa-4671-8bfa-3606fd356306" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes amounts that are expected to be contributed to the plans by the Company.  It reflects benefit payments that are made from the plans' assets as well as those made directly from the Company's assets.  The amounts in the table are actuarially determined and reflect the Company's best estimate given its current knowledge; actual amounts could be materially different.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employer contributions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (expectation) to participant benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzItMS0xLTEtMTg5Njk_df65b72f-b345-4279-b424-cb7852a5548b">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected benefit payments year ending March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzUtMS0xLTEtMTg5Njk_7f98c7dd-3665-44ae-a7a3-5862e9fa9a19">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzYtMS0xLTEtMTg5Njk_a39d77f5-ee4c-4d7b-8785-a052dd2ae3b2">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzctMS0xLTEtMTg5Njk_f6c3f391-7866-4fe3-8bd6-60f744dcb830">3,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzgtMS0xLTEtMTg5Njk_4c47a976-fde3-447e-a755-bc0e6965390e">3,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzktMS0xLTEtMTg5Njk_b46be8a4-f4cd-43a1-9d54-88c74cd9136f">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzEwLTEtMS0xLTE4OTY5_4cf43960-41f0-436e-97bf-4b08b6b3b463">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzExNTQ0ODcyMDk5Mzc5_bdf9b2ad-bfa6-47b1-8840-f4ca91b13c8c">no</ix:nonFraction>t make any contributions to our qualified defined benefit plan during 2022, and we contributed $<ix:nonFraction unitRef="usd" contextRef="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMwMzM_56a8e90c-44e0-4e05-84c8-d8fb89423034">3.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMwNDA_f4c4d3db-0263-4f0f-bf84-cd648fa2de90">1.0</ix:nonFraction> million to our qualified defined benefit plan during 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $<ix:nonFraction unitRef="usd" contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMzOTc_f4d26b5b-2035-42a7-ad54-528c631df90a">7.0</ix:nonFraction> million, and we recognized a settlement gain of $<ix:nonFraction unitRef="usd" contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM0NDA_0662fbfb-2b58-4bcf-9d0e-145991578b09">0.2</ix:nonFraction> million as a result of the payout.  The settlement credit was determined based on a remeasurement of the plan as of December 31, 2020, at which point a discount rate of <ix:nonFraction unitRef="number" contextRef="iba787bef5fbd42209b679fe0c7f29990_I20201231" decimals="4" name="pbh:DefinedBenefitPlanRemeasurementDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM2MDQ_4df380cd-e84c-4c2a-9893-18ba50f8add5">2.51</ix:nonFraction>% and an expected return assumption of <ix:nonFraction unitRef="number" contextRef="iba787bef5fbd42209b679fe0c7f29990_I20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM2NDQ_9c6d6648-d43d-4577-aafc-edc1430d7ee3">2.75</ix:nonFraction>% were selected.  Those remeasurement assumptions were also used to determine the net periodic pension income for the plan for the fourth quarter of fiscal 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's primary investment objective for its qualified pension plan assets is to provide a source of retirement income for the Plan's participants and beneficiaries.  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mjk_8d704e9a-c557-4a25-8d5a-7443144d81d9" continuedAt="ib37d553fd1c74d82a7f7d7f912a4b6f4" escape="true">The asset allocation for the Company's funded retirement plan as of March&#160;31, 2022 and 2021, and the target allocation by asset category are as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="ib37d553fd1c74d82a7f7d7f912a4b6f4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59ae6b30db4c49f8a69b46325778804b_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtMS0xLTEtMTg5Njk_99c28942-e48f-4e39-b1f6-078f3f4e04ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59ae6b30db4c49f8a69b46325778804b_I20220331" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtMy0xLTEtMTg5Njk_f59b9ff9-d198-4f9e-9f5b-833bb337aa5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58d96a8c72d94839a80320f2374f58ff_I20210331" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtNS0xLTEtMTg5Njk_ee1f9b90-7846-408b-87fd-785aeaee35e8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income and cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4a29f55b009477797275b056efd188d_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtMS0xLTEtMTg5Njk_3bc3dbd4-e706-433c-8afc-0f809e6fbe91">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id4a29f55b009477797275b056efd188d_I20220331" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtMy0xLTEtMTg5Njk_90779b3d-0336-415c-a8b6-b22c260cb085">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1b34dcaf34dd43b98d9f6b725d940736_I20210331" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtNS0xLTEtMTg5Njk_f6d141a2-348f-42f6-929b-bd8a61259d89">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctMS0xLTEtMTg5Njk_f23d004c-b21e-435b-9573-e0c1b69921f7">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctMy0xLTEtMTg5Njk_357ab646-cd7f-4987-b713-57964898748b">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctNS0xLTEtMTg5Njk_6f5f42c5-0c3c-4ef9-b629-7dcf1d137995">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan assets are invested in a portfolio consisting primarily of domestic fixed income held within collective investment trust funds as of March&#160;31, 2022 due to the plan termination process which began during the fourth quarter of fiscal 2021 and the plan's positive funded status. The plan assets were invested in a portfolio consisting primarily of domestic fixed income as of March&#160;31, 2022.   These assets are measured at NAV as a practical expedient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NTM_e50d4a60-d379-4ad7-ba7e-7c7cc446409a" continuedAt="i1fab79a1c242462b988372ae9cd525b9" escape="true">The following tables show the unrecognized actuarial loss (gain) included in accumulated other comprehensive income (loss) at March&#160;31, 2022, 2021 and 2020:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i66b5ac07b65241f294ffb129d55a0597" continuedAt="i6595f834547445cc9b41dcb1683354bd"><div style="text-align:center"><ix:continuation id="i1fab79a1c242462b988372ae9cd525b9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzItMS0xLTEtMTg5Njk_af44762a-f761-4214-8329-5d0f447a4885">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzMtMS0xLTEtMTg5Njk_6a088417-1874-4feb-a6f8-a91b9d76a58c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzYtMS0xLTEtMTg5Njk_6436124e-d736-4e5c-832c-13bee3503365">1,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzctMS0xLTEtMTg5Njk_f6d09915-24df-498d-a7ac-c089e05241c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzEwLTEtMS0xLTE4OTY5_df45e67e-61ba-428a-8bc1-4dd9d0435e64">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzExLTEtMS0xLTE4OTY5_c0796786-6673-4dcc-9d58-e406bf84354c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDQ_767d11ca-0c65-46e6-8775-2d348e69323c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the net periodic benefit cost (income) for the fiscal years ended March&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 *</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i724425dab8ca4eadac2088fa582751bc_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiZjg0MThhYTRhNWE0Y2FiYWYxYmRjM2Y0NjU3MDc5YV80_e7d15352-d413-4830-a812-3b419d7ea014">2.58</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i284d3a442bf04e5cb360a7e96ba61668_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiZjg0MThhYTRhNWE0Y2FiYWYxYmRjM2Y0NjU3MDc5YV8xMA_57053964-47c8-48b8-bb49-eb2ab5b827ed">2.95</ix:nonFraction>%   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd1018ca3a7741649a9198acafea0150_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplMTMxNzVjYWU4ZDY0YjA5YjdjMjhkYmU4Nzc1MGU5M180_f8a3a899-1b65-45c9-96e6-9d5bcc440366">3.37</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie702dabc815748c5bc0488c985ebed02_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplMTMxNzVjYWU4ZDY0YjA5YjdjMjhkYmU4Nzc1MGU5M18xMA_30b904bc-613d-4b76-ad5b-75dfeabbb3fe">3.55</ix:nonFraction>% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83c0747f5c71456088f94f029b3f9866_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo0ODZhZjMyOTUxNDE0MzI4OThkOGY0OTIzNjk0ZGM0Zl80_9721dc83-94f7-4367-b7f1-b5851a787332">3.80</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7d62723af3a64d1bb9252b80927be2e6_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo0ODZhZjMyOTUxNDE0MzI4OThkOGY0OTIzNjk0ZGM0Zl8xMA_5f46ce28-4d8e-4741-98ee-8853e889c43c">3.99</ix:nonFraction>%  </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets, net of administrative fees</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtMS0xLTEtMTg5Njk_59eac4d7-f9ab-4b5d-b434-8ef3f519b58d">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtMy0xLTEtMTg5Njk_621799f4-a87f-414b-b958-463ad4fc27cd">5.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtNS0xLTEtMTg5Njk_f42387df-2137-47de-8000-236102ef1b04">5.75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*The qualified plan was remeasured at December 31, 2020 for settlement accounting, at which point a discount rate of <ix:nonFraction unitRef="number" contextRef="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUwMDM_868e3d1c-4d8e-4972-ac3c-191a973b6dd5">2.51</ix:nonFraction>% and an expected return assumption of <ix:nonFraction unitRef="number" contextRef="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUwNDM_9261928f-ea25-4533-b79e-6885c10f4398">2.75</ix:nonFraction>% were selected and used to determine the net periodic benefit cost (income) for the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the benefit obligation as of March&#160;31, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjOTFmNWUxM2IzNzg0YjRjODM5OGRlYWRkMmZhZWM4Y180_87c07bd6-537b-48db-bc1c-8c912a78d28d">3.26</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjOTFmNWUxM2IzNzg0YjRjODM5OGRlYWRkMmZhZWM4Y18xMA_4cc3302d-3430-495b-b580-e4153c6f4707">3.48</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie78a158429ca4e789c941c6bb4801167_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkZGU0YTVhNzZkMjE0NDU1YWY0ZGExYzgzODA1N2RkZV80_9640bbda-6693-4504-bc77-7c42c4175888">2.58</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9808f2a5dec34206ae929d7fa60f2d90_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkZGU0YTVhNzZkMjE0NDU1YWY0ZGExYzgzODA1N2RkZV8xMA_ee26b0aa-b236-4994-8e1b-61909350d9c5">2.95</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6595f834547445cc9b41dcb1683354bd">The determination of the expected long-term rate of return was derived from an optimized portfolio using an asset allocation software program.  The risk and return assumptions, along with the correlations between the asset classes, were entered into the program.  Based on these assumptions and historical experience, the portfolio is expected to achieve a long-term rate of return of <ix:nonFraction unitRef="number" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU2Njg_dbd80670-4382-4b23-ae34-3b7e296bb76a">2.75</ix:nonFraction>%.  The investment managers engaged to manage the portfolio are expected to outperform their expected benchmarks on a relative basis over a full market cycle.</ix:continuation> </span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90ZXh0cmVnaW9uOjc2NTJiMWY4OWZjZTQ3MGU4MmQzNzE0OWQ0ZWVjMTM5XzE0OTc_9b53ba65-376f-4d7c-9834-7bbe806d477d" continuedAt="i5ebec93b699f4f17952c46d27f7fccb1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5ebec93b699f4f17952c46d27f7fccb1" continuedAt="iaf29d93a97754417b2ed3d9183d96d89"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved from time to time in routine legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Commitments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 7 for a description of our operating and finance leases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaf29d93a97754417b2ed3d9183d96d89"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have supply agreements for the manufacture of some of our products.  <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90ZXh0cmVnaW9uOjc2NTJiMWY4OWZjZTQ3MGU4MmQzNzE0OWQ0ZWVjMTM5XzE1MDc_3294df0e-5293-424d-bc96-a0c6a54ad23f" continuedAt="ib4040e610c584de99975a48389aabcac" escape="true">The following table shows the minimum amounts that we are committed to pay under these agreements:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="ib4040e610c584de99975a48389aabcac"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzItMS0xLTEtMTg5Njk_ae7668fa-cfda-441b-a5bf-eb40c72d1e10">6,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueInSecondYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzMtMS0xLTEtMTg5Njk_13949d65-61f4-4875-8ad9-1b6e975c6abb">5,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueInThirdYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzQtMS0xLTEtMTg5Njk_c25be263-fd31-450c-87dc-45e8801272c9">5,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueInFourthYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzUtMS0xLTEtMTg5Njk_e9252a9d-3a6c-431c-a3ef-bc7d0b2d6680">4,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueInFifthYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzYtMS0xLTEtMTg5Njk_baf8834a-d025-4211-ad71-77a07e6e1cee">4,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligationDueAfterFifthYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzctMS0xLTEtMTg5Njk_628d2105-99b7-4ee0-8016-13e797945da4">5,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331" decimals="-3" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzgtMS0xLTEtMTg5Njk_e3ad1e4e-12bf-4872-b335-b9a866ed6e4a">32,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzMwNDE_d07a93f2-ebdf-4195-a43c-8aba5b576dff" continuedAt="if7f499a05f004c6db8ace4216f692dd2" escape="true">Concentrations of Risk</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if7f499a05f004c6db8ace4216f692dd2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are concentrated in the areas of OTC Healthcare.&#160;&#160;We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.&#160;&#160;During 2022, 2021, and 2020, approximately <ix:nonFraction unitRef="number" contextRef="iaddcf560297f4cbdb307e23b2a762c97_D20210401-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI1Mg_41c6522a-dd06-4657-9604-7bfcae4b68b6">41.3</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="if6cfa4a5d82842f885da2acd0bc2b4de_D20200401-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI1Ng_915f7355-a8fd-4ab8-a0ab-de60073ff935">45.6</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i0b54127ec5714e2686bd5832ba581101_D20190401-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI2NA_bdddecb8-f99c-4dbd-b280-f8d48b278187">42.6</ix:nonFraction>%, respectively, of our gross revenues were derived from our five top selling brands.&#160;&#160;One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented.  During 2022, 2021, and 2020, Walmart accounted for approximately <ix:nonFraction unitRef="number" contextRef="i52bda21851d0429eac0d1110fc51c45f_D20210401-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUxNg_f45e591f-5552-43ce-b00a-87ad57563b0b">20.5</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ifc29d572ef4048c48685cf3987d915f6_D20200401-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUyMA_017fda34-7ce8-412f-9f43-e4477c25cccf">21.6</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i8a3c181fa51445a5a25f5120f9046d9b_D20190401-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUyOA_bc7c85b9-4502-446b-8c0b-2c834ec04c60">23.1</ix:nonFraction>%, respectively, of our gross revenues.&#160;At March&#160;31, 2022, approximately <ix:nonFraction unitRef="number" contextRef="i18191d87fd6b4de7a17225dc12eee7f6_D20210401-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzU5MA_0e4fffa6-0884-48b6-bb1c-3fd84cb01647">22.1</ix:nonFraction>% of our accounts receivable were owed by Walmart.    </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third-party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufacturers many of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fleet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or contagious disease outbreaks or other public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had relationships with <ix:nonFraction unitRef="manufacturer" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="INF" name="pbh:NumberOfThirdPartyManufacturers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIyMTA_227733ec-e703-45ee-a0dc-fabf1fcadae3">128</ix:nonFraction> third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with <ix:nonFraction unitRef="manufacturer" contextRef="i2a2dd8e6335e47d6909ca71624a16c91_D20210401-20220331" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIyODM_7097976c-ea43-4fa0-bbb1-00f25f52f5e8">23</ix:nonFraction> manufacturers that produced items that accounted for approximately <ix:nonFraction unitRef="number" contextRef="id3de54342685484fa1e90d25044d65b3_D20210401-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIzNTM_4c166740-845e-4187-8a89-8514575f71dd">69.0</ix:nonFraction>% of our gross sales for 2022, compared to <ix:nonFraction unitRef="manufacturer" contextRef="iec86293b1daa4d37b8ee94fb83cd3fb2_D20200401-20210331" decimals="INF" name="pbh:NumberOfThirdPartyManufacturersWithLongTermContracts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIzOTU_d907e2f9-3f1b-4da2-92b3-06283c21aa54">19</ix:nonFraction> manufacturers with long-term contracts that accounted for approximately <ix:nonFraction unitRef="number" contextRef="i84a5f4ee39164abea82cf5e9e5d39277_D20200401-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI0NzA_915b54a8-d6fd-4d04-8a7f-944b4fce988f">70.5</ix:nonFraction>% of gross sales in 2021.&#160;&#160;The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results from operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_142"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.  &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NTE_3832d9e0-fbd7-4cae-985d-f0a19d86016a" continuedAt="i12d968cee9744cdabc7265f709eef1a0" escape="true">Business Segments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i12d968cee9744cdabc7265f709eef1a0" continuedAt="i463dd9c8b1dd4ff080a085133b6e98c0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280.  Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare.  We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i463dd9c8b1dd4ff080a085133b6e98c0" continuedAt="i57720e65368b4b3ba468a9fbc95f0984"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NTQ_4c637cbd-cc03-4472-983e-3dc5e11e1860" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our operating and reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItMS0xLTEtMTg5Njk_e5733b98-d7ec-4b2c-a368-0090dc3fac67">967,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItMy0xLTEtMTg5Njk_ce0cbbfd-33d2-4bbb-867e-fc2c9b9fcd0a">118,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItNy0xLTEtMTg5Njk_8a7895a0-26b5-40d8-8fb8-1f94b059585b">1,086,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtMS0xLTEtMTg5Njk_9c0c58d8-9c44-46c3-a2c2-38f6bea2e268">419,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtMy0xLTEtMTg5Njk_0fad0cf0-9326-4b11-875a-643acfa0828d">47,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtNy0xLTEtMTg5Njk_5572f5d9-1678-498b-9bea-7d566df8ecc2">466,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtMS0xLTEtMTg5Njk_40b1b092-f919-4062-9807-858402b1adad">548,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtMy0xLTEtMTg5Njk_9991ee16-9ad0-4caf-be37-dd3edec36abe">71,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtNy0xLTEtMTg5Njk_c0a7bdfa-81e1-4094-9e7b-8a81ef54db45">620,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtMS0xLTEtMTg5Njk_00ab049b-98c4-45a6-bbff-34a442a71505">138,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtMy0xLTEtMTg5Njk_f49f3774-d55d-4f89-a65a-821bad76326e">18,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtNy0xLTEtMTg5Njk_d88d5dd9-ac74-4793-8e4e-01e28469a3c8">157,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtMS0xLTEtMTg5Njk_aa734e24-4618-4b54-a1be-902602748b0d">410,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtMy0xLTEtMTg5Njk_630247cf-12ab-44d8-a5f9-1aac835aa982">53,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtNy0xLTEtMTg5Njk_25727024-8d31-4949-a161-ccc5709091cf">463,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzctNy0xLTEtMTg5Njk_7fb5ef75-9a67-4b85-9d7b-c915547128e6">133,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzgtNy0xLTEtMTg5Njk_5f85485e-93b9-477c-9ae1-98d18d8364bf">329,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i4f656cd6192a49a8b0474d9588199e42_D20210401-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzY2Nw_a756c597-3faa-4164-b973-6db20cc8400f">3.0</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItMS0xLTEtMTg5Njk_3f5f2214-67e9-4898-af2a-fed1cf754640">849,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItMy0xLTEtMTg5Njk_7b487983-c616-4a62-a37c-1c7081e42540">94,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItNy0xLTEtMTg5Njk_60b5c902-6688-423b-80d8-4d7769de9079">943,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtMS0xLTEtMTg5Njk_434a835c-f416-48e5-8bc0-8d84a7563007">359,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtMy0xLTEtMTg5Njk_d0502ce6-fdef-4809-af42-db0aee1c114f">36,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtNy0xLTEtMTg5Njk_0c3a5b47-8856-4bb8-a0aa-d45a62928da8">395,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtMS0xLTEtMTg5Njk_bcad7248-ef96-4739-b831-c7fb317a6b6e">490,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtMy0xLTEtMTg5Njk_cc641286-123a-420b-ad42-2286d0e4e86a">57,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtNy0xLTEtMTg5Njk_53ba91ac-1c28-454f-9110-469b7fbddf7b">547,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtMS0xLTEtMTg5Njk_e8505211-976a-46b0-a15e-dab1f9658a17">122,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtMy0xLTEtMTg5Njk_ed556d10-b675-4315-b8be-95965bf3c3da">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtNy0xLTEtMTg5Njk_1b2c7a83-10a6-4f37-8bf0-ef1467fbf681">140,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtMS0xLTEtMTg5Njk_08b2c958-c4f1-4c79-917e-f47c8b719ff6">367,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtMy0xLTEtMTg5Njk_4c60f6ce-342d-4623-9480-67b06d8d7f4d">39,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtNy0xLTEtMTg5Njk_bc60a547-8753-42d9-8edd-40e083cd3969">406,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzctNy0xLTEtMTg5Njk_77f69d5f-2084-4615-8ca0-4703cc1a8ac7">109,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzgtNy0xLTEtMTg5Njk_8b4714f2-0fec-473b-9cac-1ef37c6e4196">297,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i9ff2c33ba3b24ce3835abeb593b95b50_D20200401-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0Xzc2NA_a01a6651-12ce-4402-b3f1-be047b0325c0">3.2</ix:nonFraction> million were eliminated from the North American OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues* </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItMS0xLTEtMTg5Njk_83ae2dd4-903f-4a8b-b22a-d70283bd32a9">859,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItMy0xLTEtMTg5Njk_adc72d9d-8a2a-4181-a733-889c6749bc0f">103,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItNy0xLTEtMTg5Njk_519b841f-fbe8-4ac2-b2e6-584b8be0f3b4">963,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtMS0xLTEtMTg5Njk_9b9cc18e-77b7-45f6-ab08-8f0119cc638f">372,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtMy0xLTEtMTg5Njk_4194d1c0-cdc5-4e41-b19c-956dc658667c">38,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtNy0xLTEtMTg5Njk_58f8f08f-2056-4598-82be-b3a470dc5847">410,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtMS0xLTEtMTg5Njk_cde641e2-2b27-4a73-b881-3969e9ba97c7">487,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtMy0xLTEtMTg5Njk_64ca6c75-2cc7-4df8-8710-5644904559c1">64,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtNy0xLTEtMTg5Njk_43e52cde-f1a5-4dd4-83cd-a963f60974e6">552,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtMS0xLTEtMTg5Njk_3c434e89-c402-4a2d-86e8-b270b766088f">127,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtMy0xLTEtMTg5Njk_e5a4b22c-35b6-438d-bf0d-36fcd5fb25bf">19,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:MarketingAndAdvertisingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtNy0xLTEtMTg5Njk_81a38bc0-58c3-40eb-ae12-a144e36c81a9">147,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtMS0xLTEtMTg5Njk_4374208d-8574-4b79-bbd8-98869d4f5e73">359,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtMy0xLTEtMTg5Njk_bfa1d8a6-d2ab-4eba-8f60-c8e26549a24d">45,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtNy0xLTEtMTg5Njk_23ea2be9-cd4d-47cc-acbf-ac58a7e32599">405,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzctNy0xLTEtMTg5Njk_3a54ed4c-f04e-4102-92fd-8b664f0d49c6">113,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzgtNy0xLTEtMTg5Njk_0663c092-d028-454a-9d99-b3c73e129d22">291,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $<ix:nonFraction unitRef="usd" contextRef="i5f247a503b8943d8a3ad2e615aab0ff6_D20190401-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0Xzg2MA_7d74253e-5d32-44bc-a459-de27f4b2629a">3.5</ix:nonFraction> million were eliminated from the North America OTC Healthcare segment.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i57720e65368b4b3ba468a9fbc95f0984" continuedAt="i3e88e92f0ebd4ecc80fb9ef3eab006bb"><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NDM_eaa3e0af-0395-4e86-840b-7f193bb6a346" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5aa716616894b2f84935e0374ea04e7_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItMS0xLTEtMTg5Njk_5907dcbd-afa7-49c6-874b-effe4acccbbf">117,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic029fed0956549baa7ec88dac897d2c8_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItMy0xLTEtMTg5Njk_cca22473-a057-4ab9-a7fb-82873036ea20">1,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c295d6ba7346f3a20449e046450179_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItNy0xLTEtMTg5Njk_600aa4f0-b577-461f-9056-eab20a398330">119,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef95b48e1034b91aaf6fd8e8409b9ad_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtMS0xLTEtMTg5Njk_3e48ddcc-934b-4ac5-bc92-9edcceea0f6e">86,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3294e803eb844221be72afcd3f38c4d7_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtMy0xLTEtMTg5Njk_d0c862dd-53cb-43eb-898d-2a1c8db251a9">20,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5b824968d64c17a23ce9b8e959483a_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtNy0xLTEtMTg5Njk_cdecc69f-eef1-4454-9e68-d8db7bdc8aee">107,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic37751a73f9944309da3a6209420d28a_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtMS0xLTEtMTg5Njk_e72b81c5-ca3e-44c9-a4a4-dfbe16192501">249,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if488c5f576284dd2b32d7aca3c3ac7da_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtMy0xLTEtMTg5Njk_c98eadc7-7f97-4f80-a3ab-77cbf909f817">15,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99bb552abe54bfd9db35d442b507668_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtNy0xLTEtMTg5Njk_8455c2c2-fab2-4f7c-bc15-346d40eaacce">264,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98203bb0fdee45e0a76bebb95fdaa091_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtMS0xLTEtMTg5Njk_6f409f14-9f2c-48ab-a3a1-e51e5d3b779d">152,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee5ebd4f9b4f40b4a4a08959e40f8232_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtMy0xLTEtMTg5Njk_f8aa7240-80b7-4a28-ae25-e10213c8f053">52,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04beadabffb1494192c4f1432581e3e9_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtNy0xLTEtMTg5Njk_6ac677e2-ecb0-4250-80ca-6124f7f2ad13">204,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f1098b70cf4c3a9d398ae76f4418b2_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtMS0xLTEtMTg5Njk_c237c7b6-c80f-4746-b30d-51a2fcd21e44">149,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6611cae507e467aae33483a930263e9_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtMy0xLTEtMTg5Njk_26297bf7-3dac-4b84-97f7-fbf015dae2d6">13,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6528481919014cca8fa35e096227a2a4_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtNy0xLTEtMTg5Njk_5c0a5079-cf93-4f75-a7e2-dca02c6175a0">163,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia993e09fc5da4f1bb3419721565e91c9_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctMS0xLTEtMTg5Njk_123d46eb-582e-4bc9-b299-51bee9cf4ecd">117,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d0d76f1e26446ca6c10a8acbccbda1_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctMy0xLTEtMTg5Njk_2ed17a97-1966-4bc4-8f5b-38e8aa2b923d">3,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1118888fef148b0b3d06df4c4ca9bf2_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctNy0xLTEtMTg5Njk_870092ff-2806-458a-81aa-a4bb02349fd2">120,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia83b05de81bc4440b8a7586ab5058ae8_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtMS0xLTEtMTg5Njk_641cf6f4-c18b-48b1-bb0d-89b4158a48e4">85,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb112ef71bd4025a8a7c045b35fda05_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtMy0xLTEtMTg5Njk_62401df2-22f5-47d9-bff2-d32b9ab3a94d">12,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c552006b60d4b08b007787d0e7c1b31_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtNy0xLTEtMTg5Njk_7a16f54f-6661-4b5a-8f40-262d5f47de73">97,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015c2f7ac3ca4d218c5d12d1f385211e_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktMS0xLTEtMTg5Njk_d06d1804-5b26-4189-ab68-dbd0d959a465">9,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86e42570a994afab266a376ed0ac2f9_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktMy0xLTEtMTg5Njk_2022aab3-505c-4a72-aa3f-d3d74eb395b8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fbea258f054a63ba94905ba9c1dc40_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktNy0xLTEtMTg5Njk_e93d3fd2-0f1b-4ddf-9caa-60634c968bba">9,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTEtMS0xLTE4OTY5_7427dcc5-6dfe-4350-9bb9-b0e184915bde">967,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTMtMS0xLTE4OTY5_a4597ed7-dc5e-462d-beda-1cad75da41df">118,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTctMS0xLTE4OTY5_50de5050-09ab-4994-a711-4277be7c2d09">1,086,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75173fc3463d4172a4889323f35f8ce7_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItMS0xLTEtMTg5Njk_dead42ff-0d3d-46c0-a778-3b7b40fa705d">117,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia24d6f74c12547b9b437f46f93f8e81b_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItMy0xLTEtMTg5Njk_37c16802-f3ea-44d9-8e01-7eec72e04ff2">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4612ad4393fa41f2bf9ac148b747c4ba_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItNy0xLTEtMTg5Njk_bfc5d2ff-9cb0-4c70-b2d5-954e1ccf1b69">119,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1279b5a211240cdbc3c48972315db77_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtMS0xLTEtMTg5Njk_f3c90408-11a1-450b-8884-dda7d52997a5">56,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b826369aad440f284486a46f6980adf_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtMy0xLTEtMTg5Njk_8e2a35f5-5a54-4630-be26-3eaeee87da1d">14,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847749d31c8d4decba0abfa61b2399d6_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtNy0xLTEtMTg5Njk_bf748600-507a-43b2-867f-ee74ff7ef0e7">70,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce1b2b252c24eba903fe426d1e8f9d4_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtMS0xLTEtMTg5Njk_58bc4cf2-0dce-4339-9405-77e7e02fbb29">252,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453f0da9e5204e0a9a8f290c4314b16b_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtMy0xLTEtMTg5Njk_006d57a5-1fa5-45f3-9982-d91fad9a3313">15,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43727784ec8f4d619cf24289b32d65d3_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtNy0xLTEtMTg5Njk_cd7b0cea-5275-4fae-8278-2b4b8cbbc7df">268,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8157da33ba78498d8401bafd7a8fc602_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtMS0xLTEtMTg5Njk_b94edddd-4fa4-4a34-af21-14ff513500e5">124,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5ecc92af704cae9ac690e78c08e5ef_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtMy0xLTEtMTg5Njk_05dcd315-3c75-4f39-b7aa-30d265028776">36,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf001558139e4bd8ab9cd40cebbfb430_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtNy0xLTEtMTg5Njk_6aacf7a3-a8e3-44a2-bcdd-b3070155c06e">161,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549188b894974e3f9c66c305dff4ec5c_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtMS0xLTEtMTg5Njk_229de739-3c91-4065-8f9a-9932c3ab2cae">99,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7f2a80b24c4f3a837fc32b805a4f04_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtMy0xLTEtMTg5Njk_73266a66-f8bd-4095-9e93-905d72566f13">10,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cc9eb035334f0083ea1c824a1b091d_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtNy0xLTEtMTg5Njk_f99bfe73-f2c4-4542-81d7-3fa8542abefd">110,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c0cbb726f74abe9ca0f96e0c1f9657_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctMS0xLTEtMTg5Njk_8a21edef-5a96-4839-95be-363249f9555b">103,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb44edcc32594a3a91c1dd365c21d677_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctMy0xLTEtMTg5Njk_49f1494e-b7dc-497c-ad34-cb606dd777b5">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6542cd977dd429bb80eb6e889d6eec0_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctNy0xLTEtMTg5Njk_e4f64433-6912-4b51-a95f-0027092d9ea5">107,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i690400e5143b4fab85db90f58029c2af_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtMS0xLTEtMTg5Njk_8918da01-6554-4a21-9993-f7be5ab331b0">88,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c52313a45fa4bdc8707f54d8c7b0f79_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtMy0xLTEtMTg5Njk_23b2dd11-3864-499f-98bd-9104d9de05da">12,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892942ab686d43ff9f78b51f385c281d_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtNy0xLTEtMTg5Njk_5cff37bc-9f6e-4293-a9d9-198f8aca50c3">101,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50816ace3fa42db88ab7771863e34c1_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktMS0xLTEtMTg5Njk_a8beb887-b11c-4ab7-a232-e11d628a9ce4">5,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bfd881300fd43768d4fd18c5b8399ac_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktMy0xLTEtMTg5Njk_5ca88cb9-6413-4b89-9169-19de8079b114">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef22b30afc84db9bda8dc263f3e2890_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktNy0xLTEtMTg5Njk_28f52fe7-6eb4-4efb-b780-99c85194c1f4">5,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTEtMS0xLTE4OTY5_cc29c536-7a48-4d65-9578-cb21443639f8">849,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTMtMS0xLTE4OTY5_239596e0-b653-4514-8263-17da9ffab3bd">94,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTctMS0xLTE4OTY5_b165e691-4f58-4ab5-970a-ff9680f3fd31">943,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90b15b3c2e24cb48a2cba51ae97b668_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItMS0xLTEtMTg5Njk_f8fdf512-9fac-4305-abf6-75750ef6e2c5">113,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b7b9808f604b5d8c96d94c8752d25b_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItMy0xLTEtMTg5Njk_a791f34d-93bc-48f1-9fb0-e2b0fe975a7a">877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de86537a7564a0e846cbacec3a5d86f_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItNy0xLTEtMTg5Njk_ed18f107-3c13-4d70-983c-40174eb77c31">114,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0954b90f854c9c8c6b9d5991778c49_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtMS0xLTEtMTg5Njk_f746c8f6-2896-463a-8619-c0e17476c8c3">87,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b222ffe8f542fb9a020f3fae60ba89_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtMy0xLTEtMTg5Njk_448b0001-e6f2-45a9-98ce-450ec680c5b5">23,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife659f1768004fb5be70b186e77e5297_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtNy0xLTEtMTg5Njk_f3355f96-316b-41cb-bd46-998e6b54edd9">111,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd63fc992cf4852a161722fc0811307_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtMS0xLTEtMTg5Njk_63f5aae8-fce4-4071-91ff-ad0c51e29af9">239,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie159feb199e54e298d894fb67e2ecb91_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtMy0xLTEtMTg5Njk_2eb4cd9c-414b-4fde-b17e-c2c0d7c5cee6">12,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6255fa73dfc94124a1c4ebaee132b040_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtNy0xLTEtMTg5Njk_3bb20904-5393-4b7b-80ae-a323369f11ff">251,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e964d1b021431e9f1b1934d39a6d37_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtMS0xLTEtMTg5Njk_27bd4fb3-3faa-474a-8b1e-c628f6470638">130,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if064a3f9803e44a281b0d06b27be87d4_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtMy0xLTEtMTg5Njk_f7fc67c6-706a-435b-a4b0-f533c87c1a51">42,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb2e510d032b4dd9b8d6e4efeba5bae8_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtNy0xLTEtMTg5Njk_ce2d3165-72df-495e-9d09-ac31dcead721">172,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda1d905a84541a487e2a38b30d11e2b_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtMS0xLTEtMTg5Njk_426c2fcb-d4cd-46fb-8d85-ceb070aeb86c">100,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcfc25de9722466e932dc1e06bb976b9_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtMy0xLTEtMTg5Njk_50596b0c-53e8-45e2-b8d4-76342c08267d">11,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99db4439e2494b88b17e934ed9c39536_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtNy0xLTEtMTg5Njk_7336387b-a0b9-4b17-a826-b58cd48f304d">112,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447cea4350b049899445c056e36a842e_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctMS0xLTEtMTg5Njk_07bf926e-3060-4dd9-a114-b1fdb3a9bf4a">100,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216903c2e83a43b3b92dd97b7bee014c_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctMy0xLTEtMTg5Njk_3163f35b-a4e7-4626-8ea5-43cd799ca1d4">2,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b3152923a2411e85c99e2bcf72e13b_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctNy0xLTEtMTg5Njk_89881e3f-456a-4ce2-88f8-fdb0b684da35">103,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3a43743f4d400dabfa688570f0f5d3_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtMS0xLTEtMTg5Njk_301cc695-bd3f-4b13-b2c7-fe841cdf1be2">83,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d3aa13aac246e9b25041fae4b7cc75_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtMy0xLTEtMTg5Njk_21424e38-fec6-4c3f-9aa5-864d3a9d46c3">9,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10259ed0744a4da29b08fbd71f4fa0eb_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtNy0xLTEtMTg5Njk_f95e6723-079b-46dd-a871-c1db5520dbc2">93,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb6a46d6609484692d15c0a359f03f9_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktMS0xLTEtMTg5Njk_9eb62b01-c8d9-42ff-91e0-b447b0299887">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f96d631e0f6493aa473b4f5d6764c83_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktMy0xLTEtMTg5Njk_7cc66173-9e18-4337-8bdb-348e76d1d366">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b5567d70b54cbd823e42bd98407d52_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktNy0xLTEtMTg5Njk_ed215d3c-3678-4922-8c4e-040593ad8ba6">5,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTEtMS0xLTE4OTY5_ce9de91a-75a9-4833-b194-3bd3666ea4ab">859,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTMtMS0xLTE4OTY5_410df905-edbf-4ece-b619-54a4f541fe59">103,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTctMS0xLTE4OTY5_fdb51bc2-67c0-45da-a3d1-608307998db2">963,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3e88e92f0ebd4ecc80fb9ef3eab006bb"><div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjA_c36acbeb-1b3e-4a53-b903-5fceef1aa37a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05beda4dd5af4462b06464252419026d_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItMS0xLTEtMTg5Njk_025adfc3-ce50-4247-b36e-b90c22b70312">910,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21751c4b85644cc9bc4db3085d5e2e0f_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItMy0xLTEtMTg5Njk_c0385f9f-308e-4d8e-a6dd-c8518be67cfc">799,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187399c858c245c4be01180f7d21b89f_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItNS0xLTEtMTg5Njk_f005315e-c2d0-4624-a526-85e2420187a0">812,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128d4737fe924482950bf5e29e3e58d8_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtMS0xLTEtMTg5Njk_03853781-2293-435c-8745-ad2a6e8e7fe9">176,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188dc6462826477a91b4a176c33f06fd_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtMy0xLTEtMTg5Njk_6efa45ef-94d7-48e9-a443-96e4b0822277">144,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5b66ea38624883a01debe481d7aabb_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtNS0xLTEtMTg5Njk_0925f9d6-fbb9-4334-904d-c7032b184d2b">150,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtMS0xLTEtMTg5Njk_587a1c14-e155-4d32-b69c-eb3515653aa8">1,086,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtMy0xLTEtMTg5Njk_34862693-494c-4d0a-8111-85fea573cc3b">943,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtNS0xLTEtMTg5Njk_ef1463d8-f199-478a-81b4-752298813028">963,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjE_e461c993-9a60-4f49-b32d-4758c3654f12" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtMS0xLTEtMTg5Njk_06cb090a-787c-46da-8587-f7784f49b3ed">548,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtMy0xLTEtMTg5Njk_aafd57d1-c38e-4d3a-a151-ea5c385ed8cd">30,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtNy0xLTEtMTg5Njk_84ef5614-59e5-48a9-91fb-2a69cd5f3bbe">578,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bacb62d2b764d98ab587019221feb5e_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtMS0xLTEtMTg5Njk_64c00d1c-934b-4351-bd4d-dc722ce5afb5">2,391,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ba4d3341224392858a56fe1feccb8b_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtMy0xLTEtMTg5Njk_5c3270eb-8351-4da1-9edb-cff6c4c1e361">85,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13817405df1449ac862beb623f788537_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtNy0xLTEtMTg5Njk_3c5dcdf7-c683-4284-a97e-ab4340dd34cd">2,476,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b518b4ab33c4fb7b07453e2656c888b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtMS0xLTEtMTg5Njk_94524791-c2d2-4797-85dc-5efb51e61725">198,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtMy0xLTEtMTg5Njk_f0a41f1d-bc4d-4b3e-84ea-c8c44ef89cf0">21,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtNy0xLTEtMTg5Njk_e7edc9fa-b83a-4adf-96f5-1add5bc144f3">220,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtMS0xLTEtMTg5Njk_0ce80d40-65f7-4d96-88b4-e864efd28630">2,589,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtMy0xLTEtMTg5Njk_eb5ebf28-5fb3-46f8-a507-1583ef73498f">106,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtNy0xLTEtMTg5Njk_c35d82b5-d29c-47f4-8852-54596ee0329b">2,696,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctMS0xLTEtMTg5Njk_19277bc8-f802-480b-94f7-6b32a2db2cb1">3,138,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctMy0xLTEtMTg5Njk_9a11a544-427c-41a6-9f0c-00bc8222ccf3">137,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctNy0xLTEtMTg5Njk_49c1a86d-6f70-46c3-9e7a-9130c9a1f7c5">3,275,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtMS0xLTEtMTg5Njk_28dc3a2b-b6d5-4234-9dfa-0283000f0ce6">546,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtMy0xLTEtMTg5Njk_46179f9f-dc96-4491-a02d-bda05fe92f22">31,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtNy0xLTEtMTg5Njk_8b68ce67-9715-40be-b409-b01cbe4cf52b">578,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtMS0xLTEtMTg5Njk_de86e7a4-e417-4b40-812e-7eb8edd18c64">2,195,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtMy0xLTEtMTg5Njk_916ab835-e4b7-49a9-9bc8-241b6896ced1">86,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtNy0xLTEtMTg5Njk_8efb8b32-3f91-43d1-95f4-26087de5f64c">2,281,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtMS0xLTEtMTg5Njk_1ef0e867-1e20-43d2-9158-5d9aeed386e9">190,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtMy0xLTEtMTg5Njk_5220d4ec-7b2e-4d6f-ba95-d2c2cdc14de0">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtNy0xLTEtMTg5Njk_f93db706-567b-4485-b8b6-3d8a8a98d7a1">193,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtMS0xLTEtMTg5Njk_7415cbcb-5337-4008-8b44-7384090b0255">2,386,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtMy0xLTEtMTg5Njk_0d91fd8a-fb18-465b-a2e2-4acbd7221302">89,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtNy0xLTEtMTg5Njk_730ca53c-a23f-4674-9a8d-4655a49b07d6">2,475,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctMS0xLTEtMTg5Njk_8b6a872c-9a7d-4519-acf9-c2e741b1a206">2,932,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589118616c4549cca227abd6b606ab67_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctMy0xLTEtMTg5Njk_04d81c0a-87e7-4298-9e99-b193e81c60d0">121,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctNy0xLTEtMTg5Njk_ca26397b-9177-4a64-b0c6-49c632e44ddd">3,053,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="pbh:GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjI_0d7ae8db-da55-4cc3-8d6e-1df0033cd2b5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goodwill and intangible assets by geographic area are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie501c1ea8abe4c0fb019b579c2aba132_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzItMS0xLTEtMTg5Njk_f7c6ba56-426a-422f-b8cc-8c8cce1b3736">3,138,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ed6fa3737e451aa617050d4c8ce914_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzItMy0xLTEtMTg5Njk_22929851-7eb9-49be-a686-a123c924ea6e">2,932,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5a12f3ffc1452b894efd73785526ad_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzMtMS0xLTEtMTg5Njk_2b1073aa-c829-4c94-991b-46c52b3430eb">137,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3910479bb242f9adc9ca0b36080c63_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzMtMy0xLTEtMTg5Njk_241d7912-dc99-443c-aa24-85fb5e6aeba7">121,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzQtMS0xLTEtMTg5Njk_d1f2ee8c-d7e6-471f-8a2c-d6217c1c7a25">3,275,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzQtMy0xLTEtMTg5Njk_c3f52aa0-0965-4f24-b5e1-b1aa11142bd1">3,053,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjE_baeb8571-195e-4d9b-94ab-860949f11d27" continuedAt="i6dd709567bb049f6af90b4abfb5bc69b" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6dd709567bb049f6af90b4abfb5bc69b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 3, 2022, the Company's Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ib8310fdbeb364e46af48af59d5abb8d0_I20220503" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzEwOTk1MTE2MzI2MDA_a996c1d6-4ca2-4d02-8387-17759f7f6df1">50.0</ix:nonFraction>&#160;million of the Company's issued and outstanding common stock.  Under the authorization, the Company may purchase common stock through May, 2023 utilizing open market transactions, transactions structured through investment banking institutions, in privately-negotiated transactions, by direct purchases of common stock or a combination of the foregoing in compliance with the applicable rules and regulations of the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Based Compensation</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2022, the Committee granted <ix:nonFraction unitRef="shares" contextRef="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5Xzkx_3e178bc0-3f2d-415a-b9f2-c9b49f3e7fab">67,959</ix:nonFraction> performance units, <ix:nonFraction unitRef="shares" contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzExMw_112dbb5c-65b3-444f-b5eb-0f9ff369c51a">65,721</ix:nonFraction> RSUs and stock options to acquire <ix:nonFraction unitRef="shares" contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE1MA_e0cd17d5-cc03-46a2-894f-f610b4d6bb38">195,526</ix:nonFraction> shares of our common stock to certain executive officers and employees under the 2020 Plan.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the <ix:nonNumeric contextRef="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NTk_c01c85b0-ad73-4bb9-9418-39d6c9f63592">three-year</ix:nonNumeric> anniversary of the date of grant.  RSUs vest either <ix:nonFraction unitRef="number" contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502" decimals="3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzQ1Mw_639d5d80-b5b3-4475-955a-b7de12a6217d">33.3</ix:nonFraction>% per year over <ix:nonNumeric contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjA_bdf56d71-6655-491c-a06e-c9b3c5eb2e41">three years</ix:nonNumeric> or in their entirety on the <ix:nonNumeric contextRef="ia9c7b100290a4efeb19c0cc9bfb64604_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjM_5ea90463-acdc-4fd6-9828-f691fd61e962">three-year</ix:nonNumeric> or <ix:nonNumeric contextRef="ib1dbf1db8a004389a087448443b06363_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjY_06dc9f46-7571-4949-813d-553a7edcfe1f">five-year</ix:nonNumeric> anniversary of the date of grant.  Upon vesting, both performance units and RSUs will be settled in shares of our common stock.  The stock options will vest <ix:nonFraction unitRef="number" contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502" decimals="3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzY4Mw_56dec2ed-2bde-44cf-aaa6-f6632311e2f9">33.3</ix:nonFraction>% per year over <ix:nonNumeric contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NTU_48de1973-9ea5-402c-ba05-a8875866ac17">three years</ix:nonNumeric> and are exercisable for up to <ix:nonNumeric contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzExNTQ0ODcyMDkzODcw_c929d28e-78d9-4cc5-bc51-d76352cd076b">ten years</ix:nonNumeric> from the date of grant.  These stock options were granted at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzgzMA_c688c301-e90b-4dda-93cf-6b248dfe9a31">54.47</ix:nonFraction> per share, which is equal to the closing price for our common stock on the date of the grant.  Except in cases of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested performance units, RSUs and the stock options.  Vested stock options will remain exercisable by the employee after termination, subject to the terms of the 2020 Plan.</span></div></ix:continuation><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90ZXh0cmVnaW9uOjAyN2I0YzBjMmQ3ZjRhZjBiMzA2NzI4YTA4NWRmZWU0XzM3Mg_76efa9a2-7412-40e5-b1e5-3e88befd0a6a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:33.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts<br/>Charged to<br/>Expense (Income)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434c5f76f05c469e89d0f4d63b175529_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItMS0xLTEtMTg5Njk_e7d61f73-baf7-415c-b06d-00bd9544250d">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItMy0xLTEtMTg5Njk_f4af386a-7c38-4198-abf9-4cde06ee849c">53,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItNS0xLTEtMTg5Njk_92177385-e6b0-4d92-950c-a5b888677f3f">51,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItNy0xLTEtMTg5Njk_82388616-02d2-4d63-a354-020585279860">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f8fcceb1e254220aeb7da81ab31cb58_I20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItOS0xLTEtMTg5Njk_dd186813-150c-4a8b-8c5d-49d2191ebc05">14,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b2f889b82d49398a7b0afa2193e87c_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtMS0xLTEtMTg5Njk_4807d723-712a-4251-b962-51b2d204d92e">18,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtMy0xLTEtMTg5Njk_10217cea-9c59-403e-b2de-7d7a2bc1c56f">89,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtNS0xLTEtMTg5Njk_adeacf5e-fb70-4d5c-b2c6-a2c60517835f">84,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtNy0xLTEtMTg5Njk_7a1aae5b-7a04-45a0-96d7-8918c9794f9e">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0651eae9b2249d1a150fa2d3bda71fa_I20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtOS0xLTEtMTg5Njk_90294571-d766-4882-b10e-af99b3a921e8">24,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtMS0xLTEtMTg5Njk_21899621-3aa3-4ed7-b73b-8dc984952b63">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtMy0xLTEtMTg5Njk_a730ea8e-905f-4907-8a3d-e0730adefad1">4,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtNS0xLTEtMTg5Njk_39741c48-a1b8-427e-a975-4fd3f2ee7c41">4,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtNy0xLTEtMTg5Njk_139f91ab-1d3a-4e90-a003-6bffbbd95cc1">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269d76c784f548c19f48f6c4f35139ec_I20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtOS0xLTEtMTg5Njk_61746ae9-e6ea-4eb6-a407-303c7df3a379">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9e5a57a02a949ac99c1b929db087c5c_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtMS0xLTEtMTg5Njk_1f683b1b-76f1-4840-8f37-6e05460c9730">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtMy0xLTEtMTg5Njk_2d878964-0c50-45e5-a4f7-a3ad36b48c49">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtNS0xLTEtMTg5Njk_26e041d1-d335-45e5-b390-8dc43edea2df">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtNy0xLTEtMTg5Njk_cf91061d-dc00-4066-a0d4-4613975bd065">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6361373daa34522988116123cf37d3d_I20220331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtOS0xLTEtMTg5Njk_51819fdf-7757-4398-ab53-1e71b1241941">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktMS0xLTEtMTg5Njk_b44763b3-7974-4959-80a8-d7f01aa3f933">15,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktMy0xLTEtMTg5Njk_d25a9dea-bde8-480e-8648-72ac5b029840">46,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktNS0xLTEtMTg5Njk_d3cd969c-b378-4a1d-a876-ab32357abef0">49,841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktNy0xLTEtMTg5Njk_e9823fe2-2981-414d-99f8-2e29b8cac3a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i434c5f76f05c469e89d0f4d63b175529_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktOS0xLTEtMTg5Njk_5d8d02ef-7579-4c2b-a5e6-7f6ebf08b017">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea56f97f93bb4d4a986d72945ac41527_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTEtMS0xLTE4OTY5_287b8b5a-d062-435b-9cf5-19714b5cbc2c">18,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTMtMS0xLTE4OTY5_091ea460-6f9f-4213-9e27-ec5e413d27fa">83,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTUtMS0xLTE4OTY5_3e2eaad4-a3cc-4b72-93c4-534faa306418">83,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTctMS0xLTE4OTY5_ae17eca7-7b2c-45a3-84df-602b33d19501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b2f889b82d49398a7b0afa2193e87c_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTktMS0xLTE4OTY5_095f0427-db85-49f1-aaf7-5403dd074098">18,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b960c0b2a34f049a1eb507349cdc62_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTEtMS0xLTE4OTY5_35f23902-0aa8-4987-ae62-5108016ff2d7">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTMtMS0xLTE4OTY5_acdf2cca-269f-46e5-9817-d65e95322772">3,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTUtMS0xLTE4OTY5_9b2637f5-55ae-43c5-9558-92243dfc4462">3,873</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTctMS0xLTE4OTY5_034efb12-71fc-4a57-8abc-06501ea7f15e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTktMS0xLTE4OTY5_29732501-96ea-4853-88aa-40919ccbd6a7">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTEtMS0xLTE4OTY5_1d3430ad-9440-42b0-90ab-c80d4787526c">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTMtMS0xLTE4OTY5_a7536562-4ee3-4070-80db-b86b46a32d9f">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTUtMS0xLTE4OTY5_aa1b2568-7465-4218-9943-0e272a69e29a">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTctMS0xLTE4OTY5_9a83264f-4afe-45ae-9e75-a4a9023adfc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9e5a57a02a949ac99c1b929db087c5c_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTktMS0xLTE4OTY5_c03e505e-38d8-44a9-880e-21b831455656">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0659c3b10104b4d93e871d273dc3a9e_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTEtMS0xLTE4OTY5_e2a5b275-3eb2-4a06-bf98-a17cd563e8f5">5,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTMtMS0xLTE4OTY5_dbceda1a-220e-4ae7-83fd-dae99ee7c840">5,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTUtMS0xLTE4OTY5_941e76e9-9dd8-4fef-b3bc-876a7292d5cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTctMS0xLTE4OTY5_8af4ad81-7a2f-4d35-8a29-eb2e0f2f0a4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3363e6b458345d4aefbc25a191f087a_I20210331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTktMS0xLTE4OTY5_55825c6f-8f89-49af-b8b1-79ac813f6ed6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920d5d39c27c43a7ada8c478509c80e2_I20190331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTEtMS0xLTE4OTY5_d9e273c8-fa04-4e69-a19f-b58975131cac">8,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTMtMS0xLTE4OTY5_bfb5b5ec-4bfa-4061-8e83-d8f5727add91">57,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTUtMS0xLTE4OTY5_9b2b4963-4f49-43df-b33c-99bcec422aca">50,669</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTctMS0xLTE4OTY5_071e1843-926f-459d-88c5-0d4aba6d89e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTktMS0xLTE4OTY5_0a16fbfd-3435-4e76-b2e2-5d7ce46748af">15,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21a87850c1e3427aab790ab25ea38814_I20190331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTEtMS0xLTE4OTY5_f9f3cbfc-72ce-4331-b497-a503eaeb8abe">15,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTMtMS0xLTE4OTY5_06b8dc3a-120c-479c-b1a0-b56950eea169">88,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTUtMS0xLTE4OTY5_375007b3-b524-4f07-a7aa-dda68c9a2b64">85,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTctMS0xLTE4OTY5_acfd9cdd-9e06-4b4b-9a32-664b9a9f04b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea56f97f93bb4d4a986d72945ac41527_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTktMS0xLTE4OTY5_0298deb8-3e44-42f7-b215-4ac2cde2a9be">18,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf417621972e4bfb95d92b68b8db4ee0_I20190331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTEtMS0xLTE4OTY5_6fd58d17-4d1c-474a-b3fe-24ead76218c1">1,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTMtMS0xLTE4OTY5_ba0b83cd-83f8-44f5-b737-07aeacd932e4">4,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTUtMS0xLTE4OTY5_0d237792-10cb-41b9-888f-4b7b09b3b845">3,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTctMS0xLTE4OTY5_b991adff-d30c-4e04-af91-b9bbe5798286">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b960c0b2a34f049a1eb507349cdc62_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTktMS0xLTE4OTY5_be79cbb5-2080-40c4-85f4-a98d704cadea">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf45542f39ba4a4999f6783fd74f411f_I20190331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTEtMS0xLTE4OTY5_9776831c-0d52-4412-8de9-313abf5b619d">1,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTMtMS0xLTE4OTY5_d847d83c-c075-4635-80e9-bf85943410e9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTUtMS0xLTE4OTY5_749d132b-55d8-4c9b-beec-ced5877417f3">624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTctMS0xLTE4OTY5_b500a74d-3f0f-4bc3-98cf-d988afc88d9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTktMS0xLTE4OTY5_24e66981-a1c6-4168-9814-56f84f31ff12">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840967a79d094690b99943768e44e986_I20190331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTEtMS0xLTE4OTY5_009049b9-c241-4f0d-9449-0468a3be16b9">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTMtMS0xLTE4OTY5_a0898fda-dee1-45a4-a866-ba331822161d">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTUtMS0xLTE4OTY5_ee7770e6-8988-4268-822b-17d237a676a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331" decimals="-3" name="pbh:SECSchedule1209ValuationAllowancesandReservesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTctMS0xLTE4OTY5_19e2852e-2274-4c49-aa9b-ac6c21ba9ec6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0659c3b10104b4d93e871d273dc3a9e_I20200331" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTktMS0xLTE4OTY5_c5a1f061-c720-40e2-8c93-c8399c5b524f">5,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  Relates to opening balance sheet adjustments for our Akorn acquisition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)  Relates to the release of the valuation allowance on foreign tax credits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)  Relates to the unutilized foreign tax credit carryovers.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_154"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A.  CONTROLS AND PROCEDURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures, as defined in Rule 13a&#8211;15(e) of the Exchange Act, as of March&#160;31, 2022.&#160;&#160;Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of March&#160;31, 2022, the Company&#8217;s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to the Company&#8217;s management, including the Company&#8217;s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The report of management on our internal control over financial reporting as of March&#160;31, 2022 and the attestation report of our independent registered public accounting firm on our internal control over financial reporting are set forth in Part&#160;II, Item&#160;8. &#8220;Financial Statements and Supplementary Data" beginning on page 47 of this Annual Report on Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting that occurred during the quarter ended March&#160;31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.  OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part III</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required to be disclosed by this Item will be contained in the Company&#8217;s 2022 Proxy Statement under the headings &#8220;Election of Directors,&#8221; &#8220;Executive Compensation and Other Matters,&#8221; &#8220;Delinquent Section 16(a) Reports&#8221; and &#8220;Governance of the Company&#8221;, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_166"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.  EXECUTIVE COMPENSATION</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required to be disclosed by this Item, including Items 402-(b) and 407-(e)(4) and (e)(5) of Regulation S-K, will be contained in the Company&#8217;s 2022 Proxy Statement under the headings &#8220;Executive Compensation and Other Matters&#8221;, &#8220;Governance of the Company&#8221;, "Compensation Discussion and Analysis", "Compensation Committee Report", and "Compensation Committee Interlocks and Insider Participation", which information is incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required to be disclosed by this Item will be contained in the Company&#8217;s 2022 Proxy Statement under the headings &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Securities Authorized for Issuance Under Equity Compensation Plans&#8221;, which information is incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required to be disclosed by this Item will be contained in the Company&#8217;s 2022 Proxy Statement under the headings &#8220;Certain Relationships and Related Transactions&#8221;, &#8220;Election of Directors&#8221; and &#8220;Governance of the Company&#8221;, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.  PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required to be disclosed by this Item will be contained in the Company&#8217;s 2022 Proxy Statement under the heading &#8220;Ratification of Appointment of the Independent Registered Public Accounting Firm&#8221;, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part IV</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_181"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.68pt">Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements and financial statement schedules listed below are set forth under Part II, Item 8 (pages 47 through 86) of this Annual Report on Form 10-K, which are incorporated herein to this Item as if copied verbatim.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prestige Consumer Healthcare Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm,</span></div><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PricewaterhouseCoopers LLP, Auditor Firm ID <ix:nonNumeric contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xODEvZnJhZzo1YjExNGU2NzQ1ZTg0ZWMyOWJkYjk1NDEzZmVhODUxZS90YWJsZTo2ZmJjMjMwMGQ2OTQ0ZWM0YWVjMDhkNjk0ODk4MjE2OC90YWJsZXJhbmdlOjZmYmMyMzAwZDY5NDRlYzRhZWMwOGQ2OTQ4OTgyMTY4XzEtMC0xLTEtMjgyMDQvdGV4dHJlZ2lvbjpkOGU0NGM2OWZiZDQ0YzMyOGNmMjBkZjk2ZTk5ZjE1Zl8xMDk5NTExNjI3ODk2_0febaa54-a42c-402d-b2b6-cfc2cfeabc8f">238</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Income and Comprehensive Income for each of the three years in<br/>the period ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets at March 31, 2022 and 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Stockholders&#8217; Equity for each of the three years in the period ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for each of the three years in the period ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule II&#8212;Valuation and Qualifying Accounts for the years ended March 31, 2022, 2021 and 2020</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.68pt">Financial Statement Schedules</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedule II - Valuation and Qualifying Accounts listed in (a)(1) above is incorporated herein by reference as if copied verbatim.&#160;&#160;Schedules other than those listed in the preceding sentence have been omitted as they are either not required, not applicable, or the information has otherwise been shown in the Consolidated Financial Statements or notes thereto.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Exhibit Index</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:6.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Purchase Agreement, dated April 25, 2014, by and among Medtech Products Inc., Insight Pharmaceuticals Corporation, SPC Partners IV, L.P. and the other seller parties thereto </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000015/exhibit25prestige_insight-.htm">(filed as Exhibit 2.5 to the Company's Annual Report on Form 10-K filed with the SEC on May 19, 2014).+</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of December 21, 2016, by and among Medtech Products Inc., AETAGE LLC, C.B. Fleet TopCo, LLC and Gryphon Partners 3.5, L.P. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594717000007/exhibit21projecteden-merge.htm">filed as Exhibit 2.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on February 2, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Purchase Agreement, dated May 27, 2021, by and between Medtech Products Inc. and Akorn Operating Company </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000129594721000029/exhibit21apa.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000129594721000029/exhibit21apa.htm">filed as Exhibit 2.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 5, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+ &#8224;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare&#160;Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000104746905002633/a2149526zex-3_1.txt">filed as Exhibit 3.1 to the Company's Form S-1/A filed with the SEC on February 8, 2005</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Amended and Restated Certificate of Incorporation of Prestige Consumer Healthcare Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594718000018/exhibit31certofamendment.htm">filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws of Prestige Consumer Healthcare&#160;Inc. as amended, effective October 29, 2018&#160;(</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594719000007/exhibit32redlinepbhbylaw.htm">filed as Exhibit 3.2 to the Company's Quarterly Report on form 10-Q filed with the SEC on February 7, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Designations of Series A Preferred Stock of Prestige Consumer Healthcare Inc. as filed with the Secretary of State of the State of Delaware on February 27, 2012 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000013/exhibit318-k20120227.htm">filed as Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on February 28, 2012</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form&#160;of stock certificate for common stock (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000104746905001535/a2149526zex-4_1.txt">filed as Exhibit 4.1 to the Company's Form S-1/A filed with the SEC on January 26, 2005</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of December 17, 2013, among Prestige Brands, Inc., as issuer, the Company and certain subsidiaries, as guarantors, and U.S. Bank National Association, as Trustee with respect to 5.375% Senior Notes due 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000006/exhibit41prestige-indentur.htm">filed as Exhibit 4.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on February 7, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Supplemental Indenture, dated December 17, 2013 by and among Prestige Brands, Inc., the guarantors party thereto from time to time and U.S. Bank National Association, as trustee (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420413067649/v363228_ex4-1.htm">filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 17, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:6.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Supplemental Indenture, dated as of March 21, 2018, by and among Prestige Brands, Inc., as issuer, the Company and certain subsidiaries, as guarantors, and U.S. Bank National Association, as Trustee with respect to 6.375% Senior Notes due 2024 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420418016170/tv489062_ex4-1.htm">filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the SEC on March 21, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 6.375% Senior Notes due 2024 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594716000043/exhibit41indenture1.htm">filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the SEC on February 19, 2016</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indenture, dated December 2, 2019, among Prestige Brands, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465919068959/tm1922536d2_ex4-1.htm">filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 2, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 5.125% Senior Notes due 2028 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465919068959/tm1922536d2_ex4-1.htm">filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 2, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Prestige Consumer Healthcare Inc. Securities (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000129594719000015/exhibit49_securities.htm">filed as Exhibit 4.9 to the Company's Annual Report on Form 10-K filed with the SEC on May 13, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated March 1, 2021, among Prestige Brands, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465921029994/tm215762d2_ex4-1.htm">filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 1, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 3.750% Senior Notes due 2031 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465921029994/tm215762d2_ex4-1.htm">filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 1, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$660,000,000 Term Loan Credit Agreement, dated as of January 31, 2012, among Prestige Brands Inc., the Company, and certain subsidiaries of the Company as guarantors, Citibank, N.A., Citigroup Global Markets Inc., Morgan Stanley Senior Funding, Inc. and RBC Capital Markets (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000029/exhibit103_600000000termlo.htm">filed as Exhibit 10.3 to the Company's Annual Report on Form 10-K filed with the SEC on May 18, 2012</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1, dated as of February 21, 2013, to the Term Loan Credit Agreement, dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000008/exhibit101amendno1tocredit.htm">filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on February 25, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2, dated as of September 3, 2014, to the Term Loan Credit Agreement, dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594715000006/exhibit101amendmentno2da.htm">filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on February 5, 2015</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 3, dated as of May 8, 2015, to the Term Loan Credit Agreement, dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594715000015/exhibit106amendmentno3_201.htm">filed as Exhibit 10.6 to the Company's Annual Report on Form 10-K filed with the SEC on May 14, 2015</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 4, dated as of January 26, 2017, to the Term Loan Credit Agreement, dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other guarantors from time to time party thereto, the lenders from time to time party thereto and Barclays Bank PLC (as successor in interest to Citibank, N.A.), as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420417004882/v457859_ex10-1.htm">filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 31, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 5, dated as of March 21, 2018, to the Term Loan Credit Agreement, dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other guarantors from time to time party thereto, the lenders from time to time party thereto and Barclays Bank PLC (as successor in interest to Citibank, N.A.), as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420418016170/tv489062_ex10-1.htm">filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 21, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+ </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 6 to the Term Loan Credit Agreement, dated as of July 1, 2021, among Prestige Consumer Healthcare Inc., Prestige Brands, Inc., the other guarantors from time to time party thereto, each lender from time to time party thereto and Barclays Bank PLC (as successor in interest to Citibank, N.A.), as administrative agent (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465921088218/tm2121213d1_ex10-1.htm">filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on July 1, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Security Agreement, dated as of January 31, 2012, among Prestige Brands Inc., the Company and certain subsidiaries of the Company as guarantors, Citibank N.A. and U.S. Bank National Association, as Trustee (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000029/exhibit104termloansecurity.htm">filed as Exhibit 10.4 to the Company's Annual Report on Form 10-K filed with the SEC on May 18, 2012</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50,000,000 ABL Credit Agreement, dated as of January 31, 2012, Among Prestige Brands, Inc., the Company, certain subsidiaries of the Company as guarantors, Citibank, N.A., Citigroup Global Markets Inc., Morgan Stanley Senior Funding, Inc. and RBC Capital Markets filed (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000029/exhibit105_50000000ablcred.htm">filed as Exhibit 10.5 to the Company's Annual Report on Form 10-K filed with the SEC on May 18, 2012.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Amendment, dated as of September 12, 2012, to the ABL Credit Agreement dated as of January 31, 2012 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000045/exhibit102prestige-ablincr.htm">filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed with the SEC on November 7, 2012</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:6.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment, dated as of June 11, 2013, to the ABL Credit Agreement dated as of January 31, 2012 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000026/exhibit102ablamendment.htm">filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 1, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 3, dated as of September 3, 2014, to the ABL Credit Agreement (as amended by that certain Incremental Amendment, dated as of September 12, 2012, and that certain Incremental Amendment, dated as of June 11, 2013), dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent, L/C issuer and swing line lender (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420414054053/v388289_ex10-2.htm">filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 3, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 4, dated as of June 9, 2015, to the ABL Credit Agreement (as amended by that certain Incremental Amendment, dated as of September 12, 2012, and that certain Incremental Amendment, dated as of June 11, 2013, and that certain Incremental Amendment dated as of September 3, 2014), dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent, L/C issuer and swing line lender (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594715000021/exhibit101ablamendmentno4.htm">filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 6, 2015</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 5, dated as of February 4, 2016, to the ABL Credit Agreement, originally dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other Guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A. as administrative agent, L/C issuer and swing line lender (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594716000037/exhibit102-ablamendment5.htm">filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on February 9, 2016</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 6, dated as of January 26, 2017, to the ABL Credit Agreement, originally dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A., as administrative agent, L/C issue and swing line lender (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000114420417004882/v457859_ex10-2.htm">filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 31, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). + </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 7, dated as of December 11, 2019, to the ABL Credit Agreement, originally dated as of January 31, 2012, among the Company, Prestige Brands, Inc., the other guarantors from time to time party thereto, the lenders from time to time party thereto and Citibank, N.A., as administrative agent, L/C issue and swing line lender (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465919072219/tm1925086d1_ex10-1.htm">filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 12, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement of Lease between RA 660 White Plains Road LLC and Prestige Brands, Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594712000037/exhibit102agreementoflease.htm">filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 9, 2012</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Agreement of Lease between RA 660 White Plains Road LLC and Prestige Brands, Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000021/exhibit1011stamendmenttole.htm">filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter Agreement, dated August 26, 2014, to Amendment to Agreement of Lease between RA 660 White Plains Road LLC and Prestige Brands, Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000028/exhibit102letteragreement.htm">filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on November 6, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+ </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Lease between GHP 660 LLC and Prestige Brands, Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594717000032/exhibit101pbhleasesecondam.htm">filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on November 2, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Master Logistics Services Agreement, dated May 13, 2019, by and between the Company and GEODIS Logistics LLC (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000129594719000023/exhibit101geodisredacted.htm">filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 1, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">). +</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8224;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prestige Brands Holdings,&#160;Inc. 2005 Long-Term Equity Incentive Plan (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000104746905001535/a2149526zex-10_38.txt">filed as Exhibit 10.38 to the Company&#8217;s Form S-1/A filed with the SEC on January 26, 2005</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+#&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Grant Agreement (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295522/000110465905037986/a05-14420_1ex10d1.htm">filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the SEC on August 9, 2005</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Nonqualified Stock Option Agreement (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000015/exhibit10202013stockoption.htm">filed as Exhibit 10.20 to the Company's Annual Report on Form 10-K filed with the SEC on May 19, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Award Agreement for Restricted Stock Units (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594714000015/exhibit10212013restricteds.htm">filed as Exhibit 10.21 to the Company's Annual Report on Form 10-K filed with the SEC on May 19, 2014</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Nonqualified Stock Option Agreement for grants beginning Fiscal 2018 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594717000018/exhibit1030opt0517.htm">filed as Exhibit 10.30 to the Company's Annual Report on Form 10-K filed with the SEC on May 17, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).&#160;+# </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Award Agreement for Restricted Stock Units for grants beginning Fiscal 2018  (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594717000018/exhibit1031pbh2017rsu.htm">filed as Exhibit 10.31 to the Company's Annual Report on Form 10-K filed with the SEC on May 17, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Award Agreement for Performance Units for grants beginning Fiscal 2018 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594717000018/exhibit1032psumgm0517.htm">filed as Exhibit 10.32 to the Company's Annual Report on Form 10-K filed with the SEC on May 17, 2017</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Director Indemnification Agreement (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000018/exhibit1021prestigebrandsd.htm">filed as Exhibit 10.21 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on May 17, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +@</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Officer Indemnification Agreement (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000018/exhibit1022prestigebrandso.htm">filed as Exhibit 10.22 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on May 17, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +@</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:6.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply Agreement, dated as of July 1, 2012, among Medtech Products Inc. and Pharmacare Limited T/A Aspen Pharmacare (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000018/exhibit1026pharmacarelimite.htm">filed as Exhibit 10.26 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on May 17, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply Agreement, dated as of November 16, 2012, among Medtech Products Inc. and BestSweet Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594713000018/exhibit1027bestsweetsupply.htm">filed as Exhibit 10.27 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on May 17, 2013</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Executive Severance Plan, adopted as of October 29, 2018 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594718000028/exhibit101amendedesp1.htm">filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q on November 1, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +#</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset Purchase Agreement, dated July 2, 2018, by and among KIK International LLC, Prestige Brands International, Inc., The Spic and Span Company, Medtech Holdings, Inc. (as guarantor only) and Prestige Brands Holdings, Inc. (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1295947/000129594718000020/exhibit101-assetpurchaseag.htm">filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 2, 2018</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).+</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">AIA Document A141&#8482;-2014, Standard Form of Agreement, dated July 1, 2018, by and between C.B. Fleet Company, Incorporated, including its affiliates, subsidiaries, officers, directors, employees and agents and CRB Builders, LLC, including its affiliates, subsidiaries, officers, directors, employees and agents, as amended by Exhibit A Design-Build Amendment, dated March 16, 2020 </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">(<a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001295947/000129594720000018/exhibit1034to202010k.htm">filed as Exhibit 10.34 to the Company&#8217;s 10-K filed with the SEC on May 8, 2020)</a>.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">*&#8224;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prestige Brands Holdings, Inc. 2020 Long-Term Incentive Plan (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1295947/000110465920077655/tm2023357-1_def14a.htm">filed as Appendix A to the Company&#8217;s Proxy Statement on Schedule 14A filed on June 29, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). +# </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211directindirectsu.htm">Subsidiaries of the Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211directindirectsu.htm">.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pbhconsentfy22.htm">Consent of PricewaterhouseCoopers&#160;LLP</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.*&#160;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311certification_lo.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*&#160;</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312certification_sa.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*&#160;</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321certificationofe.htm">Certification of Principal Executive Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*&#160;</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322certificationofc.htm">Certification of Principal Financial Officer of Prestige Consumer Healthcare Inc. pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*&#160;</a></span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain confidential portions have been omitted.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated herein by reference.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">@</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a management contract.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a compensatory plan.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16.  FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i93b55e0f793c4f3ba5f606ea7711c37f_187"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prestige Consumer Healthcare Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Christine Sacco</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-indent:288pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ RONALD M. LOMBARDI</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, President<br/>and Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald M. Lombardi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ CHRISTINE SACCO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ JOHN E. BYOM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John E. Byom</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ CELESTE A. CLARK</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celeste A. Clark</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ CHRISTOPHER J. COUGHLIN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher J. Coughlin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ SHEILA  A. HOPKINS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sheila A. Hopkins</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ NATALE S. RICCIARDI</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natale S. Ricciardi</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">/s/ DAWN M. ZIER</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dawn M. Zier</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>exhibit211directindirectsu.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4e6039e77aae48b5aa563b8f088a4221_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SUBSIDIARIES LIST</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Direct and Indirect Subsidiaries</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">of Prestige Consumer Healthcare Inc.</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Name</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Jurisdiction of Incorporated&#47;Organization</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Blacksmith Brands, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.B. Fleet Company, Incorporated</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.B. Fleet Investment Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.B. Fleet International LLC (formerly C.B. Fleet, International, Inc.)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.B. Fleet International(s) Pte. Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Care Acquisition Company Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Care Pharmaceuticals Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cellegy Australia Pty</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Clear Eyes Pharma Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DenTek Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DenTek Oral Care, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tennessee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DenTek Oral Care Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Insight Pharmaceuticals Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Insight Pharmaceuticals LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medtech Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medtech Online Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medtech Personal Products Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Medtech Products Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PBH Australia Holdings Company Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Peaks HBC Company, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Practical Health Products, Inc</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Brands Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Brands, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Brands Gmbh</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Brands International, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Brands (UK) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">England and Wales</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prestige Services Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Spic and Span Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Wartner USA B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Netherlands</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>pbhconsentfy22.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6bd9de2a2d08433faf5051332ffb9ead_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:right"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 23.1</font></div><div style="margin-bottom:24pt;margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8</font><font style="background-color:#ffffff;color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%"> (No. 333-240329, 33</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">3-123487 and 333-198443) of Prestige Consumer Healthcare Inc. of our report dated May 6, 2022 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PricewaterhouseCoopers LLP<br>Stamford, Connecticut</font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:700;line-height:100%"><br></font><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit311certification_lo.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ife268e84988b4ab38ecb2b326dd272b2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify that&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Prestige Consumer Healthcare Inc.&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47; Ronald M. Lombardi</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald M. Lombardi</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit312certification_sa.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9e4d490681fa48ff81de505d5ba96c3a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify that&#58;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:2.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of Prestige Consumer Healthcare Inc.&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.821%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:5.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#47;s&#47; Christine Sacco</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit321certificationofe.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7bb9c83dfe644e7d835c3887d6f1c8b5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ronald M. Lombardi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Prestige Consumer Healthcare Inc. on Form 10-K for the year ended March&#160;31, 2022, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Annual Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.532%"><tr><td style="width:1.0%"></td><td style="width:46.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.255%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Ronald M. Lombardi</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ronald M. Lombardi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:355.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit322certificationofc.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia884b0ba0dbf4020bc2b00aa287f48f4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Sacco, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Prestige Consumer Healthcare Inc. on Form 10-K for the year ended March&#160;31, 2022, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that information contained in such Annual Report fairly presents, in all material respects, the financial condition and results of operations of Prestige Consumer Healthcare Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.356%"><tr><td style="width:1.0%"></td><td style="width:44.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Christine Sacco</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Sacco</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>pbh-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pbh="http://www.prestigebrandsinc.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.prestigebrandsinc.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pbh-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.prestigebrandsinc.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.prestigebrandsinc.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncomeandComprehensiveIncome" roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome">
        <link:definition>100010003 - Statement - Consolidated Statements of Income and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets">
        <link:definition>100020004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinStockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity">
        <link:definition>100040006 - Statement - Consolidated Statements of Changes in Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100050007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentation" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation">
        <link:definition>210011001 - Disclosure - Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationPolicies" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies">
        <link:definition>220022001 - Disclosure - Business and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationTables" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables">
        <link:definition>230033001 - Disclosure - Business and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationCashandCashEquivalentsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails">
        <link:definition>240044001 - Disclosure - Business and Basis of Presentation (Cash and Cash Equivalents) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationPropertyPlantandEquipmentDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails">
        <link:definition>240054002 - Disclosure - Business and Basis of Presentation (Property, Plant and Equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationIntangibleAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails">
        <link:definition>240064003 - Disclosure - Business and Basis of Presentation (Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationRevenueRecognitionDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails">
        <link:definition>240074004 - Disclosure - Business and Basis of Presentation (Revenue Recognition) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationCostofSalesDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails">
        <link:definition>240084005 - Disclosure - Business and Basis of Presentation (Cost of Sales) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationPensionExpenseDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails">
        <link:definition>240094006 - Disclosure - Business and Basis of Presentation (Pension Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationEarningsPerShareDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails">
        <link:definition>240104007 - Disclosure - Business and Basis of Presentation (Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessandBasisofPresentationLeasesDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails">
        <link:definition>240114008 - Disclosure - Business and Basis of Presentation (Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisition" roleURI="http://www.prestigebrandsinc.com/role/Acquisition">
        <link:definition>210121002 - Disclosure - Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionTables" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionTables">
        <link:definition>230133002 - Disclosure - Acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails">
        <link:definition>240144009 - Disclosure - Acquisition (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>240154010 - Disclosure - Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.prestigebrandsinc.com/role/Inventories">
        <link:definition>210161003 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables">
        <link:definition>230173003 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails">
        <link:definition>240184011 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment">
        <link:definition>210191004 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables">
        <link:definition>230203004 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentDetails" roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails">
        <link:definition>240214012 - Disclosure - Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.prestigebrandsinc.com/role/Goodwill">
        <link:definition>210221005 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables">
        <link:definition>230233005 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofChangesDetails" roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails">
        <link:definition>240244013 - Disclosure - Goodwill (Schedule of Changes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails">
        <link:definition>240254014 - Disclosure - Goodwill (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssets">
        <link:definition>210261006 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsTables">
        <link:definition>230273006 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsReconciliationofActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails">
        <link:definition>240284015 - Disclosure - Intangible Assets (Reconciliation of Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>240294016 - Disclosure - Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsExpectedAmortizationExpenseDetails" roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails">
        <link:definition>240304017 - Disclosure - Intangible Assets (Expected Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.prestigebrandsinc.com/role/Leases">
        <link:definition>210311007 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.prestigebrandsinc.com/role/LeasesTables">
        <link:definition>230323007 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails">
        <link:definition>240334018 - Disclosure - Leases (Lease Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails">
        <link:definition>240344019 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_1" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1">
        <link:definition>240344019 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturitiesDetails_2" roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2">
        <link:definition>240344019 - Disclosure - Leases (Lease Maturities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails">
        <link:definition>240354020 - Disclosure - Leases (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails">
        <link:definition>240364021 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilities" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities">
        <link:definition>210371008 - Disclosure - Other Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesTables" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables">
        <link:definition>230383008 - Disclosure - Other Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAccruedLiabilitiesDetails" roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails">
        <link:definition>240394022 - Disclosure - Other Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt">
        <link:definition>210401009 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables">
        <link:definition>230413009 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails">
        <link:definition>240424023 - Disclosure - Long-Term Debt (Schedule of Long-term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails">
        <link:definition>240434024 - Disclosure - Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrative2013SeniorNotesDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails">
        <link:definition>240444025 - Disclosure - Long-Term Debt (Narrative 2013 Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrative2016SeniorNotesDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails">
        <link:definition>240454026 - Disclosure - Long-Term Debt (Narrative 2016 Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrative2019and2021SeniorNotesDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails">
        <link:definition>240464027 - Disclosure - Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeRedemptionsandRestrictionsDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails">
        <link:definition>240474028 - Disclosure - Long-Term Debt (Narrative Redemptions and Restrictions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeInterestRateSwapsDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails">
        <link:definition>240484029 - Disclosure - Long-Term Debt (Narrative Interest Rate Swaps) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtMaturitiesofLongtermDebtDetails" roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails">
        <link:definition>240494030 - Disclosure - Long-Term Debt (Maturities of Long-term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements">
        <link:definition>210501010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables">
        <link:definition>230513010 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails">
        <link:definition>240524031 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments">
        <link:definition>210531011 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingActivitiesTables" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables">
        <link:definition>230543011 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>240554032 - Disclosure - Derivative Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsFairValueDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails">
        <link:definition>240564033 - Disclosure - Derivative Instruments (Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails" roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails">
        <link:definition>240574034 - Disclosure - Derivative Instruments (Schedule of Derivative Gains and Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity">
        <link:definition>210581012 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables">
        <link:definition>230593012 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails">
        <link:definition>240604035 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofSharesRepurchasedDetails" roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails">
        <link:definition>240614036 - Disclosure - Stockholders' Equity (Schedule of Shares Repurchased) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation">
        <link:definition>210621013 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables">
        <link:definition>230633013 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>240644037 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockBasedCompensationInformationDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails">
        <link:definition>240654038 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedSharesActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails">
        <link:definition>240664039 - Disclosure - Share-Based Compensation (Restricted Shares Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionValuationAssumptionsDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails">
        <link:definition>240674040 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>240684041 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>210691014 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>230703014 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossDetails" roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails">
        <link:definition>240714042 - Disclosure - Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes">
        <link:definition>210721015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesTables">
        <link:definition>230733015 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeContinuingOperationsDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails">
        <link:definition>240744043 - Disclosure - Income Taxes (Income Before Continuing Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
        <link:definition>240754044 - Disclosure - Income Taxes (Components of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofDeferredTaxBalancesDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails">
        <link:definition>240764045 - Disclosure - Income Taxes (Components of Deferred Tax Balances) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240774046 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveTaxRateDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails">
        <link:definition>240784047 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUncertainTaxLiabilityActivityDetails" roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails">
        <link:definition>240794048 - Disclosure - Income Taxes (Uncertain Tax Liability Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlans" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans">
        <link:definition>210801016 - Disclosure - Employee Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansTables" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables">
        <link:definition>230813016 - Disclosure - Employee Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansNarrativeDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails">
        <link:definition>240824049 - Disclosure - Employee Retirement Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansPeriodicServiceCostsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails">
        <link:definition>240834050 - Disclosure - Employee Retirement Plans (Periodic Service Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails">
        <link:definition>240844051 - Disclosure - Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails">
        <link:definition>240854052 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails">
        <link:definition>240864053 - Disclosure - Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansExpectedBenefitPaymentsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails">
        <link:definition>240874054 - Disclosure - Employee Retirement Plans (Expected Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansCategoryofPlanAssetsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails">
        <link:definition>240884055 - Disclosure - Employee Retirement Plans (Category of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240894056 - Disclosure - Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeRetirementPlansWeightedAverageAssumptionsDetails" roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails">
        <link:definition>240904057 - Disclosure - Employee Retirement Plans (Weighted Average Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies">
        <link:definition>210911017 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables">
        <link:definition>230923017 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLongtermSupplyAgreementDetails" roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails">
        <link:definition>240934058 - Disclosure - Commitments and Contingencies (Long-term Supply Agreement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRisk" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk">
        <link:definition>210941018 - Disclosure - Concentrations of Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConcentrationsofRiskDetails" roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails">
        <link:definition>240954059 - Disclosure - Concentrations of Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegments" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments">
        <link:definition>210961019 - Disclosure - Business Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsTables" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables">
        <link:definition>230973018 - Disclosure - Business Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
        <link:definition>240984060 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsRevenuebyProductDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails">
        <link:definition>240994061 - Disclosure - Business Segments (Revenue by Product) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsRevenuebyGeographicAreaDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails">
        <link:definition>241004062 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAssetsbySegmentDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails">
        <link:definition>241014063 - Disclosure - Business Segments (Assets by Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails" roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails">
        <link:definition>241024064 - Disclosure - Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.prestigebrandsinc.com/role/SubsequentEvents">
        <link:definition>211031020 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.prestigebrandsinc.com/role/SubsequentEventsDetails">
        <link:definition>241044065 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccounts" roleURI="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts">
        <link:definition>211051021 - Disclosure - Schedule II Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>241064066 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pbh_WalmartMember" abstract="true" name="WalmartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" abstract="false" name="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_Amendment52012TermLoanMember" abstract="true" name="Amendment52012TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" abstract="false" name="GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DefinedBenefitPlanRemeasurementDiscountRate" abstract="false" name="DefinedBenefitPlanRemeasurementDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" abstract="true" name="FiniteLivedTradenamesandCustomerRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" abstract="false" name="IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_GEODISLogisticsLLCMember" abstract="true" name="GEODISLogisticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" abstract="true" name="ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_DebtInstrumentVariableRateMinimum" abstract="false" name="DebtInstrumentVariableRateMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_ThirdPartyManufacturingMember" abstract="true" name="ThirdPartyManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_OtherOtcMember" abstract="true" name="OtherOtcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_TermLoan2012Member" abstract="true" name="TermLoan2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LineofCreditFacilityIncreaseinAccordionFeature" abstract="false" name="LineofCreditFacilityIncreaseinAccordionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_SECSchedule1209ValuationAllowancesandReservesOther" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pbh_IntangibleAssetsAcquired" abstract="false" name="IntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" abstract="false" name="ScheduleofAccruedandOtherLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" abstract="false" name="DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_AblRevolver2012Member" abstract="true" name="AblRevolver2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" abstract="true" name="ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="pbh_ContributionTrancheOneMember" abstract="true" name="ContributionTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" abstract="false" name="DebtInstrumentBasisSpreadOnVariableRateFixedComponent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" abstract="true" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentReferenceRateFloor" abstract="false" name="DebtInstrumentReferenceRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_CostOfSalesExclusiveOfDepreciation" abstract="false" name="CostOfSalesExclusiveOfDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" abstract="false" name="EffectiveIncomeTaxRateIncludingDiscontinuedOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" abstract="false" name="DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pbh_DeferredTaxLiabilityRightOfUseAsset" abstract="false" name="DeferredTaxLiabilityRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ManufacturesMember" abstract="true" name="ManufacturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_Top5BrandsMember" abstract="true" name="Top5BrandsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DeferredTaxAssetsInventoryReserves" abstract="false" name="DeferredTaxAssetsInventoryReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" abstract="true" name="OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_VotingRightsNumberOfVotesPerCommonShareOwned" abstract="false" name="VotingRightsNumberOfVotesPerCommonShareOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="pbh_RetirementPlanContributionAxis" abstract="true" name="RetirementPlanContributionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" abstract="false" name="DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_LoansPayableTermB2Member" abstract="true" name="LoansPayableTermB2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ContributionTrancheTwoMember" abstract="true" name="ContributionTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LoansPayableTermB4Member" abstract="true" name="LoansPayableTermB4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" abstract="false" name="IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_AccruedAndOtherLiabilitiesCurrent" abstract="false" name="AccruedAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_InternationalAnalgesicsMember" abstract="true" name="InternationalAnalgesicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" abstract="false" name="SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_ABLAmendmentNumber5Member" abstract="true" name="ABLAmendmentNumber5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ReservesForConsumerCouponRedemptionsMember" abstract="true" name="ReservesForConsumerCouponRedemptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_A2019SeniorNotesMember" abstract="true" name="A2019SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LoansPayableTermB5AmendmentNo6Member" abstract="true" name="LoansPayableTermB5AmendmentNo6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_SeniorNotes2016Member" abstract="true" name="SeniorNotes2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IncreaseDecreaseInOperatingLeasesLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeasesLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentVariableRateConditionalVariableRate" abstract="false" name="DebtInstrumentVariableRateConditionalVariableRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" abstract="false" name="IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_SeniorNotes2013Member" abstract="true" name="SeniorNotes2013Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsRSUsStockOptionsMember" abstract="true" name="RestrictedStockUnitsRSUsStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_SeniorNotes2012Member" abstract="true" name="SeniorNotes2012Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_GastrointestinalMember" abstract="true" name="GastrointestinalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" abstract="false" name="IntangibleAssetsTranslationAdjustmentsGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_A2012ABLRevolverAmendment6Member" abstract="true" name="A2012ABLRevolverAmendment6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsTableTextBlock" abstract="false" name="ScheduleOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_DebtInstrumentDiscountPercentage" abstract="false" name="DebtInstrumentDiscountPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IndefinitelivedTradenamesMember" abstract="true" name="IndefinitelivedTradenamesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_A2021SeniorNotesMember" abstract="true" name="A2021SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" abstract="false" name="BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" abstract="false" name="NumberOfThirdPartyManufacturersWithLongTermContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_LongTermIncentivePlan2020Member" abstract="true" name="LongTermIncentivePlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ZaditenMember" abstract="true" name="ZaditenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_AdditionsToOperatingLeaseRightOfUseAssets" abstract="false" name="AdditionsToOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" abstract="false" name="DebtInstrumentBasisSpreadOnVariableRateIfIncreased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_ReservesforTradePromotionsMember" abstract="true" name="ReservesforTradePromotionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_FederalFundsRateMember" abstract="true" name="FederalFundsRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" abstract="false" name="DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceNewShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_LongtermEquityIncentivePlan2005Member" abstract="true" name="LongtermEquityIncentivePlan2005Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_LoansPayableTermB3Member" abstract="true" name="LoansPayableTermB3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" abstract="false" name="IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" abstract="false" name="EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_LoansPayableTermB1Member" abstract="true" name="LoansPayableTermB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" abstract="false" name="EstimatedReductionInUncertainTaxProvisionsNext12Months" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_PercentageofDepositsHeldinOneLocation" abstract="false" name="PercentageofDepositsHeldinOneLocation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_ABLRevolverAmendment4Member" abstract="true" name="ABLRevolverAmendment4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_AnalgesicsMember" abstract="true" name="AnalgesicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" abstract="false" name="GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_SydneyAustraliaMember" abstract="true" name="SydneyAustraliaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsLineItems" abstract="true" name="ScheduleOfIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_AccumulatedOtherComprehensiveIncomeTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_NumberOfThirdPartyManufacturers" abstract="false" name="NumberOfThirdPartyManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pbh_LoansPayableTermB5AmendmentNo5Member" abstract="true" name="LoansPayableTermB5AmendmentNo5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" abstract="false" name="BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" abstract="false" name="OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_IntangibleAssetsRollForward" abstract="true" name="IntangibleAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_Amended22012TermLoanMember" abstract="true" name="Amended22012TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_EyeAndEarCareMember" abstract="true" name="EyeAndEarCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_NorthAmericanOTCHealthcareMember" abstract="true" name="NorthAmericanOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_AkornOperatingCompanyLLCMember" abstract="true" name="AkornOperatingCompanyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" abstract="true" name="RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" abstract="false" name="DebtInstrumentAlternativeBasisSpreadOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pbh_CoughAndColdMember" abstract="true" name="CoughAndColdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DeferredTaxAssetsLeaseLiabilities" abstract="false" name="DeferredTaxAssetsLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" abstract="false" name="EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" abstract="false" name="LineOfCreditFacilityConditionalCommitmentFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" abstract="false" name="RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pbh_InternationalOTCHealthcareMember" abstract="true" name="InternationalOTCHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="pbh_WeightedAverageSharesOutstandingAbstract" abstract="true" name="WeightedAverageSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" abstract="false" name="LineOfCreditFacilityIncreaseInBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_RetirementPlanContributionDomain" abstract="true" name="RetirementPlanContributionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DeferredTaxAssetsInventoryRecapitalization" abstract="false" name="DeferredTaxAssetsInventoryRecapitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EscrowReceipt" abstract="false" name="EscrowReceipt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" abstract="false" name="DebtInstrumentPeriodicPaymentVoluntaryPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_CostOfSalesPolicyPolicyTextBlock" abstract="false" name="CostOfSalesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pbh_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_Amended2012TermLoanMember" abstract="true" name="Amended2012TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DermatologicalsMember" abstract="true" name="DermatologicalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_TotalOtherIncomeExpense" abstract="false" name="TotalOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_AccruedProductionCostsCurrent" abstract="false" name="AccruedProductionCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_A2012ABLRevolverAmendment3Member" abstract="true" name="A2012ABLRevolverAmendment3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_Amendment32012TermLoanMember" abstract="true" name="Amendment32012TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_SupplyCommitmentTermOfAgreement" abstract="false" name="SupplyCommitmentTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pbh_WeightedAverageDiscountRateAbstract" abstract="true" name="WeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" abstract="false" name="RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pbh_SeniorNotes2019Member" abstract="true" name="SeniorNotes2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" abstract="false" name="DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>pbh-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_875190f7-4e20-481e-b4e0-4171ad57e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_689cc3d6-ea4f-40cb-82aa-816159634500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_875190f7-4e20-481e-b4e0-4171ad57e79e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_689cc3d6-ea4f-40cb-82aa-816159634500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d862dc2-de3b-4b59-8e72-4ff663945959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_875190f7-4e20-481e-b4e0-4171ad57e79e" xlink:to="loc_us-gaap_NetIncomeLoss_5d862dc2-de3b-4b59-8e72-4ff663945959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af1dd5e6-fa8e-430b-9a86-623320dd4458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_03c73b47-9c5d-4ff8-97d2-0ef352c6ba14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af1dd5e6-fa8e-430b-9a86-623320dd4458" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_03c73b47-9c5d-4ff8-97d2-0ef352c6ba14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5ed39a19-6507-4ab3-897b-d2d5c42f4e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af1dd5e6-fa8e-430b-9a86-623320dd4458" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_5ed39a19-6507-4ab3-897b-d2d5c42f4e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_44ea7395-1481-4d9c-a0e2-041c67ca21a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af1dd5e6-fa8e-430b-9a86-623320dd4458" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_44ea7395-1481-4d9c-a0e2-041c67ca21a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_cc7a49ed-0318-47bc-86f8-54d467d83bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_af1dd5e6-fa8e-430b-9a86-623320dd4458" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_cc7a49ed-0318-47bc-86f8-54d467d83bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3a73d88-d234-4c38-a305-623f485ee015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d34e8e44-1e64-4238-a14f-88624fa2965a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3a73d88-d234-4c38-a305-623f485ee015" xlink:to="loc_us-gaap_OperatingIncomeLoss_d34e8e44-1e64-4238-a14f-88624fa2965a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_31e2cb46-6b41-4051-a548-d1c1d975c23d" xlink:href="pbh-20220331.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3a73d88-d234-4c38-a305-623f485ee015" xlink:to="loc_pbh_TotalOtherIncomeExpense_31e2cb46-6b41-4051-a548-d1c1d975c23d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d4375d2a-dc4e-43ba-9a55-76fc4ea084bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e66b98-a7a4-4534-99d2-19100d092ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d4375d2a-dc4e-43ba-9a55-76fc4ea084bf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e66b98-a7a4-4534-99d2-19100d092ea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_bd362b99-8e31-4a77-9feb-9ee1f0804a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d4375d2a-dc4e-43ba-9a55-76fc4ea084bf" xlink:to="loc_us-gaap_CostOfRevenue_bd362b99-8e31-4a77-9feb-9ee1f0804a0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ee555282-39ef-438e-b6e4-f2f6e3230313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_a506c5f8-4ddc-4ff4-9f7b-39250a9aee6e" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_ee555282-39ef-438e-b6e4-f2f6e3230313" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_a506c5f8-4ddc-4ff4-9f7b-39250a9aee6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_bfb45d29-2676-4266-80b9-9563fcd12f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostOfRevenue_ee555282-39ef-438e-b6e4-f2f6e3230313" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_bfb45d29-2676-4266-80b9-9563fcd12f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_910daff7-8ca7-41c7-bd4a-8774da0b236f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cdef1df7-c804-4fc8-8c20-49fa4feb3817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_910daff7-8ca7-41c7-bd4a-8774da0b236f" xlink:to="loc_us-gaap_GrossProfit_cdef1df7-c804-4fc8-8c20-49fa4feb3817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a0001a66-a975-4db0-b386-79bcb2c30cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_910daff7-8ca7-41c7-bd4a-8774da0b236f" xlink:to="loc_us-gaap_OperatingExpenses_a0001a66-a975-4db0-b386-79bcb2c30cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b349b09f-6a26-4808-8b37-bf474b8ea045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fbd8a4b7-1fea-445b-8a43-f0dc43f645f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b349b09f-6a26-4808-8b37-bf474b8ea045" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fbd8a4b7-1fea-445b-8a43-f0dc43f645f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_05f36a5b-e6cd-4ca0-8480-bd75f36b1847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b349b09f-6a26-4808-8b37-bf474b8ea045" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_05f36a5b-e6cd-4ca0-8480-bd75f36b1847" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_a4830f36-ff06-4f44-a52f-eb5633ac9c6a" xlink:href="pbh-20220331.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_55159044-c2c8-4b90-975e-f9bdb08eb9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_a4830f36-ff06-4f44-a52f-eb5633ac9c6a" xlink:to="loc_us-gaap_InterestExpenseDebt_55159044-c2c8-4b90-975e-f9bdb08eb9a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b87db00e-5294-4409-a9ea-32d81348f766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_a4830f36-ff06-4f44-a52f-eb5633ac9c6a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b87db00e-5294-4409-a9ea-32d81348f766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d185dbd7-e951-4fb0-801d-2b0a1ab36a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_TotalOtherIncomeExpense_a4830f36-ff06-4f44-a52f-eb5633ac9c6a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d185dbd7-e951-4fb0-801d-2b0a1ab36a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_07120292-9dc5-4eae-bdb3-d90ae49a5ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_768f5e27-6ff6-42e7-996e-a6acb62e0317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07120292-9dc5-4eae-bdb3-d90ae49a5ef7" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_768f5e27-6ff6-42e7-996e-a6acb62e0317" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_839171fd-4c5e-49ad-934f-3f69d93bbef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07120292-9dc5-4eae-bdb3-d90ae49a5ef7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_839171fd-4c5e-49ad-934f-3f69d93bbef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_b7d3c336-2df9-4fd9-858a-17c35cd92e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07120292-9dc5-4eae-bdb3-d90ae49a5ef7" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_b7d3c336-2df9-4fd9-858a-17c35cd92e5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_40b56cbf-2fd6-4300-b0b8-115af2e1f62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_46cd02fc-38a3-4581-bd66-46654142b092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_40b56cbf-2fd6-4300-b0b8-115af2e1f62e" xlink:to="loc_us-gaap_StockholdersEquity_46cd02fc-38a3-4581-bd66-46654142b092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_313be883-a3ea-40d2-9786-4d3584fd745e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_40b56cbf-2fd6-4300-b0b8-115af2e1f62e" xlink:to="loc_us-gaap_Liabilities_313be883-a3ea-40d2-9786-4d3584fd745e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5df0fc3c-2a81-4fa6-b663-002231cc000f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_40b56cbf-2fd6-4300-b0b8-115af2e1f62e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5df0fc3c-2a81-4fa6-b663-002231cc000f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b9c78a6-668b-4e9e-ac42-916a6804a38e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b9c78a6-668b-4e9e-ac42-916a6804a38e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f9c735d8-14e9-418b-b5d2-2b3161b594a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_Goodwill_f9c735d8-14e9-418b-b5d2-2b3161b594a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_055376dc-987d-4535-a326-8bf1754a23b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_055376dc-987d-4535-a326-8bf1754a23b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8f5d16f6-b47d-40c1-a62b-42260dee0c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8f5d16f6-b47d-40c1-a62b-42260dee0c2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_64d012a4-542e-4369-a546-388b02c8b687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_AssetsCurrent_64d012a4-542e-4369-a546-388b02c8b687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_dd5f3202-7295-4e20-bed1-058f2295c42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_dd5f3202-7295-4e20-bed1-058f2295c42f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c052c4bf-70cf-4989-841e-bf9f5c53ff5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7da0bee5-b271-4bbc-9ced-c76adb6eaa6a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c052c4bf-70cf-4989-841e-bf9f5c53ff5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_79791052-2a9c-4f9b-9e8b-6ea6dfed1f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_79791052-2a9c-4f9b-9e8b-6ea6dfed1f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fec373af-30f5-4156-b190-9b5b7fb877e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fec373af-30f5-4156-b190-9b5b7fb877e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c87f6f1f-06f5-42f0-b50e-34656569053b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c87f6f1f-06f5-42f0-b50e-34656569053b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a3a4b1eb-719a-46ff-8d19-2f2294debd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_LiabilitiesCurrent_a3a4b1eb-719a-46ff-8d19-2f2294debd39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38b8b030-11cd-499d-821f-e91e913c166d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38b8b030-11cd-499d-821f-e91e913c166d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fcd3d649-107e-42f5-b1b0-5b556d11bb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd6aee54-434a-4b97-8e69-53ae6741cb1b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fcd3d649-107e-42f5-b1b0-5b556d11bb59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a0a29f82-75da-4642-8d5d-ee269576f1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_PreferredStockValue_a0a29f82-75da-4642-8d5d-ee269576f1a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ee012031-2f37-4b69-be15-ae51db5b1658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_CommonStockValue_ee012031-2f37-4b69-be15-ae51db5b1658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ca8a55ab-215d-4693-9ae0-2c965ae0e3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ca8a55ab-215d-4693-9ae0-2c965ae0e3af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3b708d2b-5c04-4c55-b90c-e1e9e2bb70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_TreasuryStockValue_3b708d2b-5c04-4c55-b90c-e1e9e2bb70a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b047e6b0-8135-4d92-a7a8-68df16cbb150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b047e6b0-8135-4d92-a7a8-68df16cbb150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5e4ef0a5-a65d-42cd-bc35-c13be22659ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e1c70414-0872-4fde-88bd-c34ea0cf0aa4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5e4ef0a5-a65d-42cd-bc35-c13be22659ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_92f51799-2f0a-438e-b18f-099646e91de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:to="loc_us-gaap_AccountsPayableCurrent_92f51799-2f0a-438e-b18f-099646e91de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_4c668e79-4420-4ee5-8025-159649dacb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_4c668e79-4420-4ee5-8025-159649dacb9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_179ea4b9-7ee2-469c-9c41-4ddc6ce9b25d" xlink:href="pbh-20220331.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_179ea4b9-7ee2-469c-9c41-4ddc6ce9b25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9251be6a-cb35-4511-a33b-0e2ab2f704e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9251be6a-cb35-4511-a33b-0e2ab2f704e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_17bfbf8d-a2f1-4416-8ed3-a838c3e0fc68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f79271f3-1e39-445d-b5c9-3eb484760110" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_17bfbf8d-a2f1-4416-8ed3-a838c3e0fc68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_61847b60-dec3-4513-8c0a-88600674a77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4505712e-873c-448b-9cf9-2f19805a5d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61847b60-dec3-4513-8c0a-88600674a77d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4505712e-873c-448b-9cf9-2f19805a5d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_69cb8a65-4786-4465-9f6d-203eefd0c984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61847b60-dec3-4513-8c0a-88600674a77d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_69cb8a65-4786-4465-9f6d-203eefd0c984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_579c2523-2a3a-4a61-9d6f-732e7a148dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61847b60-dec3-4513-8c0a-88600674a77d" xlink:to="loc_us-gaap_InventoryNet_579c2523-2a3a-4a61-9d6f-732e7a148dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_833ecb90-519c-4e2f-bc2f-221843fdad0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61847b60-dec3-4513-8c0a-88600674a77d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_833ecb90-519c-4e2f-bc2f-221843fdad0b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d775121c-959f-4354-8920-eb34f7b994aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d775121c-959f-4354-8920-eb34f7b994aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_32589746-f8d3-452d-be58-361b70bf4ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_32589746-f8d3-452d-be58-361b70bf4ce6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a50ca7c1-763f-4e30-b888-6322b10baf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a50ca7c1-763f-4e30-b888-6322b10baf2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8ab8b3ac-e572-405a-b7f7-d2529ea783a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8ab8b3ac-e572-405a-b7f7-d2529ea783a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f890a53-2c8a-4d0b-83c3-21b52f3e5e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9f890a53-2c8a-4d0b-83c3-21b52f3e5e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0c5a13f9-3ed4-4fd6-9e3c-abe01b4f428f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0c5a13f9-3ed4-4fd6-9e3c-abe01b4f428f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_be4ddc8f-9bdf-47ef-9306-faa7dd7f08c0" xlink:href="pbh-20220331.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_be4ddc8f-9bdf-47ef-9306-faa7dd7f08c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5355946e-d687-4a37-a086-5c207201187f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5355946e-d687-4a37-a086-5c207201187f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_2767de47-77a4-4f34-bdb6-0cf46cfa64d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_AssetImpairmentCharges_2767de47-77a4-4f34-bdb6-0cf46cfa64d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e6ab20c7-b5a2-4da0-b079-f6059a7963f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e6ab20c7-b5a2-4da0-b079-f6059a7963f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_0fc3239e-c4e8-4935-a0c2-345343b681c7" xlink:href="pbh-20220331.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_0fc3239e-c4e8-4935-a0c2-345343b681c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_2b757407-d57d-4dd6-89aa-edb2ee9f016a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_2b757407-d57d-4dd6-89aa-edb2ee9f016a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f671e2ae-25ca-427c-96f2-ee4d9721e653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f671e2ae-25ca-427c-96f2-ee4d9721e653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_61b7980e-438e-4ca7-9c07-c583382de0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_61b7980e-438e-4ca7-9c07-c583382de0a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b6bb7b3d-c7ab-43d5-bb90-5746ab9e2081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b6bb7b3d-c7ab-43d5-bb90-5746ab9e2081" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f36c4cee-63b7-43b7-ac69-1662f8773c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_NetIncomeLoss_f36c4cee-63b7-43b7-ac69-1662f8773c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_120bd859-2435-4ddd-9984-33bcc8ec3643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d65eebb-d8cd-45c3-afb9-fc3b7b9479e0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_120bd859-2435-4ddd-9984-33bcc8ec3643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_051347cf-f68b-4527-8144-61bb2354acbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_051347cf-f68b-4527-8144-61bb2354acbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a8dcab43-3bbc-4efc-a2f6-649e31e4c2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a8dcab43-3bbc-4efc-a2f6-649e31e4c2ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b1140e7e-7097-484b-aac3-58145a20a0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b1140e7e-7097-484b-aac3-58145a20a0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_e88b48ce-fdfa-4eeb-b11a-5f10aa6b4ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_e88b48ce-fdfa-4eeb-b11a-5f10aa6b4ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_bcdd44bf-8381-42a7-b975-fd1137720baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_bcdd44bf-8381-42a7-b975-fd1137720baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6717ecd4-fe12-4628-ad97-4f02907e006b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6717ecd4-fe12-4628-ad97-4f02907e006b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_e66e1354-998e-411b-a765-8da374c0f821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_e66e1354-998e-411b-a765-8da374c0f821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_85a7a304-bb66-4e27-a6ba-70b0d41a317b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_85a7a304-bb66-4e27-a6ba-70b0d41a317b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_db4adb7e-c2a3-4e3a-a785-cb47ab618604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_db4adb7e-c2a3-4e3a-a785-cb47ab618604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_09fe46d5-f993-4c23-8b69-4462675fc101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_09fe46d5-f993-4c23-8b69-4462675fc101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_156e4077-9498-41ba-aa8e-ac27a6a50327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ab324e5-c42d-426d-bf07-82ed62062502" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_156e4077-9498-41ba-aa8e-ac27a6a50327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_314a780d-f047-4ec2-b2ba-b1835356470d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7fa7ed03-1532-4a28-80a1-cc8b834faab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_314a780d-f047-4ec2-b2ba-b1835356470d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7fa7ed03-1532-4a28-80a1-cc8b834faab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bec7e03b-4013-44e8-80a3-352d433b8699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_314a780d-f047-4ec2-b2ba-b1835356470d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bec7e03b-4013-44e8-80a3-352d433b8699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9c249fad-eb2a-45cc-82f2-31d9747b626a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_314a780d-f047-4ec2-b2ba-b1835356470d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9c249fad-eb2a-45cc-82f2-31d9747b626a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50168478-e81c-4cc7-a444-4aa993f76d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_314a780d-f047-4ec2-b2ba-b1835356470d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50168478-e81c-4cc7-a444-4aa993f76d0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e13be232-637c-4617-b41c-e313cbea80ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e1228b2-1c6c-4da6-adf7-5d6a76fb55d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e13be232-637c-4617-b41c-e313cbea80ca" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0e1228b2-1c6c-4da6-adf7-5d6a76fb55d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt_a474602b-6ca4-4a52-a6da-83f136db48c3" xlink:href="pbh-20220331.xsd#pbh_EscrowReceipt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e13be232-637c-4617-b41c-e313cbea80ca" xlink:to="loc_pbh_EscrowReceipt_a474602b-6ca4-4a52-a6da-83f136db48c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a30fd92e-7ed4-4230-848d-a5ec720f8971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e13be232-637c-4617-b41c-e313cbea80ca" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a30fd92e-7ed4-4230-848d-a5ec720f8971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_18d8a0af-001a-472d-8c58-1af3078b4986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e13be232-637c-4617-b41c-e313cbea80ca" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_18d8a0af-001a-472d-8c58-1af3078b4986" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_673d8d5e-ba2e-481d-9068-eade3ae229df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04db11de-d804-4cf9-8edc-b55722e9e113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_673d8d5e-ba2e-481d-9068-eade3ae229df" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_04db11de-d804-4cf9-8edc-b55722e9e113" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eb0d5fff-03b7-4946-b7e8-ae3e4d54e1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_673d8d5e-ba2e-481d-9068-eade3ae229df" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_eb0d5fff-03b7-4946-b7e8-ae3e4d54e1c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a2ea15e3-2d86-410e-9fa4-0eec0fef5094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_39ec5f17-ccaf-4f4c-a27b-9ee064f8281a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a2ea15e3-2d86-410e-9fa4-0eec0fef5094" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_39ec5f17-ccaf-4f4c-a27b-9ee064f8281a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_3ff2f801-2807-4cba-bb17-f970fbede9d2" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a2ea15e3-2d86-410e-9fa4-0eec0fef5094" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_3ff2f801-2807-4cba-bb17-f970fbede9d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_aee3e4be-5ae0-48c2-94eb-001e9749edcb" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a2ea15e3-2d86-410e-9fa4-0eec0fef5094" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_aee3e4be-5ae0-48c2-94eb-001e9749edcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d64ec80-3dd8-4c68-9e4a-5688d32efbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cd01eaf1-9d19-4d09-9f5a-9ced0d66f710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d64ec80-3dd8-4c68-9e4a-5688d32efbc0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cd01eaf1-9d19-4d09-9f5a-9ced0d66f710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_90973650-8189-4045-b22f-1c9a5e67791e" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d64ec80-3dd8-4c68-9e4a-5688d32efbc0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_90973650-8189-4045-b22f-1c9a5e67791e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_c9549324-6a9e-4b8b-b8f1-ba6fe91c88c7" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_03b4412f-204c-4324-9b30-d962f6ac0b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_c9549324-6a9e-4b8b-b8f1-ba6fe91c88c7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_03b4412f-204c-4324-9b30-d962f6ac0b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_845497a0-b7cf-4fa9-aa6e-5264284ba3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_c9549324-6a9e-4b8b-b8f1-ba6fe91c88c7" xlink:to="loc_us-gaap_Goodwill_845497a0-b7cf-4fa9-aa6e-5264284ba3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9a3f7cf7-62f0-4422-a90d-e3a972692b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_c9549324-6a9e-4b8b-b8f1-ba6fe91c88c7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9a3f7cf7-62f0-4422-a90d-e3a972692b27" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f1a3dd62-62dc-4fe8-a73f-38c7b8435d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_96f1e322-fda4-4d45-be7b-63dcb18bca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f1a3dd62-62dc-4fe8-a73f-38c7b8435d5a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_96f1e322-fda4-4d45-be7b-63dcb18bca4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_930df93d-2421-4085-a184-81ca45c8e0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f1a3dd62-62dc-4fe8-a73f-38c7b8435d5a" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_930df93d-2421-4085-a184-81ca45c8e0a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_aeaedb16-5cb5-4c60-b78d-26d8740a2f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f1a3dd62-62dc-4fe8-a73f-38c7b8435d5a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_aeaedb16-5cb5-4c60-b78d-26d8740a2f8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#PropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_35446034-abf7-474b-8071-b669376190b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a47843d0-f501-4d2d-864c-f1a6d84828c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_35446034-abf7-474b-8071-b669376190b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a47843d0-f501-4d2d-864c-f1a6d84828c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4d7f3933-dd93-4b56-ada0-553f495ee48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_35446034-abf7-474b-8071-b669376190b1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4d7f3933-dd93-4b56-ada0-553f495ee48c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsExpectedAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fd0c4e03-8085-45e4-bb65-e540678ff38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fd0c4e03-8085-45e4-bb65-e540678ff38c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f4a94e6c-0572-457c-ad89-588a6d087f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f4a94e6c-0572-457c-ad89-588a6d087f34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ca8e08fc-7830-4356-a619-2a0ac1668733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ca8e08fc-7830-4356-a619-2a0ac1668733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a6cbf308-2989-429a-ad08-09d64597676d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a6cbf308-2989-429a-ad08-09d64597676d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72347fad-16d9-40b1-9407-3a2a5fd8175c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_72347fad-16d9-40b1-9407-3a2a5fd8175c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d80bb9cf-7321-47cd-893d-b3f5f55067ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bba2eaf4-5850-4aab-8d9c-d9ff7eadcef0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d80bb9cf-7321-47cd-893d-b3f5f55067ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_c5500b22-61a0-4b83-b30f-cb0b381406c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_OperatingLeaseCost_c5500b22-61a0-4b83-b30f-cb0b381406c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_0027d381-2b84-4405-baf5-e03fbe1a6ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_VariableLeaseCost_0027d381-2b84-4405-baf5-e03fbe1a6ff4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_cc42965f-e950-40c1-b11d-de19d66eca07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_SubleaseIncome_cc42965f-e950-40c1-b11d-de19d66eca07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d3f84d87-8259-404c-bc32-7fff5f4e267e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_d3f84d87-8259-404c-bc32-7fff5f4e267e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_036aa2f3-eef3-40fa-8274-3276dc5c0d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_036aa2f3-eef3-40fa-8274-3276dc5c0d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_45f44a6d-49a8-47ff-bc85-495f5d245ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_830d56e8-be81-4fca-818e-f7aef3eeefc6" xlink:to="loc_us-gaap_ShortTermLeaseCost_45f44a6d-49a8-47ff-bc85-495f5d245ca2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_953cb539-9bc6-41b0-8f3b-654c737d817c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4b9f92b0-3ee5-4d64-939a-a55a5ce74343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_953cb539-9bc6-41b0-8f3b-654c737d817c" xlink:to="loc_us-gaap_FinanceLeaseLiability_4b9f92b0-3ee5-4d64-939a-a55a5ce74343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f9d3a2ae-f267-4030-a437-40d1cef85e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_953cb539-9bc6-41b0-8f3b-654c737d817c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f9d3a2ae-f267-4030-a437-40d1cef85e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_ce5b82eb-c218-4a15-9ea4-59a15f3e044d" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a602fa12-a21a-4237-b645-8c24bfc2eab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_ce5b82eb-c218-4a15-9ea4-59a15f3e044d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a602fa12-a21a-4237-b645-8c24bfc2eab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f0458bf9-808d-4a6b-a044-b43c77d4a3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_ce5b82eb-c218-4a15-9ea4-59a15f3e044d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f0458bf9-808d-4a6b-a044-b43c77d4a3ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f49e5d45-106c-44f6-bd4b-871a7d5ceb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5182bd97-59c9-4b5a-8e9f-fd762fcdb80c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f49e5d45-106c-44f6-bd4b-871a7d5ceb55" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5182bd97-59c9-4b5a-8e9f-fd762fcdb80c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_aa722fa0-e19a-45f3-bb6f-2078a71ca970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f49e5d45-106c-44f6-bd4b-871a7d5ceb55" xlink:to="loc_us-gaap_OperatingLeaseLiability_aa722fa0-e19a-45f3-bb6f-2078a71ca970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_b615f3bd-1427-4fd3-972b-63b70a18e3db" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_b615f3bd-1427-4fd3-972b-63b70a18e3db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_b2c5f214-3b22-4d4f-8096-923857e20555" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_b2c5f214-3b22-4d4f-8096-923857e20555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_e6fbe971-ecd1-48ba-8107-ef673338cdfc" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_e6fbe971-ecd1-48ba-8107-ef673338cdfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_4cd2c6a2-51ee-49e6-9b69-7b7de9260bdb" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_4cd2c6a2-51ee-49e6-9b69-7b7de9260bdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_13005e19-41cf-4647-a48e-574373ac559c" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_13005e19-41cf-4647-a48e-574373ac559c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_c178e8c4-bbbf-4af7-b172-3274d72bd669" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_ba54b32d-73a1-4efa-a494-0e1891bca2c5" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_c178e8c4-bbbf-4af7-b172-3274d72bd669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_315a8cd4-abdf-4380-b4de-13bafa9c431b" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6b701de0-0f40-41a4-affe-b95f3b7697cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_315a8cd4-abdf-4380-b4de-13bafa9c431b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6b701de0-0f40-41a4-affe-b95f3b7697cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_942d6f66-7d1f-423f-84f8-59422c41df79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_315a8cd4-abdf-4380-b4de-13bafa9c431b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_942d6f66-7d1f-423f-84f8-59422c41df79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_581d499e-129e-4d20-9df5-e9462218217e" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_16eeec9a-0ffd-4783-bfd7-21909a7c2d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_581d499e-129e-4d20-9df5-e9462218217e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_16eeec9a-0ffd-4783-bfd7-21909a7c2d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b1daa5e8-f947-4acc-a764-d718839f4db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_581d499e-129e-4d20-9df5-e9462218217e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b1daa5e8-f947-4acc-a764-d718839f4db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_4281e5ff-a7da-443d-97c9-e5ca1faed534" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_49288066-90eb-4a67-9527-e67bfcc9ecae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_4281e5ff-a7da-443d-97c9-e5ca1faed534" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_49288066-90eb-4a67-9527-e67bfcc9ecae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_aa08dcaf-cbf0-4695-8034-1b6495d3c69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_4281e5ff-a7da-443d-97c9-e5ca1faed534" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_aa08dcaf-cbf0-4695-8034-1b6495d3c69b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_8763e34d-9328-472f-bd55-2b4a426f369a" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_48cfd185-fe46-43e7-bd36-1e1363e9bf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_8763e34d-9328-472f-bd55-2b4a426f369a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_48cfd185-fe46-43e7-bd36-1e1363e9bf2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_73bef38e-40e5-4a56-8987-cf889c137b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_8763e34d-9328-472f-bd55-2b4a426f369a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_73bef38e-40e5-4a56-8987-cf889c137b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_062f890f-f6dc-42ef-a5ef-e8b4582b6ba3" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_973ed8ce-4db7-450f-bf29-8594c9d0b330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_062f890f-f6dc-42ef-a5ef-e8b4582b6ba3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_973ed8ce-4db7-450f-bf29-8594c9d0b330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_97ef5f78-b293-4ed0-948e-b8d038aaed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_062f890f-f6dc-42ef-a5ef-e8b4582b6ba3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_97ef5f78-b293-4ed0-948e-b8d038aaed3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_91653b84-ecaf-4742-94b8-5e5c5df55a45" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f59c9385-bd32-402f-b940-8eb4c58dc93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_91653b84-ecaf-4742-94b8-5e5c5df55a45" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f59c9385-bd32-402f-b940-8eb4c58dc93a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a8b86c27-1b05-4e16-82ed-e5978ebac014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_91653b84-ecaf-4742-94b8-5e5c5df55a45" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a8b86c27-1b05-4e16-82ed-e5978ebac014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_f8e8766e-a5d9-4fda-90cb-d36c8239fe1b" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9fc1c300-5451-4dc6-b8fe-8dc46ae374e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_f8e8766e-a5d9-4fda-90cb-d36c8239fe1b" xlink:to="loc_us-gaap_FinanceLeaseLiability_9fc1c300-5451-4dc6-b8fe-8dc46ae374e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8b3efa08-d9b6-4e56-8d4c-652903a21a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability_f8e8766e-a5d9-4fda-90cb-d36c8239fe1b" xlink:to="loc_us-gaap_OperatingLeaseLiability_8b3efa08-d9b6-4e56-8d4c-652903a21a9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e9e6bbd1-b59f-45bd-bb29-515a471517fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e9e6bbd1-b59f-45bd-bb29-515a471517fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ebe50b82-c89b-4630-9d1f-138aca3a310c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ebe50b82-c89b-4630-9d1f-138aca3a310c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_12946566-97e3-4339-af91-19f7e39acb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_12946566-97e3-4339-af91-19f7e39acb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_66433502-5c00-4ba2-b7c9-9e7ee8620aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_66433502-5c00-4ba2-b7c9-9e7ee8620aa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2409adfe-859a-4026-8f65-0e17abb83ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2409adfe-859a-4026-8f65-0e17abb83ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2bb9e343-36a4-46a8-9afb-46356568e9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26778b44-3615-4aba-b71e-bd4cbe56d0a8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2bb9e343-36a4-46a8-9afb-46356568e9f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_00e9a0fc-d6b2-41e5-bfa3-3b826144a2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_00e9a0fc-d6b2-41e5-bfa3-3b826144a2d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_70e14081-b554-4a6a-abf0-26f7334c0f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_70e14081-b554-4a6a-abf0-26f7334c0f48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a3b5dcaf-f8b8-46b7-8739-6d561e536c05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a3b5dcaf-f8b8-46b7-8739-6d561e536c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8ac56856-258f-4cb7-bb7e-931789086233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8ac56856-258f-4cb7-bb7e-931789086233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ac4eec9-0843-4c0c-9773-7c2fa42c9346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1ac4eec9-0843-4c0c-9773-7c2fa42c9346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c3520b0c-e443-4f9e-8337-abfc81f8ecac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d6bc5bf-e18c-486b-a084-aa4e6c3d7edf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c3520b0c-e443-4f9e-8337-abfc81f8ecac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_3ef8887c-6b20-47b3-8a27-99ce22180e90" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_72884baa-efe1-4f29-bd65-7200ffb74d9f" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_3ef8887c-6b20-47b3-8a27-99ce22180e90" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_72884baa-efe1-4f29-bd65-7200ffb74d9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_860a7263-c702-401d-b0f9-5e6fe5b22f33" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_3ef8887c-6b20-47b3-8a27-99ce22180e90" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_860a7263-c702-401d-b0f9-5e6fe5b22f33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_25fcd898-9eac-473e-8146-1fd7bb043539" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3e0325a0-39ca-4324-b2f7-b5dfb7baeec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_25fcd898-9eac-473e-8146-1fd7bb043539" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3e0325a0-39ca-4324-b2f7-b5dfb7baeec1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_26e4f8b1-002d-4d34-a1d1-73dc65645323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_25fcd898-9eac-473e-8146-1fd7bb043539" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_26e4f8b1-002d-4d34-a1d1-73dc65645323" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:href="pbh-20220331.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_b5c1220f-61c5-4e0b-af07-0d9d91b256b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_b5c1220f-61c5-4e0b-af07-0d9d91b256b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4e175d55-2d85-44c0-af40-928d7016e8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4e175d55-2d85-44c0-af40-928d7016e8cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_addd7957-ea75-4bcd-bc05-88c01ff19ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_addd7957-ea75-4bcd-bc05-88c01ff19ec6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_b0e14057-d2e8-44ce-99be-a8072cdc9861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_b0e14057-d2e8-44ce-99be-a8072cdc9861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bf1907e9-959e-4de8-8cf6-43550b85fadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bf1907e9-959e-4de8-8cf6-43550b85fadd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_86879a15-2cc8-48dd-847e-d063c41fce2e" xlink:href="pbh-20220331.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_pbh_AccruedProductionCostsCurrent_86879a15-2cc8-48dd-847e-d063c41fce2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_451f6f8a-314c-4399-afa3-ead5cd99f8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_451f6f8a-314c-4399-afa3-ead5cd99f8e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_64012963-061b-4642-9d1c-8781f58f8376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent_afbba50f-3333-459c-88e2-088b7d855282" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_64012963-061b-4642-9d1c-8781f58f8376" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f034ada1-c1cf-4e92-acdf-5a77c165e325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_92d7bc1f-d417-43b5-95e5-ee49199931fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f034ada1-c1cf-4e92-acdf-5a77c165e325" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_92d7bc1f-d417-43b5-95e5-ee49199931fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_3d73295d-28e8-4a4e-864b-189036a81d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f034ada1-c1cf-4e92-acdf-5a77c165e325" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_3d73295d-28e8-4a4e-864b-189036a81d9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_540c5bd8-6826-483f-9fa1-b689318f4930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_540c5bd8-6826-483f-9fa1-b689318f4930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8c328a5e-b25e-4c74-962e-c70590db88fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8c328a5e-b25e-4c74-962e-c70590db88fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9e587369-8cf8-41ea-9618-34a8cb9ba5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9e587369-8cf8-41ea-9618-34a8cb9ba5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_090e9e13-3666-4b4e-bd02-870a388bb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_090e9e13-3666-4b4e-bd02-870a388bb2f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f19d1301-4893-426d-ba9d-94099eba3765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_f19d1301-4893-426d-ba9d-94099eba3765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dbc0e008-f8d7-4f90-86b7-ffc5955c00be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_977b4e67-24e0-4435-b254-fc1c191d2334" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_dbc0e008-f8d7-4f90-86b7-ffc5955c00be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesIncomeBeforeContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f650ebe-85af-4578-9f97-935f8fc01bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7e1f9f34-023d-4bb9-b0dc-f15c3884b602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f650ebe-85af-4578-9f97-935f8fc01bb9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7e1f9f34-023d-4bb9-b0dc-f15c3884b602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1dd7ac0b-72ef-4e92-a011-e5201a020dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f650ebe-85af-4578-9f97-935f8fc01bb9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1dd7ac0b-72ef-4e92-a011-e5201a020dfc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fd15a823-57f0-4dea-bf9f-e8de8ef6c3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fd15a823-57f0-4dea-bf9f-e8de8ef6c3de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_741d1242-c17b-4917-a6ba-8b58bbb95022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_741d1242-c17b-4917-a6ba-8b58bbb95022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_0761f584-8bab-4d30-b9fd-66c3f8214754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_0761f584-8bab-4d30-b9fd-66c3f8214754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e4c5a34f-2287-4fba-a8f9-a295502df19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e4c5a34f-2287-4fba-a8f9-a295502df19d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ef96dbb2-362b-4a6e-b0c2-b9e1488fc708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ef96dbb2-362b-4a6e-b0c2-b9e1488fc708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_985fa426-e752-4cb8-bcd6-bfbe88a988da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ad80227c-3c8f-4276-a783-2c8361ab3762" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_985fa426-e752-4cb8-bcd6-bfbe88a988da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesComponentsofDeferredTaxBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f475bcf8-48f3-41c3-b277-5b2825a1230d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3bfa1bf1-3251-45c8-bd4a-efe96e63c569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f475bcf8-48f3-41c3-b277-5b2825a1230d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_3bfa1bf1-3251-45c8-bd4a-efe96e63c569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_05b525c2-37b8-4975-a383-611f0445c14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f475bcf8-48f3-41c3-b277-5b2825a1230d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_05b525c2-37b8-4975-a383-611f0445c14b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_1b047788-76e3-46e2-a4b8-c530adf855b9" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f475bcf8-48f3-41c3-b277-5b2825a1230d" xlink:to="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_1b047788-76e3-46e2-a4b8-c530adf855b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilityRightOfUseAsset_d56d4ae8-7fc9-4508-aced-825110bd6fa0" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilityRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_f475bcf8-48f3-41c3-b277-5b2825a1230d" xlink:to="loc_pbh_DeferredTaxLiabilityRightOfUseAsset_d56d4ae8-7fc9-4508-aced-825110bd6fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryRecapitalization_ad4062e3-5fb9-44c2-b2c2-f7c65919616b" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryRecapitalization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_pbh_DeferredTaxAssetsInventoryRecapitalization_ad4062e3-5fb9-44c2-b2c2-f7c65919616b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_9be77fed-a3da-4971-ac7f-473692f46461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_9be77fed-a3da-4971-ac7f-473692f46461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_d096da1b-ec62-4a64-b567-f702b136442e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_d096da1b-ec62-4a64-b567-f702b136442e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_30f6ce84-aa67-4efc-aa1b-7f1054a01c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_30f6ce84-aa67-4efc-aa1b-7f1054a01c2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_1273a231-ec0a-4d73-b7e3-d625577fa214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_1273a231-ec0a-4d73-b7e3-d625577fa214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9b37a5eb-533b-4740-9088-f287d5cdfa48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_9b37a5eb-533b-4740-9088-f287d5cdfa48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_756db5d2-477e-4e7a-a460-d02bc4043a2e" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_756db5d2-477e-4e7a-a460-d02bc4043a2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryReserves_5aa0070e-fe5e-4fc5-9eab-1ecf388b1ee8" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryReserves"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_pbh_DeferredTaxAssetsInventoryReserves_5aa0070e-fe5e-4fc5-9eab-1ecf388b1ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dc1a6210-c5d2-4f5e-8567-517dda36c42e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_dc1a6210-c5d2-4f5e-8567-517dda36c42e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsLeaseLiabilities_deceb4f0-adc5-469c-866b-438c5fdff199" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsLeaseLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_pbh_DeferredTaxAssetsLeaseLiabilities_deceb4f0-adc5-469c-866b-438c5fdff199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_e74e343a-fc3e-4d51-8260-2bfa23e76fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_e74e343a-fc3e-4d51-8260-2bfa23e76fb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_289f5733-25bd-4088-a1b9-e341a3ce85e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_32205cf1-3c65-40b3-b1b0-253a3da8f872" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_289f5733-25bd-4088-a1b9-e341a3ce85e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e5797b75-3ee2-49f3-9346-2bb553b00002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9ecaf71e-a643-4071-9372-bdc9e8a2bc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e5797b75-3ee2-49f3-9346-2bb553b00002" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9ecaf71e-a643-4071-9372-bdc9e8a2bc24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_8a29830a-f5e2-4174-a46a-5362475731e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e5797b75-3ee2-49f3-9346-2bb553b00002" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_8a29830a-f5e2-4174-a46a-5362475731e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5ad2a51e-8b77-413e-8e15-abcb60aad844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5ad2a51e-8b77-413e-8e15-abcb60aad844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5ad3d3a1-0c04-4bbb-91ee-c09f6c6e0f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5ad3d3a1-0c04-4bbb-91ee-c09f6c6e0f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_15a365a4-4b52-47ef-a7db-13ef141386f5" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_15a365a4-4b52-47ef-a7db-13ef141386f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f3cbe1e1-d478-4890-acf0-2fd9ced752b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f3cbe1e1-d478-4890-acf0-2fd9ced752b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_5ecb2527-c381-4024-a950-93720ad7b40e" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_5ecb2527-c381-4024-a950-93720ad7b40e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2b3364e8-1371-4d77-8ab5-d7341a4eb843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2b3364e8-1371-4d77-8ab5-d7341a4eb843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_e4862522-f0b5-4e83-854f-fe7b37ec0f2b" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_e4862522-f0b5-4e83-854f-fe7b37ec0f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c37f79f5-0f68-46a5-8c36-3347963f5ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_4514d79a-bc02-46de-b544-80420184dcc8" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c37f79f5-0f68-46a5-8c36-3347963f5ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dc2a0acd-391b-468c-88f9-bde64c9a2e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dc2a0acd-391b-468c-88f9-bde64c9a2e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_390df3b2-806f-4c45-b376-ce12b3a31eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_390df3b2-806f-4c45-b376-ce12b3a31eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_68235a0f-dd34-4185-87ea-31dfc5a20a84" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_68235a0f-dd34-4185-87ea-31dfc5a20a84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ef5ff256-c7fd-482d-816b-125da8d1b983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ef5ff256-c7fd-482d-816b-125da8d1b983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_5607a48d-36d4-459d-8622-25b994177ec2" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_5607a48d-36d4-459d-8622-25b994177ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_56b66acf-ec5a-474a-8b0f-506264d6456c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_56b66acf-ec5a-474a-8b0f-506264d6456c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_268d48fe-887b-4d79-9d49-06054593964b" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_268d48fe-887b-4d79-9d49-06054593964b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0d70a840-73e7-496e-9f36-644075a5a3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_770f3f20-0582-43c3-b58e-59b1a8183ed7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0d70a840-73e7-496e-9f36-644075a5a3a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansPeriodicServiceCostsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b61d2fa8-c0a0-44a0-a744-3c3ad6d58bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a9c0f2d0-2859-4f93-8db2-451efff790fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b61d2fa8-c0a0-44a0-a744-3c3ad6d58bb8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a9c0f2d0-2859-4f93-8db2-451efff790fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f1526af5-e8f1-49ee-9aae-61a8722caef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_b61d2fa8-c0a0-44a0-a744-3c3ad6d58bb8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f1526af5-e8f1-49ee-9aae-61a8722caef9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_2d345763-a431-46fb-903f-7afd3e58fce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c393a3ef-158e-496a-be8e-b01f7a40b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_2d345763-a431-46fb-903f-7afd3e58fce8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c393a3ef-158e-496a-be8e-b01f7a40b6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6890d9ba-a86a-4628-9cc4-b31a7e830ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_2d345763-a431-46fb-903f-7afd3e58fce8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6890d9ba-a86a-4628-9cc4-b31a7e830ddf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_75f77df1-457f-4b9e-aac3-7858a5917829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8dc60dd1-7b39-4abf-ad17-67114c037bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_75f77df1-457f-4b9e-aac3-7858a5917829" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_8dc60dd1-7b39-4abf-ad17-67114c037bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_63f63045-64fe-4eea-8ead-d4c03c291509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_75f77df1-457f-4b9e-aac3-7858a5917829" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_63f63045-64fe-4eea-8ead-d4c03c291509" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_475df64d-182f-4db3-9290-157aef374dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_582bacce-b29e-4207-99c7-56e45db6df56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_475df64d-182f-4db3-9290-157aef374dad" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_582bacce-b29e-4207-99c7-56e45db6df56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7c7efd13-6eaf-4202-b0d3-f1bc664c82e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_475df64d-182f-4db3-9290-157aef374dad" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7c7efd13-6eaf-4202-b0d3-f1bc664c82e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#CommitmentsandContingenciesLongtermSupplyAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2dba4e65-2ea4-4f4a-a30e-05a30a815bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2dba4e65-2ea4-4f4a-a30e-05a30a815bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_7a1fbb46-1353-4cea-b527-0b7fc4c4710a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_7a1fbb46-1353-4cea-b527-0b7fc4c4710a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_cc30c890-6ae9-4e46-85ba-5827d1f01d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_cc30c890-6ae9-4e46-85ba-5827d1f01d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_dd9a1896-7dfe-4bff-a080-c89001d25100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_dd9a1896-7dfe-4bff-a080-c89001d25100" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_04e3558c-50f7-4562-8b35-07f32ad37c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_04e3558c-50f7-4562-8b35-07f32ad37c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_6de68544-0392-4fa5-a804-74339d0eec1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_08ddd311-8f63-4630-af60-8303227b0294" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_6de68544-0392-4fa5-a804-74339d0eec1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_8c06c46f-6eef-43bf-8f37-cc91f6385166" xlink:href="pbh-20220331.xsd#pbh_ContributionMargin"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3be0bc96-21f8-436a-a9aa-e91f45f76898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_8c06c46f-6eef-43bf-8f37-cc91f6385166" xlink:to="loc_us-gaap_GrossProfit_3be0bc96-21f8-436a-a9aa-e91f45f76898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_3e1ab129-cb45-4b7b-8340-d080166c874b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pbh_ContributionMargin_8c06c46f-6eef-43bf-8f37-cc91f6385166" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_3e1ab129-cb45-4b7b-8340-d080166c874b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsAssetsbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_da3aa10f-79d9-4c32-a6a7-4ef31a887314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17c3955f-869f-416c-bedf-d7a4fe35238e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_da3aa10f-79d9-4c32-a6a7-4ef31a887314" xlink:to="loc_us-gaap_Goodwill_17c3955f-869f-416c-bedf-d7a4fe35238e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83ae568b-aee9-4ce6-b8db-8f7a41b07af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_da3aa10f-79d9-4c32-a6a7-4ef31a887314" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_83ae568b-aee9-4ce6-b8db-8f7a41b07af3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>pbh-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended" id="i82411c6c0aae480e8473dc2d951d62e9_ConsolidatedStatementsofIncomeandComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06be6cd9-3143-44c5-8226-7799f65ef166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06be6cd9-3143-44c5-8226-7799f65ef166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_c7982527-4cf7-4a08-af90-7960bc188997" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_c7982527-4cf7-4a08-af90-7960bc188997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_87fd04d7-d284-4bd5-addb-8b9b6d49ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_87fd04d7-d284-4bd5-addb-8b9b6d49ba49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b5c46cda-9f46-4856-89ea-f665fcbe7f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_us-gaap_CostOfRevenue_b5c46cda-9f46-4856-89ea-f665fcbe7f40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9c2d0b40-7cbe-4f1c-a2e3-11b477120fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_GrossProfit_9c2d0b40-7cbe-4f1c-a2e3-11b477120fb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_18ac5de2-3e88-4191-8621-b445e0163344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_18ac5de2-3e88-4191-8621-b445e0163344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7cfa99d7-99f5-47e0-95c3-51cd512209ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7cfa99d7-99f5-47e0-95c3-51cd512209ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_a210ec41-e68f-45c6-ba6d-ef9633fc4388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_a210ec41-e68f-45c6-ba6d-ef9633fc4388" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d9dac929-2a55-43a6-9027-fa1398f4ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_OperatingExpenses_d9dac929-2a55-43a6-9027-fa1398f4ed2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e30822fa-afc2-4a0f-85b2-da0f0e7cf2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OperatingIncomeLoss_e30822fa-afc2-4a0f-85b2-da0f0e7cf2c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_64ab2b37-7de1-4f08-b6ed-8e1b885ee64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_InterestExpenseDebt_64ab2b37-7de1-4f08-b6ed-8e1b885ee64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fc0c2478-4d95-444c-b34a-2d3622e0beb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fc0c2478-4d95-444c-b34a-2d3622e0beb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5cd4bb9d-d4fc-43cd-b136-8155dcd11810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5cd4bb9d-d4fc-43cd-b136-8155dcd11810" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_6a815b46-0c7b-4a79-92af-3a1de2316bf9" xlink:href="pbh-20220331.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_pbh_TotalOtherIncomeExpense_6a815b46-0c7b-4a79-92af-3a1de2316bf9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6b46c452-c27e-4968-9365-8c7d48b24f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6b46c452-c27e-4968-9365-8c7d48b24f00" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5a58526f-d063-4364-8c84-33beb5165316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5a58526f-d063-4364-8c84-33beb5165316" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b29d2b6d-26a2-462f-984e-32bc3ca3626b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_NetIncomeLoss_b29d2b6d-26a2-462f-984e-32bc3ca3626b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ac581b8c-f20c-4779-9a63-91e0d371ff5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:to="loc_us-gaap_EarningsPerShareBasic_ac581b8c-f20c-4779-9a63-91e0d371ff5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f360db51-7bba-4a35-9387-78c8467abde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f360db51-7bba-4a35-9387-78c8467abde8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390d6ed9-6092-41ad-9073-314b29897326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390d6ed9-6092-41ad-9073-314b29897326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc318af2-02fb-4365-9a62-839230dfd573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc318af2-02fb-4365-9a62-839230dfd573" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d9a806f0-f6d3-48ff-8ac0-64eb29094bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d9a806f0-f6d3-48ff-8ac0-64eb29094bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_729595ad-3bde-48ab-aff1-83d0dae5f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_729595ad-3bde-48ab-aff1-83d0dae5f4f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_0e0cef31-839b-4c93-a9c2-095c091b835f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_0e0cef31-839b-4c93-a9c2-095c091b835f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ccb92acf-0f62-4325-b50c-c6873811c4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ccb92acf-0f62-4325-b50c-c6873811c4e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b58c9bfa-027c-4f46-bbdc-dba106abf341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b58c9bfa-027c-4f46-bbdc-dba106abf341" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4cbe22d4-e6cf-430c-b5d7-a23fa6305db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4cbe22d4-e6cf-430c-b5d7-a23fa6305db5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:to="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_87833223-1472-47ca-9b0f-e8da09b805ac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:to="loc_srt_ProductsAndServicesDomain_87833223-1472-47ca-9b0f-e8da09b805ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:to="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ce3874d4-3c64-48ef-bb20-5020c08182b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:to="loc_us-gaap_ProductMember_ce3874d4-3c64-48ef-bb20-5020c08182b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a90ff753-4792-487a-8275-99ba9581f43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a90ff753-4792-487a-8275-99ba9581f43b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended" id="i0f75db426964488fbad437d9e065aca0_ConsolidatedStatementsofChangesinStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_83db0560-adca-4159-8a58-bdc45fba96b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_83db0560-adca-4159-8a58-bdc45fba96b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_0459b5e0-0890-4507-bc06-15a1aeb229a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockShares_0459b5e0-0890-4507-bc06-15a1aeb229a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_69a18cda-2179-4fde-b662-12014fd35e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockholdersEquity_69a18cda-2179-4fde-b662-12014fd35e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3f831b2c-e94f-40dc-8294-be9efc656ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3f831b2c-e94f-40dc-8294-be9efc656ea3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_49f2183a-f836-4da7-9c1f-70b69d2d30f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_49f2183a-f836-4da7-9c1f-70b69d2d30f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fddd1d36-c8b7-461f-9797-7af6361aacad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fddd1d36-c8b7-461f-9797-7af6361aacad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6871cbc2-ae99-4a2d-b711-b170e6d60aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6871cbc2-ae99-4a2d-b711-b170e6d60aa5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f86620d9-ed99-43f2-92ea-5f90bdd34b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f86620d9-ed99-43f2-92ea-5f90bdd34b5a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4bdbfa48-09e3-439b-af91-57507b7b40ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4bdbfa48-09e3-439b-af91-57507b7b40ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6efd3af7-8615-4c27-b6d0-56fc6cb6e7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6efd3af7-8615-4c27-b6d0-56fc6cb6e7c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d0a5758a-37dc-4632-9374-2375084817fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_NetIncomeLoss_d0a5758a-37dc-4632-9374-2375084817fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63cc3df5-8f82-410b-8376-734cc0b971d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63cc3df5-8f82-410b-8376-734cc0b971d5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_49a2d0a8-9f70-4aea-8d3b-56b6c25111d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3b9747f4-43b8-4627-ac5c-9e49e12e5b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c503b08a-4144-4688-ab90-63350a54e7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:to="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d33d7793-8200-4f5b-ad2a-34aed35bb3fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:to="loc_us-gaap_EquityComponentDomain_d33d7793-8200-4f5b-ad2a-34aed35bb3fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:to="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0d95f277-3e6e-4057-a930-36b3697ed05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_CommonStockMember_0d95f277-3e6e-4057-a930-36b3697ed05a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_db4ac54c-6da2-4d0a-adfb-a063e12696c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_db4ac54c-6da2-4d0a-adfb-a063e12696c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_94e96ea5-2ef0-4979-afd7-5f403ce77ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_TreasuryStockMember_94e96ea5-2ef0-4979-afd7-5f403ce77ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df0c66a-c94f-4ba3-aa3f-9879f2baa105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df0c66a-c94f-4ba3-aa3f-9879f2baa105" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1e0b3c30-1fff-43d9-895d-43b116d1571b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_RetainedEarningsMember_1e0b3c30-1fff-43d9-895d-43b116d1571b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationCashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails" xlink:type="extended" id="if344f7accd0c44eabb2b767d6525c965_BusinessandBasisofPresentationCashandCashEquivalentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_PercentageofDepositsHeldinOneLocation_2c01b485-d189-4671-9b33-65aaa9f05df0" xlink:href="pbh-20220331.xsd#pbh_PercentageofDepositsHeldinOneLocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:to="loc_pbh_PercentageofDepositsHeldinOneLocation_2c01b485-d189-4671-9b33-65aaa9f05df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:to="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c85b17c1-88fc-466f-9b10-26648e033036_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:to="loc_srt_SegmentGeographicalDomain_c85b17c1-88fc-466f-9b10-26648e033036_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:to="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SydneyAustraliaMember_7e90764b-6ed4-4995-8355-b94642d174a1" xlink:href="pbh-20220331.xsd#pbh_SydneyAustraliaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:to="loc_pbh_SydneyAustraliaMember_7e90764b-6ed4-4995-8355-b94642d174a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_0617efa2-98b9-4fd3-9deb-f002e013b502" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:to="loc_country_SG_0617efa2-98b9-4fd3-9deb-f002e013b502" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails" xlink:type="extended" id="i73434b68a466498ab253d25ca5eff657_BusinessandBasisofPresentationPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_58ae84ae-ae18-43ad-9140-a2b4f61f79c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_58ae84ae-ae18-43ad-9140-a2b4f61f79c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de4c96aa-05fb-4b26-b89b-8473f730ed48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de4c96aa-05fb-4b26-b89b-8473f730ed48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b4919f72-cf25-4fab-ba90-f651df14aea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_BuildingMember_b4919f72-cf25-4fab-ba90-f651df14aea2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherMachineryAndEquipmentMember_d3948553-1e6f-442d-89e4-a165965d62f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_OtherMachineryAndEquipmentMember_d3948553-1e6f-442d-89e4-a165965d62f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_9a489976-36b7-44d2-ba31-760dc5270f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_ComputerEquipmentMember_9a489976-36b7-44d2-ba31-760dc5270f5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_96c37639-9f86-4451-ad00-67357f62603c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_96c37639-9f86-4451-ad00-67357f62603c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:to="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17b2580a-0e26-4227-9768-8e3d2318b02b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:to="loc_srt_RangeMember_17b2580a-0e26-4227-9768-8e3d2318b02b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:to="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d2814954-3822-44aa-9945-cc8cce8063c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:to="loc_srt_MinimumMember_d2814954-3822-44aa-9945-cc8cce8063c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2dab7e0-a51e-40e0-a635-7da95d46034b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:to="loc_srt_MaximumMember_a2dab7e0-a51e-40e0-a635-7da95d46034b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails" xlink:type="extended" id="i0dcd50a117d94ac99e20196c61ea45a4_BusinessandBasisofPresentationIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eba436f4-f053-4d64-a094-9ef11989e49e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eba436f4-f053-4d64-a094-9ef11989e49e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:to="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a51a314f-b1e3-4c02-96ae-1b5c9242a451_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:to="loc_srt_RangeMember_a51a314f-b1e3-4c02-96ae-1b5c9242a451_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:to="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_036f7fec-9bc4-4da0-bd5d-9ee97c08a98a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:to="loc_srt_MinimumMember_036f7fec-9bc4-4da0-bd5d-9ee97c08a98a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7ffaa4f-3918-4ff4-97ef-896b2ca578d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:to="loc_srt_MaximumMember_a7ffaa4f-3918-4ff4-97ef-896b2ca578d1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationCostofSalesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails" xlink:type="extended" id="ieddab825fbbd40eba78bc66ab67c3ead_BusinessandBasisofPresentationCostofSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5453725c-3774-48b8-836f-a888a2833805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5453725c-3774-48b8-836f-a888a2833805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:to="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:to="loc_srt_ProductsAndServicesDomain_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:to="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_12b52baa-7c53-4ef7-8d3d-249b9fa39db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:to="loc_us-gaap_ShippingAndHandlingMember_12b52baa-7c53-4ef7-8d3d-249b9fa39db4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails" xlink:type="extended" id="ia7cb63316be74d908dfe5d8fcf63d21c_BusinessandBasisofPresentationLeasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffbab4d5-3d41-4357-8e2e-200eddad13fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffbab4d5-3d41-4357-8e2e-200eddad13fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f98c147c-b726-4b55-a017-70e4d2e4daf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f98c147c-b726-4b55-a017-70e4d2e4daf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:to="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:to="loc_srt_RangeMember_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:to="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a06f65db-73cb-4d66-bfa4-d8f36c5353fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:to="loc_srt_MinimumMember_a06f65db-73cb-4d66-bfa4-d8f36c5353fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6719a456-1501-4a9a-b352-ff00276f70f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:to="loc_srt_MaximumMember_6719a456-1501-4a9a-b352-ff00276f70f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="extended" id="i649a84f92608447caad78c40c20f950f_AcquisitionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a40c96de-b5dd-40c9-8e7e-f955ff0c8ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a40c96de-b5dd-40c9-8e7e-f955ff0c8ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_86e2afa0-6990-4b3d-80fa-db5fdce57c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_86e2afa0-6990-4b3d-80fa-db5fdce57c83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement_6605b2b4-90ae-4d21-b897-5560d8824f7e" xlink:href="pbh-20220331.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_SupplyCommitmentTermOfAgreement_6605b2b4-90ae-4d21-b897-5560d8824f7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_a130fe2d-17ab-4b82-bba7-b4f1476e2fc8" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_a130fe2d-17ab-4b82-bba7-b4f1476e2fc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_da71991a-ee86-4a2f-89f8-f049dd715adf" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_da71991a-ee86-4a2f-89f8-f049dd715adf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33afb911-ba92-4809-b9e8-228ca81b0adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33afb911-ba92-4809-b9e8-228ca81b0adf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ecf62061-fe18-495a-afd2-7faadc149fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_Goodwill_ecf62061-fe18-495a-afd2-7faadc149fdb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2392a04f-21da-4d66-9c2f-3faf9092c928_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2392a04f-21da-4d66-9c2f-3faf9092c928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3a2b9f7d-17fb-4b4b-b9cf-4cd50b64bb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3a2b9f7d-17fb-4b4b-b9cf-4cd50b64bb61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fe2d76ed-d834-4297-bba8-b232921d8915_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fe2d76ed-d834-4297-bba8-b232921d8915_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0f2566ab-dc90-4664-af1b-f940f5813a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0f2566ab-dc90-4664-af1b-f940f5813a0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_ec50fec8-ef68-4cab-b785-5a4ca49aa604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:to="loc_us-gaap_TrademarksMember_ec50fec8-ef68-4cab-b785-5a4ca49aa604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_093c3671-ce52-4e31-ac83-68a134479ae2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_093c3671-ce52-4e31-ac83-68a134479ae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_1178708f-ba1c-4288-b034-df3b61de1e51" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_1178708f-ba1c-4288-b034-df3b61de1e51" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i3eb1b41efdee42d0a9c2f85bee76ca89_AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fe891a27-5259-43ea-bfef-9e05efbe46c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fe891a27-5259-43ea-bfef-9e05efbe46c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_77dee03d-91e0-4c5e-98c3-e5f3d95aa192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_Goodwill_77dee03d-91e0-4c5e-98c3-e5f3d95aa192" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_90f5fdd9-06bb-4084-80fa-d01097e94403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_90f5fdd9-06bb-4084-80fa-d01097e94403" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_e339842e-4275-4ec9-bf8d-8a74827e865e" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_e339842e-4275-4ec9-bf8d-8a74827e865e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ce8b5b5f-390e-44e0-92c5-f0455654ca4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ce8b5b5f-390e-44e0-92c5-f0455654ca4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_265a398e-9ec0-4147-a64a-7b6df8dc4c0d" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_265a398e-9ec0-4147-a64a-7b6df8dc4c0d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0b9125a4-4676-47c4-b5e5-b1106a3dd6c8" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0b9125a4-4676-47c4-b5e5-b1106a3dd6c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e8778be1-1c7f-46c9-ad63-52d7cfba8f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e8778be1-1c7f-46c9-ad63-52d7cfba8f2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a1f9e77c-2233-46db-8234-11415b5eaea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a1f9e77c-2233-46db-8234-11415b5eaea6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_01e9f262-1711-4384-b2b7-85a059d32e1c" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_01e9f262-1711-4384-b2b7-85a059d32e1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#PropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="extended" id="ibe7305b484774df891054337ea6b1964_PropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_09bfe3d4-25c3-4425-b765-93093acfc71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_09bfe3d4-25c3-4425-b765-93093acfc71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_80430fc1-3037-4728-bd59-678945d7075f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_80430fc1-3037-4728-bd59-678945d7075f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cbf13e83-8578-49d7-985b-8ef352e9643e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cbf13e83-8578-49d7-985b-8ef352e9643e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7eb803a8-0ce0-4b94-8039-8441ea9935de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:to="loc_us-gaap_Depreciation_7eb803a8-0ce0-4b94-8039-8441ea9935de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a36c97fe-46e4-4631-a585-e05634678e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_LandMember_a36c97fe-46e4-4631-a585-e05634678e4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_9a04b2cf-fe52-4cf1-bfd3-d7dae28da221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_BuildingMember_9a04b2cf-fe52-4cf1-bfd3-d7dae28da221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherMachineryAndEquipmentMember_94d177b1-43c9-45e6-8782-1c9ad78b97f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_OtherMachineryAndEquipmentMember_94d177b1-43c9-45e6-8782-1c9ad78b97f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_0cd4024b-7373-4118-92f0-2f8f92e8af99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_ComputerEquipmentMember_0cd4024b-7373-4118-92f0-2f8f92e8af99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_53a894fa-2b0f-4a3e-a31c-3075f880ea01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_53a894fa-2b0f-4a3e-a31c-3075f880ea01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f2cc7a6e-9774-4c02-96b1-b49d38c3d124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f2cc7a6e-9774-4c02-96b1-b49d38c3d124" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6903502a-0010-4b32-8f92-c56d4e6b2d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_ConstructionInProgressMember_6903502a-0010-4b32-8f92-c56d4e6b2d56" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#GoodwillScheduleofChangesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="extended" id="i875006c940414a6ab08c4f7b89ed668e_GoodwillScheduleofChangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:to="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_87f4a9d5-be95-4ff3-b92a-3e3ea5b69241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillGross_87f4a9d5-be95-4ff3-b92a-3e3ea5b69241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1f0ee85a-9b3c-49ee-aa83-eb6f623f9779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1f0ee85a-9b3c-49ee-aa83-eb6f623f9779" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1494348b-aa55-46ce-b65e-c4355a2803a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_Goodwill_1494348b-aa55-46ce-b65e-c4355a2803a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef0b7642-64e5-4bf6-9d4f-2ce2ea4f4dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef0b7642-64e5-4bf6-9d4f-2ce2ea4f4dff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3e97bff6-9940-4ca5-be45-eabeb5715bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3e97bff6-9940-4ca5-be45-eabeb5715bb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5eb3d006-b291-4a40-b2a3-b2e728184e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5eb3d006-b291-4a40-b2a3-b2e728184e47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_6db41123-1056-4cc9-a2d6-dab7dab13ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8b34b5f3-a537-44d5-a7df-218463a87029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9b74d471-ee90-40b1-8fed-82dde8e6d249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8781cb84-d5cb-413f-b6bb-3f89d167ddee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:to="loc_us-gaap_SegmentDomain_8781cb84-d5cb-413f-b6bb-3f89d167ddee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:to="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_e0977ea6-daa8-4d73-b94f-05641120de3b" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_e0977ea6-daa8-4d73-b94f-05641120de3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_8eda3b83-9b9c-4530-9417-a612d8b91034" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:to="loc_pbh_InternationalOTCHealthcareMember_8eda3b83-9b9c-4530-9417-a612d8b91034" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#GoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="extended" id="i94ea5f2856dd4331aacefe81f81e445e_GoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1470f630-90aa-4bdf-b824-a2644f16b516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_us-gaap_Goodwill_1470f630-90aa-4bdf-b824-a2644f16b516" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_02b66b3f-d961-4216-bd20-9b5071f0a12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_02b66b3f-d961-4216-bd20-9b5071f0a12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_b53db5f0-8592-492a-92d2-4e2520f4edc3" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_b53db5f0-8592-492a-92d2-4e2520f4edc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_64279735-ddc2-43d5-871d-145b8b04f46b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:to="loc_us-gaap_SegmentDomain_64279735-ddc2-43d5-871d-145b8b04f46b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:to="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_255b432c-ecc4-4e3b-ab02-0e66703c0ef9" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:to="loc_pbh_InternationalOTCHealthcareMember_255b432c-ecc4-4e3b-ab02-0e66703c0ef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalAnalgesicsMember_2234e653-4b60-44b2-9504-ea42d1be5cf7" xlink:href="pbh-20220331.xsd#pbh_InternationalAnalgesicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:to="loc_pbh_InternationalAnalgesicsMember_2234e653-4b60-44b2-9504-ea42d1be5cf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87e48322-6ca6-4b63-b50a-b26e43d25814_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87e48322-6ca6-4b63-b50a-b26e43d25814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_23d893b7-dad2-47f7-a7bb-de0161bea891" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_23d893b7-dad2-47f7-a7bb-de0161bea891" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_68327194-14df-4af1-98d9-6936ef933a25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_68327194-14df-4af1-98d9-6936ef933a25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7298ade5-c9c2-49d6-9c30-553da6584e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7298ade5-c9c2-49d6-9c30-553da6584e5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_427ad07c-907f-44d8-98f8-4aa455c4e347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_427ad07c-907f-44d8-98f8-4aa455c4e347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputCapRateMember_575f19e9-5b8f-4088-a4b6-4ec9a8e5afca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputCapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputCapRateMember_575f19e9-5b8f-4088-a4b6-4ec9a8e5afca" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsReconciliationofActivityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails" xlink:type="extended" id="i2bc45ec8b1b34fdd954ebc5e09c2ade1_IntangibleAssetsReconciliationofActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68afc946-b731-46fe-b166-d4e9e1c21002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68afc946-b731-46fe-b166-d4e9e1c21002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_05031fdf-6103-48d8-b05e-8a0c56df4e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_05031fdf-6103-48d8-b05e-8a0c56df4e33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ff994d6-a909-410f-915e-8687b3f61d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ff994d6-a909-410f-915e-8687b3f61d1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_a155f68c-0e78-42f1-85cb-4602c83c6956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_a155f68c-0e78-42f1-85cb-4602c83c6956" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0c2ea719-8c9b-4945-9484-e6e4c55cc828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2cb65b7e-7fe4-4f61-94a5-41ea60ce1126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2cb65b7e-7fe4-4f61-94a5-41ea60ce1126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6ba55ff1-e536-462b-9f41-41163d886261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6ba55ff1-e536-462b-9f41-41163d886261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e82b1922-71b7-4d72-bf42-d807f287e4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e82b1922-71b7-4d72-bf42-d807f287e4cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_75af6044-60c6-47d3-b8d3-d13e212f811d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_75af6044-60c6-47d3-b8d3-d13e212f811d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32f42cbd-b69d-4441-a585-7607a0b30195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b26b94b1-fae4-479f-879c-19bc17098a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b26b94b1-fae4-479f-879c-19bc17098a52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_070600ca-7c48-45ef-9f9c-bc5b2ec3d405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_070600ca-7c48-45ef-9f9c-bc5b2ec3d405" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_d952b477-8ce4-4944-bb8d-a94a4aac1b4d" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_d952b477-8ce4-4944-bb8d-a94a4aac1b4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_d0234edf-4a49-4619-a7f7-5dc07d5fcf2f" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_d0234edf-4a49-4619-a7f7-5dc07d5fcf2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6166cfea-ac38-49f9-bb32-488cbf4a37ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1ca502a-861b-4d6a-878e-bffc82168665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1ca502a-861b-4d6a-878e-bffc82168665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c85aac5d-bb4d-4777-935c-40fbbd084228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c85aac5d-bb4d-4777-935c-40fbbd084228" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_9d61d23c-8180-4544-8b6d-0104f5d91ec0" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_9d61d23c-8180-4544-8b6d-0104f5d91ec0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ed31956e-be22-4c96-9060-45ecc97dbd95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b7ce24a4-252c-4f44-a909-447b851e7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e1ae8d3-4873-4303-939d-034f2185d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e1ae8d3-4873-4303-939d-034f2185d72b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dfc793f0-b2eb-49ac-b200-3963585695c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dfc793f0-b2eb-49ac-b200-3963585695c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired_0ed5fa74-2495-4432-918d-ef3e5452cde9" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_pbh_IntangibleAssetsAcquired_0ed5fa74-2495-4432-918d-ef3e5452cde9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a87b538-27a7-45a4-94e1-0223d5c14727_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a87b538-27a7-45a4-94e1-0223d5c14727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_3bad5e98-2ece-4fb4-ac34-4e7670c46922" xlink:href="pbh-20220331.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_3bad5e98-2ece-4fb4-ac34-4e7670c46922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_db10bd04-842a-4a35-966c-d69a9a9e18fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_db10bd04-842a-4a35-966c-d69a9a9e18fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_b4a986dd-1df1-48f5-a892-d4b9cdd4248b" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_b4a986dd-1df1-48f5-a892-d4b9cdd4248b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d65def4c-3037-4918-89d9-8e761477e8d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:to="loc_us-gaap_SegmentDomain_d65def4c-3037-4918-89d9-8e761477e8d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:to="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_6104c49b-3fa7-4fb7-9e51-b777ce6dcefc" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_6104c49b-3fa7-4fb7-9e51-b777ce6dcefc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_6fef869f-f607-4034-8646-b17d0f613e19" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:to="loc_pbh_InternationalOTCHealthcareMember_6fef869f-f607-4034-8646-b17d0f613e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_38fcbadf-6959-4063-b541-7b08be778772_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:to="loc_us-gaap_AssetAcquisitionDomain_38fcbadf-6959-4063-b541-7b08be778772_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_569343a2-a5ac-4721-952e-b62e8bc46840" xlink:href="pbh-20220331.xsd#pbh_ZaditenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:to="loc_pbh_ZaditenMember_569343a2-a5ac-4721-952e-b62e8bc46840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_131ee776-3b67-412c-aaec-a4c3a3bbac82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_131ee776-3b67-412c-aaec-a4c3a3bbac82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_b7610aa7-ffc4-4917-9f8f-33c30e8761f8" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_b7610aa7-ffc4-4917-9f8f-33c30e8761f8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended" id="id8ca08ed2c184a54a97e7075d5f1880e_IntangibleAssetsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8c03e5ce-52d7-4209-8419-3630c95ed99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8c03e5ce-52d7-4209-8419-3630c95ed99f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_c43c619d-32ce-408f-9c73-2720b0efef14" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_c43c619d-32ce-408f-9c73-2720b0efef14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_9bd71cca-1a12-4280-8301-32e5f3d5eab8" xlink:href="pbh-20220331.xsd#pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_9bd71cca-1a12-4280-8301-32e5f3d5eab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_eaef7e8f-48f1-42c3-a94f-af790b9a5107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_AssetImpairmentCharges_eaef7e8f-48f1-42c3-a94f-af790b9a5107" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_721806c8-cdb7-4b23-97c6-9b485187267d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_721806c8-cdb7-4b23-97c6-9b485187267d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f9bb5578-b596-43ff-b842-e7511d16bd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f9bb5578-b596-43ff-b842-e7511d16bd7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3ce479e-b279-4d7b-ac34-0a63eaa5723a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3ce479e-b279-4d7b-ac34-0a63eaa5723a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_74205f83-6334-4af0-988d-13f8ec6c71e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:to="loc_us-gaap_SegmentDomain_74205f83-6334-4af0-988d-13f8ec6c71e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:to="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_93f7ef23-ab45-496d-805a-1cf9754f4cc9" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:to="loc_pbh_InternationalOTCHealthcareMember_93f7ef23-ab45-496d-805a-1cf9754f4cc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_219b48d4-86bf-4cc6-b51b-098c79125d34_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:to="loc_srt_RangeMember_219b48d4-86bf-4cc6-b51b-098c79125d34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:to="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_43ca3b16-cffb-419b-80fb-92291c4a4d20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:to="loc_srt_MinimumMember_43ca3b16-cffb-419b-80fb-92291c4a4d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_622982d4-c858-4503-b24b-dba6298e3052" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:to="loc_srt_MaximumMember_622982d4-c858-4503-b24b-dba6298e3052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_8a338fbe-330c-4e23-8fab-f8171cbffbd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_8a338fbe-330c-4e23-8fab-f8171cbffbd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_da629a5d-d7fe-409c-846f-f60b69ac4baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_da629a5d-d7fe-409c-846f-f60b69ac4baf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputCapRateMember_63f626f0-33a9-4bac-8fd4-7126e0662574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputCapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:to="loc_us-gaap_MeasurementInputCapRateMember_63f626f0-33a9-4bac-8fd4-7126e0662574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35428b0c-0f9e-4085-990b-5e96a90d0fc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_35428b0c-0f9e-4085-990b-5e96a90d0fc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a79197fc-fe9f-4f16-8749-33bf219909e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:to="loc_us-gaap_TradeNamesMember_a79197fc-fe9f-4f16-8749-33bf219909e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i2e6b2d2387b54ecca01aff57e9e7b52e_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_96b6a4df-d4b1-4d6c-8f4a-cae547bd5f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_96b6a4df-d4b1-4d6c-8f4a-cae547bd5f21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:to="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d80bb2d8-6ed9-4069-8e5a-9845446b2d57_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d80bb2d8-6ed9-4069-8e5a-9845446b2d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember_688b8b54-0b07-467f-90f6-4a72860c5187" xlink:href="pbh-20220331.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:to="loc_pbh_GEODISLogisticsLLCMember_688b8b54-0b07-467f-90f6-4a72860c5187" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended" id="i33589face38d4a6ea267667f60f7d488_LongTermDebtScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_55867738-2f2e-44c6-8b42-d7c45ec47893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_55867738-2f2e-44c6-8b42-d7c45ec47893" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_558c7116-616e-4c68-a788-8fd4d121bf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_558c7116-616e-4c68-a788-8fd4d121bf6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7f169d4a-ffb6-4ceb-a0cd-74c5cb226dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_LongTermDebt_7f169d4a-ffb6-4ceb-a0cd-74c5cb226dee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f34c6f1-070a-484f-aa00-9cdd7f89e382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f34c6f1-070a-484f-aa00-9cdd7f89e382" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_de9c4c21-9f6c-48ef-9a3e-3698711ef2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_de9c4c21-9f6c-48ef-9a3e-3698711ef2eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_c6ee351e-0d2b-4359-b087-5d8214a82846" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_c6ee351e-0d2b-4359-b087-5d8214a82846" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_707f2673-6684-4a59-ba62-d895593a6f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_707f2673-6684-4a59-ba62-d895593a6f14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ec2eee22-ce1e-4d3f-a0a7-8b061467a52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ec2eee22-ce1e-4d3f-a0a7-8b061467a52e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f9fcc0f-5035-4a19-97db-f1551d495598_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f9fcc0f-5035-4a19-97db-f1551d495598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_5282f04f-9f67-42a9-9083-8ef8a796cac5" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_A2021SeniorNotesMember_5282f04f-9f67-42a9-9083-8ef8a796cac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_dac68d68-3d90-49f9-bd37-0e9ace04cabf" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_SeniorNotes2019Member_dac68d68-3d90-49f9-bd37-0e9ace04cabf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_2fd3cd32-acb9-48e4-b01d-80efa603bb1b" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_SeniorNotes2012Member_2fd3cd32-acb9-48e4-b01d-80efa603bb1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_d59880bc-fac8-4275-b7cc-70d8c2a08e1a" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_AblRevolver2012Member_d59880bc-fac8-4275-b7cc-70d8c2a08e1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_91d43944-804a-4519-b1a6-609032482ef4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_91d43944-804a-4519-b1a6-609032482ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_61168603-72d5-49c0-8d76-258bbdc4cb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_us-gaap_SeniorNotesMember_61168603-72d5-49c0-8d76-258bbdc4cb27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b9ab1951-d9c2-42d3-84c4-0fc70034ff29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_us-gaap_LoansPayableMember_b9ab1951-d9c2-42d3-84c4-0fc70034ff29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo5Member_60f90543-0f17-4dec-a6fb-d3c1c098edb0" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo5Member_60f90543-0f17-4dec-a6fb-d3c1c098edb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_dac8e388-3ab2-4980-ae66-af513160fd59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:to="loc_us-gaap_CreditFacilityDomain_dac8e388-3ab2-4980-ae66-af513160fd59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:to="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1a6d502e-9c53-4943-b8a1-8a65aed33962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1a6d502e-9c53-4943-b8a1-8a65aed33962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a06ecc23-9626-4b5d-b883-3b5514b66aa9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:to="loc_us-gaap_VariableRateDomain_a06ecc23-9626-4b5d-b883-3b5514b66aa9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:to="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f522ac88-04ba-4001-8ffd-cc2bfb9e4276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f522ac88-04ba-4001-8ffd-cc2bfb9e4276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_779cb1de-8c24-4b06-83af-deab4246d77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:to="loc_us-gaap_BaseRateMember_779cb1de-8c24-4b06-83af-deab4246d77f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails" xlink:type="extended" id="i708d158392bb48e6bf1c63cb7a9acedb_LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7d78c9b-b16c-447b-ac0c-0122431fb07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7d78c9b-b16c-447b-ac0c-0122431fb07b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6a5056a7-77d1-4cae-84ca-021a3c76f654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentTerm_6a5056a7-77d1-4cae-84ca-021a3c76f654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e48a566c-fdb8-4eee-a76c-bfb738b0e782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e48a566c-fdb8-4eee-a76c-bfb738b0e782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_e6b5563c-cfc6-43c6-9e30-a17906978826" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_e6b5563c-cfc6-43c6-9e30-a17906978826" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_52a56ccc-c2ef-4ad2-9def-c45b2ac3ec29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_52a56ccc-c2ef-4ad2-9def-c45b2ac3ec29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentDiscountPercentage_741657d4-b427-4aa2-8f44-2ceedbfbba0b" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentDiscountPercentage_741657d4-b427-4aa2-8f44-2ceedbfbba0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b7eca05d-26fb-4afa-8cc2-6eeb97bc5785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b7eca05d-26fb-4afa-8cc2-6eeb97bc5785" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e35006c-ff61-4dde-a3ec-6ad1cbdb4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e35006c-ff61-4dde-a3ec-6ad1cbdb4b08" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentReferenceRateFloor_8fe3d113-44c0-4405-8457-c4d80340f966" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentReferenceRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentReferenceRateFloor_8fe3d113-44c0-4405-8457-c4d80340f966" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_4e743d3a-72c8-4434-be38-36842247bc28" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_4e743d3a-72c8-4434-be38-36842247bc28" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_8c7f5df2-bfb2-47e8-a2dc-cda91799d76c" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_8c7f5df2-bfb2-47e8-a2dc-cda91799d76c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate_f1f2b8cc-0273-47c8-9124-c358f106b870" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateConditionalVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate_f1f2b8cc-0273-47c8-9124-c358f106b870" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_1dfd4bfa-b7f0-4ae0-bed4-c9a62364b31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_1dfd4bfa-b7f0-4ae0-bed4-c9a62364b31c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_5ffd67cd-478b-49c3-a0e1-b9d1f5705aa4" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_5ffd67cd-478b-49c3-a0e1-b9d1f5705aa4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature_2ab859e1-1044-4972-8410-313de6ca69a9" xlink:href="pbh-20220331.xsd#pbh_LineofCreditFacilityIncreaseinAccordionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature_2ab859e1-1044-4972-8410-313de6ca69a9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_c966d5a3-0770-4294-a12d-45c0ffdf0107" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_c966d5a3-0770-4294-a12d-45c0ffdf0107" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_0b8312bf-2dde-4925-9867-694d72c0b403" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_0b8312bf-2dde-4925-9867-694d72c0b403" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_97530227-817f-43e9-a8e9-39eb0e2209f7" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_97530227-817f-43e9-a8e9-39eb0e2209f7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_821b850f-4233-456a-b991-b1c7b94d1c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_821b850f-4233-456a-b991-b1c7b94d1c85" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_2e6b2d2e-d377-4eed-89ae-14abc97efd88" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_2e6b2d2e-d377-4eed-89ae-14abc97efd88" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0721db89-dcf5-4316-907d-ba832dd4a7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0721db89-dcf5-4316-907d-ba832dd4a7b3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_43f82511-851b-48fd-8c88-8df7f3449789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_43f82511-851b-48fd-8c88-8df7f3449789" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_e9b6b199-23a8-4d3a-854b-829d99c2077f" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_e9b6b199-23a8-4d3a-854b-829d99c2077f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2df12882-dd4c-419c-a2de-411578f6d7c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2df12882-dd4c-419c-a2de-411578f6d7c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TermLoan2012Member_2174ac4f-2dab-4d46-be47-ecdebab4b7cd" xlink:href="pbh-20220331.xsd#pbh_TermLoan2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_TermLoan2012Member_2174ac4f-2dab-4d46-be47-ecdebab4b7cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_da691dbe-2389-4e1c-aa73-adc16da9ef83" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_AblRevolver2012Member_da691dbe-2389-4e1c-aa73-adc16da9ef83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended2012TermLoanMember_dc170f82-7b59-4049-bd64-af2732e286b9" xlink:href="pbh-20220331.xsd#pbh_Amended2012TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amended2012TermLoanMember_dc170f82-7b59-4049-bd64-af2732e286b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended22012TermLoanMember_e5e7f990-9840-42da-a5cc-376fefb877aa" xlink:href="pbh-20220331.xsd#pbh_Amended22012TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amended22012TermLoanMember_e5e7f990-9840-42da-a5cc-376fefb877aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment3Member_70108a69-7193-4c17-9e43-b881572f93d9" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_A2012ABLRevolverAmendment3Member_70108a69-7193-4c17-9e43-b881572f93d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment32012TermLoanMember_ce1f6f22-e53e-42f1-a2cc-f9b05a31e877" xlink:href="pbh-20220331.xsd#pbh_Amendment32012TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amendment32012TermLoanMember_ce1f6f22-e53e-42f1-a2cc-f9b05a31e877" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLRevolverAmendment4Member_0f98bf38-8e7e-472a-8b48-f4dabe89c023" xlink:href="pbh-20220331.xsd#pbh_ABLRevolverAmendment4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_ABLRevolverAmendment4Member_0f98bf38-8e7e-472a-8b48-f4dabe89c023" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLAmendmentNumber5Member_5e32fbfb-512a-4816-8445-dc09ccd5c4a7" xlink:href="pbh-20220331.xsd#pbh_ABLAmendmentNumber5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_ABLAmendmentNumber5Member_5e32fbfb-512a-4816-8445-dc09ccd5c4a7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_88a7d21b-147b-4329-b4c2-1a32e5853c3d" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_SeniorNotes2012Member_88a7d21b-147b-4329-b4c2-1a32e5853c3d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment6Member_b348201e-d347-4104-aaa4-9986752b3d01" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_A2012ABLRevolverAmendment6Member_b348201e-d347-4104-aaa4-9986752b3d01" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment52012TermLoanMember_917ec867-0711-4242-98cb-f7f12a993d89" xlink:href="pbh-20220331.xsd#pbh_Amendment52012TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amendment52012TermLoanMember_917ec867-0711-4242-98cb-f7f12a993d89" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2013Member_2374cf2a-4456-42e0-b0be-acac377b9fa4" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2013Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_SeniorNotes2013Member_2374cf2a-4456-42e0-b0be-acac377b9fa4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a86cc919-576e-4a11-9869-28dcac4b035c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a86cc919-576e-4a11-9869-28dcac4b035c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_bf73aabf-0369-4781-adbb-c5f85a89422d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_us-gaap_LoansPayableMember_bf73aabf-0369-4781-adbb-c5f85a89422d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB2Member_a067518d-0152-4ff9-87c5-6bbf8b942248" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB2Member_a067518d-0152-4ff9-87c5-6bbf8b942248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB3Member_64f50db5-7033-4f95-8cd2-827bd1a9782b" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB3Member_64f50db5-7033-4f95-8cd2-827bd1a9782b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB1Member_b9c1588d-667c-4419-9eaf-7a1ee9b45b1a" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB1Member_b9c1588d-667c-4419-9eaf-7a1ee9b45b1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member_349f29ef-0ea5-4753-9974-c4a5188bee48" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB4Member_349f29ef-0ea5-4753-9974-c4a5188bee48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_79c62929-309f-47e8-960b-a3378a5bc674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_us-gaap_SecuredDebtMember_79c62929-309f-47e8-960b-a3378a5bc674" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_34f0eb1c-2043-464e-a360-0ba6946f8289_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:to="loc_us-gaap_CreditFacilityDomain_34f0eb1c-2043-464e-a360-0ba6946f8289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:to="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_24b40cce-8317-48f5-b606-b3e60e2b8112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_24b40cce-8317-48f5-b606-b3e60e2b8112" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c6270433-7692-47bd-b1ed-1d6b817d39c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:to="loc_us-gaap_VariableRateDomain_c6270433-7692-47bd-b1ed-1d6b817d39c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:to="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c1eddf26-400f-4ac5-90f5-e81e8458df5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c1eddf26-400f-4ac5-90f5-e81e8458df5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_5cc57bbc-943d-4ed2-a43c-d1e6df80616e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_us-gaap_BaseRateMember_5cc57bbc-943d-4ed2-a43c-d1e6df80616e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FederalFundsRateMember_5a464c19-54fd-4233-b205-867786ab3cfb" xlink:href="pbh-20220331.xsd#pbh_FederalFundsRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_pbh_FederalFundsRateMember_5a464c19-54fd-4233-b205-867786ab3cfb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_803c6f6b-9cdb-43c6-86de-38679aaa7cd9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:to="loc_srt_RangeMember_803c6f6b-9cdb-43c6-86de-38679aaa7cd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:to="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb39ce14-6372-4918-91ac-003b2dd7daac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:to="loc_srt_MinimumMember_fb39ce14-6372-4918-91ac-003b2dd7daac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d974a05-812a-424f-930f-f4cd5bc5f1e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:to="loc_srt_MaximumMember_3d974a05-812a-424f-930f-f4cd5bc5f1e1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2013SeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails" xlink:type="extended" id="i5f91bab67591408481fd695cba6d4e19_LongTermDebtNarrative2013SeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_56f9e18c-c061-4831-89d4-b0256e902f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_56f9e18c-c061-4831-89d4-b0256e902f48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9a20233c-8edb-48b7-ae5e-d409f53f202d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9a20233c-8edb-48b7-ae5e-d409f53f202d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e2196b4d-5ea1-43c4-9a54-3c2d7bbde695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e2196b4d-5ea1-43c4-9a54-3c2d7bbde695" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_af3211cc-917e-4a0b-abe1-831038264af9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_af3211cc-917e-4a0b-abe1-831038264af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6ab5ae11-0547-4a1b-9369-026e8422b236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:to="loc_us-gaap_SeniorNotesMember_6ab5ae11-0547-4a1b-9369-026e8422b236" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5f8ccc49-fcdc-455d-94bd-0af68ed51f00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5f8ccc49-fcdc-455d-94bd-0af68ed51f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2013Member_1ccfbd94-e120-487d-baee-e7e91fc31cc7" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2013Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:to="loc_pbh_SeniorNotes2013Member_1ccfbd94-e120-487d-baee-e7e91fc31cc7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2016SeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails" xlink:type="extended" id="i1b6eb0a0ae8547e89bdcc05b7165dfc0_LongTermDebtNarrative2016SeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_097b2c93-0265-4495-97dc-72f5006e8973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_097b2c93-0265-4495-97dc-72f5006e8973" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_276794b4-4749-4c2f-994f-cb5397b9f370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_276794b4-4749-4c2f-994f-cb5397b9f370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_460808c0-66fd-4280-90a8-8491865f27d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_460808c0-66fd-4280-90a8-8491865f27d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_cf557e1a-4db7-46aa-97d5-0d722c523016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_cf557e1a-4db7-46aa-97d5-0d722c523016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c14ccc76-f746-4836-8ef6-2fa4df4f541b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c14ccc76-f746-4836-8ef6-2fa4df4f541b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_aebd9cb4-260f-4acd-8495-2abae24374e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:to="loc_us-gaap_SeniorNotesMember_aebd9cb4-260f-4acd-8495-2abae24374e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:to="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_003fdfbd-ddce-4290-a44c-bb6047af8785_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_003fdfbd-ddce-4290-a44c-bb6047af8785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_306d190f-d0ff-4a5f-a642-d81ce86b9b72" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:to="loc_pbh_SeniorNotes2016Member_306d190f-d0ff-4a5f-a642-d81ce86b9b72" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2019and2021SeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails" xlink:type="extended" id="id2c85a4d054c46e9932f756e3e7b9c86_LongTermDebtNarrative2019and2021SeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7de60762-d1c1-4675-8f90-1c1e0cfa5c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7de60762-d1c1-4675-8f90-1c1e0cfa5c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60344b74-f444-4224-bb5f-d2c132b5f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60344b74-f444-4224-bb5f-d2c132b5f27e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_3b9db4ef-01a2-4fc1-a604-2f3ca154f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_3b9db4ef-01a2-4fc1-a604-2f3ca154f5e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d3d6a0c8-55bf-45db-9588-7ae4867d2af3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d3d6a0c8-55bf-45db-9588-7ae4867d2af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_4c2323c5-4239-4195-8753-a07067578330" xlink:href="pbh-20220331.xsd#pbh_A2019SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:to="loc_pbh_A2019SeniorNotesMember_4c2323c5-4239-4195-8753-a07067578330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_7e5499da-651f-42d7-ae28-2ee9013a6bef" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:to="loc_pbh_A2021SeniorNotesMember_7e5499da-651f-42d7-ae28-2ee9013a6bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_db537392-7184-44f9-83c4-4c449bc4eedc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_db537392-7184-44f9-83c4-4c449bc4eedc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6742e630-75a1-4cea-837d-3433c2ea6dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:to="loc_us-gaap_SeniorNotesMember_6742e630-75a1-4cea-837d-3433c2ea6dda" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrativeRedemptionsandRestrictionsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails" xlink:type="extended" id="i49d3f03027ab45e5a88f24040ee7b5ab_LongTermDebtNarrativeRedemptionsandRestrictionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_754407b8-0457-48fc-bb04-f13968796b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_754407b8-0457-48fc-bb04-f13968796b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:to="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5bf6b1d2-addf-468c-8ed1-5801dd208837_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5bf6b1d2-addf-468c-8ed1-5801dd208837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d836a34c-4975-4c2d-9175-2cd4fe8eb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:to="loc_us-gaap_SeniorNotesMember_d836a34c-4975-4c2d-9175-2cd4fe8eb0de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_e899b834-4d1f-40d0-8da4-8914e54a6924_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_e899b834-4d1f-40d0-8da4-8914e54a6924_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember_ec4f1c08-8099-4b36-895b-afc73f198d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndirectGuaranteeOfIndebtednessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:to="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember_ec4f1c08-8099-4b36-895b-afc73f198d6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_92ac1253-f605-4a21-827e-433056b27cf7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_92ac1253-f605-4a21-827e-433056b27cf7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_daf96c5b-b3ec-49d9-8d73-ce621756eca6" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:to="loc_pbh_SeniorNotes2019Member_daf96c5b-b3ec-49d9-8d73-ce621756eca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_f3d1df03-5924-43de-9c0b-ad658c752293" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:to="loc_pbh_SeniorNotes2016Member_f3d1df03-5924-43de-9c0b-ad658c752293" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrativeInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails" xlink:type="extended" id="i33f4848ceb3949fe86657dabb46e523b_LongTermDebtNarrativeInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_82a726a7-5a36-4e1c-a051-51058e975994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_82a726a7-5a36-4e1c-a051-51058e975994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:to="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3116cb27-61a4-472a-8a91-d5dad69054d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3116cb27-61a4-472a-8a91-d5dad69054d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4a1686cd-9635-4f5f-9054-e43483757ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:to="loc_us-gaap_InterestRateSwapMember_4a1686cd-9635-4f5f-9054-e43483757ef6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:to="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:to="loc_us-gaap_HedgingDesignationDomain_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:to="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_51ff694f-2a2c-4b14-8238-1fcd589426f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_51ff694f-2a2c-4b14-8238-1fcd589426f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i46204d65d160447b8459dda6e9b2ee36_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_eafd1ad0-85ac-429e-bff2-01590b96141e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:to="loc_us-gaap_LongTermDebtFairValue_eafd1ad0-85ac-429e-bff2-01590b96141e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_31105757-1520-49e3-a01c-a4601f79d52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_31105757-1520-49e3-a01c-a4601f79d52a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0fcd6dc8-619e-4de8-8516-7ea505991751_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0fcd6dc8-619e-4de8-8516-7ea505991751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_072c1a50-5d1b-46f5-a351-0c3fcd7f9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_072c1a50-5d1b-46f5-a351-0c3fcd7f9d31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_abff169e-16ec-438c-9493-4f78250128ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_abff169e-16ec-438c-9493-4f78250128ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b4858c2-28ac-45a1-9b59-3392dcce931b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9b4858c2-28ac-45a1-9b59-3392dcce931b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0262402b-4999-4f4e-ac69-9877e13f7e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0262402b-4999-4f4e-ac69-9877e13f7e04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_92571eea-a185-481b-98a1-89ef00c8c074_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_92571eea-a185-481b-98a1-89ef00c8c074_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_649a4f63-fe30-48a1-8710-cc71019aa9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_SeniorNotesMember_649a4f63-fe30-48a1-8710-cc71019aa9f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_812ff9b9-9128-4b79-9a5d-081439968071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_LoansPayableMember_812ff9b9-9128-4b79-9a5d-081439968071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d6791fcb-e489-48cc-82f2-904e2862f12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d6791fcb-e489-48cc-82f2-904e2862f12d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b734595c-9935-4e2c-bacb-8e2a8817a49d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b734595c-9935-4e2c-bacb-8e2a8817a49d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_804c1e1e-74fb-476b-b62d-32e8fdbba354" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_SeniorNotes2019Member_804c1e1e-74fb-476b-b62d-32e8fdbba354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_e62e64f0-4cf3-49ab-a427-13069b1f0ec3" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_A2021SeniorNotesMember_e62e64f0-4cf3-49ab-a427-13069b1f0ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment52012TermLoanMember_e9a4bcb7-bc5e-41ea-87be-b1bef87d68d7" xlink:href="pbh-20220331.xsd#pbh_Amendment52012TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_Amendment52012TermLoanMember_e9a4bcb7-bc5e-41ea-87be-b1bef87d68d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_7c5cd911-ff09-4f62-a2fd-f6b01479ec2f" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_7c5cd911-ff09-4f62-a2fd-f6b01479ec2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_f4bfd92e-4544-4f2e-a98f-355f828ddc72" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_AblRevolver2012Member_f4bfd92e-4544-4f2e-a98f-355f828ddc72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_53cccdea-faf8-4ea0-b250-3e6202aacaad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_53cccdea-faf8-4ea0-b250-3e6202aacaad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9fb2ac81-e286-428b-88db-70730841968a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:to="loc_us-gaap_InterestRateSwapMember_9fb2ac81-e286-428b-88db-70730841968a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended" id="i70ee32b1d7a74234987225013babef99_DerivativeInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4337ab63-0e57-400a-a75e-9610b315b16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4337ab63-0e57-400a-a75e-9610b315b16b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:to="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:to="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c3c95e8c-9df5-49c7-bef1-7e4f5452969d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:to="loc_us-gaap_HedgingDesignationDomain_c3c95e8c-9df5-49c7-bef1-7e4f5452969d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:to="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36fc89bb-4e86-4347-989f-01142e362ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36fc89bb-4e86-4347-989f-01142e362ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3f5fec34-55df-461c-a0c2-0d042412339b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3f5fec34-55df-461c-a0c2-0d042412339b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4e2b2dd-fcd7-4fd1-a55d-feba114f03d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:to="loc_us-gaap_InterestRateSwapMember_e4e2b2dd-fcd7-4fd1-a55d-feba114f03d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails" xlink:type="extended" id="i24befa6b56a549428c74e99f2db9e173_DerivativeInstrumentsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6b7b3665-a0ca-45ee-95d6-a7e4c2bc13f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6b7b3665-a0ca-45ee-95d6-a7e4c2bc13f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a59432d4-de56-4317-b6a6-10b801150688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a59432d4-de56-4317-b6a6-10b801150688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:to="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8aecf83f-6e23-4b5f-9e06-17546eea83f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:to="loc_us-gaap_InterestRateSwapMember_8aecf83f-6e23-4b5f-9e06-17546eea83f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_86a634ea-7d1a-4a6c-8118-10feec4d5e3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:to="loc_us-gaap_HedgingDesignationDomain_86a634ea-7d1a-4a6c-8118-10feec4d5e3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:to="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b317c343-06ac-42e5-9ab2-6c6538b51a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b317c343-06ac-42e5-9ab2-6c6538b51a74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_23b7faa7-203d-4b1d-a5ea-e56df05cda3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_23b7faa7-203d-4b1d-a5ea-e56df05cda3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d9d17b04-c824-4127-a59b-247a73dd6fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d9d17b04-c824-4127-a59b-247a73dd6fd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4d3ddbec-425d-44d7-aad6-11c71d112c26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4d3ddbec-425d-44d7-aad6-11c71d112c26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c989e165-d0fb-47af-980b-782aa8ca55b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:to="loc_us-gaap_CashFlowHedgingMember_c989e165-d0fb-47af-980b-782aa8ca55b9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails" xlink:type="extended" id="i1f536cdb06184643ac15b4698fca1ecc_DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae8c1eec-6f84-4591-805a-112edb9d4153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae8c1eec-6f84-4591-805a-112edb9d4153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8a156906-6160-446e-ace8-efd65ed202bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8a156906-6160-446e-ace8-efd65ed202bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:to="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_20d5a336-1630-498b-94ce-04383cb6d8da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_20d5a336-1630-498b-94ce-04383cb6d8da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c5ac6ba2-0814-4e85-9052-64678f2f1287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:to="loc_us-gaap_InterestRateSwapMember_c5ac6ba2-0814-4e85-9052-64678f2f1287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_125ae900-bdc3-4223-b30b-a124bd8cd233_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:to="loc_us-gaap_HedgingRelationshipDomain_125ae900-bdc3-4223-b30b-a124bd8cd233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8a4b8e3a-28a2-40ea-ae39-8b2622ef526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8a4b8e3a-28a2-40ea-ae39-8b2622ef526a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c723747a-5c3c-48c4-814f-e1e53ef2db33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c723747a-5c3c-48c4-814f-e1e53ef2db33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fac4a573-4852-47a5-9195-fa7b2a5b60fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:to="loc_us-gaap_InterestExpenseMember_fac4a573-4852-47a5-9195-fa7b2a5b60fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#StockholdersEquityScheduleofSharesRepurchasedDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails" xlink:type="extended" id="i3e69b4713d154fe4885862031a3e3610_StockholdersEquityScheduleofSharesRepurchasedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_803b1413-13de-41a6-a47d-d0a93b5e9e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_803b1413-13de-41a6-a47d-d0a93b5e9e3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4465668a-665f-4a1f-bc46-a5b29688bb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4465668a-665f-4a1f-bc46-a5b29688bb3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b837266-f658-4aab-b688-e13ecd6952b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b837266-f658-4aab-b688-e13ecd6952b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:to="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ebef002-e7cc-4654-91d2-25b66f31df14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ebef002-e7cc-4654-91d2-25b66f31df14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_59588982-44a7-44b6-ab61-186a9dfd54be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:to="loc_us-gaap_RestrictedStockMember_59588982-44a7-44b6-ab61-186a9dfd54be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_b460545a-e757-45a4-96e5-55bde03d7261" xlink:href="pbh-20220331.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:to="loc_pbh_ShareRepurchaseProgramMember_b460545a-e757-45a4-96e5-55bde03d7261" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="ic0fa5b8326e64c13ae116c9c5c83b8b4_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e9bf86bb-582a-4dd5-a4d6-038018fe78fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e9bf86bb-582a-4dd5-a4d6-038018fe78fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3a66763d-3878-415d-8ef1-0a72e4355493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3a66763d-3878-415d-8ef1-0a72e4355493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_a1dca69a-a184-4dbe-bf0b-c71938321787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_a1dca69a-a184-4dbe-bf0b-c71938321787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_0f1dab62-d348-40f7-9ac4-b121852bbdba" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_0f1dab62-d348-40f7-9ac4-b121852bbdba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8030fbd8-8eb4-49f8-94f8-dfb46f5d6c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8030fbd8-8eb4-49f8-94f8-dfb46f5d6c1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_00ee7e9d-3843-4a94-ade4-09e95233c7a5" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_00ee7e9d-3843-4a94-ade4-09e95233c7a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_34df0f9c-19d6-4196-a26d-b728d97bf7a7" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_34df0f9c-19d6-4196-a26d-b728d97bf7a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4e7c8b16-a43c-4644-b8fe-d4776dc56688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4e7c8b16-a43c-4644-b8fe-d4776dc56688" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9958755-4f62-4a6e-a144-0cba5cd9879e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9958755-4f62-4a6e-a144-0cba5cd9879e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_054ed7fa-72a9-46ae-b8f4-4a1986e55de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_054ed7fa-72a9-46ae-b8f4-4a1986e55de3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e3f1b49c-ddb9-4c10-9984-c3ff51d2c800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e3f1b49c-ddb9-4c10-9984-c3ff51d2c800" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_489f91b7-da69-4807-906b-e38acadc6227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_489f91b7-da69-4807-906b-e38acadc6227" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80f40098-70e8-49a0-bf79-08cd058d11c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80f40098-70e8-49a0-bf79-08cd058d11c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_8778bd71-34c2-4cb2-be8d-be7f73ddcfcc" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_8778bd71-34c2-4cb2-be8d-be7f73ddcfcc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53add711-22e4-480f-9873-8eebdc7aa728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53add711-22e4-480f-9873-8eebdc7aa728" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_a1d16680-9373-4e7d-b6b3-078627af111e" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_a1d16680-9373-4e7d-b6b3-078627af111e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_b9e89aae-72ca-46ba-9b4e-93de8d406900" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_b9e89aae-72ca-46ba-9b4e-93de8d406900" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_51a38add-c88b-4a7c-81aa-7aebbe30d178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_51a38add-c88b-4a7c-81aa-7aebbe30d178" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_285216c2-8436-42b7-bee7-52a4301ebcc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:to="loc_us-gaap_PlanNameDomain_285216c2-8436-42b7-bee7-52a4301ebcc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:to="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_d37cac7d-dc24-4eba-8076-2354fac73252" xlink:href="pbh-20220331.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_d37cac7d-dc24-4eba-8076-2354fac73252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_182f69cd-2568-41a0-b2dd-e6358ec5e367" xlink:href="pbh-20220331.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_182f69cd-2568-41a0-b2dd-e6358ec5e367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d1d174-92f8-4421-a246-38083a7e259d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9d1d174-92f8-4421-a246-38083a7e259d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_a348de72-d878-41ef-874a-f648f6ccabab" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_a348de72-d878-41ef-874a-f648f6ccabab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c0360f1c-6da2-406b-b15f-d2c2a475451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_PerformanceSharesMember_c0360f1c-6da2-406b-b15f-d2c2a475451f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_66ad8546-869a-4f6a-96e3-a0d11bff94ed" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_66ad8546-869a-4f6a-96e3-a0d11bff94ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d28f8515-42f7-4baa-b658-93d2f57f5c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d28f8515-42f7-4baa-b658-93d2f57f5c42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a2fcea57-19a1-4a40-b72d-2a21d84c3d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a2fcea57-19a1-4a40-b72d-2a21d84c3d9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9a994aa1-0289-4951-b6d6-12ae2210782e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:to="loc_srt_RangeMember_9a994aa1-0289-4951-b6d6-12ae2210782e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:to="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ae33654-b8c3-4f73-809c-84d421367d9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:to="loc_srt_MinimumMember_8ae33654-b8c3-4f73-809c-84d421367d9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e7f34c81-da8c-4446-bdd7-5ca38a54c7da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e7f34c81-da8c-4446-bdd7-5ca38a54c7da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_316bb005-06bb-4dc6-b75f-8bef9eebe091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:to="loc_srt_DirectorMember_316bb005-06bb-4dc6-b75f-8bef9eebe091" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationRestrictedSharesActivityDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails" xlink:type="extended" id="i5e59dff128224011a5435ddb2c1aec01_ShareBasedCompensationRestrictedSharesActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_42afce09-ef99-4274-84e6-c124aee25194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_42afce09-ef99-4274-84e6-c124aee25194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b85ca48f-cdbc-43e8-9019-b5abc103ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b85ca48f-cdbc-43e8-9019-b5abc103ce5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_687e1181-3ba9-4618-bc5b-154fbd461de1" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_687e1181-3ba9-4618-bc5b-154fbd461de1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_192778aa-0485-4c9c-90c8-9d32df16d393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_192778aa-0485-4c9c-90c8-9d32df16d393" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fa68569f-b2a7-4501-a7ba-23560c58ca24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_576c50e0-43a4-437f-aefc-d90ca3d72adf" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_576c50e0-43a4-437f-aefc-d90ca3d72adf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_d5de9567-9eb5-400d-82e6-ad60f082cd4d" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_d5de9567-9eb5-400d-82e6-ad60f082cd4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afa31ce2-9ba8-415a-afb9-ee80377e3112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afa31ce2-9ba8-415a-afb9-ee80377e3112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_201fa31f-4f30-4372-8bf8-d63c713f69dc" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_201fa31f-4f30-4372-8bf8-d63c713f69dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40b4a850-ba09-4aef-8c82-39c46d9d2dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40b4a850-ba09-4aef-8c82-39c46d9d2dda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_875cac9e-b398-4455-99c1-a5d20f318147" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_d84ade09-139d-455d-a534-50ceadbe288d" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_d84ade09-139d-455d-a534-50ceadbe288d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:to="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a3d8b2c4-a53f-465e-82df-911402608611_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a3d8b2c4-a53f-465e-82df-911402608611_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_31e8a499-35c5-451c-bc3e-eaf50c7766fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_31e8a499-35c5-451c-bc3e-eaf50c7766fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended" id="i796bbff61f774508b9cdf7dd557ca132_ShareBasedCompensationStockOptionValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388138b4-4cae-4302-8574-0ed7486d238f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388138b4-4cae-4302-8574-0ed7486d238f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9e1f83b6-ef24-40cf-b1c2-1b76102fc7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9e1f83b6-ef24-40cf-b1c2-1b76102fc7c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_93586184-9141-4bfd-a4f6-c0b4ab2f388c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_93586184-9141-4bfd-a4f6-c0b4ab2f388c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_056d5f6e-0689-4359-81ac-81e75be6244a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_056d5f6e-0689-4359-81ac-81e75be6244a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c58f6251-7191-4a43-8a9a-d529deefc838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c58f6251-7191-4a43-8a9a-d529deefc838" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:to="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9a1fe3d-92db-4366-a71b-42696c322092_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c9a1fe3d-92db-4366-a71b-42696c322092_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5bd62b46-a321-45e9-842c-79ce1d1088de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5bd62b46-a321-45e9-842c-79ce1d1088de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:to="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14a591cf-845b-493c-a5ab-477e8b6647f4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:to="loc_srt_RangeMember_14a591cf-845b-493c-a5ab-477e8b6647f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:to="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1db3111d-e7ce-4c80-a2d1-5a71e697a953" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:to="loc_srt_MinimumMember_1db3111d-e7ce-4c80-a2d1-5a71e697a953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5dff66a8-02a1-47a7-b8cd-c6ba6b2fbda3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:to="loc_srt_MaximumMember_5dff66a8-02a1-47a7-b8cd-c6ba6b2fbda3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="ib39fa2e95ad243bea18a7bebf268de3d_AccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_46971d77-d6ae-4aaa-907e-f888654d1636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_StockholdersEquity_46971d77-d6ae-4aaa-907e-f888654d1636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_6afd90ad-9dcb-4359-9b4e-cdcf561bef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_6afd90ad-9dcb-4359-9b4e-cdcf561bef5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_1c155f7e-3ac7-434e-951d-bdac7bcd376e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_1c155f7e-3ac7-434e-951d-bdac7bcd376e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_05fb95b4-4277-4f12-893a-8ceb45951a32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:to="loc_us-gaap_EquityComponentDomain_05fb95b4-4277-4f12-893a-8ceb45951a32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:to="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_03817353-5051-4a6f-a6df-d61a2626152a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_03817353-5051-4a6f-a6df-d61a2626152a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22b9a382-4552-4367-86b8-a0ca1bc2ec20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22b9a382-4552-4367-86b8-a0ca1bc2ec20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a6f991f-8296-4537-a4ce-4505e945b235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a6f991f-8296-4537-a4ce-4505e945b235" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i4fd1c9c3b4f944cd9c6dab938ede9b04_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8c6b2ed5-68c6-4f5b-8c58-bfa512fcc54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8c6b2ed5-68c6-4f5b-8c58-bfa512fcc54d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d67a78e-4a06-463b-9ec5-d0feb9aef759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d67a78e-4a06-463b-9ec5-d0feb9aef759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_8adf566b-2b75-4b84-9e3f-d4794669c664" xlink:href="pbh-20220331.xsd#pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_8adf566b-2b75-4b84-9e3f-d4794669c664" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_55c16fb5-1932-4aca-9b3d-cf447f1cccb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_55c16fb5-1932-4aca-9b3d-cf447f1cccb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_381005c1-54df-4ec2-a157-06224fc55822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:to="loc_us-gaap_ForeignCountryMember_381005c1-54df-4ec2-a157-06224fc55822" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended" id="i302da835c797456bb2753851be2f13b3_EmployeeRetirementPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_88cb5dcc-b3bf-43f5-8798-ded489acb753" xlink:href="pbh-20220331.xsd#pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_88cb5dcc-b3bf-43f5-8798-ded489acb753" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_187c9127-19cc-47db-ba78-efddfef2a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_187c9127-19cc-47db-ba78-efddfef2a0f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2c4f7782-6b0f-4307-b4c7-ce827fd2fa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2c4f7782-6b0f-4307-b4c7-ce827fd2fa4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_9d366d94-b698-4399-aa2e-68359c1297e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_9d366d94-b698-4399-aa2e-68359c1297e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_fb91cb58-c6be-4c02-a3f0-6ebd13c94fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_fb91cb58-c6be-4c02-a3f0-6ebd13c94fec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f6562b8a-7b21-4b5f-aa82-8af948a06c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f6562b8a-7b21-4b5f-aa82-8af948a06c8a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2b7cdec3-006e-40f2-aad7-f1c54aab6034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2b7cdec3-006e-40f2-aad7-f1c54aab6034" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_de11b043-22e1-4fc0-8c5a-82ad66a27996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_de11b043-22e1-4fc0-8c5a-82ad66a27996" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_5b4063ed-e8c3-422d-aa4d-29780b4a695e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_5b4063ed-e8c3-422d-aa4d-29780b4a695e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate_00186369-8755-4297-9ee0-a9e6d9fe8523" xlink:href="pbh-20220331.xsd#pbh_DefinedBenefitPlanRemeasurementDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate_00186369-8755-4297-9ee0-a9e6d9fe8523" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a814f3c2-2c69-473a-b4c8-5236d066cd04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a814f3c2-2c69-473a-b4c8-5236d066cd04" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b0bbc208-f2ea-4604-9169-09a1c3aebe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b0bbc208-f2ea-4604-9169-09a1c3aebe8b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionDomain_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c_default" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:to="loc_pbh_RetirementPlanContributionDomain_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:to="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheOneMember_361c56ac-e50d-40b1-8c40-0e5e9318b5cc" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:to="loc_pbh_ContributionTrancheOneMember_361c56ac-e50d-40b1-8c40-0e5e9318b5cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheTwoMember_e95ba532-ad19-4b93-999b-9940b7ab0d52" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:to="loc_pbh_ContributionTrancheTwoMember_e95ba532-ad19-4b93-999b-9940b7ab0d52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_edff5238-155f-4c2b-8550-bc11e9307f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:to="loc_us-gaap_UnfundedPlanMember_edff5238-155f-4c2b-8550-bc11e9307f45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_e4406687-5b78-47d0-b9ab-fa41713f919e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_e4406687-5b78-47d0-b9ab-fa41713f919e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_34228f26-2897-4bda-b4a1-714385d5c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:to="loc_us-gaap_QualifiedPlanMember_34228f26-2897-4bda-b4a1-714385d5c8eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_706095cf-9aaa-4a6f-9d9b-50e36dbaa094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_706095cf-9aaa-4a6f-9d9b-50e36dbaa094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2de60949-7526-4b85-bf91-8209a2357021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2de60949-7526-4b85-bf91-8209a2357021" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails" xlink:type="extended" id="i5ae0949d6bbb4bcdb4dc07f29b15dd22_EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_bbbe2c9c-839f-4286-afd8-254ebbc2dc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_bbbe2c9c-839f-4286-afd8-254ebbc2dc11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_901123e7-a81d-465d-8c97-12ebe1d0cb15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_901123e7-a81d-465d-8c97-12ebe1d0cb15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e1bcb708-ddd5-488f-818f-ea2dc60ebe02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e1bcb708-ddd5-488f-818f-ea2dc60ebe02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_33e13997-d5fc-4ba2-8e62-fdb208c46fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_33e13997-d5fc-4ba2-8e62-fdb208c46fc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2db44e62-857a-4cb6-91c7-0278ff2a30ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2db44e62-857a-4cb6-91c7-0278ff2a30ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8cbe6a92-e4aa-43f7-b378-1b96db5db8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8cbe6a92-e4aa-43f7-b378-1b96db5db8b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansCategoryofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails" xlink:type="extended" id="i4f99ca81e7684dc3896f84f8c2689709_EmployeeRetirementPlansCategoryofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_75337c2f-a6ee-4fad-b79c-6d4ab72451dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_75337c2f-a6ee-4fad-b79c-6d4ab72451dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_b70c6c87-1bbb-415b-be49-751383a9f9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_b70c6c87-1bbb-415b-be49-751383a9f9ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f8d3313d-afba-477c-8d02-9c37056cf6cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f8d3313d-afba-477c-8d02-9c37056cf6cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_659a0d50-8881-4e0c-b068-6a94cb0e36cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_659a0d50-8881-4e0c-b068-6a94cb0e36cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_1b2fd8f8-1118-4152-b6e1-159cd49604ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:to="loc_us-gaap_FixedIncomeFundsMember_1b2fd8f8-1118-4152-b6e1-159cd49604ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails" xlink:type="extended" id="i336726bb665b4845a72cc1ccc314bd0d_EmployeeRetirementPlansWeightedAverageAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_3c957339-af11-4ffb-b849-f17052101ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_3c957339-af11-4ffb-b849-f17052101ab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0950cbd1-0ce5-4319-b87b-054f9bd2ad85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0950cbd1-0ce5-4319-b87b-054f9bd2ad85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:to="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc37bad2-a0f6-42c2-b861-d22bc5e6808b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:to="loc_srt_RangeMember_cc37bad2-a0f6-42c2-b861-d22bc5e6808b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:to="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0efa5545-07e2-4f99-b5ea-4cf643ddc283" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:to="loc_srt_MinimumMember_0efa5545-07e2-4f99-b5ea-4cf643ddc283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85442141-f115-4442-baad-ecbd06e3331b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:to="loc_srt_MaximumMember_85442141-f115-4442-baad-ecbd06e3331b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_7404ce1f-6c29-4df8-9898-3abebe9a37ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_7404ce1f-6c29-4df8-9898-3abebe9a37ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_6496cef2-7575-43af-997e-2b360e57aa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:to="loc_us-gaap_QualifiedPlanMember_6496cef2-7575-43af-997e-2b360e57aa5b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#CommitmentsandContingenciesLongtermSupplyAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="extended" id="i0223f429c0d84a3dbf5a48a43eda2c5a_CommitmentsandContingenciesLongtermSupplyAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2cce7fa8-4d17-4607-996c-091e67d6c032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2cce7fa8-4d17-4607-996c-091e67d6c032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_b8a4ec01-4a7c-4941-929c-995247b9a346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_b8a4ec01-4a7c-4941-929c-995247b9a346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_667f33cb-5027-4feb-b523-0148ed353661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_667f33cb-5027-4feb-b523-0148ed353661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_c5754749-a9b7-4edb-b883-0d0005153c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c5754749-a9b7-4edb-b883-0d0005153c46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_a51681ee-fbc7-44a2-a554-51b56d6d89d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_a51681ee-fbc7-44a2-a554-51b56d6d89d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_4008e22e-6341-4239-8a63-9da22938c56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_4008e22e-6341-4239-8a63-9da22938c56a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_4125a58e-021e-466c-8e3a-e04bb9042c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligation_4125a58e-021e-466c-8e3a-e04bb9042c85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_5ea3e355-3b65-4565-98c4-b259b6a22f8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_5ea3e355-3b65-4565-98c4-b259b6a22f8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ThirdPartyManufacturingMember_68c4e0d9-738c-4e4c-bd76-4f99688894c8" xlink:href="pbh-20220331.xsd#pbh_ThirdPartyManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:to="loc_pbh_ThirdPartyManufacturingMember_68c4e0d9-738c-4e4c-bd76-4f99688894c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConcentrationsofRiskDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended" id="i86ac45a9a6ee4b8bb795c3a6b9f2a9c8_ConcentrationsofRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cdb4cf6a-0ea5-4b56-9705-ffeaf3b3bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cdb4cf6a-0ea5-4b56-9705-ffeaf3b3bb54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_b27c62e5-948c-4842-8e89-0aa74fd7c9da" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_b27c62e5-948c-4842-8e89-0aa74fd7c9da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_578b09f3-2bcd-4984-ae13-9528239fc905" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_578b09f3-2bcd-4984-ae13-9528239fc905" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8b19579-2f62-4887-bb1d-2453df81c4f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f8b19579-2f62-4887-bb1d-2453df81c4f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_7d4b5ffd-68e3-426d-b345-fdfd0a508d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:to="loc_us-gaap_SalesMember_7d4b5ffd-68e3-426d-b345-fdfd0a508d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_4456df2e-9fd6-4d5e-8997-ab7241ded836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:to="loc_us-gaap_AccountsReceivableMember_4456df2e-9fd6-4d5e-8997-ab7241ded836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_946f9763-105a-43d0-a483-08569cf6d093_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_946f9763-105a-43d0-a483-08569cf6d093_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_3f9e6506-5d1b-4ab0-bfac-c4f2676ff6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_3f9e6506-5d1b-4ab0-bfac-c4f2676ff6d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_17cc12f1-d36e-4ade-89d9-7193845525d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_17cc12f1-d36e-4ade-89d9-7193845525d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_0779619e-595d-4924-a61d-fe10b76e9035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_0779619e-595d-4924-a61d-fe10b76e9035" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_dff94cfa-32c8-42a2-a674-86c1b307d3bb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:to="loc_srt_NameOfMajorCustomerDomain_dff94cfa-32c8-42a2-a674-86c1b307d3bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:to="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Top5BrandsMember_22460db0-7c91-4845-8654-6d2f71be7576" xlink:href="pbh-20220331.xsd#pbh_Top5BrandsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:to="loc_pbh_Top5BrandsMember_22460db0-7c91-4845-8654-6d2f71be7576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_fe07a370-eb9b-4c24-8e20-33f70da8d7c2" xlink:href="pbh-20220331.xsd#pbh_WalmartMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:to="loc_pbh_WalmartMember_fe07a370-eb9b-4c24-8e20-33f70da8d7c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_68992ec2-450a-4424-a353-e5b46716a3be_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:to="loc_srt_ProductsAndServicesDomain_68992ec2-450a-4424-a353-e5b46716a3be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:to="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember_d09c3e05-f568-4caa-b076-7c2c1a27d531" xlink:href="pbh-20220331.xsd#pbh_ManufacturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:to="loc_pbh_ManufacturesMember_d09c3e05-f568-4caa-b076-7c2c1a27d531" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended" id="i0e05900751384eaf9f01ea881e380f43_BusinessSegmentsInformationonOperatingandReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5181cff-6b51-4aa3-949a-6ebbce198392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5181cff-6b51-4aa3-949a-6ebbce198392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b9308f3c-057d-4cb1-9a23-64ba5d166836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_CostOfRevenue_b9308f3c-057d-4cb1-9a23-64ba5d166836" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8ae7026b-7b4f-4ae8-aca8-967ee180b3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_GrossProfit_8ae7026b-7b4f-4ae8-aca8-967ee180b3b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_ae8be21c-254c-4322-937c-eb1c126257e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_ae8be21c-254c-4322-937c-eb1c126257e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_1568ac9a-51f8-459d-9af3-d47390ddaba1" xlink:href="pbh-20220331.xsd#pbh_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_pbh_ContributionMargin_1568ac9a-51f8-459d-9af3-d47390ddaba1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_e26e49b5-4026-4634-8379-808e805a9de7" xlink:href="pbh-20220331.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_e26e49b5-4026-4634-8379-808e805a9de7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9bfe90d0-8a49-4384-9362-d1222e03fb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_9bfe90d0-8a49-4384-9362-d1222e03fb26" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_857b4d81-6c57-4804-8a98-c223ba5966e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:to="loc_us-gaap_SegmentDomain_857b4d81-6c57-4804-8a98-c223ba5966e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:to="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_5834264f-00dc-4125-9675-482d4fe5c9c3" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_5834264f-00dc-4125-9675-482d4fe5c9c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_038eb133-7406-41c0-93d2-a1fdc08c370a" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:to="loc_pbh_InternationalOTCHealthcareMember_038eb133-7406-41c0-93d2-a1fdc08c370a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:to="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:to="loc_srt_ConsolidationItemsDomain_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:to="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_ef286a9d-dc71-46fa-8026-71531146ddd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:to="loc_us-gaap_IntersegmentEliminationMember_ef286a9d-dc71-46fa-8026-71531146ddd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsRevenuebyProductDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails" xlink:type="extended" id="i3105b49e112b4397a19ffdfcbe5c61e1_BusinessSegmentsRevenuebyProductDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1465f09-2e25-455f-8163-13f85c833584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1465f09-2e25-455f-8163-13f85c833584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50e8967b-9eae-4c87-a5bf-c548894c026c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:to="loc_us-gaap_SegmentDomain_50e8967b-9eae-4c87-a5bf-c548894c026c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:to="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_1ee56834-6765-4fcd-aa4b-1473df6a79f5" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_1ee56834-6765-4fcd-aa4b-1473df6a79f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_179ae533-4d76-4e9c-9fdb-359f3e1e5e1b" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:to="loc_pbh_InternationalOTCHealthcareMember_179ae533-4d76-4e9c-9fdb-359f3e1e5e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:to="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6422134c-33be-46d2-8fc5-8949d6f42f82_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:to="loc_srt_ProductsAndServicesDomain_6422134c-33be-46d2-8fc5-8949d6f42f82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:to="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_1f5d69a1-4935-4322-80fc-1e19ce420014" xlink:href="pbh-20220331.xsd#pbh_AnalgesicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_AnalgesicsMember_1f5d69a1-4935-4322-80fc-1e19ce420014" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f678a5ef-4676-4d55-8285-5c0db51bb427" xlink:href="pbh-20220331.xsd#pbh_CoughAndColdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_CoughAndColdMember_f678a5ef-4676-4d55-8285-5c0db51bb427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_ed700e3c-bce0-403f-911e-03957a1fa227" xlink:href="pbh-20220331.xsd#pbh_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_WomensHealthMember_ed700e3c-bce0-403f-911e-03957a1fa227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_7b1f005a-effd-462a-becc-d0369632d706" xlink:href="pbh-20220331.xsd#pbh_GastrointestinalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_GastrointestinalMember_7b1f005a-effd-462a-becc-d0369632d706" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_0c8d8dfe-d08e-4a9a-b357-35898cd33d60" xlink:href="pbh-20220331.xsd#pbh_EyeAndEarCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_EyeAndEarCareMember_0c8d8dfe-d08e-4a9a-b357-35898cd33d60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_a1ea95cb-ed3c-4a8d-878c-720d233081c6" xlink:href="pbh-20220331.xsd#pbh_DermatologicalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_DermatologicalsMember_a1ea95cb-ed3c-4a8d-878c-720d233081c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_bf82ec02-99d8-4f68-a16d-73c9fd63492e" xlink:href="pbh-20220331.xsd#pbh_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_OralCareMember_bf82ec02-99d8-4f68-a16d-73c9fd63492e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_373b02c4-51a9-4840-89bf-f702dce428e5" xlink:href="pbh-20220331.xsd#pbh_OtherOtcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_OtherOtcMember_373b02c4-51a9-4840-89bf-f702dce428e5" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsRevenuebyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="extended" id="i9b94fd332a734f3d9f2101a5c37ca32e_BusinessSegmentsRevenuebyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_adf5559e-fae3-47d4-b3eb-13dbff5e386b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_adf5559e-fae3-47d4-b3eb-13dbff5e386b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:to="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e195bf22-f42f-4aa5-a62e-97e37eac6717_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:to="loc_srt_SegmentGeographicalDomain_e195bf22-f42f-4aa5-a62e-97e37eac6717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:to="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_11c6f091-c2ce-4dc5-84b8-0fff72bb2f9b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:to="loc_country_US_11c6f091-c2ce-4dc5-84b8-0fff72bb2f9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_18d8da05-8ec5-4a4b-879c-5524cab38251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:to="loc_us-gaap_NonUsMember_18d8da05-8ec5-4a4b-879c-5524cab38251" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsAssetsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="extended" id="icb2f3b406cd14d8784d16211a19fd4ec_BusinessSegmentsAssetsbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f2e997c1-f9d4-4a8a-ae3d-866631c19f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_Goodwill_f2e997c1-f9d4-4a8a-ae3d-866631c19f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2004b223-4a92-4df1-9e95-33dc3705be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2004b223-4a92-4df1-9e95-33dc3705be7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64b1b8af-ffa4-4778-b985-6e35ece3ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64b1b8af-ffa4-4778-b985-6e35ece3ae58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5430611-d0ae-4a10-ac79-3cc9e056355c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5430611-d0ae-4a10-ac79-3cc9e056355c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f53ce99c-a9c0-465b-b436-1b282d3e1d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f53ce99c-a9c0-465b-b436-1b282d3e1d7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_86f2f6a9-7993-473a-ab12-72a07ee588c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_86f2f6a9-7993-473a-ab12-72a07ee588c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_d44aee5b-70b0-49d5-aa94-cd47b2bc15b5" xlink:href="pbh-20220331.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_d44aee5b-70b0-49d5-aa94-cd47b2bc15b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f3dc1606-394d-4141-b416-c138c02c8af0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f3dc1606-394d-4141-b416-c138c02c8af0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_19b8334d-218f-46c6-bb11-9177e0fb9b63" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_19b8334d-218f-46c6-bb11-9177e0fb9b63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:to="loc_us-gaap_SegmentDomain_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:to="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_186483c1-643d-439e-93f9-1b29ad52d745" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_186483c1-643d-439e-93f9-1b29ad52d745" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_40e535c9-63a1-464a-ad14-d3bb50c12b39" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:to="loc_pbh_InternationalOTCHealthcareMember_40e535c9-63a1-464a-ad14-d3bb50c12b39" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails" xlink:type="extended" id="ia4a14a1c74c0469f8604856c68c3ef78_BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2b0e1e7-d647-4cae-b06a-abfd016db394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2b0e1e7-d647-4cae-b06a-abfd016db394" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:to="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:to="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_76120278-b7c0-448c-94db-5c13da14665a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:to="loc_srt_SegmentGeographicalDomain_76120278-b7c0-448c-94db-5c13da14665a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:to="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b98a1f1-6630-441d-9550-c236cc7d599b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:to="loc_country_US_8b98a1f1-6630-441d-9550-c236cc7d599b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_6d3f4db3-6f1b-458a-aced-312cfba420f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:to="loc_us-gaap_NonUsMember_6d3f4db3-6f1b-458a-aced-312cfba420f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/SubsequentEventsDetails" xlink:type="extended" id="ie7f410c17f5d4248a9b4b41cf96a95f6_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6d995f-a2e5-47a1-b12b-4ae8c2060c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6d995f-a2e5-47a1-b12b-4ae8c2060c49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4b94884f-bf0d-4b22-8a0e-31f57afc4356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4b94884f-bf0d-4b22-8a0e-31f57afc4356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_98aeec16-d2aa-47f2-b831-6adaf18c5f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_98aeec16-d2aa-47f2-b831-6adaf18c5f3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3897d1e2-2829-4095-b490-898a35a8ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3897d1e2-2829-4095-b490-898a35a8ed46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aeba8895-74b9-4f25-979c-ec438912e106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aeba8895-74b9-4f25-979c-ec438912e106" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_9d6f3255-7c8c-40df-a4cc-4ee687bc7030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_9d6f3255-7c8c-40df-a4cc-4ee687bc7030" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_a40ef6f1-bc7d-47cc-93d8-5e35f97e87ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_a40ef6f1-bc7d-47cc-93d8-5e35f97e87ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ebea5a84-9dec-40ac-88ed-cec95ba20f16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ebea5a84-9dec-40ac-88ed-cec95ba20f16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2112b2bf-1096-43f2-93fd-424f2bc591fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:to="loc_us-gaap_SubsequentEventMember_2112b2bf-1096-43f2-93fd-424f2bc591fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dc8ea4a-4a4a-4dda-99a7-2401c697120f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1dc8ea4a-4a4a-4dda-99a7-2401c697120f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_67157896-0720-4cbf-bafc-13b7a1224fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_PerformanceSharesMember_67157896-0720-4cbf-bafc-13b7a1224fcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7d57806f-847e-45ef-9fff-f22dc99161e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7d57806f-847e-45ef-9fff-f22dc99161e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_df3648f5-6145-45b5-8882-52bf49b075d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_df3648f5-6145-45b5-8882-52bf49b075d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7aaf7602-e7c9-46be-982f-d16b946ad61b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:to="loc_srt_RangeMember_7aaf7602-e7c9-46be-982f-d16b946ad61b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:to="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_87f2d34d-10e2-4394-8fce-7ab11309dd46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:to="loc_srt_MinimumMember_87f2d34d-10e2-4394-8fce-7ab11309dd46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_80dedbb6-3ac1-4555-9d9a-24e842106e39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:to="loc_srt_MaximumMember_80dedbb6-3ac1-4555-9d9a-24e842106e39" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="ib4502d489b8143f2a5722f03a8ed2c98_ScheduleIIValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_791128b1-f090-4717-9d3a-e7a41cb47374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_791128b1-f090-4717-9d3a-e7a41cb47374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5319fefc-2068-498f-b3b3-07a48b8e177b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5319fefc-2068-498f-b3b3-07a48b8e177b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_70261be0-9269-4926-92fb-c0d78c92f283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_70261be0-9269-4926-92fb-c0d78c92f283" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther_d798e21a-b68e-44d5-add4-a10dbd89887d" xlink:href="pbh-20220331.xsd#pbh_SECSchedule1209ValuationAllowancesandReservesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther_d798e21a-b68e-44d5-add4-a10dbd89887d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_39177d10-8c82-4751-8e72-454a030559f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9bc0ac24-988a-4642-b7a4-821d314803fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9bc0ac24-988a-4642-b7a4-821d314803fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_aa903ad8-64e1-4c49-b866-ba8138e0aef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_aa903ad8-64e1-4c49-b866-ba8138e0aef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesforTradePromotionsMember_4492a343-2a2b-4513-b3de-b1b23ec82b3e" xlink:href="pbh-20220331.xsd#pbh_ReservesforTradePromotionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_pbh_ReservesforTradePromotionsMember_4492a343-2a2b-4513-b3de-b1b23ec82b3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesForConsumerCouponRedemptionsMember_32b94984-22b8-487d-bfde-15db268de44c" xlink:href="pbh-20220331.xsd#pbh_ReservesForConsumerCouponRedemptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_pbh_ReservesForConsumerCouponRedemptionsMember_32b94984-22b8-487d-bfde-15db268de44c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_43afedf7-29db-49dc-80fb-65b09e90d03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_43afedf7-29db-49dc-80fb-65b09e90d03c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e47b943d-e07b-4397-904f-5cd95e53baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e47b943d-e07b-4397-904f-5cd95e53baf6" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>pbh-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_srt_NameOfMajorCustomerDomain_1d214888-799f-4d2f-8176-970348d96d96_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_d36dc114-178d-4143-9235-75c421e22ce1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_72117807-e95f-4c5a-9210-12303bfd21f1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_56680d7a-05a3-40d7-b5ea-e18a41f579a8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_0227f852-c204-4ca8-be85-6f95949c452c_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_b48d6b35-eb93-44d4-9867-e8d87d11bd74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_0b23ec05-dab2-4b9b-9128-b63cdadceea5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_6fb7c7d3-3ff2-4c4b-ba2b-a1cefa36a310_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AnalgesicsMember_2f2e887e-4b2e-4433-99d0-64045d3b86f0_terseLabel_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_label_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:label id="lab_pbh_AnalgesicsMember_documentation_en-US" xlink:label="lab_pbh_AnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Analgesics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember" xlink:href="pbh-20220331.xsd#pbh_AnalgesicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AnalgesicsMember" xlink:to="lab_pbh_AnalgesicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e03ef4ad-4d9c-4c82-a8e1-f19fb71f3bc7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_64b30caf-6d7f-4949-bd58-2e743e8564ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_e051945a-a001-4948-afb0-6c269dc7c3e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net gain (loss) on pension plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_90c79771-f766-426d-926b-97d610ffd72f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b94a2a28-4b5f-4c78-bc34-95eefed80aaa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years), operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_23b17474-d040-4ad8-861a-9ec25937c990_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liability</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f07e517-4ba1-4f43-9d22-da329db43e45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5a1ca423-2c93-4b0a-9ee4-7bd43c393eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for issuance under plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_27f88f36-6bd5-4307-bd7a-317ea8db5f09_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_98772722-dafe-4d83-a4e7-85f332133ea1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging and raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_814e0d32-611f-4c08-b994-ccc337763028_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_96b7cd26-87cc-4616-ba1b-57e3a6a607ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_10785196-0b17-4ec6-a9a1-c58e1dd680fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_445ed418-660b-4a83-a8a4-ea7688ad02d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9fc47b8c-4e60-41c4-9435-5a06a8ef059b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Charged to Expense (Income)</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_220691e5-2878-426c-b9a9-9da6d90d27ff_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_61ce1b1d-ff6a-4189-a99c-347c81e7d9cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d103c7d1-8043-4f32-a557-fb037e15aae4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, accumulated amortization, additions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2b3fbd91-6b50-4175-a023-c6349ac8c970_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7e0c4a04-f2e6-4f77-b534-e4c234a8225f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TermLoan2012Member_8d7e61fa-7d24-445c-880f-06f78c3a708f_terseLabel_en-US" xlink:label="lab_pbh_TermLoan2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term Loan</link:label>
    <link:label id="lab_pbh_TermLoan2012Member_label_en-US" xlink:label="lab_pbh_TermLoan2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan 2012 [Member]</link:label>
    <link:label id="lab_pbh_TermLoan2012Member_documentation_en-US" xlink:label="lab_pbh_TermLoan2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TermLoan2012Member" xlink:href="pbh-20220331.xsd#pbh_TermLoan2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TermLoan2012Member" xlink:to="lab_pbh_TermLoan2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_5c490f90-dcd0-48fb-b82b-967783fa4950_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lump sum payout</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_e917285b-6817-46c4-8c5f-f711529820f8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2882bf22-ab5d-488b-9eee-3572a8a80f51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_553ed819-1c48-4df7-b844-00d6f021ba8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_5da0eb42-1543-4806-9993-89701a7560d9_terseLabel_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply commitment, term of agreement</link:label>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_label_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment, Term of Agreement</link:label>
    <link:label id="lab_pbh_SupplyCommitmentTermOfAgreement_documentation_en-US" xlink:label="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment, Term of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement" xlink:href="pbh-20220331.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SupplyCommitmentTermOfAgreement" xlink:to="lab_pbh_SupplyCommitmentTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca93ed8a-527a-4841-aa4f-d714fb8683f5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_80797c03-7f4c-45da-9dbe-2fde3187655a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_c8982889-a80b-495a-b9f2-b140bac84c2f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_da767afd-3be6-468e-95f5-c63aa353dfe1_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock_84218375-5d59-47a0-9dc7-8010614ef95b_terseLabel_en-US" xlink:label="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets by Geographic Areas</link:label>
    <link:label id="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock_documentation_en-US" xlink:label="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:href="pbh-20220331.xsd#pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:to="lab_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WalmartMember_6b13274c-a9d8-451e-bcc2-ac32743c7655_terseLabel_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart</link:label>
    <link:label id="lab_pbh_WalmartMember_label_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:label id="lab_pbh_WalmartMember_documentation_en-US" xlink:label="lab_pbh_WalmartMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walmart [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember" xlink:href="pbh-20220331.xsd#pbh_WalmartMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WalmartMember" xlink:to="lab_pbh_WalmartMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_e5db921c-59ab-4a38-83d5-ec2d487d8b22_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment, voluntary payment</link:label>
    <link:label id="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_label_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Voluntary Payment</link:label>
    <link:label id="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Voluntary Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:to="lab_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_88b0c431-d818-4261-84a0-aa3f9e8d336c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_245e7836-3e72-4eab-9210-c6a4345c35e0_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_1dedc3b4-abc8-4fe8-ace9-c0a31a79cd32_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_321e7983-fd9c-4d06-bb39-4e59e6a4d339_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_eadbccb8-1594-45c4-bb94-e8a4f2e59b23_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_648a0230-f5b9-4bf8-ba75-dfedbacf2911_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_7d817d81-533e-4014-8199-2cb0581c19c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RetirementPlanContributionAxis_ac93bc8c-75ea-4d6e-8824-5a397399c35e_terseLabel_en-US" xlink:label="lab_pbh_RetirementPlanContributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan, Contribution [Axis]</link:label>
    <link:label id="lab_pbh_RetirementPlanContributionAxis_label_en-US" xlink:label="lab_pbh_RetirementPlanContributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan, Contribution [Axis]</link:label>
    <link:label id="lab_pbh_RetirementPlanContributionAxis_documentation_en-US" xlink:label="lab_pbh_RetirementPlanContributionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan, Contribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionAxis" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RetirementPlanContributionAxis" xlink:to="lab_pbh_RetirementPlanContributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_dcee9234-718e-45af-8d98-f2f68bb6b3c7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock &#8211; $0.01 par value; Authorized &#8211; 5,000 shares; Issued and outstanding &#8211; None</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_ce662157-3a39-409e-af07-8f3e2450fc6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, additions</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_88c6850a-63d0-4179-a318-a76c106e857f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate_8f2b0f63-a504-4bac-a2d9-55caf3f0cf3d_terseLabel_en-US" xlink:label="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, remeasurement, discount rate</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate_label_en-US" xlink:label="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Remeasurement, Discount Rate</link:label>
    <link:label id="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate_documentation_en-US" xlink:label="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Remeasurement, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:href="pbh-20220331.xsd#pbh_DefinedBenefitPlanRemeasurementDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:to="lab_pbh_DefinedBenefitPlanRemeasurementDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ReservesforTradePromotionsMember_61aa75f3-c542-425a-ac2a-5cf5b2e24adb_terseLabel_en-US" xlink:label="lab_pbh_ReservesforTradePromotionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for trade promotions</link:label>
    <link:label id="lab_pbh_ReservesforTradePromotionsMember_label_en-US" xlink:label="lab_pbh_ReservesforTradePromotionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for Trade Promotions [Member]</link:label>
    <link:label id="lab_pbh_ReservesforTradePromotionsMember_documentation_en-US" xlink:label="lab_pbh_ReservesforTradePromotionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for trade promotions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesforTradePromotionsMember" xlink:href="pbh-20220331.xsd#pbh_ReservesforTradePromotionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ReservesforTradePromotionsMember" xlink:to="lab_pbh_ReservesforTradePromotionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfundedPlanMember_d3a58ca1-2797-44a6-814a-2d98b6b6c1fb_terseLabel_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded plan</link:label>
    <link:label id="lab_us-gaap_UnfundedPlanMember_label_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Unfunded Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfundedPlanMember" xlink:to="lab_us-gaap_UnfundedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_218634b5-4f13-42df-8a18-621535946584_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2019Member_699c36b0-f784-4415-92b5-2909709cee5b_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2019Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2019Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2019Member" xlink:to="lab_pbh_SeniorNotes2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_2169ffc0-a007-4f6a-ba07-6504c05b6a89_terseLabel_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease cost</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions To Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:href="pbh-20220331.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:to="lab_pbh_AdditionsToOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_33f2672c-4629-4120-8d16-d83f97807d7d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_f3a8503a-56bd-4566-81ab-6020d572d10c_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_147d5027-1cd7-41d9-a472-b78f3cd40e6f_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,, Uncertain Tax Position</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,, Uncertain Tax Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_7abe6a74-2c58-4535-b855-a5d95c9d867d_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GastrointestinalMember_7219cccd-12dc-4db5-b9f4-7e6f0e66fe3d_terseLabel_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_label_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:label id="lab_pbh_GastrointestinalMember_documentation_en-US" xlink:label="lab_pbh_GastrointestinalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gastrointestinal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember" xlink:href="pbh-20220331.xsd#pbh_GastrointestinalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GastrointestinalMember" xlink:to="lab_pbh_GastrointestinalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_73d23fed-2e95-4329-86e6-8980c5a00ab1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_feffb0ce-806e-48f9-90c3-834788cbba4a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WomensHealthMember_175b0222-6310-41e1-ae94-167447ac1673_terseLabel_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_pbh_WomensHealthMember_label_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_pbh_WomensHealthMember_documentation_en-US" xlink:label="lab_pbh_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember" xlink:href="pbh-20220331.xsd#pbh_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WomensHealthMember" xlink:to="lab_pbh_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_eb6b190a-5729-42cb-be9a-a65c0a841aa6_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_df17b2c3-f6b4-483a-b05c-63e95fa9c302_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_d6c504f5-2320-421e-bee7-d71232e3485d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_PercentageofDepositsHeldinOneLocation_3549ea9b-4b43-48f3-8829-1917a9abd771_terseLabel_en-US" xlink:label="lab_pbh_PercentageofDepositsHeldinOneLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of deposits held in one location (as percent)</link:label>
    <link:label id="lab_pbh_PercentageofDepositsHeldinOneLocation_label_en-US" xlink:label="lab_pbh_PercentageofDepositsHeldinOneLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Deposits Held in One Location</link:label>
    <link:label id="lab_pbh_PercentageofDepositsHeldinOneLocation_documentation_en-US" xlink:label="lab_pbh_PercentageofDepositsHeldinOneLocation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Deposits Held in One Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_PercentageofDepositsHeldinOneLocation" xlink:href="pbh-20220331.xsd#pbh_PercentageofDepositsHeldinOneLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_PercentageofDepositsHeldinOneLocation" xlink:to="lab_pbh_PercentageofDepositsHeldinOneLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_5df04e10-b04c-44f2-aeb3-72d87626b241_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0025ffa2-5826-4c3f-bae4-d52fa965d942_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_72a57f01-6209-412d-a536-c77026bb3fe9_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_d74d63e6-b3a6-49d3-a10c-19b637c50009_terseLabel_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_label_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020 [Member]</link:label>
    <link:label id="lab_pbh_LongTermIncentivePlan2020Member_documentation_en-US" xlink:label="lab_pbh_LongTermIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Plan, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member" xlink:href="pbh-20220331.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongTermIncentivePlan2020Member" xlink:to="lab_pbh_LongTermIncentivePlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_59f33c28-6cb8-4dbb-9a5b-8202291f2e89_terseLabel_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS Logistics LLC</link:label>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_label_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS Logistics LLC [Member]</link:label>
    <link:label id="lab_pbh_GEODISLogisticsLLCMember_documentation_en-US" xlink:label="lab_pbh_GEODISLogisticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEODIS Logistics LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember" xlink:href="pbh-20220331.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GEODISLogisticsLLCMember" xlink:to="lab_pbh_GEODISLogisticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_3c6a5887-0013-43d9-bf32-9475c1755bfe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent asset</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_646f195c-49d7-4e21-bb97-fccd1593bf6e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_6ef4c280-ac06-47fe-a39d-ddbdee51cf1d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b12a9058-b16f-4108-83ff-ccd56174db23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_5db5b3f0-58d4-4d9e-bfd9-fab82b1fd67d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_baed677e-303d-4a3d-9e39-576e649c8638_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate, fixed component (as percent)</link:label>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_label_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate, Fixed Component</link:label>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate, Fixed Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:to="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_66989d09-0213-4f8f-bb06-7fa6ace55b6e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2b131dc6-cea7-497c-89d2-f586c0571d84_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_3f124882-7b4e-4c99-8eb6-b3f682115cd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OtherDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_OtherDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDepreciationAndAmortization" xlink:to="lab_us-gaap_OtherDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock_c0457dc4-a3d0-4dde-b23e-58034fce2caa_terseLabel_en-US" xlink:label="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Liabilities [Table Text Block]</link:label>
    <link:label id="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:href="pbh-20220331.xsd#pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:to="lab_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_669d8c5d-ea6b-4aef-be15-ff1a68a706f9_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_58688f1a-b1c8-4fe9-9e5f-cb627c05b767_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_1f353361-456a-48b3-9a51-e281accaa38f_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Position, Percentage</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Uncertain Tax Position, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_3103d172-749a-49ea-92b1-b4aececca1b8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from refinancing of Term Loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_027bf006-5986-4308-80ed-f651d45711f4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_bd83d30e-3892-4b57-a2a1-00f1d9b6bb6b_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income and cash</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3e8c0cad-581b-4faa-b8bb-d0ae39b030bf_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4fd85f03-71e2-430c-8d89-83f4d4a49974_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_e97f3b73-575a-4da6-9ad4-7f9ab4f8cc79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a5d99d53-6844-4b11-94d9-f52efce62f32_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e3b3209d-3ea9-40a4-9546-6040e245a1c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_71769778-7d29-44d5-9ab1-cf5fe5a18ef8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_178ad5b9-d9fb-40be-ac5d-cfdbb1cf2598_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_09dd03d5-5d01-4779-a024-955524bebc25_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b41d98f5-f59b-4e74-9496-ebffc2a87288_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_fb8d87e6-a7db-40fd-92ac-018bf9103782_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_b317e4df-6bb1-4dbc-8b5b-03695e62f15f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_689cf9a6-5a55-4647-a726-ed88ce219077_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation limitations</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SydneyAustraliaMember_19d8d992-3fd9-41d3-a8a9-78fc871ba336_terseLabel_en-US" xlink:label="lab_pbh_SydneyAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sydney, Australia</link:label>
    <link:label id="lab_pbh_SydneyAustraliaMember_label_en-US" xlink:label="lab_pbh_SydneyAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sydney, Australia [Member]</link:label>
    <link:label id="lab_pbh_SydneyAustraliaMember_documentation_en-US" xlink:label="lab_pbh_SydneyAustraliaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sydney, Australia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SydneyAustraliaMember" xlink:href="pbh-20220331.xsd#pbh_SydneyAustraliaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SydneyAustraliaMember" xlink:to="lab_pbh_SydneyAustraliaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_ecac3e4b-14a7-46d8-bf41-cafa4af60334_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment3Member_69882322-6dfa-4c78-8304-086d137d2e29_terseLabel_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver, Amendment No. 3</link:label>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment3Member_label_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver Amendment 3 [Member]</link:label>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment3Member_documentation_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver Amendment 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment3Member" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2012ABLRevolverAmendment3Member" xlink:to="lab_pbh_A2012ABLRevolverAmendment3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f8c03d45-3834-4f84-83a9-27a2cff868e4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_107c7695-6953-40d4-a201-e69a500b7730_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Benefit Obligation and Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3c282e40-3311-4984-8c36-f774c3743f0a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of indefinite-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c23ddf9d-d02b-4820-8b94-1c4bbf7f2a65_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_c4d4ec32-3b9e-4224-923f-5041d423f3dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_ff443dff-6f7d-4e2c-bdc3-de3620ea16d6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_94c098e4-1e13-433b-9036-081e107b9402_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_d0e7d722-f945-44c7-b087-9b02d8302a2e_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_0c8a4854-d5c1-40cd-95bb-d31692072f58_terseLabel_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC</link:label>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_label_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC [Member]</link:label>
    <link:label id="lab_pbh_AkornOperatingCompanyLLCMember_documentation_en-US" xlink:label="lab_pbh_AkornOperatingCompanyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Akorn Operating Company LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AkornOperatingCompanyLLCMember" xlink:to="lab_pbh_AkornOperatingCompanyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_45792408-f0f0-4327-9fc2-3640f93c3301_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fc154f9d-2e60-428e-87e5-6db0729c5b9f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_140d40c2-ce5e-47db-9f5f-33ad194b7f28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_32787b0e-a73b-4b17-a11e-d665b4c0eb52_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_1431985a-262e-4d70-8851-aaafe9edf4dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0ce0912f-fe6e-4907-9aeb-41d782603a03_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_6fcfe016-f5c4-448d-8f73-30761736339f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Tradenames and Customer Relationships</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_40d4bc64-0387-48be-95f4-ff415cb00a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Long-Term Assets to Segments</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_aed0df19-cd38-4d7e-b34c-9540e099e397_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal income tax benefit</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_11f0dc85-087f-49c3-9e63-16f3649e1ae0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_d6635fcd-e30b-4e4f-84c3-68308320ec31_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CostOfSalesPolicyPolicyTextBlock_36bfff4e-9930-4ec3-a247-1d12aec4e092_terseLabel_en-US" xlink:label="lab_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_pbh_CostOfSalesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Policy [Policy Text Block]</link:label>
    <link:label id="lab_pbh_CostOfSalesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:to="lab_pbh_CostOfSalesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_05c46d25-36f0-4300-b8fe-427ffab0c8c6_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance &#8211; beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_eab1af07-2a3b-4fb5-a4ea-8f0f3fd489f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance &#8211; end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f37d2d32-6ded-4186-a381-0660d1452a77_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_1c818700-72ca-4f1f-9ab0-0b3b5878dc3e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_Amended2012TermLoanMember_dd948581-fdb4-48e6-a5f0-d4097ce5c7ad_terseLabel_en-US" xlink:label="lab_pbh_Amended2012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term Loan, Amendment No. 1</link:label>
    <link:label id="lab_pbh_Amended2012TermLoanMember_label_en-US" xlink:label="lab_pbh_Amended2012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2012 Term Loan [Member]</link:label>
    <link:label id="lab_pbh_Amended2012TermLoanMember_documentation_en-US" xlink:label="lab_pbh_Amended2012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2012 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended2012TermLoanMember" xlink:href="pbh-20220331.xsd#pbh_Amended2012TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_Amended2012TermLoanMember" xlink:to="lab_pbh_Amended2012TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b40addb4-9e4a-4b7f-91f6-2791f11f61fe_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_94db63f7-06b9-43cf-954c-61abab24c112_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_33ec0dfc-717b-445d-94e7-68b5cf0860ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_c64b8481-fa06-4614-8d0f-9e89e781fd23_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing costs</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_0685cbb9-9865-4d3e-8052-65ea4c2ed384_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_61d20d56-bd39-4dfc-bf87-c90d078f4df3_terseLabel_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_InternationalOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_InternationalOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_InternationalOTCHealthcareMember" xlink:to="lab_pbh_InternationalOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a2c3fd0a-5b0a-47a1-a03a-a25fee17c034_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_947a3689-2cbf-41d6-b4a5-e63a63fe3eb7_totalLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_4a3a6e9c-741e-4246-a576-479291dcb2d0_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_2c0aaa0e-09c5-4835-8e59-22fc5bbc0086_terseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early repayment of senior debt</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6f57dc0d-53fe-4d83-8058-bbb29c044b50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_11c58ac1-4cb7-4e03-b5e6-ee64033ac27f_terseLabel_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2005 Long-term Equity Incentive Plan</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_label_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:label id="lab_pbh_LongtermEquityIncentivePlan2005Member_documentation_en-US" xlink:label="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Equity Incentive Plan, 2005 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:href="pbh-20220331.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LongtermEquityIncentivePlan2005Member" xlink:to="lab_pbh_LongtermEquityIncentivePlan2005Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_0c1f2c71-b09d-455f-8850-95dfa7b01aad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, by Type [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_28b19dad-f1cd-4e80-a1b7-d3f84db51a2a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_7bf93c5f-646a-4aad-be43-30ea8c000039_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_de8c6cca-8796-4a45-b9eb-5f1da7e00cac_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c46a98d9-5387-43f8-be46-9f6e67b2d88e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_457b3ad1-2763-4621-abd5-58313c7e8d93_periodStartLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_889ccb9a-5ee2-4391-be56-dbd2d5964b0b_periodEndLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_057f8ac5-163f-4b3c-9555-1e5691c2d744_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_38f3b74e-7f52-47f8-b146-9743529e534e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bfbf47c4-368c-4664-bb4a-fee167258280_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1c7ea148-23c5-407d-8f3d-8dbece9cb7f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8211; $0.01 par value; Authorized &#8211; 250,000 shares; Issued &#8211; 54,430 shares at March 31, 2022 and 53,999 shares at March 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_8f278be1-e635-4e15-a535-8c309971db34_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate, financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2bfa39c8-fb19-4b74-bb9e-9e3808685bc4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB3Member_3d7ee8b7-08fa-4e5e-bbe3-a5c978a22097_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-3 Loan</link:label>
    <link:label id="lab_pbh_LoansPayableTermB3Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-3 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB3Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB3Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB3Member" xlink:to="lab_pbh_LoansPayableTermB3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_0800e79f-decd-43da-b7b0-74898e3ef9e6_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_073bb671-7adb-4c57-9336-3b26593ab85c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_dc66fdd6-6191-4eff-a454-9a96824bb939_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DermatologicalsMember_152fd099-3a50-4d52-ae2d-b3924d9b8257_terseLabel_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_label_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:label id="lab_pbh_DermatologicalsMember_documentation_en-US" xlink:label="lab_pbh_DermatologicalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dermatologicals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember" xlink:href="pbh-20220331.xsd#pbh_DermatologicalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DermatologicalsMember" xlink:to="lab_pbh_DermatologicalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_947fc086-05a7-45a1-abd9-e81023aca062_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_0a809a25-8a96-4cfa-817a-729bbe60e406_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ContributionMargin_19cd89b3-95f2-4424-8615-42ae1761e4cf_totalLabel_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_label_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_pbh_ContributionMargin_documentation_en-US" xlink:label="lab_pbh_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin" xlink:href="pbh-20220331.xsd#pbh_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ContributionMargin" xlink:to="lab_pbh_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_b2801b26-c364-478b-8a24-bda308c604b9_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fd24d4eb-17d0-4aac-b1a9-a2d4714d0516_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_7491a48c-1a4e-4d82-92bd-805e023fbb9d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product concentration risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_5538e4ca-9f37-47e7-be10-199917a3e6d8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_adebc5e5-8afc-42d8-a7f7-f19a742cb8fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo5Member_0517a955-15ed-492a-b371-5176669e5aa3_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 5</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo5Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 5 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo5Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:to="lab_pbh_LoansPayableTermB5AmendmentNo5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_473f576c-988b-421e-803f-12c21b49999d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_f62f3ab1-60e0-45a9-b87c-ca972c9bcb62_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Geographic Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c7bdacef-c7f5-4885-a4e2-67558463504a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_0b9f91ee-22fe-4018-8cf1-d50103598b0c_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_5d822387-d5d4-47ef-a0de-1476a6445d40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Primary Components of Net Periodic Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB2Member_0f6b1f8e-0212-4a57-856d-4deb3aa14be2_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-2</link:label>
    <link:label id="lab_pbh_LoansPayableTermB2Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-2 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB2Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB2Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB2Member" xlink:to="lab_pbh_LoansPayableTermB2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_e2033d3a-b2ff-41e4-a7de-f36968da0676_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_314d9956-1045-4af6-b301-cf4de101a7df_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain Tax Liability Activity</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_b2e2dd07-d82c-4ce2-9736-9b237b7ae29c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_a328e337-823c-4fd6-bcad-63478180eeb8_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension of plan term</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3fe390c5-ba19-48a7-afa7-043b02e3b558_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b27634de-f829-43a0-8e3f-14e3ceaa65d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_73bfdcb6-b5e2-4377-b280-a3a40cb26f94_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d1529e1e-c8a0-4846-8fc1-f0e72260c781_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_3dae0569-ac9d-4713-b7ea-5d57b4fddc6b_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_1c6993ec-2bef-49c8-9234-d2fb1c21bbc8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (expectation) to participant benefits</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d17736d7-ef03-4c6a-b1c5-e9fd866a705d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_32a08d54-2739-4c0b-954f-683a83a7f89b_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fea5aa31-2713-4e6e-99e4-10807cd02628_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_277e3d7f-fc94-4c85-ade1-8baa8433e3db_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e300b5e4-281d-43af-a38f-8b22d33c79a7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_eb0420e7-d704-4aba-af2c-e66a1052c66b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on pension distribution reclassified to net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_871a7771-d6c9-4a38-80d5-ddb29dbe33ff_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_df55872c-387d-4d74-ba8f-a5290cdf601a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_75a889b9-ab90-4fb2-8e5f-f6981699db14_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_67f51d4e-0577-40fa-b897-3be9f87dfde5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_8046c0b2-53e8-442d-9966-5bf7a78b9c4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_e1309700-0f29-417f-87f0-d58f93ea9e1f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b39e0674-bc7b-4fdd-8533-cb3e6dfbaac9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years), financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3740c9b0-3682-4b16-9718-6ea27bcc4dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_edcbb1d5-c236-4f68-8f2f-91d9f79ae785_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_44938587-0424-4326-be46-4b4a476bd6d5_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_79f6422d-81f6-438d-9f32-46960f87d367_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b9612325-ec8e-4c60-9a11-d5d41a5ab99a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7ef46f54-2da2-44d5-95ff-695842441ef1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d0d84950-7956-4585-ad36-2f2dc8e9460f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b79687a8-9153-4001-b229-209ef10ac3a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AuditInformationAbstract_label_en-US" xlink:label="lab_pbh_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_pbh_AuditInformationAbstract_documentation_en-US" xlink:label="lab_pbh_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AuditInformationAbstract" xlink:href="pbh-20220331.xsd#pbh_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AuditInformationAbstract" xlink:to="lab_pbh_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_4fa9c735-6a89-4137-9a93-7c69ee5de8c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_8195de23-79e4-4314-832d-7167e99ce5eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_685d91b6-3617-4ff3-9bd2-0f662c5f5ccd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_080c20fc-2de6-4e39-b178-3e150aced36e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_cf2dacd4-6515-495b-a3f6-f7f4ed1abe94_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles, effects of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_30eb3bf1-5632-422c-bc7e-c05bc248dd1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_9a5d3e1a-a32b-41fa-bf71-035f41eead39_terseLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due [Abstract]</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_1729f7a0-e1f6-421b-a045-054cff6e6bc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_697f2560-a62f-43d0-851b-613acdfb2d11_totalLabel_en-US" xlink:label="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Including Discontinued Operations</link:label>
    <link:label id="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_documentation_en-US" xlink:label="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:to="lab_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_72f2adec-1d50-4a21-9f67-e65d23cd3900_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_20f44a12-0b96-4b4f-8863-fe042f63c757_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_98b956ba-028e-4931-9321-f162e72cf7d3_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a3800ddf-8d4f-4316-b8b5-102da929de76_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_8ed49c08-84a6-48bc-a67a-4b03df33b62d_totalLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Including Discontinued Operations</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:to="lab_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f8ac1994-3180-4c1d-b5fe-d38fd4fd4a13_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ebaa56d8-50fb-49cb-9bba-1351e1bf7ff9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_df7fddd7-e8cb-4c4b-80b5-ba42152baeaa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a839c61b-289b-4cc0-b698-b1cd283e74b7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d09d0149-395a-4cab-90da-a071ce9d6e3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1bc0c187-d1fa-486b-9008-0fbd4bacd838_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5813a5d3-b61d-45c5-b907-af94f0bed615_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_b4a6e9d5-54a7-43d9-8c1d-0f8b7f868504_periodEndLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2021SeniorNotesMember_7ae09609-4941-47e5-bb85-696f889a2217_terseLabel_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes</link:label>
    <link:label id="lab_pbh_A2021SeniorNotesMember_label_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes [Member]</link:label>
    <link:label id="lab_pbh_A2021SeniorNotesMember_documentation_en-US" xlink:label="lab_pbh_A2021SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2021SeniorNotesMember" xlink:to="lab_pbh_A2021SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_48edafc0-5387-44b3-8f20-a7b8d0cc35f3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_33080669-c7b3-4af9-b007-6e9487bbbe8a_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Shares Outstanding [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract" xlink:to="lab_pbh_WeightedAverageSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b64b8023-c4fb-4e32-a000-2a674ef84e7a_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b1d7f08d-2579-4b57-8cd6-d92656dadd4d_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8e3f3876-475e-4487-85d2-7526dd5acd90_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2013Member_3f3500fd-9947-45a2-99cb-bf52cb0dfb26_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2013Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2013Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2013Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2013Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2013Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2013 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2013Member" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2013Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2013Member" xlink:to="lab_pbh_SeniorNotes2013Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_0a8027b8-7a9c-4947-a1cb-91e20283d8c9_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_8272f94f-d7fc-44ed-a0bd-0b81891d0e1a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_61af5f60-0c54-4e27-aae6-a88b9669cc65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ba8a4964-cc81-4656-9692-e295c7f6215a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_35ef60c2-31f9-4021-903b-dc71b31b1be3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_cd998d63-721b-4e8c-a13e-8ef4174f1f2a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_060736c8-b673-4b15-9343-a3b1425c7bfa_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_4afd784a-6627-423f-96ca-66cc2d597aed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2e3f4f13-a22f-4efd-a0c2-b77717c88393_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_8c0426a5-ea52-491c-804f-f00c0128ff8f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit recognized on compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_1e3959a6-ccd9-4700-af3a-3022763c3389_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_7bf31073-3d50-4b74-b2a7-39bdffb4c962_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_662c77b1-0891-4a9d-ae69-e1db4352719e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_5dc4b52d-0ad5-4a7b-a2d6-050e54d0446a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_398050c3-4bf6-4853-bbc0-213ea61efcd4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4e5925a2-9990-408a-a430-e4c98cd863fd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer matching contribution, percent of match (as percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_8d7bae33-59cc-4b22-b58c-a5a67c563cd2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_40aa27b7-5890-4ee5-abcf-aa40030c6567_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_568a1bf9-2a74-4fa3-b25d-c71a68ae1f9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_eda2d0e4-11eb-48ef-94b1-e5b37b8b242a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cb9ad539-c92e-40aa-bf89-1cdaf79fec92_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_48370f8a-9a39-44fc-b57f-10e102ac2c03_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_98a15092-9637-484f-81aa-523d24058e27_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_1b4b92c2-cd08-4d28-93c9-a8eeb367b541_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#160; Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_89cb9401-c1bc-4a03-9142-dd54e5d559ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fb568065-c808-42fd-9af4-274e4f433a06_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ba8d3683-dae0-4daf-9ef9-fcfab1971f69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e8945fdc-8cca-42db-9521-95e01c2cb1f4_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_a7bcf7ed-a74d-47ee-9516-412e136e1a8d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_ff03e8ab-4c21-436e-8fc7-faee2d49ab77_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance of $19,720 and $16,457, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b0be40e5-c47f-41b7-9344-fe55442b2645_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_18388371-7ffa-4dba-b1de-cac543c21e58_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_875bca65-e2e9-4bd1-9404-c034566a5af6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_377a4537-85ac-43bb-a262-506225822547_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_36bd0e85-5fab-4066-861f-3ee3ee62cfd6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_11b79bec-873a-4d62-9c96-9dda18ed9b20_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d54a12e4-88e0-4413-a6d4-fe6b4fc0e4fe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_80790b6e-3d68-466a-afd8-93423f0a992b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_abf4aacb-0803-4f8b-9a05-5baf55554651_negatedTerseLabel_en-US" xlink:label="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred cumulative catch-up adjustments - revenue recognition adjustments</link:label>
    <link:label id="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_label_en-US" xlink:label="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Impact of Adopting New Accounting Pronouncement</link:label>
    <link:label id="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_documentation_en-US" xlink:label="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Impact of Adopting New Accounting Pronouncement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:to="lab_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_38083d10-9025-4c7c-aa4a-cb8d88be53ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_b56cff06-045b-42fc-9b58-3383b177ac83_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_f7bb9ac4-e855-4ab9-ab67-ed24ed52f9ec_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options [Member]</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:to="lab_pbh_RestrictedStockUnitsRSUsStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_46cf2761-2ead-4fbb-a979-430e2402d174_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_afce4f2c-9056-46ff-9f46-477a166c0134_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_86cb3120-be17-4450-b42a-7aec40ed4b3f_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_3cbc705a-f6b7-47f1-9533-2d0fce0cceb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, decrease (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_0874c2e7-a88b-469f-a9b4-9d1f36961d8b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_776ffbf1-0852-49bc-ae8b-340886b87066_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_7406afa7-ffc7-481c-b5dc-d1bf1e4ee040_terseLabel_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_label_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:label id="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_documentation_en-US" xlink:label="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:to="lab_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_96b57584-8b74-4423-912a-87f9d004a79c_terseLabel_en-US" xlink:label="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, conditional commitment fee (as percent)</link:label>
    <link:label id="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_label_en-US" xlink:label="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Conditional Commitment Fee Percentage</link:label>
    <link:label id="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_documentation_en-US" xlink:label="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Conditional Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:to="lab_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9cc01511-c79f-4fdf-854e-46f6b9053859_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_23fa7790-d9d6-4641-9f05-15d033b847ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_c0ba98f1-004c-4903-a6a1-b0a5aad0ed93_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Asset Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingAssetReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_3053176e-6768-4f3f-b127-5b14eaf36d79_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:to="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_216d82e8-f4cf-4a6a-8f11-d6a63ff2f33d_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Tradenames and Customer Relationships</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_label_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:label id="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_documentation_en-US" xlink:label="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Tradenames and Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:to="lab_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_d59dff20-1e27-4534-b944-e833e651b006_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ab0b52c0-f5cb-4c24-b6e7-e89ed63232df_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d4dd2687-0eb0-423a-b442-4d2c1baba1f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e3a9d274-947f-4d05-9fb0-043701739d5e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxLiabilityRightOfUseAsset_472065e9-1b91-442e-866c-6680c2498404_negatedLabel_en-US" xlink:label="lab_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_pbh_DeferredTaxLiabilityRightOfUseAsset_label_en-US" xlink:label="lab_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Right-Of-Use Asset</link:label>
    <link:label id="lab_pbh_DeferredTaxLiabilityRightOfUseAsset_documentation_en-US" xlink:label="lab_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilityRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:to="lab_pbh_DeferredTaxLiabilityRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_5f657ffb-53d0-4ac2-a8b4-fbb50fe86713_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award exercisability period, from date of grant (not greater than)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisability Period, from Date of Grant</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisability Period, from Date of Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_46809e6a-5a65-4b3e-a9c0-06a126f621bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ba179756-271f-499b-acc1-3712aa1a81c4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock_cee5b6bf-0feb-4b3a-a9eb-c70fab75b877_terseLabel_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock_label_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Text Block]</link:label>
    <link:label id="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock_documentation_en-US" xlink:label="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:href="pbh-20220331.xsd#pbh_AccumulatedOtherComprehensiveIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:to="lab_pbh_AccumulatedOtherComprehensiveIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_82455b6b-ba7d-4654-9be4-7965d1e84205_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, tradename impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e8e19783-4dc1-422d-800b-a3bd848eeebb_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, tradename impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_22bcbaf9-9ca8-4401-a45b-fb1c83a59998_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities into which each restricted stock unit may be converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:to="lab_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_f45732dd-ff15-4c6d-9a01-cac3b196ff0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award grant exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2c370997-142c-49c3-bad8-61e9f95cf288_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_7480a847-f7f7-4f25-aa40-0b56c0c06181_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_a4678ca0-259c-4977-ae0e-153240c65fa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3db680cd-87cb-4370-89fa-f8f20bcdeab5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_e980d1ab-b3f3-4a93-abfb-0c5dc708b95e_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_bec06728-5420-4942-9e0b-790e29a5069a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest payable</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendsPayableCurrent" xlink:to="lab_us-gaap_InterestAndDividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0a8aeb2e-2eb1-477e-b64a-dd4559ffacd5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_6530e98d-fdd0-44f0-83ac-48310182b9e7_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross, beginning</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_97a2a28e-52d9-4dca-bc12-46d664749647_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross, ending</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_55cca677-29b6-4faf-ac37-796d02e80581_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_6b9ed164-306c-4e37-979f-79e3c21bd745_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_52fe7911-be30-4a2c-9665-def011052d4d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_4734b082-9d25-4e51-8237-0f721e15eb9a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentReferenceRateFloor_087a70af-dd4d-4f94-8631-122994062cb4_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentReferenceRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, reference rate floor (as percent)</link:label>
    <link:label id="lab_pbh_DebtInstrumentReferenceRateFloor_label_en-US" xlink:label="lab_pbh_DebtInstrumentReferenceRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Reference Rate Floor</link:label>
    <link:label id="lab_pbh_DebtInstrumentReferenceRateFloor_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentReferenceRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Reference Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentReferenceRateFloor" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentReferenceRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentReferenceRateFloor" xlink:to="lab_pbh_DebtInstrumentReferenceRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_860a083e-799b-4266-8bea-0c3e311fcab9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_745e21e1-8d3c-4bfd-975e-4591e0e888da_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_56a99648-ba82-4cff-83e0-489357af2b35_terseLabel_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_label_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:label id="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_documentation_en-US" xlink:label="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:to="lab_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_d8b7e23d-b072-41d9-9416-327b74f12561_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_a5e6b4c1-ef8e-4bff-9068-9bc7833c2688_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_ba5006eb-9458-4a07-b787-67b941b86069_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful lives</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_eb82a839-a721-4b0d-8997-2e4e34584eb7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a4ff51d6-87f8-4cfa-ad45-1ad45ac4d34d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0f56c9cf-eb99-497c-b7ce-a21a5c24c41d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2cfb54e1-2229-4e22-8a1e-af96a18fdcec_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c8c98978-6f11-411c-a866-4e3276ada155_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_a4acff9f-8044-4862-a6cc-1b7eada64ea0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_36d4888a-150e-478a-a340-34d0dc7ebed0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_353380b8-112e-424b-8d5f-8562a778836b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax credit</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OtherOtcMember_b1cba206-fe00-431f-b703-a22f35c160ff_terseLabel_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC</link:label>
    <link:label id="lab_pbh_OtherOtcMember_label_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:label id="lab_pbh_OtherOtcMember_documentation_en-US" xlink:label="lab_pbh_OtherOtcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other OTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember" xlink:href="pbh-20220331.xsd#pbh_OtherOtcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OtherOtcMember" xlink:to="lab_pbh_OtherOtcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9aa72df6-6de3-405f-8478-38af486aaf01_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_6c6181b5-a3a9-4adb-bba0-ca654f0887bd_terseLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_5c96ac39-21ef-4ed8-97f7-1cd81d479c15_totalLabel_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other accrued liabilities</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:label id="lab_pbh_AccruedAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:href="pbh-20220331.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:to="lab_pbh_AccruedAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CoughAndColdMember_28fda743-5070-4cf4-a52f-9f9285b8c833_terseLabel_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough &amp; Cold</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_label_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:label id="lab_pbh_CoughAndColdMember_documentation_en-US" xlink:label="lab_pbh_CoughAndColdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cough and Cold [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember" xlink:href="pbh-20220331.xsd#pbh_CoughAndColdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CoughAndColdMember" xlink:to="lab_pbh_CoughAndColdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_de310326-d949-443c-9280-32007b93d808_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_SG_6272cd7e-4a50-42fe-8f5b-8518959cb9f6_terseLabel_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Singapore</link:label>
    <link:label id="lab_country_SG_label_en-US" xlink:label="lab_country_SG" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SINGAPORE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_SG" xlink:to="lab_country_SG" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3983d2e3-e02a-4985-b3c5-1c1f09a3cee5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_3cfaac54-866b-4868-96e2-340922ff6fdb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:to="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_74437c29-f17b-4b59-8994-f2117bcfb43e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e4e89a6f-dc15-4bec-9023-c1e00bc3548e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_fce779f6-532e-4238-ad7a-edd38f092741_terseLabel_en-US" xlink:label="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated reduction in uncertain tax provisions, next 12 months</link:label>
    <link:label id="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_label_en-US" xlink:label="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Reduction In Uncertain Tax Provisions, Next 12 Months</link:label>
    <link:label id="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_documentation_en-US" xlink:label="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Reduction In Uncertain Tax Provisions, Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:href="pbh-20220331.xsd#pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:to="lab_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_52f14ba2-441d-4f01-b066-ecd2c4a63edf_terseLabel_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales excluding depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_label_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Exclusive Of Depreciation</link:label>
    <link:label id="lab_pbh_CostOfSalesExclusiveOfDepreciation_documentation_en-US" xlink:label="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_CostOfSalesExclusiveOfDepreciation" xlink:to="lab_pbh_CostOfSalesExclusiveOfDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_90d827ea-390d-4af6-9a97-731782edf4af_terseLabel_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting rights, number of votes per common share owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_label_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:label id="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_documentation_en-US" xlink:label="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting Rights, Number of Votes Per Common Share Owned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:href="pbh-20220331.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:to="lab_pbh_VotingRightsNumberOfVotesPerCommonShareOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c5830002-481a-46cb-858f-3f5ee834cbe8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_d395f691-56a7-40a5-a496-0cbde9c8603c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_7da41cc7-113c-4036-91ed-3d59bf3e1954_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, effects of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37aafb35-7677-4b45-bf08-00117b7ccc49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0ca8e0f6-25e7-43e7-a165-752d515d0dee_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_77857dfe-9d0c-4afb-8c4d-1e83d8c31015_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherMachineryAndEquipmentMember_4866f924-1cff-4fe5-8582-aa2877fb051d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherMachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery</link:label>
    <link:label id="lab_us-gaap_OtherMachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OtherMachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherMachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherMachineryAndEquipmentMember" xlink:to="lab_us-gaap_OtherMachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e22235d0-d738-4449-8158-2675c0bea99b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_102c46ef-95c5-4c97-80ed-af3b2090d477_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_0b85a3ca-ce25-4c53-9ef1-8ac5eb6ffdd9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB4Member_ce3445c3-7f5d-4f48-a5a4-d1ae57f7bf92_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-4 Loans</link:label>
    <link:label id="lab_pbh_LoansPayableTermB4Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-4 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB4Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB4Member" xlink:to="lab_pbh_LoansPayableTermB4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_946551dd-0206-4ad0-9065-af9c252af897_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ThirdPartyManufacturingMember_ac937fa3-d11e-40bd-8d7c-153d4ce5fe65_terseLabel_en-US" xlink:label="lab_pbh_ThirdPartyManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-party Manufacturing</link:label>
    <link:label id="lab_pbh_ThirdPartyManufacturingMember_label_en-US" xlink:label="lab_pbh_ThirdPartyManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-party Manufacturing [Member]</link:label>
    <link:label id="lab_pbh_ThirdPartyManufacturingMember_documentation_en-US" xlink:label="lab_pbh_ThirdPartyManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-party Manufacturing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ThirdPartyManufacturingMember" xlink:href="pbh-20220331.xsd#pbh_ThirdPartyManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ThirdPartyManufacturingMember" xlink:to="lab_pbh_ThirdPartyManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1b2dda22-31d8-4e1b-a1bc-79b36b374766_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_6477c68a-fb1f-4685-8f5f-a7b9e2f3615e_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, period payment, percentage of principal amount</link:label>
    <link:label id="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Period Payment, Percentage Of Principal Amount</link:label>
    <link:label id="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Period Payment, Percentage Of Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:to="lab_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_bae346d7-448b-4ea0-ab49-8953bf109696_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c73ac285-7b30-4c4a-8007-911df5f45352_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c088396f-bbed-4487-ab85-3cc8b5010d8c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_fe557f8a-843f-45dc-bfd0-22931d4e3f52_totalLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_e6a34d08-879a-4372-98bb-b0bc2015a533_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_11a305a2-f75f-4f1e-a652-eb2efc50c648_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ReservesForConsumerCouponRedemptionsMember_a7ddc217-0f9c-4f56-b727-853b9c21db35_terseLabel_en-US" xlink:label="lab_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for consumer coupon redemptions</link:label>
    <link:label id="lab_pbh_ReservesForConsumerCouponRedemptionsMember_label_en-US" xlink:label="lab_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for Consumer Coupon Redemptions [Member]</link:label>
    <link:label id="lab_pbh_ReservesForConsumerCouponRedemptionsMember_documentation_en-US" xlink:label="lab_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for Consumer Coupon Redemptions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:href="pbh-20220331.xsd#pbh_ReservesForConsumerCouponRedemptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:to="lab_pbh_ReservesForConsumerCouponRedemptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_1b5a3c4d-c612-4018-a780-e0e01cfaa454_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 4,151 shares at March 31, 2022 and 4,088 shares at March 31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9707d7f2-c169-45ae-8225-2b45c988030c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e5c03914-303b-455c-9003-eac4a9ea797b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_04aa640f-d4f2-4cca-99cf-4f07bd47c569_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature_5ebbd310-7b5f-474e-99cf-564744ce5d8f_terseLabel_en-US" xlink:label="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver increase in accordion feature</link:label>
    <link:label id="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature_label_en-US" xlink:label="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase in Accordion Feature</link:label>
    <link:label id="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature_documentation_en-US" xlink:label="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase in Accordion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:href="pbh-20220331.xsd#pbh_LineofCreditFacilityIncreaseinAccordionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:to="lab_pbh_LineofCreditFacilityIncreaseinAccordionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_6b1e2cbc-3171-4278-864c-123792aa0c76_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_8b82ecd2-ab5b-4bf8-8a72-e80714870b75_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_8826a0ef-e31e-4ec3-a9d8-a0546f926c99_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_94eebc0b-940e-4def-8bea-771447def730_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_2f2ba4ee-2845-4717-8016-49e772aab194_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_41bf22b8-1e59-4d50-b67c-5380d49b64b5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_aad6eacc-0720-4824-9b7e-3f918ab9e708_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier concentration risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_e595c522-7c2d-4028-9607-422b044261b7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_f02a1733-0065-435e-bcb0-6b26d90ae1a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_e8b2dcda-88a6-487c-a255-d0159931fb08_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:to="lab_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_Amended22012TermLoanMember_c3c219f4-8ef2-40f4-99de-e0cc332c1580_terseLabel_en-US" xlink:label="lab_pbh_Amended22012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term Loan, Amendment No. 2</link:label>
    <link:label id="lab_pbh_Amended22012TermLoanMember_label_en-US" xlink:label="lab_pbh_Amended22012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2 2012 Term Loan [Member]</link:label>
    <link:label id="lab_pbh_Amended22012TermLoanMember_documentation_en-US" xlink:label="lab_pbh_Amended22012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2 2012 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended22012TermLoanMember" xlink:href="pbh-20220331.xsd#pbh_Amended22012TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_Amended22012TermLoanMember" xlink:to="lab_pbh_Amended22012TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_96712bac-d2d4-4c4a-a2ba-1006eb32ce13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_270e1bc5-975f-4726-9bf0-1df1d0c47dee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8afde0a5-b60a-4c44-8332-2a2b1e8d413e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_0a2aadfa-4194-403d-af58-cabafab0db4f_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1fcc9f16-d202-4a79-81ed-4a0fcf4d8cdd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RetirementPlanContributionDomain_09efeb52-3252-468c-ae6d-fcf03028b445_terseLabel_en-US" xlink:label="lab_pbh_RetirementPlanContributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan, Contribution [Domain]</link:label>
    <link:label id="lab_pbh_RetirementPlanContributionDomain_label_en-US" xlink:label="lab_pbh_RetirementPlanContributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan, Contribution [Domain]</link:label>
    <link:label id="lab_pbh_RetirementPlanContributionDomain_documentation_en-US" xlink:label="lab_pbh_RetirementPlanContributionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Retirement Plan, Contribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionDomain" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RetirementPlanContributionDomain" xlink:to="lab_pbh_RetirementPlanContributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fe4b0242-3ade-406b-9981-c373442113e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_af266149-1640-4425-b188-9fc72c71efb3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for sales returns and allowance</link:label>
    <link:label id="lab_us-gaap_SalesReturnsAndAllowancesMember_label_en-US" xlink:label="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Returns and Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesReturnsAndAllowancesMember" xlink:to="lab_us-gaap_SalesReturnsAndAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a3795284-ef6b-41ac-9452-6d74d8780c71_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_041305e0-2d3e-4519-bcd3-0f688d0671b1_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_a8929556-9fed-4742-af40-fb810cb8595b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8c40fcc2-ecdf-48c8-8f11-b96fc6d87bb8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_ad84eaa4-a084-4ed9-8c27-1dc71c9c6529_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_cd43257a-a4b5-47fc-a346-f96aaf930848_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized under plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_03ba4cab-12ae-4c19-a8a0-fd0c0aebff98_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e40ca266-3844-4aad-a244-da4513d6cf42_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_746526d9-4bee-45cb-bda3-41d377ffac16_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_26f9cc2c-ffea-4490-8e19-4fa202453402_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_fb75531f-7be1-4fa8-9f52-84af42fcbf87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1ce7260b-3e9f-4f3a-8659-d0865adcef52_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_46f9e885-dc94-44a5-9011-3146f4e432e6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ef1a440a-3cc8-42e7-97bd-330135292a94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_c701b42e-3f1f-4a95-ac94-2e50e20d146a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_InternationalAnalgesicsMember_c65197e6-9abd-47a3-8de9-597b20c8848b_terseLabel_en-US" xlink:label="lab_pbh_InternationalAnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Analgesics</link:label>
    <link:label id="lab_pbh_InternationalAnalgesicsMember_label_en-US" xlink:label="lab_pbh_InternationalAnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Analgesics [Member]</link:label>
    <link:label id="lab_pbh_InternationalAnalgesicsMember_documentation_en-US" xlink:label="lab_pbh_InternationalAnalgesicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Analgesics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalAnalgesicsMember" xlink:href="pbh-20220331.xsd#pbh_InternationalAnalgesicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_InternationalAnalgesicsMember" xlink:to="lab_pbh_InternationalAnalgesicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_81167d25-c8e3-4fb4-a033-18d0d4bc2bb2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_aed14b5f-d05c-448a-80c2-1624d9749a4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_de7fd545-1f04-4c29-a203-4a3899e51a5a_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_97867438-b70e-4140-802a-7f12f78dd4d8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e1d80b6e-fbf9-44de-83ef-0c0f0a4bc164_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9a97e4fb-64e4-4d21-ac1b-4b8e25f5f219_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bb17ecbb-bd7f-41d2-8635-853e65e4110a_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1662fd32-e1eb-49a2-b2f1-a38a9e94471e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_550043a5-6977-4044-8a62-4dcbbf50d31f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_274dac5d-b096-47fa-8196-f936e342055e_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale or disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_968dca50-03ea-463a-bfc9-73d8b683272d_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_356eaf2f-ffa7-4113-874e-e0bff31a4b96_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4fd7193c-28f8-4b61-bed8-f3005f0b2e97_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_e290ac99-7557-4f0a-82b4-6c869ec45647_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_85799198-73d8-4574-87ff-e9a4c1d246e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_e25cc1cb-3521-4f00-b1b4-8d756f814fb7_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_f9fdcb8a-c5a1-483f-a696-5e442196fd83_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, weighted average remaining period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_94a28bb6-4cda-45b1-b053-b00508d17bda_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of options and RSUs vested during the period</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_b86fc88b-6ea3-4e9e-9954-fe170148dbcc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6a6e5ca2-a80d-495c-a564-7d3dcec4600c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QualifiedPlanMember_f902ead7-df5d-4304-af7c-de1f805bf9bf_terseLabel_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified plan</link:label>
    <link:label id="lab_us-gaap_QualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QualifiedPlanMember" xlink:to="lab_us-gaap_QualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fe396ff9-82a9-4481-9b8d-cc24fec59d52_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ContributionTrancheOneMember_90287f19-8f39-49bd-9790-e291c09252b6_terseLabel_en-US" xlink:label="lab_pbh_ContributionTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche One</link:label>
    <link:label id="lab_pbh_ContributionTrancheOneMember_label_en-US" xlink:label="lab_pbh_ContributionTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche One [Member]</link:label>
    <link:label id="lab_pbh_ContributionTrancheOneMember_documentation_en-US" xlink:label="lab_pbh_ContributionTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheOneMember" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ContributionTrancheOneMember" xlink:to="lab_pbh_ContributionTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_01e2b266-c63e-4fb7-a844-0d400b225cfa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_5c5587f4-59e0-4995-8503-53970a133565_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0dee0773-2e69-4eff-a3ea-4a9de8d57a63_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70379e5c-a2a0-48d9-9eb2-f0eb84e713b2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for diluted earnings (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b4f6b32b-dc6a-46bf-ba1b-19580b4b3593_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_96a089dd-f9ca-4655-9ef3-423af6a7b72d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_54153a5c-8494-4ced-aa8d-fb79973af965_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3c64b976-45e4-48e7-bc99-d0057dd1beaf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2b3e0f7d-df7a-49d3-a006-ed8e60895e44_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3d1f2b50-21e6-4936-a436-13aa25a8a4da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_13d445d9-6969-4b57-99fe-86a2fa1b8feb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_54c8fbb8-b0f7-4b1c-8dd9-322401a44561_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amounts</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_41d2cd84-a7ec-484e-96d3-7cdb370eb023_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase commitment</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c734271c-e3c3-47b0-bba9-a209c8a5d5f7_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aac01bcb-b43f-4ddd-86dd-56f5b11c3f2b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3de114d7-4d94-4a8a-ba64-27a5a17be48e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_ea7d66aa-abdf-4bd2-8ddd-bc6a55811c77_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3ba1b8b3-5ac4-446f-bdc4-b7ca20f7be1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ManufacturesMember_ee3479ac-4161-42da-819c-6e5799ce3c2d_terseLabel_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures</link:label>
    <link:label id="lab_pbh_ManufacturesMember_label_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures [Member]</link:label>
    <link:label id="lab_pbh_ManufacturesMember_documentation_en-US" xlink:label="lab_pbh_ManufacturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember" xlink:href="pbh-20220331.xsd#pbh_ManufacturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ManufacturesMember" xlink:to="lab_pbh_ManufacturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d60b28e7-5aed-4086-85af-d98feeed32ac_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_30d6e55f-6fde-42db-8f2e-919a654b2d05_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d84aee6b-5556-4ece-a0f3-227cd2e734b8_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_182cfec9-aa52-46f3-98aa-388076bfe7c8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3b1b9162-abfa-4261-9802-edc6809e0ff7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f06b85de-e088-40e6-be38-f82437562f62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares surrendered as payment of tax withholding</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_34507ea0-8c7b-45c9-95e4-502d00c01022_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_5d106056-2eec-4b0f-acce-412841d68361_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1ac5cc61-872a-4ebc-a3cb-b7000933888d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer matching contribution, percent of employees pay (as percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_93dce6ef-97cd-4434-a9a6-6c273b34cdd5_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_34a05840-e813-4fc6-8da4-b83e692cdafe_terseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, end of period (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aff12d45-8359-45e8-83b9-9cc9f7962d83_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less unamortized debt costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_361260f2-2dc8-4262-91c4-c86b228e136a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued broker commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_672612ec-f424-405a-995c-5c35ef18088c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5cc04c2f-e8b6-476a-a4ee-4c2a04028cde_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_0e884c2b-fac4-41c0-a662-977f1438ab05_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c7bddcd8-e14d-4c0a-b4e4-f168460bafc2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9e3b137e-82ef-4dbc-bd8e-8d6261c39747_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8e9459d9-ddc1-4539-a3c7-9d6fd23a4b53_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_dcf32972-ec8a-49bc-93e8-b6ce17e28a8d_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_aed092c2-ab67-4a95-be50-1d1836103d60_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2019SeniorNotesMember_9a1b7f5c-0612-4c37-b75a-68f1f221526c_terseLabel_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_label_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes [Member]</link:label>
    <link:label id="lab_pbh_A2019SeniorNotesMember_documentation_en-US" xlink:label="lab_pbh_A2019SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember" xlink:href="pbh-20220331.xsd#pbh_A2019SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2019SeniorNotesMember" xlink:to="lab_pbh_A2019SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2a025e4d-eeaf-41da-a544-118ee280a1f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_004dd4bb-2f6c-443b-9005-6d0223e854a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b8429bf6-4882-4cb7-aa95-e27533bf67b8_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_73d424b4-0414-48a6-9287-3503982db9b3_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ed80bbc1-3d8c-47af-997e-bbe9b90dfec4_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, beginning</link:label>
    <link:label id="lab_us-gaap_Goodwill_dbb92bd4-41ab-4f96-aee6-1ac96cd34af2_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net, ending</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f9546818-5c03-4680-bd40-5f9f7d9fcc4b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax provision</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6c9fca05-c58a-4650-9151-567e1133b9fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1081d150-fb68-40be-8410-ac16c8622f06_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0a2c6581-b0f2-488f-bcad-8ead7a5ea00d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EyeAndEarCareMember_fb7fc199-6590-4d15-8937-47e809cbf1c4_terseLabel_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye &amp; Ear Care</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_label_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:label id="lab_pbh_EyeAndEarCareMember_documentation_en-US" xlink:label="lab_pbh_EyeAndEarCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eye and Ear Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember" xlink:href="pbh-20220331.xsd#pbh_EyeAndEarCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EyeAndEarCareMember" xlink:to="lab_pbh_EyeAndEarCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b7b30992-85c2-4222-a8af-4cf79d84527c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_ca3f9c12-1d1f-426c-ba24-ac84a1807479_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_2934d6c5-cd4d-4652-be9c-9d28fd04281b_verboseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_17a9ff04-6ccb-4781-a4c2-0c5135ff65ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_93436afa-dc4d-4369-afd9-f75ed95e6548_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, maximum annual contributions per employee (as percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_977dbb29-0d73-4998-8dc8-eb23bf892881_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c5ed0cd9-e13b-4471-b50f-5d90e5021252_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_625f2010-49b6-4a26-962c-05ad6e03950a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_e4cd98e0-44b4-4ae6-a84c-cd4cf269dcc2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_e3a48567-ba2e-4626-b7d8-847141338d57_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_746dbf9b-4f69-42d5-bd51-df7780af69b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_fec26a02-f2fc-4c96-aa2c-fc2e5ecff98d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44210a10-5c06-4736-a686-664d40879fa2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7c970810-14e3-43df-9956-38cffc751917_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c26a5424-ea12-4d36-a07d-4a2e748c8ba7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_875a7cd0-7b79-4fc9-9252-961b854eded5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a4964887-7652-47f6-aeb3-85b3e86b828f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_ecf56096-acac-4ca9-8747-3de24e696518_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Expense</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_91c8ba84-7785-4b8a-8163-de8a32aff731_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_33515184-11c8-499f-86c8-3a915c7902bf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ec6b9b2a-eb50-4a0c-a449-0488393c9a96_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_7eef5fb6-e378-4477-8d0b-9a27a88cff03_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and other movements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_916059f5-c5fa-40e5-97df-4340f635eadc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_56b42267-d6dd-4699-8ad5-a2b49bf92c07_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, accumulated amortization, beginning</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_021fd5a2-b88f-435b-86b5-a84f60e4db18_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, accumulated amortization, ending</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_89de362f-d9c6-4e21-8eca-690e6e4cd605_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_cb3f85ae-5f52-4743-a8a4-6d4a78074569_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Principal Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FederalFundsRateMember_0ddc8a8a-a238-4229-a7b4-40e3ff169b74_terseLabel_en-US" xlink:label="lab_pbh_FederalFundsRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate</link:label>
    <link:label id="lab_pbh_FederalFundsRateMember_label_en-US" xlink:label="lab_pbh_FederalFundsRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate [Member]</link:label>
    <link:label id="lab_pbh_FederalFundsRateMember_documentation_en-US" xlink:label="lab_pbh_FederalFundsRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FederalFundsRateMember" xlink:href="pbh-20220331.xsd#pbh_FederalFundsRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FederalFundsRateMember" xlink:to="lab_pbh_FederalFundsRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4dfe08b9-6e1e-4362-acfd-39ecb196d7b0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_1921774b-1afb-48a4-b23e-3a146707c8e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares awarded, per employee, annual (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryRecapitalization_b9bfab66-7576-40b2-bb86-5fbcefccea07_terseLabel_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory capitalization</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryRecapitalization_label_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory Recapitalization</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryRecapitalization_documentation_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:to="lab_pbh_DeferredTaxAssetsInventoryRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_5b0841b1-75c1-4268-8e3c-eef2b00e61b2_negatedLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradename impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_25fd8567-73c7-4b47-88e7-6ce0155b8b14_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3b68aaa7-d328-425e-8d8d-7bf148e87a77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6a2d0758-ce13-4355-8009-0e45732299f7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d19796c7-d887-4575-8f16-4fc9d14257f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations before Income Taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ab7d4469-740f-4dc8-a373-d5e4a4149ede_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_b49b27ee-95d1-4685-bd44-4ce3c021acef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, redemption price, percentage of principal amount (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_d6ac9429-514c-468d-8b65-970bcc7bfd48_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_pbh_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_18465658-8a55-4a46-b955-1819af10b307_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3959b591-24ba-4193-89fa-d9bb9c1321c8_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_e3e40066-ea5b-490c-b544-af4e37d6d4ed_terseLabel_en-US" xlink:label="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity analysis, increase In intangible asset measurement input that would not have resulted In fair value exceeding carrying value</link:label>
    <link:label id="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_label_en-US" xlink:label="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Increase In Intangible Asset Measurement Input That Would Not Have Resulted In Fair Value Exceeding Carrying Value</link:label>
    <link:label id="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_documentation_en-US" xlink:label="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Increase In Intangible Asset Measurement Input That Would Not Have Resulted In Fair Value Exceeding Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:href="pbh-20220331.xsd#pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:to="lab_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b87d8da3-e1da-4eac-80f2-e4ff7a54f9b0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_ee59895e-a491-4649-ab14-74d9ceaf9700_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_7f3ead49-23a0-4d51-85e0-7c344f5cff55_terseLabel_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_label_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</link:label>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_documentation_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:to="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_b51c41fd-6c86-46ba-be87-385697a12432_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OralCareMember_0c9279df-0b44-4d64-844f-bc3cbe3913b5_terseLabel_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_pbh_OralCareMember_label_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_pbh_OralCareMember_documentation_en-US" xlink:label="lab_pbh_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember" xlink:href="pbh-20220331.xsd#pbh_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OralCareMember" xlink:to="lab_pbh_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_54558355-818a-4959-a28a-0187808de30f_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_baae86f4-b8bd-4f68-b345-a056906cf835_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, weighted-average grant-date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0e8e234e-e275-47bc-80e5-90a84188338c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value of options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6e5bfd64-418d-4416-8ab4-2c256d82ab16_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, commitment fee (as percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_c9578b65-bf15-4eea-b660-b89b4846eee9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_2bf442da-5b3f-4a3f-8e70-e2290b972f0c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_cc1740b9-213e-4109-937a-145a1091ff44_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total present value of lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiability_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiability" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_21d5a4ee-d1c7-4ed3-bcef-2c62b19aaa36_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liability</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_397a9263-9239-43c9-9d49-8ee3b8b023cc_terseLabel_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_pbh_WeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract" xlink:to="lab_pbh_WeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_655bc992-f0a4-4d02-adf5-9a0691a6c7ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_3920fd4a-ddba-42a2-9b7c-20442bb73835_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_77f51a30-6572-4203-8cf3-adfd0001316d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1ff0c030-f004-42c5-9efe-b0960dbaa039_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_cf319efa-489e-4fdc-a2ca-35b8d23d931b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, beginning</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0291afa7-827a-49ee-a8c2-ff8231e4a867_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, ending</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_d890cdee-265b-4fa2-901e-ee63f7380ef9_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2016Member_065a43cd-dcd4-4cdf-bc28-a7dbc5877e12_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2016Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2016 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2016Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2016Member" xlink:to="lab_pbh_SeniorNotes2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c856a18b-5dc4-4510-a68f-83219b1d8434_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a36fa264-f43b-4886-ac05-b80945137f5b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock units granted in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c816072d-0d0e-4681-8844-55a85db8bccd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_5c000f26-5b7b-41d6-9ba5-385c29045957_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e8b9720e-3a85-4184-91d6-7467b3c07fcb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_54251f36-d8fa-4d27-b635-79cfb5654d7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a41efea6-f531-4840-b9a9-6909860242ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_9c450d01-5e67-4ffc-a54e-b02d504ef717_terseLabel_en-US" xlink:label="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, increase in borrowing capacity</link:label>
    <link:label id="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_label_en-US" xlink:label="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase in Borrowing Capacity</link:label>
    <link:label id="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_documentation_en-US" xlink:label="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase in Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:to="lab_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f6cc46cc-c9da-47bc-bcf6-6bdaeef41fcb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, assumptions used calculating benefit obligation, discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e20674ae-c261-47e9-a2bd-29b5b2bc28f8_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c2fcfef5-9be0-43c0-a79b-20d71a505a10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e90d9ea9-6f21-44d1-a471-b17887457e8c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_c4267933-4871-47c3-a738-0c47100cff9e_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising and Marketing Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_9ad8d220-fdbe-4581-90fa-6b15f63881a2_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising and marketing</link:label>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ee894cbf-3056-41a7-aff2-73cb9ab5c3a1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_71459c86-8458-417f-b9ee-650fe22c488d_terseLabel_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_label_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:label id="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_documentation_en-US" xlink:label="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Leases Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:href="pbh-20220331.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:to="lab_pbh_IncreaseDecreaseInOperatingLeasesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_d9a16c41-5d5a-46f0-a637-b37397f1a703_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible asset, increase (decrease) in measurement input</link:label>
    <link:label id="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_2c812cba-43d4-48b5-a85a-51783d0ecf8c_negatedTerseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible asset, increase (decrease) in measurement input</link:label>
    <link:label id="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_label_en-US" xlink:label="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:to="lab_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxAssetsLeaseLiabilities_17d80260-0acc-4094-a757-4349e9455d39_terseLabel_en-US" xlink:label="lab_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsLeaseLiabilities_label_en-US" xlink:label="lab_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liabilities</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsLeaseLiabilities_documentation_en-US" xlink:label="lab_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:to="lab_pbh_DeferredTaxAssetsLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_503b5494-8961-40b6-93a7-f935df05f864_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ABLAmendmentNumber5Member_51e26e02-6563-4d82-b5b3-3ca8ef3d9cb3_terseLabel_en-US" xlink:label="lab_pbh_ABLAmendmentNumber5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Amendment No. 5</link:label>
    <link:label id="lab_pbh_ABLAmendmentNumber5Member_label_en-US" xlink:label="lab_pbh_ABLAmendmentNumber5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Amendment Number 5 [Member]</link:label>
    <link:label id="lab_pbh_ABLAmendmentNumber5Member_documentation_en-US" xlink:label="lab_pbh_ABLAmendmentNumber5Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Amendment Number 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLAmendmentNumber5Member" xlink:href="pbh-20220331.xsd#pbh_ABLAmendmentNumber5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ABLAmendmentNumber5Member" xlink:to="lab_pbh_ABLAmendmentNumber5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1b396eef-ecbc-4a9a-8992-48281a1a3a82_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_68cd312c-8e96-463f-bc98-5bc2bba80d2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_b780ed1a-7b18-41b1-8cb4-5a070cda0074_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of foreign currency exchange rates</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f236c7b2-c510-42ec-a0d4-ab1bb5b6fb14_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting rights (as percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06071c8f-53b9-452e-9f6e-0b82bc039bf0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_a2683cff-03ea-4dc2-bcbb-87ad56e5cf35_terseLabel_en-US" xlink:label="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation limitations</link:label>
    <link:label id="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_label_en-US" xlink:label="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation, Nondeductible Expense, Compensation Limitations</link:label>
    <link:label id="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_documentation_en-US" xlink:label="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:to="lab_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_c62b4279-9fe6-48f2-b813-6edf5e23a02d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target Allocation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock_aa2eb176-9a6e-4336-aecc-6c5593db7a58_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Activity Affecting Intangible Assets</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7863c4c9-6b9a-4796-8a93-5a20a66b4555_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6b457304-9f9c-4eb8-a22d-75677b4109b7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7f7790cd-54ae-4c4f-8170-d61562ace014_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b9e6c7d9-566b-48c5-8a32-475ee7c46beb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_b0942cd3-14d5-42cf-885b-b75f7cca75d5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa4ecd8f-e4c5-404d-85b7-2367d4581c2f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4103850c-c237-402d-a81b-90d913af5225_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_7803c95f-3c33-47fd-9d45-45b739271049_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_8c48e64f-a35d-494b-b5c0-0f3646b4ae27_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_2ee2f841-d28f-4ec3-8568-695acebf5c3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_081bec48-b445-42a7-b5f4-24923113b2bc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_d1463bdd-6270-42b4-8528-682e9cd66b63_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, cost recognized</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_d0cd78d4-ff99-4f7e-87dd-c3f36b9cf252_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warehousing, shipping and handling and storage costs</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b1ba5f8b-c978-4832-b294-1803306fce7e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_fec3c1d1-ec9b-4317-919b-18c6fe30e533_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_8dc8f4a0-24cd-45ab-a6ac-9c89ebffeee6_negatedTerseLabel_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in shares)</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_label_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:label id="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_documentation_en-US" xlink:label="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:to="lab_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_Top5BrandsMember_e61e9bfc-8f7f-4e83-8f36-a17b45648a1f_terseLabel_en-US" xlink:label="lab_pbh_Top5BrandsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top 5 brands</link:label>
    <link:label id="lab_pbh_Top5BrandsMember_label_en-US" xlink:label="lab_pbh_Top5BrandsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top 5 Brands [Member]</link:label>
    <link:label id="lab_pbh_Top5BrandsMember_documentation_en-US" xlink:label="lab_pbh_Top5BrandsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top 5 Brands [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Top5BrandsMember" xlink:href="pbh-20220331.xsd#pbh_Top5BrandsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_Top5BrandsMember" xlink:to="lab_pbh_Top5BrandsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_834eff03-b4ae-4b6b-bf51-f63538ae1e9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0a8a08b1-606f-4a79-b5d0-e1732fd6214c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_6b022460-d1e9-4c21-b03f-ebae7531f4ab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_52bad146-51dc-437d-a902-e6261fa5ce62_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_37f9a043-edae-442b-a0af-c879fc761e2b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_f4d3a280-1c63-46e8-acdc-cbee312f91b5_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Alternative Basis Spread on Variable Rate</link:label>
    <link:label id="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Alternative Basis Spread on Variable Rate</link:label>
    <link:label id="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Alternative Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:to="lab_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_3f30ccb2-99a2-4df6-acca-84953cb7ce4e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d164af4d-93cf-40b4-a8a8-e430ea8f4c45_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_43a4c799-9746-4d36-8fbc-dd435dd375b5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_43a4b633-7153-46d0-b130-6feecbdc6750_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c27eb131-4e28-44e3-8d4b-713a740ff0c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d3906ef1-f685-4ace-8cda-1a417d48dc9b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b3db7d74-532e-443d-9441-c60db09350e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, weighted-average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_7de2a151-ca7a-4611-a660-dd99627c7379_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_6ce1d2dc-2d7a-4715-8829-bd7507f76c7e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_7255fbc5-d566-43f7-a327-8fd19bbb750a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f963eb36-dcff-432a-bbdb-6437f0979bb6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_fc9c91b5-01b0-4b52-853d-f53a488eb650_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_eddefe03-63c1-450c-932e-79a42e92b37f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_bd4a17cd-b564-47f9-86a1-e5e0105418c2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ABLRevolverAmendment4Member_5887cb93-1403-4df7-986b-e08f3c63af0a_terseLabel_en-US" xlink:label="lab_pbh_ABLRevolverAmendment4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver Amendment 4</link:label>
    <link:label id="lab_pbh_ABLRevolverAmendment4Member_label_en-US" xlink:label="lab_pbh_ABLRevolverAmendment4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver Amendment 4 [Member]</link:label>
    <link:label id="lab_pbh_ABLRevolverAmendment4Member_documentation_en-US" xlink:label="lab_pbh_ABLRevolverAmendment4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver Amendment 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLRevolverAmendment4Member" xlink:href="pbh-20220331.xsd#pbh_ABLRevolverAmendment4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ABLRevolverAmendment4Member" xlink:to="lab_pbh_ABLRevolverAmendment4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a5506925-35de-4593-abe3-4f29b4ac598f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a1293ab2-c93c-45d7-b9bc-90403906782a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock acquired, average cost per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_c734606f-96c2-469b-86fc-7378012e009a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:to="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment6Member_7ec7f51a-f9fb-44b9-a043-5d2a4cab09ed_terseLabel_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver, Amendment No. 6</link:label>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment6Member_label_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver Amendment 6 [Member]</link:label>
    <link:label id="lab_pbh_A2012ABLRevolverAmendment6Member_documentation_en-US" xlink:label="lab_pbh_A2012ABLRevolverAmendment6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver Amendment 6 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment6Member" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_A2012ABLRevolverAmendment6Member" xlink:to="lab_pbh_A2012ABLRevolverAmendment6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_614ea578-63d7-4bf7-bce9-351f347fc25e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss):</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2f135f87-bfbc-4ed5-a9eb-be8e1f555860_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ec5717be-d70e-4834-8223-d7aac032dcbd_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SeniorNotes2012Member_3caa7fb3-acbe-47fe-8450-3d253a994178_terseLabel_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Senior Notes</link:label>
    <link:label id="lab_pbh_SeniorNotes2012Member_label_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 [Member]</link:label>
    <link:label id="lab_pbh_SeniorNotes2012Member_documentation_en-US" xlink:label="lab_pbh_SeniorNotes2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SeniorNotes2012Member" xlink:to="lab_pbh_SeniorNotes2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_86ea35e5-9d98-4eaa-80ce-18c9c430b025_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0f911350-64b3-49a4-be39-e2878bb6dad2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cd9a1b8-e745-4d65-88f1-b842ece5090a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_27af9837-d23f-4d72-88eb-d92abcef584a_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_ba7a4714-4e82-47dc-8262-6838a6a48dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_54bea23b-ae07-4350-962f-e0fa6da4f321_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ZaditenMember_523b8cb7-5695-49db-b46b-c02be4be7430_terseLabel_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen</link:label>
    <link:label id="lab_pbh_ZaditenMember_label_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen [Member]</link:label>
    <link:label id="lab_pbh_ZaditenMember_documentation_en-US" xlink:label="lab_pbh_ZaditenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zaditen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember" xlink:href="pbh-20220331.xsd#pbh_ZaditenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ZaditenMember" xlink:to="lab_pbh_ZaditenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6c650d6d-0ac0-4da3-9219-4a579c7a7469_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2e7db920-173a-43c4-ba2c-d175c64f73fd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_464b7b41-7c29-44e4-ad85-d4cdddd8e2ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_d055bd58-3667-4f55-9738-9177c3bed01c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_af976927-50ba-4ed7-aa7f-3719de663286_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d282ca1f-f6e7-41a5-823a-e4349a2efb59_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_0c910290-0480-4328-8167-2310f9f6771a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_5b46f264-74d0-4f82-a953-7f5895ccc1ce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_b44720ac-bad0-457c-9939-945f92796b99_terseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, accumulated amortization, effects of foreign currency exchange rates</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_a92582a6-b9c5-4c92-98e5-eeb4325466aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_e8aa6b88-b728-42ba-9baf-1d0bf266911e_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_ffc72bf4-51fa-4d58-a082-d7490a9c292c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Revenues from Similar Product Groups</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_9d2354b7-374a-4307-bec9-cb88d6ad2fcf_negatedTotalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_ebc0bcb3-ea67-4e94-9c78-87c32ee356cc_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-5 Loans, No. 6</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 6 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB5AmendmentNo6Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-5 Amendment No. 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:to="lab_pbh_LoansPayableTermB5AmendmentNo6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_137738a2-724e-46c8-98bd-b5f59b4f95e7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e55f35e6-2873-451a-b4c4-c3ed7f87e2c5_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_f43791ab-2975-4883-bab7-5f6e6028793c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_41b1604b-46e3-4eee-a477-5d775ec968fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies &#8211; Note 17</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_75b42415-1d72-4a67-9499-642a677a5405_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33357de8-70db-4450-95fe-24d45a5a2452_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c08ed376-2728-4e10-950e-b039baf076a0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_17160ea0-b07d-4cbd-8e0a-846689c2ef1c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9767f558-df70-4189-bc06-65f5bc008531_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_d79aa8f5-988b-4e1c-bc25-af317c300a82_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:to="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_cafa9d93-12a7-46f8-aeb1-3d4b4ea5427a_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_a0dfa429-68da-464d-888a-f7b30803a25c_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_label_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Acquired</link:label>
    <link:label id="lab_pbh_IntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsAcquired" xlink:to="lab_pbh_IntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_4ec30b38-cec8-425c-9038-e25360a3adee_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8e77d676-4e89-4546-8c10-ce05e85cead4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aceab503-57ed-4895-beef-5d3959465f1a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_df063f43-91e6-4363-bc91-e67116fdb4e1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0fd56d4d-942f-4cc6-9e71-eeeea31b60d9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_e105798c-75a7-4695-9410-393606f8e901_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_63ec9fc6-9436-440f-a45b-950b686219d8_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_c9cc4c9b-629b-40d7-b078-cb6bb7ab2cee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9989ee21-ea02-425b-b501-123c77db8e0a_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_dab0b129-acab-42fb-beff-4c1e281b8fb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost Not yet Recognized</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_cce15194-0b72-4fd9-9817-756c7ab76fc5_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, contingent margin step-down per annum (as percent)</link:label>
    <link:label id="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_label_en-US" xlink:label="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Contingent Margin Step Down Per Annum, Interest Rate</link:label>
    <link:label id="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Contingent Margin Step Down Per Annum, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:to="lab_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_184e046c-552d-4122-9467-f5589fd12414_terseLabel_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]</link:label>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_label_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]</link:label>
    <link:label id="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_documentation_en-US" xlink:label="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:to="lab_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_42f681d8-8263-4d0f-9aef-724f9235eae6_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves for sales allowances and cash discounts</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e63a706f-fa84-4c7c-a472-a9f9cc4ebf84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_cd8bbcdc-e7d4-4ea3-a7f0-f2c6b5d9cd57_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_6c7940ec-febd-4c0c-8156-dcd5f70be9d5_terseLabel_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:label id="lab_pbh_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable" xlink:to="lab_pbh_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_fae1ab47-2c8e-4ceb-81a1-6eda089236b6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e3bf9124-0977-471b-ae19-c0b787b15e30_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1ad530e8-853c-40c4-8197-6e4c1e44c038_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_cd472c12-89e9-449a-8f7c-fa4fbadac455_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_LoansPayableTermB1Member_ea7a3f1e-7a51-4456-a1c8-7964db7e66b5_terseLabel_en-US" xlink:label="lab_pbh_LoansPayableTermB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-1 Loan</link:label>
    <link:label id="lab_pbh_LoansPayableTermB1Member_label_en-US" xlink:label="lab_pbh_LoansPayableTermB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-1 [Member]</link:label>
    <link:label id="lab_pbh_LoansPayableTermB1Member_documentation_en-US" xlink:label="lab_pbh_LoansPayableTermB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Term B-1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB1Member" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_LoansPayableTermB1Member" xlink:to="lab_pbh_LoansPayableTermB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_eb2a6745-7914-494e-b734-03a754ece655_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndirectGuaranteeOfIndebtednessMember_868c730a-9386-4444-94d6-bf30d4057962_terseLabel_en-US" xlink:label="lab_us-gaap_IndirectGuaranteeOfIndebtednessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indirect guarantee of indebtedness</link:label>
    <link:label id="lab_us-gaap_IndirectGuaranteeOfIndebtednessMember_label_en-US" xlink:label="lab_us-gaap_IndirectGuaranteeOfIndebtednessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indirect Guarantee of Indebtedness [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndirectGuaranteeOfIndebtednessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember" xlink:to="lab_us-gaap_IndirectGuaranteeOfIndebtednessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_231efc4c-9ef9-4003-9176-daa7886fe17d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_697fd1af-6b8d-4cd7-b955-eec8233b0ce3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_e0351ffa-5462-4b4d-ade2-096376772434_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5405db32-29c4-4b68-a656-b6acc2f2eed6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e10a0a6c-70e3-4165-a5e9-7c23b26fa871_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_93fdc306-5921-4478-9407-b98036550258_negatedTotalLabel_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_label_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Income (Expense)</link:label>
    <link:label id="lab_pbh_TotalOtherIncomeExpense_documentation_en-US" xlink:label="lab_pbh_TotalOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense" xlink:href="pbh-20220331.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_TotalOtherIncomeExpense" xlink:to="lab_pbh_TotalOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_0e1b5ed2-c864-49be-8b2a-89344e3d1778_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_92ede063-3a63-42dd-82e2-e56cb0a368a5_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers with long-term contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers with Long-term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:to="lab_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f3a70e8-350c-4f29-87ed-419a394c3c10_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f94fb2a8-b210-4dd0-960a-d53be9165832_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8a29d570-e0d6-4801-bba0-231647086566_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_f985a27e-9cbf-4e7b-82f0-7647eff9da9c_terseLabel_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third-party manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_label_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:label id="lab_pbh_NumberOfThirdPartyManufacturers_documentation_en-US" xlink:label="lab_pbh_NumberOfThirdPartyManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third-party Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NumberOfThirdPartyManufacturers" xlink:to="lab_pbh_NumberOfThirdPartyManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_2734ea19-2531-4ef8-be05-3e926b5796cf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:to="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_a101e8a0-f2a4-478d-9279-f72d6b40ab2a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_1ea8f552-b6be-46b3-a752-b7cbda40c8af_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_f23c6d16-983a-4a2b-9ec6-f12bcf598e87_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_185741b9-d588-4d32-a558-1aded1ee00c7_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_6dae5cfb-dc46-4149-a54a-a11960b01df2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_4ed74b5b-32a9-4bd1-bb16-7a43dc7a6a00_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a20c366c-c81b-446c-8a73-13d04e8c860f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_dd816c71-f95f-4a61-8fc4-8aaa04741fb9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_a414c1d2-fa66-4d9d-8ea6-86175faba2f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions to the qualified plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_06268079-4cb5-4dbb-afb7-32187fe2f28d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7585f2ee-9238-4a63-9932-1606c76f67aa_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_dd8927b6-e5b1-4f0b-bbe0-63efca889dbe_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_da12729a-ba4d-4050-9081-ee69c45e0782_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e149da62-70c9-4ee2-a9cb-e6131004bb79_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_8a7b5ba6-6431-4580-a474-7f7524f714e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_72ce322e-6a54-4ff3-8c21-cf7cf91db249_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_b94d84da-8db1-4abf-bf92-f63605155085_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8ad01492-ce85-4c50-a8b1-6bbb398bcb31_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_9e217a9f-2bb0-4519-8c75-24e2f1493c29_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_b2921e4e-d133-4f29-8f4e-823781c79762_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_98244ea8-37a5-4b67-bbc2-0479ef534eee_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_29d7db88-5485-467b-a929-a52702572adc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_f36a9b77-2521-478f-9310-5415192599fb_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_284130c1-614f-4445-919b-4e51779dd0b1_totalLabel_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_347f06c3-659c-4e40-9526-a7602e0c6f48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected to be Contributed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f433fbfe-ce82-48cf-bad7-88215df29350_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_c4ccee56-06db-4911-ab49-5eefc9d21b33_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a5f69b39-0776-40d9-b1f4-33982c1f9f9a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_ffeab399-8b21-4724-9bce-0935c4c9a9de_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30601642-eda9-4417-96cb-638ed2a13a5c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0fd38e8d-1bb9-4fa5-9d36-615a63642b86_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets, net of administrative fees (as percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_81e80ada-484d-4747-9d04-f80506c90322_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets, net of administrative fees</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryReserves_83f91ace-5d7c-461f-a3ad-d41188c9d3b4_terseLabel_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserves</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryReserves_label_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory Reserves</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsInventoryReserves_documentation_en-US" xlink:label="lab_pbh_DeferredTaxAssetsInventoryReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryReserves" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxAssetsInventoryReserves" xlink:to="lab_pbh_DeferredTaxAssetsInventoryReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_9ff5d189-a141-4646-a35e-11175b62b79a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b5af11eb-e4e5-4fa4-8e98-7d065dbb15b5_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1316f3b0-c538-4ffc-9b38-6393c8f0a509_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_a5aef043-a6d2-4334-b645-d231934f306e_terseLabel_en-US" xlink:label="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal income tax benefit</link:label>
    <link:label id="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_label_en-US" xlink:label="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</link:label>
    <link:label id="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_documentation_en-US" xlink:label="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:to="lab_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9fe50e5f-6aec-4835-b9aa-36c798f7a710_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_9772fffa-7a05-4bf2-8b42-0cc458d55fcd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b1934242-7f56-49e5-b42e-a4297c720e99_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_cb5e48df-06f4-4c29-9c32-76a95c014675_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f6abe974-5ea4-490c-9cca-41516cf596a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_70845e2a-4642-47ea-93cd-f123f9c829bd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_62839ba0-57cb-465c-91de-546a835f232a_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_4ae8c631-75b0-4865-895a-f9f7b923dc32_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_27eaa5a1-7fd3-4e5e-926a-b4f9b792ea91_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e9a1d2ee-1635-4b3d-8962-adec747e42ed_periodStartLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles, beginning</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59aea962-1bef-406f-94d6-85b2c46bf69a_periodEndLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangibles, ending</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1926ea1d-21aa-4da0-abd0-fcd4b1f4059b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_847886cb-32a3-4d14-ac82-934714df3a79_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_70373905-0a06-4241-b4b8-d8def6820bc8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5d3da551-f2b2-4d68-9b5a-94d977db52ce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f1561bcf-3dc4-4960-b8cc-60a4eeb9a036_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_51c4f289-47ce-4159-b583-b56a8ae89038_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e5f2e342-9997-4841-ad56-ee1a4eeb2bf2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_3d9b7b45-9820-4368-9ea5-d6b1745d92c1_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d07e7db7-63ca-4285-9a6a-82bf9d3eb96c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_46facb88-c14d-458f-a4f6-dcb15c7c5967_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4f5dbfb9-98d5-4c48-acc1-7dbd9e0301a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e71ac79c-18c6-4b12-b194-a64f578d5e6a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_4442aaf7-4704-401c-8a08-d56cafa3d21b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6b353a49-3619-41a3-9282-75cc2d2382d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about our Operating and Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ad9589de-fa29-411f-8d25-f42768d69dfa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_f7dea4e7-44d9-4d67-bb71-6193436557df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_08cef218-48c7-4ec8-8ee5-5f1234f7230b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_589444ab-623e-49e2-a319-a4866f09393f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ec2f6d52-4238-4e93-9c58-169ff09cd997_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_bfd66fd1-6d84-423a-a353-b2547d5eb0f5_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_5b9676cb-7b0c-4648-a131-26322dfd0b5d_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_62703c76-629c-4df7-b71d-38e6145ea4f5_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_2e898165-5ff8-4814-bd42-140c0429c34a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_bc7e01d3-19e5-475b-b2aa-711a511fdab9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_353d6a18-af12-4713-8f7f-03193fa7b7d3_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_44d69b91-669c-4f0c-b826-83e13ca35859_terseLabel_en-US" xlink:label="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, conversion ratio for securities into which each RSU may be converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_label_en-US" xlink:label="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Conversion Ratio For Securities Into Which Each RSU May Be Converted</link:label>
    <link:label id="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_documentation_en-US" xlink:label="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Conversion Ratio For Securities Into Which Each RSU May Be Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:to="lab_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_db77e782-c14d-46c2-83d7-ba580d9235ec_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_005afa8e-56c4-4730-9e05-7a92a43b1ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_528f4350-3ca9-4c66-966f-f7fd59c7f353_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_fc118bb8-5038-4d5d-a585-b6d8a41176af_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c856b9a6-64e4-4133-a85a-84dc200a1c11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ba3225b2-163e-4dc0-b7d8-f203c46d7ad7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_73998ed4-6ae1-42a0-97b5-d6cc86362a27_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate_15e19617-664a-41f3-8dd8-0b8390dccab1_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, conditional variable rate (as percent)</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate_label_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Conditional Variable Rate</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Conditional Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateConditionalVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:to="lab_pbh_DebtInstrumentVariableRateConditionalVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_4dd3b18b-a739-494d-9872-1b6950331567_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_3323c741-c42c-4463-a84f-a36a7192baa2_terseLabel_en-US" xlink:label="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, minimum annual contributions per participating employee (as percent)</link:label>
    <link:label id="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_label_en-US" xlink:label="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Minimum Annual Contributions Per Participating Employee, Percent</link:label>
    <link:label id="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_documentation_en-US" xlink:label="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Minimum Annual Contributions Per Participating Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:href="pbh-20220331.xsd#pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:to="lab_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5251119a-74ea-48f7-8669-943fc573de3c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0b29d2a1-a90c-4000-81d8-22b3f8f580d1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_d8850184-4732-45bb-94b7-64069d25f10b_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5cb61c29-014b-4b1b-b850-6dc57a852307_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ea42c14-9bee-4429-b81f-9ce63aebf11f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5e0779b6-b3b4-4521-89df-22f6d2a20fce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_05e20977-6156-44da-89d2-1cbea717a387_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_7f87720d-bed1-487f-b79a-3da66aef24fc_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_097203b4-b648-4c42-ba23-ef47791bbf34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_dc4f6a7f-6490-4652-9926-2290a5906090_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_014c7605-c0a1-4d65-a8ef-d0f2a7b6d91a_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_bac371af-82d9-4d92-8e58-038806ea2327_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_12b5e7c2-9390-4305-b004-52c5258d2923_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_48193ef0-4363-4fd7-b97e-d666aabb4455_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_a511b144-fecf-467b-abe3-9529eac6a105_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_27f9c695-459b-474d-aed3-423ffd0603d6_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_80a2c382-95a9-4c69-a592-e210151e208f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputCapRateMember_6b5917f1-de94-4537-9c92-b3ed6ddab9e0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputCapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Cap Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputCapRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputCapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Cap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputCapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputCapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputCapRateMember" xlink:to="lab_us-gaap_MeasurementInputCapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_ee908a73-48e5-40fd-9efe-9c9fa3f6ee1d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d036521c-5b6a-4375-99c1-b5bae28943cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_6be11bea-2c60-41bb-9b79-f20df7ecd709_terseLabel_en-US" xlink:label="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts and sales returns</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_label_en-US" xlink:label="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts and Sales Returns</link:label>
    <link:label id="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_documentation_en-US" xlink:label="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts and Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:to="lab_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0f800d5e-2e25-4863-a682-d247850de159_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_8783ffb3-89c8-4247-8d12-76d0861f3c6c_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_92891a69-6939-42eb-bc98-4d1e43781b0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_f262d9e1-84d1-4c36-b37d-c00b05cb7f0f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_03944347-9957-4dc5-a5d0-bfa4d2919464_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Origination Costs</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_efd2c8ba-60d2-4460-933e-0f38ff27b5fc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_a7896747-afd7-4c98-9eed-0cf4c93e37ca_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_6ee86537-a748-4ba7-9a28-3b1d6162850e_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, variable rate, minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_label_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:label id="lab_pbh_DebtInstrumentVariableRateMinimum_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentVariableRateMinimum" xlink:to="lab_pbh_DebtInstrumentVariableRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_48bb6a9a-9e46-43ab-b419-0bf96d062934_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_453495f2-2018-46c9-8c62-fd64d082b51f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for basic earnings per share - weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c00e2600-64da-42ef-bdd3-fcb0957d5290_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_aad8d128-e457-4b49-b1ad-eb3a57d5a003_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_6e4a324b-1d5b-4ed2-83c2-aa4a0ebd40b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_06dbf917-4276-410e-9ffb-1477d0a1ed53_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt origination costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_cf4f7e83-bd47-4266-a5fb-80dd7e31f920_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_604668c1-f598-4e14-94f9-07232fe7077d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangibles, additions</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_1e435492-2e20-4246-a6b0-39f444bc4421_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_30eac5c7-1057-4796-8a2f-9ab90edb5175_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f2dbd440-6572-4d04-ad29-9be2f7ca78bc_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_918d6526-851e-4eb2-8f57-00b2449bb8ec_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_dcd3b52b-7b0e-4a28-aa0c-310fe9810ed7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_117f6ee8-1ca9-4b39-9b55-dd0660b91a37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_76859072-a8ab-431b-8e88-48ab06f0f993_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_c640c0eb-83d5-4683-82eb-3ef657b6da28_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loans</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_0e32d2ac-b7c5-421d-b7f1-8b10101b83a3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_95055a2f-7edb-4d71-9b89-e095df5e1c78_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1030f760-ed51-4b1a-a5ec-33e6a83f8077_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0178ae2e-98b7-4906-be1a-5834fb51bee9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2995bebe-f461-4bf0-a6d4-25136ef54c8d_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_d3c8e215-43bb-4386-9df6-7a73acf7ab63_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_ce077329-52e3-49b1-be32-766b40e417b4_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d0c0bc59-bbf5-4db3-8d1d-6bbaed999187_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4cff6f8a-60ba-4fd4-8a6a-2c666a270274_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_408da237-beb3-4611-baf6-9f477c4f916f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_e7c15aa8-43f9-4bd6-8969-f2a2e3e57138_terseLabel_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued production costs</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_label_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:label id="lab_pbh_AccruedProductionCostsCurrent_documentation_en-US" xlink:label="lab_pbh_AccruedProductionCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Production Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent" xlink:href="pbh-20220331.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AccruedProductionCostsCurrent" xlink:to="lab_pbh_AccruedProductionCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7d9a01fb-e9e0-449d-90af-a0e3863a6558_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5affbbed-3821-4bd9-a3ac-842cac48ba4a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_abee2fd9-834b-47c4-8c76-b39d6d85165f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warehousing, shipping and handling, and storage costs</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_409637dd-eb0c-4a93-866a-2a0829ec909d_negatedTerseLabel_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization, tradename impairment</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization, Written off Related to Sale of Business Unit</link:label>
    <link:label id="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_documentation_en-US" xlink:label="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Accumulated Amortization, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_128444ae-917d-4c61-b21e-3fc663658729_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_af9e4b32-605b-4415-8a64-60c17df7bf6f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_c934a94a-0b5d-4490-b896-4e7554696348_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales depreciation</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_a41b59bf-d77d-45f2-8522-d599ca4c9c91_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_f3d066c9-c6a2-4d56-9229-f2adf005ce71_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ac1169cd-8482-4e58-8eab-10094f0451f8_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_882515c7-e802-4034-a742-d8e2565698ca_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_EscrowReceipt_b4482e33-d58e-4adb-8358-314090680fb9_terseLabel_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow receipt</link:label>
    <link:label id="lab_pbh_EscrowReceipt_label_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Receipt</link:label>
    <link:label id="lab_pbh_EscrowReceipt_documentation_en-US" xlink:label="lab_pbh_EscrowReceipt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt" xlink:href="pbh-20220331.xsd#pbh_EscrowReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_EscrowReceipt" xlink:to="lab_pbh_EscrowReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentDiscountPercentage_bc3d18f7-819a-48dd-8de1-647595b23e34_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, discount (as percent)</link:label>
    <link:label id="lab_pbh_DebtInstrumentDiscountPercentage_label_en-US" xlink:label="lab_pbh_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Percentage</link:label>
    <link:label id="lab_pbh_DebtInstrumentDiscountPercentage_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentDiscountPercentage" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentDiscountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentDiscountPercentage" xlink:to="lab_pbh_DebtInstrumentDiscountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_29afae3b-954c-4eaf-9b25-c70512921505_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_037828f2-cc39-4070-853c-126aaa752f7f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_24fe7e4d-bb32-453b-be2f-e5bbfe7e0ea9_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, amortizable intangible assets, allocated amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_label_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:to="lab_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_77fb9b0d-1f90-477b-8254-8486005d603e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ea363aa2-f1d8-4517-9686-4a5015080bbc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_b59106e0-adf6-4ebe-9025-739551545857_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_9ab3f77b-31de-4601-8574-2deeb1980b5b_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_e7c286c5-28f8-42eb-b3f6-05ef4cb4cada_totalLabel_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7b14559a-de63-4ce8-bedf-5f29a9571860_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b1eace35-8bb3-4fa3-963c-e681692f27e1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_6ffb779e-e400-4c2e-8d8c-c1ab888b7eeb_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_47280abb-8b5d-4a7e-a78a-0f5fef7c5e8e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9999ba2a-b702-458d-8eac-51376340510e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_43793612-4234-4579-809e-07005c41c726_terseLabel_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, non-amortizable intangible assets, allocated amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_label_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:label id="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_documentation_en-US" xlink:label="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:to="lab_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_fd1abf3b-96d7-4e79-8b19-3c1caffa25d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_Amendment52012TermLoanMember_9914e4fb-9d5c-400f-bb4a-aa905515d089_terseLabel_en-US" xlink:label="lab_pbh_Amendment52012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term B-5 Loans, No. 5</link:label>
    <link:label id="lab_pbh_Amendment52012TermLoanMember_label_en-US" xlink:label="lab_pbh_Amendment52012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment 5 2012 Term Loan [Member]</link:label>
    <link:label id="lab_pbh_Amendment52012TermLoanMember_documentation_en-US" xlink:label="lab_pbh_Amendment52012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment 5 2012 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment52012TermLoanMember" xlink:href="pbh-20220331.xsd#pbh_Amendment52012TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_Amendment52012TermLoanMember" xlink:to="lab_pbh_Amendment52012TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_e35347ae-b9c0-47b7-8a47-7ec18b047ebe_terseLabel_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_label_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:label id="lab_pbh_NorthAmericanOTCHealthcareMember_documentation_en-US" xlink:label="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North American OTC Healthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_NorthAmericanOTCHealthcareMember" xlink:to="lab_pbh_NorthAmericanOTCHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_5e0cb22a-944c-4b2f-a0ff-4480137183d3_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, beginning</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_f8067abb-9d51-4759-97e5-9e4b546ad9ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, gross, ending</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_a38dd44a-006e-4c9f-a4ba-955d41391982_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_f259928b-7948-41d7-b4b2-3d2e5cf67b25_terseLabel_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_pbh_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_pbh_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember" xlink:href="pbh-20220331.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ShareRepurchaseProgramMember" xlink:to="lab_pbh_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_45a1bced-a450-469b-bf65-08adf7f00f7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_8b88f8ea-757f-471a-8b45-1400851ec7c1_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_b07c21d8-c739-46b2-991a-ac50823f8f85_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (including goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2b63d44-e5d4-428c-86e5-51d1ee8d7898_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (including goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3b4d6f95-326d-4f76-8064-8136c26a7fd8_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of period, weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther_2d980e5e-3549-4676-bd8a-deb66f7da34e_terseLabel_en-US" xlink:label="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther_label_en-US" xlink:label="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Other</link:label>
    <link:label id="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther_documentation_en-US" xlink:label="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:href="pbh-20220331.xsd#pbh_SECSchedule1209ValuationAllowancesandReservesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:to="lab_pbh_SECSchedule1209ValuationAllowancesandReservesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a86ab59f-e40d-482a-845b-92120844e535_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_a2281568-37fd-457d-a67d-a0098907138c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_b14aba7a-7bef-4249-9dc6-533aaddea067_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, temporary suspension of financial reporting covenant, period</link:label>
    <link:label id="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_label_en-US" xlink:label="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Temporary Suspension of Financial Reporting Covenant, Period</link:label>
    <link:label id="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Temporary Suspension of Financial Reporting Covenant, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:to="lab_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_68066f44-9daf-4c48-946e-ad7bbc8bf702_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement gain, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_ce21a3d4-eedf-4b50-9f03-bfcb3d990a4a_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_14026ce8-01f9-49e5-b5a2-b41051f5b8c2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves related to obsolete and slow-moving inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_61bd1bb7-57cf-41e9-8928-59411d0c5da5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Continuing Operations Before Income Taxes, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_285bd361-052a-4b2d-96b4-be1977903cfb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_4841cba3-c0fa-4af9-916a-4b216fe37645_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f31c8c30-3f45-4ec2-a261-3c7886bb2985_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e9cdd89-6d70-456f-892f-286128247d96_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2892554a-6bdf-45ec-894b-87b9f1e927a5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_fdb3575f-1eac-4fb7-8781-c674826a7551_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_2dc16279-5656-412b-bc3b-6d8e3a03f9a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_328d0ccd-5679-49ec-b590-13b979b9b253_terseLabel_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_label_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:label id="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_documentation_en-US" xlink:label="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative, and Depreciation and Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:href="pbh-20220331.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:to="lab_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_Amendment32012TermLoanMember_0c5c5091-c97f-4d23-bb1a-bb6c4cac4fc5_terseLabel_en-US" xlink:label="lab_pbh_Amendment32012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Term Loan, Amendment No. 3</link:label>
    <link:label id="lab_pbh_Amendment32012TermLoanMember_label_en-US" xlink:label="lab_pbh_Amendment32012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment 3, 2012 Term Loan [Member]</link:label>
    <link:label id="lab_pbh_Amendment32012TermLoanMember_documentation_en-US" xlink:label="lab_pbh_Amendment32012TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment 3, 2012 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment32012TermLoanMember" xlink:href="pbh-20220331.xsd#pbh_Amendment32012TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_Amendment32012TermLoanMember" xlink:to="lab_pbh_Amendment32012TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bf97ed38-8212-49bf-92f2-477cd6299020_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_7aa951a5-3e45-4504-ad01-4e9215d04a91_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, gross, beginning</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_a1d9f377-6764-43fb-b5d2-eb1c65c8ae35_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles, gross, ending</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_b540d1be-d2dd-409a-82ec-0115374eac15_terseLabel_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite- Lived Tradenames</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_label_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:label id="lab_pbh_IndefinitelivedTradenamesMember_documentation_en-US" xlink:label="lab_pbh_IndefinitelivedTradenamesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Tradenames [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember" xlink:href="pbh-20220331.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IndefinitelivedTradenamesMember" xlink:to="lab_pbh_IndefinitelivedTradenamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6403efb4-a201-4241-80f7-9ec2b95da57d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1022082e-6fd2-4c4b-95af-414639edcc05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ae5d348e-cb98-408e-97cd-14d7bd2cafc3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_93ecc1fc-0e4f-4088-8567-ff12c706c974_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_4bb70532-9801-44bc-98da-ca08ebc117c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_55720d1d-53bf-4689-b661-a4e534b8c3ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_989f8576-e6c2-4b30-9d1e-b79b90551572_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9b35ec69-2e42-49f8-ab8f-f018ce2ab69b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_f2ec48f8-8c63-473e-a229-eba9fbf52a3c_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e83ccfd-edf4-4e07-bfe1-935cd0a2d5be_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_61a71fe9-460f-4a6b-8052-beaa679c9b39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_7538b110-5441-475b-954e-958af7172f5d_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_388545c4-35fd-4200-8683-b44213667200_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_5a362581-77fc-4998-966a-a3a3134471ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, average interest rate (as percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_ContributionTrancheTwoMember_f89146b0-0d38-4d16-a33a-abb5eb6db52b_terseLabel_en-US" xlink:label="lab_pbh_ContributionTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche Two</link:label>
    <link:label id="lab_pbh_ContributionTrancheTwoMember_label_en-US" xlink:label="lab_pbh_ContributionTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche Two [Member]</link:label>
    <link:label id="lab_pbh_ContributionTrancheTwoMember_documentation_en-US" xlink:label="lab_pbh_ContributionTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheTwoMember" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_ContributionTrancheTwoMember" xlink:to="lab_pbh_ContributionTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_602e1587-2a75-495e-93ce-2768953a2148_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8290ae39-67a4-47d3-9264-3591eb9a2e47_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0c848047-3370-4259-929f-ed68766aed71_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_61856215-7f9f-4d74-afdb-eac1703704b6_terseLabel_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amounts</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_label_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_pbh_IntangibleAssetsRollForward_documentation_en-US" xlink:label="lab_pbh_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_IntangibleAssetsRollForward" xlink:to="lab_pbh_IntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_3addf469-dcd6-494f-90e2-2c5dcb0d7224_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_a697703a-ea6a-4934-b3b3-5e0fd7825154_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_24ce1f9d-3bdd-476d-a072-c65944c6ccda_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_d65499ba-0fe9-4f56-9092-a1c8fabc1926_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net liability</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_AblRevolver2012Member_14dfb628-daaf-4ed2-942f-cd05b1098c1f_terseLabel_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 ABL Revolver</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_label_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:label id="lab_pbh_AblRevolver2012Member_documentation_en-US" xlink:label="lab_pbh_AblRevolver2012Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABL Revolver 2012 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_AblRevolver2012Member" xlink:to="lab_pbh_AblRevolver2012Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_ae509616-8815-443f-b9d9-51d9eac91178_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c227bd34-9e14-4013-b542-2b66904828f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_5c9e3ab0-2424-4778-b720-e4a980e67180_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ee1402b8-3cb0-4e4f-81ca-9c4abb64e672_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_db4885bc-bdb1-4724-8c85-fb9a6f08f5f3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_a7b988f7-10fb-4052-8721-671bd23918f3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_0fa48c92-920a-4a7e-87a3-cac4b2bf24ef_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_403b89d2-6b25-4918-b5eb-702568845c2f_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_e45cb1a0-5b66-453a-8f38-609f67c160ae_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_dccc2c9c-1afa-49b4-b92b-3446899075b2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_cce1a6b2-97da-4c2d-9b35-300c624ce745_terseLabel_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate, if increased</link:label>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_label_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, If Increased</link:label>
    <link:label id="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_documentation_en-US" xlink:label="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread On Variable Rate, If Increased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:to="lab_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_8e32c64f-b442-4c3b-b034-ecd1a6a6b399_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_6d926067-467f-4e21-8d6c-05ef68ae6998_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite- Lived Tradenames</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_3cf7d14a-1dbb-41c8-bfbc-0452bc29510a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_90800287-80fa-4b47-b436-7745fa7255aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_96c474c8-cb11-470b-8562-80746214b37e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_110b08c9-8a30-4f2e-bf77-13f39cb67083_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>pbh-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:2e5324cc-5a4a-4425-a2e5-b5d30d788607,g:99ea3758-dfef-48db-a0e3-c7e57366515e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="simple" xlink:href="pbh-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b334c11a-5efb-455e-a252-91361cd213c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentType_b334c11a-5efb-455e-a252-91361cd213c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_c2e1f144-baed-4cf6-98ca-feb8ada95d33" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentAnnualReport_c2e1f144-baed-4cf6-98ca-feb8ada95d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_04e17e8c-d068-4cff-b2f2-c3a25ed0c869" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentPeriodEndDate_04e17e8c-d068-4cff-b2f2-c3a25ed0c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2878fea8-75b4-4818-a71e-b775e0524fcb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_CurrentFiscalYearEndDate_2878fea8-75b4-4818-a71e-b775e0524fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_162d260a-7d59-4689-89c0-3963c2fb483c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentTransitionReport_162d260a-7d59-4689-89c0-3963c2fb483c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ad553d2a-00a9-41ea-9501-8c1b7684e032" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityFileNumber_ad553d2a-00a9-41ea-9501-8c1b7684e032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2775a519-cc26-466d-97ef-4fbf6ddb85da" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityRegistrantName_2775a519-cc26-466d-97ef-4fbf6ddb85da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_72acf4b5-7ac1-4a06-9190-6f554001933c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_72acf4b5-7ac1-4a06-9190-6f554001933c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_74250abc-7349-4b60-8ebf-dca18797df1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityTaxIdentificationNumber_74250abc-7349-4b60-8ebf-dca18797df1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b29e5353-4126-465f-ad3e-b97934cf6cb9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityAddressAddressLine1_b29e5353-4126-465f-ad3e-b97934cf6cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d5f82651-f327-4a89-ac2c-7204a886849a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityAddressCityOrTown_d5f82651-f327-4a89-ac2c-7204a886849a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8a31c1ef-a534-4bc7-8c0d-fceb456b5c2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityAddressStateOrProvince_8a31c1ef-a534-4bc7-8c0d-fceb456b5c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b43b28d0-bdd6-4a0e-956c-547f12d2920a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityAddressPostalZipCode_b43b28d0-bdd6-4a0e-956c-547f12d2920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f7e79246-5b46-4318-8db0-a97649d132cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_CityAreaCode_f7e79246-5b46-4318-8db0-a97649d132cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b64ad4d2-aaa2-459e-abe7-6e89563d09b7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_LocalPhoneNumber_b64ad4d2-aaa2-459e-abe7-6e89563d09b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5181c242-527f-4bfd-aa1b-5465dbbef2b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_Security12bTitle_5181c242-527f-4bfd-aa1b-5465dbbef2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f6482469-b248-4c96-9225-950cb66716bd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_TradingSymbol_f6482469-b248-4c96-9225-950cb66716bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d14447c2-54d9-4ff5-b1e8-d6ab266234d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_SecurityExchangeName_d14447c2-54d9-4ff5-b1e8-d6ab266234d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_bd7fc5c6-0aab-4326-892a-9a7e16df1cbd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_bd7fc5c6-0aab-4326-892a-9a7e16df1cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_fc030e51-242e-4987-b837-19004ac31167" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityVoluntaryFilers_fc030e51-242e-4987-b837-19004ac31167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ab7f790c-0086-4dd7-8a8f-3abd0958a98b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityCurrentReportingStatus_ab7f790c-0086-4dd7-8a8f-3abd0958a98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_bbe22b2e-a428-43db-a487-a2c24fed2331" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityInteractiveDataCurrent_bbe22b2e-a428-43db-a487-a2c24fed2331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ee57d1ba-3243-4760-95a6-55c09a7aa8b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityFilerCategory_ee57d1ba-3243-4760-95a6-55c09a7aa8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c00f8ea7-b238-42bb-ad39-aa50db040123" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntitySmallBusiness_c00f8ea7-b238-42bb-ad39-aa50db040123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_491d25ca-086b-45eb-a3d0-8ad402ae6c54" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityEmergingGrowthCompany_491d25ca-086b-45eb-a3d0-8ad402ae6c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_02e2dd1b-af78-4368-be7f-360aacea698e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_02e2dd1b-af78-4368-be7f-360aacea698e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a7cfc42b-68e5-4a85-9dfe-1fa33557645f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityShellCompany_a7cfc42b-68e5-4a85-9dfe-1fa33557645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_654c25d7-bbee-4b10-bea3-e2fc5315d46e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityPublicFloat_654c25d7-bbee-4b10-bea3-e2fc5315d46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c65a7884-3d01-4f98-a7dc-7b107581a646" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c65a7884-3d01-4f98-a7dc-7b107581a646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f97234f-c3f6-413e-9ca9-60143af2bfac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f97234f-c3f6-413e-9ca9-60143af2bfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_19b1acb1-4d54-4596-b36f-b2196f4ca22a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_EntityCentralIndexKey_19b1acb1-4d54-4596-b36f-b2196f4ca22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f8eb0898-a8f0-4bdb-a006-cf4ce1766abc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentFiscalYearFocus_f8eb0898-a8f0-4bdb-a006-cf4ce1766abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_df2628e7-8447-4d9f-aa69-6a0ce144a0b3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_df2628e7-8447-4d9f-aa69-6a0ce144a0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0472b47a-ea8b-4d5e-b7cb-19a2df72db87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43374ec6-0f55-4c80-b34a-565d9f6b7f7e" xlink:to="loc_dei_AmendmentFlag_0472b47a-ea8b-4d5e-b7cb-19a2df72db87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AuditInformation" xlink:type="simple" xlink:href="pbh-20220331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AuditInformationAbstract_1170d641-8569-462d-b07f-a57d26d25e0e" xlink:href="pbh-20220331.xsd#pbh_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_09c4890a-0132-4df8-a633-00abf584a718" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_AuditInformationAbstract_1170d641-8569-462d-b07f-a57d26d25e0e" xlink:to="loc_dei_AuditorName_09c4890a-0132-4df8-a633-00abf584a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_33a3b622-1c2a-483d-af86-0592aa2fcfcb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_AuditInformationAbstract_1170d641-8569-462d-b07f-a57d26d25e0e" xlink:to="loc_dei_AuditorLocation_33a3b622-1c2a-483d-af86-0592aa2fcfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_bcb37890-9081-4d2e-808f-e8b655b695cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_AuditInformationAbstract_1170d641-8569-462d-b07f-a57d26d25e0e" xlink:to="loc_dei_AuditorFirmId_bcb37890-9081-4d2e-808f-e8b655b695cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofIncomeandComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7197070d-ba11-41d6-ac73-21a44b2103fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7197070d-ba11-41d6-ac73-21a44b2103fc" xlink:to="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:to="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_87833223-1472-47ca-9b0f-e8da09b805ac" xlink:to="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ce3874d4-3c64-48ef-bb20-5020c08182b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:to="loc_us-gaap_ProductMember_ce3874d4-3c64-48ef-bb20-5020c08182b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a90ff753-4792-487a-8275-99ba9581f43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2b0b470-ee5a-46b8-9625-1a83eeba5072" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a90ff753-4792-487a-8275-99ba9581f43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8231f1c6-b1a9-4743-8fda-ae65452745a2" xlink:to="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06be6cd9-3143-44c5-8226-7799f65ef166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d100a8b5-7f30-4a2b-a59c-edaeecbfb0d8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06be6cd9-3143-44c5-8226-7799f65ef166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesExclusiveOfDepreciation_c7982527-4cf7-4a08-af90-7960bc188997" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesExclusiveOfDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_pbh_CostOfSalesExclusiveOfDepreciation_c7982527-4cf7-4a08-af90-7960bc188997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_87fd04d7-d284-4bd5-addb-8b9b6d49ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_87fd04d7-d284-4bd5-addb-8b9b6d49ba49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b5c46cda-9f46-4856-89ea-f665fcbe7f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_db228c59-11f3-4d28-9587-2e4b56eab4fb" xlink:to="loc_us-gaap_CostOfRevenue_b5c46cda-9f46-4856-89ea-f665fcbe7f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9c2d0b40-7cbe-4f1c-a2e3-11b477120fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_GrossProfit_9c2d0b40-7cbe-4f1c-a2e3-11b477120fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_18ac5de2-3e88-4191-8621-b445e0163344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_18ac5de2-3e88-4191-8621-b445e0163344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7cfa99d7-99f5-47e0-95c3-51cd512209ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7cfa99d7-99f5-47e0-95c3-51cd512209ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_a210ec41-e68f-45c6-ba6d-ef9633fc4388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_a210ec41-e68f-45c6-ba6d-ef9633fc4388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d9dac929-2a55-43a6-9027-fa1398f4ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0f15fcc8-3535-4064-9f05-74dbe164e78d" xlink:to="loc_us-gaap_OperatingExpenses_d9dac929-2a55-43a6-9027-fa1398f4ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e30822fa-afc2-4a0f-85b2-da0f0e7cf2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OperatingIncomeLoss_e30822fa-afc2-4a0f-85b2-da0f0e7cf2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_64ab2b37-7de1-4f08-b6ed-8e1b885ee64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_InterestExpenseDebt_64ab2b37-7de1-4f08-b6ed-8e1b885ee64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fc0c2478-4d95-444c-b34a-2d3622e0beb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fc0c2478-4d95-444c-b34a-2d3622e0beb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5cd4bb9d-d4fc-43cd-b136-8155dcd11810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5cd4bb9d-d4fc-43cd-b136-8155dcd11810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TotalOtherIncomeExpense_6a815b46-0c7b-4a79-92af-3a1de2316bf9" xlink:href="pbh-20220331.xsd#pbh_TotalOtherIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_adb0a889-033a-4405-ab32-4c94e3a4abf1" xlink:to="loc_pbh_TotalOtherIncomeExpense_6a815b46-0c7b-4a79-92af-3a1de2316bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6b46c452-c27e-4968-9365-8c7d48b24f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6b46c452-c27e-4968-9365-8c7d48b24f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5a58526f-d063-4364-8c84-33beb5165316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5a58526f-d063-4364-8c84-33beb5165316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b29d2b6d-26a2-462f-984e-32bc3ca3626b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_NetIncomeLoss_b29d2b6d-26a2-462f-984e-32bc3ca3626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ac581b8c-f20c-4779-9a63-91e0d371ff5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:to="loc_us-gaap_EarningsPerShareBasic_ac581b8c-f20c-4779-9a63-91e0d371ff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f360db51-7bba-4a35-9387-78c8467abde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b880d7d7-c39e-4c93-af93-b91e61bc4f8b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f360db51-7bba-4a35-9387-78c8467abde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390d6ed9-6092-41ad-9073-314b29897326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_390d6ed9-6092-41ad-9073-314b29897326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc318af2-02fb-4365-9a62-839230dfd573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageSharesOutstandingAbstract_ac87adfb-eaf9-4a14-93c9-5ccbfab19565" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc318af2-02fb-4365-9a62-839230dfd573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bd2a7394-48d7-4e74-a606-20ea4d245fe2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d9a806f0-f6d3-48ff-8ac0-64eb29094bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d9a806f0-f6d3-48ff-8ac0-64eb29094bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_729595ad-3bde-48ab-aff1-83d0dae5f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_729595ad-3bde-48ab-aff1-83d0dae5f4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_0e0cef31-839b-4c93-a9c2-095c091b835f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_0e0cef31-839b-4c93-a9c2-095c091b835f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ccb92acf-0f62-4325-b50c-c6873811c4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_ccb92acf-0f62-4325-b50c-c6873811c4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b58c9bfa-027c-4f46-bbdc-dba106abf341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b58c9bfa-027c-4f46-bbdc-dba106abf341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4cbe22d4-e6cf-430c-b5d7-a23fa6305db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_7d665c6e-d4ee-4647-9f30-b175e038351f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4cbe22d4-e6cf-430c-b5d7-a23fa6305db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d8ec3025-ffad-403d-be6c-ca8c9a6d9d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d8ec3025-ffad-403d-be6c-ca8c9a6d9d7a" xlink:to="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d2c4b1c5-d2ab-4960-8d95-6ff3083f9ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d2c4b1c5-d2ab-4960-8d95-6ff3083f9ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b98d981f-912b-4819-a781-1f40ae997430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b98d981f-912b-4819-a781-1f40ae997430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b1b300a9-e5e2-4588-9cb4-6203baf00983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:to="loc_us-gaap_InventoryNet_b1b300a9-e5e2-4588-9cb4-6203baf00983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_45ecc588-b879-4573-a9b5-34f2da8baaba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_45ecc588-b879-4573-a9b5-34f2da8baaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_49027626-b0c0-4b43-a87d-ad84ae7cb0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_12b05e5c-5bd7-4078-addc-61408f939123" xlink:to="loc_us-gaap_AssetsCurrent_49027626-b0c0-4b43-a87d-ad84ae7cb0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ef2e65a2-23de-4d50-945a-4a7ce1909024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ef2e65a2-23de-4d50-945a-4a7ce1909024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7bae273e-0049-44b7-8b7f-702e09052e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7bae273e-0049-44b7-8b7f-702e09052e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_006e27d5-2be9-44a6-aa7b-6e2f70f3198a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_006e27d5-2be9-44a6-aa7b-6e2f70f3198a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ade28976-aaf6-4293-8de1-be42a9a16a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_Goodwill_ade28976-aaf6-4293-8de1-be42a9a16a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf3d413f-c559-4b2c-b806-fe37765f1515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf3d413f-c559-4b2c-b806-fe37765f1515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_304d14f2-3dab-4435-809b-72bd96633468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_304d14f2-3dab-4435-809b-72bd96633468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b89b77c1-1d19-459a-8e36-81742ac75603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b06c4a35-2380-4abe-b7f9-c71934ccc7de" xlink:to="loc_us-gaap_Assets_b89b77c1-1d19-459a-8e36-81742ac75603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d8ec3025-ffad-403d-be6c-ca8c9a6d9d7a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_cb46c9fb-6bfa-4b27-a188-fc7600ed8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_us-gaap_AccountsPayableCurrent_cb46c9fb-6bfa-4b27-a188-fc7600ed8b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendsPayableCurrent_e7364b39-dc72-409b-8a78-880464b9e3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_us-gaap_InterestAndDividendsPayableCurrent_e7364b39-dc72-409b-8a78-880464b9e3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_76798e94-ae4f-4d57-b378-fefe063fc322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_76798e94-ae4f-4d57-b378-fefe063fc322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d9008aff-1cb5-494d-9f53-1e1b642d6c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d9008aff-1cb5-494d-9f53-1e1b642d6c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_970cf57a-1b59-4dcc-bc51-53c39be12828" xlink:href="pbh-20220331.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_970cf57a-1b59-4dcc-bc51-53c39be12828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d159daea-2fc3-4c93-8600-95bcd14a2a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_0a579159-f0b2-46f6-bcbf-d1514b903c07" xlink:to="loc_us-gaap_LiabilitiesCurrent_d159daea-2fc3-4c93-8600-95bcd14a2a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7401eda1-b33d-41a9-a44f-a280d3e1b739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7401eda1-b33d-41a9-a44f-a280d3e1b739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3532464a-60d7-44ef-aa59-cf90ebb11421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3532464a-60d7-44ef-aa59-cf90ebb11421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2503ea3c-f15a-426a-b3d5-0615ce3aeaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2503ea3c-f15a-426a-b3d5-0615ce3aeaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d008deb0-ebc7-4afa-b0fa-fa1db4d98690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_d008deb0-ebc7-4afa-b0fa-fa1db4d98690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8995780a-4251-4227-aef6-c3a8a065735c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8995780a-4251-4227-aef6-c3a8a065735c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a9f8ee99-63ae-4896-ad47-36f2cb170881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_Liabilities_a9f8ee99-63ae-4896-ad47-36f2cb170881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c81eb169-9cef-4404-84f0-c251753167ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c81eb169-9cef-4404-84f0-c251753167ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_66e1a6d7-57fe-433a-98de-580eefad27c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_PreferredStockValue_66e1a6d7-57fe-433a-98de-580eefad27c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_775290d6-bce3-429c-b957-8149a6d3d306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_CommonStockValue_775290d6-bce3-429c-b957-8149a6d3d306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2356aeef-f737-42c1-a078-9bb63db99c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2356aeef-f737-42c1-a078-9bb63db99c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dfd23a5e-53d3-4b1d-88b0-524e177eca36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_TreasuryStockValue_dfd23a5e-53d3-4b1d-88b0-524e177eca36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2171780d-ddaf-44c2-a5a9-c6f30fc0137e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2171780d-ddaf-44c2-a5a9-c6f30fc0137e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f867afa5-4d29-4c54-a013-482b730274b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f867afa5-4d29-4c54-a013-482b730274b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_354c4933-f501-452a-9ed0-1ca9a8d44698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c6037777-d91c-4daa-bf62-f5a39e57a7f3" xlink:to="loc_us-gaap_StockholdersEquity_354c4933-f501-452a-9ed0-1ca9a8d44698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_27947f8c-8233-4fe2-b45f-9297c5dfbd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a40737d4-9062-4970-ac4e-9f47b22478af" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_27947f8c-8233-4fe2-b45f-9297c5dfbd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_49bf4409-d1fb-4035-a504-99eb408558ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_49bf4409-d1fb-4035-a504-99eb408558ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8ab1305d-83d7-4e23-af2b-53360c1f4954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8ab1305d-83d7-4e23-af2b-53360c1f4954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4d6f368c-dade-4e38-905e-7ee6fb97e350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4d6f368c-dade-4e38-905e-7ee6fb97e350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6adf70ab-e995-480a-ae05-6224e5588f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6adf70ab-e995-480a-ae05-6224e5588f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_bdb2efcb-5e4d-4b23-9412-0adc3bd7cb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_bdb2efcb-5e4d-4b23-9412-0adc3bd7cb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6c6519f5-0ac8-416f-a15d-3e86ea9cee7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6c6519f5-0ac8-416f-a15d-3e86ea9cee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8d2683d8-46b2-4e37-8047-ecc87b682585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8d2683d8-46b2-4e37-8047-ecc87b682585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1e3146a4-1326-45b3-b659-96ecb8bd538a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_CommonStockSharesIssued_1e3146a4-1326-45b3-b659-96ecb8bd538a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d53a2b2d-cbae-4067-a8e0-2fd061b72507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d3c1db6f-24d8-4831-a3e2-366139d5f9c3" xlink:to="loc_us-gaap_TreasuryStockShares_d53a2b2d-cbae-4067-a8e0-2fd061b72507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofChangesinStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b40c853f-8c9a-4f20-9f91-559adfe5cd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b40c853f-8c9a-4f20-9f91-559adfe5cd50" xlink:to="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d33d7793-8200-4f5b-ad2a-34aed35bb3fc" xlink:to="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0d95f277-3e6e-4057-a930-36b3697ed05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_CommonStockMember_0d95f277-3e6e-4057-a930-36b3697ed05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_db4ac54c-6da2-4d0a-adfb-a063e12696c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_db4ac54c-6da2-4d0a-adfb-a063e12696c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_94e96ea5-2ef0-4979-afd7-5f403ce77ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_TreasuryStockMember_94e96ea5-2ef0-4979-afd7-5f403ce77ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df0c66a-c94f-4ba3-aa3f-9879f2baa105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df0c66a-c94f-4ba3-aa3f-9879f2baa105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1e0b3c30-1fff-43d9-895d-43b116d1571b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b440e3a4-7759-47aa-aacb-4c6119350484" xlink:to="loc_us-gaap_RetainedEarningsMember_1e0b3c30-1fff-43d9-895d-43b116d1571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_32f72002-1dae-4758-b98b-09b23b77364b" xlink:to="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e840cc38-bd17-4447-b7cf-e7689e250b42" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_83db0560-adca-4159-8a58-bdc45fba96b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_83db0560-adca-4159-8a58-bdc45fba96b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_0459b5e0-0890-4507-bc06-15a1aeb229a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockShares_0459b5e0-0890-4507-bc06-15a1aeb229a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_69a18cda-2179-4fde-b662-12014fd35e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockholdersEquity_69a18cda-2179-4fde-b662-12014fd35e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3f831b2c-e94f-40dc-8294-be9efc656ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3f831b2c-e94f-40dc-8294-be9efc656ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_49f2183a-f836-4da7-9c1f-70b69d2d30f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_49f2183a-f836-4da7-9c1f-70b69d2d30f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fddd1d36-c8b7-461f-9797-7af6361aacad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fddd1d36-c8b7-461f-9797-7af6361aacad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6871cbc2-ae99-4a2d-b711-b170e6d60aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6871cbc2-ae99-4a2d-b711-b170e6d60aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f86620d9-ed99-43f2-92ea-5f90bdd34b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f86620d9-ed99-43f2-92ea-5f90bdd34b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4bdbfa48-09e3-439b-af91-57507b7b40ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4bdbfa48-09e3-439b-af91-57507b7b40ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6efd3af7-8615-4c27-b6d0-56fc6cb6e7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6efd3af7-8615-4c27-b6d0-56fc6cb6e7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d0a5758a-37dc-4632-9374-2375084817fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_NetIncomeLoss_d0a5758a-37dc-4632-9374-2375084817fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63cc3df5-8f82-410b-8376-734cc0b971d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63cc3df5-8f82-410b-8376-734cc0b971d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_49a2d0a8-9f70-4aea-8d3b-56b6c25111d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_49a2d0a8-9f70-4aea-8d3b-56b6c25111d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3b9747f4-43b8-4627-ac5c-9e49e12e5b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_TreasuryStockShares_3b9747f4-43b8-4627-ac5c-9e49e12e5b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c503b08a-4144-4688-ab90-63350a54e7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a022139e-acc0-439b-97d8-6bdac8d40d73" xlink:to="loc_us-gaap_StockholdersEquity_c503b08a-4144-4688-ab90-63350a54e7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_786bab3a-9d6d-4b6d-a4a3-69b68293ac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_786bab3a-9d6d-4b6d-a4a3-69b68293ac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6989eb1e-1585-4f36-8022-ca7441567cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_786bab3a-9d6d-4b6d-a4a3-69b68293ac4a" xlink:to="loc_us-gaap_NetIncomeLoss_6989eb1e-1585-4f36-8022-ca7441567cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_786bab3a-9d6d-4b6d-a4a3-69b68293ac4a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f8212b4d-23a8-4c1e-b556-2b9f52111709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f8212b4d-23a8-4c1e-b556-2b9f52111709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_186cc0e2-8247-452c-bb0e-12149924c674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_186cc0e2-8247-452c-bb0e-12149924c674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e0955a2-ec31-46df-a7c7-a01dd2366c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e0955a2-ec31-46df-a7c7-a01dd2366c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_faf90220-0e31-4a01-8cb7-2480e6e295d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_faf90220-0e31-4a01-8cb7-2480e6e295d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e953abcf-f183-4c1f-b6bf-cdd185fd3353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e953abcf-f183-4c1f-b6bf-cdd185fd3353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ea21408-3300-41f5-8976-66323df32348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8ea21408-3300-41f5-8976-66323df32348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_45d39e57-3579-4d2a-a623-a2dd8c43619e" xlink:href="pbh-20220331.xsd#pbh_AdditionsToOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_pbh_AdditionsToOperatingLeaseRightOfUseAssets_45d39e57-3579-4d2a-a623-a2dd8c43619e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_313ab390-4d7b-4c54-acf4-c8c9bde6e63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_AssetImpairmentCharges_313ab390-4d7b-4c54-acf4-c8c9bde6e63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_40c86f82-ecbf-4065-9b77-0c8c0f041e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_40c86f82-ecbf-4065-9b77-0c8c0f041e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0bd57b14-815b-4228-8ab0-432a7b11e2f5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b10e99a0-714d-43ea-9800-833d5bf2084d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b10e99a0-714d-43ea-9800-833d5bf2084d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_daca0938-0294-47e6-9679-4ef86cdd040c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_daca0938-0294-47e6-9679-4ef86cdd040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9fc23378-911a-413b-a1af-8d52972c72f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9fc23378-911a-413b-a1af-8d52972c72f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_22220e60-f930-4b97-a4e3-444c65ec49e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_22220e60-f930-4b97-a4e3-444c65ec49e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_184c1e2e-4b4d-4e7b-9a7c-cab3cbe03af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_184c1e2e-4b4d-4e7b-9a7c-cab3cbe03af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_5191c749-91f2-45c9-97dc-38ee93b99e47" xlink:href="pbh-20220331.xsd#pbh_IncreaseDecreaseInOperatingLeasesLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_pbh_IncreaseDecreaseInOperatingLeasesLiabilities_5191c749-91f2-45c9-97dc-38ee93b99e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_fa1df009-52fd-47a0-a59f-253c4c4c6a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cef0aae2-6704-4dc4-aa14-30779400e76f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_fa1df009-52fd-47a0-a59f-253c4c4c6a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da129c68-ef8b-4fee-99ed-9354a5331178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_786bab3a-9d6d-4b6d-a4a3-69b68293ac4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da129c68-ef8b-4fee-99ed-9354a5331178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a18939e3-41fe-42c0-ac50-246ee54fa1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a18939e3-41fe-42c0-ac50-246ee54fa1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EscrowReceipt_3abe5960-27a8-4c2b-9478-1e03803cb8fa" xlink:href="pbh-20220331.xsd#pbh_EscrowReceipt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:to="loc_pbh_EscrowReceipt_3abe5960-27a8-4c2b-9478-1e03803cb8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_156f1a64-87b8-4a5c-93f3-7937a6c1e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_156f1a64-87b8-4a5c-93f3-7937a6c1e20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0257dbd9-597e-4f4a-acdc-9a450270f86e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0257dbd9-597e-4f4a-acdc-9a450270f86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f9895193-b369-49fd-b627-d6a5c9cad92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_977a5fe0-3ea5-453c-85b3-3b8d041b49c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f9895193-b369-49fd-b627-d6a5c9cad92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_8d4e4af6-1176-4192-ad21-39d7cb6a861f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_8d4e4af6-1176-4192-ad21-39d7cb6a861f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_12762b11-4542-4595-8141-c19310debea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_12762b11-4542-4595-8141-c19310debea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_afc46f46-e75d-4134-a28e-7fb3e765e321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_afc46f46-e75d-4134-a28e-7fb3e765e321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_b3768c91-55d0-44c5-95ce-8b8f6ee1e359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_b3768c91-55d0-44c5-95ce-8b8f6ee1e359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_20621a9c-3e73-465f-973c-2a7f5dd2e74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_20621a9c-3e73-465f-973c-2a7f5dd2e74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_29b540b9-1828-4ffb-8585-5cc437a78fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_29b540b9-1828-4ffb-8585-5cc437a78fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_4435301e-1247-4090-acf0-d9ecc3b5d9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_4435301e-1247-4090-acf0-d9ecc3b5d9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_417793bc-a08d-424c-9d32-2c86474abee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_417793bc-a08d-424c-9d32-2c86474abee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c6bb245c-9455-47d0-9a0f-141486e79adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c6bb245c-9455-47d0-9a0f-141486e79adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c864391e-96ba-40e8-bf33-ab84faec07e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c864391e-96ba-40e8-bf33-ab84faec07e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a7a63e27-8568-4e49-bd78-6f89c30a948d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a7a63e27-8568-4e49-bd78-6f89c30a948d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_92aac83c-12cd-4f6d-9a1d-3328baf9a75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7089a41f-f3b9-4e4a-a496-f667c86b35a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_92aac83c-12cd-4f6d-9a1d-3328baf9a75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_992c795e-273b-4ce5-8614-c08b17a3176e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_992c795e-273b-4ce5-8614-c08b17a3176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4ebb9b8-69ff-41ef-ae4e-eae4d4dba9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b4ebb9b8-69ff-41ef-ae4e-eae4d4dba9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee38a177-fcd8-4394-9020-012d00c3902b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee38a177-fcd8-4394-9020-012d00c3902b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_215a8329-19b7-46e5-a63e-65cc24bf6cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_215a8329-19b7-46e5-a63e-65cc24bf6cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b6a3cafd-f232-4bbe-9f57-6154af0668d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_InterestPaidNet_b6a3cafd-f232-4bbe-9f57-6154af0668d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_edd20f17-a411-48c4-a1e7-bcc74d8ea26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6c25fa3c-9f08-4ba8-b9aa-339a2503a533" xlink:to="loc_us-gaap_IncomeTaxesPaid_edd20f17-a411-48c4-a1e7-bcc74d8ea26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e7e53ac-d95c-4899-84cf-f4c74aac8c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_72b644f5-c4b8-4fe1-ba6a-867f6dd38575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e7e53ac-d95c-4899-84cf-f4c74aac8c4a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_72b644f5-c4b8-4fe1-ba6a-867f6dd38575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_be6e69be-05c6-477f-8fbe-1a8a83b81e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_be6e69be-05c6-477f-8fbe-1a8a83b81e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ecfa84f8-8af3-469a-b094-0e6abe554d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_UseOfEstimates_ecfa84f8-8af3-469a-b094-0e6abe554d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d6b0151f-46e8-4568-ba4f-ad00c12cc7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d6b0151f-46e8-4568-ba4f-ad00c12cc7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e07b883e-739e-441d-bc5d-c06d15a8517c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e07b883e-739e-441d-bc5d-c06d15a8517c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_e4743aba-3bc6-44d6-9c5a-efb1eba60431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_e4743aba-3bc6-44d6-9c5a-efb1eba60431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_06e0652b-b63d-4cc5-a694-efe919293872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_06e0652b-b63d-4cc5-a694-efe919293872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_9a06aba7-325f-4c27-8842-c7884bbaef7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_9a06aba7-325f-4c27-8842-c7884bbaef7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_e637b9a9-6d02-4a35-bff7-221255edb4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_e637b9a9-6d02-4a35-bff7-221255edb4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_b0f099cc-75b4-4241-94e7-74955c5c5c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_b0f099cc-75b4-4241-94e7-74955c5c5c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a8c31d1c-8142-42d2-9c90-70ada20c08c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a8c31d1c-8142-42d2-9c90-70ada20c08c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CostOfSalesPolicyPolicyTextBlock_1ef3e41a-e26d-441b-ae69-f7dfd0fd1584" xlink:href="pbh-20220331.xsd#pbh_CostOfSalesPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_pbh_CostOfSalesPolicyPolicyTextBlock_1ef3e41a-e26d-441b-ae69-f7dfd0fd1584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_57a6043f-cc70-4de3-8456-388d2afadcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_57a6043f-cc70-4de3-8456-388d2afadcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b65b1eef-b661-4f24-9f3a-8869c33f996c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b65b1eef-b661-4f24-9f3a-8869c33f996c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_bc65fafc-47df-4820-a6cb-6770ded1f545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_bc65fafc-47df-4820-a6cb-6770ded1f545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ac4d39ac-ca10-4efc-8cdc-85bc6467a09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ac4d39ac-ca10-4efc-8cdc-85bc6467a09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_730c8b7a-d9ba-4bb2-aeb1-a061f2d8e259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_730c8b7a-d9ba-4bb2-aeb1-a061f2d8e259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_fe1bdabc-80d1-45f8-8e2b-7867353b3400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_fe1bdabc-80d1-45f8-8e2b-7867353b3400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ebf9eebd-12e6-43f5-b1ff-79b6a0e95d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03ff6425-12a9-47aa-8adc-9ff32c2b3f23" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ebf9eebd-12e6-43f5-b1ff-79b6a0e95d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23099745-7614-4d85-a1bd-445707e5f50b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_80f71cdc-92ee-42ed-a114-ccabd7d1d7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23099745-7614-4d85-a1bd-445707e5f50b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_80f71cdc-92ee-42ed-a114-ccabd7d1d7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d33836d8-a6a3-4043-9569-9c45482b0631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_23099745-7614-4d85-a1bd-445707e5f50b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d33836d8-a6a3-4043-9569-9c45482b0631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60e1de7c-55c5-427e-b58f-15e751b6e054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60e1de7c-55c5-427e-b58f-15e751b6e054" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:to="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c85b17c1-88fc-466f-9b10-26648e033036" xlink:to="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SydneyAustraliaMember_7e90764b-6ed4-4995-8355-b94642d174a1" xlink:href="pbh-20220331.xsd#pbh_SydneyAustraliaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:to="loc_pbh_SydneyAustraliaMember_7e90764b-6ed4-4995-8355-b94642d174a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_SG_0617efa2-98b9-4fd3-9deb-f002e013b502" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_SG"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7d613716-d7f3-4949-9458-8046d18ce6a0" xlink:to="loc_country_SG_0617efa2-98b9-4fd3-9deb-f002e013b502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_12f2fc9e-fdc7-4928-9f6d-c89cc2f2362f" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_PercentageofDepositsHeldinOneLocation_2c01b485-d189-4671-9b33-65aaa9f05df0" xlink:href="pbh-20220331.xsd#pbh_PercentageofDepositsHeldinOneLocation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_5030b867-836b-41b1-8d7f-8a1851fa1180" xlink:to="loc_pbh_PercentageofDepositsHeldinOneLocation_2c01b485-d189-4671-9b33-65aaa9f05df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2e849837-222c-4d61-b85d-527256344526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2e849837-222c-4d61-b85d-527256344526" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de4c96aa-05fb-4b26-b89b-8473f730ed48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b4919f72-cf25-4fab-ba90-f651df14aea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_BuildingMember_b4919f72-cf25-4fab-ba90-f651df14aea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherMachineryAndEquipmentMember_d3948553-1e6f-442d-89e4-a165965d62f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_OtherMachineryAndEquipmentMember_d3948553-1e6f-442d-89e4-a165965d62f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_9a489976-36b7-44d2-ba31-760dc5270f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_ComputerEquipmentMember_9a489976-36b7-44d2-ba31-760dc5270f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_96c37639-9f86-4451-ad00-67357f62603c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b8080e99-e20f-4683-9ed2-4ff40529f58d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_96c37639-9f86-4451-ad00-67357f62603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:to="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17b2580a-0e26-4227-9768-8e3d2318b02b" xlink:to="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d2814954-3822-44aa-9945-cc8cce8063c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:to="loc_srt_MinimumMember_d2814954-3822-44aa-9945-cc8cce8063c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2dab7e0-a51e-40e0-a635-7da95d46034b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87ed636a-f10b-4e0c-997f-3dc5784a5abe" xlink:to="loc_srt_MaximumMember_a2dab7e0-a51e-40e0-a635-7da95d46034b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a838128a-0584-49b4-89b4-31a38c5a65fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_58ae84ae-ae18-43ad-9140-a2b4f61f79c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3c5c354c-9156-4dce-af59-f86ef2d5ee0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_58ae84ae-ae18-43ad-9140-a2b4f61f79c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0464ccb3-9f19-43f5-a8a4-956e5986245b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0464ccb3-9f19-43f5-a8a4-956e5986245b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:to="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a51a314f-b1e3-4c02-96ae-1b5c9242a451" xlink:to="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_036f7fec-9bc4-4da0-bd5d-9ee97c08a98a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:to="loc_srt_MinimumMember_036f7fec-9bc4-4da0-bd5d-9ee97c08a98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7ffaa4f-3918-4ff4-97ef-896b2ca578d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_74376d65-ff9d-478c-a312-4a05295b2e3e" xlink:to="loc_srt_MaximumMember_a7ffaa4f-3918-4ff4-97ef-896b2ca578d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c8f9e984-25af-438b-92ea-29de1bc249d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eba436f4-f053-4d64-a094-9ef11989e49e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae5c1b0b-e930-4252-8c1b-adcac596da7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_eba436f4-f053-4d64-a094-9ef11989e49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ad7dbe0-2c2e-4ad3-89dc-c29376de78d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c6bbcf3f-3c5e-4d92-9903-df1d6f597f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2ad7dbe0-2c2e-4ad3-89dc-c29376de78d2" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c6bbcf3f-3c5e-4d92-9903-df1d6f597f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationCostofSalesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6967df96-f8ae-4d42-a06b-f02be4525429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6967df96-f8ae-4d42-a06b-f02be4525429" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:to="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ade8b7e0-6d2d-4d61-a1fe-eeb968d88eca" xlink:to="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_12b52baa-7c53-4ef7-8d3d-249b9fa39db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_69b7d9c2-9591-45e1-b186-cbd2d92aec40" xlink:to="loc_us-gaap_ShippingAndHandlingMember_12b52baa-7c53-4ef7-8d3d-249b9fa39db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_4a206dd9-284a-4d21-8a5c-bce35595879f" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5453725c-3774-48b8-836f-a888a2833805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_db7631c2-d56a-44b5-9a42-b0bb0eef447c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5453725c-3774-48b8-836f-a888a2833805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationPensionExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_113833a7-b826-480a-91ec-a38c81883d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_b3a93231-98a7-4d3f-b9a4-8a8434d46519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_113833a7-b826-480a-91ec-a38c81883d25" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_b3a93231-98a7-4d3f-b9a4-8a8434d46519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_dcf5a9df-02f9-44fa-9d9f-1ec8b6735c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_113833a7-b826-480a-91ec-a38c81883d25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_dcf5a9df-02f9-44fa-9d9f-1ec8b6735c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36dd559b-8005-41d9-b0eb-5a74fd7eb74c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_35a2154b-e205-4bff-bf6d-2e6092c2034d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36dd559b-8005-41d9-b0eb-5a74fd7eb74c" xlink:to="loc_us-gaap_NetIncomeLossAbstract_35a2154b-e205-4bff-bf6d-2e6092c2034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0665a57f-2aae-40b6-b7b4-c692879d2140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_35a2154b-e205-4bff-bf6d-2e6092c2034d" xlink:to="loc_us-gaap_NetIncomeLoss_0665a57f-2aae-40b6-b7b4-c692879d2140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dfac86e1-004f-478e-a50b-01244963ad63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36dd559b-8005-41d9-b0eb-5a74fd7eb74c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dfac86e1-004f-478e-a50b-01244963ad63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdef622f-289b-481b-a2ea-66c0c67730ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dfac86e1-004f-478e-a50b-01244963ad63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdef622f-289b-481b-a2ea-66c0c67730ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a35176f5-71b8-4f8c-93b8-5bc4141c92c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dfac86e1-004f-478e-a50b-01244963ad63" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a35176f5-71b8-4f8c-93b8-5bc4141c92c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d43e3d1a-c5c8-4a08-b7dc-84a95b7abb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dfac86e1-004f-478e-a50b-01244963ad63" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d43e3d1a-c5c8-4a08-b7dc-84a95b7abb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cbf806a7-d8a5-4cbc-83b5-04e12e30707e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36dd559b-8005-41d9-b0eb-5a74fd7eb74c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cbf806a7-d8a5-4cbc-83b5-04e12e30707e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_eec8c3d5-fa72-4511-8689-1d0d6d138abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cbf806a7-d8a5-4cbc-83b5-04e12e30707e" xlink:to="loc_us-gaap_EarningsPerShareBasic_eec8c3d5-fa72-4511-8689-1d0d6d138abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bdea055b-a15d-4ff9-ad86-bfeac28755c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cbf806a7-d8a5-4cbc-83b5-04e12e30707e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bdea055b-a15d-4ff9-ad86-bfeac28755c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3a2150d9-0ece-4999-9d83-e740124b3628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36dd559b-8005-41d9-b0eb-5a74fd7eb74c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3a2150d9-0ece-4999-9d83-e740124b3628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessandBasisofPresentationLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_54e304b0-d6c8-4f8e-9dfa-b3db06694e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_54e304b0-d6c8-4f8e-9dfa-b3db06694e3d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:to="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_755dd7b4-fac2-45d5-bdd2-7f09bb7fccf5" xlink:to="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a06f65db-73cb-4d66-bfa4-d8f36c5353fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:to="loc_srt_MinimumMember_a06f65db-73cb-4d66-bfa4-d8f36c5353fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6719a456-1501-4a9a-b352-ff00276f70f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_da02272d-4ae9-4011-96f6-a34557e03b9a" xlink:to="loc_srt_MaximumMember_6719a456-1501-4a9a-b352-ff00276f70f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f40554b4-0e26-402b-9138-a70d96b88e23" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffbab4d5-3d41-4357-8e2e-200eddad13fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_ffbab4d5-3d41-4357-8e2e-200eddad13fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f98c147c-b726-4b55-a017-70e4d2e4daf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85afbd6e-177c-45d9-b39b-09113c908fa1" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f98c147c-b726-4b55-a017-70e4d2e4daf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Acquisition" xlink:type="simple" xlink:href="pbh-20220331.xsd#Acquisition"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Acquisition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_70e483f9-e90b-4c18-95b7-b2a49616ec38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16ad791e-ff5a-4529-a4b0-fe5e9de7b0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_70e483f9-e90b-4c18-95b7-b2a49616ec38" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16ad791e-ff5a-4529-a4b0-fe5e9de7b0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_04a02c3a-2ee8-41f6-9394-fa05a6beeb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bed1b1a7-1b15-4ff9-8ff6-590f76c068d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_04a02c3a-2ee8-41f6-9394-fa05a6beeb92" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_bed1b1a7-1b15-4ff9-8ff6-590f76c068d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1c967998-1eeb-4c69-a60a-b3e7f22af085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1c967998-1eeb-4c69-a60a-b3e7f22af085" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2392a04f-21da-4d66-9c2f-3faf9092c928" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3a2b9f7d-17fb-4b4b-b9cf-4cd50b64bb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6708ce51-306c-49ad-a077-5dfcc3e670e5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3a2b9f7d-17fb-4b4b-b9cf-4cd50b64bb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fe2d76ed-d834-4297-bba8-b232921d8915" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0f2566ab-dc90-4664-af1b-f940f5813a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0f2566ab-dc90-4664-af1b-f940f5813a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_ec50fec8-ef68-4cab-b785-5a4ca49aa604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5433f923-2cd5-427a-af1e-17f6fd58db5c" xlink:to="loc_us-gaap_TrademarksMember_ec50fec8-ef68-4cab-b785-5a4ca49aa604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_093c3671-ce52-4e31-ac83-68a134479ae2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_1178708f-ba1c-4288-b034-df3b61de1e51" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_21b22aa2-3242-40c9-91ca-2228f6a7ef3f" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_1178708f-ba1c-4288-b034-df3b61de1e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a025d5d2-b348-4753-b15d-22d28dd64359" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a40c96de-b5dd-40c9-8e7e-f955ff0c8ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a40c96de-b5dd-40c9-8e7e-f955ff0c8ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_86e2afa0-6990-4b3d-80fa-db5fdce57c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_86e2afa0-6990-4b3d-80fa-db5fdce57c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SupplyCommitmentTermOfAgreement_6605b2b4-90ae-4d21-b897-5560d8824f7e" xlink:href="pbh-20220331.xsd#pbh_SupplyCommitmentTermOfAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_SupplyCommitmentTermOfAgreement_6605b2b4-90ae-4d21-b897-5560d8824f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_a130fe2d-17ab-4b82-bba7-b4f1476e2fc8" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount_a130fe2d-17ab-4b82-bba7-b4f1476e2fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_da71991a-ee86-4a2f-89f8-f049dd715adf" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount_da71991a-ee86-4a2f-89f8-f049dd715adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33afb911-ba92-4809-b9e8-228ca81b0adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_33afb911-ba92-4809-b9e8-228ca81b0adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ecf62061-fe18-495a-afd2-7faadc149fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58a65740-f80d-4af5-a3b7-292e26362506" xlink:to="loc_us-gaap_Goodwill_ecf62061-fe18-495a-afd2-7faadc149fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7f32d3e7-3a19-4f02-910b-1e8afb9e8007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7f32d3e7-3a19-4f02-910b-1e8afb9e8007" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7866c18-fd0b-4f2b-bfb4-5306bb7471b7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_01e9f262-1711-4384-b2b7-85a059d32e1c" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8db40e4f-bea5-4402-a01e-f8b5cdb4c930" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_01e9f262-1711-4384-b2b7-85a059d32e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_51d947ab-508d-4c59-95c8-c142026080bc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e612841a-24f5-4031-9993-f19547f6cd3c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fe891a27-5259-43ea-bfef-9e05efbe46c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fe891a27-5259-43ea-bfef-9e05efbe46c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_77dee03d-91e0-4c5e-98c3-e5f3d95aa192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_Goodwill_77dee03d-91e0-4c5e-98c3-e5f3d95aa192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_90f5fdd9-06bb-4084-80fa-d01097e94403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_90f5fdd9-06bb-4084-80fa-d01097e94403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_e339842e-4275-4ec9-bf8d-8a74827e865e" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_e339842e-4275-4ec9-bf8d-8a74827e865e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ce8b5b5f-390e-44e0-92c5-f0455654ca4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ce8b5b5f-390e-44e0-92c5-f0455654ca4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_265a398e-9ec0-4147-a64a-7b6df8dc4c0d" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves_265a398e-9ec0-4147-a64a-7b6df8dc4c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0b9125a4-4676-47c4-b5e5-b1106a3dd6c8" xlink:href="pbh-20220331.xsd#pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0b9125a4-4676-47c4-b5e5-b1106a3dd6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e8778be1-1c7f-46c9-ad63-52d7cfba8f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e8778be1-1c7f-46c9-ad63-52d7cfba8f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a1f9e77c-2233-46db-8234-11415b5eaea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f340214a-baa5-41f2-bef6-92074762e4f0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a1f9e77c-2233-46db-8234-11415b5eaea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="simple" xlink:href="pbh-20220331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_852352af-2b4c-4a47-b6bf-574f0a3bfa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_ba12ce7c-0e24-4197-a27f-f4bdcea5e86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_852352af-2b4c-4a47-b6bf-574f0a3bfa3a" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_ba12ce7c-0e24-4197-a27f-f4bdcea5e86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_76091265-8ef0-4995-8d5c-7bf39897ea6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a1a534c8-93ad-4262-a89d-89af26422d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_76091265-8ef0-4995-8d5c-7bf39897ea6e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a1a534c8-93ad-4262-a89d-89af26422d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_5dceafb8-2474-4c62-bd00-b63860f7baa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_5dceafb8-2474-4c62-bd00-b63860f7baa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e85a453b-0983-426a-a462-48ba5ab5db46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e85a453b-0983-426a-a462-48ba5ab5db46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bd50edde-e6c9-4b16-9fc3-70033d850c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bd50edde-e6c9-4b16-9fc3-70033d850c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d821dce3-c02b-42ea-90ef-716b07521c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:to="loc_us-gaap_InventoryNet_d821dce3-c02b-42ea-90ef-716b07521c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_8eed924e-5baa-48ac-a185-3e26ee9cec2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_396e0f47-a647-4ca5-8247-560c8ab43b0b" xlink:to="loc_us-gaap_InventoryValuationReserves_8eed924e-5baa-48ac-a185-3e26ee9cec2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="pbh-20220331.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0f55cefa-d32c-4fe1-b7f9-e093e53ec725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_89a62fae-c9b9-4aee-8dff-bd41f87c347f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0f55cefa-d32c-4fe1-b7f9-e093e53ec725" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_89a62fae-c9b9-4aee-8dff-bd41f87c347f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_892cfd8a-cbe6-4c0b-97fc-ac64f198747a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3e6bfd8a-d680-44e8-8f5b-aeacc29f85c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_892cfd8a-cbe6-4c0b-97fc-ac64f198747a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_3e6bfd8a-d680-44e8-8f5b-aeacc29f85c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#PropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_904a2e49-aa01-4104-bdc9-8940005fc392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_904a2e49-aa01-4104-bdc9-8940005fc392" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7fd8bbad-a4ad-4498-84ac-f1d62d0d9db6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_a36c97fe-46e4-4631-a585-e05634678e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_LandMember_a36c97fe-46e4-4631-a585-e05634678e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_9a04b2cf-fe52-4cf1-bfd3-d7dae28da221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_BuildingMember_9a04b2cf-fe52-4cf1-bfd3-d7dae28da221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherMachineryAndEquipmentMember_94d177b1-43c9-45e6-8782-1c9ad78b97f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_OtherMachineryAndEquipmentMember_94d177b1-43c9-45e6-8782-1c9ad78b97f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_0cd4024b-7373-4118-92f0-2f8f92e8af99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_ComputerEquipmentMember_0cd4024b-7373-4118-92f0-2f8f92e8af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_53a894fa-2b0f-4a3e-a31c-3075f880ea01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_53a894fa-2b0f-4a3e-a31c-3075f880ea01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f2cc7a6e-9774-4c02-96b1-b49d38c3d124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f2cc7a6e-9774-4c02-96b1-b49d38c3d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6903502a-0010-4b32-8f92-c56d4e6b2d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_60c0d35f-9007-4474-9b45-e07e34fcecf7" xlink:to="loc_us-gaap_ConstructionInProgressMember_6903502a-0010-4b32-8f92-c56d4e6b2d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9773e1f0-70dd-456b-8fbb-081ec9e7d073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_09bfe3d4-25c3-4425-b765-93093acfc71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_09bfe3d4-25c3-4425-b765-93093acfc71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_80430fc1-3037-4728-bd59-678945d7075f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_80430fc1-3037-4728-bd59-678945d7075f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cbf13e83-8578-49d7-985b-8ef352e9643e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_ed6501d1-11cc-4e48-84b0-61502bc01161" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cbf13e83-8578-49d7-985b-8ef352e9643e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7eb803a8-0ce0-4b94-8039-8441ea9935de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_098ab8b3-fc0e-496a-9329-05f7d5c9b875" xlink:to="loc_us-gaap_Depreciation_7eb803a8-0ce0-4b94-8039-8441ea9935de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="simple" xlink:href="pbh-20220331.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e78ff45-ac3a-4c53-9deb-f61f4aad07c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_b8782d4b-cff9-4841-8c26-ff7c34abc8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e78ff45-ac3a-4c53-9deb-f61f4aad07c2" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_b8782d4b-cff9-4841-8c26-ff7c34abc8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_92655da0-39f6-4732-b892-6937055f21f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6a57c028-8a75-4ec7-bf30-b214fbe9e0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_92655da0-39f6-4732-b892-6937055f21f3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6a57c028-8a75-4ec7-bf30-b214fbe9e0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#GoodwillScheduleofChangesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f2947401-f884-4eda-9d4f-907757be9b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f2947401-f884-4eda-9d4f-907757be9b4b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8781cb84-d5cb-413f-b6bb-3f89d167ddee" xlink:to="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_e0977ea6-daa8-4d73-b94f-05641120de3b" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_e0977ea6-daa8-4d73-b94f-05641120de3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_8eda3b83-9b9c-4530-9417-a612d8b91034" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1eb3d21f-326c-40db-b59a-1f0320afd019" xlink:to="loc_pbh_InternationalOTCHealthcareMember_8eda3b83-9b9c-4530-9417-a612d8b91034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e0362e84-54ed-470c-a1e4-77d0f50a96a7" xlink:to="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a30a5ccd-5ec7-4b8e-b89f-3a99fbac4d0b" xlink:to="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_87f4a9d5-be95-4ff3-b92a-3e3ea5b69241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillGross_87f4a9d5-be95-4ff3-b92a-3e3ea5b69241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1f0ee85a-9b3c-49ee-aa83-eb6f623f9779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_1f0ee85a-9b3c-49ee-aa83-eb6f623f9779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1494348b-aa55-46ce-b65e-c4355a2803a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_Goodwill_1494348b-aa55-46ce-b65e-c4355a2803a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef0b7642-64e5-4bf6-9d4f-2ce2ea4f4dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_ef0b7642-64e5-4bf6-9d4f-2ce2ea4f4dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3e97bff6-9940-4ca5-be45-eabeb5715bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_3e97bff6-9940-4ca5-be45-eabeb5715bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5eb3d006-b291-4a40-b2a3-b2e728184e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5eb3d006-b291-4a40-b2a3-b2e728184e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_6db41123-1056-4cc9-a2d6-dab7dab13ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillGross_6db41123-1056-4cc9-a2d6-dab7dab13ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8b34b5f3-a537-44d5-a7df-218463a87029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8b34b5f3-a537-44d5-a7df-218463a87029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9b74d471-ee90-40b1-8fed-82dde8e6d249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5d1f2f0a-9919-4dbd-b9f6-6acc1fd68a4c" xlink:to="loc_us-gaap_Goodwill_9b74d471-ee90-40b1-8fed-82dde8e6d249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f819ef4c-3ff8-4440-9ca2-691a19640cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f819ef4c-3ff8-4440-9ca2-691a19640cd0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_64279735-ddc2-43d5-871d-145b8b04f46b" xlink:to="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_255b432c-ecc4-4e3b-ab02-0e66703c0ef9" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:to="loc_pbh_InternationalOTCHealthcareMember_255b432c-ecc4-4e3b-ab02-0e66703c0ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalAnalgesicsMember_2234e653-4b60-44b2-9504-ea42d1be5cf7" xlink:href="pbh-20220331.xsd#pbh_InternationalAnalgesicsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_108b81d3-e1fd-412d-a2b6-415ec8721e07" xlink:to="loc_pbh_InternationalAnalgesicsMember_2234e653-4b60-44b2-9504-ea42d1be5cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87e48322-6ca6-4b63-b50a-b26e43d25814" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_23d893b7-dad2-47f7-a7bb-de0161bea891" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce3d4aae-858d-4802-ad43-181b60a63798" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_23d893b7-dad2-47f7-a7bb-de0161bea891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_68327194-14df-4af1-98d9-6936ef933a25" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7298ade5-c9c2-49d6-9c30-553da6584e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_7298ade5-c9c2-49d6-9c30-553da6584e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_427ad07c-907f-44d8-98f8-4aa455c4e347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_427ad07c-907f-44d8-98f8-4aa455c4e347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputCapRateMember_575f19e9-5b8f-4088-a4b6-4ec9a8e5afca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputCapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dfc8e027-6584-4735-b6cc-9c8ab978ff85" xlink:to="loc_us-gaap_MeasurementInputCapRateMember_575f19e9-5b8f-4088-a4b6-4ec9a8e5afca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_39185384-f603-4d5d-9bb2-046c29e0cecb" xlink:to="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1470f630-90aa-4bdf-b824-a2644f16b516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_us-gaap_Goodwill_1470f630-90aa-4bdf-b824-a2644f16b516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_02b66b3f-d961-4216-bd20-9b5071f0a12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_02b66b3f-d961-4216-bd20-9b5071f0a12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_b53db5f0-8592-492a-92d2-4e2520f4edc3" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4fd20c1e-8278-43bb-84c9-459757d30249" xlink:to="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_b53db5f0-8592-492a-92d2-4e2520f4edc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssets" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_c79c9c9f-9078-4823-8093-943bfa0f0555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_9a99f2f1-e8b6-4a2d-9f0f-422c6bb63944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_c79c9c9f-9078-4823-8093-943bfa0f0555" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_9a99f2f1-e8b6-4a2d-9f0f-422c6bb63944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_8eba138a-1e0b-4708-a97c-49bac048b353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTableTextBlock_0b765b42-2811-46e7-9e5f-b6e46a0c7cd3" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_8eba138a-1e0b-4708-a97c-49bac048b353" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTableTextBlock_0b765b42-2811-46e7-9e5f-b6e46a0c7cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bc9b23ee-5b55-4140-ae12-6403feecd4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_8eba138a-1e0b-4708-a97c-49bac048b353" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bc9b23ee-5b55-4140-ae12-6403feecd4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsReconciliationofActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_99c3989e-d6a0-4f17-b5fc-f0e749e8c823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_99c3989e-d6a0-4f17-b5fc-f0e749e8c823" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_0a87b538-27a7-45a4-94e1-0223d5c14727" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_3bad5e98-2ece-4fb4-ac34-4e7670c46922" xlink:href="pbh-20220331.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9e07cf21-96fe-4e46-98c1-11f5183ee1a9" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_3bad5e98-2ece-4fb4-ac34-4e7670c46922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_db10bd04-842a-4a35-966c-d69a9a9e18fb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_b4a986dd-1df1-48f5-a892-d4b9cdd4248b" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fec072f5-283c-4a4b-b0a4-7ca5c7494c7f" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_b4a986dd-1df1-48f5-a892-d4b9cdd4248b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d65def4c-3037-4918-89d9-8e761477e8d5" xlink:to="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_6104c49b-3fa7-4fb7-9e51-b777ce6dcefc" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_6104c49b-3fa7-4fb7-9e51-b777ce6dcefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_6fef869f-f607-4034-8646-b17d0f613e19" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_61465e68-47b1-4bb4-bf62-68b581a6996f" xlink:to="loc_pbh_InternationalOTCHealthcareMember_6fef869f-f607-4034-8646-b17d0f613e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_38fcbadf-6959-4063-b541-7b08be778772" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ZaditenMember_569343a2-a5ac-4721-952e-b62e8bc46840" xlink:href="pbh-20220331.xsd#pbh_ZaditenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4c82e171-af28-4042-b1a9-473c4eed67f9" xlink:to="loc_pbh_ZaditenMember_569343a2-a5ac-4721-952e-b62e8bc46840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_131ee776-3b67-412c-aaec-a4c3a3bbac82" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AkornOperatingCompanyLLCMember_b7610aa7-ffc4-4917-9f8f-33c30e8761f8" xlink:href="pbh-20220331.xsd#pbh_AkornOperatingCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f9bd8ab-46a6-463a-a245-395389e7836e" xlink:to="loc_pbh_AkornOperatingCompanyLLCMember_b7610aa7-ffc4-4917-9f8f-33c30e8761f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_8b589e54-2092-4a91-a630-673e81b29e1f" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68afc946-b731-46fe-b166-d4e9e1c21002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68afc946-b731-46fe-b166-d4e9e1c21002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_05031fdf-6103-48d8-b05e-8a0c56df4e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_05031fdf-6103-48d8-b05e-8a0c56df4e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ff994d6-a909-410f-915e-8687b3f61d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5ff994d6-a909-410f-915e-8687b3f61d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_a155f68c-0e78-42f1-85cb-4602c83c6956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_a155f68c-0e78-42f1-85cb-4602c83c6956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0c2ea719-8c9b-4945-9484-e6e4c55cc828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_268cab12-7a56-4167-b9e7-420dc35e23e6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0c2ea719-8c9b-4945-9484-e6e4c55cc828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2cb65b7e-7fe4-4f61-94a5-41ea60ce1126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2cb65b7e-7fe4-4f61-94a5-41ea60ce1126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6ba55ff1-e536-462b-9f41-41163d886261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6ba55ff1-e536-462b-9f41-41163d886261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e82b1922-71b7-4d72-bf42-d807f287e4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_e82b1922-71b7-4d72-bf42-d807f287e4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_75af6044-60c6-47d3-b8d3-d13e212f811d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_75af6044-60c6-47d3-b8d3-d13e212f811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32f42cbd-b69d-4441-a585-7607a0b30195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract_b5d0449a-a1fe-4cd6-ba72-00698cd49983" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_32f42cbd-b69d-4441-a585-7607a0b30195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_6e974568-27f9-4243-a016-4002e1e0e220" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b26b94b1-fae4-479f-879c-19bc17098a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b26b94b1-fae4-479f-879c-19bc17098a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_070600ca-7c48-45ef-9f9c-bc5b2ec3d405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_070600ca-7c48-45ef-9f9c-bc5b2ec3d405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_d952b477-8ce4-4944-bb8d-a94a4aac1b4d" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit_d952b477-8ce4-4944-bb8d-a94a4aac1b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_d0234edf-4a49-4619-a7f7-5dc07d5fcf2f" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss_d0234edf-4a49-4619-a7f7-5dc07d5fcf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6166cfea-ac38-49f9-bb32-488cbf4a37ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract_c3ec57fa-2602-44ae-a299-9e07866db719" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6166cfea-ac38-49f9-bb32-488cbf4a37ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1ca502a-861b-4d6a-878e-bffc82168665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e1ca502a-861b-4d6a-878e-bffc82168665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c85aac5d-bb4d-4777-935c-40fbbd084228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_c85aac5d-bb4d-4777-935c-40fbbd084228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_9d61d23c-8180-4544-8b6d-0104f5d91ec0" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsTranslationAdjustmentsGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss_9d61d23c-8180-4544-8b6d-0104f5d91ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ed31956e-be22-4c96-9060-45ecc97dbd95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_IntangibleAssetsRollForward_4d6ae3c0-8c26-4859-94bc-842dae00671d" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ed31956e-be22-4c96-9060-45ecc97dbd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b7ce24a4-252c-4f44-a909-447b851e7eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b7ce24a4-252c-4f44-a909-447b851e7eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e1ae8d3-4873-4303-939d-034f2185d72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e1ae8d3-4873-4303-939d-034f2185d72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dfc793f0-b2eb-49ac-b200-3963585695c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dfc793f0-b2eb-49ac-b200-3963585695c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsAcquired_0ed5fa74-2495-4432-918d-ef3e5452cde9" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_42be7f4c-6cc9-4fed-957a-2e3710da6176" xlink:to="loc_pbh_IntangibleAssetsAcquired_0ed5fa74-2495-4432-918d-ef3e5452cde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_497ffac4-8478-4b6d-bab8-5a712a96d40c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_497ffac4-8478-4b6d-bab8-5a712a96d40c" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_74205f83-6334-4af0-988d-13f8ec6c71e6" xlink:to="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_93f7ef23-ab45-496d-805a-1cf9754f4cc9" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5a77d3a-0a21-4c56-a0de-8b4100f3e64b" xlink:to="loc_pbh_InternationalOTCHealthcareMember_93f7ef23-ab45-496d-805a-1cf9754f4cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_219b48d4-86bf-4cc6-b51b-098c79125d34" xlink:to="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_43ca3b16-cffb-419b-80fb-92291c4a4d20" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:to="loc_srt_MinimumMember_43ca3b16-cffb-419b-80fb-92291c4a4d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_622982d4-c858-4503-b24b-dba6298e3052" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e697090c-50c2-4560-8c3d-951f31bd914a" xlink:to="loc_srt_MaximumMember_622982d4-c858-4503-b24b-dba6298e3052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_8a338fbe-330c-4e23-8fab-f8171cbffbd7" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_da629a5d-d7fe-409c-846f-f60b69ac4baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_da629a5d-d7fe-409c-846f-f60b69ac4baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputCapRateMember_63f626f0-33a9-4bac-8fd4-7126e0662574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputCapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_93112550-f146-45fa-9654-0f17266e62ba" xlink:to="loc_us-gaap_MeasurementInputCapRateMember_63f626f0-33a9-4bac-8fd4-7126e0662574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_35428b0c-0f9e-4085-990b-5e96a90d0fc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a79197fc-fe9f-4f16-8749-33bf219909e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41c0d22f-5281-4bdd-a65a-cfbc511859e8" xlink:to="loc_us-gaap_TradeNamesMember_a79197fc-fe9f-4f16-8749-33bf219909e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:href="pbh-20220331.xsd#pbh_ScheduleOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsTable_e0ff9ebf-832f-471c-9fca-f9639a2a920d" xlink:to="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8c03e5ce-52d7-4209-8419-3630c95ed99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_8c03e5ce-52d7-4209-8419-3630c95ed99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_c43c619d-32ce-408f-9c73-2720b0efef14" xlink:href="pbh-20220331.xsd#pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount_c43c619d-32ce-408f-9c73-2720b0efef14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_9bd71cca-1a12-4280-8301-32e5f3d5eab8" xlink:href="pbh-20220331.xsd#pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue_9bd71cca-1a12-4280-8301-32e5f3d5eab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_eaef7e8f-48f1-42c3-a94f-af790b9a5107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_AssetImpairmentCharges_eaef7e8f-48f1-42c3-a94f-af790b9a5107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_721806c8-cdb7-4b23-97c6-9b485187267d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_721806c8-cdb7-4b23-97c6-9b485187267d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f9bb5578-b596-43ff-b842-e7511d16bd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f9bb5578-b596-43ff-b842-e7511d16bd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3ce479e-b279-4d7b-ac34-0a63eaa5723a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleOfIntangibleAssetsLineItems_851ecf73-f420-408c-9881-a0a3e1a5316e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3ce479e-b279-4d7b-ac34-0a63eaa5723a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IntangibleAssetsExpectedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0facd7c6-0080-44b9-9a51-78328f09b68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0facd7c6-0080-44b9-9a51-78328f09b68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32fe785a-37d7-45c3-be47-588e684a1add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32fe785a-37d7-45c3-be47-588e684a1add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f1771081-50bb-488a-83be-1e23623c12ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f1771081-50bb-488a-83be-1e23623c12ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4f92685b-b984-49a0-afad-6cdb5c783310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4f92685b-b984-49a0-afad-6cdb5c783310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5424b98a-3205-4589-902f-fca46266daa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5424b98a-3205-4589-902f-fca46266daa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3d551ccc-9631-438c-adaf-daa00125fbff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_3d551ccc-9631-438c-adaf-daa00125fbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8fc60815-4fc8-4ef3-9a2e-904ba22784a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2056d843-6812-41fd-b63f-5303bd695f55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8fc60815-4fc8-4ef3-9a2e-904ba22784a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/Leases" xlink:type="simple" xlink:href="pbh-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_aba0a7f4-c0b7-424f-8376-076eb8783ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9f8365ac-977c-407e-8dda-c00fdfeb9963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba0a7f4-c0b7-424f-8376-076eb8783ae4" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9f8365ac-977c-407e-8dda-c00fdfeb9963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_bfcbc583-3ca9-4f14-9a84-5abdde2138eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_aba0a7f4-c0b7-424f-8376-076eb8783ae4" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_bfcbc583-3ca9-4f14-9a84-5abdde2138eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_423c4332-c554-430d-9ffe-d226a705159d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_8ea74e2f-e13b-448c-9dbc-aee44ed1c994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_423c4332-c554-430d-9ffe-d226a705159d" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_8ea74e2f-e13b-448c-9dbc-aee44ed1c994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_017e3b14-8326-4ee1-88e9-fc0cdc19c192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_423c4332-c554-430d-9ffe-d226a705159d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_017e3b14-8326-4ee1-88e9-fc0cdc19c192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_2f0d523e-73dc-4dbd-842a-74a1af6a2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_423c4332-c554-430d-9ffe-d226a705159d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_2f0d523e-73dc-4dbd-842a-74a1af6a2a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a7fd55ac-ada0-4d54-99e0-b45d395a350a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a7fd55ac-ada0-4d54-99e0-b45d395a350a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3c54685d-b07b-4336-9ea2-52ada0fcbe28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3c54685d-b07b-4336-9ea2-52ada0fcbe28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bd5315ea-c87b-4aca-a6ca-02c7c546f0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_OperatingLeaseCost_bd5315ea-c87b-4aca-a6ca-02c7c546f0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_1ce52666-f4c8-459d-a735-b1ff1286afd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_ShortTermLeaseCost_1ce52666-f4c8-459d-a735-b1ff1286afd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3097f717-1c3f-4c93-b6e7-28a462fb590c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_VariableLeaseCost_3097f717-1c3f-4c93-b6e7-28a462fb590c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_48c3e7cc-0dd6-4e77-99de-f883e8888839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_SubleaseIncome_48c3e7cc-0dd6-4e77-99de-f883e8888839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_118d3600-13b8-412b-8dbe-65d36c1789be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bfb66485-b2f8-4292-91df-4e92c6cc0140" xlink:to="loc_us-gaap_LeaseCost_118d3600-13b8-412b-8dbe-65d36c1789be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_95b48939-1bbc-411c-a2f2-40d71a48948d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_95b48939-1bbc-411c-a2f2-40d71a48948d" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c11d2f53-c832-406c-8d32-9768a7868232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c11d2f53-c832-406c-8d32-9768a7868232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4d74d3b7-4b6a-439a-952d-ca40f5b0ad92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4d74d3b7-4b6a-439a-952d-ca40f5b0ad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2d707cc3-7642-4a82-8d11-7b9d0e4c99a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2d707cc3-7642-4a82-8d11-7b9d0e4c99a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_036544f0-4f42-42e2-823d-5765a62db704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_036544f0-4f42-42e2-823d-5765a62db704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c2ef1869-ac0b-4e23-bb3a-cd0d70e72419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c2ef1869-ac0b-4e23-bb3a-cd0d70e72419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_699e49f8-0f53-4bf1-aed5-4499a8f3b467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_699e49f8-0f53-4bf1-aed5-4499a8f3b467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0f3d9b5-a177-4f8c-9cf6-433b20684e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0f3d9b5-a177-4f8c-9cf6-433b20684e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_81f4b823-0c1d-40d0-8519-d68c68f1bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_81f4b823-0c1d-40d0-8519-d68c68f1bc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_653d0a04-f7b6-414f-9037-aa4626958253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4a390c22-5db0-4496-8489-26734d95bb54" xlink:to="loc_us-gaap_OperatingLeaseLiability_653d0a04-f7b6-414f-9037-aa4626958253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_95b48939-1bbc-411c-a2f2-40d71a48948d" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_02a63021-9b6a-4e63-a731-af08d891cad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_02a63021-9b6a-4e63-a731-af08d891cad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c1367511-3d68-4f38-ae9a-ee38c394585b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c1367511-3d68-4f38-ae9a-ee38c394585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_830def06-dab6-4d18-b19e-732a6818917f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_830def06-dab6-4d18-b19e-732a6818917f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_981000b8-629f-47d9-8a82-dc47ca9a7f97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_981000b8-629f-47d9-8a82-dc47ca9a7f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8c32001-b77a-4e8d-9a85-84106ccae6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8c32001-b77a-4e8d-9a85-84106ccae6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_9b44bfbb-1c7d-433f-af5a-3dd7aa01948c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_9b44bfbb-1c7d-433f-af5a-3dd7aa01948c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_47d6269d-cd0b-462b-b343-4e511123e6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_47d6269d-cd0b-462b-b343-4e511123e6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f5e0d515-80ef-473d-8087-18692d100632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f5e0d515-80ef-473d-8087-18692d100632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6ec5420b-5a82-46c5-a480-dbf50f3fa636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_31e62212-8f18-47e3-808a-83f7637deebe" xlink:to="loc_us-gaap_FinanceLeaseLiability_6ec5420b-5a82-46c5-a480-dbf50f3fa636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_95b48939-1bbc-411c-a2f2-40d71a48948d" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_97b88f28-8bf1-4506-9811-80e7e5b0a360" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne_97b88f28-8bf1-4506-9811-80e7e5b0a360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_ffe959f3-4edf-4280-a56f-525966a6ceb7" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo_ffe959f3-4edf-4280-a56f-525966a6ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_dfe3ee97-c67e-4b80-bc55-9b133c4e25ff" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree_dfe3ee97-c67e-4b80-bc55-9b133c4e25ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_34b03111-3b64-4a27-bec6-fa9573e91f94" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour_34b03111-3b64-4a27-bec6-fa9573e91f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_411a5f81-e0bd-455e-a1ee-6c3bbc27b14f" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive_411a5f81-e0bd-455e-a1ee-6c3bbc27b14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_14684785-1cf4-427a-94bd-c0708f1e47c3" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive_14684785-1cf4-427a-94bd-c0708f1e47c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_b4edcf5c-1cf0-4ed7-bca8-1db2958ca06c" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityPaymentDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue_b4edcf5c-1cf0-4ed7-bca8-1db2958ca06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_b6c04c69-900d-4637-89a1-7682e4730c2d" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount_b6c04c69-900d-4637-89a1-7682e4730c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OperatingAndFinanceLeaseLiability_c62c9df0-4ff5-4924-9aec-16c57238edb7" xlink:href="pbh-20220331.xsd#pbh_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract_dfc78aea-ecff-405f-bfe4-d7bdad5ffe18" xlink:to="loc_pbh_OperatingAndFinanceLeaseLiability_c62c9df0-4ff5-4924-9aec-16c57238edb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesLeaseMaturitiesDetails_2"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c280d086-de2d-43be-85b5-495c3e29fda7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_a9d87253-04bc-44b0-bd34-2d7d0a77258e" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c280d086-de2d-43be-85b5-495c3e29fda7" xlink:to="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_a9d87253-04bc-44b0-bd34-2d7d0a77258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88f28e66-d212-48b0-bafe-031cca945a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_a9d87253-04bc-44b0-bd34-2d7d0a77258e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_88f28e66-d212-48b0-bafe-031cca945a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_6d458dd4-bbd6-4711-b75a-1d00ae462ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageRemainingLeaseTermAbstract_a9d87253-04bc-44b0-bd34-2d7d0a77258e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_6d458dd4-bbd6-4711-b75a-1d00ae462ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WeightedAverageDiscountRateAbstract_9a8a12dd-fd2b-41f4-a54f-d33dce3c5790" xlink:href="pbh-20220331.xsd#pbh_WeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c280d086-de2d-43be-85b5-495c3e29fda7" xlink:to="loc_pbh_WeightedAverageDiscountRateAbstract_9a8a12dd-fd2b-41f4-a54f-d33dce3c5790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_199d6f26-cdfa-410b-965e-e5517fc90ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_9a8a12dd-fd2b-41f4-a54f-d33dce3c5790" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_199d6f26-cdfa-410b-965e-e5517fc90ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_de52e0c9-5f68-46db-b0d4-16f85bf589b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_WeightedAverageDiscountRateAbstract_9a8a12dd-fd2b-41f4-a54f-d33dce3c5790" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_de52e0c9-5f68-46db-b0d4-16f85bf589b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_354317d8-d63a-41b8-b7c3-a9126dac0352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_354317d8-d63a-41b8-b7c3-a9126dac0352" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:to="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d80bb2d8-6ed9-4069-8e5a-9845446b2d57" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GEODISLogisticsLLCMember_688b8b54-0b07-467f-90f6-4a72860c5187" xlink:href="pbh-20220331.xsd#pbh_GEODISLogisticsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_50d90fca-f3c3-43d3-9b39-d48be85271c2" xlink:to="loc_pbh_GEODISLogisticsLLCMember_688b8b54-0b07-467f-90f6-4a72860c5187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea34ab8e-46ee-41f3-8b8b-552d1c8004bf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_96b6a4df-d4b1-4d6c-8f4a-cae547bd5f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_284c8914-47b9-4600-a110-894ec0d9c961" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_96b6a4df-d4b1-4d6c-8f4a-cae547bd5f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="simple" xlink:href="pbh-20220331.xsd#OtherAccruedLiabilities"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1e9b5b25-6cb3-4b42-be05-af8697577514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_b4cc6617-2ed8-488a-bbf1-667f135c2a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e9b5b25-6cb3-4b42-be05-af8697577514" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_b4cc6617-2ed8-488a-bbf1-667f135c2a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#OtherAccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b2bdaff1-838e-4c2e-a86a-cdfd879ee5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock_4295698c-6b25-4c31-8fd4-90b74b77b542" xlink:href="pbh-20220331.xsd#pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b2bdaff1-838e-4c2e-a86a-cdfd879ee5c1" xlink:to="loc_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock_4295698c-6b25-4c31-8fd4-90b74b77b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#OtherAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_75007865-e102-498b-b2b0-5cabb147cd42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_75007865-e102-498b-b2b0-5cabb147cd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5c91cc13-112a-4510-a939-c8d290f6f29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5c91cc13-112a-4510-a939-c8d290f6f29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_3efbc709-49f9-42b7-8d80-5ffaa62c2e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_3efbc709-49f9-42b7-8d80-5ffaa62c2e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_359ae516-f03d-4c16-8870-1256d4050307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_359ae516-f03d-4c16-8870-1256d4050307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_9dc765ad-8e47-4e56-9155-d510b8c7bce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_9dc765ad-8e47-4e56-9155-d510b8c7bce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedProductionCostsCurrent_2ae89654-848c-422d-a585-45e4477ba9a7" xlink:href="pbh-20220331.xsd#pbh_AccruedProductionCostsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_pbh_AccruedProductionCostsCurrent_2ae89654-848c-422d-a585-45e4477ba9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_ee212b4e-285f-4cdd-8898-668b7519b3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_ee212b4e-285f-4cdd-8898-668b7519b3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5b79b561-6be4-4f83-8529-8066e17ae3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5b79b561-6be4-4f83-8529-8066e17ae3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1d5f229a-37cb-4f50-b484-4318fa4cb6ee" xlink:href="pbh-20220331.xsd#pbh_AccruedAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_49b0c65b-9beb-429f-b7a2-24743acf9a0e" xlink:to="loc_pbh_AccruedAndOtherLiabilitiesCurrent_1d5f229a-37cb-4f50-b484-4318fa4cb6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_00cf4728-7d57-4030-bf17-aea31a187be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_e719501f-ab89-43f2-a235-80b56df8cf17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_00cf4728-7d57-4030-bf17-aea31a187be5" xlink:to="loc_us-gaap_LongTermDebtTextBlock_e719501f-ab89-43f2-a235-80b56df8cf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_403a4d7a-e0c9-4ab3-8461-abd80795df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_66659615-fc29-4737-8063-b2a54980cd01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_403a4d7a-e0c9-4ab3-8461-abd80795df5f" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_66659615-fc29-4737-8063-b2a54980cd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30439ed1-1028-4fa8-a05e-d7abd71ad15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_403a4d7a-e0c9-4ab3-8461-abd80795df5f" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30439ed1-1028-4fa8-a05e-d7abd71ad15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7d5b84da-1860-4b74-80cf-15f2a9ab1375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7d5b84da-1860-4b74-80cf-15f2a9ab1375" xlink:to="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f9fcc0f-5035-4a19-97db-f1551d495598" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_5282f04f-9f67-42a9-9083-8ef8a796cac5" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_A2021SeniorNotesMember_5282f04f-9f67-42a9-9083-8ef8a796cac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_dac68d68-3d90-49f9-bd37-0e9ace04cabf" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_SeniorNotes2019Member_dac68d68-3d90-49f9-bd37-0e9ace04cabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_2fd3cd32-acb9-48e4-b01d-80efa603bb1b" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2012Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_SeniorNotes2012Member_2fd3cd32-acb9-48e4-b01d-80efa603bb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_d59880bc-fac8-4275-b7cc-70d8c2a08e1a" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d7a8753d-c1c3-4004-9906-d6340650e810" xlink:to="loc_pbh_AblRevolver2012Member_d59880bc-fac8-4275-b7cc-70d8c2a08e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91d43944-804a-4519-b1a6-609032482ef4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_61168603-72d5-49c0-8d76-258bbdc4cb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_us-gaap_SeniorNotesMember_61168603-72d5-49c0-8d76-258bbdc4cb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b9ab1951-d9c2-42d3-84c4-0fc70034ff29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_us-gaap_LoansPayableMember_b9ab1951-d9c2-42d3-84c4-0fc70034ff29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo5Member_60f90543-0f17-4dec-a6fb-d3c1c098edb0" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo5Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a25273bf-bd42-4de7-98ac-dea3eee3ed1d" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo5Member_60f90543-0f17-4dec-a6fb-d3c1c098edb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_dac8e388-3ab2-4980-ae66-af513160fd59" xlink:to="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1a6d502e-9c53-4943-b8a1-8a65aed33962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_964e1a0b-3422-472a-98cf-2fd7ac9eb1c3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1a6d502e-9c53-4943-b8a1-8a65aed33962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a06ecc23-9626-4b5d-b883-3b5514b66aa9" xlink:to="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f522ac88-04ba-4001-8ffd-cc2bfb9e4276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_f522ac88-04ba-4001-8ffd-cc2bfb9e4276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_779cb1de-8c24-4b06-83af-deab4246d77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bf88fd47-58ce-4ff8-8c7d-206b279add36" xlink:to="loc_us-gaap_BaseRateMember_779cb1de-8c24-4b06-83af-deab4246d77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a7350b2b-de54-405f-af19-ca90ccbba550" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_55867738-2f2e-44c6-8b42-d7c45ec47893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_55867738-2f2e-44c6-8b42-d7c45ec47893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_558c7116-616e-4c68-a788-8fd4d121bf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_558c7116-616e-4c68-a788-8fd4d121bf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7f169d4a-ffb6-4ceb-a0cd-74c5cb226dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_LongTermDebt_7f169d4a-ffb6-4ceb-a0cd-74c5cb226dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f34c6f1-070a-484f-aa00-9cdd7f89e382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f34c6f1-070a-484f-aa00-9cdd7f89e382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_de9c4c21-9f6c-48ef-9a3e-3698711ef2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_de9c4c21-9f6c-48ef-9a3e-3698711ef2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateMinimum_c6ee351e-0d2b-4359-b087-5d8214a82846" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_pbh_DebtInstrumentVariableRateMinimum_c6ee351e-0d2b-4359-b087-5d8214a82846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_707f2673-6684-4a59-ba62-d895593a6f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_707f2673-6684-4a59-ba62-d895593a6f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ec2eee22-ce1e-4d3f-a0a7-8b061467a52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d8d8a327-338b-4957-a171-1db8d14a9bef" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ec2eee22-ce1e-4d3f-a0a7-8b061467a52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_33d837f8-90e1-4811-aa10-905dd4a7ddc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_33d837f8-90e1-4811-aa10-905dd4a7ddc4" xlink:to="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2df12882-dd4c-419c-a2de-411578f6d7c6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_TermLoan2012Member_2174ac4f-2dab-4d46-be47-ecdebab4b7cd" xlink:href="pbh-20220331.xsd#pbh_TermLoan2012Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_TermLoan2012Member_2174ac4f-2dab-4d46-be47-ecdebab4b7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_da691dbe-2389-4e1c-aa73-adc16da9ef83" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_AblRevolver2012Member_da691dbe-2389-4e1c-aa73-adc16da9ef83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended2012TermLoanMember_dc170f82-7b59-4049-bd64-af2732e286b9" xlink:href="pbh-20220331.xsd#pbh_Amended2012TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amended2012TermLoanMember_dc170f82-7b59-4049-bd64-af2732e286b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amended22012TermLoanMember_e5e7f990-9840-42da-a5cc-376fefb877aa" xlink:href="pbh-20220331.xsd#pbh_Amended22012TermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amended22012TermLoanMember_e5e7f990-9840-42da-a5cc-376fefb877aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment3Member_70108a69-7193-4c17-9e43-b881572f93d9" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment3Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_A2012ABLRevolverAmendment3Member_70108a69-7193-4c17-9e43-b881572f93d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment32012TermLoanMember_ce1f6f22-e53e-42f1-a2cc-f9b05a31e877" xlink:href="pbh-20220331.xsd#pbh_Amendment32012TermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amendment32012TermLoanMember_ce1f6f22-e53e-42f1-a2cc-f9b05a31e877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLRevolverAmendment4Member_0f98bf38-8e7e-472a-8b48-f4dabe89c023" xlink:href="pbh-20220331.xsd#pbh_ABLRevolverAmendment4Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_ABLRevolverAmendment4Member_0f98bf38-8e7e-472a-8b48-f4dabe89c023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ABLAmendmentNumber5Member_5e32fbfb-512a-4816-8445-dc09ccd5c4a7" xlink:href="pbh-20220331.xsd#pbh_ABLAmendmentNumber5Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_ABLAmendmentNumber5Member_5e32fbfb-512a-4816-8445-dc09ccd5c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2012Member_88a7d21b-147b-4329-b4c2-1a32e5853c3d" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2012Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_SeniorNotes2012Member_88a7d21b-147b-4329-b4c2-1a32e5853c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2012ABLRevolverAmendment6Member_b348201e-d347-4104-aaa4-9986752b3d01" xlink:href="pbh-20220331.xsd#pbh_A2012ABLRevolverAmendment6Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_A2012ABLRevolverAmendment6Member_b348201e-d347-4104-aaa4-9986752b3d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment52012TermLoanMember_917ec867-0711-4242-98cb-f7f12a993d89" xlink:href="pbh-20220331.xsd#pbh_Amendment52012TermLoanMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_Amendment52012TermLoanMember_917ec867-0711-4242-98cb-f7f12a993d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2013Member_2374cf2a-4456-42e0-b0be-acac377b9fa4" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2013Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6429f40d-f649-4696-a7c8-3c24f8b4e944" xlink:to="loc_pbh_SeniorNotes2013Member_2374cf2a-4456-42e0-b0be-acac377b9fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a86cc919-576e-4a11-9869-28dcac4b035c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_bf73aabf-0369-4781-adbb-c5f85a89422d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_us-gaap_LoansPayableMember_bf73aabf-0369-4781-adbb-c5f85a89422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB2Member_a067518d-0152-4ff9-87c5-6bbf8b942248" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB2Member_a067518d-0152-4ff9-87c5-6bbf8b942248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB3Member_64f50db5-7033-4f95-8cd2-827bd1a9782b" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB3Member_64f50db5-7033-4f95-8cd2-827bd1a9782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB1Member_b9c1588d-667c-4419-9eaf-7a1ee9b45b1a" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB1Member_b9c1588d-667c-4419-9eaf-7a1ee9b45b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB4Member_349f29ef-0ea5-4753-9974-c4a5188bee48" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB4Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_pbh_LoansPayableTermB4Member_349f29ef-0ea5-4753-9974-c4a5188bee48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_79c62929-309f-47e8-960b-a3378a5bc674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9e392e4-c630-413a-acaf-5019093582c0" xlink:to="loc_us-gaap_SecuredDebtMember_79c62929-309f-47e8-960b-a3378a5bc674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_34f0eb1c-2043-464e-a360-0ba6946f8289" xlink:to="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_24b40cce-8317-48f5-b606-b3e60e2b8112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2a3590fc-5b86-4c9f-b52e-4d845da78e36" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_24b40cce-8317-48f5-b606-b3e60e2b8112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c6270433-7692-47bd-b1ed-1d6b817d39c4" xlink:to="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c1eddf26-400f-4ac5-90f5-e81e8458df5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_c1eddf26-400f-4ac5-90f5-e81e8458df5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_5cc57bbc-943d-4ed2-a43c-d1e6df80616e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_us-gaap_BaseRateMember_5cc57bbc-943d-4ed2-a43c-d1e6df80616e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FederalFundsRateMember_5a464c19-54fd-4233-b205-867786ab3cfb" xlink:href="pbh-20220331.xsd#pbh_FederalFundsRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_be00fa45-55ba-4d34-8d91-900b2c064392" xlink:to="loc_pbh_FederalFundsRateMember_5a464c19-54fd-4233-b205-867786ab3cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_803c6f6b-9cdb-43c6-86de-38679aaa7cd9" xlink:to="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb39ce14-6372-4918-91ac-003b2dd7daac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:to="loc_srt_MinimumMember_fb39ce14-6372-4918-91ac-003b2dd7daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d974a05-812a-424f-930f-f4cd5bc5f1e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5d150577-7157-4732-a2ca-329fc3876db7" xlink:to="loc_srt_MaximumMember_3d974a05-812a-424f-930f-f4cd5bc5f1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8d3b0313-2a7c-4f73-8bd5-6648c41f8d2c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7d78c9b-b16c-447b-ac0c-0122431fb07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7d78c9b-b16c-447b-ac0c-0122431fb07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6a5056a7-77d1-4cae-84ca-021a3c76f654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentTerm_6a5056a7-77d1-4cae-84ca-021a3c76f654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e48a566c-fdb8-4eee-a76c-bfb738b0e782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e48a566c-fdb8-4eee-a76c-bfb738b0e782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_e6b5563c-cfc6-43c6-9e30-a17906978826" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity_e6b5563c-cfc6-43c6-9e30-a17906978826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_52a56ccc-c2ef-4ad2-9def-c45b2ac3ec29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_52a56ccc-c2ef-4ad2-9def-c45b2ac3ec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentDiscountPercentage_741657d4-b427-4aa2-8f44-2ceedbfbba0b" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentDiscountPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentDiscountPercentage_741657d4-b427-4aa2-8f44-2ceedbfbba0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b7eca05d-26fb-4afa-8cc2-6eeb97bc5785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b7eca05d-26fb-4afa-8cc2-6eeb97bc5785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e35006c-ff61-4dde-a3ec-6ad1cbdb4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3e35006c-ff61-4dde-a3ec-6ad1cbdb4b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentReferenceRateFloor_8fe3d113-44c0-4405-8457-c4d80340f966" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentReferenceRateFloor"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentReferenceRateFloor_8fe3d113-44c0-4405-8457-c4d80340f966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_4e743d3a-72c8-4434-be38-36842247bc28" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate_4e743d3a-72c8-4434-be38-36842247bc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_8c7f5df2-bfb2-47e8-a2dc-cda91799d76c" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent_8c7f5df2-bfb2-47e8-a2dc-cda91799d76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate_f1f2b8cc-0273-47c8-9124-c358f106b870" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentVariableRateConditionalVariableRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentVariableRateConditionalVariableRate_f1f2b8cc-0273-47c8-9124-c358f106b870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_1dfd4bfa-b7f0-4ae0-bed4-c9a62364b31c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_1dfd4bfa-b7f0-4ae0-bed4-c9a62364b31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_5ffd67cd-478b-49c3-a0e1-b9d1f5705aa4" xlink:href="pbh-20220331.xsd#pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage_5ffd67cd-478b-49c3-a0e1-b9d1f5705aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature_2ab859e1-1044-4972-8410-313de6ca69a9" xlink:href="pbh-20220331.xsd#pbh_LineofCreditFacilityIncreaseinAccordionFeature"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_LineofCreditFacilityIncreaseinAccordionFeature_2ab859e1-1044-4972-8410-313de6ca69a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_c966d5a3-0770-4294-a12d-45c0ffdf0107" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod_c966d5a3-0770-4294-a12d-45c0ffdf0107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_0b8312bf-2dde-4925-9867-694d72c0b403" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased_0b8312bf-2dde-4925-9867-694d72c0b403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_97530227-817f-43e9-a8e9-39eb0e2209f7" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate_97530227-817f-43e9-a8e9-39eb0e2209f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_821b850f-4233-456a-b991-b1c7b94d1c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_821b850f-4233-456a-b991-b1c7b94d1c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_2e6b2d2e-d377-4eed-89ae-14abc97efd88" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount_2e6b2d2e-d377-4eed-89ae-14abc97efd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0721db89-dcf5-4316-907d-ba832dd4a7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0721db89-dcf5-4316-907d-ba832dd4a7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_43f82511-851b-48fd-8c88-8df7f3449789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_43f82511-851b-48fd-8c88-8df7f3449789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_e9b6b199-23a8-4d3a-854b-829d99c2077f" xlink:href="pbh-20220331.xsd#pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe6b6d32-8a33-4fa0-bbf2-f34c17f1c222" xlink:to="loc_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment_e9b6b199-23a8-4d3a-854b-829d99c2077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2013SeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_91ad6c36-a643-4bde-b9de-792cb1942ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91ad6c36-a643-4bde-b9de-792cb1942ec0" xlink:to="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af3211cc-917e-4a0b-abe1-831038264af9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6ab5ae11-0547-4a1b-9369-026e8422b236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7259422b-0cd5-4ed8-aba0-9009efb1f73d" xlink:to="loc_us-gaap_SeniorNotesMember_6ab5ae11-0547-4a1b-9369-026e8422b236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f8ccc49-fcdc-455d-94bd-0af68ed51f00" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2013Member_1ccfbd94-e120-487d-baee-e7e91fc31cc7" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2013Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7196a211-3958-41d2-bf4f-1daef7d539ba" xlink:to="loc_pbh_SeniorNotes2013Member_1ccfbd94-e120-487d-baee-e7e91fc31cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1e6097c7-da04-4a8c-9ac1-faa148342fb1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_56f9e18c-c061-4831-89d4-b0256e902f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_56f9e18c-c061-4831-89d4-b0256e902f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9a20233c-8edb-48b7-ae5e-d409f53f202d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9a20233c-8edb-48b7-ae5e-d409f53f202d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e2196b4d-5ea1-43c4-9a54-3c2d7bbde695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c5041d5e-5f18-4e37-8abc-ca2a49ae8ebb" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e2196b4d-5ea1-43c4-9a54-3c2d7bbde695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2016SeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed7bad85-3967-4f6b-b161-3563f0f2bbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed7bad85-3967-4f6b-b161-3563f0f2bbf5" xlink:to="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c14ccc76-f746-4836-8ef6-2fa4df4f541b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_aebd9cb4-260f-4acd-8495-2abae24374e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fa91ec2-e4bc-4c66-ad27-f695db98e573" xlink:to="loc_us-gaap_SeniorNotesMember_aebd9cb4-260f-4acd-8495-2abae24374e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:to="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_003fdfbd-ddce-4290-a44c-bb6047af8785" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_306d190f-d0ff-4a5f-a642-d81ce86b9b72" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93ad77c4-abe3-4c74-b9ab-77e6e553e31a" xlink:to="loc_pbh_SeniorNotes2016Member_306d190f-d0ff-4a5f-a642-d81ce86b9b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e3f9179e-9cbc-446a-b78e-e1eb931187f0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_097b2c93-0265-4495-97dc-72f5006e8973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_097b2c93-0265-4495-97dc-72f5006e8973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_276794b4-4749-4c2f-994f-cb5397b9f370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_276794b4-4749-4c2f-994f-cb5397b9f370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_460808c0-66fd-4280-90a8-8491865f27d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_460808c0-66fd-4280-90a8-8491865f27d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_cf557e1a-4db7-46aa-97d5-0d722c523016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9ec8bf2e-70c5-4ae9-80f6-7bc8b2e1c5f9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_cf557e1a-4db7-46aa-97d5-0d722c523016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrative2019and2021SeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_baf757cb-7bd2-4a88-8454-042f505d268e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_baf757cb-7bd2-4a88-8454-042f505d268e" xlink:to="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d3d6a0c8-55bf-45db-9588-7ae4867d2af3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2019SeniorNotesMember_4c2323c5-4239-4195-8753-a07067578330" xlink:href="pbh-20220331.xsd#pbh_A2019SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:to="loc_pbh_A2019SeniorNotesMember_4c2323c5-4239-4195-8753-a07067578330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_7e5499da-651f-42d7-ae28-2ee9013a6bef" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b31b28d6-4efb-4aad-9073-d5a3cff38075" xlink:to="loc_pbh_A2021SeniorNotesMember_7e5499da-651f-42d7-ae28-2ee9013a6bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_db537392-7184-44f9-83c4-4c449bc4eedc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6742e630-75a1-4cea-837d-3433c2ea6dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b34649a2-b25c-48ce-ad8f-bc653e8a7d48" xlink:to="loc_us-gaap_SeniorNotesMember_6742e630-75a1-4cea-837d-3433c2ea6dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_79803b17-11f7-480c-8524-d16d5103e34b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7de60762-d1c1-4675-8f90-1c1e0cfa5c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7de60762-d1c1-4675-8f90-1c1e0cfa5c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60344b74-f444-4224-bb5f-d2c132b5f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_60344b74-f444-4224-bb5f-d2c132b5f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_3b9db4ef-01a2-4fc1-a604-2f3ca154f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_caf14dc3-31ca-42d4-a3d9-a2584052cc47" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_3b9db4ef-01a2-4fc1-a604-2f3ca154f5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrativeRedemptionsandRestrictionsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2efa64b4-22e6-4ad4-90be-0132662cf854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2efa64b4-22e6-4ad4-90be-0132662cf854" xlink:to="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5bf6b1d2-addf-468c-8ed1-5801dd208837" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d836a34c-4975-4c2d-9175-2cd4fe8eb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_16671df7-ca89-4997-beca-4de99984b3f3" xlink:to="loc_us-gaap_SeniorNotesMember_d836a34c-4975-4c2d-9175-2cd4fe8eb0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_e899b834-4d1f-40d0-8da4-8914e54a6924" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember_ec4f1c08-8099-4b36-895b-afc73f198d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndirectGuaranteeOfIndebtednessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_735e1d8d-c7af-46a1-951f-1afbf5aa9a04" xlink:to="loc_us-gaap_IndirectGuaranteeOfIndebtednessMember_ec4f1c08-8099-4b36-895b-afc73f198d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_92ac1253-f605-4a21-827e-433056b27cf7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_daf96c5b-b3ec-49d9-8d73-ce621756eca6" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:to="loc_pbh_SeniorNotes2019Member_daf96c5b-b3ec-49d9-8d73-ce621756eca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2016Member_f3d1df03-5924-43de-9c0b-ad658c752293" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2016Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59c6f96e-3657-4c4d-9a9b-8b980cf88257" xlink:to="loc_pbh_SeniorNotes2016Member_f3d1df03-5924-43de-9c0b-ad658c752293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_14d0e933-d082-4ef8-844b-ce89dab91cd0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_754407b8-0457-48fc-bb04-f13968796b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_610aa148-000b-4252-ab71-f802d67611d5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_754407b8-0457-48fc-bb04-f13968796b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtNarrativeInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_253ffaf3-f990-4427-948c-7a016ac2093d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_253ffaf3-f990-4427-948c-7a016ac2093d" xlink:to="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3116cb27-61a4-472a-8a91-d5dad69054d4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_4a1686cd-9635-4f5f-9054-e43483757ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f8f4d196-1651-4f0f-8162-1dd909809004" xlink:to="loc_us-gaap_InterestRateSwapMember_4a1686cd-9635-4f5f-9054-e43483757ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:to="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffd09317-899f-4992-8f6e-0b9cb0ae2b6b" xlink:to="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_51ff694f-2a2c-4b14-8238-1fcd589426f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6aaf5257-16d6-436e-bb0b-fe7b589cd3e9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_51ff694f-2a2c-4b14-8238-1fcd589426f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_aa90f065-4f64-460b-b23f-99b53fff6766" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_82a726a7-5a36-4e1c-a051-51058e975994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bc8d09c8-7618-428e-aedc-db3fec22bdb4" xlink:to="loc_us-gaap_DerivativeNotionalAmount_82a726a7-5a36-4e1c-a051-51058e975994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#LongTermDebtMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d0fef8a-baed-45f4-90db-b2e143d5d5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8d0fef8a-baed-45f4-90db-b2e143d5d5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_62e817bd-4b25-4792-a7c9-79fb491ee109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_62e817bd-4b25-4792-a7c9-79fb491ee109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3f6f74e6-3ba0-404b-8ef7-7fbe2fae8464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3f6f74e6-3ba0-404b-8ef7-7fbe2fae8464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_853586b2-42ec-406b-a5b1-1ee4ff3f37f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_853586b2-42ec-406b-a5b1-1ee4ff3f37f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9638bb43-796c-4ed0-8288-3337b5ed0c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9638bb43-796c-4ed0-8288-3337b5ed0c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1bc5e9f4-a310-4cc6-ab1b-c2b840c70387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_1bc5e9f4-a310-4cc6-ab1b-c2b840c70387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c939580c-17c7-41a4-8a40-3c85c50b7630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_91487fd7-ebb7-4deb-aa18-2e310ae04d7f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c939580c-17c7-41a4-8a40-3c85c50b7630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pbh-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1cf239ca-5b68-40eb-a120-c788a68cb2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_2a0a5db2-1398-402b-b449-126bb09f4f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1cf239ca-5b68-40eb-a120-c788a68cb2db" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_2a0a5db2-1398-402b-b449-126bb09f4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_53747592-03d6-4944-8929-229956ca7cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_a32902c8-6bac-4cd5-ba93-f9dd7f93a805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_53747592-03d6-4944-8929-229956ca7cfb" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_a32902c8-6bac-4cd5-ba93-f9dd7f93a805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5d64d2ba-445c-4e58-8f68-df21412d037b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5d64d2ba-445c-4e58-8f68-df21412d037b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_0fcd6dc8-619e-4de8-8516-7ea505991751" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_cf30fa8f-bd5d-4651-95ff-4f2f9fd1c5a0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_072c1a50-5d1b-46f5-a351-0c3fcd7f9d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_072c1a50-5d1b-46f5-a351-0c3fcd7f9d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_abff169e-16ec-438c-9493-4f78250128ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a1cd3785-9b77-4788-8729-50677c94b3bf" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_abff169e-16ec-438c-9493-4f78250128ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9b4858c2-28ac-45a1-9b59-3392dcce931b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0262402b-4999-4f4e-ac69-9877e13f7e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4d80235c-6d90-4298-99b7-f1b11d21c70d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0262402b-4999-4f4e-ac69-9877e13f7e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_92571eea-a185-481b-98a1-89ef00c8c074" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_649a4f63-fe30-48a1-8710-cc71019aa9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_SeniorNotesMember_649a4f63-fe30-48a1-8710-cc71019aa9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_812ff9b9-9128-4b79-9a5d-081439968071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_LoansPayableMember_812ff9b9-9128-4b79-9a5d-081439968071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d6791fcb-e489-48cc-82f2-904e2862f12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bc4d451-a1e1-4757-9e66-82b3abf980d0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d6791fcb-e489-48cc-82f2-904e2862f12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b734595c-9935-4e2c-bacb-8e2a8817a49d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SeniorNotes2019Member_804c1e1e-74fb-476b-b62d-32e8fdbba354" xlink:href="pbh-20220331.xsd#pbh_SeniorNotes2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_SeniorNotes2019Member_804c1e1e-74fb-476b-b62d-32e8fdbba354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_A2021SeniorNotesMember_e62e64f0-4cf3-49ab-a427-13069b1f0ec3" xlink:href="pbh-20220331.xsd#pbh_A2021SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_A2021SeniorNotesMember_e62e64f0-4cf3-49ab-a427-13069b1f0ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Amendment52012TermLoanMember_e9a4bcb7-bc5e-41ea-87be-b1bef87d68d7" xlink:href="pbh-20220331.xsd#pbh_Amendment52012TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_Amendment52012TermLoanMember_e9a4bcb7-bc5e-41ea-87be-b1bef87d68d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LoansPayableTermB5AmendmentNo6Member_7c5cd911-ff09-4f62-a2fd-f6b01479ec2f" xlink:href="pbh-20220331.xsd#pbh_LoansPayableTermB5AmendmentNo6Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_LoansPayableTermB5AmendmentNo6Member_7c5cd911-ff09-4f62-a2fd-f6b01479ec2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AblRevolver2012Member_f4bfd92e-4544-4f2e-a98f-355f828ddc72" xlink:href="pbh-20220331.xsd#pbh_AblRevolver2012Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ee1a0bed-ce27-417c-a771-85257ad45eed" xlink:to="loc_pbh_AblRevolver2012Member_f4bfd92e-4544-4f2e-a98f-355f828ddc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_53cccdea-faf8-4ea0-b250-3e6202aacaad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_9fb2ac81-e286-428b-88db-70730841968a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_569dce25-203d-432b-abe2-e9407b7df516" xlink:to="loc_us-gaap_InterestRateSwapMember_9fb2ac81-e286-428b-88db-70730841968a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_169c1e83-0d0f-49ac-896b-2e78c567394b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_eafd1ad0-85ac-429e-bff2-01590b96141e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:to="loc_us-gaap_LongTermDebtFairValue_eafd1ad0-85ac-429e-bff2-01590b96141e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_31105757-1520-49e3-a01c-a4601f79d52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1f032af0-e363-4f48-a372-2122045e573a" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_31105757-1520-49e3-a01c-a4601f79d52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0725ebd7-bffb-4528-9752-b3076edd1d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_de18eda9-1e45-41c0-b5fa-8f19333b0f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0725ebd7-bffb-4528-9752-b3076edd1d84" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_de18eda9-1e45-41c0-b5fa-8f19333b0f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_458c6411-39a3-4a99-89e5-9764d3dbe670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_09556fd1-9688-455b-bde7-8caab1dec8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_458c6411-39a3-4a99-89e5-9764d3dbe670" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_09556fd1-9688-455b-bde7-8caab1dec8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a8839de9-fe50-4245-a30e-7a368f808be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_458c6411-39a3-4a99-89e5-9764d3dbe670" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a8839de9-fe50-4245-a30e-7a368f808be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b85e5332-1d74-4704-a20e-f214fb01e7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b85e5332-1d74-4704-a20e-f214fb01e7b3" xlink:to="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:to="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c3c95e8c-9df5-49c7-bef1-7e4f5452969d" xlink:to="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36fc89bb-4e86-4347-989f-01142e362ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0766f130-0318-4e18-8b1f-4b1adc669e6f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36fc89bb-4e86-4347-989f-01142e362ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3f5fec34-55df-461c-a0c2-0d042412339b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e4e2b2dd-fcd7-4fd1-a55d-feba114f03d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7956b23a-2c9f-4b1a-a4d8-dc8d9518ce47" xlink:to="loc_us-gaap_InterestRateSwapMember_e4e2b2dd-fcd7-4fd1-a55d-feba114f03d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1f5a500c-2451-4c8a-8e93-aa58d6a8d98e" xlink:to="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4337ab63-0e57-400a-a75e-9610b315b16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_fc07ab21-84a0-4cd8-abe4-b5719c6974d2" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4337ab63-0e57-400a-a75e-9610b315b16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_33adb71e-de97-4778-845b-9b67fa333fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_33adb71e-de97-4778-845b-9b67fa333fbf" xlink:to="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_976fa2d8-ce8e-4b63-bbf2-75eea996c5d7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8aecf83f-6e23-4b5f-9e06-17546eea83f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5f454c59-1740-44ed-b9b6-8dadb9486941" xlink:to="loc_us-gaap_InterestRateSwapMember_8aecf83f-6e23-4b5f-9e06-17546eea83f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_86a634ea-7d1a-4a6c-8118-10feec4d5e3d" xlink:to="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b317c343-06ac-42e5-9ab2-6c6538b51a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f510e05a-bdfa-46d1-b9cd-157f9b5f592d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b317c343-06ac-42e5-9ab2-6c6538b51a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_23b7faa7-203d-4b1d-a5ea-e56df05cda3b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d9d17b04-c824-4127-a59b-247a73dd6fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a7031042-65da-463d-9f10-75edeef0643f" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d9d17b04-c824-4127-a59b-247a73dd6fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4d3ddbec-425d-44d7-aad6-11c71d112c26" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_c989e165-d0fb-47af-980b-782aa8ca55b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c18d8bdf-ab07-419e-9cdb-3ce34ba91b91" xlink:to="loc_us-gaap_CashFlowHedgingMember_c989e165-d0fb-47af-980b-782aa8ca55b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_304448de-4a15-4abc-afb4-87b593f7a5a2" xlink:to="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6b7b3665-a0ca-45ee-95d6-a7e4c2bc13f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6b7b3665-a0ca-45ee-95d6-a7e4c2bc13f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a59432d4-de56-4317-b6a6-10b801150688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c76bece6-fedb-42dc-8261-3a35ed4baab3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_a59432d4-de56-4317-b6a6-10b801150688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe08d27f-def1-4365-b8b7-523cbf6b0037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_fe08d27f-def1-4365-b8b7-523cbf6b0037" xlink:to="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_20d5a336-1630-498b-94ce-04383cb6d8da" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_c5ac6ba2-0814-4e85-9052-64678f2f1287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e8a97959-ecf0-443f-97ff-3f393d305b5c" xlink:to="loc_us-gaap_InterestRateSwapMember_c5ac6ba2-0814-4e85-9052-64678f2f1287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_125ae900-bdc3-4223-b30b-a124bd8cd233" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8a4b8e3a-28a2-40ea-ae39-8b2622ef526a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c28cc7e8-1243-4d0f-9896-0ef6db35e82e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8a4b8e3a-28a2-40ea-ae39-8b2622ef526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c723747a-5c3c-48c4-814f-e1e53ef2db33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fac4a573-4852-47a5-9195-fa7b2a5b60fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fee0ad00-3c6d-4100-b7dc-62794ff786b8" xlink:to="loc_us-gaap_InterestExpenseMember_fac4a573-4852-47a5-9195-fa7b2a5b60fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_a04d668e-6b8c-419a-bdfe-5aec5dc7d28c" xlink:to="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae8c1eec-6f84-4591-805a-112edb9d4153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ae8c1eec-6f84-4591-805a-112edb9d4153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8a156906-6160-446e-ace8-efd65ed202bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4832c216-6e1a-4cb6-b349-88c0119760ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_8a156906-6160-446e-ace8-efd65ed202bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="simple" xlink:href="pbh-20220331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_17ca6863-9ec1-427c-a95c-a60e1498df2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ac7e2371-e200-44aa-810d-dc002a9b87be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_17ca6863-9ec1-427c-a95c-a60e1498df2c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ac7e2371-e200-44aa-810d-dc002a9b87be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b9a780e1-ce1e-4299-9238-f5112fd570d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_643286dc-a562-4689-8b89-829ff80ba3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b9a780e1-ce1e-4299-9238-f5112fd570d9" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_643286dc-a562-4689-8b89-829ff80ba3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_48900c0e-bc7c-4726-abf2-6831926af188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_48900c0e-bc7c-4726-abf2-6831926af188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b596b026-8284-48d4-ba62-fe7ff5a4c4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b596b026-8284-48d4-ba62-fe7ff5a4c4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_caff0c9d-d871-455a-8efc-808561072ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_caff0c9d-d871-455a-8efc-808561072ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e63e1cb7-a5b8-4314-a88d-73f8c7920b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e63e1cb7-a5b8-4314-a88d-73f8c7920b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_4922618c-a11a-4b03-8414-a4996ebdccb3" xlink:href="pbh-20220331.xsd#pbh_VotingRightsNumberOfVotesPerCommonShareOwned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_pbh_VotingRightsNumberOfVotesPerCommonShareOwned_4922618c-a11a-4b03-8414-a4996ebdccb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_e2686c4d-3eca-4780-80a5-64be11ffc182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c5c1a39c-9e6c-47a2-98ea-60d1fbdc1f26" xlink:to="loc_us-gaap_DividendsCommonStock_e2686c4d-3eca-4780-80a5-64be11ffc182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#StockholdersEquityScheduleofSharesRepurchasedDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_47bdd373-4c9f-4afe-afdd-8ae3c69232e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_47bdd373-4c9f-4afe-afdd-8ae3c69232e0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:to="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7ebef002-e7cc-4654-91d2-25b66f31df14" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_59588982-44a7-44b6-ab61-186a9dfd54be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b91bc944-31ed-443d-87aa-b90caa92e17c" xlink:to="loc_us-gaap_RestrictedStockMember_59588982-44a7-44b6-ab61-186a9dfd54be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7f6dcf4c-c7ba-45e3-b41f-2b27bbd46cf3" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareRepurchaseProgramMember_b460545a-e757-45a4-96e5-55bde03d7261" xlink:href="pbh-20220331.xsd#pbh_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_320bb90c-bd63-476c-8527-e38b348f1a35" xlink:to="loc_pbh_ShareRepurchaseProgramMember_b460545a-e757-45a4-96e5-55bde03d7261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b660994e-a799-446c-881c-ee35f387b6b9" xlink:to="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_803b1413-13de-41a6-a47d-d0a93b5e9e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_803b1413-13de-41a6-a47d-d0a93b5e9e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4465668a-665f-4a1f-bc46-a5b29688bb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_4465668a-665f-4a1f-bc46-a5b29688bb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b837266-f658-4aab-b688-e13ecd6952b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9092d4fc-55df-4ca1-8935-097954d4adf7" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0b837266-f658-4aab-b688-e13ecd6952b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66b0075f-69da-4ea3-8a0d-b4266f46f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_077e29db-b3f3-4910-80c7-b81d6822a00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66b0075f-69da-4ea3-8a0d-b4266f46f7f0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_077e29db-b3f3-4910-80c7-b81d6822a00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50890ee8-7221-4f86-8716-c92fb9e90048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6b45d7a2-9804-4ad4-b7ac-aa181cd738ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50890ee8-7221-4f86-8716-c92fb9e90048" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6b45d7a2-9804-4ad4-b7ac-aa181cd738ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_15342078-733a-4640-bb6a-767fa51d64fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50890ee8-7221-4f86-8716-c92fb9e90048" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_15342078-733a-4640-bb6a-767fa51d64fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4b9180bc-5e46-4fa8-aff8-eca7b6545412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50890ee8-7221-4f86-8716-c92fb9e90048" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4b9180bc-5e46-4fa8-aff8-eca7b6545412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019f86cf-38c0-4575-b7ec-b0735964cf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50890ee8-7221-4f86-8716-c92fb9e90048" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019f86cf-38c0-4575-b7ec-b0735964cf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46d4e59a-4bd8-4a15-aafd-c6344f0b6df7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46d4e59a-4bd8-4a15-aafd-c6344f0b6df7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_285216c2-8436-42b7-bee7-52a4301ebcc0" xlink:to="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongtermEquityIncentivePlan2005Member_d37cac7d-dc24-4eba-8076-2354fac73252" xlink:href="pbh-20220331.xsd#pbh_LongtermEquityIncentivePlan2005Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:to="loc_pbh_LongtermEquityIncentivePlan2005Member_d37cac7d-dc24-4eba-8076-2354fac73252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_LongTermIncentivePlan2020Member_182f69cd-2568-41a0-b2dd-e6358ec5e367" xlink:href="pbh-20220331.xsd#pbh_LongTermIncentivePlan2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_21899d64-c616-47aa-a10c-c8e88f0acb8a" xlink:to="loc_pbh_LongTermIncentivePlan2020Member_182f69cd-2568-41a0-b2dd-e6358ec5e367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c9d1d174-92f8-4421-a246-38083a7e259d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_a348de72-d878-41ef-874a-f648f6ccabab" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember_a348de72-d878-41ef-874a-f648f6ccabab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c0360f1c-6da2-406b-b15f-d2c2a475451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_PerformanceSharesMember_c0360f1c-6da2-406b-b15f-d2c2a475451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_66ad8546-869a-4f6a-96e3-a0d11bff94ed" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsRSUsStockOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_pbh_RestrictedStockUnitsRSUsStockOptionsMember_66ad8546-869a-4f6a-96e3-a0d11bff94ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d28f8515-42f7-4baa-b658-93d2f57f5c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d28f8515-42f7-4baa-b658-93d2f57f5c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a2fcea57-19a1-4a40-b72d-2a21d84c3d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53d7079f-d78c-4564-b9c5-6019f0483817" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a2fcea57-19a1-4a40-b72d-2a21d84c3d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9a994aa1-0289-4951-b6d6-12ae2210782e" xlink:to="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ae33654-b8c3-4f73-809c-84d421367d9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cb42b15f-1138-48ce-ad45-d1cffefa5e32" xlink:to="loc_srt_MinimumMember_8ae33654-b8c3-4f73-809c-84d421367d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_e7f34c81-da8c-4446-bdd7-5ca38a54c7da" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_316bb005-06bb-4dc6-b75f-8bef9eebe091" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a576c2a4-ee32-4c27-92e7-b0c59016180c" xlink:to="loc_srt_DirectorMember_316bb005-06bb-4dc6-b75f-8bef9eebe091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94d61a5f-e072-4850-86de-ef28029e5ab2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e9bf86bb-582a-4dd5-a4d6-038018fe78fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e9bf86bb-582a-4dd5-a4d6-038018fe78fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3a66763d-3878-415d-8ef1-0a72e4355493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3a66763d-3878-415d-8ef1-0a72e4355493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_a1dca69a-a184-4dbe-bf0b-c71938321787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_a1dca69a-a184-4dbe-bf0b-c71938321787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_0f1dab62-d348-40f7-9ac4-b121852bbdba" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod_0f1dab62-d348-40f7-9ac4-b121852bbdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8030fbd8-8eb4-49f8-94f8-dfb46f5d6c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8030fbd8-8eb4-49f8-94f8-dfb46f5d6c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_00ee7e9d-3843-4a94-ade4-09e95233c7a5" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares_00ee7e9d-3843-4a94-ade4-09e95233c7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_34df0f9c-19d6-4196-a26d-b728d97bf7a7" xlink:href="pbh-20220331.xsd#pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares_34df0f9c-19d6-4196-a26d-b728d97bf7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4e7c8b16-a43c-4644-b8fe-d4776dc56688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4e7c8b16-a43c-4644-b8fe-d4776dc56688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9958755-4f62-4a6e-a144-0cba5cd9879e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b9958755-4f62-4a6e-a144-0cba5cd9879e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_054ed7fa-72a9-46ae-b8f4-4a1986e55de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_054ed7fa-72a9-46ae-b8f4-4a1986e55de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e3f1b49c-ddb9-4c10-9984-c3ff51d2c800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e3f1b49c-ddb9-4c10-9984-c3ff51d2c800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_489f91b7-da69-4807-906b-e38acadc6227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_489f91b7-da69-4807-906b-e38acadc6227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80f40098-70e8-49a0-bf79-08cd058d11c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_80f40098-70e8-49a0-bf79-08cd058d11c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_8778bd71-34c2-4cb2-be8d-be7f73ddcfcc" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted_8778bd71-34c2-4cb2-be8d-be7f73ddcfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53add711-22e4-480f-9873-8eebdc7aa728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53add711-22e4-480f-9873-8eebdc7aa728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_a1d16680-9373-4e7d-b6b3-078627af111e" xlink:href="pbh-20220331.xsd#pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted_a1d16680-9373-4e7d-b6b3-078627af111e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_b9e89aae-72ca-46ba-9b4e-93de8d406900" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant_b9e89aae-72ca-46ba-9b4e-93de8d406900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_51a38add-c88b-4a7c-81aa-7aebbe30d178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d16ceb2-2f60-4763-a60f-c55ddf56ca9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_51a38add-c88b-4a7c-81aa-7aebbe30d178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationStockBasedCompensationInformationDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad76847f-e73a-430c-8e48-e47712e5de6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ad76847f-e73a-430c-8e48-e47712e5de6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_80fdbed7-781d-4bba-b45b-62f5feddcea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_80fdbed7-781d-4bba-b45b-62f5feddcea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_662ece70-4140-4a6f-9e31-35255e262d3c" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue_662ece70-4140-4a6f-9e31-35255e262d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d43922ae-5468-43d7-8166-849c3a88435f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d43922ae-5468-43d7-8166-849c3a88435f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_c04552b2-e6e8-4c1e-a2b8-6bd9d207e248" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ae69fc3-a5b6-4662-9724-1ca5e86e9228" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount_c04552b2-e6e8-4c1e-a2b8-6bd9d207e248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationRestrictedSharesActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0225a1c2-13ce-45ff-819c-b16285e4d96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0225a1c2-13ce-45ff-819c-b16285e4d96f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:to="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a3d8b2c4-a53f-465e-82df-911402608611" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_31e8a499-35c5-451c-bc3e-eaf50c7766fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2fe1e9d9-3c74-435d-9ac6-c4e5de663ddb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_31e8a499-35c5-451c-bc3e-eaf50c7766fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afbdbe47-1823-4e58-ae0a-f1c5866971ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_42afce09-ef99-4274-84e6-c124aee25194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_42afce09-ef99-4274-84e6-c124aee25194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b85ca48f-cdbc-43e8-9019-b5abc103ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b85ca48f-cdbc-43e8-9019-b5abc103ce5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_687e1181-3ba9-4618-bc5b-154fbd461de1" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued_687e1181-3ba9-4618-bc5b-154fbd461de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_192778aa-0485-4c9c-90c8-9d32df16d393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_192778aa-0485-4c9c-90c8-9d32df16d393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fa68569f-b2a7-4501-a7ba-23560c58ca24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88b919f9-bbae-4152-bda7-402c99f31c80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fa68569f-b2a7-4501-a7ba-23560c58ca24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_576c50e0-43a4-437f-aefc-d90ca3d72adf" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber_576c50e0-43a4-437f-aefc-d90ca3d72adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_d5de9567-9eb5-400d-82e6-ad60f082cd4d" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_d5de9567-9eb5-400d-82e6-ad60f082cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afa31ce2-9ba8-415a-afb9-ee80377e3112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afa31ce2-9ba8-415a-afb9-ee80377e3112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_201fa31f-4f30-4372-8bf8-d63c713f69dc" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_201fa31f-4f30-4372-8bf8-d63c713f69dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40b4a850-ba09-4aef-8c82-39c46d9d2dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40b4a850-ba09-4aef-8c82-39c46d9d2dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_875cac9e-b398-4455-99c1-a5d20f318147" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_39736810-44a6-46ac-97b3-65b5f667d198" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_875cac9e-b398-4455-99c1-a5d20f318147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_d84ade09-139d-455d-a534-50ceadbe288d" xlink:href="pbh-20220331.xsd#pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2d624a4-3c8e-4cdf-8f22-7828dc33ace6" xlink:to="loc_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue_d84ade09-139d-455d-a534-50ceadbe288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationStockOptionValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f760da7-edab-4601-9033-14a0b4195c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f760da7-edab-4601-9033-14a0b4195c86" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:to="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c9a1fe3d-92db-4366-a71b-42696c322092" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5bd62b46-a321-45e9-842c-79ce1d1088de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67c8705c-c052-447a-91af-8f8a79b98eb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5bd62b46-a321-45e9-842c-79ce1d1088de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:to="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_14a591cf-845b-493c-a5ab-477e8b6647f4" xlink:to="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1db3111d-e7ce-4c80-a2d1-5a71e697a953" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:to="loc_srt_MinimumMember_1db3111d-e7ce-4c80-a2d1-5a71e697a953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5dff66a8-02a1-47a7-b8cd-c6ba6b2fbda3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55aaa48e-1694-449c-a1b0-2629a1ecbd40" xlink:to="loc_srt_MaximumMember_5dff66a8-02a1-47a7-b8cd-c6ba6b2fbda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c27b76e3-ede9-41a3-adea-b9fd588ce93e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388138b4-4cae-4302-8574-0ed7486d238f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_388138b4-4cae-4302-8574-0ed7486d238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9e1f83b6-ef24-40cf-b1c2-1b76102fc7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9e1f83b6-ef24-40cf-b1c2-1b76102fc7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_93586184-9141-4bfd-a4f6-c0b4ab2f388c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_93586184-9141-4bfd-a4f6-c0b4ab2f388c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_056d5f6e-0689-4359-81ac-81e75be6244a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_056d5f6e-0689-4359-81ac-81e75be6244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c58f6251-7191-4a43-8a9a-d529deefc838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5904e4c5-049a-40f8-82c9-772b332f0e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c58f6251-7191-4a43-8a9a-d529deefc838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8737fa29-44ec-4f6c-bb55-9e45967651a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8737fa29-44ec-4f6c-bb55-9e45967651a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d6a98421-f468-41b8-8b48-fdf7f0152174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d6a98421-f468-41b8-8b48-fdf7f0152174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90737f5c-26a2-495f-b1b4-0c0129eb517e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90737f5c-26a2-495f-b1b4-0c0129eb517e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c66dfe52-e953-4886-ae5f-225199d22c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c66dfe52-e953-4886-ae5f-225199d22c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3947d73d-c49f-413a-b5ff-f59c35e890b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3947d73d-c49f-413a-b5ff-f59c35e890b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_56de9cd5-46f2-4f1c-8b86-fb41f45a34bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_152df220-036d-4ec4-b46e-25b38e3c304d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_56de9cd5-46f2-4f1c-8b86-fb41f45a34bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3e6b3ed8-0970-4f9f-83a1-628c7f1dec27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3e6b3ed8-0970-4f9f-83a1-628c7f1dec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13e0ae55-70c3-46ff-84e2-d1e9d8ae348d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13e0ae55-70c3-46ff-84e2-d1e9d8ae348d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7d091c4d-6ff6-4747-8fe6-6b7d53b9984a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7d091c4d-6ff6-4747-8fe6-6b7d53b9984a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ad751be7-0ff8-492c-af2c-5514561f2825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ad751be7-0ff8-492c-af2c-5514561f2825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_54053ac5-a122-4b03-8a15-c132ec913408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_54053ac5-a122-4b03-8a15-c132ec913408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b07fb557-93de-45a2-850c-62a136b8ecf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_b07fb557-93de-45a2-850c-62a136b8ecf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10f28ad8-1914-48c8-bc94-cc41704acbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f12a68e2-2c0d-4e3a-a4f2-dd15fd661b9e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10f28ad8-1914-48c8-bc94-cc41704acbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c381979-fc71-4e9b-b1b4-10db130f814d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8c381979-fc71-4e9b-b1b4-10db130f814d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7ca77d10-bbb6-483c-a3bf-f0dd5c124886" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_003cf459-9973-4876-a63f-6548a1ca325b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_003cf459-9973-4876-a63f-6548a1ca325b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_531fcda3-24b7-4ae8-b576-27f2f2c398a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_531fcda3-24b7-4ae8-b576-27f2f2c398a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5ac81e74-f391-423c-8844-4a0791a9a92b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5ac81e74-f391-423c-8844-4a0791a9a92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a98315db-bb04-4eb6-a65b-5211de99c3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_7af75eb2-41cb-4e82-884a-743b5bb99493" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_a98315db-bb04-4eb6-a65b-5211de99c3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="pbh-20220331.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_060a73e9-ee59-4e0c-aec2-98e1d04cdea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AccumulatedOtherComprehensiveIncomeTextBlock_73212dfd-1267-4352-a023-58373075a2bf" xlink:href="pbh-20220331.xsd#pbh_AccumulatedOtherComprehensiveIncomeTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_060a73e9-ee59-4e0c-aec2-98e1d04cdea2" xlink:to="loc_pbh_AccumulatedOtherComprehensiveIncomeTextBlock_73212dfd-1267-4352-a023-58373075a2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e417f55b-5d40-4dba-a891-039b92202c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b2a02a34-6519-4c63-9ade-18f52683a40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_e417f55b-5d40-4dba-a891-039b92202c36" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b2a02a34-6519-4c63-9ade-18f52683a40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#AccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_576e40fa-8879-45af-a129-b44ff97708aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_576e40fa-8879-45af-a129-b44ff97708aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05fb95b4-4277-4f12-893a-8ceb45951a32" xlink:to="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1a9b5e1f-b154-4893-9c73-8e33eccbd47f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_03817353-5051-4a6f-a6df-d61a2626152a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_03817353-5051-4a6f-a6df-d61a2626152a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22b9a382-4552-4367-86b8-a0ca1bc2ec20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_22b9a382-4552-4367-86b8-a0ca1bc2ec20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a6f991f-8296-4537-a4ce-4505e945b235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_750bbe0b-ed93-4103-b5ce-9d02afb51b67" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a6f991f-8296-4537-a4ce-4505e945b235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_80437407-6bbf-463a-b1ee-242453933a6b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_46971d77-d6ae-4aaa-907e-f888654d1636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_StockholdersEquity_46971d77-d6ae-4aaa-907e-f888654d1636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_6afd90ad-9dcb-4359-9b4e-cdcf561bef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_6afd90ad-9dcb-4359-9b4e-cdcf561bef5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_1c155f7e-3ac7-434e-951d-bdac7bcd376e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02f2d8be-455d-4c06-91ae-9b35a5a92154" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_1c155f7e-3ac7-434e-951d-bdac7bcd376e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e4a6062f-e5e3-4b0f-98c3-093e011e1942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_0b2f654c-9cd1-4152-a5b8-07928b227ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e4a6062f-e5e3-4b0f-98c3-093e011e1942" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_0b2f654c-9cd1-4152-a5b8-07928b227ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_76ac0cab-b160-4db6-a54c-26bffea57b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_76ac0cab-b160-4db6-a54c-26bffea57b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0482d1e9-2beb-4cd2-8142-91071749a571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0482d1e9-2beb-4cd2-8142-91071749a571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_52859dca-6ca2-4e05-9be6-13fad78d4dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_52859dca-6ca2-4e05-9be6-13fad78d4dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_52f87e85-0d6f-4288-aeae-72daa8f02ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_52f87e85-0d6f-4288-aeae-72daa8f02ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_731aa2b3-b0ee-453c-b5fa-0656fd16b558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c622fbe3-484a-4348-bae5-02350d230a05" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_731aa2b3-b0ee-453c-b5fa-0656fd16b558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesIncomeBeforeContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_327ea2e3-79e7-485c-9c68-60d8ee418dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_a130dd04-1002-4205-a696-5a9824fdc763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_327ea2e3-79e7-485c-9c68-60d8ee418dad" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_a130dd04-1002-4205-a696-5a9824fdc763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e75f6065-1d0e-4722-a830-be67248e9595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_a130dd04-1002-4205-a696-5a9824fdc763" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e75f6065-1d0e-4722-a830-be67248e9595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d3001394-eb42-4b09-986f-61b3f5d2632a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_a130dd04-1002-4205-a696-5a9824fdc763" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d3001394-eb42-4b09-986f-61b3f5d2632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f27ec4b-cba1-4971-b852-0cc27cde8ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_a130dd04-1002-4205-a696-5a9824fdc763" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f27ec4b-cba1-4971-b852-0cc27cde8ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_109a79df-4574-4b20-8200-32fe6b41fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7d5312f6-127c-4507-9d27-cdf539309e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_109a79df-4574-4b20-8200-32fe6b41fdf0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7d5312f6-127c-4507-9d27-cdf539309e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_814e0d0f-cdff-44d2-91cf-6ad6092a9ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7d5312f6-127c-4507-9d27-cdf539309e97" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_814e0d0f-cdff-44d2-91cf-6ad6092a9ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f5929fdd-9e04-4bc4-b54d-6f8fb33c6f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7d5312f6-127c-4507-9d27-cdf539309e97" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f5929fdd-9e04-4bc4-b54d-6f8fb33c6f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_53166d06-a5b7-4cf4-990d-42885c99f4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7d5312f6-127c-4507-9d27-cdf539309e97" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_53166d06-a5b7-4cf4-990d-42885c99f4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c90ed19d-fbb7-43ff-b8eb-39782c170922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_109a79df-4574-4b20-8200-32fe6b41fdf0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c90ed19d-fbb7-43ff-b8eb-39782c170922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d7a0eccf-a574-49f3-9255-02971aab2558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c90ed19d-fbb7-43ff-b8eb-39782c170922" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d7a0eccf-a574-49f3-9255-02971aab2558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_828efa03-23cd-462f-82eb-5e21ed6e77db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c90ed19d-fbb7-43ff-b8eb-39782c170922" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_828efa03-23cd-462f-82eb-5e21ed6e77db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e430eca1-44ab-4159-aea8-71ca942e3df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c90ed19d-fbb7-43ff-b8eb-39782c170922" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e430eca1-44ab-4159-aea8-71ca942e3df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4a19d780-5930-4473-89e5-d59c12349f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_109a79df-4574-4b20-8200-32fe6b41fdf0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4a19d780-5930-4473-89e5-d59c12349f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesComponentsofDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_db428596-ad15-4797-8de3-ad4e17931c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_db428596-ad15-4797-8de3-ad4e17931c30" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_2144b1d4-93b7-4e09-b9da-6e54be409b84" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns_2144b1d4-93b7-4e09-b9da-6e54be409b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryRecapitalization_29d841fa-74e8-4ab7-ac0d-ffdbfc14ec87" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryRecapitalization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_pbh_DeferredTaxAssetsInventoryRecapitalization_29d841fa-74e8-4ab7-ac0d-ffdbfc14ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsInventoryReserves_cc3045a3-27fa-4d42-a107-b1cd0fbba8b4" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsInventoryReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_pbh_DeferredTaxAssetsInventoryReserves_cc3045a3-27fa-4d42-a107-b1cd0fbba8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_74fbf8c4-acf9-40c0-b9ac-40e99694bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_74fbf8c4-acf9-40c0-b9ac-40e99694bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_d96ff92a-79a6-479d-82ad-4a897ba29c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_d96ff92a-79a6-479d-82ad-4a897ba29c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8e90e94-835d-4d02-a438-a5ec6073c57f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_c8e90e94-835d-4d02-a438-a5ec6073c57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5bb47c01-8ee9-44b1-80aa-e63940cbf240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5bb47c01-8ee9-44b1-80aa-e63940cbf240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7aee2fd5-2230-4f72-8a1f-93ffb7f9ab80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7aee2fd5-2230-4f72-8a1f-93ffb7f9ab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_6d3837dc-0067-437b-be0f-99905e49ddf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_6d3837dc-0067-437b-be0f-99905e49ddf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxAssetsLeaseLiabilities_1b1f267c-96fb-4643-9ef9-bbc64086269b" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxAssetsLeaseLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_pbh_DeferredTaxAssetsLeaseLiabilities_1b1f267c-96fb-4643-9ef9-bbc64086269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_a4f0d7d5-3abd-44a3-9d58-d0e4c0c0032b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_a4f0d7d5-3abd-44a3-9d58-d0e4c0c0032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2560b6c9-e612-4fa1-ad51-ea748d25f69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2560b6c9-e612-4fa1-ad51-ea748d25f69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4b9d0693-1a29-43e2-8330-b632e52d5a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c2ae9af5-abf0-45df-b5cd-a83b551810f1" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4b9d0693-1a29-43e2-8330-b632e52d5a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_db428596-ad15-4797-8de3-ad4e17931c30" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d67a876d-c678-4b36-bc5c-289e167b5881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d67a876d-c678-4b36-bc5c-289e167b5881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a4247f95-a2c1-4014-ba54-c880dd098a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a4247f95-a2c1-4014-ba54-c880dd098a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_b3dbc555-65b3-45a7-bf4d-12bc1bae6f42" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:to="loc_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement_b3dbc555-65b3-45a7-bf4d-12bc1bae6f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DeferredTaxLiabilityRightOfUseAsset_2792b4a3-1c32-4d03-831a-7315182a77fe" xlink:href="pbh-20220331.xsd#pbh_DeferredTaxLiabilityRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:to="loc_pbh_DeferredTaxLiabilityRightOfUseAsset_2792b4a3-1c32-4d03-831a-7315182a77fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_ac8f74bd-5eb9-4a08-b6a4-2ad77a491775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_ba999924-9864-425f-a959-53c89c73e030" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_ac8f74bd-5eb9-4a08-b6a4-2ad77a491775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_249ff523-cbc5-4f83-ab04-5689eb005348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_db428596-ad15-4797-8de3-ad4e17931c30" xlink:to="loc_us-gaap_DeferredTaxLiabilities_249ff523-cbc5-4f83-ab04-5689eb005348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8c053354-cf0e-4c84-b44e-113b178f29e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c053354-cf0e-4c84-b44e-113b178f29e3" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_55c16fb5-1932-4aca-9b3d-cf447f1cccb5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_381005c1-54df-4ec2-a157-06224fc55822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ee0f40c3-cefd-4f89-a373-7bc69b50c7e8" xlink:to="loc_us-gaap_ForeignCountryMember_381005c1-54df-4ec2-a157-06224fc55822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_aeba3568-253c-4e2c-a882-e63199a6cdf3" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8c6b2ed5-68c6-4f5b-8c58-bfa512fcc54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8c6b2ed5-68c6-4f5b-8c58-bfa512fcc54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d67a78e-4a06-463b-9ec5-d0feb9aef759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d67a78e-4a06-463b-9ec5-d0feb9aef759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_8adf566b-2b75-4b84-9e3f-d4794669c664" xlink:href="pbh-20220331.xsd#pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b164038f-7f4b-4116-8608-7a5adf79ac26" xlink:to="loc_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months_8adf566b-2b75-4b84-9e3f-d4794669c664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_d5c7242b-86d1-4769-8dc6-5e27e12bba60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_d5c7242b-86d1-4769-8dc6-5e27e12bba60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_148a7bb4-c7a4-4f3d-8442-51924b12f0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_148a7bb4-c7a4-4f3d-8442-51924b12f0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_2e897ee4-0eb0-46c4-bdc1-2fbacc6c6a3a" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_2e897ee4-0eb0-46c4-bdc1-2fbacc6c6a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_6f7a84a9-e311-4a3b-b054-e2d7792b85b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_6f7a84a9-e311-4a3b-b054-e2d7792b85b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_50383498-3172-446f-8c03-df3d19ae1166" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations_50383498-3172-446f-8c03-df3d19ae1166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5ae6e726-5874-40ea-8e9f-5ecdf784df0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5ae6e726-5874-40ea-8e9f-5ecdf784df0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_9e686c60-991f-443e-8c4c-70b7afb37b64" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition_9e686c60-991f-443e-8c4c-70b7afb37b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_68dc2d7a-a862-4834-b26a-5be641c58727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_68dc2d7a-a862-4834-b26a-5be641c58727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_a90ba009-0327-478b-8c2f-133f00abb0d4" xlink:href="pbh-20220331.xsd#pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations_a90ba009-0327-478b-8c2f-133f00abb0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_145dfe11-f576-4b68-9c39-da824d3737e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_145dfe11-f576-4b68-9c39-da824d3737e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_bd504dfd-9850-45b5-a698-c7b07502692a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_bd504dfd-9850-45b5-a698-c7b07502692a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_91b28157-776b-46ee-9e31-fd010331e032" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate_91b28157-776b-46ee-9e31-fd010331e032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ffdf84cd-1fb6-443f-b8f5-d846fa77160c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_ffdf84cd-1fb6-443f-b8f5-d846fa77160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_99114448-fdf6-46d1-a79b-51683584f60c" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations_99114448-fdf6-46d1-a79b-51683584f60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e384a774-cbac-459c-8d64-a2eb55d0915e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e384a774-cbac-459c-8d64-a2eb55d0915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_14c5bcde-f55e-496d-a670-e17b6d2cd34f" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage_14c5bcde-f55e-496d-a670-e17b6d2cd34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_da537302-21af-4baf-900b-a5e6d380337b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_da537302-21af-4baf-900b-a5e6d380337b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_96fad777-4e56-4452-9145-640d7d81452c" xlink:href="pbh-20220331.xsd#pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d1e2152-590c-4342-8e36-7f45f8ef629b" xlink:to="loc_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations_96fad777-4e56-4452-9145-640d7d81452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#IncomeTaxesUncertainTaxLiabilityActivityDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f9701291-5a14-4218-86f5-19effb3cca6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f9701291-5a14-4218-86f5-19effb3cca6a" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e5e71100-4097-43ee-a259-161c8d68ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e5e71100-4097-43ee-a259-161c8d68ef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5164dbdb-a9d5-4b2d-9649-318951e508b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5164dbdb-a9d5-4b2d-9649-318951e508b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ba076565-f7e2-4d98-85c3-63db4c3b395f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ba076565-f7e2-4d98-85c3-63db4c3b395f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_00720534-bf50-45e9-aef8-7b1173104b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_00720534-bf50-45e9-aef8-7b1173104b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ec05932d-ef26-4880-bb96-283444a2ae59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f25e5e41-e906-4ec4-98d2-f2536355071c" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ec05932d-ef26-4880-bb96-283444a2ae59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlans"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8598264-565a-4d26-89ff-67291c9840a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_472614d6-bfae-440e-9daa-ae257e8c4032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8598264-565a-4d26-89ff-67291c9840a8" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_472614d6-bfae-440e-9daa-ae257e8c4032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_62b7271d-fc3f-440d-9d57-effe5799ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_62b7271d-fc3f-440d-9d57-effe5799ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_5a90600e-024f-41e4-a8f5-95de43a46462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_5a90600e-024f-41e4-a8f5-95de43a46462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_4b26968d-7b85-45c6-9c2a-c47148518e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_4b26968d-7b85-45c6-9c2a-c47148518e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_6723394e-e7e1-4319-85a9-543a6b26987e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_6723394e-e7e1-4319-85a9-543a6b26987e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_5ea0fb9d-51ad-4950-97cf-41288adacbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_5ea0fb9d-51ad-4950-97cf-41288adacbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_70c5831f-e43f-4f90-a1a5-8037d6914e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock_70c5831f-e43f-4f90-a1a5-8037d6914e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_2c1a2c07-1a5a-4c1f-8836-93461d256a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8336b2f3-0fbb-44c6-91af-f85062e61bcf" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_2c1a2c07-1a5a-4c1f-8836-93461d256a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61792bdc-ddeb-4e09-8da4-339fb04f797d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_61792bdc-ddeb-4e09-8da4-339fb04f797d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:href="pbh-20220331.xsd#pbh_RetirementPlanContributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_RetirementPlanContributionAxis_00ab05e8-c19d-423c-8d2b-6cd3f69dc96c" xlink:to="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheOneMember_361c56ac-e50d-40b1-8c40-0e5e9318b5cc" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:to="loc_pbh_ContributionTrancheOneMember_361c56ac-e50d-40b1-8c40-0e5e9318b5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionTrancheTwoMember_e95ba532-ad19-4b93-999b-9940b7ab0d52" xlink:href="pbh-20220331.xsd#pbh_ContributionTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_RetirementPlanContributionDomain_3b4be82a-105d-4941-8705-1256187362f7" xlink:to="loc_pbh_ContributionTrancheTwoMember_e95ba532-ad19-4b93-999b-9940b7ab0d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_41d52c2d-6c5a-4ce1-bc5f-ecd0e3bf646a" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_edff5238-155f-4c2b-8550-bc11e9307f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfundedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_bd5c0a5c-9191-42ae-884c-2219b0648e28" xlink:to="loc_us-gaap_UnfundedPlanMember_edff5238-155f-4c2b-8550-bc11e9307f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_e4406687-5b78-47d0-b9ab-fa41713f919e" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_34228f26-2897-4bda-b4a1-714385d5c8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_8bae0e14-1b5c-4434-be28-56d74559dbfb" xlink:to="loc_us-gaap_QualifiedPlanMember_34228f26-2897-4bda-b4a1-714385d5c8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_706095cf-9aaa-4a6f-9d9b-50e36dbaa094" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2de60949-7526-4b85-bf91-8209a2357021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_bc9274a5-44cd-4a10-8763-cb9aa8f56961" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2de60949-7526-4b85-bf91-8209a2357021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_fc769f65-15b3-4378-9f88-4debf15cd49f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_88cb5dcc-b3bf-43f5-8798-ded489acb753" xlink:href="pbh-20220331.xsd#pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent_88cb5dcc-b3bf-43f5-8798-ded489acb753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_187c9127-19cc-47db-ba78-efddfef2a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_187c9127-19cc-47db-ba78-efddfef2a0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2c4f7782-6b0f-4307-b4c7-ce827fd2fa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2c4f7782-6b0f-4307-b4c7-ce827fd2fa4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_9d366d94-b698-4399-aa2e-68359c1297e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_9d366d94-b698-4399-aa2e-68359c1297e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_fb91cb58-c6be-4c02-a3f0-6ebd13c94fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_fb91cb58-c6be-4c02-a3f0-6ebd13c94fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f6562b8a-7b21-4b5f-aa82-8af948a06c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f6562b8a-7b21-4b5f-aa82-8af948a06c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2b7cdec3-006e-40f2-aad7-f1c54aab6034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2b7cdec3-006e-40f2-aad7-f1c54aab6034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_de11b043-22e1-4fc0-8c5a-82ad66a27996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_de11b043-22e1-4fc0-8c5a-82ad66a27996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_5b4063ed-e8c3-422d-aa4d-29780b4a695e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_5b4063ed-e8c3-422d-aa4d-29780b4a695e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate_00186369-8755-4297-9ee0-a9e6d9fe8523" xlink:href="pbh-20220331.xsd#pbh_DefinedBenefitPlanRemeasurementDiscountRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_pbh_DefinedBenefitPlanRemeasurementDiscountRate_00186369-8755-4297-9ee0-a9e6d9fe8523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a814f3c2-2c69-473a-b4c8-5236d066cd04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a814f3c2-2c69-473a-b4c8-5236d066cd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b0bbc208-f2ea-4604-9169-09a1c3aebe8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_4fe2a837-46bf-4eba-b102-f0954d97409a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_b0bbc208-f2ea-4604-9169-09a1c3aebe8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansPeriodicServiceCostsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47b37e8e-0b7c-40cd-9406-e125cad804ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47b37e8e-0b7c-40cd-9406-e125cad804ac" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4b480ecd-f697-464f-abb5-f9434b5877c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4b480ecd-f697-464f-abb5-f9434b5877c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_70043443-88df-48a2-89dd-31bfc13356e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_70043443-88df-48a2-89dd-31bfc13356e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70e16198-ed04-402c-94fe-72c299e79c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_70e16198-ed04-402c-94fe-72c299e79c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2b204719-e5f1-48dc-a473-db2b06d46a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_2b204719-e5f1-48dc-a473-db2b06d46a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9a3e972e-5d9e-4819-b921-c83bb3f0e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_044f6b29-2193-493e-8117-dc8d6b75ecec" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_9a3e972e-5d9e-4819-b921-c83bb3f0e17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47b37e8e-0b7c-40cd-9406-e125cad804ac" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b15479-cf2a-40a0-a72f-72b52b7a3e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_51b15479-cf2a-40a0-a72f-72b52b7a3e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d342459e-63e0-4635-9402-35a0c7ccef84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_d342459e-63e0-4635-9402-35a0c7ccef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_6533a7e7-afed-4dad-80fa-7b2c849db155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_6533a7e7-afed-4dad-80fa-7b2c849db155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_552e3942-a2bb-4fb5-94d8-a8f7079a0df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_552e3942-a2bb-4fb5-94d8-a8f7079a0df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4a18e56c-8f86-4b5e-b856-0beb1503e995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4422fb6-d736-4a61-a86e-d3040d43519f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4a18e56c-8f86-4b5e-b856-0beb1503e995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8ee3a201-5318-4631-af20-8b77a3ba3c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47b37e8e-0b7c-40cd-9406-e125cad804ac" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8ee3a201-5318-4631-af20-8b77a3ba3c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0a67a972-cbb9-476f-96d1-52f32ab016fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0a67a972-cbb9-476f-96d1-52f32ab016fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_9ab9324e-da94-4140-aede-62d76886a020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_9ab9324e-da94-4140-aede-62d76886a020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7c2168cd-d966-49aa-a972-8d866055f756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7c2168cd-d966-49aa-a972-8d866055f756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_5e0a00fe-b97c-4b6c-9ce9-766439b2fefc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent_5e0a00fe-b97c-4b6c-9ce9-766439b2fefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_f76fad3f-7304-41c5-8ea6-eaecb0af88c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9b969504-89a6-4328-8adb-5c201d2bda75" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_f76fad3f-7304-41c5-8ea6-eaecb0af88c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_866a4982-bb5d-434c-8928-c36cd905f52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_e80cd0fb-afb0-45a8-a266-87214d3a1dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_866a4982-bb5d-434c-8928-c36cd905f52e" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_e80cd0fb-afb0-45a8-a266-87214d3a1dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1ba05859-2d6f-4bac-9668-048819ab3b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_866a4982-bb5d-434c-8928-c36cd905f52e" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_1ba05859-2d6f-4bac-9668-048819ab3b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5615ee9-bfa1-4886-ae24-71e915842ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_866a4982-bb5d-434c-8928-c36cd905f52e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f5615ee9-bfa1-4886-ae24-71e915842ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_29a51769-1ea9-44ba-aa7a-4b944f8965cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_29a51769-1ea9-44ba-aa7a-4b944f8965cc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2db44e62-857a-4cb6-91c7-0278ff2a30ba" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8cbe6a92-e4aa-43f7-b378-1b96db5db8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e48ebf53-e4bd-4377-a2de-bae27abaa01c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8cbe6a92-e4aa-43f7-b378-1b96db5db8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3bc35467-433d-419e-a036-e2781de40c9d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_bbbe2c9c-839f-4286-afd8-254ebbc2dc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_bbbe2c9c-839f-4286-afd8-254ebbc2dc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_901123e7-a81d-465d-8c97-12ebe1d0cb15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_901123e7-a81d-465d-8c97-12ebe1d0cb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e1bcb708-ddd5-488f-818f-ea2dc60ebe02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e1bcb708-ddd5-488f-818f-ea2dc60ebe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_33e13997-d5fc-4ba2-8e62-fdb208c46fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2ecf6b01-d910-4f20-bf47-25b91042fa70" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_33e13997-d5fc-4ba2-8e62-fdb208c46fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_fc0f897e-d0d0-4518-ac51-32b2a6c971ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_fc0f897e-d0d0-4518-ac51-32b2a6c971ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95b68b40-5eae-4221-81ab-35d2660dc39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_95b68b40-5eae-4221-81ab-35d2660dc39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_81051cd6-2a7b-42d4-a728-37b7af19a901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_81051cd6-2a7b-42d4-a728-37b7af19a901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad9bc43d-4712-4ad3-b735-eccaf706cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_ad9bc43d-4712-4ad3-b735-eccaf706cb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ed0b9a48-64fe-4a1b-b465-130b6538d71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_ed0b9a48-64fe-4a1b-b465-130b6538d71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_b1c4102d-4bf3-40af-805a-17389522e979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_b1c4102d-4bf3-40af-805a-17389522e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a7917b9c-259f-44d6-81d5-09439380ad34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c403d2d-3f44-4df1-991c-254ce5004528" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_a7917b9c-259f-44d6-81d5-09439380ad34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansCategoryofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_604c2ac7-7bd9-45fd-a237-c1808f24c99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_604c2ac7-7bd9-45fd-a237-c1808f24c99c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_f8d3313d-afba-477c-8d02-9c37056cf6cf" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_659a0d50-8881-4e0c-b068-6a94cb0e36cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_659a0d50-8881-4e0c-b068-6a94cb0e36cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_1b2fd8f8-1118-4152-b6e1-159cd49604ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e3345c8b-ceb0-41e3-a528-79efe7be4244" xlink:to="loc_us-gaap_FixedIncomeFundsMember_1b2fd8f8-1118-4152-b6e1-159cd49604ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b72b5711-26e3-497b-b067-2323514be0a7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_75337c2f-a6ee-4fad-b79c-6d4ab72451dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_75337c2f-a6ee-4fad-b79c-6d4ab72451dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_b70c6c87-1bbb-415b-be49-751383a9f9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f0af7308-0acc-44a2-9026-83682a49923b" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_b70c6c87-1bbb-415b-be49-751383a9f9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9afd2aa-ad13-4e6e-9ac3-69ad6406b6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_d8fbc5e1-e43d-4d3a-8573-721ef351384e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9afd2aa-ad13-4e6e-9ac3-69ad6406b6fc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_d8fbc5e1-e43d-4d3a-8573-721ef351384e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a9a6fe17-d72a-4a61-8c8c-898ede5cfce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d9afd2aa-ad13-4e6e-9ac3-69ad6406b6fc" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a9a6fe17-d72a-4a61-8c8c-898ede5cfce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#EmployeeRetirementPlansWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37aac321-b05e-4b00-a7c0-521727a1f06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37aac321-b05e-4b00-a7c0-521727a1f06d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:to="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc37bad2-a0f6-42c2-b861-d22bc5e6808b" xlink:to="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0efa5545-07e2-4f99-b5ea-4cf643ddc283" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:to="loc_srt_MinimumMember_0efa5545-07e2-4f99-b5ea-4cf643ddc283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85442141-f115-4442-baad-ecbd06e3331b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e7cb951c-72c3-4cc9-84e9-60123c2aeae6" xlink:to="loc_srt_MaximumMember_85442141-f115-4442-baad-ecbd06e3331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_7404ce1f-6c29-4df8-9898-3abebe9a37ca" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_6496cef2-7575-43af-997e-2b360e57aa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_df5a8136-2b42-46e8-9ac7-feddc4d626c0" xlink:to="loc_us-gaap_QualifiedPlanMember_6496cef2-7575-43af-997e-2b360e57aa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_0b67d28b-1033-450e-b0b9-6c397e737da5" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_3c957339-af11-4ffb-b849-f17052101ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_3c957339-af11-4ffb-b849-f17052101ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0950cbd1-0ce5-4319-b87b-054f9bd2ad85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f6564329-2f15-4381-96a7-6554358a8708" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0950cbd1-0ce5-4319-b87b-054f9bd2ad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pbh-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0830bb6-f6ce-41ba-b065-93836320a50d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1550d3fd-e03a-4be3-920d-066920507f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0830bb6-f6ce-41ba-b065-93836320a50d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1550d3fd-e03a-4be3-920d-066920507f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96be9e86-9554-46cd-9d2c-884895b83f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_71070f27-bd45-4080-b0e1-37675c875782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_96be9e86-9554-46cd-9d2c-884895b83f2b" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_71070f27-bd45-4080-b0e1-37675c875782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#CommitmentsandContingenciesLongtermSupplyAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d45ea939-eb11-410a-b083-523fb4129b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d45ea939-eb11-410a-b083-523fb4129b44" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_5ea3e355-3b65-4565-98c4-b259b6a22f8c" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ThirdPartyManufacturingMember_68c4e0d9-738c-4e4c-bd76-4f99688894c8" xlink:href="pbh-20220331.xsd#pbh_ThirdPartyManufacturingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_6f84a6b0-10cf-42c3-acab-063e3b9d9c4d" xlink:to="loc_pbh_ThirdPartyManufacturingMember_68c4e0d9-738c-4e4c-bd76-4f99688894c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_6ad28458-aea1-4034-9883-312fdc1e55b1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2cce7fa8-4d17-4607-996c-091e67d6c032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2cce7fa8-4d17-4607-996c-091e67d6c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_b8a4ec01-4a7c-4941-929c-995247b9a346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_b8a4ec01-4a7c-4941-929c-995247b9a346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_667f33cb-5027-4feb-b523-0148ed353661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_667f33cb-5027-4feb-b523-0148ed353661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_c5754749-a9b7-4edb-b883-0d0005153c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c5754749-a9b7-4edb-b883-0d0005153c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_a51681ee-fbc7-44a2-a554-51b56d6d89d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_a51681ee-fbc7-44a2-a554-51b56d6d89d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_4008e22e-6341-4239-8a63-9da22938c56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_4008e22e-6341-4239-8a63-9da22938c56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_4125a58e-021e-466c-8e3a-e04bb9042c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_45793972-6747-41f2-8f0d-88ccc606f4a7" xlink:to="loc_us-gaap_PurchaseObligation_4125a58e-021e-466c-8e3a-e04bb9042c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConcentrationsofRisk"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_9e555e29-06ba-4fe8-b50f-8607d9f9ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_e004eb9c-3674-498d-bd72-c71ec6c91f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_9e555e29-06ba-4fe8-b50f-8607d9f9ae57" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_e004eb9c-3674-498d-bd72-c71ec6c91f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ConcentrationsofRiskDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_5955d141-9c05-47a1-bb06-f8f0f86be927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_5955d141-9c05-47a1-bb06-f8f0f86be927" xlink:to="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f8b19579-2f62-4887-bb1d-2453df81c4f9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_7d4b5ffd-68e3-426d-b345-fdfd0a508d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:to="loc_us-gaap_SalesMember_7d4b5ffd-68e3-426d-b345-fdfd0a508d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_4456df2e-9fd6-4d5e-8997-ab7241ded836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1e861a60-42ab-431e-a15d-a27e084e5055" xlink:to="loc_us-gaap_AccountsReceivableMember_4456df2e-9fd6-4d5e-8997-ab7241ded836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_946f9763-105a-43d0-a483-08569cf6d093" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_3f9e6506-5d1b-4ab0-bfac-c4f2676ff6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_3f9e6506-5d1b-4ab0-bfac-c4f2676ff6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_17cc12f1-d36e-4ade-89d9-7193845525d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_17cc12f1-d36e-4ade-89d9-7193845525d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_0779619e-595d-4924-a61d-fe10b76e9035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_eda298c6-057f-4acf-8e73-be06fa9d57af" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_0779619e-595d-4924-a61d-fe10b76e9035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_dff94cfa-32c8-42a2-a674-86c1b307d3bb" xlink:to="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_Top5BrandsMember_22460db0-7c91-4845-8654-6d2f71be7576" xlink:href="pbh-20220331.xsd#pbh_Top5BrandsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:to="loc_pbh_Top5BrandsMember_22460db0-7c91-4845-8654-6d2f71be7576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WalmartMember_fe07a370-eb9b-4c24-8e20-33f70da8d7c2" xlink:href="pbh-20220331.xsd#pbh_WalmartMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ad9b274-8e10-430b-9052-2f7c587a7a7f" xlink:to="loc_pbh_WalmartMember_fe07a370-eb9b-4c24-8e20-33f70da8d7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_68992ec2-450a-4424-a353-e5b46716a3be" xlink:to="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ManufacturesMember_d09c3e05-f568-4caa-b076-7c2c1a27d531" xlink:href="pbh-20220331.xsd#pbh_ManufacturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_40ffb9bb-6405-411f-bf1d-e559fc2b3904" xlink:to="loc_pbh_ManufacturesMember_d09c3e05-f568-4caa-b076-7c2c1a27d531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_bb879b68-af89-41ce-a035-b9c262efe064" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_cdb4cf6a-0ea5-4b56-9705-ffeaf3b3bb54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_cdb4cf6a-0ea5-4b56-9705-ffeaf3b3bb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturers_b27c62e5-948c-4842-8e89-0aa74fd7c9da" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_pbh_NumberOfThirdPartyManufacturers_b27c62e5-948c-4842-8e89-0aa74fd7c9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_578b09f3-2bcd-4984-ae13-9528239fc905" xlink:href="pbh-20220331.xsd#pbh_NumberOfThirdPartyManufacturersWithLongTermContracts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5d6e7dd4-01cd-402b-8012-5d93dcccf6ba" xlink:to="loc_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts_578b09f3-2bcd-4984-ae13-9528239fc905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegments"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5aa157d7-6fa7-428b-8b0f-d78930734801" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c605d658-bcf9-48d3-afcc-95ed3af4ce31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5aa157d7-6fa7-428b-8b0f-d78930734801" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c605d658-bcf9-48d3-afcc-95ed3af4ce31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsTables"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_536a6487-39cd-49e8-ada4-fb2b3a083be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_536a6487-39cd-49e8-ada4-fb2b3a083be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7e486d76-2d8d-4d71-8853-f4c8c062837e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_7e486d76-2d8d-4d71-8853-f4c8c062837e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_43f86f9b-818e-4307-8848-53ccc9647199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_43f86f9b-818e-4307-8848-53ccc9647199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_65737b58-9e49-4e58-9fc9-d8717d5b50ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_65737b58-9e49-4e58-9fc9-d8717d5b50ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock_de782d94-5252-43d5-88bd-d55fa39de89e" xlink:href="pbh-20220331.xsd#pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec3f8bbc-55a7-42a8-95a9-c916b23d8195" xlink:to="loc_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock_de782d94-5252-43d5-88bd-d55fa39de89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a35da865-1cf2-4926-bc47-c3b0fa7f0b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a35da865-1cf2-4926-bc47-c3b0fa7f0b3e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_857b4d81-6c57-4804-8a98-c223ba5966e3" xlink:to="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_5834264f-00dc-4125-9675-482d4fe5c9c3" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_5834264f-00dc-4125-9675-482d4fe5c9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_038eb133-7406-41c0-93d2-a1fdc08c370a" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_340888f5-e455-45f3-a35a-186e2f9c9e8d" xlink:to="loc_pbh_InternationalOTCHealthcareMember_038eb133-7406-41c0-93d2-a1fdc08c370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:to="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d6a10921-43ad-4b93-a1b2-7fc1d78f9ac7" xlink:to="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_ef286a9d-dc71-46fa-8026-71531146ddd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f74e55d4-da89-41d8-9f02-eca108790200" xlink:to="loc_us-gaap_IntersegmentEliminationMember_ef286a9d-dc71-46fa-8026-71531146ddd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b5595573-4704-4811-a197-7de0ea9913cc" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_83d8a34e-f2d8-464d-9616-8573facbaba1" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5181cff-6b51-4aa3-949a-6ebbce198392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5181cff-6b51-4aa3-949a-6ebbce198392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b9308f3c-057d-4cb1-9a23-64ba5d166836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_CostOfRevenue_b9308f3c-057d-4cb1-9a23-64ba5d166836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8ae7026b-7b4f-4ae8-aca8-967ee180b3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_GrossProfit_8ae7026b-7b4f-4ae8-aca8-967ee180b3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_ae8be21c-254c-4322-937c-eb1c126257e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_ae8be21c-254c-4322-937c-eb1c126257e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ContributionMargin_1568ac9a-51f8-459d-9af3-d47390ddaba1" xlink:href="pbh-20220331.xsd#pbh_ContributionMargin"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_pbh_ContributionMargin_1568ac9a-51f8-459d-9af3-d47390ddaba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_e26e49b5-4026-4634-8379-808e805a9de7" xlink:href="pbh-20220331.xsd#pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense_e26e49b5-4026-4634-8379-808e805a9de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9bfe90d0-8a49-4384-9362-d1222e03fb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_4499f38f-9ae4-486c-8734-e96dfd0dad3c" xlink:to="loc_us-gaap_OperatingIncomeLoss_9bfe90d0-8a49-4384-9362-d1222e03fb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsRevenuebyProductDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8df83c4b-bc56-46eb-9116-f5877c03aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8df83c4b-bc56-46eb-9116-f5877c03aa38" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_50e8967b-9eae-4c87-a5bf-c548894c026c" xlink:to="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_1ee56834-6765-4fcd-aa4b-1473df6a79f5" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_1ee56834-6765-4fcd-aa4b-1473df6a79f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_179ae533-4d76-4e9c-9fdb-359f3e1e5e1b" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_72bf8136-035d-44c0-9e37-6e964c7850e3" xlink:to="loc_pbh_InternationalOTCHealthcareMember_179ae533-4d76-4e9c-9fdb-359f3e1e5e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:to="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6422134c-33be-46d2-8fc5-8949d6f42f82" xlink:to="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_AnalgesicsMember_1f5d69a1-4935-4322-80fc-1e19ce420014" xlink:href="pbh-20220331.xsd#pbh_AnalgesicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_AnalgesicsMember_1f5d69a1-4935-4322-80fc-1e19ce420014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_CoughAndColdMember_f678a5ef-4676-4d55-8285-5c0db51bb427" xlink:href="pbh-20220331.xsd#pbh_CoughAndColdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_CoughAndColdMember_f678a5ef-4676-4d55-8285-5c0db51bb427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_WomensHealthMember_ed700e3c-bce0-403f-911e-03957a1fa227" xlink:href="pbh-20220331.xsd#pbh_WomensHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_WomensHealthMember_ed700e3c-bce0-403f-911e-03957a1fa227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_GastrointestinalMember_7b1f005a-effd-462a-becc-d0369632d706" xlink:href="pbh-20220331.xsd#pbh_GastrointestinalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_GastrointestinalMember_7b1f005a-effd-462a-becc-d0369632d706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_EyeAndEarCareMember_0c8d8dfe-d08e-4a9a-b357-35898cd33d60" xlink:href="pbh-20220331.xsd#pbh_EyeAndEarCareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_EyeAndEarCareMember_0c8d8dfe-d08e-4a9a-b357-35898cd33d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_DermatologicalsMember_a1ea95cb-ed3c-4a8d-878c-720d233081c6" xlink:href="pbh-20220331.xsd#pbh_DermatologicalsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_DermatologicalsMember_a1ea95cb-ed3c-4a8d-878c-720d233081c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OralCareMember_bf82ec02-99d8-4f68-a16d-73c9fd63492e" xlink:href="pbh-20220331.xsd#pbh_OralCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_OralCareMember_bf82ec02-99d8-4f68-a16d-73c9fd63492e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_OtherOtcMember_373b02c4-51a9-4840-89bf-f702dce428e5" xlink:href="pbh-20220331.xsd#pbh_OtherOtcMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3ad7fd6e-e9a6-406f-b0c5-d9ae9d22238c" xlink:to="loc_pbh_OtherOtcMember_373b02c4-51a9-4840-89bf-f702dce428e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_d8edec4c-531a-43a8-a7ea-1a40fbeb0c87" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1465f09-2e25-455f-8163-13f85c833584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4e3c6f74-2b07-4cfd-bf93-bb84425af1a8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1465f09-2e25-455f-8163-13f85c833584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsRevenuebyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_63dd9c37-5949-4074-b6f8-12e2c10a76c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63dd9c37-5949-4074-b6f8-12e2c10a76c4" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:to="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e195bf22-f42f-4aa5-a62e-97e37eac6717" xlink:to="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_11c6f091-c2ce-4dc5-84b8-0fff72bb2f9b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:to="loc_country_US_11c6f091-c2ce-4dc5-84b8-0fff72bb2f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_18d8da05-8ec5-4a4b-879c-5524cab38251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7e8f05e5-69fe-482d-8b27-ac9d8715e35c" xlink:to="loc_us-gaap_NonUsMember_18d8da05-8ec5-4a4b-879c-5524cab38251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_18c46624-ace9-492d-a0fd-93456c16cf1d" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_adf5559e-fae3-47d4-b3eb-13dbff5e386b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_79ee9a56-19e9-4440-b478-771500506093" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_adf5559e-fae3-47d4-b3eb-13dbff5e386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsAssetsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_14578893-b901-4396-ab8f-4a75ad55a05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_14578893-b901-4396-ab8f-4a75ad55a05c" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_86f2f6a9-7993-473a-ab12-72a07ee588c2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_IndefinitelivedTradenamesMember_d44aee5b-70b0-49d5-aa94-cd47b2bc15b5" xlink:href="pbh-20220331.xsd#pbh_IndefinitelivedTradenamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_aff67ff9-fdf0-4431-b849-6574aaa668ae" xlink:to="loc_pbh_IndefinitelivedTradenamesMember_d44aee5b-70b0-49d5-aa94-cd47b2bc15b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f3dc1606-394d-4141-b416-c138c02c8af0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_19b8334d-218f-46c6-bb11-9177e0fb9b63" xlink:href="pbh-20220331.xsd#pbh_FiniteLivedTradenamesandCustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f237bc2e-31ab-4f92-a90d-36665938bb0e" xlink:to="loc_pbh_FiniteLivedTradenamesandCustomerRelationshipsMember_19b8334d-218f-46c6-bb11-9177e0fb9b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e68d0bf5-4de9-4dcd-bf7e-beed9d805c1f" xlink:to="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_NorthAmericanOTCHealthcareMember_186483c1-643d-439e-93f9-1b29ad52d745" xlink:href="pbh-20220331.xsd#pbh_NorthAmericanOTCHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:to="loc_pbh_NorthAmericanOTCHealthcareMember_186483c1-643d-439e-93f9-1b29ad52d745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_InternationalOTCHealthcareMember_40e535c9-63a1-464a-ad14-d3bb50c12b39" xlink:href="pbh-20220331.xsd#pbh_InternationalOTCHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d83b51c-d7e4-40b9-9527-83240bf36471" xlink:to="loc_pbh_InternationalOTCHealthcareMember_40e535c9-63a1-464a-ad14-d3bb50c12b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAssetReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable_0232672a-7a01-47b8-98f1-f4d85f7f824a" xlink:to="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f2e997c1-f9d4-4a8a-ae3d-866631c19f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_Goodwill_f2e997c1-f9d4-4a8a-ae3d-866631c19f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2004b223-4a92-4df1-9e95-33dc3705be7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2004b223-4a92-4df1-9e95-33dc3705be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64b1b8af-ffa4-4778-b985-6e35ece3ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64b1b8af-ffa4-4778-b985-6e35ece3ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5430611-d0ae-4a10-ac79-3cc9e056355c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a5430611-d0ae-4a10-ac79-3cc9e056355c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f53ce99c-a9c0-465b-b436-1b282d3e1d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAssetReconcilingItemLineItems_5510ff34-93ab-4de0-b1a0-b989d698c798" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f53ce99c-a9c0-465b-b436-1b282d3e1d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0b3449e2-43ae-4f12-88da-8e5f3b702034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0b3449e2-43ae-4f12-88da-8e5f3b702034" xlink:to="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:to="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_76120278-b7c0-448c-94db-5c13da14665a" xlink:to="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b98a1f1-6630-441d-9550-c236cc7d599b" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:to="loc_country_US_8b98a1f1-6630-441d-9550-c236cc7d599b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_6d3f4db3-6f1b-458a-aced-312cfba420f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ed6dc4d5-65a7-4a09-8dd8-45ea186cb2ee" xlink:to="loc_us-gaap_NonUsMember_6d3f4db3-6f1b-458a-aced-312cfba420f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:href="pbh-20220331.xsd#pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable_2ccf98f7-150e-42bc-bcac-0362a1c5c645" xlink:to="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2b0e1e7-d647-4cae-b06a-abfd016db394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems_28fe3024-7d96-4c01-8714-2cc16e9514c0" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_b2b0e1e7-d647-4cae-b06a-abfd016db394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="pbh-20220331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_cd249d5b-523d-45b8-85af-98ff9bf29cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3da8d9d3-d8f7-4287-9340-a29e13ba6e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_cd249d5b-523d-45b8-85af-98ff9bf29cb6" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3da8d9d3-d8f7-4287-9340-a29e13ba6e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_06121d1a-3303-497d-bb65-9138f0825e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_06121d1a-3303-497d-bb65-9138f0825e4e" xlink:to="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ebea5a84-9dec-40ac-88ed-cec95ba20f16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2112b2bf-1096-43f2-93fd-424f2bc591fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_18075236-48dd-4873-8256-2141c455d160" xlink:to="loc_us-gaap_SubsequentEventMember_2112b2bf-1096-43f2-93fd-424f2bc591fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1dc8ea4a-4a4a-4dda-99a7-2401c697120f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_67157896-0720-4cbf-bafc-13b7a1224fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_PerformanceSharesMember_67157896-0720-4cbf-bafc-13b7a1224fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7d57806f-847e-45ef-9fff-f22dc99161e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7d57806f-847e-45ef-9fff-f22dc99161e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_df3648f5-6145-45b5-8882-52bf49b075d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06398506-35d0-4e13-8ec0-e8c5bfe698bc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_df3648f5-6145-45b5-8882-52bf49b075d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7aaf7602-e7c9-46be-982f-d16b946ad61b" xlink:to="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_87f2d34d-10e2-4394-8fce-7ab11309dd46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:to="loc_srt_MinimumMember_87f2d34d-10e2-4394-8fce-7ab11309dd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_80dedbb6-3ac1-4555-9d9a-24e842106e39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_221e86fc-b428-4569-8580-d56e89e1f9b8" xlink:to="loc_srt_MaximumMember_80dedbb6-3ac1-4555-9d9a-24e842106e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_afb36487-ba23-4193-aba7-189fbbbce720" xlink:to="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6d995f-a2e5-47a1-b12b-4ae8c2060c49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6d995f-a2e5-47a1-b12b-4ae8c2060c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4b94884f-bf0d-4b22-8a0e-31f57afc4356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4b94884f-bf0d-4b22-8a0e-31f57afc4356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_98aeec16-d2aa-47f2-b831-6adaf18c5f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_98aeec16-d2aa-47f2-b831-6adaf18c5f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3897d1e2-2829-4095-b490-898a35a8ed46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_3897d1e2-2829-4095-b490-898a35a8ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aeba8895-74b9-4f25-979c-ec438912e106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aeba8895-74b9-4f25-979c-ec438912e106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_9d6f3255-7c8c-40df-a4cc-4ee687bc7030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_9d6f3255-7c8c-40df-a4cc-4ee687bc7030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_a40ef6f1-bc7d-47cc-93d8-5e35f97e87ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_677f8157-9a3a-4254-b125-9cbb4a48c28d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_a40ef6f1-bc7d-47cc-93d8-5e35f97e87ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="pbh-20220331.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_b1fde1b5-6164-40a4-91f6-e76b16dd8aa9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_b41632d3-c343-4dd3-92f6-bcc485d24e60" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_b1fde1b5-6164-40a4-91f6-e76b16dd8aa9" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_b41632d3-c343-4dd3-92f6-bcc485d24e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="pbh-20220331.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_8ac5c9c7-f042-42d3-a278-162a3f5e1d3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_8ac5c9c7-f042-42d3-a278-162a3f5e1d3c" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9bc0ac24-988a-4642-b7a4-821d314803fb" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesReturnsAndAllowancesMember_aa903ad8-64e1-4c49-b866-ba8138e0aef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesReturnsAndAllowancesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_SalesReturnsAndAllowancesMember_aa903ad8-64e1-4c49-b866-ba8138e0aef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesforTradePromotionsMember_4492a343-2a2b-4513-b3de-b1b23ec82b3e" xlink:href="pbh-20220331.xsd#pbh_ReservesforTradePromotionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_pbh_ReservesforTradePromotionsMember_4492a343-2a2b-4513-b3de-b1b23ec82b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_ReservesForConsumerCouponRedemptionsMember_32b94984-22b8-487d-bfde-15db268de44c" xlink:href="pbh-20220331.xsd#pbh_ReservesForConsumerCouponRedemptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_pbh_ReservesForConsumerCouponRedemptionsMember_32b94984-22b8-487d-bfde-15db268de44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_43afedf7-29db-49dc-80fb-65b09e90d03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_43afedf7-29db-49dc-80fb-65b09e90d03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e47b943d-e07b-4397-904f-5cd95e53baf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_e07c8e40-e428-465a-94dc-a9909c9e5b5b" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_e47b943d-e07b-4397-904f-5cd95e53baf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_bbc771db-61ab-4712-a762-35027f3cd1d1" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_c4e3f265-f95e-403e-a985-73393b0aa1be" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_791128b1-f090-4717-9d3a-e7a41cb47374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_791128b1-f090-4717-9d3a-e7a41cb47374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5319fefc-2068-498f-b3b3-07a48b8e177b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5319fefc-2068-498f-b3b3-07a48b8e177b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_70261be0-9269-4926-92fb-c0d78c92f283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_70261be0-9269-4926-92fb-c0d78c92f283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther_d798e21a-b68e-44d5-add4-a10dbd89887d" xlink:href="pbh-20220331.xsd#pbh_SECSchedule1209ValuationAllowancesandReservesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_pbh_SECSchedule1209ValuationAllowancesandReservesOther_d798e21a-b68e-44d5-add4-a10dbd89887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_39177d10-8c82-4751-8e72-454a030559f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_410cbb8f-0328-457a-a96c-8f24407cea02" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_39177d10-8c82-4751-8e72-454a030559f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>pbh-20220331_g1.jpg
<TEXT>
begin 644 pbh-20220331_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-A;6%N=&AA
M+D-H:71T96YD96X   60 P "    %   $*R0!  "    %   $,"2D0 "
M S4R  "2D@ "     S4R  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **9)*D,9>5U1%Y+,< ?C6->>-/#-@I-UKVGICJHN59OR!)II-[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK,S'+$D^YI***HD**** "BBB@ HHHH **** "BBB@ HHIZ02R?ZN)V_W5)H
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MQB*JH,(H4>@&*6BBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=E**70K6^G6=HV;6T@A(Z&.)5_E5FBBH*"BBB@ HHHH **** "BBB@ HHHH
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MS.*]\Q163Q$V:*E%'EVG? ;PY;8-]=7=X?3<$'Z5U6G?#CPEIA4VVB6S.O\
M%,OF$_\ ?6173T5DZDWNRU&*V1%;VT%I%Y5K#'!'UV1H%'Y"I,4M%04%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<8I6N,UJ***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX_M*Z7CR[4@J#[MT_+->0W6N>//B?<-;VR7$EJ3S!;C9"O\ O'O^)-=?X;^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\][&CGV.I5E;!!'(.:^M-*_Y UE_U[Q_^@BII+FNC7-ZCI2I5(]&W^1\W_\
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MBLCVCI?!7@N[\9:H\$$GD6T(#3W!7.P'H .Y/I7M^@?#3PUH&R2*S^UW"_\
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M16BITZJO'0ESG!ZGVK17AOPS^+TBSQ:+XLGWQMA+>^<\J>RO[>_;OZCW$$$
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MQ!8W"KKL4.IVY/S$((I!]"O'YC\:I>+O@WK7AC39=1M[F+4K.$9D:-2CHO\
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M# ]JEHH ^3_B%X0?P;XKFLDW-9R_O;60]T/8^X/'Z]Z^F_"__(HZ1_UY0_\
MH KC_C1X;&L^"VOH8]USIS>:I'4H>&']?PKL?#''A/2<\'[%#_Z *Z*D^>"N
M91CRR9J5S_CQ0W@#7 1D?8I/_0:Z"L#QU_R(.M_]>4G_ *#6,?B1H]CY%KU?
M]G]0?%^HG'(LN#_P-:\HKUC]G[_D;M2_Z\O_ &=:]&M_#9R4_C1] T445YAV
M!1110!Y3^T H/@_3R1R+T8/_  !J^?*^A/C_ /\ (FV'_7Z/_0&KY[KT</\
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M'_7I'_Z#7RM7U3X/_P"1+TC_ *](_P#T&MZ'Q'BYY_#AZFS11176?*A1110
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M/^WN/^35Z!7G_P :/^1 _P"WN/\ DU54^!F.!_WJGZH^?:***X#[X]]^"/\
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MS!?OQGAXSZ,O;^5;-<[33LS8*P/'7_(@ZW_UY2?^@UOU@>.O^1!UO_KRD_\
M0:<=T)['R+7K'[/W_(W:E_UY?^SK7D]>L?L_?\C=J7_7E_[.M>C6_ALY*?QH
M^@:***\P[ HHHH \J^/_ /R)MA_U^C_T!J^>Z^A/C_\ \B;8?]?H_P#0&KY[
MKT</\!R5?B/H[X$?\D\D_P"OV3^2UZ77FGP(_P"2>2?]?LG\EKTNN*K\;.F'
MPH****S*/D#QE_R/&M_]?TW_ *&:E\"_\C[HO_7Y'_.HO&7_ "/&M_\ 7]-_
MZ&:E\"_\C[HO_7Y'_.O5^Q\CB^V?75%%%>4=H4444 <_X\_Y)[K_ /V#YO\
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M_P"@[)_WY%<-J'<ZKU.QT?\ PO'P=_STO?\ P'_^O1_PO'P=_P ]+W_P'_\
MKUSG_#/4/_0=D_[\BC_AGJ'_ *#LG_?D46H=QWJ=CH)OCIX1CA9HOMTK@<((
M ,GZDUX9XS\4S>+_ !+/JD\?E*P"QQ9SL4=!7J?_  SU#_T'9/\ OR*/^&>H
M?^@[)_WY%7"5&#NF1)5)*S/#J]P_9ZN6-MK%M_"'23\<$4O_  SU!_T'9/\
MOR*[/X?_  [3P*]XR7[7?VH*#N3;MQ15JPE!I!"G*,KL[6N7^)7_ "3;6_\
MKW_J*ZBN7^)7_)-M;_Z]_P"HKDA\2-WL?)U>O?L]_P#(PZM_UZK_ .ABO(:]
M>_9[_P"1AU;_ *]5_P#0Q7HUOX;.2G\:/>Z***\P[ HHHH **** "BBB@#Y;
M\<_\C[K?_7[)_P"A5@UO>.?^1]UO_K]D_P#0JP:\T_1*'\&/HOR"OJGP?_R)
M>D?]>D?_ *#7RM7U3X/_ .1+TC_KTC_]!K>A\1XN>?PX>ILT445UGRH4444
M%%%% !1110 5\[?&'_DHUU_UQB_] %?1-?.WQA_Y*-=?]<8O_0!6%?X3VLE_
MWE^C_0X:GP?\?$?^^/YTRGP?\?$?^^/YUR'U[V/K^BBBO2/S8**** "N;^(-
MB=1\!:K ,EA 9% '4K\P_E725'-&LT,D3_==2I^A&*4E=6+IS=.:FNC/D&BM
M/Q'I$FA>(KW3I5P892%]U['\JS*\X_18R4HJ2V9O>!]471_'&E7DC!(UN DC
M'HJO\I/X!B:^I,U\>@X/%?3'P]\4)XG\*P2R2;KRW417 )R=P_B_$<_G710E
MK8^=SN@WRUEZ/]#JJ***ZCYD**** "BH+R[@L+.6ZNY5BAB4L[L<  5YSX2^
M(>J^*?B#<65G!&VCA6?++AHU48#9]R1P?6IE-)I'12P]2K"4X[1W/3&.U2?0
M9K&\,^)K7Q18S7%JC1&"9H9(V.2I!_K6Q)_JV^AKP#X>>*5\/>/KFWNY-EE?
MS-%(3T1]QVM^?!^OM43GRR1OAL+[>E4:WC9K]3Z!HI*6M3@,/6O!N@:_N;4M
M,A>5NLR+LD_[Z')_&O-?$?P2>-'G\-79EQDBWN.#] W^->S45G*G&1V4,=7H
M?!+3MT/D.\L[C3[R2UO87@GB.UXW&"#4->Z?&KP];W/A^/6T0+=6CK&[CJ\;
M'&#]"<_G7A=<<X\KL?98/%+%454M;N%>U_ O4Y9M+U+3G8E+:1)$R?N[\Y'Y
MKG\:\4KU;X$PNVL:M,/N+ BGZECC^1JJ?QHQS2*EA)7Z6_,]LKS_ .-'_(@?
M]O<?\FKT"O/_ (T?\B!_V]Q_R:NNI\#/D\#_ +U3]4?/M%%%<!]\>^_!'_D1
M)_\ K_D_] 2O1:\X^"$BMX(N4!&Y;Y\CTRB8KT>NZG\"/@LP_P!ZGZA1116A
MQ'G7QN_Y$2#_ *_X_P#T!Z\"KWWXW?\ (B0?]?\ '_Z ]>!5Q5OC/LLG_P!U
M^;"OH+X+_P#(@?\ ;W)_):^?:^@O@O\ \B!_V]R?R6BC\8LY_P!U^:/0*\B^
M.VG%K72]251B-GA<]^<$?R/YUZ[7/>.="_X2+PA>V2C,VSS(O]]>17545XM'
MS6!K*CB(S>Q\O44K*R.5<893@@]C25P'WQZC\#-1$/B'4=/8J!<VXD7/4LC=
M!^#D_A7N-?*OA/6V\.^*;'4U^[#)^\ [H>&'Y$U]2VUQ%=VL=Q;N'BE4,C+T
M(-==&6ECY#.J+A753I)?BB6BBBMSQ KQ_P".NIKY>F:8I!;+3N.X'0?U_*O6
M[BXBM+:2XN9%CAB4N[L<!0.IKY@\:>(V\4^*KK4?F$)/EP*?X8QT_/D_C6%:
M5HV/9R>@ZF(]ITC^9@T445R'V)]&_"/_ ))KI_\ OS?^C&KM:XKX1_\ )-=/
M_P!^;_T8U=K7H0^%'Y_C/]YJ>K_,^6O&MB=.\:ZK;GG%PS ^H)S_ %K"KU#X
MVZ&UKKUMJ\:_NKM/+<@='7_$?R->7UPR5I-'VV#JJKAX378*^GOA_J0U7P'I
M4X(+) (7QV*?+S^0/XU\PUZQ\%?%"VUU/H%U)M6<^;;Y/\>.1^('Z5=*5I'#
MF]!U</S+>.I[51117:?&A1110 44E>8^/OB;<:3K5MI7AHQS7*2C[067<">@
MC_QQ4RDHJ[-\/AZF(GR0/3Z*AM7F>TA:Y0),R*9$4Y"MCD?G4U48;".JNA1U
M#*PP01D$5\A>,=!?PUXOU#2V!V0RDQ$_Q1GE3^1%?7U>1_'/PBVH:7%XALT+
M36:^7< #K'G@_@3^M=%"?+*SZF56-XG@5>O_   UH6^M:CH\C8%U&)HP?[R9
MR/R/Z5Y!6IX;UN7P[XCLM4@SNMY0Q']Y>X_*NVI'FBT<T'RRN?8M%5M.OX-4
MTVWOK1P\-Q&)$8>A%6:\H[@HHHH **** "BBB@ HHKS&_P#$2ZG\?]&TJW?=
M#IL$X?'3S7B8M^0"C\ZJ,7(3=CTZO$OVAK7#:)=CN)8S^&T_U->VUYS\;](.
MI?#Y[J-,R:?.DV>^P_*W_H0/X5=%VFB9J\6?-E>I? .;9XVNX?\ GI9L?R8?
MXUY;7:?"74AIOQ*TPNVU+@M;L?7<.!_WUBN^HKP9RP=I(^I:***\L[0HHHH
M***KW]TMEI]Q=2-M2&)I"Q[8&: /DOQM<?:O'.L3$EMUV_)]CC^E853WMRU[
MJ%Q=/]Z:5I#]2<U%&C22*B LS$  =S7KK16.!ZL^G_@];-;?#/3B_P#RV+R#
MZ%B/Z5W%9?AK2QHOAG3M. P;:W1&_P!['S?KFM2O*D[R;.Y:*QX7^T/_ ,A'
M0O\ KE-_-:\:KV7]H?\ Y".A?]<IOYK7C5>C1_AHY*GQL^J?A3_R2_1O^N3?
M^AM785Q_PI_Y)?HW_7)O_0VKL*\^?Q,ZX[(****@85YK\=_^2=)_U_1_^@M7
MI5>:_'?_ ))TG_7]'_Z"U:4OC1$_A9\X5]!_ #_D4-0_Z_/_ &45\^5]!_ #
M_D4-0_Z_/_917;B/@.>E\1ZM117,_$#7[CPSX3?4[1@KQ7$(;*@Y0N P_(FO
M/2N[(ZF[*YTU0W5G;7ULUO>P1W$+C#1RH&5OJ#3K>=+FUBGB.4E0.I]B,U)2
M&>>:W\%?"NJ[GLXI=-E/>W;*_P#?)_IBO/-<^ ^N60:31[J#4$'(0_NW_7@U
M]#45M&M./4ATXL^,]4T?4=%NC;:M936DH_AE0C/T/?\ "J5?9.M:%IOB'3GL
MM8LX[J!NSCE3ZJ>H/N*^8_B)X)D\$^(?LR.TME.-]M(W4CN#[BNNE64]'N<\
MZ;CJC$T'7M0\-ZO%J.E3M%-&>1GAQW4CN#7U9X1\2VWBSPS;:K:_+Y@VRQYY
MC<?>7_/8BOD&O:_V>]3??J^EL28\)<*/0_=/Y\?E4XB"<>8=*5G8]NK \=?\
MB#K?_7E)_P"@UOU@>.O^1!UO_KRD_P#0:XH[HZ7L?(M>L?L_?\C=J7_7E_[.
MM>3UZO\ L_L!XPU%>YL21_WVO^->C6_ALY*?QH^@J***\P[ HHHH \J^/_\
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MPK_Q&:TO@"BBBL#0*\?_ &A/^0#I'_7R_P#Z#7L%>/\ [0G_ " =(_Z^7_\
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MY9*S"BBBF2%%%% !112$@ DG '4T +7S?\5[E+KXC7YCZ1A(S]0H!KV'Q/\
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M\$[OQ[5U'P_^%MUJ]S#J6OPM!IZ$,L+C#3^V.RUU/QM18_"-@D:A46Y 50,
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MS3/$>CZQ"LNFZE;7"MTVR#/Y=:TR<#)KCV.D**Q]5\5Z%HL)EU+5+:$#/'F
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M\B&TA>WLX89)FG>.-4:5_O2$#!8^YZU-116IP/4**** "BBB@#F?$7P_\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX,_Y^+O_ ,!FH_X7?X,_Y^+O_P !FH]G/L'/'N>AT5YY_P +O\&?\_%W_P"
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M10 4451UG5K70M'N-3U!F6VMEW2%%W$#..GXT;@7J*\\_P"%W^#/^?B[_P#
M9J/^%W^#/^?B[_\  9JT]G/L1SQ[GH=%>>?\+O\ !G_/Q=_^ S4?\+O\&?\
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MZV&&1]D<\_2M(2:DK$R2:/D>O2_@SX+L/%&KWEWK$ N+6Q5<0L?E=VSC/J,
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M&^W3RF'OE<5U%%8<S74ULCYB^)'PVF\%7"W-G(]SI<S821Q\T9_NMC^=>C_
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M%&  .E.KS6[NYUI65@HHHI#"BBB@#)\4:+'XB\+ZAI<H'^DP,J$_POC*G\&
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M:76=2C,=W?J!'&PP8XNHS[D\X],5Z%:2C!G)33<CU&BBBO-.P**** "BBB@
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MD=OJ6)K1\#)YGCS15QG_ $R,X'LV:RM20QZK=HXPRS."/0[C6MX%D\KQ]HK
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M )'C6/\ K[?^==6&^)F%;8Z/X*?\E0L_^N,W_H!KZ:KYE^"G_)4+/_KC-_Z
M:^FJG$?&52^$****YS4**** /CSQ5_R-^K?]?DO_ *$:ZWX(?\E+@_Z]Y?\
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M._7),AC@SSMSV'T4 5K3TO/L1+7W3='P+\(;1G[>3W_T@?X4O_"B_!_I?_\
M@0/\*]'%%+VL^X<D>QYQ_P *+\'^E_\ ^! _PIK_  +\(E&V?;@V#@FX[_E7
MI-%'M9]PY(]CXTUG2YM%UJ[TZY!$EM*T9SWP>#^5=U\$_$@T?QH-.G?;;ZFO
ME#/02#[GY\C\16I\>?#GV/6K778$Q%>+Y4I X$BCC\Q_(UY/!/);7$<\#E)8
MG#HRG!4@Y!%=ZM5IG,_<F?:M%8WA+7H_$OA>QU2,C=-$/, _A<<,/SK9KS6F
MG9G8%%%%( HHHH **** /-OCM_R3E?\ K]C_ )-7S?7TA\=O^2<K_P!?L?\
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MNO,T^U++!$%&%VMMSGJ>AKK?&GB%/#'A&_U-R/,CC*PJ?XI#PH_/GZ UX]\
MG:3Q;J3N2S-;9)/<[JVA&\)2,Y2]Y(]_HHHK$T"BBB@ HHHH *\Z^-'B,Z/X
M+;3[9\76J-Y("GD1_P ?YCC\37HM>+2'_A/OCTD3?O-.T/YBIY4E#T_%\<>@
M-:TU[UWT(D]+&GHGP-\/OH=F^L?;/MS1*TX2;: QY(QCMTJ__P *+\'^E_\
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M;>#O^A?L_P#OD_XT44<\NX60?\*V\'?]"_9_]\G_ !H_X5MX._Z%^S_[Y/\
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@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>pbh-20220331_g2.jpg
<TEXT>
begin 644 pbh-20220331_g2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" -D!=P# 2(  A$! Q$!_\0
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M_P"&3O@A_P!$;^'_ /X2]C_\:H_X9.^"'_1&_A__ .$O8_\ QJO5:* /*O\
MAD[X(?\ 1&_A_P#^$O8__&J/^&3O@A_T1OX?_P#A+V/_ ,:KU6B@#RK_ (9.
M^"'_ $1OX?\ _A+V/_QJC_AD[X(?]$;^'_\ X2]C_P#&J]5HH \J_P"&3O@A
M_P!$;^'_ /X2]C_\:H_X9.^"'_1&_A__ .$O8_\ QJO5:* /*O\ AD[X(?\
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M_P#&J]5HH \J_P"&3O@A_P!$;^'_ /X2]C_\:H_X9.^"'_1&_A__ .$O8_\
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M_P#^$O8__&J/^&3O@A_T1OX?_P#A+V/_ ,:KU6B@#RK_ (9.^"'_ $1OX?\
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MX;\-?$'PUK^OQJS'3M-U6">8A1EB%1CNV]\9QWKT"@#RK_AD[X(?]$;^'_\
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M4?\ #)WP0_Z(W\/_ /PE['_XU7JM% 'E7_#)WP0_Z(W\/_\ PE['_P"-4?\
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MV/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\
M\:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_
MX9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^
M"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1
M&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A_
M_P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$
MO8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__
M !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO
M5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:*
M/*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^
M&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@
MA_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1
MOX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_
M /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+
MV/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\
M\:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_
MX9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^
M"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1
M&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A_
M_P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$
MO8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__
M !JO5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO
M5:* /*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:*
M/*O^&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^
M&3O@A_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@
MA_T1OX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1
MOX?_ /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_
M /A+V/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+
MV/\ \:H_X9.^"'_1&_A__P"$O8__ !JO5:* /*O^&3O@A_T1OX?_ /A+V/\
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M\WOVIOAKX:^"/_!4;X$VW@31K/PK8ZI=:!=SV>E0K;P!Y-3EMI-L: *H:.,
M@  Y8]S4W_!5CPS:>-/VY/@YX>U R+8:MI>FV%P86"N(Y=3N$;:2#@X8X.*
M/LO3?^"GG[.NJ>.%\,Q^.&CE><6T>IS6$Z6+R%MH_?%<!<_QL F.=V.:]Z^*
M'Q>\'?!?P=-XJ\:^(+3P_H$;*GVRX+-O=@2J(J@M(Q )"J"2 3C@U^>G_!5#
M]ECX5?"W]F/0=<\'>#M(\*:KI6L6UA'<:;;K%+=0R12ADF?[TS916WN6;Y3S
MR:] _P"%L?"[0_\ @G1\'O$7Q^T>3Q=8I;VGV#2&3SI[VZB22.$A2Z*V(0Q8
MR';@G.20" =YH?\ P5<_9TUO7(]-;Q3J&G+))Y:7U]I4\=N3G )8*2H/7+
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MB_\ H^*@#\]OV0?V*?&7[57P+F\>6_QO\2>'-5%]<65O9,TTT.^(*59I!.K
M$MS@''OTKVW_ (),_M*?$/Q]XC\<_#+QWK=WXH70;<7=GJ.H3&XGA*S>5)$T
MS9:1264KN)(VD#C 'R;\$?AO^T<W[&?B/QS\-OB%-IO@/3Y[PW_AO3[N2"\*
MHJFXFCVI@_*<G#@X4XYX/VM_P1UL_AE)\%-<O_"=G=P>.?M,5MXG?4)EED)
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MN[KPOI<TTTC%F=VM(BS$GJ2230!Z%1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^
M*W_!:O\ Y.F\+?\ 8F6O_I=?5^U-?BM_P6K_ .3IO"W_ &)EK_Z77U 'ZJ?L
MG?\ )K/P;_[$S1O_ $AAKU6O*OV3O^36?@W_ -B9HW_I##7JM !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>??'KX)>'OVB/A5KG@3Q,CC3M3C&VXAQYM
MK,I#1S1D]&5@#Z$9!X)KT&B@#\I_"/[#W[8W[,=QJ6D?"#XE:3/X8N9FDC3[
M0BJ<\>8UO<PND4A&,^6S=!\QP,?0'PR_89\<^*O@C\4?#7QY^(<GB[Q%X\%L
MPN+>22XCTA[?>T#Q%P@)#L"R*J+A-H."37VQ10!^6_@G]DW]MSX(>#[WX:^
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M\&_^Q,T;_P!(8:]5KRK]D[_DUGX-_P#8F:-_Z0PUZK0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7XK?\
M%J_^3IO"W_8F6O\ Z77U?M37XK?\%J_^3IO"W_8F6O\ Z77U 'ZJ?LG?\FL_
M!O\ [$S1O_2&&O5:\J_9._Y-9^#?_8F:-_Z0PUZK0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7XK?\%J
M_P#DZ;PM_P!B9:_^EU]7[4U^*W_!:O\ Y.F\+?\ 8F6O_I=?4 ?JI^R=_P F
ML_!O_L3-&_\ 2&&O5:\J_9._Y-9^#?\ V)FC?^D,->JT %%%% !1110 4444
M %%%% !1110 4444 %%00WUM<74]M%<127-OM,T*."\>X97<.HR <9ZXJ>@
MHHHH **R?%/B[0O VAW&M>)-:T_P_H]OM$VH:I=1VUO%N8*NZ1R%&6( R>20
M*R? _P 6O _Q,:Y'@_QGX?\ %9ML&<:'JD%YY6>F[RG;;^- '64444 %%%%
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M)VBXU*ZCMX\^FYR!F@#6HJAH>OZ9XFT^._T?4K35;"3[EU8SK-$WT920:OT
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MT-%%% !1110 4444 %%%% !1110 4444 %%%% !7XK?\%J_^3IO"W_8F6O\
MZ77U?M37XK?\%J_^3IO"W_8F6O\ Z77U 'ZJ?LG?\FL_!O\ [$S1O_2&&O5:
M\J_9._Y-9^#?_8F:-_Z0PUZK0 45YE\3/C]X:^&NH6NGW%U#=ZD]Q%'<VJ.^
MZVA;[TK;4;E00=G!(/%=-KGQ-\+>&_#MKKNHZW:V^E7:A[>?)?S@1GY%4%FX
M]!Q0!T]%<MX5^*'A7QII-YJ6CZW;75G9 M<R-NB,"@$[G5P&5< \D8.#Z5G^
M&/C=X'\9:W_9&C^((+O43G;"8Y(_,QU"%U 8X!/RD\#- '<T5Q'BSXU>"O V
MK#2];UZ&SO\  +0+%)*R9 (W;%.W((/..#FNOL;^VU2R@O+.>.ZM9T$D4T+!
MD=2,@@CJ* +%%%% &?XAUZQ\*^']3UK4YOLVFZ;:RWEU-M+>7%&A=VP.3A5)
MP*^(KC_@L=\%(;B2-/#OCF=%8J)8]/LPK@'[PW70.#[@'VK[JEB2>)XI462-
MP59&&0P/!!'<5YFW[+?P8D8LWPB\",S')8^&K(DG_OU7K8&I@*:E]=IREVL[
M$24OLL^7O^'R7P7_ .A8\>?^"^R_^2ZH:S_P5J\&^-K6/P]\.]#UC3O%^JRI
M9V-_XNBMK;3;1G./.E:.=V;;U" ?,<#(S7U?_P ,L_!?_HD/@/\ \)FR_P#C
M507O[)OP3U"SGM9?A'X(6.:-HV:'P]:1. 1@E72,,IYX92".H(->O'%9'&2?
MU>?_ (%<R<:K5E(^2;CP#JGP(AF^)_AKQ5(_CNQ62]\0:IX@N2MMXCC/S2Q7
M0SMC''[IE_U6% R,UL6O_!93X.O:PM<^%/'$5R44RQQ6=G(BMCD*QNE+ 'H2
M!GT'2O0_"?[#LZ^+(K'QSXK/C7X7:'()M!\-WT6Z2=NJ+J+GBX2'HB]'X+CC
M!]B_X99^"_\ T2'P'_X3-E_\:KOQN8936DO;P=1I;Q]W3M\OPV1Q82CB:46J
MDKZGR_\ \/DO@O\ ]"QX\_\ !?9?_)=7M"_X*_\ P2UK6+.QETCQEI4=Q((S
M>7FGVQAAS_$_EW+OC_=4GVKZ2_X99^"__1(? ?\ X3-E_P#&JFL?V9_@_IMY
M!=V?PI\$6EW XDBG@\.6:/&X.0RL(\@@]Q7F2Q&1V=J$_P#P)'?:IW/+?^"D
M$T%M^R1XGFNBJVL=_I3RM(,J$&H6Y8GVQFO+;'Q!\,_C#^U=\(-8^ &E6MS)
MH,M\_BKQ)X>TLV=A'I[VQ5+:XE\M5E=Y"I1/F*X)^7K7TC^U9\(=8^.?P5U3
MPAH-S8VFI75Y8W"2ZC(Z0A8;N*9P2B.<E8R!QU(Z=:]=KY8V/EW]G_XT?&SX
MW>*-7U"32/!.C_#_ $/Q-J>AW4SFZ?4;^*WFD19(%#E(BN(U;S-V\AR @P*\
MLU?_ (*&:GJ>D^(O&'AWQ9\)-/T#3)Y_L/@_Q!JTBZ]JL$#LKMYBRA+>24(3
M%&8I/O+N(S7TQ^S3\(=8^#?A#Q-I6MW-C=3ZGXHU76XFL)'=%@NKAI8U8NBD
M.%.& ! /0GK7FO@'X&?&#X'Z7?\ @OP._P /=8\%?;KBXT;4O$:W:7^EPSRM
M*8'@B0I<B,N0I\Z(L, [>P OQ%_:JUZ7Q3\-]&\)W?A3P78^,?#R^(+?Q#X^
M2=K65GV;+")8Y(E,^'#',OW>BFN)^.UK\7+C]JK]G IJW@JRUV2PUK[/G3+N
MYM8;D647VLN?M$;21MQY8&PK_$7KV[XU>#OB?XPL?[ TW0OAIXT\+7>FK#>V
MOC%;J B\!(:41QQS(\>-I$?R,I!_>'@CS>\_9/\ 'W@/P7\!V\ >(="UCQC\
M,([JUW>*OM$5E?6]U"8Y5#1"21-F$$8P?E4 GC! .\\3>,;K1_VIOA'X9U#0
M_#>H:EJGAS5I[G7_ .SB+VWDA%ON2UD+DQ0NSL60[B0%YXR?'?&7[5/QKG^$
MK?%OPO;_  _TOP/+KXTB#2M9M+V\U,0_;_L/G%HYXD:4R#=Y 4$+QO+#%>U^
M*OA=XEOOC=\-OB;J%QIIMO"OAO5+35[:R\TRRW-PD!S;1E3N3=$_WF#<KUYK
MX(^'&AV_@GX%6?QTDO\ X7>*DTVZN->CTGQ%?ZB+^YN/-=U:5%O9+0:DRD
M6Q(<J-W&2 ?67Q9_:\U+PM\5;CX<V/C+X:>#-4T'3;:YUS7/'$TD<%Q=31[U
M@L[5;B-R  '9VE.T2*,,>3ZE^RM\>W_:$^&]YK5S%IB:II6JW.BWTVAW?VK3
MKF6$K^_M93RT,BNC+GD9(.<9/%WWPJ^(5K\3[GXM?#NS\-N_C31[!?$'A/QJ
MT]L8+B&,^5+'<0QRE7".(W0QX.P'=T ]P^&]CXIL/"\2>,I]%EUQY'DDC\/V
MTD-I I/RQ+YC%G*CK(0NX\[5Z4 ?-]KX7TKX_?MT>/['QQ80Z]H?PUT?2TT+
M1-2B66S6YO4>6:\\I@5=P$5 S [<<<@&O5?B-<?#_P#9-^'7CGXEZ7X-TW3)
M8[2)[R'1+.*TDU*56*6T;%% +&2;:&() ?O@"N>^+7P-\>6OQAA^+'P@UK0=
M/\57&G)H^MZ+XHCG.FZK;))OBD,D.7BFCRP#!6R& . "&9KGP9^)_P >/A+X
M[\'_ !>UOPKI4>NVL=OIL/@RUN)5TZ6-_,2X>:X96F;>L9V!(P F <G=0!R7
MB#X\?'?X)V?AOQ?\5- \"/X$U34K73]1M/#<MVNHZ']I<)%)))*S17"HS*K[
M%3).5R.1/+\:OCS\0/BQ\5_!WPZT7P':V?@O4K>WBU?Q.UV1<++9QS"#R87R
M7WLQ,N54*5 1SDB+7O@3\=OCA:^'/"GQ8UWP);>!=,U&VU#49/"T5V]_K9MG
M#Q1NLRB.W5F56?87.1@8'7U7X0_"'6/ 'Q4^,?B74+FQFL/&6KVM_I\=K([2
MQ1Q6<<#"4,@ ;<A(VEAC'(/% 'F&I?MD:Q<?LE>%OBKI^@:?IFK:SJ,>CWIU
M665]-T67[3);375P\8W&WC>(GJO#+\PZUM>+/C;\0OA[\$8?%U_J7@3Q;=WG
MB/2]/L-2\-17']GW%E=7<$#N4,[D2+YDF"LK+PI(ZK4GPE^#_P 4O@?^SGH'
M@WP^?!FL>)+/4[Z:_@UB:Z%A<VEQ=7$VQ)4CWI)B6/EHG7AA@\-7"VW[$OB*
M\^%7Q/T[^T/#O@SQ'XLURQ\0Z=I/AB*4Z)I-S9M$T04,J,WFM$#*ZHF21A>.
M0#VOXI?%[6/ _P </@WX-L;:QETOQE=:G!J$UQ&[31+;6;3QF(APJDL,'<K<
M=,'FO++[XX?'GQQ\3?B_X4^'.@^!8[;P/?0PP:GXC:[8W8DLXYEM_*A<'S"[
M,3*650I4!&.2+=G\%_CAXZ^-WPJ\?_$35_ UM:>#KB_,FB>&!=E66XLWA\Y9
MIDW.Y=D^0A%503N<GCT?X1_"'6? /Q2^,GB74+FQFL?&6K6M_I\=M([2Q1Q6
M<<#"4,@"MN0D;2PQCD'B@#Y]7]LCXSW7P,TKX['P-X1TKX:0^2VIZ-<:A<3Z
MQ<0F8037$$B!8H@LA.V-U=BJDD@D"NQ^-'[84GA_XQ:A\/O#_B[X=^!GT6Q@
MN]3UCXA73[9I9T+Q6]M;QS1,Q";6>0O@>8H"DT^Z_92\6S_L"O\  ]=1T4>+
M&L3;"\,\WV'=]M\_._RM^-O'^KZ^W-=#XH^"'C[PC\:-8^(?PW;PIJR^)=/M
M+/7= \6//;QF>U5DANH+B&.4@E&",ACP0H.[H  <#>_MP>(KK]E'5?B/H.B>
M']9\6:+XG@\,W-I97K3Z5J$ANX8FDM9P5(CDCF5D9L["WS!@O/T;\(V^)LFD
M7LGQ.7PK'J4DX>SA\*BY\N&$J#Y<K3$[W5LC>H4$<[1TKS;XN?!7XA?%[X!1
M>%M5U#PO%XK?7-/U23^SXI[;3X(8+V*<PH2)'=@D9 <JNYC]U!T^A: /C+XA
M?%:W^$O[?^J:A<>&/%7BA;KX=6L M_">BS:G/'_Q,)6WND8RJ<8W'N0*S/"G
MQXTGQ'^VMXF\;7GA[Q1X3TK0OA3)-=0>*=&ETVZ,<-^TKR)%)@LFTD!NA*L.
MU?0=C\(=8MOVKM4^)S7-B=!NO"$/A]+<2/\ :A<)=O,6*[-NS:P&=V<]N]9/
MBS]GNZ\:?M$:WXOU2:RE\':O\/Y/!US9K(XNVDDNGD=MNS9L\M\9W9S_  XY
MH ^=X_\ @HEK%GX?TOQS>>)?A/>:%>74#3> M-U9Y/$EK9S.J@^=YICDN(PX
M9X1"HPK /D5](_&GQA\3O#^J;_#.M?#7PGX?%MF&_P#&TUS)+>W)!/E+'')"
ML2#CY]\A.?N#'/(?"WX6_'3X:^'?#_@<7GPYU'0-$$-E!XLN(+MM2ELHL!=]
MD%$?G; %W_:,9^8ANAQ?BU^RAXC\4_'KQ%XYM/#WPW^(&GZ]I]G91P_$:UFN
M6T$P@JQM85B=)4?<9"I:)BW&\ YH Y#Q#\9O^&@?#G[)/CIK"/3+C4O'I2XM
M(9?-CCFAM[V&38^!N0O&Q!]"*T-=L?B?)_P48O1HFM^$K:0^ 4>!M0T:ZF"Z
M=_:3?NV"729GWY/F A,$#R\C)U/AW^Q[XO\ !GPT^ WAJXU/0);GP!XPN]?U
M&2U::.&:VD>\*+;KY?#XN(_D;"C# ,< GO/BI\(/B.O[0VA?%+X;7GA9K@Z
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M+'CSQO:_"'2_ MMX5\'ZH^A7%WXPDO&GU2^B1'G6'R,"!$+^7N82989QU ]
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MJEE;ZEIUU&8KBTNXEEBF0\%71@0P/H17'3<%-.HKQOK;L/T/AO\ X?)?!?\
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MW\96GP\T*W^($NEW/C&"W$6HW.BR.]K<2+D>:F^-""X 8KM 4L0,@ GK* /
M_P!I+]M3X?\ [+NK:5I7BF#6=1U/48#=1VFC6L<K)#N*AW,DD:@%E8  D\=,
M5XU_P]X^#O\ T+7CC_P L_\ Y+KZZ\9?"_P;\1&MF\5^$="\3M:AA =9TV&[
M,0.,[/,4[<X&<>E<W_PS'\'?^B3^!_\ PG+/_P"-US2C6;]V2L<DXUW+W))+
MT)/@'\?/"_[1W@(>+?"1O%T\7+V<T&H0B*:&955F1@&92=KH<JQ'/6OC_P"
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MQH/@2TE@2.:2XBDCED<PQB?*HV7V1E?E4*V"U 'DOP[_ .3?_P!A7_L9X/\
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MW@/2?AG#XCT'1;VW1[:&:[N?*\QH.4#I$BH!SM(..@JZ/V;?CIX)T'QK\.?
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MW8L H=0!&Q)-9GAG]M/6=:^"OQQU>*7PAXA\5?#>Q:[AU;PW<276AZHKP/+
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M)?"\54M[=K3^*5IV$@]<)L(/_?56Z* *D<E\;QE>WMUM/X95G8R'TRFP ?\
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M6VB:*TM7N#_K(WN65%^C",D_D*=<2Z@K1>1;6TBD?O#)<,A4^P$9S^.*N44
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M^K&,$?D:O44 4?.U'['N^R6OVO=_JOM+>7CUW^7G/MMHFFU%;:)HK2U>X/\
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MOA>*J6]NUI_%*T["0>N$V$'_ +ZHCDOC>,KV]NMI_#*L[&0^F4V #_OJK=%
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MNH*T7D6UM(I'[PR7#(5/L!&<_CBKE% %222^%XJI;V[6G\4K3L)!ZX380?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *_%;_ (+5_P#)TWA;_L3+7_TNOJ_:FOQ6_P""U?\
MR=-X6_[$RU_]+KZ@#]5/V3O^36?@W_V)FC?^D,->JUY5^R=_R:S\&_\ L3-&
M_P#2&&O5: "BBB@ HHHH **** "O*?'_ /R53PY_V[?^CVKU:O*?'_\ R53P
MY_V[?^CVH ]6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR"*X;X-?MO\ Q=_9O^)<-_\ $67QQXDTF2%X;C0?$U_<(S9!VNGV@/M96P>
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MS\-7?B'Q5K-GH.BVHS+>7THC0>BC/WF/91DD\ &OSG^*_P#P4B^(GQX\4S>
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MWA;_ +$RU_\ 2Z^H _53]D[_ )-9^#?_ &)FC?\ I##7JM>5?LG?\FL_!O\
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ME!0CL@HHHJS0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^;[J+M7() P .*](F\-:=<>(K;79+<MJEM ]M%/YCX6-R"PVYV\D#DC/%:E
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M6Z* *D>DV,-XUXEE;I=M]ZX6)1(<]<MC-);Z-I]FTK06-M TPQ(T<*J7!['
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M]C^Q_P!GVOV3=N^S^2OEY]=N,9HFT/3KBVBMY=/M9;>+_5Q/"I1/H","KU%
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MHHHH **** "OQ6_X+5_\G3>%O^Q,M?\ TNOJ_:FOQ6_X+5_\G3>%O^Q,M?\
MTNOJ /U4_9._Y-9^#?\ V)FC?^D,->JUY5^R=_R:S\&_^Q,T;_TAAKU6@ HH
MHH **** "BBB@ KRGQ__ ,E4\.?]NW_H]J]6KRGQ_P#\E4\.?]NW_H]J /5J
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW2'[JCC;!@   , !M/Z,45\W*DIR4I;+H1.BJDU*3NETZ"*HC4*H"JHP !@
M4M%%;G0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7XK?\%J_P#DZ;PM_P!B9:_^EU]7[4U^*W_!:O\ Y.F\+?\ 8F6O_I=?
M4 ?JI^R=_P FL_!O_L3-&_\ 2&&O5:\J_9._Y-9^#?\ V)FC?^D,->JT %%%
M% !1110 4444 %>4^/\ _DJGAS_MV_\ 1[5ZM7E/C_\ Y*IX<_[=O_1[4 >K
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#K$$]M+.L=T$C^\'M)5<_12H+?@#1_;$'V/[5Y=UY6[;M^R2^9_WQMW8]\4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%U[DE%%%><=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117SS^VE^UMI/[*?PS:
M_'DW_C#5 \&B:6Y^_(!\TT@'/E1Y!/J2JC&<CIPV'JXNM&A15Y2V%)J*NSR?
M_@HM^VE+\&=$7X:^ [A[CXDZ]&L;R6>7ETR"3A2H7GSY,X0#D [N/DS\]Z%I
MMA_P39^"HU.^2"^_:)\<69,$4@$O]A6;'J?5MPY[/(NWYEC8GTG_ ()V?LDZ
MMXBUQ_VAOBSYVJ>)]8E:^T6WU!<N-_/VZ0'HS9_=+@!5PPZIM^P?'/[+GPY^
M)'Q8T/XB^(M#_M+Q)H\216YDF;R&V.SQL\6=K%&9B,^HSG Q]!FV(C@<,\IP
M$M?^7DOYGV7DOZZWXY1J5(\T='T\O^"?.O\ P3X_9 O? L3?%WXB1S77Q UQ
M7GM(;XEIK&*7)>60MSY\H8YSRJM@\LP'W%117R5.FJ<>6)T4J<:,5&(4445H
M:A1110 4444 %%%% !112$A02>!0 M%>*_$S]L+X7?"YY;>]\0+K&I1G#:?H
MBBZE!'4%@1&I'HS@UW_PM^)6E?%WP+IGBS1([J+3=0#F..\C$<JE'9&# $C[
MRGH2/>N:&)HU*CI0FG)=#VL1DF98/"1Q^)P\H4I.RE)-)NS>E]]$_+0Z>XN(
M[6"2::18H8U+O(YPJJ!DDGL *^&+[X@:O-\0#\>X7N6TVWO/LD>G#/S>'P3&
MS;?[Y)-Q@^@KUW]M+Q1I\WA70_ $^I)IUQXFO4-Q,UP(1#90D23,Q)Q\Q"H%
M/4L?2N,7Q7X,CTM=-76]%%@L/V<6_P!MBV>7MV[,;NF.*\K&5%6JNGS6Y-?^
MWNGW?C?R/O>'<+++<#'&NDZCQ%XM<NGL4[2UUUJ.ZOHX\C_F/>/C1\<M)^#?
MPS'C2:TN-<L97B2V2Q(Q+Y@RC%SPJ$#[W/4#!S7RK)^WU\3_ !Q(R^ _A:+A
M.0/W%SJ3?7]T(Q7LG[(_C:PU;0==^&MU>VNL_P#",R 6,GF+.MQILAW0Y/()
MC.8SZ83UKZ-CC6&-4151%&U548  Z "K<<1CHQJ4JW)&VJ23=^NIA#$91PO5
MJX/'9:L364KQG.<HQ<&DX>XE;5:N[OK;H?/O[,/CCXU^,M4UF3XF^&X=$T=8
M0UG(UM]FF\[=@H$+%BNW)R1U Y.:^A***].A2=&FH2DY>;W/ALVQ]/,L7+$T
MJ$**=O=@FHJRMU;U?7S/*?AG\(?$/@CXF^-O$VJ>.+_Q!INNS&2TTFX#".S!
M?< ,L1E5P@VA?E'/8#U:BBKITHT8\L-O\SGQV.KYA5]OB&G*R6B2TBDEHDEL
MOF?+7CK_ ()[^"/'7C+6?$4WB#7K.XU2ZDO)H8Y(G19)&+-M+(3C). 2<5G6
M/_!-3X;P[6N=>\3W+*V2JW%NBL/0CR2?R(KZVHKSWE>"E)R=)79]?3X\XFIT
MHT88Z:C%)+;9:+6URKI>G0:/IMI86JE+:UA2")2<D(JA0,]^ *XGXU?!/0/C
MQX3@\/\ B*:^M[."[2]CDT^81R!U5E_B5@05=AR._'->@45Z,Z<*D'3FKI]#
MX["XW$X/$QQ>'FXU(NZDMT^Y5TO3X=(TVTL+8,+>UA2",,Q8[54*,D]3@=:\
MZ_:(^"*_'WP /#1UZX\/E;I+H7$$?FJ^U6&R2/<NY?FSC(Y53VKT^BE4I0JT
MW2FKQ>A>#Q^)R_%PQV&G:K!\R>CU[ZW3^:/A(_\ !.'Q/HBC^POBF8\#@?8I
M;;J>1\DS5[E^S'\#_'_P?N-;_P"$P\=/XIL[I8UM;/SYIEA92<OF7E21@87C
MUZ"O>Z*\ZCE>%P]15*2::\W;\S[#,^.L\SG"3P>/J1G&5KOV<%+1WT:BK;!7
ME/PIU3XK7OCWQQ#XXTK3['PO#=8T&>V=#)+'N;'W6)(V;"2X4[C@#J%]6HKT
M94^:49<S5OQ]3X[#XM4*-:BZ49>T25VFW&S3O%WT;V>CT"OD;Q5_P44\/>#_
M !QK?A^_\&ZP$TR[DM#<+-&'<HQ4MY;8P"1D?-T-?7-9.L>$]#\19&JZ-I^I
M_P#7Y:QR^G]X'T'Y5AB:>(J17U>IROTO<];(\9E.$JS>;X5UXM:6FX.+[Z+7
MT9\^^'_^"A?PDUJ:..YGUG1-[!=VH6&57GJ3$S\?XU]*PS)<0I+$ZR1NH964
MY!!&017F=]^S%\)]1NDN)?A]H*2(P8"WLUA7(QU5, CCH17IRJ(U"J JJ,
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MCN:SG4A3MSNUW9>IVX7!XC&\ZP\'+DBY2MTBMV_)'I%%%%:'$%%%% !1110
M5^*W_!:O_DZ;PM_V)EK_ .EU]7[4U^*W_!:O_DZ;PM_V)EK_ .EU]0!^JG[)
MW_)K/P;_ .Q,T;_TAAKU6O*OV3O^36?@W_V)FC?^D,->JT >9?$SX_>&OAKJ
M%KI]Q=0W>I/<11W-JCONMH6^]*VU&Y4$'9P2#Q797GC;0=/\.1:_<ZO:0:-*
MBR1WDDH$;@C(VGN3Z#FO'O$'A/QM\)?&'BKQCX:MM/\ $FBZJ1=7^GW)*72*
MH8L$;H0,G'7@XVDC)[_P?K&A_$;X9Z9KEKHT%K;+#));6LL*'[)(N]&\O P,
M$, PQD'MG% &UHOQ$\.^(/"K^)++5(CH:;MU[.K0HNTX;.\ CGCI67X3^-G@
MGQQK!TO1=?@N]0P2L#1R1%\9SLWJ _ )^7/ STKBOV6[>TNO@39QWT4,UH9[
M@R)<*&CP)"<L#Q@8SSZ5BZ);CXT_'RU\7Z3"8?#'AN,VZZEMV_;YANX3U4;^
MOHO^T* /3_%GQJ\%>!M6&EZWKT-G?X!:!8I)63(!&[8IVY!!YQP<UU]C?VVJ
M64%Y9SQW5K.@DBFA8,CJ1D$$=17@GP;AL]6'QDEU)(Y)YM4NH;II!D^0 X53
MGL/FKI?V4VF;X)Z/YQ8KYMP(]W]WS6Z>V<T >O5Y3X__ .2J>'/^W;_T>U>E
MZM<3VFE7L]K'YUS'"[Q1[2V]PI(&!R<G' KQ*^UC6-8\=:)<:G8+9WRRP)'"
MZ/"& E)!.[) ))&0#TZ4 >\451FFU%;:)HK2U>X/^LC>Y947Z,(R3^0IUQ+J
M"M%Y%M;2*1^\,EPR%3[ 1G/XXH N454DDOA>*J6]NUI_%*T["0>N$V$'_OJB
M.2^-XRO;VZVG\,JSL9#Z938 /^^J +=%4[>74&:7S[:VC4#]V8[AG+'W!C&/
MPS389M1:VE:6TM4N!_JXTN69&^K&,$?D: +U%4?.U'['N^R6OVO=_JOM+>7C
MUW^7G/MMHFFU%;:)HK2U>X/^LC>Y947Z,(R3^0H O453N)=05HO(MK:12/WA
MDN&0J?8",Y_'%+))?"\54M[=K3^*5IV$@]<)L(/_ 'U0!;HJI')?&\97M[=;
M3^&59V,A],IL '_?5);RZ@S2^?;6T:@?NS'<,Y8^X,8Q^&: +E%489M1:VE:
M6TM4N!_JXTN69&^K&,$?D:/.U'['N^R6OVO=_JOM+>7CUW^7G/MMH O451FF
MU%;:)HK2U>X/^LC>Y947Z,(R3^0IUQ+J"M%Y%M;2*1^\,EPR%3[ 1G/XXH N
M454DDOA>*J6]NUI_%*T["0>N$V$'_OJB.2^-XRO;VZVG\,JSL9#Z938 /^^J
M +=%4[>74&:7S[:VC4#]V8[AG+'W!C&/PS389M1:VE:6TM4N!_JXTN69&^K&
M,$?D: +U%4?.U'['N^R6OVO=_JOM+>7CUW^7G/MMHFFU%;:)HK2U>X/^LC>Y
M947Z,(R3^0H O453N)=05HO(MK:12/WADN&0J?8",Y_'%+))?"\54M[=K3^*
M5IV$@]<)L(/_ 'U0!;HJI')?&\97M[=;3^&59V,A],IL '_?5);RZ@S2^?;6
MT:@?NS'<,Y8^X,8Q^&: +E%489M1:VE:6TM4N!_JXTN69&^K&,$?D:/.U'['
MN^R6OVO=_JOM+>7CUW^7G/MMH O451FFU%;:)HK2U>X/^LC>Y947Z,(R3^0I
MUQ+J"M%Y%M;2*1^\,EPR%3[ 1G/XXH N454DDOA>*J6]NUI_%*T["0>N$V$'
M_OJB.2^-XRO;VZVG\,JSL9#Z938 /^^J +=%4[>74&:7S[:VC4#]V8[AG+'W
M!C&/PS389M1:VE:6TM4N!_JXTN69&^K&,$?D: +U%4?.U'['N^R6OVO=_JOM
M+>7CUW^7G/MMHFFU%;:)HK2U>X/^LC>Y947Z,(R3^0H O453N)=05HO(MK:1
M2/WADN&0J?8",Y_'%+))?"\54M[=K3^*5IV$@]<)L(/_ 'U0!;HJI')?&\97
MM[=;3^&59V,A],IL '_?5);RZ@S2^?;6T:@?NS'<,Y8^X,8Q^&: +E%489M1
M:VE:6TM4N!_JXTN69&^K&,$?D:/.U'['N^R6OVO=_JOM+>7CUW^7G/MMH O4
M51FFU%;:)HK2U>X/^LC>Y947Z,(R3^0IUQ+J"M%Y%M;2*1^\,EPR%3[ 1G/X
MXH N454DDOA>*J6]NUI_%*T["0>N$V$'_OJB.2^-XRO;VZVG\,JSL9#Z938
M/^^J +=%4[>74&:7S[:VC4#]V8[AG+'W!C&/PS389M1:VE:6TM4N!_JXTN69
M&^K&,$?D: +U%4?.U'['N^R6OVO=_JOM+>7CUW^7G/MMHFFU%;:)HK2U>X/^
MLC>Y947Z,(R3^0H O453N)=05HO(MK:12/WADN&0J?8",Y_'%+))?"\54M[=
MK3^*5IV$@]<)L(/_ 'U0!;HJI')?&\97M[=;3^&59V,A],IL '_?5);RZ@S2
M^?;6T:@?NS'<,Y8^X,8Q^&: +E%489M1:VE:6TM4N!_JXTN69&^K&,$?D:/.
MU'['N^R6OVO=_JOM+>7CUW^7G/MMH O451FFU%;:)HK2U>X/^LC>Y947Z,(R
M3^0IUQ+J"M%Y%M;2*1^\,EPR%3[ 1G/XXH N454DDOA>*J6]NUI_%*T["0>N
M$V$'_OJB.2^-XRO;VZVG\,JSL9#Z938 /^^J +=%4[>74&:7S[:VC4#]V8[A
MG+'W!C&/PS389M1:VE:6TM4N!_JXTN69&^K&,$?D: +U%4?.U'['N^R6OVO=
M_JOM+>7CUW^7G/MMHFFU%;:)HK2U>X/^LC>Y947Z,(R3^0H O453N)=05HO(
MMK:12/WADN&0J?8",Y_'%+))?"\54M[=K3^*5IV$@]<)L(/_ 'U0!;HJI')?
M&\97M[=;3^&59V,A],IL '_?5);RZ@S2^?;6T:@?NS'<,Y8^X,8Q^&: +E%4
M89M1:VE:6TM4N!_JXTN69&^K&,$?D:/.U'['N^R6OVO=_JOM+>7CUW^7G/MM
MH O451FFU%;:)HK2U>X/^LC>Y947Z,(R3^0IUQ+J"M%Y%M;2*1^\,EPR%3[
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MI')?&\97M[=;3^&59V,A],IL '_?5);RZ@S2^?;6T:@?NS'<,Y8^X,8Q^&:
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MK:_<NIXT:3G55*+5V[7Z?>^ATU%>'?\ "Z/&NG\ZAX3V =?]&GB_]"SVKI?
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M2CA9J5/1QY9*:2DK\O-%M-QORNSW04445U'@!1110 5^*W_!:O\ Y.F\+?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ,FFCMH9)II%BBC4N\CD!54#)))Z
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MXR;4#'%9K'LNK:TNUCAD .UL3E,=>0<D\5^GM?+G_!0K]G?2KSP'I?BOP+X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L+QYH-]XJ\#^(=%TS59="U+4=.N+2UU2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2,P!02(H!CR&7KSSTQDCQO1;RWU?]D'4M(L;RWN-6M9FNY["*93.D*W*DNR
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MIMF%[C!F+2XXQ\N>O-?9FC?''6?M%S#/H6I:C<-#(T5M;E/,WJI;:B^4,DG
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M*IV]C/"TI?4;FX#C"K(L0$?N-J#]<TV'3YXK:6)M3NIG?[LSK%O3Z80#\P:
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MVKP_6?VV/@]96Z0Q^/[V>>+[TEGI<C-)QW+0;/\ OG%<]7$4:'\6:CZM(]C
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MHW-P'&%618@(_<;4'ZYIL.GSQ6TL3:G=3._W9G6+>GTP@'Y@T 7J*H_V?/\
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M2;B[HJQZ590@B.SMXP>H6)1_2K*J%4 # '  I:*2BH[(;DY;L****HD****
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MO8%"6 (P"IYSBNT^%/[8_P &OC/Y,7ACQ[I<M_+@+IM_(;.[+?W1%,%9R/\
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MC+8[FBBBO&- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1EM<APEM%M V+N)(!()P.!GCN3Z?KNLVWAW0]0U:]++9V%O)=3&-2S!$4LV
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M.\&^"]>U^.'QMJ[Z783WJZ?9ZE$9KDQQL_EH/(Y9MN![FOJ53R"4>95:EO\
M"BU.I*/-;0^@=8_;K^ .A@&Y^*>@2< _Z'*USU)'_+)6]*O_  =_;(^$'Q\\
M57'AOP-XO76=9AMVNS;/8W-L7C4@,5,T:!L%AD#GG/0$U^.FF6_P]2:2&T^
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M]O#XP9'A?X<OX1AD/[N1=#6T&T]/GU!RI^HX^E?IIH/AK2/"]F+31=*L=(M
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MZ*IV^C:?9M*T%C;0-,,2-'"JEP>QP.?QIL.AZ=;VTMO%I]K%;R_ZR)(5"/\
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M2K4BI<MK]S*\8?\ !7[X+Z%O31=-\3>)9AG8]O91V\)],M+(K#/^X:\FOO\
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MI=]=M!,O<K#=IC@]-D@P>[U^E5%>O@<VQ>7Z4)^Z]XO6+^1G*$9;GY?>!?\
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MFI])1UC]ZV^9<:D9:=3V&BBBO#-0HHHH **** "BBB@ HHHH **** "BBB@
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MT,57PO-[&;C=6=OZ_'<F4(SMS*]A.G X%+117*6%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7XK?\%J_P#DZ;PM_P!B9:_^EU]7[4U^*W_!:O\
MY.F\+?\ 8F6O_I=?4 ?JI^R=_P FL_!O_L3-&_\ 2&&O5:\J_9._Y-9^#?\
MV)FC?^D,->JT %%%% !1110 4444 %>4^/\ _DJGAS_MV_\ 1[5ZM7E/C_\
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M?B#3?$6F/Q]JTVY2= ?[K;2=K>QP170U\S*,H-QDK-&P4445(!1110 4444
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M?\(]X$\-Z&R# ?3])@A;IC)94!)]SSS1[;(J/P4:E3_%)1_])"U5]4C\\O\
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M3H48&T)IEC%;C'IA%%;U%%>5*4I.\G=F@4445(!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?B
MM_P6K_Y.F\+?]B9:_P#I=?5^U-?BM_P6K_Y.F\+?]B9:_P#I=?4 ?JI^R=_R
M:S\&_P#L3-&_](8:]5KRK]D[_DUGX-_]B9HW_I##7JM !115?4+Z#2[&YO;I
M_*MK>-II7P3M5023@<G@=J +%%4]'U>TU_2;/4K"7S[*[B6>&0HR;T894X8
MC(/<5<H **** "O*?'__ "53PY_V[?\ H]J]6KRGQ_\ \E4\.?\ ;M_Z/:@#
MU:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]5@NFE5$N5,0RWF6LJ _0LHW?AFKE% %&'6()[:6=8[H)']X/:2JY^BE06_
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M?P-);ZK!=-*J)<J8AEO,M94!^A91N_#->)>*/V[_ ( >#]WV_P"*>A3[>O\
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ML006T4[1W123[H2TE9Q]5"DK^(%6DG5V50'!9=XW(P&/J1P?;K4E% !1110
M4444 %%%% !7XK?\%J_^3IO"W_8F6O\ Z77U?M37XK?\%J_^3IO"W_8F6O\
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MV, <'IVQQVH_X7-_P4"^&_.M^!SXI"<D?V/:WF[O_P N#KGTX]/6OU"HK?\
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M-W][8>SOO)GY??\ #M']HGQYSX\^/'G!^67^T]0U+'?&)/+'8=./RKH/#?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OQ6_P""U?\ R=-X6_[$RU_]
M+KZOVIK\5O\ @M7_ ,G3>%O^Q,M?_2Z^H _53]D[_DUGX-_]B9HW_I##7JM>
M5?LG?\FL_!O_ +$S1O\ TAAKU6@ HHHH **** "BBB@ KRGQ_P#\E4\.?]NW
M_H]J]6KRGQ__ ,E4\.?]NW_H]J /5J*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\C^(G[*_PY^*7Q%TCQIX@T4W&KV.SSHHY2
MEMJ0C.81>1#Y9Q$WS+NZ8 .1Q7KE%;4:U6A+GI2<7MH)I2T8G3@<"EHHK$84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQ6_X+5_\G3>%O\
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M&0^F4V #_OJDMY=09I?/MK:-0/W9CN&<L?<&,8_#-7** *,,VHM;2M+:6J7
M_P!7&ERS(WU8Q@C\C1YVH_8]WV2U^U[O]5]I;R\>N_R\Y]MM7J* *,TVHK;1
M-%:6KW!_UD;W+*B_1A&2?R%.N)=05HO(MK:12/WADN&0J?8",Y_'%7** *DD
ME\+Q52WMVM/XI6G82#UPFP@_]]41R7QO&5[>W6T_AE6=C(?3*; !_P!]5;HH
M IV\NH,TOGVUM&H'[LQW#.6/N#&,?AFFPS:BUM*TMI:I<#_5QI<LR-]6,8(_
M(U>HH H^=J/V/=]DM?M>[_5?:6\O'KO\O.?;;1--J*VT316EJ]P?]9&]RRHO
MT81DG\A5ZB@"G<2Z@K1>1;6TBD?O#)<,A4^P$9S^.*622^%XJI;V[6G\4K3L
M)!ZX380?^^JMT4 5(Y+XWC*]O;K:?PRK.QD/IE-@ _[ZI+>74&:7S[:VC4#]
MV8[AG+'W!C&/PS5RB@"C#-J+6TK2VEJEP/\ 5QI<LR-]6,8(_(T>=J/V/=]D
MM?M>[_5?:6\O'KO\O.?;;5ZB@"C--J*VT316EJ]P?]9&]RRHOT81DG\A3KB7
M4%:+R+:VD4C]X9+AD*GV C.?QQ5RB@"I))?"\54M[=K3^*5IV$@]<)L(/_?5
M$<E\;QE>WMUM/X95G8R'TRFP ?\ ?56Z* *=O+J#-+Y]M;1J!^[,=PSEC[@Q
MC'X9IL,VHM;2M+:6J7 _U<:7+,C?5C&"/R-7J* */G:C]CW?9+7[7N_U7VEO
M+QZ[_+SGVVT33:BMM$T5I:O<'_61O<LJ+]&$9)_(5>HH IW$NH*T7D6UM(I'
M[PR7#(5/L!&<_CBEDDOA>*J6]NUI_%*T["0>N$V$'_OJK=% %2.2^-XRO;VZ
MVG\,JSL9#Z938 /^^J2WEU!FE\^VMHU _=F.X9RQ]P8QC\,U<HH HPS:BUM*
MTMI:I<#_ %<:7+,C?5C&"/R-'G:C]CW?9+7[7N_U7VEO+QZ[_+SGVVU>HH H
MS3:BMM$T5I:O<'_61O<LJ+]&$9)_(4ZXEU!6B\BVMI%(_>&2X9"I]@(SG\<5
M<HH J227PO%5+>W:T_BE:=A(/7";"#_WU1')?&\97M[=;3^&59V,A],IL '_
M 'U5NB@"G;RZ@S2^?;6T:@?NS'<,Y8^X,8Q^&:;#-J+6TK2VEJEP/]7&ERS(
MWU8Q@C\C5ZB@"CYVH_8]WV2U^U[O]5]I;R\>N_R\Y]MM$TVHK;1-%:6KW!_U
MD;W+*B_1A&2?R%7J* *=Q+J"M%Y%M;2*1^\,EPR%3[ 1G/XXI9)+X7BJEO;M
M:?Q2M.PD'KA-A!_[ZJW10!4CDOC>,KV]NMI_#*L[&0^F4V #_OJDMY=09I?/
MMK:-0/W9CN&<L?<&,8_#-7** *,,VHM;2M+:6J7 _P!7&ERS(WU8Q@C\C1YV
MH_8]WV2U^U[O]5]I;R\>N_R\Y]MM7J* *,TVHK;1-%:6KW!_UD;W+*B_1A&2
M?R%.N)=05HO(MK:12/WADN&0J?8",Y_'%7** *DDE\+Q52WMVM/XI6G82#UP
MFP@_]]41R7QO&5[>W6T_AE6=C(?3*; !_P!]5;HH IV\NH,TOGVUM&H'[LQW
M#.6/N#&,?AFFPS:BUM*TMI:I<#_5QI<LR-]6,8(_(U>HH H^=J/V/=]DM?M>
M[_5?:6\O'KO\O.?;;1--J*VT316EJ]P?]9&]RRHOT81DG\A5ZB@"G<2Z@K1>
M1;6TBD?O#)<,A4^P$9S^.*622^%XJI;V[6G\4K3L)!ZX380?^^JMT4 5(Y+X
MWC*]O;K:?PRK.QD/IE-@ _[ZI+>74&:7S[:VC4#]V8[AG+'W!C&/PS5RB@"C
M#-J+6TK2VEJEP/\ 5QI<LR-]6,8(_(T>=J/V/=]DM?M>[_5?:6\O'KO\O.?;
M;5ZB@"C--J*VT316EJ]P?]9&]RRHOT81DG\A3KB74%:+R+:VD4C]X9+AD*GV
M C.?QQ5RB@"I))?"\54M[=K3^*5IV$@]<)L(/_?5$<E\;QE>WMUM/X95G8R'
MTRFP ?\ ?56Z* *=O+J#-+Y]M;1J!^[,=PSEC[@QC'X9IL,VHM;2M+:6J7 _
MU<:7+,C?5C&"/R-7J* */G:C]CW?9+7[7N_U7VEO+QZ[_+SGVVT33:BMM$T5
MI:O<'_61O<LJ+]&$9)_(5>HH IW$NH*T7D6UM(I'[PR7#(5/L!&<_CBEDDOA
M>*J6]NUI_%*T["0>N$V$'_OJK=% %2.2^-XRO;VZVG\,JSL9#Z938 /^^J2W
MEU!FE\^VMHU _=F.X9RQ]P8QC\,U<HH HPS:BUM*TMI:I<#_ %<:7+,C?5C&
M"/R-'G:C]CW?9+7[7N_U7VEO+QZ[_+SGVVU>HH HS3:BMM$T5I:O<'_61O<L
MJ+]&$9)_(4ZXEU!6B\BVMI%(_>&2X9"I]@(SG\<5<HH J227PO%5+>W:T_BE
M:=A(/7";"#_WU1')?&\97M[=;3^&59V,A],IL '_ 'U5NB@"G;RZ@S2^?;6T
M:@?NS'<,Y8^X,8Q^&:;#-J+6TK2VEJEP/]7&ERS(WU8Q@C\C5ZB@"CYVH_8]
MWV2U^U[O]5]I;R\>N_R\Y]MM$TVHK;1-%:6KW!_UD;W+*B_1A&2?R%7J* *=
MQ+J"M%Y%M;2*1^\,EPR%3[ 1G/XXI9)+X7BJEO;M:?Q2M.PD'KA-A!_[ZJW1
M0!4CDOC>,KV]NMI_#*L[&0^F4V #_OJDMY=09I?/MK:-0/W9CN&<L?<&,8_#
M-7** *,,VHM;2M+:6J7 _P!7&ERS(WU8Q@C\C1YVH_8]WV2U^U[O]5]I;R\>
MN_R\Y]MM7J* *,TVHK;1-%:6KW!_UD;W+*B_1A&2?R%.N)=05HO(MK:12/WA
MDN&0J?8",Y_'%7** *DDE\+Q52WMVM/XI6G82#UPFP@_]]41R7QO&5[>W6T_
MAE6=C(?3*; !_P!]5;HH IV\NH,TOGVUM&H'[LQW#.6/N#&,?AFFPS:BUM*T
MMI:I<#_5QI<LR-]6,8(_(U>HH H^=J/V/=]DM?M>[_5?:6\O'KO\O.?;;1--
MJ*VT316EJ]P?]9&]RRHOT81DG\A5ZB@"G<2Z@K1>1;6TBD?O#)<,A4^P$9S^
M.*622^%XJI;V[6G\4K3L)!ZX380?^^JMT4 5(Y+XWC*]O;K:?PRK.QD/IE-@
M _[ZI+>74&:7S[:VC4#]V8[AG+'W!C&/PS5RB@"C#-J+6TK2VEJEP/\ 5QI<
MLR-]6,8(_(T>=J/V/=]DM?M>[_5?:6\O'KO\O.?;;5ZB@"C--J*VT316EJ]P
M?]9&]RRHOT81DG\A5I&E++N1 NW)*N20WIC'3W_2I** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK:6)M3NIG?[LSK%O3Z80#\P:O44 4?[/G^Q^1_:=UYN[/VG;%YGTQLVX_P"
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M>*VEB;4[J9W^[,ZQ;T^F$ _,&KU% %'^SY_L?D?VG=>;NS]IVQ>9],;-N/\
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M!1_L^?['Y']IW7F[L_:=L7F?3&S;C_@-$VGSRVT42ZG=0NGWID6+>_URA'Y
M5>HH IW%C/,T134;FW"##+&L1$GN=R'],4LEG,]XLXO[B.(=;95C\L_4E-WY
M-5NB@"I'9S)>-.;^XDB/2V98_+'T(3=^;4EO8SPM*7U&YN XPJR+$!'[C:@_
M7-7** *,.GSQ6TL3:G=3._W9G6+>GTP@'Y@T?V?/]C\C^T[KS=V?M.V+S/IC
M9MQ_P&KU% %&;3YY;:*)=3NH73[TR+%O?ZY0C\@*=<6,\S1%-1N;<(,,L:Q$
M2>YW(?TQ5RB@"I)9S/>+.+^XCB'6V58_+/U)3=^341V<R7C3F_N)(CTMF6/R
MQ]"$W?FU6Z* *=O8SPM*7U&YN XPJR+$!'[C:@_7--AT^>*VEB;4[J9W^[,Z
MQ;T^F$ _,&KU% %'^SY_L?D?VG=>;NS]IVQ>9],;-N/^ T3:?/+;11+J=U"Z
M?>F18M[_ %RA'Y 5>HH IW%C/,T134;FW"##+&L1$GN=R'],4LEG,]XLXO[B
M.(=;95C\L_4E-WY-5NB@"I'9S)>-.;^XDB/2V98_+'T(3=^;4EO8SPM*7U&Y
MN XPJR+$!'[C:@_7-7** *,.GSQ6TL3:G=3._P!V9UBWI],(!^8-']GS_8_(
M_M.Z\W=G[3MB\SZ8V;<?\!J]10!1FT^>6VBB74[J%T^],BQ;W^N4(_("G7%C
M/,T134;FW"##+&L1$GN=R'],5<HH J26<SWBSB_N(XAUME6/RS]24W?DU$=G
M,EXTYO[B2(]+9EC\L?0A-WYM5NB@"G;V,\+2E]1N;@.,*LBQ 1^XVH/US38=
M/GBMI8FU.ZF=_NS.L6]/IA /S!J]10!1_L^?['Y']IW7F[L_:=L7F?3&S;C_
M (#1-I\\MM%$NIW4+I]Z9%BWO]<H1^0%7J* *=Q8SS-$4U&YMP@PRQK$1)[G
M<A_3%+)9S/>+.+^XCB'6V58_+/U)3=^35;HH J1V<R7C3F_N)(CTMF6/RQ]"
M$W?FU);V,\+2E]1N;@.,*LBQ 1^XVH/US5RB@"C#I\\5M+$VIW4SO]V9UBWI
M],(!^8-']GS_ &/R/[3NO-W9^T[8O,^F-FW'_ :O44 49M/GEMHHEU.ZA=/O
M3(L6]_KE"/R IUQ8SS-$4U&YMP@PRQK$1)[G<A_3%7** *DEG,]XLXO[B.(=
M;95C\L_4E-WY-1'9S)>-.;^XDB/2V98_+'T(3=^;5;HH IV]C/"TI?4;FX#C
M"K(L0$?N-J#]<TV'3YXK:6)M3NIG?[LSK%O3Z80#\P:O44 4?[/G^Q^1_:=U
MYN[/VG;%YGTQLVX_X#1-I\\MM%$NIW4+I]Z9%BWO]<H1^0%7J* *=Q8SS-$4
MU&YMP@PRQK$1)[G<A_3%+)9S/>+.+^XCB'6V58_+/U)3=^35;HH J1V<R7C3
MF_N)(CTMF6/RQ]"$W?FU);V,\+2E]1N;@.,*LBQ 1^XVH/US5RB@"C#I\\5M
M+$VIW4SO]V9UBWI],(!^8-']GS_8_(_M.Z\W=G[3MB\SZ8V;<?\  :O44 49
MM/GEMHHEU.ZA=/O3(L6]_KE"/R IUQ8SS-$4U&YMP@PRQK$1)[G<A_3%7**
M*DEG,]XLXO[B.(=;95C\L_4E-WY-1'9S)>-.;^XDB/2V98_+'T(3=^;5;HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;L)/B)H=]%>0SVENL#2S0.) NV9B?NYY YQ0!['17*?\+2\,?]!/_P EY?\
MXFC_ (6EX8_Z"?\ Y+R__$T =717*?\ "TO#'_03_P#)>7_XFC_A:7AC_H)_
M^2\O_P 30!U=%<I_PM+PQ_T$_P#R7E_^)H_X6EX8_P"@G_Y+R_\ Q- '5T5R
MG_"TO#'_ $$__)>7_P")H_X6EX8_Z"?_ )+R_P#Q- '5T5RG_"TO#'_03_\
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M&/\ H)_^2\O_ ,30!U=%<I_PM+PQ_P!!/_R7E_\ B:/^%I>&/^@G_P"2\O\
M\30!U=%<I_PM+PQ_T$__ "7E_P#B:/\ A:7AC_H)_P#DO+_\30!U=%<I_P +
M2\,?]!/_ ,EY?_B:/^%I>&/^@G_Y+R__ !- '5T5RG_"TO#'_03_ /)>7_XF
MC_A:7AC_ *"?_DO+_P#$T =717*?\+2\,?\ 03_\EY?_ (FC_A:7AC_H)_\
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MI>&/^@G_ .2\O_Q- '5T5RG_  M+PQ_T$_\ R7E_^)H_X6EX8_Z"?_DO+_\
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M)_\ DO+_ /$T =717*?\+2\,?]!/_P EY?\ XFC_ (6EX8_Z"?\ Y+R__$T
M=717*?\ "TO#'_03_P#)>7_XFC_A:7AC_H)_^2\O_P 30!U=%<I_PM+PQ_T$
M_P#R7E_^)H_X6EX8_P"@G_Y+R_\ Q- '5T5RG_"TO#'_ $$__)>7_P")H_X6
MEX8_Z"?_ )+R_P#Q- '5T5RG_"TO#'_03_\ )>7_ .)H_P"%I>&/^@G_ .2\
MO_Q- '5T5RG_  M+PQ_T$_\ R7E_^)H_X6EX8_Z"?_DO+_\ $T =717*?\+2
M\,?]!/\ \EY?_B:/^%I>&/\ H)_^2\O_ ,30!U=%<I_PM+PQ_P!!/_R7E_\
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M6H?]_(__ (BO0** //\ _A2FA_\ /UJ'_?R/_P"(H_X4IH?_ #]:A_W\C_\
MB*] HH \_P#^%*:'_P _6H?]_(__ (BC_A2FA_\ /UJ'_?R/_P"(KT"B@#S_
M /X4IH?_ #]:A_W\C_\ B*/^%*:'_P _6H?]_(__ (BO0** //\ _A2FA_\
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M  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\
MGZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'
M_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!1
M0!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *
M4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M
M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\
MQ%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I3
M0_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#
M_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$
M5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y_
M_P *4T/_ )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_
M )^M0_[^1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^
M1_\ Q%'_  I30_\ GZU#_OY'_P#$5Z!10!Y__P *4T/_ )^M0_[^1_\ Q%<'
MJO@E;/QRFDPQW;Z>T\,9G*Y;:X7<=P7'&X]NU>^44 >?_P#"E-#_ .?K4/\
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M4 >?_P#"E-#_ .?K4/\ OY'_ /$4?\*4T/\ Y^M0_P"_D?\ \17H%% 'G_\
MPI30_P#GZU#_ +^1_P#Q%'_"E-#_ .?K4/\ OY'_ /$5Z!10!Y__ ,*4T/\
MY^M0_P"_D?\ \11_PI30_P#GZU#_ +^1_P#Q%>@44 >?_P#"E-#_ .?K4/\
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M4 >?_P#"E-#_ .?K4/\ OY'_ /$4?\*4T/\ Y^M0_P"_D?\ \17H%% 'G_\
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M6D$F0"K2,5!/(Z9KTVO$/C?XEN?'UT_PP\*QI>ZI>;&U2[/,.GP!@WSD?Q'
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M48%7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3(=+US79-+&=0GTBQ\Z&SZG$CEEQ@ \\C@\Y!%8'PP_Y.*^*?^Y:?^@"O/\
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M[,NGSZ;\$_#J7 96D66958$81Y79?P((/XUZE0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>9>,?C_ *%X
M+O+J*YTG7[VTM)OL]UJ5GIY:T@DR 5:1BH)Y'3->FUXA\;_$MSX^NG^&'A6-
M+W5+S8VJ79YAT^ ,&^<C^(X''7'N10!W?B3XN>'/#?A;3->DGFOK752BZ?#9
M0EY[MG&55$.#GZXP2 >3BL[0?CMX<UJUUEKB'4]$O-(C$MWINJ6;1W2H<!6$
M:[B02RCCGD9QD5Y[X\T*T\!_$+X):6&8Z1I[RVJ33 8,N(U5CV#%L'ZU=FU.
MQM/VJ-6U)KF*WL=-\.9U"X9\)&=R_>/K@KQ[4 =AX;^/>@^(/%\/AFXTS6_#
M^K7"EK>'6K'[/YXP3\OS$C(4D;@,XQUXI/%?Q\T#PMK6H:8FG:UK<VFJ'U"7
M2++SXK($9S*Y8!>,YZXP>X(KCO!>FW?QK^*UM\1+BUDL/#&D1FWT=)AMEO&!
M;]Z1V7+,?J%'.&JM\&M1L[%?C(FJ.D4T6JW4UUYV%;R2' )]N&_/WH ]T\.^
M(-/\5:+9ZMI=PMW87:"2*501D>X/((.00>016C7D7[*EM-;_  3T8S*RB26X
MD0-_=,K8/Z&O7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KR?6?VE/#&@WL2WNFZ_#I4DQ@36FTUELF8$
M@[6)#-C!^ZIZ5ZQ7S]\4+J7X_>*(/ ?A_P"?0],NEGUK65P8T9<@11GH6Y;\
M?8&@#TWQQ\6-&\"R:;;S0WVKZCJ0+6FG:1;_ &BXF4#)8+D<8]^<'&<&L_2_
MCKX:U;PY=ZK%'J2S6MR+*;26LF-\DYSMB,2YY.#CG'!&<@UQUXL.D_M7:#;R
MJ(K<^'3;V._&-P9^%)[[0U9G@CQ7I'A;XJ?&'Q+=W20:';/;H\RG(>8!@57^
M\Q8,,#N: /1_ ?QMT/Q[X@O-"BL]4T76[5/,?3]8M?(E*C&2 &8<;AP2#SG&
M*)/CAX<_X3C3_"UNE]=WE[/);)=0V^+59(\[U\QB-Q&,'8&P>M<C\'?"NI^+
M/'FJ_%+7;0Z8VHQ"#2]/;[Z6^ !(_N548^K'IBE^+/\ R7WX3_[]W_Z"M 'M
MU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5Y/K/[2GAC0;V);W3=?ATJ28P)K3::RV3,"0=K$AFQ@_=
M4]*]8KY^^*%U+\?O%$'@/P_\^AZ9=+/K6LK@QHRY BC/0MRWX^P- 'IOCCXL
M:-X%DTVWFAOM7U'4@6M-.TBW^T7$R@9+!<CC'OS@XS@UGZ7\=?#6K>'+O58H
M]26:UN193:2UDQODG.=L1B7/)P<<XX(SD&N.O%ATG]J[0;>51%;GPZ;>QWXQ
MN#/PI/?:&K,\$>*](\+?%3XP^);NZ2#0[9[='F4Y#S ,"J_WF+!A@=S0!Z/X
M#^-NA^/?$%YH45GJFBZW:IYCZ?K%KY$I48R0 S#C<."0><XQ61K/[2GAC0;V
M);W3=?ATJ28P)K3::RV3,"0=K$AFQ@_=4]*R/@[X5U/Q9X\U7XI:[:'3&U&(
M0:7I[??2WP )']RJC'U8],5F_%"ZE^/WBB#P'X?^?0],NEGUK65P8T9<@11G
MH6Y;\?8&@#WZ*1)HTDC8.C@,K+T(/0T^HK6UCLK6&WA79#"BQHOHH& /RJ6@
M HHHH *_%;_@M7_R=-X6_P"Q,M?_ $NOJ_:FOQ6_X+5_\G3>%O\ L3+7_P!+
MKZ@#]5/V3O\ DUGX-_\ 8F:-_P"D,->JUY5^R=_R:S\&_P#L3-&_](8:]5H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OQ6_X+5_\ )TWA;_L3+7_TNOJ_:FOQ6_X+5_\ )TWA;_L3+7_TNOJ
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MI1TM49B RJJ<@ #C^G2N[HH \Q\$_#WQ#I.AZKH&LS:6^D7T<Q,EF9&G623
M_B 7:!GWSBH]-^&_B29=#TO6=1TZ;0='G6>'[,CB><IG8'S\H SV_7K7J5%
M'EU]\-_$MG-X@LM$U+3H]&UR5Y9_M2/Y\&_APFW@Y![_ *=:Z;7?!;7'PYF\
M-:=(BM]E6VBDG)"\8Y; /7'I75T4 <1;^"+Z'Q5X8U,RVY@TO3C9S*&;<SE,
M97Y<$?4CZ51TOX9WFC_$:/5[>Z@_L./SI(K4EO,C>4?.H&,;=W/7C/2O1:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^M '8VNLZ??7D]I;7UM<75OQ-!%,K/'SCYE!R/QJMJ'BO1-)N3;WVL:?97
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MU*YBO-%^*UQ XDAE:!T=>C*4!!_*@#U[3?%&C:Q,8;#5K&^F R8[:Y21L>N
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?BM_P6K_Y.F\+?]B9:_P#I=?5^U-?BM_P6K_Y.F\+?]B9:_P#I=?4
M?JI^R=_R:S\&_P#L3-&_](8:]5KRK]D[_DUGX-_]B9HW_I##7JM !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3Y8;=D)QP,L>N>U,TOX::7I<^@2)/>3#18Y$M8YG4KE\Y9@%&6Y[8Z"NMHH
MPM0\'V6H^*=-U]I9X;^Q1HE\IE"2(P/RN""2!D]".M4+7X:Z3:^&-4T'?<S6
M6H2O-*TCJ75FP<J0H P0",@_C7644 <O9_#ZPL]4T34/M5[-<:3;&T@\V4$.
MA!&7PHR<'MCH*=XF\!VWB2^6\&IZKI-SY?E/)IEV8?,0$D!A@@X)/;O7344
M<M:_#O3M+\+OH>F7%]I4+N)'NK.<I<,^1EB^#UP >.E9>D_"[_A$=-U)-#U7
M4+B>X@DCCMM2NLVP=\?O"JI][CK7>T4 <]HG@^#1_!<7AT3R^2+9H'FC.U\L
M#N9?0Y8D>E8>@_""T\-R6WV'Q#XACM[>42BT%Z!"Q!R0R! "#W]:[VB@#A]7
M^$.BZOJ5Y=_:=1LTO6#WEI9W)C@N6SG+KCG\".M2>)/A5IGB+4M/O?MVI:7+
M80"WMAITZQ"-1G&,J2#@XX/0"NTHH XG4/A59ZMX;;1;_6M:OH#<BY\^YNED
MFR%P$W%<;>^,=:O^%_ J^%[PSKKVMZDOE>4+?4;SS8E&0<A=HP1C'T)KIZ*
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M!$L2,Y6[4%BJ#)  SG '2N@_X?5_&_\ Z%;X?_\ @NOO_DRBB@ _X?5_&_\
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M .A6^'__ (+K[_Y,H_X?5_&__H5OA_\ ^"Z^_P#DRBB@ _X?5_&__H5OA_\
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M;X?_ /@NOO\ Y,HHH /^'U?QO_Z%;X?_ /@NOO\ Y,H_X?5_&_\ Z%;X?_\
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M;X?_ /@NOO\ Y,H_X?5_&_\ Z%;X?_\ @NOO_DRBB@ _X?5_&_\ Z%;X?_\
M@NOO_DRC_A]7\;_^A6^'_P#X+K[_ .3*** #_A]7\;_^A6^'_P#X+K[_ .3*
M/^'U?QO_ .A6^'__ (+K[_Y,HHH /^'U?QO_ .A6^'__ (+K[_Y,H_X?5_&_
M_H5OA_\ ^"Z^_P#DRBB@ _X?5_&__H5OA_\ ^"Z^_P#DRC_A]7\;_P#H5OA_
M_P""Z^_^3*** #_A]7\;_P#H5OA__P""Z^_^3*/^'U?QO_Z%;X?_ /@NOO\
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M .3*** #_A]7\;_^A6^'_P#X+K[_ .3*/^'U?QO_ .A6^'__ (+K[_Y,HHH
M/^'U?QO_ .A6^'__ (+K[_Y,H_X?5_&__H5OA_\ ^"Z^_P#DRBB@ _X?5_&_
M_H5OA_\ ^"Z^_P#DRC_A]7\;_P#H5OA__P""Z^_^3*** #_A]7\;_P#H5OA_
M_P""Z^_^3*/^'U?QO_Z%;X?_ /@NOO\ Y,HHH /^'U?QO_Z%;X?_ /@NOO\
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M'U?QO_Z%;X?_ /@NOO\ Y,HHH /^'U?QO_Z%;X?_ /@NOO\ Y,H_X?5_&_\
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M .A6^'__ (+K[_Y,HHH /^'U?QO_ .A6^'__ (+K[_Y,H_X?5_&__H5OA_\
M^"Z^_P#DRBB@ _X?5_&__H5OA_\ ^"Z^_P#DRC_A]7\;_P#H5OA__P""Z^_^
M3*** #_A]7\;_P#H5OA__P""Z^_^3*/^'U?QO_Z%;X?_ /@NOO\ Y,HHH /^
M'U?QO_Z%;X?_ /@NOO\ Y,H_X?5_&_\ Z%;X?_\ @NOO_DRBB@ _X?5_&_\
MZ%;X?_\ @NOO_DRC_A]7\;_^A6^'_P#X+K[_ .3*** #_A]7\;_^A6^'_P#X
M+K[_ .3*/^'U?QO_ .A6^'__ (+K[_Y,HHH /^'U?QO_ .A6^'__ (+K[_Y,
MKY?_ &H/VH/%7[67C[3_ !=XNT_1].U*RTR/2HXM$AEBA,22RRAB))9#NW3/
+SG& ..I)10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516292728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 02, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRESTIGE CONSUMER HEALTHCARE INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1297589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">660 White Plains Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tarrytown<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">524-6800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PBH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,798.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,279,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the Registrant&#8217;s Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders (the &#8220;2022 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent described herein.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001295947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516098552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Stamford, Connecticut<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517400360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income and Comprehensive Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,086,812<span></span>
</td>
<td class="nump">$ 943,365<span></span>
</td>
<td class="nump">$ 963,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Cost of Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CostOfSalesExclusiveOfDepreciation', window );">Cost of sales excluding depreciation</a></td>
<td class="nump">458,942<span></span>
</td>
<td class="nump">389,670<span></span>
</td>
<td class="nump">406,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Cost of sales depreciation</a></td>
<td class="nump">7,224<span></span>
</td>
<td class="nump">6,223<span></span>
</td>
<td class="nump">4,233<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">466,166<span></span>
</td>
<td class="nump">395,893<span></span>
</td>
<td class="nump">410,787<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">620,646<span></span>
</td>
<td class="nump">547,472<span></span>
</td>
<td class="nump">552,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">157,343<span></span>
</td>
<td class="nump">140,589<span></span>
</td>
<td class="nump">147,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">108,516<span></span>
</td>
<td class="nump">85,540<span></span>
</td>
<td class="nump">89,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">24,868<span></span>
</td>
<td class="nump">23,941<span></span>
</td>
<td class="nump">24,762<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">290,727<span></span>
</td>
<td class="nump">250,070<span></span>
</td>
<td class="nump">261,068<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">329,919<span></span>
</td>
<td class="nump">297,402<span></span>
</td>
<td class="nump">291,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, net</a></td>
<td class="nump">64,287<span></span>
</td>
<td class="nump">82,328<span></span>
</td>
<td class="nump">96,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">12,327<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">1,052<span></span>
</td>
<td class="num">(1,366)<span></span>
</td>
<td class="nump">1,625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_TotalOtherIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">67,461<span></span>
</td>
<td class="nump">93,289<span></span>
</td>
<td class="nump">100,004<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">262,458<span></span>
</td>
<td class="nump">204,113<span></span>
</td>
<td class="nump">191,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">57,077<span></span>
</td>
<td class="nump">39,431<span></span>
</td>
<td class="nump">48,870<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 205,381<span></span>
</td>
<td class="nump">$ 164,682<span></span>
</td>
<td class="nump">$ 142,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 4.09<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="nump">$ 2.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">$ 2.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50,259<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
<td class="nump">50,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">50,842<span></span>
</td>
<td class="nump">50,605<span></span>
</td>
<td class="nump">51,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="num">$ (1,296)<span></span>
</td>
<td class="nump">$ 20,333<span></span>
</td>
<td class="num">$ (12,363)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Unrealized gain (loss) on interest rate swaps</a></td>
<td class="nump">1,819<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
<td class="num">(4,864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrecognized net gain (loss) on pension plans</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Net gain on pension distribution reclassified to net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">769<span></span>
</td>
<td class="nump">24,360<span></span>
</td>
<td class="num">(18,414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">206,150<span></span>
</td>
<td class="nump">189,042<span></span>
</td>
<td class="nump">123,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,086,770<span></span>
</td>
<td class="nump">943,324<span></span>
</td>
<td class="nump">962,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CostOfSalesExclusiveOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CostOfSalesExclusiveOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_TotalOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_TotalOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Shares Outstanding [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517574984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 27,185<span></span>
</td>
<td class="nump">$ 32,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $19,720 and $16,457, respectively</a></td>
<td class="nump">139,330<span></span>
</td>
<td class="nump">114,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">120,342<span></span>
</td>
<td class="nump">114,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,410<span></span>
</td>
<td class="nump">7,903<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">293,267<span></span>
</td>
<td class="nump">269,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">71,300<span></span>
</td>
<td class="nump">70,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,372<span></span>
</td>
<td class="nump">23,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">6,858<span></span>
</td>
<td class="nump">8,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">578,976<span></span>
</td>
<td class="nump">578,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,696,635<span></span>
</td>
<td class="nump">2,475,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,273<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,670,681<span></span>
</td>
<td class="nump">3,429,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">55,760<span></span>
</td>
<td class="nump">45,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendsPayableCurrent', window );">Accrued interest payable</a></td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">6,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">6,360<span></span>
</td>
<td class="nump">5,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current portion</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">74,113<span></span>
</td>
<td class="nump">61,402<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">143,422<span></span>
</td>
<td class="nump">122,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">1,476,658<span></span>
</td>
<td class="nump">1,479,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">444,917<span></span>
</td>
<td class="nump">434,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities, net of current portion</a></td>
<td class="nump">16,088<span></span>
</td>
<td class="nump">19,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities, net of current portion</a></td>
<td class="nump">4,501<span></span>
</td>
<td class="nump">6,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">7,484<span></span>
</td>
<td class="nump">8,612<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,093,070<span></span>
</td>
<td class="nump">2,070,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies &#8211; Note 17</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock &#8211; $0.01 par value; Authorized &#8211; 5,000 shares; Issued and outstanding &#8211; None</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8211; $0.01 par value; Authorized &#8211; 250,000 shares; Issued &#8211; 54,430 shares at March 31, 2022 and 53,999 shares at March 31, 2021</a></td>
<td class="nump">544<span></span>
</td>
<td class="nump">540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">515,583<span></span>
</td>
<td class="nump">499,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 4,151 shares at March 31, 2022 and 4,088 shares at March 31, 2021</a></td>
<td class="num">(133,648)<span></span>
</td>
<td class="num">(130,732)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(19,032)<span></span>
</td>
<td class="num">(19,801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,214,164<span></span>
</td>
<td class="nump">1,008,783<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">1,577,611<span></span>
</td>
<td class="nump">1,358,298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">$ 3,670,681<span></span>
</td>
<td class="nump">$ 3,429,273<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516212792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for accounts receivable</a></td>
<td class="nump">$ 19,720<span></span>
</td>
<td class="nump">$ 16,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">54,430,000<span></span>
</td>
<td class="nump">53,999,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">4,151,000<span></span>
</td>
<td class="nump">4,088,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508811128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, common stock (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance, treasury stock (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,871,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 1,095,831<span></span>
</td>
<td class="nump">$ 536<span></span>
</td>
<td class="nump">$ 479,150<span></span>
</td>
<td class="num">$ (59,928)<span></span>
</td>
<td class="num">$ (25,747)<span></span>
</td>
<td class="nump">$ 701,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 7,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">47,900<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,324<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,848,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(57,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (57,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">142,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(18,414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,805,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury stock (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,719,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">1,170,971<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
<td class="nump">488,116<span></span>
</td>
<td class="num">$ (117,623)<span></span>
</td>
<td class="num">(44,161)<span></span>
</td>
<td class="nump">844,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 8,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">119,600<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 2,851<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(13,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">164,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">$ 24,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,999,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury stock (in shares) at Mar. 31, 2021</a></td>
<td class="nump">4,088,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,088,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,358,298<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
<td class="nump">499,508<span></span>
</td>
<td class="num">$ (130,732)<span></span>
</td>
<td class="num">(19,801)<span></span>
</td>
<td class="nump">1,008,783<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 9,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">226,000.0<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 7,040<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of shares related to restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury share repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="num">(2,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">205,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">$ 769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, common stock (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,430,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, treasury stock (in shares) at Mar. 31, 2022</a></td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 1,577,611<span></span>
</td>
<td class="nump">$ 544<span></span>
</td>
<td class="nump">$ 515,583<span></span>
</td>
<td class="num">$ (133,648)<span></span>
</td>
<td class="num">$ (19,032)<span></span>
</td>
<td class="nump">$ 1,214,164<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508637208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 205,381<span></span>
</td>
<td class="nump">$ 164,682<span></span>
</td>
<td class="nump">$ 142,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">32,092<span></span>
</td>
<td class="nump">30,164<span></span>
</td>
<td class="nump">28,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale or disposal of property and equipment</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">9,979<span></span>
</td>
<td class="nump">18,628<span></span>
</td>
<td class="nump">13,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt origination costs</a></td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">3,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">9,039<span></span>
</td>
<td class="nump">8,543<span></span>
</td>
<td class="nump">7,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">12,327<span></span>
</td>
<td class="nump">2,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets', window );">Non-cash operating lease cost</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">7,082<span></span>
</td>
<td class="nump">8,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">2,434<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(7,854)<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(24,654)<span></span>
</td>
<td class="nump">36,872<span></span>
</td>
<td class="num">(2,849)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">2,972<span></span>
</td>
<td class="nump">2,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,448<span></span>
</td>
<td class="num">(3,227)<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">9,154<span></span>
</td>
<td class="num">(17,342)<span></span>
</td>
<td class="nump">6,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">9,616<span></span>
</td>
<td class="num">(14,912)<span></span>
</td>
<td class="nump">12,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(6,448)<span></span>
</td>
<td class="num">(6,718)<span></span>
</td>
<td class="num">(8,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other</a></td>
<td class="num">(725)<span></span>
</td>
<td class="num">(3,243)<span></span>
</td>
<td class="num">(1,448)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">259,922<span></span>
</td>
<td class="nump">235,607<span></span>
</td>
<td class="nump">217,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(9,642)<span></span>
</td>
<td class="num">(22,243)<span></span>
</td>
<td class="num">(14,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EscrowReceipt', window );">Escrow receipt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions</a></td>
<td class="num">(247,046)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(256,511)<span></span>
</td>
<td class="num">(22,243)<span></span>
</td>
<td class="num">(16,570)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Term Loan repayments</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(195,000)<span></span>
</td>
<td class="num">(48,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from refinancing of Term Loan</a></td>
<td class="nump">597,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under revolving credit agreement</a></td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit agreement</a></td>
<td class="num">(85,000)<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(120,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of debt costs</a></td>
<td class="num">(6,111)<span></span>
</td>
<td class="num">(17,718)<span></span>
</td>
<td class="num">(6,584)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments of finance leases</a></td>
<td class="num">(2,582)<span></span>
</td>
<td class="num">(1,443)<span></span>
</td>
<td class="num">(476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="nump">2,851<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Fair value of shares surrendered as payment of tax withholding</a></td>
<td class="num">(2,916)<span></span>
</td>
<td class="num">(1,242)<span></span>
</td>
<td class="num">(974)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,867)<span></span>
</td>
<td class="num">(56,721)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(7,569)<span></span>
</td>
<td class="num">(279,419)<span></span>
</td>
<td class="num">(131,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(959)<span></span>
</td>
<td class="nump">3,597<span></span>
</td>
<td class="num">(1,893)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(5,117)<span></span>
</td>
<td class="num">(62,458)<span></span>
</td>
<td class="nump">67,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of year</a></td>
<td class="nump">32,302<span></span>
</td>
<td class="nump">94,760<span></span>
</td>
<td class="nump">27,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of year</a></td>
<td class="nump">27,185<span></span>
</td>
<td class="nump">32,302<span></span>
</td>
<td class="nump">94,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">61,364<span></span>
</td>
<td class="nump">80,290<span></span>
</td>
<td class="nump">92,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 46,568<span></span>
</td>
<td class="nump">$ 34,381<span></span>
</td>
<td class="nump">$ 30,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AdditionsToOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions To Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AdditionsToOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EscrowReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow Receipt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EscrowReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncreaseDecreaseInOperatingLeasesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Leases Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncreaseDecreaseInOperatingLeasesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510017928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Business and Basis of Presentation</a></td>
<td class="text">Business and Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prestige Consumer Healthcare Inc. (referred to herein as the &#8220;Company&#8221; or &#8220;we&#8221;, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#8220;OTC&#8221;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 9 to these Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic Environment  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the World Health Organization ("WHO") declared a global pandemic due to a new strain of coronavirus ("COVID-19").  The pandemic has caused significant volatility in the United States and global economies.  In addition, the Russian invasion of Ukraine has led to further economic uncertainty.  We expect economic conditions will continue to be highly volatile and uncertain and could affect demand for our products and put pressure on prices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We experienced a temporary but significant decline in consumer consumption of our brands in the first quarter of fiscal 2021, followed by more stable consumption and customer orders over the remainder of the year. Generally, throughout the pandemic, some categories were positively impacted (for instance, Women&#8217;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp; Cold and Gastrointestinal).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products, as consumers increased their focus on hygiene and self-care at home related to COVID-19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel-related activity. In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio. Our business also benefited from a significant increase in demand in travel-related categories and channels as well as the Cough &amp; Cold category, previously impacted by the COVID-19 virus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both the COVID-19 pandemic and the geopolitical environment have also impacted the supply of labor and raw materials and exacerbated rising costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We continue to generate operating cash flows to meet our short-term liquidity needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These circumstances could change, however, in this dynamic, unprecedented environment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the COVID-19 outbreak worsens or geopolitical conditions cause further disruption in the global supply chain, the availability of labor or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreak and recovery period and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;Our fiscal year ends on March 31st of each year.&#160;&#160;References in these Consolidated Financial Statements or notes to a year (e.g., &#8220;2022&#8221;) mean our fiscal year ended on March 31st of that year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160;&#160;As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents.&#160;&#160;At March&#160;31, 2022, approximately 44% of our cash is held by a bank in Australia and approximately 18% is held by a bank in Singapore.  Substantially all of our remaining cash is held by a large U.S. domestic bank.&#160;&#160;We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.  Substantially all of the Company's cash balances at March&#160;31, 2022 are uninsured. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We extend non-interest-bearing trade credit to our customers in the ordinary course of business.&#160;&#160;We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable.&#160;&#160;In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers&#8217; financial condition, (iii) monitor the payment history and aging of customers&#8217; receivables, and (iv) monitor open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, where cost is determined by using the first-in, first-out method.&#160;&#160;We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value.&#160;&#160;Factors utilized in the determination of estimated net realizable value include (i) product expiration dates, (ii) current sales data and historical return rates, (iii) estimates of future demand, (iv) competitive pricing pressures, (v) new product introductions, and (vi) component and packaging obsolescence.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 15</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 to 10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred.&#160;&#160;When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill.&#160;&#160;Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level.  An impairment loss is recognized if the carrying amount of the reporting unit exceeds its fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets generally represent tradenames, brand names and patents and are stated at cost less accumulated amortization.&#160;&#160;For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are tested for impairment at the individual asset level at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Intangible assets with finite lives are reviewed for impairment on an annual basis, or whenever events or changes in circumstances indicate that their carrying amount may exceed their fair values and may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Origination Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred debt origination costs in connection with the issuance of long-term debt.&#160;&#160;These costs are amortized over the term of the related debt, using the effective interest method for our senior notes and our term loan facility and the straight-line method for our revolving credit facility.  Costs associated with our revolving credit facility are reported as a long-term asset and costs related to our senior notes and the term loan facility are recorded as a reduction of debt. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Nature of Goods and Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from product sales.  We primarily ship finished goods to our customers and operate in two segments: North American OTC Healthcare and International OTC Healthcare.  The segments are based on differences in geographical area.  The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough &amp; Cold, Women's Health, Gastrointestinal, Eye &amp; Ear Care, Dermatologicals, and Oral Care.  Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels, all of which sell our products to consumers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 19 for disaggregated revenue information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Satisfaction of Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#8217;s carrier. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to the disclosure of remaining performance obligations.  Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time.  Accordingly, we have elected the practical expedient available under ASC 606 not to disclose </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remaining performance obligations for our contracts.  The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less.  As such, we do not adjust product consideration for the effects of a significant financing component.  The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes costs related to the manufacturing of our products, including raw materials, direct labor and indirect plant costs (including but not limited to depreciation), warehousing costs, inbound and outbound shipping costs, and handling and storage costs.&#160;&#160;Warehousing, shipping and handling and storage costs were $67.8 million for 2022, $52.1 million for 2021 and $61.9 million for 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising and Marketing Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising and marketing costs are expensed as incurred.&#160;&#160;Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense by measuring the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million and we recognized a settlement gain of $0.2 million as a result of the payout.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process.  The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute.  Changes in interest rates and the market value of the securities held by the plans could materially change the funded status of the plans, positively or negatively, and affect the level of pension expense and required contributions in fiscal 2023 and beyond. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Income Taxes topic of the FASB ASC 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&#160;&#160;The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.  As a result, we have applied such guidance in determining our tax uncertainties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the United States and various state and foreign jurisdictions.&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an antidilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share.  The following table sets forth the computation of basic and diluted earnings per share:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share - weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2022, 2021, and 2020 there were 0.4 million, 0.5 million, and 0.3 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. These leases have lease terms of 1 to 10 years, some of which include options to terminate or extend leases for up to 1 to 5 years or on a month-to-month basis.  The exercise of lease renewal options is at our sole discretion and our lease right-of-use ("ROU") assets and liabilities reflect only the options we are reasonably certain that we will exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset.  ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.  Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments, which do not vary based on an index or rate, are excluded from the ROU asset and lease liability determination.  Variable lease payments are typically usage-based and are recorded in the period in which the obligation for those payments is incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in our leases is unknown, we used our incremental borrowing rate based on the information available at the date of adoption for existing leases and at the lease commencement date for new leases in determining the present value of future lease payments. We give consideration to our credit risk, term of the lease, total lease payments and adjust for the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impacts of collateral, as necessary, when calculating our incremental borrowing rates.  Rent expense for our operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the measurement and classification of our lease agreements, we group lease and non-lease components into a single lease component for all underlying asset classes. We have also elected to exclude any leases within our existing classes of assets with a term of twelve months or less.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We adopted this standard effective April 1, 2021, and the adoption of this standard did not have a material impact on our Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020 using the modified retrospective approach, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We adopted this standard effective April 1, 2021 and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This update amended a number of aspects of lease accounting, including requiring lessees to recognize all leases with a term greater than one year as a ROU asset and corresponding lease liability, measured at the present value of the lease payments.  On April 1, 2019, we adopted Topic 842 using the modified retrospective approach.  Results for the years ended March&#160;31, 2022, 2021 and 2020 are presented under Topic 842. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020 (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above).  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022,  including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510869368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisition</a></td>
<td class="text">Acquisition<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Akorn</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn"), pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9&#160;million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 9).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was accounted for as a business combination.  During 2022, we incurred acquisition-related costs of $5.1&#160;million, which are included in General and administrative expense.  In connection with the acquisition, we also entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  These purchase price allocations are preliminary as we are in the process of finalizing the valuation.  The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this preliminary analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years (see Note 6).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded goodwill of $1.6&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired (see Note 5).  Goodwill is deductible and is being amortized for income tax purposes. </span></div>The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510699976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,959&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.9 million and $4.0 million at March&#160;31, 2022 and 2021, respectively, related to obsolete and slow-moving inventory.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510854664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Property, Plant and Equipment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>We recorded depreciation expense of $8.0 million, $8.5 million, and $8.8 million for 2022, 2021, and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555519138936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2020, 2021, and 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 43.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2, on July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn.  In connection with this acquisition, we recorded goodwill of $1.6&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At February 28, 2021, in conjunction with the annual test for goodwill impairment, we recorded an impairment charge of $1.2&#160;million to adjust the carrying amount of goodwill related to our International Analgesics reporting unit in our International OTC Healthcare segment to its fair value.  The goodwill impairment was a result of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> tradename impairment discussed in Note 5.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At February 28, 2022, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, we recorded an impairment charge of $0.3&#160;million to write off the remaining goodwill related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Painstop </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">brand in our International OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify our reporting units in accordance with the FASB ASC Subtopic 280.  The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies.  The discounted cash flow methodology is a widely-accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently.&#160;&#160;We also considered our market capitalization at February&#160;28, 2022 and February&#160;28, 2021, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.&#160;&#160;The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, increased product costs, supply chain/material cost inflation, or the potential impacts of COVID-19.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value. If these assumptions are adversely affected, we may be required to record impairment charges in the future. </span></div>As a result of our analysis at February&#160;28, 2022, all reporting units had a fair value that exceeded their carrying value by at least 10%.  We performed a sensitivity analysis on our weighted average cost of capital and we determined that a 50 basis point increase in the weighted average cost of capital would not have resulted in any of our other reporting units' fair value being less than their carrying value.  Additionally, a 50 basis point decrease in the terminal growth rate used for each reporting unit would also not have resulted in any of our other reporting units' fair value being less than their carrying value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510699976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net for each of 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets based on our preliminary analysis for Akorn and $18.1 million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of each fiscal year, in conjunction with our strategic planning process, we perform our annual impairment analysis.  We utilized the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins and advertising and marketing expenses.   The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, increased product costs, changes in advertising and marketing expenses, or the potential impacts of COVID-19, we may be required to record impairment charges in the future.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, did not exceed its carrying amount.  As such, we recorded an impairment charge of $1.2&#160;million. The decline in the fair value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was primarily related to a decline in expected future sales due to a regulatory change that now requires </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Painstop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be prescribed by physicians rather than sold over-the-counter direct to consumers</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February&#160;28, 2022, in conjunction with the annual test for impairment of intangible assets, we recorded an impairment charge of $0.7&#160;million.  In connection with our long-term planning, two non-core brands in our North American OTC Healthcare segment were discontinued and therefore the related finite-lived intangible assets were written off. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our analysis at February&#160;28, 2022, all indefinite-lived intangible assets tested had a fair value that exceeded their carrying value by at least 10%, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename which had a fair value exceeding its carrying value by 7%.  We performed a sensitivity analysis of our weighted average cost of capital, and we determined that a 50 basis point increase in the weighted average cost of capital used to value the indefinite-lived intangible assets would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value, with the exception of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename was acquired on July 1, 2021 and given the close proximity of the acquisition to the annual impairment test, we would expect the fair value to more closely approximate the carrying value.  A 50 basis point increase in the weighted average cost of capital would result in an impairment charge of $4.3&#160;million on our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TheraTears</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tradename.  Additionally, a 50 basis point decrease in the terminal growth rate used for each of our indefinite-lived </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intangible assets' would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining life for finite-lived intangible assets at March&#160;31, 2022 was approximately 9.8 years, and the amortization expense for the year ended March&#160;31, 2022 was $21.5 million.  At March&#160;31, 2022, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514842264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:6.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:70.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during 2022, 2021 and 2020.  The noncash lease liability arising from obtaining ROU assets was $0.5&#160;million for the assets that went into service in 2022, $5.2&#160;million for the assets that went into service in 2021 and $6.4&#160;million for assets that went into service in 2020.  These amounts represent noncash financing activities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:6.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:70.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during 2022, 2021 and 2020.  The noncash lease liability arising from obtaining ROU assets was $0.5&#160;million for the assets that went into service in 2022, $5.2&#160;million for the assets that went into service in 2021 and $6.4&#160;million for assets that went into service in 2020.  These amounts represent noncash financing activities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510793304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text">Other Accrued Liabilities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510793304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a floor of 1.00%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479,653&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had no balance outstanding on the 2012 ABL Revolver and a borrowing capacity of $123.3 million. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2012 Term Loan and 2012 ABL Revolver:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2012, Prestige Brands, Inc. (the &#8220;Borrower")  entered into a senior secured credit facility, which consists of (i) the $660.0 million 2012 Term Loan with an original 7-year maturity and (ii) the $50.0 million 2012 ABL Revolver with an original 5-year maturity.  In subsequent years, we have utilized portions of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $85.0 million to $135.0 million and reduced our borrowing rate on the 2012 ABL Revolver by 0.25% (discussed below).  The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to us of $650.1 million.  The 2012 Term Loan is unconditionally guaranteed by Prestige Consumer Healthcare Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower.  Each of these guarantees is joint and several.  There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 21, 2013, we entered into Amendment No. 1 ("Term Loan Amendment No. 1") to the 2012 Term Loan.  Term Loan Amendment No. 1 provided for the refinancing of all of our existing Term B Loans with new Term B-1 Loans (the "Term B-1 Loans").  The interest rate on the Term B-1 Loans under Term Loan Amendment No. 1 was based, at our option, on a LIBOR rate plus a margin of 2.75% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin.  In addition, Term Loan Amendment No. 1 provided the Borrower with certain additional capacity to prepay subordinated debt, our then-outstanding senior notes and certain other unsecured indebtedness permitted to be incurred under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2014, we entered into Amendment No. 2 ("Term Loan Amendment No. 2") to the 2012 Term Loan.  Term Loan Amendment No. 2 provided for (i) the creation of a new class of Term B-2 Loans under the 2012 Term Loan (the "Term B-2 Loans") in an aggregate principal amount of $720.0 million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility and financial maintenance covenant relief, and (iii) an interest rate on (x) the Term B-1 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.125% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin, and (y) the Term B-2 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.50% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin (with a margin step-down to 3.25% per annum, based upon achievement of a specified secured net leverage ratio). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, on September 3, 2014, we entered into Amendment No. 3 ("ABL Amendment No. 3") to the 2012 ABL Revolver.  ABL Amendment No. 3 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility.  Borrowings under the 2012 ABL Revolver, as amended, bore interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., and (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs.  The applicable margin for borrowings under the 2012 ABL Revolver could be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter.  In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we were required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder.  The initial commitment fee rate was 0.50% per annum.  The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments by an amount set forth in the credit agreement covering the 2012 ABL Revolver.  We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2015, we entered into Amendment No. 3 ("Term Loan Amendment No. 3") to the 2012 Term Loan.  Term Loan Amendment No. 3 provided for (i) the creation of a new class of Term B-3 Loans under the 2012 Term Loan (the "Term B-3 Loans") in an aggregate principal amount of $852.5 million, which combined the outstanding balances of the Term B-1 Loans of $207.5 million and the Term B-2 Loans of $645.0 million, and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  The maturity date of the Term B-3 Loans remained the same as the Term B-2 Loans' original maturity date of September 3, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2015, we entered into Amendment No. 4 (&#8220;ABL Amendment No. 4&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 4 provided for (i) a $35.0 million increase in the accordion feature under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief and (iii) extended the maturity date of the 2012 ABL Revolver to June 9, 2020, which was five years from the effective date of ABL Amendment No. 4.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2016, we entered into Amendment No. 5 (&#8220;ABL Amendment No. 5&#8221;) to the 2012 ABL Revolver.  ABL Amendment No. 5 temporarily suspended certain financial and related reporting covenants in the 2012 ABL Revolver until the earliest of (i) the date that was 60 calendar days following February 4, 2016, (ii) the date upon which certain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DenTek&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assets were included in the Company&#8217;s borrowing base under the 2012 ABL Revolver and (iii) the date upon which the Company received net proceeds from an offering of debt securities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Fleet acquisition, on January 26, 2017, we entered into Amendment No. 4 ("Term Loan Amendment No. 4") to the 2012 Term Loan.  Term Loan Amendment No. 4 provided for (i) the refinancing of all of our outstanding term loans and the creation of a new class of Term B-4 Loans under the 2012 Term Loan (the "Term B-4 Loans") in an aggregate principal amount of $1,427.0 million and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  Term Loan Amendment No. 4 also extended the maturity date of the 2012 Term Loan to January 26, 2024.  In addition, Citibank, N.A. was succeeded by Barclays Bank PLC as administrative agent under the 2012 Term Loan.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, on January 26, 2017, we entered into Amendment No. 6 ("ABL Amendment No. 6") to the 2012 ABL Revolver.  ABL Amendment No. 6 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver, (ii) an extension of the maturity date of revolving commitments to January 26, 2022, and (iii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility consistent with Term Loan Amendment No. 4.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2018, we entered into Amendment No. 5 (&#8220;Term Loan Amendment No. 5&#8221;) to the 2012 Term Loan.  Term Loan Amendment No. 5 provided for the creation of Term B-5 Loans (the "Term B-5 Loans") by repricing of the Term B-4 Loans under the credit agreement governing the 2012 Term Loan to an interest rate that is based, at our option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.00%, or an alternative base rate plus a margin of 1.00% per annum, with a floor of 1.00%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, we entered into Amendment No. 7 ("ABL Amendment No. 7") to the 2012 ABL Revolver.  ABL Amendment No. 7 provides for (i) an extension of the maturity date of the 2012 ABL Revolver to December 11, 2024, which is five years from the effective date of ABL Amendment No. 7, (ii) increased flexibility under the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility, (iii) an initial applicable margin for borrowings under the 2012 ABL Revolver that is 1.00% with respect to LIBOR borrowings and 0.0% with respect to base-rate borrowings (which may be increased to 1.25% or 1.50% for LIBOR borrowings and 0.25% or 0.50% for base-rate borrowings, depending on </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">average excess availability under the facility during the prior fiscal quarter), and (iv) a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder of 0.25% per annum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 1, 2021, we entered into Amendment No. 6 ("Term Loan Amendment No. 6") to the 2012 Term Loan.  Term Loan Amendment No. 6 provided for (i) the refinancing of our outstanding term loans and the creation of a new class of Term B-5 Loans under the credit agreement governing the 2012 Term Loan in an aggregate principal amount of $600.0&#160;million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, and (iii) an interest rate on the Term B-5 Loans that is based, at the Borrower's option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.50%, or an alternative base rate plus a margin of 1.00% per annum.   In addition, Term Loan Amendment No. 6 provided for an extension of the maturity date of the 2012 Term Loan to July 1, 2028.  In connection with this refinancing, we recorded a loss on extinguishment of debt of $2.1&#160;million to write off a portion of new and old debt costs relating to this refinancing.  Under Term Loan Amendment No. 6, we are required to make quarterly payments each equal to 0.25% of the aggregate principal amount of the 2012 Term Loan.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds from the new class of Term B-5 Loans were used to refinance our outstanding term loans, finance the acquisition of Akorn and pay fees and expenses incurred in connection with these transactions (see Note 2).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March&#160;31, 2022, the average interest rate on the 2012 Term Loan was 3.6% and the average interest rate on the amounts borrowed under the 2012 ABL Revolver was 1.2%.  For the year ended March&#160;31, 2021, the average interest rate on the 2012 Term Loan was 3.9% and the average interest rate on the amounts borrowed under the 2021 ABL Revolver was 1.7%.   During the year ended March&#160;31, 2022, we made required repayments of $1.5&#160;million as well as voluntary principal payments of $103.5&#160;million against the outstanding balance under our 2012 Term Loan.  Since we have made optional payments that exceed all of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity on July 1, 2028.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2013 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2013, the Borrower issued $400.0 million of senior unsecured notes, with an interest rate of 5.375% and a maturity date of December 15, 2021 (the "2013 Senior Notes").  These notes were redeemed on December 16, 2019 using the funds from the issuance of our 2019 Senior Notes described below.  In conjunction with the redemption of our 2013 Senior Notes, we wrote off related debt costs of $2.2 million in the year ended March 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2016 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 19, 2016, the Borrower completed the sale of $350.0 million aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#8220;Initial Notes&#8221;). On March 21, 2018, the Borrower completed the sale of $250.0 million additional aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#8220;Additional Notes&#8221;).  Both the Initial Notes and the Additional Notes (the "2016 Senior Notes") were redeemed on March 1, 2021 using funds from the issuance of our 2021 Senior Notes described below.  In conjunction with the redemption of the 2016 Senior Notes, we wrote off related debt costs of $2.7 million and paid a premium to redeem the 2016 Senior Notes of $9.6 million in the year ended March 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2019, the Borrower issued $400.0&#160;million aggregate principal amount of 5.125% senior notes due January 15, 2028 (the "2019 Senior Notes") pursuant to an indenture dated December 2, 2019, among the Borrower, the guarantors party thereto (including the Company) and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2019 Senior Notes, together with cash on hand, to redeem all $400.0&#160;million of our outstanding 2013 Senior Notes, which were due in 2021, and to pay related fees and expenses.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Senior Notes:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Borrower issued $600.0&#160;million aggregate principal amount of 3.750% senior notes due April 1, 2031 (the "2021 Senior Notes") pursuant to an indenture dated March 1, 2021, among Prestige Brands, Inc., the guarantors party thereto (including the Company), and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2021 Senior Notes to redeem all $600.0&#160;million of our outstanding 2016 Senior Notes, which were due in 2024, and to pay related fees and expenses. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemptions and Restrictions:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2019 Senior Notes at any time on or after January 15, 2023 at the redemption prices set forth in the indenture governing the 2019 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2019 Senior Notes), the Borrower will be required to make an offer to purchase the 2019 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the option to redeem all or a portion of the 2021 Senior Notes at any time on or after April 1, 2026 at the redemption prices set forth in the indenture governing the 2021 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2021 Senior Notes), the Borrower will be required to make an offer to purchase the 2021 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates.  Additionally, the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  At March&#160;31, 2022, we were in compliance with the covenants under our long-term indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swaps:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, we entered into two interest rate swaps to hedge a total of $400.0&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and the other settled on January 31, 2022 (see Note 11 for further details).    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:63.760%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510820888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Quoted market prices for identical instruments in active markets;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the Term B-5 Loans, the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March&#160;31, 2022 and 2021). </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and 2021, we did not have any assets or liabilities measured in Level 1 or 3.  During 2022, 2021 and 2020, there were no transfers of assets or liabilities between Levels 1, 2 and 3.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASU 2015-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, investments that are measured at fair value using net asset value ("NAV") per share as a practical expedient have not been classified in the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510898840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">Derivative Instruments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020, we entered into two interest rate swaps to hedge a total of $400.0&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and other settled on January 31, 2022.  The fair value of these interest rate swaps was reflected in the Consolidated Balance Sheets in other accrued liabilities.  We do not use derivatives for trading purposes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,363)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterparty Credit Risk:</span></div>We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510684728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on the Company's common stock through March&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.04</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.91</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.2 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.9 million</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510775960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#8220;2005 Plan&#8221;), which provided for grants of up to a maximum of 5.0&#160;million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8&#160;million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0&#160;million to 2.5&#160;million shares, and an extension of the term of the 2005 Plan by ten years to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#8220;2020 Plan&#8221;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of 2,827,210 shares were available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, there were $2.8 million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">weighted average period of 1.7 years.  At March&#160;31, 2022, there were&#160;$8.5 million of unrecognized compensation costs related to unvested RSUs and performance-based stock units ("PSUs") under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures that may occur.  We expect to recognize such costs over a weighted average period of 1.5 years.    </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, there were 2.5 million shares available for issuance under the 2020 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">On May 3, 2021, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 77,345 performance units, 73,108 RSUs and stock options to acquire 222,660 shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $44.33 per share, which was equal to the closing price for our common stock on the date of the grant. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">A newly appointed independent member of the Board of Directors received a grant under the 2020 Plan of 1,636 RSUs on May 3, 2021.  </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Each of the independent members of the Board of Directors received a grant of 2,808 RSUs on August 3, 2021 under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of one share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted to employees under the 2005 Plan and the 2020 Plan generally vest in three years, primarily upon the attainment of certain time vesting thresholds, and, in the case of performance share units, may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before interest, income taxes, depreciation and amortization targets.&#160;&#160;The RSUs provide for accelerated vesting if there is a change of control, as defined in the 2005 Plan and the 2020 Plan.&#160; The RSUs granted to employees generally vest either ratably over three years or in their entirety on the three-year anniversary of the date of the grant.  Upon vesting, the units will be settled in shares of our common stock.  Termination of employment prior to vesting will result in forfeiture of the RSUs, unless otherwise accelerated by the Committee or, in the case of RSUs granted in May 2018 and later, subject to pro-rata vesting in the event of death, disability or retirement.  The RSUs granted to directors prior to fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's disability or (iii) the six-month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.  The RSUs granted to directors beginning in fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's separation from service or (iii) a change in control of the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSUs granted under the 2005 Plan and 2020 Plan is presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:66.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2005 Plan and the 2020 Plan provide that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted.&#160;&#160;Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three years.&#160;&#160;The option awards provide for accelerated vesting in the event of a change in control, as defined in the 2005 Plan and the 2020 Plan.  Except in the case of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested stock options.  Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the 2005 Plan and the 2020 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below.&#160;&#160;Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies.&#160;&#160;We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors.&#160;&#160;Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation.&#160;&#160;The expected terms of the options granted are derived from our historical experience, management&#8217;s estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding.&#160;&#160;The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1% - 31.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1% - 32.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9% to 31.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0% to 1.3% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3% to 2.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.83</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and 2020 Plan is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted <br/>Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The aggregate intrinsic value of options exercised during 2022, 2021 and 2020 was $6.0 million, $2.2 million and $0.4 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514375352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccumulatedOtherComprehensiveIncomeTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI consisted of the following at March&#160;31, 2022 and 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,032)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,801)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccumulatedOtherComprehensiveIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccumulatedOtherComprehensiveIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514376744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(715)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal components of our deferred tax balances are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,722&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred cumulative catch-up adjustments - revenue recognition adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484,776)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,054)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432,860)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net deferred tax liability shown above is net of $1.9 million of foreign deferred tax assets as of March&#160;31, 2022 and $1.2 million of foreign deferred tax assets as of March&#160;31, 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no valuation allowance as of March&#160;31, 2021 and March&#160;31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax liability activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other movements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize interest and penalties related to uncertain tax positions as a component of income tax (benefit) expense.  We did not incur any material interest or penalties related to income taxes in 2022, 2021 or 2020.  We reasonably anticipate that uncertain tax positions could decrease in the next year by approximately $0.5 million, principally due to the statute of limitation expirations if recognized and would impact the effective tax rate in a future period.  We are subject to taxation in the United States and various state and foreign jurisdictions, and we are generally open to examination from the year ended March 31, 2018 forward.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514378136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Retirement Plans</a></td>
<td class="text">Employee Retirement Plans<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined contribution plan in which all U.S. full-time employees are eligible to participate.  The participants may contribute from 1% to 70% of their compensation, as defined in the plan.  We match 100% of the first 3%, plus 50% of the next 3%, of each participant's base compensation with full vesting immediately.  We may also make additional contributions to the plan as determined by the Board of Directors.  The total expense for the defined contribution plan was $1.7 million, $1.6 million and $1.5 million for 2022, 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under ERISA. The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan (the "Plan") with an effective date of March 1, 2015.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the Plan and began the Plan termination process.  Pension obligations related to the Plan of $47.2&#160;million are expected to be distributed through a combination of lump sum payments to eligible Plan participants who elect such payments and through the purchase of annuity contracts to the remaining participants. The benefit obligation for the Plan as of March 31, 2021 was therefore determined on a plan termination basis for which it is assumed that a portion of eligible active and deferred vested participants will elect lump sum payments.  The Plan likely has sufficient assets to satisfy all transaction obligations and all payments related to the termination are expected to be paid out of Plan assets.  No distributions have been made as of March 31, 2022.   The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefit Obligations and Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the U.S. pension plan obligations and plan assets and includes a statement of the plans' funded status as of March&#160;31, 2022 and 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,405)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet at the end of the period consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefit Cost (Income) consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.908%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our pension plans with an accumulated benefit obligation and a projected benefit obligation in excess of plan assets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pension benefit amounts stated above include one pension plan that is an unfunded plan.  The projected benefit obligation and accumulated benefit obligation for this unfunded plan were $4.3 million as of March&#160;31, 2022 and $4.7 million as of March&#160;31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes amounts that are expected to be contributed to the plans by the Company.  It reflects benefit payments that are made from the plans' assets as well as those made directly from the Company's assets.  The amounts in the table are actuarially determined and reflect the Company's best estimate given its current knowledge; actual amounts could be materially different.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employer contributions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (expectation) to participant benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected benefit payments year ending March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not make any contributions to our qualified defined benefit plan during 2022, and we contributed $3.0 million and $1.0 million to our qualified defined benefit plan during 2021 and 2020, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million, and we recognized a settlement gain of $0.2 million as a result of the payout.  The settlement credit was determined based on a remeasurement of the plan as of December 31, 2020, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected.  Those remeasurement assumptions were also used to determine the net periodic pension income for the plan for the fourth quarter of fiscal 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's primary investment objective for its qualified pension plan assets is to provide a source of retirement income for the Plan's participants and beneficiaries.  The asset allocation for the Company's funded retirement plan as of March&#160;31, 2022 and 2021, and the target allocation by asset category are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income and cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan assets are invested in a portfolio consisting primarily of domestic fixed income held within collective investment trust funds as of March&#160;31, 2022 due to the plan termination process which began during the fourth quarter of fiscal 2021 and the plan's positive funded status. The plan assets were invested in a portfolio consisting primarily of domestic fixed income as of March&#160;31, 2022.   These assets are measured at NAV as a practical expedient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the unrecognized actuarial loss (gain) included in accumulated other comprehensive income (loss) at March&#160;31, 2022, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the net periodic benefit cost (income) for the fiscal years ended March&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.277%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 *</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58% to 2.95%   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37% to 3.55% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% to 3.99%  </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets, net of administrative fees</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*The qualified plan was remeasured at December 31, 2020 for settlement accounting, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected and used to determine the net periodic benefit cost (income) for the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the benefit obligation as of March&#160;31, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26% to 3.48%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58% to 2.95%</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The determination of the expected long-term rate of return was derived from an optimized portfolio using an asset allocation software program.  The risk and return assumptions, along with the correlations between the asset classes, were entered into the program.  Based on these assumptions and historical experience, the portfolio is expected to achieve a long-term rate of return of 2.75%.  The investment managers engaged to manage the portfolio are expected to outperform their expected benchmarks on a relative basis over a full market cycle.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514376744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved from time to time in routine legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Commitments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 7 for a description of our operating and finance leases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have supply agreements for the manufacture of some of our products.  The following table shows the minimum amounts that we are committed to pay under these agreements:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514367592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations of Risk</a></td>
<td class="text">Concentrations of Risk<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are concentrated in the areas of OTC Healthcare.&#160;&#160;We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.&#160;&#160;During 2022, 2021, and 2020, approximately 41.3%, 45.6%, and 42.6%, respectively, of our gross revenues were derived from our five top selling brands.&#160;&#160;One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented.  During 2022, 2021, and 2020, Walmart accounted for approximately 20.5%, 21.6%, and 23.1%, respectively, of our gross revenues.&#160;At March&#160;31, 2022, approximately 22.1% of our accounts receivable were owed by Walmart.    </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our product distribution in the United States is managed by a third-party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufacturers many of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Summer's Eve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Fleet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or contagious disease outbreaks or other public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had relationships with 128 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 23 manufacturers that produced items that accounted for approximately 69.0% of our gross sales for 2022, compared to 19 manufacturers with long-term contracts that accounted for approximately 70.5% of gross sales in 2021.&#160;&#160;The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results from operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555511224680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments</a></td>
<td class="text">Business Segments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280.  Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare.  We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our operating and reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues* </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $3.5 million were eliminated from the North America OTC Healthcare segment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275,611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goodwill and intangible assets by geographic area are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275,611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517441128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 3, 2022, the Company's Board of Directors authorized the repurchase of up to $50.0&#160;million of the Company's issued and outstanding common stock.  Under the authorization, the Company may purchase common stock through May, 2023 utilizing open market transactions, transactions structured through investment banking institutions, in privately-negotiated transactions, by direct purchases of common stock or a combination of the foregoing in compliance with the applicable rules and regulations of the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Based Compensation</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2022, the Committee granted 67,959 performance units, 65,721 RSUs and stock options to acquire 195,526 shares of our common stock to certain executive officers and employees under the 2020 Plan.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the three-year anniversary of the date of grant.  RSUs vest either 33.3% per year over three years or in their entirety on the three-year or five-year anniversary of the date of grant.  Upon vesting, both performance units and RSUs will be settled in shares of our common stock.  The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant.  These stock options were granted at an exercise price of $54.47 per share, which is equal to the closing price for our common stock on the date of the grant.  Except in cases of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested performance units, RSUs and the stock options.  Vested stock options will remain exercisable by the employee after termination, subject to the terms of the 2020 Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510823400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II Valuation and Qualifying Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.063%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of<br/>Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts<br/>Charged to<br/>Expense (Income)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,270)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,586)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,873)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales returns and allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,669)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for trade promotions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for consumer coupon redemptions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)  Relates to opening balance sheet adjustments for our Akorn acquisition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)  Relates to the release of the valuation allowance on foreign tax credits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)  Relates to the unutilized foreign tax credit carryovers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517467672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;Our fiscal year ends on March 31st of each year.&#160;&#160;References in these Consolidated Financial Statements or notes to a year (e.g., &#8220;2022&#8221;) mean our fiscal year ended on March 31st of that year.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are </span></div>based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160;&#160;As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsWe consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents.&#160;&#160;At March&#160;31, 2022, approximately 44% of our cash is held by a bank in Australia and approximately 18% is held by a bank in Singapore.  Substantially all of our remaining cash is held by a large U.S. domestic bank.&#160;&#160;We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We extend non-interest-bearing trade credit to our customers in the ordinary course of business.&#160;&#160;We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable.&#160;&#160;In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers&#8217; financial condition, (iii) monitor the payment history and aging of customers&#8217; receivables, and (iv) monitor open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, where cost is determined by using the first-in, first-out method.&#160;&#160;We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value.&#160;&#160;Factors utilized in the determination of estimated net realizable value include (i) product expiration dates, (ii) current sales data and historical return rates, (iii) estimates of future demand, (iv) competitive pricing pressures, (v) new product introductions, and (vi) component and packaging obsolescence.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 15</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 to 10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred.&#160;&#160;When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill.&#160;&#160;Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level.  An impairment loss is recognized if the carrying amount of the reporting unit exceeds its fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets generally represent tradenames, brand names and patents and are stated at cost less accumulated amortization.&#160;&#160;For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years.</span></div>Indefinite-lived intangible assets are tested for impairment at the individual asset level at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Intangible assets with finite lives are reviewed for impairment on an annual basis, or whenever events or changes in circumstances indicate that their carrying amount may exceed their fair values and may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Debt Origination Costs</a></td>
<td class="text">Debt Origination CostsWe have incurred debt origination costs in connection with the issuance of long-term debt.&#160;&#160;These costs are amortized over the term of the related debt, using the effective interest method for our senior notes and our term loan facility and the straight-line method for our revolving credit facility.  Costs associated with our revolving credit facility are reported as a long-term asset and costs related to our senior notes and the term loan facility are recorded as a reduction of debt.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Nature of Goods and Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue from product sales.  We primarily ship finished goods to our customers and operate in two segments: North American OTC Healthcare and International OTC Healthcare.  The segments are based on differences in geographical area.  The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough &amp; Cold, Women's Health, Gastrointestinal, Eye &amp; Ear Care, Dermatologicals, and Oral Care.  Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels, all of which sell our products to consumers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 19 for disaggregated revenue information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Satisfaction of Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 606, revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#8217;s carrier. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Variable Consideration</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Practical Expedients</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to the disclosure of remaining performance obligations.  Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time.  Accordingly, we have elected the practical expedient available under ASC 606 not to disclose </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remaining performance obligations for our contracts.  The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less.  As such, we do not adjust product consideration for the effects of a significant financing component.  The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CostOfSalesPolicyPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text">Cost of SalesCost of sales includes costs related to the manufacturing of our products, including raw materials, direct labor and indirect plant costs (including but not limited to depreciation), warehousing costs, inbound and outbound shipping costs, and handling and storage costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Marketing Costs</a></td>
<td class="text">Advertising and Marketing CostsAdvertising and marketing costs are expensed as incurred.&#160;&#160;Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation expense by measuring the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Pension Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#8217;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million and we recognized a settlement gain of $0.2 million as a result of the payout.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process.  The plan termination is expected to be completed in the first quarter of fiscal 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div>The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute.  Changes in interest rates and the market value of the securities held by the plans could materially change the funded status of the plans, positively or negatively, and affect the level of pension expense and required contributions in fiscal 2023 and beyond.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Income Taxes topic of the FASB ASC 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&#160;&#160;The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.  As a result, we have applied such guidance in determining our tax uncertainties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the United States and various state and foreign jurisdictions.&#160;&#160;</span></div>We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per ShareBasic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an antidilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real estate and equipment for use in our operations. These leases have lease terms of 1 to 10 years, some of which include options to terminate or extend leases for up to 1 to 5 years or on a month-to-month basis.  The exercise of lease renewal options is at our sole discretion and our lease right-of-use ("ROU") assets and liabilities reflect only the options we are reasonably certain that we will exercise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset.  ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.  Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments, which do not vary based on an index or rate, are excluded from the ROU asset and lease liability determination.  Variable lease payments are typically usage-based and are recorded in the period in which the obligation for those payments is incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the implicit rate in our leases is unknown, we used our incremental borrowing rate based on the information available at the date of adoption for existing leases and at the lease commencement date for new leases in determining the present value of future lease payments. We give consideration to our credit risk, term of the lease, total lease payments and adjust for the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impacts of collateral, as necessary, when calculating our incremental borrowing rates.  Rent expense for our operating leases is recognized on a straight-line basis over the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the measurement and classification of our lease agreements, we group lease and non-lease components into a single lease component for all underlying asset classes. We have also elected to exclude any leases within our existing classes of assets with a term of twelve months or less.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We adopted this standard effective April 1, 2021, and the adoption of this standard did not have a material impact on our Consolidated Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020 using the modified retrospective approach, and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2018, the FASB issued ASU 2018-14,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We adopted this standard effective April 1, 2021 and the adoption did not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  This update amended a number of aspects of lease accounting, including requiring lessees to recognize all leases with a term greater than one year as a ROU asset and corresponding lease liability, measured at the present value of the lease payments.  On April 1, 2019, we adopted Topic 842 using the modified retrospective approach.  Results for the years ended March&#160;31, 2022, 2021 and 2020 are presented under Topic 842. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which we adopted effective April 1, 2020 (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above).  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022,  including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the FASB issued ASU 2022-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The purpose of the ASU is to address questions raised on ASU 2017-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#8220;IBORs&#8221;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#8220;LIBOR&#8221;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CostOfSalesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost Of Sales Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CostOfSalesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555511440040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 15</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 to 10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Property, Plant and Equipment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text">The following table sets forth the computation of basic and diluted earnings per share:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for basic earnings per share - weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of unvested restricted stock units and options issued to employees and directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for diluted earnings per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,140&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Common Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net earnings per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net earnings per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.04&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510712040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text">The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 1, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves for sales allowances </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510818552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.153%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Inventories</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging and raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,342&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,959&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510751864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 40</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 15</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 to 10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Property, Plant and Equipment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,414&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510715240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Changes in Goodwill</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2020, 2021, and 2022:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,179&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 43.75pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164,958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,436&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516261720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsTableTextBlock', window );">Reconciliation of the Activity Affecting Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the activity affecting intangible assets, net for each of 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912,733&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets based on our preliminary analysis for Akorn and $18.1 million for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Zaditen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-<br/>Lived<br/>Tradenames</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-Lived<br/>Tradenames and Customer Relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amounts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradename impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,671,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of foreign currency exchange rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets, net by Reportable Segment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North American OTC Healthcare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International OTC Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net &#8211; March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Expected Amortization Expense</a></td>
<td class="text">At March&#160;31, 2022, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.062%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.738%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510742920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted average discount rate were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"/><td style="width:6.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:70.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.110%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Finance Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the maturities of lease liabilities were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:56.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amount of lease payments representing interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,717)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total present value of lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510768680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock', window );">Other Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued broker commissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued production costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued and Other Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555605532088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following, as of the dates indicated:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:72.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a floor of 1.00%, due on January 26, 2024.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479,653&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal Payments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:63.760%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510768680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the Term B-5 Loans, the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March&#160;31, 2022 and 2021). <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:30.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Term B-5 Loans, No. 6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 ABL Revolver</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510878936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Final Settlement Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Accrued Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,363)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our interest rate swaps, net of tax, for the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510705080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchases</a></td>
<td class="text">Our share repurchases consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased pursuant to the provisions of the various employee restricted stock awards:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$46.04</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.91</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 million</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.2 million</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased in conjunction with our share repurchase program:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amount repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11.9 million</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514543352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our stock-based compensation:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.105%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.815%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax share-based compensation costs charged against income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,644&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit recognized on compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of options and RSUs vested during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from the exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Shares</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSUs granted under the 2005 Plan and 2020 Plan is presented below:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:66.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock Options, Valuation Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1% - 31.9%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1% - 32.2%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9% to 31.3%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term in years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 to 7.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0% to 1.3% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5% </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3% to 2.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average grant date fair value of options granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.91</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.83</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2005 Plan and 2020 Plan is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted <br/>Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510720120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI consisted of the following at March&#160;31, 2022 and 2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Components of Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,032)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,801)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508602136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Income from Continuing Operations Before Income Taxes, Domestic and Foreign</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,151&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Provision for Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(715)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Deferred Tax Balances</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal components of our deferred tax balances are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts and sales returns</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign exchange loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,722&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred Tax Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471,327)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred cumulative catch-up adjustments - revenue recognition adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,239)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484,776)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,054)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432,860)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Effective Tax Rate</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,633)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,870&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Uncertain Tax Liability Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uncertain tax liability activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other movements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508556104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Benefit Obligation and Plan Assets</a></td>
<td class="text">The following table summarizes the changes in the U.S. pension plan obligations and plan assets and includes a statement of the plans' funded status as of March&#160;31, 2022 and 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation at beginning of period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,405)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contribution</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding our pension plans with an accumulated benefit obligation and a projected benefit obligation in excess of plan assets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of Amounts Recognized in Balance Sheet</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in the balance sheet at the end of the period consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent asset</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,799)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Primary Components of Net Periodic Benefits</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary components of Net Periodic Benefit Cost (Income) consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:49.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.908%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected to be Contributed</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes amounts that are expected to be contributed to the plans by the Company.  It reflects benefit payments that are made from the plans' assets as well as those made directly from the Company's assets.  The amounts in the table are actuarially determined and reflect the Company's best estimate given its current knowledge; actual amounts could be materially different.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension Benefits</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employer contributions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (expectation) to participant benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected benefit payments year ending March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text">The asset allocation for the Company's funded retirement plan as of March&#160;31, 2022 and 2021, and the target allocation by asset category are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income and cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock', window );">Schedule of Net Periodic Benefit Cost Not yet Recognized</a></td>
<td class="text">The following tables show the unrecognized actuarial loss (gain) included in accumulated other comprehensive income (loss) at March&#160;31, 2022, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">&#160;(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances in accumulated other comprehensive loss as of March 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial (gain)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Assumptions Used</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the net periodic benefit cost (income) for the fiscal years ended March&#160;31, 2022, 2021 and 2020 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.277%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 *</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58% to 2.95%   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37% to 3.55% </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% to 3.99%  </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets, net of administrative fees</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*The qualified plan was remeasured at December 31, 2020 for settlement accounting, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected and used to determine the net periodic benefit cost (income) for the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions used in determining the actuarial present value of the benefit obligation as of March&#160;31, 2022 and 2021 were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.323%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key assumptions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.26% to 3.48%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.58% to 2.95%</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555511230376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock', window );">Unrecorded Unconditional Purchase Obligations</a></td>
<td class="text">The following table shows the minimum amounts that we are committed to pay under these agreements:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligation not recognized as liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516086872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Information about our Operating and Reportable Segments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our operating and reportable segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.770%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues* </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*Intersegment revenues of $3.5 million were eliminated from the North America OTC Healthcare segment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Information about our Revenues from Similar Product Groups</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarize information about our segment revenues from similar product groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,931&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,319&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Analgesics</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cough &amp; Cold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women's Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye &amp; Ear Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatologicals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other OTC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Segment Revenue by Geographic Area</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total segment revenues by geographic area are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">943,365&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Allocation of Long-Term Assets to Segments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275,611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">(In thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">North American OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International OTC<br/>Healthcare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,195,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,281,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475,729&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock', window );">Goodwill and Intangible Assets by Geographic Areas</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goodwill and intangible assets by geographic area are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,932,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275,611&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508617912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business and Basis of Presentation (Cash and Cash Equivalents) (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=pbh_SydneyAustraliaMember', window );">Sydney, Australia</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_PercentageofDepositsHeldinOneLocation', window );">Percentage of deposits held in one location (as percent)</a></td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SG', window );">Singapore</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_PercentageofDepositsHeldinOneLocation', window );">Percentage of deposits held in one location (as percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_PercentageofDepositsHeldinOneLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Deposits Held in One Location</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_PercentageofDepositsHeldinOneLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=pbh_SydneyAustraliaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=pbh_SydneyAustraliaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508368920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Property, Plant and Equipment) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Machinery | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Machinery | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555605959288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Intangible Assets) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful lives</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510825080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Revenue Recognition) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555510950552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Cost of Sales) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Warehousing, shipping and handling and storage costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Warehousing, shipping and handling, and storage costs</a></td>
<td class="nump">$ 67.8<span></span>
</td>
<td class="nump">$ 52.1<span></span>
</td>
<td class="nump">$ 61.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516218248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Pension Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement', window );">Lump sum payout</a></td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement gain, before tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555511070328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business and Basis of Presentation (Earnings Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 205,381<span></span>
</td>
<td class="nump">$ 164,682<span></span>
</td>
<td class="nump">$ 142,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic earnings per share - weighted average shares outstanding</a></td>
<td class="nump">50,259<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
<td class="nump">50,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)</a></td>
<td class="nump">583<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted earnings (loss) per share (in shares)</a></td>
<td class="nump">50,842<span></span>
</td>
<td class="nump">50,605<span></span>
</td>
<td class="nump">51,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per Common Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share (in USD per share)</a></td>
<td class="nump">$ 4.09<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
<td class="nump">$ 2.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share (in USD per share)</a></td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">$ 2.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512495192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business and Basis of Presentation (Leases) (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508408664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="nump">$ 578,079<span></span>
</td>
<td class="nump">$ 575,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 228,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SupplyCommitmentTermOfAgreement', window );">Supply commitment, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">195,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, amortizable intangible assets, allocated amount</a></td>
<td class="nump">$ 29,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful lives</a></td>
<td class="text">12 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">20,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks | Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount', window );">Business combination, non-amortizable intangible assets, allocated amount</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense | Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Amortizable Intangible Assets, Allocated Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Non-Amortizable Intangible Assets, Allocated Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_SupplyCommitmentTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supply Commitment, Term of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_SupplyCommitmentTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515830168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,079<span></span>
</td>
<td class="nump">$ 575,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves', window );">Reserves for sales allowances and cash discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512488424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Packaging and raw materials</a></td>
<td class="nump">$ 16,984<span></span>
</td>
<td class="nump">$ 8,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">103,020<span></span>
</td>
<td class="nump">106,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">120,342<span></span>
</td>
<td class="nump">114,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves related to obsolete and slow-moving inventory</a></td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515991144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 132,015<span></span>
</td>
<td class="nump">$ 124,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(60,715)<span></span>
</td>
<td class="num">(54,355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">71,300<span></span>
</td>
<td class="nump">70,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">$ 8,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">550<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">29,046<span></span>
</td>
<td class="nump">27,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">48,390<span></span>
</td>
<td class="nump">45,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">25,245<span></span>
</td>
<td class="nump">24,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,238<span></span>
</td>
<td class="nump">3,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">9,080<span></span>
</td>
<td class="nump">9,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Components of Property, Plant and Equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 16,466<span></span>
</td>
<td class="nump">$ 14,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508414280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Schedule of Changes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 743,037<span></span>
</td>
<td class="nump">$ 738,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(164,958)<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,079<span></span>
</td>
<td class="nump">575,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="nump">4,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(340)<span></span>
</td>
<td class="num">(1,247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,274<span></span>
</td>
<td class="nump">743,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165,298)<span></span>
</td>
<td class="num">(164,958)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,976<span></span>
</td>
<td class="nump">578,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,354<span></span>
</td>
<td class="nump">710,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,002<span></span>
</td>
<td class="nump">710,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
<td class="num">(163,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548,291<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,683<span></span>
</td>
<td class="nump">28,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,247)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,436<span></span>
</td>
<td class="nump">28,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="nump">4,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment loss</a></td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="num">(340)<span></span>
</td>
<td class="num">(1,247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, gross, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,272<span></span>
</td>
<td class="nump">32,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,587)<span></span>
</td>
<td class="num">(1,247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,685<span></span>
</td>
<td class="nump">$ 31,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555509134632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="nump">$ 578,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">1,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember', window );">Measurement Input, Cap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,685<span></span>
</td>
<td class="nump">31,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">$ 1,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalAnalgesicsMember', window );">International Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalAnalgesicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalAnalgesicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555503647736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Reconciliation of Activity) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Dec. 15, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,281,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,281,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangibles, accumulated amortization, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,606<span></span>
</td>
<td class="nump">175,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Finite-lived intangibles, accumulated amortization, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,499<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit', window );">Finite-lived intangible assets, accumulated amortization, tradename impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Finite-lived intangibles, accumulated amortization, effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangibles, accumulated amortization, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,098<span></span>
</td>
<td class="nump">195,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,671,335<span></span>
</td>
<td class="nump">2,655,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Tradename impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,700)<span></span>
</td>
<td class="num">(1,186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss', window );">Effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(444)<span></span>
</td>
<td class="nump">17,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,912,733<span></span>
</td>
<td class="nump">2,671,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,281,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,076<span></span>
</td>
<td class="nump">193,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,696,635<span></span>
</td>
<td class="nump">2,475,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsAcquired', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember', window );">Akorn Operating Company LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsAcquired', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember', window );">Zaditen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsAcquired', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,589,870<span></span>
</td>
<td class="nump">2,386,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Finite-lived intangibles, tradename impairment</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,765<span></span>
</td>
<td class="nump">89,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangibles, gross, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,347<span></span>
</td>
<td class="nump">389,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangibles, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Finite-lived intangibles, tradename impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,700)<span></span>
</td>
<td class="num">(1,186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Finite-lived intangibles, effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">885<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangibles, gross, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">436,174<span></span>
</td>
<td class="nump">389,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract', window );"><strong>Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangibles, accumulated amortization, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,606<span></span>
</td>
<td class="nump">175,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Finite-lived intangibles, accumulated amortization, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,499<span></span>
</td>
<td class="nump">19,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit', window );">Finite-lived intangible assets, accumulated amortization, tradename impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss', window );">Finite-lived intangibles, accumulated amortization, effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangibles, accumulated amortization, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,098<span></span>
</td>
<td class="nump">195,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,281,988<span></span>
</td>
<td class="nump">2,265,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite lived intangibles, additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Indefinite-lived intangibles, effects of foreign currency exchange rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,329)<span></span>
</td>
<td class="nump">16,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,476,559<span></span>
</td>
<td class="nump">2,281,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,476,559<span></span>
</td>
<td class="nump">$ 2,281,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,391,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,391,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite- Lived Tradenames</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangibles, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsRollForward', window );"><strong>Gross Carrying Amounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Accumulated Amortization [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Accumulated Amortization, Written off Related to Sale of Business Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsTranslationAdjustmentsGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Translation Adjustments Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsTranslationAdjustmentsGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pbh_AkornOperatingCompanyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=pbh_ZaditenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515916568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,057<span></span>
</td>
<td class="nump">$ 2,434<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-lived intangible assets, weighted average remaining period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,499<span></span>
</td>
<td class="nump">$ 19,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Measurement Input, Long-term Revenue Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember', window );">Measurement Input, Long-term Revenue Growth Rate | Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember', window );">Measurement Input, Cap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount', window );">Indefinite-lived intangible asset, increase (decrease) in measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue', window );">Sensitivity analysis, increase In intangible asset measurement input that would not have resulted In fair value exceeding carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Intangible assets, tradename impairment</a></td>
<td class="num">$ (700)<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Increase In Intangible Asset Measurement Input That Would Not Have Resulted In Fair Value Exceeding Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512401528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Expected Amortization Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 22,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">22,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">20,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">18,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">16,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">119,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 220,076<span></span>
</td>
<td class="nump">$ 193,741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555511072024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Lease Cost) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 2,579<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">6,670<span></span>
</td>
<td class="nump">6,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">42,868<span></span>
</td>
<td class="nump">46,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total net lease cost</a></td>
<td class="nump">$ 52,463<span></span>
</td>
<td class="nump">$ 55,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516180248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Lease Maturities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 6,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">6,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">24,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">22,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">7,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">7,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne', window );">2023</a></td>
<td class="nump">9,853<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">9,726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">6,133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,308<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,969<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">31,694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount of lease payments representing interest</a></td>
<td class="num">(1,993)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_OperatingAndFinanceLeaseLiability', window );">Total present value of lease payments</a></td>
<td class="nump">$ 29,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payment Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due after Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514427432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Additional Information) (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years), operating leases</a></td>
<td class="text">4 years 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years), financing leases</a></td>
<td class="text">2 years 7 months 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_WeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, operating leases</a></td>
<td class="nump">3.03%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, financing leases</a></td>
<td class="nump">2.96%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514490008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">$ 6,858<span></span>
</td>
<td class="nump">$ 8,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember', window );">GEODIS Logistics LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets, net</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pbh_GEODISLogisticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515918440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing costs</a></td>
<td class="nump">$ 36,149<span></span>
</td>
<td class="nump">$ 29,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation costs</a></td>
<td class="nump">19,587<span></span>
</td>
<td class="nump">14,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Accrued broker commissions</a></td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">2,670<span></span>
</td>
<td class="nump">1,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">4,150<span></span>
</td>
<td class="nump">4,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedProductionCostsCurrent', window );">Accrued production costs</a></td>
<td class="nump">3,686<span></span>
</td>
<td class="nump">2,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Accrued sales tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">6,687<span></span>
</td>
<td class="nump">4,976<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_AccruedAndOtherLiabilitiesCurrent', window );">Total other accrued liabilities</a></td>
<td class="nump">$ 74,113<span></span>
</td>
<td class="nump">$ 61,402<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_AccruedProductionCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Production Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_AccruedProductionCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555504313992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Schedule of Long-term Debt) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 11, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,495,000,000<span></span>
</td>
<td class="nump">$ 1,495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less unamortized debt costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,342,000)<span></span>
</td>
<td class="num">(15,347,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,476,658,000<span></span>
</td>
<td class="nump">1,479,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember', window );">2021 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember', window );">2021 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member', window );">2019 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Revolving credit facility, remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Loans Payable, Term B-5 Amendment No. 5 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateMinimum', window );">Debt instrument, variable rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Loans Payable, Term B-5 Amendment No. 5 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Loans Payable, Term B-5 Amendment No. 5 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentVariableRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentVariableRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5AmendmentNo5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB5AmendmentNo5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555497645448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 11, 2019</div></th>
<th class="th"><div>Mar. 21, 2018</div></th>
<th class="th"><div>Feb. 04, 2016</div></th>
<th class="th">
<div>Jun. 09, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 03, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 21, 2013</div></th>
<th class="th">
<div>Jan. 31, 2012 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 26, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 08, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,122,000<span></span>
</td>
<td class="nump">$ 12,327,000<span></span>
</td>
<td class="nump">$ 2,155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount', window );">Debt instrument, period payment, percentage of principal amount</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate', window );">Debt Instrument, Alternative Basis Spread on Variable Rate</a></td>
<td class="nump">0.0100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_TermLoan2012Member', window );">2012 Term Loan | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 660,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentDiscountPercentage', window );">Debt instrument, discount (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit facility, commitment fee (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased', window );">Debt instrument, basis spread on variable rate, if increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased', window );">Debt instrument, basis spread on variable rate, if increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased', window );">Debt instrument, basis spread on variable rate, if increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased', window );">Debt instrument, basis spread on variable rate, if increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity', window );">Revolving credit facility, increase in borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Debt instrument, interest rate, decrease (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit facility, commitment fee (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage', window );">Line of credit facility, conditional commitment fee (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LineofCreditFacilityIncreaseinAccordionFeature', window );">Revolver increase in accordion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, average interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent', window );">Debt instrument, basis spread on variable rate, fixed component (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateConditionalVariableRate', window );">Debt instrument, conditional variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateConditionalVariableRate', window );">Debt instrument, conditional variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateConditionalVariableRate', window );">Debt instrument, conditional variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentVariableRateConditionalVariableRate', window );">Debt instrument, conditional variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Revolving Credit Facility | Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent', window );">Debt instrument, basis spread on variable rate, fixed component (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member', window );">2012 ABL Revolver | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt instrument, periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment', window );">Debt instrument, periodic payment, voluntary payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended2012TermLoanMember', window );">2012 Term Loan, Amendment No. 1 | Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended2012TermLoanMember', window );">2012 Term Loan, Amendment No. 1 | Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Loans Payable, Term B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 720,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Loans Payable, Term B-2 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember', window );">2012 Term Loan, Amendment No. 2 | Loans Payable, Term B-2 | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate', window );">Interest rate, contingent margin step-down per annum (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment3Member', window );">2012 ABL Revolver, Amendment No. 3 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity', window );">Revolving credit facility, increase in borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amendment32012TermLoanMember', window );">2012 Term Loan, Amendment No. 3 | Loans Payable, Term B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amendment32012TermLoanMember', window );">2012 Term Loan, Amendment No. 3 | 2012 Term B-3 Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amendment32012TermLoanMember', window );">2012 Term Loan, Amendment No. 3 | 2012 Term B-1 Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 207,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_ABLRevolverAmendment4Member', window );">ABL Revolver Amendment 4 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_ABLAmendmentNumber5Member', window );">ABL Amendment No. 5 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod', window );">Debt Instrument, temporary suspension of financial reporting covenant, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member', window );">2012 Senior Notes | 2012 Term B-4 Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,427,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, average interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment6Member', window );">2012 ABL Revolver, Amendment No. 6 | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity', window );">Revolving credit facility, increase in borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember', window );">2012 Term B-5 Loans, No. 5 | Term Loans | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember', window );">2012 Term B-5 Loans, No. 5 | Term Loans | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DebtInstrumentReferenceRateFloor', window );">Debt instrument, reference rate floor (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2013Member', window );">2013 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Alternative Basis Spread on Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread on Variable Rate, Fixed Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread On Variable Rate, If Increased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Contingent Margin Step Down Per Annum, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Temporary Suspension of Financial Reporting Covenant, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Period Payment, Percentage Of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Voluntary Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentReferenceRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Reference Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentReferenceRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DebtInstrumentVariableRateConditionalVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate, Conditional Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DebtInstrumentVariableRateConditionalVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Conditional Commitment Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase in Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_LineofCreditFacilityIncreaseinAccordionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase in Accordion Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_LineofCreditFacilityIncreaseinAccordionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_TermLoan2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_TermLoan2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=pbh_FederalFundsRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=pbh_FederalFundsRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_Amended2012TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_Amended2012TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_Amended22012TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_Amendment32012TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_Amendment32012TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_ABLRevolverAmendment4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_ABLRevolverAmendment4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_ABLAmendmentNumber5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_ABLAmendmentNumber5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pbh_LoansPayableTermB4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2012ABLRevolverAmendment6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2013Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2013Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517174168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Narrative 2013 Senior Notes) (Details) - Senior Notes - 2013 Senior Notes - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 17, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2013Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2013Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512414408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Narrative 2016 Senior Notes) (Details) - Senior Notes - 2016 Senior Notes - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 21, 2018</div></th>
<th class="th"><div>Feb. 19, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.375%<span></span>
</td>
<td class="nump">6.375%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Unamortized premium</a></td>
<td class="nump">$ 9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555497593976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Dec. 02, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember', window );">2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember', window );">2019 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Early repayment of senior debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember', window );">2021 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember', window );">2021 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Early repayment of senior debt</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2019SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555506987128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Narrative Redemptions and Restrictions) (Details) - Senior Notes - Indirect guarantee of indebtedness<br></strong></div></th>
<th class="th"><div>Feb. 19, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage of principal amount (as percent)</a></td>
<td class="nump">101.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2016 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument, redemption price, percentage of principal amount (as percent)</a></td>
<td class="nump">101.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_IndirectGuaranteeOfIndebtednessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_IndirectGuaranteeOfIndebtednessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515729480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Narrative Interest Rate Swaps) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 400.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512320120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Maturities of Long-term Debt) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 1,495,000<span></span>
</td>
<td class="nump">$ 1,495,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516145640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Senior Notes | 2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Senior Notes | 2021 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Term Loans | 2012 Term B-5 Loans, No. 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Term Loans | 2012 Term B-5 Loans, No. 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">495,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying value | Revolving Credit Facility | 2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Interest rate swaps</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Senior Notes | 2019 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">397,000<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Senior Notes | 2021 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">534,000<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Term Loans | 2012 Term B-5 Loans, No. 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">493,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Term Loans | 2012 Term B-5 Loans, No. 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">493,144<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Fair Value, Inputs, Level 2 | Revolving Credit Facility | 2012 ABL Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Debt, fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_SeniorNotes2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_A2021SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_Amendment52012TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_LoansPayableTermB5AmendmentNo6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pbh_AblRevolver2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555519115288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 400.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515849432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments (Fair Value) (Details) - Interest Rate Swap - Designated as Hedging Instrument - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Other Accrued Liabilities | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,363,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508926328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Schedule of Derivative Gains and Losses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="nump">$ 3,045<span></span>
</td>
<td class="num">$ (4,864)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)</a></td>
<td class="nump">1,819<span></span>
</td>
<td class="nump">3,045<span></span>
</td>
<td class="num">(4,864)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Designated as Hedging Instrument | Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income</a></td>
<td class="num">$ (2,429)<span></span>
</td>
<td class="num">$ (4,760)<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508612520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized | shares</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned', window );">Voting rights, number of votes per common share owned | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_VotingRightsNumberOfVotesPerCommonShareOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Voting Rights, Number of Votes Per Common Share Owned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_VotingRightsNumberOfVotesPerCommonShareOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516156424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Schedule of Shares Repurchased) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="nump">$ 2,916<span></span>
</td>
<td class="nump">$ 13,109<span></span>
</td>
<td class="nump">$ 57,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Restricted stock repurchased during period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">337,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Restricted stock acquired, average cost per share (in USD per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 35.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Restricted stock repurchased during period (in shares)</a></td>
<td class="nump">63,314<span></span>
</td>
<td class="nump">31,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Restricted stock acquired, average cost per share (in USD per share)</a></td>
<td class="nump">$ 46.04<span></span>
</td>
<td class="nump">$ 39.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury share repurchases</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=pbh_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508304728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 03, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 03, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2014 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 04, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares awarded, per employee, annual (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod', window );">Extension of plan term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based compensation expense, not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based compensation expense, not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for issuance under plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,200<span></span>
</td>
<td class="nump">249,900<span></span>
</td>
<td class="nump">302,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised, intrinsic value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember', window );">Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based compensation expense, not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based compensation expense, not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock units granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember', window );">Restricted Stock Units (RSUs) &amp; Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock units granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Award grant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant', window );">Award exercisability period, from date of grant (not greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock units granted in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,800<span></span>
</td>
<td class="nump">179,700<span></span>
</td>
<td class="nump">220,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Common stock units granted in period (in shares)</a></td>
<td class="nump">2,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted', window );">Number of securities into which each restricted stock unit may be converted</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted', window );">Restricted stock units, conversion ratio for securities into which each RSU may be converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member', window );">2005 Long-term Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized under plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member', window );">Long-term Incentive Plan, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,827,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares', window );">Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares', window );">Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">827,210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares, Reserved for Future Issuance, New Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Stock Units, Conversion Ratio For Securities Into Which Each RSU May Be Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisability Period, from Date of Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=pbh_RestrictedStockUnitsRSUsStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongtermEquityIncentivePlan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pbh_LongTermIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512390424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Based Compensation Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">$ 9,039<span></span>
</td>
<td class="nump">$ 8,543<span></span>
</td>
<td class="nump">$ 7,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit recognized on compensation costs</a></td>
<td class="nump">633<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue', window );">Total fair value of options and RSUs vested during the period</a></td>
<td class="nump">7,943<span></span>
</td>
<td class="nump">6,796<span></span>
</td>
<td class="nump">7,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="nump">2,851<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount', window );">Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises</a></td>
<td class="nump">$ 3,419<span></span>
</td>
<td class="nump">$ 1,153<span></span>
</td>
<td class="nump">$ 745<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517266840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Restricted Shares Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457,000.0<span></span>
</td>
<td class="nump">387,900<span></span>
</td>
<td class="nump">299,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,636<span></span>
</td>
<td class="nump">170,800<span></span>
</td>
<td class="nump">179,700<span></span>
</td>
<td class="nump">220,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued', window );">Vested and issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162,300)<span></span>
</td>
<td class="num">(100,200)<span></span>
</td>
<td class="num">(98,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,600)<span></span>
</td>
<td class="num">(10,400)<span></span>
</td>
<td class="num">(34,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,900<span></span>
</td>
<td class="nump">457,000.0<span></span>
</td>
<td class="nump">387,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber', window );">Vested, end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,800<span></span>
</td>
<td class="nump">150,400<span></span>
</td>
<td class="nump">124,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.52<span></span>
</td>
<td class="nump">$ 33.11<span></span>
</td>
<td class="nump">$ 38.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.32<span></span>
</td>
<td class="nump">40.22<span></span>
</td>
<td class="nump">31.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and issued, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.99<span></span>
</td>
<td class="nump">42.94<span></span>
</td>
<td class="nump">44.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.54<span></span>
</td>
<td class="nump">43.37<span></span>
</td>
<td class="nump">35.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.45<span></span>
</td>
<td class="nump">33.52<span></span>
</td>
<td class="nump">33.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, end of period, weighted-average grant-date fair value (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.42<span></span>
</td>
<td class="nump">$ 31.98<span></span>
</td>
<td class="nump">$ 30.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555509115016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Valuation Assumptions) (Details) - Stock Options - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of options granted (in USD per share)</a></td>
<td class="nump">$ 14.87<span></span>
</td>
<td class="nump">$ 12.91<span></span>
</td>
<td class="nump">$ 10.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">31.10%<span></span>
</td>
<td class="nump">32.10%<span></span>
</td>
<td class="nump">30.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">31.90%<span></span>
</td>
<td class="nump">32.20%<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515904120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Stock Option Activity) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">1,114,900<span></span>
</td>
<td class="nump">1,020,200<span></span>
</td>
<td class="nump">944,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">234,200<span></span>
</td>
<td class="nump">249,900<span></span>
</td>
<td class="nump">302,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(226,000.0)<span></span>
</td>
<td class="num">(119,600)<span></span>
</td>
<td class="num">(47,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(13,700)<span></span>
</td>
<td class="num">(21,700)<span></span>
</td>
<td class="num">(79,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(8,500)<span></span>
</td>
<td class="num">(13,900)<span></span>
</td>
<td class="num">(100,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">1,100,900<span></span>
</td>
<td class="nump">1,114,900<span></span>
</td>
<td class="nump">1,020,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period (in shares)</a></td>
<td class="nump">621,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">$ 37.92<span></span>
</td>
<td class="nump">$ 35.90<span></span>
</td>
<td class="nump">$ 38.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, grant date fair value (in USD per share)</a></td>
<td class="nump">44.74<span></span>
</td>
<td class="nump">39.98<span></span>
</td>
<td class="nump">30.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">31.15<span></span>
</td>
<td class="nump">23.83<span></span>
</td>
<td class="nump">27.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited weighted average exercise price (in USD per share)</a></td>
<td class="nump">37.83<span></span>
</td>
<td class="nump">34.65<span></span>
</td>
<td class="nump">32.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired weighted average exercise price (in USD per share)</a></td>
<td class="nump">56.63<span></span>
</td>
<td class="nump">52.86<span></span>
</td>
<td class="nump">50.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">40.62<span></span>
</td>
<td class="nump">$ 37.92<span></span>
</td>
<td class="nump">$ 35.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of period, weighted-average exercise price (in USD per share)</a></td>
<td class="nump">$ 40.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, end of period, weighted-average remaining contractual term</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, end of period, weighted-average remaining contractual term</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, end of period, aggregate intrinsic value</a></td>
<td class="nump">$ 14,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, end of period, aggregate intrinsic value</a></td>
<td class="nump">$ 8,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555516130600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="nump">$ 1,577,611<span></span>
</td>
<td class="nump">$ 1,358,298<span></span>
</td>
<td class="nump">$ 1,170,971<span></span>
</td>
<td class="nump">$ 1,095,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="num">(19,032)<span></span>
</td>
<td class="num">(19,801)<span></span>
</td>
<td class="num">$ (44,161)<span></span>
</td>
<td class="num">$ (25,747)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Cumulative translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="num">(20,204)<span></span>
</td>
<td class="num">(18,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,819)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="nump">$ 1,172<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508916392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Income Before Continuing Operations) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Income from Continuing Operations before Income Taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 236,381<span></span>
</td>
<td class="nump">$ 195,796<span></span>
</td>
<td class="nump">$ 167,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">26,077<span></span>
</td>
<td class="nump">8,317<span></span>
</td>
<td class="nump">23,643<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 262,458<span></span>
</td>
<td class="nump">$ 204,113<span></span>
</td>
<td class="nump">$ 191,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512226936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Components of Provision for Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 34,446<span></span>
</td>
<td class="nump">$ 11,513<span></span>
</td>
<td class="nump">$ 24,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">3,961<span></span>
</td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">8,709<span></span>
</td>
<td class="nump">5,849<span></span>
</td>
<td class="nump">8,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">12,055<span></span>
</td>
<td class="nump">14,430<span></span>
</td>
<td class="nump">14,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(1,379)<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
<td class="num">(341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(715)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 57,077<span></span>
</td>
<td class="nump">$ 39,431<span></span>
</td>
<td class="nump">$ 48,870<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515950600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Components of Deferred Tax Balances) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred Tax Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns', window );">Allowance for doubtful accounts and sales returns</a></td>
<td class="nump">$ 4,605<span></span>
</td>
<td class="nump">$ 4,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxAssetsInventoryRecapitalization', window );">Inventory capitalization</a></td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxAssetsInventoryReserves', window );">Inventory reserves</a></td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State income taxes</a></td>
<td class="nump">9,661<span></span>
</td>
<td class="nump">10,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">2,026<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued compensation</a></td>
<td class="nump">4,597<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">4,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign tax credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxAssetsLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">6,808<span></span>
</td>
<td class="nump">8,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Unrealized foreign exchange loss</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">5,682<span></span>
</td>
<td class="nump">5,916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">41,722<span></span>
</td>
<td class="nump">40,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred Tax Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="num">(7,210)<span></span>
</td>
<td class="num">(7,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(471,327)<span></span>
</td>
<td class="num">(458,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement', window );">Deferred cumulative catch-up adjustments - revenue recognition adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DeferredTaxLiabilityRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="num">(6,239)<span></span>
</td>
<td class="num">(7,605)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(484,776)<span></span>
</td>
<td class="num">(473,827)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">$ (443,054)<span></span>
</td>
<td class="num">$ (432,860)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxAssetsInventoryRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Inventory Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxAssetsInventoryRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxAssetsInventoryReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Inventory Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxAssetsInventoryReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts and Sales Returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Impact of Adopting New Accounting Pronouncement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DeferredTaxLiabilityRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DeferredTaxLiabilityRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517395144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months', window );">Estimated reduction in uncertain tax provisions, next 12 months</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax assets</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Reduction In Uncertain Tax Provisions, Next 12 Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515822104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Reconciliation of Effective Tax Rate) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax provision at statutory rate</a></td>
<td class="nump">$ 55,116<span></span>
</td>
<td class="nump">$ 42,864<span></span>
</td>
<td class="nump">$ 40,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax provision</a></td>
<td class="nump">2,876<span></span>
</td>
<td class="nump">3,972<span></span>
</td>
<td class="nump">2,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate', window );">State income taxes, net of federal income tax benefit</a></td>
<td class="nump">1,737<span></span>
</td>
<td class="nump">7,284<span></span>
</td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">R&amp;D</a></td>
<td class="num">(213)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations', window );">Compensation limitations</a></td>
<td class="nump">1,563<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,441)<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition', window );">Uncertain tax positions</a></td>
<td class="num">(369)<span></span>
</td>
<td class="num">(7,218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(3,633)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
<td class="nump">2,177<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations', window );">Total provision for income taxes</a></td>
<td class="nump">$ 57,077<span></span>
</td>
<td class="nump">$ 39,431<span></span>
</td>
<td class="nump">$ 48,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax provision at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax provision</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate', window );">State income taxes, net of federal income tax benefit</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">R&amp;D</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations', window );">Compensation limitations</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.70%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage', window );">Uncertain tax positions</a></td>
<td class="num">(0.001)<span></span>
</td>
<td class="num">(0.035)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations', window );">Total provision for income taxes</a></td>
<td class="nump">21.70%<span></span>
</td>
<td class="nump">19.30%<span></span>
</td>
<td class="nump">25.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate, Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation,, Uncertain Tax Position</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Uncertain Tax Position, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514904712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Uncertain Tax Liability Activity) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance &#8211; beginning of year</a></td>
<td class="nump">$ 4,030<span></span>
</td>
<td class="nump">$ 10,369<span></span>
</td>
<td class="nump">$ 9,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions based on lapse of statute of limitations</a></td>
<td class="num">(585)<span></span>
</td>
<td class="num">(6,756)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities', window );">Payments and other movements</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance &#8211; end of year</a></td>
<td class="nump">$ 3,562<span></span>
</td>
<td class="nump">$ 4,030<span></span>
</td>
<td class="nump">$ 10,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508178808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent', window );">Defined contribution plan, minimum annual contributions per participating employee (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Defined contribution plan, maximum annual contributions per employee (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,507<span></span>
</td>
<td class="nump">56,818<span></span>
</td>
<td class="nump">61,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement', window );">Lump sum payout</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement gain, before tax</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_DefinedBenefitPlanRemeasurementDiscountRate', window );">Defined benefit plan, remeasurement, discount rate</a></td>
<td class="nump">0.0251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Defined benefit plan, assumptions used calculating benefit obligation, discount rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets, net of administrative fees (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,507<span></span>
</td>
<td class="nump">56,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember', window );">Qualified plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contributions to the qualified plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets, net of administrative fees (as percent)</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember', window );">Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheOneMember', window );">Contribution Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined contribution plan, employer matching contribution, percent of match (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined contribution plan, employer matching contribution, percent of employees pay (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheTwoMember', window );">Contribution Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined contribution plan, employer matching contribution, percent of match (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined contribution plan, employer matching contribution, percent of employees pay (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DefinedBenefitPlanRemeasurementDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Remeasurement, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DefinedBenefitPlanRemeasurementDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Minimum Annual Contributions Per Participating Employee, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_RetirementPlanContributionAxis=pbh_ContributionTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515979400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Periodic Service Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation at beginning of period</a></td>
<td class="nump">$ 56,818<span></span>
</td>
<td class="nump">$ 61,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">$ 2,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(2,888)<span></span>
</td>
<td class="nump">3,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(3,530)<span></span>
</td>
<td class="num">(10,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations at end of year</a></td>
<td class="nump">51,507<span></span>
</td>
<td class="nump">56,818<span></span>
</td>
<td class="nump">61,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">53,275<span></span>
</td>
<td class="nump">52,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(1,405)<span></span>
</td>
<td class="nump">7,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Employer contribution</a></td>
<td class="nump">368<span></span>
</td>
<td class="nump">3,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(3,530)<span></span>
</td>
<td class="num">(10,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">48,708<span></span>
</td>
<td class="nump">53,275<span></span>
</td>
<td class="nump">$ 52,760<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of year</a></td>
<td class="num">$ (2,799)<span></span>
</td>
<td class="num">$ (3,543)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555517160024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent asset</a></td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="nump">$ 1,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liability</a></td>
<td class="nump">365<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liability</a></td>
<td class="nump">3,968<span></span>
</td>
<td class="nump">4,327<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent', window );">Total liabilities</a></td>
<td class="nump">4,333<span></span>
</td>
<td class="nump">4,684<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total net liability</a></td>
<td class="num">$ (2,799)<span></span>
</td>
<td class="num">$ (3,543)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512324920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Expected Return on Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="nump">$ 1,972<span></span>
</td>
<td class="nump">$ 2,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(1,163)<span></span>
</td>
<td class="num">(2,336)<span></span>
</td>
<td class="num">(2,886)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">$ (364)<span></span>
</td>
<td class="num">$ (559)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512228152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations</a></td>
<td class="nump">$ 51,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,818<span></span>
</td>
<td class="nump">$ 61,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">51,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">48,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations</a></td>
<td class="nump">51,507<span></span>
</td>
<td class="nump">$ 47,200<span></span>
</td>
<td class="nump">56,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 48,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508602104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Plans (Expected Benefit Payments) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear', window );">2023 (expectation) to participant benefits</a></td>
<td class="nump">$ 365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">3,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">3,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">3,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">3,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">3,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2031</a></td>
<td class="nump">$ 16,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512270456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Plans (Category of Plan Assets) (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Allocation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of Plan Assets</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember', window );">Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Allocation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of Plan Assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember', window );">Fixed income and cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target Allocation</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Percentage of Plan Assets</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512385320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized actuarial (gain) loss</a></td>
<td class="num">$ (1,522)<span></span>
</td>
<td class="num">$ (1,202)<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service credit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555497626152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Retirement Plans (Weighted Average Assumptions) (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets, net of administrative fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember', window );">Qualified plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets, net of administrative fees</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.26%<span></span>
</td>
<td class="nump">2.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Qualified plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.58%<span></span>
</td>
<td class="nump">3.37%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.48%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Qualified plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="nump">3.99%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555514410824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Long-term Supply Agreement) (Details) - Third-party Manufacturing<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">2024</a></td>
<td class="nump">5,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">2025</a></td>
<td class="nump">5,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">2026</a></td>
<td class="nump">4,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">2027</a></td>
<td class="nump">4,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">5,367<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total purchase commitment</a></td>
<td class="nump">$ 32,609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=pbh_ThirdPartyManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=pbh_ThirdPartyManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555497628568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations of Risk (Details) - manufacturer<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturers', window );">Number of third-party manufacturers</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Product concentration risk | Top 5 brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">41.30%<span></span>
</td>
<td class="nump">45.60%<span></span>
</td>
<td class="nump">42.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Customer concentration risk | Walmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">20.50%<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Supplier concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts', window );">Number of third-party manufacturers with long-term contracts</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales | Supplier concentration risk | Manufactures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">70.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Customer concentration risk | Walmart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">22.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_NumberOfThirdPartyManufacturersWithLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Third-party Manufacturers with Long-term Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_NumberOfThirdPartyManufacturersWithLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pbh_Top5BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pbh_Top5BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pbh_WalmartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pbh_WalmartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_ManufacturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_ManufacturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555509064488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">$ 1,086,812<span></span>
</td>
<td class="nump">$ 943,365<span></span>
</td>
<td class="nump">$ 963,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">466,166<span></span>
</td>
<td class="nump">395,893<span></span>
</td>
<td class="nump">410,787<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">620,646<span></span>
</td>
<td class="nump">547,472<span></span>
</td>
<td class="nump">552,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">157,343<span></span>
</td>
<td class="nump">140,589<span></span>
</td>
<td class="nump">147,194<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">463,303<span></span>
</td>
<td class="nump">406,883<span></span>
</td>
<td class="nump">405,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense', window );">Other operating expenses</a></td>
<td class="nump">133,384<span></span>
</td>
<td class="nump">109,481<span></span>
</td>
<td class="nump">113,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">329,919<span></span>
</td>
<td class="nump">297,402<span></span>
</td>
<td class="nump">291,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">967,881<span></span>
</td>
<td class="nump">849,319<span></span>
</td>
<td class="nump">859,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">419,162<span></span>
</td>
<td class="nump">359,100<span></span>
</td>
<td class="nump">372,133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">548,719<span></span>
</td>
<td class="nump">490,219<span></span>
</td>
<td class="nump">487,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">138,714<span></span>
</td>
<td class="nump">122,857<span></span>
</td>
<td class="nump">127,972<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">410,005<span></span>
</td>
<td class="nump">367,362<span></span>
</td>
<td class="nump">359,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Segment Reporting Information, Profit (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">118,931<span></span>
</td>
<td class="nump">94,046<span></span>
</td>
<td class="nump">103,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">47,004<span></span>
</td>
<td class="nump">36,793<span></span>
</td>
<td class="nump">38,654<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">71,927<span></span>
</td>
<td class="nump">57,253<span></span>
</td>
<td class="nump">64,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing</a></td>
<td class="nump">18,629<span></span>
</td>
<td class="nump">17,732<span></span>
</td>
<td class="nump">19,222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ContributionMargin', window );">Contribution margin</a></td>
<td class="nump">$ 53,298<span></span>
</td>
<td class="nump">$ 39,521<span></span>
</td>
<td class="nump">$ 45,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contribution Margin</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and Administrative, and Depreciation and Amortization Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508150744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Revenue by Product) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">$ 1,086,812<span></span>
</td>
<td class="nump">$ 943,365<span></span>
</td>
<td class="nump">$ 963,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember', window );">Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">119,323<span></span>
</td>
<td class="nump">119,142<span></span>
</td>
<td class="nump">114,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember', window );">Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">107,080<span></span>
</td>
<td class="nump">70,641<span></span>
</td>
<td class="nump">111,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember', window );">Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">264,509<span></span>
</td>
<td class="nump">268,097<span></span>
</td>
<td class="nump">251,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember', window );">Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">204,559<span></span>
</td>
<td class="nump">161,136<span></span>
</td>
<td class="nump">172,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember', window );">Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">163,449<span></span>
</td>
<td class="nump">110,409<span></span>
</td>
<td class="nump">112,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember', window );">Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">120,386<span></span>
</td>
<td class="nump">107,083<span></span>
</td>
<td class="nump">103,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OralCareMember', window );">Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">97,521<span></span>
</td>
<td class="nump">101,431<span></span>
</td>
<td class="nump">93,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember', window );">Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">9,985<span></span>
</td>
<td class="nump">5,426<span></span>
</td>
<td class="nump">5,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">967,881<span></span>
</td>
<td class="nump">849,319<span></span>
</td>
<td class="nump">859,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">117,868<span></span>
</td>
<td class="nump">117,775<span></span>
</td>
<td class="nump">113,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">86,855<span></span>
</td>
<td class="nump">56,158<span></span>
</td>
<td class="nump">87,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">249,136<span></span>
</td>
<td class="nump">252,535<span></span>
</td>
<td class="nump">239,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">152,191<span></span>
</td>
<td class="nump">124,755<span></span>
</td>
<td class="nump">130,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">149,454<span></span>
</td>
<td class="nump">99,774<span></span>
</td>
<td class="nump">100,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">117,173<span></span>
</td>
<td class="nump">103,998<span></span>
</td>
<td class="nump">100,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">85,239<span></span>
</td>
<td class="nump">88,903<span></span>
</td>
<td class="nump">83,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">9,965<span></span>
</td>
<td class="nump">5,421<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">118,931<span></span>
</td>
<td class="nump">94,046<span></span>
</td>
<td class="nump">103,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Analgesics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">877<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Cough &amp; Cold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">20,225<span></span>
</td>
<td class="nump">14,483<span></span>
</td>
<td class="nump">23,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">15,373<span></span>
</td>
<td class="nump">15,562<span></span>
</td>
<td class="nump">12,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Gastrointestinal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">52,368<span></span>
</td>
<td class="nump">36,381<span></span>
</td>
<td class="nump">42,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Eye &amp; Ear Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">13,995<span></span>
</td>
<td class="nump">10,635<span></span>
</td>
<td class="nump">11,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Dermatologicals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">3,213<span></span>
</td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">12,282<span></span>
</td>
<td class="nump">12,528<span></span>
</td>
<td class="nump">9,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare | Other OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_AnalgesicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_AnalgesicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_CoughAndColdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_CoughAndColdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_GastrointestinalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_GastrointestinalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_DermatologicalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_DermatologicalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pbh_OtherOtcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pbh_OtherOtcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555512352536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments (Revenue by Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">$ 1,086,812<span></span>
</td>
<td class="nump">$ 943,365<span></span>
</td>
<td class="nump">$ 963,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">910,106<span></span>
</td>
<td class="nump">799,038<span></span>
</td>
<td class="nump">812,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total segment revenues</a></td>
<td class="nump">$ 176,706<span></span>
</td>
<td class="nump">$ 144,327<span></span>
</td>
<td class="nump">$ 150,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508233048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segments (Assets by Segment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 578,976<span></span>
</td>
<td class="nump">$ 578,079<span></span>
</td>
<td class="nump">$ 575,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,281,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="nump">220,076<span></span>
</td>
<td class="nump">193,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,696,635<span></span>
</td>
<td class="nump">2,475,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">3,275,611<span></span>
</td>
<td class="nump">3,053,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember', window );">North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">548,291<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
<td class="nump">546,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,195,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,589,870<span></span>
</td>
<td class="nump">2,386,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">3,138,161<span></span>
</td>
<td class="nump">2,932,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember', window );">International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">30,685<span></span>
</td>
<td class="nump">31,436<span></span>
</td>
<td class="nump">28,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">106,765<span></span>
</td>
<td class="nump">89,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">137,450<span></span>
</td>
<td class="nump">121,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="nump">220,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="nump">198,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember', window );">Finite-Lived Tradenames and Customer Relationships | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets</a></td>
<td class="nump">21,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">2,476,559<span></span>
</td>
<td class="nump">$ 2,281,988<span></span>
</td>
<td class="nump">$ 2,265,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames | North American OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">2,391,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember', window );">Indefinite- Lived Tradenames | International OTC Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems', window );"><strong>Segment Reporting, Asset Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 85,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAssetReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAssetReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pbh_FiniteLivedTradenamesandCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=pbh_IndefinitelivedTradenamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555515804984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems', window );"><strong>Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">$ 3,275,611<span></span>
</td>
<td class="nump">$ 3,053,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems', window );"><strong>Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">3,138,161<span></span>
</td>
<td class="nump">2,932,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems', window );"><strong>Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets, net (including goodwill)</a></td>
<td class="nump">$ 137,450<span></span>
</td>
<td class="nump">$ 121,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555504321544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 02, 2022</div></th>
<th class="th"><div>May 03, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>May 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,200<span></span>
</td>
<td class="nump">249,900<span></span>
</td>
<td class="nump">302,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
<td class="nump">170,800<span></span>
</td>
<td class="nump">179,700<span></span>
</td>
<td class="nump">220,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Award grant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">67,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">65,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rights (as percent)</a></td>
<td class="nump">33.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">195,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rights (as percent)</a></td>
<td class="nump">33.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Award term</a></td>
<td class="text">ten years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Award grant exercise price (in dollars per share)</a></td>
<td class="nump">$ 54.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140555508143528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember', window );">Reserves for sales returns and allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 12,163<span></span>
</td>
<td class="nump">$ 15,809<span></span>
</td>
<td class="nump">$ 8,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts Charged to Expense (Income)</a></td>
<td class="nump">53,230<span></span>
</td>
<td class="nump">46,195<span></span>
</td>
<td class="nump">57,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">&#160; Deductions</a></td>
<td class="num">(51,579)<span></span>
</td>
<td class="num">(49,841)<span></span>
</td>
<td class="num">(50,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther', window );">Other</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">14,561<span></span>
</td>
<td class="nump">12,163<span></span>
</td>
<td class="nump">15,809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesforTradePromotionsMember', window );">Reserves for trade promotions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">18,422<span></span>
</td>
<td class="nump">18,389<span></span>
</td>
<td class="nump">15,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts Charged to Expense (Income)</a></td>
<td class="nump">89,547<span></span>
</td>
<td class="nump">83,479<span></span>
</td>
<td class="nump">88,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">&#160; Deductions</a></td>
<td class="num">(84,270)<span></span>
</td>
<td class="num">(83,446)<span></span>
</td>
<td class="num">(85,604)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther', window );">Other</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">24,644<span></span>
</td>
<td class="nump">18,422<span></span>
</td>
<td class="nump">18,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesForConsumerCouponRedemptionsMember', window );">Reserves for consumer coupon redemptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">1,941<span></span>
</td>
<td class="nump">2,063<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts Charged to Expense (Income)</a></td>
<td class="nump">4,107<span></span>
</td>
<td class="nump">3,751<span></span>
</td>
<td class="nump">4,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">&#160; Deductions</a></td>
<td class="num">(4,586)<span></span>
</td>
<td class="num">(3,873)<span></span>
</td>
<td class="num">(3,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther', window );">Other</a></td>
<td class="nump">2,429<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">1,941<span></span>
</td>
<td class="nump">2,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">1,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts Charged to Expense (Income)</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">&#160; Deductions</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="num">(624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,441<span></span>
</td>
<td class="nump">3,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Amounts Charged to Expense (Income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,441)<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">&#160; Deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pbh_SECSchedule1209ValuationAllowancesandReservesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Valuation Allowances and Reserves, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pbh_SECSchedule1209ValuationAllowancesandReservesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pbh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_SalesReturnsAndAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesforTradePromotionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesforTradePromotionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesForConsumerCouponRedemptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=pbh_ReservesForConsumerCouponRedemptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>pbh-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pbh="http://www.prestigebrandsinc.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pbh-20220331.xsd" xlink:type="simple"/>
    <context id="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7683433268a44f5ea2cd487803f35f28_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib4fe5d55882d42cba9c5a5c6c603bfa9_I20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-05-02</instant>
        </period>
    </context>
    <context id="i7d976548ec964eb5954900d40178b30f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7de1d5544ee45609a500258ca33677e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9a00f6c3c9634209a4b9779c5515e978_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic98e8e0686d4426182259a392bf61706_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i53deaff486304c7d94652052dc9167fa_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id433e0cb04fa4a559bfc9daff43da79c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iab3ff8d1f6794953b2718ae0cc777203_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic0c43cd8d468472d94116a8e5f90b255_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ied280415580b4c01b9d20134fe0942a6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i82cf1b32e6744300b132ae0f6010879a_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ia8c44dcdbf354244af1c10b649888486_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5017c74f1406407b84f0e42bfc4e14b9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0f04dcc6a386483c8e41444865c3338e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i26e4d56df93243c68792ea4edcfb7c70_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7078a151136c4d6ca604de73f3a0f375_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i885a0fcf0beb4e3390d5033af15a8d3e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1558437735154cda9e3f0cd847af31a4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied0563f46bd444eeb3340a8c043684ce_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia00682c142e94501beff83d90b5f454e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i30644c0d223c4d21aedacfe884a3e842_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0b41f5abff7240c98ef304b465718181_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9bc55215d50342ce978c618ef06bf4d4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id898db802a534902a0a79a56b47eda29_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3c94e91055aa44298481132638e69b2d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if58b3ac1efda48e494333a3e29f1a136_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibed41fa55067490bae70eb2e695faf9d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50b265cae0684a099432fb41e9650c63_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e37d99ba11a4709b212d9d7ca7583bd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id26512b5a56544dc91371cd7b2b3ac87_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i72dfac16b5ac44ea83be7c443c0e2c13_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3ecdca0932c648d682c7125240a2a75d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icbaca07b4355474988048d221f663307_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3178bc0f361448aca1bad203c38ba1d1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i93685426db444f7bb2e2083559bad12c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">pbh:SydneyAustraliaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf52d5526c8542f5ba5ef401cb74e77f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie68302d173624012909bcb1af5423f95_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idf17434e163e4883b63bc1d499d3bfcd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8afee60cac74f0bbb72d34f37171669_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i472664bf20994bc58e71a154e858a6ed_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib57c0f0620294543a556b227a34dfc06_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5cc44748f9f649259312b1379e06e3bf_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib91d87e0f74c461e83248aab966de593_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if25f80c767b745ce88d01566c788c2ec_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i628847fe21c845faa7ad04720f019f4b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9932c6e574f043a6b2eba1f46190d488_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied214f5ee4e64721bc76b33c5c12a69d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07f4c56c383e4cadb7732fd1d3749213_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="iedfff890d1e84d249e980571ec6bbcf9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibd914b5ed7ee4a2c8bba1ee5e7e2efe8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8fb8878771394bb997fb34a8c9708c34_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="icc3645f563ff42219ffff940481757a4_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="ic475742a3fe44eb5ac7769813e20ce42_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pbh:AkornOperatingCompanyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i63adfa16455749529a578a107f9b488f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e0c797835694c38b0ed72ecec2427b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie6359612b8c648048fe362216a04a7f3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i33cda2011cd9439296ec2aee3a52e2a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia73a57ecc254455cae6f5b9d171bc153_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia73e9364fde841a2a844b91fca700d71_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i68eec35a89b640abb6b59a67cc2c458e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3b8a0ad3b3d24ce481be054872bcc00e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i609a7e847bec4a5eb87c67671f78c7e0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i63d91fe5ae4e4557a2fa616f58e373cc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04801f9b35a145479c2f926a02758888_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d090ede7de343c8a1442413f0a934af_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iacff4498c9324023bb8e6dc3cbbd98d6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f29776a97564733a0caac2100d77ef5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5038f7608994e62940ad33470b50c1b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4d5785a0756b4597a3f801623955484e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i589118616c4549cca227abd6b606ab67_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c1d8c3521584fbe86801d6a297495f6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i19e3761c71cf440882e905e4bc852d25_D20210228-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-28</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i5f61b06bc453405295e67e755ad9dc7d_D20210228-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalAnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-28</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8bb6c96119cc4504a07f59227add5e1a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia591d66195e84c68ad6bca8e400d493a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieb7b8be027404cf685507df5499990e1_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13817405df1449ac862beb623f788537_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7bacb62d2b764d98ab587019221feb5e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3b518b4ab33c4fb7b07453e2656c888b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic9ba4d3341224392858a56fe1feccb8b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6e7c6d4c44a9497fbbbbe5882fa1a870_D20211215-20211215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pbh:ZaditenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="i4b414dfd69f8433e8240e27a0edef648_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ied44a8b51f55435492975e4a49f6cfb9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">pbh:IndefinitelivedTradenamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pbh:FiniteLivedTradenamesandCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i69d08238dbfa4d19a42daf28b60de30d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0b1d55aab74e4d9d9ebe57a0c1b36420_D20220228-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i55324cd11967477cb55c9dbf85c8b0ba_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd308cfa7f4743acae74277795a0cbde_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i335edd3216614cc694f48efa6d5a9a28_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i589c5b16c5f2469aaba1478b0dd6dd6d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5fe2ba61b566469dbb5a593ca0b80d99_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pbh:GEODISLogisticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i09fd1299e2a3429cbcae381ab51a8154_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6bcfb0f753744a1ab751cb65c0dc7aea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idb76c60a4e494bd39785dbbddef2aee3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id7902118aff74b92a991aec7dec64d48_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0046cff099774243b2fe9bcef53f28b4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9f62c80458240b1a4ab90648a7ad1aa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e7166028fc3449da1b745c1053364a9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6cfd3cfbed7740a9a4326dec51b02b1f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i67542c5b47c4477989e0e9f42edffbf8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB5AmendmentNo5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic16a8c37cbf24b36ae290009040fbdb3_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13e53b28c8d5419cba8e60d19ff30867_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i35c7d3689acf4430baf1e0a96d60aabd_I20120131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:TermLoan2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-01-31</instant>
        </period>
    </context>
    <context id="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:TermLoan2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-31</startDate>
            <endDate>2012-01-31</endDate>
        </period>
    </context>
    <context id="i0c172aec253140b2b6067b78d9e369bc_I20120131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-01-31</instant>
        </period>
    </context>
    <context id="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-31</startDate>
            <endDate>2012-01-31</endDate>
        </period>
    </context>
    <context id="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba56d9afb135474e8bfe4cffa9c2e86f_D20130221-20130221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-21</startDate>
            <endDate>2013-02-21</endDate>
        </period>
    </context>
    <context id="iee6d3227d18744bdbefdbd1cecdc8ae8_I20130221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-21</instant>
        </period>
    </context>
    <context id="i18f08dc2f7ca4e3ba24144835eb55cb2_I20130221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended2012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-21</instant>
        </period>
    </context>
    <context id="iaa2b839503ec42fc8fe2a49df981bff1_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i0558c1bb126d4298b73cefd18fa9c46f_D20140903-20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-09-03</startDate>
            <endDate>2014-09-03</endDate>
        </period>
    </context>
    <context id="ia42ad38caa804913950ccf7ea487d0bb_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i319c15fd01bd47548445643d00863bf3_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i5ef2f1d69f724bb493a3a655ac79be25_D20140903-20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-09-03</startDate>
            <endDate>2014-09-03</endDate>
        </period>
    </context>
    <context id="iaf4727399a7346ea91615137b5e4dc2f_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i3cbc0bb0d6054954997646711fb51951_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i59f95eb55c54445286593337ec154069_D20140903-20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amended22012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-09-03</startDate>
            <endDate>2014-09-03</endDate>
        </period>
    </context>
    <context id="i2c9d6e5813094b2c81201639ca24cd5c_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2012ABLRevolverAmendment3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i6b0e800bd3d649b68c6b357ca77f8220_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">pbh:FederalFundsRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="ic759cbf7a7b842cb9529c38f67458e9b_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i2cd6d3dec26f448899c5ad59eb21db2f_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i3e52034a43564d1586e14c7c32da2efd_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i55b044eff678498fbe6c714272119acf_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="i4df9522b555a408989b96f6b0910ddd7_I20140903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-09-03</instant>
        </period>
    </context>
    <context id="ib2bcbe34278c447fb245a931855163bc_I20150508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-08</instant>
        </period>
    </context>
    <context id="i5ac25b9d7e324eea8f7f44cb83be491e_I20150508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-08</instant>
        </period>
    </context>
    <context id="i786615716fbf49968cb2764459adaf9e_I20150508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment32012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-05-08</instant>
        </period>
    </context>
    <context id="id49b28f7f8b24a8e9f452cf83fddd6d0_D20150609-20150609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-09</startDate>
            <endDate>2015-06-09</endDate>
        </period>
    </context>
    <context id="i1611c74aa45e494f956f74b6f8d18d37_D20150609-20150609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:ABLRevolverAmendment4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-06-09</startDate>
            <endDate>2015-06-09</endDate>
        </period>
    </context>
    <context id="iddb5f29165d140ce8590ce4f580057ba_D20160204-20160204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:ABLAmendmentNumber5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-04</startDate>
            <endDate>2016-02-04</endDate>
        </period>
    </context>
    <context id="i6aa9ed85523f4bffa275deb4f8aac069_I20170126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-26</instant>
        </period>
    </context>
    <context id="i4ccccc1f26f341a68d9ca89cfab4434c_I20170126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2012ABLRevolverAmendment6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-26</instant>
        </period>
    </context>
    <context id="i122c1f4cf7fe4f93a9cccfdf65056fa3_D20180321-20180321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-21</startDate>
            <endDate>2018-03-21</endDate>
        </period>
    </context>
    <context id="i4de06c1d14cf41cb863a5a08b674bea3_I20180321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-21</instant>
        </period>
    </context>
    <context id="icde342a964df4c25b081ffb70c172b7a_D20180321-20180321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-21</startDate>
            <endDate>2018-03-21</endDate>
        </period>
    </context>
    <context id="i0224233392114adf91fe01fed058dea0_I20180321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-21</instant>
        </period>
    </context>
    <context id="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="i70fb5e5a361b41159fce56b86161af71_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="i6a04c87c425240ca949ab30cc154c591_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="i3be594bcf6624e02a2fa508bbcec16c8_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="i329303f1b639409c82598b0f32e87c4e_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="i1e71bab1d60d488aa52d8528a9dd9265_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="ib88dbcd32abb43569e49cbca38a7b8e8_D20191211-20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-11</startDate>
            <endDate>2019-12-11</endDate>
        </period>
    </context>
    <context id="icf0b48ee76264f7a92f392720f3b43d6_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i1e6d0ebd6d014edc800dfa6316c8c320_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ibc75511f253c4893ab0567e3b34323e1_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="i7e22f021780647258b15b6e00a871903_D20210701-20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="ia969b1c646c440768cf974287fc7426e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i415c7e0679e349e58f0e0f20395cc300_I20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="i4baae0737d004ba09ced690b2fcdc5b1_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i39e0fc9224654a75a98d2b9ed9edc137_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pbh:LoansPayableTermB4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2fefd0d85f3643e9802fd44c8698e2bb_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-17</instant>
        </period>
    </context>
    <context id="i7127b05ed9074792951125aaeef43725_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2013Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-19</instant>
        </period>
    </context>
    <context id="i76d5fa51d2444398b1d51583678eaf8b_I20180321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-21</instant>
        </period>
    </context>
    <context id="i1eb1f46f0bf54dc5a706fbd97b3158e1_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5421f769ee30441db0b2ce75192fb6f4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05cfda891a7744f5b7d546839fc9debe_I20191202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-02</instant>
        </period>
    </context>
    <context id="i08f3231c50694b299fb23343bca2e463_D20191202-20191202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2019SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-02</startDate>
            <endDate>2019-12-02</endDate>
        </period>
    </context>
    <context id="if0f3a14330e24f06a067b44676509588_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="ie5055f03438d40a28763e3b37020019b_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="ib5924d593cc74de19659e3600415162d_D20160219-20160219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndirectGuaranteeOfIndebtednessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-19</startDate>
            <endDate>2016-02-19</endDate>
        </period>
    </context>
    <context id="id053d9ccecdc4922a30a236b55ee8a89_D20160219-20160219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:IndirectGuaranteeOfIndebtednessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-02-19</startDate>
            <endDate>2016-02-19</endDate>
        </period>
    </context>
    <context id="iea11cc7d2fda42e280337193b1699cff_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="ibbc097b28fbd4380a0360d7a9dfa4ddb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia447a00c02b64ada88fb01a499a27242_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5e5a200e2c9f497380a032d410c1bf18_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia4a985936f76451ab3fba68c9cfbb22a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:SeniorNotes2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iacf2802073574efd967d051aa138686d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59e28d594c87497abef8cb2c70f091a9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i812c0fab06ed49c4a178a37547c973b2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i12ce07c5f2394037b12bb08cd70c30b6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:A2021SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i999987ebde3747f6b643feea79f7c7ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i37214d0e0e284a65a18a75b349e2c4a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i14f58c0d3bfd4d80880075fbd365ccff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i82b6829a1a1044fe8860313bc836df84_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:Amendment52012TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4af8d5e816894fc2b3902012dc67bcab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie316289b2f544ed59d0d0c3677efd55a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i875d8339508c48e8978c56e91c5f446d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iad6deab13ed5410ca24419a0d749762c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:LoansPayableTermB5AmendmentNo6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7d45f458359341cb9aed375cbf7b034c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if5d83887fa7a4b3c9a18182a81d1150b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f5131113e97495bb1af3c5ddaaf3fed_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3d1883fd10de4c37988d741ed8d438e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pbh:AblRevolver2012Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8b76519112f34e67a8eec0a25b6d11bd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia9090b056ebb41eba6e4947e52c3b6ca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia009767826ab453aa6bb77d03d05a92b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib347d67febad441b8e0c8e676e6f04af_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1b30d6662357490791b05cb990415ede_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if895d74cebc04b28ab194e74118c2951_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia6fb85e27ce8425b9221751a38ecb76d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i63aa3373adc547ef8f9843d4e4e99a56_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i605faa87f3fa47b3bd583aa47c0b905f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i46552cb961884a2e9f30308dfc3d5c18_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i66f5cb1ef37b47e0a992d6060ab3a446_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iacae129a7469439e8699880e38e9c750_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i01612b88bf7d4228961f615de0e3bc6c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie1065eae966a4e23a6d80c3a4c53c9e1_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib6409d99de594b52889f5652216b4812_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice4373da025543d89003a05d5de73749_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">pbh:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i59613ba2ed6449e8ac420dc8ea0ee548_I20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-31</instant>
        </period>
    </context>
    <context id="i872fd2fcec7d4bceb22e9ecae5396854_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongtermEquityIncentivePlan2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="i0e8537058553437296cbf47a294cbc0c_D20140531-20140531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-05-31</startDate>
            <endDate>2014-05-31</endDate>
        </period>
    </context>
    <context id="i11506770ce994fd08f2fc8766933e916_D20140601-20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="i688dea0bee1948f2a6d571409bce4665_I20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pbh:LongTermIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-04</instant>
        </period>
    </context>
    <context id="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i22f7753689274ada97cf2c0bb4c3001d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44a6c8be63164b3a838a938732b3f2c9_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i907bf7654d494d8786dce88601c9edf2_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">pbh:RestrictedStockUnitsRSUsStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i330f93470c3944a7884dc0e46ce08542_D20210503-20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-03</startDate>
            <endDate>2021-05-03</endDate>
        </period>
    </context>
    <context id="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-03</startDate>
            <endDate>2021-08-03</endDate>
        </period>
    </context>
    <context id="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c27223f84a24212910eb3aeea93eaf1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5bc5220759bc469998f6d5c89b112a71_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i22fb9cffca2c4cddb633b8b7447cd658_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id15a44884d6e49a5a914ecd71387e80c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i80f789044f294f2593d384da1434a1aa_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if27256c09baf422db24a2becba8b461a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i410e808bfa6046c0b7bc6cd1eeb717fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1687a3f206264e8a9491e1485f31dbb2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe7fc1c11e8e4d5ab859abc4f504db82_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i57c394a5473c4367bd8d152963753341_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f0e76da8d7e4425bd35dcb13791235b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iee2c3f181ff64a18befbaf556c259b21_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if1862059d98a4f86a844ec510bb54683_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pbh:RetirementPlanContributionAxis">pbh:ContributionTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20570904260143f09bd86146ffd27dba_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="pbh:RetirementPlanContributionAxis">pbh:ContributionTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice63f8b82a3a41e5b98abd0d12861032_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="ib3582466457e4fa4b369b2316cdd0686_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9a3457f45285462fb87d13aa61a3f683_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18eeee208fa54c9c94b0e5c5a0efc290_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iba787bef5fbd42209b679fe0c7f29990_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59ae6b30db4c49f8a69b46325778804b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i58d96a8c72d94839a80320f2374f58ff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id4a29f55b009477797275b056efd188d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1b34dcaf34dd43b98d9f6b725d940736_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i724425dab8ca4eadac2088fa582751bc_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i284d3a442bf04e5cb360a7e96ba61668_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd1018ca3a7741649a9198acafea0150_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie702dabc815748c5bc0488c985ebed02_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i83c0747f5c71456088f94f029b3f9866_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7d62723af3a64d1bb9252b80927be2e6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie78a158429ca4e789c941c6bb4801167_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9808f2a5dec34206ae929d7fa60f2d90_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if67fb66e7897486a9f80811afd7f6951_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">pbh:ThirdPartyManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaddcf560297f4cbdb307e23b2a762c97_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6cfa4a5d82842f885da2acd0bc2b4de_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0b54127ec5714e2686bd5832ba581101_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:Top5BrandsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i52bda21851d0429eac0d1110fc51c45f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifc29d572ef4048c48685cf3987d915f6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8a3c181fa51445a5a25f5120f9046d9b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i18191d87fd6b4de7a17225dc12eee7f6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pbh:WalmartMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a2dd8e6335e47d6909ca71624a16c91_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id3de54342685484fa1e90d25044d65b3_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec86293b1daa4d37b8ee94fb83cd3fb2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i84a5f4ee39164abea82cf5e9e5d39277_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:ManufacturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f656cd6192a49a8b0474d9588199e42_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ff2c33ba3b24ce3835abeb593b95b50_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i805e095e068a4cee9a97a49955d93124_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5f247a503b8943d8a3ad2e615aab0ff6_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia5aa716616894b2f84935e0374ea04e7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic029fed0956549baa7ec88dac897d2c8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2c295d6ba7346f3a20449e046450179_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ef95b48e1034b91aaf6fd8e8409b9ad_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3294e803eb844221be72afcd3f38c4d7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifd5b824968d64c17a23ce9b8e959483a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic37751a73f9944309da3a6209420d28a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if488c5f576284dd2b32d7aca3c3ac7da_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic99bb552abe54bfd9db35d442b507668_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i98203bb0fdee45e0a76bebb95fdaa091_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iee5ebd4f9b4f40b4a4a08959e40f8232_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i04beadabffb1494192c4f1432581e3e9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48f1098b70cf4c3a9d398ae76f4418b2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6611cae507e467aae33483a930263e9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6528481919014cca8fa35e096227a2a4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia993e09fc5da4f1bb3419721565e91c9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07d0d76f1e26446ca6c10a8acbccbda1_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1118888fef148b0b3d06df4c4ca9bf2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia83b05de81bc4440b8a7586ab5058ae8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iecb112ef71bd4025a8a7c045b35fda05_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1c552006b60d4b08b007787d0e7c1b31_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i015c2f7ac3ca4d218c5d12d1f385211e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia86e42570a994afab266a376ed0ac2f9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i53fbea258f054a63ba94905ba9c1dc40_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i75173fc3463d4172a4889323f35f8ce7_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia24d6f74c12547b9b437f46f93f8e81b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4612ad4393fa41f2bf9ac148b747c4ba_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id1279b5a211240cdbc3c48972315db77_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9b826369aad440f284486a46f6980adf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i847749d31c8d4decba0abfa61b2399d6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0ce1b2b252c24eba903fe426d1e8f9d4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i453f0da9e5204e0a9a8f290c4314b16b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i43727784ec8f4d619cf24289b32d65d3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8157da33ba78498d8401bafd7a8fc602_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c5ecc92af704cae9ac690e78c08e5ef_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaf001558139e4bd8ab9cd40cebbfb430_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i549188b894974e3f9c66c305dff4ec5c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f7f2a80b24c4f3a837fc32b805a4f04_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic7cc9eb035334f0083ea1c824a1b091d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5c0cbb726f74abe9ca0f96e0c1f9657_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icb44edcc32594a3a91c1dd365c21d677_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id6542cd977dd429bb80eb6e889d6eec0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i690400e5143b4fab85db90f58029c2af_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2c52313a45fa4bdc8707f54d8c7b0f79_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i892942ab686d43ff9f78b51f385c281d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib50816ace3fa42db88ab7771863e34c1_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1bfd881300fd43768d4fd18c5b8399ac_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idef22b30afc84db9bda8dc263f3e2890_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib90b15b3c2e24cb48a2cba51ae97b668_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i86b7b9808f604b5d8c96d94c8752d25b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4de86537a7564a0e846cbacec3a5d86f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:AnalgesicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6f0954b90f854c9c8c6b9d5991778c49_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if5b222ffe8f542fb9a020f3fae60ba89_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ife659f1768004fb5be70b186e77e5297_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:CoughAndColdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1fd63fc992cf4852a161722fc0811307_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie159feb199e54e298d894fb67e2ecb91_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6255fa73dfc94124a1c4ebaee132b040_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:WomensHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic0e964d1b021431e9f1b1934d39a6d37_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if064a3f9803e44a281b0d06b27be87d4_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icb2e510d032b4dd9b8d6e4efeba5bae8_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:GastrointestinalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieda1d905a84541a487e2a38b30d11e2b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibcfc25de9722466e932dc1e06bb976b9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i99db4439e2494b88b17e934ed9c39536_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:EyeAndEarCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i447cea4350b049899445c056e36a842e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i216903c2e83a43b3b92dd97b7bee014c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic0b3152923a2411e85c99e2bcf72e13b_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:DermatologicalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ide3a43743f4d400dabfa688570f0f5d3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i38d3aa13aac246e9b25041fae4b7cc75_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i10259ed0744a4da29b08fbd71f4fa0eb_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OralCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icfb6a46d6609484692d15c0a359f03f9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:NorthAmericanOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6f96d631e0f6493aa473b4f5d6764c83_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pbh:InternationalOTCHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib8b5567d70b54cbd823e42bd98407d52_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pbh:OtherOtcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i05beda4dd5af4462b06464252419026d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i21751c4b85644cc9bc4db3085d5e2e0f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i187399c858c245c4be01180f7d21b89f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i128d4737fe924482950bf5e29e3e58d8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i188dc6462826477a91b4a176c33f06fd_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5c5b66ea38624883a01debe481d7aabb_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie501c1ea8abe4c0fb019b579c2aba132_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i80ed6fa3737e451aa617050d4c8ce914_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9f5a12f3ffc1452b894efd73785526ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1f3910479bb242f9adc9ca0b36080c63_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib8310fdbeb364e46af48af59d5abb8d0_I20220503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="ieea466101e6d42e8838d33899174afc3_D20220502-20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="ia9c7b100290a4efeb19c0cc9bfb64604_D20220502-20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="ib1dbf1db8a004389a087448443b06363_D20220502-20220502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-02</startDate>
            <endDate>2022-05-02</endDate>
        </period>
    </context>
    <context id="i434c5f76f05c469e89d0f4d63b175529_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f8fcceb1e254220aeb7da81ab31cb58_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45b2f889b82d49398a7b0afa2193e87c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib0651eae9b2249d1a150fa2d3bda71fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i269d76c784f548c19f48f6c4f35139ec_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic9e5a57a02a949ac99c1b929db087c5c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic6361373daa34522988116123cf37d3d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea56f97f93bb4d4a986d72945ac41527_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i54b960c0b2a34f049a1eb507349cdc62_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id0659c3b10104b4d93e871d273dc3a9e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia3363e6b458345d4aefbc25a191f087a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i920d5d39c27c43a7ada8c478509c80e2_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:SalesReturnsAndAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i21a87850c1e3427aab790ab25ea38814_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesforTradePromotionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibf417621972e4bfb95d92b68b8db4ee0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">pbh:ReservesForConsumerCouponRedemptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibf45542f39ba4a4999f6783fd74f411f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4b62934366984576b94bf37d4e78c277_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i840967a79d094690b99943768e44e986_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001295947</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>pbh:segment</measure>
    </unit>
    <unit id="vote">
        <measure>pbh:vote</measure>
    </unit>
    <unit id="manufacturer">
        <measure>pbh:manufacturer</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl8zLTEtMS0xLTE4OTY5_04295d65-2c2d-44b9-b493-08b9daa78f14">0001295947</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl81LTEtMS0xLTE4OTY5_7d3f80ba-c6f6-4309-868f-3b8914799ab3">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl82LTEtMS0xLTE4OTY5_e7f52d62-2b28-4d4c-ae63-a8e6c047f7f4">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl80L2ZyYWc6YTUxOTUwNDI3ODg5NGRmYWI4YjJiZDdiY2Q1NWRkMWQvdGFibGU6Y2E5MzYyOWVjMjgyNDhjMWFiMDgwYWE3ZmE1YjVkYmYvdGFibGVyYW5nZTpjYTkzNjI5ZWMyODI0OGMxYWIwODBhYTdmYTViNWRiZl83LTEtMS0xLTE4OTY5_c8375154-86c1-4faa-a5bd-49779052af5d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg4_53e5da3a-118f-4bb6-9cc6-7d15411cc32c">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MmVjOWI1YjYwOGRlNDQwNDk2MGVjOWFjNmU2MTMxZTAvdGFibGVyYW5nZToyZWM5YjViNjA4ZGU0NDA0OTYwZWM5YWM2ZTYxMzFlMF8wLTEtMS0xLTE4OTY5_917da7f9-4b64-4fb1-a3c9-fd8b88e58494">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMzc_6b458dbe-d552-4fe1-85c9-1944a1a09f2a">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMzc_f0cb451d-9c97-4705-bb90-4d5e7b8fd727">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6NjZlYzU4N2E4NzQ2NGNhMjgyZjczOWQyYWNhNjZmZTYvdGFibGVyYW5nZTo2NmVjNTg3YTg3NDY0Y2EyODJmNzM5ZDJhY2E2NmZlNl8wLTEtMS0xLTE4OTY5_e9cb0c2b-b4c8-4fd8-8073-432820aac911">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgy_73cc1db9-7d8f-44d1-b20f-b0f69f4d9561">001-32433</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg5_5b8a3a17-d2af-4db1-b4eb-42693ed39290">PRESTIGE CONSUMER HEALTHCARE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTkyMGJhMjk3MDFiNGQ4MTkxYjVjYWYyNjg1N2I3YWUvdGFibGVyYW5nZTphOTIwYmEyOTcwMWI0ZDgxOTFiNWNhZjI2ODU3YjdhZV8wLTAtMS0xLTE4OTY5_168365e2-9db8-4717-8168-5c80f71df4eb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTkyMGJhMjk3MDFiNGQ4MTkxYjVjYWYyNjg1N2I3YWUvdGFibGVyYW5nZTphOTIwYmEyOTcwMWI0ZDgxOTFiNWNhZjI2ODU3YjdhZV8wLTItMS0xLTE4OTY5_88bf1d3c-7993-4caa-8b38-f1fddedacb0e">20-1297589</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc2_272dc5d2-8940-4c35-9433-0c2e34ba05ca">660 White Plains Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgz_259623e3-b4c7-4e4e-a77a-98e4a431920a">Tarrytown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc3_b8b858d0-df9a-405c-b7ef-118dff2ea021">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc4_33e68135-d9a7-4858-bbee-fc2b84e6fb9f">10591</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg2_79ef80ff-b7a7-4bff-a704-7b8cb446a901">914</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTkw_ff6ffa3f-b099-4f49-9496-2f0cb97631cb">524-6800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTAtMS0xLTE4OTY5_0086026a-a5be-41a6-8fc7-7cb03de38e74">Common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTEtMS0xLTE4OTY5_99913a83-6031-44b0-99ad-11aee2e9e1dd">PBH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6YTBiYmI1ZDM4OWY3NDAzYmJjNWNlYTMxZjM2MTY2ZjgvdGFibGVyYW5nZTphMGJiYjVkMzg5Zjc0MDNiYmM1Y2VhMzFmMzYxNjZmOF8yLTItMS0xLTE4OTY5_5bfe0fc2-0229-48c0-b804-a2eca492125e">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTc5_6f091532-9389-4d23-9822-4c7902b115ed">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTkx_9ab3d2f6-fe41-4039-b809-9684416212c6">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgw_fea0a133-539f-48ec-a956-960021e7502e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTgx_a23c3866-1fac-44b7-9760-b0261b0c9ca3">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8wLTAtMS0xLTE4OTY5_bf90ce44-14de-4b18-8250-8d349513ca9c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8xLTYtMS0xLTE4OTY5_32010fab-669e-48cb-9340-989508915843">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGFibGU6MTE4MGEwZDk2OGNhNGRkZjkyZGZmNWExNjYzMWQxZTUvdGFibGVyYW5nZToxMTgwYTBkOTY4Y2E0ZGRmOTJkZmY1YTE2NjMxZDFlNV8yLTYtMS0xLTE4OTY5_129e0098-7d62-4086-b687-143e4eb372b3">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg0_22a2b162-589f-4b7c-a40a-103d7f3c72ec">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8xMTU0NDg3MjA5NDkwMg_8110bac8-2c20-49e1-8c44-bccca093cef6">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i7683433268a44f5ea2cd487803f35f28_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8yODIz_37ed4c83-bb80-42d9-be62-cedc80204c4f"
      unitRef="usd">2798600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib4fe5d55882d42cba9c5a5c6c603bfa9_I20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8yODY1_fed61e45-26d8-4a73-8175-657d3709181c"
      unitRef="shares">50279419</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xL2ZyYWc6Y2FiOTFlNTMwZmM5NDA0YmEwMzkzZGQwMjE5MzJmNGIvdGV4dHJlZ2lvbjpjYWI5MWU1MzBmYzk0MDRiYTAzOTNkZDAyMTkzMmY0Yl8zMTg3_42edf133-4aee-4c5e-b8a8-0c865b434425">Portions of the Registrant&#x2019;s Definitive Proxy Statement for the 2022 Annual Meeting of Stockholders (the &#x201c;2022 Proxy Statement&#x201d;) are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent described herein.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82NC9mcmFnOmEzZjZmOTEyNjBiZDQ4MmQ4ZmRlNTdiNmE0ZmQxZTRkL3RleHRyZWdpb246YTNmNmY5MTI2MGJkNDgyZDhmZGU1N2I2YTRmZDFlNGRfMzg0ODI5MDcxODUwMw_2bc5886a-391d-4bf0-ba0e-31e79b3079d6">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82NC9mcmFnOmEzZjZmOTEyNjBiZDQ4MmQ4ZmRlNTdiNmE0ZmQxZTRkL3RleHRyZWdpb246YTNmNmY5MTI2MGJkNDgyZDhmZGU1N2I2YTRmZDFlNGRfMzg0ODI5MDcxODUwNQ_e5b4573f-869c-40e3-be1d-80f6f3a9f515">Stamford, Connecticut</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d976548ec964eb5954900d40178b30f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy0xLTEtMS0xODk2OQ_9268f5e5-cabd-4b97-b535-58314ecec268"
      unitRef="usd">1086770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7de1d5544ee45609a500258ca33677e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy0zLTEtMS0xODk2OQ_6cd595c3-4ab4-4d63-8bf9-99206b418d61"
      unitRef="usd">943324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a00f6c3c9634209a4b9779c5515e978_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMy01LTEtMS0xODk2OQ_7311dc4b-cdd4-4aed-961f-d68bcc022709"
      unitRef="usd">962936000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic98e8e0686d4426182259a392bf61706_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC0xLTEtMS0xODk2OQ_1358c210-e86a-4d2a-a947-26ed5bd2b06a"
      unitRef="usd">42000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53deaff486304c7d94652052dc9167fa_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC0zLTEtMS0xODk2OQ_2926dd5d-7235-4645-97a4-913d49ae4ee1"
      unitRef="usd">41000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id433e0cb04fa4a559bfc9daff43da79c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNC01LTEtMS0xODk2OQ_0f0ca570-0e98-4937-8488-c5476f7887ac"
      unitRef="usd">74000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS0xLTEtMS0xODk2OQ_8e55c7d9-18f7-40aa-a32e-00e7f7458946"
      unitRef="usd">1086812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS0zLTEtMS0xODk2OQ_71f1fe47-c2b9-45ee-9aad-b91a210d1bff"
      unitRef="usd">943365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNS01LTEtMS0xODk2OQ_2523c53d-4d6d-4760-9680-7ff85acb245e"
      unitRef="usd">963010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC0xLTEtMS0xODk2OQ_8406da1a-6d81-4b7a-8ec3-185d6de50766"
      unitRef="usd">458942000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC0zLTEtMS0xODk2OQ_1c07eae8-764f-43a8-b202-5e1160474e3b"
      unitRef="usd">389670000</pbh:CostOfSalesExclusiveOfDepreciation>
    <pbh:CostOfSalesExclusiveOfDepreciation
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOC01LTEtMS0xODk2OQ_2e30bb57-fdd6-4483-b4c3-9bbffe876e6a"
      unitRef="usd">406554000</pbh:CostOfSalesExclusiveOfDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS0xLTEtMS0xODk2OQ_55a7c6e7-b8f7-49ca-b203-8b781bae8074"
      unitRef="usd">7224000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS0zLTEtMS0xODk2OQ_503adc6b-4e22-4198-92b6-dc0e6330d2a2"
      unitRef="usd">6223000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfOS01LTEtMS0xODk2OQ_989adfd4-2531-4306-83b3-c1479f16e0f7"
      unitRef="usd">4233000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfRevenue
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtMS0xLTEtMTg5Njk_609af7a9-50fb-4091-be59-c8ad153b2774"
      unitRef="usd">466166000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtMy0xLTEtMTg5Njk_e67986d1-372e-4eec-9b69-4c8d9a718f87"
      unitRef="usd">395893000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTAtNS0xLTEtMTg5Njk_25c09ffb-c218-489f-b148-10c81913dde3"
      unitRef="usd">410787000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtMS0xLTEtMTg5Njk_1f503224-e784-45ea-b02e-7635c6457e77"
      unitRef="usd">620646000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtMy0xLTEtMTg5Njk_0a2fc5d0-b0e4-4265-a9d9-fcb9a8a8e507"
      unitRef="usd">547472000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTEtNS0xLTEtMTg5Njk_78180621-c547-4247-9533-52ec2ea417eb"
      unitRef="usd">552223000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtMS0xLTEtMTg5Njk_f8c9b5f2-de52-4769-8b05-54cb241ec38c"
      unitRef="usd">157343000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtMy0xLTEtMTg5Njk_4736bd59-a6b6-4510-8e68-2eaa99499ef2"
      unitRef="usd">140589000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTQtNS0xLTEtMTg5Njk_ce7219eb-6502-41ed-a3b8-1fd5b85bcfcb"
      unitRef="usd">147194000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtMS0xLTEtMTg5Njk_15d79cc8-f07f-4fcf-81da-30e527f3559c"
      unitRef="usd">108516000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtMy0xLTEtMTg5Njk_ddc5d787-2349-4cb0-bd47-6e4ef4674f30"
      unitRef="usd">85540000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTUtNS0xLTEtMTg5Njk_c52539b3-4953-4195-b41f-8cac234d6787"
      unitRef="usd">89112000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtMS0xLTEtMTg5Njk_b746c819-40d6-4236-93ff-3b2a2d9eee5e"
      unitRef="usd">24868000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtMy0xLTEtMTg5Njk_ae478e7e-57db-454f-854e-33c00fd26080"
      unitRef="usd">23941000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTYtNS0xLTEtMTg5Njk_55e621fe-e8b9-41f7-bb95-78e02db73cd6"
      unitRef="usd">24762000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktMS0xLTEtMTg5Njk_72c7da96-a022-4628-9193-03ab92ca8cd8"
      unitRef="usd">290727000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktMy0xLTEtMTg5Njk_367440f9-b356-4591-a3a0-20cce0765182"
      unitRef="usd">250070000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMTktNS0xLTEtMTg5Njk_a22c6ee2-2e8e-4559-b720-e16380122268"
      unitRef="usd">261068000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtMS0xLTEtMTg5Njk_65f8cc1a-93c0-4884-a986-f529740b6563"
      unitRef="usd">329919000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtMy0xLTEtMTg5Njk_6d3a514b-3b41-4b51-aeaa-cdd0d719ba3c"
      unitRef="usd">297402000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjAtNS0xLTEtMTg5Njk_14780245-5469-4b06-98b5-4b1f83169571"
      unitRef="usd">291155000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtMS0xLTEtMTg5Njk_1d6f6462-353d-4f12-8265-8b83e9660d88"
      unitRef="usd">64287000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtMy0xLTEtMTg5Njk_25fa11f2-e251-474f-bf60-5e8aad73707e"
      unitRef="usd">82328000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjMtNS0xLTEtMTg5Njk_e0c25b78-1ac1-49ea-818c-b6df9a1bd876"
      unitRef="usd">96224000</us-gaap:InterestExpenseDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtMS0xLTEtMTg5Njk_6f5d9880-d082-4435-8cec-8757f738b020"
      unitRef="usd">-2122000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtMy0xLTEtMTg5Njk_f69595a9-3c24-4e1d-bece-f3f2388d48c8"
      unitRef="usd">-12327000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjQtNS0xLTEtMTg5Njk_887c1467-46c5-4819-8b92-d9f8401358e8"
      unitRef="usd">-2155000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtMS0xLTEtMTg5Njk_b2e5712c-f371-4271-a2d7-ec5de096999e"
      unitRef="usd">-1052000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtMy0xLTEtMTg5Njk_29ab1533-795e-47d7-9d20-5016da4b5000"
      unitRef="usd">1366000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjUtNS0xLTEtMTg5Njk_9260da82-f09f-44c7-b7ec-cd65d9c482aa"
      unitRef="usd">-1625000</us-gaap:OtherNonoperatingIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtMS0xLTEtMTg5Njk_eff040b8-be16-4b6a-90be-5831db2061dd"
      unitRef="usd">-67461000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtMy0xLTEtMTg5Njk_b68b1dd0-dec9-4642-9c87-0b7ddd90ffa2"
      unitRef="usd">-93289000</pbh:TotalOtherIncomeExpense>
    <pbh:TotalOtherIncomeExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjYtNS0xLTEtMTg5Njk_8766894b-8372-4858-856a-f8d51d06eb41"
      unitRef="usd">-100004000</pbh:TotalOtherIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctMS0xLTEtMTg5Njk_8d4f64c4-8082-45f0-9a17-43d947dde22d"
      unitRef="usd">262458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctMy0xLTEtMTg5Njk_51d1fdbb-760f-4ae0-9e60-97b23d54064f"
      unitRef="usd">204113000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjctNS0xLTEtMTg5Njk_398d8ed7-6b64-4929-9b6b-6190097b62bb"
      unitRef="usd">191151000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtMS0xLTEtMTg5Njk_8811d5fb-1a80-440d-bdd1-93e642266e47"
      unitRef="usd">57077000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtMy0xLTEtMTg5Njk_622e9a05-8ac4-4948-92fa-6dc57f618c10"
      unitRef="usd">39431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjgtNS0xLTEtMTg5Njk_863785d0-36fe-4571-a551-d83a9254a318"
      unitRef="usd">48870000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktMS0xLTEtMTg5Njk_3379c5b0-ebe7-4624-8d7a-b8222161ecca"
      unitRef="usd">205381000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktMy0xLTEtMTg5Njk_3d25d341-137c-4f84-b8aa-e1ee49eb44f8"
      unitRef="usd">164682000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMjktNS0xLTEtMTg5Njk_b3c65e37-217f-47fa-9709-c8a12983c3f0"
      unitRef="usd">142281000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItMS0xLTEtMTg5Njk_6e161bdd-1cd7-4d1b-b516-cee27ffd8c3d"
      unitRef="usdPerShare">4.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItMy0xLTEtMTg5Njk_44d9d325-47f9-4c96-8bcb-0aaf2def4380"
      unitRef="usdPerShare">3.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzItNS0xLTEtMTg5Njk_168dd05c-e083-403d-afd8-81c0d9128839"
      unitRef="usdPerShare">2.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctMS0xLTEtMTg5Njk_fabefc69-5047-4d48-b45b-38e0d05ce721"
      unitRef="usdPerShare">4.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctMy0xLTEtMTg5Njk_14a21c17-f255-4828-a5ff-e5e95c631d9e"
      unitRef="usdPerShare">3.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfMzctNS0xLTEtMTg5Njk_2f1c0ff6-d079-4426-89cd-067b7585659a"
      unitRef="usdPerShare">2.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItMS0xLTEtMTg5Njk_2cbf55dd-d86f-436b-9d5f-60744e8f3621"
      unitRef="shares">50259000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItMy0xLTEtMTg5Njk_b0a440a3-a906-461b-a91b-e53f3ca3518b"
      unitRef="shares">50210000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDItNS0xLTEtMTg5Njk_b16ae0c1-e4e0-4948-848d-48f2b5e3fd25"
      unitRef="shares">50723000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtMS0xLTEtMTg5Njk_5b8eeea6-4b66-4598-9c38-2841fc2f396e"
      unitRef="shares">50842000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtMy0xLTEtMTg5Njk_89ba20ff-a53a-4f42-b21b-75d858371725"
      unitRef="shares">50605000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDMtNS0xLTEtMTg5Njk_c40954eb-8da2-4b4e-bed5-5e50d43fab9f"
      unitRef="shares">51140000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtMS0xLTEtMTg5Njk_242e68a1-ac91-4f92-b312-823084c1a18e"
      unitRef="usd">-1296000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtMy0xLTEtMTg5Njk_12cb31d6-776e-4c92-a2bd-391ff0fafcfb"
      unitRef="usd">20333000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDYtNS0xLTEtMTg5Njk_693fadb7-777c-4ec3-887b-3553a3c0ca41"
      unitRef="usd">-12363000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctMS0xLTEtMTg5Njk_b3ffcbbd-2ad8-429f-b802-4e6ecd5664cc"
      unitRef="usd">1819000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctMy0xLTEtMTg5Njk_9de25d7d-bcef-4d3e-87ff-16eb3386bc0b"
      unitRef="usd">3045000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDctNS0xLTEtMTg5Njk_b9d7ab8e-39c4-4b3f-a873-745c08d0da9d"
      unitRef="usd">-4864000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtMS0xLTEtMTg5Njk_9ca2ad47-87aa-4d84-bf8d-c87c963cc109"
      unitRef="usd">-246000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtMy0xLTEtMTg5Njk_56e82455-0759-460c-950b-0d015064ddf7"
      unitRef="usd">-1172000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDgtNS0xLTEtMTg5Njk_8d07c104-ad3c-437d-a4de-8b4e3dae7d9f"
      unitRef="usd">1187000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktMS0xLTEtMTg5Njk_c052e649-07d0-402e-a4b3-7cc8f6c4d4c4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktMy0xLTEtMTg5Njk_b661cc04-f864-4276-b2aa-b8a6a744cee5"
      unitRef="usd">-190000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNDktNS0xLTEtMTg5Njk_7695e2d7-40f3-4dc6-87d2-94dc90dd371a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtMS0xLTEtMTg5Njk_bc20c2db-5cd5-48f2-8623-391a5b978c03"
      unitRef="usd">769000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtMy0xLTEtMTg5Njk_2d964429-66d9-465f-9a79-b916deb84fdd"
      unitRef="usd">24360000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTAtNS0xLTEtMTg5Njk_dcd27201-7dc9-4d93-9904-cfc5a9f5ca23"
      unitRef="usd">-18414000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtMS0xLTEtMTg5Njk_927b6889-f20d-4c7d-a907-265737917a97"
      unitRef="usd">206150000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtMy0xLTEtMTg5Njk_cf57ff80-c3a3-4f89-b0cb-2d62aa91d317"
      unitRef="usd">189042000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl82Ny9mcmFnOmEzNDVjZDA1Y2JkYjRhZmViNGFiMmFjYTdhZjQyZWJkL3RhYmxlOjYzNzdhMTMzNGQyZjQyNTU5M2I3ZDEyMDI2ZWZiOTBiL3RhYmxlcmFuZ2U6NjM3N2ExMzM0ZDJmNDI1NTkzYjdkMTIwMjZlZmI5MGJfNTEtNS0xLTEtMTg5Njk_2dd2a9ce-5dca-4972-9a1b-f164062fbb2b"
      unitRef="usd">123867000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMy0xLTEtMS0xODk2OQ_ba68c0fa-297d-43c6-8bab-0db4eef6062d"
      unitRef="usd">27185000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMy0zLTEtMS0xODk2OQ_8c3bc867-7c5c-488c-a09d-c886613be657"
      unitRef="usd">32302000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0wLTEtMS0xODk2OS90ZXh0cmVnaW9uOjlkNTIzNDhmYTJjMjQ2YTA4YTU0ZTVhZWMyMzU4NGY2XzQ1_5e41b527-ccaf-4fc1-92d7-274ed7499fb8"
      unitRef="usd">19720000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0wLTEtMS0xODk2OS90ZXh0cmVnaW9uOjlkNTIzNDhmYTJjMjQ2YTA4YTU0ZTVhZWMyMzU4NGY2XzUy_0984d1e6-4228-461a-a0cc-f0bd19fa5fc6"
      unitRef="usd">16457000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0xLTEtMS0xODk2OQ_6cef6026-2342-4c21-9676-fa174a4bcc65"
      unitRef="usd">139330000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNC0zLTEtMS0xODk2OQ_4e9e7e8b-e77e-48a4-9fc7-795c79faec35"
      unitRef="usd">114671000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNS0xLTEtMS0xODk2OQ_4bc3ff8a-8369-4c5a-af11-96175f19bb39"
      unitRef="usd">120342000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNS0zLTEtMS0xODk2OQ_d7a1b983-d310-4aed-ba76-b4f9af64c82c"
      unitRef="usd">114959000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNy0xLTEtMS0xODk2OQ_f9db42fb-cf2e-4701-b41c-101955fce8ef"
      unitRef="usd">6410000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNy0zLTEtMS0xODk2OQ_b98397ed-6edf-4fd6-90f4-1a37f21f9f7e"
      unitRef="usd">7903000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfOC0xLTEtMS0xODk2OQ_33eeee8a-06a6-4589-92ac-c379abec474a"
      unitRef="usd">293267000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfOC0zLTEtMS0xODk2OQ_3902f42b-f8e5-471a-9f64-f71a8f67c587"
      unitRef="usd">269835000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTAtMS0xLTEtMTg5Njk_e58bf2b9-306d-4d12-9948-5096c9072870"
      unitRef="usd">71300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTAtMy0xLTEtMTg5Njk_35b8cd78-cad8-484d-8f63-6c7d9e1c8efc"
      unitRef="usd">70059000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTEtMS0xLTEtMTg5Njk_7c6fec2d-b11a-4b38-958e-c97701fdfb3d"
      unitRef="usd">20372000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTEtMy0xLTEtMTg5Njk_f0ffe99b-4d6d-43f9-978c-5a22cf5c624a"
      unitRef="usd">23722000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTItMS0xLTEtMTg5Njk_c3736d56-ccb4-4425-88ab-a773a053b471"
      unitRef="usd">6858000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTItMy0xLTEtMTg5Njk_33145386-3d2a-484c-94e6-4852ade6ff44"
      unitRef="usd">8986000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTMtMS0xLTEtMTg5Njk_de1152db-c550-4125-bc79-6e5a9c20d503"
      unitRef="usd">578976000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTMtMy0xLTEtMTg5Njk_2f32ba8c-6aef-4230-a18c-7d9566ccfb7f"
      unitRef="usd">578079000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTQtMS0xLTEtMTg5Njk_642012fc-8ae0-4f92-836f-c6682811afe8"
      unitRef="usd">2696635000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTQtMy0xLTEtMTg5Njk_b83fd866-a7f0-45d8-a366-13dc7bcd3e46"
      unitRef="usd">2475729000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTUtMS0xLTEtMTg5Njk_9894e25e-3cc6-4803-8101-e0c04d81380d"
      unitRef="usd">3273000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTUtMy0xLTEtMTg5Njk_2388a35d-d36a-4017-8f89-46bf2edc8dee"
      unitRef="usd">2863000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTYtMS0xLTEtMTg5Njk_e7666e8b-1374-45d4-8ac4-a32cf89d2cb1"
      unitRef="usd">3670681000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMTYtMy0xLTEtMTg5Njk_082889eb-59d9-405d-9a46-f92f27e0d25b"
      unitRef="usd">3429273000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjAtMS0xLTEtMTg5Njk_13ef7e98-cfc5-4d50-a228-5550cb06353c"
      unitRef="usd">55760000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjAtMy0xLTEtMTg5Njk_7a3bf7e6-5d14-4d64-81d3-efed73127345"
      unitRef="usd">45978000</us-gaap:AccountsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjEtMS0xLTEtMTg5Njk_50dc3f2c-8e49-400d-b845-973dea8196e0"
      unitRef="usd">4437000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:InterestAndDividendsPayableCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjEtMy0xLTEtMTg5Njk_b722bd11-64dd-465f-94ae-ae6a18539559"
      unitRef="usd">6312000</us-gaap:InterestAndDividendsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjItMS0xLTEtMTg5Njk_c19c6b5b-190e-4481-9b37-436e93581df9"
      unitRef="usd">6360000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjItMy0xLTEtMTg5Njk_3a834227-a538-4ad9-b486-496b6b891cab"
      unitRef="usd">5858000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjMtMS0xLTEtMTg5Njk_cac5de5f-33fb-4e97-bc50-a9a857b1ff2b"
      unitRef="usd">2752000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjMtMy0xLTEtMTg5Njk_bdd49d9d-477d-4275-9913-f33984d974ce"
      unitRef="usd">2588000</us-gaap:FinanceLeaseLiabilityCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjQtMS0xLTEtMTg5Njk_112a2d9d-1e0e-40d1-81a5-948f4ee2b1a3"
      unitRef="usd">74113000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjQtMy0xLTEtMTg5Njk_f68b0459-7328-462f-ab1d-c3a3129163ca"
      unitRef="usd">61402000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjUtMS0xLTEtMTg5Njk_c8a70cb0-8a92-4ab6-8ce1-a4da4d2d98c7"
      unitRef="usd">143422000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjUtMy0xLTEtMTg5Njk_9cf5a85d-0d67-40ee-8971-6dd46bdcf6db"
      unitRef="usd">122138000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjktMS0xLTEtMTg5Njk_716fa786-0159-455b-9cd1-69e95510a5c5"
      unitRef="usd">1476658000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMjktMy0xLTEtMTg5Njk_d7d01352-24a7-4633-b19b-5a795b1a7620"
      unitRef="usd">1479653000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzAtMS0xLTEtMTg5Njk_80186aa7-ea95-46e9-83a0-730bf1520089"
      unitRef="usd">444917000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzAtMy0xLTEtMTg5Njk_80003cb8-b8fe-4215-b5d9-3f1f804ce4a3"
      unitRef="usd">434050000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzEtMS0xLTEtMTg5Njk_b3ac40f3-5bb6-41a0-a221-5f1f168e12f5"
      unitRef="usd">16088000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzEtMy0xLTEtMTg5Njk_421eb9d2-84ef-4434-abac-02c31d72272a"
      unitRef="usd">19706000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzItMS0xLTEtMTg5Njk_73475206-5930-4b21-9373-f850904cb500"
      unitRef="usd">4501000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzItMy0xLTEtMTg5Njk_e6d78957-079b-4fd1-b1d6-f37754b38bf2"
      unitRef="usd">6816000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzMtMS0xLTEtMTg5Njk_e18ffd82-0ab5-4514-9a89-d6161c805ea8"
      unitRef="usd">7484000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzMtMy0xLTEtMTg5Njk_c465b28f-6e5a-49b8-9229-8c35218a4d49"
      unitRef="usd">8612000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzQtMS0xLTEtMTg5Njk_9585d99c-aa6b-46ac-9443-e770956e8d8d"
      unitRef="usd">2093070000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzQtMy0xLTEtMTg5Njk_fd7fccbf-c7fe-4052-97b4-cc674a16a7bd"
      unitRef="usd">2070975000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzYtMS0xLTEtMTg5Njk_19c9764f-6103-4938-8ace-2c0851ccd14b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzYtMy0xLTEtMTg5Njk_1b72e6f8-1846-4493-b1ad-aa825106129b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzktMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5OGI4NjhmNmJhNmQ0YTNlYmQyNzBlZWNkNGE3MzQxZF8yMg_02b0485f-7109-4039-a6a1-802660405ccb"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfMzktMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5OGI4NjhmNmJhNmQ0YTNlYmQyNzBlZWNkNGE3MzQxZF8yMg_eb5ad547-6e1b-4247-b846-02dfd9f16fb5"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDAtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjowNjliNWRmMGQ2MTY0NjI2Yjc5YWE5OWY3ZDg5ZjMyYV8xNw_4f151594-eaaa-4cd7-af96-d8efd5f9240a"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDAtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjowNjliNWRmMGQ2MTY0NjI2Yjc5YWE5OWY3ZDg5ZjMyYV8xNw_9b7cec9d-2050-4efc-a5c4-39c5301ad1ac"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_3503f7b3-dca0-48f6-a306-9aad9423d079"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_823bbb85-4ae1-47f5-9113-d015c091e9b3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_c0c0f3c9-68d7-4c66-850a-6412737a038f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkY2M4OWEzMDhlZmU0ODg1YWUzYTlhNzMwM2M4YmQ5OV8yOQ_e372ef43-9d2a-4b9a-8bb2-a65f94081faf"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMS0xLTEtMTg5Njk_22efbdbd-5525-4a57-ba19-76cd436f987c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDEtMy0xLTEtMTg5Njk_8da9e3dd-65be-4a68-a70d-47ec9aee129a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDMtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplOWI5OTBiODVhOGE0MTE3YTljMzMyNTRjNWFjZTNjM18xOQ_b2e9da50-8b83-446f-a1a2-5c4bdff88758"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDMtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplOWI5OTBiODVhOGE0MTE3YTljMzMyNTRjNWFjZTNjM18xOQ_ff356ad6-1a3a-4eda-8bca-7f2920e0f895"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ODgzN2NkYTIxNzQ0ODg2YjU5Y2I4YzI2NmVkODI2YV8xNw_1bc508a9-b4b8-4d51-84c6-ff01e8baea45"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ODgzN2NkYTIxNzQ0ODg2YjU5Y2I4YzI2NmVkODI2YV8xNw_efd832aa-837c-44a3-9b19-75019d8fc153"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo1YmQyNzQ5MmJmMTA0ZGEyOTFiZDkwYTg1YjJkZmJjNF8xMw_8c6e188e-e42b-493a-b918-52e96c1c2b56"
      unitRef="shares">54430000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo1YmQyNzQ5MmJmMTA0ZGEyOTFiZDkwYTg1YjJkZmJjNF80NQ_fce393d2-a527-4361-949d-38a00c02b395"
      unitRef="shares">53999000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMS0xLTEtMTg5Njk_ada1b955-f511-46a8-8163-7ad529a0bbd9"
      unitRef="usd">544000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDUtMy0xLTEtMTg5Njk_548d1125-cd28-4cff-951d-c9547af10a42"
      unitRef="usd">540000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDYtMS0xLTEtMTg5Njk_5c50569f-4903-4763-951e-73fd21aa45b4"
      unitRef="usd">515583000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDYtMy0xLTEtMTg5Njk_6f0d9259-7dc1-4f95-9293-3bc608db5be8"
      unitRef="usd">499508000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozNzVlOGUyMDc3NDI0NDliYWJmOTliZTRmNzNmMDdmNV8zMA_08f83b89-d5b0-47df-96fc-d9819c184db1"
      unitRef="shares">4151000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozNzVlOGUyMDc3NDI0NDliYWJmOTliZTRmNzNmMDdmNV82Mg_89c60232-60f0-4543-a0f8-846192b5076c"
      unitRef="shares">4088000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMS0xLTEtMTg5Njk_d67e15c5-d328-457a-b45e-5f05705154b0"
      unitRef="usd">133648000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDctMy0xLTEtMTg5Njk_299446ce-7817-4ddd-b447-132a329b61d1"
      unitRef="usd">130732000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDgtMS0xLTEtMTg5Njk_9b5c4d67-c85c-40a1-9689-2a7bac23ec62"
      unitRef="usd">-19032000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDgtMy0xLTEtMTg5Njk_ffd05cc4-5e95-4d9f-9251-b8fb06dd4987"
      unitRef="usd">-19801000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDktMS0xLTEtMTg5Njk_f384c8be-0ca6-4101-abf7-5cd420f61f00"
      unitRef="usd">1214164000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNDktMy0xLTEtMTg5Njk_07cb121b-fe27-4e11-b70a-1a73ddd7b7bd"
      unitRef="usd">1008783000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTAtMS0xLTEtMTg5Njk_63e7ef16-53c6-435b-8869-8b93c4914c89"
      unitRef="usd">1577611000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTAtMy0xLTEtMTg5Njk_3e136979-4ecb-4e2f-a4c4-821d3d3ed9e5"
      unitRef="usd">1358298000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTEtMS0xLTEtMTg5Njk_9163a2c7-81e5-488e-b329-7d98dafd2a7f"
      unitRef="usd">3670681000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83MC9mcmFnOjE3MjU5MmUyMTAwZjQzMGI5YjQ1ZWU0ZGVlMjA4MGU0L3RhYmxlOjBlMTBkMTFiYTU4ZTQwM2NiODRkODJlMWFlZWQ2NDY2L3RhYmxlcmFuZ2U6MGUxMGQxMWJhNThlNDAzY2I4NGQ4MmUxYWVlZDY0NjZfNTEtMy0xLTEtMTg5Njk_c934e73c-4249-4b88-9b27-48d6ae67440f"
      unitRef="usd">3429273000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xLTEtMS0xODk2OQ_ed9bb19e-7316-4143-a53f-13c97f8b68aa"
      unitRef="shares">53670000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if8bb0dd398b14b6793d19cdc2c6789cb_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0zLTEtMS0xODk2OQ_f1ec618a-c35e-484c-9091-a49e66b23d41"
      unitRef="usd">536000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied280415580b4c01b9d20134fe0942a6_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi01LTEtMS0xODk2OQ_da27901b-9f67-402f-8618-537111805548"
      unitRef="usd">479150000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i82cf1b32e6744300b132ae0f6010879a_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi03LTEtMS0xODk2OQ_8b49ceec-5e23-4fdd-97e0-48996818274a"
      unitRef="shares">1871000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i82cf1b32e6744300b132ae0f6010879a_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi05LTEtMS0xODk2OQ_16e74634-acaa-4984-82b8-acd197ef811f"
      unitRef="usd">-59928000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia8c44dcdbf354244af1c10b649888486_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xMS0xLTEtMTg5Njk_1cb256d0-573c-4f72-9331-7899b18a5ea8"
      unitRef="usd">-25747000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5017c74f1406407b84f0e42bfc4e14b9_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xNS0xLTEtMTg5Njk_d0916339-aa08-4373-9340-ec20668d1627"
      unitRef="usd">701820000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMi0xNy0xLTEtMTg5Njk_eacdb805-24e0-4bcd-9f4f-2707a875fb47"
      unitRef="usd">1095831000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNS01LTEtMS0xODk2OQ_c26bc704-59be-49de-b1a6-44681bda4e92"
      unitRef="usd">7644000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNS0xNy0xLTEtMTg5Njk_2aeccde4-80a7-4e3c-806a-21f0d896046f"
      unitRef="usd">7644000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0xLTEtMS0xODk2OQ_905c6fdd-7d25-4caf-9474-33bb5191fc01"
      unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0zLTEtMS0xODk2OQ_c9d2ada3-74c2-4319-bc14-68d3194855a1"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi01LTEtMS0xODk2OQ_bc64d4bf-2393-46f6-8fa6-526e7753f7f3"
      unitRef="usd">1323000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNi0xNy0xLTEtMTg5Njk_f89e7cc8-f504-4b3e-ac65-d0c96ef21d64"
      unitRef="usd">1324000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0xLTEtMS0xODk2OQ_57ea0296-a398-413e-aefc-7765c27314b1"
      unitRef="shares">87000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i762a139e38e044a5a5f121fc0cf14580_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0zLTEtMS0xODk2OQ_6d198f63-1311-4696-b10e-e801d83bfbc3"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4c9f0c17e5cd4b9a8cf8019f2a2f3542_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC01LTEtMS0xODk2OQ_e88bfa70-0212-490c-9d0e-9a305c5abcaf"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOC0xNy0xLTEtMTg5Njk_88dae8e2-726b-4476-ac4e-850c579cced7"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS03LTEtMS0xODk2OQ_3507a824-19ba-49d0-83fc-b6a4614a7158"
      unitRef="shares">1848000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icb79778af9584a59a08aff1e8633d8c0_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS05LTEtMS0xODk2OQ_a4921d92-0cf4-49cb-9246-62e78de9c34d"
      unitRef="usd">57695000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfOS0xNy0xLTEtMTg5Njk_84a5c06a-3d5e-4eaf-b6cf-889b0c24e045"
      unitRef="usd">57695000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i0f04dcc6a386483c8e41444865c3338e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTQtMTUtMS0xLTE4OTY5_c21bad6b-d1c4-4c74-83f9-55fe5aa9f377"
      unitRef="usd">142281000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTQtMTctMS0xLTE4OTY5_6845b4ae-d62d-45d5-a6eb-a14259b2b18c"
      unitRef="usd">142281000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i26e4d56df93243c68792ea4edcfb7c70_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTctMTEtMS0xLTE4OTY5_800d5998-a885-4fbc-8521-82f36c538978"
      unitRef="usd">-18414000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTctMTctMS0xLTE4OTY5_e82ac9ab-acf9-4173-a1de-23fba5d0132e"
      unitRef="usd">-18414000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7078a151136c4d6ca604de73f3a0f375_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMS0xLTEtMTg5Njk_f3c95391-6f3f-41d7-b483-114e9bb86357"
      unitRef="shares">53805000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7078a151136c4d6ca604de73f3a0f375_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMy0xLTEtMTg5Njk_ae4f7e01-f179-4fbd-838d-4b0ad30dbe28"
      unitRef="usd">538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i885a0fcf0beb4e3390d5033af15a8d3e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktNS0xLTEtMTg5Njk_78f08c9a-d9e2-4500-884d-33f765e8cfc3"
      unitRef="usd">488116000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i1558437735154cda9e3f0cd847af31a4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktNy0xLTEtMTg5Njk_547fcdde-34ea-497d-81d1-372c054a9237"
      unitRef="shares">3719000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i1558437735154cda9e3f0cd847af31a4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktOS0xLTEtMTg5Njk_503096a8-7f8a-42b7-aa28-e22e24e20156"
      unitRef="usd">-117623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ied0563f46bd444eeb3340a8c043684ce_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTEtMS0xLTE4OTY5_3b991dbc-4d82-4f14-b87c-0aeea146005c"
      unitRef="usd">-44161000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia00682c142e94501beff83d90b5f454e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTUtMS0xLTE4OTY5_af108679-99c6-4d56-af59-1fbfc5e9d366"
      unitRef="usd">844101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMTktMTctMS0xLTE4OTY5_ccaa3920-d23c-4bdb-be3f-5003a3cbd799"
      unitRef="usd">1170971000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjItNS0xLTEtMTg5Njk_2e79abfd-4e34-4885-8478-d5fe483afc82"
      unitRef="usd">8543000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjItMTctMS0xLTE4OTY5_5e0f4cf2-dbe9-4047-81b4-731df764d6d3"
      unitRef="usd">8543000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMS0xLTEtMTg5Njk_bd4c944a-ad11-46ae-ada0-66ad79cc14c9"
      unitRef="shares">120000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMy0xLTEtMTg5Njk_5030c08f-9400-4266-9351-96c1380e4e6a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtNS0xLTEtMTg5Njk_5a03ae41-0248-42e0-828b-34538d338c7a"
      unitRef="usd">2850000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjMtMTctMS0xLTE4OTY5_57fcc768-f205-4bae-b218-b6635544f043"
      unitRef="usd">2851000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMS0xLTEtMTg5Njk_adc4c7f4-351b-44c2-bb50-59ff40db8e1e"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i0b41f5abff7240c98ef304b465718181_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMy0xLTEtMTg5Njk_18134987-8664-4b0c-88b6-41e119299803"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i369821e581154cfbb738574f76ef5b8e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtNS0xLTEtMTg5Njk_1f7e247b-e674-49b2-87ea-b608eb786038"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjUtMTctMS0xLTE4OTY5_95edcb0b-eecb-440f-adaf-8039fd298539"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtNy0xLTEtMTg5Njk_77ecd82f-f679-449b-937e-6f5934d4ffe3"
      unitRef="shares">369000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie68d8aee7e6b44d69dcae54436f3b44e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtOS0xLTEtMTg5Njk_ce7a7bdf-a5a8-466d-b752-b6fc3630f16e"
      unitRef="usd">13109000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMjYtMTctMS0xLTE4OTY5_418327cc-336d-44d2-8fbe-3fb624e91348"
      unitRef="usd">13109000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i9bc55215d50342ce978c618ef06bf4d4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzAtMTUtMS0xLTE4OTY5_40756784-c647-4d71-983d-6fadb60bdbc7"
      unitRef="usd">164682000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzAtMTctMS0xLTE4OTY5_27c7150d-e0b1-4b81-b0f6-e65e7b521249"
      unitRef="usd">164682000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id898db802a534902a0a79a56b47eda29_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzMtMTEtMS0xLTE4OTY5_3ff6dfbf-85a0-4072-992e-ca2c634a2c1f"
      unitRef="usd">24360000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzMtMTctMS0xLTE4OTY5_97dbfbc1-730f-4895-9814-379a0800465d"
      unitRef="usd">24360000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMS0xLTEtMTg5Njk_66fbb2a2-d322-4c18-86df-4940fcc2222a"
      unitRef="shares">53999000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9ee3b130a11c4868ac1f63bed3f196f3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMy0xLTEtMTg5Njk_66ecd082-0699-4dd7-8eb5-280146d9b476"
      unitRef="usd">540000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c94e91055aa44298481132638e69b2d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtNS0xLTEtMTg5Njk_4ac6321b-c746-4014-8b29-1b6010ea18b9"
      unitRef="usd">499508000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="if58b3ac1efda48e494333a3e29f1a136_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtNy0xLTEtMTg5Njk_cd57d984-c2a5-4839-868e-1b8fef80cbc5"
      unitRef="shares">4088000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="if58b3ac1efda48e494333a3e29f1a136_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtOS0xLTEtMTg5Njk_954d50bb-101c-42de-8617-af9c779fc6df"
      unitRef="usd">-130732000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTEtMS0xLTE4OTY5_f7ab8a99-6eb4-47b4-9651-d44f6204ec43"
      unitRef="usd">-19801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibed41fa55067490bae70eb2e695faf9d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTUtMS0xLTE4OTY5_b1471658-0002-4b95-9f51-6df9d1ce7a7e"
      unitRef="usd">1008783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzUtMTctMS0xLTE4OTY5_17e4c834-ec64-45cf-99a7-72d572ecad61"
      unitRef="usd">1358298000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzgtNS0xLTEtMTg5Njk_51150fd4-66ff-484c-be0e-1a421ba98c5d"
      unitRef="usd">9039000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzgtMTctMS0xLTE4OTY5_ea50510d-ec34-45eb-b076-925a3ca1140d"
      unitRef="usd">9039000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMS0xLTEtMTg5Njk_c4e8d558-6739-4e5e-8b6f-14f79fd3d365"
      unitRef="shares">226000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMy0xLTEtMTg5Njk_93772fac-88db-42bc-9ca5-570d33c960e6"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktNS0xLTEtMTg5Njk_de5847b8-b1cf-4f08-be40-dcb9366093b8"
      unitRef="usd">7038000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfMzktMTctMS0xLTE4OTY5_8b1dbddd-248f-4df6-b6a2-da5c4b203f40"
      unitRef="usd">7040000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMS0xLTEtMTg5Njk_c105a81b-1de9-4e98-a831-e79139e0e97f"
      unitRef="shares">205000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i9db90627f2754667a3b26bfca0d65f49_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMy0xLTEtMTg5Njk_d8e15315-c5d8-422e-9f35-830f19faed0a"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ia0649c21cf3b442cad8f71d241b22784_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtNS0xLTEtMTg5Njk_cccd8389-c309-45ed-8214-f517df45bf70"
      unitRef="usd">-2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDEtMTctMS0xLTE4OTY5_d259a5b4-0016-4314-a040-eb5ac70aae3e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItNy0xLTEtMTg5Njk_126d10ba-c1a7-4d58-823b-f311aa308c2e"
      unitRef="shares">63000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iaf581b1d84f24fc1bc5c48057fc32444_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItOS0xLTEtMTg5Njk_59bb353d-9e75-4ed7-9435-b16eb4f092ce"
      unitRef="usd">2916000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDItMTctMS0xLTE4OTY5_9e8d0d9d-2934-4e8a-990f-7baa37e0cfa7"
      unitRef="usd">2916000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss
      contextRef="i50b265cae0684a099432fb41e9650c63_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDUtMTUtMS0xLTE4OTY5_09bcc222-6b7e-4906-9f91-6a73abad55a5"
      unitRef="usd">205381000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDUtMTctMS0xLTE4OTY5_68ce6b26-9ed6-4654-bbb9-cb9104be1a28"
      unitRef="usd">205381000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9e37d99ba11a4709b212d9d7ca7583bd_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDgtMTEtMS0xLTE4OTY5_843e9c31-728e-4c1f-92ba-b9eb833179dc"
      unitRef="usd">769000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNDgtMTctMS0xLTE4OTY5_87380145-e690-4ea8-9181-bdefe5416177"
      unitRef="usd">769000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id26512b5a56544dc91371cd7b2b3ac87_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMS0xLTEtMTg5Njk_0f9800e2-9c0b-4534-b42c-23d9c09a3cf1"
      unitRef="shares">54430000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id26512b5a56544dc91371cd7b2b3ac87_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMy0xLTEtMTg5Njk_91b17ad9-1396-4937-b0a2-797f777ab9fe"
      unitRef="usd">544000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72dfac16b5ac44ea83be7c443c0e2c13_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtNS0xLTEtMTg5Njk_4d162012-d9fd-4121-a6a4-75bb9a4e2f87"
      unitRef="usd">515583000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="i3ecdca0932c648d682c7125240a2a75d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtNy0xLTEtMTg5Njk_307b8da6-bbc0-4d64-85c7-1e2836ef58fd"
      unitRef="shares">4151000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquity
      contextRef="i3ecdca0932c648d682c7125240a2a75d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtOS0xLTEtMTg5Njk_3090e616-8062-4028-85ca-6b4d7041e269"
      unitRef="usd">-133648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbaca07b4355474988048d221f663307_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTEtMS0xLTE4OTY5_6a2eea27-7fa0-411b-b819-5fa9477d0b74"
      unitRef="usd">-19032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3178bc0f361448aca1bad203c38ba1d1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTUtMS0xLTE4OTY5_2b9241b6-960d-4cfe-9d03-607580158d82"
      unitRef="usd">1214164000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83My9mcmFnOmRlNjliNmI0M2RmNDQ3ZWJhZjU2NjViYjFiYmVmN2IyL3RhYmxlOjRhNDMwNDU1NTY5OTQxOGI5Yjc0OWNjMjhmODE4MWM3L3RhYmxlcmFuZ2U6NGE0MzA0NTU1Njk5NDE4YjliNzQ5Y2MyOGY4MTgxYzdfNTAtMTctMS0xLTE4OTY5_afca13d4-2157-4648-8a65-60ca11f673d7"
      unitRef="usd">1577611000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy0xLTEtMS0xODk2OQ_574ea72a-3742-4a1a-a8dd-54ee612b297d"
      unitRef="usd">205381000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy0zLTEtMS0xODk2OQ_1d317902-3c57-474c-aeb5-c576e1634c75"
      unitRef="usd">164682000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMy01LTEtMS0xODk2OQ_a2704a9e-00f5-4b8c-8441-ad34851e3b7a"
      unitRef="usd">142281000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS0xLTEtMS0xODk2OQ_4cc674aa-26ec-4a2c-8803-02e269a99c01"
      unitRef="usd">32092000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS0zLTEtMS0xODk2OQ_1e0eaae9-7d93-4c97-b829-d2ae716c207c"
      unitRef="usd">30164000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNS01LTEtMS0xODk2OQ_5c4c346a-a408-4218-9c2e-9ea770ba56a2"
      unitRef="usd">28995000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy0xLTEtMS0xODk2OQ_dd35f4be-68fb-47f7-a892-16966fa580c9"
      unitRef="usd">-271000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy0zLTEtMS0xODk2OQ_dcc7305d-f57e-436d-ae4f-d03a5593cd1e"
      unitRef="usd">-220000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNy01LTEtMS0xODk2OQ_ce54f124-823f-493a-a277-43e1b7302c49"
      unitRef="usd">-713000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS0xLTEtMS0xODk2OQ_e20d08ec-9880-4122-ba26-999f5f166bcc"
      unitRef="usd">9979000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS0zLTEtMS0xODk2OQ_3e48f651-a966-4bfd-9967-da00ba7295ed"
      unitRef="usd">18628000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfOS01LTEtMS0xODk2OQ_40f9695d-ec15-4677-ae03-38279f9fe0ab"
      unitRef="usd">13852000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtMS0xLTEtMTg5Njk_bd980ccd-5a65-4366-ad2b-e11db0197dfc"
      unitRef="usd">4230000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtMy0xLTEtMTg5Njk_2199ebcb-1cd1-43e4-9ffd-754c6c5a0d87"
      unitRef="usd">4979000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTEtNS0xLTEtMTg5Njk_409a4849-f5e9-4783-8ec9-f2bfec88e674"
      unitRef="usd">3812000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtMS0xLTEtMTg5Njk_10400bb4-1279-4d56-af82-29ad6759facc"
      unitRef="usd">9039000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtMy0xLTEtMTg5Njk_e869f459-c0ed-49c6-ade5-da0b5609306c"
      unitRef="usd">8543000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTMtNS0xLTEtMTg5Njk_5e467d7a-8410-40a7-8b7a-cad996d0172c"
      unitRef="usd">7644000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtMS0xLTEtMTg5Njk_4f602eca-72bb-4b2e-a070-c30cfdf0205f"
      unitRef="usd">-2122000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtMy0xLTEtMTg5Njk_757c54c2-0ce2-454b-92c3-cc3260b8d84c"
      unitRef="usd">-12327000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTUtNS0xLTEtMTg5Njk_4bd0c8cd-690d-470d-a5e6-d03f3e22b30a"
      unitRef="usd">-2155000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtMS0xLTEtMTg5Njk_702e63eb-9442-4b35-a56b-a9413688bad3"
      unitRef="usd">6706000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtMy0xLTEtMTg5Njk_0af06b23-0a15-42de-aab0-b5aed965414e"
      unitRef="usd">7082000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <pbh:AdditionsToOperatingLeaseRightOfUseAssets
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMTYtNS0xLTEtMTg5Njk_85ac985f-5ccd-4b9f-874f-c64bc134c4d1"
      unitRef="usd">8786000</pbh:AdditionsToOperatingLeaseRightOfUseAssets>
    <us-gaap:AssetImpairmentCharges
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtMS0xLTEtMTg5Njk_c8d67a19-be6f-4498-a506-d80405e40c24"
      unitRef="usd">1057000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtMy0xLTEtMTg5Njk_79276060-01bd-4de3-a48f-882d1e1f94f1"
      unitRef="usd">2434000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjAtNS0xLTEtMTg5Njk_4a122e0c-ddde-4a5e-afa0-e3cf321d9abc"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItMS0xLTEtMTg5Njk_8692ea48-98fe-44b1-b714-b06f2ae5c848"
      unitRef="usd">9000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItMy0xLTEtMTg5Njk_86b75e3a-f250-40d9-99a1-a4b11ed85b93"
      unitRef="usd">7854000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjItNS0xLTEtMTg5Njk_0aff628f-b14f-4e7c-a788-2c84fa692860"
      unitRef="usd">-84000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtMS0xLTEtMTg5Njk_c56418aa-f466-4080-867c-3167024b0952"
      unitRef="usd">24654000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtMy0xLTEtMTg5Njk_15fc1335-b87c-4589-a60d-9f857c1c801e"
      unitRef="usd">-36872000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjQtNS0xLTEtMTg5Njk_c9cbff04-773c-47c9-ab3b-c62969b7cc64"
      unitRef="usd">2849000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtMS0xLTEtMTg5Njk_162e0fc7-cea5-425b-b2f1-b226dbb541d0"
      unitRef="usd">-663000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtMy0xLTEtMTg5Njk_f2cb07f6-e135-4563-8333-0c39e9b4c7c0"
      unitRef="usd">-2972000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjUtNS0xLTEtMTg5Njk_bbea4548-da33-4d18-a105-787952478f41"
      unitRef="usd">-2930000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtMS0xLTEtMTg5Njk_cea6dfbc-2ef9-41e5-a6a5-37c46d3e1a89"
      unitRef="usd">-1448000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtMy0xLTEtMTg5Njk_ad2f69f4-71bb-40c0-a38b-9799b3305c43"
      unitRef="usd">3227000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjYtNS0xLTEtMTg5Njk_6d83864a-2570-4c6a-a577-107cb0754489"
      unitRef="usd">-687000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctMS0xLTEtMTg5Njk_3f97e725-d697-4b17-a97f-e6bd59c85ff8"
      unitRef="usd">9154000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctMy0xLTEtMTg5Njk_ae487174-89fc-4f3c-924c-64d11fe113b5"
      unitRef="usd">-17342000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjctNS0xLTEtMTg5Njk_a43f98bf-3aaf-423a-a968-0ae142e79e98"
      unitRef="usd">6210000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtMS0xLTEtMTg5Njk_b1410a74-fea8-4276-a4e0-837946490044"
      unitRef="usd">9616000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtMy0xLTEtMTg5Njk_a93cd7f9-f15b-4a6c-b627-efae415aed3a"
      unitRef="usd">-14912000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjgtNS0xLTEtMTg5Njk_c142b8f2-9daa-4557-9451-01a897f956d4"
      unitRef="usd">12096000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktMS0xLTEtMTg5Njk_db0c22eb-46ca-456e-8039-cbc0c201f099"
      unitRef="usd">-6448000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktMy0xLTEtMTg5Njk_1a055527-060c-456c-92f9-a518122e8a4a"
      unitRef="usd">-6718000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <pbh:IncreaseDecreaseInOperatingLeasesLiabilities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMjktNS0xLTEtMTg5Njk_7aa623e6-321a-4897-b377-93702e50ec6d"
      unitRef="usd">-8824000</pbh:IncreaseDecreaseInOperatingLeasesLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtMS0xLTEtMTg5Njk_7fe353e9-c6ab-4b69-b75a-f41f44dca453"
      unitRef="usd">725000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtMy0xLTEtMTg5Njk_ea4e446e-c3f4-47ec-b9c9-1fa66e09b5d4"
      unitRef="usd">3243000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzEtNS0xLTEtMTg5Njk_63a2ba1d-eead-4072-91a1-457a2aa703ae"
      unitRef="usd">1448000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItMS0xLTEtMTg5Njk_4ad6679a-2d51-41e6-a288-f8b61441c8b5"
      unitRef="usd">259922000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItMy0xLTEtMTg5Njk_1c109627-f6a9-4936-a600-1294a9572478"
      unitRef="usd">235607000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzItNS0xLTEtMTg5Njk_aa56a832-547a-49d6-b82e-7af42a87176d"
      unitRef="usd">217124000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtMS0xLTEtMTg5Njk_c6819ec1-9a5f-4a58-880c-e2a2859a853c"
      unitRef="usd">9642000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtMy0xLTEtMTg5Njk_5b0acb0c-820b-460e-8c8f-196cc0e234f2"
      unitRef="usd">22243000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzUtNS0xLTEtMTg5Njk_656654a4-59cc-4bc9-8b30-e95f117c50a5"
      unitRef="usd">14560000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <pbh:EscrowReceipt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctMS0xLTEtMTg5Njk_2aa1d046-4864-49d0-8bb2-9b0f0da40457"
      unitRef="usd">0</pbh:EscrowReceipt>
    <pbh:EscrowReceipt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctMy0xLTEtMTg5Njk_fc374d38-48d5-4095-8a11-b74c71854b74"
      unitRef="usd">0</pbh:EscrowReceipt>
    <pbh:EscrowReceipt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfMzctNS0xLTEtMTg5Njk_f201612c-b747-4599-8fd7-04f3701fa3e8"
      unitRef="usd">750000</pbh:EscrowReceipt>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtMS0xLTEtMTg5Njk_e882c67c-bcf9-4cde-9c09-2c267713704d"
      unitRef="usd">247046000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtMy0xLTEtMTg5Njk_53152268-1674-40d1-af60-90b4336a265d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDMtNS0xLTEtMTg5Njk_7ea7402d-fb03-4c70-9551-af8bf30ddfcf"
      unitRef="usd">2760000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctMS0xLTEtMTg5Njk_dab23772-26cf-4ecc-8561-6c5b8640885a"
      unitRef="usd">-177000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctMy0xLTEtMTg5Njk_645b50d5-dd66-421d-b418-4a70cd48c225"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDctNS0xLTEtMTg5Njk_985861ff-2698-4aba-93e5-8f605ce436b5"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtMS0xLTEtMTg5Njk_66ce4e62-5b85-4c2f-bbc7-d55fa555e187"
      unitRef="usd">-256511000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtMy0xLTEtMTg5Njk_4492a0a6-47b1-4ad8-8792-b4486bbfe976"
      unitRef="usd">-22243000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNDgtNS0xLTEtMTg5Njk_eb5ca9a0-7e96-44e2-a502-8966d06e6027"
      unitRef="usd">-16570000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtMS0xLTEtMTg5Njk_c7daf199-f22d-4ae8-b05f-c049cf91f514"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtMy0xLTEtMTg5Njk_c4927eae-9965-49b7-9785-02620aedb197"
      unitRef="usd">600000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTMtNS0xLTEtMTg5Njk_3500cca5-4635-4097-b3be-93e210e6d2bc"
      unitRef="usd">400000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctMS0xLTEtMTg5Njk_7851b417-437d-479d-9671-b941675b3a5b"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctMy0xLTEtMTg5Njk_32501c5c-7168-447e-805e-bbd38d2af60c"
      unitRef="usd">600000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNTctNS0xLTEtMTg5Njk_921389d2-c170-4b11-ba60-dfeba1da3fa9"
      unitRef="usd">400000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtMS0xLTEtMTg5Njk_c4b915ae-3871-4bea-8592-1a04bfa238cf"
      unitRef="usd">600000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtMy0xLTEtMTg5Njk_6c90dd81-59f8-43eb-818d-be3da59028b8"
      unitRef="usd">195000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjEtNS0xLTEtMTg5Njk_7d4c6427-05b8-45b0-9ced-50dafe775d93"
      unitRef="usd">48000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMS0xLTEtMTk1NzQ_ca9a3a89-74c6-479d-b816-a3b005855885"
      unitRef="usd">597000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMy0xLTEtMTk1ODE_bd0fba0d-ad85-495a-9023-7c60016f75c2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItNS0xLTEtMTk1ODg_60386104-f08f-41c3-b4ff-11e0e6ce4a49"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMS0xLTEtMTg5Njk_3cd3a320-3498-4d3c-8024-867dd5bb2e52"
      unitRef="usd">85000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItMy0xLTEtMTg5Njk_44e349f7-2a1b-4ede-b8b4-bdb02aa54cc8"
      unitRef="usd">15000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjItNS0xLTEtMTg5Njk_88d4c0b6-4aef-4693-abc3-b5c3bb15e56a"
      unitRef="usd">100000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtMS0xLTEtMTg5Njk_18e66a6f-7b15-42f6-aa5d-854474ae400b"
      unitRef="usd">85000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtMy0xLTEtMTg5Njk_6b1c6ee5-7d73-473c-a84f-d537ffcf70c4"
      unitRef="usd">70000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjMtNS0xLTEtMTg5Njk_edead6ad-35db-4c5e-9eae-259c0f37e115"
      unitRef="usd">120000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtMS0xLTEtMTg5Njk_4bf41191-3073-4095-85d4-79ffbe62defd"
      unitRef="usd">6111000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtMy0xLTEtMTg5Njk_52eae641-2435-4b78-b7ca-f69bedf292c0"
      unitRef="usd">17718000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjQtNS0xLTEtMTg5Njk_c898453f-e51f-476a-9b7b-460911ee5d31"
      unitRef="usd">6584000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtMS0xLTEtMTg5Njk_81091f30-17f6-4588-a666-8221d581f01f"
      unitRef="usd">2582000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtMy0xLTEtMTg5Njk_24c49ee7-e69c-42ce-9b22-2c8e773cfe33"
      unitRef="usd">1443000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjUtNS0xLTEtMTg5Njk_c4fb26b6-2a10-47de-b522-2ef212ba018d"
      unitRef="usd">476000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtMS0xLTEtMTg5Njk_70829fc2-f7af-4d37-b7bf-6cb92b1e0dc3"
      unitRef="usd">7040000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtMy0xLTEtMTg5Njk_21de9338-6e02-4b68-85fc-a9da529bb27d"
      unitRef="usd">2851000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjYtNS0xLTEtMTg5Njk_fc1ae561-10a0-4a69-822b-933df03ed82e"
      unitRef="usd">1324000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtMS0xLTEtMTg5Njk_0bf02190-7d0a-452b-87b8-1bc72e954887"
      unitRef="usd">2916000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtMy0xLTEtMTg5Njk_c124f2a3-9132-4724-8bf3-d028089fdc68"
      unitRef="usd">1242000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjgtNS0xLTEtMTg5Njk_b06dd3ec-a753-47e3-bf70-dc59cd3bbcdb"
      unitRef="usd">974000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktMS0xLTEtMTg5Njk_82f21834-f2cc-40cb-b197-f95d1d1b9114"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktMy0xLTEtMTg5Njk_33f70bfb-1439-44b9-b116-59ca8ae330d6"
      unitRef="usd">11867000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNjktNS0xLTEtMTg5Njk_7ca821fb-e4da-470f-8d17-1d596094fcd3"
      unitRef="usd">56721000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtMS0xLTEtMTg5Njk_dbd78d56-8bb0-44ba-8374-6734e64e306e"
      unitRef="usd">-7569000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtMy0xLTEtMTg5Njk_2ef6aabe-91a1-40db-92f0-2f1f615c3453"
      unitRef="usd">-279419000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzAtNS0xLTEtMTg5Njk_deb8c543-fcb1-4bb7-a3b1-72b9760eb963"
      unitRef="usd">-131431000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItMS0xLTEtMTg5Njk_5a641b91-941f-4904-9d52-2a90c044e2e7"
      unitRef="usd">-959000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItMy0xLTEtMTg5Njk_8843bd0a-107b-47d9-bd98-b8677db68e46"
      unitRef="usd">3597000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzItNS0xLTEtMTg5Njk_936037fb-eb17-40b1-b058-3ef2e00a13dc"
      unitRef="usd">-1893000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtMS0xLTEtMTg5Njk_4c86ddf5-7e44-4fc5-9069-b226ddcb5807"
      unitRef="usd">-5117000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtMy0xLTEtMTg5Njk_1e841d57-2bcb-4d9f-b66d-be678ff85890"
      unitRef="usd">-62458000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzMtNS0xLTEtMTg5Njk_96ac4fc5-0226-4808-8481-a07e3cb65439"
      unitRef="usd">67230000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtMS0xLTEtMTg5Njk_c862926f-a542-407a-b643-6492a0b929f7"
      unitRef="usd">32302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtMy0xLTEtMTg5Njk_f9e355b5-7805-4a3b-8889-7c0011fa753a"
      unitRef="usd">94760000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzQtNS0xLTEtMTg5Njk_837d7c86-69b6-4eb3-93d3-71852b1ba9fd"
      unitRef="usd">27530000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtMS0xLTEtMTg5Njk_95ea6dda-40cd-4767-b2c5-740e1b3dab02"
      unitRef="usd">27185000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtMy0xLTEtMTg5Njk_7ae43179-ed55-4d26-bcd1-708bf77ec146"
      unitRef="usd">32302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzUtNS0xLTEtMTg5Njk_86b272c1-90c7-4e26-b5e4-9671c5575a04"
      unitRef="usd">94760000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctMS0xLTEtMTg5Njk_d84631b7-7348-436f-b63f-56159130f504"
      unitRef="usd">61364000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctMy0xLTEtMTg5Njk_f78a221d-e243-4f0e-855e-4553e7225ea1"
      unitRef="usd">80290000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzctNS0xLTEtMTg5Njk_69a9baaf-5194-4ef5-8755-1f05a3f12b99"
      unitRef="usd">92166000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtMS0xLTEtMTg5Njk_442460cd-00e9-4406-ac2e-58d656a07fe0"
      unitRef="usd">46568000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtMy0xLTEtMTg5Njk_46921eed-49a4-44b2-aec1-7d28f753ae67"
      unitRef="usd">34381000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl83Ni9mcmFnOjA5MTI1MTBjNzc3YzRjYTdhYmVmMTQ5YzVjM2UxNzM4L3RhYmxlOmY5NDMxY2E5ODIxZDRhYzI4NzliNmZkNjBiMDgxOTk4L3RhYmxlcmFuZ2U6Zjk0MzFjYTk4MjFkNGFjMjg3OWI2ZmQ2MGIwODE5OThfNzgtNS0xLTEtMTg5Njk_4463e80c-c532-4f0c-9019-71844b598dd8"
      unitRef="usd">30602000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1OTI_3b3914d8-09ae-4159-9d07-b81a27701044">Business and Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prestige Consumer Healthcare Inc. (referred to herein as the &#x201c;Company&#x201d; or &#x201c;we&#x201d;, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (&#x201c;OTC&#x201d;) healthcare products to mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets.&#160;&#160;Prestige Consumer Healthcare Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 9 to these Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Economic Environment  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the World Health Organization ("WHO") declared a global pandemic due to a new strain of coronavirus ("COVID-19").  The pandemic has caused significant volatility in the United States and global economies.  In addition, the Russian invasion of Ukraine has led to further economic uncertainty.  We expect economic conditions will continue to be highly volatile and uncertain and could affect demand for our products and put pressure on prices.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We experienced a temporary but significant decline in consumer consumption of our brands in the first quarter of fiscal 2021, followed by more stable consumption and customer orders over the remainder of the year. Generally, throughout the pandemic, some categories were positively impacted (for instance, Women&#x2019;s Health, Oral Care and Dermatological) and some categories negatively impacted (for instance, Cough &amp;amp; Cold and Gastrointestinal).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The positively impacted categories benefited from the consumer shift to over-the-counter healthcare products, as consumers increased their focus on hygiene and self-care at home related to COVID-19.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The declining categories were impacted by reduced incidence levels and usage rates due to shelter-at-home restrictions and limited travel-related activity. In fiscal 2022, we experienced solid consumer consumption and share gains across most of our brand portfolio. Our business also benefited from a significant increase in demand in travel-related categories and channels as well as the Cough &amp;amp; Cold category, previously impacted by the COVID-19 virus.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We have continued to see changes in the purchasing patterns of our consumers, including the frequency of visits by consumers to retailers and a shift in many markets to purchasing our products online.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Both the COVID-19 pandemic and the geopolitical environment have also impacted the supply of labor and raw materials and exacerbated rising costs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Although we have not experienced a material disruption to our overall supply chain to date, we have and may continue to experience delays and backorders for certain ingredients and products, difficulty scheduling shipping for our products, as well as price increases from many of our suppliers for both shipping and product costs. In addition, labor shortages have impacted our manufacturing operations and may impact our ability to supply certain products to our customers. To date, the pandemic and other global conditions have not had a material negative impact on our operations, supply chain, overall costs or demand for most of our products or resulting aggregate sales and earnings, and, as such, it has also not negatively impacted our liquidity position.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We continue to generate operating cash flows to meet our short-term liquidity needs.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;These circumstances could change, however, in this dynamic, unprecedented environment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;If the COVID-19 outbreak worsens or geopolitical conditions cause further disruption in the global supply chain, the availability of labor or otherwise increase costs, it may materially affect our operations and those of third parties on which we rely, including causing disruptions in the supply and distribution of our products. The extent to which these conditions impact our results and liquidity will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity and duration of any further COVID-19 outbreak and recovery period and further global instability. These effects could have a material adverse impact on our business, liquidity, capital resources, and results of operations and those of the third parties on which we rely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;Our fiscal year ends on March 31st of each year.&#160;&#160;References in these Consolidated Financial Statements or notes to a year (e.g., &#x201c;2022&#x201d;) mean our fiscal year ended on March 31st of that year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160;&#160;As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents.&#160;&#160;At March&#160;31, 2022, approximately 44% of our cash is held by a bank in Australia and approximately 18% is held by a bank in Singapore.  Substantially all of our remaining cash is held by a large U.S. domestic bank.&#160;&#160;We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.  Substantially all of the Company's cash balances at March&#160;31, 2022 are uninsured. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We extend non-interest-bearing trade credit to our customers in the ordinary course of business.&#160;&#160;We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable.&#160;&#160;In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers&#x2019; financial condition, (iii) monitor the payment history and aging of customers&#x2019; receivables, and (iv) monitor open orders against an individual customer&#x2019;s outstanding receivable balance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, where cost is determined by using the first-in, first-out method.&#160;&#160;We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value.&#160;&#160;Factors utilized in the determination of estimated net realizable value include (i) product expiration dates, (ii) current sales data and historical return rates, (iii) estimates of future demand, (iv) competitive pricing pressures, (v) new product introductions, and (vi) component and packaging obsolescence.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 40&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 to 10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for maintenance and repairs are charged to expense as incurred.&#160;&#160;When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill.&#160;&#160;Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level.  An impairment loss is recognized if the carrying amount of the reporting unit exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets generally represent tradenames, brand names and patents and are stated at cost less accumulated amortization.&#160;&#160;For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are tested for impairment at the individual asset level at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Intangible assets with finite lives are reviewed for impairment on an annual basis, or whenever events or changes in circumstances indicate that their carrying amount may exceed their fair values and may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Origination Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have incurred debt origination costs in connection with the issuance of long-term debt.&#160;&#160;These costs are amortized over the term of the related debt, using the effective interest method for our senior notes and our term loan facility and the straight-line method for our revolving credit facility.  Costs associated with our revolving credit facility are reported as a long-term asset and costs related to our senior notes and the term loan facility are recorded as a reduction of debt. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Nature of Goods and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from product sales.  We primarily ship finished goods to our customers and operate in two segments: North American OTC Healthcare and International OTC Healthcare.  The segments are based on differences in geographical area.  The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough &amp;amp; Cold, Women's Health, Gastrointestinal, Eye &amp;amp; Ear Care, Dermatologicals, and Oral Care.  Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels, all of which sell our products to consumers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 19 for disaggregated revenue information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Satisfaction of Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#x2019;s carrier. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to the disclosure of remaining performance obligations.  Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time.  Accordingly, we have elected the practical expedient available under ASC 606 not to disclose &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;remaining performance obligations for our contracts.  The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less.  As such, we do not adjust product consideration for the effects of a significant financing component.  The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales includes costs related to the manufacturing of our products, including raw materials, direct labor and indirect plant costs (including but not limited to depreciation), warehousing costs, inbound and outbound shipping costs, and handling and storage costs.&#160;&#160;Warehousing, shipping and handling and storage costs were $67.8 million for 2022, $52.1 million for 2021 and $61.9 million for 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising and Marketing Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising and marketing costs are expensed as incurred.&#160;&#160;Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize stock-based compensation expense by measuring the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#x2019;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million and we recognized a settlement gain of $0.2 million as a result of the payout.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process.  The plan termination is expected to be completed in the first quarter of fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute.  Changes in interest rates and the market value of the securities held by the plans could materially change the funded status of the plans, positively or negatively, and affect the level of pension expense and required contributions in fiscal 2023 and beyond. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Income Taxes topic of the FASB ASC 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&#160;&#160;The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.  As a result, we have applied such guidance in determining our tax uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to taxation in the United States and various state and foreign jurisdictions.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an antidilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share.  The following table sets forth the computation of basic and diluted earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share - weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For 2022, 2021, and 2020 there were 0.4 million, 0.5 million, and 0.3 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. These leases have lease terms of 1 to 10 years, some of which include options to terminate or extend leases for up to 1 to 5 years or on a month-to-month basis.  The exercise of lease renewal options is at our sole discretion and our lease right-of-use ("ROU") assets and liabilities reflect only the options we are reasonably certain that we will exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset.  ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.  Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease payments, which do not vary based on an index or rate, are excluded from the ROU asset and lease liability determination.  Variable lease payments are typically usage-based and are recorded in the period in which the obligation for those payments is incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the implicit rate in our leases is unknown, we used our incremental borrowing rate based on the information available at the date of adoption for existing leases and at the lease commencement date for new leases in determining the present value of future lease payments. We give consideration to our credit risk, term of the lease, total lease payments and adjust for the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impacts of collateral, as necessary, when calculating our incremental borrowing rates.  Rent expense for our operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the measurement and classification of our lease agreements, we group lease and non-lease components into a single lease component for all underlying asset classes. We have also elected to exclude any leases within our existing classes of assets with a term of twelve months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We adopted this standard effective April 1, 2021, and the adoption of this standard did not have a material impact on our Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020 using the modified retrospective approach, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2018, the FASB issued ASU 2018-14,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We adopted this standard effective April 1, 2021 and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  This update amended a number of aspects of lease accounting, including requiring lessees to recognize all leases with a term greater than one year as a ROU asset and corresponding lease liability, measured at the present value of the lease payments.  On April 1, 2019, we adopted Topic 842 using the modified retrospective approach.  Results for the years ended March&#160;31, 2022, 2021 and 2020 are presented under Topic 842. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which we adopted effective April 1, 2020 (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above).  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022,  including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The purpose of the ASU is to address questions raised on ASU 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#x201c;IBORs&#x201d;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MDc_673eb927-550a-408c-b05f-449d3bced185">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Consolidated Financial Statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). All significant intercompany transactions and balances have been eliminated in consolidation.&#160;&#160;Our fiscal year ends on March 31st of each year.&#160;&#160;References in these Consolidated Financial Statements or notes to a year (e.g., &#x201c;2022&#x201d;) mean our fiscal year ended on March 31st of that year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk0OTk_5574e086-f303-495b-ae40-e945b38cd860">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Although these estimates are &lt;/span&gt;&lt;/div&gt;based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.&#160;&#160;As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NTU_943cced4-3226-456d-bb7e-abbfccf3dc28">Cash and Cash EquivalentsWe consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents.&#160;&#160;At March&#160;31, 2022, approximately 44% of our cash is held by a bank in Australia and approximately 18% is held by a bank in Singapore.  Substantially all of our remaining cash is held by a large U.S. domestic bank.&#160;&#160;We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <pbh:PercentageofDepositsHeldinOneLocation
      contextRef="i93685426db444f7bb2e2083559bad12c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfNTgyOA_73503135-3153-4c73-884c-282612a3898d"
      unitRef="number">0.44</pbh:PercentageofDepositsHeldinOneLocation>
    <pbh:PercentageofDepositsHeldinOneLocation
      contextRef="iaf52d5526c8542f5ba5ef401cb74e77f_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfNTg5Mg_5984458c-b914-4565-a5d7-93da9d623f48"
      unitRef="number">0.18</pbh:PercentageofDepositsHeldinOneLocation>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MTk_9dc38f22-0627-4567-bb70-bd1ea65f34cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We extend non-interest-bearing trade credit to our customers in the ordinary course of business.&#160;&#160;We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable.&#160;&#160;In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers&#x2019; financial condition, (iii) monitor the payment history and aging of customers&#x2019; receivables, and (iv) monitor open orders against an individual customer&#x2019;s outstanding receivable balance.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDc_ec1a62fc-ebaf-4c84-8137-cbf8813650cb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, where cost is determined by using the first-in, first-out method.&#160;&#160;We reduce inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated net realizable value.&#160;&#160;Factors utilized in the determination of estimated net realizable value include (i) product expiration dates, (ii) current sales data and historical return rates, (iii) estimates of future demand, (iv) competitive pricing pressures, (v) new product introductions, and (vi) component and packaging obsolescence.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MDU_4cc8254d-cdfe-4f05-a3fa-8747b0f9425a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 40&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 to 10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for maintenance and repairs are charged to expense as incurred.&#160;&#160;When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Income and Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NzA_ebae8444-1501-4c9b-bbb2-17aed19d7d62">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 40&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 to 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 to 10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Leasehold improvements are amortized over the lesser of the lease term or the estimated useful life of the related assets.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMS0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjBiM2YyNjA3NzdkMjRiNWRhMzVmMmNiMWUxNGFmYjExXzQ_d4792571-9688-46c3-b036-839c197bc982">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie68302d173624012909bcb1af5423f95_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMS0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjBiM2YyNjA3NzdkMjRiNWRhMzVmMmNiMWUxNGFmYjExXzEw_5f9a1bfc-55d8-4f9c-a46d-f95615adb97b">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="idf17434e163e4883b63bc1d499d3bfcd_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMi0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjhhZmMxNDczYjBiMDQwODhhOWQ2Yjc0Yjc3MTRjMmE3XzQ_62c15434-d934-4aab-a286-54abe7b7681c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie8afee60cac74f0bbb72d34f37171669_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMi0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjhhZmMxNDczYjBiMDQwODhhOWQ2Yjc0Yjc3MTRjMmE3XzEw_84f3d94b-509e-4bed-9669-bbb55dc71cec">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i472664bf20994bc58e71a154e858a6ed_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMy0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOmNhMzdhMmI5MWM1ZjQ4NmE5YTg1NWM3MDFjNmI4NWI2XzQ_cbab24cd-fca5-49a7-a63d-8021a3d77851">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib57c0f0620294543a556b227a34dfc06_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfMy0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOmNhMzdhMmI5MWM1ZjQ4NmE5YTg1NWM3MDFjNmI4NWI2XzEw_c1b312b8-d821-444d-b554-efea69af9c50">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5cc44748f9f649259312b1379e06e3bf_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfNC0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjZlOWU5YmViNmMwZTRhZWQ5NWM1MTA1MDE3NGQ2YTMxXzQ_421370ac-9545-4573-b37a-7408735586e9">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib91d87e0f74c461e83248aab966de593_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOmViNmY1ZDgxNjM1MjQ3YzJhMGNjYWM5N2UwNzhiY2EyL3RhYmxlcmFuZ2U6ZWI2ZjVkODE2MzUyNDdjMmEwY2NhYzk3ZTA3OGJjYTJfNC0xLTEtMS0xODk2OS90ZXh0cmVnaW9uOjZlOWU5YmViNmMwZTRhZWQ5NWM1MTA1MDE3NGQ2YTMxXzEw_6501f810-4e42-44d2-825b-16ef254ebfba">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NTc_43f593af-165c-4f49-93eb-874d04ff4b64">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill.&#160;&#160;Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Goodwill is tested for impairment at the reporting unit level, which is one level below the operating segment level.  An impairment loss is recognized if the carrying amount of the reporting unit exceeds its fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1Mzg_0383e695-4c0e-4a2d-9203-d8d9b96d07ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets generally represent tradenames, brand names and patents and are stated at cost less accumulated amortization.&#160;&#160;For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years.&lt;/span&gt;&lt;/div&gt;Indefinite-lived intangible assets are tested for impairment at the individual asset level at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired.&#160;&#160;Intangible assets with finite lives are reviewed for impairment on an annual basis, or whenever events or changes in circumstances indicate that their carrying amount may exceed their fair values and may not be recoverable.&#160;&#160;An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfOTM5OA_633be965-e6b9-4718-a9cf-f89672ddcaeb">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfOTQwNA_d78af178-780d-46b7-b0c7-816923dc7c64">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDU_ba381a59-d449-4dcd-8a9d-b3f6968c6179">Debt Origination CostsWe have incurred debt origination costs in connection with the issuance of long-term debt.&#160;&#160;These costs are amortized over the term of the related debt, using the effective interest method for our senior notes and our term loan facility and the straight-line method for our revolving credit facility.  Costs associated with our revolving credit facility are reported as a long-term asset and costs related to our senior notes and the term loan facility are recorded as a reduction of debt.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1ODU_31162139-b488-437d-85e4-02ce6b03cc3d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Nature of Goods and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue from product sales.  We primarily ship finished goods to our customers and operate in two segments: North American OTC Healthcare and International OTC Healthcare.  The segments are based on differences in geographical area.  The North America and International OTC Healthcare segments market a variety of personal care and over-the-counter products in the following product groups: Analgesics, Cough &amp;amp; Cold, Women's Health, Gastrointestinal, Eye &amp;amp; Ear Care, Dermatologicals, and Oral Care.  Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell consumer products under a variety of brands through a broad distribution platform that includes mass merchandisers, drug, food, dollar, convenience and club stores, and e-commerce channels, all of which sell our products to consumers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 19 for disaggregated revenue information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Satisfaction of Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 606, revenue is recognized when control of a promised good is transferred to a customer, in an amount that reflects the consideration that we expect to be entitled to receive in exchange for that good.  This occurs either when finished goods are transferred to a common carrier for delivery to the customer or when product is picked up by the customer or the customer&#x2019;s carrier. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Once a product has transferred to the common carrier or been picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the product. It is at this point that we have a right to payment and the customer has legal title. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for certain rebates, customer promotional programs, product returns, and discounts to customers are accounted for as variable consideration and recorded as a reduction in sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of future product returns, chargebacks and logistic deductions concurrent with recording sales, which is made using the most likely amount method that incorporates (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in the promotional programs of our customers to enhance the sale of our products.  These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. The costs of such activities are recorded as a reduction to revenue when the related sale takes place.  Estimates of the costs of these promotional programs are derived using the most likely amount method, which incorporates (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel.  At the completion of the promotional program, the estimated amounts are adjusted to actual results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the nature (short duration) of our contracts with customers, we apply the practical expedient related to the disclosure of remaining performance obligations.  Remaining performance obligations relate to contracts with a duration of less than one year, in which we have the right to invoice the customer at the time the performance obligation is satisfied for the amount of revenue recognized at that time.  Accordingly, we have elected the practical expedient available under ASC 606 not to disclose &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;remaining performance obligations for our contracts.  The period between when control of the promised products transfers to the customer and when the customer pays for the products is one year or less.  As such, we do not adjust product consideration for the effects of a significant financing component.  The amortization period of any asset resulting from incremental costs of obtaining a contract would be one year or less. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for shipping and handling costs as fulfillment activities and therefore recognize them upon shipment of goods.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTA4MTY_b756d201-92f5-4158-bf75-e10328a28bca"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <pbh:CostOfSalesPolicyPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NjY_ec70f3fb-d668-4fbb-85c2-30ad4157194f">Cost of SalesCost of sales includes costs related to the manufacturing of our products, including raw materials, direct labor and indirect plant costs (including but not limited to depreciation), warehousing costs, inbound and outbound shipping costs, and handling and storage costs.</pbh:CostOfSalesPolicyPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if25f80c767b745ce88d01566c788c2ec_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2MjQ_09ecb3ab-c6ba-47ae-9022-941924411433"
      unitRef="usd">67800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i628847fe21c845faa7ad04720f019f4b_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2MzU_4b28e83e-f395-4235-8948-ee8c91e5e6bf"
      unitRef="usd">52100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9932c6e574f043a6b2eba1f46190d488_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTU2NDk_e0a79d57-2a31-4e80-8eeb-f74b403fa992"
      unitRef="usd">61900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1MDI_7149f08e-678d-41ee-8fe8-79aa675c7923">Advertising and Marketing CostsAdvertising and marketing costs are expensed as incurred.&#160;&#160;Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NDA_7f1271dc-7b44-41d0-999a-e545319ca784">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize stock-based compensation expense by measuring the cost of services to be rendered based on the grant-date fair value of the equity award.&#160;&#160;Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1ODc_067588f1-0a83-4f46-bbce-78030cfffd8a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pension Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#x2019;s policy is to contribute at least the minimum amount required under The Employee Retirement Income Security Act of 1974 ("ERISA"). The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan with an effective date of March 1, 2015.  During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million and we recognized a settlement gain of $0.2 million as a result of the payout.  During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the U.S. qualified defined benefit pension plan and began the plan termination process.  The plan termination is expected to be completed in the first quarter of fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;The funded status of our pension plans is dependent upon many factors, including returns on invested assets and the level of certain market interest rates. We review pension assumptions regularly, and we may from time to time make voluntary contributions to our pension plans that exceed the amounts required by statute.  Changes in interest rates and the market value of the securities held by the plans could materially change the funded status of the plans, positively or negatively, and affect the level of pension expense and required contributions in fiscal 2023 and beyond.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTcxMDE_f4d26b5b-2035-42a7-ad54-528c631df90a"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMTcxNDM_0662fbfb-2b58-4bcf-9d0e-145991578b09"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NzY_a8b68fbe-e8d4-441c-befb-bf2bf7e73437">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law. The TCJA, among other things, reduced the U.S. federal corporate tax rate from 35% to 21% and imposed a new minimum tax on Global Intangible Low-Taxed Income ("GILTI") earned by foreign subsidiaries. In July 2020, final regulations were issued for GILTI, which include a high-tax exception for certain income earned by foreign subsidiaries if the foreign tax rate is in excess of 90% of the U.S. corporate tax rate of 21%.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.&#160;&#160;A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Income Taxes topic of the FASB ASC 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&#160;&#160;The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities.  As a result, we have applied such guidance in determining our tax uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to taxation in the United States and various state and foreign jurisdictions.&#160;&#160;&lt;/span&gt;&lt;/div&gt;We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Income and Comprehensive Income.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1NDg_ab111b19-68e0-44ee-895e-510479c9399c">Earnings Per ShareBasic earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share is computed based on income available to common stockholders and the weighted average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units ("RSUs").  Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested RSUs, are included in the diluted earnings per share calculation to the extent that they are dilutive.  In loss periods, the assumed exercise of in-the-money stock options and RSUs has an antidilutive effect, and therefore these instruments are excluded from the computation of diluted earnings per share.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk2MTU_9a549462-ef8b-449b-9a64-f0c877d1b038">The following table sets forth the computation of basic and diluted earnings per share:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for basic earnings per share - weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of unvested restricted stock units and options issued to employees and directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy0xLTEtMS0xODk2OQ_418a4bca-bbc4-4bff-9196-9322e25f2a0e"
      unitRef="usd">205381000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy0zLTEtMS0xODk2OQ_ebeb65a2-14a1-4377-892b-e2ec9dd975cb"
      unitRef="usd">164682000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMy01LTEtMS0xODk2OQ_48038d0e-3c0b-4fe2-9c4b-f257fc8189c7"
      unitRef="usd">142281000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC0xLTEtMS0xODk2OQ_2cbf55dd-d86f-436b-9d5f-60744e8f3621"
      unitRef="shares">50259000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC0zLTEtMS0xODk2OQ_b0a440a3-a906-461b-a91b-e53f3ca3518b"
      unitRef="shares">50210000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOC01LTEtMS0xODk2OQ_b16ae0c1-e4e0-4948-848d-48f2b5e3fd25"
      unitRef="shares">50723000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS0xLTEtMS0xODk2OQ_f7f7cf0f-a8a9-4c24-89a1-9dece65c6a61"
      unitRef="shares">583000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS0zLTEtMS0xODk2OQ_0430ab08-4448-423c-a44d-a27c72d22278"
      unitRef="shares">395000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfOS01LTEtMS0xODk2OQ_6aa3bd7d-8813-4c25-836b-babf51d1d5d7"
      unitRef="shares">417000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtMS0xLTEtMTg5Njk_ef065b64-322f-4234-9c4a-09da1c724116"
      unitRef="shares">50842000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtMy0xLTEtMTg5Njk_368d3cd4-dc4b-4b4c-9d40-22d62f4a8f2a"
      unitRef="shares">50605000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTAtNS0xLTEtMTg5Njk_5f549077-55b6-45c2-acc7-9a009258b71d"
      unitRef="shares">51140000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtMS0xLTEtMTg5Njk_6e161bdd-1cd7-4d1b-b516-cee27ffd8c3d"
      unitRef="usdPerShare">4.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtMy0xLTEtMTg5Njk_44d9d325-47f9-4c96-8bcb-0aaf2def4380"
      unitRef="usdPerShare">3.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTMtNS0xLTEtMTg5Njk_168dd05c-e083-403d-afd8-81c0d9128839"
      unitRef="usdPerShare">2.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctMS0xLTEtMTg5Njk_fabefc69-5047-4d48-b45b-38e0d05ce721"
      unitRef="usdPerShare">4.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctMy0xLTEtMTg5Njk_14a21c17-f255-4828-a5ff-e5e95c631d9e"
      unitRef="usdPerShare">3.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RhYmxlOjZkYzU5ZDdkYmYwMjQ1ZTE4MTY3OGZkNDMyMDVlYWNhL3RhYmxlcmFuZ2U6NmRjNTlkN2RiZjAyNDVlMTgxNjc4ZmQ0MzIwNWVhY2FfMTctNS0xLTEtMTg5Njk_2f1c0ff6-d079-4426-89cd-067b7585659a"
      unitRef="usdPerShare">2.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEyOTA_5b8ddf6e-5c40-4866-aec7-012b2508cd3c"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEyOTQ_9f92b200-e7f6-4442-8bea-841ef2a813bd"
      unitRef="shares">500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjEzMDI_8eed4bf3-fc73-438f-abe4-e39bef029037"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk1Njg_389eb137-0319-4c3e-9528-cbb70266abed">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease real estate and equipment for use in our operations. These leases have lease terms of 1 to 10 years, some of which include options to terminate or extend leases for up to 1 to 5 years or on a month-to-month basis.  The exercise of lease renewal options is at our sole discretion and our lease right-of-use ("ROU") assets and liabilities reflect only the options we are reasonably certain that we will exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is or contains a lease at inception by assessing whether the arrangement contains an identified asset and whether we have the right to control the identified asset.  ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.  Lease liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. ROU assets are based on the measurement of the lease liability and also include any lease payments made prior to or on lease commencement and exclude lease incentives and initial direct costs incurred, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease payments, which do not vary based on an index or rate, are excluded from the ROU asset and lease liability determination.  Variable lease payments are typically usage-based and are recorded in the period in which the obligation for those payments is incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the implicit rate in our leases is unknown, we used our incremental borrowing rate based on the information available at the date of adoption for existing leases and at the lease commencement date for new leases in determining the present value of future lease payments. We give consideration to our credit risk, term of the lease, total lease payments and adjust for the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impacts of collateral, as necessary, when calculating our incremental borrowing rates.  Rent expense for our operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the measurement and classification of our lease agreements, we group lease and non-lease components into a single lease component for all underlying asset classes. We have also elected to exclude any leases within our existing classes of assets with a term of twelve months or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ied214f5ee4e64721bc76b33c5c12a69d_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2MDM_736558b2-f216-48dd-9c58-e1f787f8f9cb">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i07f4c56c383e4cadb7732fd1d3749213_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2MDk_988d1110-020e-437d-bbb9-56fd004183fb">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ied214f5ee4e64721bc76b33c5c12a69d_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2ODk_e7716278-ac0c-4f94-b5f9-5abcc48bb06e">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i07f4c56c383e4cadb7732fd1d3749213_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjE2OTU_8b5a3536-b71f-4f61-87b2-65bb40e56eb9">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl84Mi9mcmFnOmU4NTFjNGQ1NWY2ODQwOGVhZDlkZDVmZjVmY2MwYWI2L3RleHRyZWdpb246ZTg1MWM0ZDU1ZjY4NDA4ZWFkOWRkNWZmNWZjYzBhYjZfMjk0OTg_617f7fd2-5ce2-46c6-a241-4f3ac8755868">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the FASB issued Accounting Standards Update ("ASU") 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  The amendments in this update eliminate the need for an organization to analyze whether certain exceptions apply for tax purposes.  It also simplifies GAAP for certain taxes.  The amendments in these updates are effective for us for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years.  We adopted this standard effective April 1, 2021, and the adoption of this standard did not have a material impact on our Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amendments in this update modify the disclosure requirements in Topic 820, with a particular focus on Level 3 investments, by eliminating certain required disclosures and incorporating others.  The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  We adopted this standard effective April 1, 2020, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(with subsequent targeted amendments).  The amendments in this update provide financial statement users with more useful information about expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date.  The guidance requires entities to utilize an expected credit loss model for certain financial instruments, including most trade receivables, which replaces the incurred credit loss model previously used. Under this new model, we are required to recognize estimated credit losses expected to occur over time using a broad range of information including historical information, current conditions and reasonable and supportable forecasts. The amendments in these updates were effective for us in the first quarter of our fiscal year 2021.  We adopted this standard effective April 1, 2020 using the modified retrospective approach, and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2018, the FASB issued ASU 2018-14,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amendments in this update modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans by eliminating certain required disclosures and incorporating others. The amendments are effective for public companies for fiscal years ending after December 15, 2020.  We adopted this standard effective April 1, 2021 and the adoption did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  This update amended a number of aspects of lease accounting, including requiring lessees to recognize all leases with a term greater than one year as a ROU asset and corresponding lease liability, measured at the present value of the lease payments.  On April 1, 2019, we adopted Topic 842 using the modified retrospective approach.  Results for the years ended March&#160;31, 2022, 2021 and 2020 are presented under Topic 842. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU responds to feedback received by the FASB during the post-implementation review of ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which we adopted effective April 1, 2020 (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above).  The amendments in this update, among other things, eliminate the troubled debt restructuring recognition and measurement guidance and, instead, require the entity to evaluate whether the modification represents a new loan or a continuation of an existing loan.  This ASU is effective for fiscal years beginning after December 15, 2022,  including interim periods within those fiscal years.  The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, the FASB issued ASU 2022-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The purpose of the ASU is to address questions raised on ASU 2017-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU expands the currently used single-layer method of hedge accounting to allow multiple layers of a single closed portfolio under the method.  This ASU is effective for fiscal years &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;beginning after December 15, 2022, and interim periods within those fiscal years. The impact of adoption of this new standard is not expected to have a material effect on our Consolidated Financial Statements.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This ASU requires entities to apply Topic 606 to recognize and measure contract assets and liabilities in a business combination.  This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The impact of adoption of this new standard will depend on the magnitude of future acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2020, the FASB issued ASU 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;.  This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met.  In response to the concerns about structural risks of interbank offered rates (&#x201c;IBORs&#x201d;) and, particularly, the risk of cessation of the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation.  The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued.  In January 2021, the FASB issued ASU 2021-01, which adds implementation guidance to clarify certain optional expedients in Topic 848. The ASUs can be adopted no later than December 31, 2022, with early adoption permitted. The adoption of the standard is not expected to have a material effect on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8zODQ4MjkwNjk5OTc1_f541d3fc-03ba-41ee-96ee-78393ed1a025">Acquisition&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Akorn&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn Operating Company LLC ("Akorn"), pursuant to an Asset Purchase Agreement, dated May 27, 2021 (the "Purchase Agreement"), for a purchase price of $228.9&#160;million in cash, subject to certain closing adjustments specified in the Purchase Agreement.  As a result of the purchase, we acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and certain other over-the-counter consumer brands.  The financial results from this acquisition are included in our North American and International OTC Healthcare segments.  The purchase price was funded by a combination of available cash on hand, additional borrowings under our asset-based revolving credit facility (the "2012 ABL Revolver") and the net proceeds from the refinancing of our term loan entered into on January 31, 2012 (the "2012 Term Loan") (see Note 9).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was accounted for as a business combination.  During 2022, we incurred acquisition-related costs of $5.1&#160;million, which are included in General and administrative expense.  In connection with the acquisition, we also entered into a supply arrangement with Akorn for a term of three years with optional renewals at prevailing market rates.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition.  These purchase price allocations are preliminary as we are in the process of finalizing the valuation.  The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales allowances &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on this preliminary analysis, we allocated $195.9&#160;million to non-amortizable intangible assets and $29.5&#160;million to amortizable intangible assets.  The non-amortizable intangible assets are classified as trademarks and, of the amortizable intangible assets, $20.4&#160;million are classified as customer relationships and $9.1&#160;million are classified as trademarks.  We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 12.5 years (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded goodwill of $1.6&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired (see Note 5).  Goodwill is deductible and is being amortized for income tax purposes. &lt;/span&gt;&lt;/div&gt;The financial impact of this acquisition was not material to our Consolidated Financial Statements, and, therefore, we have not presented pro forma results of operations for the acquisition.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNzU2_13c57913-7f89-4586-910a-211e33b21e18"
      unitRef="usd">228900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="iedfff890d1e84d249e980571ec6bbcf9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwMzM1_2916705f-a048-4936-83f5-b03e58b90bec"
      unitRef="usd">5100000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <pbh:SupplyCommitmentTermOfAgreement
      contextRef="ibd914b5ed7ee4a2c8bba1ee5e7e2efe8_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjI4OTM5_4796d278-634b-4de5-b61a-cf9cb53fd900">P3Y</pbh:SupplyCommitmentTermOfAgreement>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8zODQ4MjkwNjk5OTc2_78b34fd1-91e8-4e93-81c8-7cd1253cf68b">The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the July 1, 2021 acquisition date.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales allowances &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl80LTEtMS0xLTE5ODU4_59068d04-4ee1-4360-8f8b-5204aa2dfa0b"
      unitRef="usd">6455000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:Goodwill
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl83LTEtMS0xLTE5ODU4_e82ef5c1-a3bf-4572-a404-92d88cd7f62a"
      unitRef="usd">1648000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl84LTEtMS0xLTE5ODU4_f8c6efb9-8378-495d-a771-bf6895bcbb46"
      unitRef="usd">225410000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMC0xLTEtMS0xOTg1OA_b209dda5-6577-442c-9e33-08603f86d895"
      unitRef="usd">233513000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMi0xLTEtMS0xOTg1OA_60019b66-11c9-4581-adc7-56c7dc3f2940"
      unitRef="usd">478000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xMy0xLTEtMS0xOTg1OA_9688acde-76da-4428-8eaa-3b8418c5b0c4"
      unitRef="usd">747000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves>
    <pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xNC0xLTEtMS0xOTg1OA_ad92fe7a-6c96-4cdd-b356-177fd976bacd"
      unitRef="usd">3374000</pbh:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xNy0xLTEtMS0xOTg1OA_2dde8979-0ff7-49f6-ab4f-289278e4533b"
      unitRef="usd">4599000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGFibGU6MTgxMjM3MWFlNGRhNGE4NmI0ZjRiMTIxZDgyMWNkZmIvdGFibGVyYW5nZToxODEyMzcxYWU0ZGE0YTg2YjRmNGIxMjFkODIxY2RmYl8xOC0xLTEtMS0xOTg1OA_bcb7d3a4-4e0a-4a6e-acec-a3589d080c16"
      unitRef="usd">228914000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDI1_04dbe9f5-b5a7-43af-8b19-57bada958276"
      unitRef="usd">195900000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDI5_5a2fc805-c96b-4a32-8689-39e2bd526720"
      unitRef="usd">29500000</pbh:BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="icc3645f563ff42219ffff940481757a4_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDUz_2f593f5e-96b0-491f-ab39-dbcf372f96e4"
      unitRef="usd">20400000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount
      contextRef="ic475742a3fe44eb5ac7769813e20ce42_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDQz_24dba9ad-2928-4dc2-9912-77c726478953"
      unitRef="usd">9100000</pbh:BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDg0_1511d76d-1f5c-4f6c-adea-475b9cee4a7e">P12Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:Goodwill
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNzI5L2ZyYWc6MmNmODI0ZWFiMzE5NGUwYjgxNjIwMDliZTQ0MTNkOTYvdGV4dHJlZ2lvbjoyY2Y4MjRlYWIzMTk0ZTBiODE2MjAwOWJlNDQxM2Q5Nl8xMDk5NTExNjMwNDk2_1b4baf6f-fb2d-4fe7-b3e5-f41561d1255c"
      unitRef="usd">1600000</us-gaap:Goodwill>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMzAw_bbe2674f-aca8-4a38-a1b3-b70d1f8d5346">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are carried and depicted above at the lower of cost or net realizable value, which includes a reduction in inventory values of $4.9 million and $4.0 million at March&#160;31, 2022 and 2021, respectively, related to obsolete and slow-moving inventory.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjkx_795b8769-17a0-4d6d-8471-b40d8a5eb2f6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging and raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfMy0xLTEtMS0xODk2OQ_ddda218f-f5db-458d-940b-b7a6a882183a"
      unitRef="usd">16984000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfMy0zLTEtMS0xODk2OQ_dd9aae36-88c6-482d-ac13-1b13d6166e7b"
      unitRef="usd">8463000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNC0xLTEtMS0xODk2OQ_4990dd3d-c736-4065-91ba-98596afcc032"
      unitRef="usd">338000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNC0zLTEtMS0xODk2OQ_0d5957ef-9c01-4316-9c3f-c7c67d3c03e2"
      unitRef="usd">326000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNS0xLTEtMS0xODk2OQ_d8329495-34be-4963-a1d7-4a82c7315517"
      unitRef="usd">103020000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNS0zLTEtMS0xODk2OQ_6e865a18-869f-4a7d-8978-1ee03e07dd2e"
      unitRef="usd">106170000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNi0xLTEtMS0xODk2OQ_a6512b82-d568-40a1-8fa2-8b226cd903af"
      unitRef="usd">120342000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RhYmxlOmJjZGFiYTJjYTBjMzRmZDFiYjA0NzQ2MjY5Mzc2NzMzL3RhYmxlcmFuZ2U6YmNkYWJhMmNhMGMzNGZkMWJiMDQ3NDYyNjkzNzY3MzNfNi0zLTEtMS0xODk2OQ_2f140ea6-b20b-4f4b-86bf-35b13aac0b12"
      unitRef="usd">114959000</us-gaap:InventoryNet>
    <us-gaap:InventoryValuationReserves
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjAy_38f6c721-1a9a-45e7-ac75-5349f69dd1cd"
      unitRef="usd">4900000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85MS9mcmFnOjFkYzdkYTJjNzllZTQzN2M5NzE4NDUwYWMyMGU3MmU0L3RleHRyZWdpb246MWRjN2RhMmM3OWVlNDM3Yzk3MTg0NTBhYzIwZTcyZTRfMjA5_e4ee506a-0946-4b1b-9b4f-1faa6dbe0a15"
      unitRef="usd">4000000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTk1_3413b731-fb5b-460b-add9-2d872b4f8930">Property, Plant and Equipment&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;We recorded depreciation expense of $8.0 million, $8.5 million, and $8.8 million for 2022, 2021, and 2020, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i63adfa16455749529a578a107f9b488f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMy0xLTEtMS0xODk2OQ_8acc6acb-228c-4914-911d-c7348db55ce0"
      unitRef="usd">550000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0e0c797835694c38b0ed72ecec2427b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMy0zLTEtMS0xODk2OQ_d376643c-e8eb-490e-af6d-0b92ed0086bb"
      unitRef="usd">550000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie6359612b8c648048fe362216a04a7f3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNC0xLTEtMS0xODk2OQ_5d41b099-9d40-43f7-8b21-e4d887f3a9e4"
      unitRef="usd">29046000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i33cda2011cd9439296ec2aee3a52e2a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNC0zLTEtMS0xODk2OQ_7668ad00-1c84-44f0-aee2-1659187b2e6f"
      unitRef="usd">27180000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia73a57ecc254455cae6f5b9d171bc153_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNS0xLTEtMS0xODk2OQ_a57327a1-f8ba-4d6d-b33d-6f0ae516c5e9"
      unitRef="usd">48390000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia73e9364fde841a2a844b91fca700d71_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNS0zLTEtMS0xODk2OQ_2909a7b9-96ec-404c-ab65-9f217468eb8a"
      unitRef="usd">45371000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i68eec35a89b640abb6b59a67cc2c458e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNi0xLTEtMS0xODk2OQ_778127b0-6558-4936-b731-5a04a651f37b"
      unitRef="usd">25245000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3b8a0ad3b3d24ce481be054872bcc00e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNi0zLTEtMS0xODk2OQ_7c8b30b5-a3a3-42e7-969a-c7d07548c009"
      unitRef="usd">24449000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i609a7e847bec4a5eb87c67671f78c7e0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNy0xLTEtMS0xODk2OQ_83ceda14-5c40-42f3-8cf3-2a45c567038d"
      unitRef="usd">3238000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i63d91fe5ae4e4557a2fa616f58e373cc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfNy0zLTEtMS0xODk2OQ_49cd8c34-c1a1-4519-b047-aafc9f9e8bab"
      unitRef="usd">3256000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i04801f9b35a145479c2f926a02758888_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOC0xLTEtMS0xODk2OQ_e2c6b5a1-2e27-43a3-87c5-944e96af41d2"
      unitRef="usd">9080000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d090ede7de343c8a1442413f0a934af_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOC0zLTEtMS0xODk2OQ_067f3721-3ef6-4efa-aa9b-86ba4415c93a"
      unitRef="usd">9071000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iacff4498c9324023bb8e6dc3cbbd98d6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOS0xLTEtMS0xODk2OQ_d89a14c2-d42e-4df2-8357-58cbf710656a"
      unitRef="usd">16466000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3f29776a97564733a0caac2100d77ef5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfOS0zLTEtMS0xODk2OQ_baec4e70-9723-4197-8470-a792083807c6"
      unitRef="usd">14537000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTAtMS0xLTEtMTg5Njk_4269f79d-979e-40ba-9fef-6be5cbf16eb8"
      unitRef="usd">132015000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTAtMy0xLTEtMTg5Njk_11049afd-b3a2-4f40-be98-c3646ea460e4"
      unitRef="usd">124414000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTEtMS0xLTEtMTg5Njk_5a035c97-7f5a-47b7-b927-1fcc68a027aa"
      unitRef="usd">60715000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTEtMy0xLTEtMTg5Njk_ca5b0ba1-5586-45a9-8193-d8900c691c36"
      unitRef="usd">54355000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTItMS0xLTEtMTg5Njk_8c25876f-7633-47ed-b2a7-0d928b25f3ef"
      unitRef="usd">71300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RhYmxlOjg4MTg1YzFhMDhjZDQ3MjZhZGRlNGEyZDgyODgwYzZjL3RhYmxlcmFuZ2U6ODgxODVjMWEwOGNkNDcyNmFkZGU0YTJkODI4ODBjNmNfMTItMy0xLTEtMTg5Njk_3edc1957-537c-4eb8-a732-a091022a9045"
      unitRef="usd">70059000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTQy_94f602c1-53f1-4f53-9448-19099bcec5d0"
      unitRef="usd">8000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTQ2_65cec828-e143-49a5-9efb-f6587956a99b"
      unitRef="usd">8500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85NC9mcmFnOjhhNWRmMGE3ZGViNzQ5NDE5YzZkYzk5ODY4M2UxY2RmL3RleHRyZWdpb246OGE1ZGYwYTdkZWI3NDk0MTljNmRjOTk4NjgzZTFjZGZfMTU0_740a7e21-c56d-431f-b9ed-d0a29a733a03"
      unitRef="usd">8800000</us-gaap:Depreciation>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMzA0Mw_b22b1324-fe05-4255-84ac-acb82fc614bc">Goodwill&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2020, 2021, and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 43.75pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As discussed in Note 2, on July 1, 2021, we completed the acquisition of the consumer health business assets from Akorn.  In connection with this acquisition, we recorded goodwill of $1.6&#160;million based on the amount by which the purchase price exceeded the preliminary estimate of the fair value of the net assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At February 28, 2021, in conjunction with the annual test for goodwill impairment, we recorded an impairment charge of $1.2&#160;million to adjust the carrying amount of goodwill related to our International Analgesics reporting unit in our International OTC Healthcare segment to its fair value.  The goodwill impairment was a result of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; tradename impairment discussed in Note 5.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At February 28, 2022, in conjunction with the annual test for goodwill impairment, which coincides with our annual strategic planning process, we recorded an impairment charge of $0.3&#160;million to write off the remaining goodwill related to our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Painstop &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;brand in our International OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We identify our reporting units in accordance with the FASB ASC Subtopic 280.  The carrying value and fair value for intangible assets and goodwill for a reporting unit are calculated based on key assumptions and valuation methodologies.  The discounted cash flow methodology is a widely-accepted valuation technique utilized by market participants in the transaction evaluation process and has been applied consistently.&#160;&#160;We also considered our market capitalization at February&#160;28, 2022 and February&#160;28, 2021, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology.&#160;&#160;The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties related to future sales, gross margins, and advertising and marketing expenses, which can be impacted by increases in competition, changing consumer preferences, technical advances, increased product costs, supply chain/material cost inflation, or the potential impacts of COVID-19.  The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value. If these assumptions are adversely affected, we may be required to record impairment charges in the future. &lt;/span&gt;&lt;/div&gt;As a result of our analysis at February&#160;28, 2022, all reporting units had a fair value that exceeded their carrying value by at least 10%.  We performed a sensitivity analysis on our weighted average cost of capital and we determined that a 50 basis point increase in the weighted average cost of capital would not have resulted in any of our other reporting units' fair value being less than their carrying value.  Additionally, a 50 basis point decrease in the terminal growth rate used for each reporting unit would also not have resulted in any of our other reporting units' fair value being less than their carrying value.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMzA0MA_e469a150-b760-4d8a-b037-9d0555798ea5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying value of goodwill by operating segment for each of 2020, 2021, and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 43.75pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi0xLTEtMS0xODk2OQ_cd10b70b-a2d0-462e-8064-ba9556230366"
      unitRef="usd">710354000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i4d5785a0756b4597a3f801623955484e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi0zLTEtMS0xODk2OQ_8ab371fa-4538-4429-9d6f-6afbbb814a20"
      unitRef="usd">28536000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMi03LTEtMS0xODk2OQ_b5b7f871-9344-40d0-9f6d-63509d7f65a5"
      unitRef="usd">738890000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy0xLTEtMS0xODk2OQ_2a5d7951-6586-4d9e-aae2-9bfbff9215d6"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4d5785a0756b4597a3f801623955484e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy0zLTEtMS0xODk2OQ_96a620ba-89b9-4b7f-a76a-77a2356985cb"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMy03LTEtMS0xODk2OQ_dece9361-11ad-4587-9a91-584684652483"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ib5038f7608994e62940ad33470b50c1b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC0xLTEtMS0xODk2OQ_d2761a85-53f8-47aa-8154-65a0b892b089"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4d5785a0756b4597a3f801623955484e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC0zLTEtMS0xODk2OQ_a988f4a8-b127-41dd-ab33-0577806bbf08"
      unitRef="usd">28536000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfNC03LTEtMS0xODk2OQ_bbfe1775-bbe1-434d-9377-8e1c6e28b067"
      unitRef="usd">575179000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtMS0xLTEtMTg5Njk_ab876bf1-f8fb-4200-bc65-2457825d65de"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtMy0xLTEtMTg5Njk_4b5c76ac-d91a-4eee-aed0-b270c53d29ed"
      unitRef="usd">4147000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTAtNy0xLTEtMTg5Njk_ce5aec9d-9ed4-43c4-a79b-44f43353611f"
      unitRef="usd">4147000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtMS0xLTEtMTg5Njk_2b427a26-496b-4083-8a1f-cd356c7ca974"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtMy0xLTEtMTg5Njk_5675d08b-753f-44cc-8b11-e3b4073c511b"
      unitRef="usd">1247000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTEtNy0xLTEtMTg5Njk_5b40d0d2-957a-4888-88cb-cb8b26c31786"
      unitRef="usd">1247000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtMS0xLTEtMTg5Njk_62067ce8-4807-4ae7-ac95-2d2113e9047c"
      unitRef="usd">710354000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtMy0xLTEtMTg5Njk_b5ab5642-d0ad-492d-b2ad-0887701988f3"
      unitRef="usd">32683000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTQtNy0xLTEtMTg5Njk_8a1250c1-e5eb-47b1-9230-ce64594fd383"
      unitRef="usd">743037000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtMS0xLTEtMTg5Njk_38fe0bac-cee6-42c9-aad3-9f405ff4779c"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtMy0xLTEtMTg5Njk_b64c1165-0398-40ed-bf75-d7c2fb12ce62"
      unitRef="usd">1247000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTUtNy0xLTEtMTg5Njk_8b88d91f-fe8d-4f61-b440-608e28ee726e"
      unitRef="usd">164958000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtMS0xLTEtMTg5Njk_28dc3a2b-b6d5-4234-9dfa-0283000f0ce6"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtMy0xLTEtMTg5Njk_46179f9f-dc96-4491-a02d-bda05fe92f22"
      unitRef="usd">31436000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTYtNy0xLTEtMTg5Njk_8b68ce67-9715-40be-b409-b01cbe4cf52b"
      unitRef="usd">578079000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtMS0xLTEtMTg5Njk_c42c3712-9d9c-44da-b5ab-536864ce3658"
      unitRef="usd">1648000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtMy0xLTEtMTg5Njk_8308fe14-5737-4be9-a600-2cdc3bf109e9"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMTgtNy0xLTEtMTg5Njk_3c701922-cf82-45a3-854e-1a354b4385b6"
      unitRef="usd">1648000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItMS0xLTEtMTg5Njk_131c4ee9-0b3d-4847-8f47-2e64591f8596"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItMy0xLTEtMTg5Njk_856b7d48-86bc-4e1a-baeb-accdc92e8241"
      unitRef="usd">-411000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjItNy0xLTEtMTg5Njk_39f6bcdf-c6bc-42b3-9610-e2041a96d2ba"
      unitRef="usd">-411000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtMS0xLTEtMTg5Njk_88c6c549-844d-4383-a0ab-36b9a1e324ca"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtMy0xLTEtMTg5Njk_59c90e21-7de9-4a1e-a330-efa1d490f565"
      unitRef="usd">340000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjMtNy0xLTEtMTg5Njk_a52b639b-d040-497a-b365-399ed6df7877"
      unitRef="usd">340000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillGross
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtMS0xLTEtMTg5Njk_00230eca-a407-4ef6-baf8-39ebcbb360ac"
      unitRef="usd">712002000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtMy0xLTEtMTg5Njk_e1a700a3-81b4-468a-a9e3-6541938648f6"
      unitRef="usd">32272000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjYtNy0xLTEtMTg5Njk_27a24e7b-1a5e-4d73-b7c6-d3490108e472"
      unitRef="usd">744274000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctMS0xLTEtMTg5Njk_0dbb3652-958f-40ce-b36c-ccddcc7d52e0"
      unitRef="usd">163711000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctMy0xLTEtMTg5Njk_581bd8bd-1c33-4c49-9750-0fe1b1522938"
      unitRef="usd">1587000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjctNy0xLTEtMTg5Njk_e791f0b1-90c9-4a6a-bbad-1dea0e43e34e"
      unitRef="usd">165298000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtMS0xLTEtMTg5Njk_06cb090a-787c-46da-8587-f7784f49b3ed"
      unitRef="usd">548291000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtMy0xLTEtMTg5Njk_aafd57d1-c38e-4d3a-a151-ea5c385ed8cd"
      unitRef="usd">30685000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RhYmxlOjc0Y2Q4MjFjMDBlNjRhNmU4OGQ3ODQxZjUyZmZhZmUyL3RhYmxlcmFuZ2U6NzRjZDgyMWMwMGU2NGE2ZTg4ZDc4NDFmNTJmZmFmZTJfMjgtNy0xLTEtMTg5Njk_84ef5614-59e5-48a9-91fb-2a69cd5f3bbe"
      unitRef="usd">578976000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8fb8878771394bb997fb34a8c9708c34_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzMTIwNA_16771e69-f564-420c-a5b3-672d5efef09a"
      unitRef="usd">1600000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i19e3761c71cf440882e905e4bc852d25_D20210228-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzMjU0OA_6a622862-ac72-448a-84e0-152f4896bc9d"
      unitRef="usd">1200000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5f61b06bc453405295e67e755ad9dc7d_D20210228-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMTA5OTUxMTYzNzI4OQ_dbc22bf1-139e-4059-bbd2-724f4eb3f53f"
      unitRef="usd">300000</us-gaap:GoodwillImpairmentLoss>
    <pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjU0Mg_e24fc4fd-a160-402e-b10d-486f2b9efb60"
      unitRef="number">0.10</pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount>
    <pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i8bb6c96119cc4504a07f59227add5e1a_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjY0OA_2a5fd539-fccf-4f98-8232-df3cedf2f90c"
      unitRef="number">0.0050</pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount>
    <pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl85Ny9mcmFnOjEyMWJmZmI3ZTE4MDRiYjI4NDY1NmYyN2I4NWU4NWU1L3RleHRyZWdpb246MTIxYmZmYjdlMTgwNGJiMjg0NjU2ZjI3Yjg1ZTg1ZTVfMjgzOQ_d156492e-e654-4621-b418-5eb33f5dbcc4"
      unitRef="number">0.0050</pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQzODY_ffa1e90a-50b2-43ad-89fa-c1f33a38f630">Intangible Assets&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net for each of 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Tradenames and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets, net by Reportable Segment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets based on our preliminary analysis for Akorn and $18.1 million for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Tradenames and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets, net by Reportable Segment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of each fiscal year, in conjunction with our strategic planning process, we perform our annual impairment analysis.  We utilized the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets.  The assumptions subject to significant uncertainties include the discount rate utilized in the analyses, as well as future sales, gross margins and advertising and marketing expenses.   The discount rate assumption may be influenced by such factors as changes in interest rates and rates of inflation, which can have an impact on the determination of fair value.  Additionally, should the related fair values of intangible assets be adversely affected as a result of declining sales or margins caused by competition, changing consumer needs or preferences, technological advances, increased product costs, changes in advertising and marketing expenses, or the potential impacts of COVID-19, we may be required to record impairment charges in the future.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, we determined that the fair value of one of our finite-lived intangible assets in our International OTC Healthcare segment, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, did not exceed its carrying amount.  As such, we recorded an impairment charge of $1.2&#160;million. The decline in the fair value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was primarily related to a decline in expected future sales due to a regulatory change that now requires &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Painstop&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to be prescribed by physicians rather than sold over-the-counter direct to consumers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At February&#160;28, 2022, in conjunction with the annual test for impairment of intangible assets, we recorded an impairment charge of $0.7&#160;million.  In connection with our long-term planning, two non-core brands in our North American OTC Healthcare segment were discontinued and therefore the related finite-lived intangible assets were written off. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of our analysis at February&#160;28, 2022, all indefinite-lived intangible assets tested had a fair value that exceeded their carrying value by at least 10%, with the exception of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tradename which had a fair value exceeding its carrying value by 7%.  We performed a sensitivity analysis of our weighted average cost of capital, and we determined that a 50 basis point increase in the weighted average cost of capital used to value the indefinite-lived intangible assets would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value, with the exception of our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tradename.  The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tradename was acquired on July 1, 2021 and given the close proximity of the acquisition to the annual impairment test, we would expect the fair value to more closely approximate the carrying value.  A 50 basis point increase in the weighted average cost of capital would result in an impairment charge of $4.3&#160;million on our &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TheraTears&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tradename.  Additionally, a 50 basis point decrease in the terminal growth rate used for each of our indefinite-lived &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intangible assets' would not have resulted in any of our indefinite-lived intangible assets' fair value being less than their carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining life for finite-lived intangible assets at March&#160;31, 2022 was approximately 9.8 years, and the amortization expense for the year ended March&#160;31, 2022 was $21.5 million.  At March&#160;31, 2022, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <pbh:ScheduleOfIntangibleAssetsTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQ0MDQ_ff2b5e62-94af-437d-a4b9-b3e81fcc6859">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the activity affecting intangible assets, net for each of 2022 and 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Tradenames and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets, net by Reportable Segment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021, we completed the acquisition of certain assets from Akorn (see Note 2) and on December 15, 2021 our Australian subsidiary acquired the rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; brand in certain territories from Novartis Pharma AG.  In connection with these acquisitions, we allocated $225.4 million to intangible assets based on our preliminary analysis for Akorn and $18.1 million for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zaditen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Indefinite-&lt;br/&gt;Lived&lt;br/&gt;Tradenames&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finite-Lived&lt;br/&gt;Tradenames and Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradename impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,671,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets, net by Reportable Segment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North American OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International OTC Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets, net &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</pbh:ScheduleOfIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtMS0xLTEtMTg5Njk_24f6d7ba-f100-4f0e-9c68-073e7ee7e53e"
      unitRef="usd">2281988000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtMy0xLTEtMTg5Njk_29bd5cf2-8d3a-48d6-a55f-836e375bb040"
      unitRef="usd">389347000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzMtNS0xLTEtMTg5Njk_3f54a844-6b28-4328-bdfc-01ff93d7e392"
      unitRef="usd">2671335000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtMS0xLTEtMTg5Njk_2fdd146c-5244-4be1-9648-6dfc5ea0a9ea"
      unitRef="usd">195900000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtMy0xLTEtMTg5Njk_4a42cd7f-c7d4-4272-b54d-9c4d208a85b0"
      unitRef="usd">47642000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <pbh:IntangibleAssetsAcquired
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzQtNS0xLTEtMTg5Njk_bbe9da3f-dee6-48f2-a1dc-3b2289a9b938"
      unitRef="usd">243542000</pbh:IntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctMS0xLTEtMTg5Njk_a887f8ff-12d8-441a-b368-4633576caad4"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctMy0xLTEtMTg5Njk_98715a27-2227-4155-8679-b98801e422fb"
      unitRef="usd">1700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzctNS0xLTEtMTg5Njk_5216ecb2-c440-48f5-a1a3-639c6365af5f"
      unitRef="usd">1700000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i106b6a012f234f36babdb24e0a55238b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtMS0xLTEtMTg5Njk_4380d9ef-e38c-4dcf-97cf-4fe077844d6f"
      unitRef="usd">-1329000</us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtMy0xLTEtMTg5Njk_4a76a035-5f86-4a60-9275-a29403d56c96"
      unitRef="usd">885000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <pbh:IntangibleAssetsTranslationAdjustmentsGainLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzgtNS0xLTEtMTg5Njk_126b06d6-9806-486e-82d1-afaa279e6916"
      unitRef="usd">-444000</pbh:IntangibleAssetsTranslationAdjustmentsGainLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i13817405df1449ac862beb623f788537_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktMS0xLTEtMTg5Njk_d76c4e8d-9a7a-49c1-b583-cf45f0466816"
      unitRef="usd">2476559000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktMy0xLTEtMTg5Njk_f6b5fec8-7cb9-4d24-81bd-00b690094943"
      unitRef="usd">436174000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzktNS0xLTEtMTg5Njk_998424e7-869f-448b-976e-c8fbb68fa42f"
      unitRef="usd">2912733000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEyLTMtMS0xLTE4OTY5_bbf46585-6a94-40bb-a708-a56732a75aef"
      unitRef="usd">195606000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEyLTUtMS0xLTE4OTY5_06db1e57-7d5e-4a67-816a-9dd6ba58ea86"
      unitRef="usd">195606000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEzLTMtMS0xLTE4OTY5_33d391fd-59bd-48cb-8cd2-7d2f03260823"
      unitRef="usd">21499000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzEzLTUtMS0xLTE4OTY5_ae7d25ef-c200-417b-ae35-250a6cd89ce5"
      unitRef="usd">21499000</us-gaap:AmortizationOfIntangibleAssets>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE0LTMtMS0xLTE4OTY5_75cdbc9f-4874-4175-9def-aa3000e5f5f1"
      unitRef="usd">983000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE0LTUtMS0xLTE4OTY5_c773ca65-a23b-44fb-8e82-52227faba850"
      unitRef="usd">983000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="ieb7b8be027404cf685507df5499990e1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE1LTMtMS0xLTE4OTY5_d7e0b107-f7be-41d9-afd3-8e951e2877c8"
      unitRef="usd">-24000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE1LTUtMS0xLTE4OTY5_89be38f7-1f94-4df7-9f2e-5061e319675f"
      unitRef="usd">-24000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE2LTMtMS0xLTE4OTY5_ca7cd9f7-9d02-4c95-ab20-21e41590a625"
      unitRef="usd">216098000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE2LTUtMS0xLTE4OTY5_546679bd-e421-4be1-892d-f9135d1ea0cf"
      unitRef="usd">216098000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i13817405df1449ac862beb623f788537_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTEtMS0xLTE4OTY5_dfac46e2-67d6-4dc9-9c02-8a80b235a3d9"
      unitRef="usd">2476559000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTMtMS0xLTE4OTY5_1634f32b-9bee-4b4b-bae5-8325e1352b7e"
      unitRef="usd">220076000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzE4LTUtMS0xLTE4OTY5_dbcbf9e5-65e0-4875-9231-b4683ed610c4"
      unitRef="usd">2696635000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7bacb62d2b764d98ab587019221feb5e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTEtMS0xLTE4OTY5_64c00d1c-934b-4351-bd4d-dc722ce5afb5"
      unitRef="usd">2391517000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3b518b4ab33c4fb7b07453e2656c888b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTMtMS0xLTE4OTY5_94524791-c2d2-4797-85dc-5efb51e61725"
      unitRef="usd">198353000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIxLTUtMS0xLTE4OTY5_0ce80d40-65f7-4d96-88b4-e864efd28630"
      unitRef="usd">2589870000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic9ba4d3341224392858a56fe1feccb8b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTEtMS0xLTE4OTY5_5c3270eb-8351-4da1-9edb-cff6c4c1e361"
      unitRef="usd">85042000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTMtMS0xLTE4OTY5_f0a41f1d-bc4d-4b3e-84ea-c8c44ef89cf0"
      unitRef="usd">21723000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzIyLTUtMS0xLTE4OTY5_eb5ebf28-5fb3-46f8-a507-1583ef73498f"
      unitRef="usd">106765000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i13817405df1449ac862beb623f788537_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTEtMS0xLTE4OTY5_3c5dcdf7-c683-4284-a97e-ab4340dd34cd"
      unitRef="usd">2476559000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTMtMS0xLTE4OTY5_e7edc9fa-b83a-4adf-96f5-1add5bc144f3"
      unitRef="usd">220076000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTo2NzNiNTg0NTczYzM0NjljOGEwZmE0YzRiYjNmNDlkNi90YWJsZXJhbmdlOjY3M2I1ODQ1NzNjMzQ2OWM4YTBmYTRjNGJiM2Y0OWQ2XzI0LTUtMS0xLTE4OTY5_c35d82b5-d29c-47f4-8852-54596ee0329b"
      unitRef="usd">2696635000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <pbh:IntangibleAssetsAcquired
      contextRef="i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2Mzc4NTg_4b64bf83-ecfd-42a4-b84b-7accd03aa197"
      unitRef="usd">225400000</pbh:IntangibleAssetsAcquired>
    <pbh:IntangibleAssetsAcquired
      contextRef="i6e7c6d4c44a9497fbbbbe5882fa1a870_D20211215-20211215"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2MzMzNzQ_8c3ea7ab-1f98-4ba2-a511-89fbdbf7047d"
      unitRef="usd">18100000</pbh:IntangibleAssetsAcquired>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4b414dfd69f8433e8240e27a0edef648_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtMS0xLTEtMTg5Njk_7a8a05fb-66f6-417c-ac9f-0b9c3a0f9d98"
      unitRef="usd">2265331000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ied44a8b51f55435492975e4a49f6cfb9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtMy0xLTEtMTg5Njk_a43893a3-96f2-448e-811e-4db9899fe357"
      unitRef="usd">389801000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzMtNi0xLTEtMTg5Njk_342782d7-6138-4dc3-922e-4687e7c5b653"
      unitRef="usd">2655132000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctMS0xLTEtMTg5Njk_c4561ed6-2dfe-43f9-8676-6df1dcf93ab2"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctMy0xLTEtMTg5Njk_2db31aab-a1bb-4ba6-8345-689012f82639"
      unitRef="usd">1186000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzctNi0xLTEtMTg5Njk_ae2138c9-25cd-4be3-aea9-c3a4c500cc6d"
      unitRef="usd">1186000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="i0e2e07d963474d1892efff9937cbb3ec_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtMS0xLTEtMTg5Njk_da79405a-dac8-4fa7-94a9-2e28729df023"
      unitRef="usd">16657000</us-gaap:IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
      contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtMy0xLTEtMTg5Njk_5a504e3a-f082-441f-9c9a-ff1fa9660101"
      unitRef="usd">732000</us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss>
    <pbh:IntangibleAssetsTranslationAdjustmentsGainLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzgtNi0xLTEtMTg5Njk_50854343-d6f3-4f95-aca2-e068b408a2a2"
      unitRef="usd">17389000</pbh:IntangibleAssetsTranslationAdjustmentsGainLoss>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia2e28f0399dd48bc81e7b6ff38d211b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktMS0xLTEtMTg5Njk_09094d8d-2b82-42c6-89c2-69f616b2af48"
      unitRef="usd">2281988000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktMy0xLTEtMTg5Njk_5d6f5ced-10d0-4579-a965-85740004222e"
      unitRef="usd">389347000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzktNi0xLTEtMTg5Njk_89d4f5a2-9ba2-4272-8097-fa4eec5ff227"
      unitRef="usd">2671335000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ied44a8b51f55435492975e4a49f6cfb9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEyLTMtMS0xLTE4OTY5_119175c2-2fd2-49fc-a557-242968787872"
      unitRef="usd">175741000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEyLTYtMS0xLTE4OTY5_55f65508-6bac-4344-8eea-b3f564d8ff78"
      unitRef="usd">175741000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEzLTMtMS0xLTE4OTY5_ccd62783-24de-4ca2-a4fe-e7a02b50e430"
      unitRef="usd">19580000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzEzLTYtMS0xLTE4OTY5_7ce31aea-50e2-4aed-a83b-6cc5fc02feb8"
      unitRef="usd">19580000</us-gaap:AmortizationOfIntangibleAssets>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="if1f24c7992864e35a441671ea9d2feb2_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE1LTMtMS0xLTE4OTY5_7e7ab8f9-dd59-4f3b-a72e-6eb9d2d87b0b"
      unitRef="usd">285000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE1LTYtMS0xLTE4OTY5_0f324ac4-eba1-4469-83b6-1366b7f7f5c6"
      unitRef="usd">285000</pbh:FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia591d66195e84c68ad6bca8e400d493a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE2LTMtMS0xLTE4OTY5_b4cdc0e9-02b3-47a6-8e55-d8b4d1fa8fc2"
      unitRef="usd">195606000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE2LTYtMS0xLTE4OTY5_6171c274-7206-49f7-8e30-c5c9caae98ce"
      unitRef="usd">195606000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTEtMS0xLTE4OTY5_b68a632a-636e-4d59-81d0-d6422e0da835"
      unitRef="usd">2281988000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTMtMS0xLTE4OTY5_c5973f57-c617-4ea2-bb8d-805bfb992fe9"
      unitRef="usd">193741000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzE4LTYtMS0xLTE4OTY5_60b7c9f3-d0d7-4ce0-8ddf-b9112b6487c2"
      unitRef="usd">2475729000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTEtMS0xLTE4OTY5_de86e7a4-e417-4b40-812e-7eb8edd18c64"
      unitRef="usd">2195617000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTMtMS0xLTE4OTY5_1ef0e867-1e20-43d2-9158-5d9aeed386e9"
      unitRef="usd">190462000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIxLTYtMS0xLTE4OTY5_7a33cafb-c7f9-4c14-af51-683f8771356e"
      unitRef="usd">2386079000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTEtMS0xLTE4OTY5_916ab835-e4b7-49a9-9bc8-241b6896ced1"
      unitRef="usd">86371000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTMtMS0xLTE4OTY5_5220d4ec-7b2e-4d6f-ba95-d2c2cdc14de0"
      unitRef="usd">3279000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzIyLTYtMS0xLTE4OTY5_e0dbfe7e-5259-4d72-80eb-30837d78784d"
      unitRef="usd">89650000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTEtMS0xLTE4OTY5_5ceccd99-20da-4a86-81f0-f5420ddc6773"
      unitRef="usd">2281988000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTMtMS0xLTE4OTY5_35df9ec1-5efa-4462-a743-a6a8ecc35579"
      unitRef="usd">193741000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTozNmU5NWM0MDE4MjY0NzRiODUxOWRlYjZhNjkzOGE2Mi90YWJsZXJhbmdlOjM2ZTk1YzQwMTgyNjQ3NGI4NTE5ZGViNmE2OTM4YTYyXzI0LTYtMS0xLTE4OTY5_56941b62-8c11-4502-8a2f-274894f9c7fa"
      unitRef="usd">2475729000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i69d08238dbfa4d19a42daf28b60de30d_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2NDk4MDA_1df453b3-b27c-4f4e-b993-e7f6b9d2540d"
      unitRef="usd">1200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i0b1d55aab74e4d9d9ebe57a0c1b36420_D20220228-20220228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzEwOTk1MTE2MzgwMzU_08d30e51-879f-43d9-a759-10fd2e70e3a7"
      unitRef="usd">-700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i18f973eace6d4dedaae4fa2ae0e244d1_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzM4NDgyOTA3MTY5ODM_acd901b1-5702-4b1d-8907-1d5286fbaa15"
      unitRef="number">0.10</pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount>
    <pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="i55324cd11967477cb55c9dbf85c8b0ba_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3ODI_3c22f652-7eeb-4970-9b47-d5fc1a372eea"
      unitRef="number">0.07</pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount>
    <pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue
      contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NTY_7c736a59-6089-4837-9b01-ec05490765b1"
      unitRef="number">50</pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue>
    <pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue
      contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NjA_2da662d5-7ee7-4ea8-9515-2bb74bd21de9"
      unitRef="number">50</pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="icd308cfa7f4743acae74277795a0cbde_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3Njg_f9dc6a4e-e719-408c-97f7-cb9f43ad14e4"
      unitRef="usd">4300000</us-gaap:AssetImpairmentCharges>
    <pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue
      contextRef="i8d37c6668df24de7bd94b7bc5b048e1e_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3Xzk4OTU2MDQ2Njk3NjQ_538b7520-4a2e-42c3-b98b-fd3ca4e77b48"
      unitRef="number">50</pbh:SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQwMzY_f20b1838-06e9-45c7-9945-e55b777e9439">P9Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQwOTY_d19ccf6d-070b-48a7-bfca-7f32a9758ffc"
      unitRef="usd">21500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQzOTk_bc312eb0-8952-46d0-8beb-4d79215104ae">At March&#160;31, 2022, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.738%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQyNDE_0ff0b1f0-b934-45c7-8362-6c789e4c0ab1">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90ZXh0cmVnaW9uOmIxNWE1M2FjMTU2YTRkNjJhMGY1NjBkOGYxYWIxYjc3XzQyNDc_ac8a96be-cdf0-4f9d-b3f1-b97ea9dcf499">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzItMS0xLTEtMTg5Njk_28be3bbc-099e-423d-8ba0-4d8f87f29934"
      unitRef="usd">22576000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzMtMS0xLTEtMTg5Njk_fbd1103d-9279-4242-a4c1-ebd7a6fdce6c"
      unitRef="usd">22533000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzQtMS0xLTEtMTg5Njk_262420a0-eb3b-45ca-86af-b1a9a05d2b85"
      unitRef="usd">20479000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzUtMS0xLTEtMTg5Njk_d72cf59d-32a7-4ac1-942a-c55fd3eaea88"
      unitRef="usd">18232000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzYtMS0xLTEtMTg5Njk_906ecf02-a2a5-4eee-9d56-f3b8d3a5deea"
      unitRef="usd">16591000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzctMS0xLTEtMTg5Njk_864f5c54-73e8-4496-bda8-285f5106d50d"
      unitRef="usd">119665000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDAvZnJhZzpiMTVhNTNhYzE1NmE0ZDYyYTBmNTYwZDhmMWFiMWI3Ny90YWJsZTpmNzY4M2I2Y2Y5OTc0ZmJjOGVhY2VlODM1MDZlY2FlMy90YWJsZXJhbmdlOmY3NjgzYjZjZjk5NzRmYmM4ZWFjZWU4MzUwNmVjYWUzXzgtMS0xLTEtMTg5Njk_0ced082b-077b-4b80-8f56-9f9a42e8aaa8"
      unitRef="usd">220076000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OA_52014afe-4618-4ee2-8ae9-807e2bb50389">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.64&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during 2022, 2021 and 2020.  The noncash lease liability arising from obtaining ROU assets was $0.5&#160;million for the assets that went into service in 2022, $5.2&#160;million for the assets that went into service in 2021 and $6.4&#160;million for assets that went into service in 2020.  These amounts represent noncash financing activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OA_fc88f4b2-0a62-4c10-b750-a4c2065d2261">Leases&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.64&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our Master Services Agreement with GEODIS Logistics LLC ("GEODIS"), GEODIS purchased certain assets for our use that went into service during 2022, 2021 and 2020.  The noncash lease liability arising from obtaining ROU assets was $0.5&#160;million for the assets that went into service in 2022, $5.2&#160;million for the assets that went into service in 2021 and $6.4&#160;million for assets that went into service in 2020.  These amounts represent noncash financing activities.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY0OQ_5744463c-dc92-4c60-b14f-8f13a34c0507">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the years ended March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.715%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted average discount rate were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.64&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzMtMS0xLTEtMTg5Njk_ce674889-64fe-428c-831b-95695f40a0f5"
      unitRef="usd">2579000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzMtMy0xLTEtMTg5Njk_19adc31a-c485-4889-9120-e747817463c7"
      unitRef="usd">2039000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzQtMS0xLTEtMTg5Njk_5b46e8a1-5d2e-40b9-88f2-1eb851bc8425"
      unitRef="usd">239000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzQtMy0xLTEtMTg5Njk_97335b22-51ed-41bb-a8ed-af66bdd35893"
      unitRef="usd">254000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzUtMS0xLTEtMTg5Njk_6389669f-d9d1-4b65-bd11-c2c592fab350"
      unitRef="usd">6670000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzUtMy0xLTEtMTg5Njk_397b673a-6674-47fe-b4c7-dd4cc4e00753"
      unitRef="usd">6754000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzYtMS0xLTEtMTg5Njk_4424d99d-8ceb-4434-8bcc-7121d97c0f03"
      unitRef="usd">107000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzYtMy0xLTEtMTg5Njk_fed98efb-bce5-4e21-9c0f-2ff8d6303a18"
      unitRef="usd">85000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzctMS0xLTEtMTg5Njk_4fac9aee-f7b3-4570-8a65-eaef21a40b87"
      unitRef="usd">42868000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzctMy0xLTEtMTg5Njk_4f7d854d-f16d-44f7-b070-7ccdfe078414"
      unitRef="usd">46771000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzgtMS0xLTEtMTg5Njk_9a7c86ba-ea6c-418e-b29c-dfec1d61ff07"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzgtMy0xLTEtMTg5Njk_b56fb888-5e91-4c1c-8e4e-e1bfc8b92d09"
      unitRef="usd">188000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzktMS0xLTEtMTg5Njk_97d4e8d6-e4af-4faa-bf0e-66ffb4671549"
      unitRef="usd">52463000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo3ZmE5Y2I5NTA5ZGI0YmIyYTIwNDExNTg3NDRhNzQ0YS90YWJsZXJhbmdlOjdmYTljYjk1MDlkYjRiYjJhMjA0MTE1ODc0NGE3NDRhXzktMy0xLTEtMTg5Njk_b11fdeb0-e920-41d1-84a2-a30cbd130ace"
      unitRef="usd">55715000</us-gaap:LeaseCost>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY1MA_327101b0-1d54-4f44-a773-a73fd229e01c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzY1MA_a0eec146-edac-438d-bf34-5c531c1894da">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financing Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,717)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total present value of lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItMi0xLTEtMTg5Njk_94e65519-796d-487b-8423-c0ca968701a4"
      unitRef="usd">6931000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItNC0xLTEtMTg5Njk_3d17831b-d644-4ec9-a8a6-dd6cb1fb87a6"
      unitRef="usd">2922000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzItNi0xLTEtMTg5Njk_1d0627fb-6ec9-45a6-9635-42bf8d83bfd1"
      unitRef="usd">9853000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtMi0xLTEtMTg5Njk_6022f668-db36-4dbe-b709-df4f42c9ff0c"
      unitRef="usd">6804000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtNC0xLTEtMTg5Njk_33cd937a-d100-455c-b401-820e4f300243"
      unitRef="usd">2922000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzMtNi0xLTEtMTg5Njk_3844a7fb-563b-46f5-abd4-39195b7ad1c7"
      unitRef="usd">9726000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtMi0xLTEtMTg5Njk_9a677bac-4530-42e8-b008-b028d5f194cf"
      unitRef="usd">4624000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtNC0xLTEtMTg5Njk_1972b080-b710-4ea7-9a7c-b44b096f583e"
      unitRef="usd">1509000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzQtNi0xLTEtMTg5Njk_f7775938-6d30-4728-8c2c-1960f7cf9802"
      unitRef="usd">6133000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtMi0xLTEtMTg5Njk_25836e51-42b5-45d7-9267-96424ed2cd85"
      unitRef="usd">2212000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtNC0xLTEtMTg5Njk_af8f258a-0f87-46a5-9019-171d94f5e95e"
      unitRef="usd">96000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzUtNi0xLTEtMTg5Njk_562e9f04-067d-4ac2-9946-2859c962d847"
      unitRef="usd">2308000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtMi0xLTEtMTg5Njk_6cbe5acb-70f2-4868-bc2f-9a28e43f73a5"
      unitRef="usd">1889000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtNC0xLTEtMTg5Njk_a6721e94-f306-44f2-827a-f41ef4b30fba"
      unitRef="usd">80000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzYtNi0xLTEtMTg5Njk_a4f69a5f-d31a-4be3-8ad6-9f537597a7b6"
      unitRef="usd">1969000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctMi0xLTEtMTg5Njk_b9112ae1-c88b-4f85-8f4e-bc929dee7cad"
      unitRef="usd">1705000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctNC0xLTEtMTg5Njk_48c20288-7692-4b45-9160-78a368632634"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzctNi0xLTEtMTg5Njk_1d0c28f6-0485-4b5c-8442-2544143d2c4c"
      unitRef="usd">1705000</pbh:OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtMi0xLTEtMTg5Njk_d849f38e-fead-406c-8d3a-b69511728593"
      unitRef="usd">24165000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtNC0xLTEtMTg5Njk_cf1aacab-6cff-421a-8730-07e61e96a36c"
      unitRef="usd">7529000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <pbh:OperatingAndFinanceLeaseLiabilityPaymentDue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzgtNi0xLTEtMTg5Njk_7a6b1679-9218-4cd1-9bd2-d71760bb16cd"
      unitRef="usd">31694000</pbh:OperatingAndFinanceLeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktMi0xLTEtMTg5Njk_c9295b40-c888-4658-8444-70c8bb6ea38d"
      unitRef="usd">1717000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktNC0xLTEtMTg5Njk_c46135a5-d1d1-43d4-bcaf-ceb8e36b615d"
      unitRef="usd">276000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzktNi0xLTEtMTg5Njk_5562b0de-6a11-4249-ad27-6ff8edad3a66"
      unitRef="usd">1993000</pbh:OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTItMS0xLTE4OTY5_4f2ab02d-efe4-48f9-b44f-cde8d8949657"
      unitRef="usd">22448000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTQtMS0xLTE4OTY5_dcb88167-2a11-45cf-aa52-9a2293e39a5c"
      unitRef="usd">7253000</us-gaap:FinanceLeaseLiability>
    <pbh:OperatingAndFinanceLeaseLiability
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTo4NjU1MTFmNGFkNDU0YWExOTU5OTBlOWMyMjA3ZTA5YS90YWJsZXJhbmdlOjg2NTUxMWY0YWQ0NTRhYTE5NTk5MGU5YzIyMDdlMDlhXzEwLTYtMS0xLTE4OTY5_9c5ee95f-5dec-4ddf-b69a-f058ccd3283e"
      unitRef="usd">29701000</pbh:OperatingAndFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzItMy0xLTEtMTg5Njk_9908dce8-0e7b-4d2d-bdcd-00a883962cf2">P4Y10D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzMtMy0xLTEtMTg5Njk_da2da686-9d0b-4ee8-840d-5a45d5fbce69">P2Y7M20D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzUtMy0xLTEtMTg5Njk_5f94a776-dcf9-4a84-953c-818a6e26b991"
      unitRef="number">0.0303</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90YWJsZTpjMzYyNTYxNmRkZWU0MzY5ODIwMjIwMjRhNWUzNGNmOC90YWJsZXJhbmdlOmMzNjI1NjE2ZGRlZTQzNjk4MjAyMjAyNGE1ZTM0Y2Y4XzYtMy0xLTEtMTg5Njk_c86e8e42-9d41-4fef-b34e-03e9ac8a3bc9"
      unitRef="number">0.0296</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i335edd3216614cc694f48efa6d5a9a28_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzM4NDgyOTA2OTc5OTA_befe6721-ee79-4312-a13c-29383cb19f24"
      unitRef="usd">500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i589c5b16c5f2469aaba1478b0dd6dd6d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzQ5NA_503b9901-9b47-46ff-a555-bc1f6bc15c9b"
      unitRef="usd">5200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i5fe2ba61b566469dbb5a593ca0b80d99_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDYvZnJhZzo2OWZiODFiMmMwYjU0ZmEzYmZkYWFhYjE0OTk2MWVmNi90ZXh0cmVnaW9uOjY5ZmI4MWIyYzBiNTRmYTNiZmRhYWFiMTQ5OTYxZWY2XzU0Nw_4a15c23c-c58d-4634-97d6-78f75e6744ab"
      unitRef="usd">6400000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90ZXh0cmVnaW9uOmFkMjlmZjBiZDNlNjRlMTViMjk2NDIzN2ZlOWQyNWFjXzk1_0fe9f371-28bf-4ff4-97a6-7f11935975d1">Other Accrued Liabilities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90ZXh0cmVnaW9uOmFkMjlmZjBiZDNlNjRlMTViMjk2NDIzN2ZlOWQyNWFjXzEwMw_7e8150f1-ceb6-48a3-97a9-b83cb7d4e31a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following: &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued broker commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued production costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzItMS0xLTEtMTg5Njk_c360b78d-23ad-43a6-a95d-b2e7b094a4d1"
      unitRef="usd">36149000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzItMy0xLTEtMTg5Njk_8ba0d7ac-8987-4049-a8e3-1f9d08a30fad"
      unitRef="usd">29955000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzMtMS0xLTEtMTg5Njk_4f6346c2-5e7b-46a9-a960-812717c589fa"
      unitRef="usd">19587000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzMtMy0xLTEtMTg5Njk_2e761648-b649-40de-ba5a-531fd32428ec"
      unitRef="usd">14074000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzQtMS0xLTEtMTg5Njk_ae337e3e-8aba-462b-ba5b-f315ae0ff8d0"
      unitRef="usd">1179000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzQtMy0xLTEtMTg5Njk_09386a7b-4ca4-4545-a264-08ee4779135a"
      unitRef="usd">1023000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzUtMS0xLTEtMTg5Njk_68df6c5c-15bf-465e-a098-8a468188ce71"
      unitRef="usd">2670000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzUtMy0xLTEtMTg5Njk_7d0ce473-6449-4785-9048-ba0a82d78c4b"
      unitRef="usd">1652000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzYtMS0xLTEtMTg5Njk_fdb0e8cf-977d-4861-8375-3e512896f46c"
      unitRef="usd">4150000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzYtMy0xLTEtMTg5Njk_c1b9fe6d-cedd-4c56-bc4b-1da7e0ae7b27"
      unitRef="usd">4472000</us-gaap:AccruedProfessionalFeesCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzktMS0xLTEtMTg5Njk_59eda578-b1a0-4088-9ac7-7133f6163fa3"
      unitRef="usd">3686000</pbh:AccruedProductionCostsCurrent>
    <pbh:AccruedProductionCostsCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzktMy0xLTEtMTg5Njk_b2be7160-f255-45ec-b68d-dfa823cb1d1b"
      unitRef="usd">2882000</pbh:AccruedProductionCostsCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEyLTEtMS0xLTE4OTY5_3ff72072-32b6-4380-b0ce-f74b07900325"
      unitRef="usd">5000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEyLTMtMS0xLTE4OTY5_571a2f2e-ebb2-4cd4-8136-4a24dbbec339"
      unitRef="usd">2368000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEzLTEtMS0xLTE4OTY5_16973341-918c-413f-9d75-afce2d548461"
      unitRef="usd">6687000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzEzLTMtMS0xLTE4OTY5_90322d71-3bad-45c7-9a65-1a60c0b626b2"
      unitRef="usd">4976000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzE0LTEtMS0xLTE4OTY5_21ebba8b-cb83-4fcc-90b1-b49451c1ff88"
      unitRef="usd">74113000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <pbh:AccruedAndOtherLiabilitiesCurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMDkvZnJhZzphZDI5ZmYwYmQzZTY0ZTE1YjI5NjQyMzdmZTlkMjVhYy90YWJsZTpiYjFmMTBlYmFlODA0MTdjOGJlYmYxZTc0NDYzZWE1My90YWJsZXJhbmdlOmJiMWYxMGViYWU4MDQxN2M4YmViZjFlNzQ0NjNlYTUzXzE0LTMtMS0xLTE4OTY5_b5b4fa63-6b1d-461d-8c52-63a3de1fd0bd"
      unitRef="usd">61402000</pbh:AccruedAndOtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ3_b82a9c63-c214-43e0-8be2-9ed7467a1b63">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a floor of 1.00%, due on January 26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, we had no balance outstanding on the 2012 ABL Revolver and a borrowing capacity of $123.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2012 Term Loan and 2012 ABL Revolver:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2012, Prestige Brands, Inc. (the &#x201c;Borrower")  entered into a senior secured credit facility, which consists of (i) the $660.0 million 2012 Term Loan with an original 7-year maturity and (ii) the $50.0 million 2012 ABL Revolver with an original 5-year maturity.  In subsequent years, we have utilized portions of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $85.0 million to $135.0 million and reduced our borrowing rate on the 2012 ABL Revolver by 0.25% (discussed below).  The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to us of $650.1 million.  The 2012 Term Loan is unconditionally guaranteed by Prestige Consumer Healthcare Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower.  Each of these guarantees is joint and several.  There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 21, 2013, we entered into Amendment No. 1 ("Term Loan Amendment No. 1") to the 2012 Term Loan.  Term Loan Amendment No. 1 provided for the refinancing of all of our existing Term B Loans with new Term B-1 Loans (the "Term B-1 Loans").  The interest rate on the Term B-1 Loans under Term Loan Amendment No. 1 was based, at our option, on a LIBOR rate plus a margin of 2.75% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin.  In addition, Term Loan Amendment No. 1 provided the Borrower with certain additional capacity to prepay subordinated debt, our then-outstanding senior notes and certain other unsecured indebtedness permitted to be incurred under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 3, 2014, we entered into Amendment No. 2 ("Term Loan Amendment No. 2") to the 2012 Term Loan.  Term Loan Amendment No. 2 provided for (i) the creation of a new class of Term B-2 Loans under the 2012 Term Loan (the "Term B-2 Loans") in an aggregate principal amount of $720.0 million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility and financial maintenance covenant relief, and (iii) an interest rate on (x) the Term B-1 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.125% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin, and (y) the Term B-2 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.50% per annum, with a LIBOR floor of 1.00%, or an alternate base rate, with a floor of 2.00%, plus a margin (with a margin step-down to 3.25% per annum, based upon achievement of a specified secured net leverage ratio). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also, on September 3, 2014, we entered into Amendment No. 3 ("ABL Amendment No. 3") to the 2012 ABL Revolver.  ABL Amendment No. 3 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility.  Borrowings under the 2012 ABL Revolver, as amended, bore interest at a rate per annum equal to an applicable margin, plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50%, (b) the prime rate of Citibank, N.A., and (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs.  The applicable margin for borrowings under the 2012 ABL Revolver could be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter.  In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we were required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder.  The initial commitment fee rate was 0.50% per annum.  The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments by an amount set forth in the credit agreement covering the 2012 ABL Revolver.  We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 8, 2015, we entered into Amendment No. 3 ("Term Loan Amendment No. 3") to the 2012 Term Loan.  Term Loan Amendment No. 3 provided for (i) the creation of a new class of Term B-3 Loans under the 2012 Term Loan (the "Term B-3 Loans") in an aggregate principal amount of $852.5 million, which combined the outstanding balances of the Term B-1 Loans of $207.5 million and the Term B-2 Loans of $645.0 million, and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  The maturity date of the Term B-3 Loans remained the same as the Term B-2 Loans' original maturity date of September 3, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2015, we entered into Amendment No. 4 (&#x201c;ABL Amendment No. 4&#x201d;) to the 2012 ABL Revolver.  ABL Amendment No. 4 provided for (i) a $35.0 million increase in the accordion feature under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief and (iii) extended the maturity date of the 2012 ABL Revolver to June 9, 2020, which was five years from the effective date of ABL Amendment No. 4.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 5, 2016, we entered into Amendment No. 5 (&#x201c;ABL Amendment No. 5&#x201d;) to the 2012 ABL Revolver.  ABL Amendment No. 5 temporarily suspended certain financial and related reporting covenants in the 2012 ABL Revolver until the earliest of (i) the date that was 60 calendar days following February 4, 2016, (ii) the date upon which certain of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DenTek&#x2019;s&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; assets were included in the Company&#x2019;s borrowing base under the 2012 ABL Revolver and (iii) the date upon which the Company received net proceeds from an offering of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Fleet acquisition, on January 26, 2017, we entered into Amendment No. 4 ("Term Loan Amendment No. 4") to the 2012 Term Loan.  Term Loan Amendment No. 4 provided for (i) the refinancing of all of our outstanding term loans and the creation of a new class of Term B-4 Loans under the 2012 Term Loan (the "Term B-4 Loans") in an aggregate principal amount of $1,427.0 million and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief.  Term Loan Amendment No. 4 also extended the maturity date of the 2012 Term Loan to January 26, 2024.  In addition, Citibank, N.A. was succeeded by Barclays Bank PLC as administrative agent under the 2012 Term Loan.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also, on January 26, 2017, we entered into Amendment No. 6 ("ABL Amendment No. 6") to the 2012 ABL Revolver.  ABL Amendment No. 6 provided for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver, (ii) an extension of the maturity date of revolving commitments to January 26, 2022, and (iii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility consistent with Term Loan Amendment No. 4.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 21, 2018, we entered into Amendment No. 5 (&#x201c;Term Loan Amendment No. 5&#x201d;) to the 2012 Term Loan.  Term Loan Amendment No. 5 provided for the creation of Term B-5 Loans (the "Term B-5 Loans") by repricing of the Term B-4 Loans under the credit agreement governing the 2012 Term Loan to an interest rate that is based, at our option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.00%, or an alternative base rate plus a margin of 1.00% per annum, with a floor of 1.00%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 11, 2019, we entered into Amendment No. 7 ("ABL Amendment No. 7") to the 2012 ABL Revolver.  ABL Amendment No. 7 provides for (i) an extension of the maturity date of the 2012 ABL Revolver to December 11, 2024, which is five years from the effective date of ABL Amendment No. 7, (ii) increased flexibility under the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility, (iii) an initial applicable margin for borrowings under the 2012 ABL Revolver that is 1.00% with respect to LIBOR borrowings and 0.0% with respect to base-rate borrowings (which may be increased to 1.25% or 1.50% for LIBOR borrowings and 0.25% or 0.50% for base-rate borrowings, depending on &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;average excess availability under the facility during the prior fiscal quarter), and (iv) a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder of 0.25% per annum.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 1, 2021, we entered into Amendment No. 6 ("Term Loan Amendment No. 6") to the 2012 Term Loan.  Term Loan Amendment No. 6 provided for (i) the refinancing of our outstanding term loans and the creation of a new class of Term B-5 Loans under the credit agreement governing the 2012 Term Loan in an aggregate principal amount of $600.0&#160;million, (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver, and (iii) an interest rate on the Term B-5 Loans that is based, at the Borrower's option, on a LIBOR rate plus a margin of 2.00% per annum, with a LIBOR floor of 0.50%, or an alternative base rate plus a margin of 1.00% per annum.   In addition, Term Loan Amendment No. 6 provided for an extension of the maturity date of the 2012 Term Loan to July 1, 2028.  In connection with this refinancing, we recorded a loss on extinguishment of debt of $2.1&#160;million to write off a portion of new and old debt costs relating to this refinancing.  Under Term Loan Amendment No. 6, we are required to make quarterly payments each equal to 0.25% of the aggregate principal amount of the 2012 Term Loan.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds from the new class of Term B-5 Loans were used to refinance our outstanding term loans, finance the acquisition of Akorn and pay fees and expenses incurred in connection with these transactions (see Note 2).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended March&#160;31, 2022, the average interest rate on the 2012 Term Loan was 3.6% and the average interest rate on the amounts borrowed under the 2012 ABL Revolver was 1.2%.  For the year ended March&#160;31, 2021, the average interest rate on the 2012 Term Loan was 3.9% and the average interest rate on the amounts borrowed under the 2021 ABL Revolver was 1.7%.   During the year ended March&#160;31, 2022, we made required repayments of $1.5&#160;million as well as voluntary principal payments of $103.5&#160;million against the outstanding balance under our 2012 Term Loan.  Since we have made optional payments that exceed all of our required quarterly payments, we will not be required to make another payment on the 2012 Term Loan until maturity on July 1, 2028.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2013 Senior Notes:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2013, the Borrower issued $400.0 million of senior unsecured notes, with an interest rate of 5.375% and a maturity date of December 15, 2021 (the "2013 Senior Notes").  These notes were redeemed on December 16, 2019 using the funds from the issuance of our 2019 Senior Notes described below.  In conjunction with the redemption of our 2013 Senior Notes, we wrote off related debt costs of $2.2 million in the year ended March 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2016 Senior Notes:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 19, 2016, the Borrower completed the sale of $350.0 million aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#x201c;Initial Notes&#x201d;). On March 21, 2018, the Borrower completed the sale of $250.0 million additional aggregate principal amount of 6.375% senior notes due March 1, 2024 (the &#x201c;Additional Notes&#x201d;).  Both the Initial Notes and the Additional Notes (the "2016 Senior Notes") were redeemed on March 1, 2021 using funds from the issuance of our 2021 Senior Notes described below.  In conjunction with the redemption of the 2016 Senior Notes, we wrote off related debt costs of $2.7 million and paid a premium to redeem the 2016 Senior Notes of $9.6 million in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Senior Notes:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 2, 2019, the Borrower issued $400.0&#160;million aggregate principal amount of 5.125% senior notes due January 15, 2028 (the "2019 Senior Notes") pursuant to an indenture dated December 2, 2019, among the Borrower, the guarantors party thereto (including the Company) and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2019 Senior Notes, together with cash on hand, to redeem all $400.0&#160;million of our outstanding 2013 Senior Notes, which were due in 2021, and to pay related fees and expenses.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Senior Notes:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, the Borrower issued $600.0&#160;million aggregate principal amount of 3.750% senior notes due April 1, 2031 (the "2021 Senior Notes") pursuant to an indenture dated March 1, 2021, among Prestige Brands, Inc., the guarantors party thereto (including the Company), and U.S. Bank National Association, as trustee.  We used the net proceeds from the 2021 Senior Notes to redeem all $600.0&#160;million of our outstanding 2016 Senior Notes, which were due in 2024, and to pay related fees and expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemptions and Restrictions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have the option to redeem all or a portion of the 2019 Senior Notes at any time on or after January 15, 2023 at the redemption prices set forth in the indenture governing the 2019 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2019 Senior Notes), the Borrower will be required to make an offer to purchase the 2019 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have the option to redeem all or a portion of the 2021 Senior Notes at any time on or after April 1, 2026 at the redemption prices set forth in the indenture governing the 2021 Senior Notes, plus accrued and unpaid interest, if any.  Subject to certain limitations, in the event of a change of control (as defined in the indenture governing the 2021 Senior Notes), the Borrower will be required to make an offer to purchase the 2021 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates.  Additionally, the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes.  At March&#160;31, 2022, we were in compliance with the covenants under our long-term indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swaps:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, we entered into two interest rate swaps to hedge a total of $400.0&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and the other settled on January 31, 2022 (see Note 11 for further details).    &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ1_1e8f79d1-14e8-4102-a8fb-d87c6dbb53d2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following, as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes bearing interest at 3.750%, with interest payable on April 1 and October 1 of each year.  The 2021 Senior Notes mature on April 1, 2031.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes bearing interest at 5.125%, with interest payable on January 15 and July 15 of each year.  The 2019 Senior Notes mature on January 15, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.00%, or an alternate base rate plus a margin of 1.00%, with a floor of 1.00%, due on January 26, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans bearing interest at the Borrower's option at either LIBOR plus a margin of 2.00%, with a LIBOR floor of 0.50%, or an alternate base rate plus a margin of 1.00% per annum, due on July 1, 2028.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i09fd1299e2a3429cbcae381ab51a8154_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo5ZDdlYjQ0MTJjMWU0NTA4YjkzYTVlZTMxNDNlNzk1Nl80Mg_1f1f907f-3d30-418a-9236-f90803283f09"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i09fd1299e2a3429cbcae381ab51a8154_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItMi0xLTEtMTg5Njk_500492ab-cb24-4820-b500-f5bab3fe83e0"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6bcfb0f753744a1ab751cb65c0dc7aea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzItNC0xLTEtMTg5Njk_98503333-a1a7-4ec8-be5c-ce5dfe2a4715"
      unitRef="usd">600000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idb76c60a4e494bd39785dbbddef2aee3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiMDhlZDRkNWI3MWQ0ZDgwYWQ3YzBkZjczYWMzZmVkNF80Mg_1fc68beb-8efa-42b5-8387-a7949ae22893"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idb76c60a4e494bd39785dbbddef2aee3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtMi0xLTEtMTg5Njk_c019ae55-1efa-4ab4-b4ec-93892387924b"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7902118aff74b92a991aec7dec64d48_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzUtNC0xLTEtMTg5Njk_61e6a65b-3592-4836-899f-a20765e6777f"
      unitRef="usd">400000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml85OQ_c00134fe-a314-49c9-a43c-9b6b4a78b352"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="i2f4ec156207d4a85ba4552177e62c412_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xMjU_56c8ed22-37d6-4ce9-856f-aec58cd7256a"
      unitRef="number">0.0000</pbh:DebtInstrumentVariableRateMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xNzI_06b38bbb-9149-428a-ba45-390d1a45e6da"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="i8f53e3d9abef4448ae0af6e69112b9f6_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3YjA3Y2U2MDQ5MDU0NjE2OWUzM2YzYzUyMjFlYWY2Ml8xOTI_90b912ac-352d-4639-8e27-adf62aa0c0c2"
      unitRef="number">0.0100</pbh:DebtInstrumentVariableRateMinimum>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0046cff099774243b2fe9bcef53f28b4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtMi0xLTEtMTg5Njk_e400b389-f2e2-42f1-92c0-318a2edd316d"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib9f62c80458240b1a4ab90648a7ad1aa_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzYtNC0xLTEtMTg5Njk_a839871c-7788-4db7-a327-269cf20c0aaa"
      unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF85OQ_2fa2fa1a-29ab-4055-8780-e65c61fc021c"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentVariableRateMinimum
      contextRef="i04b85c0793bb48299186c77ba333d6d6_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF8xMjU_cd2431cf-f49e-40e1-b520-2edfbb07b4a7"
      unitRef="number">0.0050</pbh:DebtInstrumentVariableRateMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7e7166028fc3449da1b745c1053364a9_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMC0xLTEtMjA2MjAvdGV4dHJlZ2lvbjpmYTA1M2VjZjMzYTM0ZWY2YjhkYTM4ZjY0ODk0MTk0NF8xNzI_874c68e8-89b9-4b7f-aa79-64cd2909e39c"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6cfd3cfbed7740a9a4326dec51b02b1f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctMi0xLTEtMjA2MjM_74beb768-ada4-4c30-8655-b0bd5543e49c"
      unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i67542c5b47c4477989e0e9f42edffbf8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzctNC0xLTEtMjA2MjM_29c6deca-a6b5-4126-af3e-4f3affe73b33"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzExLTItMS0xLTE4OTY5_bc3a18a1-cc91-4a96-969b-c09c6990810d"
      unitRef="usd">1495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzExLTQtMS0xLTE4OTY5_22fce555-b40a-4ad7-bf47-dc19830f7a5f"
      unitRef="usd">1495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEyLTItMS0xLTE4OTY5_16f94f45-9aee-4ae1-8469-4d59615e156d"
      unitRef="usd">18342000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEyLTQtMS0xLTE4OTY5_a410c69b-a466-4938-b378-fd4332715dc7"
      unitRef="usd">15347000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEzLTItMS0xLTE4OTY5_bab2de6c-825c-4c29-88f0-0aa335c3bb89"
      unitRef="usd">1476658000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTphOWMzNzM2MDMyODg0NTczYTUwYzE4MjBmZjIxZWQwMS90YWJsZXJhbmdlOmE5YzM3MzYwMzI4ODQ1NzNhNTBjMTgyMGZmMjFlZDAxXzEzLTQtMS0xLTE4OTY5_69f9c058-6297-4689-8987-6fb09f7968be"
      unitRef="usd">1479653000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic16a8c37cbf24b36ae290009040fbdb3_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNg_14385518-f713-4dd2-85d5-e345c4c4761e"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE5Mg_fce68ea6-5218-44f4-8b91-47f11d850da6"
      unitRef="usd">123300000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i35c7d3689acf4430baf1e0a96d60aabd_I20120131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzM2OQ_558beacf-e2ad-4a0a-b01c-d7d5ff03b4f9"
      unitRef="usd">660000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyMg_4cf40436-a27c-4223-8120-9f2b2713b281">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0c172aec253140b2b6067b78d9e369bc_I20120131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ1MA_98348aff-3b63-46fc-b253-20f59be4cd5a"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzUzNA_6f0fa544-5a85-4a87-bf39-58443d02b7b1">P5Y</us-gaap:DebtInstrumentTerm>
    <pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity
      contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzcwNQ_443b728e-9219-4792-90f1-5de927919b5a"
      unitRef="usd">85000000</pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i13e53b28c8d5419cba8e60d19ff30867_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzcxMQ_f9044374-7762-4c63-9473-7fe6e4b1c4b9"
      unitRef="usd">135000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzc3Mw_8f225ef1-ff9b-435a-a233-2b1a6b1e4e57"
      unitRef="number">-0.0025</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <pbh:DebtInstrumentDiscountPercentage
      contextRef="i35c7d3689acf4430baf1e0a96d60aabd_I20120131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg2MQ_aeaa3ca1-ab78-4c1b-8db5-d7805899b3da"
      unitRef="number">0.015</pbh:DebtInstrumentDiscountPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i14ed362c9e3e4ccfbf210f91ddd657d4_D20120131-20120131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzMg_bb69ca13-6499-40f8-837e-29cf2c3276a4"
      unitRef="usd">650100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iba56d9afb135474e8bfe4cffa9c2e86f_D20130221-20130221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE2OTk_33d0f4ca-a26b-4f68-af0a-4efcc86f0717"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="iee6d3227d18744bdbefdbd1cecdc8ae8_I20130221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE3MzU_5489139e-ff0f-4fa6-9d11-1d39cdb31303"
      unitRef="number">0.0100</pbh:DebtInstrumentReferenceRateFloor>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="i18f08dc2f7ca4e3ba24144835eb55cb2_I20130221"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE3ODI_8b24cb40-aa0e-465b-80f7-9c3d541a052d"
      unitRef="number">0.0200</pbh:DebtInstrumentReferenceRateFloor>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaa2b839503ec42fc8fe2a49df981bff1_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzIzNzU_7916c887-b7d5-40ec-9f6d-ed84bde889e6"
      unitRef="usd">720000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0558c1bb126d4298b73cefd18fa9c46f_D20140903-20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI3Mjk_58c5b942-6e14-4753-bb91-6ba932f3f84e"
      unitRef="number">0.03125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="ia42ad38caa804913950ccf7ea487d0bb_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI3NjU_9295bd8a-dc1b-4328-8ebd-da942df21dd9"
      unitRef="number">0.0100</pbh:DebtInstrumentReferenceRateFloor>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="i319c15fd01bd47548445643d00863bf3_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI4MTI_eb942edd-fe8e-4d48-9c24-368a6fd5dc20"
      unitRef="number">0.0200</pbh:DebtInstrumentReferenceRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5ef2f1d69f724bb493a3a655ac79be25_D20140903-20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI5MjI_4c8bd2ba-9927-42ad-bfbd-56c00afb5166"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="iaf4727399a7346ea91615137b5e4dc2f_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzI5NTg_a6605b5e-c140-4e74-b16f-cdca0c6c1115"
      unitRef="number">0.0100</pbh:DebtInstrumentReferenceRateFloor>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="i3cbc0bb0d6054954997646711fb51951_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMwMDU_4c8022fd-6afc-4f4d-b60c-b68888a13e56"
      unitRef="number">0.0200</pbh:DebtInstrumentReferenceRateFloor>
    <pbh:DebtInstrumentContingentMarginStepDownPerAnnumInterestRate
      contextRef="i59f95eb55c54445286593337ec154069_D20140903-20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMwNTE_698a2212-bd13-470f-9985-5fed7d9a76ba"
      unitRef="number">0.0325</pbh:DebtInstrumentContingentMarginStepDownPerAnnumInterestRate>
    <pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity
      contextRef="i2c9d6e5813094b2c81201639ca24cd5c_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzMyODQ_55dac0d0-9013-450a-ad8b-5fd53a53beed"
      unitRef="usd">40000000.0</pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent
      contextRef="i6b0e800bd3d649b68c6b357ca77f8220_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzM3ODg_807026fe-d43b-4a0d-904e-7c2f07bc7d42"
      unitRef="number">0.0050</pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent
      contextRef="ic759cbf7a7b842cb9529c38f67458e9b_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQwMDQ_13141477-5318-4441-8693-080135a26944"
      unitRef="number">0.0100</pbh:DebtInstrumentBasisSpreadOnVariableRateFixedComponent>
    <pbh:DebtInstrumentVariableRateConditionalVariableRate
      contextRef="i2cd6d3dec26f448899c5ad59eb21db2f_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyNzg_8e6ac83a-3c9f-43d9-8860-82752d48605a"
      unitRef="number">0.0200</pbh:DebtInstrumentVariableRateConditionalVariableRate>
    <pbh:DebtInstrumentVariableRateConditionalVariableRate
      contextRef="i3e52034a43564d1586e14c7c32da2efd_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQyODQ_0d94a2f4-1635-4d71-97e0-a00737f85915"
      unitRef="number">0.0225</pbh:DebtInstrumentVariableRateConditionalVariableRate>
    <pbh:DebtInstrumentVariableRateConditionalVariableRate
      contextRef="i55b044eff678498fbe6c714272119acf_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQzMTI_ed281e6d-12ac-42a1-b46e-ec23f35c94a0"
      unitRef="number">0.0100</pbh:DebtInstrumentVariableRateConditionalVariableRate>
    <pbh:DebtInstrumentVariableRateConditionalVariableRate
      contextRef="i4df9522b555a408989b96f6b0910ddd7_I20140903"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQzMTg_42ce5d63-bc3a-43d3-b97f-706e78249391"
      unitRef="number">0.0125</pbh:DebtInstrumentVariableRateConditionalVariableRate>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i4eb8f99d34664779ab0f4af7d5abf4e7_D20120131-20120131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ3MDc_cc90bbbf-6a60-4e31-9db1-f6884644d162"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <pbh:LineOfCreditFacilityConditionalCommitmentFeePercentage
      contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzQ3NjU_83589f35-2eb2-485c-9cbb-0f14b7c0aa19"
      unitRef="number">0.00375</pbh:LineOfCreditFacilityConditionalCommitmentFeePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib2bcbe34278c447fb245a931855163bc_I20150508"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzUzNzA_11153703-3a86-4483-ba93-be8d9f9947fb"
      unitRef="usd">852500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5ac25b9d7e324eea8f7f44cb83be491e_I20150508"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU0Mzk_f8c0fa93-ba83-46fd-afc1-53768ff836e9"
      unitRef="usd">207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i786615716fbf49968cb2764459adaf9e_I20150508"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU0Njg_7780a89d-a90c-41c9-8684-029d89813501"
      unitRef="usd">645000000</us-gaap:DebtInstrumentFaceAmount>
    <pbh:LineofCreditFacilityIncreaseinAccordionFeature
      contextRef="id49b28f7f8b24a8e9f452cf83fddd6d0_D20150609-20150609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzU5NzY_52e0528d-df80-4ebf-a21f-73a57f454031"
      unitRef="usd">35000000</pbh:LineofCreditFacilityIncreaseinAccordionFeature>
    <us-gaap:DebtInstrumentTerm
      contextRef="i1611c74aa45e494f956f74b6f8d18d37_D20150609-20150609"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzYzNzA_d44b0b03-c23a-4ad9-bda5-d2b4b65b514c">P5Y</us-gaap:DebtInstrumentTerm>
    <pbh:DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod
      contextRef="iddb5f29165d140ce8590ce4f580057ba_D20160204-20160204"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzY2ODg_ed46dba1-9d0e-4bd4-bd23-ebd97942f7ed">P60D</pbh:DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6aa9ed85523f4bffa275deb4f8aac069_I20170126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzczNDE_5c6e8d30-96cf-40dd-b57d-87636acc08d9"
      unitRef="usd">1427000000</us-gaap:DebtInstrumentFaceAmount>
    <pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity
      contextRef="i4ccccc1f26f341a68d9ca89cfab4434c_I20170126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzc5NTQ_03a3aeb8-b023-4ac5-92f1-1f942123294d"
      unitRef="usd">40000000</pbh:LineOfCreditFacilityIncreaseInBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i122c1f4cf7fe4f93a9cccfdf65056fa3_D20180321-20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg3MjI_5cc056bc-405a-4b90-995c-685391b9686d"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="i4de06c1d14cf41cb863a5a08b674bea3_I20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg3NTg_45de5c9c-84ed-4de4-ab09-e333a7ad936f"
      unitRef="number">0.0000</pbh:DebtInstrumentReferenceRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icde342a964df4c25b081ffb70c172b7a_D20180321-20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg4MDc_5c93ee0d-60f6-4eeb-a873-0c0fd311d7b9"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentReferenceRateFloor
      contextRef="i0224233392114adf91fe01fed058dea0_I20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzg4Mzc_bb4204a9-b718-4a2d-928b-12993f64f395"
      unitRef="number">0.0100</pbh:DebtInstrumentReferenceRateFloor>
    <us-gaap:DebtInstrumentTerm
      contextRef="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkwODM_2a4726b7-7e1c-43d1-a694-8fdbe19df0de">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i70fb5e5a361b41159fce56b86161af71_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzNTY_4f13b962-050b-43e0-8abe-03bcd5ddb0b1"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6a04c87c425240ca949ab30cc154c591_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzkzOTY_5f61b4b8-a353-4c11-9060-9e74260115ac"
      unitRef="number">0.000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased
      contextRef="i3be594bcf6624e02a2fa508bbcec16c8_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0NjM_0968dbf5-ac2b-4b62-b60d-919664c7ba4a"
      unitRef="number">0.0125</pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased
      contextRef="i329303f1b639409c82598b0f32e87c4e_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0Njk_fdda98a1-6e9d-404b-a0e4-1a7f66a32c46"
      unitRef="number">0.0150</pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased
      contextRef="i1e71bab1d60d488aa52d8528a9dd9265_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk0OTc_89fe8c28-0a21-4493-845b-e37c7879917c"
      unitRef="number">0.0025</pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased>
    <pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased
      contextRef="ib88dbcd32abb43569e49cbca38a7b8e8_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk1MDM_a41dfad3-935d-4745-b2e2-1065d21f0d5c"
      unitRef="number">0.0050</pbh:DebtInstrumentBasisSpreadOnVariableRateIfIncreased>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="if3bc6ca63c004662ab573a9e2800ce21_D20191211-20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk3NTA_7c522122-8940-4615-b825-402a44394f17"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icf0b48ee76264f7a92f392720f3b43d6_I20210701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0NTU_a243da21-7437-46eb-b673-dbf28ddd922a"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1e6d0ebd6d014edc800dfa6316c8c320_D20210701-20210701"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0Nzc_ab2504b4-64d6-4d67-add2-4b36c4ba49fa"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibc75511f253c4893ab0567e3b34323e1_D20210701-20210701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ0OTA_660ac795-050b-49a9-9efe-bd2743ade429"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <pbh:DebtInstrumentAlternativeBasisSpreadOnVariableRate
      contextRef="i7e22f021780647258b15b6e00a871903_D20210701-20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1MDM_78e75458-dfac-4765-ad51-374222bfbc8e"
      unitRef="number">0.0100</pbh:DebtInstrumentAlternativeBasisSpreadOnVariableRate>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia969b1c646c440768cf974287fc7426e_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1MjM_a8b0b4c0-a4b8-4f94-aa71-e03f03eb2b81"
      unitRef="usd">-2100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <pbh:DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount
      contextRef="i415c7e0679e349e58f0e0f20395cc300_I20210701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDQ1NDM_60f0b549-9565-4b59-b160-21a00cb1abe3"
      unitRef="number">0.0025</pbh:DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i4baae0737d004ba09ced690b2fcdc5b1_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk4NDA_ae00d714-eb50-4f04-bffe-e9f45e23e884"
      unitRef="number">0.036</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i7cdeb5ac408f44c3a921f6a0bf15d20f_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0Xzk5Mjk_1ed2d43a-6d48-443a-94b1-a7198bd37b18"
      unitRef="number">0.012</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i39e0fc9224654a75a98d2b9ed9edc137_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDY1OTM_3d99675d-80ab-46e2-9b67-a32b4cf3235a"
      unitRef="number">0.039</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i2fefd0d85f3643e9802fd44c8698e2bb_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDY2OTg_8840a3f5-b61a-4cf6-a0c9-f84fe8e23a20"
      unitRef="number">0.017</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDUxNjU_bf113f08-0878-4deb-a6a3-49cae6d67143"
      unitRef="usd">1500000</us-gaap:DebtInstrumentPeriodicPayment>
    <pbh:DebtInstrumentPeriodicPaymentVoluntaryPayment
      contextRef="i72ba903891544d96ac89ed7e389f04a6_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwOTk1MTE2NDUyMTM_0583cf15-fe11-46e6-9c90-2924cf6eed37"
      unitRef="usd">103500000</pbh:DebtInstrumentPeriodicPaymentVoluntaryPayment>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwMTU1_83807784-b71f-4581-ba81-01c9459c5c71"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwMjEw_154c2ef5-1c66-49d2-b7b3-a8dd019c18fb"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i7127b05ed9074792951125aaeef43725_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNTAy_528fec94-a460-4452-bdf7-bf43a5196285"
      unitRef="usd">2200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNTg0_091a053c-27ea-45d6-bfe9-1a1704263150"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i07dc6632ef1f4dbe8d23ee084c117f2d_I20160219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNjE3_d5ef9ea7-50e1-423c-9cd3-c37fd50d2cd8"
      unitRef="number">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i76d5fa51d2444398b1d51583678eaf8b_I20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNzI4_6cabed01-31b3-4a83-9b83-b8b24ecbe655"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i76d5fa51d2444398b1d51583678eaf8b_I20180321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEwNzYx_f42d2fa8-1558-435a-a240-471c8d5ae718"
      unitRef="number">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i1eb1f46f0bf54dc5a706fbd97b3158e1_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMDg3_b0f7f96f-ce2a-4f08-a670-231f196c34a0"
      unitRef="usd">2700000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i5421f769ee30441db0b2ce75192fb6f4_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMTQ0_deb4736f-498e-4de3-81d0-94393683e3b8"
      unitRef="usd">9600000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i05cfda891a7744f5b7d546839fc9debe_I20191202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMjA5_8a064a7d-7680-4fdd-9934-8e67cb92b017"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i05cfda891a7744f5b7d546839fc9debe_I20191202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExMjQy_9e31b894-e7f8-49e9-ae8f-265fe5941c8b"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="i08f3231c50694b299fb23343bca2e463_D20191202-20191202"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNjA2_d8a9912d-34b9-4f51-8a6a-efce79cb5f83"
      unitRef="usd">400000000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if0f3a14330e24f06a067b44676509588_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExNzY5_c6f3d389-1e5b-4c3f-8a24-430e4677797c"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0f3a14330e24f06a067b44676509588_I20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzExODAy_d02465ac-194d-4938-8407-42a0be62582b"
      unitRef="number">0.03750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="ie5055f03438d40a28763e3b37020019b_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEyMTMy_f9aa0a23-476a-4746-8153-f4e01fa72818"
      unitRef="usd">600000000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ib5924d593cc74de19659e3600415162d_D20160219-20160219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEyNzQ1_b07d2e22-8c93-4e30-9b5f-8cd3255d7177"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="id053d9ccecdc4922a30a236b55ee8a89_D20160219-20160219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzEzMzQ3_b84a5733-3fe6-4955-976b-da900d4e2ec8"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iea11cc7d2fda42e280337193b1699cff_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE0NjI2_17ea6316-d741-4805-875f-9025721e11ba"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90ZXh0cmVnaW9uOmVkMTc2ZjE4MTdhODQxNGFiZDZiOGJhYjNkMjE4MWE0XzE1MDQ2_0c489fef-21d2-42f6-bafc-91d7b3c65f70">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2021 Senior Notes and the 2019 Senior Notes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzItMi0xLTEtMTg5Njk_0177e135-877a-4d98-b926-3dc6d72ed42a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzMtMi0xLTEtMTg5Njk_ea8419b3-4e7e-424a-a772-deb49c344286"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzQtMi0xLTEtMTg5Njk_be4201e5-70ea-4b6e-8083-e80a0bf005a0"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzUtMi0xLTEtMTg5Njk_f79af13e-1357-46ed-8a23-0d494f3011e0"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzYtMi0xLTEtMTg5Njk_97093ea1-4035-41d5-9304-16d8dd4b1b54"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzctMi0xLTEtMTg5Njk_7f1ab41c-d38f-4d12-a8cf-b1a47903f8f0"
      unitRef="usd">1495000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTIvZnJhZzplZDE3NmYxODE3YTg0MTRhYmQ2YjhiYWIzZDIxODFhNC90YWJsZTo1MGUyNzFjYjVlMjY0ZGVhYjg3NzljMDlhYjgwOGVhMi90YWJsZXJhbmdlOjUwZTI3MWNiNWUyNjRkZWFiODc3OWMwOWFiODA4ZWEyXzgtMi0xLTEtMTg5Njk_84e807a9-7e4b-499d-85d9-87b2a0306e72"
      unitRef="usd">1495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90ZXh0cmVnaW9uOmFjYjM0ZGZjNmYwOTQ4MTNhNTNhN2U1MTY5MzI0YzllXzIyOTM_a30903f5-62a0-45ee-b841-b0332f813e77">Fair Value Measurements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants.  The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs.  Based upon the above, the following fair value hierarchy was created:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - Quoted market prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the Term B-5 Loans, the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March&#160;31, 2022 and 2021). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans, No. 5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans, No. 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022 and 2021, we did not have any assets or liabilities measured in Level 1 or 3.  During 2022, 2021 and 2020, there were no transfers of assets or liabilities between Levels 1, 2 and 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASU 2015-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, investments that are measured at fair value using net asset value ("NAV") per share as a practical expedient have not been classified in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90ZXh0cmVnaW9uOmFjYjM0ZGZjNmYwOTQ4MTNhNTNhN2U1MTY5MzI0YzllXzIyODk_321460c6-cae4-45e2-84ce-aeabd47c5369">The market values have been determined based on market values for similar instruments adjusted for certain factors.  As such, the 2021 Senior Notes, the 2019 Senior Notes, the Term B-5 Loans, the 2012 ABL Revolver and our interest rate swaps are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these instruments at March&#160;31, 2022 and 2021). &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans, No. 5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Term B-5 Loans, No. 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 ABL Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="ibbc097b28fbd4380a0360d7a9dfa4ddb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtMi0xLTEtMTg5Njk_57f549cc-695b-4920-aea6-fdd2425e32b1"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia447a00c02b64ada88fb01a499a27242_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtNC0xLTEtMTg5Njk_e648ac23-c831-468a-8c3a-5e55b9fd6177"
      unitRef="usd">397000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5e5a200e2c9f497380a032d410c1bf18_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtNi0xLTEtMTg5Njk_7efcbe05-cd64-433e-8287-a123714e0e16"
      unitRef="usd">400000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia4a985936f76451ab3fba68c9cfbb22a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzUtOC0xLTEtMTg5Njk_5b3080d0-6915-4e12-8680-d7f25fa1e812"
      unitRef="usd">417000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="iacf2802073574efd967d051aa138686d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtMi0xLTEtMTg5Njk_5397d71e-2e58-4363-aa19-95ebe3f6df2c"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i59e28d594c87497abef8cb2c70f091a9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtNC0xLTEtMTg5Njk_59bcfdc4-c2b9-4c39-9cf9-ffc03eb9fb5b"
      unitRef="usd">534000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i812c0fab06ed49c4a178a37547c973b2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtNi0xLTEtMTg5Njk_a4824630-4128-47fe-89b3-b4495dc2c45b"
      unitRef="usd">600000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i12ce07c5f2394037b12bb08cd70c30b6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzYtOC0xLTEtMTg5Njk_af4e3427-6067-4c31-ad9f-942d9ad17d3a"
      unitRef="usd">570000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i999987ebde3747f6b643feea79f7c7ef_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctMi0xLTEtMTg5Njk_ded7ad5d-e50f-4653-946d-2f6b64cac303"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i37214d0e0e284a65a18a75b349e2c4a3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctNC0xLTEtMTg5Njk_b9135d46-83e7-449e-a767-90715b788f06"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i14f58c0d3bfd4d80880075fbd365ccff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctNi0xLTEtMTg5Njk_b49e8549-df24-4057-a45c-488e33b20ea2"
      unitRef="usd">495000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i82b6829a1a1044fe8860313bc836df84_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzctOC0xLTEtMTg5Njk_c18adf51-61d4-4454-af76-d7c7713d640c"
      unitRef="usd">493763000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i4af8d5e816894fc2b3902012dc67bcab_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtMi0xLTEtMjA4MjI_e8225054-9ecc-42b3-8181-7a006b72dbdb"
      unitRef="usd">495000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ie316289b2f544ed59d0d0c3677efd55a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNC0xLTEtMjA4MjI_29d1a97e-ad15-464a-b3d8-6c5195af962b"
      unitRef="usd">493144000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i875d8339508c48e8978c56e91c5f446d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNi0xLTEtMjA4MzE_907faa4c-bdd3-4e49-9985-62259bef41fd"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="iad6deab13ed5410ca24419a0d749762c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtOC0xLTEtMjA4MzE_dab613b6-5e63-4562-859d-f62957095e04"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i7d45f458359341cb9aed375cbf7b034c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtMi0xLTEtMTg5Njk_6493a330-aa82-42b6-87ce-d39b6b462d47"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="if5d83887fa7a4b3c9a18182a81d1150b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNC0xLTEtMTg5Njk_7c2cb2d0-b083-4ca6-8431-1c7731c070f1"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i2f5131113e97495bb1af3c5ddaaf3fed_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtNi0xLTEtMTg5Njk_a009c02a-3614-456c-88b0-a5a07d875250"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i3d1883fd10de4c37988d741ed8d438e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzgtOC0xLTEtMTg5Njk_0cfa7007-34ae-4050-a057-916fbd6243c9"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i8b76519112f34e67a8eec0a25b6d11bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktMi0xLTEtMTg5Njk_2b72e732-11fe-452c-adf3-8ac34b3d2bca"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ia9090b056ebb41eba6e4947e52c3b6ca_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktNC0xLTEtMTg5Njk_f5588b53-ac16-4a1a-a109-bb1fd1967dd6"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ia009767826ab453aa6bb77d03d05a92b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktNi0xLTEtMTg5Njk_5ee34f94-9b9a-4717-8914-369562fc8697"
      unitRef="usd">2363000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ib347d67febad441b8e0c8e676e6f04af_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTUvZnJhZzphY2IzNGRmYzZmMDk0ODEzYTUzYTdlNTE2OTMyNGM5ZS90YWJsZToyOTExYTRmNGRhOTE0NDQ5OTVlNTcyZjBlZjM4NTUzZi90YWJsZXJhbmdlOjI5MTFhNGY0ZGE5MTQ0NDk5NWU1NzJmMGVmMzg1NTNmXzktOC0xLTEtMTg5Njk_1095a61b-eebd-4096-b8ba-50ec83fd49ef"
      unitRef="usd">2363000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzA_f4104578-4be7-4ec5-955e-1d96fc1c11d1">Derivative Instruments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in interest rates expose us to risks.  To help us manage these risks, in January 2020, we entered into two interest rate swaps to hedge a total of $400.0&#160;million of our variable interest debt.  One swap settled on January 31, 2021 and other settled on January 31, 2022.  The fair value of these interest rate swaps was reflected in the Consolidated Balance Sheets in other accrued liabilities.  We do not use derivatives for trading purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Counterparty Credit Risk:&lt;/span&gt;&lt;/div&gt;We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iea11cc7d2fda42e280337193b1699cff_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzE4OA_4e91f263-6418-4d08-9593-a4bee90ea226"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzE_bd00a4a5-79c4-462b-a44d-6fac04861b89">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair values of our derivative instruments as of the end of the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Final Settlement Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/31/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1b30d6662357490791b05cb990415ede_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzMtNi0xLTEtMTg5Njk_f2aa6db3-8fde-4934-862d-f7c02d2643fc"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if895d74cebc04b28ab194e74118c2951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzMtOC0xLTEtMTg5Njk_cdf6b568-eec3-4265-bac3-f0c587fd79b7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if895d74cebc04b28ab194e74118c2951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4OTBkNmZmZGNmYzg0N2RhOTBlYWU5NGE5YzBlNTE1YS90YWJsZXJhbmdlOjg5MGQ2ZmZkY2ZjODQ3ZGE5MGVhZTk0YTljMGU1MTVhXzQtOC0xLTEtMTg5Njk_6fe4233e-41dd-432f-82a5-dd0b601fd108"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia6fb85e27ce8425b9221751a38ecb76d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzMtNi0xLTEtMTg5Njk_decf9220-0a99-4368-8524-02f45335f40b"
      unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i63aa3373adc547ef8f9843d4e4e99a56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzMtOC0xLTEtMTg5Njk_20befc91-1f66-4788-9b13-d6d70982593b"
      unitRef="usd">2363000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i63aa3373adc547ef8f9843d4e4e99a56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo5NWYyMWQ2MmFlNzY0NDc5Yjg3YzViN2M1MTQ3MWM1ZC90YWJsZXJhbmdlOjk1ZjIxZDYyYWU3NjQ0NzliODdjNWI3YzUxNDcxYzVkXzQtOC0xLTEtMTg5Njk_867b2dcc-9bfa-4f80-add4-7f3bbfbe2143"
      unitRef="usd">2363000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90ZXh0cmVnaW9uOmM4OTE1Yzg1ZmM4OTQ0YjJiMTAwMTlkZWRmYmJhOTdmXzEzNzI_54b8dd60-144c-4980-928c-0f1742e91a20">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our interest rate swaps, net of tax, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i605faa87f3fa47b3bd583aa47c0b905f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtNC0xLTEtMTg5Njk_d2258279-9a89-48e4-ad73-24270379d33f"
      unitRef="usd">1819000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i46552cb961884a2e9f30308dfc3d5c18_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtNi0xLTEtMTg5Njk_fd10c741-4ddf-438d-bc38-ee14d88a9103"
      unitRef="usd">3045000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i66f5cb1ef37b47e0a992d6060ab3a446_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzEtOC0xLTEtMTg5Njk_3e8816d8-14a3-4011-93f9-1bc5f2e59a2e"
      unitRef="usd">-4864000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iacae129a7469439e8699880e38e9c750_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItNC0xLTEtMTg5Njk_93b135a1-fc29-465a-8ed6-f2c24361f100"
      unitRef="usd">-2429000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i01612b88bf7d4228961f615de0e3bc6c_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItNi0xLTEtMTg5Njk_daa9ebba-fe70-4915-93f4-aa0972a6ba42"
      unitRef="usd">-4760000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie1065eae966a4e23a6d80c3a4c53c9e1_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMTgvZnJhZzpjODkxNWM4NWZjODk0NGIyYjEwMDE5ZGVkZmJiYTk3Zi90YWJsZTo4Y2JlODJhMGJmZTQ0YTU2ODUyODFjYzExNTg0MThiNy90YWJsZXJhbmdlOjhjYmU4MmEwYmZlNDRhNTY4NTI4MWNjMTE1ODQxOGI3XzItOC0xLTEtMTg5Njk_101a1ed5-92d7-40ca-bd78-f1b80fbc841e"
      unitRef="usd">62000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk2Ng_2a0a14ce-e20a-447b-a2d0-222a338bf520">Stockholders' Equity &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share.&#160;&#160;The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders.&#160;&#160;The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends.&#160;&#160;No dividends have been declared or paid on the Company's common stock through March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended March&#160;31, 2022 and 2021, we repurchased shares of our common stock and recorded them as treasury stock.  Our share repurchases consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.2 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11.9 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzY4_186e954c-25b2-4a8c-a20e-36483125d414"
      unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk1_d2eb04f8-a1ea-4aed-81d7-0e6ec296548e"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzEyMw_bf74b355-b5d7-4a8d-aa18-b5aa90d8693f"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzE1Mw_d694c561-9ff6-4013-8650-c92d83ff3385"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <pbh:VotingRightsNumberOfVotesPerCommonShareOwned
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzM5Mg_f72b1b03-f372-479b-8abf-fbe3f95a53ec"
      unitRef="vote">1</pbh:VotingRightsNumberOfVotesPerCommonShareOwned>
    <us-gaap:DividendsCommonStock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4XzcxNA_1bc17e9c-289d-47c2-a989-349e01bf4e89"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90ZXh0cmVnaW9uOmQwZjdmNjBjYjIxMDRjNDdhMzI1YWY4NTk4ZDQ3MGU4Xzk2Nw_2714e2a6-da22-4d9a-8627-d88d48d7a90a">Our share repurchases consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased pursuant to the provisions of the various employee restricted stock awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$46.04&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.9 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.2 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased in conjunction with our share repurchase program:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amount repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$11.9 million&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzMtMS0xLTEtMTg5Njk_af168718-7262-46f8-b87f-3f2d3d1946f8"
      unitRef="shares">63314</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzMtMy0xLTEtMTg5Njk_08640077-8cec-4d2d-b386-f7a248c16fd3"
      unitRef="shares">31117</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzQtMS0xLTEtMTg5Njk_830a8e97-ba54-4d9c-a73c-9cd2adf73326"
      unitRef="usdPerShare">46.04</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzQtMy0xLTEtMTg5Njk_ca29cf0f-af0c-4659-968c-2dd124b1ac89"
      unitRef="usdPerShare">39.91</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8e94357c07754c688e8c7c75cc64eb5f_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzUtMS0xLTEtMTg5Njk_9132a697-b26e-4752-a026-0c90804eef3f"
      unitRef="usd">2900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib6409d99de594b52889f5652216b4812_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzUtMy0xLTEtMTg5Njk_b773b74b-0773-4953-b8d8-a52c78f2808d"
      unitRef="usd">1200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzgtMS0xLTEtMTg5Njk_f522e965-86e8-4964-aacb-9e74ec81144e"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzgtMy0xLTEtMTg5Njk_30367323-6c29-4d51-8651-67cab469f897"
      unitRef="shares">337117</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzktMS0xLTEtMTg5Njk_46a0833f-7cb0-475b-8f03-b85784fc6ad0"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzktMy0xLTEtMTg5Njk_85f8c5c8-3e3e-418e-9071-47fd06ecf2eb"
      unitRef="usdPerShare">35.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzEwLTEtMS0xLTE4OTY5_59326eb1-99bc-4896-bf8d-575c2580e9eb"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ice4373da025543d89003a05d5de73749_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjEvZnJhZzpkMGY3ZjYwY2IyMTA0YzQ3YTMyNWFmODU5OGQ0NzBlOC90YWJsZTpmZGJiYTFiZmU3MjE0OTRhOTZjMWQ5ZGU2Mjc2NmQ4Ni90YWJsZXJhbmdlOmZkYmJhMWJmZTcyMTQ5NGE5NmMxZDlkZTYyNzY2ZDg2XzEwLTMtMS0xLTE4OTY5_7b30d5ad-553e-4b96-9c1f-e1d15d563f60"
      unitRef="usd">11900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTE_49bf5e83-2e46-45ed-9d46-73cf10a54d21">Share-Based Compensation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the &#x201c;2005 Plan&#x201d;), which provided for grants of up to a maximum of 5.0&#160;million shares of restricted stock, stock options, RSUs and other equity-based awards.  In June 2014, the Board of Directors approved, and in July 2014, our stockholders ratified, an increase of an additional 1.8&#160;million shares of our common stock for issuance under the 2005 Plan, an increase of the maximum number of shares subject to stock options that could be awarded to any one participant under the 2005 Plan during any fiscal 12-month period from 1.0&#160;million to 2.5&#160;million shares, and an extension of the term of the 2005 Plan by ten years to February 2025. &#160;Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, were eligible for grants under the 2005 Plan. &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 23, 2020, the Board of Directors adopted the Prestige Consumer Healthcare Inc. 2020 Long-Term Incentive Plan (the &#x201c;2020 Plan&#x201d;). The 2020 Plan became effective on August 4, 2020, upon the approval of the 2020 Plan by our stockholders.  On June 23, 2020, a total of 2,827,210 shares were available for issuance under the 2020 Plan (comprised of 2,000,000 new shares plus 827,210 shares that were unissued under the 2005 Plan).  All future equity awards will be made from the 2020 Plan, and the Company will not grant any additional awards under the 2005 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, there were $2.8 million of unrecognized compensation costs related to unvested stock options under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures which may occur.&#160;&#160;We expect to recognize such costs over a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;weighted average period of 1.7 years.  At March&#160;31, 2022, there were&#160;$8.5 million of unrecognized compensation costs related to unvested RSUs and performance-based stock units ("PSUs") under the 2005 Plan and the 2020 Plan, excluding an estimate for forfeitures that may occur.  We expect to recognize such costs over a weighted average period of 1.5 years.    &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, there were 2.5 million shares available for issuance under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;On May 3, 2021, the Compensation and Talent Management Committee (the "Committee") of our Board of Directors granted 77,345 performance units, 73,108 RSUs and stock options to acquire 222,660 shares of our common stock under the 2020 Plan to certain executive officers and employees.  The stock options were granted at an exercise price of $44.33 per share, which was equal to the closing price for our common stock on the date of the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;A newly appointed independent member of the Board of Directors received a grant under the 2020 Plan of 1,636 RSUs on May 3, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;Each of the independent members of the Board of Directors received a grant of 2,808 RSUs on August 3, 2021 under the 2020 Plan.  The RSUs are fully vested upon receipt of the award and will be settled by delivery to each director of one share of our common stock for each vested RSU promptly following the earliest of (i) such director's death, (ii) such director's separation from service or (iii) a change in control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs granted to employees under the 2005 Plan and the 2020 Plan generally vest in three years, primarily upon the attainment of certain time vesting thresholds, and, in the case of performance share units, may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before interest, income taxes, depreciation and amortization targets.&#160;&#160;The RSUs provide for accelerated vesting if there is a change of control, as defined in the 2005 Plan and the 2020 Plan.&#160; The RSUs granted to employees generally vest either ratably over three years or in their entirety on the three-year anniversary of the date of the grant.  Upon vesting, the units will be settled in shares of our common stock.  Termination of employment prior to vesting will result in forfeiture of the RSUs, unless otherwise accelerated by the Committee or, in the case of RSUs granted in May 2018 and later, subject to pro-rata vesting in the event of death, disability or retirement.  The RSUs granted to directors prior to fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's disability or (iii) the six-month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.  The RSUs granted to directors beginning in fiscal 2020 vest immediately upon grant, and will be settled by delivery to the director of one share of our common stock for each vested RSU promptly following the earliest of (i) the director's death, (ii) the director's separation from service or (iii) a change in control of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the RSUs is determined using the closing price of our common stock on the date of the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSUs granted under the 2005 Plan and 2020 Plan is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2005 Plan and the 2020 Plan provide that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted.&#160;&#160;Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three years.&#160;&#160;The option awards provide for accelerated vesting in the event of a change in control, as defined in the 2005 Plan and the 2020 Plan.  Except in the case of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested stock options.  Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the 2005 Plan and the 2020 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below.&#160;&#160;Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies.&#160;&#160;We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors.&#160;&#160;Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation.&#160;&#160;The expected terms of the options granted are derived from our historical experience, management&#x2019;s estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding.&#160;&#160;The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1% - 31.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1% - 32.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9% to 31.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0% to 1.3% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3% to 2.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.83&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and 2020 Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted &lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The aggregate intrinsic value of options exercised during 2022, 2021 and 2020 was $6.0 million, $2.2 million and $0.4 million, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i59613ba2ed6449e8ac420dc8ea0ee548_I20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIyNA_4862a428-7eaa-4dcb-ac15-bca6823f94e6"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i872fd2fcec7d4bceb22e9ecae5396854_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQyOA_ecd35bfc-bb2c-45bb-8dd0-32a3929166ea"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i0e8537058553437296cbf47a294cbc0c_D20140531-20140531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzY2NQ_01b7a85b-910c-4d4b-87f2-2903d0346927"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i11506770ce994fd08f2fc8766933e916_D20140601-20140630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzY3MQ_8169e701-fc91-4a24-a522-0f9198cacda9"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod
      contextRef="i11506770ce994fd08f2fc8766933e916_D20140601-20140630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMQ_d8dd1325-2abd-4a56-b4bf-d1f3ab16dc3d">P10Y</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzExODk_7ff0f72a-8627-4d4f-af7e-d6627c458083"
      unitRef="shares">2827210</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares
      contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEyNjA_4e5c0270-db19-48c4-a98a-b90fa4b5ad71"
      unitRef="shares">2000000</pbh:CommonStockCapitalSharesReservedForFutureIssuanceNewShares>
    <pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares
      contextRef="i688dea0bee1948f2a6d571409bce4665_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEyNzk_3c616b22-780a-4816-96c8-df0d8dc371b3"
      unitRef="shares">827210</pbh:CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzM_fbe79a93-eeb1-401f-98d9-29f105cd7f84">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our stock-based compensation:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax share-based compensation costs charged against income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit recognized on compensation costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of options and RSUs vested during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItMi0xLTEtMTg5Njk_805a7d3f-cf04-4f88-be4a-333465e40bf4"
      unitRef="usd">9039000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItNC0xLTEtMTg5Njk_a16e811e-bbe4-49d4-b483-640f60afab7b"
      unitRef="usd">8543000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzItNi0xLTEtMTg5Njk_4302e44d-3773-4369-ac86-26646ca47327"
      unitRef="usd">7644000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtMi0xLTEtMTg5Njk_64968296-981c-468f-8e38-ad161199a042"
      unitRef="usd">633000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtNC0xLTEtMTg5Njk_96fb67f3-fdb4-4060-8517-9f63eac481a6"
      unitRef="usd">1224000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzMtNi0xLTEtMTg5Njk_3edef5dd-dbaa-4f77-930f-6d70751861ca"
      unitRef="usd">1207000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtMi0xLTEtMTg5Njk_c289b1ed-dc85-47cf-9832-d1e7e94eca24"
      unitRef="usd">7943000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtNC0xLTEtMTg5Njk_fff7dd10-2fcb-44e1-a5e4-615815afeffd"
      unitRef="usd">6796000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzQtNi0xLTEtMTg5Njk_9b7bc2e6-7627-437e-b1ee-ece3cd08f686"
      unitRef="usd">7830000</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtMi0xLTEtMTg5Njk_4453080b-20cc-43dd-9084-6b5b96d04126"
      unitRef="usd">7040000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtNC0xLTEtMTg5Njk_7d615404-ee14-4a2a-b144-32f787a8e80e"
      unitRef="usd">2851000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzUtNi0xLTEtMTg5Njk_2006892a-1c63-4760-9a68-1d007f3ea8f8"
      unitRef="usd">1324000</us-gaap:ProceedsFromStockOptionsExercised>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtMi0xLTEtMTg5Njk_52ee89ac-4639-4647-8183-6b2c79871e78"
      unitRef="usd">3419000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtNC0xLTEtMTg5Njk_2fd39387-f529-499f-a205-fb7d67cb8fa5"
      unitRef="usd">1153000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTphNWNhNTkxYjI0MWM0N2I2ODY0Y2ZlMmM1MGY0OTQ2OS90YWJsZXJhbmdlOmE1Y2E1OTFiMjQxYzQ3YjY4NjRjZmUyYzUwZjQ5NDY5XzYtNi0xLTEtMTg5Njk_93e19bab-1043-41b2-af60-5af781e20fea"
      unitRef="usd">745000</pbh:EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE1NjY_efbd2c2c-2f60-4edf-b913-9e2c593dca82"
      unitRef="usd">2800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE4MjQ_d353e8eb-b15c-44f7-a89b-463f54cb4baf">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU0MDE_7da6503c-1517-4795-b097-b469f3871feb"
      unitRef="usd">8500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i57d3c321154c4e9aaa1bbcb78e0701f5_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU0MDE_db0afacf-cc15-4257-81e3-db5b83db46da"
      unitRef="usd">8500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i22f7753689274ada97cf2c0bb4c3001d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzEwOTk1MTE2MzU2NDM_b2c1eac1-5847-4010-b542-918357114c98">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzE4NDc_7e660656-6e41-4cb5-8468-ce814fd33553"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i44a6c8be63164b3a838a938732b3f2c9_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwMTk_e7d04f4b-b8a9-4fc1-8db0-2fa53793c10b"
      unitRef="shares">77345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i907bf7654d494d8786dce88601c9edf2_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwNDE_e3638e07-5c96-4dd0-84ff-64da1123a47a"
      unitRef="shares">73108</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzIwNzc_a26d8637-3e3f-481e-88a4-1e6647a58b80"
      unitRef="shares">222660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="i4420e0ab0fb44a9686287d27929f33da_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzI2ODM_7c21e5a3-fb77-4708-bde0-662e68a4acca"
      unitRef="usdPerShare">44.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i330f93470c3944a7884dc0e46ce08542_D20210503-20210503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzI4ODU_41756fb5-9d65-4df2-acad-38063c1c7e4f"
      unitRef="shares">1636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzMwMDY_44af429e-77c4-4feb-bccf-69a240b9b7bf"
      unitRef="shares">2808</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted
      contextRef="i9c7f6039985b49a982f72d1750af2386_D20210803-20210803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzMxNDA_b9825144-7596-437e-b9cc-c2cad6d99f42"
      unitRef="shares">1</pbh:RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzQ_0e8394e3-6ded-4acd-8467-121adb7fe197">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTU_636f26fc-1ee2-468b-af7d-a2bd525ae3b2">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzY_3c6d8286-bad0-4700-a1a2-cf57ab2c0ffa">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted
      contextRef="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQ0Nzg_1a474602-d9c3-4c52-9230-0b957a6a1824"
      unitRef="number">1</pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted>
    <pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted
      contextRef="if3769c0be74b4cf194fc7256a6060069_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzQ4ODY_a6bffce9-43ff-4f92-93a2-04146ed48cb7"
      unitRef="number">1</pbh:RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNDE_7050ec73-c57e-4c31-9338-9e14b933d9b3">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSUs granted under the 2005 Plan and 2020 Plan is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i0c27223f84a24212910eb3aeea93eaf1_I20190331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzItMi0xLTEtMTg5Njk_388a9d23-4635-4fb9-8e48-d37a474a8f4a"
      unitRef="shares">299900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i0c27223f84a24212910eb3aeea93eaf1_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzItNC0xLTEtMTg5Njk_09e07044-c8fe-4c71-b70f-b420aae17a2a"
      unitRef="usdPerShare">38.66</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzQtMi0xLTEtMTg5Njk_22d5dabf-8855-481b-b616-0c696d1dd02c"
      unitRef="shares">220300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzQtNC0xLTEtMTg5Njk_989eb93a-6be8-4d4c-8ecd-29110bdebf4a"
      unitRef="usdPerShare">31.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzUtMi0xLTEtMTg5Njk_7a0f21b1-9f69-4e6b-92b8-b33fe8f50b04"
      unitRef="shares">98100</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzUtNC0xLTEtMTg5Njk_22a5d4d9-41d1-4938-90bd-026c961c92bd"
      unitRef="usdPerShare">44.35</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzYtMi0xLTEtMTg5Njk_ca373a17-a2ff-464d-944b-531bc67de1f9"
      unitRef="shares">34200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ied6509f3c6c44c0991daa39db0f13baf_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzYtNC0xLTEtMTg5Njk_8853e7d0-71c6-4594-ac34-6df920e44b75"
      unitRef="usdPerShare">35.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzctMi0xLTEtMTg5Njk_a4391729-a4c0-4f73-a0c1-3a9dbe6327cf"
      unitRef="shares">387900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzctNC0xLTEtMTg5Njk_3eefb9ec-b084-4517-8f26-42c2131481f4"
      unitRef="usdPerShare">33.11</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzgtMi0xLTEtMTg5Njk_12fc631f-4f7f-4767-b3d3-ca7fb433e0c9"
      unitRef="shares">124200</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i5bc5220759bc469998f6d5c89b112a71_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzgtNC0xLTEtMTg5Njk_0426b012-fa7b-40a6-b150-a9d134b5fc44"
      unitRef="usdPerShare">30.54</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEwLTItMS0xLTE4OTY5_a5fc1a42-1fb6-4ca8-878f-c922f2a1df3a"
      unitRef="shares">179700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEwLTQtMS0xLTE4OTY5_b7a0d12c-2747-4439-939a-496da15512e2"
      unitRef="usdPerShare">40.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzExLTItMS0xLTE4OTY5_b2dc58db-821d-4ef4-b818-5bed4e9dce3e"
      unitRef="shares">100200</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzExLTQtMS0xLTE4OTY5_5e0e1e7a-55a7-4d9a-94e9-637a34f54d2d"
      unitRef="usdPerShare">42.94</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEyLTItMS0xLTE4OTY5_b5eaf37b-9530-4b1e-8181-f7d617aa753e"
      unitRef="shares">10400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibf683ceabce54b3e8d16d334a82e217a_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEyLTQtMS0xLTE4OTY5_785a630b-1054-44cf-b730-fde2b1ae18f1"
      unitRef="usdPerShare">43.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEzLTItMS0xLTE4OTY5_c165ffb8-f599-471b-8ee1-0578044c89fe"
      unitRef="shares">457000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzEzLTQtMS0xLTE4OTY5_e6f87a52-fdd0-4d9f-8c29-df0d2b7a2c05"
      unitRef="usdPerShare">33.52</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE0LTItMS0xLTE4OTY5_613b82f5-527c-42b7-b9f3-1cbeceb13dc1"
      unitRef="shares">150400</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i22fb9cffca2c4cddb633b8b7447cd658_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE0LTQtMS0xLTE4OTY5_9997d694-572b-4d91-9ef1-4a9e918800b8"
      unitRef="usdPerShare">31.98</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE2LTItMS0xLTE4OTY5_8978a0f5-5672-4a92-8ac9-c900443d8440"
      unitRef="shares">170800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE2LTQtMS0xLTE4OTY5_a293c31d-098c-4d69-aa20-97a6fd3e081b"
      unitRef="usdPerShare">45.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE3LTItMS0xLTE4OTY5_aaec605c-a005-463b-a448-49138ac1d8cd"
      unitRef="shares">162300</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE3LTQtMS0xLTE4OTY5_59cc5e4c-edf7-408f-83c6-a7d5797c4591"
      unitRef="usdPerShare">32.99</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE4LTItMS0xLTE4OTY5_b0f34664-5a7e-499b-84d5-4b6af2dfd52d"
      unitRef="shares">24600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i12c850cdeac2428fb5465b499660d4d6_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE4LTQtMS0xLTE4OTY5_c9f8609b-d1a0-492f-a660-95af59b53b27"
      unitRef="usdPerShare">30.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE5LTItMS0xLTE4OTY5_145c39d7-c483-4bdf-bfe6-c756ef1bf040"
      unitRef="shares">440900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzE5LTQtMS0xLTE4OTY5_9b8c0c31-8f9c-446c-8be4-1f94ac200566"
      unitRef="usdPerShare">38.45</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber
      contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzIwLTItMS0xLTE4OTY5_5d2dd719-0007-4508-9250-f00dc453aa0c"
      unitRef="shares">106800</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="id15a44884d6e49a5a914ecd71387e80c_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTowMmYxZjg5OTdhNzA0ZmQ4OTM4ZjE3MGMzOTkzY2U2MC90YWJsZXJhbmdlOjAyZjFmODk5N2E3MDRmZDg5MzhmMTcwYzM5OTNjZTYwXzIwLTQtMS0xLTE4OTY5_9a58e39c-11b3-412f-9547-955fd2540aa4"
      unitRef="usdPerShare">36.42</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue>
    <pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant
      contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzU1NDc_24cbafb9-4aec-40b1-b623-e834274e3c46">P10Y</pbh:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMjk_6bfc3a33-dc5f-4501-87dd-9c70ccaf9abd">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMzA_32948ca3-f9ec-4101-a0ff-345c224d7987">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1% - 31.9%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1% - 32.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9% to 31.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0 to 7.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0% to 1.3% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3% to 2.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average grant date fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$12.91&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.83&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxMzIxODg4ZDZlZmU0ZWRmOWE4YjYxYzVlNDI0MzVjYl80_48ae8931-729d-4ea9-bf7c-6cf8f0a55757"
      unitRef="number">0.311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxMzIxODg4ZDZlZmU0ZWRmOWE4YjYxYzVlNDI0MzVjYl85_ee83c3e0-97ee-4645-a698-543bb4844336"
      unitRef="number">0.319</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo4NGI0YjU2YmM1YmU0YjgwYTlmZjkxYjA3ZDZiMTBjNF80_db493ffa-8ee5-4286-bcf4-538b813b8956"
      unitRef="number">0.321</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo4NGI0YjU2YmM1YmU0YjgwYTlmZjkxYjA3ZDZiMTBjNF85_4d9d2847-a731-43db-82c7-5f641c9beac8"
      unitRef="number">0.322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZGRlZDZiMTJhMjc0NzlkODdkZjViM2JhNjkyYzJiYl8xMDk5NTExNjI3Nzkw_087304e2-cc9e-477f-b0e5-332f224a9508"
      unitRef="number">0.309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzItNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZGRlZDZiMTJhMjc0NzlkODdkZjViM2JhNjkyYzJiYl8xMDk5NTExNjI3Nzk3_8fd14696-0f54-4613-a549-e823c60eac2f"
      unitRef="number">0.313</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtMS0xLTEtMTg5Njk_6c3b79b7-3a90-40e1-ad09-5584fbad3a03"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtMy0xLTEtMTg5Njk_bd864855-e8f0-4cf0-a440-9991991e8abf"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzMtNS0xLTEtMTg5Njk_563b5d86-ef1d-41e3-b126-552c4336b3c7"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozOTMzZDY0M2I2Nzg0ZjM0Yjc3OGJjZTE1NzE0MjEyM180_f33b5c1e-281d-4866-b03c-9268890c9cdc">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjozOTMzZDY0M2I2Nzg0ZjM0Yjc3OGJjZTE1NzE0MjEyM18xMA_26448002-8859-4fec-b7cb-b87506dfbd59">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplNGU1ZWI0NzM4YmE0ZjI1YThmMDUxNzJjODEzNzE3Yl80_c88ff491-46fc-4a49-9ace-fc7a57b00f90">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id2a227beaa894ccc99d1967588a5ae29_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplNGU1ZWI0NzM4YmE0ZjI1YThmMDUxNzJjODEzNzE3Yl8xMA_c8a18af2-47db-42ad-af8a-9681281a6cf3">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxOGRhYzYyY2E5MDY0YmUzYWZiODM4ZWU3ZmU0MDM4Ml8xMDk5NTExNjI3Nzg2_c1ae966e-6318-4f85-8f1d-d06386916e27">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzQtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjoxOGRhYzYyY2E5MDY0YmUzYWZiODM4ZWU3ZmU0MDM4Ml8xMDk5NTExNjI3Nzkz_4462986e-8e06-48d1-b2c3-ecea4328c5af">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if3a6c8b2235d42d18f116b59e6fe33ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjMGIyM2Y2MjNlZmE0OTlmYWExOGU1ZDliMTU4ZDNmZF8xMDk5NTExNjI3Nzg0_565d3676-08f6-4211-ba2b-fa8d4d38d616"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i4c395208275f4a05b76fc2f94878a254_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjMGIyM2Y2MjNlZmE0OTlmYWExOGU1ZDliMTU4ZDNmZF8xMDk5NTExNjI3Nzky_c0893b5d-61d0-43d5-b97b-1dec6e5aaabb"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia86a9afe44b54a8a80c614ac56db9305_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo2YTg1MjA3NGFjMjI0YmFiYWEyYzI1M2NiYTE3NzllZl80_4513ec75-5234-47e7-ad2d-1f5a6e3f5bbd"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idd3a65f894d3401a992804e203d4ba8c_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiNTAyMGNlN2M0MTA0Y2E5OWI5NjM1NDc1MWMwY2FmMl8xMDk5NTExNjI3Nzg4_fa36a688-2aac-48b6-aa05-8e03fe3f2ee8"
      unitRef="number">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i325a7768e36d4c6d8cd8d18455c348cc_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzUtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiNTAyMGNlN2M0MTA0Y2E5OWI5NjM1NDc1MWMwY2FmMl8xMDk5NTExNjI3Nzk1_b5e0454b-f4da-49c7-8dda-885ec5f4c220"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i80f789044f294f2593d384da1434a1aa_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtMS0xLTEtMTg5Njk_868304ce-2eaf-4723-91f3-d3064fb281d6"
      unitRef="usdPerShare">14.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3e99d7f8ba14400e8bd0dc52954c4ad0_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtMy0xLTEtMTg5Njk_b28de132-f195-4c3e-81c6-9c2a18b37062"
      unitRef="usdPerShare">12.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7c27841e287449a389ec06ba8e613db3_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTplZmRlZDQxOTcwZWU0ODg0OWVhNTA5MDNmMzkwYTJlOC90YWJsZXJhbmdlOmVmZGVkNDE5NzBlZTQ4ODQ5ZWE1MDkwM2YzOTBhMmU4XzYtNS0xLTEtMTg5Njk_744efe1b-c957-41e3-9ec6-e46c556eb891"
      unitRef="usdPerShare">10.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczNTY_8b537d45-9ddd-42e9-aa6a-c5928491e140">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2005 Plan and 2020 Plan is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted &lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzItMi0xLTEtMTg5Njk_85e6421a-7053-4a4d-b13b-95af7f501542"
      unitRef="shares">944600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzItNC0xLTEtMTg5Njk_cac51471-275b-46f0-8566-d1a7ec96e3ec"
      unitRef="usdPerShare">38.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzQtMi0xLTEtMTg5Njk_12f53cee-017d-40ef-b9f6-f22032194d8a"
      unitRef="shares">302700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzQtNC0xLTEtMTg5Njk_e2f5badc-98da-456d-89de-444b8293825a"
      unitRef="usdPerShare">30.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzUtMi0xLTEtMTg5Njk_40cafb65-f3b4-4060-a4b1-dc1d78314578"
      unitRef="shares">47900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzUtNC0xLTEtMTg5Njk_a913dcf0-5c13-4714-9d54-cc861a042221"
      unitRef="usdPerShare">27.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtMi0xLTEtMjExNTU_556bb23c-61ec-4174-b7df-a0911fb44ee8"
      unitRef="shares">79200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtNC0xLTEtMjExNjI_2f84719d-843c-4316-88e8-0c81f3455c5e"
      unitRef="usdPerShare">32.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtMi0xLTEtMTg5Njk_bddaa164-0460-4b9c-8922-51a45837de64"
      unitRef="shares">100000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzYtNC0xLTEtMTg5Njk_3970102f-4bcb-4995-a714-7a08754d7adc"
      unitRef="usdPerShare">50.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzctMi0xLTEtMTg5Njk_140124c9-eb01-4bb4-b58d-320f246bae82"
      unitRef="shares">1020200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzctNC0xLTEtMTg5Njk_cf06daee-15ff-4a21-b41d-cdbaedbe03ef"
      unitRef="usdPerShare">35.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzktMi0xLTEtMTg5Njk_56b3d4af-7bee-4cc7-8c93-93f7f8b4b4cf"
      unitRef="shares">249900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzktNC0xLTEtMTg5Njk_048800b2-a003-419e-a628-bb6c04acf155"
      unitRef="usdPerShare">39.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEwLTItMS0xLTE4OTY5_677ed8e5-5821-41e4-8e76-9c7b79f09cf4"
      unitRef="shares">119600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEwLTQtMS0xLTE4OTY5_280fefd5-d335-41d7-a5c2-f9fccbd64b12"
      unitRef="usdPerShare">23.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTItMS0xLTIxMTcx_afc99931-c94f-4e4d-b188-6c39651d5a46"
      unitRef="shares">21700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTQtMS0xLTIxMTc4_c0e72f41-923e-456a-a036-c105a91fc979"
      unitRef="usdPerShare">34.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzExLTItMS0xLTE4OTY5_cc6d0462-341e-42df-8ede-d95af65125b6"
      unitRef="shares">13900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzExLTQtMS0xLTE4OTY5_fd291e0b-aa75-4413-8a39-81b60cc00577"
      unitRef="usdPerShare">52.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTItMS0xLTE4OTY5_d80daa4f-5d5c-4a78-a128-778bd607d244"
      unitRef="shares">1114900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzEyLTQtMS0xLTE4OTY5_f6f6077a-3cd3-4019-a33e-00a1e7db7964"
      unitRef="usdPerShare">37.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE0LTItMS0xLTE4OTY5_141f2526-e4cb-431d-b688-b1b8d66d2039"
      unitRef="shares">234200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE0LTQtMS0xLTE4OTY5_4d6ac76e-f60e-4005-83cf-4b7aa461e4e3"
      unitRef="usdPerShare">44.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE1LTItMS0xLTE4OTY5_7d4b0855-a30c-4f1b-8c54-14b0b39b8eda"
      unitRef="shares">226000.0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE1LTQtMS0xLTE4OTY5_adcb6b73-2613-4a2e-9088-b92eb2deba0b"
      unitRef="usdPerShare">31.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTItMS0xLTIxMTg2_59adcf45-ce59-4a0d-8c7c-2182b090ca39"
      unitRef="shares">13700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTQtMS0xLTIxMTk0_8d5a5b8e-961f-4c45-8a4d-c62a3c5c6f3c"
      unitRef="usdPerShare">37.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE2LTItMS0xLTE4OTY5_29c036af-25cf-4e49-b7fa-8d6e16ba3046"
      unitRef="shares">8500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE2LTQtMS0xLTE4OTY5_d311f3c2-6a84-4628-b51b-72ac0dcbce28"
      unitRef="usdPerShare">56.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTItMS0xLTE4OTY5_2c707004-cf3d-4088-992a-24b695350013"
      unitRef="shares">1100900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTQtMS0xLTE4OTY5_68e7a6f2-1d4c-4c2a-a65a-7430a7071f87"
      unitRef="usdPerShare">40.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTYtMS0xLTE4OTY5_e04ecb96-46d8-4b05-ab2c-145d12e2d21b">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE3LTgtMS0xLTE4OTY5_55bfee92-03ae-4f03-82ab-230e467cae53"
      unitRef="usd">14239000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTItMS0xLTE4OTY5_2da2907a-bffd-4584-8d96-218db76626ac"
      unitRef="shares">621300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTQtMS0xLTE4OTY5_16a8e3e6-4e7c-4903-82fb-85c03d262b5c"
      unitRef="usdPerShare">40.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTYtMS0xLTE4OTY5_3fdc512a-abb9-478e-aa1e-384389246436">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90YWJsZTpkNjBiY2U5NzU0Njk0MmFjYTY4MDliNjJlYWY1OGE4Yi90YWJsZXJhbmdlOmQ2MGJjZTk3NTQ2OTQyYWNhNjgwOWI2MmVhZjU4YThiXzE4LTgtMS0xLTE4OTY5_13b6f091-80bb-4288-b17b-0df7be732e23"
      unitRef="usd">8226000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzcyOTc_6b97984b-bab8-4623-affa-3c7204122555"
      unitRef="usd">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMDE_8681f698-50ca-454d-a67f-f4cce8cee663"
      unitRef="usd">2200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjQvZnJhZzoxYjQ2ZjAzZjVhNzA0ZWYzOTQ1MjU1ZGYxZWNkNDI4Yi90ZXh0cmVnaW9uOjFiNDZmMDNmNWE3MDRlZjM5NDUyNTVkZjFlY2Q0MjhiXzczMDg_9b754292-f156-4b19-a8a7-23264896dcbd"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <pbh:AccumulatedOtherComprehensiveIncomeTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90ZXh0cmVnaW9uOjA5NTZhZTllZWQ5NDRmYTlhNjA4NjNkNDFlYTRmOTllXzMzNA_7ab35938-59db-435a-978f-73d6e2f78892">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AOCI consisted of the following at March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,801)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pbh:AccumulatedOtherComprehensiveIncomeTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90ZXh0cmVnaW9uOjA5NTZhZTllZWQ5NDRmYTlhNjA4NjNkNDFlYTRmOTllXzM0NA_1aa2eee9-e391-46af-954b-8376c50bbd47">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AOCI consisted of the following at March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Components of Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,801)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="if27256c09baf422db24a2becba8b461a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzMtMS0xLTEtMTg5Njk_9d565104-0200-4866-9682-292e3264c524"
      unitRef="usd">-20204000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i410e808bfa6046c0b7bc6cd1eeb717fc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzMtMy0xLTEtMTg5Njk_0ad39f18-075e-4e96-9cfa-b0d955f7fb25"
      unitRef="usd">-18908000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ZTg3MDkzMjFjOGI0Y2JmOTY4MjY5ODdlZTMxZTk0Zl81OA_73887818-0800-419a-942e-e6491da20f30"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo3ZTg3MDkzMjFjOGI0Y2JmOTY4MjY5ODdlZTMxZTk0Zl82NQ_79ea7f78-ebe9-42e4-a693-ee6150a26d8c"
      unitRef="usd">543000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:StockholdersEquity
      contextRef="i1687a3f206264e8a9491e1485f31dbb2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMS0xLTEtMTg5Njk_b01e7062-ac35-4051-a301-12092f549103"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe7fc1c11e8e4d5ab859abc4f504db82_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzQtMy0xLTEtMTg5Njk_616a92a6-7a63-4ea8-b052-24c85e6a48ae"
      unitRef="usd">-1819000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZDlkMmY4N2MxYTU0YWYwOGRkMWIyZDE3MWFiYWQ1OV82NQ_ef6ccfc5-9ede-4922-88ca-118d25047e89"
      unitRef="usd">-350000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMC0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpmZDlkMmY4N2MxYTU0YWYwOGRkMWIyZDE3MWFiYWQ1OV83Mg_2b9e9fba-aac4-4f9f-8d19-9862bc0f827e"
      unitRef="usd">-276000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:StockholdersEquity
      contextRef="i57c394a5473c4367bd8d152963753341_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMS0xLTEtMTg5Njk_16e46d9c-9387-4b4b-801f-be56f26e335d"
      unitRef="usd">1172000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f0e76da8d7e4425bd35dcb13791235b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzUtMy0xLTEtMTg5Njk_1adcb974-36b8-4f86-9da9-6ce1c2a6adb2"
      unitRef="usd">926000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icbaca07b4355474988048d221f663307_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzctMS0xLTEtMTg5Njk_c4e7932b-e558-42ee-ab8d-86a7b5d153d3"
      unitRef="usd">-19032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4d7342d42af4b0cbbd9dc2b98c91160_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMjcvZnJhZzowOTU2YWU5ZWVkOTQ0ZmE5YTYwODYzZDQxZWE0Zjk5ZS90YWJsZTo5OGYxOGM1ZTU5YjE0NmEwYmJhM2MxNzBlMjFiOTE5Ny90YWJsZXJhbmdlOjk4ZjE4YzVlNTliMTQ2YTBiYmEzYzE3MGUyMWI5MTk3XzctMy0xLTEtMTg5Njk_b9a6e0b3-de65-42f0-ae07-59a5aa0591a0"
      unitRef="usd">-19801000</us-gaap:StockholdersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NDI_567646d1-6fed-4374-a895-0eb84099b674">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal components of our deferred tax balances are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts and sales returns&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred cumulative catch-up adjustments - revenue recognition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(484,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net deferred tax liability shown above is net of $1.9 million of foreign deferred tax assets as of March&#160;31, 2022 and $1.2 million of foreign deferred tax assets as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no valuation allowance as of March&#160;31, 2021 and March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Uncertain tax liability activity is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize interest and penalties related to uncertain tax positions as a component of income tax (benefit) expense.  We did not incur any material interest or penalties related to income taxes in 2022, 2021 or 2020.  We reasonably anticipate that uncertain tax positions could decrease in the next year by approximately $0.5 million, principally due to the statute of limitation expirations if recognized and would impact the effective tax rate in a future period.  We are subject to taxation in the United States and various state and foreign jurisdictions, and we are generally open to examination from the year ended March 31, 2018 forward.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0MzY_4d67872f-4a03-42a9-99cd-d1575769912c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItMS0xLTEtMTg5Njk_e8f9515b-c708-4c35-9d4c-7708ac6431d6"
      unitRef="usd">236381000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItMy0xLTEtMTg5Njk_ed4550f9-7255-4994-aafe-f73f7e3623d2"
      unitRef="usd">195796000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzItNS0xLTEtMTg5Njk_11630177-1564-473c-84d5-fbd038105cbf"
      unitRef="usd">167508000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtMS0xLTEtMTg5Njk_a215fc0d-6d2e-4125-bc68-e7fb159a7a2d"
      unitRef="usd">26077000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtMy0xLTEtMTg5Njk_c9477408-b1e8-4a9a-a20b-2df4ccc5b9d6"
      unitRef="usd">8317000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzMtNS0xLTEtMTg5Njk_5e1f9f49-be2f-4a86-aad1-d04fc72ee4af"
      unitRef="usd">23643000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtMS0xLTEtMTg5Njk_f0275bc9-27a0-4485-a600-cd96537172f2"
      unitRef="usd">262458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtMy0xLTEtMTg5Njk_f970d1e3-acc8-4d75-9849-85f3a0580e35"
      unitRef="usd">204113000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo1MjE4YmEwM2QwMzA0MTQ3ODhjZWJmZTVkZDQwMzg1Zi90YWJsZXJhbmdlOjUyMThiYTAzZDAzMDQxNDc4OGNlYmZlNWRkNDAzODVmXzUtNS0xLTEtMTg5Njk_6ab5cda4-d887-44d3-ba37-f6eb884e8b3c"
      unitRef="usd">191151000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0Mzg_c4ddd125-8af0-4431-8fa7-577bd0f9d1c6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtMS0xLTEtMTg5Njk_aa5917ba-7758-4151-9dd6-29423e6294d5"
      unitRef="usd">34446000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtMy0xLTEtMTg5Njk_7f420ed7-9dfe-4f03-8881-d89fcf93b855"
      unitRef="usd">11513000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzMtNS0xLTEtMTg5Njk_f6978c4d-1818-4476-8e61-9a253c674c35"
      unitRef="usd">24051000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtMS0xLTEtMTg5Njk_d373cb2c-24c1-4822-b32f-4d89af332828"
      unitRef="usd">3961000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtMy0xLTEtMTg5Njk_13552eb6-c0a8-407d-a152-297988a05fff"
      unitRef="usd">3403000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzQtNS0xLTEtMTg5Njk_7673b703-d8e0-4a86-bd76-0497966e0f35"
      unitRef="usd">2506000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtMS0xLTEtMTg5Njk_5c11888e-3d4f-4095-a450-52c6b1a1c520"
      unitRef="usd">8709000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtMy0xLTEtMTg5Njk_7053c151-4a94-4864-a36f-e46b4eab362a"
      unitRef="usd">5849000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzUtNS0xLTEtMTg5Njk_1e94c778-5ad1-4df6-8e8f-d77073aed5d8"
      unitRef="usd">8473000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctMS0xLTEtMTg5Njk_c034f195-5d8b-4670-88f2-b6c4504d9844"
      unitRef="usd">12055000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctMy0xLTEtMTg5Njk_c4ca94bb-2d49-49cb-acc1-b47437b009f5"
      unitRef="usd">14430000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzctNS0xLTEtMTg5Njk_5256ad69-637a-452f-b8af-b29399d4a6f4"
      unitRef="usd">14119000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtMS0xLTEtMTg5Njk_ca7f8070-2d35-42bc-b133-29b21610858c"
      unitRef="usd">-1379000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtMy0xLTEtMTg5Njk_de709cbb-f2e6-419d-ab14-be0e3a996e9b"
      unitRef="usd">4572000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzgtNS0xLTEtMTg5Njk_921436f5-e813-4d9f-bdb0-a9e8d5a0e821"
      unitRef="usd">-341000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktMS0xLTEtMTg5Njk_dfda9cfc-5107-46a8-9d14-d93b3f4e0625"
      unitRef="usd">-715000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktMy0xLTEtMTg5Njk_31aee113-deab-4990-9c96-3c0ba6184474"
      unitRef="usd">-336000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzktNS0xLTEtMTg5Njk_6313c82d-44e5-438f-a069-1bb542afaf78"
      unitRef="usd">62000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTEtMS0xLTE4OTY5_6c0a8dc7-7ba7-4e11-91a4-5e58cb3b6f6a"
      unitRef="usd">57077000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTMtMS0xLTE4OTY5_5dfd0f38-3016-48b9-aad0-6ddf59fcc58f"
      unitRef="usd">39431000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphMTdkM2FjZDRjMzY0NjU2OTI2ZjAwNTA0ODBjZGQwYy90YWJsZXJhbmdlOmExN2QzYWNkNGMzNjQ2NTY5MjZmMDA1MDQ4MGNkZDBjXzEwLTUtMS0xLTE4OTY5_af80fcbb-ca9a-46ca-a4ce-70df012e7093"
      unitRef="usd">48870000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NjY_234ff41d-1184-4c15-80ad-b77ea3d74c59">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal components of our deferred tax balances are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts and sales returns&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred cumulative catch-up adjustments - revenue recognition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(484,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzMtMS0xLTEtMTg5Njk_b36f9485-7f39-43e6-8144-be70b97d155d"
      unitRef="usd">4605000</pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns>
    <pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzMtMy0xLTEtMTg5Njk_ac874320-2b66-4a81-a11c-27c3f954695a"
      unitRef="usd">4267000</pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns>
    <pbh:DeferredTaxAssetsInventoryRecapitalization
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzQtMS0xLTEtMTg5Njk_386e2b14-3bbc-421b-abc5-50178a1aee44"
      unitRef="usd">2201000</pbh:DeferredTaxAssetsInventoryRecapitalization>
    <pbh:DeferredTaxAssetsInventoryRecapitalization
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzQtMy0xLTEtMTg5Njk_d1a9d7d8-00ba-41ee-83d3-0dd143a64d2c"
      unitRef="usd">1124000</pbh:DeferredTaxAssetsInventoryRecapitalization>
    <pbh:DeferredTaxAssetsInventoryReserves
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzUtMS0xLTEtMTg5Njk_a132ee54-bd39-44e3-8361-a8aa511a3a44"
      unitRef="usd">1264000</pbh:DeferredTaxAssetsInventoryReserves>
    <pbh:DeferredTaxAssetsInventoryReserves
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzUtMy0xLTEtMTg5Njk_a88ba283-6510-4dcd-8b0f-2dcb770025d9"
      unitRef="usd">1119000</pbh:DeferredTaxAssetsInventoryReserves>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzYtMS0xLTEtMTg5Njk_6b1eb97c-0b9a-43ba-a1d1-14f284bec5bd"
      unitRef="usd">115000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzYtMy0xLTEtMTg5Njk_62bd0fe3-2d00-41f3-9502-260730060ac9"
      unitRef="usd">115000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzctMS0xLTEtMTg5Njk_fc21acd2-1aad-4d19-9e6a-932ca3dee17c"
      unitRef="usd">9661000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzctMy0xLTEtMTg5Njk_a316d643-ba2f-4f78-badc-11080329b920"
      unitRef="usd">10028000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzgtMS0xLTEtMTg5Njk_907c6caa-a767-440a-abd6-d974d9db7f33"
      unitRef="usd">2026000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzgtMy0xLTEtMTg5Njk_a798baac-5904-47f8-a877-0a7c9cf9fde2"
      unitRef="usd">1078000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzktMS0xLTEtMTg5Njk_b3dd77d3-ed61-44ed-a29b-2d28921081a4"
      unitRef="usd">4597000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzktMy0xLTEtMTg5Njk_40fbfa0b-5bf1-4a8a-93f9-78c9ff96e061"
      unitRef="usd">3736000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEwLTEtMS0xLTE4OTY5_a0a6350e-932d-4469-8481-d6b4c763ddc6"
      unitRef="usd">4548000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEwLTMtMS0xLTE4OTY5_77a87554-d259-45a3-a7bd-26ebaabe2eeb"
      unitRef="usd">4369000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzExLTEtMS0xLTE4OTY5_bd36905d-9a57-49f7-ad9f-527330e1792f"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzExLTMtMS0xLTE4OTY5_96738095-2e52-4323-be6a-a855a12c9c2b"
      unitRef="usd">699000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <pbh:DeferredTaxAssetsLeaseLiabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEzLTEtMS0xLTE4OTY5_7080f02b-fdda-48a8-9deb-a62deed49839"
      unitRef="usd">6808000</pbh:DeferredTaxAssetsLeaseLiabilities>
    <pbh:DeferredTaxAssetsLeaseLiabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzEzLTMtMS0xLTE4OTY5_3c9cb283-19bb-4ceb-ad04-0c670bc0f575"
      unitRef="usd">8132000</pbh:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE0LTEtMS0xLTE4OTY5_c36ff6ff-4bb0-459f-b28f-ea2e979c8bab"
      unitRef="usd">215000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE0LTMtMS0xLTE4OTY5_0337b3d6-896a-407c-814e-7f6e22fc5bd4"
      unitRef="usd">384000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE1LTEtMS0xLTE4OTY5_ad31a743-6ba4-4ffe-9268-40f24ca836cd"
      unitRef="usd">5682000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE1LTMtMS0xLTE4OTY5_2b08ecd0-dd89-4be2-96b6-a5de694898a1"
      unitRef="usd">5916000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE2LTEtMS0xLTE4OTY5_4e8a3c1e-0b6d-48a5-a8af-fd4020b404d0"
      unitRef="usd">41722000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE2LTMtMS0xLTE4OTY5_2939298a-05e7-4729-b92a-9acc3583640d"
      unitRef="usd">40967000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE5LTEtMS0xLTE4OTY5_7025d6f5-1120-40a3-b6e0-3cabc3c25c44"
      unitRef="usd">7210000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzE5LTMtMS0xLTE4OTY5_8c8a2c7f-71a1-4b85-8f30-970595184dcd"
      unitRef="usd">7245000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIwLTEtMS0xLTE4OTY5_8f2e8962-0024-4648-a04a-6499b8757d82"
      unitRef="usd">471327000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIwLTMtMS0xLTE4OTY5_b6ddad40-e205-4a08-a96d-74645750ab24"
      unitRef="usd">458713000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIxLTEtMS0xLTE4OTY5_26fb6eb2-294f-4650-a5fa-2fa1323c0ffa"
      unitRef="usd">0</pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement>
    <pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIxLTMtMS0xLTE4OTY5_c9bd8474-7a2e-4971-89fd-95faecff7193"
      unitRef="usd">264000</pbh:DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement>
    <pbh:DeferredTaxLiabilityRightOfUseAsset
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIyLTEtMS0xLTE4OTY5_9f0908b1-c9e7-4dda-80f7-d8f0b6d786c9"
      unitRef="usd">6239000</pbh:DeferredTaxLiabilityRightOfUseAsset>
    <pbh:DeferredTaxLiabilityRightOfUseAsset
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIyLTMtMS0xLTE4OTY5_554d6fb0-b3b4-439d-be7c-a2a6ae9a338f"
      unitRef="usd">7605000</pbh:DeferredTaxLiabilityRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIzLTEtMS0xLTE4OTY5_c97d1b42-d3c6-46cb-bad7-3c6b3f219c60"
      unitRef="usd">484776000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzIzLTMtMS0xLTE4OTY5_b4e4a543-e92f-457e-bbda-1f7cda5e789b"
      unitRef="usd">473827000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzI3LTEtMS0xLTE4OTY5_71cc56f9-63dc-458e-a694-3b01f705e3ce"
      unitRef="usd">443054000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTphNzU2ZjQ1MWU1ZDc0MzlmYWEwNDkzZjkzYzRiMWRkZC90YWJsZXJhbmdlOmE3NTZmNDUxZTVkNzQzOWZhYTA0OTNmOTNjNGIxZGRkXzI3LTMtMS0xLTE4OTY5_94857d65-ef08-4b37-95cf-c7dc9a4ed560"
      unitRef="usd">432860000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iee2c3f181ff64a18befbaf556c259b21_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEyNTU_7a0ff3b8-8a6f-4c4d-bdb8-e461bd95c3ab"
      unitRef="usd">1900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if1862059d98a4f86a844ec510bb54683_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzMDI_d5dcb223-8f6a-425a-ac46-8fb37b88c6e7"
      unitRef="usd">1200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzNTQ_c2a98ef8-dc2d-42e8-ac27-b498e5c9dd9d"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzEzNTQ_caec7ab2-920c-475d-9e03-fe4877c11dc9"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0NDg_c265b8a6-2497-4599-b571-3e7468399c00">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the effective tax rate compared to the statutory U.S. Federal tax rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMS0xLTEtMTg5Njk_dd2eb0a7-07e4-41a5-bc4c-3f3aec075935"
      unitRef="usd">55116000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMy0xLTEtMTg5Njk_51cbdd87-a5e9-4b3c-88b5-cfe05589acae"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtNS0xLTEtMTg5Njk_df37ea0c-b750-448c-8c32-c9dbc2f0f72b"
      unitRef="usd">42864000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtNy0xLTEtMTg5Njk_177be8b3-f788-4641-ae35-6a92272d59a1"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtOS0xLTEtMTg5Njk_db7259e9-dbf6-4dab-8d79-3059af817ad8"
      unitRef="usd">40142000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzMtMTEtMS0xLTE4OTY5_0e6e147c-d227-4d46-9b1c-eefb5e9bacf1"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMS0xLTEtMTg5Njk_97e99fe1-cae4-40f7-8aba-957da6c6a1ce"
      unitRef="usd">2876000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMy0xLTEtMTg5Njk_e23f4107-ab32-4b28-800c-c31cb37b1103"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtNS0xLTEtMTg5Njk_9d17bd15-5357-49d7-96ff-517d4565b6e0"
      unitRef="usd">3972000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtNy0xLTEtMTg5Njk_2181484c-8660-4c26-9c16-9064df48e9ba"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtOS0xLTEtMTg5Njk_dac26a24-37f3-48d3-95bd-2a948d1c8d94"
      unitRef="usd">2498000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzQtMTEtMS0xLTE4OTY5_8b13f947-c8c7-427a-ab0a-ecc6abb81fd7"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMS0xLTEtMTg5Njk_cd0c8f16-a7ee-4206-b871-064376d9d50f"
      unitRef="usd">1737000</pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMy0xLTEtMTg5Njk_2635dc84-512a-4b73-a13e-b8ca219c32c1"
      unitRef="number">0.007</pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtNS0xLTEtMTg5Njk_28d9296d-667a-44b7-aaa4-4f5e3590b5c3"
      unitRef="usd">7284000</pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtNy0xLTEtMTg5Njk_36aef1a6-7b5c-4e21-967a-0d09755fe253"
      unitRef="number">0.036</pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtOS0xLTEtMTg5Njk_cbc3fc9c-1757-4de7-8c54-2c8357ba9185"
      unitRef="usd">1606000</pbh:IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzUtMTEtMS0xLTE4OTY5_ea333a7e-b849-4677-8d56-b4083e36449e"
      unitRef="number">0.008</pbh:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMS0xLTEtMTg5Njk_5ede7e7b-2180-43f3-afca-d81ebba977fa"
      unitRef="usd">213000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMy0xLTEtMTg5Njk_fbb0c2a6-7ab0-4dbf-a5b7-a070ed3a71e5"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktNS0xLTEtMTg5Njk_9cca5276-a77a-4d24-a529-c5cf6330e1c3"
      unitRef="usd">156000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktNy0xLTEtMTg5Njk_b3e39185-5b79-42c7-8edc-15b5b20de578"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktOS0xLTEtMTg5Njk_d2372657-8581-41b0-a1ba-f83977cc9e18"
      unitRef="usd">320000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzktMTEtMS0xLTE4OTY5_cf7d617b-7059-4c44-ac8d-06296cedc6ff"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTEtMS0xLTE4OTY5_f67b53c6-4303-4b2c-ad56-6031612ee437"
      unitRef="usd">1563000</pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations>
    <pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTMtMS0xLTE4OTY5_0a940c41-bc30-47be-b2b4-68dd0726f959"
      unitRef="number">0.006</pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations>
    <pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTUtMS0xLTE4OTY5_80bea642-4a60-4dbb-a228-ecc2ca435813"
      unitRef="usd">735000</pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations>
    <pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTctMS0xLTE4OTY5_67dbbe93-d720-4c5e-b071-1bd52045b377"
      unitRef="number">0.004</pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations>
    <pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTktMS0xLTE4OTY5_454c63a1-81a8-4443-ad2d-7b020ecb4660"
      unitRef="usd">562000</pbh:IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations>
    <pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzEwLTExLTEtMS0xODk2OQ_b2cd970c-6c87-4895-94d4-33476f9c1a7c"
      unitRef="number">0.003</pbh:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTEtMS0xLTE4OTY5_60c43685-4568-40b5-bafe-c31ef73057f9"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTMtMS0xLTE4OTY5_5509bde1-deb0-48cf-94ec-d8fc2ca3ab76"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTUtMS0xLTE4OTY5_c87c124c-c7a8-4462-aeb8-81a64dad3da1"
      unitRef="usd">-5441000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTctMS0xLTE4OTY5_70233c09-aa58-4685-8549-7b98739b42ac"
      unitRef="number">-0.027</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTktMS0xLTE4OTY5_7afc3ac1-8c6f-4d7c-9598-d3e5980b9f01"
      unitRef="usd">2205000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzExLTExLTEtMS0xODk2OQ_564ddf88-75f7-4baf-871d-4f335bc9102c"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTEtMS0xLTE4OTY5_3d510630-affa-4570-a71b-85e4d84f02f7"
      unitRef="usd">-369000</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTMtMS0xLTE4OTY5_ee1da7f3-bf38-4568-bf74-b74dbf171b59"
      unitRef="number">-0.001</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTUtMS0xLTE4OTY5_a76babd6-b3f1-484b-a7e7-3007d5a460dc"
      unitRef="usd">-7218000</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTctMS0xLTE4OTY5_1bfbf4be-656b-472c-aa85-b92a5f7a42c1"
      unitRef="number">-0.035</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTktMS0xLTE4OTY5_35a1c361-db40-470e-9d96-d0f982275c8b"
      unitRef="usd">0</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPosition>
    <pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE0LTExLTEtMS0xODk2OQ_4f5767d4-9fba-405c-b81d-8e09beac84f0"
      unitRef="number">0</pbh:EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTEtMS0xLTE4OTY5_92b50bb7-910d-4e33-bcd5-03e41f336a8a"
      unitRef="usd">-3633000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTMtMS0xLTE4OTY5_b72da1ea-2733-4f97-a904-3b4571725cdc"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTUtMS0xLTE4OTY5_0f92ce69-4171-4fc5-bfa0-38f73313868e"
      unitRef="usd">-2609000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTctMS0xLTE4OTY5_0b6c021e-1dbd-4e68-aa41-1028e5a164dc"
      unitRef="number">-0.013</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTktMS0xLTE4OTY5_0a446134-6e2e-4558-91bc-f2b93d399560"
      unitRef="usd">2177000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE1LTExLTEtMS0xODk2OQ_d7c9b250-e20e-4a9e-a7b3-35058a34ff4f"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTEtMS0xLTE4OTY5_0003dfbe-f06e-4191-b9d6-8763be1cbc1e"
      unitRef="usd">57077000</pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations>
    <pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTMtMS0xLTE4OTY5_2908a332-6d5c-49dd-ac65-b0b7a066d75f"
      unitRef="number">0.217</pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations>
    <pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTUtMS0xLTE4OTY5_89fcc945-58db-49a6-a53b-b6b44d7d6a44"
      unitRef="usd">39431000</pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations>
    <pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTctMS0xLTE4OTY5_1b65c421-5221-4ce1-b2e1-8c1f3c2991fa"
      unitRef="number">0.193</pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations>
    <pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTktMS0xLTE4OTY5_f4b89d3a-c0e1-463e-b04c-6c3a3d7e3558"
      unitRef="usd">48870000</pbh:IncomeTaxExpenseBenefitIncludingDiscontinuedOperations>
    <pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTpkM2I5OGI0NDViYjk0MDk3ODY1ZWYzNDk4MDZmNGM4ZS90YWJsZXJhbmdlOmQzYjk4YjQ0NWJiOTQwOTc4NjVlZjM0OTgwNmY0YzhlXzE2LTExLTEtMS0xODk2OQ_b89377ab-bdd9-4c55-b02d-867adc7f951f"
      unitRef="number">0.256</pbh:EffectiveIncomeTaxRateIncludingDiscontinuedOperations>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzI0Njg_a01a1653-97cb-4f30-a891-8b9c95bf2c67">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Uncertain tax liability activity is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and other movements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItMS0xLTEtMTg5Njk_e5ecee92-5913-4021-a8f5-c885fbbbdf10"
      unitRef="usd">4030000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItMy0xLTEtMTg5Njk_a2c9cbcb-5036-4fe1-8a9b-9fb07d978e43"
      unitRef="usd">10369000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ieb0901ffc8ca4fcc820553ea63006d9f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzItNS0xLTEtMTg5Njk_35f76193-fd42-45db-af11-9076f8bf15d4"
      unitRef="usd">9874000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtMS0xLTEtMTg5Njk_5950c3ba-6323-439e-a474-2b89b072b142"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtMy0xLTEtMTg5Njk_41d376ce-0176-4267-b2d8-e6ed6013d8ee"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzMtNS0xLTEtMTg5Njk_fa54286c-9d1e-41ac-9419-9ed140e2d19b"
      unitRef="usd">495000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtMS0xLTEtMTg5Njk_b00f9ae9-65ba-43c8-81fa-56d54132a24b"
      unitRef="usd">585000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtMy0xLTEtMTg5Njk_9dbe33b6-ec05-4004-b672-417a408ca318"
      unitRef="usd">6756000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzQtNS0xLTEtMTg5Njk_d54213ad-99b5-40b0-80a7-5b493061c67c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtMS0xLTEtMTg5Njk_df65d222-4a18-4460-9b74-40e3c8628adf"
      unitRef="usd">117000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtMy0xLTEtMTg5Njk_98aad7f9-4440-46a7-9c96-7d1882a994e9"
      unitRef="usd">417000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzUtNS0xLTEtMTg5Njk_c45a7209-9f7f-41b7-be27-e14c1f3cce2a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtMS0xLTEtMTg5Njk_237c548c-6b57-47ee-adea-7b86ddf4eadb"
      unitRef="usd">3562000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtMy0xLTEtMTg5Njk_aec38681-1581-4232-a468-a040e06f2a16"
      unitRef="usd">4030000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90YWJsZTo2NzQ3OGVlNzUxOGE0ODI2OWEzZjM2NzI0MDY2ZGVkZS90YWJsZXJhbmdlOjY3NDc4ZWU3NTE4YTQ4MjY5YTNmMzY3MjQwNjZkZWRlXzYtNS0xLTEtMTg5Njk_74f4556e-3ffa-4715-a589-bd805cca25f1"
      unitRef="usd">10369000</us-gaap:UnrecognizedTaxBenefits>
    <pbh:EstimatedReductionInUncertainTaxProvisionsNext12Months
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzAvZnJhZzo3MmQzYzUyNThkYzE0YTc1OTAyZmFkOGM3MWQxYzhjYS90ZXh0cmVnaW9uOjcyZDNjNTI1OGRjMTRhNzU5MDJmYWQ4YzcxZDFjOGNhXzIxMTY_8257399c-5748-4424-8694-b86658351a22"
      unitRef="usd">500000</pbh:EstimatedReductionInUncertainTaxProvisionsNext12Months>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mjg_793530de-46af-4ee7-9b1b-5257976e4fcc">Employee Retirement Plans&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a defined contribution plan in which all U.S. full-time employees are eligible to participate.  The participants may contribute from 1% to 70% of their compensation, as defined in the plan.  We match 100% of the first 3%, plus 50% of the next 3%, of each participant's base compensation with full vesting immediately.  We may also make additional contributions to the plan as determined by the Board of Directors.  The total expense for the defined contribution plan was $1.7 million, $1.6 million and $1.5 million for 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain employees of our Lynchburg manufacturing facility are covered by defined benefit pension plans.  The Company&#x2019;s policy is to contribute at least the minimum amount required under ERISA. The Company may elect to make additional contributions.  Benefits are based on years of service and levels of compensation.  On December 16, 2014, the decision was made to freeze the benefits under the Company's U.S. qualified defined benefit pension plan (the "Plan") with an effective date of March 1, 2015.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the fourth quarter of 2021, we adopted a plan termination date of April 30, 2021 for the Plan and began the Plan termination process.  Pension obligations related to the Plan of $47.2&#160;million are expected to be distributed through a combination of lump sum payments to eligible Plan participants who elect such payments and through the purchase of annuity contracts to the remaining participants. The benefit obligation for the Plan as of March 31, 2021 was therefore determined on a plan termination basis for which it is assumed that a portion of eligible active and deferred vested participants will elect lump sum payments.  The Plan likely has sufficient assets to satisfy all transaction obligations and all payments related to the termination are expected to be paid out of Plan assets.  No distributions have been made as of March 31, 2022.   The plan termination is expected to be completed in the first quarter of fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Benefit Obligations and Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the U.S. pension plan obligations and plan assets and includes a statement of the plans' funded status as of March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet at the end of the period consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefit Cost (Income) consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our pension plans with an accumulated benefit obligation and a projected benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pension benefit amounts stated above include one pension plan that is an unfunded plan.  The projected benefit obligation and accumulated benefit obligation for this unfunded plan were $4.3 million as of March&#160;31, 2022 and $4.7 million as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes amounts that are expected to be contributed to the plans by the Company.  It reflects benefit payments that are made from the plans' assets as well as those made directly from the Company's assets.  The amounts in the table are actuarially determined and reflect the Company's best estimate given its current knowledge; actual amounts could be materially different.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employer contributions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (expectation) to participant benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected benefit payments year ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not make any contributions to our qualified defined benefit plan during 2022, and we contributed $3.0 million and $1.0 million to our qualified defined benefit plan during 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the third quarter of 2021, we offered participants of our qualified defined benefit plan the option to receive a lump sum payout of their benefits.  The amount paid out of plan assets during the third quarter of 2021 to those who elected to take the lump sum payout was $7.0 million, and we recognized a settlement gain of $0.2 million as a result of the payout.  The settlement credit was determined based on a remeasurement of the plan as of December 31, 2020, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected.  Those remeasurement assumptions were also used to determine the net periodic pension income for the plan for the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's primary investment objective for its qualified pension plan assets is to provide a source of retirement income for the Plan's participants and beneficiaries.  The asset allocation for the Company's funded retirement plan as of March&#160;31, 2022 and 2021, and the target allocation by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percentage of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Target Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income and cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The plan assets are invested in a portfolio consisting primarily of domestic fixed income held within collective investment trust funds as of March&#160;31, 2022 due to the plan termination process which began during the fourth quarter of fiscal 2021 and the plan's positive funded status. The plan assets were invested in a portfolio consisting primarily of domestic fixed income as of March&#160;31, 2022.   These assets are measured at NAV as a practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the unrecognized actuarial loss (gain) included in accumulated other comprehensive income (loss) at March&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions used in determining the actuarial present value of the net periodic benefit cost (income) for the fiscal years ended March&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58% to 2.95%   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.37% to 3.55% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% to 3.99%  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets, net of administrative fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*The qualified plan was remeasured at December 31, 2020 for settlement accounting, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected and used to determine the net periodic benefit cost (income) for the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions used in determining the actuarial present value of the benefit obligation as of March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26% to 3.48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58% to 2.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The determination of the expected long-term rate of return was derived from an optimized portfolio using an asset allocation software program.  The risk and return assumptions, along with the correlations between the asset classes, were entered into the program.  Based on these assumptions and historical experience, the portfolio is expected to achieve a long-term rate of return of 2.75%.  The investment managers engaged to manage the portfolio are expected to outperform their expected benchmarks on a relative basis over a full market cycle.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <pbh:DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzE3OA_0a506826-e1bc-4915-9835-4b4626a2f31c"
      unitRef="number">0.01</pbh:DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzE4NA_658960a5-e149-4a69-943e-74af01b6047b"
      unitRef="number">0.70</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI0NA_388c4e88-3bf9-411a-ac6f-d575ff34bb51"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ibcc16415186e4158a663bd54af4e5b2a_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2MA_7ae0e432-c7ff-43aa-ab0a-b4c949c7fa8b"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i20570904260143f09bd86146ffd27dba_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2OQ_f722f811-4508-42c4-b004-a5edc8fc3af9"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i20570904260143f09bd86146ffd27dba_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI4NA_60438279-5a1d-4a77-81f7-3bdb465a5c96"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUxMg_6b821428-18b4-47b8-8f01-02a13179e024"
      unitRef="usd">1700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUxNg_29ee6999-76e9-4a24-8808-eed9e9da5ed6"
      unitRef="usd">1600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUyMw_0e866118-9293-468c-8f4a-d4d05d8eabb8"
      unitRef="usd">1500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ice63f8b82a3a41e5b98abd0d12861032_I20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzEyNTA_0134d069-3000-4648-8fe6-e38457907d16"
      unitRef="usd">47200000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDY_e0cc0029-470d-497d-b9cc-fc2f45f33dbe">The following table summarizes the changes in the U.S. pension plan obligations and plan assets and includes a statement of the plans' funded status as of March&#160;31, 2022 and 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contribution&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information regarding our pension plans with an accumulated benefit obligation and a projected benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzMtMS0xLTEtMTg5Njk_8c52fb6c-a3c5-4b03-8700-0f02af03fe58"
      unitRef="usd">56818000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzMtMy0xLTEtMTg5Njk_c5153b41-4147-4a8a-be67-32ad37fcb408"
      unitRef="usd">61570000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzQtMS0xLTEtMTg5Njk_4dd12d0d-4233-42dd-a2ea-94d9eebe43d1"
      unitRef="usd">1107000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzQtMy0xLTEtMTg5Njk_8ccada31-bbed-48b2-8218-b43f2123ff36"
      unitRef="usd">1972000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzUtMS0xLTEtMTg5Njk_79c12776-6982-4886-9261-5a3017a7a4d8"
      unitRef="usd">2888000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzUtMy0xLTEtMTg5Njk_36069e45-d077-4e56-88e1-0a07b7937127"
      unitRef="usd">-3779000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzYtMS0xLTEtMTg5Njk_49323757-33cc-4d77-bce2-337f700664c6"
      unitRef="usd">3530000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzYtMy0xLTEtMTg5Njk_52a7e59d-5844-4275-be78-b94b39d3d33f"
      unitRef="usd">10503000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzctMS0xLTEtMTg5Njk_226be842-5b22-4638-a315-fdb4e4d2ab3c"
      unitRef="usd">51507000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzctMy0xLTEtMTg5Njk_b042d018-ef4e-4ed3-84b4-45d9cee62efa"
      unitRef="usd">56818000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEwLTEtMS0xLTE4OTY5_e6baff4f-fef7-4423-a7a5-1d43a611609d"
      unitRef="usd">53275000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEwLTMtMS0xLTE4OTY5_31c8f522-b865-45d8-ba10-bbed64fb1d7f"
      unitRef="usd">52760000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzExLTEtMS0xLTE4OTY5_ceebdae2-4c14-4062-ba13-a7e6bc10ebb7"
      unitRef="usd">-1405000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzExLTMtMS0xLTE4OTY5_1b8ad970-38f0-4fa4-8e9b-813da4b8b484"
      unitRef="usd">7650000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEyLTEtMS0xLTE4OTY5_e0bad1d3-973f-4934-bbea-932d6f0a2be2"
      unitRef="usd">368000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEyLTMtMS0xLTE4OTY5_99253f38-a359-410c-8747-e5756f18d7a9"
      unitRef="usd">3368000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEzLTEtMS0xLTE4OTY5_95e0e950-a4c0-4651-8e80-3590402b9aa9"
      unitRef="usd">3530000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzEzLTMtMS0xLTE4OTY5_92ede9c7-547a-4c22-9d13-4fd03629defe"
      unitRef="usd">10503000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE0LTEtMS0xLTE4OTY5_bc1e6274-0146-40b4-a0df-d09ae20cb1f7"
      unitRef="usd">48708000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE0LTMtMS0xLTE4OTY5_bea0f7a4-cad9-4d0f-933c-5392bc644792"
      unitRef="usd">53275000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE2LTEtMS0xLTE4OTY5_b0a68a59-4cdf-48f3-ace9-b61aa7209016"
      unitRef="usd">-2799000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToxNDg4NDY5OGU2YzM0YWQ5OGM4YmIwODk4NjkyMDJmMS90YWJsZXJhbmdlOjE0ODg0Njk4ZTZjMzRhZDk4YzhiYjA4OTg2OTIwMmYxXzE2LTMtMS0xLTE4OTY5_655c2724-7658-423a-b169-3230d64e45ba"
      unitRef="usd">-3543000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mzg_35106df6-b762-4451-97bd-9c88ce30d9fd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in the balance sheet at the end of the period consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzItMS0xLTEtMTg5Njk_ea048754-c2ad-4fee-ae03-2328a06d5923"
      unitRef="usd">1534000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzItMy0xLTEtMTg5Njk_20716533-0f10-4261-9416-7e3c3bee299f"
      unitRef="usd">1141000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzQtMS0xLTEtMTg5Njk_c8df6e7d-8c46-4f1d-9833-f7036a871b98"
      unitRef="usd">365000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzQtMy0xLTEtMTg5Njk_c2e9e291-cfc3-4b70-91ec-871b0201fa39"
      unitRef="usd">357000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzUtMS0xLTEtMTg5Njk_b70a0ff4-9856-44f9-8d99-442de61686eb"
      unitRef="usd">3968000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzUtMy0xLTEtMTg5Njk_d55dd255-a249-4652-98be-61ae4a1b9426"
      unitRef="usd">4327000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzYtMS0xLTEtMTg5Njk_245f4350-4fd3-41dc-9b37-b56921ad82ce"
      unitRef="usd">4333000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzYtMy0xLTEtMTg5Njk_9f5f89a2-fb9a-4a39-a0fa-4d637007e92d"
      unitRef="usd">4684000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzgtMS0xLTEtMTg5Njk_45926dab-e670-4f2a-a29b-3da1e5d2d53d"
      unitRef="usd">-2799000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo0YzRhYmJhOGNjY2Y0NTA1OWUzMTBhNjA1NmE5YWZkMy90YWJsZXJhbmdlOjRjNGFiYmE4Y2NjZjQ1MDU5ZTMxMGE2MDU2YTlhZmQzXzgtMy0xLTEtMTg5Njk_d6ba9777-5d58-4847-8839-226e8c51fe7c"
      unitRef="usd">-3543000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4MzU_2803e467-c48a-4b84-8c24-1c479bbeb28e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary components of Net Periodic Benefit Cost (Income) consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,886)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(559)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItMS0xLTEtMTg5Njk_5134dd50-ebf8-4207-b826-7bdda356268e"
      unitRef="usd">1107000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItMy0xLTEtMTg5Njk_a502ece6-88f5-40c1-beae-2650d60b1805"
      unitRef="usd">1972000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzItNS0xLTEtMTg5Njk_a5463015-e120-4a47-be6c-be52d9e5eae6"
      unitRef="usd">2327000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtMS0xLTEtMTg5Njk_93c62438-72d2-495f-85e9-539ed6cb0a91"
      unitRef="usd">1163000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtMy0xLTEtMTg5Njk_2fcbc9f1-b103-4b76-88a9-cbd168224fbc"
      unitRef="usd">2336000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzMtNS0xLTEtMTg5Njk_f237238e-fdfa-49e9-9aec-7afd277c429c"
      unitRef="usd">2886000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtMS0xLTEtMTg5Njk_1687b3fc-eac2-4b01-8cf6-360e7f154886"
      unitRef="usd">-56000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtMy0xLTEtMTg5Njk_ae739d64-878a-40d0-b663-358dc704af08"
      unitRef="usd">-364000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozOWE1YmQ1ZmY1ZDk0NWQzYWM0ZjIyZDhiZGVkZTc3ZS90YWJsZXJhbmdlOjM5YTViZDVmZjVkOTQ1ZDNhYzRmMjJkOGJkZWRlNzdlXzQtNS0xLTEtMTg5Njk_2fdd4d1c-5ca2-439b-8654-5cfa5721b3ff"
      unitRef="usd">-559000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzItMS0xLTEtMTg5Njk_5998874c-ba38-4f98-a4cc-826017a5125f"
      unitRef="usd">51507000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzItMy0xLTEtMTg5Njk_194e731d-e9f7-4852-88ce-a6c6215f6c6f"
      unitRef="usd">56818000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzMtMS0xLTEtMTg5Njk_a6a79152-19b2-40d6-8aee-92c1f578fa89"
      unitRef="usd">48708000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzMtMy0xLTEtMTg5Njk_824cba37-5f26-450d-a13b-6f5feaff6e7c"
      unitRef="usd">53275000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzUtMS0xLTEtMTg5Njk_e34265ac-9a5d-4023-bbbb-36049b9b62cf"
      unitRef="usd">51507000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzUtMy0xLTEtMTg5Njk_4e97ce6d-c1fa-4872-9db5-6307fcb3c12c"
      unitRef="usd">56818000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="ib3582466457e4fa4b369b2316cdd0686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzYtMS0xLTEtMTg5Njk_161c274d-15f4-4c92-9213-e6091412f4b5"
      unitRef="usd">48708000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="i5a2be6cacbd94e4899a431ed6e87b6a6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3NzllYTdlZWEzYmQ0MTFjYmMxZjhlY2RiNjBmM2VkYi90YWJsZXJhbmdlOjc3OWVhN2VlYTNiZDQxMWNiYzFmOGVjZGI2MGYzZWRiXzYtMy0xLTEtMTg5Njk_d2264b9d-ea7e-4c64-9073-a810cb415d6f"
      unitRef="usd">53275000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i9a3457f45285462fb87d13aa61a3f683_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI1ODQ_f41f1c6b-c4cc-4348-b66c-6604a2bea4ad"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i18eeee208fa54c9c94b0e5c5a0efc290_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzI2MDA_937cd53d-dfcc-4879-90d0-7203e7be7efc"
      unitRef="usd">4700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDg_540117dd-90fa-4671-8bfa-3606fd356306">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes amounts that are expected to be contributed to the plans by the Company.  It reflects benefit payments that are made from the plans' assets as well as those made directly from the Company's assets.  The amounts in the table are actuarially determined and reflect the Company's best estimate given its current knowledge; actual amounts could be materially different.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employer contributions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (expectation) to participant benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected benefit payments year ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzItMS0xLTEtMTg5Njk_df65b72f-b345-4279-b424-cb7852a5548b"
      unitRef="usd">365000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzUtMS0xLTEtMTg5Njk_7f98c7dd-3665-44ae-a7a3-5862e9fa9a19"
      unitRef="usd">3452000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzYtMS0xLTEtMTg5Njk_a39d77f5-ee4c-4d7b-8785-a052dd2ae3b2"
      unitRef="usd">3519000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzctMS0xLTEtMTg5Njk_f6c3f391-7866-4fe3-8bd6-60f744dcb830"
      unitRef="usd">3481000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzgtMS0xLTEtMTg5Njk_4c47a976-fde3-447e-a755-bc0e6965390e"
      unitRef="usd">3415000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzktMS0xLTEtMTg5Njk_b46be8a4-f4cd-43a1-9d54-88c74cd9136f"
      unitRef="usd">3385000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpiYWU5NmFjMzg0YWE0ODM3YjEwZmQ2NjFiY2U1YzZkOC90YWJsZXJhbmdlOmJhZTk2YWMzODRhYTQ4MzdiMTBmZDY2MWJjZTVjNmQ4XzEwLTEtMS0xLTE4OTY5_4cf43960-41f0-436e-97bf-4b08b6b3b463"
      unitRef="usd">16205000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzExNTQ0ODcyMDk5Mzc5_bdf9b2ad-bfa6-47b1-8840-f4ca91b13c8c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMwMzM_56a8e90c-44e0-4e05-84c8-d8fb89423034"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMwNDA_f4c4d3db-0263-4f0f-bf84-cd648fa2de90"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzMzOTc_f4d26b5b-2035-42a7-ad54-528c631df90a"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM0NDA_0662fbfb-2b58-4bcf-9d0e-145991578b09"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <pbh:DefinedBenefitPlanRemeasurementDiscountRate
      contextRef="iba787bef5fbd42209b679fe0c7f29990_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM2MDQ_4df380cd-e84c-4c2a-9893-18ba50f8add5"
      unitRef="number">0.0251</pbh:DefinedBenefitPlanRemeasurementDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="iba787bef5fbd42209b679fe0c7f29990_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzM2NDQ_9c6d6648-d43d-4577-aafc-edc1430d7ee3"
      unitRef="number">0.0275</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4Mjk_8d704e9a-c557-4a25-8d5a-7443144d81d9">The asset allocation for the Company's funded retirement plan as of March&#160;31, 2022 and 2021, and the target allocation by asset category are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Percentage of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Target Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income and cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i59ae6b30db4c49f8a69b46325778804b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtMS0xLTEtMTg5Njk_99c28942-e48f-4e39-b1f6-078f3f4e04ae"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i59ae6b30db4c49f8a69b46325778804b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtMy0xLTEtMTg5Njk_f59b9ff9-d198-4f9e-9f5b-833bb337aa5d"
      unitRef="number">0</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i58d96a8c72d94839a80320f2374f58ff_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzUtNS0xLTEtMTg5Njk_ee1f9b90-7846-408b-87fd-785aeaee35e8"
      unitRef="number">0.06</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="id4a29f55b009477797275b056efd188d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtMS0xLTEtMTg5Njk_3bc3dbd4-e706-433c-8afc-0f809e6fbe91"
      unitRef="number">1</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="id4a29f55b009477797275b056efd188d_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtMy0xLTEtMTg5Njk_90779b3d-0336-415c-a8b6-b22c260cb085"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1b34dcaf34dd43b98d9f6b725d940736_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzYtNS0xLTEtMTg5Njk_f6d141a2-348f-42f6-929b-bd8a61259d89"
      unitRef="number">0.94</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctMS0xLTEtMTg5Njk_f23d004c-b21e-435b-9573-e0c1b69921f7"
      unitRef="number">1</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctMy0xLTEtMTg5Njk_357ab646-cd7f-4987-b713-57964898748b"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTozYjQ1NDgwYzA2OGQ0ZTg3OTZlOWRhYjY1NWM1ZDExMy90YWJsZXJhbmdlOjNiNDU0ODBjMDY4ZDRlODc5NmU5ZGFiNjU1YzVkMTEzXzctNS0xLTEtMTg5Njk_6f5f42c5-0c3c-4ef9-b629-7dcf1d137995"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NTM_e50d4a60-d379-4ad7-ba7e-7c7cc446409a">The following tables show the unrecognized actuarial loss (gain) included in accumulated other comprehensive income (loss) at March&#160;31, 2022, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances in accumulated other comprehensive loss as of March 31, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzItMS0xLTEtMTg5Njk_af44762a-f761-4214-8329-5d0f447a4885"
      unitRef="usd">-73000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i30644c0d223c4d21aedacfe884a3e842_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzMtMS0xLTEtMTg5Njk_6a088417-1874-4feb-a6f8-a91b9d76a58c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzYtMS0xLTEtMTg5Njk_6436124e-d736-4e5c-832c-13bee3503365"
      unitRef="usd">1202000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzctMS0xLTEtMTg5Njk_f6d09915-24df-498d-a7ac-c089e05241c0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzEwLTEtMS0xLTE4OTY5_df45e67e-61ba-428a-8bc1-4dd9d0435e64"
      unitRef="usd">1522000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTpmN2QzMjNjMTAyNTI0MGEwOWFkMjUzYWNiNTE0MGNjYS90YWJsZXJhbmdlOmY3ZDMyM2MxMDI1MjQwYTA5YWQyNTNhY2I1MTQwY2NhXzExLTEtMS0xLTE4OTY5_c0796786-6673-4dcc-9d58-e406bf84354c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU4NDQ_767d11ca-0c65-46e6-8775-2d348e69323c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions used in determining the actuarial present value of the net periodic benefit cost (income) for the fiscal years ended March&#160;31, 2022, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58% to 2.95%   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.37% to 3.55% &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% to 3.99%  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets, net of administrative fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*The qualified plan was remeasured at December 31, 2020 for settlement accounting, at which point a discount rate of 2.51% and an expected return assumption of 2.75% were selected and used to determine the net periodic benefit cost (income) for the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions used in determining the actuarial present value of the benefit obligation as of March&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.322%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.323%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Key assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.26% to 3.48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.58% to 2.95%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i724425dab8ca4eadac2088fa582751bc_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiZjg0MThhYTRhNWE0Y2FiYWYxYmRjM2Y0NjU3MDc5YV80_e7d15352-d413-4830-a812-3b419d7ea014"
      unitRef="number">0.0258</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i284d3a442bf04e5cb360a7e96ba61668_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpiZjg0MThhYTRhNWE0Y2FiYWYxYmRjM2Y0NjU3MDc5YV8xMA_57053964-47c8-48b8-bb49-eb2ab5b827ed"
      unitRef="number">0.0295</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="icd1018ca3a7741649a9198acafea0150_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplMTMxNzVjYWU4ZDY0YjA5YjdjMjhkYmU4Nzc1MGU5M180_f8a3a899-1b65-45c9-96e6-9d5bcc440366"
      unitRef="number">0.0337</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie702dabc815748c5bc0488c985ebed02_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjplMTMxNzVjYWU4ZDY0YjA5YjdjMjhkYmU4Nzc1MGU5M18xMA_30b904bc-613d-4b76-ad5b-75dfeabbb3fe"
      unitRef="number">0.0355</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i83c0747f5c71456088f94f029b3f9866_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo0ODZhZjMyOTUxNDE0MzI4OThkOGY0OTIzNjk0ZGM0Zl80_9721dc83-94f7-4367-b7f1-b5851a787332"
      unitRef="number">0.0380</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i7d62723af3a64d1bb9252b80927be2e6_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzMtNS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjo0ODZhZjMyOTUxNDE0MzI4OThkOGY0OTIzNjk0ZGM0Zl8xMA_5f46ce28-4d8e-4741-98ee-8853e889c43c"
      unitRef="number">0.0399</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i5019c3ce5e2a4f2ba47a05522262defc_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtMS0xLTEtMTg5Njk_59eac4d7-f9ab-4b5d-b434-8ef3f519b58d"
      unitRef="number">0.0225</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i36d2961200bf4fa59552adfb08672fe8_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtMy0xLTEtMTg5Njk_621799f4-a87f-414b-b958-463ad4fc27cd"
      unitRef="number">0.0500</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i4802672b0a424a0d84f93d18bed89cf8_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZTo3MDkxYzI5MzIyYjg0ZTZhOTQyYjMxZTJlM2FmZTg3Yy90YWJsZXJhbmdlOjcwOTFjMjkzMjJiODRlNmE5NDJiMzFlMmUzYWZlODdjXzQtNS0xLTEtMTg5Njk_f42387df-2137-47de-8000-236102ef1b04"
      unitRef="number">0.0575</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUwMDM_868e3d1c-4d8e-4972-ac3c-191a973b6dd5"
      unitRef="number">0.0251</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzUwNDM_9261928f-ea25-4533-b79e-6885c10f4398"
      unitRef="number">0.0275</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjOTFmNWUxM2IzNzg0YjRjODM5OGRlYWRkMmZhZWM4Y180_87c07bd6-537b-48db-bc1c-8c912a78d28d"
      unitRef="number">0.0326</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i7d102a7c72924f5289566ad3115e9efa_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMS0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpjOTFmNWUxM2IzNzg0YjRjODM5OGRlYWRkMmZhZWM4Y18xMA_4cc3302d-3430-495b-b580-e4153c6f4707"
      unitRef="number">0.0348</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie78a158429ca4e789c941c6bb4801167_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkZGU0YTVhNzZkMjE0NDU1YWY0ZGExYzgzODA1N2RkZV80_9640bbda-6693-4504-bc77-7c42c4175888"
      unitRef="number">0.0258</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i9808f2a5dec34206ae929d7fa60f2d90_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90YWJsZToyMzRhMDQwZWI0ZjM0M2MyODEyM2VmMTNlYTI3NTNkYy90YWJsZXJhbmdlOjIzNGEwNDBlYjRmMzQzYzI4MTIzZWYxM2VhMjc1M2RjXzMtMy0xLTEtMTg5NjkvdGV4dHJlZ2lvbjpkZGU0YTVhNzZkMjE0NDU1YWY0ZGExYzgzODA1N2RkZV8xMA_ee26b0aa-b236-4994-8e1b-61909350d9c5"
      unitRef="number">0.0295</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzMvZnJhZzo0YWQ1NDZiZTYzMmY0MzI1YWRhYzAyZDU0NWVmZGY0Zi90ZXh0cmVnaW9uOjRhZDU0NmJlNjMyZjQzMjVhZGFjMDJkNTQ1ZWZkZjRmXzU2Njg_dbd80670-4382-4b23-ae34-3b7e296bb76a"
      unitRef="number">0.0275</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90ZXh0cmVnaW9uOjc2NTJiMWY4OWZjZTQ3MGU4MmQzNzE0OWQ0ZWVjMTM5XzE0OTc_9b53ba65-376f-4d7c-9834-7bbe806d477d">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved from time to time in routine legal matters and other claims incidental to our business.&#160;&#160;We review outstanding claims and proceedings internally and with external counsel as necessary to assess probability and amount of potential loss.&#160;&#160;These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted.&#160;&#160;The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve.&#160;&#160;In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement).&#160;&#160;We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 7 for a description of our operating and finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have supply agreements for the manufacture of some of our products.  The following table shows the minimum amounts that we are committed to pay under these agreements:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90ZXh0cmVnaW9uOjc2NTJiMWY4OWZjZTQ3MGU4MmQzNzE0OWQ0ZWVjMTM5XzE1MDc_3294df0e-5293-424d-bc96-a0c6a54ad23f">The following table shows the minimum amounts that we are committed to pay under these agreements:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzItMS0xLTEtMTg5Njk_ae7668fa-cfda-441b-a5bf-eb40c72d1e10"
      unitRef="usd">6873000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzMtMS0xLTEtMTg5Njk_13949d65-61f4-4875-8ad9-1b6e975c6abb"
      unitRef="usd">5277000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzQtMS0xLTEtMTg5Njk_c25be263-fd31-450c-87dc-45e8801272c9"
      unitRef="usd">5293000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzUtMS0xLTEtMTg5Njk_e9252a9d-3a6c-431c-a3ef-bc7d0b2d6680"
      unitRef="usd">4941000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzYtMS0xLTEtMTg5Njk_baf8834a-d025-4211-ad71-77a07e6e1cee"
      unitRef="usd">4858000</us-gaap:PurchaseObligationDueInFifthYear>
    <us-gaap:PurchaseObligationDueAfterFifthYear
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzctMS0xLTEtMTg5Njk_628d2105-99b7-4ee0-8016-13e797945da4"
      unitRef="usd">5367000</us-gaap:PurchaseObligationDueAfterFifthYear>
    <us-gaap:PurchaseObligation
      contextRef="if67fb66e7897486a9f80811afd7f6951_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzYvZnJhZzo3NjUyYjFmODlmY2U0NzBlODJkMzcxNDlkNGVlYzEzOS90YWJsZTo5MzhkYTJmNTA1NTU0ZDZlOTA5MTM2ZmUyMjQ3NTcxOC90YWJsZXJhbmdlOjkzOGRhMmY1MDU1NTRkNmU5MDkxMzZmZTIyNDc1NzE4XzgtMS0xLTEtMTg5Njk_e3ad1e4e-12bf-4872-b335-b9a866ed6e4a"
      unitRef="usd">32609000</us-gaap:PurchaseObligation>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzMwNDE_d07a93f2-ebdf-4195-a43c-8aba5b576dff">Concentrations of Risk&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are concentrated in the areas of OTC Healthcare.&#160;&#160;We sell our products to mass merchandisers, drug, food, dollar, convenience and club stores and e-commerce channels.&#160;&#160;During 2022, 2021, and 2020, approximately 41.3%, 45.6%, and 42.6%, respectively, of our gross revenues were derived from our five top selling brands.&#160;&#160;One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented.  During 2022, 2021, and 2020, Walmart accounted for approximately 20.5%, 21.6%, and 23.1%, respectively, of our gross revenues.&#160;At March&#160;31, 2022, approximately 22.1% of our accounts receivable were owed by Walmart.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our product distribution in the United States is managed by a third-party through one primary distribution center in Clayton, Indiana.  In addition, we operate one manufacturing facility for certain of our products located in Lynchburg, Virginia, which manufacturers many of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Summer's Eve&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Fleet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; products.  A natural disaster, such as tornado, earthquake, flood, or fire, could damage our inventory and/or materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost.  In addition, a serious disruption caused by performance or contractual issues with our third-party distribution manager or labor shortages or contagious disease outbreaks or other public health emergencies at our distribution center or manufacturing facility could materially impact our product distribution. Any disruption could result in increased costs, expense and/or shipping times, and could cause us to incur customer fees and penalties.  We could also incur significantly higher costs and experience longer lead times if we need to replace our distribution center, the third-party distribution manager or the manufacturing facility.&#160; As a result, any serious disruption could have a material adverse effect on our business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2022, we had relationships with 128 third-party manufacturers.&#160;&#160;Of those, we had long-term contracts with 23 manufacturers that produced items that accounted for approximately 69.0% of our gross sales for 2022, compared to 19 manufacturers with long-term contracts that accounted for approximately 70.5% of gross sales in 2021.&#160;&#160;The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results from operations.  Although we are continually in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach a timely agreement, which could have a material adverse effect on our business and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iaddcf560297f4cbdb307e23b2a762c97_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI1Mg_41c6522a-dd06-4657-9604-7bfcae4b68b6"
      unitRef="number">0.413</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if6cfa4a5d82842f885da2acd0bc2b4de_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI1Ng_915f7355-a8fd-4ab8-a0ab-de60073ff935"
      unitRef="number">0.456</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0b54127ec5714e2686bd5832ba581101_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI2NA_bdddecb8-f99c-4dbd-b280-f8d48b278187"
      unitRef="number">0.426</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i52bda21851d0429eac0d1110fc51c45f_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUxNg_f45e591f-5552-43ce-b00a-87ad57563b0b"
      unitRef="number">0.205</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifc29d572ef4048c48685cf3987d915f6_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUyMA_017fda34-7ce8-412f-9f43-e4477c25cccf"
      unitRef="number">0.216</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8a3c181fa51445a5a25f5120f9046d9b_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzUyOA_bc7c85b9-4502-446b-8c0b-2c834ec04c60"
      unitRef="number">0.231</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18191d87fd6b4de7a17225dc12eee7f6_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzU5MA_0e4fffa6-0884-48b6-bb1c-3fd84cb01647"
      unitRef="number">0.221</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturers
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIyMTA_227733ec-e703-45ee-a0dc-fabf1fcadae3"
      unitRef="manufacturer">128</pbh:NumberOfThirdPartyManufacturers>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="i2a2dd8e6335e47d6909ca71624a16c91_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIyODM_7097976c-ea43-4fa0-bbb1-00f25f52f5e8"
      unitRef="manufacturer">23</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id3de54342685484fa1e90d25044d65b3_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIzNTM_4c166740-845e-4187-8a89-8514575f71dd"
      unitRef="number">0.690</us-gaap:ConcentrationRiskPercentage1>
    <pbh:NumberOfThirdPartyManufacturersWithLongTermContracts
      contextRef="iec86293b1daa4d37b8ee94fb83cd3fb2_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzIzOTU_d907e2f9-3f1b-4da2-92b3-06283c21aa54"
      unitRef="manufacturer">19</pbh:NumberOfThirdPartyManufacturersWithLongTermContracts>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i84a5f4ee39164abea82cf5e9e5d39277_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xMzkvZnJhZzo1OTBhZjM5NGE1MWM0ZDkyOGEwOGNjNTI1ZmQxNGM2Ny90ZXh0cmVnaW9uOjU5MGFmMzk0YTUxYzRkOTI4YTA4Y2M1MjVmZDE0YzY3XzI0NzA_915b54a8-d6fd-4d04-8a7f-944b4fce988f"
      unitRef="number">0.705</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NTE_3832d9e0-fbd7-4cae-985d-f0a19d86016a">Business Segments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280.  Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare.  We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our operating and reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues* &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Intersegment revenues of $3.5 million were eliminated from the North America OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total segment revenues by geographic area are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our goodwill and intangible assets by geographic area are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NTQ_4c637cbd-cc03-4472-983e-3dc5e11e1860">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our operating and reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;* Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues* &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advertising and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*Intersegment revenues of $3.5 million were eliminated from the North America OTC Healthcare segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItMS0xLTEtMTg5Njk_e5733b98-d7ec-4b2c-a368-0090dc3fac67"
      unitRef="usd">967881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItMy0xLTEtMTg5Njk_ce0cbbfd-33d2-4bbb-867e-fc2c9b9fcd0a"
      unitRef="usd">118931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzItNy0xLTEtMTg5Njk_8a7895a0-26b5-40d8-8fb8-1f94b059585b"
      unitRef="usd">1086812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtMS0xLTEtMTg5Njk_9c0c58d8-9c44-46c3-a2c2-38f6bea2e268"
      unitRef="usd">419162000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtMy0xLTEtMTg5Njk_0fad0cf0-9326-4b11-875a-643acfa0828d"
      unitRef="usd">47004000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzMtNy0xLTEtMTg5Njk_5572f5d9-1678-498b-9bea-7d566df8ecc2"
      unitRef="usd">466166000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtMS0xLTEtMTg5Njk_40b1b092-f919-4062-9807-858402b1adad"
      unitRef="usd">548719000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtMy0xLTEtMTg5Njk_9991ee16-9ad0-4caf-be37-dd3edec36abe"
      unitRef="usd">71927000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzQtNy0xLTEtMTg5Njk_c0a7bdfa-81e1-4094-9e7b-8a81ef54db45"
      unitRef="usd">620646000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtMS0xLTEtMTg5Njk_00ab049b-98c4-45a6-bbff-34a442a71505"
      unitRef="usd">138714000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtMy0xLTEtMTg5Njk_f49f3774-d55d-4f89-a65a-821bad76326e"
      unitRef="usd">18629000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzUtNy0xLTEtMTg5Njk_d88d5dd9-ac74-4793-8e4e-01e28469a3c8"
      unitRef="usd">157343000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtMS0xLTEtMTg5Njk_aa734e24-4618-4b54-a1be-902602748b0d"
      unitRef="usd">410005000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtMy0xLTEtMTg5Njk_630247cf-12ab-44d8-a5f9-1aac835aa982"
      unitRef="usd">53298000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzYtNy0xLTEtMTg5Njk_25727024-8d31-4949-a161-ccc5709091cf"
      unitRef="usd">463303000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzctNy0xLTEtMTg5Njk_7fb5ef75-9a67-4b85-9d7b-c915547128e6"
      unitRef="usd">133384000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmN2Q4MjA0MWI2MWQ0MmFiOTI5ZGQ5MmQxYzVhMzdlYi90YWJsZXJhbmdlOmY3ZDgyMDQxYjYxZDQyYWI5MjlkZDkyZDFjNWEzN2ViXzgtNy0xLTEtMTg5Njk_5f85485e-93b9-477c-9ae1-98d18d8364bf"
      unitRef="usd">329919000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f656cd6192a49a8b0474d9588199e42_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzY2Nw_a756c597-3faa-4164-b973-6db20cc8400f"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItMS0xLTEtMTg5Njk_3f5f2214-67e9-4898-af2a-fed1cf754640"
      unitRef="usd">849319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItMy0xLTEtMTg5Njk_7b487983-c616-4a62-a37c-1c7081e42540"
      unitRef="usd">94046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzItNy0xLTEtMTg5Njk_60b5c902-6688-423b-80d8-4d7769de9079"
      unitRef="usd">943365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtMS0xLTEtMTg5Njk_434a835c-f416-48e5-8bc0-8d84a7563007"
      unitRef="usd">359100000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtMy0xLTEtMTg5Njk_d0502ce6-fdef-4809-af42-db0aee1c114f"
      unitRef="usd">36793000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzMtNy0xLTEtMTg5Njk_0c3a5b47-8856-4bb8-a0aa-d45a62928da8"
      unitRef="usd">395893000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtMS0xLTEtMTg5Njk_bcad7248-ef96-4739-b831-c7fb317a6b6e"
      unitRef="usd">490219000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtMy0xLTEtMTg5Njk_cc641286-123a-420b-ad42-2286d0e4e86a"
      unitRef="usd">57253000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzQtNy0xLTEtMTg5Njk_53ba91ac-1c28-454f-9110-469b7fbddf7b"
      unitRef="usd">547472000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtMS0xLTEtMTg5Njk_e8505211-976a-46b0-a15e-dab1f9658a17"
      unitRef="usd">122857000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtMy0xLTEtMTg5Njk_ed556d10-b675-4315-b8be-95965bf3c3da"
      unitRef="usd">17732000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzUtNy0xLTEtMTg5Njk_1b2c7a83-10a6-4f37-8bf0-ef1467fbf681"
      unitRef="usd">140589000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtMS0xLTEtMTg5Njk_08b2c958-c4f1-4c79-917e-f47c8b719ff6"
      unitRef="usd">367362000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtMy0xLTEtMTg5Njk_4c60f6ce-342d-4623-9480-67b06d8d7f4d"
      unitRef="usd">39521000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzYtNy0xLTEtMTg5Njk_bc60a547-8753-42d9-8edd-40e083cd3969"
      unitRef="usd">406883000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzctNy0xLTEtMTg5Njk_77f69d5f-2084-4615-8ca0-4703cc1a8ac7"
      unitRef="usd">109481000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2ZDY4M2VkOTAxZGQ0ODdkYjhlNThhMDE3ZTVlZDQxZi90YWJsZXJhbmdlOjZkNjgzZWQ5MDFkZDQ4N2RiOGU1OGEwMTdlNWVkNDFmXzgtNy0xLTEtMTg5Njk_8b4714f2-0fec-473b-9cac-1ef37c6e4196"
      unitRef="usd">297402000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ff2c33ba3b24ce3835abeb593b95b50_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0Xzc2NA_a01a6651-12ce-4402-b3f1-be047b0325c0"
      unitRef="usd">3200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItMS0xLTEtMTg5Njk_83ae2dd4-903f-4a8b-b22a-d70283bd32a9"
      unitRef="usd">859368000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItMy0xLTEtMTg5Njk_adc72d9d-8a2a-4181-a733-889c6749bc0f"
      unitRef="usd">103642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzItNy0xLTEtMTg5Njk_519b841f-fbe8-4ac2-b2e6-584b8be0f3b4"
      unitRef="usd">963010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtMS0xLTEtMTg5Njk_9b9cc18e-77b7-45f6-ab08-8f0119cc638f"
      unitRef="usd">372133000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtMy0xLTEtMTg5Njk_4194d1c0-cdc5-4e41-b19c-956dc658667c"
      unitRef="usd">38654000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzMtNy0xLTEtMTg5Njk_58f8f08f-2056-4598-82be-b3a470dc5847"
      unitRef="usd">410787000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtMS0xLTEtMTg5Njk_cde641e2-2b27-4a73-b881-3969e9ba97c7"
      unitRef="usd">487235000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtMy0xLTEtMTg5Njk_64ca6c75-2cc7-4df8-8710-5644904559c1"
      unitRef="usd">64988000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzQtNy0xLTEtMTg5Njk_43e52cde-f1a5-4dd4-83cd-a963f60974e6"
      unitRef="usd">552223000</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtMS0xLTEtMTg5Njk_3c434e89-c402-4a2d-86e8-b270b766088f"
      unitRef="usd">127972000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtMy0xLTEtMTg5Njk_e5a4b22c-35b6-438d-bf0d-36fcd5fb25bf"
      unitRef="usd">19222000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzUtNy0xLTEtMTg5Njk_81a38bc0-58c3-40eb-ae12-a144e36c81a9"
      unitRef="usd">147194000</us-gaap:MarketingAndAdvertisingExpense>
    <pbh:ContributionMargin
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtMS0xLTEtMTg5Njk_4374208d-8574-4b79-bbd8-98869d4f5e73"
      unitRef="usd">359263000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtMy0xLTEtMTg5Njk_bfa1d8a6-d2ab-4eba-8f60-c8e26549a24d"
      unitRef="usd">45766000</pbh:ContributionMargin>
    <pbh:ContributionMargin
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzYtNy0xLTEtMTg5Njk_23ea2be9-cd4d-47cc-acbf-ac58a7e32599"
      unitRef="usd">405029000</pbh:ContributionMargin>
    <pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzctNy0xLTEtMTg5Njk_3a54ed4c-f04e-4102-92fd-8b664f0d49c6"
      unitRef="usd">113874000</pbh:GeneralAndAdministrativeAndDepreciationAndAmortizationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo2NjVjY2M5ZDRjMzg0YjcxODkzZGVmMGM1NmE3Nzg0YS90YWJsZXJhbmdlOjY2NWNjYzlkNGMzODRiNzE4OTNkZWYwYzU2YTc3ODRhXzgtNy0xLTEtMTg5Njk_0663c092-d028-454a-9d99-b3c73e129d22"
      unitRef="usd">291155000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f247a503b8943d8a3ad2e615aab0ff6_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0Xzg2MA_7d74253e-5d32-44bc-a459-de27f4b2629a"
      unitRef="usd">3500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NDM_eaa3e0af-0395-4e86-840b-7f193bb6a346">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarize information about our segment revenues from similar product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;967,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Analgesics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cough &amp;amp; Cold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gastrointestinal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eye &amp;amp; Ear Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dermatologicals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5aa716616894b2f84935e0374ea04e7_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItMS0xLTEtMTg5Njk_5907dcbd-afa7-49c6-874b-effe4acccbbf"
      unitRef="usd">117868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic029fed0956549baa7ec88dac897d2c8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItMy0xLTEtMTg5Njk_cca22473-a057-4ab9-a7fb-82873036ea20"
      unitRef="usd">1455000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2c295d6ba7346f3a20449e046450179_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzItNy0xLTEtMTg5Njk_600aa4f0-b577-461f-9056-eab20a398330"
      unitRef="usd">119323000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ef95b48e1034b91aaf6fd8e8409b9ad_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtMS0xLTEtMTg5Njk_3e48ddcc-934b-4ac5-bc92-9edcceea0f6e"
      unitRef="usd">86855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3294e803eb844221be72afcd3f38c4d7_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtMy0xLTEtMTg5Njk_d0c862dd-53cb-43eb-898d-2a1c8db251a9"
      unitRef="usd">20225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd5b824968d64c17a23ce9b8e959483a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzMtNy0xLTEtMTg5Njk_cdecc69f-eef1-4454-9e68-d8db7bdc8aee"
      unitRef="usd">107080000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic37751a73f9944309da3a6209420d28a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtMS0xLTEtMTg5Njk_e72b81c5-ca3e-44c9-a4a4-dfbe16192501"
      unitRef="usd">249136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if488c5f576284dd2b32d7aca3c3ac7da_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtMy0xLTEtMTg5Njk_c98eadc7-7f97-4f80-a3ab-77cbf909f817"
      unitRef="usd">15373000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic99bb552abe54bfd9db35d442b507668_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzQtNy0xLTEtMTg5Njk_8455c2c2-fab2-4f7c-bc15-346d40eaacce"
      unitRef="usd">264509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98203bb0fdee45e0a76bebb95fdaa091_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtMS0xLTEtMTg5Njk_6f409f14-9f2c-48ab-a3a1-e51e5d3b779d"
      unitRef="usd">152191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee5ebd4f9b4f40b4a4a08959e40f8232_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtMy0xLTEtMTg5Njk_f8aa7240-80b7-4a28-ae25-e10213c8f053"
      unitRef="usd">52368000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04beadabffb1494192c4f1432581e3e9_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzUtNy0xLTEtMTg5Njk_6ac677e2-ecb0-4250-80ca-6124f7f2ad13"
      unitRef="usd">204559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f1098b70cf4c3a9d398ae76f4418b2_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtMS0xLTEtMTg5Njk_c237c7b6-c80f-4746-b30d-51a2fcd21e44"
      unitRef="usd">149454000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6611cae507e467aae33483a930263e9_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtMy0xLTEtMTg5Njk_26297bf7-3dac-4b84-97f7-fbf015dae2d6"
      unitRef="usd">13995000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6528481919014cca8fa35e096227a2a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzYtNy0xLTEtMTg5Njk_5c0a5079-cf93-4f75-a7e2-dca02c6175a0"
      unitRef="usd">163449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia993e09fc5da4f1bb3419721565e91c9_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctMS0xLTEtMTg5Njk_123d46eb-582e-4bc9-b299-51bee9cf4ecd"
      unitRef="usd">117173000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07d0d76f1e26446ca6c10a8acbccbda1_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctMy0xLTEtMTg5Njk_2ed17a97-1966-4bc4-8f5b-38e8aa2b923d"
      unitRef="usd">3213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1118888fef148b0b3d06df4c4ca9bf2_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzctNy0xLTEtMTg5Njk_870092ff-2806-458a-81aa-a4bb02349fd2"
      unitRef="usd">120386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia83b05de81bc4440b8a7586ab5058ae8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtMS0xLTEtMTg5Njk_641cf6f4-c18b-48b1-bb0d-89b4158a48e4"
      unitRef="usd">85239000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecb112ef71bd4025a8a7c045b35fda05_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtMy0xLTEtMTg5Njk_62401df2-22f5-47d9-bff2-d32b9ab3a94d"
      unitRef="usd">12282000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c552006b60d4b08b007787d0e7c1b31_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzgtNy0xLTEtMTg5Njk_7a16f54f-6661-4b5a-8f40-262d5f47de73"
      unitRef="usd">97521000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i015c2f7ac3ca4d218c5d12d1f385211e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktMS0xLTEtMTg5Njk_d06d1804-5b26-4189-ab68-dbd0d959a465"
      unitRef="usd">9965000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia86e42570a994afab266a376ed0ac2f9_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktMy0xLTEtMTg5Njk_2022aab3-505c-4a72-aa3f-d3d74eb395b8"
      unitRef="usd">20000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53fbea258f054a63ba94905ba9c1dc40_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzktNy0xLTEtMTg5Njk_e93d3fd2-0f1b-4ddf-9caa-60634c968bba"
      unitRef="usd">9985000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1c922cc109e453c93fff4de932d01eb_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTEtMS0xLTE4OTY5_7427dcc5-6dfe-4350-9bb9-b0e184915bde"
      unitRef="usd">967881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c4428c349684f4eb08c1f65c19763a4_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTMtMS0xLTE4OTY5_a4597ed7-dc5e-462d-beda-1cad75da41df"
      unitRef="usd">118931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo5ZTQxYWFlODlmNWM0MjYxOGI3Yzg0YmQ5MmJiZjJkYS90YWJsZXJhbmdlOjllNDFhYWU4OWY1YzQyNjE4YjdjODRiZDkyYmJmMmRhXzExLTctMS0xLTE4OTY5_50de5050-09ab-4994-a711-4277be7c2d09"
      unitRef="usd">1086812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75173fc3463d4172a4889323f35f8ce7_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItMS0xLTEtMTg5Njk_dead42ff-0d3d-46c0-a778-3b7b40fa705d"
      unitRef="usd">117775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia24d6f74c12547b9b437f46f93f8e81b_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItMy0xLTEtMTg5Njk_37c16802-f3ea-44d9-8e01-7eec72e04ff2"
      unitRef="usd">1367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4612ad4393fa41f2bf9ac148b747c4ba_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzItNy0xLTEtMTg5Njk_bfc5d2ff-9cb0-4c70-b2d5-954e1ccf1b69"
      unitRef="usd">119142000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1279b5a211240cdbc3c48972315db77_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtMS0xLTEtMTg5Njk_f3c90408-11a1-450b-8884-dda7d52997a5"
      unitRef="usd">56158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b826369aad440f284486a46f6980adf_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtMy0xLTEtMTg5Njk_8e2a35f5-5a54-4630-be26-3eaeee87da1d"
      unitRef="usd">14483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i847749d31c8d4decba0abfa61b2399d6_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzMtNy0xLTEtMTg5Njk_bf748600-507a-43b2-867f-ee74ff7ef0e7"
      unitRef="usd">70641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ce1b2b252c24eba903fe426d1e8f9d4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtMS0xLTEtMTg5Njk_58bc4cf2-0dce-4339-9405-77e7e02fbb29"
      unitRef="usd">252535000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i453f0da9e5204e0a9a8f290c4314b16b_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtMy0xLTEtMTg5Njk_006d57a5-1fa5-45f3-9982-d91fad9a3313"
      unitRef="usd">15562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43727784ec8f4d619cf24289b32d65d3_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzQtNy0xLTEtMTg5Njk_cd7b0cea-5275-4fae-8278-2b4b8cbbc7df"
      unitRef="usd">268097000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8157da33ba78498d8401bafd7a8fc602_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtMS0xLTEtMTg5Njk_b94edddd-4fa4-4a34-af21-14ff513500e5"
      unitRef="usd">124755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c5ecc92af704cae9ac690e78c08e5ef_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtMy0xLTEtMTg5Njk_05dcd315-3c75-4f39-b7aa-30d265028776"
      unitRef="usd">36381000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf001558139e4bd8ab9cd40cebbfb430_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzUtNy0xLTEtMTg5Njk_6aacf7a3-a8e3-44a2-bcdd-b3070155c06e"
      unitRef="usd">161136000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i549188b894974e3f9c66c305dff4ec5c_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtMS0xLTEtMTg5Njk_229de739-3c91-4065-8f9a-9932c3ab2cae"
      unitRef="usd">99774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f7f2a80b24c4f3a837fc32b805a4f04_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtMy0xLTEtMTg5Njk_73266a66-f8bd-4095-9e93-905d72566f13"
      unitRef="usd">10635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7cc9eb035334f0083ea1c824a1b091d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzYtNy0xLTEtMTg5Njk_f99bfe73-f2c4-4542-81d7-3fa8542abefd"
      unitRef="usd">110409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5c0cbb726f74abe9ca0f96e0c1f9657_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctMS0xLTEtMTg5Njk_8a21edef-5a96-4839-95be-363249f9555b"
      unitRef="usd">103998000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb44edcc32594a3a91c1dd365c21d677_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctMy0xLTEtMTg5Njk_49f1494e-b7dc-497c-ad34-cb606dd777b5"
      unitRef="usd">3085000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6542cd977dd429bb80eb6e889d6eec0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzctNy0xLTEtMTg5Njk_e4f64433-6912-4b51-a95f-0027092d9ea5"
      unitRef="usd">107083000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i690400e5143b4fab85db90f58029c2af_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtMS0xLTEtMTg5Njk_8918da01-6554-4a21-9993-f7be5ab331b0"
      unitRef="usd">88903000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c52313a45fa4bdc8707f54d8c7b0f79_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtMy0xLTEtMTg5Njk_23b2dd11-3864-499f-98bd-9104d9de05da"
      unitRef="usd">12528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i892942ab686d43ff9f78b51f385c281d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzgtNy0xLTEtMTg5Njk_5cff37bc-9f6e-4293-a9d9-198f8aca50c3"
      unitRef="usd">101431000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib50816ace3fa42db88ab7771863e34c1_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktMS0xLTEtMTg5Njk_a8beb887-b11c-4ab7-a232-e11d628a9ce4"
      unitRef="usd">5421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bfd881300fd43768d4fd18c5b8399ac_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktMy0xLTEtMTg5Njk_5ca88cb9-6413-4b89-9169-19de8079b114"
      unitRef="usd">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idef22b30afc84db9bda8dc263f3e2890_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzktNy0xLTEtMTg5Njk_28f52fe7-6eb4-4efb-b780-99c85194c1f4"
      unitRef="usd">5426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fcab429e0bd489aa7ff36dc355d9d9e_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTEtMS0xLTE4OTY5_cc29c536-7a48-4d65-9578-cb21443639f8"
      unitRef="usd">849319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20b60cad77814787b0aaa73c5cc4276f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTMtMS0xLTE4OTY5_239596e0-b653-4514-8263-17da9ffab3bd"
      unitRef="usd">94046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1MmJkZjM5ZjY2M2I0NzNlOTI4MzEyMjgyZWU1NGYzYy90YWJsZXJhbmdlOjUyYmRmMzlmNjYzYjQ3M2U5MjgzMTIyODJlZTU0ZjNjXzExLTctMS0xLTE4OTY5_b165e691-4f58-4ab5-970a-ff9680f3fd31"
      unitRef="usd">943365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib90b15b3c2e24cb48a2cba51ae97b668_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItMS0xLTEtMTg5Njk_f8fdf512-9fac-4305-abf6-75750ef6e2c5"
      unitRef="usd">113130000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86b7b9808f604b5d8c96d94c8752d25b_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItMy0xLTEtMTg5Njk_a791f34d-93bc-48f1-9fb0-e2b0fe975a7a"
      unitRef="usd">877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4de86537a7564a0e846cbacec3a5d86f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzItNy0xLTEtMTg5Njk_ed18f107-3c13-4d70-983c-40174eb77c31"
      unitRef="usd">114007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f0954b90f854c9c8c6b9d5991778c49_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtMS0xLTEtMTg5Njk_f746c8f6-2896-463a-8619-c0e17476c8c3"
      unitRef="usd">87601000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5b222ffe8f542fb9a020f3fae60ba89_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtMy0xLTEtMTg5Njk_448b0001-e6f2-45a9-98ce-450ec680c5b5"
      unitRef="usd">23505000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife659f1768004fb5be70b186e77e5297_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzMtNy0xLTEtMTg5Njk_f3355f96-316b-41cb-bd46-998e6b54edd9"
      unitRef="usd">111106000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fd63fc992cf4852a161722fc0811307_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtMS0xLTEtMTg5Njk_63f5aae8-fce4-4071-91ff-ad0c51e29af9"
      unitRef="usd">239330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie159feb199e54e298d894fb67e2ecb91_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtMy0xLTEtMTg5Njk_2eb4cd9c-414b-4fde-b17e-c2c0d7c5cee6"
      unitRef="usd">12221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6255fa73dfc94124a1c4ebaee132b040_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzQtNy0xLTEtMTg5Njk_3bb20904-5393-4b7b-80ae-a323369f11ff"
      unitRef="usd">251551000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0e964d1b021431e9f1b1934d39a6d37_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtMS0xLTEtMTg5Njk_27bd4fb3-3faa-474a-8b1e-c628f6470638"
      unitRef="usd">130088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if064a3f9803e44a281b0d06b27be87d4_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtMy0xLTEtMTg5Njk_f7fc67c6-706a-435b-a4b0-f533c87c1a51"
      unitRef="usd">42820000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb2e510d032b4dd9b8d6e4efeba5bae8_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzUtNy0xLTEtMTg5Njk_ce2d3165-72df-495e-9d09-ac31dcead721"
      unitRef="usd">172908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieda1d905a84541a487e2a38b30d11e2b_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtMS0xLTEtMTg5Njk_426c2fcb-d4cd-46fb-8d85-ceb070aeb86c"
      unitRef="usd">100245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcfc25de9722466e932dc1e06bb976b9_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtMy0xLTEtMTg5Njk_50596b0c-53e8-45e2-b8d4-76342c08267d"
      unitRef="usd">11911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99db4439e2494b88b17e934ed9c39536_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzYtNy0xLTEtMTg5Njk_7336387b-a0b9-4b17-a826-b58cd48f304d"
      unitRef="usd">112156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i447cea4350b049899445c056e36a842e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctMS0xLTEtMTg5Njk_07bf926e-3060-4dd9-a114-b1fdb3a9bf4a"
      unitRef="usd">100591000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i216903c2e83a43b3b92dd97b7bee014c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctMy0xLTEtMTg5Njk_3163f35b-a4e7-4626-8ea5-43cd799ca1d4"
      unitRef="usd">2421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0b3152923a2411e85c99e2bcf72e13b_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzctNy0xLTEtMTg5Njk_89881e3f-456a-4ce2-88f8-fdb0b684da35"
      unitRef="usd">103012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide3a43743f4d400dabfa688570f0f5d3_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtMS0xLTEtMTg5Njk_301cc695-bd3f-4b13-b2c7-fe841cdf1be2"
      unitRef="usd">83323000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38d3aa13aac246e9b25041fae4b7cc75_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtMy0xLTEtMTg5Njk_21424e38-fec6-4c3f-9aa5-864d3a9d46c3"
      unitRef="usd">9882000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10259ed0744a4da29b08fbd71f4fa0eb_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzgtNy0xLTEtMTg5Njk_f95e6723-079b-46dd-a871-c1db5520dbc2"
      unitRef="usd">93205000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfb6a46d6609484692d15c0a359f03f9_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktMS0xLTEtMTg5Njk_9eb62b01-c8d9-42ff-91e0-b447b0299887"
      unitRef="usd">5060000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f96d631e0f6493aa473b4f5d6764c83_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktMy0xLTEtMTg5Njk_7cc66173-9e18-4337-8bdb-348e76d1d366"
      unitRef="usd">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8b5567d70b54cbd823e42bd98407d52_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzktNy0xLTEtMTg5Njk_ed215d3c-3678-4922-8c4e-040593ad8ba6"
      unitRef="usd">5065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805e095e068a4cee9a97a49955d93124_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTEtMS0xLTE4OTY5_ce9de91a-75a9-4833-b194-3bd3666ea4ab"
      unitRef="usd">859368000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c12b872cf19478a96f9342489a2b1bc_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTMtMS0xLTE4OTY5_410df905-edbf-4ece-b619-54a4f541fe59"
      unitRef="usd">103642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo1NzE2YmZhOWU2YWY0MjU3OWNmNWI3NGIwZDZkZjViZi90YWJsZXJhbmdlOjU3MTZiZmE5ZTZhZjQyNTc5Y2Y1Yjc0YjBkNmRmNWJmXzExLTctMS0xLTE4OTY5_fdb51bc2-67c0-45da-a3d1-608307998db2"
      unitRef="usd">963010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjA_c36acbeb-1b3e-4a53-b903-5fceef1aa37a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total segment revenues by geographic area are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;910,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;943,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05beda4dd5af4462b06464252419026d_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItMS0xLTEtMTg5Njk_025adfc3-ce50-4247-b36e-b90c22b70312"
      unitRef="usd">910106000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21751c4b85644cc9bc4db3085d5e2e0f_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItMy0xLTEtMTg5Njk_c0385f9f-308e-4d8e-a6dd-c8518be67cfc"
      unitRef="usd">799038000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i187399c858c245c4be01180f7d21b89f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzItNS0xLTEtMTg5Njk_f005315e-c2d0-4624-a526-85e2420187a0"
      unitRef="usd">812653000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i128d4737fe924482950bf5e29e3e58d8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtMS0xLTEtMTg5Njk_03853781-2293-435c-8745-ad2a6e8e7fe9"
      unitRef="usd">176706000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i188dc6462826477a91b4a176c33f06fd_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtMy0xLTEtMTg5Njk_6efa45ef-94d7-48e9-a443-96e4b0822277"
      unitRef="usd">144327000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c5b66ea38624883a01debe481d7aabb_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzMtNS0xLTEtMTg5Njk_0925f9d6-fbb9-4334-904d-c7032b184d2b"
      unitRef="usd">150357000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtMS0xLTEtMTg5Njk_587a1c14-e155-4d32-b69c-eb3515653aa8"
      unitRef="usd">1086812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4f751d72ab94e068db1ebc888321fe4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtMy0xLTEtMTg5Njk_34862693-494c-4d0a-8111-85fea573cc3b"
      unitRef="usd">943365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad3f90183b174774a6c0d82d5f3a27c2_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpkYjIzYjMxZmExN2Y0YTdhODRhMGZhYTFmMTU4YjZmYy90YWJsZXJhbmdlOmRiMjNiMzFmYTE3ZjRhN2E4NGEwZmFhMWYxNThiNmZjXzQtNS0xLTEtMTg5Njk_ef1463d8-f199-478a-81b4-752298813028"
      unitRef="usd">963010000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjE_e461c993-9a60-4f49-b32d-4758c3654f12">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,391,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;North American OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International OTC&lt;br/&gt;Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,195,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,281,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Goodwill
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtMS0xLTEtMTg5Njk_06cb090a-787c-46da-8587-f7784f49b3ed"
      unitRef="usd">548291000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtMy0xLTEtMTg5Njk_aafd57d1-c38e-4d3a-a151-ea5c385ed8cd"
      unitRef="usd">30685000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzEtNy0xLTEtMTg5Njk_84ef5614-59e5-48a9-91fb-2a69cd5f3bbe"
      unitRef="usd">578976000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7bacb62d2b764d98ab587019221feb5e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtMS0xLTEtMTg5Njk_64c00d1c-934b-4351-bd4d-dc722ce5afb5"
      unitRef="usd">2391517000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic9ba4d3341224392858a56fe1feccb8b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtMy0xLTEtMTg5Njk_5c3270eb-8351-4da1-9edb-cff6c4c1e361"
      unitRef="usd">85042000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i13817405df1449ac862beb623f788537_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzQtNy0xLTEtMTg5Njk_3c5dcdf7-c683-4284-a97e-ab4340dd34cd"
      unitRef="usd">2476559000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3b518b4ab33c4fb7b07453e2656c888b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtMS0xLTEtMTg5Njk_94524791-c2d2-4797-85dc-5efb51e61725"
      unitRef="usd">198353000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2f2efae60cb04996a6f9e3e4f3dd7477_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtMy0xLTEtMTg5Njk_f0a41f1d-bc4d-4b3e-84ea-c8c44ef89cf0"
      unitRef="usd">21723000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i14d89fbbf2134c92a0ccfd63a42f6368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzUtNy0xLTEtMTg5Njk_e7edc9fa-b83a-4adf-96f5-1add5bc144f3"
      unitRef="usd">220076000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtMS0xLTEtMTg5Njk_0ce80d40-65f7-4d96-88b4-e864efd28630"
      unitRef="usd">2589870000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtMy0xLTEtMTg5Njk_eb5ebf28-5fb3-46f8-a507-1583ef73498f"
      unitRef="usd">106765000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzYtNy0xLTEtMTg5Njk_c35d82b5-d29c-47f4-8852-54596ee0329b"
      unitRef="usd">2696635000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="iadf26bfc5aea44eda26fbbf6b3c61126_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctMS0xLTEtMTg5Njk_19277bc8-f802-480b-94f7-6b32a2db2cb1"
      unitRef="usd">3138161000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i9c1d8c3521584fbe86801d6a297495f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctMy0xLTEtMTg5Njk_9a11a544-427c-41a6-9f0c-00bc8222ccf3"
      unitRef="usd">137450000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo0OTQ1Y2YyZjA0YzY0MGRiYTE5N2IyYzIwYmJlNzIzOS90YWJsZXJhbmdlOjQ5NDVjZjJmMDRjNjQwZGJhMTk3YjJjMjBiYmU3MjM5XzctNy0xLTEtMTg5Njk_49c1a86d-6f70-46c3-9e7a-9130c9a1f7c5"
      unitRef="usd">3275611000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtMS0xLTEtMTg5Njk_28dc3a2b-b6d5-4234-9dfa-0283000f0ce6"
      unitRef="usd">546643000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtMy0xLTEtMTg5Njk_46179f9f-dc96-4491-a02d-bda05fe92f22"
      unitRef="usd">31436000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzEtNy0xLTEtMTg5Njk_8b68ce67-9715-40be-b409-b01cbe4cf52b"
      unitRef="usd">578079000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtMS0xLTEtMTg5Njk_de86e7a4-e417-4b40-812e-7eb8edd18c64"
      unitRef="usd">2195617000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtMy0xLTEtMTg5Njk_916ab835-e4b7-49a9-9bc8-241b6896ced1"
      unitRef="usd">86371000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzQtNy0xLTEtMTg5Njk_8efb8b32-3f91-43d1-95f4-26087de5f64c"
      unitRef="usd">2281988000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtMS0xLTEtMTg5Njk_1ef0e867-1e20-43d2-9158-5d9aeed386e9"
      unitRef="usd">190462000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtMy0xLTEtMTg5Njk_5220d4ec-7b2e-4d6f-ba95-d2c2cdc14de0"
      unitRef="usd">3279000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzUtNy0xLTEtMTg5Njk_f93db706-567b-4485-b8b6-3d8a8a98d7a1"
      unitRef="usd">193741000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtMS0xLTEtMTg5Njk_7415cbcb-5337-4008-8b44-7384090b0255"
      unitRef="usd">2386079000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtMy0xLTEtMTg5Njk_0d91fd8a-fb18-465b-a2e2-4acbd7221302"
      unitRef="usd">89650000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzYtNy0xLTEtMTg5Njk_730ca53c-a23f-4674-9a8d-4655a49b07d6"
      unitRef="usd">2475729000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ie1909e4932f34bf6a6c901cf09a8e13d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctMS0xLTEtMTg5Njk_8b6a872c-9a7d-4519-acf9-c2e741b1a206"
      unitRef="usd">2932722000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i589118616c4549cca227abd6b606ab67_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctMy0xLTEtMTg5Njk_04d81c0a-87e7-4298-9e99-b193e81c60d0"
      unitRef="usd">121086000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTo3ZmU5NTQzYWVhMTc0ZDJhYTVkZjZiOTY3OTU0Nzg0NS90YWJsZXJhbmdlOjdmZTk1NDNhZWExNzRkMmFhNWRmNmI5Njc5NTQ3ODQ1XzctNy0xLTEtMTg5Njk_ca26397b-9177-4a64-b0c6-49c632e44ddd"
      unitRef="usd">3053808000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <pbh:GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90ZXh0cmVnaW9uOmEzMGU0YjhlYjdkZTQyNTY5OWNkYjgzZTljMjUzZDc0XzE0NjI_0d7ae8db-da55-4cc3-8d6e-1df0033cd2b5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our goodwill and intangible assets by geographic area are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,138,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,932,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pbh:GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ie501c1ea8abe4c0fb019b579c2aba132_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzItMS0xLTEtMTg5Njk_f7c6ba56-426a-422f-b8cc-8c8cce1b3736"
      unitRef="usd">3138161000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i80ed6fa3737e451aa617050d4c8ce914_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzItMy0xLTEtMTg5Njk_22929851-7eb9-49be-a686-a123c924ea6e"
      unitRef="usd">2932722000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i9f5a12f3ffc1452b894efd73785526ad_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzMtMS0xLTEtMTg5Njk_2b1073aa-c829-4c94-991b-46c52b3430eb"
      unitRef="usd">137450000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i1f3910479bb242f9adc9ca0b36080c63_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzMtMy0xLTEtMTg5Njk_241d7912-dc99-443c-aa24-85fb5e6aeba7"
      unitRef="usd">121086000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="iab3ff8d1f6794953b2718ae0cc777203_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzQtMS0xLTEtMTg5Njk_d1f2ee8c-d7e6-471f-8a2c-d6217c1c7a25"
      unitRef="usd">3275611000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="ic0c43cd8d468472d94116a8e5f90b255_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDIvZnJhZzphMzBlNGI4ZWI3ZGU0MjU2OTljZGI4M2U5YzI1M2Q3NC90YWJsZTpmYzA0ODU3MTNkZjg0ZDQyYmViZWMwNzM3MWMzNjc2Ny90YWJsZXJhbmdlOmZjMDQ4NTcxM2RmODRkNDJiZWJlYzA3MzcxYzM2NzY3XzQtMy0xLTEtMTg5Njk_c3f52aa0-0965-4f24-b5e1-b1aa11142bd1"
      unitRef="usd">3053808000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjE_baeb8571-195e-4d9b-94ab-860949f11d27">Subsequent Events&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On May 3, 2022, the Company's Board of Directors authorized the repurchase of up to $50.0&#160;million of the Company's issued and outstanding common stock.  Under the authorization, the Company may purchase common stock through May, 2023 utilizing open market transactions, transactions structured through investment banking institutions, in privately-negotiated transactions, by direct purchases of common stock or a combination of the foregoing in compliance with the applicable rules and regulations of the Securities and Exchange Commission.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 2, 2022, the Committee granted 67,959 performance units, 65,721 RSUs and stock options to acquire 195,526 shares of our common stock to certain executive officers and employees under the 2020 Plan.  Performance units are earned based on achievement of the performance objectives set by the Committee and, if earned, vest in their entirety on the three-year anniversary of the date of grant.  RSUs vest either 33.3% per year over three years or in their entirety on the three-year or five-year anniversary of the date of grant.  Upon vesting, both performance units and RSUs will be settled in shares of our common stock.  The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant.  These stock options were granted at an exercise price of $54.47 per share, which is equal to the closing price for our common stock on the date of the grant.  Except in cases of death, disability or retirement, termination of employment prior to vesting will result in forfeiture of the unvested performance units, RSUs and the stock options.  Vested stock options will remain exercisable by the employee after termination, subject to the terms of the 2020 Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib8310fdbeb364e46af48af59d5abb8d0_I20220503"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzEwOTk1MTE2MzI2MDA_a996c1d6-4ca2-4d02-8387-17759f7f6df1"
      unitRef="usd">50000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5Xzkx_3e178bc0-3f2d-415a-b9f2-c9b49f3e7fab"
      unitRef="shares">67959</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzExMw_112dbb5c-65b3-444f-b5eb-0f9ff369c51a"
      unitRef="shares">65721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE1MA_e0cd17d5-cc03-46a2-894f-f610b4d6bb38"
      unitRef="shares">195526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4c0b4cf315694670b66b51463b7a0a09_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NTk_c01c85b0-ad73-4bb9-9418-39d6c9f63592">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzQ1Mw_639d5d80-b5b3-4475-955a-b7de12a6217d"
      unitRef="number">0.333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie2eae1b59c434401a9677ef636701b2d_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjA_bdf56d71-6655-491c-a06e-c9b3c5eb2e41">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia9c7b100290a4efeb19c0cc9bfb64604_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjM_5ea90463-acdc-4fd6-9828-f691fd61e962">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib1dbf1db8a004389a087448443b06363_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NjY_06dc9f46-7571-4949-813d-553a7edcfe1f">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzY4Mw_56dec2ed-2bde-44cf-aaa6-f6632311e2f9"
      unitRef="number">0.333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzE2NTU_48de1973-9ea5-402c-ba05-a8875866ac17">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzExNTQ0ODcyMDkzODcw_c929d28e-78d9-4cc5-bc51-d76352cd076b">ten years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="ieea466101e6d42e8838d33899174afc3_D20220502-20220502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDUvZnJhZzoxMDZkNjlkM2Y3NzU0OTE2YjI3OTM0NWY2ZWNkNjg2OS90ZXh0cmVnaW9uOjEwNmQ2OWQzZjc3NTQ5MTZiMjc5MzQ1ZjZlY2Q2ODY5XzgzMA_c688c301-e90b-4dda-93cf-6b248dfe9a31"
      unitRef="usdPerShare">54.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90ZXh0cmVnaW9uOjAyN2I0YzBjMmQ3ZjRhZjBiMzA2NzI4YTA4NWRmZWU0XzM3Mg_76efa9a2-7412-40e5-b1e5-3e88befd0a6a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts&lt;br/&gt;Charged to&lt;br/&gt;Expense (Income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales returns and allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for trade promotions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for consumer coupon redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,586)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales returns and allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for trade promotions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for consumer coupon redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for sales returns and allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for trade promotions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserves for consumer coupon redemptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,667)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)  Relates to opening balance sheet adjustments for our Akorn acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)  Relates to the release of the valuation allowance on foreign tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(c)  Relates to the unutilized foreign tax credit carryovers.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i434c5f76f05c469e89d0f4d63b175529_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItMS0xLTEtMTg5Njk_e7d61f73-baf7-415c-b06d-00bd9544250d"
      unitRef="usd">12163000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItMy0xLTEtMTg5Njk_f4af386a-7c38-4198-abf9-4cde06ee849c"
      unitRef="usd">53230000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItNS0xLTEtMTg5Njk_92177385-e6b0-4d92-950c-a5b888677f3f"
      unitRef="usd">51579000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i5efc64adb6f14235b8aabd4a240bf65a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItNy0xLTEtMTg5Njk_82388616-02d2-4d63-a354-020585279860"
      unitRef="usd">747000</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i8f8fcceb1e254220aeb7da81ab31cb58_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzItOS0xLTEtMTg5Njk_dd186813-150c-4a8b-8c5d-49d2191ebc05"
      unitRef="usd">14561000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45b2f889b82d49398a7b0afa2193e87c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtMS0xLTEtMTg5Njk_4807d723-712a-4251-b962-51b2d204d92e"
      unitRef="usd">18422000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtMy0xLTEtMTg5Njk_10217cea-9c59-403e-b2de-7d7a2bc1c56f"
      unitRef="usd">89547000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtNS0xLTEtMTg5Njk_adeacf5e-fb70-4d5c-b2c6-a2c60517835f"
      unitRef="usd">84270000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="ic0f5c676a1c94cf28f926249d9a94462_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtNy0xLTEtMTg5Njk_7a1aae5b-7a04-45a0-96d7-8918c9794f9e"
      unitRef="usd">945000</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib0651eae9b2249d1a150fa2d3bda71fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzMtOS0xLTEtMTg5Njk_90294571-d766-4882-b10e-af99b3a921e8"
      unitRef="usd">24644000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtMS0xLTEtMTg5Njk_21899621-3aa3-4ed7-b73b-8dc984952b63"
      unitRef="usd">1941000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtMy0xLTEtMTg5Njk_a730ea8e-905f-4907-8a3d-e0730adefad1"
      unitRef="usd">4107000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtNS0xLTEtMTg5Njk_39741c48-a1b8-427e-a975-4fd3f2ee7c41"
      unitRef="usd">4586000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i584bb9bfd2d3458497e8312506db395a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtNy0xLTEtMTg5Njk_139f91ab-1d3a-4e90-a003-6bffbbd95cc1"
      unitRef="usd">2429000</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i269d76c784f548c19f48f6c4f35139ec_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzQtOS0xLTEtMTg5Njk_61746ae9-e6ea-4eb6-a407-303c7df3a379"
      unitRef="usd">3891000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic9e5a57a02a949ac99c1b929db087c5c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtMS0xLTEtMTg5Njk_1f683b1b-76f1-4840-8f37-6e05460c9730"
      unitRef="usd">1545000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtMy0xLTEtMTg5Njk_2d878964-0c50-45e5-a4f7-a3ad36b48c49"
      unitRef="usd">58000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtNS0xLTEtMTg5Njk_26e041d1-d335-45e5-b390-8dc43edea2df"
      unitRef="usd">5000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i3f70d3ff1e29457e9435bb4772386b99_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtNy0xLTEtMTg5Njk_cf91061d-dc00-4066-a0d4-4613975bd065"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic6361373daa34522988116123cf37d3d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzUtOS0xLTEtMTg5Njk_51819fdf-7757-4398-ab53-1e71b1241941"
      unitRef="usd">1598000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktMS0xLTEtMTg5Njk_b44763b3-7974-4959-80a8-d7f01aa3f933"
      unitRef="usd">15809000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktMy0xLTEtMTg5Njk_d25a9dea-bde8-480e-8648-72ac5b029840"
      unitRef="usd">46195000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktNS0xLTEtMTg5Njk_d3cd969c-b378-4a1d-a876-ab32357abef0"
      unitRef="usd">49841000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i24cd3f59e5224bb69627bab8977a50b9_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktNy0xLTEtMTg5Njk_e9823fe2-2981-414d-99f8-2e29b8cac3a3"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i434c5f76f05c469e89d0f4d63b175529_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzktOS0xLTEtMTg5Njk_5d8d02ef-7579-4c2b-a5e6-7f6ebf08b017"
      unitRef="usd">12163000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea56f97f93bb4d4a986d72945ac41527_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTEtMS0xLTE4OTY5_287b8b5a-d062-435b-9cf5-19714b5cbc2c"
      unitRef="usd">18389000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTMtMS0xLTE4OTY5_091ea460-6f9f-4213-9e27-ec5e413d27fa"
      unitRef="usd">83479000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTUtMS0xLTE4OTY5_3e2eaad4-a3cc-4b72-93c4-534faa306418"
      unitRef="usd">83446000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="ice3a31ba8f864cbe8bc391e0d21ee9f3_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTctMS0xLTE4OTY5_ae17eca7-7b2c-45a3-84df-602b33d19501"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45b2f889b82d49398a7b0afa2193e87c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEwLTktMS0xLTE4OTY5_095f0427-db85-49f1-aaf7-5403dd074098"
      unitRef="usd">18422000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i54b960c0b2a34f049a1eb507349cdc62_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTEtMS0xLTE4OTY5_35f23902-0aa8-4987-ae62-5108016ff2d7"
      unitRef="usd">2063000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTMtMS0xLTE4OTY5_acdf2cca-269f-46e5-9817-d65e95322772"
      unitRef="usd">3751000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTUtMS0xLTE4OTY5_9b2637f5-55ae-43c5-9558-92243dfc4462"
      unitRef="usd">3873000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i58e2d10ece104372ba7c67d17e391bdf_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTctMS0xLTE4OTY5_034efb12-71fc-4a57-8abc-06501ea7f15e"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i217b2f80c43646b3ab8f022c0d9a0e40_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzExLTktMS0xLTE4OTY5_29732501-96ea-4853-88aa-40919ccbd6a7"
      unitRef="usd">1941000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTEtMS0xLTE4OTY5_1d3430ad-9440-42b0-90ab-c80d4787526c"
      unitRef="usd">1385000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTMtMS0xLTE4OTY5_a7536562-4ee3-4070-80db-b86b46a32d9f"
      unitRef="usd">259000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTUtMS0xLTE4OTY5_aa1b2568-7465-4218-9943-0e272a69e29a"
      unitRef="usd">99000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="id313c1ff1bea4451994a3b0033d698a6_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTctMS0xLTE4OTY5_9a83264f-4afe-45ae-9e75-a4a9023adfc7"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic9e5a57a02a949ac99c1b929db087c5c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEyLTktMS0xLTE4OTY5_c03e505e-38d8-44a9-880e-21b831455656"
      unitRef="usd">1545000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id0659c3b10104b4d93e871d273dc3a9e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTEtMS0xLTE4OTY5_e2a5b275-3eb2-4a06-bf98-a17cd563e8f5"
      unitRef="usd">5441000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTMtMS0xLTE4OTY5_dbceda1a-220e-4ae7-83fd-dae99ee7c840"
      unitRef="usd">-5441000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTUtMS0xLTE4OTY5_941e76e9-9dd8-4fef-b3bc-876a7292d5cb"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i713183d1c46f4bdf9fdd37ee1d996747_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTctMS0xLTE4OTY5_8af4ad81-7a2f-4d35-8a29-eb2e0f2f0a4a"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia3363e6b458345d4aefbc25a191f087a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzEzLTktMS0xLTE4OTY5_55825c6f-8f89-49af-b8b1-79ac813f6ed6"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i920d5d39c27c43a7ada8c478509c80e2_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTEtMS0xLTE4OTY5_d9e273c8-fa04-4e69-a19f-b58975131cac"
      unitRef="usd">8973000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTMtMS0xLTE4OTY5_bfb5b5ec-4bfa-4061-8e83-d8f5727add91"
      unitRef="usd">57505000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTUtMS0xLTE4OTY5_9b2b4963-4f49-43df-b33c-99bcec422aca"
      unitRef="usd">50669000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i59ffd4d4e7fc43c8a9d0f6563600fd21_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTctMS0xLTE4OTY5_071e1843-926f-459d-88c5-0d4aba6d89e5"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i936d6758b61f4f7cae0e07fd0fc40ba2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE2LTktMS0xLTE4OTY5_0a16fbfd-3435-4e76-b2e2-5d7ce46748af"
      unitRef="usd">15809000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i21a87850c1e3427aab790ab25ea38814_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTEtMS0xLTE4OTY5_f9f3cbfc-72ce-4331-b497-a503eaeb8abe"
      unitRef="usd">15491000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTMtMS0xLTE4OTY5_06b8dc3a-120c-479c-b1a0-b56950eea169"
      unitRef="usd">88502000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTUtMS0xLTE4OTY5_375007b3-b524-4f07-a7aa-dda68c9a2b64"
      unitRef="usd">85604000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i09b9bacbcbfe476180fd853fc6dee18e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTctMS0xLTE4OTY5_acfd9cdd-9e06-4b4b-9a32-664b9a9f04b6"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="iea56f97f93bb4d4a986d72945ac41527_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE3LTktMS0xLTE4OTY5_0298deb8-3e44-42f7-b215-4ac2cde2a9be"
      unitRef="usd">18389000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf417621972e4bfb95d92b68b8db4ee0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTEtMS0xLTE4OTY5_6fd58d17-4d1c-474a-b3fe-24ead76218c1"
      unitRef="usd">1175000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTMtMS0xLTE4OTY5_ba0b83cd-83f8-44f5-b737-07aeacd932e4"
      unitRef="usd">4555000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTUtMS0xLTE4OTY5_0d237792-10cb-41b9-888f-4b7b09b3b845"
      unitRef="usd">3667000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="ib7ac2db3186e4cac948da31addcef25f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTctMS0xLTE4OTY5_b991adff-d30c-4e04-af91-b9bbe5798286"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i54b960c0b2a34f049a1eb507349cdc62_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE4LTktMS0xLTE4OTY5_be79cbb5-2080-40c4-85f4-a98d704cadea"
      unitRef="usd">2063000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf45542f39ba4a4999f6783fd74f411f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTEtMS0xLTE4OTY5_9776831c-0d52-4412-8de9-313abf5b619d"
      unitRef="usd">1259000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTMtMS0xLTE4OTY5_d847d83c-c075-4635-80e9-bf85943410e9"
      unitRef="usd">750000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTUtMS0xLTE4OTY5_749d132b-55d8-4c9b-beec-ced5877417f3"
      unitRef="usd">624000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="i4b62934366984576b94bf37d4e78c277_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTctMS0xLTE4OTY5_b500a74d-3f0f-4bc3-98cf-d988afc88d9d"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i79b84efd66d64a3a8c65ce65f842bbe0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzE5LTktMS0xLTE4OTY5_24e66981-a1c6-4168-9814-56f84f31ff12"
      unitRef="usd">1385000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i840967a79d094690b99943768e44e986_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTEtMS0xLTE4OTY5_009049b9-c241-4f0d-9449-0468a3be16b9"
      unitRef="usd">3236000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTMtMS0xLTE4OTY5_a0898fda-dee1-45a4-a866-ba331822161d"
      unitRef="usd">2205000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTUtMS0xLTE4OTY5_ee7770e6-8988-4268-822b-17d237a676a1"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <pbh:SECSchedule1209ValuationAllowancesandReservesOther
      contextRef="ib6eeab6432874631889b01b7c0376b85_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTctMS0xLTE4OTY5_19e2852e-2274-4c49-aa9b-ac6c21ba9ec6"
      unitRef="usd">0</pbh:SECSchedule1209ValuationAllowancesandReservesOther>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="id0659c3b10104b4d93e871d273dc3a9e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xNDgvZnJhZzowMjdiNGMwYzJkN2Y0YWYwYjMwNjcyOGEwODVkZmVlNC90YWJsZTo3ZjJjNmYwYjk4NGM0YzFmOTVkZDNmZDY1NTVjYTQxOS90YWJsZXJhbmdlOjdmMmM2ZjBiOTg0YzRjMWY5NWRkM2ZkNjU1NWNhNDE5XzIwLTktMS0xLTE4OTY5_c5a1f061-c720-40e2-8c93-c8399c5b524f"
      unitRef="usd">5441000</us-gaap:ValuationAllowancesAndReservesBalance>
    <dei:AuditorFirmId
      contextRef="i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzYjU1ZTBmNzkzYzRmM2JhNWY2MDZlYTc3MTFjMzdmL3NlYzo5M2I1NWUwZjc5M2M0ZjNiYTVmNjA2ZWE3NzExYzM3Zl8xODEvZnJhZzo1YjExNGU2NzQ1ZTg0ZWMyOWJkYjk1NDEzZmVhODUxZS90YWJsZTo2ZmJjMjMwMGQ2OTQ0ZWM0YWVjMDhkNjk0ODk4MjE2OC90YWJsZXJhbmdlOjZmYmMyMzAwZDY5NDRlYzRhZWMwOGQ2OTQ4OTgyMTY4XzEtMC0xLTEtMjgyMDQvdGV4dHJlZ2lvbjpkOGU0NGM2OWZiZDQ0YzMyOGNmMjBkZjk2ZTk5ZjE1Zl8xMDk5NTExNjI3ODk2_0febaa54-a42c-402d-b2b6-cfc2cfeabc8f">238</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>129
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MPH7) /'Y/>?-\X5\C&/_Z-'%_U!+ P04    " "!@J94/(*]*  )  "P*
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MBF5Y'N-63H^,TB"CWY2&M=\078!E54N6E=XJN##Q "P*=NS>>J;RGUVU-=[
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M_4$&T>+4SH\1D#/P$.1\T*,(L[ ('V/+3O?; /!W6(87X@JBN2Q.8FIO;:!
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M>#UNN.C4MG]A[%%UG=KT7]>R@)S! .#WE8*B>']A'G!\2?'FOU!+ P04
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M' -B<W O-,3*B?G"X% S'FL:I6K(&R;'#,M9Y!(=KUOV,EQ"]>@%D#D:UH.
M'!@!PA-J/@0W#!HX/-@NRR:0>_V;L[M4$RVY"DN^'4H6*MBC4#(-(!>H=,-=
M9?>3N*!S*W1$W3B],/D*OD:-P:$DR.[O&NCD:Z21&V1++!Q!KCG6$L;).Y@2
ME"TD3F%L%5UWQXE*CJ0 *Y*1%K ACM&\CN95Q)1?-BD(@@0?D44<N#@T/+L'
M3%GW>8X\(RO3&$I,LA_;MN24E&2WYG"?]4&M2CA-> =FYL=%P\> Q(+..4?"
MY6[TB<!7]'*H*1$U9JJ:>4GSFNZBZ(IY/5LJ9 F,= \0% 2,]%T2548$J"ZG
M0( $:Y>*1 Z(( C?#.R$6M#8(G=EV82D7ASR&GG&F>@N%(!Z/+WXQ_A!* .R
MSYS"!Y%,EWMP >,@FWSA7JJ/ECQ$YJK1BJ1$L>+1AA2U=TOA)]SQ3S/9%BB'
MN.UUC'@OA6%>;\? 21*L@_;PG$R!M]X4:UA J5/R%[5M?4P-[-HD#@A3G:3<
MHWFM5QS?;L/ D0QYI161BRU//GJ,F54,S!<-'(O-?G-&(?K=!IX"U@H(S.LB
MRT/Z^NR$68XK1*43:([Q8+D'8JS\7F9)/%OA.V&-_W!9V&6/'=+<J[!;,6Z\
M-FD^8ZC_*3U>=3M2P,EUYGGK0 A,'^MR_W;=_L+-^NRMY$V8;:^XK&9E<7,"
M.)ED^16^3\IO!U)8</;9U4!AAP(]2][,^E#$XL</N$+B]HP]&\EF14&2 @$7
M#C5N-VFRPNRHLXQ+D_2C%-9:(OAN)]H^T;3!B'G:^B:)5^WQB6)L.\=Q[T/*
MCY8T118FHDD()DU3GD/VT(*R=UD!8UO+ZH2/NM*FX##/@APAQGM)TB(I F[:
MZEZ%E9$YKEUW@SXLB1;-!=,4[S@,Y%B'PTKR"<@%J$CB$?^S0'+N8,G#[B14
MF$0;*9-"P=RV9H#(J1^U1S;9VP]7:>,B'GT]:G@<WR"%.1MMG$Z.L2:S\]*U
MRZ[8K#@ZHQL+>7;<GOFE^>)4Z@,5)&\45TM"AM;H^:$ ^TX_4RA>5]M1CZ%Y
MV;7#AA!S20.13JKF?K<-2WO _CMV?VWW9.79RSNG3[PL.FX,R[>ZPC1D#(UC
M4NB)37L=N_\TG+;\>BF2<)D<Y6;RUCAZAM*PQ!!*$6CR9K5*H7Q;<<*9)8>-
M1\I-T<BS=@L36"I)-,VLKI9%*+Y[)UV*TN84@.4:P)@:V@:H[7=(QW9ML57G
MI1B@YZ05ZW=- /A_:4]P;@DU\=5X/:.V!I*?T$DT(0%UTC [?2;)Q<J'5H<R
M"&I2\J5'Z*]?%$$CO$NP^39@TV<?&6>7UU?9XY/'>1QK9(-@+86J+4-=<%&A
M\BKN[*>BOAA;W(O #=RM !,L=HMQW+E%S05@:P!$-4 LC]5TM$=5$OE@CKZV
MQG4DWEB)D-ECFZWY+'H0T$"DX?R2QT=ZQU6<H.(5;.DH]IAVP"92@9?)W%:H
M$'$+"MR,[L[R5TD;J(P;4C$^(V_N$Z=VK24MO3G]'I**.A/)'3-0& S-*5O0
M";9&\*&]" FT@_/F8RC0TPUQ1:N5M.[C\L"I;>'6=L8);7\H1Q]K%-H,*/U/
MVBPDP)/;QMA@=PE8@5(*I-5Z?P=SS,UOFM4U<Q> E9[F)3*'(/\D^X4$F\&_
M&O$,A?-HP ,[I\U?G9M)XBT,F);"Z#.9@K7/ \:UC):'XJHD)B"*T8QU(66A
MOB;!>&-@C5G9,AK[;#0P'$RIW,3I>@T3DMS@#G22T$'#FY9X29%S-:BTT:7,
MH]E)UKHR T=]!:?#0XS(M<KH>'&-LZX^0;^;:RN^DBG'MD-C-MP3+AW<D^R,
M&=+0:=YW:!NP5&CJ<1N)1JE06[LT0T@W,O*?G@(6$%%K((GFI*\D+Z'?2U*A
M[+1J,\DBG=4>@F8<:JV)Q50I!Y1H1NFY\U'<'G2+S*N-^3$KMY>KMHLES$:N
M6;'^97\4IF]?AY$_,"#SEF3(17*/^_8XV,"*RWH24VI*"36K3>A["?WTDLL)
MG#@N]\=A=CRX.&XL(K, (!F=VM.T$\G7;2^U!&?6<-YJ"@)*($7NAY4%#B$M
M)GW/50CQ]LL2&P4Q6ZR.T\""T8RV  \SCXSWRS3_WJ=S]H>1+SGMCD/OKQ"6
M(%_WB(M4#6*A3T5&%*"(30J*\;7)#F'>S0L.]U%YL-J!/JF.:6Q+,VG@NL!Z
M:!#0AJ NZL?0AOPH;+E2A[;A'%%O-FA3._,L#HA OI77MN81UJ#EWP:O4<^X
M/P.Y69 =&$*:6WMW7TBC)9>>)8!YP'T#H5OM8=*OK;[G:&E>:MW<Z"< VRS.
M9DE#,2E3I>TUT>SM]TL]PJTOW*(SJ'.7@EF,VNYT-Q]:FQJGF98JZ4YC \I<
M;B94G>RQ^=3$"A% +NR'BE/^["Q6:M$XKQ"R#"9:B3M8J"W'R%)[9]N"ADN#
MCK<0:Z?Y/EQK@VCMU&E7!Y13).R;,.[=E]$>8OB 4=V((OV(5F#<]F"-:=F'
MC5ZW^EM^Q]6#] 3E$N4%[>>&LAC5^4 W:TCAIB+I.[X-W1HB!4DS>.H\V*C6
M*LE>=]I\I"5SW<;'E3Y9^2A/J6C07DY)/FQ5>+D1%PY844==*%Z@1&2&V>R6
M>Z=F;L_R= -78XV].I[ZF/</^X!BLD\<-JZ)'NS'/?P:3?YK<,486Z,.>\1L
M==BM (NQ&.I%5=?B:2:&19Q.BDC:+LU^T&]KZ=# N))*7$C@($DA?+UF'6[?
M1*.'^'$GO\,F8]R[/[;_J>4<;<7(#9%QJT;8>BL5+)GL07P>V^; 9&%+43NJ
MQ3TD1B1-O&J'N*<#T\\(G:7FTWKY$O"J-XW0RRD!,FG%TMENAE_CN/D!HNP\
M)7NKOGG\9/(T6Q.53 *D1>N;B]/)=/OW*8_RS>/IY-GVI1,2M^A9\'T_!7,F
M";WMZ]'<Q=RE,G0YKI=>CKV?429AOC=9N(^\VXY1-U:P.PD]#1:ND^[ JZ0[
M<)RY.]1#&$04^QS)A8[=FM9[X2T3*'$WO'77N:TB_1);@(^YC73<D\CZZN\#
MYR>)N\K)&,:@($:YA9 7M@YR&=_I?5I-1)B(**]T!N.>!("3:?-1!2D)[JV=
ME<;TJ![82-:A^DX/SGBI@%YI($F^<]W>.1>\^C=WS7PU&[KEECR/TK.<Y)=>
M'2[><#,I1\S91B>"[*J]2K;_<UH ^S'F=YQ946\!3.9BN8:U">G2]; V:QVP
M)385P[Y4T,DYZ2M1RU8>OW;S@;O^+R4NFCY[<IX].'KY_O7UI6UL5JBDO%%K
M0H:[FFW#DK1L!1&@U3RWM, H$<N%K(3%)'25[9+<!Q49!:F0[(6;N_6,5C%]
MC):_Z7FN[3QSCO1)>VGLB@W/G7/:,Q!R$H*"<5,A-T^B$TE*S/=11=VR)JE$
M6-^T=")R(^+T8D*N:9 BV4^05,ID>_&M$^_=E3%ZU$X%,-,]  $0*=K&0$>R
M7T56#^L-SH6!$X*.+Y&_J@LH"-X 6&-35*S2.4-=6[O'J&-[+_1BM^")W:[:
MZ-6U;(FEEV4+#A#FFR>3DZ"4V74:JS=B@KZOA1N7NL/^FY/):7QFNW75Z? C
M?&N%<A_"B[+EW1.%(C'I 3,Z7E(D7&=G)[DLU%3([V$2WD?AEDJEG9E(8\W9
M._JP[VKE8U^G]BM+7!6;U^[9MGXFHRX&WNR DO<0.&JD7J1S$ U#P#9[-+Q5
M<2$-<R.?0_O(.3]U([7D9"^!="ZA9@R!5=VHD68HTW720_^K560#,.G&A\XM
MA[KH$# H=T#!2'L01RNM_&5-<]/6Q,'2A)LH&DM0C!?+<4DLQ(:H,ZA&TL:,
MK)X<R*N8"1K#'Y:[W>3"F1O1FW >K3O;J&_;"Y)-;&J@^GVT"H_EZ;YY3JG8
M7D1MQX][1 (!;-VAJ8NSC;K*,::J=-?XF7(M>KDG9@L^<&=_JG;A=Y&">R)J
MEZYG5X/RP5_;F6>CP>>8''VX^BO9"Y9[Q"?2G-"2JWHK+(KKW#T!AY>3\:1I
M.$%G^^>#V"T<XA]8%,V:\+8"_L#,<7;Q+<A^.OU6?."UM*7)81UF#/$(X>5'
MV7V6] ^\:6^/L=#25OW@Z,?7;SZ\)N"Q2528 V$ K6)TC TW4_]U(-K((2,+
MWH8@3*S'9O#1 &B"E1":QTVR0-Q26O!FOF/ !P[=A#@O[E9FL.X'QAH"[%K
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M;'B;H_$.?+XA<D?%!QC_'Y8_ 5!+ P04    " "!@J94\*YM!N4"  !A!@
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M#JD-.OX-V4R*/#)9SRFZM8#;@7!K(EIM:' .%I0 B1B&,WSO U$SB68'%;#
M"+G!YHM'R:9N$&0O*[JQ8+["EG"AH9]H4I:?%5$X84GGN/=1\>RJKK ;A;A@
M]W75>R^P8"MFX"DS!S"PO*0D]@V%% .Q=3S0AL(D9P@7A>&Z;JN4=(8C8$I"
M.$L1SJ6&",KVI?Q,OG$H 98-SI9HF8XZ0-<J]]'I[]@#'68;"0\^K]I&IP)1
M[1]N]=[J-BH@@SUM-\]C&3R1D.&Q#:5EI2JPA2"L&%Z!'M-!6\C&!RBHOP/0
MX!7C0 N0WD 0^6^4*GDE6MI<$9%1G&I5+(VM+%(=N05+9+B.9'"*&R'ROFP
M1V$]5><!P/='-")]!,<:\P.RK*V3EE>?O/GEY=,'X%LJJ3:Z3G73@N7-CRL/
M*PO*7:N<ZX13KG]8]/528\E!S>_&GRZ.7(JR/E9H9E=O=Q<8Z:>G[F0['S@U
M$F]18-CRKT6$W"Z%L37S  FN*7YM2Y?<TI%2GI.:;0X(4#Z8VS"0K2=)/^U&
MC[9\.%74#J)K'NY,V2#!U@Z,XS32KDM68"X/!5 8.1T/:UN4D,5/.K6@=FPQ
M&K7]D($UM)T.8?1[C5B!\-)NMW!Z%C)VO01-%I@7/57F4E&NT/!H4406N?4
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M%51.^(Z5>+/AHJ *MV([E3O!Z-HP%?F4V'8P+6A6#N8S<W8EYC->J3PKV94
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M>Q+BZ!/U&[_>*+XS[^H55_A*-\N444PS38#W&\Y5N]$"NA]:YO\"4$L#!!0
M   ( (&"IE3:KC?RPP(  !(&   9    >&PO=V]R:W-H965T<R]S:&5E=#$U
M+GAM;*U52V_;, S^*X*QPP88]=M.@B1 TFU8@14+6FP[##LH-AT+D25/DIOV
MWX^2$S<%EIQVD2GQX\>'1'I^D&JO&P!#GELN],)KC.EF0:#+!EJJ;V0' C6U
M5"TUN%6[0'<*:.6,6A[$89@'+67"6\[=V48MY[(WG G8**+[MJ7J90U<'A9>
MY)T.'MBN,?8@6,X[NH-',-^[C<)=,+)4K 6AF11$0;WP5M%LG5J\ _Q@<-!G
M,K&9;*7<V\U=M?!"&Q!P*(UEH/AY@EO@W!)A&'^.G-[HTAJ>RR?VSRYWS&5+
M-=Q*_I-5IEEX$X]44-.>FP=Y^ +'?#++5TJNW4H. S9)/%+VVLCV:(P1M$P,
M7_I\K,.9P22\8! ?#6(7]^#(1?F1&KJ<*WD@RJ*1S0HN56>-P3%A+^71*-0R
MM#/+;Z8!159EJ7JHR%=&MXPSPT#/ X/T%A241ZKU0!5?H(IB<B^%:33Y)"JH
MWA($&-<87'P*;AU?9;RGZH8DD4_B,(ZO\"5CLHGC2R[P;>@+W7+0A(IJR)ER
M37ZMMMHH?!Z_K[A(1Q>I<Y'^CWI>I;+M.-,=+6'A8;]I4$_@7>8G@X8>-?Q,
M4TKL(6V(K EB2"TYMB(3NQG! I>-J_#[.X%*V6LLC?[@"FZ7:'2%+;L'@U9(
MIXTF[TB2^U$Z12&>^M,L&Y&E;'%D:.JZ;@!'4S^;%"1*_;!(1^!6R3V&C/B6
M:=OE"/2C8HIK&"?D3J &B*'/F$,W7!V)_;P($9!G\<C3*5F#(Z"<U(#HU(^R
M$->T>(.J^O(LJ,3/)SD23B:O($WM\T"7)$--DD^NE#5'^P*=3(L<BU"@SRA!
M(8_\-(S)O]Y2<-:G+:B=FT;V?GIAAI8=3\>!MQKZ_!4^3$N\N1W#@G&HT32\
M*3*/J&$"#1LC.]?U6VEPACBQP:$-R@)07TMI3AOK8/P-+/\"4$L#!!0    (
M (&"IE2#A1S@YA(  /Y+   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM
M;.5<6W/;.++^*RBM9]>N8F21NMF>)%5V,JG-5&8FE61V:VMK'R 2DC"A" U!
MVO'Y]:>[ 9#@1;+D\61SZKS8NH#-1O?75S3U_$[EG_5:B()]V:29?C%8%\7V
MZOQ<QVNQX7JHMB*#;Y8JW_ "WN:K<[W-!4_HHDUZ'HU&L_,-E]G@Y7/Z['W^
M\KDJBU1FXGW.=+G9\/S^1J3J[L4@'+@//LC5NL /SE\^W_*5^"B*7[?O<WAW
M7E%)Y$9D6JJ,Y6+Y8G =7MU,<#TM^(<4=]I[S7 G"Z4^XYNWR8O!"!D2J8@+
MI,#AWZUX)=(4"0$;OUN:@^J6>*'_VE%_0WN'O2RX%J]4^D^9%.L7@XL!2\22
MEVGQ0=W]7=C]3)%>K%)-?]F=61O-!RPN=:$V]F+@8",S\Y]_L7+P+K@8[;@@
MLA=$Q+>Y$7'YFA?\Y?-<W;$<5P,U?$%;I:N!.9FA4CX6.7PKX;KBY3N5K9Y]
M$OF&O1:+XOEY 33QF_/87G]CKH]V7!]&[">5%6O-?L@2D30)G ,S%4>1X^@F
MVDOQ)YX/V3@,6#2*HCWTQM4.QT1OO(,>[HN]ECI.E2YSP?Y]O=!%#FCXSQ[B
MDXKXA(A/'BV^O=>CR5WI+8_%BP'8E!;YK1BTB#)Z6^#;!-_&"BQ"%YJI)2O6
M@BU5"I8ELU7 >/5AP@NAF<P2&<.KY(J=OLW@"U5JGB4Z8.)+++8%VXH\%ED!
MUJ?/& @^7I/DZU>@@Y!]%)E4.?M9(<V%X#G<#&@#2T(7C!=L/)Q/1]\% -UB
M77^QY?=\D0H&MG>]S67*0@8W9[_$A5J('-X!KX+#C>X%JOP3L-V]'=@=*JVF
M@3R-PR$[8;/1*!B-1MZK:!1>/LSM=!A&TWW<_LBS$AP4"Z?$\(]E2J_[V&W?
MKV:W)D)2O!BRB>5R4G,;,5+SS;,I:)EG_?RB/F]4#L@4^=] PUOCS@HF8 ,@
MR'=O;W[YP+9IJ1D'!O*5S)#7:#BJ=,+MHF6J@%7X<F2^A#<<2*5PLPQP0OZ-
MY?BJ0RYLD*L(V8^3LK'I:$:;G@S97_]R$871]VQR.?T&-CU]S*;12N"*K-S4
M^R1(5(JU>W-[;1EL&+@%]:MW0NLK5F9\H_)"_H](G&VC89^&%\%X$IW!BRF\
MF)^U* 8L@VA]@N3FLV VO;"O+^'UF%T73?N-0!R"K7G",@5[37D6PQ[*0A<
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MX?H%9HAGE6=MJ ,BF]2ZA%4=6=+G#,FXK89#(&P#(02-+)9;6&=%@=Y#J&4
M;&O(W(S?(8/:YBH6(M&XS9)D?#(#Q88UR'LXDQI$"/@"V,$2GH)?6 &^.< 4
MMW1?H_L5**[<P-[_+L#WK&,.ZB*DHPQCD1?<^!P).$W4!J^*68C^1]UE0 OQ
M(1,)KE( -A1YP6+-LX:K'+(?,$29S0,&*EY0?NPW!69#]],"M,!3VA+P@;R
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M)X^)D:!PM5F95<T#WX-2$4R47(4!NR/U-VY-\L98.FH&17-1[V)PXJAVUQ,
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M;>CE6G"P%EP WR\5B-&^P1M4/_GU\G\!4$L#!!0    ( (&"IE1H*FLG!P8
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M7(C#FZ*=.*I"'U^3XU=!&!;\#$/C!7@_)W+;B3^@?]@M_@102P,$%     @
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M>DP& J]C_"?X"B@<]DAZ0O@Z61*,',@014N"AW%"QAVBQBB80PAH,QT(D9#
MTSA8S!Z5(:)73O >^$'%N)>!,#HA]_ED*$,<ST@WBO(]1 ]V),.<1.MD6 13
MB# +9LFC(L0D0DB0%K@6AIRQ6Z+).$Z6+6_N) \WSJ![0MOF2S&%O/2.$B**
M8S\,NAC\^JI0]89_8T88M"FM^R%6=[?[&=NE^_56O]S]!@Y28'HV +QK; 7W
MZ0CEBG]7YBYLM>/?<JTJ:ZN"OVZ51,33 CQ?5VCC_H(8=#_N>_T?4$L#!!0
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M=0C)RWY>%7]0^]/\<W &(Y;&+)V.O9C-XGDZ&\,[15-8ANSY4@#9".60,NS
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M=4\V0 ;K1 V%1MK>M.1)[*5!XJYAFJ'4;V&M-@^L%#N%,*@_A,/IT L#SE!
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M;(6R@UUV,2"=>:RX5DMC_312NI Y$851QB; (Y>J[NQ#H\P_XKHZ^,D#OVJ
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M110;.W_W>1$S,'T<C6_'3\OS]$7U8WOZ+D4Y8_3C8D 5CBYFS_$EY]*W7GK
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MB0#>KZP-_8,8&-;I\W\ 4$L#!!0    ( (&"IE0L#OL\(P0  !(*   9
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;+56;6_;-A#^*P=M&&R B_5&O72.
M <5)5P-IDB9-AV+8!UJB;:V2Z))4G.S7[T@YBMTV<?9A7\P7\YY[[CF*=^.-
MD%_4BG,-]W75J&-GI?7ZS6BD\A6OF3H2:][@/PLA:Z9Q*9<CM9:<%=:HKD:^
MZT:CFI6-,QG;O2LY&8M65V7#KR2HMJZ9?#CAE=@<.Y[SN'%=+E?:;(PFXS5;
M\ANN;]=7$E>C'J4H:]ZH4C0@^>+8R;PW)Z$Y;P]\*OE&[<S!1#(7XHM9S(IC
MQS6$>,5S;1 8#G=\RJO* "&-KUM,IW=I#'?GC^AO;>P8RYPI/A75'V6A5\=.
MXD#!%ZRM]+78O./;>*C!RT6E["]LNK-1Y$#>*BWJK3$RJ,NF&]G]5H<=@\1]
MQL#?&OB6=^?(LCQEFDW&4FQ FM.(9B8V5&N-Y,K&).5&2_RW1#L]N<$L%VW%
M83:#3ZQJ6:=54\"'EE7EXJ%LEI#EN6@;K<8CC2Z-X2C?PI]T\/XS\)X/[T6C
M5PK.FH(7^P CY-H3]A\)G_@O(KYG\@@"CX#O^OX+>$$O0&#Q@N<$.)O"HP@$
M//]7-R6'E8 _L[G2$N_47R]P"'L.H>40_E]).  _?7=V>GM^9N&S\]OLX^SR
M K*+4_APFYW/WGZ>7?P.V71Z>7OQ\08&LP;T2K0*_:LAG+"*-3D'IB&KN]A/
MD:S]IA1<ZA67,&![YSYS)KM\ V8K7_7I@FNNN+SC"O U <4JG$FN6XE()EI6
MX1MA47[&3! O"G!" ^('+DX&U",T3H<XC</8' D)C;Q]4,Q)P6$M12TZAEY"
M0O2<I(2BT2 )B1^[0TA#"GY(HC#<M\_1IJVYF;1K^^X4O%YOH4@:>A 2ST4@
M])U$0_ 1/86 )*D'64_?(!6BG>M%6^'#L[TS2!^]T@0C&<(O/R6^Y_]F-M/D
M6<F\UTOF49*X*801\5**_%*2A-Z.GT[/@V(%20I)0,(X1;%P#*,=C$[+5POF
M$Q==!B2F'@Q0HSC8C=N(>5BR(,%$4223IGNBH9*G?,$E^@/-[N'NZ;OI,2G2
M1\]V&,)@_@3P[?B<_N[K]4](&@= 8T)=E)^Z)(IV&7?9.2 _,L5[E"2(X:/\
ME$1NN">_R<Y_N*]>3/&^4DJ-_%$4/V%UJ3DLOY$^IBX,(G^7B4W+0?W-EQNA
M*]\HDG^O_C8_^'I<\XII#$D+,/V&>>_FVP>EZTU8\3<60^P&=!>W:"5D7X0T
M=?UK6ZK2N#ZR.=[!PM<)%:DXEFT0"[O\$4]<("86\,:&DF-,);8ZEO,W:&W3
MZK(J_\&HOS>!G$GY(.ZX5$<_*@NCG3J-.5O:;D2!%;LKV?UNW_!D79U_.MYU
M2WA+ER7FN.(+-'6/8NJ [#J0;J'%VE;]N=#80]CI"ILV+LT!_'\AA'Y<& =]
M&SCY%U!+ P04    " "!@J94UJ4O)R,B   !:P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6S-76MSV\B5_2LH)9.54Y0LRL]Y5LD:>Z(I3^RR['%M
M;>T'$&B2B$" Z08D,[]^SWWT R1(RY-)-E]LB02Z;]^^CW,?W?KNKK4W;FE,
MEWU:U8W[_FC9=>MO'CYTQ=*L<G?:KDV#;^:M7>4=?K6+AVYM35[R2ZOZX?G9
MV=.'J[QJCG[XCC][:W_XKNV[NFK,6YNY?K7*[>:%J=N[[X^F1_Z#=]5BV=$'
M#W_X;ITOS+7I/JS?6OSV,(Q25BO3N*IM,FOFWQ]=3+]Y<<XO\!._5N;.)3]G
MM)19V][0+U?E]T=G1)&I3='1$#G^NS67IJYI)-#Q=QWT*,Q)+Z8_^]%?\>*Q
MF%GNS&5;?ZS*;OG]T?.CK#3SO*^[=^W=7XPNZ F-5[2UXW^S.WWV["@K>M>U
M*WT9%*RJ1O[//RDC[O/"N;YPSG3+1$SECWF7__"=;>\R2T]C-/J!E\IO@[BJ
MH5VY[BR^K?!>]\.+WN$3Y[*\*;,7N:M<ULZSM]8XTW0Y,^[X;5M7167<@^\>
M=IB27GQ8Z/ O9/CS/<-/S[-?VJ9;NNQE4YIR.,!#T!H(/O<$OS@_..(ON3W-
M'DTGV?G9^?F!\1X%!CSB\1[M&>^-7>1-]0]>ZB2[;!N'U9:R<N+)@!5@S:NJ
MR9NBRNOL&A\:"&CGLO^YF+G.0L+^]P!%CP-%CYFBQ_NV9&P7QEC_&X;)WO0V
M6:0IQ]>36Y-!R=?XO\PJTIVBM26>,Q#/;LF_]TU7-0L\5N'U=6U<MC"-L7E=
M;^A[L^[DW6YIL@]-1;_Q#$S3Q<K8JLBSXZ.?+B[>'CTXS2[J.G/5HJGF^+SI
M\&9G;-&NUGFSR<#;QN6LQR*IL[PF:ERVS&]--C.FR4Q=03]RG;5(-_*4ESVO
M7(%E;DQN,].4H*/)($W%$N+D.J+*Y/B%OC_-WIFYL8:GD#4X<P^^M39K6EIB
MUV:YS'1L3A>GD^Q/?WA^?G[V+0DM_SC]]D&V,CE$:I<RC+Y#6K?,.R'M@(0]
M"1+VY*!H?,!B,.9+UU4KVI$QX3HX OF*;]PZ+\SW1VL2+WMKCG:&S=XOO1@%
M]9D'MKG(-MDO<C%5MQ$)([& U?][7V%X&+P&+H(>)LZN\AN3F3 +R4/NX%;6
M(A_,JGP^A]UGX0,!K:4MRU<DM"Q_>-YT\FI=Y;.JKKI*ARJQ&77K>LN+ 5TD
MYC3SOG=D%I(*V2@SNL@)WL_NX'WH_WUD67-KFEX),9_@>AU^*7M+FA9?8KV#
M K4EZ4VW;/O%4F4T80L6<$!6G@99>7I05BYSMV1R^(>7V)#;O*8%C0G-;QSJ
MHV%]K4ICLYSLP!*+/('^K^!@UZVKE.U5<XOUB<RPE+2V6H#7-42B Y-X/W@/
MK#'92AP/=+(F!P?!F6$>FMK$J4__](?IT[-OY=^+3K1.?O-.!CNW7MOV$_,5
MQNWQXZ]H$E)<'@U6=FEJV"38/1BFYH;D^:(GAP Y$?$<##!]_M7X2]?8V!P;
M;$ZS[+J'2X$AK,2@@BLZIS4$MD@$=F>O<[N M3V]/LW*=D6R4/#@@U6"VV5+
M=@K\J"M('&L,RV>.T1WPC# 10V-;"K#)JGN\,RQ6KI_]C;4+5@[6N6]ZUV,3
MHMC;RMU@]$V+M9/8-@2@]&.H48N'2/)Y#V'CX0SX-2*5%F9-S1.Z9;5VAPS>
MLR#$SPY*WH7X*P>S7AAL_:PV8^+[Q8-DX*7YU,%F8XG-"?LL</UD!D/-*FOS
M$C('+UHQMUAF&-09ZQT+!+0$X^P&G.BMF-"9HK)3FH"VN\O)"S<D!^T=^V%8
M2VQC/^OF?>W]L0/G FF$5<NL7\/N8B>[EOQMC3EJ#XC)OMB*?%PP-P7MBCXB
M%F[C;=K(%*?9%1-EYB"&UX>%]D58,&TWR\QQ]4 <-7B#%RO U=(_1%X;H])R
M$B'W3!J*P@0C82B03;X"3G+1LA[(2 8JW<O#;+D]G\G?3I]]FX@GI!HOL$1C
M0(P(4U&!0[S0=;YA1R-,VXC^+FB>L4$C-\C"X]'CZC:.1\$3[2_M=K[ 'L*9
M@V$5IK^M2M(9/Z".!\K[CO2^%#U(=I,!SR%E>!Z4X?E!.;Z"%6U('L8=_[U?
MSM*?V2QTK-7J$"&HV#]VH01A@(P08R)PK &V:46T6P;BL83*R#.P-Z4AJX\Y
MV:"1%BS4HUJH584-DY_ )< G>+Z2543EKDH(FNMVEH0*>P\_>%(U<C3VW+8K
M0)06KX/&&>"=<06IQ 0.?07,082W&,>".L>>F8$%O8LH]L9X-9F04\%^0@ED
MUKGB1YC![H[P*7TLK!"%\L2*A)$.>-]=CK+J-'L%!-Q"DK :?!/1M6=: %F'
M!\)K1=V7HI9^[=#^2E$:(1FO:D5O+2F#RPG@XQOQ9XE!L0:>%P%Z> EO11!"
MB*_O"$N5<%M-.1'](%QONHH"<@H@"@DD8/#P)(V"1QH$])XXV#_YB71;U>RV
MDF':AK$9/@(<O5%%33;RD,9\'33FZX-"_]9"D2UM\MLZU]D(OJS)4(SIT#\Q
M7!:_78=O3?AVJ&<L3VR@F,-@H7K6J#D$0R@S<4)4J,ZH;VA%?.8M.15Z/LI-
M[PSYE1H;Y+[)_AONS&4O^JIFL_2$I/SQ&;!2L<2@D.!'],GT"2*DU;J',*8$
M@SK7SKL[(I&?>Y*]@L14+!7T[;SZ1#^[[!F/<I:]-B!OV0+45"N(P*U&"7_.
M_KSG&QH:*!K F+0"'XOJ$^P3$R2_X=V,0:6:AI'ES@.&9\=C2D7]I]E+0N-E
M)922<6&W;)K<^T^*<RHKQ!1+ F(EK4=1/*$KZ!VI$YFLI1%W3H.3W7.T)F]J
M[BI'%L0!^=)RYNQ# ?M:AFHFV?4(I>">^U4O) =!(&UF"R<+<N3@2>6"+Q>Z
MBQ9A]S^,?TI-([DK!L^M"U!E$ &G<>\<S@#:*)P@*;!F2:D[3"9?G-Y#KA']
M5.8.(Q-[L<%@)W\'%]$8VE2*CB3*!H,1E$GD6%DLG7RF!.LES%(GF%:XE5N[
MH05)G$6TNAZ1M89SJWRC6)@Y@6D$VEPT*0G"!!>9!0F<[QN>X1+OK/E4&%,Z
MMNYSC*66_(!)FI[%Q-W902OR4]N6=U5=CR;E[O<J!^A$HW.>[G6/^(<4A<RR
MB;K$U(O'4R^21-$%A^GE;FA,4;GX*8]HR6;/U%4Q1XL:3U7SBE4M6RAEIUF@
M$<_0_@3]AOU/0M[(?_5M"/2@U[M"!&D@"T!RU_0<4U7>_/4688CF8.#$;2=&
M(V2#)B1QF![/4D8"H]';\]\FCB(8)'60.*&/+$*ZW+T+&&8 ^H;@,XBH"455
M!<>"<(?R&05W$"D.,*!W.;_BS$+$F9[XIV5\BY3?(.Q)EGKZ&=@)ABXJPC 7
M+'2C4O^%8V3))RK*,85IS5KRIA+$-?F*D,G,DHSS+XHY.N,-Z8AKYL1#:II5
MBC4K^8IV>(<&CHH1K%00&W; D\%KK#3B9S_KYUE]Q[WZ).LV:T)PM%:BP*-A
M.&"XK4=G+/H'H^_I>=R^\X.L_]',NNR-)&MX#9?@SO@>_I:!$ %P>.D=+#S@
MK//)(7Z,=L/G&1N-?YG/C,1AIMB-0ZYK!)4^\S3K!GF3]YQ@DY'V( Y!%T,
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MUF%B?%^,_RYPJ'(* ;2CZNNSK[Q",G-'F$IJ./T*BAI0 ;[9=]3(FD&'=(J
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MF*T3"*Z]/'3O3Y?Y;N)@Z9BZOKEIVCNY%*#G7>CM $3,6FNEW];NR'W21)D
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M_YI#>GQVP@9'/.[@/N:8A!G^B09>GX A&Q;(94 K"ZSF(38J;,5*R_!Q1>T
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M\H]+P'UCZ0%\/V\A:/H+31#^ZM4/_P=02P,$%     @ @8*F5+AFBH[8!
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M19$'H/O'JY]8M?,/QEI9?'[\L,'WGFEG@/L;I>PX<033'\3R;U!+ P04
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MP.]CA:=T-W &UO\D./D74$L#!!0    ( (&"IE16L3 X)00   <,   9
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;.U6;6_;-A#^*P<M'6Q C23J/;,-
M)%F+!5C0H,E:#,,^T#)M"Y5(CZ3B9+^^1TI6E#@1MN_]8I.\N^=>^!QUL[V0
MW]26,0T/=<75W-EJO3OS/%5L64W5J=@QCI*UD#75N)4;3^TDHRMK5%<>\?W$
MJVG)G<7,GMW(Q4PTNBHYNY&@FKJF\O&"56(_=P+G</"YW&RU.? 6LQW=L%NF
M_]C=2-QY/<JJK!E7I> @V7KNG =G%XG1MPI?2K97@S683)9"?#.;J]7<\4U
MK&*%-@@4_^[9):LJ X1A_--A.KU+8SA<'] _VMPQER55[%)47\N5WLZ=S($5
M6].FTI_%_C?6Y1,;O$)4RO["OM4-T6/1*"WJSACW=<G;?_K0U6%@D/EO&)#.
M@-BX6T<VRE^IIHN9%'N01AO1S,*F:JTQN)*;2[G5$J4EVNG%[PQ34C"YH\N*
MJ>G,TPAJ1%[1 5RT .0-@(# M>!ZJ^ #7['5<P /H^E#(H>0+L@HXC65IQ &
M+A"?D!&\L$\QM'CA>(I_G2^5ELB"OT<PHQXSLIC1&YB7HMX)SKA6(-9@/<"'
M!^P4Q5XKX3C8W99!\0RPLH"L!01L/="H\\BH5,!,F0&+5&S[*@'E*[,(8,\D
M ZK0IL)^4V<#Q<D51QC1*%16T];.VGPL.>4%Z[P60NDS.*^%U.6_U+8.1B0-
MN]^+]?M&&7S%,- 3(&Z<YO;?#W.XXAJ]*PUHTF)5)5V65:E+K#]!#1)'\&G'
M),+RS< ?)&Z2^OB;HL+M%ET#0M5#C<!/(8OA"Y6EH>I0%!$W2S*(T#P-X+99
MMK*28U$9_/Q31@+R"TR"+)O"G="T HZOW0#@!&+B1DEH%K&;!C&8*]G;CL9:
MTWN,>,/P#3*OW%/D-D13^2/-5:D*T7 -F"D;NQ-["5__DZ.)O?[IR_HIB$[]
ML+O#P2DY3:)CY.>!'4&%!NK=:V!Y N]&^B;N^R8>I?HUU8UL^8"D>O+?]NAK
MK3.*9SY99VI'"S9W\)NDF+QGSN+<@C\OLFL[J'[F_IBC1S?UHF?^Q"LP[YP)
M^0G_91J#^G4'+>LP#D.QQ,W#P#9-CI=_ KF;Q:$11BC*_*@3Y&Y*$G,<0^0F
M* S<V,]1)0BM-LI<)#;D9A'ZF3E+42G+<LA\7.1);GB,G^HU$@@/4C_NNZ'=
MM7$U_$ +9$I;E!U]K.UC1"(W2&)(W9CD)MDDCS II8#6ED=]&7L+R>Q-<%N0
M\O D3-!AD$YA0M)D:G9Y'AZZL=.'>UHU[!5$+!6V9Y3A(G5);&I(L#I^ ".,
M3'I&)O^#D8>G\&T^CJ+]X.,//K[DHS<8SFHF-W8$56#S:^>T_K2?<L_;X>Y)
MO1V1\8HW)5<8SQI-_=,4'T?9CIWM1HN='?660N/@:)=;G-29- HH7PNA#QOC
MH)_]%]\!4$L#!!0    ( (&"IE2.)&RAR@(   $&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;)54VV[;, S]%<'80PL8]=U.@B1 TFU8@14+VET>
MACTH-AT+D2U/DIOV[T?)CIL"38"]R))X>'A(F9P?A-RK"D"3YYHW:N%46K<S
MSU-Y!355-Z*%!BVED#75>)0[3[42:&&=:NZ%OI]Z-66-LYS;NXU<SD6G.6M@
M(XGJZIK*ES5P<5@X@7.\>&"[2IL+;SEOZ0X>0?]H-Q)/WLA2L!H:Q41#))0+
M9Q7,UK'!6\!/!@=ULB<FDZT0>W.X*Q:.;P0!AUP;!HJ?)[@%S@T1RO@[<#IC
M2.-XNC^R?[:Y8RY;JN!6\%^LT-7"F3BD@))V7#^(PQ<8\DD,7RZXLBLY]-@H
M<4C>*2WJP1D5U*SIO_1YJ,.)P\0_XQ .#J'5W0>R*C]239=S*0Y$&C2RF8U-
MU7JC.-:81WG4$JT,_?3RFZY DE6>RPX*\I71+>-,,U#DZCO=<E#7<T]C'(/V
M\H%SW7.&9SB#D-R+1E>*?&H**-X2>"AP5!D>5:[#BXSW5-Z0*'!)Z(?A!;YH
MS#JR?-$9O@U]L<D1VA1]\I0K\GNU55KB?_+G0HAX#!';$/'_%O:]>EZD,GTY
M4RW-8>%@XRF03^ ,_'3@YR</EPML&:6)* EB2"DX=AYK=C."9<PK6\>KNP:-
MHE-8 '5MRVJ68!2,';H'C5Y(I[0B'TB4ND$\Q4TX=:=),B)S4>.$4-0V60\.
MIFXRR4@0NWX6C\"M%'N4C/B:*=/4"'2#;(JK'T;DKD$+$$V?,8>V?R 2NFGF
M(R!-PI&GE:($2T Y*0'1L1LD/JYQ]@95=/F)J,A-)RD23B:O($7-3X A28*6
M*)V0\V5-T3_#(-,LQ2)D&#.(<),&;NR'Y+T_QCMIRQKDS@X?\SY=H_L.'6_'
M^;;JV_H5W@]'?+D=PX)Q*-'5O\EPG,A^X/0'+5K;Y%NA<638;84S&J0!H+T4
M0A\/)L X]9?_ %!+ P04    " "!@J94.&T4=D $  "V"@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970S."YX;6S-5MMNXS80_96!FK8)X+4NMAPGM0W8FRZ:
M1;(;)-D61=$'6AK+PE*DEJ3BI%_?(25+3N*X19_Z8L_P<N8,YZ*9;*3ZJM>(
M!AX++O346QM3GON^3M98,-V7)0K:64E5,$.JRGQ=*F2INU1P/PJ"D5^P7'BS
MB5N[4;.)K S/!=XHT%51,/6T0"XW4R_TM@NW>;8V=L&?34J6X1V:+^6-(LUO
M4=*\0*%S*4#A:NK-P_-%;,^[ [_FN-$[,EA/EE)^M<IE.O4"2P@Y)L8B,/I[
MP/?(N04B&M\:3*\U:2_NREOT#\YW\F7)-+Z7_+<\->NI-_8@Q16KN+F5FU^P
M\<<13"37[A<V]=D!'4XJ;6317"8&12[J?_;8O,/.A7'PQH6HN1 YWK4AQ_*"
M&3:;*+D!94\3FA6<J^XVD<N%#<J=4;2;TSTSNY(B>W>/JH +7!HXOF=+COID
MXAL"MT?\I %:U$#1&T!A!-=2F+6&GT6*Z7, GUBUU*(MM45T$/&:J3X,PAY$
M010=P!NTK@X<WN -/.?@1:X3+G6E$/Z8+[51E!9_'@ ?MN!#!SY\ _R.JB6M
M.()<@7M3LWW3?4]Y$,O6X;DN68)3CPI-HWI ;]:!IM:/1%)=:*.M/;-&6$E.
M]96+K >L74R900VY2/.$I/0<CB\%;<A*,Y'J'N!C@J6!$E6"PE -ZA.@5T_6
M[MD[B0(0PAV*7"KX)"WF$IDB8X1-E% ;8 8&_=,X^+Y'"6S6W4;)GFQ* 57@
MO%0YAQ#(.'Q.C%RB(HVX(B-#3VCC?4^T7YNCZK,1ZS LIT'8AR,8!4$O"((=
M*0K"LW]F&_?#*#[$]B,3%;4I"&-'^&/%G;R/[DM['=T.Q+WBN _#AN6P8QN!
M*\#%NYA2AXG]?&T\%U)16J+ZD2)<UDW- )(#])!7EXO/MU#R2@,C BK+A>4:
M]8,V)JPYM.*2J-)F4&^2P@B*DS%!>>*Z'"@KO8(+G\&U0,UR6CUS.AHYIX=]
M^.&[<11&/\'P+/X?.!W_%Z=ME= -416=GRXEVL VOFU]?5&P86][H).N4.MS
MJ 0KI#+Y7YAN:]L6]G$X[@V&T0D),0FG)R\0>R#HFWUDX4Y'O5$\;N0SD@=P
MH*7%;4N+_W5+^U"YC+ZA""5YR3C<L"?Z-!N]K[L=A-W?W>:N9SWK.!%ULBQ3
MF-F8K&K[96N_;.S38/"MRA4]76X_\8E4*1,)UK&WZ6/?JVV(7=[9G.O5^GQQ
M!;?X(/F#BW#J3E+3)'BRJ2&3M"%L:IJ]S6E[Y74?8$29NG'=F_6+]GL"OU/&
MVZ^EA>Y<GQ>R$L;:&5!$M]EDZVA7B7>5T:YRVBK4G&A.6QG;9MN<.]J1]R6)
MOS-+%*@R-S%IRDDB58\5[6H[E,WK6:0[7D]TUZZ"-'!<T=6 /@\>J'I*JA4C
M2S>9+*6A.<>):QHL4=D#M+^2](R-8@VTH^KL;U!+ P04    " "!@J94#T0&
M V@#  #D!P  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R%55MOVSH,
M_BN$-PPMD,77-&V7!$C:#:= .Q1MMST,>U!L)M8J6YDD)^N_/Y3L.+<V>[$D
MFOSX\2)JL)+J6>>(!OX6HM1#+S=F<>G[.LVQ8+HK%UC2GYE4!3-T5'-?+Q2R
MS!D5PH^"X,PO&"^]T<#)[M5H("LC>(GW"G15%$R]3%#(U= +O;7@@<]S8P7^
M:+!@<WQ$\VUQK^CDMR@9+[#47):@<#;TQN'E)+'Z3N$[QY7>VH.-9"KELSW<
M9$,OL(108&HL J-EB5<HA 4B&G\:3*]U:0VW]VOT+RYVBF7*-%Y)\8-G)A]Z
MYQYD.&.5, ]R]1\V\?0L7BJ%=E]8U;K]Q(.TTD86C3$Q*'A9K^QODX<M@_/@
M#8.H,8@<[]J18WG-#!L-E%R!LMJ$9C<N5&=-Y'AIB_)H%/WE9&=&7QA7\)V)
M"N$.F:X44L:-AI,G-A6H3P>^(2]6UT\;Q$F-&+V!&$9P)TN3:_A<9ICM OA$
MK^48K3E.HJ.(=TQU(0X[$ 51= 0O;F..'5[\[YBON4Z%M&%K^#F>:J.H37X=
M\9&T/A+G(WG#QR/=GJP2"'(&5TRI%U[.:Y\:6)G!9VTX]11FL&&CK?(U3@W<
ME,2D<I5XK0!'7=MK?*D7+,6A1_=4HUJB-WK*D=I&/=,U7]:^<K9$F"*6U,0&
M%?46D;$-G@'=EEU=NOR@><$%4\ WW(!EOZE%R<(JI*@,30&840JETET8:[KK
M:=X!0\ZI=B$\8LE)\ZLTJ-?B\.(5\1,1@LG''MQ*5FY4(QA/;N$!EU(L4;E$
MRLI2H@!0&U"44= KMB!JB@*N.SHC!;C%)0J(;(HM&)M*"C_GJ)A*\Q<XT8CK
MR419H5EET\*XL'6S!NFZB*R0E8N=G&-;Q9FMXK*M(EEHW$V5@3OKJFUD!V"S
M<MK=_[-S#.'DIB1 66FRT*=[[;35/T?^'*09WD,2!)T@"&@77_2;W4:6A+7L
MH&YPUNCTXL2M[;D?-!94I_T"?I5=Z,&'=^=1&'UJU^2BYTR2B[C3/XO?-CW;
M40V3Y #JL#OV-?;7FU>ZY@"U$UM:[OO:5/"W)F^!:N[>%PVI;9%Z"+?2]@D;
MUY-[HUZ_?U3T.34,")R1:=#M]SQ0]9M2'XQ<N#D^E89>!;?-Z1E&917H_TQ2
M>9J#== ^[*/_ 5!+ P04    " "!@J94\]J#J(X#  #;"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970T,"YX;6S-5DMOVS@0_BL#;5'$@!$][+AN:AMPDJ8U
MD.X&2;8]%#W0TL@B2I%:DHK3_OH.*5E5NH[;0P^]6$-RYIMO'N1XME7ZLRD0
M+3R40IIY4%A;G8:A20LLF3E6%4HZR94NF:6EWH2FTL@R;U2*,(FB25@R+H/%
MS.]=Z\5,U59PB=<:3%V63'\Y0Z&V\R .=ALW?%-8MQ$N9A7;X"W:?ZMK3:NP
M0\EXB=)P)4%C/@^6\>G9B=/W"N\Y;DU/!A?)6JG/;K'*YD'D"*' U#H$1I][
M/$<A'!#1^*_%##J7SK O[] O?>P4RYH9/%?B \]L,0^F 628LUK8&[5]BVT\
MGF"JA/&_L&UT)Z2<UL:JLC4F!B67S9<]M'GH&4RC)PR2UB#QO!M'GN4%LVPQ
MTVH+VFD3FA-\J-Z:R''IBG)K-9URLK.+"]3\GKG,P$H:JVM*N#7 9 9O,=MP
MN8&E2QRW' T<W;&U0#.8A99\.X0P;?V<-7Z2)_S$";Q3TA8&7LL,L\< (9'N
MF"<[YF?)0<1W3!_#*!Y"$B7) ;Q1EXF1QQO]EDQ<<),*96J-\'&Y)G5JKT\'
M6(P[%F//8OP$BUNZ=5DM$%0./497G*VY:%PS"Y>,:WC/1(W[*G'8PUV!D"M!
MM]&%9%U!VRO)OQ*Z=<<._M[!&\=#U9H:O>/"^]GQ"LX&*4^M6)&NR@R80FWE
M*5"ATJ*K%!RM)&FIVE!FS<#G%N'N2X5PR2430.^ %>C@@3H:X6_EKB\=+$M5
MT^8_Y$)3*5)=8_8H,2MI4:.QH)V=V;(*SIDI(*=8(0Y'<>@)/(/G?TV3.'G5
MD^Z4)0_?X^X=/:(?_PGTZ<$=1E%$TE$R'$U&@WWTVZ,#+7G2M>3)P8;9?S&&
M\(:>?#BZ4F;_>W 0U,V:4U.Q%.<!#1.#^AZ#G[6FZT/^OR01$TG#R_4>>QB2
MO=[7A#^4[4JES$\%GU)?6/J)^C'!#:9J(\ES1E[;NIVKDN@6;BA1.EK%E4Q5
M22O,<_1#!BJE'?J@M4H?6?%677CC9Q /I_%+^HZ&T?C$56X\G$[&@Q^Y"&8,
MSSFQR;4J70?592TH"]DO<*.TJ9W<]1D^T&@WV.3/=\PX>3EH&+R81$Z:)+"O
M@\+>P"E1;_Q8-10G=7@S>[K=;G(OFX'U7;T9^W2]Z&TU(# GT^CX!?6-;D9I
ML["J\N-KK2P-0R\6].\#M5.@\UPINULX!]W_F<4W4$L#!!0    ( (&"IE1,
MSK<OS0(  #(&   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;)55VV[;
M, S]%<(+=@$*7].FS9( 2==B>VA7--V&8=B#8C.Q5MER)3EN_WZ4G+@9D 38
MBRQ*Y.$A*=*C1JI'G2,:>"Y$J<=>;DPU# *=YE@P[<L*2[I92E4P0Z):!;I2
MR#)G5(@@#L.SH&"\]"8C=W:G)B-9&\%+O%.@ZZ)@ZF6&0C9C+_*V!_=\E1M[
M$$Q&%5OA',VWZDZ1%'0H&2^PU%R6H' Y]J;1<-:W^D[A.\=&[^S!1K*0\M$*
M7[*Q%UI"*# U%H'19XV7*(0%(AI/&TRO<VD-=_=;]&L7.\6R8!HOI?C!,Y./
MO7,/,ERR6IA[V7S&33RG%B^50KL5FE8W&7B0UMK(8F-,# I>ME_VO,G#CL%Y
M>, @WAC$CG?KR+'\Q R;C)1L0%EM0K,;%ZJS)G*\M$69&T6WG.S,9&YD^IA+
MD:'2[^#JJ>;F!=X_L(5 _6$4&')A%8-T S=KX>(#<%$,-[(TN8:K,L/L7X"
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M/SCU0+43JA6,K-Q46$A#,\9M<QKJJ*P"W2\E]<1&L ZZW\3D+U!+ P04
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MBM9QZS?M!:K]<7KK+RT+[? *Y#\W>.=4AA;@_$IKM_\A _TM]O)?4$L#!!0
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MH-S!B:E-K2 NYU@QD25M6PV@D3.,<U!:;FJ, [Q'=8G.!G_@_)J1-5QUH-P
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M8DDO)!KO0.=[K=U1\0FZ-W?Y!U!+ P04    " "!@J94 $C<Z-$'   @%P
M&0   'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6RU6&MOX[@5_2N$,6AW!]R8
M#U&DIDF )#N;#=!I!I-L%T71#[+-V,+(HBO*\4Q_?0\IV7$<6;/;;KY8#Y.7
ME_?<<\^E3C>N_NP7UC;DR[*L_-EHT32K=^.QGR[L,O<G;F4K_//@ZF7>X+&>
MC_VJMODL3EJ68\%8.E[F134Z/XWO/M;GIV[=E$5E/];$KY?+O/YZ:4NW.1OQ
MT?;%IV*^:,*+\?GI*I_;.]O\LOI8XVF\LS(KEK;RA:M(;1_.1A?\W:4)X^.
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MP_<XO/PUX35)1B7V"* 3R@!$N$%$4G6 K53 EC$B4ZHS262FJ,'U&;9)QJB
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M;1I54J?!R,$6;I ]#T7(D1_*XA&&H+5H\Q3700T9B 4>(Q&"\/ZT/XYG!MD
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M%>ENVF72.E8W_@$?M*5UX,V*]B\8ET#Q0FM[=MQ.Z#=Z^AM02P,$%     @
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M;I6TA8%KF6'VFB D29VN9*MKDAQDO&6Z!_WX%)(H2=XI:/IQ>/P.?/9Q>'1
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MC(V.02II2-J.S'B/.=^?!I[7SMRD\COI]7N?I2E[AE D"=5&U_49:"(3$!O
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MC W 1GPC^"A[8V!*V7+^;";W^<(+C"),<:9,"J3_#GB-*369M([O;5*OXS3
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MW01\/E?*/E^XSPGE%ZWIWU!+ P04    " "!@J94WQ_#MY "   V!P  &0
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M!VAW /<+I>QAXAI:_SM*_P!02P,$%     @ @8*F5*&7.41B @  AP8  !D
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MH]M60/V/>"Y4_ 5F$7\0Q0OT(L$QX7G2LMO 9U>)SU0@'=5 .KDO'.>2KDX
M?#STQL)<90 J@(VJ@6VG3[.HF%;*@>;@!&!,@#E(I8"/*CE]R[,I8[,"S?,L
M05%1+,-T6L<H<;41K)38%YQ-6M8;YG0P49E3X"D%$&Y[9ZD:K4 [:@^Q(JC
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MMD-# H3H& _3'MSDIK6([<YV*-NOW[43LK*F$51*XX][CL_Q=:Y'6ZF>]!K
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M,,?9=#2<+L,\V&A'TR4L]S3.T7@'.M]JZDEM^!'3_""FOP!02P,$%     @
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M?/\[+0KJFGAS'LOL/]@7MH$'YENI>%(XZPP2EN:?Y$>Q$14'&#8XH,(!G>N
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M@7Z_Y/K7KQB8J]_RJG_\'U!+ P04    " "!@J94Z_-\ZQ("  !2!   &0
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MHW8)]ORH%)T#-XC];R3]"U!+ P04    " "!@J94,[PISY$"  "R!P  &0
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M7@_W&[P)RI0%EB]H3-G\UY2-E>+I"K J#9D?2-7ND1_L\'C/541^?$%*\ME
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M=&YLQ5$7UJ1S+-\=H&UJ/1PO]G7M^+(Y]@R10@OZ77*##KE6Y';)3;K0"@;
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ME"PK+K<$)X1K@?I]S9@\WN@!ZH/+V?]02P,$%     @ @8*F5/QGR<<5!
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M7.FVP3ZFNA6DP@#T^PWGZC@P"]3-Y>P_4$L#!!0    ( (&"IE1N%O/!IP0
M -(0   9    >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;(V8;6^C.!#'OXH5
M[8NNM"G8$""K-%(?=+I*>W?5MKU[[1(G\17LK&V:]C[]C0F%!!O:-PTDX_'/
M8\_\QUWLI7K66\8,>BT+H2\F6V-VWX- YUM64GTN=TS +VNI2FK@56T"O5.,
MKNI!91&0,$R"DG(Q62[J[^[4<B$K4W#![A3255E2]7;%"KF_F.#)^Q<_^69K
M[!?!<K&C&W;/S./N3L%;T'I9\9()S:5 BJTO)I?X^S4A=D!M\3=G>WWTC.Q2
MGJ1\MB^WJXM):(E8P7)C75#X>&'7K"BL)^#XU3B=M'/:@<?/[]Y_JQ</BWFB
MFEW+XA^^,MN+239!*[:F56%^ROWOK%G0S/K+9:'KOVC?V(83E%?:R+(9# 0E
M%X=/^MH$XF@ C@<&D&8 ^>R J!D0U0L]D-7+NJ&&+A=*[I&RUN#-/M2QJ4?#
M:KBPVWAO%/S*89Q9WHI<E@P]T%>FT=FU+'=2,&$TDFMTP]9,*;:ROZ(K6E"1
M,_T5G=TP0WD!3U/T>'^#SKY\15\0%^AA*RM-Q4HO @-H=H(@;S"N#AAD .,/
MJLY1A+\A$A+B&7[]^>'X='@  6FC0MJHD-I?-.#O9.676C.C1[Q&K=>H]AH/
M>+TL(&EL$!&D'UK)ZLFLJP).<BXK&W(('=*T@(U0S%1*>.-XF"*MI[ Y^K*,
MDW"V"%Z.H^4Q(DG:&IW0QRU]/$I_*U[@8$CUAG*ZXX86_#]J,]$'>?"4',U/
M2(A[D*X1QB3V0\Y:R-DG(1733+TP;PQG[LPDB7MX'B.,YWZ\I,5+1O'^A+H,
M%5A!X,0&%5)K"*92;W >]E3Y$R?Q</3W>]SF!#5M4=-1U'M##8.LKLN#L>7!
M!Y<Z$\^3I+_1KA$.0Y+Y^;*6+QM/ICQ7%61HP>D3+[CA?L#,/8DA27J KA$.
MTP&^><LW_Q0?Q \D5P^FRMR9.Y[-TQZ@:Q2E4>('Q&%7^L,/MECFSQ\"-DY.
M">.L1^BSBI*!=,%'ZH1'$4&J08B%/8 HAX+,C1<1.Y.'?3[7))D/X74R@<DH
MW@\&'41[!-^\;,2=. N=\+E6&8[( %\G.'A<<1X%M'90J.$<KIM(LM=\2\6&
MU=7'"QRY*>,4'(]1E W4;MPI#!Z7F+_,EBDODZL5LR0C?2B/U1P/I4DG*7A<
M4QXDB)UM#0\M@3V*U-,2-*2N;,0X)0ZJQRR<#TDT[O0%)Y]O7'X,E<93YYTB
MX'%)N%-6N\S;-[2#7M#4_0K[5?$=M/7^O'0K_S0EV,E-KUD\(&"X4P@\+A&W
MPL!)YT\%&]LPM_A/XQ1RKU^#O8:S#$P'.#NEP.-2T6Y:7I550>V]!MH"DV^G
MU0[1U;]P"RCKGGP*70WT-Q6#SUQN!#_<A#H+[P)=\7 VP#69'C=$ISUTIR]D
M7%_J.^%4KJ>5;G; QT=<Y9@F))KW&'UFZ7'G>PK9*0P95QA/=G_04A!72J9Q
M%J=IOZWP&J911@;2G!Q=3\9UQ_:17F2O!#7.TA... IG_9;7:QB1+ E[P,'1
MA=/>]N'^M>%"HX*M861XGD)Y4X<+].'%R%U]!WV2!FZT]>.6T153U@!^7TMI
MWE_LM;;]-\;R?U!+ P04    " "!@J94 /8W4J "  #O!@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Y,RYX;6RU5=M.W# 0_14KZ@-(E%SV6I2-! M5D:!"
M4.A#U0>3S"86L9W:SN[R]QT[V71ILVE?N@\;7^:<.3/VC..-5"^Z #!DRTNA
M%UYA3'7F^SHM@%-]*BL0N+.2BE.#4Y7[NE) ,P?BI1\%P=3GE DOB=W:G4IB
M69N2";A31-><4_5Z :7<++S0VRW<L[PP=L%/XHKF\ #FL;I3./,[EHQQ$)I)
M012L%MYY>+:<6WMG\,1@H_?&Q$;R+.6+G5QG"R^P@J"$U%@&BI\U+*$L+1'*
M^-%R>IU+"]P?[]@_NM@QEF>J82G+KRPSQ<*;>R2#%:U+<R\WGZ"-9V+Y4EEJ
M]T\VC>UT[)&TUD;R%HP*.!/-EV[;/.P!PND!0-0"HM\!ASR,6L#(!=HH<V%=
M4D.36,D-4=8:V>S Y<:A,1HF["D^&(6[#'$FN1:IY$"^T"UH<O29*D5M7H_)
MT248RDI]3-Z3QX=+<O3N./8->K0X/VW9+QKVZ ![&)%;*4RAR97(('M+X*/4
M3F^TTWL1#3+>4G5*1N$)B8(HZA&T_'=X."!GU*5OY/A&?TT?66*@3.0@TE?R
M[0;MR+4!KK\/>!EW7L;.R_B ER=:UK2Y]266'14I])U%0S)S)+9ZUTD0^^O]
MY Q9O%$VZ91-!I5=:<.PEB##BL[JIC*9(#4J5'A]!#&8F4K)-;-EKT^(@*TA
M>"VXNQ9]430.IWL:)X']]0N==D*G@T*QYK&BQ<!AS#JFV7\\\GGG93ZH]T:*
M_+T!Q6U/ H79=:FD6H/I3=O\CZ,-/[S-6W,%>NRBOOSZ>SV%@\I=J]4DE;4P
M37OI5KMN?NZ:F/_+O'D*L.AR)C0I8870X'2&1ZR:]MI,C*Q<AWJ6!ON=&Q;X
M(H&R!KB_DM+L)M9!]\8E/P%02P,$%     @ @8*F5.AAMO.]!   /Q4  !D
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M[: <-KBFZH'OOD'K9V3X,DZE_46[-M9S4%9+Q<L6K!64A#7_^*4]AP. 'Y\
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MJ[[,VSO=1_];J.MO353'H+!2..<J4E\3;_IU,Y&L,@UIR:1J;V:8JU\<X-I
M[:\8DZ\3W>.ZGZ;Q7U!+ P04    " "!@J94>/P!C'L"  ">!@  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q,#$N>&ULA97+;MLP$$5_A1"R<( F>ED/![*
M.$G1+@(8<=,NBBYH:VP1H4B5I./D[SND;,%MY'HC\37WW"&I4;&3ZD77 (:\
M-5SHJ5<;T][XOE[5T%!]+5L0.+.6JJ$&NVKCZU8!K5Q0P_TH"%*_H4QX9>'&
MYJHLY-9P)F"NB-XV#57O,^!R-_5"[S#PQ#:UL0-^6;1T PLPS^U<8<_O52K6
M@-!,"J)@/?5NPYO9Q*YW"[XSV.FC-K&9+*5\L9VOU=0+K"'@L#)6@>+K%>Z
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MR!6$# OC&(C];'&!C#DB6\;OGC,84CK@_OB)_8/7;K6LB<:%9#]H:>I9\"Z
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M75Q=!J"Z'M1-C&S\JUQ+8]^X']:V;:-R 79_(Z5YFKB'/OP19'\!4$L#!!0
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MA.SZ8S?1HFY[TK/0V.':88&_%) F -<S(?1V8MK<\).*/P!02P,$%     @
M@8*F5(99P+QE P  X@T  !H   !X;"]W;W)K<VAE971S+W-H965T,3 V+GAM
M;+57T6Z;,!3]%0MITB:U 9N$)E42J4TVK=(Z5>VV/DQ[<, )J 8SVS2;U(_?
MM:&0M(1$6O,2L/&YY]Y[PL$>KX5\4#%C&OU)>:8F3JQU?NZZ*HQ92E5/Y"R#
M)TLA4ZIA*%>NRB6CD06EW"6>%[@I33)G.K9S-W(Z%H7F2<9N)%)%FE+Y]Y)Q
ML9XXV'F>N$U6L383[G2<TQ6[8_I[?B-AY-91HB1EF4I$AB1;3IP+?#['(P.P
M*WXD;*TV[I$I92'$@QE<11/',QDQSD)M0E"X/+(9X]Q$@CQ^5T&=FM, -^^?
MHW^RQ4,Q"ZK83/#[)-+QQ!DZ*&)+6G!]*]:?6570P,0+!5?V%ZW+M0$PAH72
M(JW ,$Z3K+S2/U4C-@ XV $@%8"\!/1W /P*X!\*Z%> ONU,68KMPYQJ.AU+
ML4;2K(9HYL8VTZ*A_"0SNM]I"4\3P.GI3&0AR[2D1@6%Q!+=)NH!O9\S31.N
M/J!38,N*)>A32";'K@92 W7#BN"R)" ["#!!UR+3L4(?LXA%VP%<R+9.F3RG
M?$DZ(UY3V4,^/D'$(Z0EH=GA<-P"GQ\.]SJJ\6L!?!O//T2 LOD_O\ :=*59
MJGYU,/1KAKYEZ.]@^%JD"R:-M#I.9'2:4ZG_;JFJVF0M@P8VJ'&/1Y!R.'8?
M6S(9U)D,.C.YHYPI](1NI(B*4*-PJW9I:G]"WT2.!F@A:1:ICNJ#FC,X4G_/
M:H:SSJIFKZHX03F39@Z<LZVUW?'ZN.=[[]K^V'MP@U[0BIOOP9'7N*U&#.M&
M# ^2=V9M"_YRK?K>4PY?&-W!-ZKY1D>2%GN-/7IO+.Z>@,3K#=K5W0?$N^3=
M!_1[N%-?O/&QP <I?%?D.4]:%>[B(0T/.9:RC>]B_W]M$;[%.D9<9*M3S61J
MJH6<0MWJEQ7=IF$2O_;+2N+7:_"HW5-Q8^^XV]\/$ 6>7C>%==DJ;KP<#XZE
M4>/=.'CKMZ\[8##J>3O>OF[@6<MKNUU4\[G W7Y[$8:BR+2";7/(DD>ZX.P-
M3!,W+HV'QQ*N<68\>FOAN@,2LLO$W(W-+_1O90\1"MD>EYO*>K8^J%S8[?F+
M^4MS@+&;ZB9,>?J!/=\J@=TQ9TL(Z?7.X,V0Y8&B'&B1VRWV0F@0T=[&< AC
MTBR YTLA]// $-3'NND_4$L#!!0    ( (&"IE1]S]5.+@4  !H6   :
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MI6"$4[)3*SB^QQ?D<X2G-_B!8BK9+,O'<$%?U0D<#U&SO% G< J/HR$<'YW
M$>0<'C(Q5XRGJNMJ2LN0N^,ZA4&50K G!3^ 6\%UIN"*IYBN$[BDIQ$5+$4-
M@H.,MTR>0>A_@\ +@AT)77X<[N^ #S\.]PZH"1N+0LL7[N&K_5 PD:*$JU>-
MDK,"+NW'@5(!E1UN!)^>WM 62N%"*20?_]P0#UQK+-7? UE$31:1S2+:D\6#
MT/1257TEM..KG':Y7?$DEL<<.R]]WVO';9^<>%DU83NN$X5AW%H/&^X(BT//
M]YJP-3FM1D[KH)Q'GFNJU4@SO:EBC2]N^.(O-"EILD@^R:2*)UZMJD]%C3<\
MV@Y+.ATO;&]XM!U&=L>M<+='[49-^Z":>U0:Q,1TCN+0L=!I^#I?Z)'OO1^Y
MWB>Y5!.M[:4D3K9LVA4716&0;/BT*Z[EA:UDPRAWI:%09::V,2L8BSG7U3'<
MK#;-_\*VO(WU@;D4V$;U3E/=*.B4G.9<08$3HO3.$MJOLFK2U42+F6U;3T*3
M/7:8T<4&I0F@YQ,A]')B7M!<E?K_ 5!+ P04    " "!@J94SXY07?L$  "1
M&0  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&ULO9E=;Z,X%(;_BA7-
M12MU"K;!P"B-U"::G4HSNU7;V;U8[863N D:/K*VT\Q(\^/7$(H)&$+I;&X2
M(.?8K\^QGV.<\2[EW\2:,0F^QU$BKD9K*3<?+$LLUBRFXC+=L$3]\I3RF$IU
MRU>6V'!&E[E3'%G(MHD5TS 93<;YLSL^&:=;&84)N^- ;..8\A\W+$IW5R,X
M>GEP'Z[6,GM@3<8;NF(/3'[=W'%U9Y6M+,.8)2),$\#9T]7H&GZ8X2!SR"W^
M#-E.5*Y!-I1YFG[+;FZ75R,[4\0BMI!9$U1]/;,IBZ*L):7CWZ+14=EGYEB]
M?FG]8SYX-9@Y%6R:1G^%2[F^&ODCL&1/=!O)^W3WB14#<K/V%FDD\D^P*VSM
M$5ALA4SCPEDIB,-D_TV_%X&H.$"GQ0$5#JBO RX<<%\'IW!P\LCLAY+'848E
MG8QYN@,\LU:M91=Y,'-O-?PPR?+^(+GZ-51^<G*S%>J)$."!K50ZI0!GUT(P
M]3W_\?+L')S-F*1A),[!>_#U80;.WIV#=R!,P.,ZW0J:+,78DDI-UJ:U*'J^
MV?>,6GK^0ODEP/ "(!LA@_NTOSLTN,_ZN]N'[I8*81E'5,81Y>WAEO:*4(%[
MMDFY#)/5!<CCJ!XLTF01*OL5N)4L!G]_5J[YI?BGHV-<=HSSCIV6CG]+T^4N
MC")3 O:>7NZ9 >!YXGI^X)&Q]5P-M-',]H)#LYG)S(45LP/]3JG?Z=1_FZA5
M&B:A9.\C18"EFE62)JMP'C% \YEHFAO[-DE%"T(^#'S?+,8MQ;B=8CZ^5LB-
M:Q!BVXT0-\U@@#T'FN624BXY$KN:P@N0,&F229HR24 (=FLZ#7:.YWJH)<E>
M*=0;(!2<A<DBVBZSI;$JIO&Y2;W74(61YQ((:^H-=K:+?;ME5OBE>K]3_>]J
M1:_!=<QXN* )^.-Q"CXQ&LGU@G+6L82#LOW@M.R MJ:_/9@>A6LUG*[CHZ >
M=:,=(0ZN\>.XW>$@*B4,_@\(*1H]F.LP4+/*:]&C2P%$OY8BTZ+!0S[8#D$M
M4G1Q@-W5H3\ABH8.PN'Z@>_9]70;#+%/[+9" '4E@,=*P9LH 9M% 4/L0]*8
ML(;J$2BBH+9PZ_(!N^N'&@'C"<UVM#3J#PJH@0_)B5&A$0Z[&=Z)"A-YB5^O
M+B8SZ&!2!T73#/ENQ>QP!!KCL)OC SGA-]3X!'LMI1MJZ,/@5U,B,-7!EF6'
M= U W36@/R-0D^#0)AZIY]E@YP?$M5N4:M"C8Z!_$R!0D_A0;<+<.N%,=@C:
M?LL$1)5WA%Z%X7.>\D=.ERRA,1- O4"!:?ZNQ[A:R5$.$+$.-Z+KS407 81/
M"PVDD8ZZD?[Z#34R;>T/=M2'4C2;4:^]_2N"#WZ"H5L_I(F.3DQTI(F.NHD^
M(#E-,JN7+NRV;.&01C/J1O.@Y RLMD@C&IUX8XXUE'$WE%^?&]R$+H(>:DD-
MUM#%O7?7H)Z?KJ%J*N)3'YU4SDZ.;8\'[ ANL&$'[*@JZ ;U@Y7FD4G]F*(X
M6C$9$A?CEET&U@#&O8]7&ME[ ]^PQBYV3YQ=C59\['AD4'8-9R X@&[;>R'6
MO,7'3D$Z<S$09UA#%OLG3H4F*>[>[ Y,1=!8%KYK._77-*MR_)W]6?&%\E68
M"!"Q)^5G7WIJAO+]^?_^1J:;_$1\GDI56?++-5.9X)F!^OTI3>7+37;(7OX+
M,_D/4$L#!!0    ( (&"IE25+>L7I0(  !<(   :    >&PO=V]R:W-H965T
M<R]S:&5E=#$Q,2YX;6S-5EU/VS 4_2M7$0^MQ,A7/U%;"8K&D)B$Z-@>ICVX
MS6UBX=B=[5#X][MV0U2@K=@#$B^)/^XY/O?<V,YHK?2]*1 M/)9"FG%06+LZ
M#4.S*+!DYD2M4-+,4NF26>KJ/#0KC2SSH%*$213UPI)Q&4Q&?NQ&3T:JLH)+
MO-%@JK)D^ND<A5J/@SAX'KCE>6'=0#@9K5B.,[1WJQM-O;!AR7B)TG E0>-R
M')S%I].AB_<!/SFNS58;7"9SI>Y=YRH;!Y$3A (7UC$P>CW@%(5P1"3C;\T9
M-$LZX';[F?VKSYURF3.#4R5^\<P6XV 00(9+5@E[J];?L,ZGZ_@62AC_A'4=
M&P6PJ(Q590TF!267FS=[K'W8 L2=/8"D!B3O!:0U(/6);I3YM"Z899.15FO0
M+IK87,-[X]&4#9>NBC.K:983SD[.*T,CQL ,<RJ.-="Z5"I;<R& R0RNI&4R
MYW.!<&8,TOS\"2Y1Y9JM"KZ ,_ITVM"Z0,NX,&WX G>S"V@=M>$(N(0?A:H,
M\9A1:$FM6S-<U,K.-\J2/<J^,WT":7P,290D.^#3]\/CE_"0/&J,2AJC$L^7
M[N&;T?[)*K)!+>&_'3+P^YKXX,IB:?X<4),V:E*OIK-'S=:BS"]Z#)*V?(O+
MA:@R+G/(:XWM7<YOR/N>W.WSATF:]+N]F(QZV+9X1US430?1H(E[H;[3J.\<
M5'\GN<4,9I99- ?<Z#9\W4]0FUZCIO>1M=F0][8]C]-!W'M=F[=QR9"JZ/;*
MKMKT&_7]@^IOT5CG(YV^(CO@QJ#A&WR"V@P;-<./K,WPS7Z(TWZG&[TJS8ZP
M)(X&O5>5";>.;7=ETI&5<VE X)* T4F?OGJ]N88V':M6_B2?*TOW@F\6='.C
M=@$TOU3*/G?<Y=#\"TS^ 5!+ P04    " "!@J94K"0ES,P$   @&0  &@
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M2TM:/- 2B$D.2I**JX+RJLC+IIM(*J8NR3?4TI3;-^4V3>&QP?!A#9X&Q!F
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M" "!@J94[BA@DKP'  #H20  #P   'AL+W=O<FMB;V]K+GAM;,6<77/:.!2&
M_XJ'FTUG=A=CC#&=IC-ITH_,I"T;LMW+CF(+T,0?5+:3IK]^91O($9AW]^;
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MF.V12**I=NH_S;D\?U2OAIY727)IMGW-;G(1;UY4M'G)TMM_ 5!+ P04
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M[K W0.^J>E> WDWU;@"]F^K= 'HWU;L!]&ZJ=P/HW53O!M"[J=X-H'=3O1M
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M'/?_.'YYQGW5#J_YR7)[_^8G4$L! A0#%     @ @8*F5 =!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "!@J94_S*/6^\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "!@J94F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (&"IE2E
M -(R>P8  ,X9   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "!@J94$&RGOR "  !V!0  &
M    @(&_#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
M@8*F5.$U0UQF!P  -R   !@              ("!%1$  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (&"IE1S5A<#\ 8  +8<   8
M          " @;$8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "!@J943)/.3!@#   ?"@  &               @('7'P  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ @8*F5'L6<K 5!P  AB0
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M965T,3 N>&UL4$L! A0#%     @ @8*F5/"N;0;E @  808  !D
M     ("!0F<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M" "!@J94/S>.U% '  #'$0  &0              @(%>:@  >&PO=V]R:W-H
M965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( (&"IE3S.8YD)PH  &4<   9
M              " @>5Q  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L!
M A0#%     @ @8*F5!1=2H2S!   =!$  !D              ("!0WP  'AL
M+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "!@J94VJXW\L,"
M   2!@  &0              @($M@0  >&PO=V]R:W-H965T<R]S:&5E=#$U
M+GAM;%!+ 0(4 Q0    ( (&"IE2#A1S@YA(  /Y+   9              "
M@2>$  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ @8*F
M5&@J:R<'!@  [@X  !D              ("!1)<  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "!@J94=P\7B2($  #D"0  &0
M        @(&"G0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( (&"IE1662%F/@0  -()   9              " @=NA  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ @8*F5/T048GZ#0  Z"<
M !D              ("!4*8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "!@J94:'9GVE$#  "!!P  &0              @(&!M
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (&"IE02Q"9O
MMP<  /01   9              " @0FX  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ @8*F5"ZBT_-,#   OB,  !D
M ("!][\  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "!
M@J94:FT?R/L$  #$"@  &0              @(%ZS   >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (&"IE3U+(W00P8  'P/   9
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M970R.2YX;6Q02P$"% ,4    " "!@J94N&:*CM@$   _"P  &0
M    @('["P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M (&"IE1@:S<AY (  !L&   9              " @0H1 0!X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ @8*F5,FQ<[Q[ @  / 4  !D
M             ("!)10! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "!@J947J]+97<#  #C!P  &0              @('7%@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (&"IE0WBVQ_E0,
M $T(   9              " @84: 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ @8*F5/UW908'!@  ,!   !D              ("!
M41X! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "!@J94
M5K$P."4$   '#   &0              @(&/) $ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( (&"IE2.)&RAR@(   $&   9
M      " @>LH 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ @8*F5#AM%'9 !   M@H  !D              ("!["L! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "!@J94#T0& V@#  #D!P
M&0              @(%C, $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( (&"IE3SVH.HC@,  -L(   9              " @0(T 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ @8*F5$S.MR_-
M @  ,@8  !D              ("!QS<! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " "!@J94,NFF8_(%  #1#@  &0
M@('+.@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( (&"
MIE2Y4V?9[@(  'H&   9              " @?1  0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ @8*F5)HWE%$5!P  7Q$  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( (&"IE0B-6/D)P,  !X/   9
M  " @1MA 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
M@8*F5.<^5G9& @  ,@8  !D              ("!>60! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " "!@J94PC>_L#D"  "F!   &0
M            @('V9@$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( (&"IE1# K#3B (  &(&   9              " @69I 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ @8*F5&L=)11. @
M_00  !D              ("!)6P! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " "!@J94 8>8\.T#  !E#   &0              @(&J
M;@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( (&"IE2/
M=6AY-0(  ($&   9              " @<YR 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ @8*F5$ &SH7% P  6@X  !D
M     ("!.G4! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (&"IE1J4>3/U ,  +L/   9              "
M@?F( 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ @8*F
M5+#<EK@<"   %3,  !D              ("!!(T! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " "!@J94R,J<!FX$  #=$@  &0
M        @(%7E0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( (&"IE3?'\.WD (  #8'   9              " @?R9 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ @8*F5/UD3Y?^ @  UP@
M !D              ("!PYP! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " "!@J94I-B$EZL#  #A$   &0              @('XGP$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( (&"IE2 ZB:.
M.@(  )H&   9              " @=JC 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ @8*F5*&7.41B @  AP8  !D
M ("!2Z8! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "!
M@J9475<YQPL#  "F"0  &0              @('DJ $ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( (&"IE2JWE?=+P4  $\=   9
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M970W-"YX;6Q02P$"% ,4    " "!@J949H&[>58"   L!@  &0
M    @($7Q@$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M (&"IE2I5@0+( (  &,$   9              " @:3( 0!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ @8*F5#IO]$AJ @  ! <  !D
M             ("!^\H! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    " "!@J94$*A#!#P$  #V%P  &0              @(&<S0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( (&"IE3K\WSK$@(
M %($   9              " @0_2 0!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @ @8*F5#.\*<^1 @  L@<  !D              ("!
M6-0! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " "!@J94
M7OPYB"(#  #)"0  &0              @($@UP$ >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    ( (&"IE1R2)7)YP(  )X(   9
M      " @7G: 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @ @8*F5,1C;\AM P  RPL  !D              ("!E]T! 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " "!@J94^8Z=V+\&  !@(0
M&0              @($[X0$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    ( (&"IE3$W6XD80,  )\)   9              " @3'H 0!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ @8*F5&V%]O0#
M!   E!   !D              ("!R>L! 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    " "!@J944F,?79\#  !W#@  &0
M@($#\ $ >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( (&"
MIE2,I<PJWP0  ,04   9              " @=GS 0!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @ @8*F5/QGR<<5!   N@\  !D
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M=#DS+GAM;%!+ 0(4 Q0    ( (&"IE3H8;;SO00  #\5   9
M  " @3$+ @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @
M@8*F5'\$>99? P  ? D  !D              ("!)1 " 'AL+W=O<FMS:&5E
M=',O<VAE970Y-2YX;6Q02P$"% ,4    " "!@J94#,5UA2<%  #;&   &0
M            @(&[$P( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4
M Q0    ( (&"IE1"1K'DT ,  #L-   9              " @1D9 @!X;"]W
M;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ @8*F5+"4&C>E @
M&0<  !D              ("!(!T" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6Q02P$"% ,4    " "!@J94./5\X<H"  !L!P  &0              @('\
M'P( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( (&"IE2S
M*]G1W0(  $ )   :              " @?TB @!X;"]W;W)K<VAE971S+W-H
M965T,3 P+GAM;%!+ 0(4 Q0    ( (&"IE1X_ &,>P(  )X&   :
M      " @1(F @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0
M   ( (&"IE3=A[+4E0(  '$)   :              " @<4H @!X;"]W;W)K
M<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( (&"IE1^ %CO> (  !0&
M   :              " @9(K @!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM
M;%!+ 0(4 Q0    ( (&"IE3(M +U@@,  (0/   :              " @4(N
M @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( (&"IE0M
M\I$+BP(  + &   :              " @?PQ @!X;"]W;W)K<VAE971S+W-H
M965T,3 U+GAM;%!+ 0(4 Q0    ( (&"IE2&6<"\90,  .(-   :
M      " @;\T @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0
M   ( (&"IE1]S]5.+@4  !H6   :              " @5PX @!X;"]W;W)K
M<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( (&"IE1J&NSOCP<  +PP
M   :              " @<(] @!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM
M;%!+ 0(4 Q0    ( (&"IE1 :8#*^P(  #8)   :              " @8E%
M @!X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( (&"IE3/
MCE!=^P0  )$9   :              " @;Q( @!X;"]W;W)K<VAE971S+W-H
M965T,3$P+GAM;%!+ 0(4 Q0    ( (&"IE25+>L7I0(  !<(   :
M      " @>]- @!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0
M   ( (&"IE2L)"7,S 0  " 9   :              " @<Q0 @!X;"]W;W)K
M<VAE971S+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( (&"IE2(_RUGY04  !L=
M   :              " @=!5 @!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM
M;%!+ 0(4 Q0    ( (&"IE2_\@(R*P,  /(2   -              "  >U;
M @!X;"]S='EL97,N>&UL4$L! A0#%     @ @8*F5)>*NQS     $P(   L
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64$L%!@    !Y 'D 5"$  "EN @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>441</ContextCount>
  <ElementCount>549</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>121</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - Consolidated Statements of Income and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Income and Comprehensive Income</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - Consolidated Statements of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation</Role>
      <ShortName>Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210121002 - Disclosure - Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Acquisition</Role>
      <ShortName>Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210161003 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210191004 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210221005 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210261006 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210311007 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210371008 - Disclosure - Other Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</Role>
      <ShortName>Other Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210401009 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210501010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210531011 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210581012 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210621013 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210691014 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210721015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210801016 - Disclosure - Employee Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</Role>
      <ShortName>Employee Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210911017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210941018 - Disclosure - Concentrations of Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</Role>
      <ShortName>Concentrations of Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210961019 - Disclosure - Business Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegments</Role>
      <ShortName>Business Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>211031020 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>211051021 - Disclosure - Schedule II Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Business and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies</Role>
      <ShortName>Business and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Business and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</Role>
      <ShortName>Business and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230133002 - Disclosure - Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionTables</Role>
      <ShortName>Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Acquisition</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230173003 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Inventories</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230203004 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230233005 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Goodwill</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230273006 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssets</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230323007 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/Leases</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230383008 - Disclosure - Other Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</Role>
      <ShortName>Other Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230413009 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebt</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230513010 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurements</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230543011 - Disclosure - Derivative Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230593012 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquity</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230633013 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230703014 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230733015 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxes</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230813016 - Disclosure - Employee Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</Role>
      <ShortName>Employee Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230923017 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/CommitmentsandContingencies</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230973018 - Disclosure - Business Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</Role>
      <ShortName>Business Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Business and Basis of Presentation (Cash and Cash Equivalents) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails</Role>
      <ShortName>Business and Basis of Presentation (Cash and Cash Equivalents) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Business and Basis of Presentation (Property, Plant and Equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails</Role>
      <ShortName>Business and Basis of Presentation (Property, Plant and Equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Business and Basis of Presentation (Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails</Role>
      <ShortName>Business and Basis of Presentation (Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Business and Basis of Presentation (Revenue Recognition) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails</Role>
      <ShortName>Business and Basis of Presentation (Revenue Recognition) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Business and Basis of Presentation (Cost of Sales) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails</Role>
      <ShortName>Business and Basis of Presentation (Cost of Sales) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240094006 - Disclosure - Business and Basis of Presentation (Pension Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails</Role>
      <ShortName>Business and Basis of Presentation (Pension Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240104007 - Disclosure - Business and Basis of Presentation (Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails</Role>
      <ShortName>Business and Basis of Presentation (Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240114008 - Disclosure - Business and Basis of Presentation (Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails</Role>
      <ShortName>Business and Basis of Presentation (Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240144009 - Disclosure - Acquisition (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails</Role>
      <ShortName>Acquisition (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AcquisitionTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240154010 - Disclosure - Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AcquisitionTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240184011 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/InventoriesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240214012 - Disclosure - Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240244013 - Disclosure - Goodwill (Schedule of Changes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails</Role>
      <ShortName>Goodwill (Schedule of Changes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/GoodwillTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240254014 - Disclosure - Goodwill (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/GoodwillTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240284015 - Disclosure - Intangible Assets (Reconciliation of Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails</Role>
      <ShortName>Intangible Assets (Reconciliation of Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240294016 - Disclosure - Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240304017 - Disclosure - Intangible Assets (Expected Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets (Expected Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IntangibleAssetsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240334018 - Disclosure - Leases (Lease Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases (Lease Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240344019 - Disclosure - Leases (Lease Maturities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails</Role>
      <ShortName>Leases (Lease Maturities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240354020 - Disclosure - Leases (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240364021 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LeasesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240394022 - Disclosure - Other Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails</Role>
      <ShortName>Other Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240424023 - Disclosure - Long-Term Debt (Schedule of Long-term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt (Schedule of Long-term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240434024 - Disclosure - Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails</Role>
      <ShortName>Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240444025 - Disclosure - Long-Term Debt (Narrative 2013 Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails</Role>
      <ShortName>Long-Term Debt (Narrative 2013 Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240454026 - Disclosure - Long-Term Debt (Narrative 2016 Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails</Role>
      <ShortName>Long-Term Debt (Narrative 2016 Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240464027 - Disclosure - Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails</Role>
      <ShortName>Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240474028 - Disclosure - Long-Term Debt (Narrative Redemptions and Restrictions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails</Role>
      <ShortName>Long-Term Debt (Narrative Redemptions and Restrictions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240484029 - Disclosure - Long-Term Debt (Narrative Interest Rate Swaps) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails</Role>
      <ShortName>Long-Term Debt (Narrative Interest Rate Swaps) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240494030 - Disclosure - Long-Term Debt (Maturities of Long-term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Long-Term Debt (Maturities of Long-term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/LongTermDebtTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240524031 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240554032 - Disclosure - Derivative Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240564033 - Disclosure - Derivative Instruments (Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails</Role>
      <ShortName>Derivative Instruments (Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240574034 - Disclosure - Derivative Instruments (Schedule of Derivative Gains and Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails</Role>
      <ShortName>Derivative Instruments (Schedule of Derivative Gains and Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240604035 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240614036 - Disclosure - Stockholders' Equity (Schedule of Shares Repurchased) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails</Role>
      <ShortName>Stockholders' Equity (Schedule of Shares Repurchased) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/StockholdersEquityTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240644037 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240654038 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails</Role>
      <ShortName>Share-Based Compensation (Stock Based Compensation Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240664039 - Disclosure - Share-Based Compensation (Restricted Shares Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails</Role>
      <ShortName>Share-Based Compensation (Restricted Shares Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240674040 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Valuation Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240684041 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation (Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240714042 - Disclosure - Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240744043 - Disclosure - Income Taxes (Income Before Continuing Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails</Role>
      <ShortName>Income Taxes (Income Before Continuing Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240754044 - Disclosure - Income Taxes (Components of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Components of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240764045 - Disclosure - Income Taxes (Components of Deferred Tax Balances) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails</Role>
      <ShortName>Income Taxes (Components of Deferred Tax Balances) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240774046 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240784047 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes (Reconciliation of Effective Tax Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240794048 - Disclosure - Income Taxes (Uncertain Tax Liability Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails</Role>
      <ShortName>Income Taxes (Uncertain Tax Liability Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240824049 - Disclosure - Employee Retirement Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails</Role>
      <ShortName>Employee Retirement Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240834050 - Disclosure - Employee Retirement Plans (Periodic Service Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails</Role>
      <ShortName>Employee Retirement Plans (Periodic Service Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240844051 - Disclosure - Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails</Role>
      <ShortName>Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240854052 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails</Role>
      <ShortName>Employee Retirement Plans (Expected Return on Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240864053 - Disclosure - Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails</Role>
      <ShortName>Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240874054 - Disclosure - Employee Retirement Plans (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Employee Retirement Plans (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240884055 - Disclosure - Employee Retirement Plans (Category of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails</Role>
      <ShortName>Employee Retirement Plans (Category of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240894056 - Disclosure - Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240904057 - Disclosure - Employee Retirement Plans (Weighted Average Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails</Role>
      <ShortName>Employee Retirement Plans (Weighted Average Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240934058 - Disclosure - Commitments and Contingencies (Long-term Supply Agreement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails</Role>
      <ShortName>Commitments and Contingencies (Long-term Supply Agreement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240954059 - Disclosure - Concentrations of Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails</Role>
      <ShortName>Concentrations of Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ConcentrationsofRisk</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240984060 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails</Role>
      <ShortName>Business Segments (Information on Operating and Reportable Segments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240994061 - Disclosure - Business Segments (Revenue by Product) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails</Role>
      <ShortName>Business Segments (Revenue by Product) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>241004062 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails</Role>
      <ShortName>Business Segments (Revenue by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>241014063 - Disclosure - Business Segments (Assets by Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails</Role>
      <ShortName>Business Segments (Assets by Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>241024064 - Disclosure - Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails</Role>
      <ShortName>Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/BusinessSegmentsTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241044065 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/SubsequentEvents</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="pbh-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241064066 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts</ParentRole>
      <Position>113</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="pbh-20220331.htm">pbh-20220331.htm</File>
    <File>exhibit211directindirectsu.htm</File>
    <File>exhibit311certification_lo.htm</File>
    <File>exhibit312certification_sa.htm</File>
    <File>exhibit321certificationofe.htm</File>
    <File>exhibit322certificationofc.htm</File>
    <File>pbh-20220331.xsd</File>
    <File>pbh-20220331_cal.xml</File>
    <File>pbh-20220331_def.xml</File>
    <File>pbh-20220331_lab.xml</File>
    <File>pbh-20220331_pre.xml</File>
    <File>pbhconsentfy22.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pbh-20220331_g1.jpg</File>
    <File>pbh-20220331_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1407">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>134
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pbh-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 40,
   "contextCount": 441,
   "dts": {
    "calculationLink": {
     "local": [
      "pbh-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pbh-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pbh-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pbh-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pbh-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pbh-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 879,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 4
   },
   "keyCustom": 84,
   "keyStandard": 465,
   "memberCustom": 53,
   "memberStandard": 66,
   "nsprefix": "pbh",
   "nsuri": "http://www.prestigebrandsinc.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.prestigebrandsinc.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210161003 - Disclosure - Inventories",
     "role": "http://www.prestigebrandsinc.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864053 - Disclosure - Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails",
     "shortName": "Employee Retirement Plans (Pension Plans in Excess of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ib3582466457e4fa4b369b2316cdd0686_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874054 - Disclosure - Employee Retirement Plans (Expected Benefit Payments) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails",
     "shortName": "Employee Retirement Plans (Expected Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884055 - Disclosure - Employee Retirement Plans (Category of Plan Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails",
     "shortName": "Employee Retirement Plans (Category of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894056 - Disclosure - Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904057 - Disclosure - Employee Retirement Plans (Weighted Average Assumptions) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails",
     "shortName": "Employee Retirement Plans (Weighted Average Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "idc21db398b234b4d975327a23a0e8e3d_D20201001-20201231",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if67fb66e7897486a9f80811afd7f6951_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934058 - Disclosure - Commitments and Contingencies (Long-term Supply Agreement) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails",
     "shortName": "Commitments and Contingencies (Long-term Supply Agreement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if67fb66e7897486a9f80811afd7f6951_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:NumberOfThirdPartyManufacturers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "manufacturer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954059 - Disclosure - Concentrations of Risk (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
     "shortName": "Concentrations of Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:NumberOfThirdPartyManufacturers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "manufacturer",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984060 - Disclosure - Business Segments (Information on Operating and Reportable Segments) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
     "shortName": "Business Segments (Information on Operating and Reportable Segments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994061 - Disclosure - Business Segments (Revenue by Product) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
     "shortName": "Business Segments (Revenue by Product) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic2c295d6ba7346f3a20449e046450179_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004062 - Disclosure - Business Segments (Revenue by Geographic Area) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
     "shortName": "Business Segments (Revenue by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i05beda4dd5af4462b06464252419026d_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210191004 - Disclosure - Property, Plant and Equipment",
     "role": "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014063 - Disclosure - Business Segments (Assets by Segment) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
     "shortName": "Business Segments (Assets by Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iadf26bfc5aea44eda26fbbf6b3c61126_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024064 - Disclosure - Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails",
     "shortName": "Business Segments (Goodwill and Intangible Assets by Geographic Area) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pbh:GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ie501c1ea8abe4c0fb019b579c2aba132_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044065 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ib8310fdbeb364e46af48af59d5abb8d0_I20220503",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i434c5f76f05c469e89d0f4d63b175529_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064066 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i920d5d39c27c43a7ada8c478509c80e2_I20190331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210221005 - Disclosure - Goodwill",
     "role": "http://www.prestigebrandsinc.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210261006 - Disclosure - Intangible Assets",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210311007 - Disclosure - Leases",
     "role": "http://www.prestigebrandsinc.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210371008 - Disclosure - Other Accrued Liabilities",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities",
     "shortName": "Other Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210401009 - Disclosure - Long-Term Debt",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210501010 - Disclosure - Fair Value Measurements",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210531011 - Disclosure - Derivative Instruments",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210581012 - Disclosure - Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.prestigebrandsinc.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210621013 - Disclosure - Share-Based Compensation",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:AccumulatedOtherComprehensiveIncomeTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210691014 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:AccumulatedOtherComprehensiveIncomeTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210721015 - Disclosure - Income Taxes",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801016 - Disclosure - Employee Retirement Plans",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans",
     "shortName": "Employee Retirement Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210911017 - Disclosure - Commitments and Contingencies",
     "role": "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210941018 - Disclosure - Concentrations of Risk",
     "role": "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk",
     "shortName": "Concentrations of Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961019 - Disclosure - Business Segments",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegments",
     "shortName": "Business Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031020 - Disclosure - Subsequent Events",
     "role": "http://www.prestigebrandsinc.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211051021 - Disclosure - Schedule II Valuation and Qualifying Accounts",
     "role": "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts",
     "shortName": "Schedule II Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Business and Basis of Presentation (Policies)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies",
     "shortName": "Business and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - Consolidated Statements of Income and Comprehensive Income",
     "role": "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome",
     "shortName": "Consolidated Statements of Income and Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pbh:CostOfSalesExclusiveOfDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Business and Basis of Presentation (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables",
     "shortName": "Business and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230133002 - Disclosure - Acquisition (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionTables",
     "shortName": "Acquisition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230173003 - Disclosure - Inventories (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230203004 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230233005 - Disclosure - Goodwill (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230273006 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230323007 - Disclosure - Leases (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230383008 - Disclosure - Other Accrued Liabilities (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables",
     "shortName": "Other Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230413009 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230513010 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - Consolidated Balance Sheets",
     "role": "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230543011 - Disclosure - Derivative Instruments and Hedging Activities (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230593012 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230633013 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230703014 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230733015 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813016 - Disclosure - Employee Retirement Plans (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables",
     "shortName": "Employee Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230923017 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230973018 - Disclosure - Business Segments (Tables)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables",
     "shortName": "Business Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i93685426db444f7bb2e2083559bad12c_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "pbh:PercentageofDepositsHeldinOneLocation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Business and Basis of Presentation (Cash and Cash Equivalents) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails",
     "shortName": "Business and Basis of Presentation (Cash and Cash Equivalents) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i93685426db444f7bb2e2083559bad12c_I20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "pbh:PercentageofDepositsHeldinOneLocation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Business and Basis of Presentation (Property, Plant and Equipment) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
     "shortName": "Business and Basis of Presentation (Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i6396d996a0354e0b8a59b68cba69775e_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i69723e2dbdb84604b529093d1958bcf0_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Business and Basis of Presentation (Intangible Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
     "shortName": "Business and Basis of Presentation (Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Business and Basis of Presentation (Revenue Recognition) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails",
     "shortName": "Business and Basis of Presentation (Revenue Recognition) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if25f80c767b745ce88d01566c788c2ec_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Business and Basis of Presentation (Cost of Sales) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails",
     "shortName": "Business and Basis of Presentation (Cost of Sales) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if25f80c767b745ce88d01566c788c2ec_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic8f7bc5814774a5a863a3afa79624f1b_D20201001-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094006 - Disclosure - Business and Basis of Presentation (Pension Expense) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails",
     "shortName": "Business and Basis of Presentation (Pension Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104007 - Disclosure - Business and Basis of Presentation (Earnings Per Share) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
     "shortName": "Business and Basis of Presentation (Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ied214f5ee4e64721bc76b33c5c12a69d_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114008 - Disclosure - Business and Basis of Presentation (Leases) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
     "shortName": "Business and Basis of Presentation (Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ied214f5ee4e64721bc76b33c5c12a69d_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144009 - Disclosure - Acquisition (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
     "shortName": "Acquisition (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0943b16dde3144f98c87f7d01dd7ac83_D20210701-20210701",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154010 - Disclosure - Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisition (Allocation of Assets Acquired and Liabilities Assumed) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i8fb8878771394bb997fb34a8c9708c34_I20210701",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184011 - Disclosure - Inventories (Details)",
     "role": "http://www.prestigebrandsinc.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214012 - Disclosure - Property, Plant and Equipment (Details)",
     "role": "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails",
     "shortName": "Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if8bb0dd398b14b6793d19cdc2c6789cb_I20190331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - Consolidated Statements of Changes in Stockholders' Equity",
     "role": "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
     "shortName": "Consolidated Statements of Changes in Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "if8bb0dd398b14b6793d19cdc2c6789cb_I20190331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic0c43cd8d468472d94116a8e5f90b255_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244013 - Disclosure - Goodwill (Schedule of Changes) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
     "shortName": "Goodwill (Schedule of Changes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i30644c0d223c4d21aedacfe884a3e842_I20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254014 - Disclosure - Goodwill (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i8bb6c96119cc4504a07f59227add5e1a_D20210401-20220331",
      "decimals": "4",
      "lang": "en-US",
      "name": "pbh:IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic0c43cd8d468472d94116a8e5f90b255_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284015 - Disclosure - Intangible Assets (Reconciliation of Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails",
     "shortName": "Intangible Assets (Reconciliation of Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i30644c0d223c4d21aedacfe884a3e842_I20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294016 - Disclosure - Intangible Assets (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304017 - Disclosure - Intangible Assets (Expected Amortization Expense) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails",
     "shortName": "Intangible Assets (Expected Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334018 - Disclosure - Leases (Lease Cost) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases (Lease Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344019 - Disclosure - Leases (Lease Maturities) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails",
     "shortName": "Leases (Lease Maturities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354020 - Disclosure - Leases (Additional Information) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails",
     "shortName": "Leases (Additional Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364021 - Disclosure - Leases (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i335edd3216614cc694f48efa6d5a9a28_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394022 - Disclosure - Other Accrued Liabilities (Details)",
     "role": "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails",
     "shortName": "Other Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "pbh:ScheduleofAccruedandOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424023 - Disclosure - Long-Term Debt (Schedule of Long-term Debt) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails",
     "shortName": "Long-Term Debt (Schedule of Long-term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434024 - Disclosure - Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
     "shortName": "Long-Term Debt (Narrative 2012 Term Loan and 2012 ABL Revolver) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i415c7e0679e349e58f0e0f20395cc300_I20210701",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pbh:DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444025 - Disclosure - Long-Term Debt (Narrative 2013 Senior Notes) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
     "shortName": "Long-Term Debt (Narrative 2013 Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0a7e22b9e58c472cae8d9d5a6dc9bb0b_I20131217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i76d5fa51d2444398b1d51583678eaf8b_I20180321",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454026 - Disclosure - Long-Term Debt (Narrative 2016 Senior Notes) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
     "shortName": "Long-Term Debt (Narrative 2016 Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i76d5fa51d2444398b1d51583678eaf8b_I20180321",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i05cfda891a7744f5b7d546839fc9debe_I20191202",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464027 - Disclosure - Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
     "shortName": "Long-Term Debt (Narrative 2019 and 2021 Senior Notes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i05cfda891a7744f5b7d546839fc9debe_I20191202",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ib5924d593cc74de19659e3600415162d_D20160219-20160219",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474028 - Disclosure - Long-Term Debt (Narrative Redemptions and Restrictions) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
     "shortName": "Long-Term Debt (Narrative Redemptions and Restrictions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ib5924d593cc74de19659e3600415162d_D20160219-20160219",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iea11cc7d2fda42e280337193b1699cff_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484029 - Disclosure - Long-Term Debt (Narrative Interest Rate Swaps) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails",
     "shortName": "Long-Term Debt (Narrative Interest Rate Swaps) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494030 - Disclosure - Long-Term Debt (Maturities of Long-term Debt) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
     "shortName": "Long-Term Debt (Maturities of Long-term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i8b76519112f34e67a8eec0a25b6d11bd_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueHedgeLiabilitiesAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524031 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i8b76519112f34e67a8eec0a25b6d11bd_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueHedgeLiabilitiesAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iea11cc7d2fda42e280337193b1699cff_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554032 - Disclosure - Derivative Instruments (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
     "shortName": "Derivative Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Business and Basis of Presentation",
     "role": "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation",
     "shortName": "Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iea11cc7d2fda42e280337193b1699cff_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564033 - Disclosure - Derivative Instruments (Fair Value) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
     "shortName": "Derivative Instruments (Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i1b30d6662357490791b05cb990415ede_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574034 - Disclosure - Derivative Instruments (Schedule of Derivative Gains and Losses) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails",
     "shortName": "Derivative Instruments (Schedule of Derivative Gains and Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i605faa87f3fa47b3bd583aa47c0b905f_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604035 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pbh:VotingRightsNumberOfVotesPerCommonShareOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614036 - Disclosure - Stockholders' Equity (Schedule of Shares Repurchased) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails",
     "shortName": "Stockholders' Equity (Schedule of Shares Repurchased) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i85535f77bb0c4445a9491dc7bfcc696a_D20210401-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0e8537058553437296cbf47a294cbc0c_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644037 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0e8537058553437296cbf47a294cbc0c_D20140531-20140531",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654038 - Disclosure - Share-Based Compensation (Stock Based Compensation Information) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails",
     "shortName": "Share-Based Compensation (Stock Based Compensation Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i22fb9cffca2c4cddb633b8b7447cd658_I20210331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664039 - Disclosure - Share-Based Compensation (Restricted Shares Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
     "shortName": "Share-Based Compensation (Restricted Shares Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i0c27223f84a24212910eb3aeea93eaf1_I20190331",
      "decimals": "-2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i80f789044f294f2593d384da1434a1aa_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674040 - Disclosure - Share-Based Compensation (Stock Option Valuation Assumptions) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
     "shortName": "Share-Based Compensation (Stock Option Valuation Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i80f789044f294f2593d384da1434a1aa_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic0c43cd8d468472d94116a8e5f90b255_I20210331",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684041 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "shortName": "Share-Based Compensation (Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ieb0901ffc8ca4fcc820553ea63006d9f_I20190331",
      "decimals": "-2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714042 - Disclosure - Accumulated Other Comprehensive Loss (Details)",
     "role": "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
     "shortName": "Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210121002 - Disclosure - Acquisition",
     "role": "http://www.prestigebrandsinc.com/role/Acquisition",
     "shortName": "Acquisition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744043 - Disclosure - Income Taxes (Income Before Continuing Operations) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails",
     "shortName": "Income Taxes (Income Before Continuing Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754044 - Disclosure - Income Taxes (Components of Provision for Income Taxes) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes (Components of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764045 - Disclosure - Income Taxes (Components of Deferred Tax Balances) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails",
     "shortName": "Income Taxes (Components of Deferred Tax Balances) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774046 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784047 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails",
     "shortName": "Income Taxes (Reconciliation of Effective Tax Rate) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic0c43cd8d468472d94116a8e5f90b255_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794048 - Disclosure - Income Taxes (Uncertain Tax Liability Activity) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails",
     "shortName": "Income Taxes (Uncertain Tax Liability Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ieb0901ffc8ca4fcc820553ea63006d9f_I20190331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824049 - Disclosure - Employee Retirement Plans (Narrative) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
     "shortName": "Employee Retirement Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pbh:DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "ic0c43cd8d468472d94116a8e5f90b255_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834050 - Disclosure - Employee Retirement Plans (Periodic Service Costs) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails",
     "shortName": "Employee Retirement Plans (Periodic Service Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844051 - Disclosure - Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails",
     "shortName": "Employee Retirement Plans (Amounts Recognized in the Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "iab3ff8d1f6794953b2718ae0cc777203_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854052 - Disclosure - Employee Retirement Plans (Expected Return on Plan Assets) (Details)",
     "role": "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails",
     "shortName": "Employee Retirement Plans (Expected Return on Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pbh-20220331.htm",
      "contextRef": "i64e2a64554d2409795d3a1e7b63e20ac_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 121,
   "tag": {
    "country_SG": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE",
        "terseLabel": "Singapore"
       }
      }
     },
     "localname": "SG",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r766",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r766",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r766",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r766",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r766",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pbh_A2012ABLRevolverAmendment3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2012 ABL Revolver Amendment 3 [Member]",
        "label": "2012 ABL Revolver Amendment 3 [Member]",
        "terseLabel": "2012 ABL Revolver, Amendment No. 3"
       }
      }
     },
     "localname": "A2012ABLRevolverAmendment3Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_A2012ABLRevolverAmendment6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2012 ABL Revolver Amendment 6 [Member]",
        "label": "2012 ABL Revolver Amendment 6 [Member]",
        "terseLabel": "2012 ABL Revolver, Amendment No. 6"
       }
      }
     },
     "localname": "A2012ABLRevolverAmendment6Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_A2019SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Senior Notes",
        "label": "2019 Senior Notes [Member]",
        "terseLabel": "2019 Senior Notes"
       }
      }
     },
     "localname": "A2019SeniorNotesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_A2021SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Senior Notes",
        "label": "2021 Senior Notes [Member]",
        "terseLabel": "2021 Senior Notes"
       }
      }
     },
     "localname": "A2021SeniorNotesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ABLAmendmentNumber5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Amendment Number 5",
        "label": "ABL Amendment Number 5 [Member]",
        "terseLabel": "ABL Amendment No. 5"
       }
      }
     },
     "localname": "ABLAmendmentNumber5Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ABLRevolverAmendment4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Revolver Amendment 4 [Member]",
        "label": "ABL Revolver Amendment 4 [Member]",
        "terseLabel": "ABL Revolver Amendment 4"
       }
      }
     },
     "localname": "ABLRevolverAmendment4Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AblRevolver2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABL Revolver 2012 [Member]",
        "label": "ABL Revolver 2012 [Member]",
        "terseLabel": "2012 ABL Revolver"
       }
      }
     },
     "localname": "AblRevolver2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AccruedAndOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued and Other Liabilities, Current",
        "label": "Accrued and Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Total other accrued liabilities"
       }
      }
     },
     "localname": "AccruedAndOtherLiabilitiesCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AccruedProductionCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Production Costs, Current",
        "label": "Accrued Production Costs, Current",
        "terseLabel": "Accrued production costs"
       }
      }
     },
     "localname": "AccruedProductionCostsCurrent",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AccumulatedOtherComprehensiveIncomeTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Text Block]",
        "label": "Accumulated Other Comprehensive Income [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_AdditionsToOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions To Operating Lease Right-Of-Use Assets",
        "label": "Additions To Operating Lease Right-Of-Use Assets",
        "terseLabel": "Non-cash operating lease cost"
       }
      }
     },
     "localname": "AdditionsToOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_AkornOperatingCompanyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Akorn Operating Company LLC",
        "label": "Akorn Operating Company LLC [Member]",
        "terseLabel": "Akorn Operating Company LLC"
       }
      }
     },
     "localname": "AkornOperatingCompanyLLCMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_Amended2012TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended 2012 Term Loan [Member]",
        "label": "Amended 2012 Term Loan [Member]",
        "terseLabel": "2012 Term Loan, Amendment No. 1"
       }
      }
     },
     "localname": "Amended2012TermLoanMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_Amended22012TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended 2 2012 Term Loan [Member]",
        "label": "Amended 2 2012 Term Loan [Member]",
        "terseLabel": "2012 Term Loan, Amendment No. 2"
       }
      }
     },
     "localname": "Amended22012TermLoanMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_Amendment32012TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment 3, 2012 Term Loan [Member]",
        "label": "Amendment 3, 2012 Term Loan [Member]",
        "terseLabel": "2012 Term Loan, Amendment No. 3"
       }
      }
     },
     "localname": "Amendment32012TermLoanMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_Amendment52012TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment 5 2012 Term Loan [Member]",
        "label": "Amendment 5 2012 Term Loan [Member]",
        "terseLabel": "2012 Term B-5 Loans, No. 5"
       }
      }
     },
     "localname": "Amendment52012TermLoanMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AnalgesicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Analgesics [Member]",
        "label": "Analgesics [Member]",
        "terseLabel": "Analgesics"
       }
      }
     },
     "localname": "AnalgesicsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "xbrltype": "stringItemType"
    },
    "pbh_BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Amortizable Intangible Assets, Allocated Amount",
        "label": "Business Combination, Amortizable Intangible Assets, Allocated Amount",
        "terseLabel": "Business combination, amortizable intangible assets, allocated amount"
       }
      }
     },
     "localname": "BusinessCombinationAmortizableIntangibleAssetsAllocatedAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Non-Amortizable Intangible Assets, Allocated Amount",
        "label": "Business Combination, Non-Amortizable Intangible Assets, Allocated Amount",
        "terseLabel": "Business combination, non-amortizable intangible assets, allocated amount"
       }
      }
     },
     "localname": "BusinessCombinationNonAmortizableIntangibleAssetsAllocatedAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Sale Allowance and Cash Discount Reserves",
        "terseLabel": "Reserves for sales allowances and cash discounts"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesSaleAllowanceAndCashDiscountReserves",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceNewShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "label": "Common Stock, Capital Shares, Reserved for Future Issuance, New Shares",
        "terseLabel": "Number of new shares for future issuance under 2020 Long-Term Incentive Plans (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceNewShares",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Unissued Shares",
        "terseLabel": "Number of unissued shares reserved for 2020 Long-Term Incentive Plans (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceUnissuedShares",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Margin",
        "label": "Contribution Margin",
        "totalLabel": "Contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_ContributionTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Tranche One [Member]",
        "label": "Contribution Tranche One [Member]",
        "terseLabel": "Contribution Tranche One"
       }
      }
     },
     "localname": "ContributionTrancheOneMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ContributionTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contribution Tranche Two [Member]",
        "label": "Contribution Tranche Two [Member]",
        "terseLabel": "Contribution Tranche Two"
       }
      }
     },
     "localname": "ContributionTrancheTwoMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_CostOfSalesExclusiveOfDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of sales of goods and services exclusive of depreciation on property, plant and equipment that is included in the depreciation and amortization line in Operating Expenses.",
        "label": "Cost Of Sales Exclusive Of Depreciation",
        "terseLabel": "Cost of sales excluding depreciation"
       }
      }
     },
     "localname": "CostOfSalesExclusiveOfDepreciation",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_CostOfSalesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Sales Policy",
        "label": "Cost Of Sales Policy [Policy Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyPolicyTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_CoughAndColdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cough and Cold [Member]",
        "label": "Cough and Cold [Member]",
        "terseLabel": "Cough &amp; Cold"
       }
      }
     },
     "localname": "CoughAndColdMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_DebtInstrumentAlternativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Alternative Basis Spread on Variable Rate",
        "label": "Debt Instrument, Alternative Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Alternative Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentAlternativeBasisSpreadOnVariableRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pbh_DebtInstrumentBasisSpreadOnVariableRateFixedComponent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread on Variable Rate, Fixed Component",
        "label": "Debt Instrument, Basis Spread on Variable Rate, Fixed Component",
        "terseLabel": "Debt instrument, basis spread on variable rate, fixed component (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRateFixedComponent",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentBasisSpreadOnVariableRateIfIncreased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Basis Spread On Variable Rate, If Increased",
        "label": "Debt Instrument, Basis Spread On Variable Rate, If Increased",
        "terseLabel": "Debt instrument, basis spread on variable rate, if increased"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRateIfIncreased",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentContingentMarginStepDownPerAnnumInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Contingent Margin Step Down Per Annum, Interest Rate",
        "label": "Debt Instrument, Contingent Margin Step Down Per Annum, Interest Rate",
        "terseLabel": "Interest rate, contingent margin step-down per annum (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentContingentMarginStepDownPerAnnumInterestRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Temporary Suspension of Financial Reporting Covenant, Period",
        "label": "Debt Instrument, Covenant Terms, Temporary Suspension of Financial Reporting Covenant, Period",
        "terseLabel": "Debt Instrument, temporary suspension of financial reporting covenant, period"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsTemporarySuspensionofFinancialReportingCovenantPeriod",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_DebtInstrumentDiscountPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Discount, Percentage",
        "label": "Debt Instrument, Discount, Percentage",
        "terseLabel": "Debt instrument, discount (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentDiscountPercentage",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Period Payment, Percentage Of Principal Amount",
        "label": "Debt Instrument, Period Payment, Percentage Of Principal Amount",
        "terseLabel": "Debt instrument, period payment, percentage of principal amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodPaymentPercentageOfPrincipalAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pbh_DebtInstrumentPeriodicPaymentVoluntaryPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Voluntary Payment",
        "label": "Debt Instrument, Periodic Payment, Voluntary Payment",
        "terseLabel": "Debt instrument, periodic payment, voluntary payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentVoluntaryPayment",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DebtInstrumentReferenceRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Reference Rate Floor",
        "label": "Debt Instrument, Reference Rate Floor",
        "terseLabel": "Debt instrument, reference rate floor (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentReferenceRateFloor",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentVariableRateConditionalVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate, Conditional Variable Rate",
        "label": "Debt Instrument, Variable Rate, Conditional Variable Rate",
        "terseLabel": "Debt instrument, conditional variable rate (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentVariableRateConditionalVariableRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DebtInstrumentVariableRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate, Minimum",
        "label": "Debt Instrument, Variable Rate, Minimum",
        "terseLabel": "Debt instrument, variable rate, minimum"
       }
      }
     },
     "localname": "DebtInstrumentVariableRateMinimum",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DeferredTaxAssetsInventoryRecapitalization": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Inventory Recapitalization",
        "label": "Deferred Tax Assets, Inventory Recapitalization",
        "terseLabel": "Inventory capitalization"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventoryRecapitalization",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DeferredTaxAssetsInventoryReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Inventory Reserves",
        "label": "Deferred Tax Assets, Inventory Reserves",
        "terseLabel": "Inventory reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventoryReserves",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DeferredTaxAssetsLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Lease Liabilities",
        "label": "Deferred Tax Assets, Lease Liabilities",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts and Sales Returns",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts and Sales Returns",
        "terseLabel": "Allowance for doubtful accounts and sales returns"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndSalesReturns",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Impact of Adopting New Accounting Pronouncement",
        "label": "Deferred Tax Liabilities, Impact of Adopting New Accounting Pronouncement",
        "negatedTerseLabel": "Deferred cumulative catch-up adjustments - revenue recognition adjustments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesImpactofAdoptingNewAccountingPronouncement",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DeferredTaxLiabilityRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Right-Of-Use Asset",
        "label": "Deferred Tax Liability, Right-Of-Use Asset",
        "negatedLabel": "Right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilityRightOfUseAsset",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_DefinedBenefitPlanRemeasurementDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Remeasurement, Discount Rate",
        "label": "Defined Benefit Plan, Remeasurement, Discount Rate",
        "terseLabel": "Defined benefit plan, remeasurement, discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRemeasurementDiscountRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pbh_DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Minimum Annual Contributions Per Participating Employee, Percent",
        "label": "Defined Contribution Plan, Minimum Annual Contributions Per Participating Employee, Percent",
        "terseLabel": "Defined contribution plan, minimum annual contributions per participating employee (as percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMinimumAnnualContributionsPerParticipatingEmployeePercent",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_DermatologicalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dermatologicals [Member]",
        "label": "Dermatologicals [Member]",
        "terseLabel": "Dermatologicals"
       }
      }
     },
     "localname": "DermatologicalsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate, Including Discontinued Operations",
        "label": "Effective Income Tax Rate, Including Discontinued Operations",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Restricted Stock Issuances And Stock Options, Amount",
        "terseLabel": "Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations",
        "terseLabel": "Compensation limitations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompensationLimitations",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate",
        "terseLabel": "State income taxes, net of federal income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPosition": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation,, Uncertain Tax Position",
        "label": "Effective Income Tax Rate Reconciliation,, Uncertain Tax Position",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPosition",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Uncertain Tax Position, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Uncertain Tax Position, Percentage",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercentage",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pbh_EscrowReceipt": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow Receipt",
        "label": "Escrow Receipt",
        "terseLabel": "Escrow receipt"
       }
      }
     },
     "localname": "EscrowReceipt",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EstimatedReductionInUncertainTaxProvisionsNext12Months": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Reduction In Uncertain Tax Provisions, Next 12 Months",
        "label": "Estimated Reduction In Uncertain Tax Provisions, Next 12 Months",
        "terseLabel": "Estimated reduction in uncertain tax provisions, next 12 months"
       }
      }
     },
     "localname": "EstimatedReductionInUncertainTaxProvisionsNext12Months",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_EyeAndEarCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eye and Ear Care [Member]",
        "label": "Eye and Ear Care [Member]",
        "terseLabel": "Eye &amp; Ear Care"
       }
      }
     },
     "localname": "EyeAndEarCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FederalFundsRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Funds Rate [Member]",
        "label": "Federal Funds Rate [Member]",
        "terseLabel": "Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsRateMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization [Abstract]",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization, Translation Adjustments Gain (Loss)",
        "terseLabel": "Finite-lived intangibles, accumulated amortization, effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Accumulated Amortization, Written off Related to Sale of Business Unit",
        "label": "Finite-lived Intangible Assets, Accumulated Amortization, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization, tradename impairment"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_FiniteLivedTradenamesandCustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Tradenames and Customer Relationships [Member]",
        "label": "Finite Lived Tradenames and Customer Relationships [Member]",
        "terseLabel": "Finite-Lived Tradenames and Customer Relationships"
       }
      }
     },
     "localname": "FiniteLivedTradenamesandCustomerRelationshipsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GEODISLogisticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GEODIS Logistics LLC [Member]",
        "label": "GEODIS Logistics LLC [Member]",
        "terseLabel": "GEODIS Logistics LLC"
       }
      }
     },
     "localname": "GEODISLogisticsLLCMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GastrointestinalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gastrointestinal [Member]",
        "label": "Gastrointestinal [Member]",
        "terseLabel": "Gastrointestinal"
       }
      }
     },
     "localname": "GastrointestinalMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_GeneralAndAdministrativeAndDepreciationAndAmortizationExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative, and Depreciation and Amortization Expense",
        "label": "General and Administrative, and Depreciation and Amortization Expense",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeAndDepreciationAndAmortizationExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]",
        "label": "Goodwill and Intangible Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Goodwill and Intangible Assets by Geographic Areas"
       }
      }
     },
     "localname": "GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), Including Discontinued Operations",
        "label": "Income Tax Expense (Benefit), Including Discontinued Operations",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate",
        "label": "Income Tax Rate Reconciliation, State and Local Income Taxes, Excluding Effect of Change in Effective State Tax Rate",
        "terseLabel": "State income taxes, net of federal income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxRateReconciliationStateAndLocalIncomeTaxesExcludingEffectOfChangeInEffectiveStateTaxRate",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Compensation Limitations",
        "label": "Income Tax Reconciliation, Nondeductible Expense, Compensation Limitations",
        "terseLabel": "Compensation limitations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseCompensationLimitations",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IncreaseDecreaseInOperatingLeasesLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Leases Liabilities",
        "label": "Increase (Decrease) In Operating Leases Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeasesLiabilities",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IndefinitelivedTradenamesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Tradenames [Member]",
        "label": "Indefinite-lived Tradenames [Member]",
        "terseLabel": "Indefinite- Lived Tradenames"
       }
      }
     },
     "localname": "IndefinitelivedTradenamesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_IntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Acquired",
        "label": "Intangible Assets Acquired",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "IntangibleAssetsAcquired",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount",
        "label": "Intangible Assets, Percentage of Fair Value in Excess of Carrying Amount",
        "negatedTerseLabel": "Indefinite-lived intangible asset, increase (decrease) in measurement input",
        "terseLabel": "Indefinite-lived intangible asset, increase (decrease) in measurement input"
       }
      }
     },
     "localname": "IntangibleAssetsPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_IntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Roll Forward]",
        "label": "Intangible Assets [Roll Forward]",
        "terseLabel": "Gross Carrying Amounts"
       }
      }
     },
     "localname": "IntangibleAssetsRollForward",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_IntangibleAssetsTranslationAdjustmentsGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "label": "Intangible Assets, Translation Adjustments Gain (Loss)",
        "terseLabel": "Effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "IntangibleAssetsTranslationAdjustmentsGainLoss",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_InternationalAnalgesicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Analgesics",
        "label": "International Analgesics [Member]",
        "terseLabel": "International Analgesics"
       }
      }
     },
     "localname": "InternationalAnalgesicsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_InternationalOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International OTC Healthcare [Member]",
        "label": "International OTC Healthcare [Member]",
        "terseLabel": "International OTC Healthcare"
       }
      }
     },
     "localname": "InternationalOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LineOfCreditFacilityConditionalCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Conditional Commitment Fee Percentage",
        "label": "Line of Credit Facility, Conditional Commitment Fee Percentage",
        "terseLabel": "Line of credit facility, conditional commitment fee (as percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityConditionalCommitmentFeePercentage",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_LineOfCreditFacilityIncreaseInBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase in Borrowing Capacity",
        "label": "Line of Credit Facility, Increase in Borrowing Capacity",
        "terseLabel": "Revolving credit facility, increase in borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseInBorrowingCapacity",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LineofCreditFacilityIncreaseinAccordionFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase in Accordion Feature",
        "label": "Line of Credit Facility, Increase in Accordion Feature",
        "terseLabel": "Revolver increase in accordion feature"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseinAccordionFeature",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_LoansPayableTermB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-1 [Member]",
        "label": "Loans Payable, Term B-1 [Member]",
        "terseLabel": "2012 Term B-1 Loan"
       }
      }
     },
     "localname": "LoansPayableTermB1Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-2 [Member]",
        "label": "Loans Payable, Term B-2 [Member]",
        "terseLabel": "Loans Payable, Term B-2"
       }
      }
     },
     "localname": "LoansPayableTermB2Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-3 [Member]",
        "label": "Loans Payable, Term B-3 [Member]",
        "terseLabel": "2012 Term B-3 Loan"
       }
      }
     },
     "localname": "LoansPayableTermB3Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-4 [Member]",
        "label": "Loans Payable, Term B-4 [Member]",
        "terseLabel": "2012 Term B-4 Loans"
       }
      }
     },
     "localname": "LoansPayableTermB4Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB5AmendmentNo5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-5 [Member]",
        "label": "Loans Payable, Term B-5 Amendment No. 5 [Member]",
        "terseLabel": "Loans Payable, Term B-5 Amendment No. 5"
       }
      }
     },
     "localname": "LoansPayableTermB5AmendmentNo5Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LoansPayableTermB5AmendmentNo6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans Payable, Term B-5 Amendment No. 6",
        "label": "Loans Payable, Term B-5 Amendment No. 6 [Member]",
        "terseLabel": "2012 Term B-5 Loans, No. 6"
       }
      }
     },
     "localname": "LoansPayableTermB5AmendmentNo6Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongTermIncentivePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Incentive Plan, 2020",
        "label": "Long-term Incentive Plan, 2020 [Member]",
        "terseLabel": "Long-term Incentive Plan, 2020"
       }
      }
     },
     "localname": "LongTermIncentivePlan2020Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_LongtermEquityIncentivePlan2005Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Equity Incentive Plan, 2005 [Member]",
        "label": "Long-term Equity Incentive Plan, 2005 [Member]",
        "terseLabel": "2005 Long-term Equity Incentive Plan"
       }
      }
     },
     "localname": "LongtermEquityIncentivePlan2005Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ManufacturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufactures",
        "label": "Manufactures [Member]",
        "terseLabel": "Manufactures"
       }
      }
     },
     "localname": "ManufacturesMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NorthAmericanOTCHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North American OTC Healthcare [Member]",
        "label": "North American OTC Healthcare [Member]",
        "terseLabel": "North American OTC Healthcare"
       }
      }
     },
     "localname": "NorthAmericanOTCHealthcareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_NumberOfThirdPartyManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers",
        "label": "Number of Third-party Manufacturers",
        "terseLabel": "Number of third-party manufacturers"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturers",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_NumberOfThirdPartyManufacturersWithLongTermContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third-party Manufacturers with Long-term Contracts",
        "label": "Number of Third-party Manufacturers with Long-term Contracts",
        "terseLabel": "Number of third-party manufacturers with long-term contracts"
       }
      }
     },
     "localname": "NumberOfThirdPartyManufacturersWithLongTermContracts",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease Liability",
        "label": "Operating And Finance Lease Liability",
        "totalLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiability",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment, Due",
        "label": "Operating And Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDue",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payment Due",
        "label": "Operating And Finance Lease, Liability, Payment Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentDueAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due after Year Five",
        "label": "Operating And Finance Lease, Liability, Payments, Due after Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Five",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2027"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year One",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "label": "Operating And Finance Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Operating And Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Care [Member]",
        "label": "Oral Care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_OtherOtcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other OTC [Member]",
        "label": "Other OTC [Member]",
        "terseLabel": "Other OTC"
       }
      }
     },
     "localname": "OtherOtcMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_PercentageofDepositsHeldinOneLocation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Deposits Held in One Location",
        "label": "Percentage of Deposits Held in One Location",
        "terseLabel": "Percentage of deposits held in one location (as percent)"
       }
      }
     },
     "localname": "PercentageofDepositsHeldinOneLocation",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_ReservesForConsumerCouponRedemptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserves for Consumer Coupon Redemptions [Member]",
        "label": "Reserves for Consumer Coupon Redemptions [Member]",
        "terseLabel": "Reserves for consumer coupon redemptions"
       }
      }
     },
     "localname": "ReservesForConsumerCouponRedemptionsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ReservesforTradePromotionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserves for trade promotions [Member]",
        "label": "Reserves for Trade Promotions [Member]",
        "terseLabel": "Reserves for trade promotions"
       }
      }
     },
     "localname": "ReservesforTradePromotionsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Conversion Ratio For Securities Into Which Each RSU May Be Converted",
        "label": "Restricted Stock Units, Conversion Ratio For Securities Into Which Each RSU May Be Converted",
        "terseLabel": "Restricted stock units, conversion ratio for securities into which each RSU may be converted"
       }
      }
     },
     "localname": "RestrictedStockUnitsConversionRatioForSecuritiesIntoWhichEachRSUMayBeConverted",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pbh_RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted",
        "label": "Restricted Stock Units, Number of Securities Into Which Each Restricted Stock Unit May Be Converted",
        "terseLabel": "Number of securities into which each restricted stock unit may be converted"
       }
      }
     },
     "localname": "RestrictedStockUnitsNumberOfSecuritiesIntoWhichEachRestrictedStockUnitMayBeConverted",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)",
        "label": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) &amp; Performance Stock Units (PSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsPerformanceStockUnitsPSUsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RestrictedStockUnitsRSUsStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs) &amp; Stock Options",
        "label": "Restricted Stock Units (RSUs) &amp; Stock Options [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) &amp; Stock Options"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsStockOptionsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_RetirementPlanContributionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement Plan, Contribution [Axis]",
        "label": "Retirement Plan, Contribution [Axis]",
        "terseLabel": "Retirement Plan, Contribution [Axis]"
       }
      }
     },
     "localname": "RetirementPlanContributionAxis",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_RetirementPlanContributionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Retirement Plan, Contribution [Axis]",
        "label": "Retirement Plan, Contribution [Domain]",
        "terseLabel": "Retirement Plan, Contribution [Domain]"
       }
      }
     },
     "localname": "RetirementPlanContributionDomain",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SECSchedule1209ValuationAllowancesandReservesOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Other",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesOther",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Line Items]",
        "label": "Schedule of Intangible Assets [Line Items]",
        "terseLabel": "Schedule of Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsLineItems",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table]",
        "label": "Schedule of Intangible Assets [Table]",
        "terseLabel": "Schedule of Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTable",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ScheduleOfIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Intangible Assets [Table Text Block]",
        "label": "Schedule of Intangible Assets [Table Text Block]",
        "terseLabel": "Reconciliation of the Activity Affecting Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_ScheduleofAccruedandOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Accrued and Other Liabilities [Table Text Block]",
        "label": "Schedule of Accrued and Other Liabilities [Table Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleofAccruedandOtherLiabilitiesTableTextBlock",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]",
        "label": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]",
        "terseLabel": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Line Items]"
       }
      }
     },
     "localname": "ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasLineItems",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]",
        "label": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]",
        "terseLabel": "Schedule of Goodwill and Intangible Assets by Geographic Areas [Table]"
       }
      }
     },
     "localname": "ScheduleofGoodwillandIntangibleAssetsbyGeographicAreasTable",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_SeniorNotes2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2012 [Member]",
        "label": "Senior Notes 2012 [Member]",
        "terseLabel": "2012 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SeniorNotes2013Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2013 [Member]",
        "label": "Senior Notes 2013 [Member]",
        "terseLabel": "2013 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2013Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SeniorNotes2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2016 [Member]",
        "label": "Senior Notes 2016 [Member]",
        "terseLabel": "2016 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2016Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SeniorNotes2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes 2019",
        "label": "Senior Notes 2019 [Member]",
        "terseLabel": "2019 Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes2019Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Increase In Intangible Asset Measurement Input That Would Not Have Resulted In Fair Value Exceeding Carrying Value",
        "label": "Sensitivity Analysis, Increase In Intangible Asset Measurement Input That Would Not Have Resulted In Fair Value Exceeding Carrying Value",
        "terseLabel": "Sensitivity analysis, increase In intangible asset measurement input that would not have resulted In fair value exceeding carrying value"
       }
      }
     },
     "localname": "SensitivityAnalysisIncreaseInIntangibleAssetMeasurementInputThatWouldNotHaveResultedInFairValueExceedingCarryingValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisability Period, from Date of Grant",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Exercisability Period, from Date of Grant",
        "terseLabel": "Award exercisability period, from date of grant (not greater than)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardExercisabilityPeriodFromDateOfGrant",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued",
        "negatedTerseLabel": "Vested and issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssued",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Issued in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and issued, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Number",
        "terseLabel": "Vested, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNumber",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Vested, end of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extension of Expiration Period",
        "terseLabel": "Extension of plan term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period, weighted-average grant-date fair value (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "pbh_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vested in Period, Total Fair Value",
        "terseLabel": "Total fair value of options and RSUs vested during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_SupplyCommitmentTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply Commitment, Term of Agreement",
        "label": "Supply Commitment, Term of Agreement",
        "terseLabel": "Supply commitment, term of agreement"
       }
      }
     },
     "localname": "SupplyCommitmentTermOfAgreement",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pbh_SydneyAustraliaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sydney, Australia [Member]",
        "label": "Sydney, Australia [Member]",
        "terseLabel": "Sydney, Australia"
       }
      }
     },
     "localname": "SydneyAustraliaMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_TermLoan2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan 2012 [Member]",
        "label": "Term Loan 2012 [Member]",
        "terseLabel": "2012 Term Loan"
       }
      }
     },
     "localname": "TermLoan2012Member",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ThirdPartyManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third-party Manufacturing [Member]",
        "label": "Third-party Manufacturing [Member]",
        "terseLabel": "Third-party Manufacturing"
       }
      }
     },
     "localname": "ThirdPartyManufacturingMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_Top5BrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top 5 Brands [Member]",
        "label": "Top 5 Brands [Member]",
        "terseLabel": "Top 5 brands"
       }
      }
     },
     "localname": "Top5BrandsMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_TotalOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other income and expense which results from ancillary business-related activities also known as other nonoperating (income) expense recognized for the period. May include (a) dividends, (b) interest income, (c) interest expense, (d) net gains/losses on securities and (e) other miscellaneous other income and expense items.",
        "label": "Total Other Income (Expense)",
        "negatedTotalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "TotalOtherIncomeExpense",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pbh_VotingRightsNumberOfVotesPerCommonShareOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting Rights, Number of Votes Per Common Share Owned",
        "label": "Voting Rights, Number of Votes Per Common Share Owned",
        "terseLabel": "Voting rights, number of votes per common share owned"
       }
      }
     },
     "localname": "VotingRightsNumberOfVotesPerCommonShareOwned",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "pbh_WalmartMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walmart [Member]",
        "label": "Walmart [Member]",
        "terseLabel": "Walmart"
       }
      }
     },
     "localname": "WalmartMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_WeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Discount Rate",
        "label": "Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "WeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Shares Outstanding [Abstract]",
        "label": "Weighted Average Shares Outstanding [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "pbh_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Women's Health [Member]",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pbh_ZaditenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zaditen",
        "label": "Zaditen [Member]",
        "terseLabel": "Zaditen"
       }
      }
     },
     "localname": "ZaditenMember",
     "nsuri": "http://www.prestigebrandsinc.com/20220331",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r137",
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r308",
      "r310",
      "r311",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r137",
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r308",
      "r310",
      "r311",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r64",
      "r66",
      "r135",
      "r136",
      "r317",
      "r348",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r227",
      "r383",
      "r386",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r316",
      "r347",
      "r479",
      "r484",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r733",
      "r737",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r316",
      "r347",
      "r479",
      "r484",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r733",
      "r737",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r227",
      "r383",
      "r386",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r222",
      "r383",
      "r384",
      "r689",
      "r732",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r222",
      "r383",
      "r384",
      "r689",
      "r732",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails",
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r316",
      "r347",
      "r415",
      "r479",
      "r484",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r733",
      "r737",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r316",
      "r347",
      "r415",
      "r479",
      "r484",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r687",
      "r733",
      "r737",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r65",
      "r66",
      "r135",
      "r136",
      "r317",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r223",
      "r224",
      "r383",
      "r385",
      "r735",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r771",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r223",
      "r224",
      "r383",
      "r385",
      "r735",
      "r745",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r229",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r47",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r25",
      "r230",
      "r231"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance of $19,720 and $16,457, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r18",
      "r697",
      "r718"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Accrued marketing costs"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r50"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r50"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Accrued broker commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r76",
      "r86",
      "r87",
      "r88",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Unrecognized net gain (loss) on pension plans, net of tax of $(350) and $(276), respectively"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r45",
      "r279"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r76",
      "r86",
      "r87",
      "r88",
      "r89",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Unrealized loss on interest rate swaps, net of tax of $0 and $543, respectively"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r73",
      "r75",
      "r76",
      "r721",
      "r742",
      "r743"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r86",
      "r87",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r72",
      "r76",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r590",
      "r738",
      "r739",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r68",
      "r76",
      "r86",
      "r87",
      "r88",
      "r590",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r524",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r521",
      "r522",
      "r523",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising and Marketing Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r487",
      "r517",
      "r526"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r236",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r119",
      "r329",
      "r337",
      "r338",
      "r648"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt origination costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r119",
      "r261",
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Finite-lived intangibles, accumulated amortization, additions",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r119",
      "r276"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "verboseLabel": "Impairment loss"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r130",
      "r204",
      "r211",
      "r218",
      "r240",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r587",
      "r591",
      "r636",
      "r671",
      "r673",
      "r695",
      "r717"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r62",
      "r130",
      "r240",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r587",
      "r591",
      "r636",
      "r671",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r489",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r601",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r474",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r474",
      "r480",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r580",
      "r581",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Acquisition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r576",
      "r577"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r577"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r42",
      "r121"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r121",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of year",
        "periodStartLabel": "Cash and cash equivalents - beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r637"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "(Decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r55",
      "r291",
      "r703",
      "r725"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies \u2013 Note 17"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r287",
      "r288",
      "r290",
      "r292",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)",
        "verboseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2013 $0.01 par value; Authorized \u2013 250,000 shares; Issued \u2013 54,430 shares at March 31, 2022 and 53,999 shares at March 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r81",
      "r83",
      "r84",
      "r93",
      "r706",
      "r728"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive income, net of tax:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment and software",
        "verboseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r227",
      "r633",
      "r634",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r227",
      "r633",
      "r634",
      "r744",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r227",
      "r633",
      "r634",
      "r744",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentrations of Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r184",
      "r185",
      "r227",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r181",
      "r184",
      "r185",
      "r186",
      "r633",
      "r635",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r227",
      "r633",
      "r634",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r98",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Warehousing, shipping and handling, and storage costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Services Sold [Abstract]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r96",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfRevenue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Cost of sales depreciation"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r99",
      "r130",
      "r240",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r636"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales",
        "totalLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r556",
      "r564"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r556"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r556",
      "r564"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r182",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r129",
      "r137",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r649",
      "r696",
      "r700",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r331",
      "r700",
      "r715"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r313",
      "r335",
      "r336",
      "r647",
      "r649",
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r52",
      "r326",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt instrument, average interest rate (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
        "label": "Debt Instrument, Interest Rate, Increase (Decrease)",
        "negatedTerseLabel": "Debt instrument, interest rate, decrease (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r129",
      "r137",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r53",
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt instrument, periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument, redemption price, percentage of principal amount (as percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r129",
      "r137",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r335",
      "r336",
      "r337",
      "r338",
      "r362",
      "r365",
      "r366",
      "r367",
      "r646",
      "r647",
      "r649",
      "r650",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r320",
      "r332",
      "r335",
      "r336",
      "r648"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Less unamortized debt costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r320",
      "r646",
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Unamortized premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Debt Origination Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r557",
      "r564"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r557",
      "r564"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r532",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r119",
      "r131",
      "r557",
      "r564",
      "r565",
      "r566"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r22",
      "r547",
      "r698",
      "r714"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r131",
      "r557",
      "r564"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.",
        "label": "Deferred Tax Assets, State Taxes",
        "terseLabel": "State income taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r553",
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Foreign tax credit"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "terseLabel": "Unrealized foreign exchange loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r533",
      "r550"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r76",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Unrecognized actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r76",
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Unrecognized prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r405",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r390",
      "r413"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Total net liability"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r16",
      "r390",
      "r391",
      "r413",
      "r465",
      "r694",
      "r716"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Noncurrent asset"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan",
        "terseLabel": "Employer contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Defined benefit plan, assumptions used calculating benefit obligation, discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r440",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets, net of administrative fees",
        "verboseLabel": "Expected return on plan assets, net of administrative fees (as percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations at end of year",
        "periodStartLabel": "Projected benefit obligation at beginning of period",
        "terseLabel": "Projected benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r400",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.",
        "label": "Defined Benefit Plan, Benefit Obligation, Payment for Settlement",
        "terseLabel": "Lump sum payout"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r443",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r407",
      "r416",
      "r418",
      "r463",
      "r465",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "verboseLabel": "Contributions to the qualified plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": {
     "auth_ref": [
      "r463",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year",
        "terseLabel": "2023 (expectation) to participant benefits"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r392",
      "r430",
      "r458",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r404",
      "r416",
      "r418",
      "r419",
      "r465"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of period"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r390",
      "r413",
      "r465"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r392",
      "r396",
      "r429",
      "r457",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r427",
      "r455",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansExpectedReturnonPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "auth_ref": [
      "r451",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r451",
      "r452",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r409",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPeriodicServiceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r415",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target Allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRealEstateMember": {
     "auth_ref": [
      "r416",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Percentage of Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r449",
      "r450",
      "r453",
      "r454",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, cost recognized"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Defined contribution plan, employer matching contribution, percent of employees pay (as percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Defined contribution plan, employer matching contribution, percent of match (as percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Defined contribution plan, maximum annual contributions per employee (as percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r119",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r119",
      "r199"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r63",
      "r66",
      "r67",
      "r604",
      "r686"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r66",
      "r602",
      "r605",
      "r610",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r619",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r599",
      "r602",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r595",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r594",
      "r596",
      "r597",
      "r599",
      "r600",
      "r607",
      "r610",
      "r615",
      "r616",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r368",
      "r710"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment of Senior Debt",
        "terseLabel": "Early repayment of senior debt"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r94",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r159",
      "r161",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r621",
      "r622",
      "r707",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)",
        "verboseLabel": "Basic net earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per Common Share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r94",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r161",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r621",
      "r622",
      "r707",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)",
        "verboseLabel": "Diluted net earnings per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effects of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r133",
      "r535",
      "r568"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax provision at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r535",
      "r568"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r535",
      "r568"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r535",
      "r568"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 8.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r535",
      "r568"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "pbh_EffectiveIncomeTaxRateIncludingDiscontinuedOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "R&amp;D"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based compensation expense, not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based compensation expense, not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit recognized on compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r174",
      "r241",
      "r361",
      "r368",
      "r521",
      "r522",
      "r523",
      "r560",
      "r561",
      "r620",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r738",
      "r739",
      "r740",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r322",
      "r335",
      "r336",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r624",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r322",
      "r335",
      "r336",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r465",
      "r625",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r322",
      "r335",
      "r336",
      "r624",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r322",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Liabilities",
        "terseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r322",
      "r335",
      "r336",
      "r416",
      "r418",
      "r423",
      "r465",
      "r625",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r322",
      "r335",
      "r336",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r465",
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r653",
      "r658",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Financing Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r652",
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r654",
      "r663"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Payments of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r651"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r653",
      "r658",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r665",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate, financing leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r664",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years), financing leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "periodEndLabel": "Finite-lived intangibles, accumulated amortization, ending",
        "periodStartLabel": "Finite-lived intangibles, accumulated amortization, beginning"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r271"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r262",
      "r265",
      "r269",
      "r273",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Finite-lived intangibles, effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r269",
      "r691"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "periodEndLabel": "Finite-lived intangibles, gross, ending",
        "periodStartLabel": "Finite-lived intangibles, gross, beginning"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross [Abstract]",
        "terseLabel": "Gross Carrying Amounts"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r262",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r269",
      "r690"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-lived intangible assets",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsExpectedAmortizationExpenseDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "verboseLabel": "Finite-lived intangible assets, weighted average remaining period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Finite-lived Intangible Assets [Roll Forward]",
        "terseLabel": "Finite-Lived Tradenames and Customer Relationships"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived intangibles, additions"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FixedIncomeFundsMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.",
        "label": "Fixed Income Funds [Member]",
        "terseLabel": "Fixed income and cash"
       }
      }
     },
     "localname": "FixedIncomeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on sale or disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r119",
      "r339",
      "r340"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r248",
      "r250",
      "r673",
      "r693"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "pbh_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net, ending",
        "periodStartLabel": "Goodwill, net, beginning",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r251",
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Goodwill, gross, ending",
        "periodStartLabel": "Goodwill, gross, beginning"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r251",
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment loss, ending",
        "negatedPeriodStartLabel": "Accumulated impairment loss, beginning"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r249",
      "r253",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Impairment loss",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r97",
      "r130",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r240",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r636"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 1.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r599",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r119",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "negatedLabel": "Tradename impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r119",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "negatedTerseLabel": "Finite-lived intangibles, tradename impairment",
        "verboseLabel": "Intangible assets, tradename impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r119",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "negatedTerseLabel": "Impairment of indefinite-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r132",
      "r567"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r692",
      "r704",
      "r708",
      "r730"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income from Continuing Operations before Income Taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r132",
      "r567"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesIncomeBeforeContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r281",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r539",
      "r544",
      "r546",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r133",
      "r536",
      "r545",
      "r552",
      "r562",
      "r569",
      "r571",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r157",
      "r158",
      "r202",
      "r534",
      "r563",
      "r570",
      "r731"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r530",
      "r531",
      "r545",
      "r546",
      "r551",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign tax provision"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax provision at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 8.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r535"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "pbh_IncomeTaxExpenseBenefitIncludingDiscontinuedOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "R&amp;D"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r116",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r168"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r264",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "periodEndLabel": "Indefinite-lived intangibles, ending",
        "periodStartLabel": "Indefinite-lived intangibles, beginning",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Indefinite-lived intangibles, effects of foreign currency exchange rates"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r264",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Indefinite-lived Intangible Assets [Roll Forward]",
        "terseLabel": "Indefinite- Lived Tradenames"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-lived Intangible Assets Acquired",
        "terseLabel": "Indefinite lived intangibles, additions"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndirectGuaranteeOfIndebtednessMember": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An indirect guarantee of the indebtedness of another party arises under an agreement that obligates one entity to transfer funds to a second entity upon the occurrence of specified events, under conditions whereby (a) the funds become legally available to creditors of the second entity and (b) those creditors may enforce the second entity's claims against the first entity under the agreement. Examples of indirect guarantees include agreements to advance funds if a second entity's net income, coverage of fixed charges, or working capital falls below a specified minimum.",
        "label": "Indirect Guarantee of Indebtedness [Member]",
        "terseLabel": "Indirect guarantee of indebtedness"
       }
      }
     },
     "localname": "IndirectGuaranteeOfIndebtednessMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "periodEndLabel": "Intangible assets, gross, ending",
        "periodStartLabel": "Intangible assets, gross, beginning"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r260",
      "r267"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Intangible assets, net (including goodwill)",
        "verboseLabel": "Intangible assets, net (including goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendsPayableCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest and Dividends Payable, Current",
        "terseLabel": "Accrued interest payable"
       }
      }
     },
     "localname": "InterestAndDividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r102",
      "r327",
      "r334",
      "r337",
      "r338"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r113",
      "r115",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsFairValueDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails",
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeInterestRateSwapsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r246"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r60",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r61",
      "r125",
      "r173",
      "r243",
      "r244",
      "r247",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r35",
      "r36",
      "r246"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Packaging and raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r60",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves related to obsolete and slow-moving inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r34",
      "r246"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r666",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails",
      "http://www.prestigebrandsinc.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_2": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r49",
      "r130",
      "r212",
      "r240",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r588",
      "r591",
      "r592",
      "r636",
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r130",
      "r240",
      "r636",
      "r673",
      "r701",
      "r723"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r130",
      "r240",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r588",
      "r591",
      "r592",
      "r636",
      "r671",
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit facility, commitment fee (as percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Revolving credit facility, remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loans"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r321",
      "r333",
      "r335",
      "r336",
      "r700",
      "r720"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Debt, fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r137",
      "r296",
      "r325"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased [Domain]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table]",
        "terseLabel": "Long-term Purchase Commitment [Table]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails": {
       "order": 2.0,
       "parentTag": "pbh_ContributionMargin",
       "weight": -1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Advertising and marketing"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputCapRateMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using ratio of net operating income produced by asset to its capital cost.",
        "label": "Measurement Input, Cap Rate [Member]",
        "terseLabel": "Measurement Input, Cap Rate"
       }
      }
     },
     "localname": "MeasurementInputCapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-term Revenue Growth Rate [Member]",
        "terseLabel": "Measurement Input, Long-term Revenue Growth Rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r117",
      "r120"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r79",
      "r82",
      "r88",
      "r92",
      "r120",
      "r130",
      "r149",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r165",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r240",
      "r298",
      "r299",
      "r300",
      "r303",
      "r304",
      "r305",
      "r307",
      "r309",
      "r311",
      "r312",
      "r622",
      "r636",
      "r705",
      "r727"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsGoodwillandIntangibleAssetsbyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationRevenueRecognitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r204",
      "r210",
      "r214",
      "r217",
      "r220"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r659",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "pbh_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Total present value of lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r651"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r665",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate, operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r664",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years), operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r3",
      "r145",
      "r190",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Business and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r50"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r71",
      "r73",
      "r585",
      "r589"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Unrecognized net gain (loss) on pension plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Other comprehensive income (loss), defined benefit plan, gain (loss) arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r585",
      "r586",
      "r589"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r69",
      "r73",
      "r603",
      "r608",
      "r617"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (Loss) Recognized in Other Comprehensive (Loss) Income (effective portion)",
        "verboseLabel": "Unrealized gain (loss) on interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome",
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r73",
      "r77",
      "r609"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into Income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsScheduleofDerivativeGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r73",
      "r77",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Settlement gain, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPensionExpenseDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r80",
      "r83",
      "r585",
      "r586",
      "r589"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive (loss) income",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r73",
      "r77",
      "r78",
      "r435"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "terseLabel": "Net gain on pension distribution reclassified to net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r100",
      "r119",
      "r277"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherMachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services.",
        "label": "Other Machinery and Equipment [Member]",
        "terseLabel": "Machinery"
       }
      }
     },
     "localname": "OtherMachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "pbh_TotalOtherIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense (income)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Payment of debt costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Fair value of shares surrendered as payment of tax withholding"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r415",
      "r417",
      "r423",
      "r442",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r465",
      "r467",
      "r470",
      "r472",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Retirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r18",
      "r390",
      "r391",
      "r413",
      "r465"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "terseLabel": "Current liability"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r391",
      "r413",
      "r699",
      "r719"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Liability, Defined Benefit Plan",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r20",
      "r390",
      "r391",
      "r413",
      "r465"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-term liability"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansAmountsRecognizedintheBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r449",
      "r468",
      "r469",
      "r472",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Pension Expense"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r388",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r443",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r489",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)",
        "verboseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock \u2013 $0.01 par value; Authorized \u2013 5,000 shares; Issued and outstanding \u2013 None"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r40",
      "r41"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from refinancing of Term Loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "verboseLabel": "Proceeds from issuance of senior notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r109",
      "r129"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under revolving credit agreement"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r108",
      "r520"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockBasedCompensationInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product concentration risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r748",
      "r749",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r278"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r280",
      "r673",
      "r709",
      "r724"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, by Type [Abstract]",
        "terseLabel": "Components of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetByTypeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r43",
      "r280",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Total purchase commitment"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueAfterFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "PurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesLongtermSupplyAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QualifiedPlanMember": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Qualified Plan [Member]",
        "terseLabel": "Qualified plan"
       }
      }
     },
     "localname": "QualifiedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": {
     "auth_ref": [
      "r211",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table]",
        "terseLabel": "Reconciliation of Assets from Segment to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r211",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Allocation of Long-Term Assets to Segments"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r111",
      "r129"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments under revolving credit agreement"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Term Loan repayments"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedLabel": "Repayment of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r368",
      "r524",
      "r673",
      "r722",
      "r741",
      "r743"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r241",
      "r521",
      "r522",
      "r523",
      "r560",
      "r561",
      "r620",
      "r738",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]",
        "terseLabel": "Retirement Plan Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]",
        "terseLabel": "Retirement Plan Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Axis]",
        "terseLabel": "Retirement Plan Tax Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Tax Status [Domain]",
        "terseLabel": "Retirement Plan Tax Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTaxStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r195",
      "r196",
      "r209",
      "r215",
      "r216",
      "r222",
      "r223",
      "r227",
      "r382",
      "r383",
      "r689"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Total segment revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r126",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Segment Revenue by Geographic Area"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r702",
      "r726"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "pbh_AccruedAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/OtherAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesReturnsAndAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers.",
        "label": "Sales Returns and Allowances [Member]",
        "terseLabel": "Reserves for sales returns and allowance"
       }
      }
     },
     "localname": "SalesReturnsAndAllowancesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r76",
      "r643",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionAllocationofAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCashandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of Primary Components of Net Periodic Benefits"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r53",
      "r137",
      "r335",
      "r337",
      "r362",
      "r365",
      "r366",
      "r367",
      "r646",
      "r647",
      "r650",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of Deferred Tax Balances"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r449",
      "r450",
      "r453",
      "r454",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansCategoryofPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansPensionPlansinExcessofPlanAssetsDetails",
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r449",
      "r450",
      "r453",
      "r454",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Benefit Obligation and Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r602",
      "r610",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/DerivativeInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r487",
      "r516",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Information about our Revenues from Similar Product Groups"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected to be Contributed"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r262",
      "r268",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r256",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r256",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Summary of Changes in Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Income from Continuing Operations Before Income Taxes, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Principal Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.",
        "label": "Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit Cost Not yet Recognized"
       }
      }
     },
     "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPropertyPlantandEquipmentDetails",
      "http://www.prestigebrandsinc.com/role/PropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r90",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyGeographicAreaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r204",
      "r207",
      "r213",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r204",
      "r207",
      "r213",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Information about our Operating and Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r489",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r495",
      "r505",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Shares"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r56",
      "r127",
      "r175",
      "r176",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r354",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Expected Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r227",
      "r285",
      "r286",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAssetReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Asset Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Asset Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingAssetReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r191",
      "r193",
      "r194",
      "r204",
      "r208",
      "r214",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r226",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss):"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/FairValueMeasurementsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2019and2021SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrativeRedemptionsandRestrictionsDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited, weighted-average grant-date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Common stock units granted in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted, weighted-average grant-date fair value (in USD per share)",
        "verboseLabel": "Weighted-average grant date fair value of options granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares awarded, per employee, annual (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r496",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized under plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for issuance under plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable, end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, end of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value",
        "terseLabel": "Award grant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Outstanding, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r497",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period, weighted-average exercise price (in USD per share)",
        "periodStartLabel": "Outstanding, beginning of period, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award",
        "terseLabel": "Award term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r486",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationRestrictedSharesActivityDetails",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails",
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised, weighted-average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, grant date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r489",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting rights (as percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r511",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Exercisable, end of period, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Exercisable, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Outstanding, end of period, weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Warehousing, shipping and handling and storage costs"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationCostofSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r660",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r227",
      "r256",
      "r282",
      "r285",
      "r286",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsAssetsbySegmentDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsInformationonOperatingandReportableSegmentsDetails",
      "http://www.prestigebrandsinc.com/role/BusinessSegmentsRevenuebyProductDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/GoodwillScheduleofChangesDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsReconciliationofActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r59",
      "r86",
      "r87",
      "r88",
      "r146",
      "r147",
      "r148",
      "r150",
      "r156",
      "r158",
      "r174",
      "r241",
      "r361",
      "r368",
      "r521",
      "r522",
      "r523",
      "r560",
      "r561",
      "r620",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r644",
      "r738",
      "r739",
      "r740",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r174",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r23",
      "r24",
      "r361",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r361",
      "r368",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r361",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of shares related to restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r368",
      "r488",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r59",
      "r361",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r130",
      "r238",
      "r240",
      "r636",
      "r673"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Components of Accumulated Other Comprehensive Loss",
        "totalLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AccumulatedOtherComprehensiveLossDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r346",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r360",
      "r368",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r662",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r645",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r645",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r645",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r645",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r674",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r537",
      "r544",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Uncertain Tax Liability Activity"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier concentration risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConcentrationsofRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/AcquisitionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Restricted stock acquired, average cost per share (in USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r58",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r58",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Ending balance, treasury stock (in shares)",
        "periodStartLabel": "Beginning balance, treasury stock (in shares)",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r24",
      "r361",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury share repurchases (in shares)",
        "verboseLabel": "Restricted stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r58",
      "r369",
      "r372"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 4,151 shares at March 31, 2022 and 4,088 shares at March 31, 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r361",
      "r368",
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Treasury share repurchases",
        "terseLabel": "Treasury share repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofChangesinStockholdersEquity",
      "http://www.prestigebrandsinc.com/role/StockholdersEquityScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnfundedPlanMember": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r441",
      "r443",
      "r446",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan in which retirement benefits are payable directly from general assets of employer sponsoring plan.",
        "label": "Defined Benefit Plan, Unfunded Plan [Member]",
        "terseLabel": "Unfunded plan"
       }
      }
     },
     "localname": "UnfundedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/EmployeeRetirementPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r529",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance \u2013 end of year",
        "periodStartLabel": "Balance \u2013 beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Payments and other movements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions based on lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/IncomeTaxesUncertainTaxLiabilityActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unconditional purchase obligation not recognized as liability.",
        "label": "Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligations"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r187",
      "r188",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r138",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Amounts Charged to Expense (Income)"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r661",
      "r668"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2012TermLoanand2012ABLRevolverDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r160",
      "r168"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Denominator for diluted earnings (loss) per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r159",
      "r168"
     ],
     "calculation": {
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Denominator for basic earnings per share - weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/BusinessandBasisofPresentationEarningsPerShareDetails",
      "http://www.prestigebrandsinc.com/role/ConsolidatedStatementsofIncomeandComprehensiveIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2013SeniorNotesDetails",
      "http://www.prestigebrandsinc.com/role/LongTermDebtNarrative2016SeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r762": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r763": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r764": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r765": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r766": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r767": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r768": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r769": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r770": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r771": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r772": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r773": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r774": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r775": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r776": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r777": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r778": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r779": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r780": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r781": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r782": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r783": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r784": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r785": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r786": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r787": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r788": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r789": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r790": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r791": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r792": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r793": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r794": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>135
<FILENAME>0001295947-22-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001295947-22-000015-xbrl.zip
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ME% L*,@W[T P0R,!4M$Y:,5RJ04IT 5@ICP7"]!>N=9/8M=N*3QED!:>!H*
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M+"2KEE \Z?T&+YLK4# +9]:\K;E0<^'1H=3?)2Z,[P31:U/%?)6KXLU6)8F
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M<"1UD/2<OV.ZL@CGQ/U--:"BU 5 VKBD/HX!A<X!MQPWX3GDZA)8#26\P)L
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M!]'A7LVU[T6NZ*$@$L?/_SE V!B^W]OY#]L.X4LA''Z#L):>0LMA+W"H>]!
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MPLZ",Z"4D+M@&P#'1J9EMTF[7BN<FU&VYOY;P-U*($882K>Q5Y9::PR^*VQ
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MZ:&SQJXPQ7 H*A(2F,T1TMP38_/%L_BT;;)SG?M'KT2:#"]%BS]ZTPJ> E4
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MY 14$F%M@5&;_2_^K((CN OF3'I$\\UECKL\<_S:F!.Z]N9:33UFB(K5A=X
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MUAQ]!HY48R6,M<3 T;#&<XB37>_BP4P@?JU#WX)S!#77 &,R>"X9Q+Q]Z"?
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M*7?Z[>/H22]W]%PG/<USD]1+[BX)9-2*S8T)CY%]22G@= /E"[#^1?LGI[M
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M9*?:+'?Z7:O?;+9EKPH\K%=KSE+&^Z?D7U\"L":.AX'_5H-K%Y.?CM-V'-G
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M2& K#-=>E)[:>"??S_5E+IGW_=F/O]9Z4(Q1YV1HE1%+J=#!+.-885\2!#E
MWXTC>) O!Y2[@/[E6N=C)&04@9*$7YD348ZC*(#FZT8*>*>+<34?CAO99!AX
M(@ FGL."3%M- *^R;+-FM9DK3SR585_"8\M'5YZ:4LK'NUI+?*V<5K8JHE-O
M8RWC>]QXMDN=Y=SW@$?G<,UQPQ&'(<?P;HD7 7I2\JU-*Y:)[<9Z797KG2M>
MYFR?4.;L6TZXB7L.PLWLY'<].7A5\[1^*RI:_5FORWJ_!L*BU<4LD7['*LMF
M599KU8;=<1I6IZZLV^=AO;!\N'\<+AHJSS,B1+R;DYM>"# !8;ZOK#,\7SQW
M^>DM9<2+5ZF9_L8\IS.<L3=H')QOPCLN)@>#G]U:K=J75K=<M^K5<K.'T[BL
M9K/<MRQ+5GL-2SGM9><:9T#7<C  SH"L SF&BG7%*E#]94!2%?4&#,'K/RTN
M<<6DGG@J %<HL9-B] [F0\*3(N(J2<PYGR&.1U>^I5#CX,0B%_X *<W%W?A5
M\:&8->1A^F04>#;%\O$:"=H%:"JB[]JLRT07J 70PV"UE%-4> [5VVCN18_K
M:_</YF2:'[*4T%3]&041*@E8L.A-6>]5N)=( ;'99D;>?Q/J;:['Y)VJ<4SC
MW9DW-JHTOZM&6_D_FF1W*0D)EI?X+A-L$MD;10KNM+N-9J-1;W=EL^FTE*Q;
M=K/;Z58;3J/EU+L_]XF">XWJ!K!KRQT!,?[?C7+K.AD?DWJTZP5R9E*/GXS*
M=A"7]>U@H<-VX-;VVZ+IZ='V_J^?C8ZRFU:W4>[WNT#%=;M7[BM0!2QE6]UJ
MO=JTFL[&IWJIT^M6VH:*S4%^$D"3'GRH+'=6]R:1P0$@?9W'RI6N6PSII,?K
M6$HEZ]$,HO:;CFK9K5:W6[>;=:LO>U9+MJRVU:XV^H[L$:+6JZUJ/8^H^X>[
M<_*5B6BI//.47G64Q&0V KNY&^I6WQSJ?J_]=)3=KJEFJUQOV]UR4W8:Y6ZM
MTRJW6QV[T:GV:MT:J*VM:JG>Z96:M=YU[.6#1=RP<GT+1)"!_ZZ(O; 3WBT#
M4Y[U*<]=7KY]M/7U8.?P[!0G?1R='!^=;)[M;(O/W\7)SN[.R<[AULYR\XUG
M&"H797VZE?UY>F)TA3-XT6</L/%M438:I(V?S;JR'2Q;:$JERDVKI<K]KNR6
MJU:WW>HW&\UF'02^ N8W!G"2V?[I&%TM.G=Q@5ZSK3,<+Y4X#H.KJ: 6MN3F
M,44K>%2"YVZ+ Z5(X8,'$F\>@C*FPDB\PPMUIB)=/_,PG:;X7@!S 5,R.]ZB
M,NCZH X>@PXE]O?WTT1T_>Z3U&NU"^Q?U*KE?QOMD=R4,<B4R K=/CP5[%OE
M^G>?I*-1O-X!&A@'[.C\$"I,E;]462\UQ/_<73H1LIK=(ON@GH*2N_"6^W"S
M_'_Q$83TO4:_U5)5IP/61--I]&7+:5?;2G8ZM9K5Z#@_.QOFGF&8!5H&@"ZA
MDA>@D,-+/TAO(J<1SMC*\Q=@+AH0S7JE@_F=L]NX;;%+V*+[;//SEQV<^+=U
M='B&G/>%>CRV*DU.C[QO(FRW4NUV'SVOLENM@$+P^(^MU.\XIV@],7:]HQ?<
MT1K]7O..0GS>\@RP/98#=1_LZTOK8A &B6^7]1(M2RG'^;B$A[AHQZC$W>$0
M5VFKOXFOKW*K]\9DA_ZW.GO>!PM&U"H/.M]5VZO)A7SVS<ZW&XB++P:%XSP9
M*'C5MK+TL+ /E*V 5\%RY-*L10Q#=+S\XW:KL-;8^%3_WS_EK-7VRH31322\
M^3 :7K7-GKC1A=B55AR$#Z/CW]GPFHZ?FH[;&Y]PK,CC$/*JR2<FY,]O0QA_
M]4,5!=XE1I)CZ3@"8V+H'E]+YU='U3V0SNTW+9[K;T,Z'X?!&->BUK+YU5%Q
MO?Z85+QJXHJHN/$V1/,7-9 >QCB!'"E]<RV27QTQM]Z\2&Y6WI!K\P"^$:?2
M4?%4;+N1Y051$JZE]"LD["X0=N>M2NG?H.CU5E=IJZ](1-T485R'&'][JR\6
M*U_'& OJ5NMMV$X'7%&$V:6%(;YZ3-Z.+M,YP>1+<GVF::;B $N5PX@J?7BJ
MC#A.0FLH(\Y8YWMS7>/79MEKT]X:3=#>NF_:+&N_#4_INQ,%=UXJ^RZ3;=<V
MV!*LY1Y4W-GXU*B]51N,J+CS5J2]Z20"(A[]*DD4N;KQR*8OO6GDDNC>33N$
M; 6^S8UF\!I@ HD7TR5'8\4HMQ;KKXXA-*N/R1!63=0Q0W@C^4G_P39/;DR5
M543B\(5G_LYY7L5F/TABH<T%S&I:ZP&OC>Q;K8U/S=:;U@.Z;T,/R.1[6A/*
M=OQI,AY[]+<,IS3::"W=7QV9=X','RWDLFH"C\B\]S:$^Q;U:,0V@$3<(,[E
M(%2:W*E'Y":WYI/X!>CXFUFG/KPA8Q.9)K 6^Z^-']1:M8U/W4?SXJV:+&2&
M\$!U?]4V"^8\]@%E84\94_:#\RK60GZIB;KYF$2]:I*/B?J!I0FKMMDC:B"Z
M[W,?+L"8M8Q^?>3<><LR^FTG#SW>5E]A<LGR,NL;$Z76F5+K3*G59U9< 5I]
M&[;3MALJJN,NB9TK9244(CER'-<R65!;II&>V,-!"^@\>9B_9&U:+;,NUFZ
M+M9[TZ95[8$M6%9MLQFA8[M]Y4=K^^J5TG3[,6EZU40;T_0#B[Y7;;,Z(7DJ
MCB8^2.ZA.\9\IBU8GG1]\5GY"D0Z!CWX=Y+L6>*4SH-:F Z]EO>OCS?TUO+^
M@:7DJ[99PP6(P#&Y$;A#5"#Y,QR]Q^WYHQ+;?!Q;9>- [ .&C7'BR$-U_[6>
ML,R\H%-?ZPG-MZ$G'(>N;[EC4 1R:1&[2NE,*15>@N6_EO>OD,9;;UG>OZ$N
M$VOW]&L15S?%6OY^$])J'3=\W6R95:\'5J6OVF9WKH9NWXVCDIB3J2Y.K:&R
M$V_=#N@5ZE[=VL:G7O5MVU</+"E?M<UF<\-.D]%(AM.U*?7ZR+D)Y/QH#;)7
M38RM3:FU*?5*F/63FA<\D7!Y[,:SD\WMG8/-DW^?BLW#;4%_'FX>[)RNS:LU
M_UKYK9Z%TE:@;UVP(SO&/W'L;R222-E8+'C;G%<<&XN#7L?</GV*\?/C4$6Q
M.\!$&3_" :_B+R6]>&CAQ?N^51%!*,"D$U'2CUS;E:&KP+Z3$3W)DI$2(SD5
M?:7;W/)_ORDQE)<*;@2H6;!)6P1)R&OF+01A?@>3H<+EJZF0X[&2X1UV\U06
M]8H0]9\T0_73W2?&WC+I>V9D[8J/[ZU5-SZMY_<R&M4SE^KBH?,/Q)K<;><)
M\!%G^D+[V]K\>K9_=+AY\EV<GFV>[>!T>'&RL[=YLKU_N"=VCTZ^P<?REZ.C
M?^/?Z36GU[:VK/N>/TC^[!:6CY/EI>M'9JRX$X03&=IE+P@N,"X:I7TD]'!Q
MJB\G[@N,74E?SRG'/X]#]Q*3I+/.D.(+_#,@.Q/>CG5L8M.*\?I:K]<JS#,_
M/OURLFD&F)=P>KF7( LNT0NQ1XWGCJB!3>#CSVE1G%E0ELJ5C5U_I$Y8!=%U
M!FMV L\+)KAU2R9X"7;5B'(M-T V]A7^/@(1)L9)&&$_'C-('>3KI1OE9\;3
M[FD!5+Z/7[D^3EO'=<$U01]/"1^(/_4IERU.[]8@C*2#8C7L!Z$YK 5O*FQH
MQ3%\=R'&B@A4A0O =V^*^H@&@(TH>N/0>P8+Z1!Y..U<66H<XY-"]=_$#4%G
M(=^)<!3\%YX297COR8G6PN"-(?JTZ:]0#1*=@&26<[JS!2@.RPJ$'\1\ZC8B
M2C*FE4I_*A83)5X8*L=30%7JDKX!Q<ER0RL9P56^A2\. 0.P\P/*M#N"@)A#
M"=4NJD&%/4MX#Y(&WN?#R>4HL"2<)$X Y;,5!'C;Q(V*6M]F\3$$&S?2^FH"
MBZ4D+0*@K2(K=/L X[X"4BO!;4!)(9.6)CKX$4$&(!A[TE)X&@D\47DN;ARW
M<@/@F,'<32]&770H8ZW(,DTK+U( 'EB-$P8C$0-*$WGCO_UIB8#@P]5#Z0'Y
M.B50PHNP\+R;EB?C&+:?D!)'V, [5U=C@%\$"/U?[.?EN B@*4(R4O-YT761
MOEKD?49;NP%2 V"&0'T $DLBP$$#1+Z9 PW:/XAODR"T"3O'PY":&4>)-43<
MW@ <<P%Y2QMB ]NF87903'\!O(&TZ!, 8:2_!73SZ=\P.-<_,]WB)VRU'*O!
M%#\/ NGAOT$?KW/Y#4PL=*E2%_@OX!7]@]NF[T'>>?2P2?K!]3SS+VP2/AHJ
M$Q'(10],(MX>DI+>7P'?;F"3)*TDVHB L<#"0@S&\<XUK\*'R@C,OS'_3=2
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M86AA@-16G@O<=VJ<B62*,[]E?8LI...S9-B#*1R0C\?+&#E*ZQ#]D.0+)"S
MD*R1'-%0>:">C]%#1DXI$@[1$,SW-68\*PM V:T5JQB[R)B#7'/CISZ*/?81
MSK-S-+>U7!:KI _#EXZ##CM4;TCET8)3JUNI:]\-T74U9M_>6D5^CJ/\.\
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M3>;.RL*CO.W@:MWTX#X5'3"W/^FQ#_R.^MM1AOD1@8R@A1/XT(T\2KS8'7N
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ME@QCL@&N:ZCDH**G^S$+^+8&38[;TZRHDDA;CI<$NC[@O]BVM21,E[N22!T
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M+<P1",88J20_96 K#\CU+(UZ%OWX$:X\)_+@:<-@PCEUN+,A@-*;:A"Z:4L
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M&>6;'Y.F#LR2HM%:NL<R'(#B:*Z,Q*4K3;3?=B6JL0,\PNRU**W*%,9':A@
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M ,(YK@],4O,MG0>*)Z5U#O8M@LIC&2Z579;WGL^$XAC=2)YHKQQH?D[BE;)
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M58$M53!<;6J6:+(>C>;%57Z-/^$_S=>J8'"* 24;%5V$F%9"NC)G26:F3PY
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M<L%HMUA#ZAP]_VQUBJT27'@NI)L@(Q?EV90EQH'CPG_1,F(M;HQ :Q1$1XV
M(^\SU1FFZS]--L(YM!C8CW?3M_HQ&>ED88FKR+ZKI]&8 .P4#IEV!,HSM^ZX
M">64R..=34[LIEF5-C.EN^4H!YL5/A1=P0F-T;)(R+-MBCE6N(VX2L$[Z![Q
M?!Z/0^.@;!84T\6D46T*4A:!?>!I, JIV;"6=V")92<Z+]16U%?+H7U6L]:,
M4/CU2R;<$D.>M!JI'E33JB6Q')&C6J%N%)M&..P9Q(=J/0WYH):MK:(TF#,J
M\5/PG^XCK'TJPV?$/4=&V*7H.'<D/K"-^57<K.C-F7?.L Y6KTLW. 7Z&!Z.
MLF_</.SE36JM$*1N3 X!MJ)^MHUACB=Y2F#][ELQANIG<!P^NH&S;&*TCDR-
M[1JWDRU/;2H+WH^GMZY^5X"XH"HM*5_*!&Y</2%WB'105$>R,%*VP;A-NJ^E
MQ\9AO$LC1G@\.@ ".Y6QS3HI'YADKG7B<0572HZY1GKN=W7'E5F' YMY.W9B
MLD[#7HUL<DQ$/7" @G%8"0>JGQ14#]'%L3!!&$ '(0]12,=-35F8;B#*Q(A9
M>WR*.OM634GB'P^XSN"4:@I)?M["7$8[VUO_C*/_X< O;-V>W_\GC@Z;BC@N
MVK^^PIO)GP55,.+R-2H[*(G9ABZ.VX&,CU7Y9<E)C:"Z5"HAP(9-/TOCL-+W
MH1$B%B 8?R4W2E8,J3@DA ?JPF0&)\S^41@(^S3@2!5@I3'F)*B)R^Y=K.TB
MA%=0 @1=2J@F?"B<F;2I7(WXT1<^T*FJ2#K.?$;ZLZ-#RW$=0G<ZS2:ZH;,\
MH](PM0F* V(Y++3G1$Z-.ER]8/&XU8WO!Z6J&66LKJM,5G!0CBA*TH #%[6E
MP-QQH2JMA7L"E9%X]UX[CJS E%A!$XTW._9P;RH/F*9GY_7>'JTER0U&U/VI
M#"[76:5UZGVF71KW\.<K'^Y?;!?L_L942-/\JVP$)S@929YMOHPXK*0A$$5*
MIEU@"X9!:B.IK!8!IFS)QV:8@[MX:M?^M,30Y@(6>IO%^BW_XVQ1$>+]AZ,X
M^@1N ZS[ CW@-X?1[O;^\]>#*-+!"7];%NX'*K340T]/NO[78T M8:A/;^@[
M6Z^VM[?@/[:V]_:V[W\IL^WB'95S"G1?U<;[$<S@=!G;2^3/J%#/3)'!/]Y:
M-AG;Y1C+;?2@C]B$,Z*B5+R+&*DP UPCDY;P8A^DE&XA4!C679A#P]*I4F)K
M!TABBY?^2A%3XH_0BCB/^?F=+6J.^196IG +'@IFZT"(_>QW42_35*KI])B@
M.YFA AP"A[#SH>0V50G0]([ OJ]%Z -?R['XCU186T?G6#G,#;7^=)WAV12=
M6-PJ]T7M,YOL9FVQ$L7(5;NT^S#/R><W^('SLJ *<(,88@GO7MD*2/<R*9F=
M7+9R""Q8+/56V[A4&TML)8$M[+:8*J_<+&$\J,LJ$R*[:X UI/4?X0%N4J;R
M-3\^ZO*FW?M3WA1@03S?OS,HB(]B/Z,:XL3>+RX3?%S<JM9]7;[IQ8OMZ-,4
M[<&/.>4C3\MD= ^_XSRIJN6BO 0S )_XK[+ZS+IJ9WO_]<X]_*"#!?5"@DY!
MJ[,B^HS[;V5@90IWEB#&0U[6EMFQ[<L%!TH<8>PM5;?(]2D).!^V[A,*A^-3
MN?[>>*5K),USZMURJ5(N+/!)RR_UW=+ QHVU%E[B8997V/D3OE^P*;\-SJ>]
MU><3#C<;_9\GV>N]X?Z^V1Z_?+V7/A_O#9/]\8OM%R9Y^7)G)]U[.?[?G1=/
M[O90NR,BP_.C7Z.= P2#.3[[9_3VX/#\Y/3LWFB/SD?M[,-'G6;UY]J:S))\
M_-EGK3D&5P5IMN]U4/*6Q=$?VREES&OZ90B2&(XCC+I,EC&W)Q+&F$</ZG*T
M/J$+0O8@5R.Z=^)55(+/PRD FV>U^2<OR2>9^!6QZAFX(6!OW.,HB"U2XRG$
MK*6;NS!58EK%QB$Q^#AOD'Z&0665KBNA?B?I[E5RARCZW95K"]J4+#P5WLYF
M)>5/? F(GIH!=H."\0KS_2SV6..Q1;@L&!8CLYF!EKQ02N!JF<D*+)W6))4+
M]M7<6XCDZX[-ATLVLKIN3!WY%0NQR)!7RA9FN*0=BB7'*^U6 #*_!"Z0M57L
MMOTYD(QS6L$<VL*,.%K)?M2W6^K6=D%D7*KA*VTSF96>!M?W,*RR\,OTZ#.'
MQA1!N1TFOX2<@Q>':QQC0?@6I-\IQ[&EP!6W*$&^T',L)F"G."J6JGX;HNLI
M[H=5RRZR'(R:BB,)-*^LI%LE*7%?,C3(-FHQEDOEV38 LMU6U6AQ4@K+,H(2
MC F75K*\P/]QI_K]U3B6)BEDW;IDG+F5E4\VC;P0987+IV5'BQ:KH10"&DVP
M2O<$Z_!P/XH*UQPQ,XD+MU=3*$--(/"F]MF8K.@'=42X92R<#GX/ 5F.EY2S
M#;X<^U#&W3<&W\LU5YU^C[Z7^G.FV$DT775R003WJ'7\,CY?!F,?KJ]>>)KY
MDF8PSSZ;7$N5.])9=]59)]=K9.:_0J<-9)YZ9J9=%X5-117Y)WB>@;^6"#!4
M*EY/..QNO9M/N$6BV)$=5YK%ZD+9A.(V39PG@#>;%)< O]WT]!6?.(CU+=G:
M8_I_/UVQT0]P;-^Z _:;JJ?=G=W]W=<_RD0EP_WWH,.LK*2J1MSIOCXO"A^W
M"V[&\#;RYCE/(Z 7;$?XJ/9B*\%)N2R+D9908]I 1$FVH&OT$":;51I/;(FK
M.L?\2I9N046/+'YGL_=;K/)*LW=?R@S<9_E8:URU4VN:S=:U<*NB76+E2TG2
M17<E!M&!;&^_:(AD)VQ7=$/04G9!46.I6JY:2[\S8\PM([%7#DJ(/=Q2TAD;
M41@HJE1PT7QU1=3JLO.KVR8O!.M'^C:[O9I!9V90S(6)2P17I>KD'LN;E*%?
MD1Z=W&S[4.'K37>'/R)Y&]%5(<E4Q=">SG*E;>^/":L5'=2LXX)IE\[911)Y
M( DJY+#58CQ[T:J-?)M*JW7:[#\VZD#;'V4:'0]'%,9TTYE.-LY1)N&8.)JA
M5007J7Z=:>V[WH4"1Z'3"5$R5'ZQVA4&Z)\][M=W/:[U &P[&#K6PD7J",B=
ML/MV'8&UG1^N9K-B)8IU/5)2:5?UPE [.1%;\S6TK;&""%^#L"PM7]AW>F.Y
M2_N07%<2@^ HMX-REH]+K^U)J['L%Y-&7-FKG@RK,D$XVU^=@T,'B9,T_-0<
ML^#<M4,[OFZ&6$DM$%X=,<2!%FA!C\K8^EBH+PWFROD1I)F\M@FJ7J7&96HO
M #U_(03%R-E-R !)"^N4/F 5Y9[HOU+@FN39/M$VP@)B/H&$P8^,]AA9OF9F
M[5@(/3IM1*>5J5$B%:S/:ND]@MTOJM"Z%%X21!JLJ%#Y^_DR]WSW:H0G-!0B
M3F?)?J#2%T9=9TE5@D5!H61PQMR"ND7U#.26HK>T.[G!5/-#CC/-[@%&<)"N
M<R)ANV1G39X'NQJ!G1"<6AZI*23N_%]@H8E<JZ\! :1AR-N5:$(:<_@Q\-Z#
MG(IY^ [W7NI@U_<N+LO>]^K7!IM5OSUXK=R-TM9P :CW26XB8#QGQI;I?<3B
MQ^,X.EZ86;0S<-F%+= F_X;5^)G@"Q0AZP9EDMRR[XK/*EO?Y*_4?1?I3^9J
MU9UH+ML/;^MZV.AV8+U66CD_*:2_33>*T)K$(0;S19)SX,9KE^4 A]\W%QB.
M4H+(AQ%;,BB>3OW&ONZ%1Z)N'3G%[.+H:I<B605[M1BJTI=F:#V+(:J-#H5D
MA6O^&YK45T:Q[7D^;);4HF'2K-;GQ7ZDW6:U23\(<*5Z1UZW!/:U9*H=.&;C
MAMGZ!!N+H7K/9)Z-\+!.YISH"(;<LPEA#!^"Z2C*"S&8!4/04TQ4<$MG BQ*
MPX>*0N>%(Z*LO%Q$:7E_SO.D*6"\VH[.H%FQ>H<E9L%-G1JELD0,_HK/TPZS
MY=4'V29I[R?MG]^?HK([FJ)O$Z\DPXNZ%WJUE>H\Y)\DZ]ZA2U?2;ZU68^S9
M$KB[!<?G_I<TGU/PJ6I<-E;YL +[B?!X@[)<]*:V;&-+6QN(]PG"62]*>3!A
M+V]A]A6--*N#=/^"\D0#"$Z.>9X@04 BIQ+R[B#9PE+A2BAYS\=13>P@O>F-
MWJA\T)4G$)'NS"QAU!6E,%JOB+N#X)'YGT<0$/9SY(0+I\5-*-UANWI5?%.M
M V[[\;WH_?=+TH(N?-_/I.3' C&S*,V/>"^A@8['GZR,%T_6;#PA8U=(YE)>
M2J[8$;;3?9P!;@2MNW6"(UKL/"DTJ,CK*= R 6NUFFZ61-$?2D*4\)784G.$
MEI+%5 PO+M_S6CJ='*Q07N>,TR\2X4-D8.N/%__SHOI]:0(:/2.:M(-["%*,
MX]ZB<?OX#?Y.[PF+TC.E9L$+ P>&8SMR.."V (Z3T$RQ@;^T9 5-[<+%MM;"
M,ZGL^W),'5:&F<'(_7,Q3+?I7!4$ 0/S"HBU.\+-P'647>M*C2L'-DK#PI43
MENOV,^2EY65ALR<ZUL02>OE"_35INX?F_]^RANN3\7J=$PL^Y1PDEZ6F5;J<
MEC,//<5C-[6$4'48/$#&.2=!G,&E;>IBZKJ6+5M8HF=!FCR +D*V&2%3DEUO
MRVV#=%OKQ2[R]KVE8^T*&?U.FN_WO^LT#_VE<T(8P0!JGY(<M,C"MO5S",QP
MFB;DF-O='NS_5Z\L7R9"$H1,3186TH^I&46$87J7(MK9;CU*E&\=@)$*)Y*E
M,>=.?K%[%N":@BOO-HD?R'#?E>5YK(>FQ9N)6T4GW< ?[RCA12)6.BJM(),A
MW-;B\/_JX0FY?<M!;F9IP' @]T6ZLYT<"%>_IC 4=K-+D$ ?N*4%<8Y9;IK-
M'S>$2,=0]T/S&K.7>=2JV?8ZQ1V%&RA1UK=:HE6W[?"@)+3O8GMA._OVB%?N
MU-C87%9X[I!:3\'2K#HF50_TZH!6'2S:JH@/F?@P,>*3N9RI,*ZV,'8MKB,?
MHK93QLF+C;!>=4PC$:R>TE2R)D/TTN5^R'RLN+WP1PS\5=52,&QFI*_0O9B:
M?"R^+3W=.8MTDY( 46:LQQ7Q'5%'U\?3L'(2.!-/$Q=ZUV75Z[563*BT[#%L
M-%1-8[-1/\]V^;Y6R_UFL+NY>^P'O3#/S-(*!Q <DD@G1%W)C@)12P,)H(]/
M9.<"CQA_C0*>C /A#&$J6:':9NO5>CAUU%Q.:1C+ ]+2MRF)F 3;0\PX5<3>
M[@!S?2:; VZQW<]H=H"P$3NL5IPD5):"$"+BM&/RP^(DR">1A-WL8XA(TP$M
MJ$N F9.FXEWB:G,39Q2)VX"8)4D10(":UBG1>-]=]WZXWCCB@%6X7]W%M(LD
M5^?I29D4O<"[U;N(4%5H;JX::/P5U?ZIZU!WJ%K=(-6]WI^W]T?=CG2>Z<K&
M!V$DLQO#+R?':.IU<4Q6Q2$ZI6]6D@"&]Q+S9UTC:Z@0KHU-&^"2\ ]L_X,=
MNH1 ,**Q@G-.4M+#8+ (2&AW#YMOL8W^NCB^.R8X3J-Q%FEM:3!LYQL$]UNP
MKE3\OB,2M#Z)K%"XKR_<L5+0))L9Q*XZD?"KY(AJ88H)5E%(!U%7D#*%F\5\
M8D<,%89VM?1@;+.2LF6YVALP]AXC/X$F(U8W)%"$#<^.G&:A,)6P7"&*1S(R
M\(2%T<8DTFKZ3)>J#M([W(=@[2=?W[7$6"YE:>52$7>(6$YQUA'+*_2"MV<)
M1@E]8-F9!&3B?WS3]\54'G+I(HFTXEQ#56-$>)14RVL41[L+&\:CF&;Q3=I,
M.L^$^?C9,.JCI+F%'K%]CT>NB59_"SXW]C/377TCT^"/R8$#HSKDX@7XO5@(
MO9HN/RN?S*'@(URJ=X3]8!>/NQKNRL5CRBXB=T S3&8VMLNAK6^\#G]ME3&R
MU"$VL0?[++!P]A"0>'=2B'?@:'8L%G.[*/SQ+L5QP0ZG\IBXRC-!Z[1-7+HU
MR\KN@KX]KR!-]%2_VK6C2D3=3ULWZ[N1&35EE8I+C=C?6.,":EU(49&-1C(Y
M%IZ8*:TM;(7O8P1^CWX-A0-< 5R[D:^MW;'7@#Z#ARG<E/:YU/?@*QT,5Q:H
M]0GA/'+JAITO5VT(9P,8N0D7%(J/P%D<XL)]Y +*/*!M 57F;6MN+L).S#XM
M[]L+8B%DJW)_7[FJWFW,*DXQE ZW<]G")[9#VU0P^15,^YL*IFNFR''XPE81
M+$_;65XS)0D?>:A5:T+,1*TG.BWFQA'?6!$][9NRG@DK]E\'9K]3N1)FGD?)
MC(JE*40X;Q9)*PY@L^W.XK:]J/&MNW&_62?*@_'^#A;,?LC9R+V=V#$EH3T5
MFND4U]K9?76%Z^?G-D_&7 ]CG[8R5K:[UPY53*F^1AQ0#=QU$H1AQO'%ZT$[
M36BKQ^2S,)="O(V@57=>]YSKO6,,1Q.^]*6F.?T7,HC!3C ;7Q=%U).J90RY
M:"+'^KUH:(L^I%THM#K2R8%WV K$*@Y[CK"3 ]R:/]/L?<N^[L=AQO@L.^B&
M*\\4(J]R!@L4:HE+0CVMUTG)9],!.^DWV[&8:.IL;UN0\IT7^%[JSUN&9=\$
MW!*4<?2T95  RC:4ACI_S[!4+$M61:QP&><51W<:9242)W=ER'-5H),LY4<2
MYK2M\)Y;Y1:AMT61.B@QO2G13W\);=%Q86QPK6]9X<&'X @0YO4QV!CP/%Z7
M2X6U-M*YU;O<[.92 >?[99%.ATTUB:V0.-_$[O8Z (OYSEIMY:;HG_VS!JNN
M_UI'1Q?FKJH(<!PT_^LU-6]SV,-W.B=^$\UL+I6]H96SL[>Z_NH@*A*0/^:!
M2^H%!G&T6@'L_B+!9EP#6V<*WL1GL ;'>5F.F%HAJTS<]02<RR 0GUX0'+V*
MK.K$ZU= N/G!GIYHDX1H$T<7P99/.RZ41#BWV#[M,0=)^'"X#( U!* (#V?,
MC$N],IW2R>J3@)5-19/29HB3)R83'0"9><I=XQ6!A9 K3)!3,*(JA\%6'#XK
M%)"'(]&:?P?TUE&GC.C@SU*K'+D%*Q5KV$27VA+I43S-=_$XF,^1/7B*EX6)
MQD8/.5/ QV=:%^A] M\1@M8)*)LK8O?(!R7M[H7V!"7]$M'='$HL&5,4C5LU
MQ;%CZ+EBZ2TF2O]JX#[SNP>IZ*A')A^R,WP'H$CG#HDO8*'HP>!3KBAO8X[M
M=;9^0BI3+?,43BW=)OV>64'%B-Y.YS*PE5O[^\&A/,QB)UK6GPT8485@*L#1
M1.7*N]MQ_]K:1)%7]'(=QH^W?]B&\U2H=JLXT$0EK+ZK\L[].RWOQ+>_H]G#
M.B^+5#(A:@X"W!#J5YE31P(.XIV3WZJ*V!:WU',BO/&VH%/99":K]I/R3#-#
M0A JI6&\<SR(L>2A2\!:C!C:F*"Q; U<W8([T'&"78,/E27VL@K=ZB5$7/M,
MG8YHBKFJ*CX"%> *,U3LJFN-0!_\E5]B/ KPF1[ROCYI$2RV".C[4,(X)-T'
M5]4.G6D_)I6>DO7JU:]:.$YUO#WC] J\X=5U)?ZBL^E:N$IU-E9L_E/K3FPT
MJ5^-8<X;XT"])70!(JN#+:K:I)4^B3.?/9[1M/H$RBP]Y'\:X>S) J0Y1AND
M&*0>B3KPFO%J'K%V?$MMH@EJN]A'E"'L:2*Z5.:K&7<FBH[$/D?;5;#";B'7
M1"!F+(@QIP1#MN2GC)+"^=8X^@2W%!9RF"E6XN@$_<##1"3]C4%$E1(;5M(D
M?\:IF]:K^HB96Z\Z)*'^;_C^G^#?<PEOO0-?L\).5Z1[ ;/_V2,6$&4&"PC:
M@QTH 4-GD$HDJKN'^VYK;<B8?6E7"XAY5:^7(B88(-0U6C:HS(GC$NLSX))K
M>*6^XA2:H[]>3+9R,V9"JI^NH8W9VGEU&]Z8*U%C;R8D!$GTXJ>[DY2?@DG:
MV1O0#(1 WUB]H(#HM@IA)+ ]:!N-;(V;5RP1(*@[Y[>.K;GK6S=UFE2IG+,!
M#P*KB+2"9Q145&1FPZ1BEC-,LI7EJ/82@X4X3"CN:.M\IZF]H0K8B/3ZB/2T
M68RPG$<,N14Q+A'K+,_5W&E['5_1H;M9U.^TJ!VT7P\C-NW%ZZO70A_<A470
MZF9T:,O@".#&@)T@H)&>/TWIL"VAHK0MJ3]M%-OZ[ %A(J.#V@$D5]=XKZ$P
M.&#7-NT)$M-P^2LWHZ)TE.EG,NG&33X&16D;/FVD7@BV3?WM=>6C+&Y\L:[%
MC9M=^[6[MMT.';0:,6RB BY>>%$A,4\J,Z^R$KN5_K!9"-=F(HDSNZDW%LOZ
MK+M%>4!.9?!_J%8GF6/^B?I][.HE+C-*"84*B9BEV+$F9.?L@M+3R,QLMLKQ
MN*/57;C7HWQ 0&NJ#5&X4;\[R48;-R*S1B)#!0[D@$AFB9 <4'(8/5?<8"(1
MIS#9 K'$43:2NA9RC21R=@+UOM4&CN\HS\9T_\B,L=+3;&&7XZCG$13TJ6&9
MD.%BY(-4.,AZ-@\)!MA,DXN,8&$]]\FW+*7:0\52$I$;PW*=Y,Y3/P&IGFM+
M\0@$/1H6+D04(&^;%OT)[]LL[]HLK\]>B<F8LH(["FG'3I>148YCXGL1Q>(Q
MP*Q8<$L!R$4W#S>U^&F:Y>::Q%I?*F-UW87-I'EMS_ WS@YGPJ/#Y?G,TQA4
M&'ANO"5?Z:-<N57-1U^:CLX9!R_A\6!H2X9#*W>$D)2^3 HI.P<S9)3A=/AX
M2Y2FAZ=5VF T:BIKWG*M3%A1$RG8/-RS%'"W;NHV1K/)S"EUY/*D24I>\07\
MQJ3BRF<ND8]%\MD4F"-V!QBJOF8Q);O;^-UY5,H582E7QF<BHX;5%J/=)=<4
MMC&LP_$14R@OK^5K'G]IX):[=X/T7F2,7LS,I8@LZF<'J3PM)U)$6AWO0(;M
M,VOR!LE-E[Q^7N*P*]669V)J\CE:"3-\J?%[KZB;Q%3@97HD)!X0JJZ@??.X
M07RJL*%R)8?7-4QO*W?6( 0.(OL'-!<>:'^*<=;)\\CP5V/:8<'L$EB4,8@^
ME(6!]^6T];"G _1BFLT)48OJ11:=K_%V[:WV:HM%K*-[7.][#]V7M<VD1:CU
M.EGB$*D\R.[ IBJK!<LI)8G:_&52*^,%W:6I)=A*V8SHBD$X71>)K9091+_"
M*87R*SJ29FIU+MOF,A6IF%D$Z$45T9*/3)W")QB!189E$TH19"V/WC+!A?*&
MU"9U)7]7\H?<[[:)6Y9$'GHL>HN*2 0['&W:<02[D \OK6]9LXK2[VHU[')>
MGKN]*RH)N\C@L3X-H8<H3\>VX/>5JM\Y+D"8?%[U:8WS/EE8W'N&/S6K:0C.
MRP6I#D8Q\0>0>5"$(V1\ WT5'9\>1S-4F5MP].9@Y?V_T:$@S7N@]#QL1D6$
M[\!-K&=R>)4K( A/3C]MXP'SVQ;*#[#/IM$!_!6^/XX.$'(1%C4)/L"._OC7
M,[2GDCAP6 3#@?KN037;O@4.GF"+P](CPYESX2O!%Z5)GC:YG?>>5;.0%%B=
MQ'T2E1D3!)I4_\L\^/=.0$<77!8A"A<7M4K2SUC( ^-O]Q[,V 34B#V=R'[=
M8Q\@HP\B*76*Q /G3F?+-.>P(=V#''ZDG(9L?X8WZQI;GH2 SYH:0.20"#'H
M'QXP^$?+#69AQ/(DF]FV._H1[-8DS^M@0O7,EO)NK^FBSSJX@KCA'LSI=<Q4
MZ$6PET&I=Q=HLIB?Q*TV#_1@,C8+#Q6JF_EZQ*W%'U2X7,3.32!Q7E0(VT#:
M>7X+"8Z%'2V7!N7+J6$;GSC5^38F(R1Y5S"<QA:3;M:&VDIFR,7(&]\>,CX'
M'49B*V[N+=&M1M-\B+!#GN2W\[QR'L--Z'"3BT>="Y)UNB&'[J9__S:*2[WM
M#GXBKI$&(*1L&_9*85<D(2>5PA2,/)' H\"?JMCO>,S3^DMY:<CM4Y%T!R3O
M@6LEG$BRLAKA=;&KU%72D[X3Q.#6GB"84XZ'E'6PBS02X6$<(HY<;Y.5X/O?
M\Q.Y@\6G"!5U,_PW<2V45'V.C3JK3@^P9 _Y/+#HO8Y8,L_I?%*"H!@-45P2
M]1.*B> $MQ>(_XDAI\(1E^-J63@V+!ROU%(M$3JY*HA5R]%Z<G5+0\B;5=\S
M[#VB?"F^@0Z9!B&XP08TIT80&?19CL*AH))A&ZJ<CV7%2$L6R31>?>RVFV9[
M#$7AA.JU%MDGLVA*<DJ(<WD5&&[7L$2F304N\WA@6QVP\X2]*(3=U^3!OQON
M)&@JC)<8YJ+4CNF0ERET>&Q1NO\2YMJ@?@>I&J:.;6D&%M":CJ4BNU:*XT?$
M!E!PT!G.NS)-D_J1:UKLUFZ[*#^BB?@K]>.CK =[N:[U8.MP6E%,TH=1$IYX
M"D5W@] >]5: G*3D(*N S527F"]S4L"(;MPLJ/>/HBB,2BK:MJO7,?S,+\1<
MD9R? 0A[&UT=;17I<XBY9THYWK@5Q[<TO;N$G,QB[U,-.QZ[V=V1Q]Q]>]1Y
M@"U]:2P\=3A/=)IPPLS"QH+/S!4K'2 \+UGG*!T6F+U*J4L<^RL5O<N,>L2$
MA&+LP;TZ>2GAF)_<K7>U!LMV#(:<248TOXY01-<.@Z#8_0BF6I44'%$FJW5J
MO#*WGDWG45(\XLD-X$3$K&,SR6%H&XQ'I&(PLZ?3FG+;1\A685*AC'?I@#P.
MM,2S.'H%'NM-V E("HOB*WGJK.9=(^FDU3B4]]S]"M&'O---V3ABL:V8N#2L
M[.2B@RM80-Q#N@L!SA.XS!B4H#H+L"IB1VRWVF/!Y3=?4J.*SLLJM)_'D$-+
M)I4EQPL!"D:"U(R)=9OB)?:KY3?B*NV ?0?,N/TXB4+ 9]W"F\P7N9PKW23!
M')I79I8U$F'E@A7]:<1IEJ%DP?@$1RX&Q.@UMQO+@TBM]F==3BFC?RJI%)B?
M@Q1FNLY<%8/F9=ZXDJ6[=+7N04CHEHFODS9'<4#3HF#ZL;."&&$N1QIKC9],
M*@;S1VA*K#]VBXCU-B/DWY/@A-N.A<&W(.ZB;',*DE\?FIM4Y27BL'4B( ^-
MV?AJES^=8L":6UR%SDO2Q2G,\+\Y5EUK5(S)Q+QU888"C^N4F#*S6CWKV$?8
MEZ!38.06'J%Q'3RZUD(C?5;M*V4G7?=]"2C_D_R[K+R4)=@VB[(B/B*14RPK
M'1I31*.*B@80B13GBH&=R4;R8GI<W4%E4P>,\\RE!DRDX@XD)E:BB#D&R)NZ
M=N%+STZ&%:BSUH[T"CYQZQ8C5KRFF#+TH8<)B ;?&$YOA'YD7$4E5X?Y_X-1
M%J,ZN> X+Q6I2:W@"(F7:J(4H2H, @I9.D D_M@I0M[DX#W!GP=MNJE #>%D
M6LS6X&,XW6Q;8[P'?#_5A>O2H[X&D4UY7,.STF'#LB-T(W';.=Q;L'0+0J;,
M"#LFYW)PC+/SX)PV]4B4@T=@]!1NJL=4*L?%G]S<0?)XB1EE.T\]#WC,D5;P
MBX*YQ!+C++=9%*Y0I"PZ[S*,XNED<@UFJ(5%4 C=TN&W='%5'D!C!4W@W396
MP!#Z&RO>J+LLQ>"J&7C)5&4;3T''?NB(F^U1E_D\NTR4RK5]R/6--;YBK3RV
M7KW[M/9\NFE)_= 49IRY@N66)"P]JR@@HO;*.;&]@PNQ)QG^2[TL3#71=H0
MTGTC%^LC%[]D'K P!4%$)Q _*XPQ: T8;99N?9;NZ M8OFBV(-EE8;>B!EDR
MT]W.&\V\?LO8U<Q:W(,<*:[K:M5:1I?3DAP=9ZSC@2RT#:3=-ZN^]JNN@6Y<
M]Z;(L+@RPLJ<45*-B.Z@6%0E%HI0;]*(@!+H8,6X,Q?/D]^()6?D(G9LN;L"
MG LCBG?ASY351O#71O /)-YI@R2(SX3(3=,RQ_0!\CTI878KG'??8VD=6H3
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MB)R#L61$XO(\K3H%GX.9OEQ7B)C0:H3RF4;0GQB< IT6+4V"R6>JY8,'8UD
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M! 5'\;>8YAQ]Z;%FS IBO,>W\F"F"&V#%_61BH@@JLXV5U["^HX$S-@(*:\
MQ?,5CLN<_N"1*>$ZDL]?>"&=,#?;(QA\Y$3TXJHC!S9JD";HWG$%?5)/?4$
MH:PF-OR MU>C1[W;@YH6,<J%WL6VTW,DW5\^LF63S^A&(?DY+/6_C52@JB_%
M12P4$TSRU-79!M%%,OU$T'A-F#^$%NQ1KTO7J:2Y0EB098W3WZI9$*:72N9V
M:'#7Y.6E+E%W-[%;V=.-)]L"3X'.SD&ZEZ!ZGO=3U@Z#>4?\Y14V_&TM69=A
MN31>G<C(UIGYRD@]=I$O"<WJGK]"/8@JPWH'29T1J)P\3DV-2^,0LK!23;)U
M]E#S5B/4J.9+:HQMFP[6A(EB1VBO@?1'O\#Z@7J+50DSS9(__Q+3ZM'!<:B
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M*68D5L=^DZ,8T>M=I;7[$JXH0P\Y%<(>]UL+.M%_MX4I]1$BO5?%VL:#=S,
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M+3C#Y:*+V_Z:JRME[E),S[*8\>>X,U#0N%SBHV?5,?+M909'H#.0"\2,.?@
M=U ^*9&VQR@KM'RMQ>#5D4H)0 TYI>@'T*Z='SGX:/P2,)'EY4]TE"/]>HFO
M%4H]'J6-W8V[,SRT: >:PW$"ZY>DR(#%QPU&Q*:IE(/@HS3IRL$X)C5$:0GN
MNM_'VK=7E+RQ^:Y8:XKJ4(+#^B*4 =I'E*6V,!^SA%&%%JS.7("3>,<CG]:<
M\IY<6$E 7$3;Z__5$W?O>&SG++M,/AI'\8:,:M(_E.D3<@9B1.0!-+O2A"@D
M5P(\ZV.ME>@A.4FJTS?1@WWW<,6-W0@WU7%D,M9">8D'!H6> ] KFBFF85D0
M'R-QC/FU(2-[HK'UWG$C*7+@ULB;=D2E*L9@':'MNPCC]D2RA#WS :)(2YM:
MS\B3'JXHHHRY+6G'0(O_$'5L0UZ2GLYZ*CG!T H2K*+/3!$1"DJ %JMEK#V:
M^WC<?QA4WA\]2Q[3"WBF,&>K'">V<JZU9@L+$HP9%1?G#I2PM3,=*VR;8>V^
MUZ3<TF$X#!$)[(R2MD,%B\9C\D7*$20W(1*I_',4_453$R/>'C <QP'U$>@Z
M-U5Q)8N)1$JN\ (>96G"_J8TX3N:&E?(?)AUOBA1QFS%:(\*\9LWE-]JS 4/
ML56,;#'C.6X;.]0\('WH%>O]?3U2%YO.P3OO'/3T-%<#DI1B,9Z T\X,N% C
M<3$7=&*C"+NXMTN>!S6=0HQ&B98& Z_*Q>;3SE'\ %0X2JE8&=]IAC:B>>]$
M\Z ( /^P9VR$7"$+*D#FI)MAP4094M*.@"%+'!.R%SD9SMGOHA;GSIG0_M\Y
MQ [RF%5*8*(IQ9\V(K(^(G*N#-%HFG-1 <X794TWBF0C)2(EH!VXA(S3Z2WO
M I5' OIB84NCM8P ?[%MO^@JFB+)R<WS"J1"%]MS.CP7)30%J8B,"K\<[0QG
MC1>+7%K)DL^8/4;8W8W"63-1PB(TM-91#DB )"HWLO&O#93).JV99^(F*1FC
M&7.,%VDVSS=@)FN\7J@[B::9:+U8*9-"GF.]A!8RNT55&')7PBR7%)W[*":(
MQ\ \9QWM^R6]?& /.8=\YL5F_]V,)AHGM85\5(TLN4XIM4M++(Q6:WE&O Q&
MS66*0R\$HH2()I32!F;6L;@<N+4[T[63_"W3!;T]./OYR;/^ZP[+D<V01D^?
M')P=PI4OGV\_XL),J@ DL2Z4,SS(95TRHU'3JO^C3(_$E9R[KNCH?H-$\H6G
MFR/JRW#7/.*)Q^2QG1R)NUW19"*5 GJU540XY1C/6]#88*G&>28POZH*O:8)
M+@9P39#APN,=3$7SV!<'H[&<B$5'GW(&RA9#982HLVS!8)N"E*:16BVE$#>I
MJJ40PCSF23WOBO%*&0TW #9_Y-S-DG A=W@VQ^X(PHN07HO".(OE8YYNG5N0
MT5EM\@M3=[+[G.QL@8QXV.!"8T&%C\L -1R[-^I<"QXDLHND#XVN;:!R.$M1
M+:*JR;'%XQ&O2XC/ CN PE!"2I=)];  TB]:@0BP:E72:]L$T031!6V_MGED
M1G?PW-"E(HB5@9;S$Z0/W'AM%[UH1YS;&3=+($NIU'%!G$W(5@9G9X.T:E3-
M[]7Q<<C(KO$C%O_C<7LR7#N6:\GA@L\O.O?$Y&9],FNP\))084Q0&X];IN(R
MNE7)(Y,0V($4*4F[T<K-T%NFH3G6;[E3LM'_>9*]WAON[YOM\<O7>^GS\=XP
MV1^_V'YADI<O=W;2O9?C_]UY_:2#M?FC>^F/SX]^C79^'D31;Q].C\Y.WO]^
M]"8Z.S]X^S8Z//GUUZ,/YV?KKP@8&6?]Q_FA++XEB^O-I&QW=TVD;!>;MT]/
M/AZ=GA\?=:7J+D7GQ__O^@OK)P2^<4QG6K<W-<GH/TU246\D50MP;.<<W:-%
M>0E'L=)_!KA5'XD,<XF -Q)JFYL* ::P]I"5O'V$0U*3LGS7@QM'=9)34:KM
M?).:^<72%;SXX +C<9)5MM.1 %WQM=+P;M)I 1,ZX1(<\E""89]/=1K,ESD!
MQL)=;TQJJ"A;H+U>WN\2OVM]:)@?;$]+;5]C%4?OCD[>')\Q&2U-$"QCA-7$
MTQ+A8*5G<FC *!C[<G*8)[#&("7'Q2A+BH2J2[/:]?024RR%-[B D,7&/IE9
M7SM+<F;F"UD39D1^_I M7]B;N$VPPXT*@*4'NVC(L::>-F\+1>^713H=-A7L
MGM^S:I(567);K.\;GC7[:W+6[(%8O3]Z=_ >3YS#HZ,WQQ_>K3IR-J1UW0K1
M%_>N0O0.MF  ]M.+&%25S0(3)QSY4D0!YT\*D 9F)#$8B<';,@@AM_$X*W.1
MF<N@"%V>04B@#LM'72SRHPII7(*Y8P\78_W@_*"2#> *!' 'GC/T@@P*/HK=
M40$&3OND%(X=#7/@_%1FRV!O)I.%+[C+H3($!<GMSE@.02^IJ:79/YVY^[<.
MP2%=.DI18RCJ1?SB]53].X^'F!HNQE3@8=NLNS=P!1&X@>W37T*5RO4*=PHE
M:L)3+_CZ,O$^=HV+1RCN#^*H6IYR(OZFR+.=7DVP52.B9J<Q!@,*0AXP/0F>
MM4QNCDW0A*U>UYEC<7UW</"1(B&V"3+Q$2)T'C#'ECLX Z1%1U1:%@3)3\ C
MX,NHR3%H$&*X<=LH5WB K;H?_+?K*^%DQYH8R8MH/)@;7E(+ND3#>4I!>G#8
M,0) 8W&!8G@)QLEBIC%7B!SNL:$&N*265I?_-%GZ.5]ZT!E>Y<VS]DYS[ R&
MU]Q%1&53=[>SMX]Y5V)@\+-2.\J'UTR((]EKH16V:+?7 B]>#=U1VIZ'Z] A
MOLEQ_VI-CGLP]J)?CS\<16<';X_._Q6!97KX_N3LM].5?N:*#U_'N,"C-$!>
MKC9 ;BZ?>SM/ULYJ^4'3N@+. ?SVZ/CX)@Y.,,X_IR;VGJ^)FMA'-7%P^L^C
M\^CMR6ET>O3N^.S\].##^5_/*-IY\B$Z^I_?CL__%<-O[P_.*11Z<OC/7T[>
MOSDZA5O/SX].SZ*##V^BX[.SW^!/'W\[/?SEX.SH+#IY*_=&9T>'OYT>7Q'C
M6C\OLW_.?N7VQV-GD=V;#UH=RPBZ[8EM':T^/%W1V-/0571&OQ]]D=SJ4ZJ9
MV_[IP[_.CNA?=WYZYO, +&?#,H_DHH\__S*0B_Y<R&_]YK5?4'[ACMQ[+AT'
MPI^PC/8]P/[*,%#1SDL?MX&-]#X$AX[_X/ ;Y"9]S*@T;+5KD-/K>RXO"[SD
M<HKI8\%Z0'=J:G(+KE<D,X:L&";%9\1*JLK/A#*"E..%,1ZVV#@;-2ESP]T?
MDK=^67LCD"/11ZIFN->;ZK:]U2QFI)K68OS7!4@8J;"T)$?S!'SH>9()TX<@
M=V%'%Z?KYXCW @[;U"<L+*[>8L<%Z.]DQ*@7X,6FV9P1VICQQR+O2:+8H[8
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M>5EGCC'%TLRT%S7 ON3C[,)P)[2:.C)<7)N=ES_5H0=,@7T<.'T@,X;!!AS
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MF,\GGN 1IMCU\$KL6K#(I7U',] #L:TZ$&],2WM E62="F:I9%/P=:7/&5-
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MK@:2=J,:3P3GU/D&2\P#Q\6>T;E#HNCV+UZ:KH8^M^QC'X==;, '%#_52D[
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M$BY_\6Z ['3%=\!+<G+O,FRI!)O24A=7;$&/.$$2Y68\>40%@%20(2!70(M
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MM>!UA1/\P?W'NW =\[-J'T-7"-]<_?;Y40+@DQYJHF71AU;$G&N X@X4V*Y
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MU$M:N2T_=(/,$^VA>"]P'"2[T][^;;Y4@WRIB\6<<:F4I'%&>/#4[[(NSFJ
M3WP^E^(*4^-T@541=WCHA6<-.R2IR$>//VL3%O=Y<9_A<K[E0RFE'T->8@O[
MO:;S*M674JZ /)E%H201P0F=E'<N0S)IKV2?5_):=2^VV>S[A756'EFAL)TV
MOWG/L/]WA&F\LBWS$N,1*M@\FX M(JK$3],;S8WS4E:#$L>@\0JE4%3N1P.-
M-^8I,K%@SUS+=OVYST= 1QH+^<C+I:ZD2N @[\E<:TD49H1LRBP\,* A^31
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M:&CH([L=#;%7*N@/]?&H@4YX>'Z6@]96WE"E,979L.\N9>7R>F/^=ZK/YY5
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MK"N:99<PL-C1#BD-IUC(05YN%":^H/"G_C/XW4^#@6+Q:&0-!0C3I_B^)V5
MPVOY@!$@[-B_I$%BPPY2IS9S0,#)J3E/?;ZV:DSQ*::=B6!J>$?+4S06ZFO5
MRZQ[LUU^,S?ZDFR2L/]FR-/PVZ08^I*E\(8?\'*<H20=*,B?'!='#Q*?9KA6
MB0&+\8915LPV+"9C@HB'?<.NJ7$W/;JT<S(K2VR8"XDJ8U:-U.(-<K+<RJ5[
M7=/^67LJIDRA &!!=/-,#)"KT F*&C'F;0F:]#E-JY)G-;JPLACQ5LR!$;"
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MX1=RV9HKWBI![R%#3S:1P^ V<K#7D(.]'3G8&K"5>11SC2C)DCF_06ET%"C
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M/ZW9Z(:I8O>D^^IJ+A>/F]TI6BK9*&=:Q*ED& ^ 6ALB!9ZX_&1=D%1[RF\
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MPF"A[S("OY^K=N,H23K D)PL2)6+1SL$2%6T0A;?*I8;KHK9$J(AG&QTR:]
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M=I4D%U'7*Q*N4;'!=9DRR0V[+%Q%I.;FH\ISII!S Y]2*=5=%!D5@LD 0F
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M+#C-&*.21N]M\16+/M<K]_!TR5=<&:XRW.HLR,IPJV.X^8%K@>7G$5*@7'G
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M#T"D<DIH(84IM1OWU IZA:V"U:H7H6Y"S?^L2]RA_,\_FC]BZ-F\*OLRGN>
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M/_[/JX-7S]CSXP>8UT1>'/]^\N*/@_<''W[+G_V<_;\/S^B?(B)U@BGPWB;
MY"F84MO)%,:@T)CD=*GY[N?#L4 0C1ESF]/7UH.EGKXM.'V_O?^3&(V!1@G(
MF :4U.;'D_>0B O4)"N2E_GTR3Z*Q4AU/Q/C]$WT)2HZ?#\7DZO%_:LB_@68
M'<9915K[2)NW-:4O!B63P#@R0,\R4TLE\\&B"BTZ[V7ISL%-G_.V4HT[E.A6
MD=SZ0[0B>3U(GC?*,)JHHG80E8K9*+,()OELHQGA57[J1<\+DBGVI:(=0O*.
M.>J?C/[*2!A/!K$V8E^Y6G&YV>\S!U7R:8U\?EU0([*B4"1F07-ILAHALLJ=
M:-$EJ!*)&N>X*=FAI,^7S[/OGL^Z(K=M-:(B=T7(G5<;@K+4&<TA<$H ;0S@
M;.G1A\G8)-%KYL_5!B/::EFS!K7A,C4S+S9^'>SKNG+'FC(_G<0W=A!Z\5UI
MR9P_MWCU+EJ(W2R)9^=-LK:TH M1/#Z7Q&7GP_.DPFJ9M4VQB_'\9()#EASX
MQ+)EI@C-[$H]4$*-$,E''=/>ONPCK1Z6+89S6ZI1A?-ZX3RO,15MR:BL)\D8
M2G K2# D(5#+56(TF:3R0U_U#5F<_[WQ;I9.ZQSG?4I;4"^^U0%I/C]V^\BJ
MM<!.I:55T-+18B2'\YC_IRT0:26@T 8,LQX\5\:ZZ%&AW=MGAO?9\@6ZMP7(
M!OEG=ACTK<6 *NA7!/IY780;PA(R!RE+*9L6U())$B'EWW3F;B]TZ10E35_S
MMG*%5P[Z"U5EKG9=-HANVRK9],_8!;7NZ63\)B_G?;^97SQK/$FEPN5-&=G0
M)"_62-KJ?4CG,BBC,6;9YGQ\N?_5/]]FKO4U_>2CT"XQ9X 3&0 #96 ,:A#$
M2&^(8KJTJ%"TSTE;C:(W5'/;;B2WYSZJ2%X3DN>:T7'AM ]*@[=! VH,D'4T
M#M*K8"+U.B:?D4SZ9),B;5O1J?DH0\+.2B.E8;33V&NV!<8)SO(?-4ZU'AWC
MHQ#^6V3P2UG,4?IM&AMSLE)3>]2TV'%8>9FB9P$<S28D.J[!"!W!&Z4(32$Y
M7DI.29\O/_*\QJBZ"^6VE(P*Y?5!>4[+2"2E:(S+ID*Q%W@R4(9.@;",^22\
M9(T?F/<5ZQ*4=\&1\=-@U%17?E''J,Z,M2@:%W*HW+1:;GJR."V<*RZ#D."]
M0T!D K2V#JQ2W)(L4%2T9,)HH3MD %571D>UC(KC=>%XWI/!*0JN)?# ;/%D
M>#!8"FZU8#9$F1+BWK[N&RT[A.-=<&3\/!Z'MX/AL'HK5JU$7.YT99KVF.9@
M06,(D5)1INEZ(0@@S1J#\\J C,(:ST@099JN4)EKU-)<4ST3W85M6SI#A>U*
M8#L_W39QYJSV(&U,@(P3L#3_J8(14GJ?G$KGL"5JZ5A']4+<L@)Y9D<O!Z7!
M??4ZK+48^7+?S_/C#N/L\3L_/"M;5UFI?59ZMJ!,2&2$LN2AB \P&5;JE1-X
M*373E-H4]=X^ZTLC^[*U?+GJ@N@@J-NK4ZZ@7C.HYU0-IWD*6DJP*F50BZ#!
M\OPGY<$KYP./* NH48F^8C6Q8LV)%4W%[W \>@FS.#FMN13KRJ7X5!-X.![Y
MFHK?-A']MCBU61N,3$3@WA=7*.&@*:&0A4<P:,HU"7O[O,]4E^H"JZ.BHYI%
M1?#J$3SOM>!:6RX"!"XM(*$*=!D9C-(E%H/7(<:B2FC9)03O@L_BO++W^CE8
MJRWHZ]Q6W'J:P,WO?VLXN-WJY4JZ[9'N\\7Z%B6E+'TK*5=8[#<$;3UF(X[Y
M3+Z!>4>+VB05Z4N]=.?*#:M<KN16R6VE5=J5W%HEMSF-DFBFM8D.A E9CR19
MMS06)23#$E.1!"9<(3=DI@V[<$<KM*_<[]R0^*LW?-?UV]^QRNU2[:\?5_K?
MK*T-AH/9X*)'X*^SL7]],A[FO9K^?_]',ZI^Z)4:Q=G[+WH--W9'EASU^?WQ
MG^5VK'N/SS8&@&Z@=_UR'.[P$X:^Z]ALX*TO 9(5].38&9!L=O/]C\//WMCW
M931%'8Z[([,GVYY3]/3\_-065VW;4*\6&Z!0'I.*1H-/7@ &0<"6P5Y"".(=
MD5QPO[<O1%_)+6R 4BEI2RFI[8%+E9)62$ES;AUEN<N<)$$$BJ70&D'3P"&F
M&!2G3'$4>_LH^D9UJ9!QQT809&1,SF+H#3+J)G$Z^Y+65W,75I#JW.SX@U%X
M-/AK$.(H5'Y:&3\MMG,1)'B>F <=L;B=20"G48!1/$2KJ9&19'[J(U^Z$W!-
M1>HNG%M,<JYP7B><YU.<%6,N4 H20P"4(H%!&\%&::D6W AA2MN$K'ET",X[
MYEN:;R%WQ2?;_SB3X,UX4J12BZW6VTON,L;TOM)5ZW1U39<7:KQTP@$U) *B
MIF <5X!<1L-%MI32.5UMH[^F0GFUO>0JE%<*Y?E&+U9S9$R!%5P#VF# H9:
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M(T&TPHI$\TGVQ">*0I.VZ.J\TJ)Y\>A<*I?B"I61;L-(BT7PA@@O2UV%"DP
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M-JI4+.L^TL6A UM1V+CNH-;&TDDE_4V0TII+YBKI;P+IST4\HF;6&^O ^F0
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MY# HG@\R,IO*T%?G@@F>.:.]H?DQ6BFI8Y2TD.F5E'7:&@,R.@14^8>1@D)
M3)(1C![+X%[3UV29^9[=HZ15! ,KS6T.S=V&Y6) FJP01"HTQ-FH2'0L2B-2
M?G973TYGR&VN 8.CJ*@4&O))8H"NI#6E3&Y9SS*!-I,+,GQIGQ#=5YI74[ 2
MTD80DB?YJ>R##B@U*A8,9F7+ZBA29B<F1"6DKA#27)XE51&]Y@C1RZQM"9_
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MD]Y/P_';C^-6&S[YA(6&Q_(ZA_;---Z__.6'2YMQ,&J^KGG3#Z=V\C(?@ L
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M#N*K>F=>]<U@\KS9F1:TKP+:ZRY][TL1N0U$JF@)KV)%C-*,4*FEC$:HPFD
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M>A2&LLU3KGY_Z+#,;VH_^1MNR-.%_:C-9BUH;PZT7ZX1+MROPEI.**L M+T
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M24N,YK242EFXIW9V9;<JY!;9B5H;\/;1C5:T[UJT5YA&86(A+2M)83#7@?E
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M0_KJ?D;=.!TE^0W-IDX'M6!/3N&Q[T(G?#U!0)V] ?Z;OV<,L@D@W%SM^#0
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MV6RH'WML?!-^,0@YGRM!)H[PL^E/9U@+VIX9'/8PE")C5Q<#^-PGDE<&]4
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MSE\\7C<"#:;'7P#@X4J8%?TM'AL\O=GC+]^\_V K(3V#5=8L"L*I4,3&2I!
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M03PQZ[420DL]C\HT!18<S;#*N5;)"HIYHH$XD=L?VD=ZU/,V9OD-FOE6UK.
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MD\0<(BK,^6T,UBBLN;P6<61&G#526_+ +_=INP>&];BB6X"3RE_V>[]88#4
M,2K_"=_M7#UKN'HI$,/R9SZ4;I-G^8\"!\.Q&P(_YV&/[. P9CJ]9-9_?E,!
M.AOT/W5"YL')_(83VL[.U4%MGY[V!\79FL;=JRY4UQ]7'H]B!]<>R>YTV2X?
MVYE9MG)B6FE1_=/33H57E1%=@BCJQQS%;B@'>_G<JS\HJ%1PYB([8*/U1S-?
MY-G4LST< \.""3%!NN$E.N53N%&G"\N<=;QEX\ZP#% ZJYHMG<2L G7:!\$\
M&N1SI@&@5>=3=BI/#T1@C%WK8^W;KL\,EKSR;! _=?KC83FRR*<*[[(3HMJM
M[$TN5[4OSX9K%(<I3;U).1ZM<VH7MV(ZT^PZ]CY[I8IW"0@27E; MN4&?1M:
MY;0TL\#L-E].%08SZ@_RR<KL!>U6F55UQ!HZM3K<"Y<GV)5'9C@^R_M5?H>;
MH[?#4145]U6=MPJJG5=ZZZ.;U!G ZO]O#%(19E3[AV9$2E%#[R SZG4I/JDL
MJ3NEZ>UHT)^$"&=]'Y;,'S72Y6[2Y88:+5\?C;:,/!='SQ[>BC40Z**C6F%K
M_1)[,76*L'D)'WHPC_I/K3^Z, CX^QOX?0";/#&GB4 K4H&7OO'A-."R5M^M
M 9<3N*I[]* .L1^>9;89M$(]7U?/-^])L2\'M7 !\WLTN-R<L[(#JU&*OZD3
MGXU=MSA;@>%[R_1BD$GA*_;Y'4SM!H7N9%>_CFXPSL$*W]!S\3JYYV9"YJ>6
M-*?_W'Q(:S<K7Y>\7;@C*Z.M7NG.4YUX9-$YO RRLU.WX:PZ5?%B=6"6PR2'
M5W6<;&[.G+!,SDX.0=<8%7TI>^_ ;BG"/T?ES$65 #_G/)]^Q7]S,2;MR0'4
M])!_X:C^\DCN\IR^M=>;9<;L!SZ_9-_I!MU<IRB'B<-QMX; ?,<4-N"F'3OP
M1U62.ZO8G\Z 0%%?,B;58X<;RH'6Y4 >N:_LK@<.VPLN^4=TWC !K++W]98O
M1RM*UQ"M;FV5_]3:'Y3R"P'$HQME?H#;_&@\*"ESF=#_[O1&]G!6+7I A:=V
M^0$$YEVH(:9@5XHQY*(3M748BU4[W;I0)E1A#6@L*!\25"$&18AGJQ#&!L"S
MGBZ7NVWN75TN#[FW$X-^!MFOLQW_ 6)KS;;H]J>N#Z)$6-?_%+_IMP*3^[0_
MT<?S%X ([;G3O-$$/4)&C\$L>DRTB6G\_FS4R=1]!%^TB\LGVM">6 CET;47
M*GNLLEJ0WS@;<U[)=C_AWUH*9TVD1 7VR_$B_'8EGJJ?*I?4)-H0KMJL5:K,
M^/"_JQ;&K<[[0!K<\<!O?^'H+EY:(MDSU1]=\2[-VQK5H&]QB-=ZW*K):J0W
M63> ?PD/^F0O@^'_$\-A)J6)\4$$R.N90[C)]ZCU1W\P2K#G_=;O%HQX@'V@
ML_"0&%-3=7U /R'JFLGR47\(P+'#UO_&V9V:79D#VZECB&L9K-8K6N/F6[0_
M.238/LVN_SAUO<]%<$QNWLJ 4WSGZZ)8 =C8HE?EL@J5U[GVF-=!?:A;Z.RT
MT%G>W2.8RZRM6?:XV^V?MT[!P.J<Y3A 6_Q+&8,GH8%9H81GGDW)=UR[XV/]
MZ)NC<Q-@?;L :[/^ =9W#9C^9DC?>@JN&^@7MSKFKSRH$S]D6@P.RHI2HV;<
M7<W8\Z-^%9.88["N430(PGK=I-@OV466I>^O_5-7IWI=^CAQEF%SHFI2_Z"U
M=9EE._W;[S,ICB7+;/)-[3S\%3:J?UH%NJR%>%MZ9EU%%E9K(+&<\X=>VB]5
MCFJ>]S49QSD/K>4F2^POEWBEIL;=+8V;(D))?P[Q+$<+3+)%;3;H2HF&:3J5
M];"8E?B[RRG&#S=^UWJ(DWCGJ06#KP46C#!?(V I(W\;4QSD/+W6VVROPZ_]
MP>GEX8DN]HO/C&)G;=U7A1.*:KC\"5<\56\G\2@/'O5<\W(=WS.L2PMD20E2
M-'1F,IXGX<LEE"\#36;<P^J8&E '].98_$4S"O39 %@\*\[#:6)\AM1V4;4K
M_TI5[&QXU#FK0P!K5\T )E:57P-T*FM;N4,'T\4M29N#:G$[:7I"ZP>=(NO+
MP<9I2;G?[M5NUF&<')##6."&_.P2F33Q^>1DVL[P9%@%ML!SG.V=P"_YG:%*
MWVK]X__]?S2E^.?M7_;>#LMG\O,_*R?09<AEK@M75048GI3TL9PM-DLOO_=[
M 7[;GKYDKWY)H9G).W[/+YF\(_N6#G.267]0$'H8/Y40@>,QO"5T)HM5*A:7
M=YSW!Y-:<,4H&=F3V+MN!4O6>F45PAK5A0M@6[LPP%[Y8N[.^IB]+',.^^H[
MH,,2TI2]5C,;V+K,J<X'=:WA>%B(J2Z7!W3<.:N+WM7P?H4B+\_&BR2>$NC4
M_Y;=:[8JA0=FV"@/'+Z>(4,W'H1<"F\X[ /W94(J3RI#+*!?I!18!97HOW::
MLXJEJV(1^G4>3D5EO]E>?43\=6V*3%S$-H"PFW/DS\[+ RGE79@0]R)WS@;_
M<KTY63Y8-@ 4=^F![O5;W<MSSZDPOCP5+$L2,^5>RM2SG(P\&N7I_6C_WK<R
MV;YJ#=]:,R\VEV%.B(B3,LSSQ)P5"92H:)4BQ#.5/A)%L\$V5SWE_F![^2DE
M!5JKCG07?]YS#M]$Z9[1N2^/U-8D<^_S[I=M\3O]<''PWLN=T]W3O9?;^,/[
MUYV=+Z_$[IMWYP?'N;3\]OG.RV[GP_Z?>&=_]V1O_^!3>/,W#__YK?N!=C^Y
MX_[% 3W@.\=ONP?OM[_L[)]@&&]G[^4KNG.\=;[W_K?N[LL_/^_0/\5N5W_9
M>_DG7'MROGM\(O;V/?F8!">!)8\PT!'B)$9D)/Q0FAD6 [&8BH7D:D^T4(X!
MR46.0S!8&JXCCB)P@LE"Q<:M2ZUUT5ETXT(_R]T6WQS*0K%)E7C@@23)5=(:
M.P_7P1TX82SXQOWRRRW/^;=.^H/>6NO099A[.; >X'B:(G5>I2!W8Q7K=<5N
MF6!RK@"1B0!4+!#=1Y=&7&WI%0E7%J U+2M6(A5S0O+OO_^:<PWSMQN@;IR-
M!\.Q[8VJO+;*;F[],0:U/HO;K4E6=;M5X?@."%"JZOB2?^3!;"Q>G)];-,C\
M].H[T!)]L<;^S]>:=,Q58,:&,T=D")$1SI/17JND B8A*.LUJ]%,36IUPX>O
M5V!>@FV_SE;3V,_: B@&H*.11U%H^2& \//.RQ.QN_\*GKMSOOOE'?U(F!?*
M$(8 %0SB0DMD"+:($A(9<Y1$HD&F4;UIKNG.,2F^G'5[.SQJYUR&XZQ+9/UH
MHO2#""I*7*E84AU6Y%BI*G2JC@!?)$:0I%O#DC>00Z@F+#0AS"HVR]<!GVMC
MI4Y2Q@9V/WM$'O84/L?)37338KCE? $$GU#1ODOJ1@U(;I#/8VH-_S)78C )
M7ZMJ.^7Z>3.HEM7NNF97F)3XV073^:BU522=K<[EBQE5,2T\<F__U]9_"OSY
M?/\P'DZ<N?LSVUOCSKF%=X]+M%S)(9EQ=A7_TK3X3R:^K+\>%5,O=WBI7S>M
M[S&LSW[R( O<UM6D!O%3O_NIA!%7P2NI<B!<U"A),:&MK5]^;[TM%\;!QC^G
M0;JY.RF80C[&,+RL?S6(]0+FV(8JE:$$-Y:8@7(F4Y8K9W%<6B65K@^OFGEK
MKB()MJ@%O*^"47;!@&J9?S[A6-[].<&9": V%B=IW</KO9\OJ\"0VF::2=29
M>20J;HV<7%-JO]U2LL60$F E#B3JK*J;:#06BD0OG?/)S%8+O8E FU$3?X7Q
M[*6M&M)>E>B4_4M#/7\];&3;363;SI<=\I$:(A46"5G,->*&2:19$LAA%H5V
M!KOH-UZ(S>LZOD\;4-3.@#FLFZ2 5*6X<E6P7/ZG>&+JVD&5UP&HIQ<KLJK\
M&E<)O!)CI0S-+##8DF65K?V9RI?E_DH[K)2T2;F9KQF6+AC"G8A!Q<@M]=HY
ML"NCB"K2F*+^BF%YYHY^^JL,X]=IAE]5K?I285Q6X_:\/PC#V'O61+C-]_9W
MQ$>NC RY9K%DW"$>(M"?)!;Y7'I<L 2V&]YX,3J"Y:R.4!:JWUYUJ]4%;4L9
MVYQJ".*OY"[:P4D<32M8/>%3T?<E'O[,%E#O504]2IVM2CM,.7BI!/E/_S0Y
M1)NHBO.G:? ]K'4N 3NY8UI!\))-*^UDN*"?Y @4;R>^W3*V*GQQD$O93M(\
M)_4ILZ8P+*_)"D*W\V42,ES%'U;ON6<OT5_^*(9Q-^ZE)2)H^,O%S&^-SVCJ
M,Z(?E7:,IT# 0(H@3J)A2!.OD?*!4,%\DMHME'YR&CLA#3&P:3)QX[$A8 $[
MF7\D-N\S*KIW/P<U%<(HBBT0)W W<,BP*))7"&Q*?'>G]5D?QA7%JZ1B?]-S
M=2^XLCSFYEMK^>+?]8)-0J=*&\A2&?!L&'^:?/AYTL2OTROH4F[Z&9;XL-.;
M-(W, 49S[1_+0*NO+V./-G$5?U3W0*S?7'^]6;Z:ZUI9?:?%)L/LVJ_Q)KGV
MNZ\]EM!-;M1-'[N:)H]SS30?NL7NS7V-L'/58$.N(EP([:>J8& G3_X?VR7
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MD/]$"*(V7H!H:&.Z_@6N[U[9]-DS],I5A(:A?PA#S^L/,FHI+-%(2Y. C55
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MZFRJ>^?TS'8&Y5RS"\SQ[/H5W";[==56WW99^QAF]F-[NAV_-U"U2JA:[%U
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MSG#VN>6M@^CSGH?68<WU^6W_YQ:HHY/3.B?.$&:X<\:HY!BWVAN%<SYDW>]
MX:NH([X/=>3C1)UN_,_;BP_OPYFC7.[L;W\^@#L/CD,74.%\]\UO'4 *O'O\
MCGXXWF8'QX<P_OS?WVEG?TOL[;_[O+,/(]C?/M_=^D@DK'F4!@&,<,0I]L@*
MQY!4-(B88FY<MO&";%X''D#NW;RWSF;BA ^%[$X!-D8M=]$Z/^KXH_*WL_'
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MJ\^^.\[+]ZC2+^_L^#IX_]OPPWZ?[G[9[>SN'^+=?0]CV\&[Q]WCO3>OSC_
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M"EQ^5MB;-&N!K H? R(X8,2%,@BL68&T4+"0F%-*8QFXS/BCW56O#/0JX*R
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MI03.(R]"&R]R^KF L4ACK;.$*^UP"#+_4\@+J>3E">3EBVAL[ O,P)[ N1P
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M+J*QB EZ,TB^P".[&:5F*R!?/)#C*5)&"=B*5CODG6:()^\1;,,$.6ZX()[
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M/:\145CB_QJTBM]GVN&3DGQEAU]=)9OB5#_&%*_21>])R!X& Q4A>T%,F+!
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MCMW]K8M#076*/F^Z\CR?D M0CI 4<O!"K"!&4EW.^[VM/=M,_[=1N;[XB;>
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M:LINXBK9D=U+4":>=5)0[CJNLD6#[MEK.+#1[[9;H9$?]\;JX<936,/_FES
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M^KX ]66!:,U2(#A$[IDR6H/C3V*>Q\ET)+7ZKH/Z3J8#8 ]L"6.%&+<QI_2
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MP&L!&^"U0%SYG-#/* H@ ]'DEE"YP9K:,"O;B'I">TTUJJW3LSV&9UZCVI-
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MMLK@#L5$%WB<4^7@D/[0G53Y:& "4 ;7:\PO3Y<-46'&*IH>6GWK6NU6UC2
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MB07$LP/)&&H1Y4["-A 8$U8E,V%<DID6WM[X,I0HR4PS@PY#U%+JJ*Q,%)'
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M[<XS';6.T= <#C_^P^OPUF5=Q,HK5W490/U5\1;[<ZW5\Z"8GG7K4VKA\OT
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M6U^R\(OFVE\@\)_Y]J7_N;/V\6#ST\;^OR\_P/6_[BJ+4V).(VUE0MSS@%R
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M^L41SL2MRBT1VKT!R-KR4 ;7)T@!+LY7TMC8:^UMPZ>=75P_VR2[.]^:NV>
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M@:6F$D7B<A=C"(@,N N(.RZIM#0QX@'=9[R&?V3A>2E)F"#_==)@?UTO#94
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M3_@!\JGYY"RID*TK9T<GS=X8(0>C(LZ[Q"HP>4@1CXT +FS)FV:[W5&&_0)
M8?3G05L_=L" 9'6[_(P2DB=8=2'Y4RHTN$"E\OP>E"QC93XNCCE7X'(LF&=H
M5E4!M%N#XK;E(1L\KNA8"O-1S!D8$[BJUY],UOF\V!(;\TL#ML9^-BHYD(7_
M7)TM6)WQ=,U,]-BP%2_3;AWEY!V8,/A*2G!]/ER%@<1RLK*]&*33XA00IA#L
M1ZGBEV$A#R9_?KXD4SAQ^<7G2,NQ;<$TC8ITJ?$$YZ?#*!N]"U$JGE2<6KH8
MNZ5=FK,2%"XKSQVGIQSF=^K!V2*VX_#B8*'<0[Z$NJF542+?ESW \#RW 7F
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MM7&_'A23NI6<</S.MC:6S.&8V6^=K,U?L#05/BT.GV:;*7##*%-"(<:\1SP
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M!:$BAXAD53Q]2=0KW%.K@.\] )^P-*>,6^^"X9%K8RQG) 89M7+2RD>T(ZV
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MO>#6X9P)>'M[ \^R=9BW!LZ]]!FXFK<O4.T!/ 68S?9I)9)XJGA 1"2.N#<
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M=5?S]TNB^>->*W]4"U?R$R RN6=G54])<,QH1QEW/!@E&%66,HNCCBR4+@%
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MJ4_F?+T;+JW'I[(*N *NQ0'7;+=PC*W#W#B(?3Q'7-A,MIP28MR";VL5$1B
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ME$C:9) Z5*E&TD:>LE"W8,PB&"D-*!X.*"8:>@FO7(B<:1=5;;(<F,]",B\
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MS/V_>S&?;=/#_7)T&@^7#L/6^>;:QMOLO<K<%\85ULY3SC '/#!;!*H0C%=
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MS10@548 PR(C T<*#FDY@F4MLDXJ6(NI:CFR*U#,D=NEQ6>F+.HYZUHO7#
M+8E 1JWG#C5FX,5))9NH+YRHCZDDQ7EO)7#F>*@9>](QGZ5F6=#$JN@*UVIE
ME21=W3^#>8XEO<5G9H >' (9RSZ4$@0@")01:%=14CN156[): N''A/):#X:
M:[-D.0;.0.J*(]$S(R19-T7Z)%2-[I)!H^]MT+3XS)T$=?TB7V:;K?M^Y]=O
M%5$NO>L%7!$<7; \%HC*8U+H?+:D"(-PH>DY"X94DQQC42H;;3"L=KYA8,&P
MH'AB6GA98I(B U3*1^R"OG?'\CGVW"Z]J!=CA(@^:VXS&.M]5JHFBZ#BTC2E
M9!%%?9P/QTBTH5BFDH\,@@.&EGXMH7"A$YDWJ9(3J"[BM*J0YE'26XQF%JGI
M6CIP @5R 3%Z5WRMZ48CI?720T./14./<9-&1^YI;T 6"ZH:H]',5PLG1<]E
M-,)J7^MKC.H"M!C-PPKJ6J[KGFZV5Y_H9IZLI?>\>$1%J%0B;7=01 @*!%HI
MM-$916Q*SH+!5)RP9X14"4P.3#N92<F)R()$)'LFY(QDQ>:81JTGQ/TS4>;8
M<;OTHLYMXLF:(K(T "9Z$P7WSL<08TB^16,73]3'[9F<A/5HF4!CJJ@#<T4'
MIEQVWLN ! 4KJZHKQ5,6]!:AF0%X)"&$H_]*+@)<X$$E;E*!"-%C*,WON7#@
M,9%R9CE'60J3CA-X:.>9$]XS#R%PJ0!+DJ0G2-Y5[MZYZ2U"<S>FQKX_:H&9
M;QLR3@6N4W:"MCT 'IRWVAD?-*>EG%M.[((!U-YDKAF(6$P!%H4+C#8AP0B9
M$G,80- <@\NPLNIT5ZIY<K>TN,RT4\UB$$+F8D5(P*4F$\9&#CJHFE?*=9/T
MA9/T\60129.7BF12%LW )F2AT*])D0WC@_((U64AN]+))RSI+2XS _0046M9
MB6P,3Q XF3+<6F<3SS:*H)H79.'08]R0L5Z8HJ$P8XQ@$#09,@4XDZ:R(1.:
M9*M65M%VM;QW2GH+R]S-CAGLY_ZP:7\+R-SDI14ZRF)]5-%#DL)%G81,HBA'
MZU7DAD^+A4^'$W9,=9P)QX'I( T#X9#Y4%N5A,03:O1@-.%3%\U3[G.T](+N
MG<D@M>4>$7RM\S3&*VMRXIX0X($BKTV6[R;+XQ$7FAE/%@G37$<&WDKFO2ID
MJ20+.2C4P=6T]B<LR"W<,@-PT*J$[*6N557@C0ID\B+7]$\4*0)O6L"B(<>X
ME9)1)5629+R(P""EPC!ZSPPW"B(:%X(?:@%NGK2 1GL^HS.7(8JU?3KP1Q.D
MK#_88OR2!U710DZGYY55M;[ S0W(EXC&X'Y#\V3V4"\B2AFCX)A!JXB*4! 2
M :],7.30]M#%VD/71_OGR)J&K>T=_=:"M"E&S4PJF8'2G&$(R +/P@$*'1(A
M+!K;=6Y:OKYI"-EB,&XUB&T0^QTS)0)(%U7MK R%#%[NHBA&1X'6J%;DLH@0
MN_$UQ'K0:'.R+$5-$&MD8B$GST3TR=:B 9&&S(6NBZI![#RP>#78;K#]G=I$
MR-(;T!J2!(X6=5)>9!N,RI+[V&![\6 [?@W;FJ>L.>G#''U@@ C,6R$8*<PV
M9!O)!,+*K\@K=8Z85A;-8P+WT(/RKX&GV]&_J??WZG_3Q]4C3U"E7TKIZI ^
M_M-[WN9KPUM\&HK1.]$P'/EW9_FGJQ]^OL+PWLE05(=?^OG8]_=Z)U?CH]]-
MO-+P?J/#/[_OI<%^%>YG?"3@E^ZARSM?'GXV/#0V0:-CAC\3VMYXF([>>.Q;
MEQ7BF9+FAR[[[6-:W7S317[8&>H"MQL =;N7_(X/\KNJCM 3YUZC3(SDZ)&V
M3GOMUKF3?;^S?I)RZFSX?MSO*-'MU"WP*_R[Y?#,B?XTO.)/O0'=+7YW"$8/
M2YOO:=]7^/^)H#WWZUDKJ_]X>=(9[)^>T_W2V3]O3-SY0E>^ P?DG"^,S=/^
M8+_SG%08>J*38>)2W2Y&1";Q6_48=QR.6Y@/3VA87]8G.AFN-'_TN*,ZB_C.
M$YHITN:'C^\'.=T%#)]$O.HYK<Z]?-:+/QJC:GS:R\.G;;6PJD0%1B405GIP
M#I541>GB8AX15/(KFUHTF_I';6I!-O/A[L&&WCV@YY$O^>;'S:.M;3K_X_K%
MQL'>Q>Z;UV+SQ<['G8MQF_HUV<ST+A_)%C^@XP>O5+T'?>?CQO;+BZVUWX]V
MMU_79S^H?-H3>9O9)Z@%LCRIQ,!$3B:U=4P%&X 7;[F^;*1A[;3:A<V<3_MA
M(TH-$)<'$+V$9(J%**0&&S" L@5,055<K=)M@+AP@#B6PJ9L%,9QR8K*G@$D
M9"[3=-J<HY690RFU8T!7&;MD</B(T9\&L<L#L6"$))U$$:1Z$$6&@C[6]BP6
M;(3@&\0N&L2.9PF'VIBOZIPX;)L?+6=!)LU00Q8Q%A%,#>,([ J8<A!G=B"[
M#)6.OYZ>[^U?=M7_]?0HM8+'FSM+28M!>RF$!!Y3B"J"0RN5T"G89C@O&(AM
M3!C.146D^7-,""\8:!Z8<PY82MXF+1&MURNKVG2%?LK,04LOZ1B<-,J@)YT%
M>)$.P!E/)J%!QWTJ3=(73M+'>\AEZ94NFFFO@8%1I*YD:1C9ASEG9Y,7U44&
M77"M V4KB;P3>CBP%C I$5T"$MC@N0_%&Q&D0DRFH<>BH<>DL6-I0^"<:6X]
M Q4D<\86EK.%4FPN/-N55<N[!N:)2W090J%O2")._NNL,XK1MRZ4-W9OB9GP
M*$@MHX0</')5,DB31'8%$S206BR0>C5AS&@7(L0B&4^QEIPI9 A<,VNSS5R6
M$"2NK-("Z&KUE$F#EE[40:O"D\>L)8?,/7I7)/((2D 0IL6W%D_4Q_01SDW2
MUFLF"GV +HHA.LD2TA\2>II15<G-N]JT-I2M#>7=T$-9::V#'%V!9 32E@+2
M85 R&9U40X]%0X]Q:R8F&T@=]$Q+2^A1?&9.6L=D@.!B"-'6PDEI7)?CM.+C
M+3IS.T%]X<\&_=,>R>/9H'?BCUITYD:OB] VT4X7/($5NN0(D8(OR9*V$PV7
M#:<6"Z=>3Q@T 2$G^J]"%##P"I@O4C !I6BA-.=9UV;;T+5ZGEI1M?#,M%62
MJ'.,*'VQ'*+/Z*-!GJV+W&6=6WAF\41]W*#1*28E-%-QJ)(H9,%ZSQ1/TF@N
MG;5F9569KKI_MYPYEO06GIE%NF_A7&CMA,(,(3D?,"8@!3B$$D#QAAZ+AA[C
M!HWQ/A;K%?,N*P;@)0N1](:@N*U3'[G)E>]8=(5J!&$/*ZCK%_DRV6S=]QM3
MV+>;5@$*YX)#0 M9%8S&1$5[8ZE<N#HVI%HLI-J9,&FDQ$KR@:3GH&# C6:N
MH&>(2D;E@R3M=F45L6LMS)'GI85HIAV-+;9([WB0$$G;]4[9$I4,CFL/A;=H
M[.))^CC7CZJL"<:PXD(B24?-,*-B2'!NI3:F#$,TO&N>=#"VA6AF@![1QH@Y
M<*65(K3@3F4OHI/@1> H4D./14./<8NF((9"B@(K,@(##9(YD2Q3Q3OZQ8=<
MAA7=O$O(,D?PL0PAFK5<USW=;*\^T40'CN9X^42'2H9W#,'*6FQ-2Q:CYP5-
MYE'0/[K5SRP83,4)<\9Y*7+*A6F/AH&K*6<Z9*:,DH %M=:A*CFJB]@*:)ZP
MJ,< D%,D$T8C>.511)&2,CI*D4PKE5M 41_32$B<!2!D%FR*#-!&YI,"%H/A
M)B5K;= KJZK+YXH5J 5H%@ \DB&5-B:T-B60&(+C.9CL'":3<VP!FH4#CPE*
M,2@&0"EF4,A*?"R81UT8Y])RE ESK;,5W!)\S%/YW3($:+;Z_JC%9;[=E;X6
MB?.L!:@ Q0>G4T!>M.,2H_0M_V3! &IOTI!!X9*G^3.ZE@>36<,04;%B0]8^
MT(0&OK+J7!?YO?%ICKVU2R_I,FJIA/*@BX>0HK/<%@W)11MXL=@D?>$D?9P7
M6069DA!,.0.5?J(PK!$:%!P2ILQU\C6IM*OEO3T6<RSI+2XSBY1TE%B=\\:9
M!*H4+-:1KEN4TU&Z%I=9//08-V1T+$79$!D6DQD9JXH,F81,H"O.1Z]Y'$9U
M11>FQCG6XC*W-&0&^[D_[-G?(C(W %30W GC8ZYM&64*SOE@K17.J*P@B@90
MBP50AQ.&C'<AT[1:%H2(9,@$R[Q4DF4ADI'.8\RPLJJ[()]R'OW2"[H()3DG
M%.>%-!%K7(*2A(LZ.(7H'RB3M,GRW61Y0MGPSL6 S(!0#()#LE),5392=MPB
MB7B5Y2<LQRW<,HMP2RY2!L5]B0Y2P)"\2U$:5526#ENX9>& 8]Q*D:YH6;)E
M)@=@D$M@P3K.$*/3 DG1*Y=*P )5P\R"#VLYSER&*-;VZ< ?=<[RWG$^&73Z
M(T3Z47:LQE/=>*J_$Q$LT0>0F'E(X-![6XHR*2JM$R;,;0]=K#UT?;1_?LE3
M':/$J)5AUH-CD$SE-K".Q2 %@#(*BUM9=8!=)::5@OV8+-4/R[?5(+9!['="
ML3P8'GVRU@FPS@;N"695U#&"M*8E72P@Q&Y\#;%2H:[U "P8K1AH :SVX6?"
M)H^E^*!"6EE%Z'*XMZ'R=!!V%I9$0^V&VM.),$&Q6B0K?>W>Q8U+0>00G7-*
MBI);8?,"HG;\&K6#,#J;VKZ@:%=#3*086^Y9*6@<+ZHDFE-";=559LILLX\"
MVT/WR;\&GFY'_Z;>WZO_31]7CSS!DGXIHZM#YOA/[WF;KPUO\6DH1N]$PW#D
MWYWEGZY^^/D*P7LG0T$=?NGG8]_?ZYU<C8]^-_%*P_N-#O_\OI<&^U6TG_&1
M>%_ZAB[O?'GXV?#0V 2-CAG^3&A[XV$Z>N.Q;UU6B&=*FA^Z[+>/:77S31?Y
M86>H"=QN -3M7O([#LCO*CI"3YQ[C2HQDJ-'VCCMM1OG3O;]SOI)RJFSX?MQ
MOZ-$MU,WP*_P[Y;#,R?:T_"*/_4&=+?XW2$8/2QMO:=]7^'_)X+VW*]GK:S^
MX^5)9[!_>D[W2V?_O#%IYPM-^0[TCW.^,#9/^X/]SG-28.B)3H9)2W6[&)&8
MQ&\58]QQ.&YA/#RA87U9G^ADN-+\T>..ZBR".T]HIDB7'SZ^'^1T%S!\$L&J
MY[0Z]_)9+_YH@*I1:2\/E79 'H0.*LHL(09P7L;@M? 9;3#&58M:X)5%S9M%
M_<,6-5U+[ASO[F^]>2UWWNS4[ZBM-YO'FW0-NM;[W;5=LKC_ZNWV)BQJ>N[=
MWN[QNM[=WMW?/7AUL;D=]8[<$3L'D>\<_'*X21;WYIO?CRN5]@0+K2NI:"$9
M%A\9**Z9#\4PJZWFN9@L8ZV.%:HK%%\4*NV'#2<U0%P>0'0FV(".NV(X!)U<
M1),0HK-:)JG#PP!BP[R[8=Y8BIJW*(J"Q% %PCQ7!*%?X"S+P OM;-I;O[+J
M[+3X9Q8%[QXQN-,P='DP%%)V1BOKK3;@>79@2*F,.2I/@#H*KC>E<I$ =J+E
M2A($JMPR%6OQ0+*<H5,$M5Q8R,':6*,T0D"7\X4!V64H8_SU]'QO_[)E_J^G
M1ZE5,]Z<A,E10^W$XC1$C"Z:@$DC"FM=!&P@ME@@MC%I&5O:ETC/9]+5_I)&
M>>:,0!9Y)A2S=*R66SO;-;R5,SYA22\Z2"E+R:YHD"6@)WDNJOAL>/"N2?KB
M2?IX>TEP@9:;8-D4R4![)'6ETIAKGJ-Q/.K:7E*JKN:MX+$5/-X-/;+16(2E
M9<2A!!VRY4$XDZW-6J)MZ+%HZ#'1+E\IK0NI"$J8P$#$P$("4TG1LPFZTHAB
M-79$5_ %*GE\$L'.-R02)_]UUAE%X5N3R1M;-I1D5(F(,A9P6GIAA"6E)W(G
MA.(-I18,I5Y-6#,TO=K[[%B)&1AP*QB*4IA/I-Z(+-$7K#H.=M74XGSSZ-I>
M>E'/@O21' 1BIKU)5O)R),7$V"QS#"B:J"^<J(]W8,@!8L)(N@B00E)29D'8
MS**,/-FH:96;89=)>?\^3',LZ:W+Y"S<GI)T76]5(F4!1"7]BI"#SUDH&0@T
M&GHL&GJ,FS,J!,EI!IE66!L_V< <]YEY)94R9,J2UD"*@A9=K><)/I8A///"
MGPWZISV2Q[-![\0?M?#,C9Q /*.!) *7 I3(M&Y)Y5&0%'J35#-H%@RG7D^R
M&=N02&]5E9;0,[#@F0N"M!PC73%@N5&.M!S%N]PU^J\G+.J%&_"JH.,J WCI
M2.@3-X$62'8V01/UA1/U<0^K+='8:!@)-8FZTH%Y")P5K51T-@JOQ<HJR*Z3
M]W9=S+&DM_C,3,@#9=:" (/L%T@)@TLF0RYDU&BR:UJ%P\*AQ[A!$[-,2AC-
MK$R% >K,,'%D/BJ18O;)RIJ,9F47^3PI"LL0GUF_R)?99NN^WXC ONVX35XD
MY-H[T" \.)NE5RXHGH3(\H%*#QI230NI=B9,&I FRA(#2Q 3 U,"<\EI%G/@
MEOL<G(F5X(-W)4RKN<D\>FZ77M1#+%'JE-%*"<9D5#)%D<FH"6A-:"EGBR?J
MX^WUN483>&1:9<= 9\E(\P1FC0(9N9/&IIHTTD4Q3T[6%J-9 /1 3 % 89:
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M9&BBB3G53JJFJ^R]<\[F6+I;)]4Y=BPUQ'A,Q)AP0.427%"2J8*"@4J"H2[
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MSO=<&W-7;GQ]?>047^H!U,!;O=D<:H##QUPC4V24Y3]F!,U:#-NLW6/6AEG
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M7X=H GZC@6\43;E5R7L%6DIT3@@CI(ID&R:5FOMQ;F5ZW/VHA1-84F'6:LM
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M,03(I@+ZMN"NP "%T(_8J_<$[>$5A>(,V*L-]@>E&W]9M!O+X',!_,L\P)&
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M.[8$<F 'Q NPQQ ,:?3J/71KX"%8[R#G[66=AQ@I7YAV3$;R)S#-@AV2,1!
MUR.VCSU7N2,36\X>LAT!?<@\*B!EK][39:(QGHJ5A6X9R#5&R))QO6"$I(P@
MZ.'(QBP2RE-1V%3XJK )HPY$+(RX;SP5=P#AINK8%H-ZP0C)'21<QQ4V(B&Q
ML82R350.) @"@@!V7:DS5*_LV"XX*AZ(2*2I"*T1^VG]F$#%9&*\AP3B>"[E
M*  .<'" 0^T_#4+HHY C1H6Q0E:5G_Y>LD(*R-P 2BD#B0!*R</Q["!2I1.
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MXPG5]+:7=AYBI7QAWC'5])Y -0N&2!_3$" 8V*ZK<DES&MB!$))Y1.@2W\?
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M,FJ[#:"&WUZ"WXR1<;W?];R4=B RV:8\V8EZWY5W5:F&% =&0F?+SH^7[R7
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M*A91R$AKAB"5T?0_S[3LI WOQ3.FV+@5$QK,? ]#>.&V!QE4Y!C!<D]#,Z6
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MMY&,*4YJ+/VC)KW=GD'.TSKV,'L3IA31OPR?I^LPFZ3@@M8A@N"U4[CQ$GQ
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MC-"LSX;_[AB/[WOP.7S;E%*^+K].YTC_O"1Y3=<3IKE4-A4HFTMBM*!Q<Z6
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MJG0,HLH(7,90@D]*\B:6;+=,5^_=4T.!#<_(@!7%:'T'&G<I"-'70,@:;].
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MRR\/> '/B?FTI\!.5#DJ%/,AU\A1UTX63%"T4(RNAYALB-')$$^3Z=J[<G3
M&W9.QZS#A7>Z4C41HT>I),U'4&2G@P,?RL9B:]*UM;U.G_91/4K5!KQ$YW0L
M.TJ$P_<G8]G$I&,!Y"Z!<ION:4Y!"/661YDMYG+2+:*352LSACZPDH!F2(#B
MJ"&60&(DM]EPI8+(I^W<-L9JY:[\:U:FO(]H3U+A5AT@2Y9(,5=C?JUJ+76H
MUZ\S$*98*55B1?5)5'4HOQE=8[,A:'>(($_#MO,=/QGUIH:ZN.C(.D4+SE(,
M9[(VM$*D2>RT^FZ4L??X&+>W,$_7C=>%1 Z0-B"T*T"^EX48+8*7W#K/*,KK
M=#]SCVZ\P]WS,S+&[2W*TQ6-\Y!4/8\*- ^24+($WEH)-HD2E$A>JEYW(K8O
M&A_NYJ"Q$6Y?40Y.N)NIAB2U8)$ HJI0BT=P4MKJ!23'B\,43M#L^)A\T7!W
M%HV(>H<+=? VMA*+<\XFH/B&@;)1@@O"@O<)ZUEKBG]NE>Z/NHWMQ KG5 P!
ML&"]L4IXB-EHL,2J4J)5V9<6XQE#"-U3UGNUTMIKUD_<-\L9%JPP$I)EM2:6
M9XBL>-!H"NHH1+GM2?;LFS7BLJDAB--$2B,HK[K5).+X\BHQ8'G5+?!'EE?M
MRRVA2\K.NWKO!]EC*\DZ<F6 EVQC9$IJV;(=X@#E4[1<F!0Z,) ^!5!2*(BB
MMA+4F71A#.2,]K]@].D,^?,P6OOP8]\=F+TD-?R.BS"HBHLD:28RJ"S)2^69
M@Y4Y&6V4EN*T28_G:,N.X5,7R0UCOEZO/^+R14K+,\P7D(^ZZO2)#VQJOO8!
MW\!\;9]$9-H\^-H37YXMER3C22@QAGHL5M)_H+1/X!P*8,Y%FYW6PHD=C-:3
M#SI6U6P?\(^P_!=6QM9;>"\'$77B!*B X:D>W&$4"1=F@66?/8]"F]@GQ?48
MJK&8J+8<N*U(FLFEF5'ZF9;\XAN2:J'IOK'*+F IY%9O.CKD>F6S2HQ@*09>
MN&P9-^A2GV+P)Z&-Q0SUY4Q;"34CSG;0[\*,@"P^?9JN5C1+EP/..5NO+6"P
M!"DFBN,2TS3JQ'@IW&/JJF/NAS6&;<'!E$P#R;0FRZLYF79\'_ZX&FC<;'T3
MG"S05>XB>!\1@F-6I)R\,WUBI@<AC6$G;S"2'"F1U@1YLUP4W- US'[!:YB(
ME\RB!Z\WG4$)F$NEMI[2]9""+L3JGBQY -<8]N &HTH+V33) 5_AR6>ISLP-
M+\H99^LELB!2(OJZG,$IBY"9D4GQDE#LTB?[T8>,80.LG]S;SG$S%;&Q9S34
MG_](TU55611XASC#+2CZS6^+>;IPB30OIKA ZUE1M"]]/6D2)!F]K%/VOCCL
M4ZJT#\I=:&2?+8VZRZW=R?O[TPP7@S>*<>&-!&9X+<JN[30RIQFPCA?MBI.V
MCR_[.*Y=V..>/7L:RF:@_:+%_,-[7'[Z">/Z7?J(^6R&BU)?76]?/3SWMOMG
MM]U%.FQ(C<[K7W_ZI#"I0@X<TN:J+_0"0LH%=+ V<:-1BDXEJ-=0'*MOZF>\
MFJ_6R[.:.'X9ELMO-8>]O9)$9!L3+Y 5MZ0!HR;'"C4@*L^]]Y*7/J[N8ZC&
MD)T[F@^W54LS,30S1#<1_3X/GQ;+]?2_,/^TW2U_L\1/T[-/I&LW;UVMSNJ>
MQ\8W^PW7$YFM%%YG$*Z&;D$A.*,B<.>9-,'QW*E5S)' ]TSDP7/D5U]I#F_;
MKNH)>EBWISZ]FWW;:UB-+-SCBLC:J-!8$ I9[9*O(0JMH+:HXIYG(6_? C*X
M/3C.IE_-^%O\O-U+?5W>+$E$T\]A]FI^YW"65BSIF!T8)PR%G[* +[1&HW&D
MEUU1OE?;X6-@C\F&-F/<G9WRP03;KBQC'\@7)[9<DL(%C75F$%2R"KP16,O6
MM&<Y.G?[<O)34'"$Y^_&P;Q#Q'A"PIUW]43MK#2^9E==/9(:""MW0 Z*2]%3
MA!TZM>H]".\8]MI&2+J]17DZVFU.;3'/T".OO0D,J62:*8B9"7"6!>E<C*)3
M>XF#X(YA[VY\I-M;D"?D7#TX4[C/7!(EE*N=XH7)$(//X!7S'F.0UHR%<R,[
MB#<BSNTKR%-P[N9YK1P30\8<%)=M/:_%*-Z.%DI)VNO:9"IVNGSP0,1CV(8<
M$_,.%^<PZ9-KQ1;GW_Z(9;'$EQ3\3.=G-%W;"N/%_(CZW ,>TC29<NP@&^54
MSI_]ZV*U^H6X>M_3SW%=@_OS'^MEH&4SG8?EMU?$]E7=F*2_I''18SZ\FA.]
M:-P35HQF&&MCL-I?7UM'8:JWX*4N%# P'F.?>^$[#NI8K7L M)_H&V)1FECD
MQ1>I@ F9R36)'B++"0K72=8#AH;UN5_Y"-!CRN:,A>NW5?=0G&CF.AP ^!?Z
M<?IA/N$YVY!8!%LO3SK?*&"< VK!>&""Y4X)H<,QCRDM]">B\"&,&-S_>+GX
M]'DQK_[3@ORGQ9=IK>NC@5Q?BBU<D#V>T\L+.72H31T1>LS/?WS&^8K<H3F6
M::W#=C1G-H%,M1V.L :"=1)$<M+P$"DVZFGT[@ Z5G=N*W)^0=(;879WO"5S
M'9R0H&V]@#EC@$@:'M!E=%AJ"XX^T=43P,9GR(_CRFT-UE(NS0SM%M2[=5CC
MBWG^E?[@'FA6\<R%$I"XC: \MQ!,#."B=I&4MJ9)Z4F9Q^&-SWQV(4Y#&;6F
MS];2W@7%K*G5?XI0A%B/X3*(OF0PQ.;B!%=6]]DS?P+8F/9$>NJ:%G)I6%15
MD&#EK09\:-RHD@Y2%1#"U701<3BXXB$(KXG$N>8R.]59[()O3#L;/:C304K-
M&71#%3Z(L'B38Q0@C8BUERM2X)H$$1VYJOO)EO5IRKL/RC'M6?1D4W.)M==*
MY[KR(6R^GI]2P@!:+6K33 <Q94,N6D3G@G<N]]GTWPW?F'8@NFJE=E(Z::A_
M,1[ZQ8]A5JM-VX?YCSQCB!!_UR$VJ]T\?]PEFFN'5":%')JX*?%P18+B24(4
MUH*.P@D=N)"LKT]Q'ZI6FNOFI[Y9+C[C<OWM#4UY/=/U\_\]FWZN&W03&4O@
ML1!&42]3U<G56S0V+0.]02.3-GUV2_8$.J9$0#-6/:30>@BON6V\"?+OBT7^
M.IW-"-^K^3K,/TSC#%^L5KA>W?YYPG340I,-E[8V-_=60Y"D\PWGA2D:!E=]
M>I8<#7U,686!6=A+P$T.G=\/^=6GSR&M%^5%7GRN_7Q^PZ\OTN9L!_U JVI.
MWR;<K"0>F;+6.;"FWGUG4$"HE[(G+5G(Q6E]>]/XWG/IQ^(84PJB.;\&%U0O
M:GU[6Z?_=?E]=4[X2=:&U"X2J)(\Z6'F("3,0%/!.8O9E+!+N^8='C6F1,-0
M!#EJNGN8O7,M]_?E8K6:2)*A3M4$)Z-!L4CC)(Z"T#+('%QQMD\6_'X\C9A^
MH=>_T));++^]Q10^3]=A-OVO#3$H:E/,"%J ND1?N]!0/"[H2[$T"YY[PTW<
MC_!//'&,[M\13'B \2VGO1_Q-VF;360W\1&M+;3TZ@BKH>>T$FVI#3R-%T49
MU:D_U".@QNBC-:!*:W'TX\?O\R56SF(^WW%(WVJ%!L'+S)M, 0M@,J*F\A1$
M;2S1EXG(I5'J=O.?7FQY".(8_:^>W&DBJGY,HF\N7MOF]&HNB?X]E\D\;U-\
MJW<?PQ)_#"L:Q[4WU+/:$\F*2;BY2H3P*RR)OJ.!V<*95H'Q)/I<D-EC-&-T
M_WKR<V@"=*7R2_IY>EY\7Q;+KV&9KZK1A)5!2$[+C9'BSI8FK5["GHW0FE1Z
M$+S7,?)]<(YI8VH@^C42VI Z\BVN</EET]5KTYHIS%9W6S21KR!MT!A!2QG)
M0Z@=:1G%U44X6[MYE=#I>M)6(QC3[M9I=&%[0;?.F.R#?#9;?*T;0K2\?EJ<
MQ74YFVV30/5MFSYU;W%]MIRO)E:;''4FQ\1:))5N P1E&&1R3I)BBI;E+ETD
MNP,=0PO!H:+6DPJY#V^O!>+G(YGH$!BS#*%@[4A0DJX75D3@F$H]ILL1W2'$
MN_.D,;0//$&^XX!I[F=9KVX4H>'>\  F.?%@!&>0-@0MNAY?(.]2<YMSD"8-
M%LD^#'(7"OGG1Z'>XNJC2FY<2E.M<L:$414&(=?K)$SMNFD,V6?IDBZYMGK?
M<\/I_@?ME#AESX\&[6=Y!&F,B\LDKO]Z@E:A)&L')<G:P5MS<(+LH(@484BT
MIG0ZS]IV'#L1\1FF\$<@]8XFL/;WG0CGB[92TCS$3--"P4/@T0,!Y$$F=!H'
MVN/:X-F)27^F#/_^4NA<[#-!;;V-5H-$)(/JBX1Z7S>Q,VHM(Z/_NC.B3]'<
M=2%Z3*%8CA!,O2*:64ZCM )B3AY=H#!$#)25NV=O]\D]T+Y]6!L0XTG>[R^%
MYKR_M[:!'NJ=9*2;=1TDMZI&I@&T-$)96J,<^^YZ/ETX.IIMS];D.%H@@U=X
MO\6TF">"NOGT1?FY%$SKZ9?ZV[=AC4U*O'=]2*\:[X,&V>!2R =J_NGEV5FF
M6'#3S'G3%@#S55> >I&%RM:'>KD6$<9DA*B5 L>48-RIG-(N>9S#GMZF#T:=
MV!N3_@"8%Q>'BVN=P%E-LUS]/0EFHD,609-Z==%:6COUYE7D&D),T; 0LE-]
MC%S388RA/F@@/M[?!.,4=&C<V>7.$&Z?Z]DHDBEIEGJ,=1IF%:S,,A"[$E.U
M#4T$SQ$A,5],,LB*Z'/WRX& QV"CQ\72IB)NDKJ[ >4FV/O/*]9>-]MY.[=Z
MK\O+CV'^ 5_-+ZW@18W69HEQ':31H8ZFGD>S6"#8'('66N&TXIRYW;3U<>/3
M"^@8BJ$&9NOX"-!;QUZ6.*SJ[@L]Y^.DR!21/&;(RM;Z;<\@I,) E.P39JM%
MUP9Z.T#<LPRJ3R0\+D5ZI!P;J\X;T'Y;5">_7E089WA/*O37Z:?I>CLS&E,4
M6EA(TG$*]@5%<EZS3<3/0K91L5UV]H]',H92IY,JOT%$V%N[7>CA.ZFE_PRS
MLW-Q7E0D3$24TBATI(8MK^5<%ER(&K*M"5:%T2DYI-K; _L82J'&I0Y[";Z)
MGKST"AYQ-7XG9,MUF%;%_F:QFIYO"BEG:&D)*(SP$60)3JL"!6V4%A,YP[L<
MNSGT^6,H9SJ!3AQ$7+TUX?E-G?G_G*W6F\;<DR1ML;YH8,60=V""!I>D 2F5
M]486'5*?)/:. ,=0 34NG7:4"#LJKJ>FPEI69!$,F'8T%;(>!=4.0?O(@^-.
MDB]ZL-;JG&O=9>T_E5++20064@;I-[?@NGK!;O$0,QJ5?! H^JRT!N#'DE?M
MS[S;BW!HR3<S +L ?S+M)CW+149!^LH44$EIJ*V8("$G=RE(CK'/)2\MT(\E
MS3I.TC:5_6#^<*/4FW%"ZL *Y"P5*.[(9%JL%]KGDG2@ -6I1A[TGRL).QR7
M1\R(077T/1D]++H4H6DIVI)!.9'!<1.!"YV#RSQZUR=%<1C>T:1IQZF(CQ3P
M8*IWK^2?838H1QZ/R;2:M*<!&(J A8[>*VXIZA6-].LS3.:.3XGVDNV@FG*?
M9)\VT9B0"B I]WH:LC9#)^VOF1%&9:.TZ7,33..!C"7E.T[5VHL1)TW_OL%E
M(A<]?,"),"XK5Y#"R=K7/UL//BL/S#!-"U-Z<[N#8M-$\!62L:2$QZ=9&TIP
M4&5Z)\O(LJT^, ,KT8+R!L$7:< HQ:P..LAPNE3 6+/&XU2+1\EVF,+IB\-0
M;W$]76Y:/M:VMRM:.=-%GJ9WN/PR35@;NQS1&_N AS0MG#YVD.VZ8T_G>'$.
MK4+XY:Q^[":;6:]NI5<FT? L2G"06*BWP]*78)4"(F?()M=[9+KU"7D278-C
M'K>?$:;+ZB3@^0.V#6V#KYMUF8%PVM?;:B6X'&F):HZE%.M9Z=;H?Q> 8TC3
M=V/5/4=!F@NMY<&A6^"VW[Z.L^F'S?Q-"M?"A*(!7>&D=9&T;@@(AI2\%2(%
M+-U.]#X%;L_<>?=#9D-3Z3AIG=1&GE_GO3F*\V%>>_I-YV3OM]<LO/N(N&YN
M,7=_Y!#V\\ ):&1-W^"\WEWY8IXW;A;Y_.OE);Z[1%M=.\"VO9F+_K1>DGK^
MPT1DJ;0U$H*2Q#M3(G@F"]A0LD3M2KK=:Z:1EF@\D&,UZA%PKLUFDEX&B05X
M=:C)TPT0T=6[A'BQ0;%H8I_+/IK 'Y-]/R7/;^OOX;G1S%'8%_IV[JX?>S7.
ML^PWEZP19&6$ Y^2@BAYL.@DR[E/:]/CL8]AB_[/0.@C6='1[;UCC%_-KUOB
MB=7%VEP]*ET[5$>/$$*28)UV07MNG1C*"7X":H>YV00HORR6USS.ZPK)Y61(
M3!QLE!2YA%@@9&[!6,Y58M+&/-C</ YU3(:I+P>?#AU:2O5D9N8IY69D,9(I
M#4:5VI41 S@,&7(=01*>:]:'FEV]TM'%N3V9>TI*G#1 KOO;:8WYO,/H8GZU
M:)L'QD\_:HB >,\!=TLK_X;KB]SV]M5-9W9E=2Y&9>!.$(ESE."%9^2&VX!%
M6I5#MPL8=T+8WO*_FJ^QBG$S?NU$#"E1H"%H_2K!+'B?+&B#2N=H<M%]VA<\
MCFO<-KT!EYXVY0>+J:-#?7,QO[ZVF"<V62R92S 8ZB6Z3%#LFB44'I,Q*CF!
M0Q'I890CM[B#\*J1#(>QHB\7GSY-SS>*Z7<O-_O5'W">R _X=3'_0"ODT[NS
MSY]GWUY\6.+6>3C4C![^K*9VM-&06V64SY;I8UCAM<T(YG+.DG-PY'-1<"\9
MA&(84%@OA;"1"=^G6]-=+$=')G<^\:<S?$7K\(_U^Z\X^X+_H.G_N)J('(-"
MHT%@;9E15( @&0+3]$]P7$?LE+G=#>"8S.61C+D3*7004;O(]GYP[VK%2_[?
M&)83&WB)41G@4M/0$P4FL38F8-&6I)*RG/79M7\2VJC2GX-PYD"Q]&;+^X_3
MY3FJE"1+M4>*">@IBB5\3L< Y/W9S OC6?=IZ?\4LC&< !J6*X<)I3=5?EF<
M+=<?-[!R]H$[;\#FFO&(I4!@CD&%2IB$YHP-R94K:&.Z(&X8LAPHENYLF98M
M*J90:NT2:%8L*&T$N"@U,%ND"%F2X]]I'_\)9&,X%3,P5PX22E^JO"@455P!
M,QF-JXTBF/3UJI*@(3BFP"HI?6:(B?<YG[(#N#&<.1F2,$>(9I@(_<<S^AE7
MJW?X81.SOIJ7Q?)\^A;SR_MPZ,_>XN?%<AWB#"_>>GBHWN"A36/VUI/0H"MU
M31PLI_&L8OA'6'Z8SB<N,9.4*6 0"R@9"]%46DC)<Z*KT]R8)R;^_D\^5BEM
MFNR_62[*=#V1$5E,9$ %+XY &HKC? B A%'I8HWS?4S5-1!C"*<;R/"V@CET
MFIL9'QK#O["NA'H=7_Z"R_5T50_)GY_YG$CD(7+A(46ER7>RD?2FJK?M.4;#
M2L[>/E'62/2/XQI%TK@#'1I*XS2FYCQK';]M?VYG3A[XX*XF8Y?!-,KIOIJO
MP_Q#/6U]_M#?\*J5V-\7B_QU.IM-<I A<%; ^DQA;Y("@@F;RZLE#\Y9V>DZ
MZ%W0'6UP+D;);9)>:UHUQM/ZX29!Q%P@VZ *N>="NCX9E_M'<MK,;7->W#%
MATQ[PZZ$=X9WV:?E$IF3 ;5Q$0+6;$]" ]%E4GVU"I='9D/IU8'U:71C2MEV
M)TMS<>UHI+:OUR^1HK'_^+?_'U!+ P04    " "!@J94:YYKOS:E  "89P<
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M:^]2,LU<EI&6S&B2T)SSW*H;7]>+O'ZNHR0)6MFB2/G1U6IMEKB@$WA4'KE
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M9!=C+;FHZ(M2OBZL(4'AV8C,LL^QS?UO!W"/?WW1)RFZ[DH'*J?!:K5[]/2
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MB.)E[C1;'WC/.2BX3U'VG+IW@V4+_1+R8HH0@%J2S2<*)^N/Z%=\9#I(CD3
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M\\02W258XVMMQY@A<LS LR$L-DN?VEB 3[F!ZC'&P%$2;F#T;^D,UP71M]E
M=2]=/=Q&\Q!!-]@(MC4'1,9*4!JTKFT;LU3@LN?@&8ODX!A%/M"S5OV^#51[
MUOP^\FUS*=:A=V>B >92^\6R6G$F)$WX:$-"QY'V.9>+#DU(\(P:J.ZCQX,:
MJ.ZCA 8&P5JG3YV2MC$F\$IF4)@%!"439(XF%\<,-]B$$D^Q@>H1NC]"K#W?
MK_R"](PP^N5RG&>W$05R<%*]!E8E+ZM-15$[!AAKG0E1IM+E=F7[TY^M^GH2
M6(^W*K/I?/ NC#\L=RG'9#+%1/ IQV4K,6<R@B04/@2R5M>3<[9/3WKJK:E)
M/ZU/RSNO?>ZF^>$R[/%(]AK$*J*Y XQ]C/#N*NU_CCYL<1^A@G4E'B&_'I?6
M=3@Z<\VTM6"Y)K_>2E$3@@)(X4N2SIH<[?-1XP[KN7\M[B.VGK7W&TGJXO)B
MU<<^DH6/7(&1ENQ_SVLG@Y" ,1E%SC:'T"F$M)/^[KSZ=)OE4<*?]"&Y'@W8
M!9!E%];5[6KV5H6Z)2\R?80JX"79U$6EK&/2A2/O3X6W7_T,57BPY';.PG__
M86WTK^G'Q2\6G]?1O</R7?WOW]^].K;7O;P5GKZUN?UL>/%IA ^8L/L\_8>;
ML=P=X]4K[NBWU:CPRWR15?[]=\/\M^^'NG@>0S16>ZZ84XZ7;+Q.,9BLD/O!
M/B_JLPC/Z^MZ94DSQ;-&(!;5ALC2@@OD":4@@O(!'<93M*Z_!M1OL:%;/>.U
M*1ZYHY&QVF3/20[.UXZ>3&B#GHFR'A739* WB!X[!^4P#MQ?;NA >3<X.-E=
M=/7]G+[D6ZU+?"#-27+W'59#R44+ 4D:63%?M"STVS;1R-TQGB-7>M-)@P/:
M?TR'<WQ32BW[77!Z%32T:OOZ<C*;#U!P;Z+*H#'P:EXK\$&KFK>5;8P9::%O
MPIJ'L9T'6WK608-TIVT'(!P-\S99R($I4($60!\2AQ("IT50B1([6;E'+B9/
MHA9J?VO%_K)]*K50MR?Y%"DX3P2?US(6H48<1N0UZ(!))XP*I4V0WU-/B-Q+
MPYT2(O>0].FRW[J@^L83(O?16\>$R .$?CI*6*%K'D\$1CY]O8)RA"ZP>AWB
MD5A?['K9D6=(A8,2(OMGPCZR;L" 6[[]*B4H1!V0DWITK:L1> 1?T_:8,%@;
M/4?1*-YS \J3B?/?2T<;<?['"+BY,[J@M2XNI:0\E)03**TS>!4SL% ,^3R:
M%]8F ?II%T0_Q@ X4LK-'81;13^ZX/JV"Z+OI;FN); /$?LI"Z);<F<#[78@
MO2:'B>?:TUT5X#E@L5E+']M$?#WU@NA-V+"/M'N.^ME>O(>LG!*S5X!<,%!N
MT?P)$="BYR5)^GV70H)/O>+17G)_L.+1/D+;N;6?]G+,-+T<V_;T4UR./3BJ
MM<LQ'@U&%EA IVOFI8\Y)::CY4;GDMC.R[%M+VIS.>8QN5@$@F6)C-" 'APK
M!FRDSP7RI!N=TYSZ<HQLKBB2E]4@IH$JK^'_9^]=F]NZD77A7]3GQ?WRT7:2
MV:E*8A_'V5/GDPJ7AL0]LNA-4IYX?OW;X$62)5):BUQ8I"373+ELRR$?=#\
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M+,:AE-(B\?0]IG5NI NHIDG[K;".DW4?4'WWLTB#R7XT8O#@HT9>'TUH0DC
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MUCX:R;T/)N729E#S3DACI;7:'1_#2/M4$E:W5^7UXF(ZFRR^+:.H6B=NR!T
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M%A(<5T4F 2+1:I2M;]=5<D#X36;&I,S&,D#W7,(K9.MQ:; EFCY4,JC32O[
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MAUA> R5ZR?LA \RA#-B]XE6VQ80LG-(. @8B*),*?+T!)1<E)XY:QS8WS!/
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M/^?3K__?^A-7>E[_8:GFI8)OOV_<^,! @I\>)+4&)NH?TZN_;A*7-8 ;& %
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MP: 'Z%X9@P[3SH E3K<)C_7"EZ]2WI<5TAIXWK1&F]YVS*D)L!IJ9D(*8T4
M&TCKRD8'WM%E6\C'T<46)U0;ZV@?M,=J5=V.5\UU=NPL44<#\.VWU6SHRS!?
M]V U1103/%CO:VI6DI<1N0!:-K-(E[F[/_)Z'*O]/M!C99C:$Z>?!7^0 IMT
M3WL4[BW8.IE\TZ6Y ^2FS0CV 'V<E@5-R="/>(-I\D1(&$HQMA0/)1<R(I3D
M$)WR8+15(01C7&AEXIT(^9YHFW#JW.NCP(%?"=W"O:QP/\U"QBM"=C.'6:E
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MH *G_R>K$E/&%V>8<IKL?)<D%NL>%%_O\?W[;_[-:[]IZ?&U=QZ<"E=0,J'
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MC;(&@B\]V+B3X(,WP*W+(82(1E3:3A]!<[:V+U5TZ%3QCIT)L6LA]&^KW.R
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MWO>HLUK<$HR/_[@/OJ."M/K+)%.5@LQX.T!7>FN=+HU3G[BW](Y;[!<T @F
MAXS0O64" *T7]$K^CT'[QR'C+?MY.&KB)4FBW>%03 $<3[?W5I4 B.'%:PP2
M %UCV!\/*'_UGOG#L);-UWSOE8&MZTCER0;<].&MB*L)MZ6^RG>U$@=ERSW^
M2%X6>Q@*/-(-)-W/ND[9I!_42<R!:*"Y"]&W!N$5FRE?@INME"=Q,;K83K+M
M[,!SI8 ._)"Q&^\ ROF3-]6E+\&9A37;>]?.T[EB_'_W@B[2$36Y,_*?X-29
M32D6D[_7Z0_D'E%2+\Z_AH!-1;OTH9.'1J#-XXA;^(-:_*>+*H6E$X]M/S;@
MIF[@)327PW6?*<_&(X@;?-#A"X(TT#QYDBT[_?.7ZWC/BZ('$9,#96L2$#_I
M-CCSXYR6BJ48ZEW3.[S[@SI)B[:1F;RR7(/PW9O08K#]C:65)*N8S'K59G;?
MZEEU]:_FH>1,-+_S5!>=_&F?I,AOQKCA,UK:$1(!$0DG8GF%[O:RD>"M(N$L
M L"?'C1:6*G#.Z]LD=>EWRD&X_MZZ5_A:\6[NTY<M,8SZI3142P)G&C@Q 88
MB+/*?J%2V.?%N)GDP#VT%.S2BV)3XJ4[5=1QM)H\*IVZL>A=4I.EO R62(P#
M+E\@APY+4*J8@44V+8<!WQ,Q]D+W]R28:('?L@),E@N#0"/.[6DJ$ZT)3NI<
M\S;W;%O1IRQ'A0EH4P8(?3EY=?I34]8/ROPJJV;><+1M-[/,\Y0L\R>Y%_I+
MX8].^LY:.(B#()3M"H5SQ\<AL'4"H))9:AQ5^3*LL3K.&CHOA.=I& 0M0=\?
M%Q>Z%/1<+X;/SI R#>5*OL_7?)"E=+\I&:7][(/=6J3JY7 .]LC(J^"/N4B;
M_PKD\C]F7:[$^TF>)7G-1:Y\)$<0T<) Y?WTJ%B_8I,DIA^N\0+4;1ZPQ6/H
M%+EZF$"FO;2T!KS%=8E[:-B9*U@_V_ZG"8=I9HUMZ9CYDW#*WDV8;.+]2\U.
M$\'2OA7/9ZI+77(S&#MI5O!.\:;>64MFCA!O)W6]^EJA<3EBV'_]?30@N7YD
M/4BUP'>O0U9J,<]1*F]K@N:T9D7,,6I"01[CCW+?2/1)VJ:^_C"<>LGO0F M
M1<!P<:E&W"MG^%A(=WG^8TF$<+*M;6Z&'.WU$O"MMP1 - I4X'O>Q=SF4N,(
M>5;DK@UZB5=_:[H#+,^]NATYLX*-CC/B<1IM>,">$ZTA!>/O^TNFXW^Z\_OS
M$J-U#)8_WK@ZF 9](X, 8#<6.NJ8N/T:RJ^14[L]&:7D70V]&NCHVY#T]%YI
MT2%'\/NUH^)IK3?FW,F*9O/VR-9C"]'9L)7:"P>VI\(Y[JI'<M6PDW/B1KY'
M-X<)_44 T'8X1@9SPP^*&Z!OFAG"KCBF/5X>ERCXBE?C9_.W*[7A7#,6V'S@
M\E[A>O7MDCBN'MQQ N(LY5?-OLH')T;)YM"7[ST[.3*6K$: VQ8>*[X+B;H?
M,WW V_F2P=0W'"%/*(/X#Q[[OZ0GAG/LB;QL_ZW/13O#!$ %+7S#H,"<MQQ4
M9C84OX!Q7*8,D;)C<$P_X)E?,_X>"$1GMS*4A=Q4#@[XM+Q_&37FJ2?WK/]$
M5,&O!D.Z)$/'$J6H$3;NXLU)C'H]6\;5+16=/^H:T;1W\-L&H2TZRV>0VA'=
MG4T?@<DG!P]<)@^5E0F 9TB1WZ"C/AWP;^;*!0QPD?'C(15N;M24!'&^0G&4
MPA]4-*]]H%+6V;4?UB8:-,OB#6Z1B\)-5;[ !"P*V%P"4_]">+\7Q0UZ5NIY
M]!T+)'B+[> D,XWO.3KQ_.20!;Z%MI<41V4&#1A"-AB!\G0EW1P%7]OYM->O
MW+7+C/G?O6>H?$>UCC\6X_<''T\%I09M/:5&WL$#7\( _8@.9K8Q^MI1P6RN
ME43B)/,&]\_;/?*-Y,"60UYO2,]@Z^NY/\YAO<L\&-6%_/#9S,RU\[AZ H#3
MZ!1T68Y%]&*B:;:ETD<0>B2(RAC1W^&ICTB4APL@%L@_I&E-'E/I\.PD<UJ>
MO0;]K."Y2!=*!=NB6?,WFH>E#]S,AY1TBK6]&"K@5FW.8-LF;=5SX3K;VSN_
MG_3A*HQJP"2-^N38Y*-SN'4R<9?T?(*,?-(75'H<]$GKL[,"E2^23%#BURHI
MWF_F#CC1PR@^4 K]7F;VJ[D4N#:U)2'(2DFG\X=Y-V^/N*^+<0T!8)$]QXO\
MP]%RN',Z>6FG^\,NLCF:Q_*XRJL^_W:TR^8MP;05&"9-4/XJ6>NJA/SR,:<?
M+H4N;SVMB-^B0.JC.D3(9^&(QU6*6S<G<05(;J\G?Z =91CVY=8"XITS XVQ
MJ4G-:5:MRU:LD;1%!?XM!Z)\T_^]T+2;"BB1Y,(AD>/R.1-(8<0<Y74N=U_G
M=>.3G ;!ZL^@SRX;AC46@$8MVL2:IC%G41R'B@$X9?FX4#^_.?/$?=O/"SAC
MBF-#5Y4GXON,'NX!.YVPMI)17@M:=)/YCFF7+NB@##%/<5W&7\Q_I!L)?R #
MOG*2.IF_"/I"3.U-3$#3D-S+-X,VPVF)Z8M*7J0SY6?$[2 !W;HJSDKWFV#^
M/4^M:/R=,OZ4IJKFW)N;;JNJ9]%@]-0!EI_[ZH"GSJ?$'UBM)YCI12==!_/&
M*>N>O%K3;] Y$ HX^VLS43:;PTSV@/(3YYW,&,E *X/7QY2#LI9"H>/( ^JE
M\'X"@+_=T/KD54'%9E"&4N!8!K'N,(A[/#M 3]14(W (G5=$#$EN,%/W:-UP
M,+&:R$2H?3X6ENLE /8RAGZ3>?1'+CD4**6G*>F,504],'BO_LV\S8<)SV=-
MA2O8>6E'IZT$^,]E93M 9D65UDU[9D&%5\7YQI,E8G*3C^./V+0637G*T&,=
M] ^2GJFGJ3WTY4LW!G757? O7U.W5H\S24]^^B.O[B6=?SSL; V"02]1#@[D
M3$T;WNDE9[<*MH4M5EDP8-Z9\)YK&=0GFQ3XO1=9N5^<%18_,S@!^X6%0M!K
MH4?R'3K(8BNO^Z)9?M'@!8%X4YY2X@JKOG.WFS(;G+8*Y[6D7=OHXSPHO919
M'<U.&?1LUMY3GL$ ,[M4K.@^)=^,8-JY[,>)EI'LVE2X,W'L\VK\6" UK8=+
M]>YM/)N +&SN7J2WLK-.P/?,W)KR^L88%7LGB5W-2UU,+Z$D9L)I^RW=QHA[
MZQ :D>*?=RY8WVGT"?WZ9/)K9;U4;PQ/@OD0E/N\N;Q2=_RN/6,P(^EQ24K'
M2= 8)V!3MNG'3GKL[8?0Y*(T.^&< G?;D-$WAHN/>*>:$=\Q\@M;M-?&4E:(
M&UQH59!ZT8PM*=233>9A^:A@9L_C.SI0\<%7:-'U"#T+@\!DFZ^;V/C0L:.!
MAD3YR\_%H7?,J,+:H<P.I.YV<8^;:VBY?'&,:T>E^>VAS^D @%;2*J%7:+%U
MF!Y$=VU Y W[[53[YO'*<QOYQPRQ2?NMH&)/*8N*V1#63=G9SKGASC("0 Y5
MIFU4?PS2F;A?$I9NA*/=#RV R\XM;82AU477]EDACVSW"8#V:I;@H8S)D":F
M>+<+QZS,C)]:WCHP,PHDUBLMZQ5R].K3=:MPR)E^"E\>WW_Y,[M_)]^]:_?U
MBNIU#Y[)+".&\Z*OL)_U^\AP_P;GRE09\D9*/#!?Z4$E.:?/?DW;Z;NUD=N1
MV$XUT&B9,/Z*K^9RJIN/(WYENH68"K)'] HTO'@313*6?: 5$_&BYU<:Y!1K
MTBA:#CB^[Q*KW%EO*9<RAZG ?EF_C&7> RJ+A]H&A>-FJB=NVX%M?OLNW=5O
M81OVKH5SE.]E<-?(CXHHA\@P25J7Y^R,WZN!/TZ76?RX#D&-OZPT3/9Z4B^J
MP!\WY6MR2Y'+=N03++IYM*ZLJA%@-JUXGRTG4OJPR&2(Q-?X(L+,SN"UEA?<
MY:#+N+,D#V$UB>"==&!(\5QRI,QWRL8?:>KA$^;7P2R!&CE C8==!8]EPS^
M\%@0LDGY<"'WO?"G,X/#:=%UJ\]H#//:7HOMH/S9V''J1WCV2!CHV]WZREST
MM<=NOV:(/M)=>MV1Y66+GT3JNV[A*U:\DSW'73XG*._3&$%D?(_<,[%2E@^7
M@Y1\V?9:J?PYYE^,;SOK>1Y**VNM.TK-MT)I&WGOUHX6ESPGC7N]"^R MI+T
MX0JE-;\T,]'G2-8K?,IL5-? U"T5DR52,_EZKPY[)?7:66SUMI4^V=_KA%['
M)+WV-H8INL\?['B<UXFOBW<$7T:*Y?*EW.7QDM"Y1*UF_./K_[9W79$3&HIZ
MWT>_'E8]Z!7B6*.2>$N"M2T&F&0VKAEA9A>=I.]:CSGH4)\M-4 .P8OF0<6!
M/J@]'YYX)R+R7N_T@V/1)LJ1J\-A.GQ88)J5LL^+@BSN\%929)V0[5+2>T_3
MHJE*'S'XF:W]^1@Q51F?Y4+04E6E,DX6NG7UE]>L>KWAF='DJT9>C:X#.^*\
M)N7R%8877X,/[(Q5\FC-P%N5T"A7XYXN$?JM!XEF!NIVTWBC*;A@L!4"67>C
MJBX'\T>&',NU0\5E!4U>5WI.++JCR5[GC[U%R*U8J0O&]UJG*,?^6JGX$H\9
M$QCS;'FKP-,XA3J8^I7E=?W\5S ISO'[F + _MZ.$T2WK@[<&<OWZ.S 7G;8
M[)%NO!Q%;F59PSCOS5_&@UX"K)<_B&U#22QT-A"4N#LY._?6AW]LX7QDDL!O
MEX]*,J>0<S]I@-DT;<Q'3V/XX:T&6K3U'!/LVV<>FACM92%U,@E[H6%$DV>[
M7# Y8K1^\,%)\(1-V_BQHQVY5Z@ZXL=2TR&=@1:-E%V^$KM9;N"5_=5JJN.)
MV<6CF9O!"1/V\S?DN+\!I::X*V0) +J!W[<(@"!KB):2]:;&[H V;)+&9/J1
M/4."XW57%92U'5WPX^PN(2#9?WWM]Y_#UR*/BPKW*.UD8\!.HX(Y7"ME;Q6#
M7[RJRLNM;M49JRPTXQ<'QL1R+--41BZZ;<2Y0?[#,;R!0L72(/5#9=GJ7!?G
M#@SE:LM>[*!$ZB\JF$!OU1"\WJ;,[DA(P03)>HU'P1AOFG*8YK,T'^$UV'?Q
M]?5M\$%_KQ\4<SIWX6:B_'X^-C6?+@A4Z)ND/)PE5+AI<))]?<>'!8XC+_8[
MJ4&O/:F829'//MV5%0_> 7<W!Q.KS9C&GZ,/6!.MXAPA:ON)3<7E4>)J]5^D
M56AB6I*7:@Q]58S$>0VTK+UDY[OA] X-<:-+\E*<L1$V9V5X=!^NS%1H]1B9
MX8IB.!4W_3'OK_JE =2)RK$'79)3]/LPONM4=/,PQ*=F1:!N5.&RK\. HT.\
MF8,P-;]%OR)&!%P,J<RA"NV3<0[<+C!Z\UQ5'L#FF#G:2+(497VE?*3$F]VG
MO]EX&?6[*^A1CJ_%X^%AX?CL*>,8T28.EJ$)."]:LCC2P+VS^6.5DI?MT)1%
MJY##,E7!)CWR7?TW:Y?]DC$U8G&7*B>5P8W\NG# A*L"AQQB4=]&#.O'@M3U
MENH9L5KO&\$9.[*:<-O76Z/Z'QD(@.:A02RRFR^SW*EI\!*,+_N__DW _^D,
M5-%!>LZRWQ+.#R(K($%"*!\RY)4*H? /[&1][8Y,[*MDPH@U.03TVP_\!N?X
MPVLO8DX0)<TQ)XP@A0X(B%; O66LSI#H#!FF^EB5$>.>\".S2QS8ZAP7)_BB
M+0M\$=FX9HXYRYGZ '_X/1&K&6($3P*AV+0VS._:YFRQWZ[O2BN>."IR2] Y
M QOO5FJ]3><>KV[.X6Y.IND.[&A"X]?QV0;-_5\4I&R'9 +YNE'- KX5YH)Q
M#CS]5Y9[*]@->[X%HW$:[K&*?GDS.Q]D2KY9C>@U,&-!3S!LBU$2 IL\RWJ?
MO0Y-K/U.]/'9*+]<NRGG^)OP9]]KJAX-*S%:K&I-M\L^(J^(QR0?FD?MP[OJ
M6R'GY+^6G'UFI7[*NR$;=EA.@BO@CEO8Q@IVM#'?(V)TEE+%A09P R,+!Q/S
ME5B14?NG[?4W=2VS3,XBX',_KI<B3*O=,"_K)964_NZQPKB!4$U=3AP%7V9,
M^__'8\T_^=_$/XGHIJ[EIN]Y1S"3,GYL?.GP36]-Q&D<"'-U [, 2?1]M[RS
MTI6Y/_>ENF\JH$@<$93U%HN,S95Y_?'3,MN0>VWM!^0MH1_Y= YB1K\  N_1
MY-T6E'9OEZO2CM5#-]CR^M=FAT")CFUK+6B+J%+O!_,.<:)+$F2?@DG?FD6_
MW><T'Y<:*)Y1S.GT.SC\/7!V@WP-8X#OOHF91%1^:J;31^&E,4GZL^RIJ_;/
MV4- *<\"ZO!O('=<<GTCNGQ2OX:<ZB3#YSO 6U/-[X>;;V @2E,'4]49]_ /
MLFJA\YRPG87J$"0-L$BT@W$]-D_[C$*^DC/[9H",^I+M&SLPB=? ;+ECDJM]
M&7L>HBG^@%'[# _<8.9MF[^VOFJNKC+.8['<X-2!/V,$Y?A\,A KEO&2T%OZ
MZ%2TL[U$,_6(]:JLH -=<((DG8%2Z'^#!/_?GH&KP9P3>!Y,0&!!8A(R8BC-
MR:F!=+S$'9S@-K]?%V@L.V!/ +Q9QCGR&@@H^U>6UT]D#6IJ.Z+P)$="P$,4
M3MB"'CIDHH4C!RVK_...^O23L7.&6ZNG1&"K$)K9[$\ A XL#9UM_=UP=O^L
M>S)"O6VJE31/  "P]+"S+3R#2 1XK3@73PI'9_V3SO03<)F;@@441[IN++ V
MCAE:2N#TJW0YMX)O&2.A;"+#><VC+V)5YD1E=* *?"<C'$8*_ ^X\+;5VJ8W
MHM!A'?[Q@CYPX30!Z)!7/W1>$?O6;)SAYNS#>!.U^"?+ EROF0S]0V21L7&)
M/0B#4&/A"8X1;CIMO9?_] &-*0'PL=%C<8_R#AXU;J5:%NO"-'^7:$DT0O>M
M!L]L3+4L16E GM%&]:!;GIFB$T5D9?Q]?5!X*14:U%.XE;:/<>YSTOV:#DT>
M6AP.KNJ=7%>0PH1["E_W\<G3P@7.E!E"UK5 (4CTU]/XLM2\ZNC<0E_X\K?0
M7(:PQQ\T="Q[DM^Q/KS0XCW .0YXM82G"Z&??9L5MOX@<X.L*2X6X2PCN<[.
MCB%WO#$9J!H\5J-+5M/?<CJR@LJU:V88:92_J@'2"IF.9- _(P(92=/QC/W"
MB$3WV5]GIP\QTDO%GD6G(\+)I%^2&L"-X'V2H378T07I CQ,HKC<05E#TQ(U
M^$ 7O O?,H]7LN4?BU7[HFT\H%4YYM1)3S]B\D26ZREQ_[V""=QZ^.\IY[Y5
M%%S\)MUTC,.$+VLO7 "-9PW4SS-UR)PCHHN"DUDA0_[?&O*WI'F"-+&.8;SW
M;>^#'@T;B!=D;L,AY(EZ72II#9Q;0"]H?5OSAS0+G@W_W?PLTVN5 QL[OU@7
M61<N5!0M'N'DT%_1'V!#KK0/SMWI/<U)_>^Q?_BHK^-M&3G ;VGU,VT$-:($
M+%O]7]M/B'S'*<W(U"HGM=$?5K>UQ/+!#S4UW&L0C#@&.]?ZU)GTI:NLR^C;
M%#E,\C&IZA[UF8TCS7*^JIJ7C>,#_L" L!RM:#RMU0__N* 7%NL3YOU!X6MP
MC]&\$N:A98:0$OQ)'K)GU(XU^"N-&4_J4A"UX91$DWG_1FJFDFPB$4%ZI"0Q
M"8VHYI85*O$X\D]WI@3-A^\>L7C[-%:$OOK\1HJ/]^V7XQ4WF$'MH /?__X7
M O]A[(:_A_')QJ3\]'M9$SVM<_M3[:,:#VA5=-WQEEDH70Z0^Y6]6M&&>OJ-
M'QC\$[MLNQG+3PFW3SA23=A%HEZBJZMC\_1-SEJ?WP,<4@/AYFY8+NY!H/"B
M>5MF(--8E1E%/UY#9Y5]"1A3D+E *PY#8[&Y;03  ?<&Z'@#A']G/ J+'S\0
M?ZUD?#/BVXZW:\M^9F4+EG(6.E]5X#-_2=<6I^[U838ZOJMGP[Q%R3. SULA
MZ)5OY=[0&>B>;WQKREYH3W*>\5[U3[).7O=@!4241\(QKDQ%3H2NMUR%(\'3
M+:9U_Q%;5^ Y&MPZL!BDZN(YSJE9;U7E?Z9U,9^;8ZF3))QWZHX;VZ(]\=+/
M.?L"=/&UZC:N"17N3 G<'J;_D?C3'8[Q5ECZ;E?D8C69=G\<+C@Q<BP=*J=O
MM33+YO+:Q#%_6D(PV"YU^-R?_;C.0ASW "V8SH)V:@SMK:ZUO+Z5?I7W'889
M:Z:Y>IGUW3#*2>902"O\QSVH?J$=3L32+A,V?A@"4WX!,_JH3\H5/PQ)P50L
M:T9D5"9./28 ',Q*F90[U:!S>QA]96'-7HV<N@VED'S!AZ1QJANFO.'-(KZ.
M'>=+(<OG:AN^!SM/^:D;/'$5YHI>);Z'2T$=)M/<G8G9AV2UDQ0$0&, G@ME
ML=CRQD%J<"EB9W:P*1__&OJU^.++'72%@I_ZHHI0,0Z"=H'M!G=E7Q,<U:UZ
M4:XS*HV[ZG&F#Z?&T:'9*V[7(5?,I'@?I X^6'U][@W6-=_+P-@J[Z^VQ&=N
M[$]%6B9#UEP*V;76C"O3'.W)7ISX(#77:!:'WL\Q[.,GJ7*G=R%XXUE A\+
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MWF$<^.'!J_2+MVWW>!@.[^>[1Q(G&59HA-\52KL +H_B_#I O(]FFFIFE@D
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M_A-44-Z4;CHFNR/[/N^;8848>X=0;%CL$J@Y;_P#H24]).-+BELPC\KOFQ4
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M[,ML?U6#J"FW]^ZE'D/28G6_$>QY&1,*WO#!FP$/,KB^O3U0HJXG(B26U[V
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MQL@8C'([18<8X+DX#:NV<J\==X"EZ8*L((<V9(&^4I"'V5R:XX2(_<^"-CJ
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MW\[6S\"9M3(Z8$C5A(*D V(+#X8UQ5(="KC%TUJ<BC= IW '39T$607>MW1
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M&.$]'L=M"A?S-U78/B?:MPHB(S!! R%+LUM$P*FDW'OJ9ERFZ>4V:3WF7D0
M):H6MH/Q( )>=2C]>G^(#;AN*=JU>[E(YK?V%C;+#3VO5LIHS%V)V'"X=E6M
ML*^V63610LE-G&?_I,9<[!^Z"^&@-P-(8:S)_8%"M['#3?W9D3;ERZ?O0HPS
MF82#1DU2:AB78+\^(;1N"VV#QYL1 =.B>J3'Y2>AIWQZ]<ZO+8_&FA$NDJC2
M6Q3^G)WLIR/R_]IL<V*0\%1F#'4Q]<>LKA=#HO1?9<[*_>@R7E]E,W5[PI=:
MJ\"@?>7?%/A-P;D8B'HOWH\\Q#KX8TH,3\7%VTT;W;2'_N[C>I*EWPL_G"A%
M_5;S\5K^F&Y<]\6DZ:?8@6DL?^PU$9'RID:3R\TYDGD1IF7W'(2[[O[=4Q79
M@!MVFBN6W0Q2?[6(UN_]5 )[]$?7Y @5SB*+ S;'XQA()%ZY=E110=,HX;=Q
MU4!B%L;Q+)4Z8536426F4"\)(L)U2,:\LL?X^K=KZJ?Q%<:(:)F4_%N'9_S:
M6%@)[+'K?]V^O[M2M VXMHMCZ>^=D*/3+_ /1ZB 4/NJH@_"2S77C[EL)^<>
M^ZI0:+W>,GLBKW[G5ISFH_3P:Q?_6+%2*&&&S9Z!4=O3VR9]&J)TI98(>O5U
MWJ; YC<'RW.U6Z'O8.S?E?Z[T,Q>7QHVQ6QZLS,N9<QY!!J]8F+RXB?X)55A
MGQA]5M'9;$D+\:-ZD"&P&:XN&]JCX,R":BRB?)94TYD,E6T;-P&WGOZAW#48
MS"3\&E%^Q_OO[I3W'T! &A+I3YV@&TGR(E$ I"=:AV3:QR?^(7;RAE[IWJUK
M]K<"_O4Q^\GV/)9'"Q%;F2[0+LH& )<VVL,NXZ^EERCM;Y4]J-$>\-A928U7
M%3&A^*-%S7Q8(N!,W/,^,<JP8[*64Y!7Y[(T(Z7S<A+6:A-;*9K8/:SV'@H>
M1QS1=]$//2N2[$5*>#[%/6;<'E\IZCM8>0?^XE:(:SXI[Y>PI%D1OGAY&7/C
ML99 VYWT.$W+#@9]CN#9#?X&X^#CU$2A:.&@$*GRJV2<,;5;+9E/SRTP:"G_
M>X4WYTEI;-B3::NGB;>W7(5[(#S/3^FQFR2M;HA8UI2$K$X$-HK9<]W8/-\B
M-FYLP#BPKO[O@>L,YL$6S&Q=M!>U]5A<*)P96Q1RMJ9JN^*ZRY5WT^4E*00[
M1\.W*\!@3W?7;TV'A^MYHKA^X2.Y9X_PE>J''!6:&/B^SA^]4:K@N8WW+XM/
M;D$?C[_BZ*22Q/L$WWB"WI@M].(-YF@B^29_48^YGA/FJ'[[!KWM07>T-B,J
MIA"FC(7-R#Z58R^#LVE+G!(Y%0'K"M?X-+ALI^4C6IB>%/6-T^U16_W5URW<
M@RE_Y=NZ[BG&0_=Z-L5EY3XZ%"2Z!3,YDTFN8'N^,^7\73@A2!ZD]%_CX4[7
MKZ#SFU^2KL/VI\^?X#/K/TX=&,0Z-21!PQ&P#?:K$QOX>@ZSVY\B;**;XH(R
MX/+:FE;&X0(Y K\O:?OO-\&"_8]6N7DB&39GN^7CZ16!3GWB=N& 17%8*))Y
MT.VP(+-G?<9#F^[98UTWV3>/1+$&;97!R;:X^([D3P@ZA#5N>A;94_3.]VF:
MKP,\^ K0WI]\L.I&KP.BT[O5>!8K*L?!AXE*^7*',6K68I)QE5;N:3/R5%'V
M.IYV)IG2/63LWE==K0C$A9_^^2Z:<^9D:#,)7ZVOD(EP2\C6&,V:A8;N+,]A
MOAY#A:.<S1.'Q^1Q5DZ,U7>7K)4977<991D,KA5K'*CTE?(I]C]WV P_?:GC
MDE_%;DN^L-/,4(A[P6U[CUYASOC^-TLAG%&14=1*VX59X7;JST%\OD8>CH.)
M)2:HR7!%>2R;?G. VUF,1 3B6%#[OH[*QY=[PY]+_ /@GE_.8E[F 7XPN4S3
M'$2Z6YQE*&]8NP4)80XC I#G":6K*J7G.L5JUCB.;*=A%X=_%)L\T[^0=S/N
M=#%$6U%SSGB_+&%??^WL)]I:NMTH\0L9:$9QQH6)FLYN$FC^$3/Z9E,AB#N'
M/+$'RL7?O:C-,LOUA?Q:&7,59%\=HN:N!ZS+".>/F#U#O_51V_7]\>5=U(=.
MT>Y+]=$%7J4^11L741A0#RL[WWN;O@5C=-YN3METLN0J3V;:GDT07B)=<X9*
MT CQEIG'1U=HP_%+7%1%HST14 ?Z#.VFUR2YL34I1XZNG?J'7-1V0=[.EXG.
MTN(PB4 9\1>9-MUB0V>LDG5)!TW+.*%U'E1^C=VJ>Y%\IZ7)OZ/ZP\(^\SRP
MF6-@35<G8H')K6$V=:D-0FWM )EU?,>OKZ@&$^Z/N/1"$2*-JZPFGQ6)2 5B
M6S/M7A0E.N68*MS\\8.:C9P0BA'?^CQOK5\Z)?Y%0=P^[5EZ^)+X;X-Z9O[J
MB^51X<D,E[M1HWSOEI#DJE7F1IAL_=39,75TZL<=<[O8$'?R=++7,#ATF:^0
M=C$^+.Y;Q?1H0JYSKKT!RZ=._QZQ)LN1>3I7"SU/^@;0K-.YX55 X#4YMOJ>
MH4 +_LE1]<=^LIEMZTGD-RMQEYS-"]!,#2CK0<=JB L14%5M(3U._R-&Z2>$
M<8E 9E8ZXVGF)K72UELBN_W'%TV_-O92!-I;7S?U<C>OD'6/V\%$NV.9/*RW
M-"?[Y2LT)-+\7)_8E?P]O\L##MRI\@P]]V^\+GYW=V/J]8JY@H62K\?#*>HY
M?JQ3!C?AT/NPJ>8"G2/+IWB]+S[1M46GGAT0V!U<C;Z%[QME6@?SF[6$UZ ]
M>6 +YE]D0)^I(<5B:,C:"*3NJS]M>G;=!&=.T\*[\HJ=*U#5#5#4E^1D:<[8
M<-8_%#>5:1D >1D &E5W!GV%X%^(-,?9(SD@-E<,A=MW.KY0@+^&U;/)M<TM
M\DR:Z@QW='"PN*I*!/C5N [[BW5%[#O!\<K=B$8B( $C]"AJ#'9FJ'S41,G&
MA@IQ@4Y2RTJ!'4 &,-#-FE/AL4S_-/;4VO\2>AY4)DRI(;<L_!"J"L5S59(?
MGQ(C O#G--$%=J"D]?Z=K3 DL&>=P&:W,VK[\L6#F,(1[M=ZB4OF01<.4Y&Y
MV (B@ =E1 04JA$!:06^!6;#T.!/>^5*W5/G$+*"1,#,O,Z4;5DB7?)'.:_'
M^L]M^L.WH#.,W9!EBFP2[;@%#7:!D)W()BD0 1;:1,!-\S#34M:EI]U8K2@"
M'7K];>FNL%1H6JG\,:@3S(/GZOO2^W2@^KJ=L,@C[6T3A0,>K2&R8HYQ@Z+>
M2^=KF<]EB;XWZV,-M_MY6#+MK]3P)E1SU\L%<@&G70VJQ4'PW%,(V<UDEHTW
M%*E7ER.2^_WO7S@P[JVJ+II7$'_RZ$3&\^')0D7IM;N]UVULM\2JI!:=:GC>
M@6[BE8ON8 O0!_)@FLH!1 V8DK6=DRW9[3R/Z70 .?M.TI[Q4K5O&A*X]CA$
M:81M9[?@*M^7_ >QSPXY:JY/=Y'00@L^:;9VB?*M":/IO>8%C^=SX P QMS6
M?.M(EI,%C#@>]6R>S\;;(TOLJ#(2DJJC534IL-[BE!RAV3GL@%(-B.J0WODT
M70#@!UFI,./B1,E7T.VY^DKQ@?H.UR\CZD*A(MLF<%&@BX(MR674,?8S^V'
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MZGY^W#QF\/=, U5=++?--9Q2$30R'QNO5J(3N@5_#PXE#R\U%S\"9W]T*)P
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MGV,84/I<8<51.45S=IO]$'P1$IPJ&UCKC5C)R2@-'CY]+Y#O-CLK^]I8 5@
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M^@\TL?J3U$1 FG\7X1 RI_27EOF2'D_N+TWYO1%B6DHR5<'O_M:.6ETB,]9
M=$$U.VDD.H8=;T.;"E? E.C-MSG"B_%?3$;'<SA56#Z]\B;9LY=DS^-_)I&%
MEFLSI-M=%UFHJ.S>>))D<YW[VZ<2^ECO/QM?P?2W?0,FF8P;JM+[W,U,]ODN
MW'##X7T";=.-4_Q\A3T*RG5PB^$Q.WU1HZFZDK&?5=:1N!N[)(,M_=[VWUL=
M+EBQ,*[_%X/8ZLQT!7''F(E1WFB3([>=)KC]89*8@=U_%LJY"@B@X=PK--8,
M!?^O"4X+F^3+=''FC,U"RR?52VDLFQW-=;(7+4A1 U-C.6;P]:/$FJM(\>D=
M1"14/ XOX@@^^.<%.)4IKX9?\ /$KL7YHE?73(A1F 0Z?;XDH3K<$#UISIH,
M]$,[P:A0P._+Q?-B#YUXJ:.3N^4VQYHWBJ"^Y,9CS:VB24B. >'B6_.;:LQ7
MOQ**RXJRW7KVS(R[RBM/'@U!3Y6A9_4>;>+'F[@MG][1::@Q_U!A*2>_^?SO
MY7^R5_6*65P5R UE8+#FTEARN[IUDFS,W?\,C3;Z*^//5M8NNG6^T#AODGOP
M-+N]&8M:;MTPUP8V\/ 7( 5HCO":SV>CT+=F%NN,5$ODQ,(@PF#!O%17)*0'
MN>SB.''P2;CI^A_2AZTN;=G5UYNKLD/EQ()CQ_^Q+ &G'>[B9^?%,LNJTI:;
MA!G\]%C?8"[<>'[EFFR)2=DG+CE.59\X2V-]D.ZG.9.\YQV_*,?X@;_U7&]N
MO5H_RW8=3GW#3/9X-Q7^4WOE+"ZI< II:<AH]3"ZBCX[N^VKU27OQ"N!K@[P
M5>X;2NO9*ZJC]YE7;9N<7UH0HCG)H;CQ0B H&W+9XTV:/X$YQFU;Y\.UTH>?
M!2]Z^>'FS,+]IR3N]DU=ZRHR.[\0V)[TX O\)_/#R5/ROL-FG>,J4VWFGYN,
MEG[";79WG<";,S5 06WES2V=:W9,VULBC+LB/*=PN:O<5%CZ$3U[_X?PH5]3
M_UR??DMWS7=ALY<JJ9;)KZ]U:2Z[=NC.>@*%G#\H=1+A %E]GTV73+YLOJQ[
MZ=8]F[>][,RF>4 'B+:N_F%]^-;=Y[>VQBI=>U:3<.+E9\%W[E&@..182(S=
M=R^9U-H[;_RM-CE;=NV^1_=BP)7,E\#@'> XVFRZE]GK(^N>@M=FAG'NTOFN
M4U(TCQF[BKQ/,-R/S]6:GT_O(*/JP9IY"0>/^99>I<,NEZ]AU)0&!([?8/Y_
M$P!02P,$%     @ @8*F5";S+?(^J $ I8$" !,   !P8F@M,C R,C S,S%?
M9S(N:G!G[+IW5)-=OS9XTZ3W7B."H-)$F@HD"-)$!$2I0I1>A B"! T)TGM5
M4$! $4%ITD%ZC8"(%.F0@H(@2*(0(PG)Y'G.=^:;F7/6FO>;->N==>:\.]GY
M([GN?>_?_K7K@IL^3\<" I?,+,T )B8F((_Q NA+@ G PLS\UYLQ6!EO-@XV
M-E96-BYV]B,</%P\/-Q<W-R\?$("O'R"?-S< F("@L(BHJ*B//SB$F(B$D(B
MHB)_+<+$PKB&E8V3C8U3A)>;5^1_>=![ 4$.%B^V91:F8P"S(!.+(!-]$  !
M !,;T]\#^!^#B9FQQR/L')Q<W Q LP# S,3"PLS*\M>N&;]&,7X'6 79A.0U
M+QP1MKO%?BQ$Y,S#[.<<"L;U?:)7)PF*6AZA,9Q<8N(2DE+'E91/G#REK:.K
M=_;<>9.+IF;F%I:7[*]==W!T<G;Q]/+V\?7S#[@;%GXO AYY/S8N/B$Q*3DE
M)_?1X[S\)T\+7I2]+']54?GZ34-C4W-+:UO[N_Z!P:%A]/N1T:GIF<^S<_,+
MBSC\VI>OZQO?-K>(/W_M[9-^D_\<_&47$\#"]._C/[5+D&$7,RLK"RO[7W8Q
M,4?\!1!D99/7/")TP8[]5HCPL3,/.42,LY_7]W$J:%TEB'J$3G*)*6KCCA/_
M,NUOR_XQPV+^'UGVOQOV/^U:!'A8F!C.8Q$$(,#!',G_L  I ,\EA9"O5VW1
M :Y.X3=;BXGQVE4=8]\Q? OCAA\F?(4M57.TO9\M)'L,YE@JSKVD P/*" $Z
M\$*/0 ?H .<#$$W'?/L9'5!J),!H@^/2=,#B5MWU4OY3="#A"EF>#ER$X>@
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MPC1B:[SO43KG1C&DS8.X4?YKE298B(#TN)7-!;6/3R.#2;\UARV8C=+ 7B-
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MXO@9U:H7) K6).?;MM<7# R[=-702F2K,Z:&9!Q">OMMWP-![RT6G3QE8H>
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MX"S/97"N@>JJ 0>1R)^FD7!>SY]OLZ5#T1*B_=',SC\1D-OM"F<[N/?+OCW
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M :*-O171EZ3$I^)&=<I.)1$8IJ:E2@ \29S74/G!H+PN*=.YND+,$1?5OI2
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MD 3 H78@&UHWXI(:^_%P<>>2X5?M8(\R:\-$S8PK+\4CL8V7[OWH*@1*&?^
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M+/K&VU#:?5O@[.D+]74IHQ<M8VD)T_*VAJ\_W/XZ["BJ?]*&_6E9E1 5+T4
MT&[) IEYIUP5@.Y?:R0#DRV0@P^:#)3%/X>0U"0BY%8KP$,!LEW:0/1O<"Q'
M$H<)COCIV)UZF]2ESO7]??2^?KQLIL23V\K]<W5//)3>)(*7:(*&'DW%G3]W
MLA!-/=5*1TU.]@PWNN0=?%C@AWLZ,>7M]]</'L:#A.W=7<9E;VT2?TM?R3J-
MOA2""&(.PG.JF\84M+^]QF4:-#5%JJ52*UI'FWWZ\8YIT209TM%@N*(PS48
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MK*,9!V7 HGA$^E?0)<MH36:24I]F916, S(88)-0N95\;_#=;((T<U[N,P*
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M7  *XHT=[')_+9;@\7MVI(XRN?JIN4I)PX8U%?R)&9LB =";% :EL\/UH0B
MV"6*8W&:/K23(K\E[;:I;FSXEFV@S6',AQ@K0Z\4WNM)'T)9CS:\H-73'=S1
M%M=PS5C9/DLZ!96<G>G%^_5CDVHQ;GPM/B/.U:5/>=[IIGU[2M$SFTEEYG8M
M6&'II!/K&Z) >_X2?WVRC?<UJ*[M9F)7-[D[?SD@8RE U96'A*).9]<ZL;8/
M+XPK1%F&^T_OT6/K.[(Y&\;;* +#M ,?W2N'5CL?9^FI]/'6I305/;5+O8<T
MS]%B6)(1WEKB@MR94M [5X,(8R_RA^+]@1'.QP$!,_PI/=T)WC=!;#%/F&[?
ME*^76(FW:Z)-) #(G=L>X>]B@2'B%4LZ<2:UA[FM";*U-0,=Z ]B:GNI=V4D
M).O9;CD0K[O=N)Q#3EC(8[BRX& $2C:^#&)4K)HWE ]FU$O3UE+/</XCUK/N
MW1A-1S_[\B[E-2). QA7T)S1*3<]Q"4';-E+ % H,-FBM.K'?D+IQ%=9,LI7
MK=@@-8D.^&B#F'B-SB<FQGOM/?Y+7>6D*UD5Q3E(7+D2!W++AY=RSTQ-J_'
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MB6U4!;Q*U4*!2]).]D#XES6[O%P-VN'<Y]O1JVVR\7 WUSI8E]!PK\K6AQD
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M[,4T]1WNB !SIMQXF_W1ZG";_:E\46'5\2/A-VX%,Z9;)P3 [X$IIA@@'\
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ML0VWN'&2#..;GN>4U'+.V<\$KBB.3LUJ_8A6'OFK1(>H@SFN/463K=NIJRF
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MMK;78=,^[5> ^Q FA#9-&P)X3SQ,1KCP6T/R!R%'HV-E[MKV[U3]UJ$0W)^
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MX.-NCD07">0P]QY3B%NM5O0 6%W#8W7BEGU8(4-:'W0\]3+TJ01GLOEA[Z^
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M0$ONRA!!=4Z)R0AV(%)^0*9A9H>1:DQ<6FU;WZYFY_%,*;]ILMQW"9EW<SY
MM-O(XNA3X,FPPJ-K@)2I40+%D18/U'8DI?1YWWGN\ 5T4)G"5HN%8G5&9$AH
M>3&(/YG#LO97B4QWN)C^W,#=1.M[OLA823V718(:.ULO'Z^R5#=+/M%NIT?2
M*#J[=]0/';T9;8<HJJW' R32S.*].2,V0DK5%5U2[=SLKQS.MZ$UO;OCUM.7
MDBW\QAF6/_Q7.W[4D/R^!L@=/-LQ\CH$H03?G'\&F=+W_BI>14F>' M0+%T#
MBJ?-8E/RBH[\UWUO<ST;VFRU=9OQ'=,QCD(([P<"";%@M'G'"ZA+I]H0Q>?^
M\2I#18M8!3JZ].@R #U >$L73,T/IL5\8J[X92@9Z?;^](Q'AET&Y#!7?A1[
M]UR^7?WN1E9[N6IVRQM98HI-7R.%=G^WZ0Q7/G'I'G%?'12[D/M:Z>S.MD\?
M>J.]51+#M[RX"R3>K#38DK9*MIOO_BG[P7ZF^_>GWC<KS!GY+44=W*30SN66
MD[(L$ 9BU%J3L2#69-F5.-C?'W>;-0@_J,?;O:PG[ 8Z^:N[:\&>STPYR&"8
MJH#IFH/LWE[QR*(C%Q%]%%RLSE]L#L.G>173*@%U'CY[6X.!NSS^1#,24[Q8
M4O8E[B.!X?T5">B(5SEZ>!]I\JG9,G=;-*G[ :2+5J*ZO>SX<CW6H5H.JW#9
M1X=_:I]3ZGNFM<?!65:U,?M*T.L\A.X<D1G2Q^[2 Q7=H]S<V\=DVF*E>Y#6
MPT&2@2*%SZIA^+N3\ 1L2DTT&)W9R\G4K3]9]BU1)[&."K^(+]!B/F+E\4:=
MH18WG>J!D20?5$%<P"&_#XW*N0:$#B;=QN^?377G];B:3W7'.[+RH-@\;:1,
MM70Z#?<5G2(\O]I58Z^3\,03\&J)D+BO6KG:K=5<[MWMO#6-@W64N-.1&$UV
MFHZ'AT?"]D'5"-Z9(0>JT>*T:T"(N.]WJ/&AF+*&>M08\O41)6])K[U\7YOP
MIA=B>+%:#J6P$HVW,_,!2,S_ -0U\WJJU>*LCE19C&/V&_4I<XCF;2)GE_3?
M*!,I3.;R2##6U#5)-"\ZW3GTAV*L*$,#*P&^5>&.X=S?;PT$/KO\?,H(W]X8
M.;K3/.CJ$A;UMM/Y^;&'K8ED<$4,\O#- UVS%]7IVG'-%BT#K8W\QT>26C57
M=9+"5^G/DI;%763O;"1RLI]K1JTR].(=E9?XX6%EIUK9?42J#N[ EPNQH )E
MIJS*3,>%(FC,*T"[0:V<?>X[A,&R__UIC)Q,\)L?1P^:94)L#%S(5!18L;=U
M$?SC)9MGM4^12AI.CUX_"]]_)LL+JB,,[AZ-EK"-LE\D3H07CF98Z4E:DIA^
M'L@*]EFDC4]=0^S6.8 3 QC9$7$=K=23)X6<L.9HE>I$5"DJR;4RY%>%)L/O
M%;PY!!M:"+D+I,,QSF#R%Q4:1W-2;)Y<"HS>=PZF2_A(%W^Q4L!4X[2(_GYR
MR=<XTBUF4.;$['.ZV5/73(H^ZS%F.*"H&<Y".M3:Q 0=<>)&.5(/2>ATW[E\
M25NOWUJI."RGT+B_0I4SQ;WASQ0$-2RBIOT:J,5>IZRTH,^\SVB@=R0&\>5<
M]\"Q'U"4!XCS%4/J!D#3-HFQ"\,_GIW?=\IR)Q)+PPL[E\,Q6BZI7E TRYQ+
M70-Z0;N4:OU2- 2?'T =NC(#ZIPAH:Q!/G3+=3^L#S<NV;L:XEA9FB?Z4&.-
M58KU10^U',]\QZ+YL,-E-!FOUT3U>AB&6LRY;7;'C#1&MP>Y@^!U29W[H0LO
MQGSXK/(Q7U0GW-CP>?J\[4CBUDD[$A7T&DYFHPUUQBB.&,.7'!Y!Y;245=]@
M/)<O'\A;6:XEAEK1#V340R=XAGT]R[\WTWD6+V+<QWS=)SE.! F&0D4=Y0EH
MA)G?K8"7=2WU @TU7'=Z%)4,ZH6+_;_5IQ(FC!<23;_QM)D9$@VSO]BIK*P-
M%D#Z1QF3H8.[A@C:]--71Z'!^A%*$-J.(4::9#6^J%OO9?&VAGGY%A$"R"$\
MQ2."T-3.1*_>$-<"^M_#IS_/V+[ZZ<Y]'DC+R(!--0_@J! A6>=YZ-J'OGO,
M)A-AFUWKFI7GA\B\UJ)1!U6)$2X:5Q<BS063.WD4-D>*HOW[NJ6TVK5G$S,8
M^*4J]-Z27Y55+B8#MRZAN$U2P])26J7X6B;YU0OZ^PGO1$;Z(>O<=- @_ZB4
MT\(#NC<-2<J-XV] 2Q,-YXPO\ COES2T'>7V'V$![UOHD.XMR]> <&4(,$3\
M 2S= .1@4VB(/>QJZJ2@>5MO[D&SPCPUE)%N!YLM>2A=2!OQ[M;(5*L5:8HJ
M\&U'0%Q^<XK'^:P6?,XW4-R=( !=;3N6!2Y34A!Z7G^8G[JF(,&";MI&\!M'
MG/H'@LDX_-BASWJ-JZ*4]"P8M>;C-_M8\MKP!D._ )P)=^8>RMVIPTJ5ZV(,
MI";<TE6<[& VIX=&AH-28DPR'+UX<1])\%+0)L28)9\7$ZM?7QYMU?6_2:SX
M01UO3MRP%=-^0:*X:0^W+J6]F() TO_R#O?\VLO,6\DK&O.YY&X[/OT[1+F<
M9$=/YC/V[$B9UJB%1E>KOFN I2J-EIFCID$6JVM96<))Y*)6D<I\\CR6$U-X
MLRP1QH_"N_QHZV-75#R-'VV\-G=UZ]&*/UL%=FDCPL1E;):!#VP;UZX!R:<,
M@E,&?=CX.9RAM5%MU 9@2K43N$N"D=ZEZQ1]+4H9-3OH+GBZ1<1D_^1'<2\'
MX<\= Z^]0KOL340=(FP$XO!(/*RX/@$O)NID7Z-X*%C+,!$!5ZX[%A_4?,[A
MLRR=EB )>5[;4.J;JHC8\@8^-OD;:V'9Z,"_F^E*#._[P*TSGE?ZH@V I78^
M3ZY:OV,J#KCET;F,>,U5T6HNP%DF^*-J.?P]ZRZEP_O.L_7'94@$TJ,SE6 >
ML@3Q=E]<MP]7K7W5=#GG<58VT ZFK@8^A&A?" 0E.YFRM)ME-KU,_1SK4GU!
M7%^>F)7,7I,#+.N>+R7W.(0G7P2)6&BB:WR#Y 2X=&SZFUL0#F$#<G:HB>.B
M0SB-C_3!5/A!<4<K[9@XY0SLR\G=>]NT9R/A.@.?A4@2W ,U@M;JELPIMA,V
M<&*8;M,E(U/7Z1(N^_P7A$I/B.J95_!/-B%;+WZ'Z=HJYMFFA>V8C)=MK'N^
ML60_C+!F'^I1'*J!%+-93U7,NTK\U>I\E<\?'7T!"SU>1I?A%L9?&J@N%BDX
MT/>L>%M4Q/O.-[VH6Y0HSHL[3:S$]_1BZ"0YA;V]>N#E'R"N! QOEK IZG9@
M*3*\TZ5^0FTF>D;O5D9M_D.O!GT,$MO?FQ?S^GWB"*'K=%N)+@T*F"J:)$MS
M,QGPO022^W=\N2H^V2U=[#*'X1TFXN93N$0WSI[[][168NAN0!(%E&JY-34'
M,](EUTU[S#(X\T7^T(*/K'!=F!A#0/?-ZK ,;CRQ.EIM,+M9:M$2N_#LJT'W
M62;>=V2S"XX*UW!#R1EQ5,.29T-,UP 6BB'1;_0916ZV"OU*Y?S5YR#&=3&1
M(6CQO5T*(AX8#>N>-,_42.F^G:KN07E@*=9I^0&D$^&B:@<IFAZPXI@:JGVM
M]["0W=?1^V!'%W@;]\CF&H"/ _[&:+QI:9K@+,U0\+GLN3V='BX( #SO6R*9
MB(70M2V2-\L@HTD-IHTP=J@2BP>M:^HOGW;$Q>J:T[3UMG@E>'U3Q/AX7"I3
M%(VA!*9/).4H.-Q-I-82K&R=;>W9\LOB%+:F$'S-,LM78MTI%+C(XIF\TV3?
M>P9SLWU?F2.#[OY<]97ZB3*6@.&ZX+>KCQK$*>A+=YS\W5C]9>.CQQK+0S+8
M#FJC2^4(@H]EFBL.O]!@$^,3F5?I22-T0-> FVGKB7,=%:_![4^_P Y#!KO7
MJ07T.DH)5=Z.89,N4R72JBY-[@5? TQ[+JE5M1-TZ"YRS\0R"; /,/[H:X"Z
M\JO.A8=CKJ72//U)CK/<:5E!=XF=.YFB2%X9#9E#)5=TFM"HM$94L_M,#MYZ
M+U#JB*&%L)V)W@K+/A("KO:O</"O](&CN)]?90Y=-EU:70/*C==$I/FU%!TK
M:U 0B=HZE_4#K0KJDE>Z167.+0UYK%PM\\?\S\L?7()[(-$)JX?!1K.E!+@O
M0ZZ,M\=QS)W(YT"3YLCJ[W3#<M;?ZOJ=ZJR'7:(16\;*'/-3A=0< C(>D/II
M;B-WL>TU]D@19:1-$VA:$75AT["M^=;8[H"DDU%XRBTW]>54[(@J*>#)(_XW
M=&EQ'UTRQ&Z8U=4;[:>Z7C[H_/5+SA'N>]+"86EQ!=^;6J(5LIO%< ^!82;'
M+ZX!J\>96&6OWB^[;D9"G;7N%Y,SB[;R)*F\SB2#\C1MPW?N.,TT\$"WZPOK
M50*R\O>FCD4KOM'JZK)U-%N5]9^="%J77/E-71S)M'Q1;C 0.W\*NK_+2]I$
M>["/>>G'YO^K]QH0-^9_(* [:/>&(]Y46@.N9?H.K7GPUCD=VC&_YQU)L;9P
M&[W1Q2#4I:90NKWEE/?T1Z)@TA"OHU,4+[&C2Z]J1XML(\^W4+/"H_[4+RVE
MG%>^Q#[&C,+Z:3$%^:7>O0X8Q^SF6200RV&"RI6DNOE%[\_- P^%[/>;AG )
M _X??-Y570/TS#=02[CU.R/P?O\$SYHC-^G<POY .?LB(=71N6/K->(6X8E(
M+]LK^A)$4<7? M0!7#60?>+IH3(#EOS\MO,*N5\^77@1:60\3AG7@$#=@SN%
MS\*SC1<[;5B.:P]H*!>XFU?=-_UCRLT$LK>\K5Q+?;5;3A=P<E\W^[1.V8<6
M9B3$'&J:1WBO\EKI,)U(6(#KT*...E%Q-:XLBJD<AY(!#B<C&9JYF$>T+]@-
MV9CPQ.0$ULZ ]W&"^C]#)1"=UD:X[3Y?K[S6C]U#'E3 :IFK^>9$M4V(E3_/
M(3*][-[=Z?H'/V#"PUX(P1E-*C+Q.LCI;#*Q17W]^?Q(X;-6R5JK&Q0S<F<N
MT\A0_7#2Y%AR6R2*E:ECO,/<YE6"(+)!,[7E?[#WWE%-?MVZ:!01D28HTHE*
M4Y#>:T"E"PA*D181I$IOH09!0+J @-*B(+U$>B?T(B)5 D$@H7<2:H"07'Z_
M[[O[G+VW]XS]W7ON.&>,>_]8(V.\8XTW,VN^\YG/G&_6L\JG#;0K=W+,[JRT
M(\*@UYNY<*&NC/C0C8YO#KXHWTGXEM?S;8MM%MU5FZ[$PM]?$YM 7HG1)W+-
MKABE%L^O^%!%\CP'K^G"K*W<Q*A=#EG^!B*#>&\A_%DSCC:EP$*P;+; SLFC
M4X!Z+$>6\_/U]*/*]?TL"H%I"Y>3D[56$D!IY4W&@L!R"L947V]&2Z&BKK$\
MY==LB?-LO^!]0UQ:V'[".T[F<05%N"G5%B\1Q#__NTH(\U[MZGN52Q>O*-"#
M!?$%1,HBM(6FQ;[PM0U3[K(1%X6FPK35>C4"JK4I_EFZ"*ZQ+V[DPR*P!V;Q
M,983R&1G2DD"6 QZQ//^%*/J%>SZGNZR)6AX6M]40DCXB+ E ::@O6"R0%?!
M[ITNNJT$2BJ[*(FO>P_Z5MA,>KI* _QD#?1<(EJS<J+'Z"(+PB.K\NK*?CY>
MD.U>F8276Z=[LVK6,+)-E^AK@G_L@:\2@K%#L4I"D!C,K[?^(4@OF5@DPR#
MS!>0\TUMIOZ]C?[W$+\>=<DU0R,.H>^S)P&3I>CX0S3_H%OBW23ERP#;'EV*
MQ[^*1]/3]5#R30A!.7:3[Q]-DV,ZGKHEW'^JLV=I=)3]O;_%8/6&<3?LQGT2
MP!$<J:2$]"8!:,&(& 5IQ?&DZ2FS7HZ.W@LO#4!5[[G)U2Z(+F9ZRQ8VTY$
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M%SWZNY@LS-C)>IKZ^)%#0SV?_O/P&_KFE[_\)9\&CI[#FB*.Y5RIH).?G$B
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M[UI Y[YSF"Y+@OJ+!EK-OU/@^&R^7G=M0.')%J?Y+9LD90Y_6J?$$:(2Q,P
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M1%5OU!VL\18'.F,-Q55U:LGF'7ID+[,G%?O0 [:E9MPPP'IV$?\0M]$&XI0
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M,$?]DPF^U3 JL:J4>AJ'+09F:.-]I"V,-E!_MB_O.W*K76.@R+:7"]Y]F@R
M>1:MW*2S@,[H?:AGLJY6<>[-7BI^1= ]\L9HO-'G_> TB':KZ6!^WP8OHB*X
M_OJD%6(AO6[#!2\4U +BU. #,32<]BML9KF]_=/A+E'O0D9C^S/LJF6]$D?/
M-5%;C=A?#_)LU]-^$I73D6+0&3__*2A3A)18D&V3S0&T)4)>I!ZYP+,>D5&<
M/0S#/P6-%Z,]"6%@9E@@;PS1VK;EK%/C='BE>*P"_:?&WN$*4N-#,F!2_.$L
M&>!B0>RD14W9E>UL;6U-:5?ZA.;.5B+";.8_-5W&S:50>V6'@!S ;R?IA&O:
M6S;/F#ZH=R(#*J:C'X^03/)9UWR,FN*@&+5-5DC-C"C!"YNV*:JT_?[9T_HG
MVN8:4EUJBKBDD2P\F'1J%?/V/NJ@][VOT5%<RT8]0KS;(;&\1Y! D["<N4%H
M<.C+H\3S(L'XY4.?NSO (U7KD &V<'J:<Y#*;<M/:N+VW@:-ZTDGHQ@9IH?F
M+ 6/8N]W7Z72207%:;'S#M]NTN@FT/*[M)KJ1]3G3];].I)L\2AZ7RV9QK]T
MA$IL60^)B3KOO4S14S_C?U]HI$X$HS&S^!H';5*<UCZ[].PMQ0[QRBFSSQ(F
M.N?]>A7ZUDNO@:@OQH):^8%$/A&#W7N$+3(@Z+.O$SZ@M[GX]9-E<](FD?O0
MD SHHV6%7(;AC:<P.K#@G_:6%Y28WVAQD/AQ,F9&::#EL.^*D,4(H=TS(:#*
MYQ^0$Q@=,+J.#)"G*8N9?$"H)P,")8GE_E=>HI%A\-'*8E+I*#YDR5:Q+M]Z
MJU=K$<FU@HLYNA7[ZJ&BAO%98.C>C3UM4HF35.F&-GBW_YOZ''R:Y'Y@KR+0
M4OW.(*=J #P1 LY@L.*N@9^#@$FG:3%W[EX[2%X,4;A-!K3$)[QS5?5:NQ1\
M 3IET>/#$ !]!!\[BLKC2LT8I$KUU2F#\P[LBPJA0<^A'<N61!6OV+*P)B16
MJ'O3$:/RJ[^6IEGI!*;WS2PCWJ<Y02O@ L=M^SAQLS#OQ\R&N\Q&L5?O:VUY
M/CW*2A^^^H<6NO\#\L\^"(>:V<#O]L%9T;8%W#(AWQ&"L@=3K1M0Q;SNG/9(
MI64V4 0:E8_L)"K>;P(K=6WPI["?D7!19=</!(2]_6G0]9?VX+_IUZTW_9N6
MWAS*H9Q_NQW'?T"$.OTE_;N@9TA*S0*$*_X,)4BD#:JFL";19W"G!3OS'CCQ
MQ AU5(2BPAVJO/(^9*)''JZU]'M+;@NT_=KDA)O -P)L!98=^4#MN-!HXU4K
MZ(MA3[.7R6_0/.>5(?L6C)"YA.Y^,F Z#5Q^8ZW/[R0,.S534%.1CHB3OO%V
M35)C10_2;-8#NTNIB$+JY15E9XTYFOKBY,(SV7#Z19U.1>DFO%%^[,;GU(8;
MXF2W6_CINL(<10\UR( 3JDI=J,;1?<3T)H'9<=JSC8FZW%^0FWEH_NM%S^ /
M)LGM8:=?/'ZB#:#IW"G^S%,5L7)J(5 E@9U93IWCI*&>Q"G>G,L-]_%'I1X5
M$B^ U>^M[=_Y1*#.[XP655! WZ3UF'CVM8UM[ 30>S_!930>5T",>QJ].CW5
MPHH5#:5ETY3I7U(VMN6KCVVT.WT@R?1=<75%5DO>_ KOF,:^PQ&1O191(MY)
M<,7'$AF&K@D=3?)F*.;A9@CPE/3-';$(T!G;D'G_.^Y.5 E.W11#A-Q;ZOXY
MNEX7BO/]6:"-=Y6H",81? AL)O?%0;ZOAS3!'XSE8GYXA3UXX//8&M15Y6K"
M^CC ? ,NY=,^"0Y:>>C09*&=N90C7%Q8(61<5"AZN:8RUE--2I2+TSN0D]&2
M!2N)^XZYT0Q\'SKCV.%^]OYD9Y3OK<)ES'ZE)7#[U+G0;"Y:I@[S#^!/7X0Z
MTP(+@Q,#+E1+%\%'=G9$]<(,YM9\YEE8"@?9AK_\'-?D:BWO*%61>L#.=:_#
MAO?-*5FJAQ7?=/ZSYN5?Y*GCY)4^@I MKM[1L*1?Y+DV'/HB4H#+_RF/JZ:
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MYN<1%'UFOI1[)-#B0]!,$1G@5!QR@9L5?]<7Y'*).-2$]X T<H&&)Y!Q7AL
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MXO" >Z3YAU8K[9^O^@N3 9U^>&T2<8KTIIQB?? ?W1YT[J!W_>I,^$D<?_V
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MXXX,>-IG!;^-X$^KC#/A;-%@Y;<6J>,LF;MQ)^)# D,3Z!3>ZM9@N9.D2LB
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M:>^\PIJ*MD4=!<0"B: T*0%!1*HB'1**TL4@*BTT!:3$@$@+A Z"=!0)TD%
M.I&2 *$)H8K44*030) >>J1YV/?MWGT?[G?N=\[>W[T^C)?Y\*^UYIQCC3'F
MF.,;BA>P2A]OV)J8*N$Y5'^7LW'UT7]Y9/%HSIG3#!5+A(+Q_1("Y75#LX@:
MVZJXL%"AN+I@_CA/QL; J_@3T4'1D_,.(\\7X-$O?M.EU0W(2TIA^?0]W3LX
MY/]'S4G='P#9=^TX- M+=7[:D'ZR_3#--F)V06V=0@B2A[S27+& @2)NO&\W
ML-ET:OP#N* S+>6A\/*QMH"D..4J"V_LADMME0[@X'E$00Z.Y."!]"E,_'SU
M;N$.,Y(SX,C53*(5T<4H7_)S2.EIH?WMNH=B:SM?O@UTU+W_7O@::LLNQW,2
MP!.I[G7J)8U*;S#Y2%<@TBP[&S^D6O)JYVP%OP().+=SR/-7=X-I=SF[=9N-
M)"TMS"P?5&UKW*B)JT5ROI)$H_7I,Q_I3[:+#E=HTD[;);U+$!SCM&8B6NTV
MK5GH75MNX*;B<AQD>/@&<?F+;SX/6C5\U'DGH10 N/ C $((5N%I_#_205.H
MZ# NS9K,7?46N>M5.4KW7E?*PY$I-ZZ\0/$@?Z5Y#FL*V/46P9P0_5E1RAHQ
MYO#'I/DMOJ12J<,,82.H<<>+I@[YWN$:B3?#^Y[0NR.+P? A'.0B\1C(GS^9
M%%+QRCQ,M4UN+AMH3S.4_^E_/N+_5\K_TY88>*4E@W&D+5TR9A]N[%2IB(8)
M3PW=>">PK7NV9]RE36YFC^6Q)M7.E\SH;YQ(])0Y\$CP?<$LEV.70*ZVB,95
MU'CO.L\NM7I+G[I#MZG@EN3%"*E)ZQ8VTP<2GT6.,P[%;\EJ?;_-\.806,US
M@@-FS5BRH KW=2-;9,?N&3OLB[RJ8KU-F-0Q*NO]5K.!KY>, &S78NFH&6J;
MXMA\JL7^ ]:# F88, ?[<1X0W?G%=3#=%ST$CPVI<O%1#E/#U8>B%QK@*Y'A
M6V_7:L6BSGI;@98LTM0!7CTX2JD>;-8V[RWSK-S.]W;(4,&+28'^(";\G,/:
MX,'!H'<8T?SA5GO[;;'60GR-I.Y+79G+MWK /^<HW=Y/KYYI_J5@%[/F=AIG
M']:FG1L[7Z*4@HZ\G_332/\L*VCK7;NT(:D)>GVXSCP782%0/?#X4,+KC5O^
M/.@6/UA1^=DOR#&B_W1R)=K9+,1)SFL"?:QM>P-+[T?72M?F_6^%RW\H?WV%
MO0?%OI^O='>FWKH)>J6N:B"/M'AJO_5(Q[G<8H\^!GPK3 T S!VXE:Z?3@J8
M]@BR"8S/6B:<JY#!'*CON%ZYD?0NST3@ZPDOFSW'?H\P1);<&"YH#M(==N=6
M0-)KIMF%K7;,>GVSL_(YRF38._8>*7BDPF/N2YENP;NB@KKN#U;^VD&^-L+X
MX_A_4YS)S<B9>9X_@#S3)=PT':Z=F%0GG:<5,6T+M\])C:NSQGR%N"R9FU\]
MTP*G7C\ LZ"L'TN.?Y2JEQO]GI7B*O_ UL^,:9=_Z8E;8ZAGLG*+_2X:G:_\
M96X[)V(0L\WOI=F3:<WIZ3H2M8-5_Q2@U-LR?7'#'<M=FDO77>=]XSMF>WI<
M'KE59])V;L(J"IA=4#1UFQ+[UED)\1D5IIKX@'D,+G4.HM59N7XSE7<'^JEV
M68@FJJ9J<]O$5)>E)T BP+T:CUJ06;_ :0+?"*)W2AVT8*(P]H;Y*):,][K0
M$F**M[IY W54.17B6#3-LY47629.0V+Z(Y%CE:/K?P A3WI?2H/XN[8]91,R
M[GJ:U[1!"LU!FINIWM9+WD7VEE9P5GQT\?<II[64)V7/HKQGC-Q/]QA/"F6C
MK8AL["/F6F _G"Q#XJH8$RTWDV05[=H&U,W'#$TNGUPH&U)B/;G6I6ZWYQXD
MN]Q9Q0F?"#JS7QH: =CZ77=E+NVQ&@PXO7R@8W]HR"$^$W//4\"ZC/YG)PUX
M#MY(">I$S"F#'&60#*86B<_WTA_?V9:G%3]WVW<+47$ZBRNZ5#NO[".-6*,J
M0O A4%E!JT3;65+V@\_RN3M5GA!4K\[8D-)-]WP?M0'I5A2TU0$ARMPVO_%\
M9HZ&G3]]@4 0HNDZ E,BYHBR#7P)ZY^21=X*X$C64]WS]W^F,+YK%W#K=9U*
M C7#QX\EFKVA6+'B RBF'#=_NXO7(0<Y+A-'3P-Y#1*L?WBZ0;LER&9^5S8;
M,@JI+L_*24IAH0?#VCDO?+:*:R;C4]WYUP^'V*',YMHS8I;JM<DC:]O3VKYV
M2B];GUM'Y[S/#&ZB!U#0(_FG824N.C9BQ*!OON;4;A,9"_0TV <K]&3.,X3D
MR_6 'DT'/]Q4QT::4K0SS98D'#=7WX\\":>4Q&^+W+S)&QC<SK-+.F6 0HX8
MBU&@IBH9[Z?=T<,5+BY[H8A*=[R!1ZC^E52 W/ZJB&*3'WC3B%A/_S2&XK"/
M"12L"9<:PL Q:65O /ETJ)U>LD6&.L!U3$#A#^"(S^7&[G?8K"#^^8MW9S]]
M4Q5F%VH[IR+'711-40XZ0I 5%]\;4G;[:ZN9+2TZ1D#NPHMQ0,",'0T[]O'I
M,A$.3S7SY<(F'2:\P*'_U]@\]M1K=-3<GIDFAHPW=4#^ ![BLN; M"N>Z<!*
M2D^@8'+RJRJXUWRCY 6H0:T.DM8U.#5BYYH032S)K9%EG,HZIY>L=TLZ)')U
M[_UX9= -E8BLC^7QU3[M@3$)_E_]KL+HJ*9=NG0\]B-N6X*OMGB,MW^#K$2R
M_@T*C/\;BXW_723GQ?G<CV25SILX,3M4V(,4T[Z-8E["X=6J.U)J,X);2>PW
M.;@KI@*4KH^T# >W8ORD%=)JS<R6>Y$W/J;YM%8(,[%_?GTGR-OS'&$CTA32
M,B5 VN6&Z=2-'(DPUIB4B/ZTZM>./VPN5%6R;I"3YV\XGFZ:/#MW&A3^Z+1S
M8)P>'>8K*/GD-=ZFC((9:'-%[;<YPK&TU+#."ETPAYF)E$?_N%Z*5,*-L3OU
M3V,[VFMH^^@Y9]%T(T=@<F3:.<[IRRC#H8G)I96[HEOB*'KPG1^O;\LO[19O
M7+&P-[*\A&0C+BPHRNV^#38U+Y.$R\K'OG^EN N!24_#CZ3K^G;0ER2 U)@5
M3835K":*F6PGJBK:,6$7 WJF#6Y6I*?@LW/-IR;,S1W9P(@,_:]&=^WX@F(
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MES76,T;8L%+^<Z-5_*U9O?VJ6ZFKML^C*$BR4,8P(BDQ"6HX9!G-8"9H(K)
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M4.=IP/NE.CNNZKVW]TG:PN:O']DBOZF>@&:;P+M5\46NUXMJ&\$\YC@+5!9
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M,9@%*($!T3\(4ATS!4YG[8]W,S6!:%'6YQX,3E>WXRB9MK[&I10-[F \96>
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MC$;NWGT5W.P.,9M#WOYSDZ\?KY>FEJ!VULT4@>8[;I8:PY#'A/(08LY2B&6
M((ME J5,<( 0Y5%J5?K(NL>I?98,,K#;25-C!UOPW7-R/4D_OSCNG<JA)S6[
M"9R!BF;WI7([/NW7R[WS.M*BN2=^G5;/G;CJ6$*W:V>T=70GL_87T]UN[+E4
M5JRTC[M^-(V::5O3U[UYOCY(_47YJAO=K@4'/%013T/(@DQ ',?*5#4.8!8+
M15,6A-3NF+M[UU.3</,%7BU- 2<34[1VS*HW8UW-*&YM<5SZLA\-RU6M03@>
M6-L[":TV3LZ,[V[0#[* [TZ:WR4J^^['77URIN79PI)["WW3>3WH5E?%XYN\
MY(M5N2GD[FA31%B8"2J@"KG6,4D"2$/MBPJD"!8L#FE$W5)ZG>YL:LK58G5>
ME.]DU$Z+?/$TL/IL88(=SH&.BMDPXCFI5T>'(R?V.F_Z\^1>%O?T/N[Q9%7;
MK#%Q'22_VZQU/^TOZKBZ_(>DQ3O]Q,U3IC+$M2>4X(1"K#T@R"0VA7PE)3S0
M_X<RQ[,@?7!,36;TXY<XGP?I-0!VTC,"K0.KTK&=.S/06@%J,W:_K0V9 6,)
M,*9X/6IR"9>^SZ'TPC+V(95+"#MR@N6BYBY8^V+GIQ_9B>G'O=0@3Z8?/TN3
MH+$ZO;>L?+\-79CT1-%<2,(3SBDD:99H<<4Q9)ED,%:AH*D, D[Y7#?"5DXK
M8>-:X:(A^[8,)R5[1IQ?%RM:NP#?&0;,K$2/!;&1GQ^'Q;'I/A._HX6R@P?K
MV4+9E@VP1T>5U\WSHMG+C*7_!;21[1A_,>UE!NKHPMH+0>D;K!3Y ZWK/9;K
MHEH.^)R7OUU]S\LYUX%(1D0&8T12B)$B)B))8*82F:0L$H189=NSZ6QJ8<<.
M*]B!!;\:J(XYRSLIMHTY_! W>&#1@[,>0<-Y,CQ'!AT=CNS^GS?]N8]O<4^/
M>HI]]Q!\6"UKM6N7HEI0'>IWN%$)QRE#5(0P2A,$<:('C3(1PYB@$/%4:L5"
M]K5L7M88E[=WO%(Y!][709V<D\[]C>9J#85)C*=H7H 'NMCTW_OVPD\8(1GG
M+*,PEC+2'[XLU!^^.(&"B4C$68)9P&QK^/S>GJ_A2P0Y!8W_OWJNSN^=^7T\
M*=,/)#4=L.9CM^EDR\BY\-)R'^:4GBR'VJ^_BR=LK)*ROX\GS:UL[8L/<%<U
MW)<#-UZ1W1<?@(/:O2^/IM_41'/^]YT4YN#>5_J].:K7+$K,@SA5A/(8A@E2
M$#/$81;'^I_:4\M"'HD4.V5I.=/?U"8H&IQN<Q'G.+6;CO#(U,">1)N;I8%:
M)<UKP((?&KBG74?GJ0E+8KS.3ISK<]0)"DL"GLY1V-[63T@^ZBB!FIR>54K@
M;0J+.2(*L11+F*I81WFIF=X,S?1FBE$<93)&6+JM"9[H:7KK=G5:E7O=I'D[
MZIA*1V$+ QLTIQT==W6=8ME.4CPP-["4;!'6*;]G8 O2GWZ<8<&K;ISJ:U2]
M.&/P4YTX=[E[@9 W39SQ5;M#96Z\G<_R?E6LYTPQA5..(4H(ASA),&0,4V@2
MP"5I%).(6!V<[>ID:BY%BQ/L@((:J7U%D).$=NN +YJ&7N%P9\BI!,@Y"GJ7
M_SC9\&BE/\Z9ME_VX^RU/2.*79&AOYE/WCSDJ:0A)C!")C='D JH?0+]AV"2
MRXRS5%E5 #K5P=1>\*;L56D ;BNT_\_@CT&H/_K-W.J?V[K#IBYY>TT4![,@
M".JYUO+/X+HL-WN_CO$,H_:W@*Y->GM^"U!HSG9%477J(D:S+,M.76-9Y/'D
M2%H&+A>,S]"1RD%%L@K=K*'98WQRPGZ_ <G33L:-0$Z8^"SD.'5=/VG9+SKR
M9$[$[#!?;9;KSW0M/\G"G+R;$Q6EA,G0I'W4PB/#&-+89 ;B*,BR-!3,+<.L
M6_=3DZ7MM&B[Z",:S$![>_HU4)5UQO5>]*A-Y#@T=DHR'.$#Z\Q!W:(C,](M
M>O"YHKXQP)\$]2/.JT Y0AA5OOK1\U3<>K;2,_?9W?UB]2CE%UD\Y%P>GV_^
ML%H^R-+ ,%/+937_L/][4V[EPVK]#[G^+/GJ9FF\CT_5FO"[5='\R%P7SB.F
M*,HX@8J%F2D!:P*S3,),(A*0A,2,.TGGN/"G)KW["UM\?P%,UC-P,[!<K<&C
MU%*\-6S6K-8#M2K:'YM['#.ZC?O8V,GZ=!^&$9?<MPN<NS6B:IFS-KI=]S16
MZI_6#\?GO8?CT^[A^&SQ<+@GKWN1,?*;$&]<$\9-LO<BP_,L<=_+H.B3Z8@N
M2_W&F61*9D/W*]3DA4$BE9*P% 9$41TBQ/KU9!+I.(%G*:%1%&2I?7*CXYU,
M[6MDRLE7QSC *XB 0>V2;><$D=W*[XN>@?6Y@@@:C+,=1WVR$IW@R241T>5\
MC99[J"=OCMF&N@GI3#!TXM81<PIU@S],(W3FVKY;/<KUZDX6KU=58J*B>BC,
M)O7FT0Q($,@T4U!(DV8#"0I9R@*88I(1B:3*I%,.Y3/]34T66[B [^,%A0;L
MNOVCFV?+651_[ T]J=H2=P 5&*P>%<"1%\^[/[K[''GWAQ4!SW=_V-UV29WW
MPY7CO>+D08H82](0IE0PB'F<P@RA!"(6)7&&*",Q=Z_T?JJ[J2E+_UKO)PFU
MTQ!_- WM>#7UWI]L_QBVXOLY7@:H^7ZRRQ>H^G[._.-UW\_>=?G*SF<SE?I1
M_5+*JM3KU=VJ6.?_JAUFP9-$"9' ),Q"':\I!2F.,<QHEI (,Y:YI>^Q['=J
MBK*/S6PI*PQTN%)P4\I>U9UM^7=?M_'$ZK@+-I];/C7LNO[S#.PC'V:EQH*J
MP99HNOI^L;49"T*Z%F5L;G>?2WJC(S(]J(O53<[IHFRS9,>1$D&6043C &(1
M1Y#*2$"&L@B+C)$HMIY(.MK#U"3H"4C[J9'C_)V?/[J8E8$EY F^'I-&QYFQ
MGS&ZF*&1IHN<F7*:)NIDH6..Z/A]HTT0=<+>GQWJOM!7-L5WFZ60YAC\>E-^
M5.8GIJBJX@%)8!#3%.*85AD!,BA)&$2(<AHDD4M159M.G51OA$JI-4)05A#-
M_KKF9/6CI*<S]O6GW,[=\DWDX$)Y+#-BP^P/ORQ5];<?00V_2MCMM>JI"UT#
M)S\\TO$+9SH\3<7YM(8=]_:3I5>;4G=1EJ]7=RROB]0?RV8<4!)D-(HAH2;M
M(%<4DC"E,(TRQF022!PX35S;=3LUA^R*_W.3ESWVB%BR;*=%_KD;6(U:P& /
M\?")I-UH\JI"EEV/JD-N=#Q5(L>[W4.^*AU<SC:FY9]I<9,OYV'&!<D8@EFL
M(HAQA"%)PACBB,HP34*I9<C&&3K>_-3<GGV$X*Z":!_6'&'O?+1W&2=#KWCM
MT_'SY738AWB7T3)2?.="CU-H=]KZCKCNR$VC!76G >]'=!U7N9^UO.:JN-J(
M7+-XM5[+LA[L=PMZ,V<1"4(6)9"C!$.<$J8])BU<3% 4$)X$F%E-GG=W,S6_
MZ/KUN\^@@0KVL (#UO[(90>OW6KFCZV!5:T?44XG+\_ST/OL94?3HYV^/&_>
M_OE+BZM[IG[GMU)L%O*C.IYSICJ/U23#-<>RZEPU9;FYJW_VM=YXU#K^2D18
M8,E@F(K E,S@D(4T@S02. VQ".+0*;SR"V]J<E.AWZ78WAH ]BQPS,3N=SCM
MXKB7&Z2!5:XUK"K[?CKAF,TPZMC06 D&B1"'&0"_2<_]0APWG_D@]#Y+53Y,
M+[TK1XH-7Y_:EICB+*28<*C_K(K81S"+F#"5[&40(<58YEHMLJ.[J<EV@_;B
MS9]G2+837W_4#2RF+6NC[/RT8\5W9<>N+L>NYFAA_I$*CC9W]5XVE$4AS4$=
MF=\LKY=\=2>?Y[N+8T0DYA1F"J4Z[I0I9#(,H'Z\LC"E2":".-9<L^AV:@K3
MH'5>);1AV'J=T#-OPZ\45H!!@QC4D(=.,.C&D^\E0INNQUXD=*#CR#*AR]U]
MR\?RHCI"6QTM-"E'J@0X.JRNYM4J+VKUW 7;';TMYU1(QF-I%A$5AS@2!-)4
MI5"%&4UQQ!E13N[/Y9"F)F!O\L6F*CLBE9+ZHZ\#J$U[7%GWH^VJ*AO6>8\V
MRWQ=5BF)5DVPE-?9C-8K()MCH_7O15[HUE9%6>6;KS,762::]SC\=@HZ[J .
M/=^W,P:TB9'JO%'[]I@!VX[\V^W(GSG*?GJ*HT?-75^<>Z[,>S&LD>OW^J+Q
M>95?;RU[.-D=7^DFA6GVPRIN3S;&VLW,3-;J6 J(LXA"AM(0ZA\G29+)F%+4
M^Y3WD0ZGIMS'S^?&8(L<?%C]$<07'&\^QOKY15[?7 XLF)8T^C@N?HS/"XZ.
M7\CKBQXCM^#SLF/D'>2X'"D_ULS+'2_O,*KSJ'G7??U\\[^L5N);OEB\SY?R
M>BWORCE.D8K3A,.,$*9=[5!"$B %PXA'(<.9_C\G5_M9#U/3WQ8@^-5 !!5&
MQ_J&SUFT\U@OXF9@/76CQ=EQ/&FZ5S_P>2^CNG4GC7SJI9V^L-]K_5D^R.5&
MOM.(WG[7+]%2>W_-$?/RU>-?Y.JFH/>W.;\J)'VVHIQ$"E$6PB20@3E)D$%&
M4@XYS=*(9XRSQ"DC\ 58IB857^1-Y4DT)IFR2#O\P!C@IAN7#).=PHQ$_L!:
MU/)MWC#0V@&VAAP9AV&7?SVPZE7F+L$SJB!Z(.ZI=/IH\K(%EJ_T>W6$5;?^
MO?U9,X'Z69:R>-#A]E)<<5YLZ**L_BM%6[DAE^6<ITSH!U]!GJH88D)B2+&,
M8)+&,<$)B@-,^RS!7 IL:O+;( 2+'<1^"S87CYC;DLZ8XS#6HH]9Y:F-FE5_
MW_[B;9LUM36MFD=NC9N!=A#?6PQB[\4A7XP/LGQT,;@766#R1>FI)2AO[;M/
M4[[+E_E:OL\?I+A>KO7CGNNO1 U&][.YVRRHR9"YEZ'@BI7K@O+U/&"9RD(I
M810I"7$0$DBX"J&(@S! <4988)4[Z3(8$Q3J%JY=9@Z?0W)^9G,<H@=6XMH(
MN#!6@)T96U$^-0;@U]88ARG0"X;#?F)TG&$9:;ITR.%QFE&]G-6.>=8+&A]M
M]O5R O;G9#VT=NFY 9.3N?RH/LMU7B_MF</<3Z<'8D&B")%4?XF$.4ZDHPL:
M" E#G"8TP5C_U*IX6[_NI_9!VM]7_JG([VCQ6!6[7BW-"J?YZ0>Y;M*VYQPT
M^UYZ'P6P&B&[&&(XW@?^/NU37D$W?]F!K])&C+5)WX6Z@3;A6T%XH4WV+O2<
MWD3OU(J'O011NW] )2Q41$(]!!'$-$XAB1,!L9 ,41IB)JWFJ[LZF9J>'5^,
MC2Y8TX[Z[POHP=&+[ 6(?*S]1Y>O]_?@ZT77^"UXNVR-/^J_KA^]^%I^Y+!^
M__3:WOMIZUVZYFAZOKR12_ZX6WF6AC&!*&214A"'$D.::L=/H21+B*!!DCH=
M".WL;6JZN+<%?0_N!2O[W5S;N7#>&!Q8-2\AK\_&T?.D^-X3VM'CV-L]SQM_
M9">GQ4T]@\O-G8F)/JHCG>3[J<U1B$66Q0D, QQK9TLED"'--5?:W0J#4$N-
M<@HK+3N>FM#\HL>Y6--\6;TNVS+LX(JO\P?]%\?(T99^RYAQ %*'CA9KR"9&
M/"I#N1PX5G2DS&^4:-OYN/&A(R7/(D/7^R_TAIJ:W>O'J^]Y.6>1C(0(4BA(
MQ"'F,H)9BA*8L0BE+*4RRIR*6ASO9FJRM/?N;'&"7PW2OG[/(:N.#D]OKL;S
M=*QIZN_A'&5A&-?FL*N7\6F.FGO2F3E^M?OTT/'RAGOG6%X]'L_R8#8-+4M]
M[4?U]OM]7A_"KF>"YQ1%1"*40A(A+2)*:&^'4P$3A%,2DD!*9G4V>BB 4Y.?
M+53S';_7OP*ZUSO[V99!!O'\C-9+#\W0OM7>:<!] _>/!()7CUT)=PX&=F=J
MLV+RP@-L/Q7WT@,]TC3>RPVXTSS@D*/1,8<X2+>CS3\.2=K^W.6@_?3U]!]T
M)ZOB\>^KXK?KY:=BQ659?I!KL^A4[Q";(R51%O!8/]5A!C&A*:1*_Q%@Q()(
M(A;'3ME,+/J<VD?8( 7Y$MS76%W]_O,<VP8!7ID;/")HT,Y RU^#>%9M#:C6
MKFO4/B,$:XH\APOG^QTY=K FXGD@87_KY=7OMA-]C>*5;S;R2NFW^A^2%N_R
M!SEG4:JC [/>0B(M0(@&4(<0"H98(BXI36*W=$I.O4]-BK[>RD)2@[!_P;OS
ME-OIT6!$#JQ,3XK?;:'/3.X/)K7CEFM_K2(9&/C X!^F!)XU;8,5PCN/X,7*
MX5F3TU44S[Z1OEDFY;U^7II]]5=+\7&M7]%Z^^+K35'H+N<I8DIPED 6RT@K
M6)I"DYL<4D1QP%F4J R[I9H\V^?4=*N!#&2-N4F59& #7B/N5<?3AGT[,?/,
MZ< 2UM+99H4S;%: M[NA&\P^TU%:$^0Y)^7Y?D=.3&E-Q//LE/:W]I,C$UH6
M\M;$BP^RGA*N/#<S+[P]/Q#&429#"3G1OA0F.(%$\1"J0*91E 0\):&+'%GT
M.34Y.H"L0Q.#>0:6=5BRIM__Y"9#-JS;R9!G+@>6H4,:FS6@']ZORO+';9"G
MD<^>95C[1"O)]WDRHP>#7G7*IM]1=<J!B*<ZY7)KG_)25=8TDS?Q-;W/UW11
M9U!KHDN3.O/=9KTIY'59;HPC]\NR3J987S9'@LH@3C)(>28@3D,$62HIC$6<
M,JR$X FS74.Z$,O4=.W#QNR&K%-5-@DHZPR3)F-E91!0JP+H1S@ [U?+&UAM
M2+VNDB6;5[@^0N"<F-+'J)Y?5!IQK(;7S2K]I#%%NVJU,6TVRL_[(U4;!%J+
M9J"UJ;EZO/%Q*=HUVCB-5N%K\/%R+ SFA>'.*F*7]3!BR3$O5!S6)_/3I*_:
MU"9<,*F&ZT[?UMF$B_TJ:FWP\"XO.5V8F8UYR),L0Y+#B$D%<<8)S"*$H8@4
M"TW>.<9=D]![@#6U[Z5^[A'X05:65!KRH_%.[VFQSGE^3[6+RGH=7/0TB'8Q
MP_A#,_#G\7C%[-:H5F-;L\"!7=N9#U";5LW@#EE,^Q*N!RZWW0O:"Q?DOH3.
M\R6[+VK]XL2!53\Z=OI[OKYM,VJ]_<X7&Y$O;\PLD/Z?R=HR%V&:HD2D4*H
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ME)*DX%G$8$P*0WP<0985!+*(BY@D,L<LM]D9O"QBG%M_^WK^Y3]('.5_:]K
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MF5/TU%DI8^./.D;A63_2;+74S7;T+.L]3N&6X(01\<:EB(3 ,0C#!1Z,(-K
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M>H-GH[BIB@A^__;.!%2#TB#B&%(]^*OB<) _TA=@B/" IL[8OO'[Q<9*P%[
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M"4DRYN)<N(D?VV?>J&5*70%>:>WF8CB";^=FA(,T,$N<Z0*WGR8+#M2?@,8
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M5QZ;LO*@$JXHY:EI&I(Q$^-+8)')&"88%7&L5*:$4QA.AZRQ?90[5:OBKU6
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M+AU.3??]@WDV5F;LNS=V-_0-QEK-?NCWXX?<Y7Z6;0; FY?_(\6#R7>7=6I
M^3A[KG8I(A8+0>-83SR"0"PC!FG$.,P+EF0LR7&>6761N4V-L?%NHR;8U[-7
M7?Z>HV+G<(7'.C!G]X&Y1\S2+2AY#DCJI<K T4:WP'4:2G33T]P=R</D]R]:
M_+*-H=_EO=^K+YIW^>R9SN^>3('K:8;SG&>$0L4B!7%&4M-,2T&:LT+&*LFB
MU"KHO;\*8Z/ D_H;SY4AX+FV9-*6W="V5*&FK36FLMG&I4EPSQ&[[KF&'X?
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M)(48%P@2J7U7K*@&%Z<)1K$+>YQ(&!ME?#<RP'*;5"\;/=V(XA1(.W:X"9[
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M!)22*HAB02'-$()QC*5>2T4T5E:;&Y;C38WP/BT7#["2Y5>UX6!N+.\J.-^
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MY8_: 3<6&W82[1COU:8F,#N^D)(SR\#6,Q. U;Z!G6_ /.F@XQWX0[L':O]
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MP[MKJ<"R]K@^0(I_HQO.[DT^&7LG%$0,T&BK1J>C.+!NJK$V&B#0('0#:HR
MON=JE&[ 43UJ=0@P4'52[2;0HBO4_$^CI=?@WOTY6H"%FM3!6H8%,] O@C5[
MX%_4VY44Y>8#Y>5<&Z<]>BPWQK@/LBNMDLN,*;/]I=_V.L9$<0XQ90@F/,ER
M@1/*XMPEQG08>VI18/5]2+]\>66\?B/7UM\ OK,?*"FOT+MQF1B[%V4@N ._
MREJD:[O!AQW2>].!MCV(^(T'8H.2O\OXH]*S!S"'!.ISB:$:4]SRS9;.3S1"
MX"0K*@D<IF*]Q)&20I;GD5Y4$X8PRJ64Q$WGRW;HJ1%<;6>G"<63:8LP3">*
ML_#;\5@84 /3V.DN%)U>$YVREE_>R?JGOP"U7(%F*EXTJ@C9F>(2FH'[4IP=
M_I6[4ER"Y7)/BHM7<!<KN"\W<VG:>HGR1RGTU?]1;K[?R7FM>_J]?+I?UI*)
M[Y9&CV:6,(50(BC,6*H@HOH/+(L(RB0A$2-%HB)N*U7@./;4&*YK*=@L06TK
M^+VVUD%YP'4.^EDN,+*!::ZRO&XCV-I^&5$G#0%/;*Y6$' ==S3] $] NNH!
MOI?P2*VH-9D7#[<+46<FUQD;GTK*JA!PQGE<($U%,(E3J5>:$8$D+2B,44;U
M7V*E"6RV66[HW"+;XM)H3IRT&S/@XV/& $]UP<=^B[=.JGIJ<KH=TA(NHFV1
MKS$DAJ%3.%I;@3:VJ3]HLJ_ SMXAX7-(]!@2QK%R/ZZ"TRT=Q!:>O@R1B]<8
M+VG$UIT7>236)WG6=YGRXZJBK-IR_+I<;U;[-BY'T>JZ';>4+WJYQB*C>F4,
M16QZN4J10L:E@@G/$Q832FGJM DXB%53BRT_[;J^SMUH9]BYLEM/CSX#P7<,
M&\AOP.E5=XA>LX.".&P!VR"6C5OM-B281Z5Q@U[\:GUNH\UE1+KNZ&;?#2XE
M!25)GD*2I 2BE.L@V)3.82E3AEF4I-QJF6XYWM3H\TB36S1& _V"=$A.MH'Z
M<@0\,("!V>_H\WMK+S &#Z&X?1)&;ZWM:^%\+97M%[ &D=?N0\9>6/OD55Y+
M4KO/I1XQ[=[3KLC<O)-/^O[XKF/LKRM3&?;8[-#E6<8X(0E4$345'U$"J5 9
M)#3*24QS7N@KN293GAEL:MQ;V0KVQH+&6L>-42N<[>+3H= +3+S^P/FE/%U
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M0H.[O=3FS#YOR>W*F#;0VY+CR(!ZY\$&RU_;6+9%]K 7=0)I9&*S&7EB#G,
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MF'"4R"#-G,+.)I1];H3=*+  =T8%($QJJJ)Y 9Y,^2A3:!O\\>V]*:8-2H.
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M-$$0*17#C.NIYRKEBH2"1<@J5OCR$'-SHSV3$E1B.G7,Z@"SFW3'@<@S9_9
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M9$S3H*())"+&$(<)Q;'F1Y;AH2VPQA79Y7N?IHK@X9"JJ 0U@86F6U83JK0
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MFR8KDIBW,\D19"4RJP&B,ES@@A+!O#8A+LN:VI3>J@I>Z.JYZ] !K>-60QC
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M$26D!4>0JY26)4URH;E/-F@D/;U(?H0$TCLK RSV"MH,1JNS'V7'&E4W*I_
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M!5;GII[LP1F+9Y]ECU%P8\5(V$:FPEY8(P0Z#$ J;(=F#_GC=FSV!^:D@_.
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MMB1WF1A&0[QPK\Q]4<[4J*HJ>&X\@/7ZN8K)?5@]+5V;L_1!VK^Q&0BHZ&?
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M$E^QENX%X[L+ZEZZZ1*='([<)_/I/_ZE_<;\A[.-^H]_^7]02P,$%     @
M@8*F5(,.0\8_!P$ .6@, !0   !P8F@M,C R,C S,S%?<')E+GAM;.R]69-;
M28XN^-Z_(J?NZZ#2]Z6MNZ]IRVK95:5DDJKKSKS0?(%+[&*0:I*AE/K7#YR,
M?>5R/(Y+=VJ10A&,<[!\#@?@#N!?_N>WD]DO7W&YFB[F__HG_F?VIU]PGA9Y
M.O_TKW_ZV\??P/WI?_[;/_W3O_Q? /_[^?LWO[Q<I-,3G*]_>;'$L,;\RQ_3
M]>=?_IYQ]8]?RG)Q\LO?%\M_3+\&@'_;_-*+Q9?OR^FGS^M?!!/BYD^7_RQ0
M2Z%2 AU4 *6$AD#?@ZBS9-DZ9YC]OS_]L_<8I-4.<L$"RN4(@:&$9%%;:8SF
M&C</G4WG__CG^D<,*_R%F)NO-O_\US]]7J^__/.OO_[QQQ]__A:7LS\OEI]^
M%8S)7\\__:>SCW^[]?D_Y.;3W'O_Z^:G%Q]=3>_Z(#V6__J___KF0_J,)P&F
M\]4ZS%-]P6KZSZO--]\L4EAO9/XH7;_<^XGZ+SC_&-1O 1<@^9^_K?*?_NV?
M?OEE*X[E8H;OL?Q2__[;^]?77OEEB:OU]!/&99CGU72>_IP6)[_63_[Z8D&X
M>!<^5;HWSUE__X+_^J?5].3+[.)[GY=8_O5/7^)GJ/IE<OOR_W'YN[]>TE'?
M1=#9\/V&OG'VB/JR(VG";VN<9]PR??ZZV2)=^]"LBGRQ//_-68@XVWQWDG$Z
MV3SY65RMER&M)TI*JS 98$5K4,DQB)( JHW.OIAHB[TA@DK_BAC8:&B%Z<^?
M%E]_I0>3I@3_+U6_A.V7&P'=>N564(?1?KXH/])G)U%*E3@G6K%$4)H61A!:
M@.?2\)0%ETD=3?K5-UZG_*J2GRW3+XMEQB59EO-7AF6ZI?#KJ#[[Q*]?PI(>
M!.GS=);/?[N:F"%TMEX,(+VM:HC</_U"7!=<+C&_V6KF7N8VG*W)WN+FDT-H
M_=E\?AIF[_'+8KF>)(&\<*4@!LPDA&+ NQ2@8'0A!T]F50ZF_:MOW@D%HG\4
M'"S-3M#P#I?317XUSR]I>YXPA=RB2Y"9<96! E$4 4D2JC&SY(P?# [77KT3
M'F3_>#A<GB,#XL7ILDKJM^DJA=G_@V%YSH-PUA4,#JR.BGPI[B!8CA"MU<BT
M4"7%X_>V>]Z^$RQ4O[ 81*J=F(J/Y%^MIE7V9^:.&Y&%80%LUAZ4<1Z<3PRD
M-S*)$I63:3C7X<;;=T*&[A<9@TAU9&2\FJ^GZ^^_36?X^^E)Q.4D9*UE%@$8
M"T0[QP!>,PXN\6B-4\BD.!H1-]^Z$Q),OT@X2HI=(. ]?II6(<S7OX<3LFUD
MPX+F'E(2AA!L,GA;X_ 2B\DY.IW#0"BX_N:=D&![1\(1TNP"#:_G:;$D4[81
M_ >2/[Y8G,[7R^\O%ADG5H145-1@0^*@ B,?F7L&AD2E&.->#K!I[$#(3EAQ
MO6-E.%EW 9V/X=OK3.*;ENDVWW5F$:T2FH68P$I%%C$:!@YC@9P"=];;7'@9
M"#3WD+ 37'SO<!E"OET Y5G.I(+5V5]OIG/DDR@\:JDE[9@;0ZD+A"S)I?;6
MRQJ,IWA\\'KOZW=+:['>$7*L8'M"QPOZ\NWRX^*/^23KXH31'(H4EBPA.=4A
M"<*[8/0/1TZ5'\HEN?7RW9#1<<9S"*'VA(O-/OEV^6ZY^#J=)YRX('GBY%(%
M+2D6C\F2J\TRE(11:1,UA5W#@N,&!;LAI.-LZ&#B[0DF[Q:K=9C]O],O&U\J
M*AF%RR20G$WUI9"",I- *ULX1>Q>L($MR+7W[P:1CA.D XEV["QIY6&)84,W
M<6J]4 9TI#^4Y Y<C@R"MT;YS*5(QX<R5]^X&PAZ3H<>*KZ1U5Z/WV?O/B_F
MYRF::%3(*@L((0A0VB/0;U@PZ BZ,C,?[=&JO_G6W=3?<<[S*#&.#($/F$Z7
M!%\NXL?I>H83S1U/0@G0PA;:UDHF+G@DJT52B!&+B,<?G-]\ZVX0Z#C9>908
M1X; QV6H%YT^?#^)B]FD&.7(>GF(0M6S/6_ "Z%KJC9%8RPW,1^M_VNOW$WY
M'><W#Q=@)XO_U;?T.<P_X28QF[E2RB9"KLH>5"D:(D<'V80HC!&2OCV8 ;CZ
MYMUPT''N\FAQ=A$F_!UGL_\UIT#X X85[6GY]6IU6C>U;$O252HA1/)KA 'G
M10 ?+'*3"T\#&(8'2=@-(-UG*X<0<!=(^8_%[)04L-P<\BU7DY*89*@YT+Z'
MH+RS$)VTP#UC*B3)N3G>>[SSU;M=N^H^2WF,0+M Q-F]D.V1?]T220FGJTFH
M?'N6@#%'(5'.%EQP!62(Y MK%[P[_J[-0Q3LAH_N<Y4#B+<+F+R>T]-('-.O
M^#*LPQE;$W*+A8B$]* $>4ZR7F]7A/D@R),NF(64?""8W$W!;C#I/F$Y@'B[
M@,G&"KX(:_RT6'Z?(&J;>0P@A9*@K&'D4@<#6B=&6V0(;H# ](X7[P:*[E.4
MAPNS"RQ\. FSV?/3U72.J]4D,58<!MH.A20HBQCKT9VG$%NS')EB7!Q_O_N.
M%^^&A8XSE<<*LPLLO#K!Y2?:_OZR7/RQ_OQB<?(ES+]/E.=9Z!2 -L%:LX#$
MALR,ML*LF AHDA[*/MQ)P&[8Z#B-.91P1\;(ZU26ST[SE#[Q;+W&U58'O\W"
MIPD3*#*9/0C%UAW0.(AHR5$R%'(E#,:[X^N9[G__;@CI.,LYD&B[,"(?/E,8
M?@[O8%-)9/G .-3UR%^#SP6!ER"EUM8H/=11^=7W[@:(CC.?1XJR"R"\.XVS
M:?IMM@CKB=$J"4WQ$_G*%'!'3G+ ( %%25IRG94YWD#<>NUN,.@X\7F<(+M
M <'WI%XU7:1_?/A,8EN]/5W7>N6:V)\DHX-U3@%M>1Q4\;6J)2>PQ)?5C@>C
MS$"P>(B.W7#2??YS,%%W4D"TNKRMC/GY]_>5$IPG_(C?UL_IP_^8B.*MD*I
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MB4H1A<@*T-"B5)*68JR37X.0)1C)=&YT$?T!HL:MDFD-OJ&T,1BPGF*4Q?-
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M1%$=6*$K?-U,A;&@K>>T^186:R,=\O)BB@4R;;TJ>B83:U.7=3]-XYZ<ML'
M_4 [1B$=0.O\_.Y=^%X/[\[SHJEV?O.%8L9ZZY(<.PN!.P<E6<,89A==FU#L
M;GJZ@=11VK[GZ/0(T7< H/-F@;387DZ_3C/.\TV.T$JCHO20DR4A57?/!>O
M.:;H!QYE:-5#\C':QMT0&P%K8)5T ++K.=-SL7T_Y\8:ZQUZ!0%5J>EW"U$2
M-X6H94:6)$6;D[*'Z1HW9=T(7 .JH@-@74VCWN(E>\;("2C 4]3D(:A,SH&6
MP)%'HT0VZ6;GHP8)[(- U2R#W0A4@ZEAY*9:M*4O3S&?7T:X+:T)N9FI:!N
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M^;YQ@LGA(7"@!#LXJ+A[ Z7P"%^3E5Q--),L.F,)N":"XI&L8ZZ-)@)WFI?
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MV5GNZVVYG+_Z^X4=N3V$]3_"['3S"\^1]K Z*W.24]'!YP),%$^[4R$M9%^
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M3"9K'40M(_FSWF)8.3'PMQ_>?__3;^_./AZSFY OWKU[^S-]2G1^Y$*[6]:
M2,+SC?-M>ER;HHE>!2>RE6%*)?FYSU\/$YW$>+8P3P<(O9[6Q>QMTD^7].GB
M2 630Y0&C$]\D=KZ,9120(B&,O,N1R?WZ.-\)6SM]-*R%JR'- 8 UPLKO(^B
M2PY-X8#3) FFM/4[U2!D),NG*[:J/L!Z@:@1W:(MA3]]F?HL20P?GK^__(/.
MW^1\?L6$W;TWWB(^?^Z3E@W0)]&[4(3^*WYI&NKBS6G9?".>W(5JDF*R25EP
M.;7)[D9!(F$!:W#16^^M[+/KY 6B=E4__'G-Z%_<?,5C+O-W;OA_[[=:_NKD
M[.+JG-Y>G;=;^SLS_SO^U'\>)9.S<]*#(G8L30@(J3W)=&SCI;99H>\S@G'9
M<ZRKY);"X$,%MZ*L#U4G;MR5!37CS>?M13\^1?L>M&12J6!E' 3='+RL"#"X
MMJ^EEN CD<U]G)8.6K)%,;_E/ZA<G=!9O6$Q/KXE&U;?W0RCHG4Q9'#MIIJL
MF1FU& YRDC?)>PY]U"OXV>Z;Q]5;<U!Q/X;LS/U#U4O;EU1>^<"]:*:>)9:7
M0&AB$MG9!#%1:CO&*R2/"I3Q1F.N$46?:?E]';C&W9_Q_)_4RM]M#?K%C:T^
M\E8('YP%DD*!B1QB\T448#.F)(W/Y:$B6LX=>Y:J<974''P\X5PM(X<!<A(_
ML!XY^T*LKTXVRU+N;N[M@6R.,F>I04J%8"R'V-C&"^505$OE5>9=%V"]2MJZ
M2:]>Z%I6(@- [.:Z_(;,K+=GGSX=7URPB&X/HZFF[$7DJU+Y!Y4\A!+XOM2*
MZ!1[#_W"R.?)6G>B5V?%M8 DQH'53Z?L@M#O^-?=_= V(EGIH I=V"ODGX7@
M!4AE73'""BWZ/ ]YEJ1UQY]WAM..$A@'2K^>GU7:7 D\^9'N3A-+;AMR"P0R
MO@V&=1"EM5!8\Z:0?<J=)OB^3->ZP\P[@VH)6:Q<9[X[2;G*32S?^(D**41G
M35MZEIE'J@#:P$&L)6,X<FUK "8D#E[\DG6GBR^-D&5Y.H#:V=AAYLX/?^7C
MBZ9 ;SAV<QS^DU_.3O/-V8B45,D0J& KJ]3"5R#$ ,Z%Y*V,29<^1FT.E>N.
M%.^EDKK):0 ,/I.V^1IJ)!^3=1)<(M,6RVH(5D4(PCF2'DE3I]>#+]*U[L3P
M7CA;4!9CF+XGBDRWAY&MCJXB@O:9^52M@&0"'TO+4-'DY&C*J^97OVC=<=\=
M3>!"O!U_0L?9Z<?V]O![2I?;/"NX_\\7?DSP+&4+Y;?;!]\59;\"1XA<C5<!
M?+'L G,L!:E*#TBH)<K@4Z=PY&EZ=FZYN\?&N\H.>1FMD!4PA<C(K0I0Z;8/
M@55@J2'SB?LTVCU%SKIY[ 5P\*BS;F>F#U].^^:(V];VG_B0?DJD8Q7_&0@Q
M:- 4C[!YCV8PL4MAV,/ 5(+PT99J^^3V^ZB2VPKR^]H^_Z=3_M2KS:#'.X@[
MYVQTTD+-[#H9WR:@":<A*;0F!I&+Z-.R\#IM0RJ9.0AY%#<M*XX!HJ6[$]V-
MCGI?']WAN_-I872D(D$*U5;?8@ 4EH YFMHZCB(M=H;;-$K7K:5U!5\'41V4
M\;OKJVF_>WGSNSN\U)W\V?U,Y8PS];6@['NE8 JVS5P"3/*&%5BN(#D$PXA)
M:G](SOBWBOKZ!0=Z;452"0I9<SU*$JN,D#&*G%-":T6W(SX@9D@;.0<##]74
MK@P?P"A^>X3->\-08\U95+""PP>#3'ST)4&5ULIBHK4Q[ $RZ[_MW5F\+\)E
M-J^'0\N]IX=L9X.WND"6[>FA$ 9B;*O:G3;"64%![D/-K/V&=RE)OPB<+=F^
M=E:Y"? W.CT^.__E[)(N;IZ86A54%:9"K,Z#894+4;3D.-6 /KJ,V;[BTCS_
MZ2.!8%NIG2W*PI5!<(]X)62\.4#![$)Q 72)XKJ!*14.)@5%S"1,QH>S1YYN
MPW_JP]</C1:%P.X,' H!ZN8 JA:=BU: N3T'#60@"5DV"W31"9V23+,1H&8@
MH%LW8&<$;,/ M0U!.OE ?YZ=_$GG]PY0V/P%D3)4S*$M;[%MO$X&+TK("D4@
MB5/LP%,?OFX#W_)F8&<&#N!)WH_\?^=_L_&1(CM".IH6@9E-;S3K,8D.G(A"
M*Q,4U3X/=Y^B9B3+L7OLL3._!\3,S3U"9977J;+-,PI,(0\Q8&8NH28B3466
MO:!FA,AC=SF_ IPMF#X =!Y[S4Y*%]@R@E>E#<_- D+Q#I0-*95L<E*=6O+&
MBE*6D._#[/U.S!X +>_.\/3V]?W-"5)+!48KH<3,_%"E53.R 5&S9PI,K2IV
M4C(/:5EY7-#R>-F1W2O[L_>I;Q6.[^P;-MEEX^R=V=L+(&H4UF@^@/2-/1G0
M5;;DFIT_$=O>I2FSRJ=\U[KQSH+PZ,+< ;3+6_[*X\L?,6]6<EV/^&.?G73@
M ![3YMVI &S+([!:J26?C[W[+MKE,2TCA<N[N[T[\GHXM-Q<I^@,AW,B@3:*
MS^!5FP:9*ZC*066.E.3#5;1=\#*"P[NKA%\$S!;L'@ RU]F!]K;]F\/<:$MV
M_(L5BB!FJYD[K#=30 D!G44J6D?79]; BV2-!*)MI'[62P0#X.D?>'[<-/%F
MYGZ[8"@<Y:PT,)T.3+*%Z0\:=+)6FN0<8A]S]9"2D3)[NQNKG?@\&$YN[E"J
MH<WT\6!#IK9T-$#(OK!\'8=\$4O1KCM21C!3N\GV!:!LP>@!H,)A0CD[_:E-
M,4YX^L_WE:F@TL[S[J?OWG^XT9/5*L6V/+3=6-@RY&U"5"W ?$LU13+*]T'/
M)/+& =0V&'B<YEM8( .@[+LV(9:/<$.]]S$G68BYHE@W)^$@:*PM"$U&&5>\
M[],P_RT=Z^9O%L;-#BP> "#?6O!W7\<3EU ":N5!ZY#:9C4/*+T$65(HTF!,
MU.]IQ1,$K3LMHF\?W'9<'PX\;_'\_$M;O?ZIS6X]LC8X[W7@:(']?&,R7X0V
M!+;X;"QEXT/L$Z&_1-5(_5!;BOU%*.T@@^'P]/=3_'1V?GG\OZG<[B'[]9P^
M'5]]>G-:-G_UXN*JS4'?#-'XA3;'S5Y*!TZZ-KK3!4#/MKKI]B*53-7UJ8/N
M2/A(A?8>J.PKR?G C=? /:6/FQ%U2U7F;U]W'/DJ72P&H=;$D4VF!"AR 6^R
MS4DI5QY.!^CP^G>D-/8RH-J:QXM-"5A*M6VB#+K8[%7\[;*!\&:[(GZD(ULU
M [ZR?+W@$",8=BQ0"(BY%%]#)!WZI">GTSA2UJF'PEI,/L,958Y6CB]^8UJP
MO#^]'PG)HT(QF\S(B-7EUD%9(:(FT"X&UL7$+D2?4993*1PI!NB!NH5DLW(W
MP+=GNG^,GX]/CS]=?3K*CDA;22 VRVJUC9!$X."[!,4,"RJ8!TFM)UL!7OVB
M=>?'+8F7Y?DZ@&+Z0)_QR^9!_;</FX^\\%4YK]O0,8ZLL9T#'4<MH;T1TLBZ
MMT\3[',4K3L7KH?B683W V"H<>-]_;;$^(%:3H^#X._.SL_/_M5*D/B9_^SR
MRQ%E141*02:^)J9H-MT"/0?%PDGC/%K5R3&?1>>Z\^&ZN.[]Y'10PPR^[NYN
M[Q;:;[;V+OX7[9=OOGMW^ZIAF>D&,[^LW[B#74[==_Z!UB5H=MHA"I+L5TG)
MOKQD7U[8PL&E+R7W,37[FW\0BDY"2PT*/;N.U;<-EL6R@C<A&UE#47D/;OVX
M\P_F8&#*_(,Y#!_ A#[Q4EN5*E4(;/6+X1/(F %5:>M/I?6ANN)SGZKS(<P_
MF"7>U^<?S.'U<&BY]Y;/M1&@1A2HSK1]IM$!\R> SLK4D Q%TT^3'L3\@UF2
MGCK_8 [;5TX,W!K^^X]VI3>83055D%W*8ARD-AB?<J&$R22?RRL.S].?/)+P
MMY76V6*L&_.],[K(H0.!TFU:)TF^#LC*%$N6KF"D&O0$V6__WGG_,P^V%?_N
M#%P; 9\V/OQ]]__V$%EZ45DI^F3Y$,*TP0W. %;EM2(57(I34/#<%XQ4!5L"
M"8LP<A T/'$*LN1KC.Q\!R/:JS<$M#F#]JY23<%[G#0$X=EO&*ERM2 >=F3E
MVH!XD CX^L)-WS;5"2D"JSOP,NJVD,E#I,V;@<"^DZI1ETE:XI7O&:G M 0X
MEF3KVA#Y2OL34,\DV]I !60U^].J<@2O&.HU)F%12V*P3]4:SWS'2+6DI?3&
M$NQ<&Q9/H-O<'$/4&%+5 0)YNGZ]Q!P)4 U[S!1B%FJ2@_G\5XQ4%UH"% LQ
M<WU,W#V1OFK4WSZ3MJ15336!W6P>#6VOGS$62A8QYV*SF;:T[+DO&*ENLPP>
M%F#DD./60D!?E$P@C6^E<L7>LLD*)+*O;(/564])/&P_;JW;SI[%4; [ ]?6
M!\^Y0>YVU(8V@?\.0=%M*:,4'#4AMEEDP7FKDGZT5&&>=^GFY*3$P0!C4;ZN
MC9%;VNT3_E"4GC*3#,)+R?Z04>T9=(+J*ZN_R%YRF)RC>.8[IF'C<!*6B_%S
M*.MQ&S<I[4VNS?(9Z_@ )"")1( 9L_8^Q8IFMO68$X/*P\E=[L[! :I>3\Z4
MP^!RCC*"]>V- C*66;%%4*'P*4P2VO8IK!_&K,9=ZJ0[\WM S-S<HQQ)1T4&
MLM."C:+&!OHV%%U&$;4-*O>9$W\PLQIGR7G:K,8Y3!\".H_'P?']04P5A'9M
MTU20@"4ER+8&BR&V;=&=8+/5]+U]3VN<)>$)T_=FL'NTZ7NW(1H*]K)E*"Q4
MJ]JC]@C!9U; *;'!;D<P88*7\MSG#SF$<1L8+,;$T8!PZVRYMD.W) N>!<MG
MB!9"+@J"\JE(C#ZH*;/EG_O\(<<M+@:$;9@X&A#DUYFB6=K 8':NN62F;6 A
M9HI'2123L6G2B/GG/G_=VFIO(&S#Q-& <)O-UR96%8G-&Z%E\V8UQ.B91P99
MV85$M)UIF%,7Z59'[0V$;9@X@%/Y&^4K_M;&E=OR;\Q.115!BUCY !0@.I$
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M#P"5:1-A,S.DU#;!F \'!K/E\["RI"")=7 HU6(7]!SHB-XY&-AJ1.\<@0R
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MQ7T.[X?#T(L572>T,<D;J*;M)U%\V5*R%8K*4JO4"F[]4MB'7'%?#F>+R6<
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MZT]+DLKM/Z\S"WY?GO\WGM^,OYLIM,E%7H?6R[H-3=4+]H*0E;4FISIFO,V
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M$?AO=TGQHO)GH01*,5" CV&S,C- *-$#HF/26I3\9B+LB9R]>XK@1(/CCCQ
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M]64P/E/&6YXIL\NFKC4.(8!G%J$XYXQ6F9M&EU /:>D^5CQ"]X\-;C]<$1U
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MI=6WX_%+UB^(^_??<#L*]O"7*@=\I%EB?A"7(V3N4E@,@J!K/5K"KZYE&^/
ML.P0%7<YM#F5FE<):^W[+9GQ8]*^E_WA^I?O]&5R(?,%V>*F:/\[G0!U+,[R
M[.QRH =6/5_++7#)<F9U"".CR$50Y!*,-Z"#=T*5G*QI,X9P!.;ZK0#L@];'
M:Y;]H**#V.  D5P52F9H=3%T]@#/C(XC*P0$)QE0^&Z%<NBU;UGR.XCH'H#=
M$0"/-Y"#T'":P-^6!6=9,L:E5X!1;79#>/".$@'#HRPZ"R,;];X?3G,/Q;%7
M!?M#L'":J-]5$S-3ZKV>BI!BX*"\Y1"=%L!2$C9E="&W>8;4D*D>:G6ORFZ:
MH.EPPUJ>A[-Q<]V;,OZR?%@M_YJOZ2,DI-M'ZA#I[A[?:9;Q'LKK"$DO9SY8
MGPLH;17Y;<' $2Y BH*F+KK/I<VSH89)[\\7J^I5GK@<>LP\;V;\92VY* 8X
M&5=]YV#!9V$AY5*;UYE'W\9W'TYS#Y'\\=BZ[U)'TF$'H<B6T[=(B@IG#UB=
M.:Z0958J_21*E>O%9:+(*F3#O @^I*:0?(JP:7$W%CX>A^4@RNH'>YL)!/5V
MDO["(TP5[84O.8/'.F$T)@51;U;KNA*E3*;8-H71G<B;-J6;%H<#*JX?-%YW
M'=UGA\1E3&:UW:B.8D]%@?=U#9AP3B?OBXIMGNN]0-BTR='$GG (976 O:MF
MC4/$F#S#S'V&$BNKDCQ_=!A!>NM$XI8<?YOV\B.([J$0-GS4.)86.P+L-A1Y
M@N-9MH%AH@@D;*3IBP0O=+V/]Y:'$$6K5H;=Z)LVB!P-+D_ =$#==83(.T')
M4[PYX; $)D'(1(="?7SA!(E/H^"8#5J;VTP\W(?*:9WDU.@<7(\=870;MCS%
M%2I)EE?KK2K$^F['U\8V!Y:GX)5 F4O;$_UY^J8-.*?&Y8"ZZP"13[&A HG)
M.@:: G'BQ4IP'C5D[1,7LIX&;9*=+C'7*F <0OJG>NMRJS_]IW 6%JG!C<LS
MWQCEMF57'D>X:<E1U19_2H@SUZ"LM^ R2OI7A=QZR9,\N9N6!T\<_KZJS^RO
MO;T(Z$/1$&(A*])DHU%3F!"<C%ISQUEI\WSJ>;KZO3'9!R-/'8\#Z&+"8[&N
MA7G 2176]O>V?OHCZ6SU%]8G-6]26EV$L_6;L[/EOZJ%4WSPM^5%/"\79_1G
MRXO%YN7-'^$,UQ_Q_&*U6,\$5RKRK,#+&H8@\Q!]#F!0JXB*^>C4"PYO%$+[
M2(^'0-2R5_7VAO5WB[](-<O5CX\4Q'Z;4X0P_]^-QF?"9T?13%TXAPXHN+40
M$J-0NN18$E>8G#T$M$]^L8_TMS7ZAA%XQS"Z-*59HK-#Z;K(UA)+*BL!@3,+
MD:?,*!T+[O[MR=[PN?Q2']GIB+ Y0, =))X/.-JFZXO/EV/%5JL?9;FJ.RC7
M,ZM*+"XIPG_QH%ABY%!#HE^A]\:K&$V;#O<]B)SV?68#V+565(\8W-0<-UG<
M+'M3BA?D?7TP-1;.E-:'3'[8>1N#J(M-Q\'<#5'3OKL<$V,'*J)'3.T67M;_
MQ=OO\V?)H2>S4>!D'567&?ES)1T$C<DP*Y-NM*-D* YV0JMY#6@=0\6G >V?
M;Z^77ES-1%S_\O7;V?('WOGCF8Y1V43X<XAT6%#*!(Z% &BDIZ,C%J':5*2&
MY6,GF-O7"?-6ZCYIL#^^!O[GY;KN<$<4)6L0HM;UBQ7@ B_@92G1%A^BZPWR
M3W.S$_#=OQ7P!U)]I_#_F?Y]?GXGXK]Z?V>R=-+F!(QMMF/;"!'K'$OOF4;E
M<RYMNL3WHW,GR/I7 MF!U-5;:>E7)/NZ'47QR(LP-@$E"A&441(\4OH98S**
M.2.,O]?+LUMEZ?Z'=JN&LQ-"S_#R[=%S_;E88:VJDE/>- VG'[5P08P%55BV
MY))EB+GV:Q!C63O(#%5BB6@3;9O 7B1Q-\B=T@U,6RWU"+_-V/B9T(9%DSR%
MNUS0\1\XA*PY8+#*9:&+\2.5DS;T[ :L4[I<&5#^/:)H(Z"9BCXSXR7P("B'
MDDA!I*S#/8P4J$76@8^$H@T]NZ'HE.Y:!I3_8'U9@Z#HUH%^+: 8*-[S0M51
M&77!KRX0O/:@97)U!RNR1BU!S]/5[]N0@?ICCM5%7_[I%C<?5LMON#K_47>@
MG%-:7'=;?:L+_6;9V."LR9",=:"B-!"33B"<1VYLU,XU;\7:A=!N.EZ.QLA.
M\!M&8?OCT5_B<8&?-VMS&\/R[\ME_M?\[(P8?$?:7'R>QS.\ND:_^^\4;0IE
MBZ=#0R0.BG$%,6@%R;DZG\6[X-H^6#J8]&[:9<:!;BNE3@_F>UGY+9[???U&
MPER6-WGYK5[ _X[_VO:@U852J^6"?IEP8[]19K)7K<'H*"GX"19B41FXB(G'
M@*;<WSGT4E'D(#JZ:<89"I2C*Z=;//[X./_\Y?Q]^7-]:68S8;V(-3VG,$C4
MVTQ)P3$/8"6G:%L$:\M+;?P[?JJ;7IO&J#I*Q,<"I\V[]MN%Q9!<L2IFT!@I
MFPK,42(5%(B0K0W*<VO;MG4]1E4W/3:MCM&C57&T1VJ<W\Z$\J5H(2&1EP55
M'&5HD2G0AH+7R)B6:LP8KM^G:\/GLWO)?F@@C?" [?>PJKV/?^$@3]4>_+1F
MC]*>IWN$YV<ND>IEC;E+'4N<'(7@2B%P+B.WK@B/+:>T-WE^]LB>B!^76^@#
MQB )\B#J<@B%(@&E&*+VNG#O@TFY-.;V/DG]/CK;!QE/OI\]2@,=U-.N&7ES
M<?YEN:+0[\WW^7JF=>*F1 W<UW@OI% W%6<2E:*$EJ>48N-MCG?HZ01$QRG[
M*0@=+ODN\?.WY=<P7\P065$LT7F,)=?SV$.05H*-R?BH6;+8)A9ZBJ).,'2$
MME\$T &B[P!"V]Z@GVO%8O7C-_P:<363CE/,ECAH52<<8*J/BK0%9H10)6GM
M&LT6>XR:WJ!SB)Z7 PN] ^ \YI<I8L7-6/%9Y$8QZ0K8HNH\%&[ &4HO;= A
M%^M#$F:T4.B:K$[N&-N<9$?KH0-0/:A67);R?\<:,)HH,&LP]"NR-QW!)>T@
MEJ"Y*"F1V8Q3-KJFJ1//=+SB7ZH9'::%CO!TS<-_A;.+2PU=O>R?L7KI:1W6
M^A>Q9&0$CTE#9@6C#UBL]DV!]0QQ_3FL81$VE%XF[E;^97T^_UIK4Q\Q7Z3*
MQKO%G\3#ZIPB!>+Q>OT"V=#W<RY^(WE^6<\<R4D;$T%$JT%%RH$IZRV0E?7*
M&)^,V>5Q_&%?[Z0^.1BT1M+#*6WVO+M&=WFS;/?3Y9K=0:J9NWZD69'S("Y'
MJ'VRS%%P+4![ENI26@$.I:F8UL5A,>+^ X43JGW>%?H3 ^W>7*TLJ.^Z+^K8
MBIN_3XJ999VL4()""),Y*&L\N$QAA49AD8L8@VD\G&P(-CJ) H]$X)-IQ>B:
M[B!L?(+Y^S- -]YE3NZF*FH>SF9<N6!C5)!L4!0=RPQ.D=0U]T)%BH]93&,"
M^B6".PDOQX'NH-J;.."\P\1=-A\?H%QWOZ6SBTRAUN7Y^+[\_"50W/5N<7U>
M7DW?V%BL0.<MH@*&D5'T7;=XY,1!E!A2,LD$&7:(39L3VDD8.Q"$^]-MO][X
M^JWKNH[=( J_S$RQP:G@ 26G8R90RAB95H BV]I#Y72C72T[DSAM#]O('O=(
M#?71 _D$;[\O:_I0D\QXAH^,!_AU_G5^J=CU3%,N*Y5WA!HK0"E3P"4F(=,1
MPWU RF_-7K[T4$JF[7)KZRQ'T4Z_WO#*X^]26=,!#5I!X;>KL\L9!A*V+Q2-
MIURL4[FP-J7TXVF?=KK4R/ZSE4ZGKI9>!27/1#IWJG;+]7PS2\BC<12=,/">
MUSV'$LE250++H@TE2AMWJY<>^/UI1SZU\)ZC:*)?G[EY(_XF_\_%^KP^T%C/
MC,N) I$ P1DZ"NA8@"A, !W1*)[(M$3+)>HO$CCM[*61O=]1VNDE/[];)J/?
MOLS3J@0O-]9@OEE8,PN>Q4!A+# I+"CKZNVJ*,"E+(R%&%G>Q<$=]O5IIR0U
M#0[;::&#Y_Z[./&7ZK.\SDF@2!>*M@94- Y\DAYR<$)E::5MU*<] /$3#VAJ
MY17'5FL'Q_0N++]8Q8U9,XIV,WBGZ_R/J"$8RNZ2C<QJ)HP783(H#U*0;S?Y
M:4HL#ZK8$\AP!JKE>AZ%JVVBUIHZI@VQ]BZ0Q6?&:U" =(@-E!.-6+!O-X-J
MJC1J G6?B$=_I$I<2BY.I0R\1%/3R[JPL6C(3ID2K.6&M;E'/8S>B0=B3>FU
MCU1>'R7^71C=IZ+L/>=**4=666KG8N80K(^@N7%2.U4>P/=@GSQT\9^?S-W3
MU(H[$>^Z3PT9I5-DH I2K-M;M$_@LE$0!$:M,_-<MYDS.# CNR']9.ZY>E#W
M"034CQ6J/^ J5=U_KKEPTC%EI%Q8(RAO,J4/E@%R&TT6*4M5!G+*SU.R&SI/
MY@YK O6<B.M]4,#.04LKF0#!0P$5Z1^>L5@7O]31[(0SVZ8C^!!J=X/IR5QW
MC::X+CWE2R5O3Y%YMK:N+=4U9B?9>JXT&%6'<#OZI3@\8AWBWH&?S*W6.$HX
MI?7OMSW_]8RS-U4^]37U$&]0=OI"LP<H^_,WPNN3XBWCPG/0@=>98=R!,Z6.
M.L!2HDPIF#9E\(:O3^YYZ5*7!Z3EYT5='T ?O-Y#=552>_-ULZCYPZ5VZ#<^
M+7_Y'K[.%YO_?+NW^>/R[.SMY:*461$:-2H.Z.N30TQUY%H60+\OC=2:6=ZF
M[M2:LW[?J.R#T_MG>5=XZ" H?8+_&?%@.6<,%/-U[P\BY7C: S<\4<9'!UFC
MI_-/$#0M&OM"S7)X%1Z,1 I%YLO\QWE8G;?$([F#5=TV5$O&%V?U]>];4M+E
M_I?S#QL:;N6(ZYGF1N68*=SVN3[/%1F\49[ YKSFJ)F+;9X)#D/_M(^L3A'M
M+0'2KYN^?K-^E^U?P[<UOB]OOGT[FZ<Z+>:RUX-^ZW;E.@9FC38:BL4Z(MC3
M,:J3!"-S5$E&Z76;M<$-F)GV2=<I&LQHT)G^ONX@U_$'GI^?;8:PK_\Q/_]"
M_WU5W':@5YU?RY@5=4@MQ++I+4$/ 8L#&SFWDC,5&U7F!F5CVL=EIV@X(\"E
MWP-GAHEI+^FTQ")(H,XQB-$;$$XJI8((V&CRT3%Y0;-KNU/$[UXJ/#(O^&61
M1Z@;7BT1)_G-5QL;K%N*#JD//O63AJT#[D3O0/6^F_+)^W*[A>$CGM7#M2Z<
MOMQ%'>LNZ@_AQ\:%W:P1<-H[8>I4=AWHH"? .%\*&"L\3]XI%AH-R#^*[F.]
MWP?ZW'RSKWMSKT-IP_GJ6EE7AG1#XB=2UD_T]_\Y4U88KK*IP^T0E&((/H=
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MANOM"#Q$2UUB[2H>35Y8%71M ,C$!V?@K)&0R)W73FGC#1\);1V>>0=I^T4
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MO\T591\(&C -'GE4TI5<_L#57_.$FVDI@T]->NXCHPQ0VIG+/F8I*1NE18?
MHDV@6,K@*<@&Y$*GD!U3H=&51&>SE'[^$A:?*65Y</;=WO'#E"HF"@^">TI
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M928B.,8%Z.QE3BD5$UM-!GV*IFF?V(QQ(W28^'L$T@=<U=\(GY'/4HYU-58
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M1]]/UUE3QMKBR*<#'V0 );2"R 4QDV)40;DD7*.1FH]0-'$E;^.+M<,$WP.
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M<V$N:'1M4$L! A0#%     @ @8*F5"XG7^#,!   2Q\  !X
M ( !,Q8  &5X:&EB:70S,C%C97)T:69I8V%T:6]N;V9E+FAT;5!+ 0(4 Q0
M   ( (&"IE0J'&;8JP0  +\>   >              "  3L;  !E>&AI8FET
M,S(R8V5R=&EF:6-A=&EO;F]F8RYH=&U02P$"% ,4    " "!@J94N38LOO$V
M! "=4C  $               @ $B(   <&)H+3(P,C(P,S,Q+FAT;5!+ 0(4
M Q0    ( (&"IE0>0(!\YAT  /9L 0 0              "  4%7! !P8F@M
M,C R,C S,S$N>'-D4$L! A0#%     @ @8*F5#M'#Y==/   ^H," !0
M         ( !574$ '!B:"TR,#(R,#,S,5]C86PN>&UL4$L! A0#%     @
M@8*F5&N>:[\VI0  F&<' !0              ( !Y+$$ '!B:"TR,#(R,#,S
M,5]D968N>&UL4$L! A0#%     @ @8*F5$LW9-;ER0  60(! !,
M     ( !3%<% '!B:"TR,#(R,#,S,5]G,2YJ<&=02P$"% ,4    " "!@J94
M)O,M\CZH 0"E@0( $P              @ %B(08 <&)H+3(P,C(P,S,Q7V<R
M+FIP9U!+ 0(4 Q0    ( (&"IE3^!,8/)*$! +2!$0 4              "
M =')!P!P8F@M,C R,C S,S%?;&%B+GAM;%!+ 0(4 Q0    ( (&"IE2##D/&
M/P<! #EH#  4              "  2=K"0!P8F@M,C R,C S,S%?<')E+GAM
M;%!+ 0(4 Q0    ( (&"IE1$AUC %0,  *8(   2              "  9AR
J"@!P8FAC;VYS96YT9GDR,BYH=&U02P4&      X #@#" P  W74*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
